url,title,articlePdf,USApolicyCitation,policyList,policyTitles,successful_policyList,successful_policyTitles,total_successful_policy,successfulPolicyPercentage,final_policy_urls,final_policy_pdfs,tfidf_sim,bert_base_uncased_sim,bert_large_uncased_sim,all_distilroberta_v1_sim,all_mpnet_base_v2_sim,all_MiniLM_L6_v2_sim,sentence_t5_base_sim,sentence_t5_xl_sim,political_bert_sim,specter_sim,clinical_bert_sim,legal_bert_sim,scibert_sim,biobert_large_cased_v11_squad_sim,biobert_large_cased_sim,biobert_v11_sim,biobert_base_cased_v12_sim,biobert_base_cased_v11_sim,mean_tfidf_sim,mean_bert_base_uncased_sim,mean_bert_large_uncased_sim,mean_all_distilroberta_v1_sim,mean_all_mpnet_base_v2_sim,mean_all_MiniLM_L6_v2_sim,mean_sentence_t5_base_sim,mean_sentence_t5_xl_sim,mean_political_bert_sim,mean_specter_sim,mean_clinical_bert_sim,mean_legal_bert_sim,mean_scibert_sim,mean_biobert_large_cased_v11_squad_sim,mean_biobert_large_cased_sim,mean_biobert_v11_sim,mean_biobert_base_cased_v12_sim,mean_biobert_base_cased_v11_sim
https://doi.org/10.1001/archderm.138.12.1584,acne vulgaris,3_acne vulgaris.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333507/pdf'],"['Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333507/pdf'],['3_0_approaches to limit systemic antibiotic use in acne systemic alternatives emerging topical therapies dietary modification and laser and lightbased treatments.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333507/pdf'],['3_0_approaches to limit systemic antibiotic use in acne systemic alternatives emerging topical therapies dietary modification and laser and lightbased treatments.pdf'],[0.384],[0.48],[0.6],[0.151],[0.162],[0.135],[0.743],[0.645],[0.579],[0.649],[0.782],[0.659],[0.58],[0.913],[0.791],[0.723],[0.772],[0.763],0.384,0.48,0.6,0.151,0.162,0.135,0.743,0.645,0.579,0.649,0.782,0.659,0.58,0.913,0.791,0.723,0.772,0.763
https://doi.org/10.1001/archderm.139.3.318,the frequency of common skin conditions in preschoolaged children in australia,5_the frequency of common skin conditions in preschoolaged children in australia.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397947/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483543/pdf']","['Topical antifungals for seborrhoeic dermatitis', 'Interventions for infantile seborrhoeic dermatitis (including cradle cap)', 'Topical anti‐inflammatory agents for seborrhoeic dermatitis of the face or scalp']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397947/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483543/pdf']","['5_1_interventions for infantile seborrhoeic dermatitis including cradle cap.pdf', '5_0_topical antifungals for seborrhoeic dermatitis.pdf', '5_2_topical anti‐inflammatory agents for seborrhoeic dermatitis of the face or scalp.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397947/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483543/pdf']","['5_1_interventions for infantile seborrhoeic dermatitis including cradle cap.pdf', '5_0_topical antifungals for seborrhoeic dermatitis.pdf', '5_2_topical anti‐inflammatory agents for seborrhoeic dermatitis of the face or scalp.pdf']","[0.172, 0.307, 0.2]","[0.515, 0.495, 0.502]","[0.597, 0.574, 0.585]","[0.152, 0.135, 0.143]","[0.168, 0.141, 0.15]","[0.138, 0.119, 0.128]","[0.728, 0.732, 0.732]","[0.631, 0.637, 0.636]","[0.577, 0.554, 0.563]","[0.673, 0.669, 0.667]","[0.776, 0.765, 0.766]","[0.694, 0.677, 0.677]","[0.599, 0.574, 0.589]","[0.911, 0.892, 0.899]","[0.8, 0.777, 0.786]","[0.737, 0.72, 0.718]","[0.773, 0.756, 0.757]","[0.758, 0.737, 0.741]",0.226,0.504,0.585,0.143,0.153,0.128,0.731,0.635,0.565,0.67,0.769,0.683,0.587,0.901,0.788,0.725,0.762,0.745
https://doi.org/10.1001/archgenpsychiatry.2009.173,brief personalitytargeted coping skills interventions and survival as a non–drug user over a 2year period during adolescence,16_brief personalitytargeted coping skills interventions and survival as a non–drug user over a 2year period during adolescence.pdf,1,['https://purl.fdlp.gov/GPO/gpo75951'],"['Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.']",['https://purl.fdlp.gov/GPO/gpo75951'],['16_0_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo75951'],['16_0_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf'],[0.508],[0.498],[0.593],[0.163],[0.185],[0.157],[0.735],[0.642],[0.557],[0.687],[0.776],[0.685],[0.599],[0.913],[0.789],[0.733],[0.767],[0.755],0.508,0.498,0.593,0.163,0.185,0.157,0.735,0.642,0.557,0.687,0.776,0.685,0.599,0.913,0.789,0.733,0.767,0.755
https://doi.org/10.1001/archgenpsychiatry.2009.186,childhood adversities and adult psychiatric disorders in the national comorbidity survey replication i,17_childhood adversities and adult psychiatric disorders in the national comorbidity survey replication i.pdf,6,"['https://www.aclu.org/legal-document/rilr-v-johnson-amended-motion-preliminary-injunction', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2820%2930280-X', 'https://www.hhs.texas.gov/sites/default/files/documents/services/mental-health-substance-use/mommies-toolkit-neonatal-abstinence-syndrome.pdf', 'https://hhs.texas.gov/sites/default/files/documents/services/mental-health-substance-use/mommies-toolkit-neonatal-abstinence-syndrome.pdf', 'https://www.congress.gov/event/116th-congress/house-event/109762', 'http://purl.fdlp.gov/GPO/gpo63620']","['RILR v. Johnson - Amended Motion for Preliminary Injunction', 'Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders', 'The Mommies Toolkit: Improving Outcomes for Families Impacted by Neonatal Abstinence Syndrome', 'The Mommies Toolkit: Improving Outcomes for Families Impacted by Neonatal Abstinence Syndrome', 'Identifying, Preventing, and Treating Childhood Trauma: A Pervasive Public Health Issue that Needs Greater Federal Attention', 'Trauma-Informed care in behavioral health services :\xa0a treatment improvement protocol.']","['https://hhs.texas.gov/sites/default/files/documents/services/mental-health-substance-use/mommies-toolkit-neonatal-abstinence-syndrome.pdf', 'http://purl.fdlp.gov/GPO/gpo63620', 'https://www.hhs.texas.gov/sites/default/files/documents/services/mental-health-substance-use/mommies-toolkit-neonatal-abstinence-syndrome.pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2820%2930280-X']","['17_3_the mommies toolkit improving outcomes for families impacted by neonatal abstinence syndrome.pdf', '17_5_traumainformed care in behavioral health services \xa0a treatment improvement protocol.pdf', '17_2_the mommies toolkit improving outcomes for families impacted by neonatal abstinence syndrome.pdf', '17_1_clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.pdf']",4,66.67,"['https://hhs.texas.gov/sites/default/files/documents/services/mental-health-substance-use/mommies-toolkit-neonatal-abstinence-syndrome.pdf', 'http://purl.fdlp.gov/GPO/gpo63620', 'https://www.hhs.texas.gov/sites/default/files/documents/services/mental-health-substance-use/mommies-toolkit-neonatal-abstinence-syndrome.pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2820%2930280-X']","['17_3_the mommies toolkit improving outcomes for families impacted by neonatal abstinence syndrome.pdf', '17_5_traumainformed care in behavioral health services \xa0a treatment improvement protocol.pdf', '17_2_the mommies toolkit improving outcomes for families impacted by neonatal abstinence syndrome.pdf', '17_1_clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.pdf']","[0.305, 0.141, 0.141, 0.239]","[0.465, 0.482, 0.465, 0.486]","[0.56, 0.582, 0.56, 0.585]","[0.092, 0.123, 0.092, 0.145]","[0.106, 0.142, 0.106, 0.157]","[0.09, 0.119, 0.09, 0.13]","[0.717, 0.728, 0.717, 0.732]","[0.614, 0.629, 0.614, 0.635]","[0.53, 0.537, 0.53, 0.549]","[0.666, 0.684, 0.666, 0.689]","[0.747, 0.757, 0.747, 0.762]","[0.668, 0.694, 0.668, 0.693]","[0.599, 0.608, 0.599, 0.602]","[0.9, 0.906, 0.9, 0.908]","[0.791, 0.796, 0.791, 0.792]","[0.708, 0.726, 0.708, 0.723]","[0.745, 0.758, 0.745, 0.761]","[0.736, 0.746, 0.736, 0.749]",0.206,0.475,0.572,0.113,0.128,0.107,0.724,0.623,0.537,0.676,0.753,0.681,0.602,0.903,0.792,0.716,0.752,0.742
https://doi.org/10.1001/archgenpsychiatry.2010.168,antidepressant monotherapy vs sequential pharmacotherapy and mindfulnessbased cognitive therapy or placebo for relapse prophylaxis in recurrent depression,20_antidepressant monotherapy vs sequential pharmacotherapy and mindfulnessbased cognitive therapy or placebo for relapse prophylaxis in recurrent depression.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204633/pdf', 'https://www.rand.org/pubs/research_reports/RR1138.html']","['Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults', 'Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder - Section 2. Psychological Treatments', 'Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents', 'Citalopram versus other anti-depressive agents for depression', 'Meditation for Major Depressive Disorder']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf']","['20_1_canadian network for mood and anxiety treatments canmat 2016 clinical guidelines for the management of adults with major depressive disorder  section 2 psychological treatments.pdf', '20_0_approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults.pdf', '20_3_citalopram versus other antidepressive agents for depression.pdf', '20_2_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf']","['20_1_canadian network for mood and anxiety treatments canmat 2016 clinical guidelines for the management of adults with major depressive disorder  section 2 psychological treatments.pdf', '20_0_approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults.pdf', '20_3_citalopram versus other antidepressive agents for depression.pdf', '20_2_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf']","[0.53, 0.488, 0.478, 0.25]","[0.537, 0.525, 0.514, 0.53]","[0.616, 0.606, 0.599, 0.611]","[0.195, 0.185, 0.165, 0.186]","[0.218, 0.196, 0.18, 0.203]","[0.174, 0.164, 0.142, 0.165]","[0.743, 0.738, 0.735, 0.739]","[0.656, 0.648, 0.648, 0.649]","[0.604, 0.589, 0.589, 0.594]","[0.714, 0.707, 0.704, 0.706]","[0.811, 0.788, 0.786, 0.79]","[0.734, 0.711, 0.714, 0.713]","[0.598, 0.591, 0.55, 0.591]","[0.928, 0.92, 0.91, 0.918]","[0.83, 0.814, 0.805, 0.82]","[0.763, 0.734, 0.738, 0.742]","[0.807, 0.782, 0.778, 0.786]","[0.793, 0.768, 0.769, 0.772]",0.436,0.526,0.608,0.183,0.199,0.161,0.739,0.65,0.594,0.708,0.794,0.718,0.583,0.919,0.817,0.744,0.788,0.776
https://doi.org/10.1001/archgenpsychiatry.2010.6,association between cannabis use and psychosisrelated outcomes using sibling pair analysis in a cohort of young adults,21_association between cannabis use and psychosisrelated outcomes using sibling pair analysis in a cohort of young adults.pdf,6,"['https://www.rand.org/pubs/working_papers/WR769.html', 'https://purl.fdlp.gov/GPO/gpo129289', 'https://www.federalregister.gov/documents/2011/07/08/2011-16994/denial-of-petition-to-initiate-proceedings-to-reschedule-marijuana', 'https://www.congress.gov/event/116th-congress/senate-event/LC64544/text?s=1&r=16383', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf']","['Examining the Impact of Marijuana Legalization on Harms Associated with Marijuana Use', 'Challenges for cannabis and banking :\xa0outside perspectives : hearing before the Committee on Banking, Housing, and Urban Affairs, United States Senate, One Hundred Sixteenth Congress, first session, on examining challenges that state-sanctioned businesses in the cannabis industry have when attempting to access mainstream financial services, July 23, 2019.', 'Denial of Petition To Initiate Proceedings To Reschedule Marijuana', 'S.Hrg. 116-82 — CHALLENGES FOR CANNABIS AND BANKING: OUTSIDE PERSPECTIVES', 'Assessment Of The Potential Impact Of Regulated Marijuana In New York State', 'Executive Summary']","['https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf']","['21_4_assessment of the potential impact of regulated marijuana in new york state.pdf', '21_5_executive summary.pdf']",2,33.33,"['https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf']","['21_4_assessment of the potential impact of regulated marijuana in new york state.pdf', '21_5_executive summary.pdf']","[0.318, 0.19]","[0.514, 0.51]","[0.604, 0.601]","[0.156, 0.15]","[0.166, 0.167]","[0.145, 0.147]","[0.728, 0.726]","[0.634, 0.633]","[0.584, 0.586]","[0.666, 0.658]","[0.788, 0.796]","[0.722, 0.733]","[0.611, 0.613]","[0.913, 0.917]","[0.813, 0.819]","[0.746, 0.753]","[0.782, 0.787]","[0.765, 0.772]",0.254,0.512,0.603,0.153,0.167,0.146,0.727,0.633,0.585,0.662,0.792,0.728,0.612,0.915,0.816,0.75,0.784,0.768
https://doi.org/10.1001/archinte.161.19.2357,reducing infections among women undergoing cesarean section in colombia by means of continuous quality improvement methods,34_reducing infections among women undergoing cesarean section in colombia by means of continuous quality improvement methods.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078551/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464541/pdf', 'https://wtgrantfoundation.org/studying-the-use-of-research-evidence-a-review-of-methods', 'http://wtgrantfoundation.org/studying-the-use-of-research-evidence-a-review-of-methods']","['Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section', 'Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section', 'Interventions to improve antibiotic prescribing practices for hospital inpatients', 'Studying the Use of Research Evidence: A Review of Methods', 'Studying the Use of Research Evidence: A Review of Methods']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078551/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464541/pdf']","['34_1_antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.pdf', '34_0_antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.pdf', '34_2_interventions to improve antibiotic prescribing practices for hospital inpatients.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078551/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464541/pdf']","['34_1_antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.pdf', '34_0_antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.pdf', '34_2_interventions to improve antibiotic prescribing practices for hospital inpatients.pdf']","[0.295, 0.344, 0.295]","[0.517, 0.523, 0.545]","[0.598, 0.606, 0.619]","[0.159, 0.14, 0.164]","[0.156, 0.154, 0.166]","[0.129, 0.123, 0.137]","[0.73, 0.722, 0.73]","[0.635, 0.629, 0.635]","[0.59, 0.604, 0.613]","[0.668, 0.671, 0.675]","[0.788, 0.786, 0.795]","[0.694, 0.72, 0.718]","[0.581, 0.574, 0.607]","[0.918, 0.919, 0.92]","[0.815, 0.828, 0.83]","[0.738, 0.743, 0.753]","[0.783, 0.79, 0.795]","[0.767, 0.77, 0.782]",0.311,0.528,0.608,0.154,0.159,0.13,0.727,0.633,0.602,0.671,0.79,0.711,0.587,0.919,0.824,0.745,0.789,0.773
https://doi.org/10.1001/archinte.162.8.893,predictors of sleepdisordered breathing in communitydwelling adultssubtitlethe sleep heart health studysubtitle,36_predictors of sleepdisordered breathing in communitydwelling adultssubtitlethe sleep heart health studysubtitle.pdf,8,"['https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=24', 'https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/obstructive-sleep-apnea-in-adults-screening', 'https://stacks.cdc.gov/view/cdc/26105', 'https://www.cms.gov/medicare-coverage-database/details/nca-details.aspx?NCAId=227&type=Closed', 'https://bopc.ca.gov/wp-content/uploads/sites/41/2018/08/NASATM_2018_219934-2_corrected.pdf', 'https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=48', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137251/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021364/pdf']","['Effectiveness of Portable Monitoring Devices for Diagnosing Obstructive Sleep Apnea: Update of a Systematic Review', 'Final Update Summary: Obstructive Sleep Apnea in Adults: Screening Task Force', 'PCD collection : veterans health', 'National Coverage Analysis (NCA) for Sleep Testing for Obstructive Sleep Apnea (OSA) (CAG-00405N)', 'San Francisco Bar Pilot Fatigue Study (NASA/TM-2018-219934)', 'Home diagnosis of Obstructive Sleep Apnea-Hypopnea Syndrome', 'Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea', 'Interactions Between Obesity and Obstructive Sleep Apnea - Implications for Treatment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021364/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137251/pdf', 'https://bopc.ca.gov/wp-content/uploads/sites/41/2018/08/NASATM_2018_219934-2_corrected.pdf']","['36_7_interactions between obesity and obstructive sleep apnea  implications for treatment.pdf', '36_6_educational supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.pdf', '36_4_san francisco bar pilot fatigue study nasatm2018219934.pdf']",3,37.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021364/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137251/pdf', 'https://bopc.ca.gov/wp-content/uploads/sites/41/2018/08/NASATM_2018_219934-2_corrected.pdf']","['36_7_interactions between obesity and obstructive sleep apnea  implications for treatment.pdf', '36_6_educational supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.pdf', '36_4_san francisco bar pilot fatigue study nasatm2018219934.pdf']","[0.172, 0.224, 0.348]","[0.504, 0.515, 0.503]","[0.597, 0.598, 0.59]","[0.142, 0.153, 0.111]","[0.173, 0.166, 0.122]","[0.128, 0.134, 0.106]","[0.734, 0.73, 0.723]","[0.64, 0.633, 0.625]","[0.579, 0.576, 0.571]","[0.69, 0.703, 0.684]","[0.78, 0.769, 0.771]","[0.699, 0.685, 0.7]","[0.609, 0.594, 0.623]","[0.897, 0.895, 0.899]","[0.788, 0.794, 0.8]","[0.728, 0.712, 0.726]","[0.772, 0.764, 0.769]","[0.755, 0.741, 0.748]",0.248,0.507,0.595,0.135,0.154,0.123,0.729,0.633,0.575,0.692,0.773,0.695,0.609,0.897,0.794,0.722,0.768,0.748
https://doi.org/10.1001/archinte.164.22.2483,clinical usefulness of ddimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism,43_clinical usefulness of ddimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457638/pdf'],['D‐dimer test for excluding the diagnosis of pulmonary embolism'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457638/pdf'],['43_0_d‐dimer test for excluding the diagnosis of pulmonary embolism.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457638/pdf'],['43_0_d‐dimer test for excluding the diagnosis of pulmonary embolism.pdf'],[0.593],[0.549],[0.631],[0.212],[0.222],[0.188],[0.747],[0.657],[0.62],[0.7],[0.804],[0.725],[0.617],[0.928],[0.842],[0.759],[0.797],[0.788],0.593,0.549,0.631,0.212,0.222,0.188,0.747,0.657,0.62,0.7,0.804,0.725,0.617,0.928,0.842,0.759,0.797,0.788
https://doi.org/10.1001/archinte.167.19.2103,race ethnicity and medical student wellbeing in the united states,45_race ethnicity and medical student wellbeing in the united states.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664003/pdf', 'https://nam.edu/burnout-among-health-care-professionals-a-call-to-explore-and-address-this-underrecognized-threat-to-safe-high-quality-care/']","['Mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors', 'Burnout Among Health Care Professionals: A Call to Explore and Address This Underrecognized Threat to Safe, High-Quality Care']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664003/pdf'],['45_0_mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664003/pdf'],['45_0_mindfulness‐based psychological interventions for improving mental well‐being in medical students and junior doctors.pdf'],[0.299],[0.519],[0.607],[0.159],[0.17],[0.142],[0.73],[0.635],[0.59],[0.7],[0.786],[0.708],[0.589],[0.913],[0.83],[0.731],[0.781],[0.765],0.299,0.519,0.607,0.159,0.17,0.142,0.73,0.635,0.59,0.7,0.786,0.708,0.589,0.913,0.83,0.731,0.781,0.765
https://doi.org/10.1001/archopht.121.4.437,efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate,56_efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173749/pdf'],['Adverse effects of biologics: a network meta‐analysis and Cochrane overview'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173749/pdf'],['56_0_adverse effects of biologics a network meta‐analysis and cochrane overview.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173749/pdf'],['56_0_adverse effects of biologics a network meta‐analysis and cochrane overview.pdf'],[0.365],[0.469],[0.566],[0.145],[0.149],[0.115],[0.734],[0.639],[0.518],[0.647],[0.738],[0.672],[0.582],[0.856],[0.742],[0.623],[0.722],[0.648],0.365,0.469,0.566,0.145,0.149,0.115,0.734,0.639,0.518,0.647,0.738,0.672,0.582,0.856,0.742,0.623,0.722,0.648
https://doi.org/10.1001/archopht.124.6.913,macular hole in the shaken baby syndrome,58_macular hole in the shaken baby syndrome.pdf,1,['https://www.optometry.ca.gov/meetings/materials/20170608_3y1.pdf'],['Board of Optometry - Meeting Materials'],['https://www.optometry.ca.gov/meetings/materials/20170608_3y1.pdf'],['58_0_board of optometry  meeting materials.pdf'],1,100.0,['https://www.optometry.ca.gov/meetings/materials/20170608_3y1.pdf'],['58_0_board of optometry  meeting materials.pdf'],[0.178],[0.514],[0.604],[0.173],[0.189],[0.163],[0.75],[0.659],[0.57],[0.644],[0.788],[0.683],[0.62],[0.906],[0.795],[0.729],[0.779],[0.767],0.178,0.514,0.604,0.173,0.189,0.163,0.75,0.659,0.57,0.644,0.788,0.683,0.62,0.906,0.795,0.729,0.779,0.767
https://doi.org/10.1001/archopht.126.12.1717,prevalence and determinants of spectacle nonwear among rural chinese secondary schoolchildren,59_prevalence and determinants of spectacle nonwear among rural chinese secondary schoolchildren.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491194/pdf'],['Vision screening for correctable visual acuity deficits in school‐age children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491194/pdf'],['59_0_vision screening for correctable visual acuity deficits in school‐age children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491194/pdf'],['59_0_vision screening for correctable visual acuity deficits in school‐age children and adolescents.pdf'],[0.421],[0.51],[0.593],[0.15],[0.171],[0.146],[0.734],[0.637],[0.585],[0.698],[0.778],[0.705],[0.6],[0.908],[0.806],[0.727],[0.776],[0.754],0.421,0.51,0.593,0.15,0.171,0.146,0.734,0.637,0.585,0.698,0.778,0.705,0.6,0.908,0.806,0.727,0.776,0.754
https://doi.org/10.1001/archophthalmol.2010.231,diagnostic performance of anterior chamber angle measurements for detecting eyes with narrow angles,61_diagnostic performance of anterior chamber angle measurements for detecting eyes with narrow angles.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['Non‐contact tests for identifying people at risk of primary angle closure glaucoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['61_0_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['61_0_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf'],[0.359],[0.517],[0.601],[0.152],[0.163],[0.134],[0.739],[0.641],[0.583],[0.703],[0.78],[0.698],[0.609],[0.911],[0.807],[0.731],[0.778],[0.76],0.359,0.517,0.601,0.152,0.163,0.134,0.739,0.641,0.583,0.703,0.78,0.698,0.609,0.911,0.807,0.731,0.778,0.76
https://doi.org/10.1001/archophthalmol.2010.293,classifying stability of misalignment in children with esotropia using simulations,62_classifying stability of misalignment in children with esotropia using simulations.pdf,1,['https://www.optometry.ca.gov/meetings/materials/20170608_3a3.pdf'],['Board of Optometry - Meeting Materials'],['https://www.optometry.ca.gov/meetings/materials/20170608_3a3.pdf'],['62_0_board of optometry  meeting materials.pdf'],1,100.0,['https://www.optometry.ca.gov/meetings/materials/20170608_3a3.pdf'],['62_0_board of optometry  meeting materials.pdf'],[0.079],[0.503],[0.6],[0.116],[0.128],[0.119],[0.737],[0.643],[0.572],[0.689],[0.781],[0.715],[0.607],[0.913],[0.813],[0.739],[0.778],[0.774],0.079,0.503,0.6,0.116,0.128,0.119,0.737,0.643,0.572,0.689,0.781,0.715,0.607,0.913,0.813,0.739,0.778,0.774
https://doi.org/10.1001/archpedi.154.11.1089,ethnic differences in adolescent substance initiation sequences,70_ethnic differences in adolescent substance initiation sequences.pdf,1,['https://health.hawaii.gov/substance-abuse/files/2013/05/2007StatewideReport.pdf'],"['The Hawai ‘ I Student Alcohol, Tobacco, And Other Drug Use Study :']",['https://health.hawaii.gov/substance-abuse/files/2013/05/2007StatewideReport.pdf'],['70_0_the hawai  i student alcohol tobacco and other drug use study .pdf'],1,100.0,['https://health.hawaii.gov/substance-abuse/files/2013/05/2007StatewideReport.pdf'],['70_0_the hawai  i student alcohol tobacco and other drug use study .pdf'],[0.545],[0.498],[0.574],[0.164],[0.179],[0.158],[0.735],[0.634],[0.559],[0.703],[0.77],[0.683],[0.61],[0.913],[0.794],[0.731],[0.767],[0.755],0.545,0.498,0.574,0.164,0.179,0.158,0.735,0.634,0.559,0.703,0.77,0.683,0.61,0.913,0.794,0.731,0.767,0.755
https://doi.org/10.1001/archpedi.154.12.1243,the impact of outreach efforts in reaching underimmunized children in a medicaid managed care practice,78_the impact of outreach efforts in reaching underimmunized children in a medicaid managed care practice.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463821/pdf']","[""Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis"", 'Patient reminder and recall interventions to improve immunization rates', 'Automated telephone communication systems for preventive healthcare and management of long‐term conditions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463821/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf']","['78_0_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf', '78_2_automated telephone communication systems for preventive healthcare and management of long‐term conditions.pdf', '78_1_patient reminder and recall interventions to improve immunization rates.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463821/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf']","['78_0_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf', '78_2_automated telephone communication systems for preventive healthcare and management of long‐term conditions.pdf', '78_1_patient reminder and recall interventions to improve immunization rates.pdf']","[0.218, 0.461, 0.29]","[0.547, 0.541, 0.522]","[0.622, 0.614, 0.601]","[0.179, 0.164, 0.183]","[0.195, 0.173, 0.2]","[0.159, 0.147, 0.167]","[0.733, 0.732, 0.738]","[0.636, 0.637, 0.642]","[0.619, 0.607, 0.585]","[0.685, 0.681, 0.697]","[0.804, 0.792, 0.782]","[0.737, 0.717, 0.702]","[0.63, 0.623, 0.615]","[0.917, 0.916, 0.907]","[0.84, 0.828, 0.82]","[0.766, 0.751, 0.734]","[0.8, 0.787, 0.775]","[0.787, 0.774, 0.763]",0.323,0.537,0.612,0.175,0.189,0.158,0.734,0.638,0.604,0.688,0.793,0.719,0.623,0.913,0.829,0.75,0.787,0.775
https://doi.org/10.1001/archpedi.154.2.143,asthma severity among children hospitalized in 1990 and 1995,81_asthma severity among children hospitalized in 1990 and 1995.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144689/pdf'],['Positioning for acute respiratory distress in hospitalised infants and children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144689/pdf'],['81_0_positioning for acute respiratory distress in hospitalised infants and children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144689/pdf'],['81_0_positioning for acute respiratory distress in hospitalised infants and children.pdf'],[0.121],[0.491],[0.573],[0.146],[0.139],[0.118],[0.732],[0.63],[0.547],[0.699],[0.752],[0.674],[0.588],[0.887],[0.791],[0.696],[0.744],[0.722],0.121,0.491,0.573,0.146,0.139,0.118,0.732,0.63,0.547,0.699,0.752,0.674,0.588,0.887,0.791,0.696,0.744,0.722
https://doi.org/10.1001/archpedi.154.4.332,the adolescents training and learning to avoid steroids program,85_the adolescents training and learning to avoid steroids program.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465038/pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention', 'https://www.congress.gov/event/109th-congress/house-event/LC12007/text', 'https://purl.fdlp.gov/GPO/gpo75951', 'https://www.gao.gov/products/GAO-08-15', 'https://www.rand.org/pubs/tools/TL145.html']","[""National Athletic Trainers' Association Position Statement: Anabolic-Androgenic Steroids"", 'Washington State Institute for Public Policy', 'STEROIDS IN SPORTS: CHEATING THE SYSTEM AND GAMBLING YOUR HEALTH', 'Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.', 'Anabolic Steroid Abuse: Federal Efforts to Prevent and Reduce Anabolic Steroid Abuse among Teenagers', 'Programs That Work']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465038/pdf', 'https://purl.fdlp.gov/GPO/gpo75951']","['85_0_national athletic trainers association position statement anabolicandrogenic steroids.pdf', '85_3_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf']",2,33.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465038/pdf', 'https://purl.fdlp.gov/GPO/gpo75951']","['85_0_national athletic trainers association position statement anabolicandrogenic steroids.pdf', '85_3_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf']","[0.491, 0.476]","[0.538, 0.538]","[0.62, 0.627]","[0.18, 0.162]","[0.187, 0.173]","[0.146, 0.137]","[0.733, 0.731]","[0.634, 0.633]","[0.621, 0.614]","[0.654, 0.657]","[0.813, 0.809]","[0.747, 0.749]","[0.627, 0.62]","[0.925, 0.927]","[0.842, 0.834]","[0.778, 0.776]","[0.814, 0.809]","[0.8, 0.795]",0.483,0.538,0.623,0.171,0.18,0.142,0.732,0.633,0.617,0.655,0.811,0.748,0.623,0.926,0.838,0.777,0.811,0.798
https://doi.org/10.1001/archpedi.154.4.339,renal function 16 to 26 years after the first urinary tract infection in childhood,86_renal function 16 to 26 years after the first urinary tract infection in childhood.pdf,2,"['https://stacks.cdc.gov/view/cdc/58459', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380991/pdf']","['Peer Review Comments and CDC Responses for “Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, STIs, and other Health Outcomes” and “Background, Methods, and Synthesis of Scientific Information Used to Inform the ‘Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV infection, STIs, and other Health Outcomes.’”', 'Interventions for primary vesicoureteric reflux']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380991/pdf'],['86_1_interventions for primary vesicoureteric reflux.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380991/pdf'],['86_1_interventions for primary vesicoureteric reflux.pdf'],[0.223],[0.523],[0.604],[0.161],[0.154],[0.12],[0.739],[0.639],[0.584],[0.647],[0.786],[0.689],[0.591],[0.906],[0.798],[0.727],[0.774],[0.757],0.223,0.523,0.604,0.161,0.154,0.12,0.739,0.639,0.584,0.647,0.786,0.689,0.591,0.906,0.798,0.727,0.774,0.757
https://doi.org/10.1001/archpedi.154.5.484,a costeffectiveness analysis of newborn hearing screening strategies,89_a costeffectiveness analysis of newborn hearing screening strategies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459803/pdf'],['Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459803/pdf'],['89_0_specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459803/pdf'],['89_0_specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.pdf'],[0.462],[0.584],[0.653],[0.203],[0.207],[0.172],[0.737],[0.646],[0.655],[0.689],[0.819],[0.766],[0.645],[0.928],[0.84],[0.787],[0.821],[0.801],0.462,0.584,0.653,0.203,0.207,0.172,0.737,0.646,0.655,0.689,0.819,0.766,0.645,0.928,0.84,0.787,0.821,0.801
https://doi.org/10.1001/archpedi.154.6.569,weightrelated behaviors among adolescent girls and boys,90_weightrelated behaviors among adolescent girls and boys.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999856/pdf'],['Interventions for preventing eating disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999856/pdf'],['90_0_interventions for preventing eating disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999856/pdf'],['90_0_interventions for preventing eating disorders in children and adolescents.pdf'],[0.372],[0.508],[0.597],[0.17],[0.182],[0.157],[0.732],[0.634],[0.578],[0.708],[0.766],[0.702],[0.592],[0.91],[0.803],[0.724],[0.762],[0.744],0.372,0.508,0.597,0.17,0.182,0.157,0.732,0.634,0.578,0.708,0.766,0.702,0.592,0.91,0.803,0.724,0.762,0.744
https://doi.org/10.1001/archpedi.154.7.657,a randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in highrisk infants,91_a randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in highrisk infants.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464137/pdf', 'https://dph.georgia.gov/document/publication/features-environmental-management-pediatric-asthma-guide-sponsored-national/download', 'https://www.michigan.gov/documents/mdch/Public_Health_Reports_Largo_et_al_Healthy_Homes_University_A_Home-Based_Environmental_Intervention_and_Education_Program_373312_7.pdf', 'https://health.mo.gov/data/InterventionMICA/Asthma/5258.pdf']","['Infant formulas containing hydrolysed protein for prevention of allergic disease', 'Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy', 'Pediatric Asthma', 'Healthy Homes University : A Home-Based Environmental Intervention and Education Program for Families with Pediatric Asthma in Michigan', 'Resource ID:']","['https://dph.georgia.gov/document/publication/features-environmental-management-pediatric-asthma-guide-sponsored-national/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464137/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517017/pdf', 'https://www.michigan.gov/documents/mdch/Public_Health_Reports_Largo_et_al_Healthy_Homes_University_A_Home-Based_Environmental_Intervention_and_Education_Program_373312_7.pdf']","['91_2_pediatric asthma.pdf', '91_1_polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.pdf', '91_0_infant formulas containing hydrolysed protein for prevention of allergic disease.pdf', '91_3_healthy homes university  a homebased environmental intervention and education program for families with pediatric asthma in michigan.pdf']",4,80.0,"['https://dph.georgia.gov/document/publication/features-environmental-management-pediatric-asthma-guide-sponsored-national/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464137/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517017/pdf']","['91_2_pediatric asthma.pdf', '91_1_polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.pdf', '91_0_infant formulas containing hydrolysed protein for prevention of allergic disease.pdf']","[0.327, 0.324, 0.354]","[0.515, 0.49, 0.509]","[0.6, 0.579, 0.589]","[0.152, 0.154, 0.167]","[0.166, 0.155, 0.165]","[0.138, 0.131, 0.137]","[0.729, 0.734, 0.733]","[0.628, 0.635, 0.635]","[0.585, 0.544, 0.562]","[0.664, 0.665, 0.665]","[0.794, 0.76, 0.767]","[0.703, 0.664, 0.682]","[0.614, 0.584, 0.588]","[0.91, 0.895, 0.901]","[0.821, 0.777, 0.782]","[0.747, 0.705, 0.719]","[0.789, 0.75, 0.762]","[0.774, 0.723, 0.735]",0.335,0.505,0.589,0.158,0.162,0.135,0.732,0.633,0.564,0.665,0.774,0.683,0.595,0.902,0.793,0.724,0.767,0.744
https://doi.org/10.1001/archpedi.154.7.685,barriers pediatricians face when using asthma practice guidelines,92_barriers pediatricians face when using asthma practice guidelines.pdf,10,"['https://dph.georgia.gov/document/publication/features-environmental-management-pediatric-asthma-guide-sponsored-national/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520934/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837004/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034210/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698499/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334649/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153534/pdf']","['Pediatric Asthma', 'An interactive workshop plus locally adapted guidelines can improve General Practitioners asthma management and knowledge: A cluster randomised trial in the Australian setting', 'The Effect of Asthma Clinical Guideline for Adults on Inhaled Corticosteroids PrescriptionTrend: A Quasi-Experimental Study', 'The effectiveness of computerized clinical guidelines in the process of care: a systematic review', 'Attitudes Toward Practice Guidelines Among ICU Personnel: A Cross-Sectional Anonymous Survey', 'Breaking new ground: challenging existing asthma guidelines', 'Asthma Treatment Decisions by Pediatric Residents Do Not Consistently Conform to Guidelines nor Improve with Level of Training', 'Adherence to asthma guidelines in children, tweens, and adults at primary care settings: A practice-based network assessment.', 'Rigorous Development does not Ensure that Guidelines are Acceptable to a Panel of Knowledgeable Providers', ""Factors affecting general practitioners' decisions about plain radiography for back pain: implications for classification of guideline barriers – a qualitative study""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837004/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034210/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334649/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520934/pdf', 'https://dph.georgia.gov/document/publication/features-environmental-management-pediatric-asthma-guide-sponsored-national/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698499/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173921/pdf']","['92_3_the effectiveness of computerized clinical guidelines in the process of care a systematic review.pdf', '92_1_an interactive workshop plus locally adapted guidelines can improve general practitioners asthma management and knowledge a cluster randomised trial in the australian setting.pdf', '92_4_attitudes toward practice guidelines among icu personnel a crosssectional anonymous survey.pdf', '92_9_factors affecting general practitioners decisions about plain radiography for back pain implications for classification of guideline barriers – a qualitative study.pdf', '92_7_adherence to asthma guidelines in children tweens and adults at primary care settings a practicebased network assessment.pdf', '92_2_the effect of asthma clinical guideline for adults on inhaled corticosteroids prescriptiontrend a quasiexperimental study.pdf', '92_0_pediatric asthma.pdf', '92_6_asthma treatment decisions by pediatric residents do not consistently conform to guidelines nor improve with level of training.pdf', '92_5_breaking new ground challenging existing asthma guidelines.pdf', '92_8_rigorous development does not ensure that guidelines are acceptable to a panel of knowledgeable providers.pdf']",10,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837004/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034210/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334649/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520934/pdf', 'https://dph.georgia.gov/document/publication/features-environmental-management-pediatric-asthma-guide-sponsored-national/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698499/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173921/pdf']","['92_3_the effectiveness of computerized clinical guidelines in the process of care a systematic review.pdf', '92_1_an interactive workshop plus locally adapted guidelines can improve general practitioners asthma management and knowledge a cluster randomised trial in the australian setting.pdf', '92_4_attitudes toward practice guidelines among icu personnel a crosssectional anonymous survey.pdf', '92_9_factors affecting general practitioners decisions about plain radiography for back pain implications for classification of guideline barriers – a qualitative study.pdf', '92_7_adherence to asthma guidelines in children tweens and adults at primary care settings a practicebased network assessment.pdf', '92_2_the effect of asthma clinical guideline for adults on inhaled corticosteroids prescriptiontrend a quasiexperimental study.pdf', '92_0_pediatric asthma.pdf', '92_6_asthma treatment decisions by pediatric residents do not consistently conform to guidelines nor improve with level of training.pdf', '92_5_breaking new ground challenging existing asthma guidelines.pdf', '92_8_rigorous development does not ensure that guidelines are acceptable to a panel of knowledgeable providers.pdf']","[0.274, 0.273, 0.342, 0.309, 0.322, 0.395, 0.258, 0.337, 0.286, 0.462]","[0.574, 0.565, 0.521, 0.602, 0.528, 0.546, 0.533, 0.554, 0.603, 0.559]","[0.641, 0.634, 0.618, 0.666, 0.618, 0.62, 0.62, 0.633, 0.677, 0.637]","[0.188, 0.186, 0.18, 0.207, 0.178, 0.175, 0.136, 0.189, 0.204, 0.187]","[0.199, 0.201, 0.192, 0.212, 0.194, 0.186, 0.14, 0.206, 0.208, 0.199]","[0.164, 0.165, 0.158, 0.175, 0.161, 0.156, 0.118, 0.168, 0.171, 0.16]","[0.734, 0.731, 0.733, 0.738, 0.733, 0.731, 0.724, 0.735, 0.743, 0.729]","[0.636, 0.635, 0.635, 0.641, 0.634, 0.627, 0.622, 0.639, 0.642, 0.631]","[0.639, 0.631, 0.595, 0.671, 0.596, 0.61, 0.599, 0.625, 0.677, 0.627]","[0.706, 0.698, 0.701, 0.695, 0.696, 0.685, 0.67, 0.692, 0.684, 0.713]","[0.804, 0.804, 0.783, 0.826, 0.782, 0.802, 0.802, 0.797, 0.829, 0.805]","[0.755, 0.749, 0.698, 0.784, 0.694, 0.719, 0.721, 0.739, 0.785, 0.74]","[0.627, 0.626, 0.598, 0.652, 0.601, 0.629, 0.612, 0.602, 0.65, 0.626]","[0.93, 0.926, 0.922, 0.935, 0.919, 0.92, 0.92, 0.921, 0.935, 0.931]","[0.851, 0.844, 0.835, 0.875, 0.827, 0.835, 0.837, 0.841, 0.86, 0.856]","[0.774, 0.769, 0.748, 0.8, 0.748, 0.762, 0.753, 0.762, 0.801, 0.773]","[0.811, 0.806, 0.786, 0.835, 0.78, 0.8, 0.802, 0.793, 0.834, 0.812]","[0.79, 0.781, 0.774, 0.818, 0.774, 0.784, 0.788, 0.782, 0.818, 0.796]",0.326,0.558,0.636,0.183,0.194,0.16,0.733,0.634,0.627,0.694,0.803,0.738,0.622,0.926,0.846,0.769,0.806,0.79
https://doi.org/10.1001/archpedi.154.8.837,adolescent obesity in a lowincome mexican american district in south texas,95_adolescent obesity in a lowincome mexican american district in south texas.pdf,1,['http://purl.fdlp.gov/GPO/gpo70336'],['An international borderland of concern :\xa0conservation of biodiversity in the lower Rio Grande Valley /'],['http://purl.fdlp.gov/GPO/gpo70336'],['95_0_an international borderland of concern \xa0conservation of biodiversity in the lower rio grande valley .pdf'],1,100.0,['http://purl.fdlp.gov/GPO/gpo70336'],['95_0_an international borderland of concern \xa0conservation of biodiversity in the lower rio grande valley .pdf'],[0.141],[0.475],[0.564],[0.081],[0.063],[0.058],[0.712],[0.612],[0.563],[0.624],[0.792],[0.706],[0.611],[0.898],[0.81],[0.743],[0.784],[0.769],0.141,0.475,0.564,0.081,0.063,0.058,0.712,0.612,0.563,0.624,0.792,0.706,0.611,0.898,0.81,0.743,0.784,0.769
https://doi.org/10.1001/archpedi.155.1.36,health effects related to environmental tobacco smoke exposure in children in the united states,99_health effects related to environmental tobacco smoke exposure in children in the united states.pdf,8,"['https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://ww2.arb.ca.gov/sites/default/files/barcu/regact/ets2006/app3partc.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/rptsmokeexp/', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://stacks.cdc.gov/view/cdc/5388', 'https://stacks.cdc.gov/view/cdc/31104', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://stacks.cdc.gov/view/cdc/45298']","['Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', 'Part C Table of Contents', 'The Health Consequences of Involuntary Exposure to Tobacco Smoke', 'America’s children and the environment.', 'Health, United States, 2007; with chartbook on trends in the health of Americans', ""America's children; key national indicators of well-being, 2005"", 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', ""America's children : key national indicators of well-being, 2003""]","['https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://ww2.arb.ca.gov/sites/default/files/barcu/regact/ets2006/app3partc.pdf', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['99_0_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '99_1_part c table of contents.pdf', '99_6_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '99_3_americas children and the environment.pdf']",4,50.0,"['https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://ww2.arb.ca.gov/sites/default/files/barcu/regact/ets2006/app3partc.pdf', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['99_0_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '99_1_part c table of contents.pdf', '99_6_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '99_3_americas children and the environment.pdf']","[0.333, 0.389, 0.552, 0.333]","[0.493, 0.503, 0.493, 0.49]","[0.588, 0.595, 0.588, 0.587]","[0.148, 0.162, 0.148, 0.14]","[0.15, 0.165, 0.15, 0.138]","[0.125, 0.135, 0.125, 0.116]","[0.737, 0.731, 0.737, 0.734]","[0.637, 0.634, 0.637, 0.636]","[0.56, 0.564, 0.56, 0.555]","[0.663, 0.706, 0.663, 0.695]","[0.772, 0.771, 0.772, 0.769]","[0.696, 0.71, 0.696, 0.692]","[0.6, 0.62, 0.6, 0.611]","[0.894, 0.891, 0.894, 0.888]","[0.777, 0.789, 0.777, 0.779]","[0.708, 0.717, 0.708, 0.711]","[0.761, 0.766, 0.761, 0.767]","[0.73, 0.732, 0.73, 0.734]",0.402,0.495,0.589,0.149,0.151,0.125,0.735,0.636,0.56,0.682,0.771,0.698,0.608,0.892,0.78,0.711,0.764,0.732
https://doi.org/10.1001/archpedi.155.1.42,randomized trial of enhanced anticipatory guidance for injury prevention,100_randomized trial of enhanced anticipatory guidance for injury prevention.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441047/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017850/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138253/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://stacks.cdc.gov/view/cdc/23443']","['Continuing education meetings and workshops: effects on professional practice and healthcare outcomes', 'Interventions for promoting smoke alarm ownership and function', 'Continuing education meetings and workshops: effects on professional practice and health care outcomes', 'Modification of the home environment for the reduction of injuries', 'Home safety education and provision of safety equipment for injury prevention', 'Bibliography of behavioral science research in unintentional injury prevention']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138253/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441047/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017850/pdf']","['100_2_continuing education meetings and workshops effects on professional practice and health care outcomes.pdf', '100_4_home safety education and provision of safety equipment for injury prevention.pdf', '100_3_modification of the home environment for the reduction of injuries.pdf', '100_0_continuing education meetings and workshops effects on professional practice and healthcare outcomes.pdf', '100_1_interventions for promoting smoke alarm ownership and function.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138253/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441047/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017850/pdf']","['100_2_continuing education meetings and workshops effects on professional practice and health care outcomes.pdf', '100_4_home safety education and provision of safety equipment for injury prevention.pdf', '100_3_modification of the home environment for the reduction of injuries.pdf', '100_0_continuing education meetings and workshops effects on professional practice and healthcare outcomes.pdf', '100_1_interventions for promoting smoke alarm ownership and function.pdf']","[0.22, 0.317, 0.216, 0.477, 0.529]","[0.545, 0.508, 0.513, 0.532, 0.51]","[0.624, 0.588, 0.59, 0.614, 0.586]","[0.172, 0.162, 0.167, 0.168, 0.159]","[0.177, 0.17, 0.174, 0.173, 0.162]","[0.152, 0.146, 0.147, 0.154, 0.14]","[0.73, 0.729, 0.727, 0.732, 0.728]","[0.633, 0.632, 0.631, 0.636, 0.633]","[0.614, 0.562, 0.568, 0.59, 0.562]","[0.678, 0.686, 0.684, 0.682, 0.679]","[0.796, 0.769, 0.777, 0.778, 0.773]","[0.726, 0.695, 0.704, 0.7, 0.678]","[0.611, 0.604, 0.605, 0.599, 0.592]","[0.926, 0.899, 0.906, 0.921, 0.909]","[0.84, 0.797, 0.799, 0.835, 0.807]","[0.751, 0.707, 0.716, 0.728, 0.725]","[0.793, 0.764, 0.772, 0.773, 0.766]","[0.78, 0.733, 0.741, 0.765, 0.75]",0.352,0.522,0.6,0.166,0.171,0.148,0.729,0.633,0.579,0.682,0.779,0.701,0.602,0.912,0.816,0.725,0.774,0.754
https://doi.org/10.1001/archpedi.155.11.1248,effects of 2 inhaled corticosteroids on growth,105_effects of 2 inhaled corticosteroids on growth.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447218/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564081/pdf']","['Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children', 'Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564081/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447218/pdf']","['105_1_inhaled corticosteroids in children with persistent asthma effects of different drugs and delivery devices on growth.pdf', '105_0_fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564081/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447218/pdf']","['105_1_inhaled corticosteroids in children with persistent asthma effects of different drugs and delivery devices on growth.pdf', '105_0_fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.pdf']","[0.28, 0.476]","[0.519, 0.483]","[0.608, 0.568]","[0.179, 0.162]","[0.186, 0.147]","[0.146, 0.13]","[0.741, 0.741]","[0.643, 0.644]","[0.59, 0.552]","[0.693, 0.689]","[0.778, 0.759]","[0.684, 0.639]","[0.606, 0.584]","[0.907, 0.904]","[0.801, 0.77]","[0.728, 0.713]","[0.768, 0.745]","[0.754, 0.737]",0.378,0.501,0.588,0.17,0.166,0.138,0.741,0.643,0.571,0.691,0.768,0.661,0.595,0.905,0.786,0.72,0.756,0.746
https://doi.org/10.1001/archpedi.155.12.1340,effectiveness of oral or nebulized dexamethasone for children with mild croup,109_effectiveness of oral or nebulized dexamethasone for children with mild croup.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513469/pdf'],['Glucocorticoids for croup in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513469/pdf'],['109_0_glucocorticoids for croup in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513469/pdf'],['109_0_glucocorticoids for croup in children.pdf'],[0.394],[0.505],[0.586],[0.178],[0.174],[0.143],[0.738],[0.641],[0.566],[0.682],[0.775],[0.675],[0.601],[0.91],[0.806],[0.728],[0.766],[0.752],0.394,0.505,0.586,0.178,0.174,0.143,0.738,0.641,0.566,0.682,0.775,0.675,0.601,0.91,0.806,0.728,0.766,0.752
https://doi.org/10.1001/archpedi.155.3.335,factors preventing gun acquisition and carrying among incarcerated adolescent males,116_factors preventing gun acquisition and carrying among incarcerated adolescent males.pdf,3,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1ACsWUgfAx1pdG_vu8TzDU60UxdZBxDFU.pdf', 'https://www.rand.org/pubs/research_reports/RR2088-1.html', 'https://www.rand.org/pubs/research_reports/RR2088.html']","['Mark W. Pennak', 'The Science of Gun Policy: Second Edition', 'The Science of Gun Policy']",['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1ACsWUgfAx1pdG_vu8TzDU60UxdZBxDFU.pdf'],['116_0_mark w pennak.pdf'],1,33.33,['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1ACsWUgfAx1pdG_vu8TzDU60UxdZBxDFU.pdf'],['116_0_mark w pennak.pdf'],[0.483],[0.552],[0.637],[0.164],[0.187],[0.16],[0.722],[0.624],[0.627],[0.694],[0.812],[0.758],[0.647],[0.917],[0.863],[0.778],[0.815],[0.799],0.483,0.552,0.637,0.164,0.187,0.16,0.722,0.624,0.627,0.694,0.812,0.758,0.647,0.917,0.863,0.778,0.815,0.799
https://doi.org/10.1001/archpedi.155.3.342,witnessing violence among innercity children of substanceabusing and non–substanceabusing women,117_witnessing violence among innercity children of substanceabusing and non–substanceabusing women.pdf,2,"['http://www.cssbmb.com/BMB.nsf/0/F649343E87FCA8C085257ED60063DBDA/$file/2009+Annual+Rpt.pdf', 'https://dbh.dc.gov/sites/default/files/dc/sites/dmh/service_content/attachments/DMH%20Report%20final.pdf']","['2009 Annual Report', 'Olga Acosta Price, PhD Julia Graham Lear, PhD']",['https://dbh.dc.gov/sites/default/files/dc/sites/dmh/service_content/attachments/DMH%20Report%20final.pdf'],['117_1_olga acosta price phd julia graham lear phd.pdf'],1,50.0,['https://dbh.dc.gov/sites/default/files/dc/sites/dmh/service_content/attachments/DMH%20Report%20final.pdf'],['117_1_olga acosta price phd julia graham lear phd.pdf'],[0.101],[0.524],[0.606],[0.151],[0.163],[0.136],[0.722],[0.624],[0.592],[0.654],[0.794],[0.727],[0.624],[0.91],[0.823],[0.755],[0.799],[0.775],0.101,0.524,0.606,0.151,0.163,0.136,0.722,0.624,0.592,0.654,0.794,0.727,0.624,0.91,0.823,0.755,0.799,0.775
https://doi.org/10.1001/archpedi.155.4.470,early effects of the healthy steps for young children program,120_early effects of the healthy steps for young children program.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.rand.org/pubs/research_reports/RR1993.html', 'https://www.commonwealthfund.org/publications/fund-reports/2003/may/building-bridge-birth-school-improving-developmental-and', 'https://www.commonwealthfund.org/publications/fund-reports/2009/apr/improving-care-coordination-case-management-and-linkages-service', 'https://www.commonwealthfund.org/publications/fund-reports/2006/oct/high-performing-system-well-child-care-vision-future', 'https://www.rand.org/pubs/tools/TL145.html']","['Home safety education and provision of safety equipment for injury prevention', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'Building a Bridge from Birth to School: Improving Developmental and Behavioral Health Services for Young Children', 'Improving Care Coordination, Case Management, and Linkages to Service for Young Children: Opportunities for States', 'A High-Performing System for Well-Child Care: A Vision for the Future', 'Programs That Work']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf'],['120_0_home safety education and provision of safety equipment for injury prevention.pdf'],1,14.29,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf'],['120_0_home safety education and provision of safety equipment for injury prevention.pdf'],[0.297],[0.503],[0.589],[0.148],[0.151],[0.127],[0.726],[0.631],[0.562],[0.68],[0.765],[0.693],[0.595],[0.898],[0.798],[0.706],[0.761],[0.731],0.297,0.503,0.589,0.148,0.151,0.127,0.726,0.631,0.562,0.68,0.765,0.693,0.595,0.898,0.798,0.706,0.761,0.731
https://doi.org/10.1001/archpedi.155.5.579,the relationship between lead exposure and homicide,122_the relationship between lead exposure and homicide.pdf,7,"['https://stacks.cdc.gov/view/cdc/37676', 'https://www.nber.org/papers/w16480?sy=480', 'https://papers.nber.org/papers/W8571', 'https://stacks.cdc.gov/view/cdc/31182', 'https://fortress.wa.gov/ecy/publications/publications/0907008.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_11342-577.pdf']","['Toxicological profile for lead', 'Lead and Mortality', 'After the Epidemic: Recent Trends in Youth Violence in the United States', 'Educational interventions for children affected by lead', 'Washington State Lead Chemical Action Plan', '2015-Lead-Poisoning', 'Association of Prenatal and Childhood Blood Lead Concentrations with Criminal Arrests in Early Adulthood']","['https://fortress.wa.gov/ecy/publications/publications/0907008.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_11342-577.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf']","['122_4_washington state lead chemical action plan.pdf', '122_6_association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood.pdf', '122_5_2015leadpoisoning.pdf']",3,42.86,"['https://fortress.wa.gov/ecy/publications/publications/0907008.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_11342-577.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf']","['122_4_washington state lead chemical action plan.pdf', '122_6_association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood.pdf', '122_5_2015leadpoisoning.pdf']","[0.686, 0.478, 0.494]","[0.531, 0.508, 0.49]","[0.615, 0.592, 0.588]","[0.168, 0.162, 0.143]","[0.179, 0.169, 0.149]","[0.152, 0.138, 0.12]","[0.725, 0.727, 0.73]","[0.629, 0.634, 0.636]","[0.61, 0.586, 0.563]","[0.672, 0.698, 0.686]","[0.812, 0.799, 0.787]","[0.723, 0.711, 0.675]","[0.639, 0.6, 0.607]","[0.918, 0.914, 0.91]","[0.837, 0.815, 0.804]","[0.773, 0.751, 0.738]","[0.806, 0.783, 0.768]","[0.795, 0.781, 0.763]",0.553,0.51,0.598,0.158,0.166,0.137,0.727,0.633,0.586,0.685,0.799,0.703,0.615,0.914,0.819,0.754,0.786,0.78
https://doi.org/10.1001/archpedi.155.6.659,love our kids lock your guns,123_love our kids lock your guns.pdf,3,"['http://purl.fdlp.gov/GPO/gpo86642', 'https://www.gao.gov/products/GAO-17-665', 'http://miamidade.floridahealth.gov/programs-and-services/wellness-programs/injury-and-violence-prevention/_documents/GSW%20Storage%20Practices%20in%2050%20States,%202002.pdf']","['Personal firearms, programs that promote safe storage and research on their effectiveness : report to congressional requesters.', 'Personal Firearms: Programs that Promote Safe Storage and Research on Their Effectiveness', 'Prevalence of Household Firearms and Firearm-Storage Practices in the 50 States and the District of Columbia : Findings From the Behavioral Risk Factor Surveillance System, 2002']","['http://purl.fdlp.gov/GPO/gpo86642', 'http://miamidade.floridahealth.gov/programs-and-services/wellness-programs/injury-and-violence-prevention/_documents/GSW%20Storage%20Practices%20in%2050%20States,%202002.pdf']","['123_0_personal firearms programs that promote safe storage and research on their effectiveness  report to congressional requesters.pdf', '123_2_prevalence of household firearms and firearmstorage practices in the 50 states and the district of columbia  findings from the behavioral risk factor surveillance system 2002.pdf']",2,66.67,"['http://purl.fdlp.gov/GPO/gpo86642', 'http://miamidade.floridahealth.gov/programs-and-services/wellness-programs/injury-and-violence-prevention/_documents/GSW%20Storage%20Practices%20in%2050%20States,%202002.pdf']","['123_0_personal firearms programs that promote safe storage and research on their effectiveness  report to congressional requesters.pdf', '123_2_prevalence of household firearms and firearmstorage practices in the 50 states and the district of columbia  findings from the behavioral risk factor surveillance system 2002.pdf']","[0.586, 0.395]","[0.552, 0.497]","[0.637, 0.587]","[0.195, 0.171]","[0.214, 0.19]","[0.182, 0.152]","[0.735, 0.728]","[0.646, 0.632]","[0.624, 0.56]","[0.672, 0.673]","[0.81, 0.797]","[0.734, 0.7]","[0.646, 0.609]","[0.922, 0.914]","[0.853, 0.839]","[0.77, 0.732]","[0.802, 0.792]","[0.79, 0.777]",0.49,0.524,0.612,0.183,0.202,0.167,0.732,0.639,0.592,0.673,0.804,0.717,0.627,0.918,0.846,0.751,0.797,0.784
https://doi.org/10.1001/archpedi.155.7.765,maternal and paternal recreational drug use and sudden infant death syndrome,126_maternal and paternal recreational drug use and sudden infant death syndrome.pdf,6,"['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/21-drug-dependency-protocol-english.pdf', 'https://www.heritage.org/crime-and-justice/report/twenty-first-century-illicit-drugs-and-their-discontents-the-potential', 'https://www.in.gov/health/laboroflove/files/breastfeeding-and-substance-use-final.pdf', 'https://oehha.ca.gov/media/downloads/proposition-65/chemicals/cannabisdarthid100419.pdf', 'http://dhss.alaska.gov/dph/Director/Documents/marijuana/Appendix_Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf', 'http://dhss.alaska.gov/dph/Director/Documents/marijuana/Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf']","['ABM Clinical Protocol #21: Guidelines for Breastfeeding and Substance Use or Substance Use Disorder, Revised 2015', 'Twenty-First Century Illicit Drugs and Their Discontents: The Potential Risks that Cannabis Use by Pregnant and Nursing Women Pose to Their Children', 'Breastfeeding and Substance Use : Evidence-based Practices', 'Evidence of Developmental Toxicity of Cannabis (Marijuana) Smoke and Delta Nine-THC', 'Monitoring Health', 'Monitoring Health']","['https://www.in.gov/health/laboroflove/files/breastfeeding-and-substance-use-final.pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/21-drug-dependency-protocol-english.pdf', 'http://dhss.alaska.gov/dph/Director/Documents/marijuana/Appendix_Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf', 'http://dhss.alaska.gov/dph/Director/Documents/marijuana/Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf']","['126_2_breastfeeding and substance use  evidencebased practices.pdf', '126_0_abm clinical protocol 21 guidelines for breastfeeding and substance use or substance use disorder revised 2015.pdf', '126_4_monitoring health.pdf', '126_5_monitoring health.pdf']",4,66.67,"['https://www.in.gov/health/laboroflove/files/breastfeeding-and-substance-use-final.pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/21-drug-dependency-protocol-english.pdf', 'http://dhss.alaska.gov/dph/Director/Documents/marijuana/Appendix_Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf', 'http://dhss.alaska.gov/dph/Director/Documents/marijuana/Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf']","['126_2_breastfeeding and substance use  evidencebased practices.pdf', '126_0_abm clinical protocol 21 guidelines for breastfeeding and substance use or substance use disorder revised 2015.pdf', '126_4_monitoring health.pdf', '126_5_monitoring health.pdf']","[0.531, 0.528, 0.522, 0.414]","[0.535, 0.548, 0.517, 0.524]","[0.622, 0.631, 0.602, 0.613]","[0.186, 0.205, 0.178, 0.181]","[0.199, 0.224, 0.182, 0.197]","[0.174, 0.19, 0.154, 0.167]","[0.739, 0.744, 0.738, 0.738]","[0.645, 0.65, 0.643, 0.642]","[0.603, 0.617, 0.579, 0.587]","[0.648, 0.652, 0.666, 0.666]","[0.805, 0.811, 0.787, 0.798]","[0.733, 0.747, 0.714, 0.726]","[0.625, 0.633, 0.615, 0.622]","[0.912, 0.912, 0.904, 0.909]","[0.808, 0.814, 0.789, 0.801]","[0.759, 0.767, 0.744, 0.752]","[0.794, 0.801, 0.778, 0.787]","[0.781, 0.786, 0.764, 0.772]",0.499,0.531,0.617,0.188,0.201,0.171,0.74,0.645,0.597,0.658,0.8,0.73,0.624,0.909,0.803,0.756,0.79,0.776
https://doi.org/10.1001/archpedi.155.7.800,parent expectations for antibiotics physicianparent communication and satisfaction,129_parent expectations for antibiotics physicianparent communication and satisfaction.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805737/pdf', 'https://stacks.cdc.gov/view/cdc/42418']","['Reducing Unnecessary Diagnostic Testing in Pediatric Syncope: A Quality Improvement Initiative', 'Core elements of outpatient antibiotic stewardship']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805737/pdf'],['129_0_reducing unnecessary diagnostic testing in pediatric syncope a quality improvement initiative.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805737/pdf'],['129_0_reducing unnecessary diagnostic testing in pediatric syncope a quality improvement initiative.pdf'],[0.145],[0.559],[0.631],[0.186],[0.178],[0.139],[0.734],[0.638],[0.629],[0.664],[0.806],[0.746],[0.605],[0.923],[0.831],[0.765],[0.799],[0.785],0.145,0.559,0.631,0.186,0.178,0.139,0.734,0.638,0.629,0.664,0.806,0.746,0.605,0.923,0.831,0.765,0.799,0.785
https://doi.org/10.1001/archpedi.155.7.822,the behavioral risks and life circumstances of adolescent mothers involved with older adult partners,130_the behavioral risks and life circumstances of adolescent mothers involved with older adult partners.pdf,1,['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['Oversight Committee Meeting'],['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['130_0_oversight committee meeting.pdf'],1,100.0,['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['130_0_oversight committee meeting.pdf'],[0.134],[0.487],[0.578],[0.092],[0.097],[0.083],[0.718],[0.615],[0.567],[0.627],[0.788],[0.702],[0.585],[0.913],[0.813],[0.738],[0.778],[0.769],0.134,0.487,0.578,0.092,0.097,0.083,0.718,0.615,0.567,0.627,0.788,0.702,0.585,0.913,0.813,0.738,0.778,0.769
https://doi.org/10.1001/archpedi.155.7.838,evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests,131_evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests.pdf,1,['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Point-of-Care-Testing/POCT-Entire-LMPG.pdf?la=en&hash=FAB661858E6C81B5467B641C99E2EE6BA29D50F6'],['Laboratory Medicine Practice Guidelines: Evidence-Based Practice for Point-of-Care Testing'],['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Point-of-Care-Testing/POCT-Entire-LMPG.pdf?la=en&hash=FAB661858E6C81B5467B641C99E2EE6BA29D50F6'],['131_0_laboratory medicine practice guidelines evidencebased practice for pointofcare testing.pdf'],1,100.0,['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Point-of-Care-Testing/POCT-Entire-LMPG.pdf?la=en&hash=FAB661858E6C81B5467B641C99E2EE6BA29D50F6'],['131_0_laboratory medicine practice guidelines evidencebased practice for pointofcare testing.pdf'],[0.41],[0.571],[0.641],[0.163],[0.164],[0.129],[0.737],[0.64],[0.646],[0.639],[0.816],[0.76],[0.637],[0.923],[0.843],[0.781],[0.812],[0.798],0.41,0.571,0.641,0.163,0.164,0.129,0.737,0.64,0.646,0.639,0.816,0.76,0.637,0.923,0.843,0.781,0.812,0.798
https://doi.org/10.1001/archpedi.155.9.1029,effectiveness of a home intervention for perceived child behavioral problems and parenting stress in children with in utero drug exposure,132_effectiveness of a home intervention for perceived child behavioral problems and parenting stress in children with in utero drug exposure.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://www.congress.gov/event/111th-congress/house-event/LC4703/text']","['Home visits during pregnancy and after birth for women with an alcohol or drug problem', 'House Hearing, 111th Congress — HEARING ON PROPOSALS TO PROVIDE FEDERAL FUNDING FOR EARLY CHILDHOOD HOME VISITATION PROGRAMS']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf'],['132_0_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf'],['132_0_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf'],[0.278],[0.518],[0.6],[0.184],[0.168],[0.15],[0.735],[0.639],[0.571],[0.674],[0.771],[0.68],[0.564],[0.904],[0.784],[0.719],[0.762],[0.742],0.278,0.518,0.6,0.184,0.168,0.15,0.735,0.639,0.571,0.674,0.771,0.68,0.564,0.904,0.784,0.719,0.762,0.742
https://doi.org/10.1001/archpedi.156.10.1021,randomized trial to prevent sensitization to mite allergens in toddlers and preschoolers by allergen reduction and educationsubtitleoneyear resultssubtitle,136_randomized trial to prevent sensitization to mite allergens in toddlers and preschoolers by allergen reduction and educationsubtitleoneyear resultssubtitle.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430554/pdf', 'https://www.allergyparameters.org/app/download/8422834070/2013+Dustmite+Allergy.pdf?t=1515169992', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.jaad.org/action/showPdf?pii=S0190-9622%2814%2901887-8', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf']","['Guidelines of Care for the Management of Atopic Dermatitis Part 4: Prevention of Disease Flares and Use of Adjunctive Therapies and Approaches', 'Environmental assessment and exposure control of dust mites: a practice parameter', 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', 'Guidelines of care for the management of atopic dermatitis (Section 4)', 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma']","['https://www.jaad.org/action/showPdf?pii=S0190-9622%2814%2901887-8', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430554/pdf', 'https://www.allergyparameters.org/app/download/8422834070/2013+Dustmite+Allergy.pdf?t=1515169992']","['136_3_guidelines of care for the management of atopic dermatitis section 4.pdf', '136_4_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '136_2_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '136_0_guidelines of care for the management of atopic dermatitis part 4 prevention of disease flares and use of adjunctive therapies and approaches.pdf', '136_1_environmental assessment and exposure control of dust mites a practice parameter.pdf']",5,100.0,"['https://www.jaad.org/action/showPdf?pii=S0190-9622%2814%2901887-8', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430554/pdf', 'https://www.allergyparameters.org/app/download/8422834070/2013+Dustmite+Allergy.pdf?t=1515169992']","['136_3_guidelines of care for the management of atopic dermatitis section 4.pdf', '136_4_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '136_2_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '136_0_guidelines of care for the management of atopic dermatitis part 4 prevention of disease flares and use of adjunctive therapies and approaches.pdf', '136_1_environmental assessment and exposure control of dust mites a practice parameter.pdf']","[0.304, 0.5, 0.408, 0.393, 0.408]","[0.574, 0.537, 0.537, 0.498, 0.533]","[0.645, 0.617, 0.617, 0.604, 0.608]","[0.183, 0.167, 0.167, 0.158, 0.156]","[0.206, 0.179, 0.179, 0.187, 0.175]","[0.168, 0.141, 0.141, 0.147, 0.143]","[0.74, 0.735, 0.735, 0.734, 0.736]","[0.642, 0.636, 0.636, 0.636, 0.633]","[0.648, 0.608, 0.608, 0.589, 0.601]","[0.657, 0.662, 0.662, 0.665, 0.664]","[0.821, 0.806, 0.806, 0.784, 0.803]","[0.765, 0.729, 0.729, 0.685, 0.722]","[0.647, 0.628, 0.628, 0.596, 0.632]","[0.93, 0.925, 0.925, 0.922, 0.916]","[0.845, 0.822, 0.822, 0.818, 0.822]","[0.791, 0.765, 0.765, 0.74, 0.765]","[0.821, 0.797, 0.797, 0.778, 0.798]","[0.809, 0.789, 0.789, 0.774, 0.786]",0.403,0.536,0.618,0.166,0.185,0.148,0.736,0.637,0.611,0.662,0.804,0.726,0.626,0.924,0.826,0.765,0.798,0.789
https://doi.org/10.1001/archpedi.156.11.1108,professional interpreters and bilingual physicians in a pediatric emergency department,140_professional interpreters and bilingual physicians in a pediatric emergency department.pdf,3,"['https://www.rand.org/pubs/rgs_dissertations/RGSD198.html', 'https://www.leg.mn.gov/docs/2008/mandated/080258.pdf', 'https://www.lrl.mn.gov/docs/2015/mandated/150235.pdf']","['Discrimination and Health Care Utilization', 'Analysis Of Scenario #1', 'Interpreting in Health Care Settings : Recommendations for a Tiered Registry']","['https://www.leg.mn.gov/docs/2008/mandated/080258.pdf', 'https://www.lrl.mn.gov/docs/2015/mandated/150235.pdf']","['140_1_analysis of scenario 1.pdf', '140_2_interpreting in health care settings  recommendations for a tiered registry.pdf']",2,66.67,"['https://www.leg.mn.gov/docs/2008/mandated/080258.pdf', 'https://www.lrl.mn.gov/docs/2015/mandated/150235.pdf']","['140_1_analysis of scenario 1.pdf', '140_2_interpreting in health care settings  recommendations for a tiered registry.pdf']","[0.344, 0.316]","[0.534, 0.537]","[0.614, 0.61]","[0.161, 0.157]","[0.176, 0.172]","[0.146, 0.145]","[0.727, 0.727]","[0.63, 0.629]","[0.604, 0.606]","[0.687, 0.688]","[0.8, 0.798]","[0.741, 0.741]","[0.633, 0.631]","[0.908, 0.912]","[0.829, 0.832]","[0.752, 0.753]","[0.805, 0.801]","[0.77, 0.769]",0.33,0.536,0.612,0.159,0.174,0.145,0.727,0.629,0.605,0.688,0.799,0.741,0.632,0.91,0.831,0.752,0.803,0.77
https://doi.org/10.1001/archpedi.156.11.1114,antibiotic prescribing by primary care physicians for children with upper respiratory tract infections,141_antibiotic prescribing by primary care physicians for children with upper respiratory tract infections.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182143/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741879/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284164/pdf', 'https://www.rand.org/pubs/technical_reports/TR1129.html', 'https://stacks.cdc.gov/view/cdc/11299']","['Saline nasal irrigation for acute upper respiratory tract infections', 'Decongestants, antihistamines and nasal irrigation for acute sinusitis in children', 'Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study', 'Selective testing strategies for diagnosing group A streptococcal infection in children with pharyngitis: a systematic review and prospective multicentre external validation study', 'Developing a Framework for Establishing Clinical Decision Support Meaningful Use Objectives for Clinical Specialties', 'Health care in America; trends in utilization']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182143/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284164/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741879/pdf']","['141_1_decongestants antihistamines and nasal irrigation for acute sinusitis in children.pdf', '141_0_saline nasal irrigation for acute upper respiratory tract infections.pdf', '141_3_selective testing strategies for diagnosing group a streptococcal infection in children with pharyngitis a systematic review and prospective multicentre external validation study.pdf', '141_2_monitoring adherence to guidelines of antibiotic use in pediatric pneumonia the marea study.pdf']",4,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182143/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284164/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741879/pdf']","['141_1_decongestants antihistamines and nasal irrigation for acute sinusitis in children.pdf', '141_0_saline nasal irrigation for acute upper respiratory tract infections.pdf', '141_3_selective testing strategies for diagnosing group a streptococcal infection in children with pharyngitis a systematic review and prospective multicentre external validation study.pdf', '141_2_monitoring adherence to guidelines of antibiotic use in pediatric pneumonia the marea study.pdf']","[0.238, 0.194, 0.431, 0.259]","[0.537, 0.529, 0.561, 0.542]","[0.626, 0.615, 0.639, 0.621]","[0.176, 0.174, 0.195, 0.202]","[0.179, 0.176, 0.19, 0.208]","[0.144, 0.139, 0.158, 0.175]","[0.739, 0.737, 0.743, 0.745]","[0.642, 0.638, 0.651, 0.652]","[0.608, 0.589, 0.624, 0.605]","[0.668, 0.678, 0.681, 0.683]","[0.795, 0.781, 0.804, 0.795]","[0.709, 0.688, 0.724, 0.698]","[0.606, 0.602, 0.631, 0.627]","[0.921, 0.907, 0.915, 0.909]","[0.815, 0.813, 0.828, 0.821]","[0.753, 0.732, 0.77, 0.756]","[0.784, 0.772, 0.8, 0.788]","[0.777, 0.757, 0.789, 0.776]",0.28,0.542,0.625,0.187,0.188,0.154,0.741,0.646,0.607,0.677,0.794,0.705,0.617,0.913,0.819,0.753,0.786,0.775
https://doi.org/10.1001/archpedi.156.11.1123,infant colic,142_infant colic.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415699/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394439/pdf']","['Parent training programmes for managing infantile colic', 'Probiotics to prevent infantile colic', 'Dietary modifications for infantile colic']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415699/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394439/pdf']","['142_0_parent training programmes for managing infantile colic.pdf', '142_1_probiotics to prevent infantile colic.pdf', '142_2_dietary modifications for infantile colic.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415699/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394439/pdf']","['142_0_parent training programmes for managing infantile colic.pdf', '142_1_probiotics to prevent infantile colic.pdf', '142_2_dietary modifications for infantile colic.pdf']","[0.424, 0.357, 0.447]","[0.528, 0.524, 0.533]","[0.611, 0.608, 0.615]","[0.158, 0.15, 0.159]","[0.165, 0.155, 0.164]","[0.136, 0.124, 0.136]","[0.728, 0.728, 0.729]","[0.632, 0.632, 0.633]","[0.602, 0.598, 0.605]","[0.686, 0.681, 0.678]","[0.782, 0.781, 0.784]","[0.714, 0.711, 0.719]","[0.602, 0.594, 0.601]","[0.917, 0.91, 0.915]","[0.825, 0.823, 0.828]","[0.746, 0.739, 0.744]","[0.782, 0.777, 0.785]","[0.772, 0.766, 0.772]",0.409,0.528,0.611,0.156,0.161,0.132,0.728,0.632,0.602,0.682,0.782,0.715,0.599,0.914,0.825,0.743,0.781,0.77
https://doi.org/10.1001/archpedi.156.12.1216,the effect of volunteer home visitation for adolescent mothers on parenting and mental health outcomes,144_the effect of volunteer home visitation for adolescent mothers on parenting and mental health outcomes.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf']","['Support for healthy breastfeeding mothers with healthy term babies', 'Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children', 'Support for healthy breastfeeding mothers with healthy term babies']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf']","['144_2_support for healthy breastfeeding mothers with healthy term babies.pdf', '144_0_support for healthy breastfeeding mothers with healthy term babies.pdf', '144_1_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf']","['144_2_support for healthy breastfeeding mothers with healthy term babies.pdf', '144_0_support for healthy breastfeeding mothers with healthy term babies.pdf', '144_1_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf']","[0.254, 0.348, 0.273]","[0.536, 0.537, 0.529]","[0.606, 0.614, 0.603]","[0.147, 0.146, 0.169]","[0.155, 0.162, 0.174]","[0.132, 0.131, 0.149]","[0.727, 0.727, 0.734]","[0.633, 0.634, 0.639]","[0.597, 0.604, 0.589]","[0.677, 0.675, 0.698]","[0.79, 0.786, 0.78]","[0.707, 0.724, 0.714]","[0.591, 0.581, 0.593]","[0.913, 0.91, 0.901]","[0.819, 0.816, 0.816]","[0.732, 0.737, 0.724]","[0.785, 0.784, 0.775]","[0.761, 0.762, 0.751]",0.292,0.534,0.608,0.154,0.164,0.137,0.729,0.635,0.597,0.683,0.785,0.715,0.588,0.908,0.817,0.731,0.781,0.758
https://doi.org/10.1001/archpedi.156.2.131,weekly vs daily iron and folic acid supplementation in adolescent nepalese girls,148_weekly vs daily iron and folic acid supplementation in adolescent nepalese girls.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360921/pdf'],['Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360921/pdf'],['148_0_intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360921/pdf'],['148_0_intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women.pdf'],[0.461],[0.509],[0.595],[0.167],[0.171],[0.143],[0.733],[0.639],[0.579],[0.688],[0.774],[0.673],[0.593],[0.909],[0.811],[0.724],[0.769],[0.757],0.461,0.509,0.595,0.167,0.171,0.143,0.733,0.639,0.579,0.688,0.774,0.673,0.593,0.909,0.811,0.724,0.769,0.757
https://doi.org/10.1001/archpedi.156.3.280,violence exposure trauma and iq andor reading deficits among urban children,152_violence exposure trauma and iq andor reading deficits among urban children.pdf,8,"['https://www.rand.org/pubs/technical_reports/TR413.html', 'http://vcsc.virginia.gov/2008AnnualReport.pdf', 'http://www.vcsc.virginia.gov/2008AnnualReport.pdf', 'https://www.rand.org/pubs/technical_reports/TR991-1.html', 'https://www.rand.org/pubs/reprints/RP1379.html', 'https://www.tn.gov/content/dam/tn/education/safety/safe_sch/prepare_manual.pdf', 'https://louisvilleky.gov/sites/default/files/safe_neighborhoods/violence_and_learning.pdf', 'https://www.rti.org/publication/literacy-and-health-outcomes-volume-i-final-evidence-report']","['Student Traumatic Experience Recovery Toolkit', '2008 Annual Report', 'singlecover', 'What Are the Best Ways to Prevent and Reduce the Impact of Childrenâ\x80\x99s Exposure to Violence?', 'Effects of Student Displacement in Louisiana During the First Academic Year After the Hurricanes of 2005', 'Tennessee Department of Education', 'Violence and Learning', 'Literacy and health outcomes. Volume I. Final evidence report']","['http://www.vcsc.virginia.gov/2008AnnualReport.pdf', 'http://vcsc.virginia.gov/2008AnnualReport.pdf', 'https://www.tn.gov/content/dam/tn/education/safety/safe_sch/prepare_manual.pdf']","['152_2_singlecover.pdf', '152_1_2008 annual report.pdf', '152_5_tennessee department of education.pdf']",3,37.5,"['http://www.vcsc.virginia.gov/2008AnnualReport.pdf', 'http://vcsc.virginia.gov/2008AnnualReport.pdf', 'https://www.tn.gov/content/dam/tn/education/safety/safe_sch/prepare_manual.pdf']","['152_2_singlecover.pdf', '152_1_2008 annual report.pdf', '152_5_tennessee department of education.pdf']","[0.285, 0.285, 0.17]","[0.535, 0.535, 0.556]","[0.617, 0.617, 0.631]","[0.154, 0.154, 0.137]","[0.161, 0.161, 0.142]","[0.144, 0.144, 0.135]","[0.724, 0.724, 0.725]","[0.627, 0.627, 0.625]","[0.599, 0.599, 0.631]","[0.671, 0.671, 0.67]","[0.802, 0.802, 0.815]","[0.732, 0.732, 0.76]","[0.629, 0.629, 0.635]","[0.925, 0.925, 0.925]","[0.821, 0.821, 0.85]","[0.765, 0.765, 0.784]","[0.8, 0.8, 0.816]","[0.783, 0.783, 0.801]",0.247,0.542,0.622,0.148,0.155,0.141,0.724,0.626,0.61,0.671,0.806,0.741,0.631,0.925,0.831,0.771,0.805,0.789
https://doi.org/10.1001/archpedi.158.3.230,childhood immunization rates before and after the implementation of medicaid managed care,226_childhood immunization rates before and after the implementation of medicaid managed care.pdf,1,['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2004.pdf'],['Disease Services'],['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2004.pdf'],['226_0_disease services.pdf'],1,100.0,['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2004.pdf'],['226_0_disease services.pdf'],[0.273],[0.555],[0.627],[0.175],[0.172],[0.147],[0.735],[0.636],[0.625],[0.65],[0.818],[0.741],[0.636],[0.915],[0.833],[0.768],[0.807],[0.794],0.273,0.555,0.627,0.175,0.172,0.147,0.735,0.636,0.625,0.65,0.818,0.741,0.636,0.915,0.833,0.768,0.807,0.794
https://doi.org/10.1001/archpedi.158.3.262,reduced school dropout rates among adolescent mothers receiving schoolbased prenatal care,228_reduced school dropout rates among adolescent mothers receiving schoolbased prenatal care.pdf,1,['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast'],['Vol6_WebCover.indd'],['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast'],['228_0_vol6webcoverindd.pdf'],1,100.0,['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast'],['228_0_vol6webcoverindd.pdf'],[0.475],[0.499],[0.597],[0.148],[0.157],[0.131],[0.73],[0.631],[0.564],[0.669],[0.786],[0.699],[0.603],[0.915],[0.8],[0.74],[0.777],[0.768],0.475,0.499,0.597,0.148,0.157,0.131,0.73,0.631,0.564,0.669,0.786,0.699,0.603,0.915,0.8,0.74,0.777,0.768
https://doi.org/10.1001/archpedi.158.3.269,effects of an advocacy intervention to reduce smoking among teenagers,229_effects of an advocacy intervention to reduce smoking among teenagers.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://nam.edu/sixth-annual-dc-public-health-case-challenge-reducing-disparities-in-cancer-and-chronic-disease-preventing-tobacco-use-in-african-american-adolescents/', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'https://stacks.cdc.gov/view/cdc/5472', 'https://stacks.cdc.gov/view/cdc/42440', 'https://www.columbus.gov/uploadedFiles/Columbus/Departments/Public_Health/All_Programs/Health_Equity/Overcoming%20Obstacles%20to%20Health.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention', 'https://stacks.cdc.gov/view/cdc/5628']","['Tobacco cessation interventions for young people', 'Sixth Annual DC Public Health Case Challenge - Reducing Disparities in Cancer and Chronic Disease: Preventing Tobacco Use in African American Adolescents', 'Washington State Institute for Public Policy', 'Key outcome indicators for evaluating comprehensive tobacco control programs', 'Preventing initiation of tobacco use : outcome indicators for comprehensive tobacco control programs–2014', 'Overcoming Obstacles to Health', 'Washington State Institute for Public Policy', 'Best practices user guide; youth engagement--state and community interventions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf']","['229_0_tobacco cessation interventions for young people.pdf', '229_2_washington state institute for public policy.pdf']",2,25.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf']","['229_0_tobacco cessation interventions for young people.pdf', '229_2_washington state institute for public policy.pdf']","[0.424, 0.256]","[0.538, 0.519]","[0.61, 0.59]","[0.198, 0.157]","[0.208, 0.178]","[0.177, 0.149]","[0.74, 0.732]","[0.647, 0.638]","[0.602, 0.581]","[0.703, 0.697]","[0.793, 0.788]","[0.728, 0.718]","[0.601, 0.605]","[0.919, 0.918]","[0.831, 0.814]","[0.742, 0.743]","[0.785, 0.783]","[0.77, 0.769]",0.34,0.528,0.6,0.177,0.193,0.163,0.736,0.643,0.591,0.7,0.79,0.723,0.603,0.919,0.823,0.742,0.784,0.77
https://doi.org/10.1001/archpedi.158.4.377,effects of 2 prevention programs on highrisk behaviors among african american youth,232_effects of 2 prevention programs on highrisk behaviors among african american youth.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf', 'https://mathematica.org/publications/evaluation-of-adolescent-pregnancy-prevention-approaches-design-of-the-impact-study', 'https://purl.fdlp.gov/GPO/gpo75951', 'https://www.rand.org/pubs/research_reports/RR2133.html', 'https://purl.fdlp.gov/GPO/gpo122832', 'https://stacks.cdc.gov/view/cdc/6879']","['School‐based programmes for preventing smoking', 'Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people', 'School‐based interventions for improving contraceptive use in adolescents', 'Interventions for encouraging sexual behaviours intended to prevent cervical cancer', 'Evaluation of Adolescent Pregnancy Prevention Approaches: Design of the Impact Study', 'Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.', 'Social and Emotional Learning Interventions Under the ESSA', 'Facing addiction in America: the Surgeon General’s spotlight on opioids.', 'The Effectiveness of universal school-based programs for the prevention of violent and aggressive behavior; a report on recommendations of the Task Force on Community Preventive Services']","['https://purl.fdlp.gov/GPO/gpo75951', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://purl.fdlp.gov/GPO/gpo122832', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf']","['232_5_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '232_2_school‐based interventions for improving contraceptive use in adolescents.pdf', '232_0_school‐based programmes for preventing smoking.pdf', '232_7_facing addiction in america the surgeon generals spotlight on opioids.pdf', '232_1_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf', '232_3_interventions for encouraging sexual behaviours intended to prevent cervical cancer.pdf']",6,66.67,"['https://purl.fdlp.gov/GPO/gpo75951', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://purl.fdlp.gov/GPO/gpo122832', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf']","['232_5_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '232_2_school‐based interventions for improving contraceptive use in adolescents.pdf', '232_0_school‐based programmes for preventing smoking.pdf', '232_7_facing addiction in america the surgeon generals spotlight on opioids.pdf', '232_1_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf', '232_3_interventions for encouraging sexual behaviours intended to prevent cervical cancer.pdf']","[0.426, 0.437, 0.419, 0.325, 0.44, 0.297]","[0.524, 0.519, 0.515, 0.525, 0.51, 0.526]","[0.613, 0.592, 0.588, 0.615, 0.587, 0.601]","[0.148, 0.167, 0.162, 0.142, 0.165, 0.157]","[0.158, 0.178, 0.168, 0.146, 0.176, 0.164]","[0.131, 0.152, 0.142, 0.124, 0.148, 0.137]","[0.728, 0.735, 0.731, 0.724, 0.735, 0.728]","[0.631, 0.638, 0.634, 0.628, 0.639, 0.632]","[0.595, 0.581, 0.58, 0.593, 0.571, 0.593]","[0.669, 0.687, 0.701, 0.649, 0.702, 0.681]","[0.797, 0.773, 0.777, 0.805, 0.77, 0.783]","[0.72, 0.695, 0.686, 0.724, 0.681, 0.702]","[0.614, 0.598, 0.592, 0.618, 0.593, 0.6]","[0.927, 0.906, 0.923, 0.929, 0.914, 0.924]","[0.821, 0.809, 0.814, 0.823, 0.805, 0.817]","[0.76, 0.718, 0.732, 0.764, 0.716, 0.738]","[0.797, 0.773, 0.776, 0.805, 0.768, 0.784]","[0.783, 0.748, 0.763, 0.789, 0.749, 0.766]",0.391,0.52,0.599,0.157,0.165,0.139,0.73,0.634,0.586,0.682,0.784,0.701,0.602,0.921,0.815,0.738,0.784,0.766
https://doi.org/10.1001/archpedi.158.7.635,randomized trial of brief officebased interventions to reduce adolescent alcohol use,236_randomized trial of brief officebased interventions to reduce adolescent alcohol use.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491186/pdf'],['Effectiveness of brief alcohol interventions in primary care populations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491186/pdf'],['236_0_effectiveness of brief alcohol interventions in primary care populations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491186/pdf'],['236_0_effectiveness of brief alcohol interventions in primary care populations.pdf'],[0.483],[0.531],[0.606],[0.175],[0.188],[0.154],[0.734],[0.64],[0.594],[0.708],[0.787],[0.703],[0.593],[0.917],[0.822],[0.737],[0.781],[0.765],0.483,0.531,0.606,0.175,0.188,0.154,0.734,0.64,0.594,0.708,0.787,0.703,0.593,0.917,0.822,0.737,0.781,0.765
https://doi.org/10.1001/archpedi.158.8.721,combined effect of mothers and fathers mental health symptoms on childrens behavioral and emotional wellbeing,238_combined effect of mothers and fathers mental health symptoms on childrens behavioral and emotional wellbeing.pdf,8,"['https://www.acf.hhs.gov/opre/report/toddlers-early-head-start-portrait-3-year-olds-their-families-and-programs-serving-them', 'https://www.acf.hhs.gov/opre/report/baby-faces-2009-learning-we-go-first-snapshot-early-head-start-programs-staff-families', 'https://mathematica.org/publications/toddlers-in-early-head-start-a-portrait-of-3yearolds-their-families-and-the-programs-serving-them', 'https://www.acf.hhs.gov/opre/resource/toddlers-in-early-head-start-a-portrait-of-3-year-olds-their-families-and-the-programs-serving-them', 'https://www.rand.org/pubs/technical_reports/TR991-1.html', 'https://www.rand.org/pubs/research_reports/RR1728.html', 'https://www.ccf.ny.gov/files/7613/7968/7930/ECReportFullDoc.pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['Toddlers in Early Head Start: A Portrait of 3-Year-Olds, Their Families, and the Programs Serving Them', 'Baby FACES 2009: Learning As We Go: A First Snapshot of Early Head Start Programs, Staff, Families, and Children, Volume I: First Report', 'Toddlers in Early Head Start: A Portrait of 3-Year-Olds, Their Families, and the Programs Serving Them. Volume I: Age 3 Report', 'Toddlers in Early Head Start: A Portrait of 3-Year-Olds, Their Families, and the Programs Serving Them', 'What Are the Best Ways to Prevent and Reduce the Impact of Childrenâ\x80\x99s Exposure to Violence?', 'Improving Outcomes for Children Exposed to Violence', 'NYS Early Childhood Data Report :', 'TennCare II Demonstration']","['https://www.ccf.ny.gov/files/7613/7968/7930/ECReportFullDoc.pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['238_6_nys early childhood data report .pdf', '238_7_tenncare ii demonstration.pdf']",2,25.0,"['https://www.ccf.ny.gov/files/7613/7968/7930/ECReportFullDoc.pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['238_6_nys early childhood data report .pdf', '238_7_tenncare ii demonstration.pdf']","[0.439, 0.314]","[0.51, 0.505]","[0.6, 0.594]","[0.148, 0.113]","[0.157, 0.126]","[0.136, 0.107]","[0.73, 0.715]","[0.627, 0.615]","[0.577, 0.577]","[0.686, 0.67]","[0.782, 0.787]","[0.708, 0.716]","[0.615, 0.608]","[0.916, 0.919]","[0.812, 0.812]","[0.735, 0.741]","[0.779, 0.778]","[0.768, 0.764]",0.377,0.508,0.597,0.131,0.142,0.121,0.722,0.621,0.577,0.678,0.784,0.712,0.611,0.917,0.812,0.738,0.778,0.766
https://doi.org/10.1001/archpedi.159.1.75,shortterm impact of a randomized multifaceted intervention for wheezing infants in lowincome families,252_shortterm impact of a randomized multifaceted intervention for wheezing infants in lowincome families.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.rand.org/pubs/research_reports/RR1993.html', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://health.mo.gov/data/InterventionMICA/Asthma/5524.pdf']","['Home‐based educational interventions for children with asthma', ""Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke"", 'Trigger recognition and management in poorly controlled asthmatics', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', 'Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', 'Resource ID:']","['https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972064/pdf', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf']","['252_8_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '252_0_home‐based educational interventions for children with asthma.pdf', '252_6_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '252_2_trigger recognition and management in poorly controlled asthmatics.pdf', '252_3_psychological interventions for parents of children and adolescents with chronic illness.pdf', '252_1_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf', '252_5_psychological interventions for parents of children and adolescents with chronic illness.pdf', '252_4_psychological interventions for parents of children and adolescents with chronic illness.pdf']",8,80.0,"['https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972064/pdf', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf']","['252_8_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '252_0_home‐based educational interventions for children with asthma.pdf', '252_6_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '252_2_trigger recognition and management in poorly controlled asthmatics.pdf', '252_3_psychological interventions for parents of children and adolescents with chronic illness.pdf', '252_1_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf', '252_5_psychological interventions for parents of children and adolescents with chronic illness.pdf', '252_4_psychological interventions for parents of children and adolescents with chronic illness.pdf']","[0.517, 0.485, 0.325, 0.36, 0.308, 0.331, 0.465, 0.465]","[0.541, 0.546, 0.541, 0.524, 0.528, 0.541, 0.516, 0.513]","[0.627, 0.628, 0.627, 0.619, 0.614, 0.622, 0.604, 0.605]","[0.171, 0.183, 0.171, 0.18, 0.149, 0.176, 0.152, 0.143]","[0.181, 0.192, 0.181, 0.197, 0.155, 0.174, 0.149, 0.154]","[0.143, 0.152, 0.143, 0.153, 0.119, 0.144, 0.123, 0.117]","[0.739, 0.738, 0.739, 0.741, 0.729, 0.735, 0.732, 0.729]","[0.642, 0.642, 0.642, 0.643, 0.632, 0.639, 0.636, 0.634]","[0.611, 0.61, 0.611, 0.597, 0.593, 0.604, 0.58, 0.577]","[0.664, 0.681, 0.664, 0.684, 0.68, 0.682, 0.684, 0.681]","[0.805, 0.797, 0.805, 0.79, 0.777, 0.79, 0.776, 0.768]","[0.729, 0.721, 0.729, 0.702, 0.718, 0.716, 0.7, 0.702]","[0.614, 0.603, 0.614, 0.596, 0.578, 0.608, 0.582, 0.568]","[0.924, 0.924, 0.924, 0.924, 0.914, 0.918, 0.916, 0.909]","[0.822, 0.829, 0.822, 0.823, 0.813, 0.823, 0.809, 0.803]","[0.765, 0.75, 0.765, 0.747, 0.739, 0.74, 0.722, 0.727]","[0.794, 0.79, 0.794, 0.785, 0.771, 0.785, 0.764, 0.758]","[0.786, 0.778, 0.786, 0.778, 0.762, 0.768, 0.753, 0.747]",0.407,0.531,0.618,0.166,0.173,0.137,0.735,0.639,0.598,0.678,0.788,0.715,0.595,0.919,0.818,0.744,0.78,0.77
https://doi.org/10.1001/archpedi.159.10.907,safety immunogenicity and immune memory of a novel meningococcal groups a c y and w135 polysaccharide diphtheria toxoid conjugate vaccine mcv4 in healthy adolescents,253_safety immunogenicity and immune memory of a novel meningococcal groups a c y and w135 polysaccharide diphtheria toxoid conjugate vaccine mcv4 in healthy adolescents.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf', 'https://stacks.cdc.gov/view/cdc/95034', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2231559/pdf', 'https://stacks.cdc.gov/view/cdc/13320']","['Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020', 'Meningococcal vaccination : 5ecommendations of the Advisory Committee on Immunization Practices, United States, 2020', 'Emerging vaccines - Evidence and considerations for practice integration', 'Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2231559/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf']","['253_2_emerging vaccines  evidence and considerations for practice integration.pdf', '253_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2231559/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf']","['253_2_emerging vaccines  evidence and considerations for practice integration.pdf', '253_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf']","[0.46, 0.307]","[0.545, 0.541]","[0.619, 0.619]","[0.192, 0.203]","[0.204, 0.214]","[0.174, 0.185]","[0.742, 0.751]","[0.649, 0.662]","[0.615, 0.609]","[0.669, 0.661]","[0.8, 0.793]","[0.737, 0.714]","[0.638, 0.624]","[0.922, 0.915]","[0.82, 0.821]","[0.769, 0.763]","[0.797, 0.783]","[0.783, 0.774]",0.384,0.543,0.619,0.198,0.209,0.179,0.746,0.655,0.612,0.665,0.796,0.726,0.631,0.919,0.821,0.766,0.79,0.778
https://doi.org/10.1001/archpedi.159.11.1038,iron deficiency prolonged bottlefeeding and racialethnic disparities in young children,257_iron deficiency prolonged bottlefeeding and racialethnic disparities in young children.pdf,2,"['http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://www.dhcs.ca.gov/formsandpubs/publications/CaliforniaFoodGuide/16HealthandDietaryIssuesAffectingLatinos.pdf']","['California Food Guide :', 'California Food Guide: Health and Dietary Issues Affecting Latinos']",['http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf'],['257_0_california food guide .pdf'],1,50.0,['http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf'],['257_0_california food guide .pdf'],[0.295],[0.514],[0.606],[0.141],[0.151],[0.123],[0.727],[0.621],[0.602],[0.665],[0.802],[0.721],[0.616],[0.919],[0.822],[0.754],[0.796],[0.782],0.295,0.514,0.606,0.141,0.151,0.123,0.727,0.621,0.602,0.665,0.802,0.721,0.616,0.919,0.822,0.754,0.796,0.782
https://doi.org/10.1001/archpedi.160.1.18,effects of alcohol advertising exposure on drinking among youth,281_effects of alcohol advertising exposure on drinking among youth.pdf,3,"['https://purl.fdlp.gov/GPO/gpo75951', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486123/pdf', 'https://legislature.idaho.gov/wp-content/uploads/budget/committee/mill/2016/2.Applications%20and%20Forms/02.Member%20Packet%20Day%202.pdf']","['Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.', 'Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents', 'Agenda Revised']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486123/pdf', 'https://purl.fdlp.gov/GPO/gpo75951', 'https://legislature.idaho.gov/wp-content/uploads/budget/committee/mill/2016/2.Applications%20and%20Forms/02.Member%20Packet%20Day%202.pdf']","['281_1_restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents.pdf', '281_0_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '281_2_agenda revised.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486123/pdf', 'https://purl.fdlp.gov/GPO/gpo75951', 'https://legislature.idaho.gov/wp-content/uploads/budget/committee/mill/2016/2.Applications%20and%20Forms/02.Member%20Packet%20Day%202.pdf']","['281_1_restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents.pdf', '281_0_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '281_2_agenda revised.pdf']","[0.272, 0.537, 0.155]","[0.502, 0.482, 0.484]","[0.592, 0.583, 0.57]","[0.167, 0.134, 0.108]","[0.184, 0.15, 0.123]","[0.157, 0.119, 0.104]","[0.731, 0.726, 0.721]","[0.631, 0.628, 0.619]","[0.559, 0.546, 0.547]","[0.722, 0.676, 0.676]","[0.756, 0.761, 0.755]","[0.701, 0.701, 0.703]","[0.59, 0.594, 0.608]","[0.878, 0.883, 0.883]","[0.789, 0.779, 0.787]","[0.681, 0.687, 0.685]","[0.759, 0.763, 0.763]","[0.705, 0.709, 0.707]",0.321,0.489,0.582,0.136,0.152,0.127,0.726,0.626,0.551,0.691,0.757,0.702,0.597,0.881,0.785,0.684,0.762,0.707
https://doi.org/10.1001/archpedi.160.1.25,neighborhood safety and overweight status in children,282_neighborhood safety and overweight status in children.pdf,9,"['https://papers.nber.org/papers/w14985', 'https://www.nber.org/papers/w15436', 'https://www.nber.org/papers/w17369', 'https://louisvilleky.gov/sites/default/files/safe_neighborhoods/violence_and_chronic_illness.pdf', 'https://www.dhcs.ca.gov/formsandpubs/publications/CaliforniaFoodGuide/21BodyWeight.pdf', 'https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP6Plan.pdf', 'https://www.rand.org/pubs/technical_reports/TR751.html', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943460-3']","['The Relationship Between Neighborhood Quality and Obesity Among Children', 'Effects of Urban Sprawl on Obesity', 'The Effects of Housing and Neighborhood Conditions on Child Mortality', 'Violence and Chronic Illness', 'California Food Guide: Body Weight', 'Microsoft Word - RHP 6 Plan FINAL REVISED_030813_CLEAN.docx', 'Major Health Care Challenges Persist for D.C. Children Despite High Rates of Insurance Coverage', 'California Food Guide :', 'Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society']","['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP6Plan.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf']","['282_5_microsoft word  rhp 6 plan final revised030813cleandocx.pdf', '282_7_california food guide .pdf']",2,22.22,"['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP6Plan.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf']","['282_5_microsoft word  rhp 6 plan final revised030813cleandocx.pdf', '282_7_california food guide .pdf']","[0.185, 0.272]","[0.566, 0.523]","[0.64, 0.619]","[0.143, 0.127]","[0.145, 0.139]","[0.11, 0.104]","[0.717, 0.718]","[0.614, 0.612]","[0.636, 0.602]","[0.638, 0.657]","[0.814, 0.802]","[0.756, 0.729]","[0.636, 0.611]","[0.927, 0.922]","[0.841, 0.825]","[0.78, 0.757]","[0.816, 0.799]","[0.79, 0.782]",0.229,0.544,0.629,0.135,0.142,0.107,0.718,0.613,0.619,0.647,0.808,0.742,0.623,0.925,0.833,0.768,0.807,0.786
https://doi.org/10.1001/archpedi.160.1.40,weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone oral contraceptive pills or no hormonal contraceptive method,283_weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone oral contraceptive pills or no hormonal contraceptive method.pdf,7,"['https://stacks.cdc.gov/view/cdc/40516', 'https://stacks.cdc.gov/view/cdc/7106', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855691/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034734/pdf', 'https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6503.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646426/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2809%2900379-5']","['U.S. medical eligibility criteria for contraceptive use, 2016', 'U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition', 'Progestin-only contraceptives: effects on weight', 'Progestin‐only contraceptives: effects on weight', 'U.S. Medical Eligibility Criteria for Contraceptive Use, 2016', 'Progestin-only contraceptives: effects on weight', 'Contraceptive considerations in obese women']","['https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6503.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034734/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855691/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646426/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2809%2900379-5']","['283_4_us medical eligibility criteria for contraceptive use 2016.pdf', '283_3_progestin‐only contraceptives effects on weight.pdf', '283_2_progestinonly contraceptives effects on weight.pdf', '283_5_progestinonly contraceptives effects on weight.pdf', '283_6_contraceptive considerations in obese women.pdf']",5,71.43,"['https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6503.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034734/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855691/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646426/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2809%2900379-5']","['283_4_us medical eligibility criteria for contraceptive use 2016.pdf', '283_3_progestin‐only contraceptives effects on weight.pdf', '283_2_progestinonly contraceptives effects on weight.pdf', '283_5_progestinonly contraceptives effects on weight.pdf', '283_6_contraceptive considerations in obese women.pdf']","[0.597, 0.583, 0.362, 0.541, 0.422]","[0.544, 0.514, 0.527, 0.52, 0.557]","[0.62, 0.591, 0.604, 0.598, 0.624]","[0.165, 0.18, 0.183, 0.174, 0.204]","[0.177, 0.193, 0.201, 0.196, 0.221]","[0.15, 0.162, 0.165, 0.16, 0.188]","[0.739, 0.741, 0.739, 0.736, 0.74]","[0.64, 0.643, 0.642, 0.641, 0.642]","[0.612, 0.573, 0.594, 0.584, 0.62]","[0.64, 0.685, 0.681, 0.68, 0.666]","[0.8, 0.77, 0.782, 0.776, 0.805]","[0.701, 0.677, 0.691, 0.688, 0.721]","[0.618, 0.594, 0.598, 0.588, 0.61]","[0.914, 0.897, 0.909, 0.905, 0.914]","[0.822, 0.801, 0.805, 0.804, 0.821]","[0.764, 0.721, 0.743, 0.739, 0.765]","[0.79, 0.763, 0.777, 0.768, 0.796]","[0.782, 0.749, 0.765, 0.759, 0.785]",0.501,0.532,0.607,0.181,0.198,0.165,0.739,0.642,0.597,0.67,0.787,0.696,0.602,0.908,0.811,0.746,0.779,0.768
https://doi.org/10.1001/archpedi.160.1.82,multisite controlled study of oros methylphenidate in the treatment of adolescents with attentiondeficithyperactivity disorder,285_multisite controlled study of oros methylphenidate in the treatment of adolescents with attentiondeficithyperactivity disorder.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763351/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2962182-1', 'https://dss.mo.gov/mhd/cs/psych/pdf/jaacap_adhd2007.pdf']","['Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)', 'Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies', 'Practice Parameter for the Assessment and Treatmentof Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder', 'chi20421 894..921']","['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2962182-1', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763351/pdf', 'https://dss.mo.gov/mhd/cs/psych/pdf/jaacap_adhd2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf']","['285_2_practice parameter for the assessment and treatmentof children and adolescents with attentiondeficit hyperactivity disorder.pdf', '285_0_methylphenidate for children and adolescents with attention deficit hyperactivity disorder adhd.pdf', '285_3_chi20421 894921.pdf', '285_1_methylphenidate for attention deficit hyperactivity disorder adhd in children and adolescents – assessment of adverse events in non‐randomised studies.pdf']",4,100.0,"['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2962182-1', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763351/pdf', 'https://dss.mo.gov/mhd/cs/psych/pdf/jaacap_adhd2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf']","['285_2_practice parameter for the assessment and treatmentof children and adolescents with attentiondeficit hyperactivity disorder.pdf', '285_0_methylphenidate for children and adolescents with attention deficit hyperactivity disorder adhd.pdf', '285_3_chi20421 894921.pdf', '285_1_methylphenidate for attention deficit hyperactivity disorder adhd in children and adolescents – assessment of adverse events in non‐randomised studies.pdf']","[0.497, 0.515, 0.583, 0.583]","[0.562, 0.516, 0.562, 0.518]","[0.637, 0.606, 0.637, 0.608]","[0.224, 0.197, 0.224, 0.197]","[0.228, 0.198, 0.228, 0.199]","[0.188, 0.169, 0.188, 0.171]","[0.746, 0.743, 0.746, 0.742]","[0.653, 0.648, 0.653, 0.648]","[0.626, 0.582, 0.626, 0.583]","[0.699, 0.707, 0.699, 0.702]","[0.811, 0.782, 0.811, 0.782]","[0.742, 0.689, 0.742, 0.7]","[0.627, 0.59, 0.627, 0.595]","[0.925, 0.917, 0.925, 0.911]","[0.827, 0.812, 0.827, 0.81]","[0.777, 0.734, 0.777, 0.73]","[0.804, 0.774, 0.804, 0.775]","[0.793, 0.763, 0.793, 0.759]",0.544,0.54,0.622,0.211,0.213,0.179,0.744,0.651,0.604,0.702,0.796,0.718,0.61,0.92,0.819,0.755,0.789,0.777
https://doi.org/10.1001/archpedi.160.11.1108,double burden of iron deficiency in infancy and low socioeconomic status,287_double burden of iron deficiency in infancy and low socioeconomic status.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092533/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053594/pdf', 'https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/iron-deficiency-anemia-in-young-children-screening']","['Intermittent oral iron supplementation during pregnancy', 'Daily oral iron supplementation during pregnancy', 'Daily oral iron supplementation during pregnancy', 'Intermittent oral iron supplementation during pregnancy (Review)', 'Final Update Summary: Iron Deficiency Anemia in Young Children: Screening Task Force']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053594/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092533/pdf']","['287_3_intermittent oral iron supplementation during pregnancy review.pdf', '287_1_daily oral iron supplementation during pregnancy.pdf', '287_2_daily oral iron supplementation during pregnancy.pdf', '287_0_intermittent oral iron supplementation during pregnancy.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053594/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092533/pdf']","['287_3_intermittent oral iron supplementation during pregnancy review.pdf', '287_1_daily oral iron supplementation during pregnancy.pdf', '287_2_daily oral iron supplementation during pregnancy.pdf', '287_0_intermittent oral iron supplementation during pregnancy.pdf']","[0.362, 0.399, 0.401, 0.347]","[0.516, 0.511, 0.512, 0.512]","[0.603, 0.592, 0.599, 0.593]","[0.152, 0.169, 0.15, 0.167]","[0.156, 0.156, 0.155, 0.157]","[0.124, 0.133, 0.121, 0.133]","[0.728, 0.733, 0.727, 0.734]","[0.632, 0.636, 0.631, 0.635]","[0.589, 0.576, 0.586, 0.58]","[0.674, 0.688, 0.679, 0.682]","[0.776, 0.777, 0.777, 0.777]","[0.706, 0.684, 0.706, 0.688]","[0.574, 0.587, 0.58, 0.592]","[0.911, 0.904, 0.904, 0.905]","[0.805, 0.8, 0.802, 0.804]","[0.729, 0.72, 0.725, 0.722]","[0.774, 0.772, 0.774, 0.774]","[0.758, 0.751, 0.751, 0.753]",0.377,0.513,0.597,0.16,0.156,0.128,0.73,0.633,0.583,0.681,0.777,0.696,0.583,0.906,0.803,0.724,0.774,0.753
https://doi.org/10.1001/archpedi.160.12.1241,the other children,291_the other children.pdf,3,"['https://dss.mo.gov/re/pdf/eliminating-child-abuse.pdf', 'https://dss.mo.gov/re/pdf/cfrar/2019-eliminating-child-abuse-and-neglect.pdf', 'https://dss.mo.gov/re/pdf/cfrar/2021-eliminating-child-abuse-and-neglect.pdf']","['Executive Report - Child Fatality Review Panel Subcommittee On Child Abuse And Neglect Fatalities', 'Executive Report - Child Fatality Review Panel Subcommittee On Child Abuse And Neglect Fatalities', 'Executive Report - Child Fatality Review Panel Subcommittee On Child Abuse And Neglect Fatalities']","['https://dss.mo.gov/re/pdf/cfrar/2019-eliminating-child-abuse-and-neglect.pdf', 'https://dss.mo.gov/re/pdf/cfrar/2021-eliminating-child-abuse-and-neglect.pdf', 'https://dss.mo.gov/re/pdf/eliminating-child-abuse.pdf']","['291_1_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf', '291_2_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf', '291_0_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf']",3,100.0,"['https://dss.mo.gov/re/pdf/cfrar/2019-eliminating-child-abuse-and-neglect.pdf', 'https://dss.mo.gov/re/pdf/cfrar/2021-eliminating-child-abuse-and-neglect.pdf', 'https://dss.mo.gov/re/pdf/eliminating-child-abuse.pdf']","['291_1_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf', '291_2_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf', '291_0_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf']","[0.557, 0.557, 0.558]","[0.601, 0.6, 0.601]","[0.67, 0.67, 0.67]","[0.227, 0.229, 0.227]","[0.247, 0.25, 0.247]","[0.205, 0.206, 0.205]","[0.743, 0.744, 0.743]","[0.645, 0.647, 0.645]","[0.662, 0.662, 0.662]","[0.685, 0.685, 0.685]","[0.83, 0.83, 0.83]","[0.779, 0.784, 0.779]","[0.651, 0.649, 0.651]","[0.925, 0.926, 0.925]","[0.859, 0.86, 0.859]","[0.799, 0.797, 0.799]","[0.835, 0.832, 0.835]","[0.819, 0.818, 0.819]",0.557,0.601,0.67,0.228,0.248,0.205,0.743,0.646,0.662,0.685,0.83,0.781,0.65,0.925,0.859,0.798,0.834,0.819
https://doi.org/10.1001/archpedi.160.12.1269,youth,293_youth.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf'],['293_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf'],['293_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.523],[0.523],[0.61],[0.166],[0.17],[0.136],[0.732],[0.635],[0.599],[0.686],[0.787],[0.713],[0.597],[0.919],[0.825],[0.742],[0.788],[0.775],0.523,0.523,0.61,0.166,0.17,0.136,0.732,0.635,0.599,0.686,0.787,0.713,0.597,0.919,0.825,0.742,0.788,0.775
https://doi.org/10.1001/archpedi.160.12.1285,the extent to which tobacco marketing and tobacco use in films contribute to childrens use of tobacco,295_the extent to which tobacco marketing and tobacco use in films contribute to childrens use of tobacco.pdf,3,"['https://www.congress.gov/event/110th-congress/senate-event/LC8595/text', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf']","['S.Hrg. 110-100 — THE NEED FOR FDA REGULATION OF TOBACCO PRODUCTS', 'Preventing Tobacco Use Among Youth and Young Adults', 'AHA Scientific Statement Population Approaches to Improve Diet, Physical Activity, and Smoking Habits A Scientific Statement From the American Heart Association']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf'],['295_2_aha scientific statement population approaches to improve diet physical activity and smoking habits a scientific statement from the american heart association.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf'],['295_2_aha scientific statement population approaches to improve diet physical activity and smoking habits a scientific statement from the american heart association.pdf'],[0.366],[0.483],[0.588],[0.148],[0.161],[0.127],[0.73],[0.634],[0.571],[0.7],[0.763],[0.67],[0.58],[0.917],[0.814],[0.723],[0.765],[0.76],0.366,0.483,0.588,0.148,0.161,0.127,0.73,0.634,0.571,0.7,0.763,0.67,0.58,0.917,0.814,0.723,0.765,0.76
https://doi.org/10.1001/archpedi.160.8.793,healthy steps in an integrated delivery system,305_healthy steps in an integrated delivery system.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.acf.hhs.gov/opre/report/design-mother-and-infant-home-visiting-program-evaluation-strong-start', 'https://www.acf.hhs.gov/opre/report/what-evidence-says-intimate-partner-violence-and-home-visiting', 'https://mathematica.org/publications/what-the-evidence-says-intimate-partner-violence-and-home-visiting', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.acf.hhs.gov/opre/resource/what-the-evidence-says-intimate-partner-violence-and-home-visiting', 'https://www.cbpp.org/research/effective-evidence-based-home-visiting-programs-in-every-state-at-risk-if-congress-does-not', 'https://www.acf.hhs.gov/opre/resource/design-mother-infant-home-visiting-program-evaluation-strong-start']","['Parenting interventions for the prevention of unintentional injuries in childhood', 'Design for the Mother and Infant Home Visiting Program Evaluation—Strong Start', 'What the Evidence Says: Intimate Partner Violence and Home Visiting', 'What the Evidence Says: Intimate Partner Violence and Home Visiting', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'What the Evidence Says: Intimate Partner Violence and Home Visiting', 'Effective, Evidence-Based Home Visiting Programs in Every State at Risk if Congress Does Not Extend Funding', 'Design for the Mother and Infant Home Visiting Program Evaluation—Strong Start']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf'],['305_0_parenting interventions for the prevention of unintentional injuries in childhood.pdf'],1,12.5,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf'],['305_0_parenting interventions for the prevention of unintentional injuries in childhood.pdf'],[0.522],[0.514],[0.593],[0.168],[0.171],[0.149],[0.731],[0.637],[0.57],[0.709],[0.76],[0.706],[0.571],[0.881],[0.777],[0.68],[0.761],[0.707],0.522,0.514,0.593,0.168,0.171,0.149,0.731,0.637,0.57,0.709,0.76,0.706,0.571,0.881,0.777,0.68,0.761,0.707
https://doi.org/10.1001/archpedi.160.9.876,longterm effects of universal preventive interventions on methamphetamine use among adolescents,308_longterm effects of universal preventive interventions on methamphetamine use among adolescents.pdf,5,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf', 'https://courts.michigan.gov/News-Events/Documents/RJOI%20REPORT_FINAL_August2019.pdf', 'http://www.wsipp.wa.gov/ReportFile/1563/Wsipp_Preventing-Youth-Substance-Use-A-Review-of-Thirteen-Programs_Benefit-Cost-Results.pdf']","['Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'WashingtonS tate Institute for Public Policy', 'REGIONAL JUDICIAL OPIOID INITIATIVE Action Research Partner Report August 2019', 'Washington State Institute for Public Policy']","['http://www.wsipp.wa.gov/ReportFile/1563/Wsipp_Preventing-Youth-Substance-Use-A-Review-of-Thirteen-Programs_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf']","['308_4_washington state institute for public policy.pdf', '308_0_washington state institute for public policy.pdf', '308_1_washington state institute for public policy.pdf', '308_2_washingtons tate institute for public policy.pdf']",4,80.0,"['http://www.wsipp.wa.gov/ReportFile/1563/Wsipp_Preventing-Youth-Substance-Use-A-Review-of-Thirteen-Programs_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf']","['308_4_washington state institute for public policy.pdf', '308_0_washington state institute for public policy.pdf', '308_1_washington state institute for public policy.pdf', '308_2_washingtons tate institute for public policy.pdf']","[0.246, 0.261, 0.289, 0.286]","[0.533, 0.529, 0.514, 0.525]","[0.606, 0.603, 0.591, 0.596]","[0.158, 0.153, 0.147, 0.155]","[0.18, 0.169, 0.164, 0.172]","[0.146, 0.138, 0.133, 0.141]","[0.731, 0.731, 0.73, 0.731]","[0.637, 0.637, 0.636, 0.638]","[0.606, 0.6, 0.583, 0.593]","[0.693, 0.687, 0.689, 0.692]","[0.799, 0.799, 0.791, 0.795]","[0.74, 0.733, 0.719, 0.729]","[0.612, 0.607, 0.604, 0.609]","[0.92, 0.919, 0.914, 0.915]","[0.83, 0.829, 0.818, 0.823]","[0.763, 0.758, 0.747, 0.754]","[0.799, 0.799, 0.789, 0.793]","[0.784, 0.784, 0.775, 0.779]",0.271,0.525,0.599,0.153,0.171,0.14,0.731,0.637,0.595,0.69,0.796,0.73,0.608,0.917,0.825,0.755,0.795,0.78
https://doi.org/10.1001/archpedi.161.10.986,homelessness and health care access after emancipation,312_homelessness and health care access after emancipation.pdf,10,"['https://www.acf.hhs.gov/opre/resource/planning-a-next-generation-evaluation-agenda-for-the-john-h-chafee-foster-care-independence-program', 'https://www.urban.org/research/publication/improving-outcomes-transitional-youth', 'https://www.colorado.gov/pacific/sites/default/files/PSD_SDOH_Homelessness_long.pdf', 'https://isc.idaho.gov/cp/docs/FAQ-Fostering%20Connections%20for%20older%20youth.pdf', 'https://www.library.ca.gov/Content/pdf/crb/reports/08-010.pdf', 'https://bscc.ca.gov/wp-content/uploads/JOJJVol1_Iss2.pdf', 'https://www.urban.org/research/publication/planning-next-generation-evaluation-agenda-john-h-chafee-foster-care-independence-program', 'https://www.acf.hhs.gov/opre/report/planning-next-generation-evaluation-agenda-john-h-chafee-foster-care-independence', 'https://mathematica.org/publications/housing-for-youth-aging-out-of-foster-care', 'https://mathematica.org/publications/housing-for-youth-aging-out-of-foster-care-a-review-of-the-literature-and-program-typology']","['Planning a Next-Generation Evaluation Agenda for the John H. Chafee Foster Care Independence Program', 'Improving Outcomes for Transitional Youth', 'HOMELESSNESS AND HEALTH', 'Fostering Connections to Success and Increasing Adoptions Act', 'Homeless Youth: Bibliography and Resources', 'OJJDP Journal of Juvenile Justice, Volume 1, Issue 2, Spring 2012', 'Planning a Next-Generation Evaluation Agenda for the John H. Chafee Foster Care Independence Program', 'Planning a Next-Generation Evaluation Agenda for the John H. Chafee Foster Care Independence Program', 'Housing for Youth Aging Out of Foster Care', 'Housing for Youth Aging Out of Foster Care: A Review of the Literature and Program Typology']",['https://isc.idaho.gov/cp/docs/FAQ-Fostering%20Connections%20for%20older%20youth.pdf'],['312_3_fostering connections to success and increasing adoptions act.pdf'],1,10.0,['https://isc.idaho.gov/cp/docs/FAQ-Fostering%20Connections%20for%20older%20youth.pdf'],['312_3_fostering connections to success and increasing adoptions act.pdf'],[0.422],[0.51],[0.604],[0.15],[0.171],[0.138],[0.722],[0.619],[0.573],[0.652],[0.789],[0.717],[0.606],[0.914],[0.827],[0.749],[0.783],[0.769],0.422,0.51,0.604,0.15,0.171,0.138,0.722,0.619,0.573,0.652,0.789,0.717,0.606,0.914,0.827,0.749,0.783,0.769
https://doi.org/10.1001/archpedi.161.11.1035,prevalence of positive substance abuse screen results among adolescent primary care patients,314_prevalence of positive substance abuse screen results among adolescent primary care patients.pdf,8,"['https://www.acf.hhs.gov/opre/report/nscaw-ii-baseline-report-childrens-services', 'https://www.acf.hhs.gov/opre/report/nscaw-ii-baseline-report-child-well-being-final-report', 'https://www.acf.hhs.gov/opre/report/nscaw-ii-wave-2-report-child-well-being', 'https://purl.fdlp.gov/GPO/gpo119727', 'https://www.acf.hhs.gov/opre/resource/nscaw-ii-baseline-report-child-well-being-final-report', 'https://www.acf.hhs.gov/opre/resource/nscaw-ii-wave-2-report-child-well-being', 'https://www.acf.hhs.gov/opre/resource/nscaw-ii-baseline-report-childrens-services', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf']","['NSCAW II Baseline Report: Children’s Services', 'NSCAW II Baseline Report: Child Well-Being, Final Report', 'NSCAW II Wave 2 Report: Child Well-Being', 'The President’s Commission on Combating Drug Addiction and the Opioid Crisis.', 'NSCAW II Baseline Report: Child Well-Being, Final Report', 'NSCAW II Wave 2 Report: Child Well-Being', 'NSCAW II Baseline Report: Children’s Services', 'Best Practices']","['https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'https://purl.fdlp.gov/GPO/gpo119727']","['314_7_best practices.pdf', '314_3_the presidents commission on combating drug addiction and the opioid crisis.pdf']",2,25.0,"['https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'https://purl.fdlp.gov/GPO/gpo119727']","['314_7_best practices.pdf', '314_3_the presidents commission on combating drug addiction and the opioid crisis.pdf']","[0.422, 0.429]","[0.511, 0.513]","[0.599, 0.604]","[0.146, 0.156]","[0.155, 0.165]","[0.134, 0.136]","[0.729, 0.725]","[0.631, 0.627]","[0.578, 0.582]","[0.684, 0.664]","[0.782, 0.792]","[0.707, 0.72]","[0.605, 0.621]","[0.909, 0.912]","[0.816, 0.823]","[0.746, 0.754]","[0.786, 0.795]","[0.771, 0.776]",0.425,0.512,0.601,0.151,0.16,0.135,0.727,0.629,0.58,0.674,0.787,0.714,0.613,0.911,0.819,0.75,0.79,0.774
https://doi.org/10.1001/archpedi.161.11.1068,randomized doubleblind placebocontrolled trial of 2 dosages of sustainedrelease bupropion for adolescent smoking cessation,315_randomized doubleblind placebocontrolled trial of 2 dosages of sustainedrelease bupropion for adolescent smoking cessation.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027688/pdf', 'https://www.thoracic.org/statements/resources/hcpeeolc/tobacco-control.pdf']","['Antidepressants for smoking cessation', 'Tobacco cessation interventions for young people', 'Antidepressants for smoking cessation', 'An Official American Thoracic Society Research Statement: Current Understanding and Future Research Needs in Tobacco Control and Treatment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027688/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175455/pdf', 'https://www.thoracic.org/statements/resources/hcpeeolc/tobacco-control.pdf']","['315_1_tobacco cessation interventions for young people.pdf', '315_2_antidepressants for smoking cessation.pdf', '315_0_antidepressants for smoking cessation.pdf', '315_3_an official american thoracic society research statement current understanding and future research needs in tobacco control and treatment.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027688/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175455/pdf', 'https://www.thoracic.org/statements/resources/hcpeeolc/tobacco-control.pdf']","['315_1_tobacco cessation interventions for young people.pdf', '315_2_antidepressants for smoking cessation.pdf', '315_0_antidepressants for smoking cessation.pdf', '315_3_an official american thoracic society research statement current understanding and future research needs in tobacco control and treatment.pdf']","[0.468, 0.459, 0.49, 0.393]","[0.515, 0.508, 0.506, 0.51]","[0.595, 0.592, 0.592, 0.599]","[0.183, 0.18, 0.177, 0.163]","[0.191, 0.185, 0.178, 0.174]","[0.156, 0.152, 0.151, 0.138]","[0.739, 0.739, 0.738, 0.735]","[0.645, 0.646, 0.645, 0.638]","[0.587, 0.585, 0.584, 0.592]","[0.703, 0.701, 0.703, 0.677]","[0.783, 0.783, 0.779, 0.791]","[0.69, 0.683, 0.683, 0.707]","[0.589, 0.586, 0.571, 0.604]","[0.91, 0.911, 0.909, 0.911]","[0.815, 0.806, 0.808, 0.816]","[0.731, 0.731, 0.722, 0.747]","[0.777, 0.776, 0.771, 0.789]","[0.762, 0.76, 0.754, 0.77]",0.453,0.51,0.595,0.176,0.182,0.149,0.738,0.643,0.587,0.696,0.784,0.691,0.587,0.91,0.811,0.733,0.778,0.761
https://doi.org/10.1001/archpedi.161.12.1162,health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the united states,318_health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the united states.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005045/pdf', 'https://stacks.cdc.gov/view/cdc/7454', 'https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_LabNucleic.pdf', 'https://stacks.cdc.gov/view/cdc/7327']","['Validation of the Pediatric Infectious Diseases Society–Infectious Diseases Society of America Severity Criteria in Children With Community-Acquired Pneumonia', 'Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Morbidity and Mortality Weekly Report www. cdc. gov / mmwr', 'Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis']","['https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_LabNucleic.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005045/pdf']","['318_2_morbidity and mortality weekly report www cdc gov  mmwr.pdf', '318_0_validation of the pediatric infectious diseases society–infectious diseases society of america severity criteria in children with communityacquired pneumonia.pdf']",2,50.0,"['https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_LabNucleic.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005045/pdf']","['318_2_morbidity and mortality weekly report www cdc gov  mmwr.pdf', '318_0_validation of the pediatric infectious diseases society–infectious diseases society of america severity criteria in children with communityacquired pneumonia.pdf']","[0.317, 0.353]","[0.507, 0.531]","[0.595, 0.599]","[0.16, 0.178]","[0.162, 0.179]","[0.137, 0.145]","[0.732, 0.734]","[0.637, 0.64]","[0.576, 0.597]","[0.678, 0.694]","[0.783, 0.783]","[0.681, 0.701]","[0.607, 0.619]","[0.898, 0.907]","[0.808, 0.814]","[0.731, 0.745]","[0.776, 0.786]","[0.756, 0.766]",0.335,0.519,0.597,0.169,0.17,0.141,0.733,0.639,0.587,0.686,0.783,0.691,0.613,0.903,0.811,0.738,0.781,0.761
https://doi.org/10.1001/archpedi.161.12.1197,persistence and remission in childhood asthma,319_persistence and remission in childhood asthma.pdf,1,['https://www.thoracic.org/statements/resources/allergy-asthma/6th-jack-pepys.pdf'],['An Official American Thoracic Society Workshop Report: Presentations and Discussion of the Sixth Jack Pepys Workshop on Asthma in the Workplace'],['https://www.thoracic.org/statements/resources/allergy-asthma/6th-jack-pepys.pdf'],['319_0_an official american thoracic society workshop report presentations and discussion of the sixth jack pepys workshop on asthma in the workplace.pdf'],1,100.0,['https://www.thoracic.org/statements/resources/allergy-asthma/6th-jack-pepys.pdf'],['319_0_an official american thoracic society workshop report presentations and discussion of the sixth jack pepys workshop on asthma in the workplace.pdf'],[0.366],[0.525],[0.611],[0.161],[0.177],[0.146],[0.742],[0.639],[0.596],[0.674],[0.8],[0.721],[0.604],[0.918],[0.809],[0.75],[0.795],[0.783],0.366,0.525,0.611,0.161,0.177,0.146,0.742,0.639,0.596,0.674,0.8,0.721,0.604,0.918,0.809,0.75,0.795,0.783
https://doi.org/10.1001/archpedi.161.2.193,time trends in reported diagnoses of childhood neuropsychiatric disorders,322_time trends in reported diagnoses of childhood neuropsychiatric disorders.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923148/pdf', 'https://www.congress.gov/event/112th-congress/house-event/LC2460/text', 'https://stacks.cdc.gov/view/cdc/5465']","['Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD)', 'House Hearing, 112th Congress — 1 IN 88 CHILDREN: A LOOK INTO THE FEDERAL RESPONSE TO RISING RATES OF AUTISM', 'Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, United States, 2006']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923148/pdf'],['322_0_interventions based on the theory of mind cognitive model for autism spectrum disorder asd.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923148/pdf'],['322_0_interventions based on the theory of mind cognitive model for autism spectrum disorder asd.pdf'],[0.329],[0.538],[0.623],[0.177],[0.18],[0.147],[0.732],[0.635],[0.609],[0.706],[0.794],[0.731],[0.59],[0.92],[0.832],[0.748],[0.791],[0.776],0.329,0.538,0.623,0.177,0.18,0.147,0.732,0.635,0.609,0.706,0.794,0.731,0.59,0.92,0.832,0.748,0.791,0.776
https://doi.org/10.1001/archpedi.161.3.252,national health care visit patterns of adolescents,324_national health care visit patterns of adolescents.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123258/pdf', 'https://www.chicago.gov/content/dam/city/depts/cdph/infectious_disease/Immunizations/PCP_Annual_Report_2012-2013.pdf', 'https://www.rand.org/pubs/documented_briefings/DB577.html']","['Physicians’ Human Papillomavirus Vaccine Recommendations in the Context of Permissive Guidelines for Male Patients: A National Study', 'Knowledge and Attitudes Regarding Category B ACIP Recommendations Among Primary Care Providers for Children', 'PCP Annual Report 2012-2013', 'Strategies and Models for Promoting Adolescent Vaccination for Low-Income Populations']","['https://www.chicago.gov/content/dam/city/depts/cdph/infectious_disease/Immunizations/PCP_Annual_Report_2012-2013.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184998/pdf']","['324_2_pcp annual report 20122013.pdf', '324_1_knowledge and attitudes regarding category b acip recommendations among primary care providers for children.pdf', '324_0_physicians human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients a national study.pdf']",3,75.0,"['https://www.chicago.gov/content/dam/city/depts/cdph/infectious_disease/Immunizations/PCP_Annual_Report_2012-2013.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184998/pdf']","['324_2_pcp annual report 20122013.pdf', '324_1_knowledge and attitudes regarding category b acip recommendations among primary care providers for children.pdf', '324_0_physicians human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients a national study.pdf']","[0.278, 0.247, 0.231]","[0.537, 0.529, 0.515]","[0.617, 0.613, 0.6]","[0.185, 0.182, 0.182]","[0.192, 0.196, 0.192]","[0.153, 0.152, 0.154]","[0.74, 0.732, 0.743]","[0.644, 0.64, 0.648]","[0.611, 0.604, 0.589]","[0.661, 0.684, 0.678]","[0.804, 0.786, 0.778]","[0.729, 0.714, 0.687]","[0.614, 0.578, 0.587]","[0.917, 0.912, 0.903]","[0.824, 0.824, 0.817]","[0.759, 0.737, 0.733]","[0.8, 0.782, 0.774]","[0.783, 0.762, 0.762]",0.252,0.527,0.61,0.183,0.193,0.153,0.738,0.644,0.601,0.674,0.789,0.71,0.593,0.911,0.822,0.743,0.785,0.769
https://doi.org/10.1001/archpedi.161.3.282,offlabel drug use in hospitalized children,325_offlabel drug use in hospitalized children.pdf,7,"['https://www.heartland.org/publications-resources/publications/a-modern-system-for-approving-the-cures-of-the-future', 'https://www.agencymeddirectors.wa.gov:443/Files/GuidelineMaster050415ForPubComment.pdf', 'https://amdg.wa.gov:443/Files/2015AMDGOpioidGuideline.pdf', 'https://amdg.wa.gov/Files/2015AMDGOpioidGuideline.pdf', 'https://www.congress.gov/event/110th-congress/senate-event/LC10034/text?s=1&r=10805', 'http://www.agencymeddirectors.wa.gov/Files/GuidelineMaster050415ForPubComment.pdf', 'http://www.agencymeddirectors.wa.gov/Files/GuidelineMaster041615ForPubComment.pdf']","['A Modern System for Approving the Cures of the Future', 'Interagency Guideline On Prescribing Opioids For Pain', 'Interagency Guideline on Prescribing Opioids for Pain', 'Interagency Guideline on Prescribing Opioids for Pain', 'S.Hrg. 110-543 — ENSURING SAFE MEDICINES AND MEDICAL DEVICES FOR CHILDREN', 'INTERAGENCY GUIDELINE ON PRESCRIBING OPIOIDS FOR PAIN', 'INTERAGENCY GUIDELINE ON PRESCRIBING OPIOIDS FOR PAIN']","['https://amdg.wa.gov/Files/2015AMDGOpioidGuideline.pdf', 'https://amdg.wa.gov:443/Files/2015AMDGOpioidGuideline.pdf']","['325_3_interagency guideline on prescribing opioids for pain.pdf', '325_2_interagency guideline on prescribing opioids for pain.pdf']",2,28.57,"['https://amdg.wa.gov/Files/2015AMDGOpioidGuideline.pdf', 'https://amdg.wa.gov:443/Files/2015AMDGOpioidGuideline.pdf']","['325_3_interagency guideline on prescribing opioids for pain.pdf', '325_2_interagency guideline on prescribing opioids for pain.pdf']","[0.269, 0.269]","[0.537, 0.537]","[0.632, 0.632]","[0.17, 0.17]","[0.171, 0.171]","[0.13, 0.13]","[0.74, 0.74]","[0.643, 0.643]","[0.607, 0.607]","[0.645, 0.645]","[0.795, 0.795]","[0.731, 0.731]","[0.621, 0.621]","[0.916, 0.916]","[0.826, 0.826]","[0.763, 0.763]","[0.793, 0.793]","[0.781, 0.781]",0.269,0.537,0.632,0.17,0.171,0.13,0.74,0.643,0.607,0.645,0.795,0.731,0.621,0.916,0.826,0.763,0.793,0.781
https://doi.org/10.1001/archpedi.161.5.440,the impact of retail cigarette marketing practices on youth smoking uptake,326_the impact of retail cigarette marketing practices on youth smoking uptake.pdf,7,"['https://stacks.cdc.gov/view/cdc/42440', 'https://www.rand.org/pubs/technical_reports/TR823.html', 'https://stacks.cdc.gov/view/cdc/21693', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/ResearchandEvaluation/FactsandFigures/DensityofTobaccoRetailersFactSheet1272017.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173757/pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20092011MasterPlanEndangeredInvestment.pdf']","['Preventing initiation of tobacco use : outcome indicators for comprehensive tobacco control programs–2014', 'Assessing the Impacts of Revising the EU Tobacco Products Directive', 'Best practices for comprehensive tobacco control programs, October 2007', 'Preventing Tobacco Use Among Youth and Young Adults', 'CDPH Letterhead', 'Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours', '2009-2011 TEROC Master Plan']","['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20092011MasterPlanEndangeredInvestment.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173757/pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/ResearchandEvaluation/FactsandFigures/DensityofTobaccoRetailersFactSheet1272017.pdf']","['326_6_20092011 teroc master plan.pdf', '326_5_impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.pdf', '326_4_cdph letterhead.pdf']",3,42.86,"['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20092011MasterPlanEndangeredInvestment.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173757/pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/ResearchandEvaluation/FactsandFigures/DensityofTobaccoRetailersFactSheet1272017.pdf']","['326_6_20092011 teroc master plan.pdf', '326_5_impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.pdf', '326_4_cdph letterhead.pdf']","[0.321, 0.613, 0.298]","[0.526, 0.528, 0.526]","[0.614, 0.611, 0.621]","[0.183, 0.192, 0.202]","[0.198, 0.212, 0.232]","[0.168, 0.182, 0.193]","[0.732, 0.739, 0.749]","[0.632, 0.641, 0.648]","[0.609, 0.592, 0.602]","[0.681, 0.708, 0.697]","[0.807, 0.783, 0.802]","[0.744, 0.726, 0.741]","[0.64, 0.615, 0.627]","[0.923, 0.911, 0.928]","[0.847, 0.822, 0.835]","[0.765, 0.732, 0.763]","[0.81, 0.787, 0.802]","[0.792, 0.761, 0.79]",0.411,0.527,0.615,0.192,0.214,0.181,0.74,0.64,0.601,0.695,0.797,0.737,0.627,0.921,0.835,0.753,0.8,0.781
https://doi.org/10.1001/archpedi.161.7.650,pay for performance alone cannot drive quality,330_pay for performance alone cannot drive quality.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208964/pdf', 'https://aspe.hhs.gov/reports/measuring-success-health-care-value-based-purchasing-programs', 'https://aspe.hhs.gov/reports/measuring-success-health-care-value-based-purchasing-programs-summary-recommendations', 'https://effectivehealthcare.ahrq.gov/products/registries-guide-2nd-edition/research', 'https://www.nber.org/papers/w16909', 'https://www.commonwealthfund.org/publications/fund-reports/2011/feb/securing-healthy-future-commonwealth-fund-state-scorecard-child', 'https://www.rand.org/pubs/research_reports/RR306z1.html', 'https://www.rand.org/pubs/research_reports/RR306.html']","['Use of an Internet Portal to Improve Community-Based Pediatric ADHD Care: A Cluster Randomized Trial', 'Measuring Success in Health Care Value-Based Purchasing Programs', 'Measuring Success in Health Care Value-Based Purchasing Programs. Summary and Recommendations.', ""Registries for Evaluating Patient Outcomes: A User's Guide: 2nd Edition"", 'Physician Response to Pay-for-Performance: Evidence from a Natural Experiment', 'Securing a Healthy Future: The Commonwealth Fund State Scorecard on Child Health System Performance, 2011', 'Measuring Success in Health Care Value-Based Purchasing Programs', 'Promise of Value-Based Purchasing in Health Care Remains to Be Demonstrated']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208964/pdf'],['330_0_use of an internet portal to improve communitybased pediatric adhd care a cluster randomized trial.pdf'],1,12.5,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208964/pdf'],['330_0_use of an internet portal to improve communitybased pediatric adhd care a cluster randomized trial.pdf'],[0.318],[0.583],[0.644],[0.202],[0.222],[0.178],[0.738],[0.648],[0.654],[0.703],[0.829],[0.772],[0.636],[0.938],[0.854],[0.79],[0.826],[0.813],0.318,0.583,0.644,0.202,0.222,0.178,0.738,0.648,0.654,0.703,0.829,0.772,0.636,0.938,0.854,0.79,0.826,0.813
https://doi.org/10.1001/archpedi.161.7.669,child care and the wellbeing of children,332_child care and the wellbeing of children.pdf,2,"['https://www.nber.org/papers/w23259', 'https://purl.fdlp.gov/GPO/gpo84232']","[""Does Quebec's Subsidized Child Care Policy Give Boys and Girls an Equal Start?"", 'Primary early care and education arrangements and achievement at kindergarten entry /']",['https://purl.fdlp.gov/GPO/gpo84232'],['332_1_primary early care and education arrangements and achievement at kindergarten entry .pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo84232'],['332_1_primary early care and education arrangements and achievement at kindergarten entry .pdf'],[0.534],[0.544],[0.629],[0.177],[0.193],[0.167],[0.739],[0.64],[0.618],[0.699],[0.807],[0.746],[0.612],[0.921],[0.841],[0.767],[0.81],[0.791],0.534,0.544,0.629,0.177,0.193,0.167,0.739,0.64,0.618,0.699,0.807,0.746,0.612,0.921,0.841,0.767,0.81,0.791
https://doi.org/10.1001/archpedi.161.7.697,maternal depressive symptoms fathers involvement and the trajectories of child problem behaviors in a us national sample,333_maternal depressive symptoms fathers involvement and the trajectories of child problem behaviors in a us national sample.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf', 'https://www.rand.org/pubs/technical_reports/TR913.html']","['Parenting interventions for people with schizophrenia or related serious mental illness', 'Children and Spouses of Deployed Military Members Report Challenges as Responsibilities Increase']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf'],['333_0_parenting interventions for people with schizophrenia or related serious mental illness.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf'],['333_0_parenting interventions for people with schizophrenia or related serious mental illness.pdf'],[0.303],[0.528],[0.614],[0.16],[0.172],[0.148],[0.731],[0.63],[0.595],[0.7],[0.791],[0.715],[0.582],[0.924],[0.829],[0.743],[0.788],[0.775],0.303,0.528,0.614,0.16,0.172,0.148,0.731,0.63,0.595,0.7,0.791,0.715,0.582,0.924,0.829,0.743,0.788,0.775
https://doi.org/10.1001/archpedi.161.9.842,the influence of school smoking policies on student tobacco use,336_the influence of school smoking policies on student tobacco use.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486025/pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://stacks.cdc.gov/view/cdc/42440']","['AHA Scientific Statement Population Approaches to Improve Diet, Physical Activity, and Smoking Habits A Scientific Statement From the American Heart Association', 'School policies for preventing smoking among young people', 'Preventing Tobacco Use Among Youth and Young Adults', 'Preventing initiation of tobacco use : outcome indicators for comprehensive tobacco control programs–2014']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486025/pdf']","['336_0_aha scientific statement population approaches to improve diet physical activity and smoking habits a scientific statement from the american heart association.pdf', '336_1_school policies for preventing smoking among young people.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486025/pdf']","['336_0_aha scientific statement population approaches to improve diet physical activity and smoking habits a scientific statement from the american heart association.pdf', '336_1_school policies for preventing smoking among young people.pdf']","[0.259, 0.723]","[0.488, 0.524]","[0.589, 0.601]","[0.153, 0.206]","[0.17, 0.226]","[0.135, 0.199]","[0.727, 0.74]","[0.629, 0.644]","[0.579, 0.595]","[0.682, 0.712]","[0.765, 0.785]","[0.67, 0.719]","[0.585, 0.605]","[0.911, 0.908]","[0.816, 0.821]","[0.725, 0.736]","[0.766, 0.781]","[0.758, 0.76]",0.491,0.506,0.595,0.179,0.198,0.167,0.734,0.637,0.587,0.697,0.775,0.695,0.595,0.909,0.819,0.73,0.774,0.759
https://doi.org/10.1001/archpedi.162.10.963,use of a fan during sleep and the risk of sudden infant death syndrome,340_use of a fan during sleep and the risk of sudden infant death syndrome.pdf,1,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['A Policy & Education Development Guide'],['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['340_0_a policy  education development guide.pdf'],1,100.0,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['340_0_a policy  education development guide.pdf'],[0.658],[0.514],[0.595],[0.139],[0.157],[0.126],[0.727],[0.629],[0.588],[0.672],[0.791],[0.712],[0.607],[0.913],[0.821],[0.747],[0.788],[0.776],0.658,0.514,0.595,0.139,0.157,0.126,0.727,0.629,0.588,0.672,0.791,0.712,0.607,0.913,0.821,0.747,0.788,0.776
https://doi.org/10.1001/archpedi.162.12.1113,influenza vaccination among college and university students,342_influenza vaccination among college and university students.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837128/pdf', 'https://stacks.cdc.gov/view/cdc/45220']","['Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017', 'Community mitigation guidelines to prevent pandemic influenza — United States, 2017']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837128/pdf'],['342_0_community mitigation guidelines to prevent pandemic influenza — united states 2017.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837128/pdf'],['342_0_community mitigation guidelines to prevent pandemic influenza — united states 2017.pdf'],[0.252],[0.525],[0.609],[0.165],[0.178],[0.15],[0.735],[0.639],[0.593],[0.677],[0.79],[0.711],[0.611],[0.908],[0.822],[0.748],[0.787],[0.768],0.252,0.525,0.609,0.165,0.178,0.15,0.735,0.639,0.593,0.677,0.79,0.711,0.611,0.908,0.822,0.748,0.787,0.768
https://doi.org/10.1001/archpedi.162.5.447,identifying treating and referring traumatized children,348_identifying treating and referring traumatized children.pdf,7,"['https://www.michigan.gov/documents/mdhhs/Foster-Adoptive_Fam_Trauma_507721_7.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/018%20Trauma2.pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Trauma0513.pdf', 'https://www.michigan.gov/documents/mdhhs/Addressing_ACEs_and_Other_Types_of_Trauma_in_Primary_Care-AAP-2014_508988_7.pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'https://rga.lis.virginia.gov/Published/2010/HD9/PDF']","['Helping Foster and', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'TRAUMA- AND STRESSOR-RELATED DISORDERS', 'TRAUMA', 'Addressing Adverse Childhood Experiences and Other Types of Trauma in the Primary Care Setting', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs, 4th Edition']","['http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/018%20Trauma2.pdf', 'https://www.michigan.gov/documents/mdhhs/Foster-Adoptive_Fam_Trauma_507721_7.pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Trauma0513.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://www.michigan.gov/documents/mdhhs/Addressing_ACEs_and_Other_Types_of_Trauma_in_Primary_Care-AAP-2014_508988_7.pdf']","['348_5_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '348_2_trauma and stressorrelated disorders.pdf', '348_0_helping foster and.pdf', '348_3_trauma.pdf', '348_1_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '348_4_addressing adverse childhood experiences and other types of trauma in the primary care setting.pdf']",6,85.71,"['http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/018%20Trauma2.pdf', 'https://www.michigan.gov/documents/mdhhs/Foster-Adoptive_Fam_Trauma_507721_7.pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Trauma0513.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://www.michigan.gov/documents/mdhhs/Addressing_ACEs_and_Other_Types_of_Trauma_in_Primary_Care-AAP-2014_508988_7.pdf']","['348_5_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '348_2_trauma and stressorrelated disorders.pdf', '348_0_helping foster and.pdf', '348_3_trauma.pdf', '348_1_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '348_4_addressing adverse childhood experiences and other types of trauma in the primary care setting.pdf']","[0.699, 0.549, 0.727, 0.69, 0.427, 0.602]","[0.559, 0.59, 0.584, 0.583, 0.568, 0.594]","[0.645, 0.675, 0.666, 0.669, 0.653, 0.666]","[0.19, 0.256, 0.212, 0.252, 0.194, 0.199]","[0.202, 0.28, 0.232, 0.276, 0.204, 0.22]","[0.176, 0.242, 0.202, 0.239, 0.178, 0.183]","[0.744, 0.762, 0.75, 0.761, 0.744, 0.743]","[0.648, 0.674, 0.66, 0.674, 0.649, 0.649]","[0.624, 0.654, 0.656, 0.644, 0.638, 0.67]","[0.683, 0.708, 0.689, 0.709, 0.681, 0.681]","[0.812, 0.824, 0.823, 0.817, 0.819, 0.823]","[0.745, 0.776, 0.777, 0.76, 0.762, 0.784]","[0.625, 0.641, 0.639, 0.637, 0.631, 0.636]","[0.918, 0.929, 0.93, 0.923, 0.924, 0.921]","[0.841, 0.851, 0.862, 0.851, 0.843, 0.87]","[0.777, 0.799, 0.8, 0.791, 0.788, 0.801]","[0.813, 0.83, 0.83, 0.823, 0.822, 0.832]","[0.802, 0.819, 0.817, 0.812, 0.809, 0.819]",0.616,0.58,0.662,0.217,0.236,0.203,0.751,0.659,0.648,0.692,0.82,0.767,0.635,0.924,0.853,0.793,0.825,0.813
https://doi.org/10.1001/archpedi.162.5.477,local restaurant smoking regulations and the adolescent smoking initiation process,349_local restaurant smoking regulations and the adolescent smoking initiation process.pdf,6,"['https://www.atlantafed.org/research/publications/wp/2020/07/28/11-dynamics-of-smoking-wage-penalty.aspx', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmoke50/', 'https://stacks.cdc.gov/view/cdc/42440', 'https://stacks.cdc.gov/view/cdc/21569', 'https://health.mo.gov/data/yts/pdf/missouriyouthandtobacco0313.pdf', 'https://health.mo.gov/data/yts/pdf/missouri_youth_tobacco_survey_2003-2009.pdf']","['The Dynamics of the Smoking Wage Penalty', 'The Health Consequences of Smoking—50 Years of Progress', 'Preventing initiation of tobacco use : outcome indicators for comprehensive tobacco control programs–2014', 'The Health consequences of smoking—50 years of progress : a report of the Surgeon General', 'Missouri Youth and Tobacco, 2003-2013A decade of progress in prevention', 'missouri youth tobacco survey 2003 2009']","['https://health.mo.gov/data/yts/pdf/missouri_youth_tobacco_survey_2003-2009.pdf', 'https://health.mo.gov/data/yts/pdf/missouriyouthandtobacco0313.pdf']","['349_5_missouri youth tobacco survey 2003 2009.pdf', '349_4_missouri youth and tobacco 20032013a decade of progress in prevention.pdf']",2,33.33,"['https://health.mo.gov/data/yts/pdf/missouri_youth_tobacco_survey_2003-2009.pdf', 'https://health.mo.gov/data/yts/pdf/missouriyouthandtobacco0313.pdf']","['349_5_missouri youth tobacco survey 2003 2009.pdf', '349_4_missouri youth and tobacco 20032013a decade of progress in prevention.pdf']","[0.217, 0.206]","[0.514, 0.519]","[0.599, 0.591]","[0.176, 0.167]","[0.189, 0.187]","[0.167, 0.165]","[0.732, 0.735]","[0.632, 0.63]","[0.587, 0.587]","[0.709, 0.702]","[0.775, 0.785]","[0.701, 0.708]","[0.604, 0.612]","[0.923, 0.92]","[0.832, 0.837]","[0.747, 0.749]","[0.777, 0.786]","[0.767, 0.772]",0.211,0.516,0.595,0.171,0.188,0.166,0.734,0.631,0.587,0.706,0.78,0.704,0.608,0.921,0.835,0.748,0.782,0.77
https://doi.org/10.1001/archpediatrics.2007.11,subjective social status in the school and change in adiposity in female adolescents,354_subjective social status in the school and change in adiposity in female adolescents.pdf,1,['https://www1.nyc.gov/assets/doh/downloads/pdf/epi/dohmhcha_2010-2013.pdf'],['New York City Department of Health & Mental Hygiene'],['https://www1.nyc.gov/assets/doh/downloads/pdf/epi/dohmhcha_2010-2013.pdf'],['354_0_new york city department of health  mental hygiene.pdf'],1,100.0,['https://www1.nyc.gov/assets/doh/downloads/pdf/epi/dohmhcha_2010-2013.pdf'],['354_0_new york city department of health  mental hygiene.pdf'],[0.154],[0.47],[0.57],[0.098],[0.108],[0.087],[0.724],[0.618],[0.548],[0.677],[0.771],[0.681],[0.593],[0.91],[0.822],[0.727],[0.765],[0.75],0.154,0.47,0.57,0.098,0.108,0.087,0.724,0.618,0.548,0.677,0.771,0.681,0.593,0.91,0.822,0.727,0.765,0.75
https://doi.org/10.1001/archpediatrics.2007.34,systematic review of randomized controlled trials examining written action plans in children,359_systematic review of randomized controlled trials examining written action plans in children.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373283/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549813/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866209/pdf']","['Personalised asthma action plans for adults with asthma', 'Canadian Thoracic Society 2012 guideline update: Diagnosis and management of asthma in preschoolers, children and adults', 'Written Asthma Action Plans (WAAPs) in Melbourne general practices: a sequential mixed methods study', 'Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for children six years of age and over, and adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373283/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549813/pdf']","['359_3_canadian thoracic society asthma management continuum – 2010 consensus summary for children six years of age and over and adults.pdf', '359_0_personalised asthma action plans for adults with asthma.pdf', '359_1_canadian thoracic society 2012 guideline update diagnosis and management of asthma in preschoolers children and adults.pdf', '359_2_written asthma action plans waaps in melbourne general practices a sequential mixed methods study.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373283/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549813/pdf']","['359_3_canadian thoracic society asthma management continuum – 2010 consensus summary for children six years of age and over and adults.pdf', '359_0_personalised asthma action plans for adults with asthma.pdf', '359_1_canadian thoracic society 2012 guideline update diagnosis and management of asthma in preschoolers children and adults.pdf', '359_2_written asthma action plans waaps in melbourne general practices a sequential mixed methods study.pdf']","[0.556, 0.457, 0.498, 0.429]","[0.55, 0.531, 0.537, 0.523]","[0.631, 0.616, 0.62, 0.608]","[0.185, 0.188, 0.19, 0.171]","[0.199, 0.196, 0.203, 0.187]","[0.156, 0.162, 0.161, 0.159]","[0.738, 0.735, 0.74, 0.732]","[0.641, 0.641, 0.647, 0.638]","[0.617, 0.593, 0.596, 0.584]","[0.673, 0.723, 0.691, 0.709]","[0.808, 0.784, 0.794, 0.781]","[0.741, 0.715, 0.726, 0.722]","[0.627, 0.591, 0.622, 0.608]","[0.916, 0.908, 0.901, 0.891]","[0.813, 0.812, 0.792, 0.807]","[0.76, 0.725, 0.735, 0.718]","[0.801, 0.776, 0.784, 0.775]","[0.781, 0.754, 0.755, 0.742]",0.485,0.535,0.619,0.183,0.196,0.16,0.736,0.642,0.598,0.699,0.792,0.726,0.612,0.904,0.806,0.734,0.784,0.758
https://doi.org/10.1001/archpediatrics.2007.36,impact of conjoined exposure to the world trade center attacks and to other traumatic events on the behavioral problems of preschool children,360_impact of conjoined exposure to the world trade center attacks and to other traumatic events on the behavioral problems of preschool children.pdf,5,"['https://www.rand.org/pubs/technical_reports/TR660.html', 'https://www.rand.org/pubs/research_reports/RRA390-1.html', 'https://www1.nyc.gov/assets/911health/downloads/pdf/news/wtc-mwg-annual-report2009.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi28-4.pdf', 'http://www.nyc.gov/html/om/pdf/2008/2008_mwg_annual_report.pdf']","['A National Agenda for Public Health Systems Research on Emergency Preparedness', 'Translational Impacts of World Trade Center Health Program Research', 'WTC Annual Report', 'City Health Information', 'WTC Annual Report']","['https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi28-4.pdf', 'http://www.nyc.gov/html/om/pdf/2008/2008_mwg_annual_report.pdf', 'https://www1.nyc.gov/assets/911health/downloads/pdf/news/wtc-mwg-annual-report2009.pdf']","['360_3_city health information.pdf', '360_4_wtc annual report.pdf', '360_2_wtc annual report.pdf']",3,60.0,"['https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi28-4.pdf', 'http://www.nyc.gov/html/om/pdf/2008/2008_mwg_annual_report.pdf', 'https://www1.nyc.gov/assets/911health/downloads/pdf/news/wtc-mwg-annual-report2009.pdf']","['360_3_city health information.pdf', '360_4_wtc annual report.pdf', '360_2_wtc annual report.pdf']","[0.241, 0.517, 0.275]","[0.522, 0.55, 0.56]","[0.612, 0.637, 0.641]","[0.153, 0.172, 0.173]","[0.173, 0.18, 0.185]","[0.144, 0.142, 0.143]","[0.733, 0.732, 0.732]","[0.637, 0.64, 0.639]","[0.591, 0.615, 0.623]","[0.681, 0.668, 0.666]","[0.79, 0.809, 0.812]","[0.717, 0.743, 0.757]","[0.608, 0.636, 0.64]","[0.925, 0.923, 0.926]","[0.826, 0.836, 0.843]","[0.756, 0.774, 0.779]","[0.789, 0.808, 0.812]","[0.778, 0.793, 0.796]",0.344,0.544,0.63,0.166,0.179,0.143,0.732,0.639,0.61,0.672,0.804,0.739,0.628,0.925,0.835,0.77,0.803,0.789
https://doi.org/10.1001/archpediatrics.2008.559,enhancing knowledge and clinical skills through an adolescent medicine workshop,367_enhancing knowledge and clinical skills through an adolescent medicine workshop.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],"[""Interventions for improving medical students' interpersonal communication in medical consultations""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['367_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['367_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],[0.465],[0.529],[0.612],[0.175],[0.188],[0.16],[0.74],[0.644],[0.6],[0.686],[0.789],[0.715],[0.595],[0.922],[0.83],[0.737],[0.782],[0.77],0.465,0.529,0.612,0.175,0.188,0.16,0.74,0.644,0.6,0.686,0.789,0.715,0.595,0.922,0.83,0.737,0.782,0.77
https://doi.org/10.1001/archpediatrics.2008.570,screening for asymptomatic chlamydia infections among sexually active adolescent girls during pediatric urgent care,369_screening for asymptomatic chlamydia infections among sexually active adolescent girls during pediatric urgent care.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457643/pdf', 'https://www.urban.org/research/publication/factors-influence-preventive-service-utilization-among-children-covered-medicaid-and-chip']","['Screening for Nonviral Sexually Transmitted Infections in Adolescents and Young Adults', 'Screening for genital chlamydia infection', 'Factors that Influence Preventive Service Utilization among Children Covered by Medicaid and CHIP']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457643/pdf']","['369_0_screening for nonviral sexually transmitted infections in adolescents and young adults.pdf', '369_1_screening for genital chlamydia infection.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457643/pdf']","['369_0_screening for nonviral sexually transmitted infections in adolescents and young adults.pdf', '369_1_screening for genital chlamydia infection.pdf']","[0.42, 0.39]","[0.547, 0.542]","[0.62, 0.615]","[0.184, 0.185]","[0.195, 0.188]","[0.165, 0.162]","[0.744, 0.738]","[0.652, 0.645]","[0.623, 0.608]","[0.654, 0.677]","[0.814, 0.8]","[0.737, 0.722]","[0.604, 0.604]","[0.924, 0.915]","[0.821, 0.824]","[0.755, 0.738]","[0.811, 0.792]","[0.788, 0.769]",0.405,0.544,0.617,0.184,0.192,0.164,0.741,0.649,0.615,0.665,0.807,0.73,0.604,0.919,0.823,0.746,0.802,0.778
https://doi.org/10.1001/archpediatrics.2009.137,antipyretic agents for preventing recurrences of febrile seizures,373_antipyretic agents for preventing recurrences of febrile seizures.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142325/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464693/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491279/pdf']","['Prophylactic drug management for febrile seizures in children', 'EEG for children with complex febrile seizures', 'EEG for children with complex febrile seizures', 'Prophylactic drug management for febrile seizures in children', 'Antipyretic measures for treating fever in malaria', 'Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491279/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142325/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464693/pdf']","['373_5_drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children.pdf', '373_0_prophylactic drug management for febrile seizures in children.pdf', '373_1_eeg for children with complex febrile seizures.pdf', '373_2_eeg for children with complex febrile seizures.pdf', '373_4_antipyretic measures for treating fever in malaria.pdf', '373_3_prophylactic drug management for febrile seizures in children.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491279/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142325/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464693/pdf']","['373_5_drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children.pdf', '373_0_prophylactic drug management for febrile seizures in children.pdf', '373_1_eeg for children with complex febrile seizures.pdf', '373_2_eeg for children with complex febrile seizures.pdf', '373_4_antipyretic measures for treating fever in malaria.pdf', '373_3_prophylactic drug management for febrile seizures in children.pdf']","[0.515, 0.466, 0.478, 0.506, 0.333, 0.362]","[0.508, 0.522, 0.53, 0.532, 0.537, 0.514]","[0.605, 0.612, 0.623, 0.625, 0.626, 0.607]","[0.172, 0.176, 0.171, 0.172, 0.173, 0.179]","[0.173, 0.178, 0.185, 0.186, 0.18, 0.182]","[0.152, 0.153, 0.155, 0.156, 0.141, 0.158]","[0.737, 0.737, 0.73, 0.73, 0.731, 0.738]","[0.643, 0.643, 0.632, 0.632, 0.638, 0.645]","[0.571, 0.585, 0.605, 0.606, 0.61, 0.577]","[0.668, 0.671, 0.667, 0.667, 0.66, 0.671]","[0.776, 0.783, 0.797, 0.798, 0.798, 0.78]","[0.702, 0.715, 0.728, 0.731, 0.733, 0.706]","[0.594, 0.587, 0.602, 0.603, 0.608, 0.593]","[0.895, 0.901, 0.914, 0.915, 0.913, 0.896]","[0.795, 0.815, 0.831, 0.832, 0.829, 0.811]","[0.719, 0.732, 0.751, 0.752, 0.755, 0.728]","[0.764, 0.774, 0.785, 0.786, 0.791, 0.768]","[0.74, 0.755, 0.777, 0.778, 0.778, 0.751]",0.443,0.524,0.616,0.174,0.181,0.152,0.734,0.639,0.592,0.667,0.789,0.719,0.598,0.906,0.819,0.739,0.778,0.763
https://doi.org/10.1001/archpediatrics.2009.141,results of a type 2 translational research trial to prevent adolescent drug use and delinquency,374_results of a type 2 translational research trial to prevent adolescent drug use and delinquency.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://www.acf.hhs.gov/opre/report/human-services-research-dissemination-what-works', 'https://nam.edu/perspectives-2015-unleashing-the-power-of-prevention/', 'https://www.rand.org/pubs/research_reports/RR639.html', 'https://louisvilleky.gov/sites/default/files/safe_neighborhoods/principles_of_prevention_programs.pdf', 'https://www.brookings.edu/research/un-burying-the-lead-public-health-tools-are-the-key-to-beating-the-opioid-epidemic/', 'https://www.acf.hhs.gov/opre/resource/human-services-research-dissemination-what-works', 'https://www.pccd.pa.gov/Juvenile-Justice/Documents/Final%202017%20JJ%20Plan.pdf', 'https://purl.fdlp.gov/GPO/gpo122621', 'https://stacks.cdc.gov/view/cdc/39809']","['School‐based programmes for preventing smoking', 'Human Services Research Dissemination: What Works?', 'Unleashing the Power of Prevention', 'Implementation Challenges Delay Home Visiting Services in New Mexico', 'Lessons from Prevention Research', 'Un-burying the lead: Public health tools are the key to beating the opioid epidemic', 'Human Services Research Dissemination: What Works?', '2017 Pennsylvania Juvenile Justice And Delinquency Prevention Plan', 'Alcohol and drug prevention and treatment/therapy.', 'Striving To Reduce Youth Violence Everywhere (STRYVE) : CDC’s national initiative to prevent youth violence foundational resource']","['https://purl.fdlp.gov/GPO/gpo122621', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://www.pccd.pa.gov/Juvenile-Justice/Documents/Final%202017%20JJ%20Plan.pdf']","['374_8_alcohol and drug prevention and treatmenttherapy.pdf', '374_0_school‐based programmes for preventing smoking.pdf', '374_7_2017 pennsylvania juvenile justice and delinquency prevention plan.pdf']",3,30.0,"['https://purl.fdlp.gov/GPO/gpo122621', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://www.pccd.pa.gov/Juvenile-Justice/Documents/Final%202017%20JJ%20Plan.pdf']","['374_8_alcohol and drug prevention and treatmenttherapy.pdf', '374_0_school‐based programmes for preventing smoking.pdf', '374_7_2017 pennsylvania juvenile justice and delinquency prevention plan.pdf']","[0.372, 0.278, 0.436]","[0.525, 0.509, 0.514]","[0.614, 0.587, 0.598]","[0.185, 0.164, 0.161]","[0.21, 0.174, 0.177]","[0.166, 0.145, 0.139]","[0.735, 0.734, 0.728]","[0.641, 0.638, 0.632]","[0.591, 0.578, 0.592]","[0.689, 0.703, 0.661]","[0.801, 0.776, 0.794]","[0.726, 0.691, 0.718]","[0.616, 0.585, 0.622]","[0.916, 0.914, 0.911]","[0.822, 0.813, 0.831]","[0.757, 0.731, 0.759]","[0.799, 0.773, 0.793]","[0.785, 0.76, 0.78]",0.362,0.516,0.6,0.17,0.187,0.15,0.732,0.637,0.587,0.684,0.79,0.712,0.608,0.914,0.822,0.749,0.788,0.775
https://doi.org/10.1001/archpediatrics.2009.160,impact of individual values on adherence to emergency contraception practice guidelines among pediatric residents,375_impact of individual values on adherence to emergency contraception practice guidelines among pediatric residents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425212/pdf'],['Clinician Perspectives on Management of Adolescents with Pelvic Inflammatory Disease Using Standardized Patient Scenarios'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425212/pdf'],['375_0_clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425212/pdf'],['375_0_clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios.pdf'],[0.141],[0.505],[0.602],[0.16],[0.181],[0.147],[0.734],[0.642],[0.588],[0.665],[0.781],[0.7],[0.575],[0.909],[0.813],[0.736],[0.776],[0.768],0.141,0.505,0.602,0.16,0.181,0.147,0.734,0.642,0.588,0.665,0.781,0.7,0.575,0.909,0.813,0.736,0.776,0.768
https://doi.org/10.1001/archpediatrics.2009.176,a longitudinal study of maternal depression and child maltreatment in a national sample of families investigated by child protective services,376_a longitudinal study of maternal depression and child maltreatment in a national sample of families investigated by child protective services.pdf,7,"['https://aspe.hhs.gov/reports/relationship-between-substance-use-indicators-child-welfare-caseloads', 'https://mathematica.org/publications/regional-partnership-grant-program-cross-site-evaluation-design-report', 'https://dcs.az.gov/file/5669/download?token=0D0BCx7k', 'https://dcs.az.gov/file/5672/download?token=Hy4HHohT', 'https://dcs.az.gov/file/9765/download?token=ea8jaqVy', 'https://dcs.az.gov/file/5673/download?token=f3lknD0u', 'https://dcs.az.gov/file/12944/download?token=3iAU1jIl']","['The Relationship between Substance Use Indicators and Child Welfare Caseloads', 'Regional Partnership Grant Program Cross-Site Evaluation Design Report', 'Healthy Families Arizona', 'Healthy Families Arizona', 'Healthy Families Arizona', 'Healthy Families Arizona', 'Healthy Families Arizona']","['https://dcs.az.gov/file/12944/download?token=3iAU1jIl', 'https://dcs.az.gov/file/5669/download?token=0D0BCx7k', 'https://dcs.az.gov/file/5672/download?token=Hy4HHohT', 'https://dcs.az.gov/file/9765/download?token=ea8jaqVy', 'https://dcs.az.gov/file/5673/download?token=f3lknD0u']","['376_6_healthy families arizona.pdf', '376_2_healthy families arizona.pdf', '376_3_healthy families arizona.pdf', '376_4_healthy families arizona.pdf', '376_5_healthy families arizona.pdf']",5,71.43,"['https://dcs.az.gov/file/12944/download?token=3iAU1jIl', 'https://dcs.az.gov/file/5669/download?token=0D0BCx7k', 'https://dcs.az.gov/file/5672/download?token=Hy4HHohT', 'https://dcs.az.gov/file/9765/download?token=ea8jaqVy', 'https://dcs.az.gov/file/5673/download?token=f3lknD0u']","['376_6_healthy families arizona.pdf', '376_2_healthy families arizona.pdf', '376_3_healthy families arizona.pdf', '376_4_healthy families arizona.pdf', '376_5_healthy families arizona.pdf']","[0.248, 0.251, 0.247, 0.248, 0.269]","[0.473, 0.476, 0.469, 0.472, 0.47]","[0.542, 0.552, 0.534, 0.538, 0.536]","[0.122, 0.113, 0.118, 0.119, 0.118]","[0.134, 0.124, 0.13, 0.131, 0.129]","[0.133, 0.118, 0.133, 0.132, 0.132]","[0.733, 0.724, 0.734, 0.733, 0.733]","[0.635, 0.623, 0.636, 0.635, 0.635]","[0.536, 0.546, 0.533, 0.534, 0.533]","[0.693, 0.694, 0.694, 0.694, 0.695]","[0.724, 0.748, 0.718, 0.722, 0.721]","[0.67, 0.683, 0.666, 0.67, 0.668]","[0.598, 0.598, 0.598, 0.6, 0.598]","[0.884, 0.888, 0.884, 0.883, 0.884]","[0.794, 0.793, 0.794, 0.794, 0.794]","[0.671, 0.68, 0.668, 0.67, 0.669]","[0.721, 0.746, 0.713, 0.718, 0.717]","[0.702, 0.714, 0.699, 0.702, 0.701]",0.253,0.472,0.54,0.118,0.13,0.13,0.731,0.633,0.536,0.694,0.727,0.671,0.598,0.885,0.794,0.672,0.723,0.704
https://doi.org/10.1001/archpediatrics.2009.178,estimating the risk of food stamp use and impoverishment during childhood,377_estimating the risk of food stamp use and impoverishment during childhood.pdf,5,"['https://purl.fdlp.gov/GPO/gpo75052', 'https://www.congress.gov/event/114th-congress/house-event/LC35502/text', 'https://www.congress.gov/event/113th-congress/senate-event/LC57353/text?s=1&r=7053', 'https://www.aclu.org/legal-document/amicus-brief-idaho-governor-cl-butch-otter-opposition-freedom-marry', 'http://purl.fdlp.gov/GPO/gpo65043']","['Dying young :\xa0why your social and economic status may be a death sentence in America : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session, on examining health relating to social and economic status, November 20, 2013.', 'House Hearing, 114th Congress — SUPPLEMENTAL NUTRITION ASSISTANCE PROGRAM', 'S.Hrg. 113-820 — DYING YOUNG: WHY YOUR SOCIAL AND ECONOMIC STATUS MAY BE A DEATH SENTENCE IN AMERICA', 'Amicus Brief of Idaho Governor CL Butch Otter in Opposition to the Freedom to Marry', 'Long-term benefits of the Supplemental Nutrition Assistance Program /']",['http://purl.fdlp.gov/GPO/gpo65043'],['377_4_longterm benefits of the supplemental nutrition assistance program .pdf'],1,20.0,['http://purl.fdlp.gov/GPO/gpo65043'],['377_4_longterm benefits of the supplemental nutrition assistance program .pdf'],[0.54],[0.556],[0.643],[0.206],[0.224],[0.188],[0.737],[0.64],[0.633],[0.706],[0.819],[0.748],[0.654],[0.924],[0.853],[0.784],[0.822],[0.806],0.54,0.556,0.643,0.206,0.224,0.188,0.737,0.64,0.633,0.706,0.819,0.748,0.654,0.924,0.853,0.784,0.822,0.806
https://doi.org/10.1001/archpediatrics.2009.2,dutch obesity intervention in teenagers,379_dutch obesity intervention in teenagers.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936257/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103347/pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention']","['Collaboration between local health and local government agencies for health improvement', 'School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18', 'Community wide interventions for increasing physical activity', 'School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18', 'Environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health', 'Interventions for preventing obesity in children', 'Current Guidelines for Obesity Prevention in Childhood and Adolescence', 'Washington State Institute for Public Policy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103347/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936257/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf']","['379_3_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '379_1_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '379_5_interventions for preventing obesity in children.pdf', '379_6_current guidelines for obesity prevention in childhood and adolescence.pdf', '379_2_community wide interventions for increasing physical activity.pdf', '379_0_collaboration between local health and local government agencies for health improvement.pdf', '379_4_environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103347/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936257/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf']","['379_3_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '379_1_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '379_5_interventions for preventing obesity in children.pdf', '379_6_current guidelines for obesity prevention in childhood and adolescence.pdf', '379_2_community wide interventions for increasing physical activity.pdf', '379_0_collaboration between local health and local government agencies for health improvement.pdf', '379_4_environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health.pdf']","[0.349, 0.443, 0.353, 0.471, 0.501, 0.545, 0.401]","[0.506, 0.501, 0.504, 0.515, 0.509, 0.502, 0.506]","[0.596, 0.592, 0.589, 0.6, 0.596, 0.585, 0.596]","[0.165, 0.161, 0.165, 0.17, 0.16, 0.148, 0.153]","[0.178, 0.173, 0.171, 0.18, 0.17, 0.154, 0.161]","[0.147, 0.145, 0.145, 0.148, 0.138, 0.128, 0.132]","[0.734, 0.735, 0.735, 0.731, 0.729, 0.728, 0.729]","[0.636, 0.638, 0.639, 0.632, 0.632, 0.631, 0.631]","[0.574, 0.569, 0.567, 0.58, 0.575, 0.566, 0.571]","[0.708, 0.708, 0.712, 0.693, 0.71, 0.695, 0.701]","[0.764, 0.759, 0.757, 0.775, 0.764, 0.758, 0.764]","[0.699, 0.689, 0.684, 0.712, 0.699, 0.691, 0.703]","[0.592, 0.585, 0.581, 0.611, 0.587, 0.583, 0.592]","[0.892, 0.891, 0.889, 0.891, 0.893, 0.89, 0.89]","[0.798, 0.793, 0.794, 0.807, 0.802, 0.789, 0.799]","[0.693, 0.685, 0.682, 0.707, 0.69, 0.682, 0.692]","[0.764, 0.756, 0.755, 0.772, 0.764, 0.757, 0.764]","[0.727, 0.72, 0.717, 0.73, 0.724, 0.715, 0.722]",0.438,0.506,0.593,0.16,0.17,0.14,0.732,0.634,0.572,0.704,0.763,0.697,0.59,0.891,0.797,0.69,0.762,0.722
https://doi.org/10.1001/archpediatrics.2009.204,predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus–infected adolescents,380_predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus–infected adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['380_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['380_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.464],[0.555],[0.631],[0.187],[0.192],[0.163],[0.742],[0.65],[0.624],[0.682],[0.8],[0.734],[0.6],[0.93],[0.844],[0.755],[0.799],[0.776],0.464,0.555,0.631,0.187,0.192,0.163,0.742,0.65,0.624,0.682,0.8,0.734,0.6,0.93,0.844,0.755,0.799,0.776
https://doi.org/10.1001/archpediatrics.2009.205,efficacy of sexually transmitted diseasehuman immunodeficiency virus sexual risk–reduction intervention for african american adolescent females seeking sexual health services,381_efficacy of sexually transmitted diseasehuman immunodeficiency virus sexual risk–reduction intervention for african american adolescent females seeking sexual health services.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf', 'https://aspe.hhs.gov/reports/using-effect-sizes-inform-policy-practice-evidence-hhs-teen-pregnancy-prevention-evidence-review', 'https://mathematica.org/publications/evaluation-of-adolescent-pregnancy-prevention-approaches-design-of-the-impact-study']","['Interventions for encouraging sexual behaviours intended to prevent cervical cancer', 'Using Effect Sizes to Inform Policy and Practice: Evidence from the HHS Teen Pregnancy Prevention Evidence Review', 'Evaluation of Adolescent Pregnancy Prevention Approaches: Design of the Impact Study']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf'],['381_0_interventions for encouraging sexual behaviours intended to prevent cervical cancer.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf'],['381_0_interventions for encouraging sexual behaviours intended to prevent cervical cancer.pdf'],[0.555],[0.509],[0.591],[0.161],[0.171],[0.152],[0.734],[0.643],[0.575],[0.691],[0.768],[0.7],[0.582],[0.899],[0.792],[0.703],[0.767],[0.73],0.555,0.509,0.591,0.161,0.171,0.152,0.734,0.643,0.575,0.691,0.768,0.7,0.582,0.899,0.792,0.703,0.767,0.73
https://doi.org/10.1001/archpediatrics.2009.209,a national survey of obesity prevention practices in head start,382_a national survey of obesity prevention practices in head start.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563467/pdf', 'https://www.acf.hhs.gov/opre/report/head-start-health-matters-findings-2012-2013-head-start-health-manager-descriptive', 'https://www.acf.hhs.gov/opre/resource/head-start-health-matters-findings-2012-2013-health-manager-descriptive-study-regions-ixii']","['Obesity Prevention in Early Child Care Settings: A Bistate (Minnesota and Wisconsin) Assessment of Best Practices, Implementation Difficulty, and Barriers', 'Head Start Health Matters: Findings from the 2012–2013 Head Start Health Manager Descriptive Study for Regions I–XII', 'Head Start Health Matters: Findings from the 2012–2013 Head Start Health Manager Descriptive Study for Regions I–XII']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563467/pdf'],['382_0_obesity prevention in early child care settings a bistate minnesota and wisconsin assessment of best practices implementation difficulty and barriers.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563467/pdf'],['382_0_obesity prevention in early child care settings a bistate minnesota and wisconsin assessment of best practices implementation difficulty and barriers.pdf'],[0.417],[0.532],[0.621],[0.166],[0.189],[0.152],[0.729],[0.631],[0.606],[0.689],[0.801],[0.729],[0.6],[0.919],[0.836],[0.755],[0.799],[0.784],0.417,0.532,0.621,0.166,0.189,0.152,0.729,0.631,0.606,0.689,0.801,0.729,0.6,0.919,0.836,0.755,0.799,0.784
https://doi.org/10.1001/archpediatrics.2009.212,improving health outcomes for youth living with the human immunodeficiency virus,383_improving health outcomes for youth living with the human immunodeficiency virus.pdf,3,"['https://effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044043/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599820/pdf']","['Interventions for Substance Use Disorders in Adolescents: A Systematic Review', 'Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel', 'Interventions to improve adherence to antiretroviral therapy in children with HIV infection']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599820/pdf'],['383_2_interventions to improve adherence to antiretroviral therapy in children with hiv infection.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599820/pdf'],['383_2_interventions to improve adherence to antiretroviral therapy in children with hiv infection.pdf'],[0.497],[0.549],[0.624],[0.195],[0.198],[0.164],[0.733],[0.64],[0.618],[0.686],[0.807],[0.744],[0.609],[0.926],[0.838],[0.763],[0.798],[0.78],0.497,0.549,0.624,0.195,0.198,0.164,0.733,0.64,0.618,0.686,0.807,0.744,0.609,0.926,0.838,0.763,0.798,0.78
https://doi.org/10.1001/archpediatrics.2009.214,adverse childhood experiences and adult risk factors for agerelated disease,384_adverse childhood experiences and adult risk factors for agerelated disease.pdf,6,"['https://s-media.nyc.gov/agencies/childrenscabinet/NYCDOH_GrowingUP_Policy_Brochure_For_WEB.pdf', 'https://purl.fdlp.gov/GPO/gpo71840', 'https://www.nber.org/papers/w21055?sy=055', 'https://www.acf.hhs.gov/opre/report/linking-administrative-data-improve-understanding-child-maltreatment-incidence-and', 'https://mathematica.org/publications/linking-administrative-data-to-improve-understanding-of-child-maltreatment-incidence-and-related', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44']","['A Policy Framework', 'Children’s exposure to violence, crime, and abuse :\xa0an update /', 'The Effect of Community Traumatic Events on Student Achievement: Evidence from the Beltway Sniper Attacks', 'Linking Administrative Data to Improve Understanding of Child Maltreatment Incidence and Related Risk and Protective Factors: A Feasibility Study', 'Linking Administrative Data to Improve Understanding of Child Maltreatment Incidence and Related Risk and Protective Factors', 'Executive Summary – Findings from Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health']","['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://s-media.nyc.gov/agencies/childrenscabinet/NYCDOH_GrowingUP_Policy_Brochure_For_WEB.pdf', 'https://purl.fdlp.gov/GPO/gpo71840']","['384_5_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '384_0_a policy framework.pdf', '384_1_childrens exposure to violence crime and abuse \xa0an update .pdf']",3,50.0,"['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://s-media.nyc.gov/agencies/childrenscabinet/NYCDOH_GrowingUP_Policy_Brochure_For_WEB.pdf', 'https://purl.fdlp.gov/GPO/gpo71840']","['384_5_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '384_0_a policy framework.pdf', '384_1_childrens exposure to violence crime and abuse \xa0an update .pdf']","[0.278, 0.2, 0.388]","[0.537, 0.501, 0.509]","[0.631, 0.597, 0.601]","[0.178, 0.126, 0.145]","[0.189, 0.136, 0.154]","[0.158, 0.122, 0.13]","[0.739, 0.726, 0.729]","[0.648, 0.625, 0.631]","[0.603, 0.57, 0.571]","[0.687, 0.675, 0.683]","[0.798, 0.78, 0.779]","[0.725, 0.704, 0.709]","[0.62, 0.596, 0.602]","[0.921, 0.915, 0.911]","[0.836, 0.814, 0.812]","[0.761, 0.741, 0.741]","[0.8, 0.781, 0.781]","[0.784, 0.764, 0.763]",0.289,0.516,0.61,0.15,0.16,0.137,0.731,0.635,0.581,0.682,0.786,0.713,0.606,0.916,0.821,0.748,0.787,0.77
https://doi.org/10.1001/archpediatrics.2009.23,impact of change in sweetened caloric beverage consumption on energy intake among children and adolescents,386_impact of change in sweetened caloric beverage consumption on energy intake among children and adolescents.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579823/pdf', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf', 'https://www.dshs.texas.gov/chs/tshp/2018-School-Health-Profiles-School-Principal-Item-Rationale.pdf', 'https://stacks.cdc.gov/view/cdc/30870', 'https://stacks.cdc.gov/view/cdc/35705', 'https://stacks.cdc.gov/view/cdc/5975', 'https://stacks.cdc.gov/view/cdc/26129', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale-0/download', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download']","['Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco', '2020 School Health Profiles Principal Item Rationale', 'Item Rationale 2018 School Health Profiles School Principal Questionnaire', 'Increasing access to drinking water and other healthier beverages in early care and education settings', 'Results from the School Health Policies and Practices Study 2014', ""Children's food environment state indicator report, 2011"", 'Increasing access to drinking water in schools', '2014 Profiles Principal Item Rationale', '2016 School Health Profiles School Principal Questionnaire']","['https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale-0/download', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579823/pdf']","['386_7_2014 profiles principal item rationale.pdf', '386_1_2020 school health profiles principal item rationale.pdf', '386_8_2016 school health profiles school principal questionnaire.pdf', '386_0_portion package or tableware size for changing selection and consumption of food alcohol and tobacco.pdf']",4,44.44,"['https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale-0/download', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579823/pdf']","['386_7_2014 profiles principal item rationale.pdf', '386_8_2016 school health profiles school principal questionnaire.pdf', '386_0_portion package or tableware size for changing selection and consumption of food alcohol and tobacco.pdf']","[0.291, 0.175, 0.17]","[0.486, 0.487, 0.522]","[0.586, 0.586, 0.611]","[0.125, 0.125, 0.162]","[0.142, 0.142, 0.18]","[0.107, 0.105, 0.139]","[0.725, 0.724, 0.732]","[0.623, 0.623, 0.631]","[0.574, 0.573, 0.585]","[0.654, 0.649, 0.711]","[0.781, 0.782, 0.775]","[0.7, 0.699, 0.709]","[0.592, 0.592, 0.59]","[0.916, 0.915, 0.914]","[0.806, 0.804, 0.815]","[0.738, 0.736, 0.732]","[0.78, 0.778, 0.776]","[0.77, 0.769, 0.762]",0.212,0.498,0.594,0.137,0.155,0.117,0.727,0.626,0.577,0.671,0.779,0.703,0.591,0.915,0.808,0.735,0.778,0.767
https://doi.org/10.1001/archpediatrics.2009.234,trends and factors associated with infant sleeping position,387_trends and factors associated with infant sleeping position.pdf,3,"['https://phpa.health.maryland.gov/mch/Documents/QI%20Project%20Improving%20Safe%20Sleep%20Practices%20in%20OH%20Hospitals%20(Peds%202016).pdf', 'https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_UPDATED_395151_7.pdf', 'https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_393783_7.pdf']","['The EASE Quality Improvement Project: Improving Safe Sleep Practices in Ohio Children’s Hospitals', 'Infant Mortality Reduction Plan', 'Infant Mortality Reduction Plan']","['https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_393783_7.pdf', 'https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_UPDATED_395151_7.pdf', 'https://phpa.health.maryland.gov/mch/Documents/QI%20Project%20Improving%20Safe%20Sleep%20Practices%20in%20OH%20Hospitals%20(Peds%202016).pdf']","['387_2_infant mortality reduction plan.pdf', '387_1_infant mortality reduction plan.pdf', '387_0_the ease quality improvement project improving safe sleep practices in ohio childrens hospitals.pdf']",3,100.0,['https://phpa.health.maryland.gov/mch/Documents/QI%20Project%20Improving%20Safe%20Sleep%20Practices%20in%20OH%20Hospitals%20(Peds%202016).pdf'],['387_0_the ease quality improvement project improving safe sleep practices in ohio childrens hospitals.pdf'],[0.331],[0.477],[0.571],[0.151],[0.161],[0.132],[0.73],[0.629],[0.531],[0.688],[0.751],[0.679],[0.605],[0.893],[0.761],[0.695],[0.747],[0.722],0.331,0.477,0.571,0.151,0.161,0.132,0.73,0.629,0.531,0.688,0.751,0.679,0.605,0.893,0.761,0.695,0.747,0.722
https://doi.org/10.1001/archpediatrics.2009.51,effect of maternal psychopathology on behavioral problems in preschool children exposed to terrorism,389_effect of maternal psychopathology on behavioral problems in preschool children exposed to terrorism.pdf,2,"['https://www.rand.org/pubs/research_reports/RRA390-1.html', 'https://www1.nyc.gov/assets/911health/downloads/pdf/news/wtc-mwg-annual-report2009.pdf']","['Translational Impacts of World Trade Center Health Program Research', 'WTC Annual Report']",['https://www1.nyc.gov/assets/911health/downloads/pdf/news/wtc-mwg-annual-report2009.pdf'],['389_1_wtc annual report.pdf'],1,50.0,['https://www1.nyc.gov/assets/911health/downloads/pdf/news/wtc-mwg-annual-report2009.pdf'],['389_1_wtc annual report.pdf'],[0.25],[0.534],[0.622],[0.161],[0.172],[0.138],[0.731],[0.635],[0.595],[0.664],[0.8],[0.74],[0.624],[0.92],[0.829],[0.765],[0.8],[0.785],0.25,0.534,0.622,0.161,0.172,0.138,0.731,0.635,0.595,0.664,0.8,0.74,0.624,0.92,0.829,0.765,0.8,0.785
https://doi.org/10.1001/archpediatrics.2009.88,project alert,390_project alert.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf']","['School‐based programmes for preventing smoking', 'Universal school‐based prevention for illicit drug use', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'WashingtonS tate Institute for Public Policy']","['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf']","['390_2_washington state institute for public policy.pdf', '390_1_universal school‐based prevention for illicit drug use.pdf', '390_0_school‐based programmes for preventing smoking.pdf', '390_3_washington state institute for public policy.pdf', '390_5_washingtons tate institute for public policy.pdf']",5,83.33,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028068/pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf']","['390_2_washington state institute for public policy.pdf', '390_1_universal school‐based prevention for illicit drug use.pdf', '390_0_school‐based programmes for preventing smoking.pdf', '390_3_washington state institute for public policy.pdf', '390_5_washingtons tate institute for public policy.pdf']","[0.475, 0.504, 0.189, 0.251, 0.271]","[0.519, 0.518, 0.511, 0.507, 0.518]","[0.595, 0.599, 0.588, 0.584, 0.59]","[0.143, 0.179, 0.167, 0.141, 0.148]","[0.166, 0.194, 0.179, 0.165, 0.173]","[0.13, 0.162, 0.146, 0.13, 0.137]","[0.725, 0.735, 0.73, 0.726, 0.727]","[0.632, 0.641, 0.635, 0.632, 0.634]","[0.594, 0.587, 0.581, 0.578, 0.589]","[0.691, 0.707, 0.706, 0.698, 0.699]","[0.793, 0.782, 0.78, 0.785, 0.79]","[0.731, 0.715, 0.703, 0.717, 0.727]","[0.598, 0.588, 0.588, 0.598, 0.602]","[0.921, 0.911, 0.918, 0.916, 0.917]","[0.821, 0.826, 0.819, 0.812, 0.817]","[0.755, 0.735, 0.737, 0.746, 0.753]","[0.792, 0.774, 0.773, 0.782, 0.787]","[0.78, 0.763, 0.764, 0.772, 0.776]",0.338,0.515,0.591,0.156,0.175,0.141,0.729,0.635,0.586,0.7,0.786,0.719,0.595,0.917,0.819,0.745,0.782,0.771
https://doi.org/10.1001/archpediatrics.2010.110,analysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation,391_analysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472619/pdf'],['Drug interventions for the treatment of obesity in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472619/pdf'],['391_0_drug interventions for the treatment of obesity in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472619/pdf'],['391_0_drug interventions for the treatment of obesity in children and adolescents.pdf'],[0.423],[0.519],[0.602],[0.171],[0.171],[0.141],[0.73],[0.632],[0.582],[0.69],[0.777],[0.691],[0.588],[0.896],[0.823],[0.738],[0.774],[0.764],0.423,0.519,0.602,0.171,0.171,0.141,0.73,0.632,0.582,0.69,0.777,0.691,0.588,0.896,0.823,0.738,0.774,0.764
https://doi.org/10.1001/archpediatrics.2010.117,child hunger and longterm adverse consequences for health,392_child hunger and longterm adverse consequences for health.pdf,7,"['https://uhfnyc.org/publications/publication/wic-and-medicaid/', 'http://purl.fdlp.gov/GPO/gpo65436', 'https://www.nber.org/papers/w19558?sy=558', 'https://www.urban.org/research/publication/young-people-and-nutrition-assistance', 'https://www.urban.org/research/publication/proposed-snap-work-requirements-and-childrens-food-security', 'https://www.urban.org/research/publication/how-households-children-are-affected-restricting-broad-based-categorical-eligibility-snap', 'https://www.urban.org/research/publication/navigating-work-requirements-safety-net-programs']","['Improving Nutrition and Infant Health Through WIC: Opportunities During and Beyond a Public Health Crisis', 'Food insecurity in households with children :\xa0prevalence, severity, and household characteristics, 2010-11 /', 'The Effect of Safety Net Programs on Food Insecurity', 'Young People and Nutrition Assistance', 'Proposed SNAP Work Requirements and Childrenâ\x80\x99s Food Security', 'How Households with Children Are Affected by Restricting Broad-Based Categorical Eligibility for SNAP', 'Navigating Work Requirements in Safety Net Programs']",['http://purl.fdlp.gov/GPO/gpo65436'],['392_1_food insecurity in households with children \xa0prevalence severity and household characteristics 201011 .pdf'],1,14.29,['http://purl.fdlp.gov/GPO/gpo65436'],['392_1_food insecurity in households with children \xa0prevalence severity and household characteristics 201011 .pdf'],[0.447],[0.488],[0.59],[0.169],[0.178],[0.154],[0.734],[0.635],[0.552],[0.695],[0.752],[0.673],[0.595],[0.908],[0.819],[0.719],[0.741],[0.741],0.447,0.488,0.59,0.169,0.178,0.154,0.734,0.635,0.552,0.695,0.752,0.673,0.595,0.908,0.819,0.719,0.741,0.741
https://doi.org/10.1001/archpediatrics.2010.124,impact of a mentoring and skills group program on mental health outcomes for maltreated children in foster care,393_impact of a mentoring and skills group program on mental health outcomes for maltreated children in foster care.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.acf.hhs.gov/opre/report/planning-next-generation-evaluation-agenda-john-h-chafee-foster-care-independence', 'https://www.acf.hhs.gov/opre/resource/planning-a-next-generation-evaluation-agenda-for-the-john-h-chafee-foster-care-independence-program', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/3/Wsipp_BenefitCost_ProgramDetails_Child-Welfare', 'http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/268/Fostering-Healthy-Futures', 'https://www.urban.org/research/publication/planning-next-generation-evaluation-agenda-john-h-chafee-foster-care-independence-program']","['Psychological therapies for children and adolescents exposed to trauma', 'Planning a Next-Generation Evaluation Agenda for the John H. Chafee Foster Care Independence Program', 'Planning a Next-Generation Evaluation Agenda for the John H. Chafee Foster Care Independence Program', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'Planning a Next-Generation Evaluation Agenda for the John H. Chafee Foster Care Independence Program']","['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/268/Fostering-Healthy-Futures', 'https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/3/Wsipp_BenefitCost_ProgramDetails_Child-Welfare', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf']","['393_3_washington state institute for public policy.pdf', '393_5_washington state institute for public policy.pdf', '393_4_washington state institute for public policy.pdf', '393_0_psychological therapies for children and adolescents exposed to trauma.pdf']",4,57.14,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/268/Fostering-Healthy-Futures', 'https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/3/Wsipp_BenefitCost_ProgramDetails_Child-Welfare', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf']","['393_3_washington state institute for public policy.pdf', '393_5_washington state institute for public policy.pdf', '393_4_washington state institute for public policy.pdf', '393_0_psychological therapies for children and adolescents exposed to trauma.pdf']","[0.478, 0.314, 0.317, 0.306]","[0.506, 0.517, 0.518, 0.494]","[0.587, 0.615, 0.606, 0.579]","[0.146, 0.142, 0.135, 0.156]","[0.169, 0.173, 0.157, 0.158]","[0.137, 0.136, 0.126, 0.136]","[0.73, 0.723, 0.72, 0.736]","[0.636, 0.628, 0.624, 0.64]","[0.568, 0.575, 0.577, 0.557]","[0.705, 0.721, 0.711, 0.719]","[0.77, 0.77, 0.774, 0.755]","[0.703, 0.717, 0.719, 0.67]","[0.59, 0.605, 0.61, 0.563]","[0.89, 0.893, 0.895, 0.885]","[0.791, 0.798, 0.801, 0.781]","[0.707, 0.714, 0.719, 0.685]","[0.773, 0.777, 0.78, 0.748]","[0.733, 0.735, 0.737, 0.715]",0.354,0.509,0.597,0.145,0.164,0.134,0.727,0.632,0.569,0.714,0.767,0.702,0.592,0.891,0.793,0.706,0.77,0.73
https://doi.org/10.1001/archpediatrics.2010.16,costeffectiveness of a motivational intervention to reduce rapid repeated childbearing in highrisk adolescent mothers,394_costeffectiveness of a motivational intervention to reduce rapid repeated childbearing in highrisk adolescent mothers.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154222/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730506/pdf']","['Education for contraceptive use by women after childbirth', 'Interventions for preventing unintended pregnancies among adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154222/pdf']","['394_1_interventions for preventing unintended pregnancies among adolescents.pdf', '394_0_education for contraceptive use by women after childbirth.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154222/pdf']","['394_1_interventions for preventing unintended pregnancies among adolescents.pdf', '394_0_education for contraceptive use by women after childbirth.pdf']","[0.352, 0.358]","[0.519, 0.521]","[0.606, 0.602]","[0.18, 0.173]","[0.188, 0.182]","[0.16, 0.158]","[0.736, 0.735]","[0.643, 0.642]","[0.583, 0.586]","[0.697, 0.687]","[0.78, 0.783]","[0.694, 0.704]","[0.586, 0.588]","[0.909, 0.907]","[0.816, 0.822]","[0.724, 0.735]","[0.775, 0.779]","[0.756, 0.762]",0.355,0.52,0.604,0.176,0.185,0.159,0.736,0.643,0.585,0.692,0.782,0.699,0.587,0.908,0.819,0.73,0.777,0.759
https://doi.org/10.1001/archpediatrics.2010.235,infant media exposure and toddler development,400_infant media exposure and toddler development.pdf,4,"['https://www.cincinnatichildrens.org/-/media/cincinnati%20childrens/home/service/j/anderson-center/evidence-based-care/recommendations/default/media%20exposure%20best%20210.pdf?la=en', 'https://www.acf.hhs.gov/opre/report/measuring-quality-caregiver-child-interactions-infants-and-toddlers-q-cciit', 'https://mathematica.org/publications/measuring-the-quality-of-caregiverchild-interactions-for-infants-and-toddlers-q-cciit', 'https://www.acf.hhs.gov/opre/resource/measuring-the-quality-of-caregiver-child-interactions-for-infants-and-toddlers-q-cciit']","['Pulmonary/Screen Media/Impact of Media Exposure/BESt210 Best Evidence Statement (BESt)', 'Measuring the Quality of Caregiver-Child Interactions for Infants and Toddlers (Q-CCIIT)', 'Measuring the Quality of Caregiver-Child Interactions for Infants and Toddlers (Q-CCIIT)', 'Measuring the Quality of Caregiver-Child Interactions for Infants and Toddlers (Q-CCIIT)']",['https://www.cincinnatichildrens.org/-/media/cincinnati%20childrens/home/service/j/anderson-center/evidence-based-care/recommendations/default/media%20exposure%20best%20210.pdf?la=en'],['400_0_pulmonaryscreen mediaimpact of media exposurebest210 best evidence statement best.pdf'],1,25.0,['https://www.cincinnatichildrens.org/-/media/cincinnati%20childrens/home/service/j/anderson-center/evidence-based-care/recommendations/default/media%20exposure%20best%20210.pdf?la=en'],['400_0_pulmonaryscreen mediaimpact of media exposurebest210 best evidence statement best.pdf'],[0.536],[0.53],[0.614],[0.197],[0.208],[0.179],[0.74],[0.646],[0.604],[0.694],[0.794],[0.739],[0.616],[0.912],[0.824],[0.751],[0.793],[0.771],0.536,0.53,0.614,0.197,0.208,0.179,0.74,0.646,0.604,0.694,0.794,0.739,0.616,0.912,0.824,0.751,0.793,0.771
https://doi.org/10.1001/archpediatrics.2010.24,word learning from baby videos,401_word learning from baby videos.pdf,1,['https://www.cincinnatichildrens.org/-/media/cincinnati%20childrens/home/service/j/anderson-center/evidence-based-care/recommendations/default/media%20exposure%20best%20210.pdf?la=en'],['Pulmonary/Screen Media/Impact of Media Exposure/BESt210 Best Evidence Statement (BESt)'],['https://www.cincinnatichildrens.org/-/media/cincinnati%20childrens/home/service/j/anderson-center/evidence-based-care/recommendations/default/media%20exposure%20best%20210.pdf?la=en'],['401_0_pulmonaryscreen mediaimpact of media exposurebest210 best evidence statement best.pdf'],1,100.0,['https://www.cincinnatichildrens.org/-/media/cincinnati%20childrens/home/service/j/anderson-center/evidence-based-care/recommendations/default/media%20exposure%20best%20210.pdf?la=en'],['401_0_pulmonaryscreen mediaimpact of media exposurebest210 best evidence statement best.pdf'],[0.357],[0.522],[0.606],[0.18],[0.194],[0.167],[0.734],[0.639],[0.59],[0.698],[0.785],[0.729],[0.622],[0.92],[0.823],[0.756],[0.784],[0.775],0.357,0.522,0.606,0.18,0.194,0.167,0.734,0.639,0.59,0.698,0.785,0.729,0.622,0.92,0.823,0.756,0.784,0.775
https://doi.org/10.1001/archpediatrics.2010.241,connecting the dots in childhood and adolescent trauma,402_connecting the dots in childhood and adolescent trauma.pdf,1,['http://purl.fdlp.gov/GPO/gpo57350'],"['Child and youth victimization known to police, school, and medical authorities /']",['http://purl.fdlp.gov/GPO/gpo57350'],['402_0_child and youth victimization known to police school and medical authorities .pdf'],1,100.0,['http://purl.fdlp.gov/GPO/gpo57350'],['402_0_child and youth victimization known to police school and medical authorities .pdf'],[0.502],[0.563],[0.645],[0.228],[0.251],[0.217],[0.748],[0.658],[0.639],[0.701],[0.817],[0.745],[0.642],[0.908],[0.852],[0.785],[0.816],[0.8],0.502,0.563,0.645,0.228,0.251,0.217,0.748,0.658,0.639,0.701,0.817,0.745,0.642,0.908,0.852,0.785,0.816,0.8
https://doi.org/10.1001/archpediatrics.2010.247,community treatment of posttraumatic stress disorder for children exposed to intimate partner violence,403_community treatment of posttraumatic stress disorder for children exposed to intimate partner violence.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://mathematica.org/publications/serving-child-welfare-families-with-substance-abuse-issues-grantees-use-of-evidencebased-practices', 'https://mathematica.org/publications/the-external-review-of-job-corps-an-evidence-scan-report', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.justice.gov/sites/default/files/defendingchildhood/cev-rpt-full.pdf', 'https://purl.fdlp.gov/GPO/gpo105863', 'https://purl.fdlp.gov/GPO/gpo87612', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/5/Wsipp_BenefitCost_ProgramDetails_Childrens-Mental-Health', 'https://stacks.cdc.gov/view/cdc/43085']","['Challenges for the implementation of World Health Organization guidelines for acute stress, PTSD, and bereavement: a qualitative study in Uganda', 'Psychological therapies for children and adolescents exposed to trauma', ""Serving Child Welfare Families with Substance Abuse Issues: Grantees' Use of Evidence-Based Practices and the Extent of Evidence"", 'The External Review of Job Corps: An Evidence Scan Report', 'Washington State Institute for Public Policy', ""Report of the Attorney General's National Task Force on Children Exposed to Violence"", 'A comprehensive technical package for the prevention of youth violence and associated risk behaviors /', 'Trauma-focused cognitive behavioral therapy for children affected by sexual abuse or trauma /', 'Washington State Institute for Public Policy', 'A Comprehensive technical package for the prevention of youth violence and associated risk behaviors']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://purl.fdlp.gov/GPO/gpo87612', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.justice.gov/sites/default/files/defendingchildhood/cev-rpt-full.pdf', 'https://purl.fdlp.gov/GPO/gpo105863']","['403_0_challenges for the implementation of world health organization guidelines for acute stress ptsd and bereavement a qualitative study in uganda.pdf', '403_7_traumafocused cognitive behavioral therapy for children affected by sexual abuse or trauma .pdf', '403_1_psychological therapies for children and adolescents exposed to trauma.pdf', '403_4_washington state institute for public policy.pdf', '403_5_report of the attorney generals national task force on children exposed to violence.pdf', '403_6_a comprehensive technical package for the prevention of youth violence and associated risk behaviors .pdf']",6,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://purl.fdlp.gov/GPO/gpo87612', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.justice.gov/sites/default/files/defendingchildhood/cev-rpt-full.pdf', 'https://purl.fdlp.gov/GPO/gpo105863']","['403_0_challenges for the implementation of world health organization guidelines for acute stress ptsd and bereavement a qualitative study in uganda.pdf', '403_7_traumafocused cognitive behavioral therapy for children affected by sexual abuse or trauma .pdf', '403_1_psychological therapies for children and adolescents exposed to trauma.pdf', '403_4_washington state institute for public policy.pdf', '403_5_report of the attorney generals national task force on children exposed to violence.pdf', '403_6_a comprehensive technical package for the prevention of youth violence and associated risk behaviors .pdf']","[0.235, 0.47, 0.246, 0.492, 0.229, 0.606]","[0.496, 0.49, 0.493, 0.493, 0.473, 0.491]","[0.586, 0.585, 0.571, 0.57, 0.577, 0.585]","[0.148, 0.175, 0.157, 0.133, 0.161, 0.148]","[0.162, 0.2, 0.159, 0.152, 0.183, 0.165]","[0.134, 0.172, 0.142, 0.128, 0.158, 0.138]","[0.725, 0.744, 0.74, 0.73, 0.736, 0.731]","[0.631, 0.65, 0.645, 0.635, 0.642, 0.634]","[0.556, 0.552, 0.559, 0.555, 0.556, 0.554]","[0.679, 0.693, 0.723, 0.7, 0.679, 0.679]","[0.771, 0.765, 0.752, 0.762, 0.767, 0.765]","[0.698, 0.693, 0.665, 0.689, 0.687, 0.701]","[0.593, 0.58, 0.565, 0.585, 0.574, 0.588]","[0.886, 0.89, 0.884, 0.887, 0.885, 0.889]","[0.798, 0.792, 0.776, 0.781, 0.794, 0.788]","[0.707, 0.708, 0.686, 0.702, 0.703, 0.705]","[0.771, 0.767, 0.746, 0.765, 0.762, 0.77]","[0.727, 0.731, 0.715, 0.725, 0.725, 0.728]",0.38,0.489,0.579,0.154,0.17,0.145,0.734,0.639,0.555,0.692,0.764,0.689,0.581,0.887,0.788,0.702,0.763,0.725
https://doi.org/10.1001/archpediatrics.2010.248,developmental trajectories of marijuana use from adolescence to adulthood,404_developmental trajectories of marijuana use from adolescence to adulthood.pdf,2,"['https://mhcc.maryland.gov/mhcc/pages/hcfs/hcfs_con/documents/filed_2015/con_comp_resp_rca_waldorf_20150831.pdf', 'https://mhcc.maryland.gov/mhcc/pages/hcfs/hcfs_con/documents/filed_2015/con_comp_resp_rca_earleville_20150831.pdf']","['Evelius & Jones Llp', 'Gallagher Evelius & Jones Llp']","['https://mhcc.maryland.gov/mhcc/pages/hcfs/hcfs_con/documents/filed_2015/con_comp_resp_rca_earleville_20150831.pdf', 'https://mhcc.maryland.gov/mhcc/pages/hcfs/hcfs_con/documents/filed_2015/con_comp_resp_rca_waldorf_20150831.pdf']","['404_1_gallagher evelius  jones llp.pdf', '404_0_evelius  jones llp.pdf']",2,100.0,"['https://mhcc.maryland.gov/mhcc/pages/hcfs/hcfs_con/documents/filed_2015/con_comp_resp_rca_earleville_20150831.pdf', 'https://mhcc.maryland.gov/mhcc/pages/hcfs/hcfs_con/documents/filed_2015/con_comp_resp_rca_waldorf_20150831.pdf']","['404_1_gallagher evelius  jones llp.pdf', '404_0_evelius  jones llp.pdf']","[0.258, 0.258]","[0.493, 0.493]","[0.589, 0.589]","[0.129, 0.129]","[0.135, 0.135]","[0.114, 0.113]","[0.721, 0.721]","[0.618, 0.618]","[0.57, 0.57]","[0.649, 0.649]","[0.79, 0.789]","[0.705, 0.705]","[0.618, 0.617]","[0.913, 0.913]","[0.815, 0.815]","[0.747, 0.747]","[0.785, 0.785]","[0.769, 0.768]",0.258,0.493,0.589,0.129,0.135,0.114,0.721,0.618,0.57,0.649,0.79,0.705,0.617,0.913,0.815,0.747,0.785,0.768
https://doi.org/10.1001/archpediatrics.2010.251,interventions to reduce sexual risk for human immunodeficiency virus in adolescents,405_interventions to reduce sexual risk for human immunodeficiency virus in adolescents.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf', 'https://www.cms.gov/medicare-coverage-database/details/nca-details.aspx?NCAId=250&type=Closed', 'https://www.icrw.org/publications/she-cannot-just-sit-around-waiting-to-turn-twenty/']","['School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents', 'National Coverage Analysis (NCA) for Screening for Sexually Transmitted Infections (STIs) and High-Intensity Behavioral Counseling (HIBC) to prevent STIs (CAG-00426N)', '“She cannot just sit around waiting to turn twenty”']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],['405_0_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],['405_0_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf'],[0.568],[0.503],[0.584],[0.169],[0.179],[0.155],[0.739],[0.645],[0.568],[0.707],[0.764],[0.694],[0.566],[0.891],[0.79],[0.686],[0.762],[0.719],0.568,0.503,0.584,0.169,0.179,0.155,0.739,0.645,0.568,0.707,0.764,0.694,0.566,0.891,0.79,0.686,0.762,0.719
https://doi.org/10.1001/archpediatrics.2010.254,primary care strategies for promoting parentchild interactions and school readiness in atrisk families,406_primary care strategies for promoting parentchild interactions and school readiness in atrisk families.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883766/pdf', 'https://www.acf.hhs.gov/opre/report/children-and-fathers-bonding-findings-b3-study-innovative-parenting-intervention', 'https://www.brookings.edu/research/the-power-of-love-why-maternal-depression-is-an-economic-mobility-issue/', 'https://tea.texas.gov/sites/default/files/Rider%2042%20-%20Children_s%20Learning%20Institute%20Report.pdf']","['Video feedback for parental sensitivity and attachment security in children under five years', 'Children and Fathers Bonding: Findings from the B3 Study of an Innovative Parenting Intervention', 'The Power of Love: Why maternal depression is an economic mobility issue', 'Completed Review of Occupational Licensing Requirements']","['https://tea.texas.gov/sites/default/files/Rider%2042%20-%20Children_s%20Learning%20Institute%20Report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883766/pdf']","['406_3_completed review of occupational licensing requirements.pdf', '406_0_video feedback for parental sensitivity and attachment security in children under five years.pdf']",2,50.0,"['https://tea.texas.gov/sites/default/files/Rider%2042%20-%20Children_s%20Learning%20Institute%20Report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883766/pdf']","['406_3_completed review of occupational licensing requirements.pdf', '406_0_video feedback for parental sensitivity and attachment security in children under five years.pdf']","[0.378, 0.294]","[0.481, 0.49]","[0.565, 0.573]","[0.134, 0.15]","[0.149, 0.155]","[0.128, 0.138]","[0.733, 0.734]","[0.633, 0.636]","[0.534, 0.543]","[0.699, 0.722]","[0.741, 0.742]","[0.688, 0.685]","[0.602, 0.579]","[0.869, 0.87]","[0.758, 0.759]","[0.666, 0.656]","[0.747, 0.742]","[0.689, 0.684]",0.336,0.485,0.569,0.142,0.152,0.133,0.734,0.635,0.538,0.71,0.742,0.686,0.591,0.869,0.758,0.661,0.744,0.686
https://doi.org/10.1001/archpediatrics.2010.256,adverse adolescent reproductive health outcomes after pelvic inflammatory disease,407_adverse adolescent reproductive health outcomes after pelvic inflammatory disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425212/pdf'],['Clinician Perspectives on Management of Adolescents with Pelvic Inflammatory Disease Using Standardized Patient Scenarios'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425212/pdf'],['407_0_clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425212/pdf'],['407_0_clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios.pdf'],[0.454],[0.505],[0.597],[0.165],[0.186],[0.157],[0.742],[0.648],[0.588],[0.671],[0.776],[0.692],[0.57],[0.906],[0.806],[0.735],[0.771],[0.766],0.454,0.505,0.597,0.165,0.186,0.157,0.742,0.648,0.588,0.671,0.776,0.692,0.57,0.906,0.806,0.735,0.771,0.766
https://doi.org/10.1001/archpediatrics.2010.26,influence of prior advice and beliefs of mothers on infant sleep position,408_influence of prior advice and beliefs of mothers on infant sleep position.pdf,5,"['https://phpa.health.maryland.gov/mch/Documents/Nocturnal%20Video%20Assessment%20of%20Sleep%20Environment%20(Peds%202016).pdf', 'https://www.congress.gov/event/116th-congress/house-event/109635', 'https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_UPDATED_395151_7.pdf', 'https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_393783_7.pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['Nocturnal Video Assessment of Infant Sleep Environments', '""Keeping Kids and Consumers Safe from Dangerous Products""', 'Infant Mortality Reduction Plan', 'Infant Mortality Reduction Plan', 'A Policy & Education Development Guide']","['https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_UPDATED_395151_7.pdf', 'https://phpa.health.maryland.gov/mch/Documents/Nocturnal%20Video%20Assessment%20of%20Sleep%20Environment%20(Peds%202016).pdf', 'https://www.michigan.gov/documents/mdch/MichiganIMReductionPlan_393783_7.pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['408_2_infant mortality reduction plan.pdf', '408_0_nocturnal video assessment of infant sleep environments.pdf', '408_3_infant mortality reduction plan.pdf', '408_4_a policy  education development guide.pdf']",4,80.0,"['https://phpa.health.maryland.gov/mch/Documents/Nocturnal%20Video%20Assessment%20of%20Sleep%20Environment%20(Peds%202016).pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['408_0_nocturnal video assessment of infant sleep environments.pdf', '408_4_a policy  education development guide.pdf']","[0.593, 0.639]","[0.554, 0.538]","[0.629, 0.617]","[0.197, 0.171]","[0.221, 0.197]","[0.183, 0.162]","[0.738, 0.735]","[0.644, 0.638]","[0.626, 0.612]","[0.685, 0.674]","[0.81, 0.807]","[0.75, 0.744]","[0.62, 0.615]","[0.914, 0.917]","[0.841, 0.834]","[0.77, 0.764]","[0.806, 0.805]","[0.791, 0.79]",0.616,0.546,0.623,0.184,0.209,0.172,0.736,0.641,0.619,0.679,0.808,0.747,0.617,0.915,0.837,0.767,0.806,0.79
https://doi.org/10.1001/archpediatrics.2010.279,post–high school service use among young adults with an autism spectrum disorder,409_post–high school service use among young adults with an autism spectrum disorder.pdf,8,"['https://mathematica.org/publications/promoting-readiness-of-minors-with-autism-spectrum-disorder-evidence-from-a-randomized-controlled', 'https://effectivehealthcare.ahrq.gov/products/asd-interventions/research-2017', 'https://effectivehealthcare.ahrq.gov/products/asd-medical/research-2017', 'https://www.congress.gov/event/112th-congress/house-event/LC3404/text', 'https://www.michigan.gov/documents/autism/ASDStatePlan_2_19_13_Final_414143_7.pdf', 'https://stacks.cdc.gov/view/cdc/39031', 'https://stacks.cdc.gov/view/cdc/29064', 'https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf']","['Promoting Readiness of Minors with Autism Spectrum Disorder: Evidence from a Randomized Controlled Trial', 'Interventions Targeting Sensory Challenges in Children with Autism Spectrum Disorder - An Update', 'Medical Therapies for Children with Autism Spectrum Disorder — An Update', ""House Hearing, 112th Congress — LEGISLATIVE HEARING ON MISCELLANEOUS PUBLIC HEALTH LEGISLATION, H.R. 1852, CHILDREN'S HOSPITAL GME SUPPORT REAUTHORIZATION ACT OF 2011, AND H.R. 2005, COMBATING AUTISM REAUTHORIZATION ACT OF 2011"", 'Michigan', 'Community report on autism, 2016', 'Community report on autism, 2014', 'Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update']","['https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf', 'https://www.michigan.gov/documents/autism/ASDStatePlan_2_19_13_Final_414143_7.pdf']","['409_7_therapies for children with autism spectrum disorder behavioral interventions update.pdf', '409_4_michigan.pdf']",2,25.0,['https://www.michigan.gov/documents/autism/ASDStatePlan_2_19_13_Final_414143_7.pdf'],['409_4_michigan.pdf'],[0.594],[0.543],[0.629],[0.163],[0.193],[0.152],[0.727],[0.63],[0.619],[0.685],[0.807],[0.749],[0.636],[0.912],[0.842],[0.777],[0.814],[0.796],0.594,0.543,0.629,0.163,0.193,0.152,0.727,0.63,0.619,0.685,0.807,0.749,0.636,0.912,0.842,0.777,0.814,0.796
https://doi.org/10.1001/archpediatrics.2010.50,prospective associations between early childhood television exposure and academic psychosocial and physical wellbeing by middle childhood,410_prospective associations between early childhood television exposure and academic psychosocial and physical wellbeing by middle childhood.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf', 'https://www1.nyc.gov/assets/dcas/downloads/pdf/cityrecord/cityrecord-03-19-15.pdf']","['Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight', 'Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight', 'The City Record']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf', 'https://www1.nyc.gov/assets/dcas/downloads/pdf/cityrecord/cityrecord-03-19-15.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf']","['410_1_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf', '410_2_the city record.pdf', '410_0_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf', 'https://www1.nyc.gov/assets/dcas/downloads/pdf/cityrecord/cityrecord-03-19-15.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf']","['410_1_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf', '410_2_the city record.pdf', '410_0_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf']","[0.334, 0.327, 0.169]","[0.489, 0.458, 0.489]","[0.576, 0.552, 0.576]","[0.145, 0.1, 0.151]","[0.149, 0.099, 0.156]","[0.126, 0.087, 0.129]","[0.731, 0.715, 0.732]","[0.631, 0.613, 0.633]","[0.551, 0.532, 0.549]","[0.706, 0.65, 0.701]","[0.751, 0.75, 0.755]","[0.679, 0.673, 0.68]","[0.578, 0.594, 0.588]","[0.892, 0.895, 0.888]","[0.777, 0.783, 0.775]","[0.699, 0.699, 0.707]","[0.752, 0.753, 0.754]","[0.727, 0.725, 0.728]",0.277,0.479,0.568,0.132,0.135,0.114,0.726,0.626,0.544,0.686,0.752,0.677,0.587,0.892,0.778,0.702,0.753,0.727
https://doi.org/10.1001/archpediatrics.2010.84,changes in statespecific childhood obesity and overweight prevalence in the united states from 2003 to 2007,411_changes in statespecific childhood obesity and overweight prevalence in the united states from 2003 to 2007.pdf,6,"['https://demographics.texas.gov/Resources/Publications/2011/2011-02_GainingCostsLosingTime.pdf', 'https://www.in.gov/indot/files/BicyclePedestrianCurriculaGuide2011.pdf', 'https://stacks.cdc.gov/view/cdc/7132', 'http://www.houstontx.gov/health/chronic-disease/documents/HE_Assessmentt_Final.pdf', 'https://www.commonwealthfund.org/publications/fund-reports/2011/feb/securing-healthy-future-commonwealth-fund-state-scorecard-child', 'https://www.urban.org/research/publication/strengthening-communities-neighborhood-data']","['Susan Combs Texas Comptroller of Public Accounts', 'Bicycle and Pedestrian Curricula Guide', 'Bicycle and Pedestrian Curricula Guide: Making the Case for Bicycle and Pedestrian Youth Education', 'Houston Departmentof V', 'Securing a Healthy Future: The Commonwealth Fund State Scorecard on Child Health System Performance, 2011', 'Strengthening Communities with Neighborhood Data']","['http://www.houstontx.gov/health/chronic-disease/documents/HE_Assessmentt_Final.pdf', 'https://demographics.texas.gov/Resources/Publications/2011/2011-02_GainingCostsLosingTime.pdf']","['411_3_houston departmentof v.pdf', '411_0_susan combs texas comptroller of public accounts.pdf']",2,33.33,"['http://www.houstontx.gov/health/chronic-disease/documents/HE_Assessmentt_Final.pdf', 'https://demographics.texas.gov/Resources/Publications/2011/2011-02_GainingCostsLosingTime.pdf']","['411_3_houston departmentof v.pdf', '411_0_susan combs texas comptroller of public accounts.pdf']","[0.394, 0.303]","[0.452, 0.458]","[0.563, 0.556]","[0.135, 0.136]","[0.149, 0.149]","[0.119, 0.117]","[0.718, 0.723]","[0.617, 0.62]","[0.504, 0.521]","[0.671, 0.695]","[0.766, 0.765]","[0.656, 0.656]","[0.605, 0.604]","[0.895, 0.893]","[0.822, 0.821]","[0.691, 0.699]","[0.757, 0.759]","[0.748, 0.751]",0.349,0.455,0.559,0.136,0.149,0.118,0.72,0.619,0.512,0.683,0.766,0.656,0.605,0.894,0.821,0.695,0.758,0.75
https://doi.org/10.1001/archpediatrics.2010.91,telephone coaching for parents of children with asthma,412_telephone coaching for parents of children with asthma.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433298/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407490/pdf']","['Psychological interventions for parents of children and adolescents with chronic illness', 'Home telemonitoring and remote feedback between clinic visits for asthma', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Remote versus face‐to‐face check‐ups for asthma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407490/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433298/pdf']","['412_0_psychological interventions for parents of children and adolescents with chronic illness.pdf', '412_3_psychological interventions for parents of children and adolescents with chronic illness.pdf', '412_4_remote versus face‐to‐face check‐ups for asthma.pdf', '412_2_psychological interventions for parents of children and adolescents with chronic illness.pdf', '412_1_home telemonitoring and remote feedback between clinic visits for asthma.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407490/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433298/pdf']","['412_0_psychological interventions for parents of children and adolescents with chronic illness.pdf', '412_3_psychological interventions for parents of children and adolescents with chronic illness.pdf', '412_4_remote versus face‐to‐face check‐ups for asthma.pdf', '412_2_psychological interventions for parents of children and adolescents with chronic illness.pdf', '412_1_home telemonitoring and remote feedback between clinic visits for asthma.pdf']","[0.337, 0.508, 0.345, 0.367, 0.476]","[0.502, 0.514, 0.522, 0.507, 0.516]","[0.584, 0.592, 0.6, 0.586, 0.596]","[0.14, 0.146, 0.169, 0.149, 0.17]","[0.162, 0.163, 0.185, 0.158, 0.185]","[0.124, 0.125, 0.149, 0.13, 0.155]","[0.732, 0.731, 0.736, 0.734, 0.739]","[0.636, 0.633, 0.639, 0.637, 0.642]","[0.565, 0.578, 0.586, 0.572, 0.581]","[0.695, 0.693, 0.702, 0.697, 0.702]","[0.757, 0.766, 0.78, 0.768, 0.776]","[0.695, 0.709, 0.707, 0.695, 0.695]","[0.557, 0.566, 0.584, 0.57, 0.586]","[0.89, 0.895, 0.899, 0.897, 0.897]","[0.787, 0.796, 0.805, 0.794, 0.8]","[0.698, 0.709, 0.708, 0.697, 0.703]","[0.749, 0.76, 0.772, 0.757, 0.767]","[0.723, 0.735, 0.739, 0.731, 0.736]",0.407,0.512,0.592,0.155,0.171,0.137,0.734,0.637,0.576,0.698,0.769,0.7,0.573,0.896,0.796,0.703,0.761,0.733
https://doi.org/10.1001/archpediatrics.2011.1,randomized controlled trial to improve care for urban children with asthma,414_randomized controlled trial to improve care for urban children with asthma.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381057/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353176/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/han/advisory/childhood-asthma-advisory33.pdf', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download']","[""Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke"", 'Working toward a Sustainable System of Asthma Care: Development of the School-Based Preventive Asthma Care Technology (SB-PACT) Trial', 'School‐based self‐management interventions for asthma in children and adolescents: a mixed methods systematic review', '2017 Advisory # 33 : Health Department reminds health care providers to help children prepare for the fall asthma season', '2016 School Health Profiles School Principal Questionnaire']","['https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353176/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381057/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf']","['414_4_2016 school health profiles school principal questionnaire.pdf', '414_2_school‐based self‐management interventions for asthma in children and adolescents a mixed methods systematic review.pdf', '414_1_working toward a sustainable system of asthma care development of the schoolbased preventive asthma care technology sbpact trial.pdf', '414_0_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf']",4,80.0,"['https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353176/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381057/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf']","['414_4_2016 school health profiles school principal questionnaire.pdf', '414_2_school‐based self‐management interventions for asthma in children and adolescents a mixed methods systematic review.pdf', '414_1_working toward a sustainable system of asthma care development of the schoolbased preventive asthma care technology sbpact trial.pdf', '414_0_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf']","[0.493, 0.617, 0.504, 0.304]","[0.497, 0.507, 0.52, 0.523]","[0.589, 0.59, 0.602, 0.602]","[0.149, 0.17, 0.186, 0.182]","[0.161, 0.174, 0.211, 0.179]","[0.138, 0.147, 0.171, 0.154]","[0.735, 0.738, 0.739, 0.736]","[0.632, 0.64, 0.64, 0.638]","[0.578, 0.572, 0.589, 0.586]","[0.661, 0.699, 0.691, 0.693]","[0.785, 0.771, 0.79, 0.779]","[0.709, 0.687, 0.719, 0.707]","[0.591, 0.585, 0.608, 0.597]","[0.907, 0.901, 0.908, 0.903]","[0.803, 0.797, 0.813, 0.802]","[0.722, 0.705, 0.734, 0.712]","[0.78, 0.763, 0.789, 0.775]","[0.754, 0.738, 0.76, 0.743]",0.479,0.512,0.596,0.172,0.181,0.153,0.737,0.637,0.581,0.686,0.781,0.705,0.595,0.905,0.804,0.718,0.777,0.749
https://doi.org/10.1001/archpediatrics.2011.1082,reliable change in postconcussive symptoms and its functional consequences among children with mild traumatic brain injury,415_reliable change in postconcussive symptoms and its functional consequences among children with mild traumatic brain injury.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975780/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602846/pdf']","[""National Athletic Trainers' Association Position Statement: Management of Sport Concussion"", 'Strengthening the Evidence Base: Recommendations for Future Research Identified Through the Development of CDC’s Pediatric Mild TBI Guideline']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602846/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975780/pdf']","['415_1_strengthening the evidence base recommendations for future research identified through the development of cdcs pediatric mild tbi guideline.pdf', '415_0_national athletic trainers association position statement management of sport concussion.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602846/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975780/pdf']","['415_1_strengthening the evidence base recommendations for future research identified through the development of cdcs pediatric mild tbi guideline.pdf', '415_0_national athletic trainers association position statement management of sport concussion.pdf']","[0.3, 0.323]","[0.473, 0.477]","[0.57, 0.569]","[0.155, 0.153]","[0.177, 0.159]","[0.14, 0.135]","[0.74, 0.739]","[0.65, 0.645]","[0.539, 0.54]","[0.71, 0.681]","[0.738, 0.745]","[0.674, 0.68]","[0.553, 0.586]","[0.869, 0.875]","[0.769, 0.772]","[0.649, 0.657]","[0.738, 0.746]","[0.688, 0.688]",0.311,0.475,0.569,0.154,0.168,0.138,0.74,0.647,0.54,0.696,0.742,0.677,0.57,0.872,0.77,0.653,0.742,0.688
https://doi.org/10.1001/archpediatrics.2011.112,safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink,417_safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.pdf,8,"['https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://stacks.cdc.gov/view/cdc/20709', 'https://stacks.cdc.gov/view/cdc/57885', 'http://www.nyc.gov/html/dcas/downloads/pdf/cityrecord/cityrecord-9-19-13.pdf', 'https://stacks.cdc.gov/view/cdc/41010', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635867/pdf', 'http://www.nyc.gov/html/nycrules/downloads/rules/P-DOHMH-09-19-13-c.pdf', 'https://stacks.cdc.gov/view/cdc/117159']","['Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014', 'White paper on studying the safety of the childhood immunization schedule for the vaccine safety datalink', 'CR- SEPTEMBER 9-19-13.qxd', 'Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices -- United States, 2016-17 influenza season', 'Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015)', 'Article 47', 'Vaccine safety publications']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635867/pdf', 'http://www.nyc.gov/html/nycrules/downloads/rules/P-DOHMH-09-19-13-c.pdf']","['417_5_technical guidelines for the application of seasonal influenza vaccine in china 2014–2015.pdf', '417_6_article 47.pdf']",2,25.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635867/pdf', 'http://www.nyc.gov/html/nycrules/downloads/rules/P-DOHMH-09-19-13-c.pdf']","['417_5_technical guidelines for the application of seasonal influenza vaccine in china 2014–2015.pdf', '417_6_article 47.pdf']","[0.451, 0.318]","[0.556, 0.516]","[0.619, 0.589]","[0.196, 0.18]","[0.194, 0.181]","[0.162, 0.154]","[0.743, 0.737]","[0.652, 0.641]","[0.626, 0.586]","[0.665, 0.675]","[0.805, 0.786]","[0.731, 0.673]","[0.627, 0.62]","[0.918, 0.917]","[0.84, 0.831]","[0.769, 0.756]","[0.806, 0.781]","[0.792, 0.772]",0.385,0.536,0.604,0.188,0.188,0.158,0.74,0.647,0.606,0.67,0.796,0.702,0.623,0.917,0.835,0.762,0.794,0.782
https://doi.org/10.1001/archpediatrics.2011.115,effectiveness of an early intervention on infant feeding practices and “tummy time”,418_effectiveness of an early intervention on infant feeding practices and “tummy time”.pdf,7,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Support for healthy breastfeeding mothers with healthy term babies', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Primary Care Interventions to Support BreastfeedingUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force']","['https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf']","['418_6_primary care interventions to support breastfeedingupdated evidence report and systematic review for the us preventive services task force.pdf', '418_5_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '418_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '418_2_educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.pdf', '418_4_support for healthy breastfeeding mothers with healthy term babies.pdf', '418_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",6,85.71,"['https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf']","['418_6_primary care interventions to support breastfeedingupdated evidence report and systematic review for the us preventive services task force.pdf', '418_5_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '418_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '418_2_educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.pdf', '418_4_support for healthy breastfeeding mothers with healthy term babies.pdf', '418_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.467, 0.592, 0.467, 0.52, 0.464, 0.531]","[0.48, 0.527, 0.526, 0.507, 0.527, 0.528]","[0.579, 0.61, 0.609, 0.59, 0.601, 0.608]","[0.161, 0.168, 0.168, 0.161, 0.173, 0.172]","[0.173, 0.173, 0.172, 0.17, 0.18, 0.176]","[0.149, 0.15, 0.15, 0.146, 0.154, 0.15]","[0.734, 0.731, 0.731, 0.733, 0.732, 0.731]","[0.641, 0.635, 0.634, 0.636, 0.638, 0.636]","[0.554, 0.594, 0.592, 0.57, 0.589, 0.596]","[0.7, 0.693, 0.693, 0.695, 0.696, 0.692]","[0.775, 0.787, 0.786, 0.77, 0.787, 0.791]","[0.661, 0.694, 0.69, 0.683, 0.685, 0.702]","[0.581, 0.596, 0.596, 0.594, 0.592, 0.603]","[0.903, 0.917, 0.917, 0.9, 0.915, 0.915]","[0.793, 0.831, 0.829, 0.801, 0.824, 0.824]","[0.712, 0.74, 0.739, 0.716, 0.739, 0.75]","[0.748, 0.78, 0.778, 0.764, 0.778, 0.784]","[0.743, 0.772, 0.771, 0.743, 0.767, 0.775]",0.507,0.516,0.6,0.167,0.174,0.15,0.732,0.637,0.583,0.695,0.783,0.686,0.594,0.911,0.817,0.733,0.772,0.762
https://doi.org/10.1001/archpediatrics.2011.122,effectiveness of interventions aimed at reducing screen time in children,419_effectiveness of interventions aimed at reducing screen time in children.pdf,3,"['https://www.rand.org/pubs/research_reports/RR1993.html', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943460-3', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103347/pdf']","['Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society', 'Current Guidelines for Obesity Prevention in Childhood and Adolescence']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103347/pdf'],['419_2_current guidelines for obesity prevention in childhood and adolescence.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103347/pdf'],['419_2_current guidelines for obesity prevention in childhood and adolescence.pdf'],[0.433],[0.52],[0.601],[0.16],[0.171],[0.133],[0.726],[0.63],[0.584],[0.688],[0.781],[0.713],[0.605],[0.902],[0.815],[0.722],[0.777],[0.745],0.433,0.52,0.601,0.16,0.171,0.133,0.726,0.63,0.584,0.688,0.781,0.713,0.605,0.902,0.815,0.722,0.777,0.745
https://doi.org/10.1001/archpediatrics.2011.127,schoolbased body mass index screening and parent notification,420_schoolbased body mass index screening and parent notification.pdf,4,"['https://www.michigan.gov/documents/mdch/MDCH_SHIP_FINAL_8-16-12_400674_7.pdf.', 'https://effectivehealthcare.ahrq.gov/products/obesity-research-methods/systematic-review', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention', 'https://www.michigan.gov/documents/healthymichigan/Michigan_Health_Wellness_4x4_Plan_387870_7.pdf']","[""Michigan's State Health Assessment and State Health Improvement Plan 2012–2017"", 'Methods for Evaluating Natural Experiments in Obesity: A Systematic Evidence Review', 'Washington State Institute for Public Policy', 'The Michigan Health and Wellness4x4 Plan']","['https://www.michigan.gov/documents/healthymichigan/Michigan_Health_Wellness_4x4_Plan_387870_7.pdf', 'https://www.michigan.gov/documents/mdch/MDCH_SHIP_FINAL_8-16-12_400674_7.pdf.']","['420_3_the michigan health and wellness4x4 plan.pdf', '420_0_michigans state health assessment and state health improvement plan 2012–2017.pdf']",2,50.0,"['https://www.michigan.gov/documents/healthymichigan/Michigan_Health_Wellness_4x4_Plan_387870_7.pdf', 'https://www.michigan.gov/documents/mdch/MDCH_SHIP_FINAL_8-16-12_400674_7.pdf.']","['420_3_the michigan health and wellness4x4 plan.pdf', '420_0_michigans state health assessment and state health improvement plan 2012–2017.pdf']","[0.218, 0.314]","[0.489, 0.461]","[0.587, 0.564]","[0.144, 0.145]","[0.159, 0.152]","[0.13, 0.131]","[0.725, 0.728]","[0.624, 0.629]","[0.568, 0.563]","[0.678, 0.678]","[0.78, 0.769]","[0.703, 0.673]","[0.595, 0.566]","[0.898, 0.888]","[0.803, 0.809]","[0.713, 0.702]","[0.77, 0.761]","[0.738, 0.726]",0.266,0.475,0.575,0.144,0.155,0.131,0.726,0.627,0.565,0.678,0.774,0.688,0.581,0.893,0.806,0.708,0.766,0.732
https://doi.org/10.1001/archpediatrics.2011.135,maternal exposure to magnetic fields during pregnancy in relation to the risk of asthma in offspring,422_maternal exposure to magnetic fields during pregnancy in relation to the risk of asthma in offspring.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf'],['Preconception Care: A New Standard of Care within Maternal Health Services'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf'],['422_0_preconception care a new standard of care within maternal health services.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf'],['422_0_preconception care a new standard of care within maternal health services.pdf'],[0.296],[0.483],[0.582],[0.144],[0.132],[0.124],[0.742],[0.648],[0.531],[0.686],[0.745],[0.609],[0.592],[0.902],[0.775],[0.705],[0.718],[0.727],0.296,0.483,0.582,0.144,0.132,0.124,0.742,0.648,0.531,0.686,0.745,0.609,0.592,0.902,0.775,0.705,0.718,0.727
https://doi.org/10.1001/archpediatrics.2011.136,comparative efficacy and safety of 4 randomized regimens to treat early emph typeitalpseudomonas aeruginosaemph infection in children with cystic fibrosis,423_comparative efficacy and safety of 4 randomized regimens to treat early emph typeitalpseudomonas aeruginosaemph infection in children with cystic fibrosis.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407188/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916140/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687954/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457863/pdf']","['Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis', 'Treatments for preventing recurrence of infection with in people with cystic fibrosis', 'Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis', 'Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis', 'Brazilian guidelines for the diagnosis and treatment of cystic fibrosis', 'Oral anti‐pseudomonal antibiotics for cystic fibrosis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687954/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457863/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916140/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407188/pdf']","['423_4_brazilian guidelines for the diagnosis and treatment of cystic fibrosis.pdf', '423_2_inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.pdf', '423_5_oral anti‐pseudomonal antibiotics for cystic fibrosis.pdf', '423_3_antibiotic strategies for eradicating pseudomonas aeruginosa in people with cystic fibrosis.pdf', '423_1_treatments for preventing recurrence of infection with in people with cystic fibrosis.pdf', '423_0_inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687954/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457863/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916140/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407188/pdf']","['423_4_brazilian guidelines for the diagnosis and treatment of cystic fibrosis.pdf', '423_2_inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.pdf', '423_5_oral anti‐pseudomonal antibiotics for cystic fibrosis.pdf', '423_3_antibiotic strategies for eradicating pseudomonas aeruginosa in people with cystic fibrosis.pdf', '423_1_treatments for preventing recurrence of infection with in people with cystic fibrosis.pdf', '423_0_inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis.pdf']","[0.48, 0.543, 0.461, 0.565, 0.46, 0.53]","[0.525, 0.54, 0.538, 0.535, 0.524, 0.516]","[0.612, 0.626, 0.624, 0.62, 0.608, 0.601]","[0.166, 0.191, 0.185, 0.185, 0.175, 0.174]","[0.167, 0.197, 0.188, 0.191, 0.176, 0.171]","[0.128, 0.152, 0.149, 0.15, 0.139, 0.137]","[0.742, 0.744, 0.741, 0.743, 0.741, 0.741]","[0.648, 0.654, 0.65, 0.653, 0.648, 0.649]","[0.599, 0.615, 0.613, 0.608, 0.598, 0.586]","[0.657, 0.679, 0.679, 0.682, 0.68, 0.681]","[0.794, 0.793, 0.794, 0.791, 0.788, 0.78]","[0.71, 0.721, 0.715, 0.712, 0.701, 0.692]","[0.604, 0.6, 0.598, 0.6, 0.594, 0.59]","[0.911, 0.917, 0.914, 0.908, 0.911, 0.902]","[0.801, 0.814, 0.816, 0.811, 0.806, 0.796]","[0.739, 0.741, 0.742, 0.736, 0.731, 0.721]","[0.779, 0.778, 0.779, 0.775, 0.773, 0.763]","[0.764, 0.766, 0.765, 0.759, 0.756, 0.743]",0.507,0.53,0.615,0.179,0.182,0.143,0.742,0.65,0.603,0.676,0.79,0.708,0.598,0.91,0.807,0.735,0.775,0.759
https://doi.org/10.1001/archpediatrics.2011.140,breastfeeding as obesity prevention,424_breastfeeding as obesity prevention.pdf,3,"['http://www.houstontx.gov/health/chronic-disease/documents/Houston-Harris_CTI_Policy_Scan_FINAL-1.pdf', 'https://stacks.cdc.gov/view/cdc/43336', 'http://volusia.floridahealth.gov/programs-and-services/community-health-planning-and-statistics/informatics/_documents/2014-phdb-obesity.pdf']","['9 Hcphes', 'PCD collection : Next steps : translating evidence to eliminate disparities in diabetes and obesity', 'Healthy Volusia Report Overweight and Obesity in Volusia County - Florida Department of Health in Volusia County']","['http://volusia.floridahealth.gov/programs-and-services/community-health-planning-and-statistics/informatics/_documents/2014-phdb-obesity.pdf', 'http://www.houstontx.gov/health/chronic-disease/documents/Houston-Harris_CTI_Policy_Scan_FINAL-1.pdf']","['424_2_healthy volusia report overweight and obesity in volusia county  florida department of health in volusia county.pdf', '424_0_9 hcphes.pdf']",2,66.67,"['http://volusia.floridahealth.gov/programs-and-services/community-health-planning-and-statistics/informatics/_documents/2014-phdb-obesity.pdf', 'http://www.houstontx.gov/health/chronic-disease/documents/Houston-Harris_CTI_Policy_Scan_FINAL-1.pdf']","['424_2_healthy volusia report overweight and obesity in volusia county  florida department of health in volusia county.pdf', '424_0_9 hcphes.pdf']","[0.173, 0.236]","[0.559, 0.543]","[0.644, 0.651]","[0.134, 0.097]","[0.143, 0.101]","[0.127, 0.087]","[0.72, 0.712]","[0.617, 0.611]","[0.644, 0.622]","[0.644, 0.607]","[0.821, 0.811]","[0.748, 0.732]","[0.623, 0.618]","[0.915, 0.912]","[0.851, 0.839]","[0.788, 0.775]","[0.824, 0.811]","[0.806, 0.793]",0.204,0.551,0.647,0.116,0.122,0.107,0.716,0.614,0.633,0.625,0.816,0.74,0.621,0.913,0.845,0.782,0.818,0.8
https://doi.org/10.1001/archpsyc.59.2.139,association between selfreported childhood sexual abuse and adverse psychosocial outcomes,465_association between selfreported childhood sexual abuse and adverse psychosocial outcomes.pdf,4,"['https://stacks.cdc.gov/view/cdc/43336', 'https://papers.nber.org/papers/w12171', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf', 'https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/suicide.pdf']","['PCD collection : Next steps : translating evidence to eliminate disparities in diabetes and obesity', 'Does Child Abuse Cause Crime?', 'Cognitive‐behavioural interventions for children who have been sexually abused', 'PRACTICE GUIDELINE FOR THE Assessment and Treatment of Patients With Suicidal Behaviors']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf'],['465_2_cognitive‐behavioural interventions for children who have been sexually abused.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf'],['465_2_cognitive‐behavioural interventions for children who have been sexually abused.pdf'],[0.369],[0.523],[0.6],[0.174],[0.184],[0.152],[0.736],[0.639],[0.587],[0.706],[0.784],[0.688],[0.591],[0.913],[0.822],[0.74],[0.779],[0.767],0.369,0.523,0.6,0.174,0.184,0.152,0.736,0.639,0.587,0.706,0.784,0.688,0.591,0.913,0.822,0.74,0.779,0.767
https://doi.org/10.1001/archpsyc.59.3.215,differences in early childhood risk factors for juvenileonset and adultonset depression,466_differences in early childhood risk factors for juvenileonset and adultonset depression.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf'],['Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf'],['466_0_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf'],['466_0_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf'],[0.319],[0.513],[0.609],[0.176],[0.185],[0.152],[0.737],[0.642],[0.582],[0.701],[0.781],[0.703],[0.583],[0.914],[0.811],[0.731],[0.776],[0.759],0.319,0.513,0.609,0.176,0.185,0.152,0.737,0.642,0.582,0.701,0.781,0.703,0.583,0.914,0.811,0.731,0.776,0.759
https://doi.org/10.1001/archpsyc.59.9.801,familial pathways to earlyonset suicide attempt,469_familial pathways to earlyonset suicide attempt.pdf,2,"['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2810%2900082-1', 'https://papers.nber.org/papers/W9638']","['Practice Parameter for the Assessment and Treatment of Children and Adolescents With Posttraumatic Stress Disorder', 'Alcohol Abuse and Suicide Attempts Among Youth - Correlation or Causation?']",['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2810%2900082-1'],['469_0_practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder.pdf'],1,50.0,['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2810%2900082-1'],['469_0_practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder.pdf'],[0.256],[0.533],[0.616],[0.184],[0.188],[0.166],[0.742],[0.648],[0.601],[0.692],[0.811],[0.732],[0.607],[0.921],[0.822],[0.765],[0.806],[0.792],0.256,0.533,0.616,0.184,0.188,0.166,0.742,0.648,0.601,0.692,0.811,0.732,0.607,0.921,0.822,0.765,0.806,0.792
https://doi.org/10.1001/archpsyc.60.11.1097,comorbid psychiatric disorders in youth in juvenile detention,470_comorbid psychiatric disorders in youth in juvenile detention.pdf,8,"['http://purl.fdlp.gov/GPO/gpo59106', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://www.aclu.org/legal-document/rilr-v-johnson-amended-motion-preliminary-injunction', 'https://www.congress.gov/event/111th-congress/house-event/LC5274/text', 'https://purl.fdlp.gov/GPO/gpo122606', 'https://purl.fdlp.gov/GPO/gpo122212', 'https://www.justice.gov/sites/default/files/defendingchildhood/cev-rpt-full.pdf', 'http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf']","['Violent death in delinquent youth after detention /', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'RILR v. Johnson - Amended Motion for Preliminary Injunction', 'House Hearing, 111th Congress — MEETING THE CHALLENGES FACED BY GIRLS IN THE JUVENILE JUSTICE SYSTEM', 'Intersection between mental health and the juvenile justice system.', 'Multi-method study on risk assessment implementation and youth outcomes in the juvenile justice system /', ""Report of the Attorney General's National Task Force on Children Exposed to Violence"", 'JUVENILE OFFENDING']","['http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf', 'https://purl.fdlp.gov/GPO/gpo122212', 'https://purl.fdlp.gov/GPO/gpo122606', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://purl.fdlp.gov/GPO/gpo59106', 'https://www.justice.gov/sites/default/files/defendingchildhood/cev-rpt-full.pdf']","['470_7_juvenile offending.pdf', '470_5_multimethod study on risk assessment implementation and youth outcomes in the juvenile justice system .pdf', '470_4_intersection between mental health and the juvenile justice system.pdf', '470_1_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '470_0_violent death in delinquent youth after detention .pdf', '470_6_report of the attorney generals national task force on children exposed to violence.pdf']",6,75.0,"['http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf', 'https://purl.fdlp.gov/GPO/gpo122212', 'https://purl.fdlp.gov/GPO/gpo122606', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://purl.fdlp.gov/GPO/gpo59106', 'https://www.justice.gov/sites/default/files/defendingchildhood/cev-rpt-full.pdf']","['470_7_juvenile offending.pdf', '470_5_multimethod study on risk assessment implementation and youth outcomes in the juvenile justice system .pdf', '470_4_intersection between mental health and the juvenile justice system.pdf', '470_1_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '470_0_violent death in delinquent youth after detention .pdf', '470_6_report of the attorney generals national task force on children exposed to violence.pdf']","[0.376, 0.686, 0.524, 0.205, 0.28, 0.557]","[0.538, 0.516, 0.538, 0.529, 0.499, 0.504]","[0.629, 0.601, 0.627, 0.624, 0.592, 0.603]","[0.205, 0.14, 0.204, 0.178, 0.166, 0.179]","[0.223, 0.163, 0.23, 0.19, 0.179, 0.192]","[0.187, 0.122, 0.19, 0.163, 0.145, 0.164]","[0.74, 0.72, 0.743, 0.734, 0.73, 0.736]","[0.647, 0.622, 0.652, 0.638, 0.632, 0.64]","[0.598, 0.579, 0.588, 0.592, 0.561, 0.592]","[0.695, 0.685, 0.703, 0.69, 0.7, 0.682]","[0.801, 0.776, 0.803, 0.798, 0.78, 0.798]","[0.733, 0.714, 0.716, 0.728, 0.684, 0.72]","[0.624, 0.61, 0.621, 0.616, 0.599, 0.592]","[0.915, 0.912, 0.916, 0.916, 0.906, 0.914]","[0.82, 0.818, 0.818, 0.818, 0.799, 0.826]","[0.767, 0.752, 0.758, 0.765, 0.732, 0.755]","[0.806, 0.786, 0.802, 0.801, 0.78, 0.794]","[0.79, 0.77, 0.787, 0.786, 0.764, 0.778]",0.438,0.521,0.613,0.179,0.196,0.162,0.734,0.639,0.585,0.693,0.793,0.716,0.61,0.913,0.817,0.755,0.795,0.779
https://doi.org/10.1001/archpsyc.60.8.837,prevalence and development of psychiatric disorders in childhood and adolescence,475_prevalence and development of psychiatric disorders in childhood and adolescence.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913803/pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2820%2930280-X', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-annotated', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-annotated-0', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-fact-sheet-mental', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-fact-sheet-mental-0', 'https://www.mass.gov/files/documents/2018/06/28/1115%20MassHealth%20Demonstration%20Attachments.pdf', 'https://www.urban.org/research/publication/state-mental-health-systems-children-review-literature-and-available-data-sources', 'https://www.aclu.org/legal-document/rilr-v-johnson-amended-motion-preliminary-injunction']","['Does long-term use of the Guidelines for Adolescent Preventive Services (GAPS) questionnaires lead to earlier mental health or substance abuse (MH/SA) diagnosis?', 'Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders', 'What Challenges Are Boys Facing, and What Opportunities Exist to Address Those Challenges? Annotated Bibliography', 'What Challenges Are Boys Facing, and What Opportunities Exist to Address Those Challenges? Annotated Bibliography', 'What Challenges Are Boys Facing, and What Opportunities Exist to Address Those Challenges? Fact Sheet: Mental Health', 'What Challenges Are Boys Facing, and What Opportunities Exist To Address Those Challenges? Fact Sheet: Mental Health*', 'ATTACHMENT A Reserved', 'State Mental Health Systems for Children: A Review of the Literature and Available Data Sources', 'RILR v. Johnson - Amended Motion for Preliminary Injunction']","['https://www.mass.gov/files/documents/2018/06/28/1115%20MassHealth%20Demonstration%20Attachments.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913803/pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2820%2930280-X']","['475_6_attachment a reserved.pdf', '475_0_does longterm use of the guidelines for adolescent preventive services gaps questionnaires lead to earlier mental health or substance abuse mhsa diagnosis.pdf', '475_1_clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.pdf']",3,33.33,"['https://www.mass.gov/files/documents/2018/06/28/1115%20MassHealth%20Demonstration%20Attachments.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913803/pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2820%2930280-X']","['475_6_attachment a reserved.pdf', '475_0_does longterm use of the guidelines for adolescent preventive services gaps questionnaires lead to earlier mental health or substance abuse mhsa diagnosis.pdf', '475_1_clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.pdf']","[0.256, 0.445, 0.114]","[0.522, 0.531, 0.533]","[0.611, 0.61, 0.619]","[0.117, 0.171, 0.18]","[0.127, 0.19, 0.194]","[0.092, 0.157, 0.166]","[0.717, 0.732, 0.736]","[0.622, 0.641, 0.644]","[0.606, 0.59, 0.603]","[0.645, 0.702, 0.698]","[0.804, 0.793, 0.803]","[0.738, 0.716, 0.728]","[0.62, 0.6, 0.61]","[0.921, 0.921, 0.921]","[0.831, 0.82, 0.825]","[0.77, 0.753, 0.766]","[0.807, 0.784, 0.801]","[0.788, 0.773, 0.789]",0.272,0.529,0.613,0.156,0.17,0.138,0.728,0.636,0.6,0.682,0.8,0.727,0.61,0.921,0.825,0.763,0.797,0.783
https://doi.org/10.1001/archpsyc.60.9.978,relationship between antidepressant medication treatment and suicide in adolescents,476_relationship between antidepressant medication treatment and suicide in adolescents.pdf,10,"['http://vcoy.virginia.gov/pdf/Antidepressants_Risk_SuicidalBehavior0513.pdf', 'https://www.congress.gov/event/109th-congress/senate-event/LC13158/text?s=1&r=13689', 'https://papers.nber.org/papers/w12232', 'http://vcoy.virginia.gov/documents/collection/024%20Antidepressants3.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/042817-4e.pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'https://rga.lis.virginia.gov/Published/2010/HD9/PDF', 'https://www.chicagofed.org/publications/working-papers/2017/wp2017-08', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786271/pdf']","['ANTIDEPRESSANTS AND THE RISK OF SUICIDAL BEHAVIOR', ""S.Hrg. 109-67 — FDA'S DRUG APPROVAL PROCESS: UP TO THE CHALLENGE?"", 'Medicaid Policy Changes in Mental Health Care and Their Effect on Mental Health Outcomes', 'ANTIDEPRESSANTS AND THE RISK OF SUICIDAL BEHAVIOR', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'Antidepressants, Selective Serotonin Reuptake Inhibitors( SSRI) Therapeutic Class Review( TCR)', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs, 4th Edition', 'Just What the Nurse Practitioner Ordered: Independent Prescriptive Authority and Population Mental Health (REVISED January 2019)', 'Newer generation antidepressants for depressive disorders in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786271/pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/024%20Antidepressants3.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/pdf/Antidepressants_Risk_SuicidalBehavior0513.pdf']","['476_9_newer generation antidepressants for depressive disorders in children and adolescents.pdf', '476_6_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '476_3_antidepressants and the risk of suicidal behavior.pdf', '476_4_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '476_0_antidepressants and the risk of suicidal behavior.pdf']",5,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786271/pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/024%20Antidepressants3.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/pdf/Antidepressants_Risk_SuicidalBehavior0513.pdf']","['476_9_newer generation antidepressants for depressive disorders in children and adolescents.pdf', '476_6_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '476_3_antidepressants and the risk of suicidal behavior.pdf', '476_4_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '476_0_antidepressants and the risk of suicidal behavior.pdf']","[0.514, 0.541, 0.362, 0.372, 0.349]","[0.485, 0.481, 0.492, 0.484, 0.49]","[0.579, 0.581, 0.591, 0.584, 0.589]","[0.163, 0.144, 0.204, 0.149, 0.197]","[0.167, 0.155, 0.219, 0.158, 0.215]","[0.143, 0.129, 0.182, 0.131, 0.178]","[0.738, 0.733, 0.744, 0.733, 0.745]","[0.645, 0.635, 0.653, 0.635, 0.653]","[0.552, 0.542, 0.548, 0.545, 0.549]","[0.704, 0.678, 0.69, 0.676, 0.69]","[0.764, 0.77, 0.779, 0.773, 0.778]","[0.679, 0.687, 0.694, 0.695, 0.693]","[0.578, 0.594, 0.608, 0.598, 0.604]","[0.896, 0.897, 0.896, 0.901, 0.894]","[0.771, 0.777, 0.781, 0.778, 0.784]","[0.699, 0.72, 0.727, 0.727, 0.722]","[0.751, 0.764, 0.773, 0.769, 0.77]","[0.734, 0.75, 0.755, 0.753, 0.753]",0.428,0.486,0.585,0.171,0.183,0.153,0.739,0.644,0.547,0.688,0.773,0.69,0.596,0.897,0.778,0.719,0.765,0.749
https://doi.org/10.1001/archpsyc.61.12.1217,contextual predictors of mental health service use among children opento child welfare,477_contextual predictors of mental health service use among children opento child welfare.pdf,6,"['https://www.jaacap.org/article/S0890-8567(15)00148-3/pdf', 'https://aspe.hhs.gov/reports/developmental-problems-maltreated-children-early-intervention-options-maltreated-children', 'https://www.acf.hhs.gov/cb/report/integrating-safety-permanency-and-well-being-series', 'https://aspe.hhs.gov/reports/developmental-problems-maltreated-children-early-intervention-options-maltreated-children-0', 'https://www.acf.hhs.gov/opre/report/nscaw-early-involvement-child-welfare-services-school-entry-5-6-year-follow-infants', 'https://www.acf.hhs.gov/opre/resource/nscaw-from-early-involvement-with-child-welfare-services-to-school-entry-a-5']","['Practice Parameter for the Assessment and Management of Youth Involved With the Child Welfare System', 'Developmental Problems of Maltreated Children and Early Intervention Options for Maltreated Children', 'Integrating Safety, Permanency and Well-Being Series', 'Developmental Problems of Maltreated Children and Early Intervention Options for Maltreated Children', 'NSCAW, From Early Involvement with Child Welfare Services to School Entry: A 5- to 6-Year Follow-Up of Infants in the National Survey of Child and Adolescent Well-Being With Tables of 5- to 6-Year Follow-Up Results', 'NSCAW, From Early Involvement with Child Welfare Services to School Entry: A 5- to 6-Year Follow-Up of Infants in the National Survey of Child and Adolescent Well-Being With Tables of 5- to 6-Year Follow-Up Results']",['https://www.jaacap.org/article/S0890-8567(15)00148-3/pdf'],['477_0_practice parameter for the assessment and management of youth involved with the child welfare system.pdf'],1,16.67,['https://www.jaacap.org/article/S0890-8567(15)00148-3/pdf'],['477_0_practice parameter for the assessment and management of youth involved with the child welfare system.pdf'],[0.668],[0.561],[0.639],[0.204],[0.229],[0.194],[0.743],[0.649],[0.628],[0.689],[0.815],[0.74],[0.638],[0.928],[0.843],[0.777],[0.811],[0.796],0.668,0.561,0.639,0.204,0.229,0.194,0.743,0.649,0.628,0.689,0.815,0.74,0.638,0.928,0.843,0.777,0.811,0.796
https://doi.org/10.1001/archpsyc.61.6.577,a randomized effectiveness trial of interpersonal psychotherapy fordepressed adolescents,478_a randomized effectiveness trial of interpersonal psychotherapy fordepressed adolescents.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Adjustment_Disorders.pdf', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research', 'http://vcoy.virginia.gov/documents/collection/019%20Adjustment2.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'https://rga.lis.virginia.gov/Published/2010/HD9/PDF']","['Treatment of Youth Depression in Primary Care Under Usual Practice Conditions: Observational Findings from Youth Partners in Care', 'Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents', 'E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', 'ADJUSTMENT DISORDERS', 'Treatment of Depression in Children and Adolescents', 'ADJUSTMENT DISORDER', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs, 4th Edition']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Adjustment_Disorders.pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/019%20Adjustment2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556660/pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['478_3_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '478_4_adjustment disorders.pdf', '478_8_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '478_6_adjustment disorder.pdf', '478_1_psychological therapies versus antidepressant medication alone and in combination for depression in children and adolescents.pdf', '478_7_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '478_0_treatment of youth depression in primary care under usual practice conditions observational findings from youth partners in care.pdf', '478_2_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']",8,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Adjustment_Disorders.pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/019%20Adjustment2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556660/pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['478_3_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '478_4_adjustment disorders.pdf', '478_8_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '478_6_adjustment disorder.pdf', '478_1_psychological therapies versus antidepressant medication alone and in combination for depression in children and adolescents.pdf', '478_7_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '478_0_treatment of youth depression in primary care under usual practice conditions observational findings from youth partners in care.pdf', '478_2_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']","[0.461, 0.404, 0.391, 0.388, 0.291, 0.305, 0.438, 0.468]","[0.503, 0.508, 0.506, 0.512, 0.507, 0.509, 0.515, 0.505]","[0.585, 0.599, 0.596, 0.606, 0.591, 0.599, 0.597, 0.587]","[0.163, 0.168, 0.156, 0.182, 0.176, 0.159, 0.176, 0.161]","[0.17, 0.185, 0.171, 0.2, 0.187, 0.173, 0.186, 0.167]","[0.142, 0.155, 0.142, 0.164, 0.158, 0.143, 0.155, 0.14]","[0.737, 0.733, 0.73, 0.736, 0.738, 0.73, 0.736, 0.734]","[0.641, 0.635, 0.633, 0.638, 0.646, 0.632, 0.645, 0.64]","[0.566, 0.57, 0.572, 0.581, 0.568, 0.578, 0.577, 0.567]","[0.715, 0.7, 0.689, 0.699, 0.711, 0.685, 0.714, 0.711]","[0.768, 0.777, 0.784, 0.789, 0.772, 0.787, 0.782, 0.77]","[0.678, 0.696, 0.704, 0.711, 0.687, 0.713, 0.71, 0.687]","[0.587, 0.612, 0.612, 0.614, 0.594, 0.616, 0.618, 0.59]","[0.912, 0.905, 0.915, 0.919, 0.907, 0.92, 0.903, 0.908]","[0.802, 0.808, 0.808, 0.809, 0.799, 0.809, 0.8, 0.8]","[0.717, 0.734, 0.744, 0.749, 0.72, 0.751, 0.73, 0.72]","[0.761, 0.767, 0.781, 0.784, 0.765, 0.787, 0.777, 0.763]","[0.752, 0.76, 0.77, 0.776, 0.751, 0.774, 0.752, 0.75]",0.393,0.508,0.595,0.168,0.18,0.15,0.734,0.639,0.572,0.703,0.779,0.698,0.605,0.911,0.804,0.733,0.773,0.761
https://doi.org/10.1001/archpsyc.62.1.66,subthreshold depression in adolescence and mental health outcomes in adulthood,479_subthreshold depression in adolescence and mental health outcomes in adulthood.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.acf.hhs.gov/opre/report/building-strong-families-project-strengthening-unmarried-parents-relationships-early-1', 'https://www.acf.hhs.gov/opre/report/building-strong-families-project-long-term-effects-building-strong-families-0', 'https://mathematica.org/publications/ts-the-longterm-effects-of-building-strong-families-a-relationship-skills-education-program', 'https://www.acf.hhs.gov/opre/resource/the-building-strong-families-project-the-long-term-effects-of-building-1', 'https://www.acf.hhs.gov/opre/resource/the-building-strong-families-project-strengthening-unmarried-parents-1']","['E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', ""The Building Strong Families Project: Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families Technical Report"", 'The Building Strong Families Project: The Long-Term Effects of Building Strong Families: A Relationship Skills Education Program for Unmarried Parents, Technical Supplement', 'The Long-Term Effects of Building Strong Families: A Relationship Skills Education Program (Technical Supplement)', 'The Building Strong Families Project: The Long-Term Effects of Building Strong Families: A Relationship Skills Education Program for Unmarried Parents, Technical Supplement', ""The Building Strong Families Project: Strengthening Unmarried Parents' Relationships: The Early Impacts of Building Strong Families Technical Report""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['479_0_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '479_1_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']",2,28.57,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['479_0_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '479_1_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']","[0.331, 0.378]","[0.509, 0.506]","[0.601, 0.599]","[0.167, 0.173]","[0.176, 0.182]","[0.144, 0.153]","[0.737, 0.74]","[0.641, 0.643]","[0.573, 0.57]","[0.715, 0.721]","[0.776, 0.774]","[0.696, 0.684]","[0.584, 0.58]","[0.907, 0.91]","[0.806, 0.809]","[0.723, 0.719]","[0.772, 0.769]","[0.756, 0.757]",0.355,0.508,0.6,0.17,0.179,0.148,0.738,0.642,0.571,0.718,0.775,0.69,0.582,0.909,0.808,0.721,0.77,0.756
https://doi.org/10.1001/archpsyc.62.11.1241,costeffectiveness of an intervention to prevent depression in atrisk teens,480_costeffectiveness of an intervention to prevent depression in atrisk teens.pdf,3,"['https://www.rand.org/pubs/technical_reports/TR643.html', 'https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf', 'https://www.rand.org/pubs/tools/TL145.html']","['Benefit-Cost Analysis Rarely Captures the Full Economic Value of Social Programs', 'Texas Healthcare Transformation and Quality Improvement Program', 'Programs That Work']",['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['480_1_texas healthcare transformation and quality improvement program.pdf'],1,33.33,['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['480_1_texas healthcare transformation and quality improvement program.pdf'],[0.364],[0.555],[0.629],[0.178],[0.191],[0.155],[0.731],[0.638],[0.626],[0.679],[0.812],[0.739],[0.632],[0.926],[0.843],[0.776],[0.818],[0.789],0.364,0.555,0.629,0.178,0.191,0.155,0.731,0.638,0.626,0.679,0.812,0.739,0.632,0.926,0.843,0.776,0.818,0.789
https://doi.org/10.1001/archpsyc.62.11.1266,randomized controlled crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity,481_randomized controlled crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.pdf,5,"['https://effectivehealthcare.ahrq.gov/products/asd-medical/research-2017', 'https://www.gao.gov/products/GAO-06-700', 'https://autismguidelines.dmh.mo.gov/pdf/MissouriAutsimGuidelinesInitiative.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486133/pdf', 'https://www.jaacap.org/article/S0890-8567(13)00819-8/pdf']","['Medical Therapies for Children with Autism Spectrum Disorder — An Update', 'Federal Autism Activities: Funding for Research Has Increased, but Agencies Need to Resolve Surveillance Challenges', 'Autism Spectrum Disorders: Guide to Evidence-based Interventions', 'Methylphenidate for children and adolescents with autism spectrum disorder', 'Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder']","['https://www.jaacap.org/article/S0890-8567(13)00819-8/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486133/pdf', 'https://autismguidelines.dmh.mo.gov/pdf/MissouriAutsimGuidelinesInitiative.pdf']","['481_4_practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.pdf', '481_3_methylphenidate for children and adolescents with autism spectrum disorder.pdf', '481_2_autism spectrum disorders guide to evidencebased interventions.pdf']",3,60.0,"['https://www.jaacap.org/article/S0890-8567(13)00819-8/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486133/pdf', 'https://autismguidelines.dmh.mo.gov/pdf/MissouriAutsimGuidelinesInitiative.pdf']","['481_4_practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.pdf', '481_3_methylphenidate for children and adolescents with autism spectrum disorder.pdf', '481_2_autism spectrum disorders guide to evidencebased interventions.pdf']","[0.19, 0.466, 0.331]","[0.531, 0.503, 0.532]","[0.617, 0.592, 0.618]","[0.174, 0.183, 0.151]","[0.19, 0.186, 0.17]","[0.152, 0.16, 0.135]","[0.735, 0.738, 0.725]","[0.64, 0.642, 0.626]","[0.598, 0.567, 0.604]","[0.693, 0.712, 0.678]","[0.798, 0.771, 0.791]","[0.736, 0.677, 0.736]","[0.611, 0.594, 0.623]","[0.924, 0.908, 0.923]","[0.818, 0.794, 0.824]","[0.762, 0.724, 0.771]","[0.796, 0.762, 0.799]","[0.783, 0.749, 0.783]",0.329,0.522,0.609,0.169,0.182,0.149,0.733,0.636,0.59,0.694,0.787,0.716,0.609,0.918,0.812,0.752,0.786,0.772
https://doi.org/10.1001/archpsyc.62.3.311,risk factors predicting changes in marijuana involvement in teenagers,482_risk factors predicting changes in marijuana involvement in teenagers.pdf,1,['https://health.hawaii.gov/substance-abuse/files/2013/05/2007StatewideReport.pdf'],"['The Hawai ‘ I Student Alcohol, Tobacco, And Other Drug Use Study :']",['https://health.hawaii.gov/substance-abuse/files/2013/05/2007StatewideReport.pdf'],['482_0_the hawai  i student alcohol tobacco and other drug use study .pdf'],1,100.0,['https://health.hawaii.gov/substance-abuse/files/2013/05/2007StatewideReport.pdf'],['482_0_the hawai  i student alcohol tobacco and other drug use study .pdf'],[0.497],[0.498],[0.574],[0.156],[0.17],[0.152],[0.732],[0.634],[0.56],[0.691],[0.774],[0.685],[0.601],[0.912],[0.797],[0.733],[0.772],[0.759],0.497,0.498,0.574,0.156,0.17,0.152,0.732,0.634,0.56,0.691,0.774,0.685,0.601,0.912,0.797,0.733,0.772,0.759
https://doi.org/10.1001/archpsyc.62.4.417,prevention of relapse following cognitive therapy vs medications in moderate to severe depression,483_prevention of relapse following cognitive therapy vs medications in moderate to severe depression.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092632/pdf', 'https://www.dir.ca.gov/dwc/DWCPropRegs/2020/MTUS-Evidence-Based-Updates-June-2020/ACOEM-Depressive-Disorders.pdf', 'https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090422/pdf']","['Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults', 'Depressive Disorders', 'PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder', 'Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation']","['https://www.dir.ca.gov/dwc/DWCPropRegs/2020/MTUS-Evidence-Based-Updates-June-2020/ACOEM-Depressive-Disorders.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090422/pdf']","['483_1_depressive disorders.pdf', '483_0_approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults.pdf', '483_3_screening assessment and care of anxiety and depressive symptoms in adults with cancer an american society of clinical oncology guideline adaptation.pdf']",3,75.0,"['https://www.dir.ca.gov/dwc/DWCPropRegs/2020/MTUS-Evidence-Based-Updates-June-2020/ACOEM-Depressive-Disorders.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090422/pdf']","['483_1_depressive disorders.pdf', '483_0_approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults.pdf', '483_3_screening assessment and care of anxiety and depressive symptoms in adults with cancer an american society of clinical oncology guideline adaptation.pdf']","[0.383, 0.294, 0.341]","[0.502, 0.535, 0.57]","[0.601, 0.618, 0.645]","[0.166, 0.197, 0.201]","[0.185, 0.204, 0.215]","[0.144, 0.17, 0.177]","[0.736, 0.739, 0.744]","[0.644, 0.647, 0.653]","[0.565, 0.594, 0.646]","[0.699, 0.705, 0.7]","[0.789, 0.791, 0.817]","[0.697, 0.716, 0.763]","[0.588, 0.604, 0.623]","[0.923, 0.923, 0.929]","[0.8, 0.82, 0.844]","[0.741, 0.741, 0.779]","[0.775, 0.786, 0.82]","[0.769, 0.773, 0.805]",0.339,0.536,0.621,0.188,0.201,0.164,0.74,0.648,0.602,0.701,0.799,0.725,0.605,0.925,0.821,0.754,0.794,0.782
https://doi.org/10.1001/archpsyc.63.11.1284,can a costly intervention be costeffective,484_can a costly intervention be costeffective.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950520/pdf', 'https://mathematica.org/publications/costs-of-early-childhood-home-visiting-an-analysis-of-programs-implemented-in-the-supporting', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention', 'http://www.wsipp.wa.gov/ReportFile/1607/Wsipp_Updated-Inventory-of-Evidence-and-Research-Based-Practices-Washingtons-Learning-Assistance-Program_Benefit-Cost-Results.pdf']","['Fifty years of preventing and treating childhood behaviour disorders: a systematic review to inform policy and practice', 'Costs of Early Childhood Home Visiting: An Analysis of Programs Implemented in the Supporting Evidence-Based Home Visiting to Prevent Child Maltreatment Initiative', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950520/pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1607/Wsipp_Updated-Inventory-of-Evidence-and-Research-Based-Practices-Washingtons-Learning-Assistance-Program_Benefit-Cost-Results.pdf']","['484_0_fifty years of preventing and treating childhood behaviour disorders a systematic review to inform policy and practice.pdf', '484_2_washington state institute for public policy.pdf', '484_4_washington state institute for public policy.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950520/pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1607/Wsipp_Updated-Inventory-of-Evidence-and-Research-Based-Practices-Washingtons-Learning-Assistance-Program_Benefit-Cost-Results.pdf']","['484_0_fifty years of preventing and treating childhood behaviour disorders a systematic review to inform policy and practice.pdf', '484_2_washington state institute for public policy.pdf', '484_4_washington state institute for public policy.pdf']","[0.39, 0.483, 0.431]","[0.56, 0.541, 0.545]","[0.624, 0.609, 0.607]","[0.179, 0.158, 0.157]","[0.192, 0.18, 0.177]","[0.159, 0.147, 0.144]","[0.724, 0.727, 0.725]","[0.632, 0.634, 0.631]","[0.637, 0.609, 0.615]","[0.701, 0.7, 0.699]","[0.815, 0.803, 0.804]","[0.758, 0.744, 0.749]","[0.619, 0.624, 0.635]","[0.932, 0.927, 0.927]","[0.848, 0.831, 0.832]","[0.778, 0.766, 0.769]","[0.819, 0.808, 0.811]","[0.799, 0.79, 0.791]",0.435,0.549,0.613,0.165,0.183,0.15,0.725,0.632,0.62,0.7,0.807,0.75,0.626,0.929,0.837,0.771,0.813,0.793
https://doi.org/10.1001/archpsyc.63.6.694,autism from 2 to 9 years of age,485_autism from 2 to 9 years of age.pdf,8,"['https://nj.gov/health/fhs/autism/documents/Age_First_Diagnosis_Autism.pdf', 'https://www.autismguidelines.dmh.mo.gov/pdf/Guidelines.pdf', 'https://stacks.cdc.gov/view/cdc/6844', 'https://stacks.cdc.gov/view/cdc/5465', 'http://www.autism.alabama.gov/Documents/Autism_Needs_%20Assessment_Full_Report.pdf', 'https://www.health.ny.gov/publications/20168.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513463/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923900/pdf']","['Age of First Autism Diagnosis as Seen in the New Jersey Autism Registry', 'Autism Spectrum Disorders:', 'Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2000; Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002 ; and, Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002', 'Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, United States, 2006', 'Baism Society of Alabama', 'Report of the Recommendations', 'Diagnostic tests for autism spectrum disorder (ASD) in preschool children', 'Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research']","['https://www.health.ny.gov/publications/20168.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923900/pdf', 'http://www.autism.alabama.gov/Documents/Autism_Needs_%20Assessment_Full_Report.pdf', 'https://www.autismguidelines.dmh.mo.gov/pdf/Guidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513463/pdf', 'https://nj.gov/health/fhs/autism/documents/Age_First_Diagnosis_Autism.pdf']","['485_5_report of the recommendations.pdf', '485_7_early screening of autism spectrum disorder recommendations for practice and research.pdf', '485_4_baism society of alabama.pdf', '485_1_autism spectrum disorders.pdf', '485_6_diagnostic tests for autism spectrum disorder asd in preschool children.pdf', '485_0_age of first autism diagnosis as seen in the new jersey autism registry.pdf']",6,75.0,"['https://www.health.ny.gov/publications/20168.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923900/pdf', 'https://www.autismguidelines.dmh.mo.gov/pdf/Guidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513463/pdf', 'https://nj.gov/health/fhs/autism/documents/Age_First_Diagnosis_Autism.pdf']","['485_5_report of the recommendations.pdf', '485_7_early screening of autism spectrum disorder recommendations for practice and research.pdf', '485_1_autism spectrum disorders.pdf', '485_6_diagnostic tests for autism spectrum disorder asd in preschool children.pdf', '485_0_age of first autism diagnosis as seen in the new jersey autism registry.pdf']","[0.569, 0.449, 0.377, 0.53, 0.435]","[0.534, 0.554, 0.537, 0.528, 0.543]","[0.608, 0.618, 0.613, 0.608, 0.623]","[0.185, 0.214, 0.198, 0.198, 0.23]","[0.201, 0.219, 0.217, 0.205, 0.242]","[0.164, 0.186, 0.178, 0.171, 0.211]","[0.738, 0.746, 0.742, 0.742, 0.755]","[0.643, 0.658, 0.649, 0.652, 0.664]","[0.598, 0.616, 0.609, 0.589, 0.607]","[0.699, 0.723, 0.711, 0.736, 0.736]","[0.794, 0.807, 0.796, 0.778, 0.794]","[0.725, 0.734, 0.731, 0.703, 0.716]","[0.621, 0.624, 0.619, 0.599, 0.632]","[0.913, 0.921, 0.919, 0.902, 0.913]","[0.824, 0.84, 0.84, 0.818, 0.841]","[0.764, 0.768, 0.768, 0.719, 0.772]","[0.797, 0.806, 0.801, 0.778, 0.796]","[0.782, 0.788, 0.787, 0.749, 0.783]",0.472,0.539,0.614,0.205,0.217,0.182,0.745,0.653,0.604,0.721,0.794,0.722,0.619,0.914,0.833,0.758,0.796,0.778
https://doi.org/10.1001/archpsyc.63.7.721,childhoodonset schizophrenia,486_childhoodonset schizophrenia.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169186/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593251/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169107/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984668/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800144/pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8https://www.jaacap.org/article/S0890-8567(13)00550-9/fulltext567%2813%2900112-3']","['Clozapine versus other atypical antipsychotics for schizophrenia', 'Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth', 'Olanzapine versus other atypical antipsychotics for schizophrenia', 'Antipsychotic medication for childhood‐onset schizophrenia', 'The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements', 'Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169186/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169107/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593251/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984668/pdf']","['486_0_clozapine versus other atypical antipsychotics for schizophrenia.pdf', '486_2_olanzapine versus other atypical antipsychotics for schizophrenia.pdf', '486_4_the 2009 schizophrenia port psychopharmacological treatment recommendations and summary statements.pdf', '486_1_canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth.pdf', '486_3_antipsychotic medication for childhood‐onset schizophrenia.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169186/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169107/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593251/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984668/pdf']","['486_0_clozapine versus other atypical antipsychotics for schizophrenia.pdf', '486_2_olanzapine versus other atypical antipsychotics for schizophrenia.pdf', '486_4_the 2009 schizophrenia port psychopharmacological treatment recommendations and summary statements.pdf', '486_1_canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth.pdf', '486_3_antipsychotic medication for childhood‐onset schizophrenia.pdf']","[0.466, 0.329, 0.362, 0.469, 0.517]","[0.489, 0.485, 0.517, 0.509, 0.495]","[0.58, 0.574, 0.603, 0.591, 0.585]","[0.158, 0.153, 0.194, 0.17, 0.169]","[0.172, 0.162, 0.215, 0.188, 0.179]","[0.147, 0.138, 0.178, 0.159, 0.151]","[0.733, 0.733, 0.742, 0.74, 0.738]","[0.643, 0.643, 0.653, 0.649, 0.645]","[0.562, 0.557, 0.584, 0.573, 0.564]","[0.714, 0.713, 0.699, 0.693, 0.712]","[0.755, 0.749, 0.79, 0.776, 0.762]","[0.685, 0.684, 0.715, 0.709, 0.685]","[0.562, 0.56, 0.611, 0.597, 0.574]","[0.884, 0.88, 0.895, 0.893, 0.885]","[0.768, 0.763, 0.787, 0.791, 0.774]","[0.692, 0.683, 0.722, 0.716, 0.696]","[0.75, 0.746, 0.781, 0.773, 0.757]","[0.717, 0.708, 0.747, 0.739, 0.724]",0.429,0.499,0.587,0.169,0.183,0.155,0.737,0.647,0.568,0.706,0.766,0.696,0.581,0.887,0.777,0.702,0.761,0.727
https://doi.org/10.1001/archpsyc.63.9.1035,school bullying and youth violence,487_school bullying and youth violence.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202995/pdf', 'https://www.urban.org/research/publication/citywide-model-bullying-prevention-policy', 'https://www.congress.gov/event/111th-congress/house-event/LC4951/text', 'https://osse.dc.gov/sites/default/files/dc/sites/ohr/publication/attachments/DCBullyingPreventionPolicy_PressQ_022513.pdf', 'https://www.rand.org/pubs/rgs_dissertations/RGSD240.html']","['Assessing Violence Risk in Adolescents in the Pediatric Emergency Department: Systematic Review and Clinical Guidance', 'Citywide Model Bullying Prevention Policy', 'House Hearing, 111th Congress — ENSURING STUDENT CYBER SAFETY', 'Mayor Vincent C. Gray ’ s Youth Bullying Prevention Task Force', 'No Bullies Allowed: Understanding Peer Victimization, the Impacts on Delinquency, and the Effectiveness of Prevention Programs']","['https://osse.dc.gov/sites/default/files/dc/sites/ohr/publication/attachments/DCBullyingPreventionPolicy_PressQ_022513.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202995/pdf']","['487_3_mayor vincent c gray  s youth bullying prevention task force.pdf', '487_0_assessing violence risk in adolescents in the pediatric emergency department systematic review and clinical guidance.pdf']",2,40.0,"['https://osse.dc.gov/sites/default/files/dc/sites/ohr/publication/attachments/DCBullyingPreventionPolicy_PressQ_022513.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202995/pdf']","['487_3_mayor vincent c gray  s youth bullying prevention task force.pdf', '487_0_assessing violence risk in adolescents in the pediatric emergency department systematic review and clinical guidance.pdf']","[0.24, 0.303]","[0.541, 0.537]","[0.616, 0.617]","[0.177, 0.192]","[0.205, 0.22]","[0.174, 0.178]","[0.73, 0.74]","[0.634, 0.647]","[0.62, 0.599]","[0.672, 0.705]","[0.802, 0.793]","[0.738, 0.713]","[0.63, 0.598]","[0.92, 0.918]","[0.842, 0.832]","[0.774, 0.755]","[0.802, 0.789]","[0.785, 0.774]",0.271,0.539,0.617,0.184,0.212,0.176,0.735,0.641,0.609,0.689,0.798,0.726,0.614,0.919,0.837,0.764,0.796,0.78
https://doi.org/10.1001/archpsyc.64.1.49,a prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up,488_a prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up.pdf,8,"['https://www.acf.hhs.gov/opre/report/nscaw-adolescents-involved-child-welfare-transition-adulthood', 'https://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://www.nber.org/papers/w21055?sy=055', 'https://purl.fdlp.gov/GPO/gpo71840', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://www.acf.hhs.gov/opre/resource/nscaw-adolescents-involved-with-child-welfare-a-transition-to-adulthood', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['NSCAW, Adolescents Involved with Child Welfare: A Transition to Adulthood', 'Return on Investment : Evidence-Based Options to Improve Statewide Outcomes', 'The Effect of Community Traumatic Events on Student Achievement: Evidence from the Beltway Sniper Attacks', 'Children’s exposure to violence, crime, and abuse :\xa0an update /', 'Return on Investment: Evidence-Based Options to Improve Statewide Outcomes <br/> April 2012 Update - Technical Appendix', 'NSCAW, Adolescents Involved with Child Welfare: A Transition to Adulthood', 'Appendix', 'December 2019']","['https://purl.fdlp.gov/GPO/gpo71840', 'https://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf']","['488_3_childrens exposure to violence crime and abuse \xa0an update .pdf', '488_1_return on investment  evidencebased options to improve statewide outcomes.pdf', '488_7_december 2019.pdf', '488_6_appendix.pdf', '488_4_return on investment evidencebased options to improve statewide outcomes br april 2012 update  technical appendix.pdf']",5,62.5,"['https://purl.fdlp.gov/GPO/gpo71840', 'https://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf']","['488_3_childrens exposure to violence crime and abuse \xa0an update .pdf', '488_1_return on investment  evidencebased options to improve statewide outcomes.pdf', '488_7_december 2019.pdf', '488_6_appendix.pdf', '488_4_return on investment evidencebased options to improve statewide outcomes br april 2012 update  technical appendix.pdf']","[0.256, 0.302, 0.256, 0.26, 0.26]","[0.516, 0.514, 0.507, 0.507, 0.514]","[0.6, 0.598, 0.593, 0.593, 0.598]","[0.171, 0.132, 0.128, 0.128, 0.132]","[0.192, 0.144, 0.141, 0.141, 0.144]","[0.163, 0.118, 0.114, 0.114, 0.118]","[0.738, 0.725, 0.726, 0.726, 0.725]","[0.64, 0.626, 0.627, 0.627, 0.626]","[0.568, 0.574, 0.567, 0.567, 0.574]","[0.703, 0.693, 0.689, 0.689, 0.693]","[0.78, 0.781, 0.773, 0.773, 0.781]","[0.712, 0.711, 0.701, 0.701, 0.711]","[0.616, 0.617, 0.611, 0.611, 0.617]","[0.91, 0.915, 0.911, 0.911, 0.915]","[0.812, 0.813, 0.805, 0.805, 0.813]","[0.748, 0.75, 0.743, 0.743, 0.75]","[0.779, 0.78, 0.773, 0.773, 0.78]","[0.768, 0.767, 0.759, 0.759, 0.767]",0.267,0.512,0.596,0.138,0.152,0.125,0.728,0.629,0.57,0.693,0.778,0.707,0.614,0.912,0.81,0.747,0.777,0.764
https://doi.org/10.1001/archpsyc.64.1.65,costeffectiveness of systematic depression treatment among people with diabetes mellitus,489_costeffectiveness of systematic depression treatment among people with diabetes mellitus.pdf,7,"['https://aspe.hhs.gov/reports/benefits-medicaid-expansion-behavioral-health', 'https://deepblue.lib.umich.edu/handle/2027.42/171504', 'http://www.wsipp.wa.gov/ReportFile/1665/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-May-2017-Update_Report.pdf', 'http://www.wsipp.wa.gov/ReportFile/1661/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-December-2016-Update_Report.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/8/Wsipp_BenefitCost_ProgramDetails_Adult-Mental-Health', 'https://www.cms.gov/medicare-coverage-database/details/nca-details.aspx?NCAId=251&type=Closed', 'https://www.rand.org/pubs/technical_reports/TR956.html']","['Benefits of Medicaid Expansion for Behavioral Health', 'MI Care Team Demonstration Evaluation Report', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'National Coverage Analysis (NCA) for Screening for Depression in Adults (CAG-00425N)', 'Care Is Expensive for Mentally Ill Veterans, but Quality Is as Good or Better Than Other Health Systems']","['http://www.wsipp.wa.gov/ReportFile/1661/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-December-2016-Update_Report.pdf', 'http://www.wsipp.wa.gov/ReportFile/1665/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-May-2017-Update_Report.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/8/Wsipp_BenefitCost_ProgramDetails_Adult-Mental-Health']","['489_3_washington state institute for public policy.pdf', '489_2_washington state institute for public policy.pdf', '489_4_washington state institute for public policy.pdf']",3,42.86,"['http://www.wsipp.wa.gov/ReportFile/1661/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-December-2016-Update_Report.pdf', 'http://www.wsipp.wa.gov/ReportFile/1665/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-May-2017-Update_Report.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/8/Wsipp_BenefitCost_ProgramDetails_Adult-Mental-Health']","['489_3_washington state institute for public policy.pdf', '489_2_washington state institute for public policy.pdf', '489_4_washington state institute for public policy.pdf']","[0.603, 0.546, 0.493]","[0.492, 0.491, 0.522]","[0.583, 0.583, 0.612]","[0.148, 0.149, 0.162]","[0.159, 0.158, 0.179]","[0.138, 0.14, 0.159]","[0.73, 0.73, 0.731]","[0.639, 0.64, 0.641]","[0.547, 0.548, 0.58]","[0.685, 0.686, 0.702]","[0.778, 0.778, 0.791]","[0.68, 0.678, 0.704]","[0.598, 0.599, 0.611]","[0.913, 0.913, 0.921]","[0.783, 0.785, 0.806]","[0.73, 0.73, 0.751]","[0.769, 0.769, 0.789]","[0.753, 0.753, 0.771]",0.547,0.502,0.593,0.153,0.165,0.146,0.73,0.64,0.558,0.691,0.782,0.687,0.603,0.916,0.791,0.737,0.776,0.759
https://doi.org/10.1001/archpsyc.64.9.1032,national trends in the outpatient diagnosis and treatment of bipolar disorder in youth,491_national trends in the outpatient diagnosis and treatment of bipolar disorder in youth.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922419/pdf', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-fact-sheet-mental', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-annotated-0', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-fact-sheet-mental-0', 'https://aspe.hhs.gov/reports/what-challenges-are-boys-facing-what-opportunities-exist-address-those-challenges-annotated', 'https://mmcp.health.maryland.gov/pap/docs/Antipsychotic-Peer-review-Project-Narrative.pdf', 'https://www.rand.org/pubs/technical_reports/TR914.html']","['Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology', 'What Challenges Are Boys Facing, and What Opportunities Exist to Address Those Challenges? Fact Sheet: Mental Health', 'What Challenges Are Boys Facing, and What Opportunities Exist to Address Those Challenges? Annotated Bibliography', 'What Challenges Are Boys Facing, and What Opportunities Exist To Address Those Challenges? Fact Sheet: Mental Health*', 'What Challenges Are Boys Facing, and What Opportunities Exist to Address Those Challenges? Annotated Bibliography', 'Antipsychotic Peer Review Project', 'DC residents have high unmet needs for mental health care']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922419/pdf'],['491_0_evidencebased guidelines for treating bipolar disorder revised third edition recommendations from the british association for psychopharmacology.pdf'],1,14.29,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922419/pdf'],['491_0_evidencebased guidelines for treating bipolar disorder revised third edition recommendations from the british association for psychopharmacology.pdf'],[0.446],[0.531],[0.618],[0.197],[0.218],[0.175],[0.744],[0.651],[0.596],[0.7],[0.805],[0.717],[0.599],[0.915],[0.82],[0.759],[0.797],[0.785],0.446,0.531,0.618,0.197,0.218,0.175,0.744,0.651,0.596,0.7,0.805,0.717,0.599,0.915,0.82,0.759,0.797,0.785
https://doi.org/10.1001/archpsyc.65.10.1185,predictive validity and early predictors of peervictimization trajectories in preschool,492_predictive validity and early predictors of peervictimization trajectories in preschool.pdf,1,['https://purl.fdlp.gov/GPO/gpo128091'],"['Individual, institutional, and community sources of school violence :\xa0a meta-analysis : National Institute of Justice Comprehensive School Safety Initiative final summary overview /']",['https://purl.fdlp.gov/GPO/gpo128091'],['492_0_individual institutional and community sources of school violence \xa0a metaanalysis  national institute of justice comprehensive school safety initiative final summary overview .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo128091'],['492_0_individual institutional and community sources of school violence \xa0a metaanalysis  national institute of justice comprehensive school safety initiative final summary overview .pdf'],[0.383],[0.515],[0.595],[0.17],[0.2],[0.173],[0.737],[0.645],[0.579],[0.711],[0.779],[0.71],[0.605],[0.921],[0.802],[0.741],[0.783],[0.769],0.383,0.515,0.595,0.17,0.2,0.173,0.737,0.645,0.579,0.711,0.779,0.71,0.605,0.921,0.802,0.741,0.783,0.769
https://doi.org/10.1001/archpsyc.65.12.1429,mental health of college students and their non–collegeattending peers,493_mental health of college students and their non–collegeattending peers.pdf,9,"['https://rga.lis.virginia.gov/Published/2013/RD119/PDF', 'http://services.dlas.virginia.gov/User_db/frmView.aspx?ViewId=2742', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.rand.org/pubs/research_reports/RR2248.html', 'https://www.rand.org/pubs/research_reports/RR1370.html', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://louisvilleky.gov/sites/default/files/safe_neighborhoods/alcoholfactsstats.pdf', 'https://www.rand.org/pubs/research_reports/RR2454.html', 'https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['Microsoft Word - VCMHS  Cover.docx', '1', 'MHSOAC Meeting Packet', 'California Community College Faculty and Staff Help Address Student Mental Health Issues', 'Investing in College Student Mental Health Yields Positive Financial Returns', 'Oppose HB0032 Cannabis - Legalization and Regulation (Inclusion, Restoration and Rehabilitation Act of 2021)', 'Alcohol Facts and Statistics Fact Sheet', 'Review and Evaluation of the Substance Abuse, Mental Health, and Homelessness Grant Formulas', 'MHSOAC Meeting Packet']","['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['493_8_mhsoac meeting packet.pdf', '493_5_oppose hb0032 cannabis  legalization and regulation inclusion restoration and rehabilitation act of 2021.pdf', '493_2_mhsoac meeting packet.pdf']",3,33.33,"['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['493_8_mhsoac meeting packet.pdf', '493_5_oppose hb0032 cannabis  legalization and regulation inclusion restoration and rehabilitation act of 2021.pdf', '493_2_mhsoac meeting packet.pdf']","[0.269, 0.518, 0.269]","[0.512, 0.516, 0.512]","[0.608, 0.614, 0.608]","[0.138, 0.173, 0.138]","[0.159, 0.192, 0.159]","[0.122, 0.16, 0.122]","[0.723, 0.733, 0.723]","[0.626, 0.643, 0.626]","[0.581, 0.584, 0.581]","[0.666, 0.689, 0.666]","[0.798, 0.802, 0.798]","[0.721, 0.726, 0.721]","[0.608, 0.609, 0.608]","[0.92, 0.922, 0.92]","[0.832, 0.83, 0.832]","[0.753, 0.757, 0.753]","[0.794, 0.794, 0.794]","[0.775, 0.78, 0.775]",0.352,0.513,0.61,0.15,0.17,0.135,0.726,0.632,0.582,0.674,0.799,0.723,0.608,0.921,0.831,0.754,0.794,0.777
https://doi.org/10.1001/archpsyc.65.5.578,breastfeeding and child cognitive development,494_breastfeeding and child cognitive development.pdf,10,"['https://www.nber.org/papers/w19054', 'http://www.floridahealth.gov/programs-and-services/wic/health-providers/_documents/provider-booklet.pdf', 'https://www.colorado.gov/pacific/sites/default/files/PF_BF_Breastfeeding-AAP-2012-Policy-Statement.pdf', 'https://purl.fdlp.gov/GPO/gpo131659', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457747/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154583/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464574/pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8918811&GUID=A57CE2BF-E6B3-4510-91C9-B13CA76F39CA']","['Unobservable Selection and Coefficient Stability: Theory and Validation', 'Refer your clients to WIC', 'PEDS20113552 827..841', 'Infant nutrition and feeding: a guide for use in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).', 'Support for healthy breastfeeding mothers with healthy term babies', 'Methods of milk expression for lactating women', 'Longchain polyunsaturated fatty acid supplementation in preterm infants', 'Optimal duration of exclusive breastfeeding', 'Long chain polyunsaturated fatty acid supplementation in infants born at term', 'Holly Atkinson - Written Testimony Supporting 2064 FINAL no links']","['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8918811&GUID=A57CE2BF-E6B3-4510-91C9-B13CA76F39CA', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457747/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154583/pdf', 'https://purl.fdlp.gov/GPO/gpo131659', 'http://www.floridahealth.gov/programs-and-services/wic/health-providers/_documents/provider-booklet.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464574/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463838/pdf']","['494_9_holly atkinson  written testimony supporting 2064 final no links.pdf', '494_5_methods of milk expression for lactating women.pdf', '494_4_support for healthy breastfeeding mothers with healthy term babies.pdf', '494_7_optimal duration of exclusive breastfeeding.pdf', '494_3_infant nutrition and feeding a guide for use in the special supplemental nutrition program for women infants and children wic.pdf', '494_1_refer your clients to wic.pdf', '494_8_long chain polyunsaturated fatty acid supplementation in infants born at term.pdf', '494_6_longchain polyunsaturated fatty acid supplementation in preterm infants.pdf']",8,80.0,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8918811&GUID=A57CE2BF-E6B3-4510-91C9-B13CA76F39CA', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457747/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154583/pdf', 'https://purl.fdlp.gov/GPO/gpo131659', 'http://www.floridahealth.gov/programs-and-services/wic/health-providers/_documents/provider-booklet.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464574/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463838/pdf']","['494_9_holly atkinson  written testimony supporting 2064 final no links.pdf', '494_5_methods of milk expression for lactating women.pdf', '494_4_support for healthy breastfeeding mothers with healthy term babies.pdf', '494_7_optimal duration of exclusive breastfeeding.pdf', '494_3_infant nutrition and feeding a guide for use in the special supplemental nutrition program for women infants and children wic.pdf', '494_1_refer your clients to wic.pdf', '494_8_long chain polyunsaturated fatty acid supplementation in infants born at term.pdf', '494_6_longchain polyunsaturated fatty acid supplementation in preterm infants.pdf']","[0.263, 0.265, 0.424, 0.317, 0.349, 0.387, 0.327, 0.15]","[0.465, 0.502, 0.506, 0.492, 0.481, 0.483, 0.494, 0.493]","[0.559, 0.582, 0.582, 0.571, 0.574, 0.573, 0.574, 0.572]","[0.101, 0.148, 0.16, 0.16, 0.112, 0.127, 0.145, 0.147]","[0.099, 0.148, 0.16, 0.149, 0.117, 0.141, 0.149, 0.144]","[0.102, 0.126, 0.14, 0.138, 0.097, 0.112, 0.127, 0.127]","[0.719, 0.731, 0.732, 0.742, 0.724, 0.722, 0.732, 0.736]","[0.622, 0.638, 0.64, 0.648, 0.624, 0.624, 0.641, 0.643]","[0.524, 0.565, 0.568, 0.549, 0.558, 0.555, 0.558, 0.556]","[0.664, 0.689, 0.693, 0.707, 0.645, 0.651, 0.699, 0.699]","[0.747, 0.76, 0.766, 0.747, 0.767, 0.766, 0.758, 0.753]","[0.649, 0.684, 0.676, 0.662, 0.685, 0.687, 0.674, 0.673]","[0.601, 0.581, 0.58, 0.565, 0.603, 0.601, 0.579, 0.574]","[0.876, 0.889, 0.892, 0.872, 0.891, 0.895, 0.885, 0.882]","[0.78, 0.791, 0.793, 0.78, 0.794, 0.795, 0.781, 0.782]","[0.678, 0.695, 0.698, 0.682, 0.703, 0.707, 0.689, 0.689]","[0.741, 0.76, 0.759, 0.741, 0.764, 0.771, 0.753, 0.748]","[0.695, 0.722, 0.725, 0.71, 0.73, 0.731, 0.717, 0.716]",0.31,0.49,0.573,0.137,0.138,0.121,0.73,0.635,0.554,0.681,0.758,0.674,0.586,0.885,0.787,0.693,0.755,0.718
https://doi.org/10.1001/archpsyc.65.6.625,effects of enhanced foster care on the longterm physical and mental health of foster care alumni,495_effects of enhanced foster care on the longterm physical and mental health of foster care alumni.pdf,2,"['https://www.jaacap.org/article/S0890-8567(15)00148-3/pdf', 'https://www.rand.org/pubs/research_reports/RR1775-1.html']","['Practice Parameter for the Assessment and Management of Youth Involved With the Child Welfare System', 'Improving Child Welfare Outcomes']",['https://www.jaacap.org/article/S0890-8567(15)00148-3/pdf'],['495_0_practice parameter for the assessment and management of youth involved with the child welfare system.pdf'],1,50.0,['https://www.jaacap.org/article/S0890-8567(15)00148-3/pdf'],['495_0_practice parameter for the assessment and management of youth involved with the child welfare system.pdf'],[0.391],[0.521],[0.604],[0.159],[0.187],[0.143],[0.732],[0.637],[0.586],[0.673],[0.792],[0.72],[0.614],[0.921],[0.814],[0.75],[0.79],[0.773],0.391,0.521,0.604,0.159,0.187,0.143,0.732,0.637,0.586,0.673,0.792,0.72,0.614,0.921,0.814,0.75,0.79,0.773
https://doi.org/10.1001/archpsyc.65.6.674,genetic and environmental influences on alcohol caffeine cannabis and nicotine use from early adolescence to middle adulthood,496_genetic and environmental influences on alcohol caffeine cannabis and nicotine use from early adolescence to middle adulthood.pdf,2,"['https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://www.pccd.pa.gov/training/Documents/Conferences%20and%20Training/Why%20is%20Addiction%20a%20Family%20Disease.pdf']","['Preventing Tobacco Use Among Youth and Young Adults', 'Why is Addiction a Family Disease?']",['https://www.pccd.pa.gov/training/Documents/Conferences%20and%20Training/Why%20is%20Addiction%20a%20Family%20Disease.pdf'],['496_1_why is addiction a family disease.pdf'],1,50.0,['https://www.pccd.pa.gov/training/Documents/Conferences%20and%20Training/Why%20is%20Addiction%20a%20Family%20Disease.pdf'],['496_1_why is addiction a family disease.pdf'],[0.092],[0.501],[0.599],[0.124],[0.151],[0.121],[0.731],[0.63],[0.571],[0.714],[0.783],[0.721],[0.604],[0.898],[0.829],[0.749],[0.78],[0.773],0.092,0.501,0.599,0.124,0.151,0.121,0.731,0.63,0.571,0.714,0.783,0.721,0.604,0.898,0.829,0.749,0.78,0.773
https://doi.org/10.1001/archsurg.137.9.1049,effects of delayed wound excision and grafting in severely burned children,498_effects of delayed wound excision and grafting in severely burned children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095153/pdf', 'https://www.federalregister.gov/documents/2021/05/10/2021-08888/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-and-the']","['Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012', 'Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2022 Rates; Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals; Proposed Changes to Medicaid Provider Enrollment; and Proposed Changes to the Medicare Shared Savings Program']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095153/pdf'],['498_0_surviving sepsis campaign international guidelines for management of severe sepsis and septic shock 2012.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095153/pdf'],['498_0_surviving sepsis campaign international guidelines for management of severe sepsis and septic shock 2012.pdf'],[0.286],[0.551],[0.631],[0.177],[0.176],[0.124],[0.741],[0.645],[0.617],[0.634],[0.8],[0.723],[0.625],[0.918],[0.817],[0.769],[0.794],[0.786],0.286,0.551,0.631,0.177,0.176,0.124,0.741,0.645,0.617,0.634,0.8,0.723,0.625,0.918,0.817,0.769,0.794,0.786
https://doi.org/10.1001/jama.2008.567,treatment of adolescent opioid dependence,500_treatment of adolescent opioid dependence.pdf,1,['http://dhss.alaska.gov/AKOpioidTaskForce/Documents/meetings/06242016/NosykEvidence-basedTreatment.pdf'],['2012-0846 1..8'],['http://dhss.alaska.gov/AKOpioidTaskForce/Documents/meetings/06242016/NosykEvidence-basedTreatment.pdf'],['500_0_20120846 18.pdf'],1,100.0,['http://dhss.alaska.gov/AKOpioidTaskForce/Documents/meetings/06242016/NosykEvidence-basedTreatment.pdf'],['500_0_20120846 18.pdf'],[0.637],[0.549],[0.637],[0.224],[0.248],[0.205],[0.744],[0.655],[0.618],[0.685],[0.824],[0.745],[0.628],[0.928],[0.836],[0.776],[0.814],[0.805],0.637,0.549,0.637,0.224,0.248,0.205,0.744,0.655,0.618,0.685,0.824,0.745,0.628,0.928,0.836,0.776,0.814,0.805
https://doi.org/10.1001/jama.2008.782,moss and adams’ heart disease in infants children and adolescents including the fetus and young adult,501_moss and adams’ heart disease in infants children and adolescents including the fetus and young adult.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796629/pdf'],['Guidelines for the management of common congenital heart diseases in India: A consensus statement on indications and timing of intervention'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796629/pdf'],['501_0_guidelines for the management of common congenital heart diseases in india a consensus statement on indications and timing of intervention.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796629/pdf'],['501_0_guidelines for the management of common congenital heart diseases in india a consensus statement on indications and timing of intervention.pdf'],[0.221],[0.599],[0.66],[0.197],[0.217],[0.171],[0.744],[0.644],[0.681],[0.653],[0.833],[0.804],[0.67],[0.929],[0.843],[0.812],[0.836],[0.824],0.221,0.599,0.66,0.197,0.217,0.171,0.744,0.644,0.681,0.653,0.833,0.804,0.67,0.929,0.843,0.812,0.836,0.824
https://doi.org/10.1001/jama.2008.803,an unwelcome side effect of directtoconsumer personal genome testing,502_an unwelcome side effect of directtoconsumer personal genome testing.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936269/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729205/pdf', 'https://stacks.cdc.gov/view/cdc/7557', 'https://stacks.cdc.gov/view/cdc/7558', 'https://stacks.cdc.gov/view/cdc/7554']","['The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary Workshop', 'Pharmacogenetics: Using Genetic Information to Guide Drug Therapy', 'The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop', 'Strengthening the reporting of Genetic Risk Prediction Studies: The GRIPS Statement', 'Assessment of cumulative evidence on genetic associations : interim guidelines']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936269/pdf']","['502_1_pharmacogenetics using genetic information to guide drug therapy.pdf', '502_0_the scientific foundation for personal genomics recommendations from a national institutes of health–centers for disease control and prevention multidisciplinary workshop.pdf']",2,40.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936269/pdf']","['502_1_pharmacogenetics using genetic information to guide drug therapy.pdf', '502_0_the scientific foundation for personal genomics recommendations from a national institutes of health–centers for disease control and prevention multidisciplinary workshop.pdf']","[0.54, 0.252]","[0.495, 0.511]","[0.616, 0.625]","[0.174, 0.2]","[0.195, 0.225]","[0.143, 0.178]","[0.736, 0.741]","[0.645, 0.651]","[0.58, 0.584]","[0.693, 0.722]","[0.784, 0.786]","[0.683, 0.682]","[0.591, 0.603]","[0.907, 0.91]","[0.816, 0.828]","[0.738, 0.742]","[0.774, 0.778]","[0.768, 0.775]",0.396,0.503,0.621,0.187,0.21,0.16,0.738,0.648,0.582,0.708,0.785,0.683,0.597,0.909,0.822,0.74,0.776,0.772
https://doi.org/10.1001/jama.2008.827,has this prepubertal girl been sexually abused,503_has this prepubertal girl been sexually abused.pdf,2,"['https://www.justice.gov/ovw/file/846856/download', 'https://dps.alaska.gov/getmedia/0a8286d7-525e-48ef-8f7d-517dbe25f583/pediatric-best-practices.pdf;.aspx']","['Pediatric', 'Pediatric']","['https://dps.alaska.gov/getmedia/0a8286d7-525e-48ef-8f7d-517dbe25f583/pediatric-best-practices.pdf;.aspx', 'https://www.justice.gov/ovw/file/846856/download']","['503_1_pediatric.pdf', '503_0_pediatric.pdf']",2,100.0,"['https://dps.alaska.gov/getmedia/0a8286d7-525e-48ef-8f7d-517dbe25f583/pediatric-best-practices.pdf;.aspx', 'https://www.justice.gov/ovw/file/846856/download']","['503_1_pediatric.pdf', '503_0_pediatric.pdf']","[0.585, 0.585]","[0.554, 0.554]","[0.634, 0.634]","[0.168, 0.168]","[0.185, 0.185]","[0.16, 0.16]","[0.735, 0.735]","[0.637, 0.637]","[0.629, 0.629]","[0.646, 0.646]","[0.811, 0.811]","[0.753, 0.753]","[0.641, 0.641]","[0.92, 0.92]","[0.84, 0.84]","[0.782, 0.782]","[0.812, 0.812]","[0.801, 0.801]",0.585,0.554,0.634,0.168,0.185,0.16,0.735,0.637,0.629,0.646,0.811,0.753,0.641,0.92,0.84,0.782,0.812,0.801
https://doi.org/10.1001/jama.2008.839,smoking and colorectal cancer,504_smoking and colorectal cancer.pdf,7,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://stacks.cdc.gov/view/cdc/21569', 'https://stacks.cdc.gov/view/cdc/84557', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmoke50/', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805047/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['Smoking cessation: a report of the Surgeon General.', 'The Health consequences of smoking—50 years of progress : a report of the Surgeon General', 'Smoking cessation : a report of the Surgeon General', 'The Health Consequences of Smoking—50 Years of Progress', 'Smoking Cessation', 'Adherence to general medical checkup and cancer screening guidelines according to self-reported smoking status: Korea National Health and Nutrition Examination Survey (KNHANES) 2010–2012', 'Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805047/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://purl.fdlp.gov/GPO/gpo132839']","['504_5_adherence to general medical checkup and cancer screening guidelines according to selfreported smoking status korea national health and nutrition examination survey knhanes 2010–2012.pdf', '504_6_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf', '504_0_smoking cessation a report of the surgeon general.pdf']",3,42.86,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805047/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://purl.fdlp.gov/GPO/gpo132839']","['504_5_adherence to general medical checkup and cancer screening guidelines according to selfreported smoking status korea national health and nutrition examination survey knhanes 2010–2012.pdf', '504_6_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf', '504_0_smoking cessation a report of the surgeon general.pdf']","[0.555, 0.44, 0.555]","[0.511, 0.497, 0.497]","[0.594, 0.588, 0.588]","[0.162, 0.157, 0.157]","[0.18, 0.167, 0.167]","[0.146, 0.134, 0.134]","[0.739, 0.737, 0.737]","[0.649, 0.645, 0.645]","[0.584, 0.569, 0.569]","[0.711, 0.695, 0.695]","[0.796, 0.79, 0.79]","[0.71, 0.697, 0.697]","[0.592, 0.59, 0.59]","[0.911, 0.911, 0.911]","[0.815, 0.801, 0.801]","[0.739, 0.734, 0.734]","[0.786, 0.774, 0.774]","[0.773, 0.764, 0.764]",0.517,0.502,0.59,0.159,0.171,0.138,0.738,0.646,0.574,0.7,0.792,0.701,0.591,0.911,0.806,0.736,0.778,0.767
https://doi.org/10.1001/jama.2008.886,birth weight and risk of type 2 diabetes,505_birth weight and risk of type 2 diabetes.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481373/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464700/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486160/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464763/pdf', 'https://www.nber.org/papers/w23492']","['Lifestyle interventions for the treatment of women with gestational diabetes', 'Interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria', 'Different types of dietary advice for women with gestational diabetes mellitus', 'Insulin for the treatment of women with gestational diabetes', 'Combined diet and exercise interventions for preventing gestational diabetes mellitus', 'Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes', 'The Value of Mandating Maternal Education in a Developing Country']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486160/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464700/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481373/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464763/pdf']","['505_3_insulin for the treatment of women with gestational diabetes.pdf', '505_4_combined diet and exercise interventions for preventing gestational diabetes mellitus.pdf', '505_1_interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria.pdf', '505_2_different types of dietary advice for women with gestational diabetes mellitus.pdf', '505_0_lifestyle interventions for the treatment of women with gestational diabetes.pdf', '505_5_oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486160/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464700/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481373/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464763/pdf']","['505_3_insulin for the treatment of women with gestational diabetes.pdf', '505_4_combined diet and exercise interventions for preventing gestational diabetes mellitus.pdf', '505_1_interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria.pdf', '505_2_different types of dietary advice for women with gestational diabetes mellitus.pdf', '505_0_lifestyle interventions for the treatment of women with gestational diabetes.pdf', '505_5_oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes.pdf']","[0.334, 0.4, 0.3, 0.336, 0.287, 0.385]","[0.495, 0.499, 0.5, 0.497, 0.499, 0.496]","[0.582, 0.589, 0.593, 0.592, 0.59, 0.59]","[0.168, 0.17, 0.168, 0.174, 0.167, 0.169]","[0.162, 0.167, 0.171, 0.17, 0.169, 0.167]","[0.141, 0.141, 0.145, 0.145, 0.143, 0.145]","[0.739, 0.738, 0.738, 0.74, 0.737, 0.74]","[0.642, 0.64, 0.643, 0.644, 0.641, 0.644]","[0.566, 0.567, 0.567, 0.565, 0.567, 0.566]","[0.709, 0.708, 0.698, 0.71, 0.71, 0.699]","[0.77, 0.771, 0.771, 0.764, 0.771, 0.77]","[0.672, 0.674, 0.683, 0.676, 0.677, 0.683]","[0.566, 0.575, 0.576, 0.572, 0.571, 0.57]","[0.901, 0.902, 0.899, 0.89, 0.901, 0.897]","[0.787, 0.792, 0.792, 0.789, 0.79, 0.787]","[0.707, 0.713, 0.715, 0.704, 0.711, 0.707]","[0.754, 0.758, 0.758, 0.751, 0.757, 0.753]","[0.738, 0.743, 0.744, 0.733, 0.741, 0.738]",0.34,0.498,0.589,0.169,0.168,0.143,0.739,0.642,0.566,0.706,0.769,0.678,0.572,0.898,0.79,0.709,0.755,0.739
https://doi.org/10.1001/jama.2009.1757,assessment of claims of improved prediction beyond the framingham risk score,506_assessment of claims of improved prediction beyond the framingham risk score.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058100/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172920/pdf']","['Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement', 'Strengthening the reporting of genetic risk prediction studies: the GRIPS statement']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172920/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058100/pdf']","['506_1_strengthening the reporting of genetic risk prediction studies the grips statement.pdf', '506_0_strengthening the reporting of genetic risk prediction studies the grips statement.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172920/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058100/pdf']","['506_1_strengthening the reporting of genetic risk prediction studies the grips statement.pdf', '506_0_strengthening the reporting of genetic risk prediction studies the grips statement.pdf']","[0.519, 0.519]","[0.523, 0.529]","[0.617, 0.616]","[0.173, 0.176]","[0.196, 0.198]","[0.143, 0.142]","[0.734, 0.734]","[0.643, 0.642]","[0.585, 0.588]","[0.735, 0.738]","[0.777, 0.774]","[0.729, 0.729]","[0.596, 0.601]","[0.899, 0.902]","[0.815, 0.818]","[0.729, 0.733]","[0.776, 0.775]","[0.748, 0.747]",0.519,0.526,0.617,0.174,0.197,0.142,0.734,0.643,0.587,0.736,0.776,0.729,0.599,0.901,0.817,0.731,0.776,0.748
https://doi.org/10.1001/jama.2009.761,timing and tempo of firstyear rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood,507_timing and tempo of firstyear rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood.pdf,1,['https://www.nature.com/articles/nrendo.2016.138.pdf'],['Diagnosis and management of Silver–Russell syndrome: first international consensus statement'],['https://www.nature.com/articles/nrendo.2016.138.pdf'],['507_0_diagnosis and management of silver–russell syndrome first international consensus statement.pdf'],1,100.0,['https://www.nature.com/articles/nrendo.2016.138.pdf'],['507_0_diagnosis and management of silver–russell syndrome first international consensus statement.pdf'],[0.308],[0.48],[0.573],[0.126],[0.125],[0.109],[0.737],[0.637],[0.54],[0.685],[0.742],[0.668],[0.598],[0.876],[0.756],[0.674],[0.736],[0.694],0.308,0.48,0.573,0.126,0.125,0.109,0.737,0.637,0.54,0.685,0.742,0.668,0.598,0.876,0.756,0.674,0.736,0.694
https://doi.org/10.1001/jama.2009.771,oneyear survival of extremely preterm infants after active perinatal care in sweden,508_oneyear survival of extremely preterm infants after active perinatal care in sweden.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379056/pdf']","['Stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants', 'In Search of Consistency: Scandinavian Approaches to Resuscitation of Extremely Preterm Infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379056/pdf']","['508_0_stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants.pdf', '508_1_in search of consistency scandinavian approaches to resuscitation of extremely preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379056/pdf']","['508_0_stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants.pdf', '508_1_in search of consistency scandinavian approaches to resuscitation of extremely preterm infants.pdf']","[0.303, 0.378]","[0.533, 0.523]","[0.618, 0.617]","[0.158, 0.172]","[0.168, 0.202]","[0.132, 0.159]","[0.735, 0.73]","[0.644, 0.64]","[0.606, 0.607]","[0.658, 0.67]","[0.792, 0.788]","[0.722, 0.713]","[0.596, 0.594]","[0.918, 0.916]","[0.812, 0.823]","[0.747, 0.748]","[0.784, 0.785]","[0.773, 0.775]",0.341,0.528,0.617,0.165,0.185,0.146,0.732,0.642,0.607,0.664,0.79,0.718,0.595,0.917,0.818,0.748,0.784,0.774
https://doi.org/10.1001/jama.2009.788,prevention of depression in atrisk adolescents,509_prevention of depression in atrisk adolescents.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'https://www.rand.org/pubs/tools/TL145.html']","['Treatment of Youth Depression in Primary Care Under Usual Practice Conditions: Observational Findings from Youth Partners in Care', 'Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents', 'Best Practices', 'Programs That Work']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf']","['509_0_treatment of youth depression in primary care under usual practice conditions observational findings from youth partners in care.pdf', '509_1_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf', '509_2_best practices.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf']","['509_0_treatment of youth depression in primary care under usual practice conditions observational findings from youth partners in care.pdf', '509_1_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf', '509_2_best practices.pdf']","[0.448, 0.497, 0.405]","[0.517, 0.508, 0.505]","[0.6, 0.59, 0.591]","[0.182, 0.175, 0.153]","[0.19, 0.18, 0.163]","[0.159, 0.157, 0.138]","[0.737, 0.736, 0.729]","[0.648, 0.644, 0.633]","[0.576, 0.57, 0.571]","[0.717, 0.724, 0.691]","[0.782, 0.767, 0.781]","[0.71, 0.678, 0.705]","[0.607, 0.579, 0.599]","[0.897, 0.904, 0.911]","[0.798, 0.799, 0.803]","[0.724, 0.707, 0.738]","[0.777, 0.761, 0.781]","[0.747, 0.743, 0.764]",0.45,0.51,0.594,0.17,0.178,0.151,0.734,0.642,0.572,0.711,0.777,0.698,0.595,0.904,0.8,0.723,0.773,0.751
https://doi.org/10.1001/jama.2010.1181,does this coughing adolescent or adult patient have pertussis,510_does this coughing adolescent or adult patient have pertussis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047603/pdf'],['The Diagnosis and Treatment of Acute Cough in Adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047603/pdf'],['510_0_the diagnosis and treatment of acute cough in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047603/pdf'],['510_0_the diagnosis and treatment of acute cough in adults.pdf'],[0.359],[0.567],[0.64],[0.196],[0.194],[0.153],[0.741],[0.647],[0.64],[0.657],[0.815],[0.757],[0.636],[0.921],[0.839],[0.78],[0.813],[0.797],0.359,0.567,0.64,0.196,0.194,0.153,0.741,0.647,0.64,0.657,0.815,0.757,0.636,0.921,0.839,0.78,0.813,0.797
https://doi.org/10.1001/jama.2010.1192,cognitive behavioral therapy vs relaxation with educational support for medicationtreated adults with adhd and persistent symptoms,511_cognitive behavioral therapy vs relaxation with educational support for medicationtreated adults with adhd and persistent symptoms.pdf,4,"['https://www.acf.hhs.gov/opre/resource/self-regulation-goal-attainment-a-new-perspective-employment-programs', 'https://www.acf.hhs.gov/opre/report/self-regulation-and-goal-attainment-new-perspective-employment-programs', 'https://mathematica.org/publications/self-regulation-and-goal-attainment-a-new-perspective-for-employment-programs', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494390/pdf']","['Self-Regulation and Goal Attainment: A New Perspective for Employment Programs', 'Self-Regulation and Goal Attainment: A New Perspective for Employment Programs', 'Self-Regulation and Goal Attainment: A New Perspective for Employment Programs', 'Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494390/pdf'],['511_3_cognitive‐behavioural interventions for attention deficit hyperactivity disorder adhd in adults.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494390/pdf'],['511_3_cognitive‐behavioural interventions for attention deficit hyperactivity disorder adhd in adults.pdf'],[0.428],[0.495],[0.582],[0.174],[0.177],[0.149],[0.739],[0.644],[0.566],[0.731],[0.765],[0.677],[0.571],[0.893],[0.78],[0.699],[0.756],[0.729],0.428,0.495,0.582,0.174,0.177,0.149,0.739,0.644,0.566,0.731,0.765,0.677,0.571,0.893,0.78,0.699,0.756,0.729
https://doi.org/10.1001/jama.2010.1635,association of adolescent obesity with risk of severe obesity in adulthood,512_association of adolescent obesity with risk of severe obesity in adulthood.pdf,4,"['https://health.maryland.gov/phpa/ohpetup/Documents/2017_standard_yrbs_item_rationale.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.commonwealthfund.org/publications/fund-reports/2011/feb/securing-healthy-future-commonwealth-fund-state-scorecard-child', 'https://stacks.cdc.gov/view/cdc/43487']","['Youth Risk Behavior Survey (YRBS) 2017 Standard Questionnaire Item Rationale', 'America’s children and the environment.', 'Securing a Healthy Future: The Commonwealth Fund State Scorecard on Child Health System Performance, 2011', 'Early care and education state indicator report, 2016']","['https://health.maryland.gov/phpa/ohpetup/Documents/2017_standard_yrbs_item_rationale.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['512_0_youth risk behavior survey yrbs 2017 standard questionnaire item rationale.pdf', '512_1_americas children and the environment.pdf']",2,50.0,"['https://health.maryland.gov/phpa/ohpetup/Documents/2017_standard_yrbs_item_rationale.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['512_0_youth risk behavior survey yrbs 2017 standard questionnaire item rationale.pdf', '512_1_americas children and the environment.pdf']","[0.217, 0.257]","[0.471, 0.477]","[0.569, 0.573]","[0.133, 0.122]","[0.145, 0.113]","[0.115, 0.097]","[0.726, 0.728]","[0.627, 0.628]","[0.542, 0.54]","[0.684, 0.697]","[0.757, 0.762]","[0.687, 0.677]","[0.584, 0.604]","[0.888, 0.882]","[0.782, 0.774]","[0.684, 0.696]","[0.759, 0.76]","[0.725, 0.726]",0.237,0.474,0.571,0.128,0.129,0.106,0.727,0.627,0.541,0.691,0.76,0.682,0.594,0.885,0.778,0.69,0.76,0.726
https://doi.org/10.1001/jama.2010.1861,prenatal micronutrient supplementation and intellectual and motor function in early schoolaged children in nepal,513_prenatal micronutrient supplementation and intellectual and motor function in early schoolaged children in nepal.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418471/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783750/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf']","['Multiple‐micronutrient supplementation for women during pregnancy', 'Effects and safety of periconceptional oral folate supplementation for preventing birth defects', 'Daily oral iron supplementation during pregnancy', 'Vitamin supplementation for preventing miscarriage']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783750/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418471/pdf']","['513_3_vitamin supplementation for preventing miscarriage.pdf', '513_2_daily oral iron supplementation during pregnancy.pdf', '513_1_effects and safety of periconceptional oral folate supplementation for preventing birth defects.pdf', '513_0_multiple‐micronutrient supplementation for women during pregnancy.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783750/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418471/pdf']","['513_3_vitamin supplementation for preventing miscarriage.pdf', '513_2_daily oral iron supplementation during pregnancy.pdf', '513_1_effects and safety of periconceptional oral folate supplementation for preventing birth defects.pdf', '513_0_multiple‐micronutrient supplementation for women during pregnancy.pdf']","[0.477, 0.263, 0.456, 0.358]","[0.503, 0.501, 0.494, 0.498]","[0.582, 0.58, 0.578, 0.581]","[0.142, 0.155, 0.156, 0.146]","[0.142, 0.146, 0.145, 0.149]","[0.116, 0.125, 0.122, 0.121]","[0.731, 0.735, 0.737, 0.734]","[0.632, 0.639, 0.642, 0.637]","[0.57, 0.566, 0.565, 0.566]","[0.675, 0.687, 0.692, 0.691]","[0.766, 0.768, 0.766, 0.767]","[0.696, 0.683, 0.676, 0.689]","[0.576, 0.582, 0.583, 0.586]","[0.895, 0.893, 0.893, 0.897]","[0.788, 0.784, 0.775, 0.786]","[0.704, 0.703, 0.701, 0.702]","[0.762, 0.76, 0.758, 0.761]","[0.734, 0.733, 0.733, 0.733]",0.388,0.499,0.58,0.15,0.145,0.121,0.734,0.637,0.567,0.686,0.767,0.686,0.582,0.895,0.783,0.703,0.76,0.733
https://doi.org/10.1001/jama.2010.250,effect of influenza vaccination of children on infection rates in hutterite communities,514_effect of influenza vaccination of children on infection rates in hutterite communities.pdf,6,"['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F95C843A7EFD0AE41D6532D6E99AD5AB/S0195941700033907a.pdf/infection-prevention-and-control-in-residential-facilities-for-pediatric-patients-and-their-families.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.nber.org/papers/w28446', 'https://stacks.cdc.gov/view/cdc/5715', 'https://www.nber.org/papers/w20432']","['Infection Prevention and Control in Residential Facilities for Pediatric Patients and Their Families', 'Effect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and Canada', 'Vaccines for preventing influenza in healthy children', 'Vaccination Planning under Uncertainty, with Application to Covid-19', 'Prevention and control of influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010', 'Vaccine Approvals and Mandates Under Uncertainty: Some Simple Analytics']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F95C843A7EFD0AE41D6532D6E99AD5AB/S0195941700033907a.pdf/infection-prevention-and-control-in-residential-facilities-for-pediatric-patients-and-their-families.pdf']","['514_1_effect of expanded us recommendations for seasonal influenza vaccination comparison of two pediatric emergency departments in the united states and canada.pdf', '514_2_vaccines for preventing influenza in healthy children.pdf', '514_0_infection prevention and control in residential facilities for pediatric patients and their families.pdf']",3,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F95C843A7EFD0AE41D6532D6E99AD5AB/S0195941700033907a.pdf/infection-prevention-and-control-in-residential-facilities-for-pediatric-patients-and-their-families.pdf']","['514_1_effect of expanded us recommendations for seasonal influenza vaccination comparison of two pediatric emergency departments in the united states and canada.pdf', '514_2_vaccines for preventing influenza in healthy children.pdf', '514_0_infection prevention and control in residential facilities for pediatric patients and their families.pdf']","[0.283, 0.337, 0.581]","[0.541, 0.521, 0.526]","[0.608, 0.589, 0.603]","[0.186, 0.182, 0.155]","[0.192, 0.185, 0.164]","[0.157, 0.157, 0.137]","[0.737, 0.74, 0.734]","[0.646, 0.647, 0.636]","[0.604, 0.58, 0.595]","[0.685, 0.692, 0.643]","[0.798, 0.777, 0.794]","[0.734, 0.695, 0.723]","[0.626, 0.606, 0.625]","[0.915, 0.909, 0.916]","[0.822, 0.803, 0.813]","[0.76, 0.731, 0.76]","[0.797, 0.774, 0.792]","[0.78, 0.757, 0.777]",0.4,0.529,0.6,0.174,0.18,0.15,0.737,0.643,0.593,0.673,0.79,0.717,0.619,0.913,0.813,0.75,0.788,0.771
https://doi.org/10.1001/jama.2010.45,brainstem serotonergic deficiency in sudden infant death syndrome,516_brainstem serotonergic deficiency in sudden infant death syndrome.pdf,1,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['A Policy & Education Development Guide'],['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['516_0_a policy  education development guide.pdf'],1,100.0,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['516_0_a policy  education development guide.pdf'],[0.4],[0.476],[0.565],[0.11],[0.11],[0.091],[0.725],[0.627],[0.546],[0.656],[0.762],[0.695],[0.599],[0.878],[0.776],[0.687],[0.761],[0.716],0.4,0.476,0.565,0.11,0.11,0.091,0.725,0.627,0.546,0.656,0.762,0.695,0.599,0.878,0.776,0.687,0.761,0.716
https://doi.org/10.1001/jama.2010.605,prenatal and postpartum depression in fathers and its association with maternal depression,517_prenatal and postpartum depression in fathers and its association with maternal depression.pdf,4,"['https://www.dcyf.wa.gov/sites/default/files/pubs/EL_0016.pdf', 'https://www.hca.wa.gov/assets/program/cybhwg-agenda-200918.pdf', 'https://dcyf.wa.gov/sites/default/files/pdf/ELP.pdf', 'https://health.mo.gov/data/mochaps/pdf/perinatal-moods.pdf']","['Washington State Early Learning Plan', 'Meeting Agenda Template', 'Washington State Early Learning Plan', '32.4%']","['https://www.dcyf.wa.gov/sites/default/files/pubs/EL_0016.pdf', 'https://www.hca.wa.gov/assets/program/cybhwg-agenda-200918.pdf', 'https://health.mo.gov/data/mochaps/pdf/perinatal-moods.pdf']","['517_0_washington state early learning plan.pdf', '517_1_meeting agenda template.pdf', '517_3_324.pdf']",3,75.0,"['https://www.dcyf.wa.gov/sites/default/files/pubs/EL_0016.pdf', 'https://www.hca.wa.gov/assets/program/cybhwg-agenda-200918.pdf', 'https://health.mo.gov/data/mochaps/pdf/perinatal-moods.pdf']","['517_0_washington state early learning plan.pdf', '517_1_meeting agenda template.pdf', '517_3_324.pdf']","[0.097, 0.167, 0.302]","[0.482, 0.494, 0.481]","[0.576, 0.586, 0.574]","[0.104, 0.128, 0.154]","[0.112, 0.142, 0.173]","[0.092, 0.121, 0.159]","[0.715, 0.724, 0.737]","[0.615, 0.629, 0.646]","[0.546, 0.556, 0.543]","[0.654, 0.674, 0.707]","[0.782, 0.79, 0.757]","[0.691, 0.691, 0.661]","[0.594, 0.601, 0.58]","[0.91, 0.908, 0.909]","[0.811, 0.809, 0.778]","[0.743, 0.745, 0.717]","[0.778, 0.782, 0.743]","[0.766, 0.768, 0.739]",0.189,0.486,0.579,0.129,0.142,0.124,0.725,0.63,0.548,0.678,0.776,0.681,0.592,0.909,0.799,0.735,0.768,0.758
https://doi.org/10.1001/jama.2010.81,laparoscopic adjustable gastric banding in severely obese adolescents,519_laparoscopic adjustable gastric banding in severely obese adolescents.pdf,5,"['https://asmbs.org/app/uploads/2018/08/PIIS155072891830145X-Pediatric-in-Press.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028049/pdf', 'https://www.hca.wa.gov/assets/program/bariatric_final_rpt_040315[1].pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-surgery.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387033/pdf']","['ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018', 'Surgery for weight loss in adults', 'Bariatric Surgery', 'Surgery', 'Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387033/pdf', 'https://asmbs.org/app/uploads/2018/08/PIIS155072891830145X-Pediatric-in-Press.pdf', 'https://www.hca.wa.gov/assets/program/bariatric_final_rpt_040315[1].pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028049/pdf']","['519_4_recommendations for growth monitoring and prevention and management of overweight and obesity in children and youth in primary care.pdf', '519_0_asmbs pediatric metabolic and bariatric surgery guidelines 2018.pdf', '519_2_bariatric surgery.pdf', '519_1_surgery for weight loss in adults.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387033/pdf', 'https://asmbs.org/app/uploads/2018/08/PIIS155072891830145X-Pediatric-in-Press.pdf', 'https://www.hca.wa.gov/assets/program/bariatric_final_rpt_040315[1].pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028049/pdf']","['519_4_recommendations for growth monitoring and prevention and management of overweight and obesity in children and youth in primary care.pdf', '519_0_asmbs pediatric metabolic and bariatric surgery guidelines 2018.pdf', '519_2_bariatric surgery.pdf', '519_1_surgery for weight loss in adults.pdf']","[0.535, 0.612, 0.543, 0.39]","[0.536, 0.522, 0.533, 0.512]","[0.612, 0.601, 0.61, 0.593]","[0.187, 0.162, 0.18, 0.173]","[0.195, 0.172, 0.18, 0.175]","[0.155, 0.139, 0.145, 0.146]","[0.731, 0.735, 0.737, 0.739]","[0.631, 0.635, 0.639, 0.641]","[0.602, 0.591, 0.597, 0.575]","[0.69, 0.67, 0.678, 0.69]","[0.795, 0.79, 0.79, 0.768]","[0.73, 0.714, 0.712, 0.693]","[0.623, 0.613, 0.626, 0.599]","[0.909, 0.913, 0.911, 0.902]","[0.816, 0.811, 0.811, 0.795]","[0.751, 0.749, 0.752, 0.715]","[0.798, 0.791, 0.792, 0.767]","[0.769, 0.774, 0.773, 0.744]",0.52,0.526,0.604,0.175,0.18,0.146,0.735,0.637,0.591,0.682,0.786,0.712,0.615,0.909,0.808,0.742,0.787,0.765
https://doi.org/10.1001/jama.2011.1060,communityimplemented trauma therapy for former child soldiers in northern uganda,521_communityimplemented trauma therapy for former child soldiers in northern uganda.pdf,7,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://purl.fdlp.gov/GPO/gpo118383', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/5/Wsipp_BenefitCost_ProgramDetails_Childrens-Mental-Health', 'https://purl.fdlp.gov/GPO/gpo115018', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf']","['Washington State Institute for Public Policy', 'VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder: cllinician summary /', 'Washington State Institute for Public Policy', 'VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.', 'Psychological therapies for children and adolescents exposed to trauma', 'Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises', 'Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries']","['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://purl.fdlp.gov/GPO/gpo115018', 'https://purl.fdlp.gov/GPO/gpo118383', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf']","['521_0_washington state institute for public policy.pdf', '521_6_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '521_5_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf', '521_3_vadod clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.pdf', '521_1_vadod clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder cllinician summary .pdf', '521_4_psychological therapies for children and adolescents exposed to trauma.pdf']",6,85.71,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://purl.fdlp.gov/GPO/gpo115018', 'https://purl.fdlp.gov/GPO/gpo118383', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf']","['521_0_washington state institute for public policy.pdf', '521_6_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '521_5_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf', '521_3_vadod clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.pdf', '521_1_vadod clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder cllinician summary .pdf', '521_4_psychological therapies for children and adolescents exposed to trauma.pdf']","[0.241, 0.361, 0.355, 0.458, 0.317, 0.308]","[0.508, 0.513, 0.487, 0.521, 0.516, 0.496]","[0.582, 0.593, 0.571, 0.606, 0.603, 0.578]","[0.136, 0.157, 0.154, 0.176, 0.178, 0.164]","[0.145, 0.155, 0.146, 0.179, 0.185, 0.157]","[0.123, 0.135, 0.131, 0.152, 0.156, 0.14]","[0.73, 0.736, 0.739, 0.736, 0.739, 0.739]","[0.635, 0.642, 0.644, 0.646, 0.649, 0.645]","[0.574, 0.576, 0.556, 0.589, 0.589, 0.564]","[0.69, 0.698, 0.716, 0.682, 0.681, 0.712]","[0.781, 0.775, 0.761, 0.791, 0.793, 0.765]","[0.7, 0.691, 0.649, 0.713, 0.716, 0.666]","[0.598, 0.586, 0.58, 0.612, 0.604, 0.575]","[0.907, 0.904, 0.899, 0.909, 0.912, 0.901]","[0.808, 0.809, 0.795, 0.826, 0.824, 0.799]","[0.729, 0.714, 0.704, 0.741, 0.737, 0.705]","[0.783, 0.772, 0.755, 0.79, 0.79, 0.758]","[0.756, 0.743, 0.736, 0.763, 0.764, 0.737]",0.34,0.507,0.589,0.161,0.161,0.14,0.736,0.644,0.575,0.697,0.778,0.689,0.592,0.905,0.81,0.722,0.775,0.75
https://doi.org/10.1001/jama.2011.1364,effect of increasing doses of saw palmetto extract on lower urinary tract symptoms,522_effect of increasing doses of saw palmetto extract on lower urinary tract symptoms.pdf,2,"['https://www.auanet.org/documents/Guidelines/PDF/BPH%20Surgical-Mgmt.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084061/pdf']","['Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE', 'for benign prostatic hyperplasia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084061/pdf', 'https://www.auanet.org/documents/Guidelines/PDF/BPH%20Surgical-Mgmt.pdf']","['522_1_for benign prostatic hyperplasia.pdf', '522_0_management of lower urinary tract symptoms attributed to benign prostatic hyperplasia aua guideline.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084061/pdf', 'https://www.auanet.org/documents/Guidelines/PDF/BPH%20Surgical-Mgmt.pdf']","['522_1_for benign prostatic hyperplasia.pdf', '522_0_management of lower urinary tract symptoms attributed to benign prostatic hyperplasia aua guideline.pdf']","[0.421, 0.357]","[0.489, 0.506]","[0.571, 0.586]","[0.144, 0.147]","[0.155, 0.15]","[0.128, 0.112]","[0.736, 0.733]","[0.646, 0.64]","[0.562, 0.572]","[0.702, 0.653]","[0.761, 0.777]","[0.679, 0.712]","[0.578, 0.609]","[0.884, 0.891]","[0.792, 0.789]","[0.684, 0.712]","[0.754, 0.774]","[0.717, 0.731]",0.389,0.497,0.579,0.145,0.152,0.12,0.734,0.643,0.567,0.677,0.769,0.696,0.593,0.887,0.79,0.698,0.764,0.724
https://doi.org/10.1001/jama.2011.1823,causes of death among stillbirths,523_causes of death among stillbirths.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494629/pdf', 'https://stacks.cdc.gov/view/cdc/61389', 'https://stacks.cdc.gov/view/cdc/42413', 'https://stacks.cdc.gov/view/cdc/86748', 'https://stacks.cdc.gov/view/cdc/61388']","['Interventions for investigating and identifying the causes of stillbirth', 'Fetal and perinatal mortality : United States, 2013', 'Cause of fetal death : data from the Fetal Death Report, 2014', 'Cause-of-death data from the fetal death file, 2015–2017', 'Fetal and perinatal mortality : United States, 2006']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494629/pdf'],['523_0_interventions for investigating and identifying the causes of stillbirth.pdf'],1,20.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494629/pdf'],['523_0_interventions for investigating and identifying the causes of stillbirth.pdf'],[0.517],[0.505],[0.594],[0.168],[0.203],[0.156],[0.738],[0.643],[0.57],[0.687],[0.779],[0.703],[0.592],[0.91],[0.799],[0.735],[0.776],[0.765],0.517,0.505,0.594,0.168,0.203,0.156,0.738,0.643,0.57,0.687,0.779,0.703,0.592,0.91,0.799,0.735,0.776,0.765
https://doi.org/10.1001/jama.2011.1830,adhd medications and risk of serious cardiovascular events in young and middleaged adults,524_adhd medications and risk of serious cardiovascular events in young and middleaged adults.pdf,6,"['http://purl.fdlp.gov/GPO/gpo60277', 'https://www.congress.gov/event/113th-congress/senate-event/LC32031/text?s=1&r=8588', 'https://www.hrsonline.org/documents/2012-paces-hrs-asymptomatic-wpwpdf/download', 'https://effectivehealthcare.ahrq.gov/products/observational-cer-protocol/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000375?download=true']","['Examining mental health :\xa0treatment options and trends : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session ... February 25, 2014.', 'S.Hrg. 113-690 — EXAMINING MENTAL HEALTH: TREATMENT OPTIONS AND TRENDS', '2012 PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern', 'Developing a Protocol for Observational Comparative Effectiveness Research: A User’s Guide', 'Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies', '2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association']","['https://www.hrsonline.org/documents/2012-paces-hrs-asymptomatic-wpwpdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf']","['524_2_2012 paceshrs expert consensus statement on the management of the asymptomatic young patient with a wolffparkinsonwhite wpw ventricular preexcitation electrocardiographic pattern.pdf', '524_4_methylphenidate for attention deficit hyperactivity disorder adhd in children and adolescents – assessment of adverse events in non‐randomised studies.pdf']",2,33.33,"['https://www.hrsonline.org/documents/2012-paces-hrs-asymptomatic-wpwpdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf']","['524_2_2012 paceshrs expert consensus statement on the management of the asymptomatic young patient with a wolffparkinsonwhite wpw ventricular preexcitation electrocardiographic pattern.pdf', '524_4_methylphenidate for attention deficit hyperactivity disorder adhd in children and adolescents – assessment of adverse events in non‐randomised studies.pdf']","[0.222, 0.309]","[0.529, 0.503]","[0.609, 0.59]","[0.145, 0.16]","[0.139, 0.162]","[0.109, 0.14]","[0.739, 0.737]","[0.645, 0.645]","[0.599, 0.571]","[0.623, 0.696]","[0.788, 0.768]","[0.732, 0.688]","[0.61, 0.586]","[0.921, 0.912]","[0.815, 0.812]","[0.753, 0.72]","[0.786, 0.763]","[0.767, 0.748]",0.266,0.516,0.599,0.152,0.151,0.124,0.738,0.645,0.585,0.659,0.778,0.71,0.598,0.917,0.814,0.736,0.774,0.758
https://doi.org/10.1001/jama.2011.235,nitric oxide for inhalation in the acute treatment of sickle cell pain crisis,525_nitric oxide for inhalation in the acute treatment of sickle cell pain crisis.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788324/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812163/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517013/pdf', 'https://effectivehealthcare.ahrq.gov/products/treatments-acute-pain/research']","['Inhaled nitric oxide for treating pain crises in people with sickle cell disease', 'Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report', 'Drugs for preventing red blood cell dehydration in people with sickle cell disease', 'Treatments for Acute Pain: A Systematic Review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812163/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517013/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788324/pdf']","['525_1_identifying clinical and research priorities in sickle cell lung disease an official american thoracic society workshop report.pdf', '525_2_drugs for preventing red blood cell dehydration in people with sickle cell disease.pdf', '525_0_inhaled nitric oxide for treating pain crises in people with sickle cell disease.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812163/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517013/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788324/pdf']","['525_1_identifying clinical and research priorities in sickle cell lung disease an official american thoracic society workshop report.pdf', '525_2_drugs for preventing red blood cell dehydration in people with sickle cell disease.pdf', '525_0_inhaled nitric oxide for treating pain crises in people with sickle cell disease.pdf']","[0.568, 0.353, 0.399]","[0.494, 0.497, 0.497]","[0.581, 0.585, 0.581]","[0.132, 0.138, 0.147]","[0.141, 0.14, 0.15]","[0.108, 0.109, 0.122]","[0.735, 0.729, 0.733]","[0.637, 0.632, 0.635]","[0.567, 0.569, 0.561]","[0.667, 0.677, 0.7]","[0.769, 0.769, 0.761]","[0.692, 0.694, 0.684]","[0.603, 0.597, 0.585]","[0.901, 0.901, 0.892]","[0.793, 0.803, 0.795]","[0.71, 0.708, 0.696]","[0.767, 0.765, 0.758]","[0.738, 0.736, 0.724]",0.44,0.496,0.582,0.139,0.144,0.113,0.732,0.635,0.566,0.681,0.766,0.69,0.595,0.898,0.797,0.705,0.763,0.733
https://doi.org/10.1001/jama.2011.656,effects of vitamin a or beta carotene supplementation on pregnancyrelated mortality and infant mortality in rural bangladesh,526_effects of vitamin a or beta carotene supplementation on pregnancyrelated mortality and infant mortality in rural bangladesh.pdf,4,"['https://www.nber.org/papers/w25969', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407451/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173731/pdf']","['Protecting Infants from Natural Disasters: The Case of Vitamin A Supplementation and a Tornado in Bangladesh', 'Vitamin A supplementation for postpartum women', 'Vitamin supplementation for preventing miscarriage', 'Vitamin A supplementation during pregnancy for maternal and newborn outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173731/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf']","['526_3_vitamin a supplementation during pregnancy for maternal and newborn outcomes.pdf', '526_2_vitamin supplementation for preventing miscarriage.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173731/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf']","['526_3_vitamin a supplementation during pregnancy for maternal and newborn outcomes.pdf', '526_2_vitamin supplementation for preventing miscarriage.pdf']","[0.495, 0.554]","[0.511, 0.512]","[0.591, 0.592]","[0.17, 0.166]","[0.174, 0.172]","[0.146, 0.141]","[0.739, 0.737]","[0.643, 0.639]","[0.577, 0.579]","[0.677, 0.674]","[0.779, 0.777]","[0.673, 0.679]","[0.58, 0.584]","[0.908, 0.908]","[0.797, 0.802]","[0.726, 0.732]","[0.772, 0.772]","[0.758, 0.76]",0.524,0.512,0.591,0.168,0.173,0.143,0.738,0.641,0.578,0.675,0.778,0.676,0.582,0.908,0.8,0.729,0.772,0.759
https://doi.org/10.1001/jama.2012.108940,emergency preparedness and public health,528_emergency preparedness and public health.pdf,3,"['https://www.federalregister.gov/documents/2017/12/01/2017-25979/medicare-program-cancellation-of-advancing-care-coordination-through-episode-payment-and-cardiac', 'https://www.federalregister.gov/documents/2018/06/08/2018-12379/medicare-program-changes-to-the-comprehensive-care-for-joint-replacement-payment-model-cjr-extreme', 'https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2815%2951985-5']","['Medicare Program; Cancellation of Advancing Care Coordination Through Episode Payment and Cardiac Rehabilitation Incentive Payment Models; Changes to Comprehensive Care for Joint Replacement Payment Model: Extreme and Uncontrollable Circumstances Policy for the Comprehensive Care for Joint Replacement Payment Model', 'Medicare Program; Changes to the Comprehensive Care for Joint Replacement Payment Model (CJR): Extreme and Uncontrollable Circumstances Policy for the CJR Model', 'Introduction and Executive Summary Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement']",['https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2815%2951985-5'],['528_2_introduction and executive summary care of the critically ill and injured during pandemics and disasters chest consensus statement.pdf'],1,33.33,['https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2815%2951985-5'],['528_2_introduction and executive summary care of the critically ill and injured during pandemics and disasters chest consensus statement.pdf'],[0.381],[0.571],[0.647],[0.228],[0.251],[0.2],[0.739],[0.658],[0.64],[0.68],[0.825],[0.765],[0.644],[0.91],[0.863],[0.787],[0.818],[0.812],0.381,0.571,0.647,0.228,0.251,0.2,0.739,0.658,0.64,0.68,0.825,0.765,0.644,0.91,0.863,0.787,0.818,0.812
https://doi.org/10.1001/jama.2012.14939,association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose california 2010,529_association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose california 2010.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf', 'https://stacks.cdc.gov/view/cdc/53561', 'https://stacks.cdc.gov/view/cdc/47585', 'https://stacks.cdc.gov/view/cdc/58772', 'https://stacks.cdc.gov/view/cdc/58986', 'https://stacks.cdc.gov/view/cdc/25289', 'https://stacks.cdc.gov/view/cdc/52823', 'https://stacks.cdc.gov/view/cdc/45555']","['Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Advisory Committee on Immunization Practices (ACIP) summary report : February 22-23, 2017, Atlanta, Georgia', 'Advisory Committee on Immunization Practices (ACIP) summary report : February 22-23, 2017, Atlanta, Georgia', 'Advisory Committee on Immunization Practices (ACIP) summary report : October 19-20, 2016, Atlanta, Georgia', 'Summary of notifiable diseases -- United States, 2012', 'Literature search topics, search terms, search period, and references selected : supplementary figures for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Advisory Committee on Immunization Practices (ACIP) summary report : October 19-20, 2016, Atlanta, Georgia']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf'],['529_0_prevention of pertussis tetanus and diphtheria with vaccines in the united states recommendations of the advisory committee on immunization practices acip.pdf'],1,12.5,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf'],['529_0_prevention of pertussis tetanus and diphtheria with vaccines in the united states recommendations of the advisory committee on immunization practices acip.pdf'],[0.583],[0.52],[0.601],[0.191],[0.207],[0.178],[0.747],[0.658],[0.588],[0.667],[0.793],[0.692],[0.614],[0.908],[0.801],[0.752],[0.783],[0.773],0.583,0.52,0.601,0.191,0.207,0.178,0.747,0.658,0.588,0.667,0.793,0.692,0.614,0.908,0.801,0.752,0.783,0.773
https://doi.org/10.1001/jama.2012.28726,effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction,531_effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572033/pdf'],['Stem cell treatment for acute myocardial infarction'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572033/pdf'],['531_0_stem cell treatment for acute myocardial infarction.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572033/pdf'],['531_0_stem cell treatment for acute myocardial infarction.pdf'],[0.51],[0.48],[0.569],[0.143],[0.144],[0.119],[0.741],[0.649],[0.544],[0.707],[0.745],[0.665],[0.573],[0.871],[0.759],[0.667],[0.738],[0.699],0.51,0.48,0.569,0.143,0.144,0.119,0.741,0.649,0.544,0.707,0.745,0.665,0.573,0.871,0.759,0.667,0.738,0.699
https://doi.org/10.1001/jama.2012.502,effect of a text messaging intervention on influenza vaccination in an urban lowincome pediatric and adolescent population,534_effect of a text messaging intervention on influenza vaccination in an urban lowincome pediatric and adolescent population.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409381/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463821/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi-40-2.pdf', 'https://www.rand.org/pubs/research_reports/RR1993.html', 'https://www.brookings.edu/research/addressing-the-parenting-divide-to-promote-early-childhood-development-for-disadvantaged-children/', 'https://www.rand.org/pubs/tools/TL145.html']","['Targeted client communication via mobile devices for improving sexual and reproductive health', 'COVID Vaccines in Adolescents and Young Adults', 'Targeted client communication via mobile devices for improving maternal, neonatal, and child health', 'Automated telephone communication systems for preventive healthcare and management of long‐term conditions', 'Patient reminder and recall interventions to improve immunization rates', 'City Health Information', 'Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'Addressing the Parenting Divide to Promote Early Childhood Development for Disadvantaged Children', 'Programs That Work']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi-40-2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463821/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409381/pdf']","['534_1_covid vaccines in adolescents and young adults.pdf', '534_5_city health information.pdf', '534_4_patient reminder and recall interventions to improve immunization rates.pdf', '534_3_automated telephone communication systems for preventive healthcare and management of long‐term conditions.pdf', '534_2_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '534_0_targeted client communication via mobile devices for improving sexual and reproductive health.pdf']",6,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi-40-2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463821/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409381/pdf']","['534_1_covid vaccines in adolescents and young adults.pdf', '534_5_city health information.pdf', '534_4_patient reminder and recall interventions to improve immunization rates.pdf', '534_3_automated telephone communication systems for preventive healthcare and management of long‐term conditions.pdf', '534_2_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '534_0_targeted client communication via mobile devices for improving sexual and reproductive health.pdf']","[0.338, 0.354, 0.37, 0.334, 0.494, 0.45]","[0.52, 0.496, 0.509, 0.517, 0.519, 0.518]","[0.604, 0.578, 0.589, 0.595, 0.597, 0.597]","[0.206, 0.179, 0.188, 0.164, 0.173, 0.17]","[0.219, 0.187, 0.199, 0.166, 0.174, 0.173]","[0.184, 0.163, 0.171, 0.141, 0.151, 0.148]","[0.744, 0.74, 0.742, 0.734, 0.735, 0.734]","[0.649, 0.645, 0.647, 0.64, 0.642, 0.641]","[0.586, 0.562, 0.572, 0.58, 0.578, 0.578]","[0.674, 0.687, 0.709, 0.691, 0.692, 0.693]","[0.798, 0.783, 0.77, 0.777, 0.777, 0.778]","[0.711, 0.672, 0.689, 0.698, 0.703, 0.702]","[0.612, 0.592, 0.591, 0.594, 0.586, 0.584]","[0.909, 0.905, 0.901, 0.908, 0.906, 0.906]","[0.806, 0.801, 0.792, 0.797, 0.796, 0.798]","[0.741, 0.717, 0.704, 0.715, 0.714, 0.712]","[0.79, 0.774, 0.762, 0.77, 0.772, 0.77]","[0.766, 0.753, 0.74, 0.746, 0.743, 0.743]",0.39,0.513,0.593,0.18,0.186,0.16,0.738,0.644,0.576,0.691,0.78,0.696,0.593,0.906,0.798,0.717,0.773,0.749
https://doi.org/10.1001/jama.2012.68,the ethical hazards and programmatic challenges of genomic newborn screening,535_the ethical hazards and programmatic challenges of genomic newborn screening.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418627/pdf'],['Sport and exercise genomics: the FIMS 2019 consensus statement update'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418627/pdf'],['535_0_sport and exercise genomics the fims 2019 consensus statement update.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418627/pdf'],['535_0_sport and exercise genomics the fims 2019 consensus statement update.pdf'],[0.239],[0.541],[0.63],[0.171],[0.184],[0.14],[0.735],[0.643],[0.606],[0.666],[0.809],[0.739],[0.616],[0.919],[0.841],[0.757],[0.803],[0.786],0.239,0.541,0.63,0.171,0.184,0.14,0.735,0.643,0.606,0.666,0.809,0.739,0.616,0.919,0.841,0.757,0.803,0.786
https://doi.org/10.1001/jama.2013.1625,immunogenicity of 2 doses of hpv vaccine in younger adolescents vs 3 doses in young women,537_immunogenicity of 2 doses of hpv vaccine in younger adolescents vs 3 doses in young women.pdf,9,"['https://stacks.cdc.gov/view/cdc/25363', 'https://www.chicago.gov/content/dam/city/depts/cdph/infectious_disease/Immunizations/PCP_Annual_Report_2012-2013.pdf', 'https://stacks.cdc.gov/view/cdc/60682', 'https://health.mo.gov/living/wellness/immunizations/pdf/hpv-update-humiston.pdf', 'https://purl.fdlp.gov/GPO/gpo118382', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823361/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf']","['Human papillomavirus vaccination : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'PCP Annual Report 2012-2013', 'GRADE process for 2-dose schedules', 'Microsoft PowerPoint - HPV Update-Humiston(03-12-2018)', 'HPV vaccination for cancer prevention :\xa0progress, opportunities, and a renewed call to action : a report to the President of the United States from the Chair of the President’s Cancer Panel.', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males', 'Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline', 'Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors']","['https://www.chicago.gov/content/dam/city/depts/cdph/infectious_disease/Immunizations/PCP_Annual_Report_2012-2013.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823361/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf', 'https://purl.fdlp.gov/GPO/gpo118382', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://health.mo.gov/living/wellness/immunizations/pdf/hpv-update-humiston.pdf']","['537_1_pcp annual report 20122013.pdf', '537_7_preventive vaccination against cervical cancer korean society of gynecologic oncology guideline.pdf', '537_6_comparison of different human papillomavirus hpv vaccine types and dose schedules for prevention of hpv‐related disease in females and males.pdf', '537_4_hpv vaccination for cancer prevention \xa0progress opportunities and a renewed call to action  a report to the president of the united states from the chair of the presidents cancer panel.pdf', '537_8_prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.pdf', '537_3_microsoft powerpoint  hpv updatehumiston03122018.pdf']",6,66.67,"['https://www.chicago.gov/content/dam/city/depts/cdph/infectious_disease/Immunizations/PCP_Annual_Report_2012-2013.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823361/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf', 'https://purl.fdlp.gov/GPO/gpo118382', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://health.mo.gov/living/wellness/immunizations/pdf/hpv-update-humiston.pdf']","['537_1_pcp annual report 20122013.pdf', '537_7_preventive vaccination against cervical cancer korean society of gynecologic oncology guideline.pdf', '537_6_comparison of different human papillomavirus hpv vaccine types and dose schedules for prevention of hpv‐related disease in females and males.pdf', '537_4_hpv vaccination for cancer prevention \xa0progress opportunities and a renewed call to action  a report to the president of the united states from the chair of the presidents cancer panel.pdf', '537_8_prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.pdf', '537_3_microsoft powerpoint  hpv updatehumiston03122018.pdf']","[0.525, 0.506, 0.496, 0.623, 0.58, 0.577]","[0.516, 0.525, 0.516, 0.521, 0.505, 0.513]","[0.602, 0.606, 0.597, 0.604, 0.59, 0.598]","[0.203, 0.212, 0.192, 0.21, 0.195, 0.184]","[0.224, 0.24, 0.199, 0.235, 0.201, 0.202]","[0.186, 0.204, 0.168, 0.192, 0.173, 0.164]","[0.747, 0.755, 0.748, 0.748, 0.75, 0.743]","[0.657, 0.671, 0.659, 0.659, 0.662, 0.655]","[0.591, 0.596, 0.574, 0.599, 0.565, 0.585]","[0.67, 0.67, 0.686, 0.672, 0.687, 0.673]","[0.794, 0.784, 0.772, 0.801, 0.767, 0.79]","[0.72, 0.714, 0.698, 0.723, 0.684, 0.708]","[0.604, 0.617, 0.588, 0.608, 0.596, 0.604]","[0.919, 0.904, 0.903, 0.921, 0.898, 0.914]","[0.802, 0.787, 0.784, 0.806, 0.776, 0.8]","[0.747, 0.747, 0.712, 0.753, 0.705, 0.742]","[0.79, 0.789, 0.769, 0.796, 0.761, 0.781]","[0.775, 0.769, 0.737, 0.782, 0.734, 0.774]",0.551,0.516,0.599,0.199,0.217,0.181,0.749,0.66,0.585,0.676,0.785,0.708,0.603,0.91,0.792,0.734,0.781,0.762
https://doi.org/10.1001/jama.2013.281348,statin therapy for primary prevention of cardiovascular disease,538_statin therapy for primary prevention of cardiovascular disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107357/pdf'],['A controversial step forward: a commentary on the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107357/pdf'],['538_0_a controversial step forward a commentary on the 2013 accaha guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107357/pdf'],['538_0_a controversial step forward a commentary on the 2013 accaha guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults.pdf'],[0.442],[0.507],[0.606],[0.194],[0.216],[0.161],[0.735],[0.647],[0.591],[0.702],[0.786],[0.694],[0.572],[0.912],[0.813],[0.733],[0.771],[0.765],0.442,0.507,0.606,0.194,0.216,0.161,0.735,0.647,0.591,0.702,0.786,0.694,0.572,0.912,0.813,0.733,0.771,0.765
https://doi.org/10.1001/jama.2013.281640,medical communication companies and continuing medical education,539_medical communication companies and continuing medical education.pdf,1,['https://www.chicago.gov/content/dam/city/depts/cdph/tobacco_alchohol_abuse/RedactedComplaintJun22014.pdf'],"['IN THE CIRCUIT COURT OF COOK COUNTY, ILLINOIS COUNTY DEPARTMENT, LAW DIVISION c ~ rte, bxt ~ N ~ ~']",['https://www.chicago.gov/content/dam/city/depts/cdph/tobacco_alchohol_abuse/RedactedComplaintJun22014.pdf'],['539_0_in the circuit court of cook county illinois county department law division c  rte bxt  n  .pdf'],1,100.0,['https://www.chicago.gov/content/dam/city/depts/cdph/tobacco_alchohol_abuse/RedactedComplaintJun22014.pdf'],['539_0_in the circuit court of cook county illinois county department law division c  rte bxt  n  .pdf'],[0.102],[0.522],[0.619],[0.182],[0.186],[0.145],[0.731],[0.645],[0.63],[0.655],[0.807],[0.74],[0.602],[0.91],[0.849],[0.766],[0.79],[0.782],0.102,0.522,0.619,0.182,0.186,0.145,0.731,0.645,0.63,0.655,0.807,0.74,0.602,0.91,0.849,0.766,0.79,0.782
https://doi.org/10.1001/jama.2013.282190,lowdose dopamine or lowdose nesiritide in acute heart failure with renal dysfunction,541_lowdose dopamine or lowdose nesiritide in acute heart failure with renal dysfunction.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044419/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154171/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954326/pdf']","['Pharmacological interventions for heart failure in people with chronic kidney disease', 'The Japanese clinical practice guideline for acute kidney injury 2016', 'Heart failure – what the general physician needs to know']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044419/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154171/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954326/pdf']","['541_0_pharmacological interventions for heart failure in people with chronic kidney disease.pdf', '541_1_the japanese clinical practice guideline for acute kidney injury 2016.pdf', '541_2_heart failure – what the general physician needs to know.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044419/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154171/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954326/pdf']","['541_0_pharmacological interventions for heart failure in people with chronic kidney disease.pdf', '541_1_the japanese clinical practice guideline for acute kidney injury 2016.pdf', '541_2_heart failure – what the general physician needs to know.pdf']","[0.495, 0.372, 0.483]","[0.482, 0.477, 0.465]","[0.566, 0.56, 0.551]","[0.162, 0.139, 0.152]","[0.163, 0.141, 0.156]","[0.128, 0.107, 0.119]","[0.743, 0.736, 0.736]","[0.652, 0.641, 0.643]","[0.547, 0.53, 0.525]","[0.701, 0.672, 0.675]","[0.737, 0.739, 0.735]","[0.666, 0.667, 0.667]","[0.566, 0.592, 0.574]","[0.855, 0.852, 0.853]","[0.749, 0.745, 0.744]","[0.623, 0.637, 0.623]","[0.732, 0.737, 0.727]","[0.658, 0.659, 0.652]",0.45,0.475,0.559,0.151,0.153,0.118,0.738,0.645,0.534,0.683,0.737,0.667,0.577,0.853,0.746,0.628,0.732,0.656
https://doi.org/10.1001/jama.2013.282533,cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents,542_cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258331/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746206/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886855/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257251/pdf', 'https://n.neurology.org/content/neurology/93/11/500.full.pdf', 'https://n.neurology.org/content/neurology/93/11/487.full.pdf']","['Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention - Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society', 'Psychological therapies for the management of chronic and recurrent pain in children and adolescents', 'Psychological therapies for the management of chronic and recurrent pain in children and adolescents', 'Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention', 'Practice guideline update summary: Acute treatment of migraine in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257251/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886855/pdf', 'https://n.neurology.org/content/neurology/93/11/487.full.pdf', 'https://n.neurology.org/content/neurology/93/11/500.full.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258331/pdf']","['542_1_psychological interventions for parents of children and adolescents with chronic illness.pdf', '542_4_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf', '542_3_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf', '542_6_practice guideline update summary acute treatment of migraine in children and adolescents.pdf', '542_5_practice guideline update summary pharmacologic treatment for pediatric migraine prevention.pdf', '542_0_recommendations on the use of anticgrp monoclonal antibodies in children and adolescents.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257251/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886855/pdf', 'https://n.neurology.org/content/neurology/93/11/487.full.pdf', 'https://n.neurology.org/content/neurology/93/11/500.full.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258331/pdf']","['542_1_psychological interventions for parents of children and adolescents with chronic illness.pdf', '542_4_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf', '542_3_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf', '542_6_practice guideline update summary acute treatment of migraine in children and adolescents.pdf', '542_5_practice guideline update summary pharmacologic treatment for pediatric migraine prevention.pdf', '542_0_recommendations on the use of anticgrp monoclonal antibodies in children and adolescents.pdf']","[0.374, 0.322, 0.399, 0.384, 0.445, 0.445]","[0.495, 0.491, 0.496, 0.524, 0.524, 0.467]","[0.584, 0.582, 0.583, 0.607, 0.607, 0.581]","[0.156, 0.163, 0.172, 0.188, 0.188, 0.158]","[0.156, 0.173, 0.182, 0.203, 0.203, 0.173]","[0.133, 0.144, 0.152, 0.167, 0.167, 0.138]","[0.738, 0.741, 0.744, 0.741, 0.741, 0.742]","[0.643, 0.646, 0.65, 0.652, 0.652, 0.649]","[0.559, 0.548, 0.551, 0.584, 0.584, 0.556]","[0.7, 0.708, 0.707, 0.685, 0.685, 0.678]","[0.761, 0.753, 0.754, 0.788, 0.788, 0.755]","[0.68, 0.666, 0.68, 0.713, 0.713, 0.65]","[0.573, 0.579, 0.586, 0.594, 0.594, 0.572]","[0.902, 0.899, 0.894, 0.909, 0.909, 0.906]","[0.784, 0.773, 0.771, 0.797, 0.797, 0.783]","[0.705, 0.697, 0.705, 0.741, 0.741, 0.713]","[0.742, 0.737, 0.739, 0.772, 0.772, 0.742]","[0.733, 0.724, 0.727, 0.754, 0.754, 0.742]",0.395,0.5,0.591,0.171,0.182,0.15,0.741,0.649,0.564,0.694,0.767,0.684,0.583,0.903,0.784,0.717,0.751,0.739
https://doi.org/10.1001/jama.2013.282540,effect of progenitor cell mobilization with granulocytemacrophage colonystimulating factor in patients with peripheral artery disease,543_effect of progenitor cell mobilization with granulocytemacrophage colonystimulating factor in patients with peripheral artery disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481523/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513643/pdf']","['Growth factors for angiogenesis in peripheral arterial disease', ""Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481523/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513643/pdf']","['543_0_growth factors for angiogenesis in peripheral arterial disease.pdf', '543_1_autologous cells derived from different sources and administered using different regimens for no‐option critical lower limb ischaemia patients.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481523/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513643/pdf']","['543_0_growth factors for angiogenesis in peripheral arterial disease.pdf', '543_1_autologous cells derived from different sources and administered using different regimens for no‐option critical lower limb ischaemia patients.pdf']","[0.314, 0.439]","[0.473, 0.472]","[0.56, 0.566]","[0.14, 0.136]","[0.131, 0.132]","[0.112, 0.105]","[0.738, 0.736]","[0.642, 0.642]","[0.547, 0.547]","[0.71, 0.681]","[0.737, 0.737]","[0.656, 0.668]","[0.56, 0.568]","[0.864, 0.864]","[0.753, 0.76]","[0.649, 0.65]","[0.723, 0.73]","[0.677, 0.675]",0.377,0.472,0.563,0.138,0.132,0.108,0.737,0.642,0.547,0.696,0.737,0.662,0.564,0.864,0.756,0.649,0.726,0.676
https://doi.org/10.1001/jama.2015.16316,will neuroimaging reveal a severe intracranial injury in this adult with minor head trauma,565_will neuroimaging reveal a severe intracranial injury in this adult with minor head trauma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314982/pdf'],['Concussion Care Practices and Utilization of Evidence-Based Guidelines in the Evaluation and Management of Concussion: A Survey of New England Emergency Departments'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314982/pdf'],['565_0_concussion care practices and utilization of evidencebased guidelines in the evaluation and management of concussion a survey of new england emergency departments.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314982/pdf'],['565_0_concussion care practices and utilization of evidencebased guidelines in the evaluation and management of concussion a survey of new england emergency departments.pdf'],[0.317],[0.498],[0.583],[0.169],[0.177],[0.152],[0.743],[0.651],[0.559],[0.693],[0.777],[0.686],[0.591],[0.91],[0.796],[0.734],[0.766],[0.759],0.317,0.498,0.583,0.169,0.177,0.152,0.743,0.651,0.559,0.693,0.777,0.686,0.591,0.91,0.796,0.734,0.766,0.759
https://doi.org/10.1001/jama.2015.16669,maintenance therapy with tumortreating fields plus temozolomide vs temozolomide alone for glioblastoma,566_maintenance therapy with tumortreating fields plus temozolomide vs temozolomide alone for glioblastoma.pdf,5,"['https://www.hca.wa.gov/assets/program/011516_meeting_materials_part-2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785619/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086476/pdf', 'https://www.hca.wa.gov/assets/program/novocure_final_report_121015%5B1%5D.pdf']","['Microsoft PowerPoint - hta_presentation_morse_011516.pptx', 'SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)', 'A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma', 'Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis', 'Novocure (Tumor Treating Fields)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785619/pdf', 'https://www.hca.wa.gov/assets/program/011516_meeting_materials_part-2.pdf', 'https://www.hca.wa.gov/assets/program/novocure_final_report_121015%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086476/pdf']","['566_1_seom clinical guidelines for diagnosis and treatment of glioblastoma 2017.pdf', '566_0_microsoft powerpoint  htapresentationmorse011516pptx.pdf', '566_4_novocure tumor treating fields.pdf', '566_2_a stateoftheart review and guidelines for tumor treating fields treatment planning and patient followup in glioblastoma.pdf', '566_3_treatment of newly diagnosed glioblastoma in the elderly a network meta‐analysis.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785619/pdf', 'https://www.hca.wa.gov/assets/program/011516_meeting_materials_part-2.pdf', 'https://www.hca.wa.gov/assets/program/novocure_final_report_121015%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086476/pdf']","['566_1_seom clinical guidelines for diagnosis and treatment of glioblastoma 2017.pdf', '566_0_microsoft powerpoint  htapresentationmorse011516pptx.pdf', '566_4_novocure tumor treating fields.pdf', '566_2_a stateoftheart review and guidelines for tumor treating fields treatment planning and patient followup in glioblastoma.pdf', '566_3_treatment of newly diagnosed glioblastoma in the elderly a network meta‐analysis.pdf']","[0.325, 0.391, 0.494, 0.457, 0.517]","[0.536, 0.518, 0.522, 0.513, 0.527]","[0.616, 0.608, 0.604, 0.597, 0.607]","[0.167, 0.164, 0.179, 0.154, 0.173]","[0.177, 0.169, 0.184, 0.163, 0.173]","[0.139, 0.134, 0.145, 0.131, 0.136]","[0.74, 0.739, 0.738, 0.744, 0.737]","[0.655, 0.651, 0.65, 0.658, 0.645]","[0.62, 0.593, 0.594, 0.59, 0.601]","[0.68, 0.685, 0.696, 0.679, 0.7]","[0.805, 0.792, 0.791, 0.791, 0.789]","[0.735, 0.709, 0.711, 0.703, 0.711]","[0.602, 0.601, 0.61, 0.606, 0.591]","[0.916, 0.91, 0.908, 0.91, 0.91]","[0.814, 0.809, 0.806, 0.793, 0.815]","[0.755, 0.753, 0.743, 0.743, 0.739]","[0.79, 0.778, 0.777, 0.774, 0.777]","[0.785, 0.776, 0.77, 0.771, 0.766]",0.437,0.523,0.606,0.167,0.173,0.137,0.74,0.652,0.6,0.688,0.794,0.714,0.602,0.911,0.807,0.747,0.779,0.774
https://doi.org/10.1001/jama.2015.16700,autologous hematopoetic stem cell transplantation for refractory crohn disease,567_autologous hematopoetic stem cell transplantation for refractory crohn disease.pdf,3,"['https://www.hca.wa.gov/assets/pebb/regence-ump-preauthreqs-transplants.pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-transplants.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872448/pdf']","['Transplants, Ventricular Assist Devices, and Utilization Management', 'Transplants, Ventricular Assist Devices, and Utilization Management', 'British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872448/pdf'],['567_2_british society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872448/pdf'],['567_2_british society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.pdf'],[0.6],[0.499],[0.584],[0.147],[0.156],[0.116],[0.742],[0.649],[0.564],[0.662],[0.763],[0.682],[0.59],[0.891],[0.766],[0.697],[0.75],[0.72],0.6,0.499,0.584,0.147,0.156,0.116,0.742,0.649,0.564,0.662,0.763,0.682,0.59,0.891,0.766,0.697,0.75,0.72
https://doi.org/10.1001/jama.2015.16840,effect of opioids vs nsaids and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion,568_effect of opioids vs nsaids and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173736/pdf'],['Interventions for the management of malignant pleural effusions: a network meta‐analysis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173736/pdf'],['568_0_interventions for the management of malignant pleural effusions a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173736/pdf'],['568_0_interventions for the management of malignant pleural effusions a network meta‐analysis.pdf'],[0.318],[0.493],[0.579],[0.153],[0.148],[0.116],[0.739],[0.643],[0.551],[0.69],[0.756],[0.67],[0.578],[0.88],[0.762],[0.68],[0.743],[0.705],0.318,0.493,0.579,0.153,0.148,0.116,0.739,0.643,0.551,0.69,0.756,0.67,0.578,0.88,0.762,0.68,0.743,0.705
https://doi.org/10.1001/jama.2015.18886,us infant mortality rate declines but still exceeds other developed countries,569_us infant mortality rate declines but still exceeds other developed countries.pdf,6,"['https://stacks.cdc.gov/view/cdc/45082', 'https://purl.fdlp.gov/GPO/gpo89946', 'http://purl.fdlp.gov/GPO/gpo80192', 'https://stacks.cdc.gov/view/cdc/50668', 'https://purl.fdlp.gov/GPO/gpo111964', 'https://stacks.cdc.gov/view/cdc/59199']","['Trends in infant mortality in the United States, 2005-2014', 'State variations in infant mortality by race and hispanic origin of mother, 2013-2015 /', 'Trends in infant mortality in the United States, 2005-2014 /', 'State variations in infant mortality by race and Hispanic origin of mother, 2013–2015', 'Infant mortality by age at death in the United States, 2016 /', 'Health, United States, 2017 : with special feature on mortality']","['https://purl.fdlp.gov/GPO/gpo89946', 'https://purl.fdlp.gov/GPO/gpo111964', 'http://purl.fdlp.gov/GPO/gpo80192']","['569_1_state variations in infant mortality by race and hispanic origin of mother 20132015 .pdf', '569_4_infant mortality by age at death in the united states 2016 .pdf', '569_2_trends in infant mortality in the united states 20052014 .pdf']",3,50.0,"['https://purl.fdlp.gov/GPO/gpo89946', 'https://purl.fdlp.gov/GPO/gpo111964', 'http://purl.fdlp.gov/GPO/gpo80192']","['569_1_state variations in infant mortality by race and hispanic origin of mother 20132015 .pdf', '569_4_infant mortality by age at death in the united states 2016 .pdf', '569_2_trends in infant mortality in the united states 20052014 .pdf']","[0.611, 0.628, 0.629]","[0.526, 0.541, 0.516]","[0.62, 0.633, 0.609]","[0.245, 0.257, 0.249]","[0.267, 0.286, 0.267]","[0.219, 0.241, 0.217]","[0.748, 0.753, 0.749]","[0.651, 0.654, 0.652]","[0.603, 0.618, 0.589]","[0.723, 0.724, 0.725]","[0.817, 0.809, 0.788]","[0.726, 0.743, 0.714]","[0.627, 0.622, 0.612]","[0.908, 0.906, 0.891]","[0.843, 0.834, 0.822]","[0.747, 0.757, 0.722]","[0.79, 0.784, 0.765]","[0.788, 0.785, 0.749]",0.623,0.528,0.621,0.25,0.273,0.226,0.75,0.652,0.603,0.724,0.805,0.728,0.62,0.902,0.833,0.742,0.78,0.774
https://doi.org/10.1001/jama.2015.5605,antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn,571_antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/research', 'https://effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/protocol', 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents/postapproval-pregnancy-safety-studies-guidance-industry', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions', 'Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions', 'Postapproval Pregnancy Safety Studies Guidance for Industry', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines']",['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['571_3_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,25.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['571_3_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.192],[0.498],[0.584],[0.131],[0.131],[0.11],[0.739],[0.642],[0.564],[0.65],[0.773],[0.674],[0.575],[0.893],[0.774],[0.731],[0.759],[0.755],0.192,0.498,0.584,0.131,0.131,0.11,0.739,0.642,0.564,0.65,0.773,0.674,0.575,0.893,0.774,0.731,0.759,0.755
https://doi.org/10.1001/jama.2018.13705,association between the liaison committee on medical education’s diversity standards and changes in percentage of medical student sex race and ethnicity,596_association between the liaison committee on medical education’s diversity standards and changes in percentage of medical student sex race and ethnicity.pdf,2,"['https://www.mass.gov/doc/sffa-v-harvard-brief/download', 'https://macyfoundation.org/publications/addressing-harmful-bias-and-eliminating-discrimination-in-health-professions-learning-environments']","['NO. 19-2005 United States Court of Appeals for the First Circuit', 'Addressing Harmful Bias and Eliminating Discrimination in Health Professions Learning Environments']",['https://www.mass.gov/doc/sffa-v-harvard-brief/download'],['596_0_no 192005 united states court of appeals for the first circuit.pdf'],1,50.0,['https://www.mass.gov/doc/sffa-v-harvard-brief/download'],['596_0_no 192005 united states court of appeals for the first circuit.pdf'],[0.282],[0.481],[0.574],[0.136],[0.147],[0.122],[0.73],[0.632],[0.547],[0.706],[0.748],[0.662],[0.586],[0.892],[0.795],[0.697],[0.751],[0.719],0.282,0.481,0.574,0.136,0.147,0.122,0.73,0.632,0.547,0.706,0.748,0.662,0.586,0.892,0.795,0.697,0.751,0.719
https://doi.org/10.1001/jama.2018.17933,effect of a program combining transitional care and longterm selfmanagement support on outcomes of hospitalized patients with chronic obstructive pulmonary disease,597_effect of a program combining transitional care and longterm selfmanagement support on outcomes of hospitalized patients with chronic obstructive pulmonary disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743569/pdf'],['Self‐management interventions for people with chronic obstructive pulmonary disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743569/pdf'],['597_0_self‐management interventions for people with chronic obstructive pulmonary disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743569/pdf'],['597_0_self‐management interventions for people with chronic obstructive pulmonary disease.pdf'],[0.644],[0.506],[0.59],[0.175],[0.177],[0.154],[0.739],[0.648],[0.569],[0.712],[0.769],[0.682],[0.584],[0.898],[0.786],[0.704],[0.758],[0.732],0.644,0.506,0.59,0.175,0.177,0.154,0.739,0.648,0.569,0.712,0.769,0.682,0.584,0.898,0.786,0.704,0.758,0.732
https://doi.org/10.1001/jama.2018.18472,opioids for chronic noncancer pain,598_opioids for chronic noncancer pain.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/interventional-treatments-pain/research', 'https://effectivehealthcare.ahrq.gov/products/opioids-chronic-pain/research', 'https://www.acep.org/globalassets/new-pdfs/clinical-policies/opioids-2020.pdf', 'https://www.rheumatology.org/Portals/0/Files/Osteoarthritis-Guideline-Early-View-2019.pdf']","['Interventional Treatments for Acute and Chronic Pain: Systematic Review', 'Opioid Treatments for Chronic Pain', 'Clinical Policy: Critical Issues Related to Opioids in Adult Patients Presenting to the Emergency Department', '2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee']","['https://www.rheumatology.org/Portals/0/Files/Osteoarthritis-Guideline-Early-View-2019.pdf', 'https://www.acep.org/globalassets/new-pdfs/clinical-policies/opioids-2020.pdf']","['598_3_2019 american college of rheumatologyarthritis foundation guideline for the management of osteoarthritis of the hand hip and knee.pdf', '598_2_clinical policy critical issues related to opioids in adult patients presenting to the emergency department.pdf']",2,50.0,['https://www.acep.org/globalassets/new-pdfs/clinical-policies/opioids-2020.pdf'],['598_2_clinical policy critical issues related to opioids in adult patients presenting to the emergency department.pdf'],[0.541],[0.46],[0.56],[0.149],[0.172],[0.141],[0.738],[0.646],[0.507],[0.697],[0.73],[0.659],[0.583],[0.847],[0.732],[0.619],[0.72],[0.644],0.541,0.46,0.56,0.149,0.172,0.141,0.738,0.646,0.507,0.697,0.73,0.659,0.583,0.847,0.732,0.619,0.72,0.644
https://doi.org/10.1001/jama.2018.21367,ocular prophylaxis for gonococcal ophthalmia neonatorum,599_ocular prophylaxis for gonococcal ophthalmia neonatorum.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524318/pdf']","['Sexually Transmitted Infections Treatment Guidelines, 2021', 'Interventions for preventing ophthalmia neonatorum']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524318/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf']","['599_1_interventions for preventing ophthalmia neonatorum.pdf', '599_0_sexually transmitted infections treatment guidelines 2021.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524318/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf']","['599_1_interventions for preventing ophthalmia neonatorum.pdf', '599_0_sexually transmitted infections treatment guidelines 2021.pdf']","[0.232, 0.293]","[0.541, 0.543]","[0.64, 0.64]","[0.171, 0.155]","[0.179, 0.162]","[0.155, 0.141]","[0.729, 0.736]","[0.636, 0.644]","[0.608, 0.608]","[0.665, 0.635]","[0.798, 0.806]","[0.722, 0.723]","[0.604, 0.602]","[0.919, 0.914]","[0.829, 0.822]","[0.745, 0.735]","[0.794, 0.801]","[0.774, 0.787]",0.263,0.542,0.64,0.163,0.17,0.148,0.732,0.64,0.608,0.65,0.802,0.722,0.603,0.917,0.825,0.74,0.798,0.78
https://doi.org/10.1001/jama.2018.3024,association between use of sodiumglucose cotransporter 2 inhibitors glucagonlike peptide 1 agonists and dipeptidyl peptidase 4 inhibitors with allcause mortality in patients with type 2 diabetes,600_association between use of sodiumglucose cotransporter 2 inhibitors glucagonlike peptide 1 agonists and dipeptidyl peptidase 4 inhibitors with allcause mortality in patients with type 2 diabetes.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],"['Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],['600_0_dipeptidyl peptidase‐4 inhibitors glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],['600_0_dipeptidyl peptidase‐4 inhibitors glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease a network meta‐analysis.pdf'],[0.504],[0.486],[0.564],[0.161],[0.156],[0.135],[0.741],[0.648],[0.547],[0.723],[0.739],[0.669],[0.575],[0.854],[0.748],[0.637],[0.735],[0.662],0.504,0.486,0.564,0.161,0.156,0.135,0.741,0.648,0.547,0.723,0.739,0.669,0.575,0.854,0.748,0.637,0.735,0.662
https://doi.org/10.1001/jama.2019.0052,highdose vitamin d supplementation during pregnancy and asthma in offspring at the age of 6 years,602_highdose vitamin d supplementation during pregnancy and asthma in offspring at the age of 6 years.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf'],['Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf'],['602_0_vitamin d supplementation for term breastfed infants to prevent vitamin d deficiency and improve bone health.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf'],['602_0_vitamin d supplementation for term breastfed infants to prevent vitamin d deficiency and improve bone health.pdf'],[0.319],[0.503],[0.584],[0.16],[0.153],[0.124],[0.733],[0.636],[0.565],[0.692],[0.764],[0.687],[0.568],[0.894],[0.781],[0.699],[0.762],[0.726],0.319,0.503,0.584,0.16,0.153,0.124,0.733,0.636,0.565,0.692,0.764,0.687,0.568,0.894,0.781,0.699,0.762,0.726
https://doi.org/10.1001/jama.284.7.843,the contribution of mild and moderate preterm birth to infant mortality,655_the contribution of mild and moderate preterm birth to infant mortality.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923517/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084921/pdf', 'https://www.in.gov/health/files/IndianaBirthReport.pdf', 'https://www.in.gov/isdh/files/IndianaBirthReport.pdf']","['Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies', 'Antibiotics for ureaplasma in the vagina in pregnancy', 'Specialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomes', 'Trends in Birth Outcomes and Maternal Characteristics in Indiana', 'Trends in Birth Outcomes and Maternal Characteristics in Indiana']","['https://www.in.gov/health/files/IndianaBirthReport.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923517/pdf', 'https://www.in.gov/isdh/files/IndianaBirthReport.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084921/pdf']","['655_3_trends in birth outcomes and maternal characteristics in indiana.pdf', '655_1_antibiotics for ureaplasma in the vagina in pregnancy.pdf', '655_0_prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies.pdf', '655_4_trends in birth outcomes and maternal characteristics in indiana.pdf', '655_2_specialised antenatal clinics for women with a pregnancy at high risk of preterm birth excluding multiple pregnancy to improve maternal and infant outcomes.pdf']",5,100.0,"['https://www.in.gov/health/files/IndianaBirthReport.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923517/pdf', 'https://www.in.gov/isdh/files/IndianaBirthReport.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084921/pdf']","['655_3_trends in birth outcomes and maternal characteristics in indiana.pdf', '655_1_antibiotics for ureaplasma in the vagina in pregnancy.pdf', '655_0_prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies.pdf', '655_4_trends in birth outcomes and maternal characteristics in indiana.pdf', '655_2_specialised antenatal clinics for women with a pregnancy at high risk of preterm birth excluding multiple pregnancy to improve maternal and infant outcomes.pdf']","[0.283, 0.197, 0.287, 0.335, 0.335]","[0.531, 0.512, 0.51, 0.531, 0.511]","[0.62, 0.607, 0.598, 0.62, 0.604]","[0.211, 0.158, 0.173, 0.211, 0.175]","[0.232, 0.167, 0.188, 0.232, 0.195]","[0.191, 0.134, 0.159, 0.191, 0.16]","[0.749, 0.727, 0.735, 0.749, 0.73]","[0.653, 0.628, 0.638, 0.653, 0.635]","[0.583, 0.574, 0.57, 0.583, 0.571]","[0.716, 0.675, 0.689, 0.716, 0.703]","[0.778, 0.777, 0.768, 0.778, 0.769]","[0.7, 0.697, 0.686, 0.7, 0.694]","[0.625, 0.586, 0.59, 0.625, 0.569]","[0.909, 0.91, 0.902, 0.909, 0.908]","[0.816, 0.798, 0.791, 0.816, 0.792]","[0.741, 0.722, 0.712, 0.741, 0.719]","[0.776, 0.771, 0.762, 0.776, 0.761]","[0.76, 0.754, 0.745, 0.76, 0.747]",0.287,0.519,0.61,0.186,0.203,0.167,0.738,0.641,0.576,0.7,0.774,0.695,0.599,0.908,0.803,0.727,0.769,0.753
https://doi.org/10.1001/jama.284.8.978,association between administration of hepatitis b vaccine at birth and completion of the hepatitis b and 4313 vaccine series,656_association between administration of hepatitis b vaccine at birth and completion of the hepatitis b and 4313 vaccine series.pdf,2,"['https://stacks.cdc.gov/view/cdc/6786', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf']","['A Comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States; recommendations of the Advisory Committee on Immunization Practices (ACIP); Immunization of infants, children and adolescents; Part I', 'A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report']",['http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf'],['656_1_a national strategy for the elimination of hepatitis b and c phase two report.pdf'],1,50.0,['http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf'],['656_1_a national strategy for the elimination of hepatitis b and c phase two report.pdf'],[0.327],[0.515],[0.607],[0.173],[0.182],[0.156],[0.739],[0.643],[0.584],[0.674],[0.805],[0.697],[0.616],[0.91],[0.805],[0.748],[0.776],[0.775],0.327,0.515,0.607,0.173,0.182,0.156,0.739,0.643,0.584,0.674,0.805,0.697,0.616,0.91,0.805,0.748,0.776,0.775
https://doi.org/10.1001/jama.284.8.993,neurological development of 5yearold children receiving a low–saturated fat lowcholesterol diet since infancy,657_neurological development of 5yearold children receiving a low–saturated fat lowcholesterol diet since infancy.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513603/pdf']","['Interventions for preventing obesity in children', 'Effects of total fat intake on bodyweight in children', 'Effects of total fat intake on bodyweight in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513603/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491333/pdf']","['657_0_interventions for preventing obesity in children.pdf', '657_2_effects of total fat intake on bodyweight in children.pdf', '657_1_effects of total fat intake on bodyweight in children.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513603/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491333/pdf']","['657_0_interventions for preventing obesity in children.pdf', '657_2_effects of total fat intake on bodyweight in children.pdf', '657_1_effects of total fat intake on bodyweight in children.pdf']","[0.451, 0.494, 0.489]","[0.497, 0.491, 0.489]","[0.582, 0.567, 0.565]","[0.159, 0.154, 0.157]","[0.155, 0.152, 0.155]","[0.134, 0.135, 0.137]","[0.734, 0.735, 0.737]","[0.637, 0.64, 0.642]","[0.564, 0.554, 0.552]","[0.694, 0.704, 0.704]","[0.756, 0.753, 0.755]","[0.678, 0.682, 0.688]","[0.588, 0.595, 0.6]","[0.888, 0.886, 0.884]","[0.787, 0.772, 0.768]","[0.68, 0.682, 0.685]","[0.754, 0.746, 0.747]","[0.715, 0.714, 0.714]",0.478,0.492,0.571,0.157,0.154,0.135,0.735,0.64,0.557,0.701,0.755,0.683,0.594,0.886,0.776,0.682,0.749,0.714
https://doi.org/10.1001/jama.285.12.1613,growth development and behavior in early childhood following prenatal cocaine exposure,659_growth development and behavior in early childhood following prenatal cocaine exposure.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894519/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/substanceuse.pdf', 'https://www.opensocietyfoundations.org/publications/expecting-better-improving-health-and-rights-pregnant-women-who-use-drugs', 'https://www.opensocietyfoundations.org/publications/women-harm-reduction-and-hiv-0', 'https://www.commonwealthfund.org/publications/fund-reports/2003/may/building-bridge-birth-school-improving-developmental-and', 'https://www.commonwealthfund.org/publications/fund-reports/2002/sep/partnering-parents-promote-healthy-development-young-children', 'https://papers.nber.org/papers/W11318', 'https://www.commonwealthfund.org/publications/fund-reports/2002/sep/primary-care-services-promoting-optimal-child-development-birth']","['Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment', 'Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions', 'Home visits during pregnancy and after birth for women with an alcohol or drug problem', 'PRACTICE GUIDELINE FOR THE Treatment of Patients With Substance Use Disorders', 'Expecting Better: Improving Health and Rights for Pregnant Women Who Use Drugs', 'Women, Harm Reduction, and HIV', 'Building a Bridge from Birth to School: Improving Developmental and Behavioral Health Services for Young Children', 'Partnering with Parents to Promote the Healthy Development of Young Children Enrolled in Medicaid', 'Measuring the Impact of Crack Cocaine', 'Primary Care Services: Promoting Optimal Child Development from Birth to Three Years']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894519/pdf']","['659_2_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf', '659_0_pharmacologic interventions for pregnant women enrolled in alcohol treatment.pdf', '659_1_psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.pdf']",3,30.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894519/pdf']","['659_2_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf', '659_0_pharmacologic interventions for pregnant women enrolled in alcohol treatment.pdf', '659_1_psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.pdf']","[0.219, 0.254, 0.185]","[0.509, 0.506, 0.515]","[0.592, 0.592, 0.6]","[0.159, 0.162, 0.156]","[0.145, 0.166, 0.164]","[0.132, 0.144, 0.135]","[0.732, 0.731, 0.728]","[0.634, 0.634, 0.632]","[0.573, 0.579, 0.581]","[0.675, 0.684, 0.681]","[0.78, 0.786, 0.783]","[0.684, 0.699, 0.708]","[0.549, 0.581, 0.567]","[0.903, 0.914, 0.914]","[0.797, 0.818, 0.811]","[0.717, 0.731, 0.735]","[0.766, 0.77, 0.773]","[0.749, 0.763, 0.765]",0.219,0.51,0.595,0.159,0.158,0.137,0.73,0.633,0.578,0.68,0.783,0.697,0.566,0.91,0.809,0.728,0.77,0.759
https://doi.org/10.1001/jama.285.13.1729,epidemiology of invasive emph typeitalstreptococcus pneumoniaeemph infections in the united states 19951998subtitleopportunities for prevention in the conjugate vaccine erasubtitle,660_epidemiology of invasive emph typeitalstreptococcus pneumoniaeemph infections in the united states 19951998subtitleopportunities for prevention in the conjugate vaccine erasubtitle.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213993/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485662/pdf', 'https://stacks.cdc.gov/view/cdc/11998', 'https://stacks.cdc.gov/view/cdc/35644', 'https://stacks.cdc.gov/view/cdc/78725', 'https://stacks.cdc.gov/view/cdc/7184', 'https://stacks.cdc.gov/view/cdc/13470', 'http://epibulletins.dhss.alaska.gov/Document/Display?DocumentId=207', 'https://dph.georgia.gov/document/document/georgia-immunization-program-complete-manual-2012/download']","['Pneumococcal Vaccines: Understanding Centers for Disease Control and Prevention Recommendations', 'Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease', 'Promoting preventive services for adults 50-64; community and clinical partnerships', 'Manual for the surveillance of vaccine-preventable diseases. Chapter 11: Pneumococcal disease', 'Epidemiology and prevention of vaccine-preventable diseases', 'Use of anthrax vaccine in response to terrorism : supplemental recommendations of the Advisory Committee on Immunization Practices', 'Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk; a report on recommendations of the Task Force on Community Preventive Services', 'New Vaccines Being Implemented in 2006', 'Immunization Office Manual']","['https://dph.georgia.gov/document/document/georgia-immunization-program-complete-manual-2012/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213993/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485662/pdf']","['660_8_immunization office manual.pdf', '660_0_pneumococcal vaccines understanding centers for disease control and prevention recommendations.pdf', '660_1_prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.pdf']",3,33.33,"['https://dph.georgia.gov/document/document/georgia-immunization-program-complete-manual-2012/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213993/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485662/pdf']","['660_8_immunization office manual.pdf', '660_0_pneumococcal vaccines understanding centers for disease control and prevention recommendations.pdf', '660_1_prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.pdf']","[0.605, 0.302, 0.423]","[0.541, 0.538, 0.534]","[0.617, 0.623, 0.612]","[0.167, 0.199, 0.18]","[0.172, 0.209, 0.185]","[0.144, 0.174, 0.146]","[0.737, 0.748, 0.735]","[0.64, 0.652, 0.638]","[0.607, 0.612, 0.598]","[0.651, 0.675, 0.688]","[0.798, 0.797, 0.787]","[0.725, 0.72, 0.712]","[0.627, 0.623, 0.605]","[0.916, 0.918, 0.911]","[0.819, 0.805, 0.809]","[0.761, 0.757, 0.734]","[0.797, 0.793, 0.782]","[0.783, 0.779, 0.762]",0.443,0.538,0.617,0.182,0.189,0.155,0.74,0.643,0.606,0.671,0.794,0.719,0.618,0.915,0.811,0.751,0.791,0.775
https://doi.org/10.1001/jama.285.16.2083,lamivudinezidovudine combination for prevention of maternalinfant transmission of hiv1,661_lamivudinezidovudine combination for prevention of maternalinfant transmission of hiv1.pdf,5,"['https://www.rand.org/pubs/drafts/DRU3071.html', 'https://stacks.cdc.gov/view/cdc/5186', 'https://stacks.cdc.gov/view/cdc/7324', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352287/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf']","['Preventing Perinatal Transmission of HIV', 'U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States', 'HIV testing and prophylaxis to prevent mother-to-child transmission in the United States', 'German-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008', 'HIV/AIDS Guidelines']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352287/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf']","['661_3_germanaustrian recommendations for hiv1therapy in pregnancy and in hiv1exposed newborn  update 2008.pdf', '661_4_hivaids guidelines.pdf']",2,40.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352287/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf']","['661_3_germanaustrian recommendations for hiv1therapy in pregnancy and in hiv1exposed newborn  update 2008.pdf', '661_4_hivaids guidelines.pdf']","[0.592, 0.536]","[0.557, 0.536]","[0.628, 0.612]","[0.2, 0.208]","[0.209, 0.202]","[0.169, 0.168]","[0.745, 0.747]","[0.655, 0.657]","[0.623, 0.62]","[0.634, 0.632]","[0.817, 0.805]","[0.743, 0.706]","[0.634, 0.606]","[0.919, 0.91]","[0.836, 0.821]","[0.769, 0.753]","[0.808, 0.792]","[0.783, 0.766]",0.564,0.546,0.62,0.204,0.206,0.169,0.746,0.656,0.621,0.633,0.811,0.724,0.62,0.915,0.829,0.761,0.8,0.774
https://doi.org/10.1001/jama.285.17.2199,cardiorespiratory events recorded on home monitorssubtitlecomparison of healthy infants with those at increased risk for sidssubtitle,662_cardiorespiratory events recorded on home monitorssubtitlecomparison of healthy infants with those at increased risk for sidssubtitle.pdf,4,"['https://www.congress.gov/event/116th-congress/house-event/109635', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728046/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459210/pdf']","['""Keeping Kids and Consumers Safe from Dangerous Products""', 'A Policy & Education Development Guide', 'Apparent Life-Threatening Events (ALTE): Italian guidelines', 'Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events - Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728046/pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['662_2_apparent lifethreatening events alte italian guidelines.pdf', '662_1_a policy  education development guide.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728046/pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['662_2_apparent lifethreatening events alte italian guidelines.pdf', '662_1_a policy  education development guide.pdf']","[0.402, 0.501]","[0.538, 0.522]","[0.62, 0.603]","[0.161, 0.135]","[0.173, 0.147]","[0.136, 0.119]","[0.733, 0.726]","[0.64, 0.629]","[0.614, 0.598]","[0.671, 0.67]","[0.8, 0.795]","[0.737, 0.729]","[0.627, 0.623]","[0.91, 0.909]","[0.827, 0.821]","[0.759, 0.755]","[0.796, 0.795]","[0.785, 0.781]",0.452,0.53,0.611,0.148,0.16,0.128,0.73,0.635,0.606,0.671,0.798,0.733,0.625,0.909,0.824,0.757,0.796,0.783
https://doi.org/10.1001/jama.285.19.2506,breastfeeding may help prevent childhood overweight,665_breastfeeding may help prevent childhood overweight.pdf,6,"['https://www.lrl.mn.gov/docs/2005/other/050570.pdf', 'https://health.mo.gov/living/healthcondiseases/obesity/pdf/ObesityBurdenWebversion.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://www.dhcs.ca.gov/formsandpubs/publications/CaliforniaFoodGuide/23Diabetes.pdf', 'https://stacks.cdc.gov/view/cdc/11310', 'https://www.dhcs.ca.gov/formsandpubs/publications/CaliforniaFoodGuide/9InfantFeeding0-12months.pdf']","['Table of Contents', 'Preventing Obesity and Other Chronic Diseases', 'California Food Guide :', 'California Food Guide: Diabetes', 'Promising practices in chronic disease prevention and control; a public health framework for action', 'California Food Guide Normal Infant Feeding (0-12 months) Life Cycle Chapter']","['https://www.lrl.mn.gov/docs/2005/other/050570.pdf', 'https://health.mo.gov/living/healthcondiseases/obesity/pdf/ObesityBurdenWebversion.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf']","['665_0_table of contents.pdf', '665_1_preventing obesity and other chronic diseases.pdf', '665_2_california food guide .pdf']",3,50.0,"['https://www.lrl.mn.gov/docs/2005/other/050570.pdf', 'https://health.mo.gov/living/healthcondiseases/obesity/pdf/ObesityBurdenWebversion.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf']","['665_0_table of contents.pdf', '665_1_preventing obesity and other chronic diseases.pdf', '665_2_california food guide .pdf']","[0.204, 0.266, 0.33]","[0.542, 0.528, 0.526]","[0.63, 0.618, 0.621]","[0.135, 0.173, 0.156]","[0.132, 0.181, 0.16]","[0.112, 0.156, 0.139]","[0.717, 0.729, 0.727]","[0.616, 0.626, 0.624]","[0.62, 0.599, 0.603]","[0.641, 0.682, 0.671]","[0.807, 0.796, 0.801]","[0.754, 0.732, 0.737]","[0.619, 0.622, 0.618]","[0.921, 0.914, 0.916]","[0.827, 0.825, 0.82]","[0.775, 0.764, 0.765]","[0.814, 0.796, 0.801]","[0.796, 0.781, 0.787]",0.267,0.532,0.623,0.155,0.158,0.136,0.724,0.622,0.607,0.665,0.801,0.741,0.62,0.917,0.824,0.768,0.804,0.788
https://doi.org/10.1001/jama.285.24.3093,pervasive developmental disorders in preschool children,667_pervasive developmental disorders in preschool children.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956617/pdf', 'https://www.acmg.net/PDFLibrary/Austism-Spectrum-Genetics-Evaluation.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.nber.org/papers/w18238?sy=238', 'https://stacks.cdc.gov/view/cdc/6844', 'https://stacks.cdc.gov/view/cdc/5465', 'https://rga.lis.virginia.gov/Published/2010/HD9/PDF']","['Music therapy for people with autism spectrum disorder', 'Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions', 'Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'The Effect of an Increase in Autism Prevalence on the Demand for Auxiliary Healthcare Workers: Evidence from California', 'Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, six sites, United States, 2000; Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002 ; and, Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002', 'Prevalence of autism spectrum disorders-- Autism and Developmental Disabilities Monitoring Network, United States, 2006', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs, 4th Edition']","['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.acmg.net/PDFLibrary/Austism-Spectrum-Genetics-Evaluation.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956617/pdf']","['667_2_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '667_1_clinical genetics evaluation in identifying the etiology of autism spectrum disorders 2013 guideline revisions.pdf', '667_0_music therapy for people with autism spectrum disorder.pdf']",3,42.86,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.acmg.net/PDFLibrary/Austism-Spectrum-Genetics-Evaluation.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956617/pdf']","['667_2_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '667_1_clinical genetics evaluation in identifying the etiology of autism spectrum disorders 2013 guideline revisions.pdf', '667_0_music therapy for people with autism spectrum disorder.pdf']","[0.264, 0.407, 0.273]","[0.508, 0.559, 0.516]","[0.592, 0.633, 0.598]","[0.129, 0.198, 0.159]","[0.123, 0.219, 0.171]","[0.095, 0.176, 0.14]","[0.723, 0.741, 0.73]","[0.627, 0.65, 0.635]","[0.582, 0.63, 0.581]","[0.662, 0.693, 0.708]","[0.795, 0.808, 0.783]","[0.713, 0.764, 0.706]","[0.608, 0.639, 0.596]","[0.91, 0.914, 0.908]","[0.807, 0.834, 0.81]","[0.745, 0.779, 0.728]","[0.787, 0.81, 0.777]","[0.772, 0.796, 0.758]",0.315,0.528,0.608,0.162,0.171,0.137,0.731,0.637,0.598,0.688,0.795,0.728,0.614,0.911,0.817,0.751,0.791,0.775
https://doi.org/10.1001/jama.285.9.1155,abacavirlamivudinezidovudine vs indinavirlamivudinezidovudine in antiretroviralnaive hivinfected adultssubtitlea randomized equivalence trialsubtitle,668_abacavirlamivudinezidovudine vs indinavirlamivudinezidovudine in antiretroviralnaive hivinfected adultssubtitlea randomized equivalence trialsubtitle.pdf,5,"['https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fixed-dose-combinations-co-packaged-drug-products-and-single-entity-versions-previously-approved', 'https://stacks.cdc.gov/view/cdc/13519', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724658/pdf', 'https://stacks.cdc.gov/view/cdc/22444', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026626/pdf']","['Fixed Dose Combinations, Co-Packaged Drug Products, and Single-Entity', 'Guidelines for using antiretroviral agents among HIV-infected adults and adolescents; recommendations of the Panel on Clinical Practices for Treatment of HIV', 'Paediatric uropean etwork for reatment of () guidelines for treatment of paediatric ‐1 infection 2015: optimizing health in preparation for adult life', 'Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents', 'Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026626/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724658/pdf']","['668_4_co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of hiv infection and aids.pdf', '668_2_paediatric uropean etwork for reatment of  guidelines for treatment of paediatric ‐1 infection 2015 optimizing health in preparation for adult life.pdf']",2,40.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026626/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724658/pdf']","['668_4_co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of hiv infection and aids.pdf', '668_2_paediatric uropean etwork for reatment of  guidelines for treatment of paediatric ‐1 infection 2015 optimizing health in preparation for adult life.pdf']","[0.401, 0.505]","[0.523, 0.569]","[0.607, 0.641]","[0.189, 0.197]","[0.194, 0.201]","[0.159, 0.161]","[0.741, 0.744]","[0.653, 0.651]","[0.59, 0.64]","[0.669, 0.646]","[0.788, 0.821]","[0.693, 0.75]","[0.593, 0.625]","[0.907, 0.927]","[0.812, 0.836]","[0.723, 0.77]","[0.768, 0.808]","[0.744, 0.782]",0.453,0.546,0.624,0.193,0.198,0.16,0.742,0.652,0.615,0.657,0.804,0.722,0.609,0.917,0.824,0.746,0.788,0.763
https://doi.org/10.1001/jama.285.9.1183,time trends in autism and in mmr immunization coverage in california,669_time trends in autism and in mmr immunization coverage in california.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458016/pdf', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16e.pdf', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://www.dds.ca.gov/wp-content/uploads/2019/06/Autism_FinalStudy_20021017.pdf', 'https://www.leg.mn.gov/docs/pre2003/other/010526.pdf', 'http://www.dnrec.delaware.gov/dwhs/info/regs/documents/d7a9dca41a624e6d8f50eb9f0df4565cpalmer_et_al.pdf']","['Vaccines for measles, mumps, rubella, and varicella in children', 'Vaccines for measles, mumps, rubella, and varicella in children', 'Vaccines for measles, mumps and rubella in children', 'Massachusetts General Hospital', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Report to the Legislature on the Principal Findings from the Epidemiology of Autism in California', 'MMR Vaccine and Autism : No Evidence of Association', 'Article In Press']","['https://www.dds.ca.gov/wp-content/uploads/2019/06/Autism_FinalStudy_20021017.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458016/pdf', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16e.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf', 'http://www.dnrec.delaware.gov/dwhs/info/regs/documents/d7a9dca41a624e6d8f50eb9f0df4565cpalmer_et_al.pdf', 'https://www.leg.mn.gov/docs/pre2003/other/010526.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf']","['669_5_report to the legislature on the principal findings from the epidemiology of autism in california.pdf', '669_2_vaccines for measles mumps and rubella in children.pdf', '669_3_massachusetts general hospital.pdf', '669_1_vaccines for measles mumps rubella and varicella in children.pdf', '669_7_article in press.pdf', '669_6_mmr vaccine and autism  no evidence of association.pdf', '669_0_vaccines for measles mumps rubella and varicella in children.pdf']",7,87.5,"['https://www.dds.ca.gov/wp-content/uploads/2019/06/Autism_FinalStudy_20021017.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458016/pdf', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16e.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf', 'https://www.leg.mn.gov/docs/pre2003/other/010526.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf']","['669_5_report to the legislature on the principal findings from the epidemiology of autism in california.pdf', '669_2_vaccines for measles mumps and rubella in children.pdf', '669_3_massachusetts general hospital.pdf', '669_1_vaccines for measles mumps rubella and varicella in children.pdf', '669_6_mmr vaccine and autism  no evidence of association.pdf', '669_0_vaccines for measles mumps rubella and varicella in children.pdf']","[0.285, 0.285, 0.311, 0.172, 0.571, 0.455]","[0.573, 0.539, 0.526, 0.527, 0.581, 0.527]","[0.646, 0.618, 0.611, 0.61, 0.655, 0.609]","[0.222, 0.201, 0.116, 0.185, 0.241, 0.185]","[0.247, 0.201, 0.103, 0.18, 0.251, 0.18]","[0.207, 0.167, 0.084, 0.15, 0.215, 0.15]","[0.744, 0.742, 0.727, 0.74, 0.742, 0.74]","[0.652, 0.649, 0.629, 0.645, 0.649, 0.645]","[0.631, 0.601, 0.602, 0.58, 0.648, 0.58]","[0.703, 0.688, 0.647, 0.687, 0.684, 0.687]","[0.807, 0.796, 0.801, 0.778, 0.819, 0.777]","[0.752, 0.74, 0.73, 0.71, 0.769, 0.709]","[0.649, 0.618, 0.619, 0.605, 0.655, 0.605]","[0.914, 0.895, 0.903, 0.893, 0.915, 0.893]","[0.844, 0.819, 0.821, 0.814, 0.85, 0.814]","[0.781, 0.74, 0.764, 0.719, 0.792, 0.718]","[0.806, 0.789, 0.793, 0.771, 0.82, 0.771]","[0.798, 0.765, 0.786, 0.746, 0.809, 0.745]",0.346,0.545,0.625,0.192,0.194,0.162,0.739,0.645,0.607,0.683,0.796,0.735,0.625,0.902,0.827,0.752,0.792,0.775
https://doi.org/10.1001/jama.286.13.1588,initial effects of graduated driver licensing on 16yearold driver crashes in north carolina,671_initial effects of graduated driver licensing on 16yearold driver crashes in north carolina.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf', 'https://www.atlantafed.org/research/publications/wp/2019/07/25/driven-from-work-graduated%20-driver-license-programs-and-teen-labor-market%20-outcomes.aspx', 'https://www.nj.gov/oag/hts/downloads/TDSC_Report_web.pdf', 'https://www.gao.gov/products/GAO-10-544']","['Mobility management to prevent, reduce, or delay driving a car in teenagers', 'Driven from Work: Graduated Driver License Programs and Teen Labor Market Outcomes', 'RECOMMENDATION REPORT • MARCH 2008', 'Teen Driver Safety: Additional Research Could Help States Strengthen Graduated Driver Licensing Systems']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf', 'https://www.nj.gov/oag/hts/downloads/TDSC_Report_web.pdf']","['671_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf', '671_2_recommendation report • march 2008.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf', 'https://www.nj.gov/oag/hts/downloads/TDSC_Report_web.pdf']","['671_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf', '671_2_recommendation report • march 2008.pdf']","[0.245, 0.545]","[0.525, 0.548]","[0.604, 0.628]","[0.161, 0.203]","[0.172, 0.228]","[0.144, 0.187]","[0.73, 0.742]","[0.632, 0.645]","[0.599, 0.622]","[0.706, 0.708]","[0.792, 0.815]","[0.719, 0.76]","[0.601, 0.658]","[0.921, 0.929]","[0.832, 0.845]","[0.742, 0.781]","[0.789, 0.816]","[0.773, 0.8]",0.395,0.536,0.616,0.182,0.2,0.165,0.736,0.639,0.611,0.707,0.803,0.74,0.629,0.925,0.839,0.762,0.802,0.786
https://doi.org/10.1001/jama.286.21.2695,schoolassociated violent deaths in the united states 19941999,673_schoolassociated violent deaths in the united states 19941999.pdf,9,"['https://mathematica.org/publications/student-victimization-in-us-schools-results-from-the-2013-school-crime-supplement-to-the-national', 'https://stacks.cdc.gov/view/cdc/21769', 'https://stacks.cdc.gov/view/cdc/11438', 'https://www.congress.gov/event/107th-congress/senate-event/LC17039/text?s=1&r=14873', 'https://www.michigan.gov/documents/msp/Final_Recommendations_SSTF_640543_7.pdf', 'https://www.rti.org/publication/violence-teenage-girls', 'https://stacks.cdc.gov/view/cdc/27357', 'http://origin-sl.michigan.gov/documents/msp/Final_Recommendations_SSTF_640543_7.pdf', 'https://www.rand.org/pubs/rgs_dissertations/RGSD240.html']","['Student Victimization in U.S. Schools: Results from the 2013 School Crime Supplement to the National Crime Victimization Survey', 'CDC injury research agenda 2009-2018', 'CDC Injury fact book', 'Senate Hearing, 107th Congress — DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 2003', 'FINAL RECOMMENDATIONS', 'Violence by teenage girls', 'Best practices of youth violence prevention : a sourcebook for community action. June 2002 (Revision)', 'Final Recommendations', 'No Bullies Allowed: Understanding Peer Victimization, the Impacts on Delinquency, and the Effectiveness of Prevention Programs']",['https://www.michigan.gov/documents/msp/Final_Recommendations_SSTF_640543_7.pdf'],['673_4_final recommendations.pdf'],1,11.11,['https://www.michigan.gov/documents/msp/Final_Recommendations_SSTF_640543_7.pdf'],['673_4_final recommendations.pdf'],[0.396],[0.503],[0.59],[0.16],[0.18],[0.149],[0.73],[0.633],[0.582],[0.674],[0.793],[0.715],[0.628],[0.914],[0.828],[0.75],[0.794],[0.776],0.396,0.503,0.59,0.16,0.18,0.149,0.73,0.633,0.582,0.674,0.793,0.715,0.628,0.914,0.828,0.75,0.794,0.776
https://doi.org/10.1001/jama.286.22.2830,lack of clinical significance of early ischemic changes on computed tomography in acute stroke,674_lack of clinical significance of early ischemic changes on computed tomography in acute stroke.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905927/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278065/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153726/pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000086?download=true', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0b013e318284056a?download=true', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0b013e318296aeca?download=true', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923159/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072500/pdf']","['Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology', 'Antithrombotic and Thrombolytic Therapy for Ischemic Stroke - Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines', 'Thrombolysis for acute ischaemic stroke', 'Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke', 'Guidelines for the Early Management of Patients With Acute Ischemic Stroke', 'An Updated Definition of Stroke for the 21st Century', 'Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society', 'Imaging Recommendations for Acute Stroke and Transient Ischemic Attack Patients: A Joint Statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923159/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153726/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278065/pdf']","['674_6_guidelines for intravenous thrombolysis recombinant tissuetype plasminogen activator the third edition march 2019 a guideline from the japan stroke society.pdf', '674_2_thrombolysis for acute ischaemic stroke.pdf', '674_1_antithrombotic and thrombolytic therapy for ischemic stroke  antithrombotic therapy and prevention of thrombosis 9th e.pdf']",3,37.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923159/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153726/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278065/pdf']","['674_6_guidelines for intravenous thrombolysis recombinant tissuetype plasminogen activator the third edition march 2019 a guideline from the japan stroke society.pdf', '674_2_thrombolysis for acute ischaemic stroke.pdf', '674_1_antithrombotic and thrombolytic therapy for ischemic stroke  antithrombotic therapy and prevention of thrombosis 9th e.pdf']","[0.513, 0.511, 0.528]","[0.579, 0.511, 0.56]","[0.651, 0.596, 0.632]","[0.213, 0.182, 0.204]","[0.217, 0.181, 0.206]","[0.17, 0.148, 0.163]","[0.754, 0.748, 0.749]","[0.665, 0.658, 0.66]","[0.64, 0.574, 0.62]","[0.67, 0.702, 0.694]","[0.816, 0.784, 0.808]","[0.758, 0.689, 0.741]","[0.649, 0.61, 0.635]","[0.924, 0.909, 0.919]","[0.839, 0.807, 0.827]","[0.788, 0.737, 0.775]","[0.811, 0.771, 0.8]","[0.798, 0.754, 0.786]",0.517,0.55,0.626,0.2,0.201,0.16,0.75,0.661,0.611,0.689,0.803,0.729,0.631,0.917,0.824,0.767,0.794,0.779
https://doi.org/10.1001/jama.286.22.2845,epidemic increase in childhood overweight 19861998,675_epidemic increase in childhood overweight 19861998.pdf,6,"['https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=23', 'https://www.congress.gov/event/110th-congress/senate-event/LC9220/text?s=1&r=10719', 'https://www.congress.gov/event/108th-congress/house-event/LC15477/text', 'https://papers.nber.org/papers/w13479', 'https://papers.nber.org/papers/w13898', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022192/pdf']","['Diagnosis and Treatment of Obesity In The Elderly', ""S.Hrg. 110-447 — CHILDHOOD OBESITY: THE DECLINING HEALTH OF AMERICA'S NEXT GENERATION--PART I"", 'IMPROVING THE QUALITY AND EFFICIENCY OF COMMODITY DISTRIBUTION TO FEDERAL CHILD NUTRITION PROGRAMS', 'Childhood Disadvantage and Obesity: Is Nurture Trumping Nature?', 'The Transition to Post-industrial BMI Values Among US Children', 'Low glycaemic index or low glycaemic load diets for overweight and obesity']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022192/pdf'],['675_5_low glycaemic index or low glycaemic load diets for overweight and obesity.pdf'],1,16.67,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022192/pdf'],['675_5_low glycaemic index or low glycaemic load diets for overweight and obesity.pdf'],[0.191],[0.483],[0.574],[0.153],[0.152],[0.13],[0.728],[0.624],[0.554],[0.718],[0.749],[0.676],[0.574],[0.889],[0.779],[0.674],[0.746],[0.705],0.191,0.483,0.574,0.153,0.152,0.13,0.728,0.624,0.554,0.718,0.749,0.676,0.574,0.889,0.779,0.674,0.746,0.705
https://doi.org/10.1001/jama.286.23.3007,the inner life of physicians and care of the seriously ill,677_the inner life of physicians and care of the seriously ill.pdf,2,"['https://watermark.silverchair.com/cix636.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsAwggK8BgkqhkiG9w0BBwagggKtMIICqQIBADCCAqIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMJnyF-QMXPD3iyggqAgEQgIICc975q89Fse_JZT0qbQqn1s24JZXh1zYxmxNvEw8izaPvjrPxVzjIsbzfyW_k7MNcnlIYCURcF9b3YxLPEDxG84Sh53pbDw5be9eiucRWUI9Pcq0WLKqTYrrUfGhSps4di6e-KAIyAFRlvLh6tR94THn1Sf54A1_46JEJxOrCLwIWB3cSF_LyNcGAkS0CVIVbPm5StoqhsMh23Qu15fHMjPFTUBjAn-XPagzOqWm_InrzT8UBiD6fscZw7E2ZcDrHzW3Gf-99jyxC3Ec_O28zg1djGhn9VTD9vS94V_IsJyk8pbFT5myPVmj1ZXpUnHzyifktaSmzAMJF33F-6WZ40hW-F7tBsN5YCFdQfDwMvN-E4sLFy-wGH3ReksGd30S1aoCtlG19PqyfORJoQ54zQXji0HwfBtwUpiTTs7ibzUbd83Frxz4gJoyzvOQBk-IirKWIVRIC7Ba7rv1uBjuUyI0hJL1jT5-9AqwNDoSJbuuaL577_axTvFiY0yUcsW45UEArjT8Dgcqiub0d4ajFK7JbMzCogaiPALs4jdMs2se78_bSqDJaNDVkA7Z51niSxRkuLhjBavkGzKoZ4tRr8xlt7QuoshTfWk6PiQTGXy5Qk6-FYZOhbp4A6UhNEp_D97_Ok85jR5olVrQSwg2SCL_tC1DIpa2JFN15xMuRuL4rnO0glakSlDr86yH4tdbhjvM8zFiZSjeNCtUzwKPWC9jOPTHGi0d-BL9fbNakxWKIu36x6wCCQkfs3-s9Qx6t37EQw0Q1xMGW100WbUnWbsEHE1IoV3oFhA7jKmqZkbOu863wNTfwoBChgaiGUs9XVVfZxg', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848240/pdf']","['2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV', '2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848240/pdf'],['677_1_2017 hivma of idsa clinical practice guideline for the management of chronic pain in patients living with hiv.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848240/pdf'],['677_1_2017 hivma of idsa clinical practice guideline for the management of chronic pain in patients living with hiv.pdf'],[0.302],[0.545],[0.629],[0.168],[0.177],[0.139],[0.741],[0.643],[0.621],[0.657],[0.818],[0.759],[0.637],[0.923],[0.842],[0.776],[0.817],[0.801],0.302,0.545,0.629,0.168,0.177,0.139,0.741,0.643,0.621,0.657,0.818,0.759,0.637,0.923,0.842,0.776,0.817,0.801
https://doi.org/10.1001/jama.286.4.421,albuminuria and risk of cardiovascular events death and heart failure in diabetic and nondiabetic individuals,678_albuminuria and risk of cardiovascular events death and heart failure in diabetic and nondiabetic individuals.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582781/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143773/pdf', 'https://www.auanet.org/documents/Guidelines/PDF/Renal-Mass-Guideline.pdf', 'https://watermark.silverchair.com/ciu617.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAyswggMnBgkqhkiG9w0BBwagggMYMIIDFAIBADCCAw0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM4g0njeAHro4RQhgIAgEQgIIC3jXe42mg61EqbrGtD-GGLuJcXoWdBElwZ-Xb2pl_KyfjStz8FIqfgokrQ_73XWBwobU1NW1EyvLnv3lhJbewinhJKrhbInPrJxoo6rkIw5Zme3FqQwwPvFwNinM-gUJ5Z8OebJ2n5oh-yw75dWVQ78nRuFjUjZikMgEdUE1Vp3bJJL8P9JxkFlC2ZSqyCcWxJooUyA3CwIE9youRm-oWiWtNnX6IDsDVO_PjZ9ueIfzVM8g7tZV4TE-lYNLSr44Wx_7pl0_gFcjp8C2E4UKFsARY6HfQZamSXatUEwP59hX6_jrpm8ljJPqu17nkVS19w-oqSwGy4MP44ZDeHK9EkX0TignEBhBXiuX3gvT6zy9aPfYDuOMvNc80A27gul5lyWE6UVLiMMdVF4W3xLZdWxiW1twfU-zDOKzom1Bmuyr29Dm0szD1FmDzj5dF68CKhATYLHGkzKGxZ5ICrLq3qRVmQWJ2bCZDsURs4Vm49cUjiRWnyjEcTL-j4qPtSlRYIK_EnCWGGkbiacBW6wua4pSBMjWQ-WDb08foRVZgtoBSL8D-9IF6LDhg9jYdsiHuuD5d0JOxB7m0XX65EGxmFJa4dSO2FCmKr40pPhAxeCjhibA6TsKgQfs3YzZ5sOvZUsd6gTOW7ufVQ3N7SV8Vfb16eEZMEtFLRNgB07UYyuq_asA4zhJ8cm1_BiS2e44Ba6EIUu5jO5zftb9t8clX8H52asMvC355IYUwdGmUIDZismeqRPqLGH7CUkVh3FWi5m7oVV4otK864E1GEnAUFQluCLbltlnqvmKKj7KxmjkXBcsI5i5fwFNN8qeWmMpWPNwHCzquH84A8KigNVuGgaygzAm8KZxd3pJxDP58oh1eIPqHQ34QpDN1CVj9b9wc5vyrmap5ex9uPXaSVFPPkAElPvItsvAIKY57VIoa-zBHu0PRgg3SMtrq9KOCUjojqJWHyEmWa3pvN5UsWpcs', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740329/pdf', 'https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/CIR.0b013e31821daaf6?download=true', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271038/pdf']","['Guidelines for the management of chronic kidney disease', 'Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017', 'RENAL MASS AND LOCALIZED RENAL CANCER: EVALUATION, MANAGEMENT, AND FOLLOW-UP: AUA GUIDELINE', 'Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America', 'KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline', 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease', 'ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly', 'Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143773/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271038/pdf', 'https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf', 'https://www.auanet.org/documents/Guidelines/PDF/Renal-Mass-Guideline.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582781/pdf']","['678_1_japan atherosclerosis society jas guidelines for prevention of atherosclerotic cardiovascular diseases 2017.pdf', '678_4_kdoqi us commentary on the 2017 accaha hypertension guideline.pdf', '678_7_clinical practice guideline for the management of chronic kidney disease in patients infected with hiv 2014 update by the hiv medicine association of the infectious diseases society of america.pdf', '678_5_kdigo 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.pdf', '678_2_renal mass and localized renal cancer evaluation management and followup aua guideline.pdf', '678_0_guidelines for the management of chronic kidney disease.pdf']",6,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143773/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271038/pdf', 'https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf', 'https://www.auanet.org/documents/Guidelines/PDF/Renal-Mass-Guideline.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582781/pdf']","['678_1_japan atherosclerosis society jas guidelines for prevention of atherosclerotic cardiovascular diseases 2017.pdf', '678_4_kdoqi us commentary on the 2017 accaha hypertension guideline.pdf', '678_7_clinical practice guideline for the management of chronic kidney disease in patients infected with hiv 2014 update by the hiv medicine association of the infectious diseases society of america.pdf', '678_5_kdigo 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.pdf', '678_2_renal mass and localized renal cancer evaluation management and followup aua guideline.pdf', '678_0_guidelines for the management of chronic kidney disease.pdf']","[0.248, 0.452, 0.243, 0.273, 0.418, 0.309]","[0.547, 0.503, 0.546, 0.535, 0.551, 0.542]","[0.624, 0.595, 0.621, 0.611, 0.623, 0.616]","[0.185, 0.176, 0.172, 0.171, 0.153, 0.183]","[0.183, 0.184, 0.171, 0.183, 0.134, 0.195]","[0.135, 0.144, 0.133, 0.138, 0.103, 0.146]","[0.745, 0.742, 0.747, 0.741, 0.741, 0.742]","[0.651, 0.653, 0.656, 0.647, 0.642, 0.646]","[0.612, 0.584, 0.612, 0.601, 0.614, 0.609]","[0.67, 0.692, 0.656, 0.685, 0.626, 0.671]","[0.807, 0.783, 0.806, 0.795, 0.796, 0.804]","[0.735, 0.685, 0.726, 0.725, 0.739, 0.732]","[0.622, 0.577, 0.608, 0.61, 0.602, 0.607]","[0.915, 0.913, 0.915, 0.912, 0.915, 0.918]","[0.819, 0.793, 0.809, 0.809, 0.81, 0.812]","[0.772, 0.738, 0.765, 0.762, 0.767, 0.77]","[0.801, 0.776, 0.795, 0.794, 0.798, 0.8]","[0.787, 0.771, 0.782, 0.778, 0.782, 0.785]",0.324,0.537,0.615,0.173,0.175,0.133,0.743,0.649,0.605,0.667,0.799,0.724,0.604,0.915,0.809,0.762,0.794,0.781
https://doi.org/10.1001/jama.287.18.2365,the association between duration of breastfeeding and adult intelligence,683_the association between duration of breastfeeding and adult intelligence.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388861/pdf', 'https://www.colorado.gov/pacific/sites/default/files/PF_BF_Getting-it-Right-After-Delivery.pdf', 'https://www.colorado.gov/pacific/sites/default/files/PF_BF_Getting-It-Right-After-Delivery-Five-Hospital-Practices-That-Support-Breastfeeding_0.pdf']","['Interventions in the workplace to support breastfeeding for women in employment', 'untitled', 'untitled']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388861/pdf'],['683_0_interventions in the workplace to support breastfeeding for women in employment.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388861/pdf'],['683_0_interventions in the workplace to support breastfeeding for women in employment.pdf'],[0.274],[0.522],[0.609],[0.163],[0.17],[0.146],[0.728],[0.634],[0.596],[0.681],[0.79],[0.696],[0.603],[0.918],[0.834],[0.744],[0.787],[0.774],0.274,0.522,0.609,0.163,0.17,0.146,0.728,0.634,0.596,0.681,0.79,0.696,0.603,0.918,0.834,0.744,0.787,0.774
https://doi.org/10.1001/jama.287.23.3103,changes in antibiotic prescribing for children after a communitywide campaign,685_changes in antibiotic prescribing for children after a communitywide campaign.pdf,10,"['https://stacks.cdc.gov/view/cdc/26235', 'https://www.federalregister.gov/documents/2003/02/06/03-2969/labeling-requirements-for-systemic-antibacterial-drug-products-intended-for-human-use', 'https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2002.pdf', 'https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2001.pdf', 'https://www.rand.org/pubs/research_reports/RR1066.html', 'https://www.lrl.mn.gov/docs/2013/mandated/130015.pdf', 'https://comptroller.tn.gov/content/dam/cot/orea/advanced-search/orea-reports-2002/2002_OREA_PrescriptionDrugCosts.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003679/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741879/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361128/pdf']","['Introduction to program evaluation for public health programs : evaluating appropriate antibiotic use programs', 'Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use', '5614 CEDS 02AnlRprt/pdf', '5332 CEDS AnlRprt', 'Reviewing Interventions to Delay Antimicrobial Resistance', 'Recommendations for Prevention and Control of Methicillin- Resistant', 'Prescription Drug Costs in Tennessee', 'Interventions to improve antibiotic prescribing practices in ambulatory care', 'Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study', 'The “Minimizing Antibiotic Resistance in Colorado” Project: Impact of Patient Education in Improving Antibiotic Use in Private Office Practices']","['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2001.pdf', 'https://comptroller.tn.gov/content/dam/cot/orea/advanced-search/orea-reports-2002/2002_OREA_PrescriptionDrugCosts.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003679/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741879/pdf', 'https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2002.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361128/pdf', 'https://www.lrl.mn.gov/docs/2013/mandated/130015.pdf']","['685_3_5332 ceds anlrprt.pdf', '685_6_prescription drug costs in tennessee.pdf', '685_7_interventions to improve antibiotic prescribing practices in ambulatory care.pdf', '685_8_monitoring adherence to guidelines of antibiotic use in pediatric pneumonia the marea study.pdf', '685_2_5614 ceds 02anlrprtpdf.pdf', '685_9_the “minimizing antibiotic resistance in colorado” project impact of patient education in improving antibiotic use in private office practices.pdf', '685_5_recommendations for prevention and control of methicillin resistant.pdf']",7,70.0,"['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2001.pdf', 'https://comptroller.tn.gov/content/dam/cot/orea/advanced-search/orea-reports-2002/2002_OREA_PrescriptionDrugCosts.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003679/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741879/pdf', 'https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2002.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1361128/pdf', 'https://www.lrl.mn.gov/docs/2013/mandated/130015.pdf']","['685_3_5332 ceds anlrprt.pdf', '685_6_prescription drug costs in tennessee.pdf', '685_7_interventions to improve antibiotic prescribing practices in ambulatory care.pdf', '685_8_monitoring adherence to guidelines of antibiotic use in pediatric pneumonia the marea study.pdf', '685_2_5614 ceds 02anlrprtpdf.pdf', '685_9_the “minimizing antibiotic resistance in colorado” project impact of patient education in improving antibiotic use in private office practices.pdf', '685_5_recommendations for prevention and control of methicillin resistant.pdf']","[0.324, 0.297, 0.208, 0.245, 0.46, 0.422, 0.477]","[0.565, 0.556, 0.544, 0.54, 0.563, 0.551, 0.583]","[0.631, 0.628, 0.618, 0.612, 0.631, 0.636, 0.652]","[0.178, 0.175, 0.205, 0.199, 0.177, 0.229, 0.214]","[0.171, 0.171, 0.199, 0.203, 0.171, 0.231, 0.216]","[0.142, 0.152, 0.173, 0.17, 0.141, 0.193, 0.177]","[0.734, 0.728, 0.743, 0.74, 0.734, 0.749, 0.747]","[0.634, 0.63, 0.651, 0.648, 0.634, 0.659, 0.655]","[0.644, 0.639, 0.617, 0.611, 0.642, 0.623, 0.659]","[0.643, 0.664, 0.688, 0.681, 0.642, 0.693, 0.658]","[0.826, 0.828, 0.806, 0.805, 0.827, 0.821, 0.83]","[0.761, 0.763, 0.722, 0.716, 0.764, 0.747, 0.768]","[0.653, 0.647, 0.62, 0.626, 0.65, 0.628, 0.64]","[0.918, 0.929, 0.922, 0.913, 0.92, 0.924, 0.926]","[0.846, 0.852, 0.839, 0.839, 0.843, 0.84, 0.852]","[0.785, 0.781, 0.758, 0.757, 0.785, 0.768, 0.791]","[0.823, 0.823, 0.797, 0.798, 0.824, 0.812, 0.827]","[0.808, 0.806, 0.785, 0.786, 0.809, 0.8, 0.814]",0.348,0.557,0.63,0.197,0.195,0.164,0.739,0.644,0.634,0.667,0.82,0.749,0.638,0.922,0.844,0.775,0.815,0.801
https://doi.org/10.1001/jama.287.5.606,varicella disease after introduction of varicella vaccine in the united states 19952000,686_varicella disease after introduction of varicella vaccine in the united states 19952000.pdf,3,"['https://stacks.cdc.gov/view/cdc/11758', 'https://stacks.cdc.gov/view/cdc/6855', 'https://purl.fdlp.gov/GPO/gpo91522']","['Evaluation of respiratory protection practices for employees at federal immigration and customs agency workplaces - nationwide', 'Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Evaluation of respiratory protection practices for employees at federal immigration and customs agency workplaces - nationwide /']",['https://purl.fdlp.gov/GPO/gpo91522'],['686_2_evaluation of respiratory protection practices for employees at federal immigration and customs agency workplaces  nationwide .pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo91522'],['686_2_evaluation of respiratory protection practices for employees at federal immigration and customs agency workplaces  nationwide .pdf'],[0.159],[0.533],[0.609],[0.15],[0.161],[0.127],[0.725],[0.629],[0.614],[0.644],[0.806],[0.724],[0.627],[0.92],[0.829],[0.76],[0.803],[0.787],0.159,0.533,0.609,0.15,0.161,0.127,0.725,0.629,0.614,0.644,0.806,0.724,0.627,0.92,0.829,0.76,0.803,0.787
https://doi.org/10.1001/jama.288.15.1874,sixyear followup of preventive interventions for children of divorce,689_sixyear followup of preventive interventions for children of divorce.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://aspe.hhs.gov/reports/state-science-practice-parenting-interventions-across-childhood-literature-review-synthesis', 'https://aspe.hhs.gov/reports/state-science-practice-parenting-interventions-across-childhood-literature-review-synthesis-0', 'https://www.rand.org/pubs/research_reports/RR1861.html', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention']","['Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people', 'Family‐based prevention programmes for alcohol use in young people', 'State of the Science and Practice in Parenting Interventions across Childhood: Literature Review and Synthesis', 'State of the Science and Practice in Parenting Interventions across Childhood: Literature Review and Synthesis', 'An Evaluation of U.S. Military Non-Medical Counseling Programs', 'Washington State Institute for Public Policy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf']","['689_1_family‐based prevention programmes for alcohol use in young people.pdf', '689_0_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf']",2,33.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf']","['689_1_family‐based prevention programmes for alcohol use in young people.pdf', '689_0_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf']","[0.4, 0.352]","[0.519, 0.511]","[0.596, 0.586]","[0.161, 0.157]","[0.171, 0.166]","[0.144, 0.141]","[0.731, 0.731]","[0.635, 0.634]","[0.58, 0.57]","[0.711, 0.711]","[0.781, 0.772]","[0.691, 0.683]","[0.588, 0.592]","[0.912, 0.908]","[0.815, 0.801]","[0.725, 0.714]","[0.773, 0.768]","[0.759, 0.746]",0.376,0.515,0.591,0.159,0.169,0.142,0.731,0.635,0.575,0.711,0.776,0.687,0.59,0.91,0.808,0.72,0.77,0.752
https://doi.org/10.1001/jama.288.16.1976-jwr1023-2-1,possible west nile virus transmission to an infant through breastfeeding—michigan 2002,690_possible west nile virus transmission to an infant through breastfeeding—michigan 2002.pdf,4,"['https://www.rand.org/pubs/technical_reports/TR285.html', 'https://stacks.cdc.gov/view/cdc/5706', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786906/pdf', 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents/eligibility-determination-donors-human-cells-tissues-and-cellular-and-tissue-based-products']","['Learning from Experience: The Public Health Response to West Nile Virus, SARS, Monkeypox, and Hepatitis A Outbreaks in the United States', 'Yellow fever vaccine; recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Arenaviruses and West Nile Virus in Solid Organ Transplant Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice', 'Eligibility Determination for Donors of HCT/Ps']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786906/pdf'],['690_2_arenaviruses and west nile virus in solid organ transplant recipients guidelines from the american society of transplantation infectious diseases community of practice.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786906/pdf'],['690_2_arenaviruses and west nile virus in solid organ transplant recipients guidelines from the american society of transplantation infectious diseases community of practice.pdf'],[0.319],[0.505],[0.596],[0.163],[0.174],[0.139],[0.735],[0.64],[0.592],[0.636],[0.788],[0.694],[0.596],[0.902],[0.814],[0.748],[0.792],[0.78],0.319,0.505,0.596,0.163,0.174,0.139,0.735,0.64,0.592,0.636,0.788,0.694,0.596,0.902,0.814,0.748,0.792,0.78
https://doi.org/10.1001/jama.288.17.2151,physician staffing patterns and clinical outcomes in critically ill patients,691_physician staffing patterns and clinical outcomes in critically ill patients.pdf,10,"['https://pdfs.journals.lww.com/ccmjournal/2016/08000/ICU_Admission,_Discharge,_and_Triage_Guidelines__A.15.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1675448337033;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzd9ia1/MJJUFmWp1b9urv13D3lmyNEo1pEFrvLajiUVFM=;hash|3GURazdWQbeLeV7rCTuHZw==', 'https://pdfs.journals.lww.com/pccmjournal/2019/09000/Criteria_for_Critical_Care_Infants_and_Children_.7.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1675445703924;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdqC6FVL99+1gGAXua892EhP7hW7mEPwcpF6mUV3GZoQHQNwe3YVJMpBm0vzMunUdX;hash|VlCgjRqAi2kD9Cl2ol7Jjg==', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054518/pdf', 'https://www.thoracic.org/statements/resources/cc/nighttime-intensivist-staffing.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749175/pdf', 'https://www.in.gov/health/files/Tab_1_Resource_CD.pdf', 'https://stacks.cdc.gov/view/cdc/6878', 'https://stacks.cdc.gov/view/cdc/45809', 'https://stacks.cdc.gov/view/cdc/61187', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119119/pdf']","['ICU Admission, Discharge, and Triage Guidelines: A Framework to Enhance Clinical Operations, Development of Institutional Policies, and Further Research', 'Criteria for Critical Care Infants and Children: PICU Admission, Discharge, and Triage Practice Statement and Levels of Care Guidance', 'Adherence to Guidelines in Adult Patients with Traumatic Brain Injury: A Living Systematic Review', 'An Official American Thoracic Society Systematic Review: The Effect of Nighttime Intensivist Staffing on Mortality and Length of Stay among Intensive Care Unit Patients', 'Patient safety in intensive care medicine: the Declaration of Vienna', 'Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008', '2007 Guideline for isolation precautions preventing transmission of infectious agents in healthcare settings', '2007 Guideline for isolation precautions preventing transmission of infectious agents in healthcare settings', '2007 Guideline for isolation precautions preventing transmission of infectious agents in healthcare settings', '2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749175/pdf', 'https://www.thoracic.org/statements/resources/cc/nighttime-intensivist-staffing.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119119/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054518/pdf', 'https://www.in.gov/health/files/Tab_1_Resource_CD.pdf']","['691_4_patient safety in intensive care medicine the declaration of vienna.pdf', '691_3_an official american thoracic society systematic review the effect of nighttime intensivist staffing on mortality and length of stay among intensive care unit patients.pdf', '691_9_2007 guideline for isolation precautions preventing transmission of infectious agents in health care settings.pdf', '691_2_adherence to guidelines in adult patients with traumatic brain injury a living systematic review.pdf', '691_5_guideline for disinfection and sterilization in healthcare facilities 2008.pdf']",5,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749175/pdf', 'https://www.thoracic.org/statements/resources/cc/nighttime-intensivist-staffing.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119119/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054518/pdf', 'https://www.in.gov/health/files/Tab_1_Resource_CD.pdf']","['691_4_patient safety in intensive care medicine the declaration of vienna.pdf', '691_3_an official american thoracic society systematic review the effect of nighttime intensivist staffing on mortality and length of stay among intensive care unit patients.pdf', '691_9_2007 guideline for isolation precautions preventing transmission of infectious agents in health care settings.pdf', '691_2_adherence to guidelines in adult patients with traumatic brain injury a living systematic review.pdf', '691_5_guideline for disinfection and sterilization in healthcare facilities 2008.pdf']","[0.382, 0.752, 0.357, 0.283, 0.348]","[0.528, 0.52, 0.53, 0.52, 0.509]","[0.62, 0.612, 0.612, 0.605, 0.598]","[0.209, 0.204, 0.153, 0.175, 0.134]","[0.226, 0.218, 0.156, 0.181, 0.139]","[0.182, 0.178, 0.119, 0.146, 0.103]","[0.742, 0.743, 0.736, 0.735, 0.731]","[0.651, 0.657, 0.645, 0.646, 0.637]","[0.596, 0.58, 0.604, 0.578, 0.584]","[0.711, 0.723, 0.649, 0.717, 0.645]","[0.802, 0.79, 0.805, 0.791, 0.792]","[0.724, 0.701, 0.719, 0.696, 0.706]","[0.609, 0.599, 0.606, 0.6, 0.599]","[0.909, 0.901, 0.913, 0.904, 0.91]","[0.842, 0.809, 0.831, 0.823, 0.814]","[0.758, 0.733, 0.759, 0.741, 0.749]","[0.796, 0.772, 0.794, 0.776, 0.783]","[0.785, 0.753, 0.785, 0.767, 0.774]",0.424,0.521,0.609,0.175,0.184,0.146,0.737,0.647,0.588,0.689,0.796,0.709,0.603,0.907,0.824,0.748,0.784,0.773
https://doi.org/10.1001/jama.288.2.189,twodose intrapartumnewborn nevirapine and standard antiretroviral therapy to reduce perinatal hiv transmissionsubtitlea randomized trialsubtitle,693_twodose intrapartumnewborn nevirapine and standard antiretroviral therapy to reduce perinatal hiv transmissionsubtitlea randomized trialsubtitle.pdf,6,"['https://stacks.cdc.gov/view/cdc/25827', 'https://stacks.cdc.gov/view/cdc/26031', 'https://stacks.cdc.gov/view/cdc/5186', 'https://stacks.cdc.gov/view/cdc/42250', 'https://stacks.cdc.gov/view/cdc/7184', 'https://www.in.gov/isdh/files/perinatalgl.pdf']","['Advancing HIV prevention : new strategies for a changing epidemic', 'Advancing HIV prevention; interim technical guidance for selected interventions', 'U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States', 'When preganant patients are unsure about HIV screening', 'Use of anthrax vaccine in response to terrorism : supplemental recommendations of the Advisory Committee on Immunization Practices', 'HIV/AIDS Guidelines']",['https://www.in.gov/isdh/files/perinatalgl.pdf'],['693_5_hivaids guidelines.pdf'],1,16.67,['https://www.in.gov/isdh/files/perinatalgl.pdf'],['693_5_hivaids guidelines.pdf'],[0.564],[0.534],[0.61],[0.207],[0.21],[0.174],[0.746],[0.657],[0.619],[0.636],[0.801],[0.703],[0.598],[0.91],[0.823],[0.747],[0.791],[0.767],0.564,0.534,0.61,0.207,0.21,0.174,0.746,0.657,0.619,0.636,0.801,0.703,0.598,0.91,0.823,0.747,0.791,0.767
https://doi.org/10.1001/jama.288.21.2717,risk factors for sudden infant death syndrome among northern plains indians,694_risk factors for sudden infant death syndrome among northern plains indians.pdf,4,"['https://stacks.cdc.gov/view/cdc/11422', 'https://www.congress.gov/event/116th-congress/house-event/109635', 'https://www.michigan.gov/documents/mdhhs/Safe_Sleep_Report_Final_1_12_2018_611613_7.pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","[""A Purchaser's guide to clinical preventive services; moving science into coverage"", '""Keeping Kids and Consumers Safe from Dangerous Products""', 'Safe Sleep Report Final 1 12 2018', 'A Policy & Education Development Guide']","['https://www.michigan.gov/documents/mdhhs/Safe_Sleep_Report_Final_1_12_2018_611613_7.pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['694_2_safe sleep report final 1 12 2018.pdf', '694_3_a policy  education development guide.pdf']",2,50.0,"['https://www.michigan.gov/documents/mdhhs/Safe_Sleep_Report_Final_1_12_2018_611613_7.pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['694_2_safe sleep report final 1 12 2018.pdf', '694_3_a policy  education development guide.pdf']","[0.467, 0.579]","[0.537, 0.519]","[0.617, 0.597]","[0.165, 0.138]","[0.18, 0.152]","[0.144, 0.127]","[0.727, 0.728]","[0.626, 0.627]","[0.605, 0.588]","[0.645, 0.656]","[0.8, 0.79]","[0.724, 0.706]","[0.631, 0.609]","[0.917, 0.916]","[0.829, 0.814]","[0.77, 0.751]","[0.805, 0.789]","[0.788, 0.777]",0.523,0.528,0.607,0.152,0.166,0.136,0.728,0.627,0.597,0.651,0.795,0.715,0.62,0.917,0.821,0.76,0.797,0.782
https://doi.org/10.1001/jama.288.22.2846,effect of a clinical practice improvement intervention on chlamydial screening among adolescent girls,695_effect of a clinical practice improvement intervention on chlamydial screening among adolescent girls.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172331/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589938/pdf', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf']","['Screening for Nonviral Sexually Transmitted Infections in Adolescents and Young Adults', 'Local opinion leaders: effects on professional practice and health care outcomes', 'Local opinion leaders: effects on professional practice and healthcare outcomes', 'A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172331/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589938/pdf', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf']","['695_0_screening for nonviral sexually transmitted infections in adolescents and young adults.pdf', '695_1_local opinion leaders effects on professional practice and health care outcomes.pdf', '695_2_local opinion leaders effects on professional practice and healthcare outcomes.pdf', '695_3_a national strategy for the elimination of hepatitis b and c phase two report.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172331/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589938/pdf', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf']","['695_0_screening for nonviral sexually transmitted infections in adolescents and young adults.pdf', '695_1_local opinion leaders effects on professional practice and health care outcomes.pdf', '695_2_local opinion leaders effects on professional practice and healthcare outcomes.pdf', '695_3_a national strategy for the elimination of hepatitis b and c phase two report.pdf']","[0.524, 0.225, 0.28, 0.231]","[0.547, 0.535, 0.535, 0.52]","[0.622, 0.612, 0.609, 0.608]","[0.183, 0.151, 0.169, 0.15]","[0.201, 0.161, 0.166, 0.155]","[0.166, 0.127, 0.141, 0.124]","[0.745, 0.73, 0.734, 0.733]","[0.656, 0.636, 0.641, 0.638]","[0.625, 0.608, 0.599, 0.595]","[0.661, 0.676, 0.681, 0.659]","[0.818, 0.79, 0.789, 0.809]","[0.734, 0.724, 0.702, 0.715]","[0.608, 0.589, 0.604, 0.614]","[0.927, 0.922, 0.92, 0.917]","[0.825, 0.828, 0.827, 0.818]","[0.766, 0.747, 0.737, 0.752]","[0.816, 0.789, 0.783, 0.788]","[0.799, 0.771, 0.765, 0.782]",0.315,0.534,0.613,0.163,0.171,0.14,0.736,0.643,0.607,0.669,0.802,0.719,0.604,0.921,0.825,0.75,0.794,0.779
https://doi.org/10.1001/jama.288.24.3147,reasonable accommodations for medical faculty with disabilities,696_reasonable accommodations for medical faculty with disabilities.pdf,1,['https://legistar.council.nyc.gov/View.ashx?M=F&ID=7731055&GUID=0236C877-520C-43F0-98DE-031EAEB5CB57'],['Brooklyn Testimony'],['https://legistar.council.nyc.gov/View.ashx?M=F&ID=7731055&GUID=0236C877-520C-43F0-98DE-031EAEB5CB57'],['696_0_brooklyn testimony.pdf'],1,100.0,['https://legistar.council.nyc.gov/View.ashx?M=F&ID=7731055&GUID=0236C877-520C-43F0-98DE-031EAEB5CB57'],['696_0_brooklyn testimony.pdf'],[0.483],[0.57],[0.651],[0.205],[0.217],[0.183],[0.735],[0.64],[0.651],[0.686],[0.834],[0.781],[0.652],[0.921],[0.872],[0.798],[0.837],[0.819],0.483,0.57,0.651,0.205,0.217,0.183,0.735,0.64,0.651,0.686,0.834,0.781,0.652,0.921,0.872,0.798,0.837,0.819
https://doi.org/10.1001/jama.288.6.738,financial ties and conflicts of interest between pharmaceutical and tobacco companies,697_financial ties and conflicts of interest between pharmaceutical and tobacco companies.pdf,2,"['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/TechnicalSupplementtothe2018-2020MasterPlanoftheTobaccoEducationandResearchOversightCommittee.pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20152017MasterPlanChangingLandscapeCounteringNewThreats.pdf']","['New Challenges—New Promise for All', 'Changing Landscapes, Countering New Threats']","['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20152017MasterPlanChangingLandscapeCounteringNewThreats.pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/TechnicalSupplementtothe2018-2020MasterPlanoftheTobaccoEducationandResearchOversightCommittee.pdf']","['697_1_changing landscapes countering new threats.pdf', '697_0_new challenges—new promise for all.pdf']",2,100.0,"['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20152017MasterPlanChangingLandscapeCounteringNewThreats.pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/TechnicalSupplementtothe2018-2020MasterPlanoftheTobaccoEducationandResearchOversightCommittee.pdf']","['697_1_changing landscapes countering new threats.pdf', '697_0_new challenges—new promise for all.pdf']","[0.357, 0.34]","[0.471, 0.473]","[0.579, 0.579]","[0.134, 0.134]","[0.144, 0.144]","[0.133, 0.134]","[0.731, 0.73]","[0.634, 0.633]","[0.548, 0.551]","[0.674, 0.667]","[0.786, 0.789]","[0.626, 0.631]","[0.613, 0.611]","[0.903, 0.904]","[0.828, 0.834]","[0.733, 0.737]","[0.775, 0.779]","[0.766, 0.767]",0.349,0.472,0.579,0.134,0.144,0.134,0.73,0.633,0.55,0.671,0.788,0.629,0.612,0.903,0.831,0.735,0.777,0.766
https://doi.org/10.1001/jama.288.7.825-jwr0821-2-1,infant mortality and low birth weight among black and white infants—united states 19802000,698_infant mortality and low birth weight among black and white infants—united states 19802000.pdf,9,"['https://www.rand.org/pubs/rgs_dissertations/RGSD220.html', 'https://www.rand.org/pubs/technical_reports/TR655.html', 'https://www.rand.org/pubs/working_papers/WR367.html', 'https://papers.nber.org/papers/w14591', 'https://papers.nber.org/papers/w12820', 'https://admin.nber.org/papers/w21049', 'https://www.tn.gov/content/dam/tn/health/documents/lowbirthweight94_04.pdf', 'https://www.rand.org/pubs/research_reports/RR1336.html', 'https://health.mo.gov/data/pdf/StateofMissouriansHealth2010.pdf']","['A Good Start in Life: Revisiting Racial and Ethnic Disparities in Health Outcomes At and After Birth', ""Assessing Health and Health Care in Prince George's County"", 'Health Endowments and Parental Investments in Infancy and Early Childhood', 'Re-examining the Effects of Medicaid Expansions for Pregnant Women', 'Mandated Health Insurance Benefits and the Utilization and Outcomes of Infertility Treatments', 'Does Medicaid Coverage for Pregnant Women Affect Prenatal Health Behaviors?', 'Low Birthweight in Tennessee 1994-2004', 'The Urban Child Institute CANDLE Study', 'StateofMissouriansHealth 2010.indd']","['https://health.mo.gov/data/pdf/StateofMissouriansHealth2010.pdf', 'https://www.tn.gov/content/dam/tn/health/documents/lowbirthweight94_04.pdf']","['698_8_stateofmissourianshealth 2010indd.pdf', '698_6_low birthweight in tennessee 19942004.pdf']",2,22.22,"['https://health.mo.gov/data/pdf/StateofMissouriansHealth2010.pdf', 'https://www.tn.gov/content/dam/tn/health/documents/lowbirthweight94_04.pdf']","['698_8_stateofmissourianshealth 2010indd.pdf', '698_6_low birthweight in tennessee 19942004.pdf']","[0.268, 0.226]","[0.505, 0.493]","[0.583, 0.578]","[0.144, 0.164]","[0.146, 0.166]","[0.116, 0.132]","[0.726, 0.733]","[0.626, 0.632]","[0.589, 0.57]","[0.654, 0.671]","[0.786, 0.768]","[0.721, 0.711]","[0.625, 0.628]","[0.901, 0.895]","[0.817, 0.802]","[0.73, 0.715]","[0.794, 0.776]","[0.76, 0.739]",0.247,0.499,0.581,0.154,0.156,0.124,0.73,0.629,0.579,0.663,0.777,0.716,0.627,0.898,0.809,0.722,0.785,0.75
https://doi.org/10.1001/jama.288.8.963,exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age,699_exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329945/pdf', 'https://stacks.cdc.gov/view/cdc/21748', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.tn.gov/content/dam/tn/health/program-areas/HUD_Healthy_Homes_Reference_Manual.pdf', 'https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Work-Group-Report-of-the-Microbes-May-20.pdf', 'https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.allergyparameters.org/app/download/7983255270/2012+Furry+Animal+Allergy.pdf?t=1515169884']","['Prevention strategies for asthma — primary prevention', 'Environmental assessment and exposure control: a practice parameter–furry animals', 'Summary of recommendations from the Canadian Asthma Consensus Guidelines, 2003', 'Healthy housing reference manual', 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', 'Healthy Homes Reference Manual', 'Evolving concepts in how viruses impact asthma: A Work Group Report of the Microbes in Allergy Committee of the American Academy of Allergy, Asthma & Immunology', 'Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma', 'Environmental assessment and exposure control: a practice parameter—furry animals']","['https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329948/pdf', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.tn.gov/content/dam/tn/health/program-areas/HUD_Healthy_Homes_Reference_Manual.pdf', 'https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Work-Group-Report-of-the-Microbes-May-20.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329945/pdf', 'https://www.allergyparameters.org/app/download/7983255270/2012+Furry+Animal+Allergy.pdf?t=1515169884', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519933/pdf']","['699_7_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '699_0_prevention strategies for asthma — primary prevention.pdf', '699_4_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '699_5_healthy homes reference manual.pdf', '699_6_evolving concepts in how viruses impact asthma a work group report of the microbes in allergy committee of the american academy of allergy asthma  immunology.pdf', '699_2_summary of recommendations from the canadian asthma consensus guidelines 2003.pdf', '699_8_environmental assessment and exposure control a practice parameter—furry animals.pdf', '699_1_environmental assessment and exposure control a practice parameter–furry animals.pdf']",8,88.89,"['https://www.nhlbi.nih.gov/sites/default/files/media/docs/EPR-3_Asthma_Full_Report_2007.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329948/pdf', 'https://www.epa.gov/sites/default/files/2014-09/documents/asthgdln.pdf', 'https://www.tn.gov/content/dam/tn/health/program-areas/HUD_Healthy_Homes_Reference_Manual.pdf', 'https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Work-Group-Report-of-the-Microbes-May-20.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1329945/pdf', 'https://www.allergyparameters.org/app/download/7983255270/2012+Furry+Animal+Allergy.pdf?t=1515169884', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519933/pdf']","['699_7_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '699_0_prevention strategies for asthma — primary prevention.pdf', '699_4_expert panel report 3 guidelines for the diagnosis and management of asthma.pdf', '699_5_healthy homes reference manual.pdf', '699_6_evolving concepts in how viruses impact asthma a work group report of the microbes in allergy committee of the american academy of allergy asthma  immunology.pdf', '699_2_summary of recommendations from the canadian asthma consensus guidelines 2003.pdf', '699_8_environmental assessment and exposure control a practice parameter—furry animals.pdf', '699_1_environmental assessment and exposure control a practice parameter–furry animals.pdf']","[0.662, 0.632, 0.364, 0.344, 0.11, 0.315, 0.344, 0.692]","[0.512, 0.544, 0.512, 0.488, 0.529, 0.524, 0.531, 0.504]","[0.598, 0.62, 0.598, 0.572, 0.614, 0.603, 0.609, 0.597]","[0.146, 0.194, 0.146, 0.065, 0.159, 0.154, 0.166, 0.159]","[0.157, 0.217, 0.157, 0.07, 0.168, 0.169, 0.193, 0.186]","[0.129, 0.184, 0.129, 0.048, 0.136, 0.139, 0.161, 0.156]","[0.733, 0.745, 0.733, 0.709, 0.741, 0.734, 0.737, 0.737]","[0.635, 0.651, 0.635, 0.603, 0.646, 0.635, 0.639, 0.639]","[0.579, 0.592, 0.579, 0.568, 0.6, 0.594, 0.594, 0.579]","[0.658, 0.689, 0.658, 0.617, 0.649, 0.651, 0.67, 0.675]","[0.787, 0.797, 0.787, 0.785, 0.795, 0.8, 0.796, 0.776]","[0.701, 0.722, 0.701, 0.707, 0.721, 0.714, 0.717, 0.684]","[0.608, 0.642, 0.608, 0.618, 0.626, 0.612, 0.629, 0.603]","[0.914, 0.914, 0.914, 0.914, 0.914, 0.919, 0.915, 0.911]","[0.793, 0.801, 0.793, 0.798, 0.806, 0.804, 0.808, 0.796]","[0.74, 0.759, 0.74, 0.745, 0.756, 0.747, 0.755, 0.732]","[0.773, 0.788, 0.773, 0.782, 0.787, 0.788, 0.791, 0.771]","[0.764, 0.773, 0.764, 0.766, 0.773, 0.775, 0.777, 0.762]",0.433,0.518,0.601,0.149,0.165,0.135,0.734,0.635,0.586,0.658,0.79,0.708,0.618,0.914,0.8,0.747,0.782,0.769
https://doi.org/10.1001/jama.289.13.1645,effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia,700_effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia.pdf,10,"['https://www.federalregister.gov/documents/2013/11/19/2013-27514/revised-medical-criteria-for-evaluating-hematological-disorders', 'https://purl.fdlp.gov/GPO/gpo85514', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390490/pdf', 'https://www.congress.gov/event/114th-congress/house-event/LC51919/text', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478259/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517046/pdf', 'https://www.thoracic.org/statements/resources/pvd/sickle-cell-disease.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275984/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983842/pdf']","['Revised Medical Criteria for Evaluating Hematological Disorders', 'Examining legislation to improve public health :\xa0hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, September 8, 2016.', 'Hematopoietic stem cell transplantation for people with sickle cell disease', 'House Hearing, 114th Congress — EXAMINING LEGISLATION TO IMPROVE PUBLIC HEALTH', 'Interventions for chronic kidney disease in people with sickle cell disease', 'Hydroxyurea (hydroxycarbamide) for sickle cell disease', 'Gene therapy for sickle cell disease', 'An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease', 'Gene therapy for sickle cell disease', 'An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478259/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275984/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517046/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983842/pdf', 'https://www.thoracic.org/statements/resources/pvd/sickle-cell-disease.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390490/pdf']","['700_5_hydroxyurea hydroxycarbamide for sickle cell disease.pdf', '700_8_gene therapy for sickle cell disease.pdf', '700_4_interventions for chronic kidney disease in people with sickle cell disease.pdf', '700_6_gene therapy for sickle cell disease.pdf', '700_9_an official american thoracic society clinical practice guideline diagnosis risk stratification and management of pulmonary hypertension of sickle cell disease.pdf', '700_7_an official american thoracic society clinical practice guideline diagnosis risk stratification and management of pulmonary hypertension of sickle cell disease.pdf', '700_2_hematopoietic stem cell transplantation for people with sickle cell disease.pdf']",7,70.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478259/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275984/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517046/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983842/pdf', 'https://www.thoracic.org/statements/resources/pvd/sickle-cell-disease.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390490/pdf']","['700_5_hydroxyurea hydroxycarbamide for sickle cell disease.pdf', '700_8_gene therapy for sickle cell disease.pdf', '700_4_interventions for chronic kidney disease in people with sickle cell disease.pdf', '700_6_gene therapy for sickle cell disease.pdf', '700_9_an official american thoracic society clinical practice guideline diagnosis risk stratification and management of pulmonary hypertension of sickle cell disease.pdf', '700_7_an official american thoracic society clinical practice guideline diagnosis risk stratification and management of pulmonary hypertension of sickle cell disease.pdf', '700_2_hematopoietic stem cell transplantation for people with sickle cell disease.pdf']","[0.302, 0.361, 0.471, 0.247, 0.478, 0.233, 0.478]","[0.521, 0.507, 0.518, 0.509, 0.528, 0.528, 0.515]","[0.601, 0.599, 0.603, 0.6, 0.61, 0.61, 0.604]","[0.178, 0.146, 0.165, 0.147, 0.171, 0.171, 0.154]","[0.176, 0.159, 0.163, 0.159, 0.173, 0.173, 0.165]","[0.142, 0.122, 0.129, 0.122, 0.131, 0.131, 0.122]","[0.742, 0.728, 0.738, 0.731, 0.74, 0.74, 0.735]","[0.646, 0.626, 0.639, 0.629, 0.644, 0.644, 0.635]","[0.585, 0.579, 0.585, 0.58, 0.595, 0.595, 0.588]","[0.689, 0.694, 0.684, 0.692, 0.672, 0.672, 0.689]","[0.78, 0.775, 0.781, 0.777, 0.788, 0.788, 0.778]","[0.694, 0.694, 0.691, 0.691, 0.711, 0.711, 0.699]","[0.592, 0.587, 0.592, 0.588, 0.624, 0.624, 0.597]","[0.912, 0.917, 0.915, 0.918, 0.92, 0.92, 0.921]","[0.819, 0.825, 0.816, 0.823, 0.815, 0.815, 0.826]","[0.729, 0.726, 0.73, 0.728, 0.751, 0.751, 0.733]","[0.766, 0.763, 0.768, 0.766, 0.782, 0.782, 0.769]","[0.756, 0.757, 0.759, 0.76, 0.771, 0.771, 0.764]",0.367,0.518,0.604,0.162,0.167,0.128,0.736,0.638,0.587,0.685,0.781,0.699,0.601,0.918,0.82,0.735,0.771,0.763
https://doi.org/10.1001/jama.289.13.1652,drugdrug interactions among elderly patients hospitalized for drug toxicity,701_drugdrug interactions among elderly patients hospitalized for drug toxicity.pdf,2,"['https://www.hrsonline.org/documents/2005-management-chronic-heart-failure-adultpdf/download', 'https://www.hrsonline.org/documents/2013-management-heart-failurepdf/download']","['2005 ACC/AHA Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult', '2013 ACCF/AHA Guideline for the Management of Heart Failure']","['https://www.hrsonline.org/documents/2013-management-heart-failurepdf/download', 'https://www.hrsonline.org/documents/2005-management-chronic-heart-failure-adultpdf/download']","['701_1_2013 accfaha guideline for the management of heart failure.pdf', '701_0_2005 accaha guideline update for the diagnosis and management of chronic heart failure in the adult.pdf']",2,100.0,"['https://www.hrsonline.org/documents/2013-management-heart-failurepdf/download', 'https://www.hrsonline.org/documents/2005-management-chronic-heart-failure-adultpdf/download']","['701_1_2013 accfaha guideline for the management of heart failure.pdf', '701_0_2005 accaha guideline update for the diagnosis and management of chronic heart failure in the adult.pdf']","[0.34, 0.286]","[0.53, 0.545]","[0.62, 0.63]","[0.154, 0.158]","[0.159, 0.167]","[0.118, 0.12]","[0.74, 0.741]","[0.648, 0.646]","[0.604, 0.62]","[0.652, 0.647]","[0.796, 0.804]","[0.701, 0.721]","[0.598, 0.607]","[0.919, 0.92]","[0.813, 0.821]","[0.746, 0.758]","[0.778, 0.791]","[0.771, 0.782]",0.313,0.538,0.625,0.156,0.163,0.119,0.74,0.647,0.612,0.649,0.8,0.711,0.603,0.919,0.817,0.752,0.784,0.776
https://doi.org/10.1001/jama.289.20.2663,effect of estrogen plus progestin on global cognitive function in postmenopausal women,702_effect of estrogen plus progestin on global cognitive function in postmenopausal women.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400714/pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/01.str.0000442009.06663.48?download=true', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599876/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943378-6']","['Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care', 'Guidelines for the Prevention of Stroke in Women', 'Hormone replacement therapy for cognitive function in postmenopausal women', 'American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause']","['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943378-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400714/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599876/pdf']","['702_3_american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.pdf', '702_0_hormone replacement therapy for the primary prevention of chronic diseases recommendation statement from the canadian task force on preventive health care.pdf', '702_2_hormone replacement therapy for cognitive function in postmenopausal women.pdf']",3,75.0,"['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943378-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400714/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599876/pdf']","['702_3_american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.pdf', '702_0_hormone replacement therapy for the primary prevention of chronic diseases recommendation statement from the canadian task force on preventive health care.pdf', '702_2_hormone replacement therapy for cognitive function in postmenopausal women.pdf']","[0.454, 0.485, 0.483]","[0.483, 0.492, 0.492]","[0.569, 0.584, 0.57]","[0.14, 0.154, 0.155]","[0.145, 0.167, 0.155]","[0.122, 0.137, 0.136]","[0.735, 0.736, 0.739]","[0.641, 0.643, 0.642]","[0.549, 0.559, 0.56]","[0.681, 0.676, 0.716]","[0.755, 0.768, 0.75]","[0.667, 0.682, 0.665]","[0.601, 0.606, 0.577]","[0.886, 0.894, 0.885]","[0.775, 0.788, 0.778]","[0.695, 0.699, 0.683]","[0.751, 0.765, 0.749]","[0.701, 0.72, 0.712]",0.474,0.489,0.574,0.15,0.156,0.132,0.737,0.642,0.556,0.691,0.758,0.671,0.595,0.888,0.78,0.692,0.755,0.711
https://doi.org/10.1001/jama.289.21.2835,beltpositioning booster seats and reduction in risk of injury among children in vehicle crashes,703_beltpositioning booster seats and reduction in risk of injury among children in vehicle crashes.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805601/pdf', 'https://stacks.cdc.gov/view/cdc/5837', 'https://www.congress.gov/event/116th-congress/house-event/109842', 'https://papers.nber.org/papers/W11591', 'https://papers.nber.org/papers/w12519', 'http://purl.fdlp.gov/GPO/gpo60619', 'https://phpa.health.maryland.gov/ohpetup/kiss/docs/Issue_Report_Laws.pdf', 'https://www.congress.gov/event/113th-congress/senate-event/LC32311/text?s=1&r=8604', 'https://www.michigan.gov/documents/msp/2015_Child_Restraint_and_Booster_Seat_Report_-_REVISED_FINAL_DRAFT_9-8-15_505073_7.pdf', 'https://phpa.health.maryland.gov/ohpetup/kiss/docs/BS_Progress_Report.pdf']","['Interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles', 'Health disparities and inequalities report--United States, 2011', '""Legislation to Make Cars in America Safer""', 'Evidence that Seat Belts are as Effective as Child Safety Seats in Preventing Death for Children Aged Two and Up', 'Evaluating the Effectiveness of Child Safety Seats and Seat Belts in Protecting Children from Injury', 'Oversight of and policy considerations for the National Highway Traffic Safety Administration :\xa0hearing before the Subcommittee on Consumer Protection, Product Safety, and Insurance of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Thirteenth Congress, second session, September 16, 2014.', 'Issue Report', 'S.Hrg. 113-698 — OVERSIGHT OF AND POLICY CONSIDERATIONS FOR THE NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION', 'Microsoft Word - 2018 Child Restraint and Booster Seat Report - FINAL REPORT - Revision #1 - 10-17-18', 'Improving theAx Older-Child Passengers']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805601/pdf', 'https://www.michigan.gov/documents/msp/2015_Child_Restraint_and_Booster_Seat_Report_-_REVISED_FINAL_DRAFT_9-8-15_505073_7.pdf']","['703_0_interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles.pdf', '703_8_microsoft word  2018 child restraint and booster seat report  final report  revision 1  101718.pdf']",2,20.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805601/pdf', 'https://www.michigan.gov/documents/msp/2015_Child_Restraint_and_Booster_Seat_Report_-_REVISED_FINAL_DRAFT_9-8-15_505073_7.pdf']","['703_0_interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles.pdf', '703_8_microsoft word  2018 child restraint and booster seat report  final report  revision 1  101718.pdf']","[0.609, 0.562]","[0.521, 0.522]","[0.59, 0.588]","[0.176, 0.182]","[0.194, 0.204]","[0.161, 0.166]","[0.733, 0.741]","[0.638, 0.646]","[0.582, 0.574]","[0.68, 0.683]","[0.787, 0.778]","[0.709, 0.693]","[0.616, 0.638]","[0.914, 0.907]","[0.818, 0.824]","[0.739, 0.746]","[0.782, 0.78]","[0.764, 0.768]",0.586,0.522,0.589,0.179,0.199,0.164,0.737,0.642,0.578,0.681,0.782,0.701,0.627,0.911,0.821,0.742,0.781,0.766
https://doi.org/10.1001/jama.289.21.joc30885,clinical features and shortterm outcomes of 144 patients with sars in the greater toronto area,704_clinical features and shortterm outcomes of 144 patients with sars in the greater toronto area.pdf,9,"['https://www.rand.org/pubs/technical_reports/TR285.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141585/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129583/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105038/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670528/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267482/pdf']","['Learning from Experience: The Public Health Response to West Nile Virus, SARS, Monkeypox, and Hepatitis A Outbreaks in the United States', 'Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS) - No. 225, April 2009', 'Update to the Latin American Thoracic Society (ALAT) Recommendations on Community-Acquired Pneumonia', 'Bronchoscopy in the Age of COVID-19', 'Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)', 'No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)', 'Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations', 'Hospital management of adults with severe acute respiratory syndrome (SARS) if SARS re-emerges—updated 10 February 2004', 'Considerations for head and neck oncology practices during the coronavirus disease 2019 (‐19) pandemic: Wuhan and Toronto experience']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129583/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141585/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267482/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670528/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105038/pdf']","['704_4_management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome sars.pdf', '704_2_update to the latin american thoracic society alat recommendations on communityacquired pneumonia.pdf', '704_1_management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome sars  no 225 april 2009.pdf', '704_3_bronchoscopy in the age of covid19.pdf', '704_8_considerations for head and neck oncology practices during the coronavirus disease 2019 ‐19 pandemic wuhan and toronto experience.pdf', '704_7_hospital management of adults with severe acute respiratory syndrome sars if sars reemerges—updated 10 february 2004.pdf', '704_6_cardiac surgery during the coronavirus disease 2019 pandemic perioperative considerations and triage recommendations.pdf', '704_5_no 225management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome sars.pdf']",8,88.89,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129583/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141585/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267482/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670528/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105038/pdf']","['704_4_management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome sars.pdf', '704_2_update to the latin american thoracic society alat recommendations on communityacquired pneumonia.pdf', '704_1_management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome sars  no 225 april 2009.pdf', '704_3_bronchoscopy in the age of covid19.pdf', '704_8_considerations for head and neck oncology practices during the coronavirus disease 2019 ‐19 pandemic wuhan and toronto experience.pdf', '704_7_hospital management of adults with severe acute respiratory syndrome sars if sars reemerges—updated 10 february 2004.pdf', '704_6_cardiac surgery during the coronavirus disease 2019 pandemic perioperative considerations and triage recommendations.pdf', '704_5_no 225management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome sars.pdf']","[0.453, 0.352, 0.332, 0.456, 0.46, 0.359, 0.522, 0.304]","[0.538, 0.547, 0.527, 0.538, 0.537, 0.553, 0.536, 0.549]","[0.614, 0.623, 0.607, 0.61, 0.616, 0.621, 0.612, 0.619]","[0.172, 0.181, 0.164, 0.163, 0.155, 0.182, 0.173, 0.176]","[0.183, 0.181, 0.177, 0.168, 0.161, 0.201, 0.172, 0.189]","[0.136, 0.132, 0.133, 0.129, 0.123, 0.148, 0.127, 0.137]","[0.737, 0.738, 0.736, 0.734, 0.736, 0.737, 0.738, 0.735]","[0.642, 0.645, 0.64, 0.639, 0.641, 0.642, 0.643, 0.642]","[0.617, 0.629, 0.606, 0.619, 0.619, 0.631, 0.615, 0.624]","[0.635, 0.656, 0.641, 0.671, 0.642, 0.659, 0.649, 0.64]","[0.802, 0.806, 0.799, 0.805, 0.806, 0.809, 0.799, 0.806]","[0.701, 0.747, 0.696, 0.748, 0.75, 0.753, 0.737, 0.741]","[0.625, 0.627, 0.612, 0.61, 0.619, 0.63, 0.622, 0.628]","[0.92, 0.916, 0.918, 0.914, 0.913, 0.919, 0.921, 0.916]","[0.819, 0.829, 0.818, 0.83, 0.833, 0.836, 0.824, 0.832]","[0.761, 0.773, 0.756, 0.769, 0.767, 0.777, 0.759, 0.771]","[0.796, 0.8, 0.794, 0.798, 0.803, 0.808, 0.795, 0.802]","[0.783, 0.787, 0.782, 0.786, 0.789, 0.794, 0.781, 0.788]",0.405,0.541,0.615,0.171,0.179,0.133,0.736,0.642,0.62,0.649,0.804,0.734,0.622,0.917,0.828,0.767,0.8,0.786
https://doi.org/10.1001/jama.289.8.989,alcohol consumption and expenditures for underage drinking and adult excessive drinking,705_alcohol consumption and expenditures for underage drinking and adult excessive drinking.pdf,7,"['https://www.michigan.gov/documents/mdch/YTS_Alcohol_Type_Brief_342096_7.pdf', 'https://www.rand.org/pubs/rgs_dissertations/RGSD228.html', 'https://www.congress.gov/event/108th-congress/house-event/LC14845/text', 'https://www.cato.org/policy-analysis/back-door-prohibition-new-war-social-drinking', 'https://stacks.cdc.gov/view/cdc/5581', 'http://www.dhss.alaska.gov/abada/Documents/FASDguide_web.pdf', 'https://www.rand.org/pubs/technical_reports/TR403.html']","['YTS Alcohol Type Brief 10-2010.pub', 'Essays on Environmental Determinants of Health Behaviors and Outcomes', 'PREVENTING UNDERAGE DRINKING: WHAT WORKS?', 'Back Door to Prohibition: The New War on Social Drinking', 'Fetal alcohol spectrum disorders; competency-based curriculum development guide for medical and allied health education and practice', 'FASDguide web', 'Preventing Underage Drinking: Using Getting To Outcomesâ\x84¢ with the SAMHSA Strategic Prevention Framework to Achieve Results']","['http://www.dhss.alaska.gov/abada/Documents/FASDguide_web.pdf', 'https://www.michigan.gov/documents/mdch/YTS_Alcohol_Type_Brief_342096_7.pdf']","['705_5_fasdguide web.pdf', '705_0_yts alcohol type brief 102010pub.pdf']",2,28.57,"['http://www.dhss.alaska.gov/abada/Documents/FASDguide_web.pdf', 'https://www.michigan.gov/documents/mdch/YTS_Alcohol_Type_Brief_342096_7.pdf']","['705_5_fasdguide web.pdf', '705_0_yts alcohol type brief 102010pub.pdf']","[0.433, 0.384]","[0.514, 0.525]","[0.609, 0.61]","[0.137, 0.207]","[0.16, 0.247]","[0.129, 0.202]","[0.726, 0.745]","[0.625, 0.648]","[0.585, 0.587]","[0.676, 0.719]","[0.788, 0.787]","[0.714, 0.72]","[0.615, 0.632]","[0.918, 0.912]","[0.824, 0.818]","[0.754, 0.743]","[0.794, 0.789]","[0.779, 0.774]",0.408,0.52,0.609,0.172,0.204,0.166,0.736,0.637,0.586,0.698,0.788,0.717,0.623,0.915,0.821,0.748,0.792,0.776
https://doi.org/10.1001/jama.290.12.1583,health status of adult longterm survivors of childhood cancer a report from the childhood cancer survivor study,707_health status of adult longterm survivors of childhood cancer a report from the childhood cancer survivor study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500837/pdf', 'https://effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/research', 'https://www.ida.org/research-and-publications/publications/all/f/fe/feasibility-study-for-evaluation-of-the-childhood-cancer-survivor-study-ccss']","['Female Reproductive Health After Childhood, Adolescent, and Young Adult Cancers: Guidelines for the Assessment and Management of Female Reproductive Complications', 'Disparities and Barriers to Pediatric Cancer Survivorship Care', 'Feasibility Study for Evaluation of the Childhood Cancer Survivor Study (CCSS)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500837/pdf'],['707_0_female reproductive health after childhood adolescent and young adult cancers guidelines for the assessment and management of female reproductive complications.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500837/pdf'],['707_0_female reproductive health after childhood adolescent and young adult cancers guidelines for the assessment and management of female reproductive complications.pdf'],[0.442],[0.508],[0.6],[0.147],[0.143],[0.123],[0.745],[0.648],[0.58],[0.638],[0.789],[0.687],[0.597],[0.908],[0.784],[0.73],[0.776],[0.761],0.442,0.508,0.6,0.147,0.143,0.123,0.745,0.648,0.58,0.638,0.789,0.687,0.597,0.908,0.784,0.73,0.776,0.761
https://doi.org/10.1001/jama.290.13.1721,early infant feeding and risk of developing type 1 diabetes–associated autoantibodies,708_early infant feeding and risk of developing type 1 diabetes–associated autoantibodies.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464122/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943460-3']","['Recommendations on complementary feeding for healthy, full-term infants', 'Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464122/pdf'],['708_0_recommendations on complementary feeding for healthy fullterm infants.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464122/pdf'],['708_0_recommendations on complementary feeding for healthy fullterm infants.pdf'],[0.504],[0.525],[0.611],[0.165],[0.174],[0.142],[0.736],[0.638],[0.598],[0.655],[0.795],[0.721],[0.621],[0.91],[0.817],[0.757],[0.793],[0.78],0.504,0.525,0.611,0.165,0.174,0.142,0.736,0.638,0.598,0.655,0.795,0.721,0.621,0.91,0.817,0.757,0.793,0.78
https://doi.org/10.1001/jama.290.13.1729,effects of estrogen plus progestin on risk of fracture and bone mineral densitysubtitlethe womens health initiative randomized trialsubtitle,709_effects of estrogen plus progestin on risk of fracture and bone mineral densitysubtitlethe womens health initiative randomized trialsubtitle.pdf,10,"['https://effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research', 'https://www.ncbi.nlm.nih.gov/books/n/rptosteo/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613968/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026233/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443956/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587294/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659514/pdf', 'https://pdf.sciencedirectassets.com/777989/1-s2.0-S1530891X20X51007/1-s2.0-S1530891X20428277/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEMj%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJGMEQCIAi8ThA1YKyLxu94WH8pBx742MUgkK%2BWaN%2B1di%2FF%2BmKgAiA8BacD7MEGz8tNmxN%2FGE%2BOE%2FpL0oDocYdT7kpr0WSPuSrMBAhhEAUaDDA1OTAwMzU0Njg2NSIMdzwoDxqDWpR%2Ba97gKqkEKUyRX2VznWZdoCgHWvat919qJDm67cFOCpldUzH%2FFZtq%2FzX42tb9YQC89%2FFrVaojEwdh1rMIEEWko6I0tDJT2CzTPMeILpfMhRQNHSrLhH2e0RXSknlV5ihiNphrFjXXgQ%2B6upQhJjatjgoxMPHEEg11yAwC8Ain9h%2BTtqLK%2B83szYjh3U2VhGH6SjR7OyExoGTxR%2FTyndpRNbOpIWHdOrpMkGDwlKbp4PWomQqNfklH0yMZE2SXDEvbfhBxex2ySCIQZGAHJERF8P%2FmcKIIcLTxSVOG4Tc2ERFC%2FoGjYIAGA%2FVe%2BnHTkrPl3otBs%2FV%2FFJlZh8tnkK4%2BvQAqNSahWWPDl3dI8Et5fiLD7XyyFOD6Q2jG92EHEOJ12rhMU0rUpoE02cFEc9AOTMRPGWqlDVOr5i5KJtcQU%2FeYhUFudwLKXWrs0ilnzFU%2B8AQ1tPsw93rncfZsAoTCH8%2B3kzImTkG2pQxwk32PrN8jdbp%2FwOKxFz%2FR4sYd2jnLGoch0%2FYF1RkUKvEQTfqj8AqOR6k3GVCqnFWE1iUf7ynRsxsedtDFmaiQeGMkgrnD%2B6GSeEDal%2BGQi%2F3MVBndAEwiuMJLV3yMHuD7lnWCpTj0bnGy9zPjmTAxknwdKE%2B5wHuAlMizzR31mAiZi8aaOozUvQfgE1uw3om6pfN%2BELbbqkRrQVWxI43s%2BF1sL0Pq4nkBMFxZfnFQ%2FW%2Bp5WjU4WIOx6cvYw%2FecbQGI1oxzzD0ur6fBjqqAT5h1y3jnvsB0Ac7CbcUGoLAWk8vUAZQg9Cy2F30LGZ%2FKRwwqn3SIDyBXQ1rHnOKhIsURN7NJbp7RuuxSRNDFzpVAdwUkAbkjlwLUEmOdtehInTnPcYMqt96%2BjtAGKdC9sWggXmvBQLI3fW83I5%2FByCbDhKd0zQZSxfH%2F6E49kzCxsrrBZrR2nWbf2LEHNU6VjQgZ0RKUInOKld58VupT9G5zwpnwU54eUKH&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20230217T154112Z&X-Amz-SignedHeaders=host&X-Amz-Expires=300&X-Amz-Credential=ASIAQ3PHCVTYT3WDLNHI%2F20230217%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Signature=c2d113dd78697d1623bb2c9429dab4f9f10aaa2ebae0ce715771b6713ab3615d&hash=c34d5dd774576e99909e88363d67fb35941070c27e3fd3ee26b83f586fb39376&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S1530891X20428277&tid=spdf-6feb6979-c8d6-491c-a318-d2c1fba0e996&sid=d8db52017bd5484cfc3b47e2b4adccf2f369gxrqb&type=client&download=true&ua=0907585f0f080e5557&rr=79afa034683924e4&cc=gb']","['Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review', 'Bone Health and Osteoporosis', 'European guidance for the diagnosis and management of osteoporosis in postmenopausal women', 'Long‐term hormone therapy for perimenopausal and postmenopausal women', 'European guidance for the diagnosis and management of osteoporosis in postmenopausal women', 'Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society', 'The 2012 Hormone Therapy Position Statement of The North American Menopause Society', 'European guidance for the diagnosis and management of osteoporosis in postmenopausal women', 'Estimates of the Proportion of Older White Women Who Would Be Recommended for Pharmacologic Treatment by the New U.S. National Osteoporosis Foundation Guidelines', 'American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026233/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613968/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443956/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587294/pdf']","['709_5_estrogen and progestogen use in postmenopausal women july 2008 position statement of the north american menopause society.pdf', '709_3_long‐term hormone therapy for perimenopausal and postmenopausal women.pdf', '709_4_european guidance for the diagnosis and management of osteoporosis in postmenopausal women.pdf', '709_8_estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new us national osteoporosis foundation guidelines.pdf', '709_2_european guidance for the diagnosis and management of osteoporosis in postmenopausal women.pdf', '709_6_the 2012 hormone therapy position statement of the north american menopause society.pdf', '709_7_european guidance for the diagnosis and management of osteoporosis in postmenopausal women.pdf']",7,70.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026233/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613968/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443956/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587294/pdf']","['709_5_estrogen and progestogen use in postmenopausal women july 2008 position statement of the north american menopause society.pdf', '709_3_long‐term hormone therapy for perimenopausal and postmenopausal women.pdf', '709_4_european guidance for the diagnosis and management of osteoporosis in postmenopausal women.pdf', '709_8_estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new us national osteoporosis foundation guidelines.pdf', '709_2_european guidance for the diagnosis and management of osteoporosis in postmenopausal women.pdf', '709_6_the 2012 hormone therapy position statement of the north american menopause society.pdf', '709_7_european guidance for the diagnosis and management of osteoporosis in postmenopausal women.pdf']","[0.684, 0.439, 0.684, 0.496, 0.507, 0.677, 0.608]","[0.482, 0.504, 0.532, 0.54, 0.525, 0.484, 0.528]","[0.593, 0.585, 0.616, 0.612, 0.615, 0.589, 0.615]","[0.162, 0.169, 0.184, 0.202, 0.183, 0.161, 0.183]","[0.178, 0.159, 0.201, 0.219, 0.195, 0.179, 0.198]","[0.143, 0.134, 0.172, 0.178, 0.164, 0.143, 0.168]","[0.736, 0.738, 0.742, 0.741, 0.739, 0.736, 0.741]","[0.642, 0.644, 0.649, 0.647, 0.645, 0.643, 0.648]","[0.575, 0.57, 0.598, 0.602, 0.596, 0.574, 0.595]","[0.691, 0.701, 0.706, 0.712, 0.704, 0.686, 0.704]","[0.773, 0.771, 0.801, 0.799, 0.797, 0.774, 0.801]","[0.662, 0.668, 0.723, 0.726, 0.718, 0.663, 0.719]","[0.58, 0.589, 0.614, 0.629, 0.62, 0.581, 0.615]","[0.912, 0.906, 0.92, 0.916, 0.918, 0.913, 0.92]","[0.807, 0.793, 0.821, 0.823, 0.818, 0.803, 0.82]","[0.723, 0.718, 0.754, 0.758, 0.754, 0.723, 0.753]","[0.767, 0.763, 0.797, 0.793, 0.795, 0.768, 0.797]","[0.762, 0.747, 0.782, 0.779, 0.778, 0.762, 0.781]",0.585,0.514,0.604,0.178,0.19,0.157,0.739,0.645,0.587,0.701,0.788,0.697,0.604,0.915,0.812,0.74,0.783,0.77
https://doi.org/10.1001/jama.290.13.1763,association between thimerosalcontaining vaccine and autism,710_association between thimerosalcontaining vaccine and autism.pdf,7,"['https://www.federalregister.gov/documents/2017/01/19/2017-00701/national-vaccine-injury-compensation-program-revisions-to-the-vaccine-injury-table', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2004_11.pdf', 'http://epibulletins.dhss.alaska.gov/Document/Display?DocumentId=357', 'https://www.bakerinstitute.org/research/vaccines-texas/', 'https://papers.nber.org/papers/w12632', 'https://stacks.cdc.gov/view/cdc/26135', 'https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf']","['National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table', 'Use of Traditional Foods in a Healthy Diet in Alaska : Risks in Perspective', 'Use of Traditional Foods ina Healthy Diet in Alaska: Risks in Perspective', 'Vaccine myths and challenges', 'Does Television Cause Autism?', 'Understanding thimerosal, mercury, and vaccine safety', 'Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update']","['https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2004_11.pdf']","['710_6_therapies for children with autism spectrum disorder behavioral interventions update.pdf', '710_1_use of traditional foods in a healthy diet in alaska  risks in perspective.pdf']",2,28.57,['http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2004_11.pdf'],['710_1_use of traditional foods in a healthy diet in alaska  risks in perspective.pdf'],[0.108],[0.487],[0.575],[0.119],[0.117],[0.1],[0.727],[0.637],[0.557],[0.65],[0.789],[0.688],[0.615],[0.901],[0.784],[0.736],[0.78],[0.767],0.108,0.487,0.575,0.119,0.117,0.1,0.727,0.637,0.557,0.65,0.789,0.688,0.615,0.901,0.784,0.736,0.78,0.767
https://doi.org/10.1001/jama.290.15.2061,race and outcome in childhood acute lymphoblastic leukemia,711_race and outcome in childhood acute lymphoblastic leukemia.pdf,1,['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf'],"['Martin Blank, PhD Columbia University New York, NY 10032 email : mb32 @ cumc. columbia. edu']",['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf'],['711_0_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf'],1,100.0,['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf'],['711_0_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf'],[0.245],[0.523],[0.606],[0.107],[0.095],[0.074],[0.728],[0.629],[0.612],[0.64],[0.806],[0.741],[0.623],[0.903],[0.818],[0.769],[0.8],[0.789],0.245,0.523,0.606,0.107,0.095,0.074,0.728,0.629,0.612,0.64,0.806,0.741,0.623,0.903,0.818,0.769,0.8,0.789
https://doi.org/10.1001/jama.290.17.2271,childhood cardiovascular risk factors and carotid vascular changes in adulthood,712_childhood cardiovascular risk factors and carotid vascular changes in adulthood.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099072/pdf', 'https://www.asecho.org/wp-content/uploads/2013/05/Use-of-Carotid-US-to-ID-Subclinical-Vasc-Disease-and-Eval-Disease-Risk.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198284/pdf']","['Guidance for Pediatric Familial Hypercholesterolemia 2017', 'Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017', 'Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the ASE Carotid Intima-Media Thickness Task Force', 'Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems - A position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the ...']","['https://www.asecho.org/wp-content/uploads/2013/05/Use-of-Carotid-US-to-ID-Subclinical-Vasc-Disease-and-Eval-Disease-Risk.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099072/pdf']","['712_2_use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk a consensus statement from the ase carotid intimamedia thickness task force.pdf', '712_0_guidance for pediatric familial hypercholesterolemia 2017.pdf', '712_1_guidelines for diagnosis and treatment of familial hypercholesterolemia 2017.pdf']",3,75.0,"['https://www.asecho.org/wp-content/uploads/2013/05/Use-of-Carotid-US-to-ID-Subclinical-Vasc-Disease-and-Eval-Disease-Risk.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099072/pdf']","['712_2_use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk a consensus statement from the ase carotid intimamedia thickness task force.pdf', '712_0_guidance for pediatric familial hypercholesterolemia 2017.pdf', '712_1_guidelines for diagnosis and treatment of familial hypercholesterolemia 2017.pdf']","[0.302, 0.289, 0.512]","[0.534, 0.55, 0.543]","[0.622, 0.632, 0.629]","[0.176, 0.172, 0.171]","[0.186, 0.177, 0.173]","[0.141, 0.135, 0.129]","[0.745, 0.741, 0.741]","[0.651, 0.638, 0.642]","[0.607, 0.626, 0.62]","[0.686, 0.63, 0.632]","[0.797, 0.814, 0.81]","[0.723, 0.737, 0.732]","[0.623, 0.632, 0.628]","[0.922, 0.924, 0.923]","[0.822, 0.831, 0.83]","[0.764, 0.777, 0.771]","[0.792, 0.805, 0.802]","[0.779, 0.795, 0.791]",0.368,0.542,0.628,0.173,0.179,0.135,0.742,0.644,0.618,0.649,0.807,0.731,0.628,0.923,0.828,0.771,0.8,0.788
https://doi.org/10.1001/jama.290.17.2277,cardiovascular risk factors in childhood and carotid artery intimamedia thickness in adulthood,713_cardiovascular risk factors in childhood and carotid artery intimamedia thickness in adulthood.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738765/pdf', 'https://www.asecho.org/wp-content/uploads/2013/05/Use-of-Carotid-US-to-ID-Subclinical-Vasc-Disease-and-Eval-Disease-Risk.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105320/pdf']","['2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents', '2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents', 'Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the ASE Carotid Intima-Media Thickness Task Force', 'Preventing Tobacco Use Among Youth and Young Adults', 'Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association']","['https://www.asecho.org/wp-content/uploads/2013/05/Use-of-Carotid-US-to-ID-Subclinical-Vasc-Disease-and-Eval-Disease-Risk.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105320/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738765/pdf']","['713_2_use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk a consensus statement from the ase carotid intimamedia thickness task force.pdf', '713_0_2017 clinical practice guidelines for dyslipidemia of korean children and adolescents.pdf', '713_4_type 1 diabetes in children and adolescents a position statement by the american diabetes association.pdf', '713_1_2017 clinical practice guidelines for dyslipidemia of korean children and adolescents.pdf']",4,80.0,"['https://www.asecho.org/wp-content/uploads/2013/05/Use-of-Carotid-US-to-ID-Subclinical-Vasc-Disease-and-Eval-Disease-Risk.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105320/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738765/pdf']","['713_2_use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk a consensus statement from the ase carotid intimamedia thickness task force.pdf', '713_0_2017 clinical practice guidelines for dyslipidemia of korean children and adolescents.pdf', '713_4_type 1 diabetes in children and adolescents a position statement by the american diabetes association.pdf', '713_1_2017 clinical practice guidelines for dyslipidemia of korean children and adolescents.pdf']","[0.382, 0.378, 0.564, 0.198]","[0.541, 0.527, 0.53, 0.529]","[0.621, 0.616, 0.607, 0.617]","[0.181, 0.174, 0.135, 0.174]","[0.192, 0.187, 0.152, 0.185]","[0.146, 0.143, 0.115, 0.143]","[0.745, 0.738, 0.735, 0.738]","[0.651, 0.64, 0.63, 0.64]","[0.609, 0.606, 0.599, 0.606]","[0.694, 0.662, 0.657, 0.66]","[0.794, 0.794, 0.795, 0.794]","[0.728, 0.722, 0.722, 0.721]","[0.626, 0.618, 0.607, 0.619]","[0.92, 0.917, 0.92, 0.917]","[0.821, 0.821, 0.811, 0.819]","[0.76, 0.754, 0.752, 0.754]","[0.787, 0.783, 0.784, 0.782]","[0.775, 0.774, 0.774, 0.774]",0.38,0.532,0.615,0.166,0.179,0.137,0.739,0.64,0.605,0.668,0.794,0.723,0.617,0.919,0.818,0.755,0.784,0.774
https://doi.org/10.1001/jama.290.18.2464,current status of pain management in children,714_current status of pain management in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf'],['Non‐pharmacological management of infant and young child procedural pain'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf'],['714_0_non‐pharmacological management of infant and young child procedural pain.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf'],['714_0_non‐pharmacological management of infant and young child procedural pain.pdf'],[0.458],[0.518],[0.605],[0.16],[0.174],[0.14],[0.737],[0.639],[0.581],[0.681],[0.776],[0.697],[0.596],[0.913],[0.807],[0.724],[0.77],[0.761],0.458,0.518,0.605,0.16,0.174,0.14,0.737,0.639,0.581,0.681,0.776,0.697,0.596,0.913,0.807,0.724,0.77,0.761
https://doi.org/10.1001/jama.290.19.2564,effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress,715_effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress.pdf,4,"['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Expanded-Newborn-Screening/Expanded_NewbornScreening09.pdf?la=en&hash=802BBC50B1E006808491DDCE913CBB3BF78BD0B5', 'https://www.acmg.net/PDFLibrary/Ethical-Policy-Issues-Genetic-Screening-Children.pdf', 'https://stacks.cdc.gov/view/cdc/11330', 'https://www.rti.org/rti-press-publication/conjoint-analysis-survey']","['Laboratory Medicine Practice Guidelines: Follow-up Testing for Metabolic Diseases Identified by Expanded Newborn Screening Using Tandem Mass Spectrometry', 'Technical report: ethical and policy issues in genetic testing and screening of children', 'Genomics and population health; United States 2003', 'Developing a conjoint analysis survey of parental attitudes regarding voluntary newborn screening']","['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Expanded-Newborn-Screening/Expanded_NewbornScreening09.pdf?la=en&hash=802BBC50B1E006808491DDCE913CBB3BF78BD0B5', 'https://www.acmg.net/PDFLibrary/Ethical-Policy-Issues-Genetic-Screening-Children.pdf']","['715_0_laboratory medicine practice guidelines followup testing for metabolic diseases identified by expanded newborn screening using tandem mass spectrometry.pdf', '715_1_technical report ethical and policy issues in genetic testing and screening of children.pdf']",2,50.0,"['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Expanded-Newborn-Screening/Expanded_NewbornScreening09.pdf?la=en&hash=802BBC50B1E006808491DDCE913CBB3BF78BD0B5', 'https://www.acmg.net/PDFLibrary/Ethical-Policy-Issues-Genetic-Screening-Children.pdf']","['715_0_laboratory medicine practice guidelines followup testing for metabolic diseases identified by expanded newborn screening using tandem mass spectrometry.pdf', '715_1_technical report ethical and policy issues in genetic testing and screening of children.pdf']","[0.333, 0.442]","[0.524, 0.548]","[0.608, 0.632]","[0.146, 0.193]","[0.147, 0.201]","[0.119, 0.169]","[0.734, 0.738]","[0.637, 0.644]","[0.602, 0.621]","[0.667, 0.679]","[0.797, 0.812]","[0.728, 0.748]","[0.627, 0.635]","[0.919, 0.925]","[0.815, 0.834]","[0.754, 0.77]","[0.79, 0.806]","[0.781, 0.793]",0.388,0.536,0.62,0.169,0.174,0.144,0.736,0.641,0.611,0.673,0.804,0.738,0.631,0.922,0.825,0.762,0.798,0.787
https://doi.org/10.1001/jama.290.21.2824,efficacy and safety of echinacea in treating upper respiratory tract infections in children,716_efficacy and safety of echinacea in treating upper respiratory tract infections in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068831/pdf', 'https://www.congress.gov/event/111th-congress/senate-event/LC4304/text?s=1&r=13704']","['Echinacea for preventing and treating the common cold', 'S.Hrg. 111-387 — PRINCIPLES OF INTEGRATIVE HEALTH: A PATH TO HEALTHCARE REFORM']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068831/pdf'],['716_0_echinacea for preventing and treating the common cold.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068831/pdf'],['716_0_echinacea for preventing and treating the common cold.pdf'],[0.457],[0.521],[0.597],[0.172],[0.181],[0.149],[0.738],[0.645],[0.598],[0.673],[0.791],[0.705],[0.604],[0.914],[0.833],[0.747],[0.788],[0.777],0.457,0.521,0.597,0.172,0.181,0.149,0.738,0.645,0.598,0.673,0.791,0.705,0.604,0.914,0.833,0.747,0.788,0.777
https://doi.org/10.1001/jama.290.22.2968,trends in pertussis among infants in the united states 19801999,717_trends in pertussis among infants in the united states 19801999.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf', 'https://stacks.cdc.gov/view/cdc/53561', 'https://stacks.cdc.gov/view/cdc/6790', 'https://stacks.cdc.gov/view/cdc/6969', 'https://stacks.cdc.gov/view/cdc/6752']","['Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants : recommendations of the Advisory Committee on Immunization Practices', 'Preventing tetanus, diphtheria, and pertussis among adolescents; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf'],['717_0_prevention of pertussis tetanus and diphtheria with vaccines in the united states recommendations of the advisory committee on immunization practices acip.pdf'],1,20.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf'],['717_0_prevention of pertussis tetanus and diphtheria with vaccines in the united states recommendations of the advisory committee on immunization practices acip.pdf'],[0.464],[0.549],[0.617],[0.206],[0.227],[0.186],[0.752],[0.661],[0.613],[0.671],[0.804],[0.72],[0.626],[0.915],[0.818],[0.764],[0.794],[0.787],0.464,0.549,0.617,0.206,0.227,0.186,0.752,0.661,0.613,0.671,0.804,0.72,0.626,0.915,0.818,0.764,0.794,0.787
https://doi.org/10.1001/jama.290.23.3122,strengthening the supply of routinely recommended vaccines in the united states,720_strengthening the supply of routinely recommended vaccines in the united states.pdf,2,"['https://www.rti.org/publication/influenza-vaccine-manufacturing-issue-brief', 'https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2003.pdf']","['Influenza vaccine manufacturing. Issue brief', '5962 CEDS_03_AnlRprt']",['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2003.pdf'],['720_1_5962 ceds03anlrprt.pdf'],1,50.0,['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2003.pdf'],['720_1_5962 ceds03anlrprt.pdf'],[0.21],[0.573],[0.645],[0.177],[0.185],[0.146],[0.729],[0.628],[0.651],[0.646],[0.828],[0.771],[0.663],[0.924],[0.845],[0.792],[0.831],[0.815],0.21,0.573,0.645,0.177,0.185,0.146,0.729,0.628,0.651,0.646,0.828,0.771,0.663,0.924,0.845,0.792,0.831,0.815
https://doi.org/10.1001/jama.290.4.465,breast cancer following radiotherapy and chemotherapy among young women with hodgkin disease,722_breast cancer following radiotherapy and chemotherapy among young women with hodgkin disease.pdf,5,"['https://www.hca.wa.gov/assets/program/director-selections-2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483617/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257601/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf']","['Health Technology Assessment Program: Selected Technologies 2014', 'Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis', 'Recommendations for Breast Cancer Surveillance for Female Childhood, Adolescent and Young Adult Cancer Survivors Treated with Chest Radiation: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group', 'ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II', 'Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group']","['https://www.hca.wa.gov/assets/program/director-selections-2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433865/pdf']","['722_0_health technology assessment program selected technologies 2014.pdf', '722_4_updated breast cancer surveillance recommendations for female survivors of childhood adolescent and young adult cancer from the international guideline harmonization group.pdf', '722_3_acr appropriateness criteria® hodgkin lymphomafavorable prognosis stage i and ii.pdf']",3,60.0,"['https://www.hca.wa.gov/assets/program/director-selections-2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433865/pdf']","['722_0_health technology assessment program selected technologies 2014.pdf', '722_4_updated breast cancer surveillance recommendations for female survivors of childhood adolescent and young adult cancer from the international guideline harmonization group.pdf', '722_3_acr appropriateness criteria® hodgkin lymphomafavorable prognosis stage i and ii.pdf']","[0.526, 0.315, 0.716]","[0.508, 0.526, 0.488]","[0.587, 0.611, 0.588]","[0.151, 0.191, 0.16]","[0.151, 0.196, 0.175]","[0.127, 0.166, 0.136]","[0.74, 0.751, 0.744]","[0.647, 0.661, 0.657]","[0.572, 0.588, 0.572]","[0.675, 0.698, 0.691]","[0.775, 0.793, 0.772]","[0.705, 0.716, 0.674]","[0.605, 0.612, 0.572]","[0.901, 0.903, 0.896]","[0.793, 0.805, 0.796]","[0.723, 0.74, 0.711]","[0.77, 0.785, 0.761]","[0.749, 0.768, 0.758]",0.519,0.507,0.595,0.167,0.174,0.143,0.745,0.655,0.577,0.688,0.78,0.698,0.596,0.9,0.798,0.725,0.772,0.758
https://doi.org/10.1001/jama.290.9.1179,trends in career choice by us medical school graduates,723_trends in career choice by us medical school graduates.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1494674/pdf'],['The Future of General Internal Medicine - Report and Recommendations from the Society of General Internal Medicine (SGIM) Task Force on the Domain of General Internal Medicine'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1494674/pdf'],['723_0_the future of general internal medicine  report and recommendations from the society of general internal medicine sgim task force on the domain of general internal medicine.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1494674/pdf'],['723_0_the future of general internal medicine  report and recommendations from the society of general internal medicine sgim task force on the domain of general internal medicine.pdf'],[0.438],[0.538],[0.619],[0.225],[0.245],[0.197],[0.743],[0.651],[0.607],[0.707],[0.804],[0.734],[0.626],[0.912],[0.844],[0.75],[0.8],[0.776],0.438,0.538,0.619,0.225,0.245,0.197,0.743,0.651,0.607,0.707,0.804,0.734,0.626,0.912,0.844,0.75,0.8,0.776
https://doi.org/10.1001/jama.291.14.1763,lung cancer in us women,724_lung cancer in us women.pdf,2,"['https://papers.nber.org/papers/W10653', 'https://www.cmap.illinois.gov/documents/10180/31442/01262010+HEALTH.pdf/f78b354c-277e-4257-81d3-8ae2f744a590']","['Sex Differences in Morbidity and Mortality', 'How will health be a part of the regional plan being created by the Chicago Metropolitan Agency for Planning']",['https://www.cmap.illinois.gov/documents/10180/31442/01262010+HEALTH.pdf/f78b354c-277e-4257-81d3-8ae2f744a590'],['724_1_how will health be a part of the regional plan being created by the chicago metropolitan agency for planning.pdf'],1,50.0,['https://www.cmap.illinois.gov/documents/10180/31442/01262010+HEALTH.pdf/f78b354c-277e-4257-81d3-8ae2f744a590'],['724_1_how will health be a part of the regional plan being created by the chicago metropolitan agency for planning.pdf'],[0.264],[0.501],[0.597],[0.121],[0.131],[0.1],[0.729],[0.625],[0.58],[0.654],[0.792],[0.72],[0.609],[0.909],[0.808],[0.744],[0.784],[0.77],0.264,0.501,0.597,0.121,0.131,0.1,0.729,0.625,0.58,0.654,0.792,0.72,0.609,0.909,0.808,0.744,0.784,0.77
https://doi.org/10.1001/jama.291.16.2013,risk factors for obstructive sleep apnea in adults,726_risk factors for obstructive sleep apnea in adults.pdf,5,"['https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/obstructive-sleep-apnea-in-adults-screening', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2944630-0', 'https://watermark.silverchair.com/jcem4576.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsgwggLEBgkqhkiG9w0BBwagggK1MIICsQIBADCCAqoGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMxBXae0lfV7sZDCkgAgEQgIICe0BEZq-R6kxVGHR4AyQ6juIhTkPXxQg3nddVZrDYfBEZ-4kbuY7IzKKjJ4TbYHeub82sgxF4kUWIxm0ekgZlk14LdUF2CWMHE39RPSMRVE-TNmqKEg9SsxkRT40ra-dkvvcvgwPEhBGd-jLIrgHE_Ivmkn0_apmV9VBUUEIEC1Mm-QU9ariT2tWpN9qjKaPmotnJOj4yFqpE6uaXatw_MKVyqBMlcPTzBVeNzo3eo_cJSggHUqmj56zs6HPdmYFx9HyxyG66ktkvH7iHnJO4IRjVysahA3qOSKSYaOBDgxZYYLIfi3LftxiIAPfFSKepqFwrgijvH9vr_C2mK9dyRwXY817pwg7LFexDRVEzulToDcNGd9k4F-ZugcdDUsBr7V7fHtWYbP9o1KqeMi-08CgQTkLgBtVq2DOZFitU3pdfBgD9L8RjZWjqvJcbZLnJKca9KIr67bH6FZPlYlerBXlxDeOo-xirXCsgkjY7nldILVVaXU6W9l5y_Y7Dn4JbkAKWpFK_e1dJ3EL6mKF1KFnljqO34__7G0nR1Gy2EuDNbp3pCrOoNLhiAhjYZP33bZyiJ5DxSppZMKN7CL1tVh5tm4iU_8Qif821D32jAIXrBrFhlyfnTN6xdggHfnwUwNKe8g7Pi0boZclfl56kjZ2uHONKnWm_gNm7aBxTSo8qv8fMsR2kAXW23X7ow9kSQn_TCqtsSUrfZM2GeHkeBtH88eHVtBhuqd9yOhZ0P_OsXLcaLubKDW9ir1AxWmJJSPeNJAVrOq2NQjowDMLhEhs3ZYPz1F-bgkrY-GmRm_wSH-hezfyfiIxW7HfYrKiwYqrI337kLuISkoGg', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535156/pdf', 'https://watermark.silverchair.com/jcem1871.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsYwggLCBgkqhkiG9w0BBwagggKzMIICrwIBADCCAqgGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM8IdfVpveuobwaULvAgEQgIICeZeZyfHcnJrF1v0jz9hqfsS_47NiqPb6g5NYuRHKZ71KdQVVKvODQTn8nhsk9JZKXUAPctiMHkqZeaa3zhMjaM8tSiFl741x-GJI0OiDYiDk1FWEeDjixxe8qCqaPcyBg8xIZkDDo0mwk9T2I5AdALjPDb_uku6MaVPco9LLTs_KGjNUKed7e08tR0me7OFBzXdK9egY7Il_HBTK6PQ35rgSCp3B6vugwOjHzhGQJvOsk1w1sMAf8MewR1mmTMTSmkq0ZAEj5HZ_cN64a9cGupIw1sHv6YuJMDK4tf6N_l2edOw6A3I6yy-XC_lgmFVYRJ4PM8G6ZL2ltDfTlvxeaedz0U2yeOLdzkVjFF9e7PNDioHS6jOwWkZuqvgNd64bGzGec4m3v9ewN-sGii-oFKLHaQ0W4FbG-8hzJW2-XZKLbT0y1OszA9-kw1w3QZt0eQEeprQUb3bU7dYFsDB1B39J670Nli6J_jj-JphNNchGdCSLfSiPe2GfdZGqDmeo8cisBbeFpdsMj3aZBKO3btK-pMNu38MoKBBOd4xHR0QzaUZfR-TO_21x__RveSOl_8kQxMgyoGzMRDTRoWTt9spFmFnOtkq38qC-iTSiVe2LYoVPMF9isEGXXMDho04CT4f16ZcB4J1-I195hSRC2vRoOrC6RkZE206LlB0ODiFFKjI_pTXE4ITFhdHmJ8v2-BOzUupF3QlOY-NDRwYhNT-LJTmr7IT6lf4nkSQxtbgWUjmM8rwblos0LvxwC7kOvfT6JHvlg8SvaD6it2iRipFKyw4AYXwNiLpuN42msUjNcA8zMnDk0EtFOxkyfrXvFhhZB60f4Iqzlg']","['Final Update Summary: Obstructive Sleep Apnea in Adults: Screening Task Force', 'American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity', 'Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion', 'Interventions for improving sleep quality in people with chronic kidney disease', 'CONSENSUS STATEMENT: Childhood Obesity']","['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2944630-0', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535156/pdf']","['726_1_american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.pdf', '726_3_interventions for improving sleep quality in people with chronic kidney disease.pdf']",2,40.0,"['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2944630-0', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535156/pdf']","['726_1_american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.pdf', '726_3_interventions for improving sleep quality in people with chronic kidney disease.pdf']","[0.252, 0.384]","[0.516, 0.532]","[0.596, 0.609]","[0.139, 0.171]","[0.145, 0.185]","[0.111, 0.145]","[0.735, 0.738]","[0.64, 0.641]","[0.58, 0.596]","[0.665, 0.686]","[0.793, 0.788]","[0.693, 0.707]","[0.611, 0.591]","[0.911, 0.908]","[0.808, 0.818]","[0.751, 0.731]","[0.78, 0.779]","[0.762, 0.764]",0.318,0.524,0.603,0.155,0.165,0.128,0.736,0.641,0.588,0.675,0.79,0.7,0.601,0.909,0.813,0.741,0.78,0.763
https://doi.org/10.1001/jama.291.20.2448,cognitive outcomes of preschool children with prenatal cocaine exposure,727_cognitive outcomes of preschool children with prenatal cocaine exposure.pdf,2,"['https://papers.nber.org/papers/w10688', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894519/pdf']","['Demand for Illicit Drugs by Pregnant Women', 'Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894519/pdf'],['727_1_psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894519/pdf'],['727_1_psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.pdf'],[0.268],[0.513],[0.592],[0.146],[0.151],[0.127],[0.725],[0.629],[0.573],[0.681],[0.772],[0.705],[0.576],[0.916],[0.799],[0.732],[0.769],[0.757],0.268,0.513,0.592,0.146,0.151,0.127,0.725,0.629,0.573,0.681,0.772,0.705,0.576,0.916,0.799,0.732,0.769,0.757
https://doi.org/10.1001/jama.291.22.2746,is this child dehydrated,730_is this child dehydrated.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331832/pdf'],['Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and in primary care'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331832/pdf'],['730_0_guidelines on acute gastroenteritis in children a critical appraisal of their quality and in primary care.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331832/pdf'],['730_0_guidelines on acute gastroenteritis in children a critical appraisal of their quality and in primary care.pdf'],[0.422],[0.535],[0.612],[0.17],[0.184],[0.136],[0.73],[0.634],[0.598],[0.691],[0.787],[0.741],[0.629],[0.899],[0.81],[0.737],[0.792],[0.755],0.422,0.535,0.612,0.17,0.184,0.136,0.73,0.634,0.598,0.691,0.787,0.741,0.629,0.899,0.81,0.737,0.792,0.755
https://doi.org/10.1001/jama.291.4.470,communication of randomization in childhood leukemia trials,731_communication of randomization in childhood leukemia trials.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518731/pdf'],"[""Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518731/pdf'],['731_0_recommendations for the return of research results to study participants and guardians a report from the childrens oncology group.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518731/pdf'],['731_0_recommendations for the return of research results to study participants and guardians a report from the childrens oncology group.pdf'],[0.255],[0.552],[0.626],[0.178],[0.205],[0.16],[0.735],[0.638],[0.633],[0.702],[0.813],[0.76],[0.635],[0.925],[0.861],[0.774],[0.81],[0.796],0.255,0.552,0.626,0.178,0.205,0.16,0.735,0.638,0.633,0.702,0.813,0.76,0.635,0.925,0.861,0.774,0.81,0.796
https://doi.org/10.1001/jama.292.10.1178-a,association between youthfocused firearm laws and youth suicides—correction,734_association between youthfocused firearm laws and youth suicides—correction.pdf,2,"['https://apps.pittsburghpa.gov/redtail/images/10464_Amicus_Brief_on_behalf_of_Philadelphia_and_Pittsburgh_and_Reproduced_Record_--_FILED_COPY.pdf', 'https://stacks.cdc.gov/view/cdc/40519']","['City Of Harrisburg, Mayor', 'Findings from the Injury Control Research Center portfolio evaluation']",['https://apps.pittsburghpa.gov/redtail/images/10464_Amicus_Brief_on_behalf_of_Philadelphia_and_Pittsburgh_and_Reproduced_Record_--_FILED_COPY.pdf'],['734_0_city of harrisburg mayor.pdf'],1,50.0,['https://apps.pittsburghpa.gov/redtail/images/10464_Amicus_Brief_on_behalf_of_Philadelphia_and_Pittsburgh_and_Reproduced_Record_--_FILED_COPY.pdf'],['734_0_city of harrisburg mayor.pdf'],[0.028],[0.467],[0.561],[0.072],[0.079],[0.064],[0.71],[0.614],[0.539],[0.651],[0.774],[0.669],[0.567],[0.922],[0.808],[0.721],[0.766],[0.743],0.028,0.467,0.561,0.072,0.079,0.064,0.71,0.614,0.539,0.651,0.774,0.669,0.567,0.922,0.808,0.721,0.766,0.743
https://doi.org/10.1001/jama.292.13.1588,favorable cardiovascular risk profile in young women and longterm risk of cardiovascular and allcause mortality,736_favorable cardiovascular risk profile in young women and longterm risk of cardiovascular and allcause mortality.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154387/pdf'],['Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science - A Statement for Healthcare Professionals from the American Heart Association'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154387/pdf'],['736_0_preventing and experiencing ischemic heart disease as a woman state of the science  a statement for healthcare professionals from the american heart association.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154387/pdf'],['736_0_preventing and experiencing ischemic heart disease as a woman state of the science  a statement for healthcare professionals from the american heart association.pdf'],[0.473],[0.483],[0.594],[0.168],[0.182],[0.135],[0.737],[0.642],[0.566],[0.699],[0.761],[0.641],[0.565],[0.908],[0.797],[0.725],[0.756],[0.753],0.473,0.483,0.594,0.168,0.182,0.135,0.737,0.642,0.566,0.699,0.761,0.641,0.565,0.908,0.797,0.725,0.756,0.753
https://doi.org/10.1001/jama.292.2.191,efficacy and safety of tenofovir df vs stavudine in combination therapy in antiretroviralnaive patientssubtitlea 3year randomized trialsubtitle,737_efficacy and safety of tenofovir df vs stavudine in combination therapy in antiretroviralnaive patientssubtitlea 3year randomized trialsubtitle.pdf,3,"['https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fixed-dose-combinations-co-packaged-drug-products-and-single-entity-versions-previously-approved', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164506/pdf', 'https://stacks.cdc.gov/view/cdc/22444']","['Fixed Dose Combinations, Co-Packaged Drug Products, and Single-Entity', 'A Review of Recommendations and Treatment Options Regarding the Management of HIV Infection', 'Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164506/pdf'],['737_1_a review of recommendations and treatment options regarding the management of hiv infection.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164506/pdf'],['737_1_a review of recommendations and treatment options regarding the management of hiv infection.pdf'],[0.434],[0.526],[0.622],[0.201],[0.213],[0.17],[0.743],[0.658],[0.61],[0.675],[0.794],[0.703],[0.597],[0.909],[0.814],[0.737],[0.784],[0.76],0.434,0.526,0.622,0.201,0.213,0.17,0.743,0.658,0.61,0.675,0.794,0.703,0.597,0.909,0.814,0.737,0.784,0.76
https://doi.org/10.1001/jama.292.2.202,nevirapine and zidovudine at birth to reduce perinatal transmission of hiv in an african setting,738_nevirapine and zidovudine at birth to reduce perinatal transmission of hiv in an african setting.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352287/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf']","['German-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008', 'HIV/AIDS Guidelines']","['https://www.in.gov/isdh/files/perinatalgl.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352287/pdf']","['738_1_hivaids guidelines.pdf', '738_0_germanaustrian recommendations for hiv1therapy in pregnancy and in hiv1exposed newborn  update 2008.pdf']",2,100.0,"['https://www.in.gov/isdh/files/perinatalgl.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352287/pdf']","['738_1_hivaids guidelines.pdf', '738_0_germanaustrian recommendations for hiv1therapy in pregnancy and in hiv1exposed newborn  update 2008.pdf']","[0.513, 0.541]","[0.539, 0.557]","[0.61, 0.624]","[0.207, 0.201]","[0.208, 0.218]","[0.177, 0.179]","[0.748, 0.746]","[0.659, 0.657]","[0.62, 0.623]","[0.634, 0.637]","[0.803, 0.816]","[0.698, 0.733]","[0.6, 0.628]","[0.907, 0.916]","[0.824, 0.838]","[0.754, 0.771]","[0.793, 0.809]","[0.77, 0.788]",0.527,0.548,0.617,0.204,0.213,0.178,0.747,0.658,0.621,0.635,0.809,0.716,0.614,0.911,0.831,0.762,0.801,0.779
https://doi.org/10.1001/jama.292.21.2569,chlamydia screening among sexually active young female enrollees of health plans—united states 19992001,739_chlamydia screening among sexually active young female enrollees of health plans—united states 19992001.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313766/pdf', 'https://www.rand.org/pubs/technical_reports/TR1129.html', 'https://stacks.cdc.gov/view/cdc/6123', 'https://stacks.cdc.gov/view/cdc/6122', 'https://stacks.cdc.gov/view/cdc/6128', 'https://stacks.cdc.gov/view/cdc/5469']","['Sexually Transmitted Disease (STD) Update: A Review of the CDC 2010 STD Treatment Guidelines and Epidemiologic Trends of Common STDs in Hawai‘i', 'Developing a Framework for Establishing Clinical Decision Support Meaningful Use Objectives for Clinical Specialties', 'Sexually transmitted disease surveillance 2009', 'Sexually transmitted disease surveillance 2010', 'Sexually transmitted disease surveillance 2008', '2007 disease profile; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313766/pdf'],['739_0_sexually transmitted disease std update a review of the cdc 2010 std treatment guidelines and epidemiologic trends of common stds in hawaii.pdf'],1,16.67,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313766/pdf'],['739_0_sexually transmitted disease std update a review of the cdc 2010 std treatment guidelines and epidemiologic trends of common stds in hawaii.pdf'],[0.303],[0.594],[0.658],[0.222],[0.235],[0.192],[0.751],[0.664],[0.667],[0.64],[0.838],[0.769],[0.64],[0.935],[0.843],[0.79],[0.832],[0.814],0.303,0.594,0.658,0.222,0.235,0.192,0.751,0.664,0.667,0.64,0.838,0.769,0.64,0.935,0.843,0.79,0.832,0.814
https://doi.org/10.1001/jama.292.22.2743,relation of body mass index in young adulthood and middle age to medicare expenditures in older age,740_relation of body mass index in young adulthood and middle age to medicare expenditures in older age.pdf,6,"['http://jlarc.virginia.gov/pdfs/reports/Rpt329.pdf', 'https://www.rand.org/pubs/working_papers/WR340.html', 'https://papers.nber.org/papers/W11529', 'https://papers.nber.org/papers/w15163', 'https://doh.dc.gov/sites/default/files/dc/sites/doh/OBESITY%20ACTION%20PLAN.pdf', 'https://www.congress.gov/event/111th-congress/house-event/LC5898/text']","['Impact of an Aging Population on State Agencies', 'Health Insurance and the Obesity Externality', 'Health Insurance and the Obesity Externality', 'Does Health Insurance Make You Fat?', 'Working Towards a Healthy DC The District of Columbia ’ s Overweight and Obesity Action Plan', 'House Hearing, 111th Congress — HEARING TO REVIEW THE STATE OF OBESITY IN THE UNITED STATES']","['http://jlarc.virginia.gov/pdfs/reports/Rpt329.pdf', 'https://doh.dc.gov/sites/default/files/dc/sites/doh/OBESITY%20ACTION%20PLAN.pdf']","['740_0_impact of an aging population on state agencies.pdf', '740_4_working towards a healthy dc the district of columbia  s overweight and obesity action plan.pdf']",2,33.33,"['http://jlarc.virginia.gov/pdfs/reports/Rpt329.pdf', 'https://doh.dc.gov/sites/default/files/dc/sites/doh/OBESITY%20ACTION%20PLAN.pdf']","['740_0_impact of an aging population on state agencies.pdf', '740_4_working towards a healthy dc the district of columbia  s overweight and obesity action plan.pdf']","[0.305, 0.215]","[0.533, 0.506]","[0.615, 0.602]","[0.14, 0.145]","[0.149, 0.156]","[0.119, 0.12]","[0.72, 0.725]","[0.619, 0.627]","[0.607, 0.583]","[0.659, 0.663]","[0.806, 0.791]","[0.738, 0.711]","[0.627, 0.609]","[0.911, 0.914]","[0.836, 0.825]","[0.764, 0.746]","[0.805, 0.789]","[0.783, 0.771]",0.26,0.52,0.609,0.143,0.152,0.119,0.722,0.623,0.595,0.661,0.798,0.724,0.618,0.913,0.831,0.755,0.797,0.777
https://doi.org/10.1001/jama.292.23.2901,mixed dementia,742_mixed dementia.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733252/pdf', 'https://www.acmg.net/PDFLibrary/Alzheimer-Disease-Genetic-Counseling-Testing.pdf', 'https://www.federalreserve.gov/pubs/feds/2013/201345/revision/201345pap.pdf', 'https://aging.idaho.gov/wp-content/uploads/2018/09/Early_DX_toolkit.pdf']","['Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors', 'Appropriate Use Criteria for Amyloid PET - A Report of the Amyloid Imaging Task Force (AIT), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer Association (AA)', 'Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors', 'Dementia Risk and Financial Decision Making by Older Households: The Impact of Information', 'Introduction']","['https://aging.idaho.gov/wp-content/uploads/2018/09/Early_DX_toolkit.pdf', 'https://www.federalreserve.gov/pubs/feds/2013/201345/revision/201345pap.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733252/pdf', 'https://www.acmg.net/PDFLibrary/Alzheimer-Disease-Genetic-Counseling-Testing.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326653/pdf']","['742_4_introduction.pdf', '742_3_dementia risk and financial decision making by older households the impact of information.pdf', '742_1_appropriate use criteria for amyloid pet  a report of the amyloid imaging task force ait the society of nuclear medicine and molecular imaging snmmi and the alzheimer association aa.pdf', '742_2_genetic counseling and testing for alzheimer disease joint practice guidelines of the american college of medical genetics and the national society of genetic counselors.pdf', '742_0_genetic counseling and testing for alzheimer disease joint practice guidelines of the american college of medical genetics and the national society of genetic counselors.pdf']",5,100.0,"['https://aging.idaho.gov/wp-content/uploads/2018/09/Early_DX_toolkit.pdf', 'https://www.federalreserve.gov/pubs/feds/2013/201345/revision/201345pap.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733252/pdf', 'https://www.acmg.net/PDFLibrary/Alzheimer-Disease-Genetic-Counseling-Testing.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326653/pdf']","['742_4_introduction.pdf', '742_3_dementia risk and financial decision making by older households the impact of information.pdf', '742_1_appropriate use criteria for amyloid pet  a report of the amyloid imaging task force ait the society of nuclear medicine and molecular imaging snmmi and the alzheimer association aa.pdf', '742_2_genetic counseling and testing for alzheimer disease joint practice guidelines of the american college of medical genetics and the national society of genetic counselors.pdf', '742_0_genetic counseling and testing for alzheimer disease joint practice guidelines of the american college of medical genetics and the national society of genetic counselors.pdf']","[0.373, 0.353, 0.427, 0.227, 0.405]","[0.488, 0.534, 0.514, 0.559, 0.492]","[0.589, 0.617, 0.62, 0.642, 0.61]","[0.154, 0.134, 0.187, 0.186, 0.18]","[0.158, 0.134, 0.196, 0.195, 0.189]","[0.125, 0.105, 0.145, 0.146, 0.141]","[0.74, 0.727, 0.748, 0.748, 0.748]","[0.649, 0.631, 0.657, 0.654, 0.658]","[0.592, 0.609, 0.595, 0.635, 0.584]","[0.672, 0.66, 0.685, 0.674, 0.683]","[0.788, 0.807, 0.785, 0.816, 0.778]","[0.709, 0.74, 0.695, 0.75, 0.666]","[0.574, 0.614, 0.593, 0.621, 0.584]","[0.906, 0.918, 0.911, 0.922, 0.915]","[0.835, 0.834, 0.816, 0.84, 0.818]","[0.734, 0.764, 0.738, 0.77, 0.729]","[0.774, 0.8, 0.773, 0.806, 0.769]","[0.764, 0.787, 0.77, 0.795, 0.768]",0.357,0.517,0.616,0.168,0.174,0.132,0.742,0.65,0.603,0.675,0.795,0.712,0.597,0.914,0.829,0.747,0.784,0.777
https://doi.org/10.1001/jama.292.5.569,mortality in a cohort of street youth in montreal,744_mortality in a cohort of street youth in montreal.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf', 'https://aspe.hhs.gov/reports/toward-understanding-homelessness-2007-national-symposium-homelessness-research-homeless-youth', 'https://aspe.hhs.gov/reports/toward-understanding-homelessness-2007-national-symposium-homelessness-research-1', 'https://aspe.hhs.gov/reports/toward-understanding-homelessness-2007-national-symposium-homelessness-research-0', 'https://aspe.hhs.gov/reports/toward-understanding-homelessness-2007-national-symposium-homelessness-research-homeless-youth-0']","['Interventions to modify sexual risk behaviours for preventing HIV in homeless youth', 'Toward Understanding Homelessness: The 2007 National Symposium on Homelessness Research. Homeless Youth in the United States: Recent Research Findings and Intervention Approaches', 'Toward Understanding Homelessness: The 2007 National Symposium on Homelessness Research', 'Toward Understanding Homelessness: The 2007 National Symposium on Homelessness Research', 'Toward Understanding Homelessness: The 2007 National Symposium on Homelessness Research. Homeless Youth in the United States: Recent Research Findings and Intervention Approaches']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['744_0_interventions to modify sexual risk behaviours for preventing hiv in homeless youth.pdf'],1,20.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['744_0_interventions to modify sexual risk behaviours for preventing hiv in homeless youth.pdf'],[0.45],[0.521],[0.606],[0.16],[0.182],[0.141],[0.725],[0.627],[0.596],[0.684],[0.785],[0.709],[0.589],[0.918],[0.828],[0.747],[0.785],[0.771],0.45,0.521,0.606,0.16,0.182,0.141,0.725,0.627,0.596,0.684,0.785,0.709,0.589,0.918,0.828,0.747,0.785,0.771
https://doi.org/10.1001/jama.292.8.927,sugarsweetened beverages weight gain and incidence of type 2 diabetes in young and middleaged women,745_sugarsweetened beverages weight gain and incidence of type 2 diabetes in young and middleaged women.pdf,7,"['http://www.nyc.gov/html/dcas/downloads/pdf/cityrecord/cityrecord-6-19-12.pdf', 'http://www.nyc.gov/html/dcas/downloads/pdf/cityrecord/cityrecord-9-21-12.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816916/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ip/un-rpt.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/press/amicus-brief.pdf', 'https://www.cbpp.org/research/statement-robert-greenstein-to-health-reform-financing-roundtable-of-the-senate-finance', 'https://www.cbpp.org/research/taxing-high-sugar-soft-drinks-could-help-pay-for-health-care-reform']","['CR- JUNE 6-19-12.qxd', 'CR- SEPTEMBER 9-21-12.qxd', 'Nutrition Therapy Recommendations for the Management of Adults With Diabetes', 'Preventing Non-Communicable Diseases and Injuries', 'Health Equities Brief (final final)', 'Statement: Robert Greenstein to Health Reform Financing Roundtable of the Senate Finance Committee', 'Taxing High-Sugar Soft Drinks Could Help Pay For Health Care Reform']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816916/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ip/un-rpt.pdf']","['745_2_nutrition therapy recommendations for the management of adults with diabetes.pdf', '745_3_preventing noncommunicable diseases and injuries.pdf']",2,28.57,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816916/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ip/un-rpt.pdf']","['745_2_nutrition therapy recommendations for the management of adults with diabetes.pdf', '745_3_preventing noncommunicable diseases and injuries.pdf']","[0.48, 0.141]","[0.517, 0.506]","[0.605, 0.604]","[0.182, 0.12]","[0.192, 0.122]","[0.16, 0.102]","[0.74, 0.719]","[0.639, 0.614]","[0.598, 0.591]","[0.69, 0.651]","[0.797, 0.794]","[0.711, 0.714]","[0.603, 0.602]","[0.922, 0.921]","[0.818, 0.823]","[0.749, 0.745]","[0.789, 0.794]","[0.778, 0.776]",0.31,0.512,0.605,0.151,0.157,0.131,0.73,0.627,0.595,0.67,0.796,0.712,0.603,0.921,0.821,0.747,0.792,0.777
https://doi.org/10.1001/jama.293.24.3003,combined tetanus diphtheria and 5component pertussis vaccine for use in adolescents and adults,750_combined tetanus diphtheria and 5component pertussis vaccine for use in adolescents and adults.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf', 'https://stacks.cdc.gov/view/cdc/6752', 'https://stacks.cdc.gov/view/cdc/53561', 'https://stacks.cdc.gov/view/cdc/6790', 'https://stacks.cdc.gov/view/cdc/6969', 'https://stacks.cdc.gov/view/cdc/6120', 'https://stacks.cdc.gov/view/cdc/52820']","['Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Preventing tetanus, diphtheria, and pertussis among adolescents; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants : recommendations of the Advisory Committee on Immunization Practices', 'Immunization of health-care personnel : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'Summary of vaccine safety studies of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and their infants : supplementary table for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf'],['750_0_prevention of pertussis tetanus and diphtheria with vaccines in the united states recommendations of the advisory committee on immunization practices acip.pdf'],1,14.29,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600/pdf'],['750_0_prevention of pertussis tetanus and diphtheria with vaccines in the united states recommendations of the advisory committee on immunization practices acip.pdf'],[0.664],[0.543],[0.619],[0.197],[0.213],[0.175],[0.748],[0.656],[0.612],[0.656],[0.805],[0.718],[0.619],[0.916],[0.817],[0.767],[0.796],[0.788],0.664,0.543,0.619,0.197,0.213,0.175,0.748,0.656,0.612,0.656,0.805,0.718,0.619,0.916,0.817,0.767,0.796,0.788
https://doi.org/10.1001/jama.293.3.311,effectiveness of a quality improvement intervention for adolescent depression in primary care clinics,751_effectiveness of a quality improvement intervention for adolescent depression in primary care clinics.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050339/pdf', 'https://www.cjtc.wa.gov/docs/default-source/course-required-forms/cit/cit-manual.pdf?sfvrsn=b778156_2', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research', 'https://www.rand.org/pubs/research_reports/RR2111.html', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/protocol', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/documents/CITResourceManual.pdf', 'https://www.rand.org/pubs/rgs_dissertations/RGSD282.html']","['Treatment of Youth Depression in Primary Care Under Usual Practice Conditions: Observational Findings from Youth Partners in Care', 'Counselling for mental health and psychosocial problems in primary care', 'Crisis Intervention Training (CIT) Suggested Course Materials', 'Treatment of Depression in Children and Adolescents', 'Provider Interventions to Increase Uptake of Evidence-Based Treatment for Depression', 'Depression in Children: Systematic Review', 'Microsoft Word - CIT Resource Manual with Presentations.doc', 'How Do Quality Improvement Interventions Succeed?']","['https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/documents/CITResourceManual.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.cjtc.wa.gov/docs/default-source/course-required-forms/cit/cit-manual.pdf?sfvrsn=b778156_2', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050339/pdf']","['751_6_microsoft word  cit resource manual with presentationsdoc.pdf', '751_0_treatment of youth depression in primary care under usual practice conditions observational findings from youth partners in care.pdf', '751_2_crisis intervention training cit suggested course materials.pdf', '751_1_counselling for mental health and psychosocial problems in primary care.pdf']",4,50.0,"['https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/documents/CITResourceManual.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281292/pdf', 'https://www.cjtc.wa.gov/docs/default-source/course-required-forms/cit/cit-manual.pdf?sfvrsn=b778156_2', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050339/pdf']","['751_6_microsoft word  cit resource manual with presentationsdoc.pdf', '751_0_treatment of youth depression in primary care under usual practice conditions observational findings from youth partners in care.pdf', '751_2_crisis intervention training cit suggested course materials.pdf', '751_1_counselling for mental health and psychosocial problems in primary care.pdf']","[0.658, 0.579, 0.301, 0.313]","[0.507, 0.521, 0.506, 0.524]","[0.593, 0.605, 0.592, 0.607]","[0.119, 0.189, 0.117, 0.193]","[0.136, 0.201, 0.134, 0.204]","[0.115, 0.165, 0.114, 0.167]","[0.723, 0.741, 0.722, 0.74]","[0.622, 0.652, 0.621, 0.649]","[0.576, 0.584, 0.576, 0.588]","[0.682, 0.72, 0.683, 0.721]","[0.782, 0.789, 0.782, 0.788]","[0.719, 0.723, 0.718, 0.708]","[0.595, 0.607, 0.597, 0.581]","[0.913, 0.898, 0.913, 0.913]","[0.822, 0.805, 0.822, 0.812]","[0.738, 0.723, 0.738, 0.72]","[0.787, 0.784, 0.787, 0.783]","[0.764, 0.75, 0.764, 0.758]",0.463,0.514,0.599,0.154,0.169,0.14,0.732,0.636,0.581,0.702,0.785,0.717,0.595,0.909,0.815,0.73,0.785,0.759
https://doi.org/10.1001/jama.294.21.2689,poliovirus infections in four unvaccinated childrenminnesota augustoctober 2005,752_poliovirus infections in four unvaccinated childrenminnesota augustoctober 2005.pdf,3,"['http://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/gsi-polio.pdf', 'http://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/cd-polio-nonpara.pdf', 'https://stacks.cdc.gov/view/cdc/6759']","['Poliomyelitis', 'Acute Arboviral Disease (neroinvasive and non-neuroinvasive)', 'Enterovirus surveillance--United States, 1970-2005']","['http://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/gsi-polio.pdf', 'http://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/cd-polio-nonpara.pdf']","['752_0_poliomyelitis.pdf', '752_1_acute arboviral disease neroinvasive and nonneuroinvasive.pdf']",2,66.67,"['http://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/gsi-polio.pdf', 'http://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/cd-polio-nonpara.pdf']","['752_0_poliomyelitis.pdf', '752_1_acute arboviral disease neroinvasive and nonneuroinvasive.pdf']","[0.453, 0.391]","[0.618, 0.628]","[0.679, 0.692]","[0.274, 0.293]","[0.29, 0.311]","[0.237, 0.252]","[0.757, 0.763]","[0.668, 0.674]","[0.69, 0.691]","[0.673, 0.682]","[0.848, 0.849]","[0.792, 0.787]","[0.687, 0.685]","[0.921, 0.915]","[0.855, 0.868]","[0.812, 0.819]","[0.844, 0.847]","[0.833, 0.835]",0.422,0.623,0.685,0.283,0.3,0.244,0.76,0.671,0.69,0.677,0.849,0.79,0.686,0.918,0.861,0.816,0.845,0.834
https://doi.org/10.1001/jama.294.23.3003,longterm air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model,753_longterm air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model.pdf,4,"['https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/07-307.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/03-313.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Uncertainty/pm_ee_report.pdf']","['The Role of Inhaled Particles in the Pathophysiology of Cardiovascular Disease', 'Report: 2007-10-01 Air Pollution and Cardiovascular Disease in the California Teachers Study Cohort', 'Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association', 'United States Environmental Protection Agency']","['https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/03-313.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/07-307.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Uncertainty/pm_ee_report.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf']","['753_1_report 20071001 air pollution and cardiovascular disease in the california teachers study cohort.pdf', '753_0_the role of inhaled particles in the pathophysiology of cardiovascular disease.pdf', '753_3_united states environmental protection agency.pdf', '753_2_particulate matter air pollution and cardiovascular disease an update to the scientific statement from the american heart association.pdf']",4,100.0,"['https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/03-313.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/07-307.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Uncertainty/pm_ee_report.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf']","['753_1_report 20071001 air pollution and cardiovascular disease in the california teachers study cohort.pdf', '753_0_the role of inhaled particles in the pathophysiology of cardiovascular disease.pdf', '753_3_united states environmental protection agency.pdf', '753_2_particulate matter air pollution and cardiovascular disease an update to the scientific statement from the american heart association.pdf']","[0.49, 0.344, 0.614, 0.283]","[0.5, 0.537, 0.51, 0.52]","[0.58, 0.62, 0.599, 0.607]","[0.132, 0.163, 0.125, 0.163]","[0.131, 0.159, 0.132, 0.168]","[0.106, 0.126, 0.099, 0.135]","[0.733, 0.745, 0.726, 0.741]","[0.638, 0.652, 0.63, 0.647]","[0.572, 0.612, 0.584, 0.603]","[0.685, 0.662, 0.688, 0.682]","[0.775, 0.797, 0.787, 0.794]","[0.696, 0.732, 0.721, 0.726]","[0.607, 0.632, 0.617, 0.608]","[0.907, 0.91, 0.913, 0.907]","[0.799, 0.82, 0.814, 0.811]","[0.738, 0.763, 0.752, 0.751]","[0.771, 0.795, 0.785, 0.789]","[0.759, 0.784, 0.771, 0.775]",0.433,0.517,0.601,0.146,0.148,0.116,0.736,0.642,0.593,0.679,0.788,0.719,0.616,0.909,0.811,0.751,0.785,0.772
https://doi.org/10.1001/jama.294.23.3011,medical and legal issues in the cardiovascular evaluation of competitive athletes,754_medical and legal issues in the cardiovascular evaluation of competitive athletes.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658989/pdf', 'https://www.michigan.gov/documents/mdch/SCDYReportfinalJan09_269478_7_274798_7.pdf']","['Preparticipation medical evaluation in professional sport in the UK: theory or practice?', 'Impact of Sudden Cardiac Death of the Young in Michigan 1999-2008']","['https://www.michigan.gov/documents/mdch/SCDYReportfinalJan09_269478_7_274798_7.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658989/pdf']","['754_1_impact of sudden cardiac death of the young in michigan 19992008.pdf', '754_0_preparticipation medical evaluation in professional sport in the uk theory or practice.pdf']",2,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658989/pdf'],['754_0_preparticipation medical evaluation in professional sport in the uk theory or practice.pdf'],[0.307],[0.541],[0.63],[0.211],[0.22],[0.19],[0.744],[0.651],[0.616],[0.684],[0.809],[0.748],[0.639],[0.915],[0.842],[0.767],[0.802],[0.79],0.307,0.541,0.63,0.211,0.22,0.19,0.744,0.651,0.616,0.684,0.809,0.748,0.639,0.915,0.842,0.767,0.802,0.79
https://doi.org/10.1001/jama.294.3.298,racialethnic disparities in infant mortality—united states 19952002,756_racialethnic disparities in infant mortality—united states 19952002.pdf,3,"['https://papers.nber.org/papers/w14333', 'https://phpa.health.maryland.gov/OEHFP/EH/Shared%20Documents/CEHPAC/Report-2008-FINAL.pdf', 'https://stacks.cdc.gov/view/cdc/58347']","['Socioeconomic Status and Health: Dimensions and Mechanisms', 'Maryland ’ s Children and the Environment', 'The Natality Program of the Division of Vital Statistics']",['https://phpa.health.maryland.gov/OEHFP/EH/Shared%20Documents/CEHPAC/Report-2008-FINAL.pdf'],['756_1_maryland  s children and the environment.pdf'],1,33.33,['https://phpa.health.maryland.gov/OEHFP/EH/Shared%20Documents/CEHPAC/Report-2008-FINAL.pdf'],['756_1_maryland  s children and the environment.pdf'],[0.212],[0.549],[0.625],[0.159],[0.164],[0.123],[0.728],[0.626],[0.617],[0.675],[0.806],[0.746],[0.66],[0.917],[0.827],[0.77],[0.81],[0.79],0.212,0.549,0.625,0.159,0.164,0.123,0.728,0.626,0.617,0.675,0.806,0.746,0.66,0.917,0.827,0.77,0.81,0.79
https://doi.org/10.1001/jama.295.12.1389,remissions in maternal depression and child psychopathology,757_remissions in maternal depression and child psychopathology.pdf,7,"['https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2962053-0', 'https://www.acf.hhs.gov/opre/report/four-strategies-overcome-barriers-employment-introduction-enhanced-services-hard-employ', 'https://www.rand.org/pubs/research_reports/RR122.html', 'https://www.acf.hhs.gov/opre/resource/four-strategies-to-overcome-barriers-to-employment-an-introduction-to-the', 'https://scaoda.wisconsin.gov/scfiles/meetings/SCAODABinder060608.pdf', 'https://scaoda.wisconsin.gov/scfiles/meetings/SCAODAPacketMarch72008.pdf']","['PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder', 'Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders', 'Four Strategies to Overcome Barriers to Employment: An Introduction to the Enhanced Services for the Hard-to-Employ Demonstration and Evaluation Project', 'Helping Families Raise Healthy Children', 'Four Strategies to Overcome Barriers to Employment: An Introduction to the Enhanced Services for the Hard-to-Employ Demonstration and Evaluation Project', 'Microsoft Word - SCAODACover06062008.doc', 'Microsoft Word - SCAODA Cover3-07-08']","['https://scaoda.wisconsin.gov/scfiles/meetings/SCAODAPacketMarch72008.pdf', 'https://scaoda.wisconsin.gov/scfiles/meetings/SCAODABinder060608.pdf', 'https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2962053-0']","['757_6_microsoft word  scaoda cover30708.pdf', '757_5_microsoft word  scaodacover06062008doc.pdf', '757_1_practice parameter for the assessment and treatment of children and adolescents with depressive disorders.pdf']",3,42.86,['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2962053-0'],['757_1_practice parameter for the assessment and treatment of children and adolescents with depressive disorders.pdf'],[0.552],[0.542],[0.63],[0.202],[0.213],[0.177],[0.741],[0.65],[0.599],[0.697],[0.805],[0.725],[0.608],[0.923],[0.822],[0.76],[0.791],[0.781],0.552,0.542,0.63,0.202,0.213,0.177,0.741,0.65,0.599,0.697,0.805,0.725,0.608,0.923,0.822,0.76,0.791,0.781
https://doi.org/10.1001/jama.295.14.1668,invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine,758_invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.pdf,4,"['https://www.rff.org/publications/reports/extending-the-cure-policy-responses-to-the-growing-threat-of-antibiotic-resistance/', 'https://stacks.cdc.gov/view/cdc/7454', 'https://stacks.cdc.gov/view/cdc/3190', 'https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2006.pdf']","['Extending the Cure: Policy responses to the growing threat of antibiotic resistance', 'Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)', 'International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005', 'Communicable and Environmental Disease Services']",['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2006.pdf'],['758_3_communicable and environmental disease services.pdf'],1,25.0,['https://www.tn.gov/content/dam/tn/health/documents/cedep-weeklyreports/AnlRprt_2006.pdf'],['758_3_communicable and environmental disease services.pdf'],[0.464],[0.532],[0.61],[0.16],[0.159],[0.13],[0.732],[0.635],[0.603],[0.657],[0.804],[0.729],[0.632],[0.91],[0.813],[0.756],[0.799],[0.78],0.464,0.532,0.61,0.16,0.159,0.13,0.732,0.635,0.603,0.657,0.804,0.729,0.632,0.91,0.813,0.756,0.799,0.78
https://doi.org/10.1001/jama.295.15.1784,neurobehavioral effects of dental amalgam in children,759_neurobehavioral effects of dental amalgam in children.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407050/pdf', 'https://www.federalregister.gov/documents/2008/04/28/E8-9147/suspension-of-running-of-period-of-limitations-during-a-proceeding-to-enforce-or-quash-a-designated', 'https://www.federalregister.gov/documents/2008/04/28/08-1187/dental-devices-classification-of-encapsulated-amalgam-alloy-and-dental-mercury-and-reclassification', 'https://stacks.cdc.gov/view/cdc/117446', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://stacks.cdc.gov/view/cdc/21813', 'https://stacks.cdc.gov/view/cdc/5462', 'https://stacks.cdc.gov/view/cdc/27534']","['Direct composite resin fillings versus amalgam fillings for permanent posterior teeth', 'Suspension of Running of Period of Limitations During a Proceeding to Enforce or Quash a Designated or Related Summons', 'Dental Devices: Classification of Encapsulated Amalgam Alloy and Dental Mercury and Reclassification of Dental Mercury; Issuance of Special Controls for Amalgam Alloy; Reopening of Comment Period', 'Toxicological profile for mercury : draft for public comment : April 2022', 'America’s children and the environment.', 'Fourth national report on human exposure to environmental chemicals', ""Children's exposure to elemental mercury; a national review of exposure events"", 'Exposición de niños al mercurio metálico : revisión nacional de incidentes de exposición']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407050/pdf']","['759_4_americas children and the environment.pdf', '759_0_direct composite resin fillings versus amalgam fillings for permanent posterior teeth.pdf']",2,25.0,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407050/pdf']","['759_4_americas children and the environment.pdf', '759_0_direct composite resin fillings versus amalgam fillings for permanent posterior teeth.pdf']","[0.532, 0.381]","[0.504, 0.524]","[0.592, 0.605]","[0.123, 0.156]","[0.118, 0.163]","[0.09, 0.133]","[0.724, 0.732]","[0.626, 0.638]","[0.578, 0.596]","[0.674, 0.692]","[0.788, 0.784]","[0.71, 0.713]","[0.614, 0.592]","[0.905, 0.911]","[0.808, 0.813]","[0.741, 0.73]","[0.784, 0.779]","[0.767, 0.759]",0.457,0.514,0.599,0.14,0.141,0.112,0.728,0.632,0.587,0.683,0.786,0.712,0.603,0.908,0.81,0.736,0.782,0.763
https://doi.org/10.1001/jama.295.20.2385,trends in the association of poverty with overweight among us adolescents 19712004,760_trends in the association of poverty with overweight among us adolescents 19712004.pdf,7,"['http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://stacks.cdc.gov/view/cdc/6024', 'https://www.rand.org/pubs/rgs_dissertations/RGSD257.html', 'https://www.congress.gov/event/111th-congress/senate-event/LC7110/text?s=1&r=14499', 'https://www.gao.gov/products/GAO-07-260R', 'https://www.dhcs.ca.gov/formsandpubs/publications/CaliforniaFoodGuide/12.9-18YearOlds.pdf', 'https://www.michigan.gov/documents/mdch/Barlow_Expert_Comm._Recommendations_351360_7.pdf']","['California Food Guide :', 'School health guidelines to promote healthy eating and physical activity', 'Evaluating the Impacts of School Nutrition and Physical Activity Policies on Child Health', 'S.Hrg. 111-1130 — CHILDHOOD OBESITY: BEGINNING THE DIALOGUE ON REVERSING THE EPIDEMIC', 'Childhood Obesity: Factors Affecting Physical Activity', 'California Food Guide Life Cycle: 9-18 Year Olds Chapter', 'Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report SarahE. Barlow and and the Expert Committee Pediatrics 2007; 120; S164-S192 DOI: 10.1542/ peds. 2007-2329C']",['http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf'],['760_0_california food guide .pdf'],1,14.29,['http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf'],['760_0_california food guide .pdf'],[0.298],[0.509],[0.609],[0.147],[0.159],[0.127],[0.725],[0.622],[0.595],[0.675],[0.796],[0.727],[0.611],[0.914],[0.823],[0.747],[0.798],[0.779],0.298,0.509,0.609,0.147,0.159,0.127,0.725,0.622,0.595,0.675,0.796,0.727,0.611,0.914,0.823,0.747,0.798,0.779
https://doi.org/10.1001/jama.296.11.1357,trends in fetal and infant survival following preeclampsia,761_trends in fetal and infant survival following preeclampsia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735207/pdf'],['Assessment of the quality and content of national and international guidelines on hypertensive disorders of pregnancy using the AGREE II instrument'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735207/pdf'],['761_0_assessment of the quality and content of national and international guidelines on hypertensive disorders of pregnancy using the agree ii instrument.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735207/pdf'],['761_0_assessment of the quality and content of national and international guidelines on hypertensive disorders of pregnancy using the agree ii instrument.pdf'],[0.267],[0.563],[0.638],[0.181],[0.197],[0.156],[0.725],[0.632],[0.635],[0.656],[0.809],[0.759],[0.624],[0.918],[0.84],[0.78],[0.813],[0.802],0.267,0.563,0.638,0.181,0.197,0.156,0.725,0.632,0.635,0.656,0.809,0.759,0.624,0.918,0.84,0.78,0.813,0.802
https://doi.org/10.1001/jama.296.17.2124,multiple serotonergic brainstem abnormalities in sudden infant death syndrome,762_multiple serotonergic brainstem abnormalities in sudden infant death syndrome.pdf,3,"['https://phpa.health.maryland.gov/mch/Documents/Concurrent%20Risks%20for%20SIDS%20(Peds%202010).pdf', 'https://www.tn.gov/content/dam/tn/health/documents/AAP_Pennsylvania_Chapter_Hospital_Policy_Manual_Toolkit_0.pdf', 'https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download']","['Concurrent Risks in Sudden Infant Death Syndrome', 'Model Hospital Policy Manual & Tool Kit', 'A Policy & Education Development Guide']","['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download', 'https://www.tn.gov/content/dam/tn/health/documents/AAP_Pennsylvania_Chapter_Hospital_Policy_Manual_Toolkit_0.pdf', 'https://phpa.health.maryland.gov/mch/Documents/Concurrent%20Risks%20for%20SIDS%20(Peds%202010).pdf']","['762_2_a policy  education development guide.pdf', '762_1_model hospital policy manual  tool kit.pdf', '762_0_concurrent risks in sudden infant death syndrome.pdf']",3,100.0,"['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download', 'https://www.tn.gov/content/dam/tn/health/documents/AAP_Pennsylvania_Chapter_Hospital_Policy_Manual_Toolkit_0.pdf', 'https://phpa.health.maryland.gov/mch/Documents/Concurrent%20Risks%20for%20SIDS%20(Peds%202010).pdf']","['762_2_a policy  education development guide.pdf', '762_1_model hospital policy manual  tool kit.pdf', '762_0_concurrent risks in sudden infant death syndrome.pdf']","[0.357, 0.229, 0.349]","[0.508, 0.513, 0.521]","[0.594, 0.599, 0.596]","[0.108, 0.095, 0.13]","[0.11, 0.097, 0.13]","[0.089, 0.075, 0.1]","[0.725, 0.719, 0.731]","[0.626, 0.616, 0.635]","[0.596, 0.601, 0.609]","[0.635, 0.607, 0.651]","[0.796, 0.8, 0.798]","[0.727, 0.737, 0.734]","[0.608, 0.615, 0.613]","[0.911, 0.909, 0.913]","[0.815, 0.822, 0.821]","[0.751, 0.761, 0.757]","[0.792, 0.798, 0.797]","[0.78, 0.785, 0.785]",0.312,0.514,0.596,0.111,0.112,0.088,0.725,0.626,0.602,0.631,0.798,0.733,0.612,0.911,0.819,0.756,0.796,0.783
https://doi.org/10.1001/jama.296.23.2839,evaluation and management of patients after implantable cardioverterdefibrillator shock,764_evaluation and management of patients after implantable cardioverterdefibrillator shock.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407095/pdf', 'https://www.rand.org/pubs/research_reports/RR308.html']","['Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death', 'Redirecting Innovation in U.S. Health Care: Decreasing Spending, Increasing Value']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407095/pdf'],['764_0_amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407095/pdf'],['764_0_amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.pdf'],[0.257],[0.506],[0.603],[0.165],[0.176],[0.134],[0.743],[0.651],[0.575],[0.675],[0.781],[0.696],[0.574],[0.905],[0.794],[0.72],[0.762],[0.749],0.257,0.506,0.603,0.165,0.176,0.134,0.743,0.651,0.575,0.675,0.781,0.696,0.574,0.905,0.794,0.72,0.762,0.749
https://doi.org/10.1001/jama.296.4.421,effect of youthonset type 2 diabetes mellitus on incidence of endstage renal disease and mortality in young and middleaged pima indians,765_effect of youthonset type 2 diabetes mellitus on incidence of endstage renal disease and mortality in young and middleaged pima indians.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481869/pdf'],['Glucose targets for preventing diabetic kidney disease and its progression'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481869/pdf'],['765_0_glucose targets for preventing diabetic kidney disease and its progression.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481869/pdf'],['765_0_glucose targets for preventing diabetic kidney disease and its progression.pdf'],[0.401],[0.51],[0.593],[0.185],[0.186],[0.154],[0.744],[0.647],[0.578],[0.7],[0.779],[0.681],[0.588],[0.912],[0.802],[0.722],[0.766],[0.753],0.401,0.51,0.593,0.185,0.186,0.154,0.744,0.647,0.578,0.7,0.779,0.681,0.588,0.912,0.802,0.722,0.766,0.753
https://doi.org/10.1001/jama.296.6.671,effectiveness of haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in kenya,766_effectiveness of haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in kenya.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596856/pdf'],['What Is the Future for Global Case Management Guidelines for Common Childhood Diseases?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596856/pdf'],['766_0_what is the future for global case management guidelines for common childhood diseases.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596856/pdf'],['766_0_what is the future for global case management guidelines for common childhood diseases.pdf'],[0.29],[0.551],[0.637],[0.178],[0.176],[0.14],[0.727],[0.632],[0.635],[0.66],[0.811],[0.764],[0.637],[0.914],[0.836],[0.772],[0.811],[0.79],0.29,0.551,0.637,0.178,0.176,0.14,0.727,0.632,0.635,0.66,0.811,0.764,0.637,0.914,0.836,0.772,0.811,0.79
https://doi.org/10.1001/jama.296.7.794,breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mothertochild hiv transmission in botswana,767_breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mothertochild hiv transmission in botswana.pdf,6,"['https://purl.fdlp.gov/GPO/gpo115827', 'https://www.icrw.org/publications/modelling-the-impact-of-stigma-on-hiv-and-aids-programmes/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107213/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366266/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf']","['Child survival by HIV status of the mother :\xa0evidence from DHS and AIS surveys /', 'Modelling the impact of stigma on HIV and AIDS programmes', 'Interventions for preventing late postnatal mother‐to‐child transmission of HIV', 'WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers', 'A.S.P.E.N. Clinical Guidelines: Nutrition Support of Children With Human Immunodeficiency Virus Infection', 'HIV/AIDS Guidelines']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107213/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf', 'https://purl.fdlp.gov/GPO/gpo115827', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389566/pdf']","['767_4_aspen clinical guidelines nutrition support of children with human immunodeficiency virus infection.pdf', '767_3_who 2010 guidelines for prevention of mothertochild hiv transmission in zimbabwe modeling clinical outcomes in infants and mothers.pdf', '767_5_hivaids guidelines.pdf', '767_0_child survival by hiv status of the mother \xa0evidence from dhs and ais surveys .pdf', '767_2_interventions for preventing late postnatal mother‐to‐child transmission of hiv.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107213/pdf', 'https://www.in.gov/isdh/files/perinatalgl.pdf', 'https://purl.fdlp.gov/GPO/gpo115827', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389566/pdf']","['767_4_aspen clinical guidelines nutrition support of children with human immunodeficiency virus infection.pdf', '767_3_who 2010 guidelines for prevention of mothertochild hiv transmission in zimbabwe modeling clinical outcomes in infants and mothers.pdf', '767_5_hivaids guidelines.pdf', '767_0_child survival by hiv status of the mother \xa0evidence from dhs and ais surveys .pdf', '767_2_interventions for preventing late postnatal mother‐to‐child transmission of hiv.pdf']","[0.365, 0.712, 0.454, 0.459, 0.425]","[0.495, 0.554, 0.523, 0.511, 0.536]","[0.591, 0.633, 0.605, 0.604, 0.618]","[0.182, 0.213, 0.202, 0.192, 0.209]","[0.182, 0.209, 0.195, 0.195, 0.209]","[0.155, 0.181, 0.173, 0.169, 0.178]","[0.745, 0.748, 0.749, 0.743, 0.745]","[0.654, 0.662, 0.66, 0.654, 0.657]","[0.569, 0.616, 0.601, 0.568, 0.6]","[0.666, 0.657, 0.635, 0.68, 0.667]","[0.77, 0.805, 0.789, 0.784, 0.791]","[0.655, 0.722, 0.681, 0.67, 0.704]","[0.59, 0.633, 0.595, 0.617, 0.615]","[0.904, 0.916, 0.9, 0.898, 0.911]","[0.796, 0.833, 0.81, 0.804, 0.819]","[0.714, 0.76, 0.732, 0.73, 0.736]","[0.76, 0.799, 0.774, 0.771, 0.783]","[0.743, 0.777, 0.748, 0.751, 0.76]",0.483,0.524,0.61,0.2,0.198,0.171,0.746,0.657,0.591,0.661,0.788,0.686,0.61,0.906,0.812,0.734,0.777,0.756
https://doi.org/10.1001/jama.296.8.943,clinical biochemical and genetic heterogeneity in shortchain acylcoenzyme a dehydrogenase deficiency,768_clinical biochemical and genetic heterogeneity in shortchain acylcoenzyme a dehydrogenase deficiency.pdf,1,['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Expanded-Newborn-Screening/Expanded_NewbornScreening09.pdf?la=en&hash=802BBC50B1E006808491DDCE913CBB3BF78BD0B5'],['Laboratory Medicine Practice Guidelines: Follow-up Testing for Metabolic Diseases Identified by Expanded Newborn Screening Using Tandem Mass Spectrometry'],['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Expanded-Newborn-Screening/Expanded_NewbornScreening09.pdf?la=en&hash=802BBC50B1E006808491DDCE913CBB3BF78BD0B5'],['768_0_laboratory medicine practice guidelines followup testing for metabolic diseases identified by expanded newborn screening using tandem mass spectrometry.pdf'],1,100.0,['https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Expanded-Newborn-Screening/Expanded_NewbornScreening09.pdf?la=en&hash=802BBC50B1E006808491DDCE913CBB3BF78BD0B5'],['768_0_laboratory medicine practice guidelines followup testing for metabolic diseases identified by expanded newborn screening using tandem mass spectrometry.pdf'],[0.314],[0.542],[0.624],[0.162],[0.166],[0.128],[0.741],[0.645],[0.621],[0.674],[0.805],[0.74],[0.632],[0.916],[0.828],[0.765],[0.797],[0.79],0.314,0.542,0.624,0.162,0.166,0.128,0.741,0.645,0.621,0.674,0.805,0.74,0.632,0.916,0.828,0.765,0.797,0.79
https://doi.org/10.1001/jama.297.11.1241,late vs early clamping of the umbilical cord in fullterm neonates,769_late vs early clamping of the umbilical cord in fullterm neonates.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026059/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544813/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372362/pdf']","['Alternative positions for the baby at birth before clamping the umbilical cord', 'Active versus expectant management for women in the third stage of labour', 'Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes', 'Active versus expectant management for women in the third stage of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372362/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026059/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544813/pdf']","['769_0_alternative positions for the baby at birth before clamping the umbilical cord.pdf', '769_3_active versus expectant management for women in the third stage of labour.pdf', '769_1_active versus expectant management for women in the third stage of labour.pdf', '769_2_effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372362/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026059/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544813/pdf']","['769_0_alternative positions for the baby at birth before clamping the umbilical cord.pdf', '769_3_active versus expectant management for women in the third stage of labour.pdf', '769_1_active versus expectant management for women in the third stage of labour.pdf', '769_2_effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.pdf']","[0.588, 0.358, 0.746, 0.355]","[0.487, 0.497, 0.497, 0.489]","[0.582, 0.583, 0.583, 0.578]","[0.157, 0.156, 0.151, 0.157]","[0.169, 0.149, 0.151, 0.158]","[0.134, 0.13, 0.127, 0.136]","[0.733, 0.738, 0.734, 0.739]","[0.641, 0.643, 0.642, 0.647]","[0.549, 0.556, 0.553, 0.551]","[0.667, 0.681, 0.681, 0.681]","[0.763, 0.764, 0.757, 0.76]","[0.677, 0.673, 0.68, 0.666]","[0.586, 0.569, 0.557, 0.579]","[0.898, 0.889, 0.889, 0.89]","[0.772, 0.766, 0.764, 0.762]","[0.685, 0.683, 0.686, 0.683]","[0.748, 0.748, 0.743, 0.744]","[0.717, 0.713, 0.712, 0.712]",0.512,0.492,0.582,0.155,0.157,0.132,0.736,0.643,0.552,0.677,0.761,0.674,0.573,0.892,0.766,0.684,0.746,0.714
https://doi.org/10.1001/jama.297.22.2468,three outbreaks of salmonellosis associated with baby poultry from three hatcheries—united states 2006,770_three outbreaks of salmonellosis associated with baby poultry from three hatcheries—united states 2006.pdf,2,"['https://www.nj.gov/health/vph/documents/measures_to_prevent_disease_animals_2017.pdf', 'https://stacks.cdc.gov/view/cdc/5277']","['Public Veterinary Medicine: Public Health', 'Compendium of measures to prevent disease associated with animals in public settings, 2009']",['https://www.nj.gov/health/vph/documents/measures_to_prevent_disease_animals_2017.pdf'],['770_0_public veterinary medicine public health.pdf'],1,50.0,['https://www.nj.gov/health/vph/documents/measures_to_prevent_disease_animals_2017.pdf'],['770_0_public veterinary medicine public health.pdf'],[0.229],[0.598],[0.657],[0.189],[0.198],[0.16],[0.74],[0.653],[0.677],[0.631],[0.843],[0.787],[0.653],[0.926],[0.859],[0.811],[0.842],[0.83],0.229,0.598,0.657,0.189,0.198,0.16,0.74,0.653,0.677,0.631,0.843,0.787,0.653,0.926,0.859,0.811,0.842,0.83
https://doi.org/10.1001/jama.297.24.2697,effects of a weight management program on body composition and metabolic parameters in overweight children,771_effects of a weight management program on body composition and metabolic parameters in overweight children.pdf,8,"['https://watermark.silverchair.com/jcem4576.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsgwggLEBgkqhkiG9w0BBwagggK1MIICsQIBADCCAqoGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMxBXae0lfV7sZDCkgAgEQgIICe0BEZq-R6kxVGHR4AyQ6juIhTkPXxQg3nddVZrDYfBEZ-4kbuY7IzKKjJ4TbYHeub82sgxF4kUWIxm0ekgZlk14LdUF2CWMHE39RPSMRVE-TNmqKEg9SsxkRT40ra-dkvvcvgwPEhBGd-jLIrgHE_Ivmkn0_apmV9VBUUEIEC1Mm-QU9ariT2tWpN9qjKaPmotnJOj4yFqpE6uaXatw_MKVyqBMlcPTzBVeNzo3eo_cJSggHUqmj56zs6HPdmYFx9HyxyG66ktkvH7iHnJO4IRjVysahA3qOSKSYaOBDgxZYYLIfi3LftxiIAPfFSKepqFwrgijvH9vr_C2mK9dyRwXY817pwg7LFexDRVEzulToDcNGd9k4F-ZugcdDUsBr7V7fHtWYbP9o1KqeMi-08CgQTkLgBtVq2DOZFitU3pdfBgD9L8RjZWjqvJcbZLnJKca9KIr67bH6FZPlYlerBXlxDeOo-xirXCsgkjY7nldILVVaXU6W9l5y_Y7Dn4JbkAKWpFK_e1dJ3EL6mKF1KFnljqO34__7G0nR1Gy2EuDNbp3pCrOoNLhiAhjYZP33bZyiJ5DxSppZMKN7CL1tVh5tm4iU_8Qif821D32jAIXrBrFhlyfnTN6xdggHfnwUwNKe8g7Pi0boZclfl56kjZ2uHONKnWm_gNm7aBxTSo8qv8fMsR2kAXW23X7ow9kSQn_TCqtsSUrfZM2GeHkeBtH88eHVtBhuqd9yOhZ0P_OsXLcaLubKDW9ir1AxWmJJSPeNJAVrOq2NQjowDMLhEhs3ZYPz1F-bgkrY-GmRm_wSH-hezfyfiIxW7HfYrKiwYqrI337kLuISkoGg', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486271/pdf', 'https://www.hca.wa.gov/assets/program/pbs_final_evidence_report[1].pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/6/Wsipp_BenefitCost_ProgramDetails_Health-Care', 'http://www.wsipp.wa.gov/ReportFile/1580/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-A-Review-of-the-Evidence_Report.pdf', 'https://www.michigan.gov/documents/healthymichigan/Michigan_Health_Wellness_4x4_Plan_387870_7.pdf', 'https://www.michigan.gov/documents/mdch/MDCH_SHIP_FINAL_8-16-12_400674_7.pdf.']","['Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion', 'Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years', 'Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus', 'Windows on Medical Technology', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'The Michigan Health and Wellness4x4 Plan', ""Michigan's State Health Assessment and State Health Improvement Plan 2012–2017""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481371/pdf', 'https://www.michigan.gov/documents/healthymichigan/Michigan_Health_Wellness_4x4_Plan_387870_7.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486271/pdf', 'https://www.hca.wa.gov/assets/program/pbs_final_evidence_report[1].pdf', 'https://www.michigan.gov/documents/mdch/MDCH_SHIP_FINAL_8-16-12_400674_7.pdf.', 'http://www.wsipp.wa.gov/ReportFile/1580/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-A-Review-of-the-Evidence_Report.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/6/Wsipp_BenefitCost_ProgramDetails_Health-Care']","['771_1_diet physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.pdf', '771_6_the michigan health and wellness4x4 plan.pdf', '771_2_diet physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.pdf', '771_3_windows on medical technology.pdf', '771_7_michigans state health assessment and state health improvement plan 2012–2017.pdf', '771_5_washington state institute for public policy.pdf', '771_4_washington state institute for public policy.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481371/pdf', 'https://www.michigan.gov/documents/healthymichigan/Michigan_Health_Wellness_4x4_Plan_387870_7.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486271/pdf', 'https://www.hca.wa.gov/assets/program/pbs_final_evidence_report[1].pdf', 'https://www.michigan.gov/documents/mdch/MDCH_SHIP_FINAL_8-16-12_400674_7.pdf.', 'http://www.wsipp.wa.gov/ReportFile/1580/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-A-Review-of-the-Evidence_Report.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/6/Wsipp_BenefitCost_ProgramDetails_Health-Care']","['771_1_diet physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.pdf', '771_6_the michigan health and wellness4x4 plan.pdf', '771_2_diet physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.pdf', '771_3_windows on medical technology.pdf', '771_7_michigans state health assessment and state health improvement plan 2012–2017.pdf', '771_5_washington state institute for public policy.pdf', '771_4_washington state institute for public policy.pdf']","[0.461, 0.341, 0.252, 0.256, 0.377, 0.36, 0.16]","[0.493, 0.479, 0.495, 0.493, 0.443, 0.47, 0.489]","[0.579, 0.574, 0.58, 0.575, 0.546, 0.557, 0.58]","[0.154, 0.141, 0.153, 0.14, 0.137, 0.122, 0.112]","[0.162, 0.156, 0.163, 0.15, 0.139, 0.135, 0.126]","[0.14, 0.132, 0.137, 0.127, 0.126, 0.121, 0.106]","[0.738, 0.731, 0.737, 0.729, 0.733, 0.734, 0.721]","[0.638, 0.629, 0.637, 0.628, 0.633, 0.636, 0.62]","[0.556, 0.544, 0.555, 0.551, 0.538, 0.537, 0.546]","[0.715, 0.686, 0.715, 0.678, 0.68, 0.702, 0.696]","[0.743, 0.755, 0.745, 0.743, 0.74, 0.741, 0.748]","[0.675, 0.688, 0.68, 0.69, 0.657, 0.67, 0.697]","[0.577, 0.591, 0.584, 0.602, 0.553, 0.582, 0.598]","[0.873, 0.874, 0.873, 0.871, 0.869, 0.872, 0.877]","[0.773, 0.77, 0.77, 0.769, 0.773, 0.753, 0.766]","[0.662, 0.67, 0.662, 0.666, 0.66, 0.667, 0.674]","[0.744, 0.752, 0.745, 0.747, 0.739, 0.74, 0.754]","[0.697, 0.697, 0.692, 0.691, 0.683, 0.699, 0.697]",0.315,0.48,0.57,0.137,0.147,0.127,0.732,0.632,0.547,0.696,0.745,0.68,0.584,0.873,0.768,0.666,0.746,0.694
https://doi.org/10.1001/jama.297.24.2716,incidence of diabetes in youth in the united states,772_incidence of diabetes in youth in the united states.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797382/pdf', 'https://stacks.cdc.gov/view/cdc/6024', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198284/pdf']","['Standards of Medical Care in Diabetes—2010', 'School health guidelines to promote healthy eating and physical activity', 'Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems - A position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the ...']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797382/pdf'],['772_0_standards of medical care in diabetes—2010.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797382/pdf'],['772_0_standards of medical care in diabetes—2010.pdf'],[0.417],[0.521],[0.609],[0.162],[0.161],[0.126],[0.737],[0.639],[0.592],[0.66],[0.801],[0.705],[0.615],[0.915],[0.816],[0.759],[0.793],[0.78],0.417,0.521,0.609,0.162,0.161,0.126,0.737,0.639,0.592,0.66,0.801,0.705,0.615,0.915,0.816,0.759,0.793,0.78
https://doi.org/10.1001/jama.297.24.2741,definitions and measurement of chronic health conditions in childhood,773_definitions and measurement of chronic health conditions in childhood.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://stacks.cdc.gov/view/cdc/51852']","['E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological interventions for parents of children and adolescents with chronic illness', 'Report to Congress : the management of traumatic brain injury in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['773_2_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '773_1_psychological interventions for parents of children and adolescents with chronic illness.pdf', '773_3_psychological interventions for parents of children and adolescents with chronic illness.pdf', '773_0_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['773_2_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '773_1_psychological interventions for parents of children and adolescents with chronic illness.pdf', '773_3_psychological interventions for parents of children and adolescents with chronic illness.pdf', '773_0_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']","[0.314, 0.346, 0.289, 0.331]","[0.504, 0.522, 0.51, 0.509]","[0.59, 0.603, 0.595, 0.595]","[0.153, 0.161, 0.155, 0.156]","[0.155, 0.171, 0.17, 0.159]","[0.132, 0.135, 0.134, 0.135]","[0.737, 0.734, 0.736, 0.736]","[0.639, 0.638, 0.641, 0.641]","[0.567, 0.585, 0.57, 0.571]","[0.709, 0.704, 0.706, 0.707]","[0.773, 0.775, 0.766, 0.775]","[0.687, 0.719, 0.704, 0.699]","[0.574, 0.569, 0.56, 0.578]","[0.908, 0.91, 0.905, 0.906]","[0.811, 0.811, 0.802, 0.808]","[0.719, 0.736, 0.725, 0.722]","[0.763, 0.768, 0.756, 0.766]","[0.754, 0.762, 0.748, 0.753]",0.32,0.511,0.596,0.156,0.164,0.134,0.736,0.64,0.573,0.706,0.772,0.702,0.57,0.907,0.808,0.726,0.763,0.754
https://doi.org/10.1001/jama.297.24.2755,the increase of childhood chronic conditions in the united states,774_the increase of childhood chronic conditions in the united states.pdf,3,"['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F95C843A7EFD0AE41D6532D6E99AD5AB/S0195941700033907a.pdf/infection-prevention-and-control-in-residential-facilities-for-pediatric-patients-and-their-families.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'https://www.nber.org/papers/w19940']","['Infection Prevention and Control in Residential Facilities for Pediatric Patients and Their Families', 'Preconception Care: A New Standard of Care within Maternal Health Services', 'Breastfeeding and Child Disability: A Comparison of Siblings from the United States']","['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F95C843A7EFD0AE41D6532D6E99AD5AB/S0195941700033907a.pdf/infection-prevention-and-control-in-residential-facilities-for-pediatric-patients-and-their-families.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf']","['774_0_infection prevention and control in residential facilities for pediatric patients and their families.pdf', '774_1_preconception care a new standard of care within maternal health services.pdf']",2,66.67,"['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F95C843A7EFD0AE41D6532D6E99AD5AB/S0195941700033907a.pdf/infection-prevention-and-control-in-residential-facilities-for-pediatric-patients-and-their-families.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf']","['774_0_infection prevention and control in residential facilities for pediatric patients and their families.pdf', '774_1_preconception care a new standard of care within maternal health services.pdf']","[0.225, 0.36]","[0.545, 0.487]","[0.63, 0.584]","[0.13, 0.129]","[0.13, 0.117]","[0.1, 0.111]","[0.726, 0.733]","[0.624, 0.638]","[0.618, 0.535]","[0.621, 0.662]","[0.813, 0.753]","[0.742, 0.631]","[0.626, 0.59]","[0.924, 0.907]","[0.83, 0.78]","[0.772, 0.699]","[0.809, 0.73]","[0.794, 0.728]",0.292,0.516,0.607,0.13,0.123,0.106,0.73,0.631,0.577,0.641,0.783,0.686,0.608,0.915,0.805,0.736,0.77,0.761
https://doi.org/10.1001/jama.297.8.800,infant deaths associated with cough and cold medications—two states 2005,775_infant deaths associated with cough and cold medications—two states 2005.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182143/pdf'],"['Decongestants, antihistamines and nasal irrigation for acute sinusitis in children']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182143/pdf'],['775_0_decongestants antihistamines and nasal irrigation for acute sinusitis in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182143/pdf'],['775_0_decongestants antihistamines and nasal irrigation for acute sinusitis in children.pdf'],[0.16],[0.559],[0.638],[0.198],[0.194],[0.164],[0.734],[0.639],[0.627],[0.64],[0.81],[0.748],[0.625],[0.925],[0.834],[0.773],[0.806],[0.798],0.16,0.559,0.638,0.198,0.194,0.164,0.734,0.639,0.627,0.64,0.81,0.748,0.625,0.925,0.834,0.773,0.806,0.798
https://doi.org/10.1001/jama.298.16.1876,improving child survival through environmental and nutritional interventions,776_improving child survival through environmental and nutritional interventions.pdf,1,['https://purl.fdlp.gov/GPO/gpo111702'],['Making the demographic and health surveys wealth index comparable /'],['https://purl.fdlp.gov/GPO/gpo111702'],['776_0_making the demographic and health surveys wealth index comparable .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo111702'],['776_0_making the demographic and health surveys wealth index comparable .pdf'],[0.384],[0.528],[0.625],[0.175],[0.19],[0.146],[0.732],[0.637],[0.601],[0.719],[0.799],[0.716],[0.634],[0.915],[0.845],[0.756],[0.794],[0.781],0.384,0.528,0.625,0.175,0.19,0.146,0.732,0.637,0.601,0.719,0.799,0.716,0.634,0.915,0.845,0.756,0.794,0.781
https://doi.org/10.1001/jama.298.22.2644,effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients,777_effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients.pdf,8,"['https://pdfs.journals.lww.com/pccmjournal/2022/02000/2022_Society_of_Critical_Care_Medicine_Clinical.15.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1675444796053;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdqC6FVL99+1gGAXua892EhKEcsguohQVRSHWxg1B3wMwqo90NiXXzMW9IuAtuEQS5;hash|QYqNTfNLqMNqjVSybJI9Zg==', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719921/pdf', 'https://pdfs.journals.lww.com/ccmjournal/2018/09000/Clinical_Practice_Guidelines_for_the_Prevention.29.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1675445804472;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzd9ia1/MJJUFmWp1b9urv13H7tDRDjcAm4ZGpkBdxbKyM=;hash|XHpF0P7uWn47CxGnSPXg/A==', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669269/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517142/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458040/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353054/pdf']","['2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility', 'Pharmacological interventions for the treatment of delirium in critically ill adults', 'Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU', 'Benzodiazepines for delirium', 'Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation', 'Interventions for preventing intensive care unit delirium in adults', 'Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence‐synthesis', 'Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517142/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458040/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353054/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669269/pdf']","['777_4_daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation.pdf', '777_1_pharmacological interventions for the treatment of delirium in critically ill adults.pdf', '777_5_interventions for preventing intensive care unit delirium in adults.pdf', '777_6_factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children a qualitative evidence‐synthesis.pdf', '777_7_alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients.pdf', '777_3_benzodiazepines for delirium.pdf']",6,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517142/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458040/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353054/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669269/pdf']","['777_4_daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation.pdf', '777_1_pharmacological interventions for the treatment of delirium in critically ill adults.pdf', '777_5_interventions for preventing intensive care unit delirium in adults.pdf', '777_6_factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children a qualitative evidence‐synthesis.pdf', '777_7_alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients.pdf', '777_3_benzodiazepines for delirium.pdf']","[0.44, 0.558, 0.568, 0.527, 0.254, 0.605]","[0.503, 0.503, 0.515, 0.528, 0.518, 0.529]","[0.593, 0.59, 0.602, 0.617, 0.606, 0.622]","[0.18, 0.167, 0.179, 0.163, 0.188, 0.185]","[0.184, 0.168, 0.187, 0.167, 0.192, 0.202]","[0.144, 0.133, 0.145, 0.125, 0.152, 0.153]","[0.741, 0.736, 0.737, 0.73, 0.74, 0.739]","[0.649, 0.644, 0.644, 0.635, 0.648, 0.647]","[0.574, 0.58, 0.589, 0.61, 0.599, 0.613]","[0.683, 0.68, 0.682, 0.669, 0.685, 0.674]","[0.772, 0.775, 0.781, 0.795, 0.789, 0.799]","[0.688, 0.689, 0.707, 0.727, 0.704, 0.725]","[0.593, 0.59, 0.596, 0.599, 0.6, 0.6]","[0.903, 0.903, 0.907, 0.915, 0.911, 0.923]","[0.808, 0.808, 0.814, 0.839, 0.819, 0.839]","[0.72, 0.717, 0.726, 0.75, 0.737, 0.749]","[0.763, 0.767, 0.772, 0.789, 0.778, 0.789]","[0.749, 0.746, 0.753, 0.78, 0.765, 0.781]",0.492,0.516,0.605,0.177,0.183,0.142,0.737,0.644,0.594,0.679,0.785,0.707,0.596,0.91,0.821,0.733,0.776,0.762
https://doi.org/10.1001/jama.298.24.2895,does this child have a urinary tract infection,778_does this child have a urinary tract infection.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/diagnostic-tests-reviews/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479592/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104675/pdf', 'https://www.acep.org/globalassets/new-pdfs/clinical-policies/pedi-fever.pdf']","['Comprehensive Overview of Methods and Reporting of Meta-Analyses of Test Accuracy', 'Procalcitonin, C‐reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children', 'Procalcitonin, C‐reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children', 'Clinical Policy for Well-Appearing Infants and Children Younger Than 2 Years of Age Presenting to the Emergency Department With Fever']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479592/pdf', 'https://www.acep.org/globalassets/new-pdfs/clinical-policies/pedi-fever.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104675/pdf']","['778_1_procalcitonin c‐reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.pdf', '778_3_clinical policy for wellappearing infants and children younger than 2 years of age presenting to the emergency department with fever.pdf', '778_2_procalcitonin c‐reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479592/pdf', 'https://www.acep.org/globalassets/new-pdfs/clinical-policies/pedi-fever.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104675/pdf']","['778_1_procalcitonin c‐reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.pdf', '778_3_clinical policy for wellappearing infants and children younger than 2 years of age presenting to the emergency department with fever.pdf', '778_2_procalcitonin c‐reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.pdf']","[0.315, 0.333, 0.621]","[0.53, 0.53, 0.531]","[0.617, 0.611, 0.62]","[0.162, 0.175, 0.167]","[0.177, 0.192, 0.186]","[0.136, 0.148, 0.142]","[0.736, 0.741, 0.737]","[0.637, 0.646, 0.641]","[0.598, 0.593, 0.598]","[0.686, 0.669, 0.68]","[0.789, 0.787, 0.793]","[0.705, 0.713, 0.7]","[0.614, 0.617, 0.609]","[0.914, 0.903, 0.916]","[0.817, 0.794, 0.816]","[0.744, 0.733, 0.743]","[0.78, 0.776, 0.781]","[0.771, 0.755, 0.771]",0.423,0.53,0.616,0.168,0.185,0.142,0.738,0.641,0.596,0.678,0.79,0.706,0.613,0.911,0.809,0.74,0.779,0.766
https://doi.org/10.1001/jama.298.5.519,interventions for depression symptoms among adolescent survivors of war and displacement in northern uganda,779_interventions for depression symptoms among adolescent survivors of war and displacement in northern uganda.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390394/pdf', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research', 'https://www.fhi360.org/resource/guiding-principles-building-youth-soft-skills-among-adolescents-and-young-adults']","['Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises', 'Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries', 'E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises', 'Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological therapies for children and adolescents exposed to trauma', 'Sports and games for post‐traumatic stress disorder (PTSD)', 'Treatment of Depression in Children and Adolescents', 'Guiding Principles for Building Youth Soft Skills among Adolescents and Young Adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390394/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf']","['779_5_psychological therapies for children and adolescents exposed to trauma.pdf', '779_1_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '779_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf', '779_6_sports and games for post‐traumatic stress disorder ptsd.pdf', '779_2_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '779_4_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '779_3_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf']",7,77.78,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390394/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf']","['779_5_psychological therapies for children and adolescents exposed to trauma.pdf', '779_1_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '779_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf', '779_6_sports and games for post‐traumatic stress disorder ptsd.pdf', '779_2_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '779_4_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '779_3_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf']","[0.444, 0.461, 0.431, 0.375, 0.429, 0.425, 0.329]","[0.489, 0.516, 0.513, 0.519, 0.499, 0.496, 0.477]","[0.576, 0.597, 0.597, 0.608, 0.586, 0.583, 0.567]","[0.166, 0.168, 0.166, 0.165, 0.163, 0.164, 0.157]","[0.167, 0.174, 0.175, 0.181, 0.167, 0.171, 0.156]","[0.14, 0.148, 0.146, 0.146, 0.141, 0.143, 0.132]","[0.734, 0.732, 0.729, 0.729, 0.731, 0.733, 0.733]","[0.639, 0.641, 0.637, 0.634, 0.638, 0.638, 0.639]","[0.562, 0.589, 0.59, 0.609, 0.574, 0.57, 0.548]","[0.71, 0.701, 0.707, 0.698, 0.706, 0.709, 0.714]","[0.772, 0.788, 0.788, 0.797, 0.779, 0.776, 0.766]","[0.669, 0.704, 0.705, 0.72, 0.691, 0.68, 0.649]","[0.573, 0.588, 0.58, 0.594, 0.584, 0.58, 0.574]","[0.904, 0.91, 0.91, 0.921, 0.901, 0.903, 0.902]","[0.808, 0.822, 0.827, 0.838, 0.816, 0.818, 0.803]","[0.711, 0.726, 0.725, 0.737, 0.717, 0.714, 0.706]","[0.758, 0.778, 0.778, 0.791, 0.767, 0.764, 0.753]","[0.741, 0.753, 0.757, 0.772, 0.746, 0.748, 0.738]",0.413,0.501,0.588,0.164,0.17,0.142,0.732,0.638,0.577,0.706,0.781,0.688,0.582,0.907,0.819,0.719,0.77,0.751
https://doi.org/10.1001/jama.298.7.743,effect of human papillomavirus 1618 l1 viruslike particle vaccine among young women with preexisting infection,781_effect of human papillomavirus 1618 l1 viruslike particle vaccine among young women with preexisting infection.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230171/pdf', 'https://stacks.cdc.gov/view/cdc/25363']","['Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors', 'Vaccination Recommendations for Germany', 'Human papillomavirus vaccination : recommendations of the Advisory Committee on Immunization Practices (ACIP)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230171/pdf']","['781_0_prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.pdf', '781_1_vaccination recommendations for germany.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230171/pdf']","['781_0_prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.pdf', '781_1_vaccination recommendations for germany.pdf']","[0.65, 0.378]","[0.505, 0.522]","[0.59, 0.604]","[0.188, 0.181]","[0.192, 0.186]","[0.172, 0.163]","[0.75, 0.743]","[0.661, 0.65]","[0.561, 0.581]","[0.695, 0.659]","[0.758, 0.783]","[0.686, 0.723]","[0.597, 0.622]","[0.871, 0.886]","[0.768, 0.787]","[0.677, 0.706]","[0.755, 0.772]","[0.703, 0.721]",0.514,0.514,0.597,0.184,0.189,0.167,0.746,0.655,0.571,0.677,0.77,0.705,0.609,0.879,0.778,0.692,0.764,0.712
https://doi.org/10.1001/jama.300.10.1135,student body racial and ethnic composition and diversityrelated outcomes in us medical schools,782_student body racial and ethnic composition and diversityrelated outcomes in us medical schools.pdf,1,['https://www.mass.gov/doc/sffa-v-harvard-brief/download'],['NO. 19-2005 United States Court of Appeals for the First Circuit'],['https://www.mass.gov/doc/sffa-v-harvard-brief/download'],['782_0_no 192005 united states court of appeals for the first circuit.pdf'],1,100.0,['https://www.mass.gov/doc/sffa-v-harvard-brief/download'],['782_0_no 192005 united states court of appeals for the first circuit.pdf'],[0.496],[0.495],[0.589],[0.163],[0.182],[0.155],[0.738],[0.642],[0.555],[0.711],[0.763],[0.678],[0.615],[0.911],[0.82],[0.723],[0.757],[0.74],0.496,0.495,0.589,0.163,0.182,0.155,0.738,0.642,0.555,0.711,0.763,0.678,0.615,0.911,0.82,0.723,0.757,0.74
https://doi.org/10.1001/jama.300.11.1303,association of urinary bisphenol a concentration with medical disorders and laboratory abnormalities in adults,783_association of urinary bisphenol a concentration with medical disorders and laboratory abnormalities in adults.pdf,6,"['https://www.pacificresearch.org/the-latest-target-of-the-eco-fundamentalists-plastics/', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.congress.gov/event/111th-congress/house-event/LC7159/text', 'https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf', 'https://www.rand.org/pubs/research_reports/RR1574.html']","['The Latest Target Of The Eco-Fundamentalists: Plastics', 'Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'America’s children and the environment.', 'House Hearing, 111th Congress — ENDOCRINE-DISRUPTING CHEMICALS IN DRINKING WATER: RISKS TO HUMAN HEALTH AND THE ENVIRONMENT', 'Evidence on the Carcinogenicity of Bisphenol A (BPA)', 'The National Institute for Health Research at 10 Years']","['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641']","['783_4_evidence on the carcinogenicity of bisphenol a bpa.pdf', '783_1_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '783_2_americas children and the environment.pdf']",3,50.0,"['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641']","['783_4_evidence on the carcinogenicity of bisphenol a bpa.pdf', '783_1_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '783_2_americas children and the environment.pdf']","[0.399, 0.417, 0.387]","[0.471, 0.465, 0.466]","[0.568, 0.562, 0.563]","[0.127, 0.119, 0.118]","[0.122, 0.121, 0.119]","[0.102, 0.098, 0.098]","[0.737, 0.732, 0.733]","[0.645, 0.635, 0.636]","[0.544, 0.536, 0.534]","[0.69, 0.681, 0.697]","[0.759, 0.752, 0.751]","[0.663, 0.669, 0.667]","[0.592, 0.588, 0.595]","[0.867, 0.867, 0.865]","[0.758, 0.758, 0.759]","[0.672, 0.664, 0.669]","[0.747, 0.745, 0.748]","[0.699, 0.695, 0.699]",0.401,0.467,0.564,0.121,0.121,0.099,0.734,0.639,0.538,0.689,0.754,0.666,0.592,0.866,0.758,0.668,0.747,0.698
https://doi.org/10.1001/jama.300.6.655,schoolbased mental health intervention for children affected by political violence in indonesia,784_schoolbased mental health intervention for children affected by political violence in indonesia.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/5/Wsipp_BenefitCost_ProgramDetails_Childrens-Mental-Health', 'https://www.icrw.org/publications/understanding-tackling-gendered-drivers-poor-adolescent-mental-health/']","['Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises', 'Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries', 'Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises', 'Psychological therapies for children and adolescents exposed to trauma', 'Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy', 'UNDERSTANDING & TACKLING THE GENDERED DRIVERS OF POOR ADOLESCENT MENTAL HEALTH']","['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf']","['784_5_washington state institute for public policy.pdf', '784_3_psychological therapies for children and adolescents exposed to trauma.pdf', '784_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf', '784_2_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf', '784_1_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '784_4_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf']",6,75.0,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf']","['784_5_washington state institute for public policy.pdf', '784_3_psychological therapies for children and adolescents exposed to trauma.pdf', '784_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf', '784_2_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf', '784_1_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '784_4_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf']","[0.502, 0.478, 0.385, 0.51, 0.418, 0.285]","[0.506, 0.499, 0.508, 0.49, 0.513, 0.505]","[0.58, 0.578, 0.591, 0.571, 0.592, 0.586]","[0.134, 0.159, 0.154, 0.147, 0.156, 0.158]","[0.153, 0.161, 0.165, 0.148, 0.162, 0.165]","[0.128, 0.139, 0.138, 0.129, 0.137, 0.143]","[0.728, 0.738, 0.731, 0.737, 0.734, 0.735]","[0.633, 0.642, 0.637, 0.642, 0.64, 0.639]","[0.566, 0.558, 0.569, 0.55, 0.57, 0.563]","[0.7, 0.721, 0.715, 0.725, 0.708, 0.723]","[0.776, 0.762, 0.772, 0.758, 0.772, 0.763]","[0.704, 0.673, 0.698, 0.657, 0.697, 0.68]","[0.592, 0.57, 0.575, 0.574, 0.583, 0.578]","[0.9, 0.894, 0.897, 0.893, 0.897, 0.893]","[0.791, 0.783, 0.797, 0.78, 0.793, 0.791]","[0.717, 0.696, 0.702, 0.694, 0.704, 0.693]","[0.775, 0.752, 0.765, 0.748, 0.766, 0.756]","[0.745, 0.728, 0.736, 0.726, 0.734, 0.728]",0.43,0.503,0.583,0.151,0.159,0.136,0.734,0.639,0.563,0.715,0.767,0.685,0.579,0.896,0.789,0.701,0.76,0.733
https://doi.org/10.1001/jama.300.9.1027,effect of physical activity on cognitive function in older adults at risk for alzheimer disease,785_effect of physical activity on cognitive function in older adults at risk for alzheimer disease.pdf,2,"['https://effectivehealthcare.ahrq.gov/products/care-interventions-pwd/report', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721454/pdf']","['Care Interventions for People Living With Dementia and Their Caregivers', 'Exercise for depression']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721454/pdf'],['785_1_exercise for depression.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721454/pdf'],['785_1_exercise for depression.pdf'],[0.388],[0.479],[0.564],[0.143],[0.151],[0.13],[0.737],[0.642],[0.545],[0.732],[0.735],[0.678],[0.563],[0.856],[0.758],[0.629],[0.734],[0.664],0.388,0.479,0.564,0.143,0.151,0.13,0.737,0.642,0.545,0.732,0.735,0.678,0.563,0.856,0.758,0.629,0.734,0.664
https://doi.org/10.1001/jamadermatol.2019.3336,efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis,787_efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis.pdf,2,"['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf']","['Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit', 'Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit']","['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf']","['787_1_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '787_0_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf']",2,100.0,"['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf']","['787_1_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '787_0_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf']","[0.292, 0.281]","[0.499, 0.501]","[0.583, 0.585]","[0.141, 0.143]","[0.138, 0.139]","[0.111, 0.111]","[0.731, 0.731]","[0.637, 0.638]","[0.567, 0.568]","[0.658, 0.657]","[0.776, 0.775]","[0.692, 0.693]","[0.6, 0.599]","[0.902, 0.902]","[0.794, 0.793]","[0.727, 0.728]","[0.777, 0.777]","[0.75, 0.749]",0.286,0.5,0.584,0.142,0.139,0.111,0.731,0.637,0.567,0.657,0.776,0.692,0.599,0.902,0.794,0.728,0.777,0.75
https://doi.org/10.1001/jamainternmed.2017.2924,injurious falls and syncope in older communitydwelling adults meeting inclusion criteria for sprint,792_injurious falls and syncope in older communitydwelling adults meeting inclusion criteria for sprint.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094587/pdf'],['Blood pressure targets in adults with hypertension'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094587/pdf'],['792_0_blood pressure targets in adults with hypertension.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094587/pdf'],['792_0_blood pressure targets in adults with hypertension.pdf'],[0.34],[0.508],[0.591],[0.15],[0.145],[0.119],[0.732],[0.634],[0.58],[0.688],[0.767],[0.682],[0.576],[0.913],[0.802],[0.722],[0.766],[0.747],0.34,0.508,0.591,0.15,0.145,0.119,0.732,0.634,0.58,0.688,0.767,0.682,0.576,0.913,0.802,0.722,0.766,0.747
https://doi.org/10.1001/jamainternmed.2020.5313,clinical outcomes in young us adults hospitalized with covid19,794_clinical outcomes in young us adults hospitalized with covid19.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf', 'https://www.heritage.org/public-health/report/statistical-analysis-covid-19-and-government-protection-measures-the-us', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://stacks.cdc.gov/view/cdc/94304']","['ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization - A Report of the American College of Cardiology Solution Set Oversight Committee', 'A Statistical Analysis of COVID-19 and Government Protection Measures in the U.S.', 'Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Changing age distribution of the COVID-19 pandemic — United States, May–August 2020']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf']","['794_2_master question list for covid19 caused by sarscov2.pdf', '794_0_acc health policy statement on cardiovascular disease considerations for covid19 vaccine prioritization  a report of the american college of cardiology solution set oversight committee.pdf']",2,50.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf']","['794_2_master question list for covid19 caused by sarscov2.pdf', '794_0_acc health policy statement on cardiovascular disease considerations for covid19 vaccine prioritization  a report of the american college of cardiology solution set oversight committee.pdf']","[0.477, 0.308]","[0.48, 0.481]","[0.576, 0.57]","[0.132, 0.16]","[0.12, 0.17]","[0.098, 0.134]","[0.73, 0.737]","[0.636, 0.645]","[0.536, 0.539]","[0.643, 0.686]","[0.766, 0.759]","[0.672, 0.672]","[0.585, 0.584]","[0.902, 0.892]","[0.797, 0.78]","[0.728, 0.713]","[0.766, 0.756]","[0.753, 0.739]",0.392,0.48,0.573,0.146,0.145,0.116,0.734,0.641,0.538,0.665,0.762,0.672,0.585,0.897,0.788,0.72,0.761,0.746
https://doi.org/10.1001/jamanetworkopen.2019.10465,association of childhood history of parental incarceration and juvenile justice involvement with mental health in early adulthood,800_association of childhood history of parental incarceration and juvenile justice involvement with mental health in early adulthood.pdf,1,['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618'],"['From Adversity to Resilience in the Justice Sector – Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health']",['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618'],['800_0_from adversity to resilience in the justice sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf'],1,100.0,['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618'],['800_0_from adversity to resilience in the justice sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf'],[0.425],[0.52],[0.617],[0.183],[0.196],[0.16],[0.741],[0.654],[0.575],[0.689],[0.79],[0.704],[0.61],[0.922],[0.809],[0.755],[0.793],[0.778],0.425,0.52,0.617,0.183,0.196,0.16,0.741,0.654,0.575,0.689,0.79,0.704,0.61,0.922,0.809,0.755,0.793,0.778
https://doi.org/10.1001/jamanetworkopen.2019.13804,association of flavored tobacco use with tobacco initiation and subsequent use among us youth and adults 20132015,801_association of flavored tobacco use with tobacco initiation and subsequent use among us youth and adults 20132015.pdf,7,"['https://www.federalregister.gov/documents/2022/05/04/2022-08994/tobacco-product-standard-for-menthol-in-cigarettes', 'https://www.federalregister.gov/documents/2022/05/04/2022-08993/tobacco-product-standard-for-characterizing-flavors-in-cigars', 'https://www.fda.gov/media/158754/download', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://stacks.cdc.gov/view/cdc/84557']","['Tobacco Product Standard for Menthol in Cigarettes', 'Tobacco Product Standard for Characterizing Flavors in Cigars', 'PM0000529', 'Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'Smoking Cessation', 'Smoking cessation: a report of the Surgeon General.', 'Smoking cessation : a report of the Surgeon General']","['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.fda.gov/media/158754/download', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['801_5_smoking cessation a report of the surgeon general.pdf', '801_2_pm0000529.pdf', '801_3_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']",3,42.86,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.fda.gov/media/158754/download', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['801_5_smoking cessation a report of the surgeon general.pdf', '801_2_pm0000529.pdf', '801_3_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']","[0.45, 0.325, 0.325]","[0.481, 0.492, 0.481]","[0.567, 0.571, 0.567]","[0.155, 0.163, 0.155]","[0.169, 0.174, 0.169]","[0.146, 0.152, 0.146]","[0.736, 0.732, 0.736]","[0.643, 0.64, 0.643]","[0.545, 0.539, 0.545]","[0.699, 0.682, 0.699]","[0.761, 0.761, 0.761]","[0.664, 0.676, 0.664]","[0.587, 0.611, 0.587]","[0.91, 0.907, 0.91]","[0.789, 0.802, 0.789]","[0.722, 0.735, 0.722]","[0.756, 0.769, 0.756]","[0.744, 0.752, 0.744]",0.367,0.485,0.568,0.158,0.171,0.148,0.735,0.642,0.543,0.693,0.761,0.668,0.595,0.909,0.793,0.726,0.76,0.747
https://doi.org/10.1001/jamanetworkopen.2019.14522,effect of a community agency–administered nurse home visitation program on program use and maternal and infant health outcomes,802_effect of a community agency–administered nurse home visitation program on program use and maternal and infant health outcomes.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf', 'https://dss.mo.gov/re/pdf/cfrar/2021-eliminating-child-abuse-and-neglect.pdf']","['Schedules for home visits in the early postpartum period', 'Executive Report - Child Fatality Review Panel Subcommittee On Child Abuse And Neglect Fatalities']","['https://dss.mo.gov/re/pdf/cfrar/2021-eliminating-child-abuse-and-neglect.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf']","['802_1_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf', '802_0_schedules for home visits in the early postpartum period.pdf']",2,100.0,"['https://dss.mo.gov/re/pdf/cfrar/2021-eliminating-child-abuse-and-neglect.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf']","['802_1_executive report  child fatality review panel subcommittee on child abuse and neglect fatalities.pdf', '802_0_schedules for home visits in the early postpartum period.pdf']","[0.405, 0.276]","[0.543, 0.529]","[0.625, 0.603]","[0.181, 0.175]","[0.199, 0.18]","[0.157, 0.15]","[0.73, 0.731]","[0.629, 0.638]","[0.601, 0.582]","[0.663, 0.699]","[0.794, 0.775]","[0.74, 0.708]","[0.623, 0.588]","[0.909, 0.902]","[0.818, 0.804]","[0.753, 0.723]","[0.802, 0.778]","[0.772, 0.748]",0.341,0.536,0.614,0.178,0.19,0.153,0.73,0.633,0.591,0.681,0.784,0.724,0.605,0.905,0.811,0.738,0.79,0.76
https://doi.org/10.1001/jamanetworkopen.2019.17134,global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of hiv infection,806_global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of hiv infection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],"['Sexually Transmitted Infections Treatment Guidelines, 2021']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],['806_0_sexually transmitted infections treatment guidelines 2021.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],['806_0_sexually transmitted infections treatment guidelines 2021.pdf'],[0.454],[0.52],[0.609],[0.163],[0.18],[0.153],[0.745],[0.656],[0.587],[0.649],[0.799],[0.7],[0.591],[0.907],[0.805],[0.728],[0.791],[0.773],0.454,0.52,0.609,0.163,0.18,0.153,0.745,0.656,0.587,0.649,0.799,0.7,0.591,0.907,0.805,0.728,0.791,0.773
https://doi.org/10.1001/jamanetworkopen.2019.20316,association of medicaid expansion with enrollee employment and student status in michigan,809_association of medicaid expansion with enrollee employment and student status in michigan.pdf,5,"['https://www.whitehouse.gov/cea/written-materials/2021/06/22/the-effects-of-earlier-medicaid-expansions-a-literature-review/', 'https://okpolicy.org/medicaid-expansions-rippling-impact-on-oklahoma/', 'https://www.whitehouse.gov/wp-content/uploads/2021/06/Medicaid-Expansions-Lit-Review-CEA-.pdf', 'https://www.kff.org/medicaid/report/the-effects-of-medicaid-expansion-under-the-aca-updated-findings-from-a-literature-review/', 'https://www.kff.org/medicaid/report/building-on-the-evidence-base-studies-on-the-effects-of-medicaid-expansion-february-2020-to-march-2021/']","['The Effects of Earlier Medicaid Expansions: A Literature Review', 'Medicaid expansion’s rippling impact on Oklahoma', 'The Effects of Earlier Medicaid Expansions: A Literature Review', 'The Effects of Medicaid Expansion under the ACA: Updated Findings from a Literature Review', 'Building on the Evidence Base: Studies on the Effects of Medicaid Expansion, February 2020 to March 2021']",['https://www.whitehouse.gov/wp-content/uploads/2021/06/Medicaid-Expansions-Lit-Review-CEA-.pdf'],['809_2_the effects of earlier medicaid expansions a literature review.pdf'],1,20.0,['https://www.whitehouse.gov/wp-content/uploads/2021/06/Medicaid-Expansions-Lit-Review-CEA-.pdf'],['809_2_the effects of earlier medicaid expansions a literature review.pdf'],[0.443],[0.52],[0.617],[0.181],[0.206],[0.157],[0.727],[0.635],[0.585],[0.711],[0.794],[0.708],[0.613],[0.924],[0.818],[0.744],[0.793],[0.771],0.443,0.52,0.617,0.181,0.206,0.157,0.727,0.635,0.585,0.711,0.794,0.708,0.613,0.924,0.818,0.744,0.793,0.771
https://doi.org/10.1001/jamaoncol.2018.4387,opioid use after open resection or videoassisted thoracoscopic surgery for earlystage lung cancer,840_opioid use after open resection or videoassisted thoracoscopic surgery for earlystage lung cancer.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907739/pdf'],['Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907739/pdf'],['840_0_educating surgical oncology providers on perioperative opioid use results of a departmental survey on perceptions of opioid needs and prescribing habits.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907739/pdf'],['840_0_educating surgical oncology providers on perioperative opioid use results of a departmental survey on perceptions of opioid needs and prescribing habits.pdf'],[0.345],[0.511],[0.596],[0.161],[0.17],[0.137],[0.736],[0.643],[0.571],[0.673],[0.774],[0.685],[0.565],[0.912],[0.801],[0.731],[0.766],[0.759],0.345,0.511,0.596,0.161,0.17,0.137,0.736,0.643,0.571,0.673,0.774,0.685,0.565,0.912,0.801,0.731,0.766,0.759
https://doi.org/10.1001/jamaophthalmol.2016.0267,ocular findings in infants with microcephaly associated with presumed zika virus congenital infection in salvador brazil,841_ocular findings in infants with microcephaly associated with presumed zika virus congenital infection in salvador brazil.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689094/pdf', 'https://www.nj.gov/health/cd/documents/topics/zika/mmwr_oct192017.pdf']","['Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection — United States, October 2017', 'Morbidity and Mortality Weekly Report, Volume 66, Issue Number 41']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689094/pdf', 'https://www.nj.gov/health/cd/documents/topics/zika/mmwr_oct192017.pdf']","['841_0_update interim guidance for the diagnosis evaluation and management of infants with possible congenital zika virus infection — united states october 2017.pdf', '841_1_morbidity and mortality weekly report volume 66 issue number 41.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689094/pdf', 'https://www.nj.gov/health/cd/documents/topics/zika/mmwr_oct192017.pdf']","['841_0_update interim guidance for the diagnosis evaluation and management of infants with possible congenital zika virus infection — united states october 2017.pdf', '841_1_morbidity and mortality weekly report volume 66 issue number 41.pdf']","[0.497, 0.497]","[0.538, 0.538]","[0.623, 0.623]","[0.183, 0.183]","[0.193, 0.193]","[0.16, 0.16]","[0.751, 0.751]","[0.656, 0.656]","[0.607, 0.607]","[0.637, 0.637]","[0.798, 0.798]","[0.715, 0.715]","[0.595, 0.595]","[0.913, 0.913]","[0.827, 0.827]","[0.754, 0.754]","[0.785, 0.785]","[0.78, 0.78]",0.497,0.538,0.623,0.183,0.193,0.16,0.751,0.656,0.607,0.637,0.798,0.715,0.595,0.913,0.827,0.754,0.785,0.78
https://doi.org/10.1001/jamaoto.2014.267,the influence of hearing aids on the speech and language development of children with hearing loss,843_the influence of hearing aids on the speech and language development of children with hearing loss.pdf,1,['http://jlarc.virginia.gov/pdfs/reports/Rpt543.pdf'],"['November 2, 2020']",['http://jlarc.virginia.gov/pdfs/reports/Rpt543.pdf'],['843_0_november 2 2020.pdf'],1,100.0,['http://jlarc.virginia.gov/pdfs/reports/Rpt543.pdf'],['843_0_november 2 2020.pdf'],[0.251],[0.509],[0.593],[0.136],[0.145],[0.124],[0.724],[0.628],[0.591],[0.653],[0.799],[0.731],[0.623],[0.919],[0.796],[0.752],[0.79],[0.773],0.251,0.509,0.593,0.136,0.145,0.124,0.724,0.628,0.591,0.653,0.799,0.731,0.623,0.919,0.796,0.752,0.79,0.773
https://doi.org/10.1001/jamaoto.2016.0051,current pediatric tertiary care admission practices following adenotonsillectomy,844_current pediatric tertiary care admission practices following adenotonsillectomy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609601/pdf'],['Impact of AAO-HNS Guideline on Obtaining Polysomnography Prior to Tonsillectomy for Pediatric Sleep-Disordered Breathing'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609601/pdf'],['844_0_impact of aaohns guideline on obtaining polysomnography prior to tonsillectomy for pediatric sleepdisordered breathing.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609601/pdf'],['844_0_impact of aaohns guideline on obtaining polysomnography prior to tonsillectomy for pediatric sleepdisordered breathing.pdf'],[0.38],[0.502],[0.605],[0.176],[0.183],[0.141],[0.736],[0.647],[0.583],[0.668],[0.78],[0.687],[0.585],[0.911],[0.802],[0.733],[0.762],[0.765],0.38,0.502,0.605,0.176,0.183,0.141,0.736,0.647,0.583,0.668,0.78,0.687,0.585,0.911,0.802,0.733,0.762,0.765
https://doi.org/10.1001/jamapediatrics.2013.1071,schoolcommunity partnerships,845_schoolcommunity partnerships.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543676/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://effectivehealthcare.ahrq.gov/products/obesity-research-methods/systematic-review']","['Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years', 'School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18', 'Interventions in outside‐school hours childcare settings for promoting physical activity amongst schoolchildren aged 4 to 12 years', 'Community wide interventions for increasing physical activity', 'Interventions for preventing obesity in children', 'Methods for Evaluating Natural Experiments in Obesity: A Systematic Evidence Review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543676/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf']","['845_2_interventions in outside‐school hours childcare settings for promoting physical activity amongst schoolchildren aged 4 to 12 years.pdf', '845_1_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '845_3_community wide interventions for increasing physical activity.pdf', '845_0_diet physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.pdf', '845_4_interventions for preventing obesity in children.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543676/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf']","['845_2_interventions in outside‐school hours childcare settings for promoting physical activity amongst schoolchildren aged 4 to 12 years.pdf', '845_1_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '845_3_community wide interventions for increasing physical activity.pdf', '845_0_diet physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.pdf', '845_4_interventions for preventing obesity in children.pdf']","[0.371, 0.551, 0.488, 0.355, 0.393]","[0.524, 0.521, 0.53, 0.514, 0.519]","[0.602, 0.606, 0.611, 0.597, 0.601]","[0.171, 0.182, 0.171, 0.161, 0.17]","[0.183, 0.196, 0.184, 0.17, 0.178]","[0.152, 0.162, 0.144, 0.142, 0.148]","[0.732, 0.737, 0.728, 0.733, 0.733]","[0.636, 0.641, 0.632, 0.635, 0.637]","[0.597, 0.595, 0.605, 0.583, 0.589]","[0.702, 0.703, 0.698, 0.698, 0.699]","[0.785, 0.786, 0.793, 0.779, 0.781]","[0.71, 0.702, 0.714, 0.689, 0.694]","[0.588, 0.587, 0.589, 0.579, 0.582]","[0.915, 0.915, 0.918, 0.914, 0.913]","[0.822, 0.824, 0.835, 0.821, 0.823]","[0.731, 0.729, 0.738, 0.725, 0.723]","[0.779, 0.779, 0.789, 0.771, 0.775]","[0.759, 0.761, 0.769, 0.755, 0.755]",0.432,0.522,0.603,0.171,0.182,0.15,0.733,0.636,0.594,0.7,0.785,0.702,0.585,0.915,0.825,0.729,0.779,0.76
https://doi.org/10.1001/jamapediatrics.2013.1095,electronic media–based health interventions promoting behavior change in youth,846_electronic media–based health interventions promoting behavior change in youth.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481357/pdf'],['Mass media interventions for preventing smoking in young people'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481357/pdf'],['846_0_mass media interventions for preventing smoking in young people.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481357/pdf'],['846_0_mass media interventions for preventing smoking in young people.pdf'],[0.436],[0.531],[0.612],[0.181],[0.191],[0.154],[0.733],[0.636],[0.599],[0.703],[0.788],[0.716],[0.603],[0.914],[0.826],[0.744],[0.786],[0.772],0.436,0.531,0.612,0.181,0.191,0.154,0.733,0.636,0.599,0.703,0.788,0.716,0.603,0.914,0.826,0.744,0.786,0.772
https://doi.org/10.1001/jamapediatrics.2013.2919,improving parenting skills for families of young children in pediatric settings,850_improving parenting skills for families of young children in pediatric settings.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://nam.edu/perspectives-2014-unique-opportunities-and-challenges-in-implementing-family-focused-interventions-for-children-with-developmental-disorders/', 'https://nam.edu/perspectives-2015-unleashing-the-power-of-prevention/', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.rand.org/pubs/research_reports/RR1993.html', 'https://www.in.gov/recovery/files/2016finalreportrevised.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/158/Incredible-Years-parent-training', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/5/Wsipp_BenefitCost_ProgramDetails_Childrens-Mental-Health']","['Group‐based parent training programmes for improving emotional and behavioural adjustment in young children', 'Unique Opportunities and Challenges in Implementing Family-Focused Interventions for Children with Developmental Disorders', 'Unleashing the Power of Prevention', 'Washington State Institute for Public Policy', 'Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'State of Indiana Fall 2016', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy']","['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.in.gov/recovery/files/2016finalreportrevised.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/158/Incredible-Years-parent-training', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf']","['850_3_washington state institute for public policy.pdf', '850_5_state of indiana fall 2016.pdf', '850_6_washington state institute for public policy.pdf', '850_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf']",4,50.0,"['http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.in.gov/recovery/files/2016finalreportrevised.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/158/Incredible-Years-parent-training', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf']","['850_3_washington state institute for public policy.pdf', '850_5_state of indiana fall 2016.pdf', '850_6_washington state institute for public policy.pdf', '850_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf']","[0.593, 0.262, 0.157, 0.339]","[0.492, 0.468, 0.486, 0.496]","[0.575, 0.567, 0.577, 0.578]","[0.134, 0.122, 0.128, 0.159]","[0.156, 0.125, 0.153, 0.168]","[0.131, 0.11, 0.133, 0.151]","[0.73, 0.724, 0.727, 0.736]","[0.635, 0.626, 0.634, 0.642]","[0.556, 0.535, 0.547, 0.559]","[0.708, 0.67, 0.715, 0.73]","[0.753, 0.757, 0.749, 0.746]","[0.695, 0.683, 0.695, 0.68]","[0.572, 0.581, 0.569, 0.557]","[0.874, 0.871, 0.876, 0.87]","[0.773, 0.771, 0.77, 0.773]","[0.674, 0.664, 0.674, 0.661]","[0.754, 0.747, 0.748, 0.739]","[0.699, 0.694, 0.697, 0.688]",0.338,0.485,0.574,0.136,0.151,0.131,0.729,0.634,0.549,0.706,0.751,0.688,0.57,0.873,0.772,0.668,0.747,0.694
https://doi.org/10.1001/jamapediatrics.2013.3817,effects of home visits by paraprofessionals and by nurses on children,852_effects of home visits by paraprofessionals and by nurses on children.pdf,9,"['https://www.acf.hhs.gov/opre/report/design-mother-and-infant-home-visiting-program-evaluation-long-term-follow-up', 'https://www.acf.hhs.gov/opre/report/evidence-long-term-effects-home-visiting-programs-laying-groundwork-long-term-follow', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudyBrief1.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudyIntro.pdf', 'https://www.rand.org/pubs/research_reports/RR1993.html', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudy.pdf', 'https://www.acf.hhs.gov/opre/resource/evidence-long-term-effects-home-visiting-programs-laying-the-groundwork-long-term-follow-up', 'https://legislature.idaho.gov/wp-content/uploads/OPE/Reports/r1701.pdf']","['Design of the Mother and Infant Home Visiting Program Evaluation Long-Term Follow-Up', 'Evidence on the Long-Term Effects of Home Visiting Programs: Laying the Groundwork for Long-Term Follow-Up in the Mother and Infant Home Visiting Program Evaluation (MIHOPE)', 'Region X Home Visiting Workforce Study', 'Region X Home', 'Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'Washington State Institute for Public Policy', 'Region X Home', 'Evidence on the Long-Term Effects of Home Visiting Programs: Laying the Groundwork for Long-Term Follow-Up in the Mother and Infant Home Visiting Program Evaluation (MIHOPE)', 'Child Welfare System']","['https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudy.pdf', 'https://legislature.idaho.gov/wp-content/uploads/OPE/Reports/r1701.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudyIntro.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudyBrief1.pdf']","['852_6_region x home.pdf', '852_8_child welfare system.pdf', '852_3_region x home.pdf', '852_2_region x home visiting workforce study.pdf']",4,44.44,"['https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudy.pdf', 'https://legislature.idaho.gov/wp-content/uploads/OPE/Reports/r1701.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudyIntro.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegXWorkforceStudyBrief1.pdf']","['852_6_region x home.pdf', '852_8_child welfare system.pdf', '852_3_region x home.pdf', '852_2_region x home visiting workforce study.pdf']","[0.231, 0.264, 0.243, 0.395]","[0.489, 0.502, 0.499, 0.483]","[0.58, 0.595, 0.593, 0.572]","[0.125, 0.145, 0.139, 0.119]","[0.136, 0.158, 0.154, 0.129]","[0.114, 0.128, 0.126, 0.109]","[0.726, 0.72, 0.73, 0.728]","[0.626, 0.619, 0.632, 0.629]","[0.556, 0.569, 0.564, 0.548]","[0.689, 0.668, 0.689, 0.687]","[0.759, 0.775, 0.763, 0.757]","[0.683, 0.717, 0.7, 0.676]","[0.588, 0.603, 0.589, 0.587]","[0.891, 0.897, 0.897, 0.889]","[0.787, 0.798, 0.791, 0.782]","[0.7, 0.717, 0.706, 0.694]","[0.752, 0.772, 0.76, 0.747]","[0.72, 0.735, 0.725, 0.718]",0.283,0.493,0.585,0.132,0.144,0.119,0.726,0.627,0.559,0.683,0.764,0.694,0.592,0.893,0.789,0.704,0.758,0.725
https://doi.org/10.1001/jamapediatrics.2013.4009,youth problem behaviors 8 years after implementing the communities that care prevention system,853_youth problem behaviors 8 years after implementing the communities that care prevention system.pdf,9,"['https://nam.edu/perspectives-2015-unleashing-the-power-of-prevention/', 'https://purl.fdlp.gov/GPO/gpo75951', 'https://purl.fdlp.gov/GPO/gpo85592', 'https://www.congress.gov/event/116th-congress/house-event/109109', 'https://nam.edu/redesigning-provider-payments-to-reduce-long-term-costs-by-promoting-healthy-development/', 'https://purl.fdlp.gov/GPO/gpo105863', 'https://stacks.cdc.gov/view/cdc/43085', 'https://nam.edu/the-communities-that-care-coalition-model-for-improving-community-health-through-clinical-community-partnerships-a-population-health-case-study/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf']","['Unleashing the Power of Prevention', 'Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.', 'Development of a standard model for school climate and safety assessment :\xa0final report /', '“Enhancing Vehicle Technology to Prevent Drunk Driving”', 'Redesigning Provider Payments to Reduce Long-Term Costs by Promoting Healthy Development', 'A comprehensive technical package for the prevention of youth violence and associated risk behaviors /', 'A Comprehensive technical package for the prevention of youth violence and associated risk behaviors', 'The Communities That Care Coalition Model for Improving Community Health through Clinical–Community Partnerships: A Population Health Case Report', 'Family‐based programmes for preventing smoking by children and adolescents']","['https://purl.fdlp.gov/GPO/gpo75951', 'https://purl.fdlp.gov/GPO/gpo85592', 'https://purl.fdlp.gov/GPO/gpo105863', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf']","['853_1_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '853_2_development of a standard model for school climate and safety assessment \xa0final report .pdf', '853_5_a comprehensive technical package for the prevention of youth violence and associated risk behaviors .pdf', '853_8_family‐based programmes for preventing smoking by children and adolescents.pdf']",4,44.44,"['https://purl.fdlp.gov/GPO/gpo75951', 'https://purl.fdlp.gov/GPO/gpo85592', 'https://purl.fdlp.gov/GPO/gpo105863', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf']","['853_1_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '853_2_development of a standard model for school climate and safety assessment \xa0final report .pdf', '853_5_a comprehensive technical package for the prevention of youth violence and associated risk behaviors .pdf', '853_8_family‐based programmes for preventing smoking by children and adolescents.pdf']","[0.385, 0.297, 0.398, 0.389]","[0.499, 0.495, 0.509, 0.517]","[0.595, 0.582, 0.602, 0.594]","[0.155, 0.146, 0.17, 0.179]","[0.173, 0.159, 0.192, 0.189]","[0.141, 0.137, 0.153, 0.155]","[0.729, 0.725, 0.732, 0.734]","[0.633, 0.629, 0.638, 0.639]","[0.568, 0.566, 0.578, 0.585]","[0.681, 0.69, 0.682, 0.703]","[0.782, 0.77, 0.785, 0.785]","[0.709, 0.702, 0.718, 0.713]","[0.595, 0.595, 0.596, 0.587]","[0.918, 0.914, 0.921, 0.916]","[0.802, 0.804, 0.809, 0.809]","[0.744, 0.731, 0.747, 0.743]","[0.774, 0.768, 0.783, 0.778]","[0.766, 0.752, 0.772, 0.767]",0.367,0.505,0.593,0.162,0.178,0.147,0.73,0.635,0.574,0.689,0.781,0.711,0.593,0.917,0.806,0.741,0.776,0.764
https://doi.org/10.1001/jamapediatrics.2013.4143,relationship between peer victimization cyberbullying and suicide in children and adolescents,854_relationship between peer victimization cyberbullying and suicide in children and adolescents.pdf,4,"['https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf', 'https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download', 'https://tdcj.texas.gov/documents/Victims_Informer_Current.pdf', 'https://www.mass.gov/doc/mahanoy-scotus-brief/download']","['1', 'Report & Recommendations For Fiscal Year 2022', 'VICTIM ’S INFORMER', 'In the Supreme Court of the United States']","['https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf', 'https://www.mass.gov/doc/mahanoy-scotus-brief/download', 'https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download']","['854_0_1.pdf', '854_3_in the supreme court of the united states.pdf', '854_1_report  recommendations for fiscal year 2022.pdf']",3,75.0,"['https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf', 'https://www.mass.gov/doc/mahanoy-scotus-brief/download', 'https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download']","['854_0_1.pdf', '854_3_in the supreme court of the united states.pdf', '854_1_report  recommendations for fiscal year 2022.pdf']","[0.156, 0.167, 0.251]","[0.515, 0.476, 0.52]","[0.605, 0.569, 0.609]","[0.128, 0.135, 0.131]","[0.138, 0.152, 0.139]","[0.122, 0.137, 0.121]","[0.723, 0.729, 0.724]","[0.629, 0.639, 0.63]","[0.587, 0.551, 0.59]","[0.663, 0.69, 0.657]","[0.802, 0.768, 0.805]","[0.728, 0.668, 0.733]","[0.602, 0.583, 0.607]","[0.915, 0.911, 0.92]","[0.815, 0.797, 0.816]","[0.75, 0.718, 0.754]","[0.791, 0.751, 0.794]","[0.779, 0.747, 0.781]",0.191,0.504,0.594,0.131,0.143,0.127,0.725,0.633,0.576,0.67,0.792,0.71,0.597,0.915,0.809,0.741,0.779,0.769
https://doi.org/10.1001/jamapediatrics.2013.42,violence crime and abuse exposure in a national sample of children and youth,855_violence crime and abuse exposure in a national sample of children and youth.pdf,8,"['https://mathematica.org/publications/the-external-review-of-job-corps-an-evidence-scan-report', 'https://www.dhs.gov/sites/default/files/publications/1005_OPSR_TP_Narratives-of-Childhood-Adversity-Adolescent-Misconduct-Precursors-Violent-Extremism_2016-508.pdf', 'https://ddc.delaware.gov/contentFolder/pdfs/rule-out-abuse-physicians-2.pdf', 'https://stacks.cdc.gov/view/cdc/31482', 'https://www.rand.org/pubs/research_reports/RR1775-1.html', 'https://purl.fdlp.gov/GPO/gpo71840', 'https://purl.fdlp.gov/GPO/gpo83365', 'http://purl.fdlp.gov/GPO/gpo106975']","['The External Review of Job Corps: An Evidence Scan Report', 'Narratives of Childhood Adversity and Adolescent Misconduct as Precursors to Violent Extremism, 2016', 'Rule Out Abuse Campaign Part 2', 'THRIVES : a global technical package to prevent violence against children', 'Improving Child Welfare Outcomes', 'Children’s exposure to violence, crime, and abuse :\xa0an update /', 'Protect, heal, thrive :\xa0lessons learned from the Defending Childhood Demonstration Program /', 'Child maltreatment :\xa0facts at a glance.']","['https://ddc.delaware.gov/contentFolder/pdfs/rule-out-abuse-physicians-2.pdf', 'http://purl.fdlp.gov/GPO/gpo106975', 'https://purl.fdlp.gov/GPO/gpo71840', 'https://purl.fdlp.gov/GPO/gpo83365', 'https://www.dhs.gov/sites/default/files/publications/1005_OPSR_TP_Narratives-of-Childhood-Adversity-Adolescent-Misconduct-Precursors-Violent-Extremism_2016-508.pdf']","['855_2_rule out abuse campaign part 2.pdf', '855_7_child maltreatment \xa0facts at a glance.pdf', '855_5_childrens exposure to violence crime and abuse \xa0an update .pdf', '855_6_protect heal thrive \xa0lessons learned from the defending childhood demonstration program .pdf', '855_1_narratives of childhood adversity and adolescent misconduct as precursors to violent extremism 2016.pdf']",5,62.5,"['https://ddc.delaware.gov/contentFolder/pdfs/rule-out-abuse-physicians-2.pdf', 'http://purl.fdlp.gov/GPO/gpo106975', 'https://purl.fdlp.gov/GPO/gpo71840', 'https://purl.fdlp.gov/GPO/gpo83365', 'https://www.dhs.gov/sites/default/files/publications/1005_OPSR_TP_Narratives-of-Childhood-Adversity-Adolescent-Misconduct-Precursors-Violent-Extremism_2016-508.pdf']","['855_2_rule out abuse campaign part 2.pdf', '855_7_child maltreatment \xa0facts at a glance.pdf', '855_5_childrens exposure to violence crime and abuse \xa0an update .pdf', '855_6_protect heal thrive \xa0lessons learned from the defending childhood demonstration program .pdf', '855_1_narratives of childhood adversity and adolescent misconduct as precursors to violent extremism 2016.pdf']","[0.278, 0.317, 0.76, 0.268, 0.172]","[0.508, 0.47, 0.517, 0.515, 0.504]","[0.594, 0.57, 0.601, 0.599, 0.591]","[0.153, 0.217, 0.183, 0.127, 0.13]","[0.175, 0.244, 0.209, 0.146, 0.158]","[0.145, 0.189, 0.176, 0.12, 0.129]","[0.733, 0.746, 0.738, 0.715, 0.72]","[0.637, 0.658, 0.645, 0.614, 0.622]","[0.568, 0.605, 0.577, 0.582, 0.574]","[0.698, 0.687, 0.71, 0.675, 0.699]","[0.773, 0.782, 0.782, 0.777, 0.787]","[0.701, 0.691, 0.712, 0.718, 0.713]","[0.602, 0.556, 0.615, 0.599, 0.604]","[0.898, 0.922, 0.912, 0.917, 0.911]","[0.815, 0.847, 0.82, 0.837, 0.831]","[0.739, 0.726, 0.748, 0.749, 0.743]","[0.766, 0.769, 0.779, 0.782, 0.785]","[0.763, 0.747, 0.771, 0.77, 0.775]",0.359,0.503,0.591,0.162,0.186,0.152,0.73,0.635,0.581,0.694,0.78,0.707,0.595,0.912,0.83,0.741,0.776,0.765
https://doi.org/10.1001/jamapediatrics.2013.421,influencing selfrated health among adolescent girls with dance intervention,857_influencing selfrated health among adolescent girls with dance intervention.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928931/pdf', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research']","['Dance movement therapy for depression', 'Treatment of Depression in Children and Adolescents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928931/pdf'],['857_0_dance movement therapy for depression.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928931/pdf'],['857_0_dance movement therapy for depression.pdf'],[0.407],[0.513],[0.596],[0.152],[0.173],[0.14],[0.724],[0.627],[0.589],[0.705],[0.784],[0.716],[0.588],[0.91],[0.822],[0.723],[0.777],[0.752],0.407,0.513,0.596,0.152,0.173,0.14,0.724,0.627,0.589,0.705,0.784,0.716,0.588,0.91,0.822,0.723,0.777,0.752
https://doi.org/10.1001/jamapediatrics.2013.455,infant feeding and childhood cognition at ages 3 and 7 years,858_infant feeding and childhood cognition at ages 3 and 7 years.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759098/pdf', 'https://aspe.hhs.gov/reports/work-family-supports-low-income-families-key-research-findings-policy-trends', 'https://aspe.hhs.gov/reports/work-family-supports-low-income-families-key-research-findings-policy-trends-0', 'https://www.rff.org/publications/working-papers/how-does-breastfeeding-affect-iq-applying-the-classical-model-of-structured-expert-judgment/']","['Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development', 'Work-Family Supports for Low-Income Families: Key Research Findings and Policy Trends', 'Work-Family Supports for Low-Income Families: Key Research Findings and Policy Trends', 'How Does Breastfeeding Affect IQ? Applying the Classical Model of Structured Expert Judgment']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759098/pdf'],['858_0_supplementation with long chain polyunsaturated fatty acids lcpufa to breastfeeding mothers for improving child growth and development.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759098/pdf'],['858_0_supplementation with long chain polyunsaturated fatty acids lcpufa to breastfeeding mothers for improving child growth and development.pdf'],[0.326],[0.493],[0.578],[0.144],[0.145],[0.122],[0.731],[0.636],[0.563],[0.704],[0.749],[0.684],[0.565],[0.876],[0.777],[0.669],[0.754],[0.698],0.326,0.493,0.578,0.144,0.145,0.122,0.731,0.636,0.563,0.704,0.749,0.684,0.565,0.876,0.777,0.669,0.754,0.698
https://doi.org/10.1001/jamapediatrics.2014.3145,effect of expanding medicaid for parents on children’s health insurance coverage,860_effect of expanding medicaid for parents on children’s health insurance coverage.pdf,7,"['https://mathematica.org/publications/on-the-road-to-universal-childrens-health-coverage-an-update-on-the-kidswell-campaign', 'https://mathematica.org/publications/on-the-road-to-universal-childrens-coverage-issue-brief', 'https://www.ppic.org/publication/medi-cal-expansion-and-childrens-well-being/', 'https://www.nber.org/papers/w26871', 'https://www.urban.org/research/publication/medicaid-and-chip-children-trends-coverage-affordability-and-provider-access', 'https://www.flgov.com/wp-content/uploads/childadvocacy/20150512_Kids_Well_Florida_Georgetown_University_Health_Policy_Institute.pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","[""On the Road to Universal Children's Health Coverage: An Update on the KidsWell Campaign"", ""On the Road to Universal Children's Coverage: A Final Update on the KidsWell Campaign (Issue Brief)"", ""Medi-Cal Expansion and Children's Well-Being - Public Policy Institute of California"", 'Out of the Woodwork: Enrollment Spillovers in the Oregon Health Insurance Experiment', 'Medicaid and CHIP for Children: Trends in Coverage, Affordability, and Provider Access', 'Many Working Parents and Families in Florida Would Benefit from Closing the Coverage Gap', 'TennCare II Demonstration']","['https://www.flgov.com/wp-content/uploads/childadvocacy/20150512_Kids_Well_Florida_Georgetown_University_Health_Policy_Institute.pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['860_5_many working parents and families in florida would benefit from closing the coverage gap.pdf', '860_6_tenncare ii demonstration.pdf']",2,28.57,"['https://www.flgov.com/wp-content/uploads/childadvocacy/20150512_Kids_Well_Florida_Georgetown_University_Health_Policy_Institute.pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['860_5_many working parents and families in florida would benefit from closing the coverage gap.pdf', '860_6_tenncare ii demonstration.pdf']","[0.528, 0.407]","[0.535, 0.518]","[0.634, 0.612]","[0.197, 0.154]","[0.224, 0.173]","[0.194, 0.147]","[0.736, 0.724]","[0.645, 0.629]","[0.603, 0.591]","[0.717, 0.698]","[0.811, 0.798]","[0.735, 0.722]","[0.628, 0.61]","[0.914, 0.912]","[0.824, 0.821]","[0.757, 0.749]","[0.792, 0.781]","[0.782, 0.772]",0.468,0.526,0.623,0.175,0.199,0.17,0.73,0.637,0.597,0.708,0.804,0.728,0.619,0.913,0.823,0.753,0.786,0.777
https://doi.org/10.1001/jamapediatrics.2014.3158,treatment for preventing tuberculosis in children and adolescents,861_treatment for preventing tuberculosis in children and adolescents.pdf,5,"['https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi-40-1.pdf', 'https://stacks.cdc.gov/view/cdc/91162', 'https://stacks.cdc.gov/view/cdc/57372', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041302/pdf']","['City Health Information', 'Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020', 'Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection', 'Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Infection', 'Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023184/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi-40-1.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041302/pdf']","['861_3_update of recommendations for use of onceweekly isoniazidrifapentine regimen to treat latent infection.pdf', '861_0_city health information.pdf', '861_4_guidelines for the treatment of latent tuberculosis infection recommendations from the national tuberculosis controllers association and cdc 2020.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023184/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/chi/chi-40-1.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041302/pdf']","['861_3_update of recommendations for use of onceweekly isoniazidrifapentine regimen to treat latent infection.pdf', '861_0_city health information.pdf', '861_4_guidelines for the treatment of latent tuberculosis infection recommendations from the national tuberculosis controllers association and cdc 2020.pdf']","[0.429, 0.469, 0.618]","[0.533, 0.496, 0.516]","[0.619, 0.59, 0.602]","[0.183, 0.163, 0.179]","[0.186, 0.17, 0.186]","[0.154, 0.139, 0.151]","[0.739, 0.74, 0.743]","[0.644, 0.645, 0.651]","[0.6, 0.569, 0.588]","[0.67, 0.672, 0.68]","[0.791, 0.778, 0.784]","[0.705, 0.68, 0.695]","[0.604, 0.58, 0.591]","[0.912, 0.906, 0.912]","[0.806, 0.795, 0.799]","[0.737, 0.722, 0.728]","[0.777, 0.767, 0.767]","[0.761, 0.753, 0.753]",0.505,0.515,0.604,0.175,0.181,0.148,0.741,0.647,0.586,0.674,0.784,0.693,0.592,0.91,0.8,0.729,0.77,0.756
https://doi.org/10.1001/jamapediatrics.2014.3445,the knowdo gap in quality of health care for childhood diarrhea and pneumonia in rural india,863_the knowdo gap in quality of health care for childhood diarrhea and pneumonia in rural india.pdf,5,"['https://www.rand.org/pubs/working_papers/WRA1414-1.html', 'https://www.nber.org/papers/w21361', 'https://www.cgdev.org/publication/different-strokes-different-folks-experimental-evidence-effectiveness-input-and-output', 'https://www.cgdev.org/publication/analysis-clinical-knowledge-absenteeism-and-availability-resources-maternal-and-child', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406991/pdf']","['When a Doctor Falls from the Sky', 'Long Run Effects of Temporary Incentives on Medical Care Productivity', 'Different Strokes for Different Folks: Experimental Evidence on the Effectiveness of Input and Output Incentive Contracts for Health Care Providers with Different Levels of Skills - Working Paper 464', 'An Analysis of Clinical Knowledge, Absenteeism, and Availability of Resources for Maternal and Child Health: A Cross-Sectional Quality of Care Study in 10 African Countries', 'Decision‐support tools via mobile devices to improve quality of care in primary healthcare settings']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406991/pdf'],['863_4_decision‐support tools via mobile devices to improve quality of care in primary healthcare settings.pdf'],1,20.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406991/pdf'],['863_4_decision‐support tools via mobile devices to improve quality of care in primary healthcare settings.pdf'],[0.254],[0.502],[0.587],[0.143],[0.155],[0.127],[0.729],[0.631],[0.564],[0.711],[0.758],[0.69],[0.582],[0.888],[0.794],[0.69],[0.759],[0.715],0.254,0.502,0.587,0.143,0.155,0.127,0.729,0.631,0.564,0.711,0.758,0.69,0.582,0.888,0.794,0.69,0.759,0.715
https://doi.org/10.1001/jamapediatrics.2015.0182,comparative effectiveness of childhood obesity interventions in pediatric primary care,865_comparative effectiveness of childhood obesity interventions in pediatric primary care.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486102/pdf']","['Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years', 'Nudge strategies to improve healthcare providers’ implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within Cochrane systematic reviews', 'Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486102/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf']","['865_1_nudge strategies to improve healthcare providers implementation of evidencebased guidelines policies and practices a systematic review of trials included within cochrane systematic reviews.pdf', '865_2_interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.pdf', '865_0_diet physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486102/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf']","['865_1_nudge strategies to improve healthcare providers implementation of evidencebased guidelines policies and practices a systematic review of trials included within cochrane systematic reviews.pdf', '865_2_interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.pdf', '865_0_diet physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.pdf']","[0.459, 0.341, 0.571]","[0.508, 0.509, 0.506]","[0.601, 0.592, 0.591]","[0.166, 0.171, 0.171]","[0.176, 0.176, 0.171]","[0.141, 0.154, 0.151]","[0.735, 0.736, 0.737]","[0.643, 0.643, 0.641]","[0.58, 0.573, 0.572]","[0.706, 0.718, 0.715]","[0.783, 0.769, 0.77]","[0.711, 0.691, 0.681]","[0.591, 0.591, 0.584]","[0.91, 0.902, 0.906]","[0.81, 0.802, 0.806]","[0.728, 0.71, 0.712]","[0.773, 0.76, 0.758]","[0.754, 0.74, 0.744]",0.457,0.508,0.595,0.169,0.174,0.149,0.736,0.642,0.575,0.713,0.774,0.694,0.589,0.906,0.806,0.717,0.764,0.746
https://doi.org/10.1001/jamapediatrics.2015.0580,effectiveness of traumafocused cognitive behavioral therapy among traumaaffected children in lusaka zambia,866_effectiveness of traumafocused cognitive behavioral therapy among traumaaffected children in lusaka zambia.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://stacks.cdc.gov/view/cdc/40392', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/5/Wsipp_BenefitCost_ProgramDetails_Childrens-Mental-Health']","['Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries', 'Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises', 'Challenges for the implementation of World Health Organization guidelines for acute stress, PTSD, and bereavement: a qualitative study in Uganda', 'Psychological therapies for children and adolescents exposed to trauma', 'INSPIRE : seven strategies for ending violence against children', 'Washington State Institute for Public Policy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf']","['866_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '866_3_psychological therapies for children and adolescents exposed to trauma.pdf', '866_2_challenges for the implementation of world health organization guidelines for acute stress ptsd and bereavement a qualitative study in uganda.pdf', '866_1_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf']",4,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf']","['866_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf', '866_3_psychological therapies for children and adolescents exposed to trauma.pdf', '866_2_challenges for the implementation of world health organization guidelines for acute stress ptsd and bereavement a qualitative study in uganda.pdf', '866_1_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf']","[0.484, 0.381, 0.422, 0.516]","[0.511, 0.492, 0.526, 0.481]","[0.597, 0.578, 0.615, 0.569]","[0.16, 0.161, 0.164, 0.148]","[0.169, 0.163, 0.185, 0.149]","[0.141, 0.138, 0.146, 0.127]","[0.735, 0.739, 0.728, 0.738]","[0.642, 0.643, 0.636, 0.642]","[0.575, 0.557, 0.596, 0.546]","[0.707, 0.718, 0.687, 0.72]","[0.775, 0.762, 0.796, 0.757]","[0.694, 0.666, 0.723, 0.648]","[0.576, 0.562, 0.601, 0.563]","[0.907, 0.903, 0.912, 0.901]","[0.805, 0.793, 0.827, 0.789]","[0.713, 0.701, 0.743, 0.697]","[0.764, 0.747, 0.79, 0.742]","[0.74, 0.731, 0.765, 0.728]",0.451,0.503,0.59,0.158,0.167,0.138,0.735,0.641,0.569,0.708,0.773,0.683,0.575,0.906,0.803,0.714,0.761,0.741
https://doi.org/10.1001/jamapediatrics.2015.1025,breastfeeding and childhood leukemia incidence,867_breastfeeding and childhood leukemia incidence.pdf,1,['https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf'],['Primary Care Interventions to Support BreastfeedingUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force'],['https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf'],['867_0_primary care interventions to support breastfeedingupdated evidence report and systematic review for the us preventive services task force.pdf'],1,100.0,['https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf'],['867_0_primary care interventions to support breastfeedingupdated evidence report and systematic review for the us preventive services task force.pdf'],[0.506],[0.479],[0.582],[0.165],[0.164],[0.141],[0.739],[0.648],[0.555],[0.704],[0.777],[0.673],[0.571],[0.902],[0.782],[0.709],[0.745],[0.741],0.506,0.479,0.582,0.165,0.164,0.141,0.739,0.648,0.555,0.704,0.777,0.673,0.571,0.902,0.782,0.709,0.745,0.741
https://doi.org/10.1001/jamapediatrics.2015.1141,integrated medicalbehavioral care compared with usual primary care for child and adolescent behavioral health,868_integrated medicalbehavioral care compared with usual primary care for child and adolescent behavioral health.pdf,5,"['https://purl.fdlp.gov/GPO/gpo75951', 'https://purl.fdlp.gov/GPO/gpo113527', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/protocol', 'https://schoolsafety.dbs.idaho.gov/wp-content/uploads/sites/106/2020/03/Federal-Commission-school-safety-report.pdf', 'https://aspe.hhs.gov/reports/building-evidence-base-social-determinants-health-interventions']","['Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.', 'Final report of the Federal Commission on School Safety :\xa0presented to the President of the United States, December 18, 2018.', 'Depression in Children: Systematic Review', 'Final Report of the Federal Commission on School Safety (PDF)', 'Building the Evidence Base for Social Determinants of Health Interventions']","['https://purl.fdlp.gov/GPO/gpo75951', 'https://purl.fdlp.gov/GPO/gpo113527']","['868_0_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '868_1_final report of the federal commission on school safety \xa0presented to the president of the united states december 18 2018.pdf']",2,40.0,"['https://purl.fdlp.gov/GPO/gpo75951', 'https://purl.fdlp.gov/GPO/gpo113527']","['868_0_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf', '868_1_final report of the federal commission on school safety \xa0presented to the president of the united states december 18 2018.pdf']","[0.502, 0.198]","[0.479, 0.466]","[0.586, 0.569]","[0.145, 0.122]","[0.162, 0.132]","[0.132, 0.11]","[0.732, 0.725]","[0.639, 0.629]","[0.538, 0.528]","[0.69, 0.662]","[0.76, 0.763]","[0.677, 0.674]","[0.578, 0.587]","[0.89, 0.89]","[0.771, 0.779]","[0.691, 0.693]","[0.748, 0.75]","[0.716, 0.717]",0.35,0.473,0.577,0.134,0.147,0.121,0.728,0.634,0.533,0.676,0.762,0.675,0.583,0.89,0.775,0.692,0.749,0.716
https://doi.org/10.1001/jamapediatrics.2015.1305,epidemiologic trends in neonatal intensive care 20072012,869_epidemiologic trends in neonatal intensive care 20072012.pdf,7,"['https://www.acf.hhs.gov/opre/report/effects-home-visiting-prenatal-health-birth-outcomes-and-health-care-use-first-year', 'https://www.acf.hhs.gov/opre/report/behavioral-interventions-scholars-2017-grantee-project-abstracts', 'http://patientsafety.pa.gov/ADVISORIES/Documents/201712_home.pdf', 'https://www.acf.hhs.gov/opre/resource/effects-home-visiting-prenatal-health-birth-outcomes-health-care-first-year-final-implementation-impact-findings-strong-start', 'https://www.acf.hhs.gov/opre/resource/behavioral-interventions-scholars-2017-grantee-project-abstracts', 'https://www.tn.gov/content/dam/tn/health/documents/Certificate_of_Need_Standards_and_Criteria_for_Neonatal_Intensive_Care_Units.pdf', 'https://www.tn.gov/content/dam/tn/health/documents/2015_Edition_of_the_State_Health_Plan.pdf']","['The Effects of Home Visiting on Prenatal Health, Birth Outcomes, and Health Care Use in the First Year of Life: Final Implementation and Impact Findings from the Mother and Infant Home Visiting Program Evaluation-Strong Start', 'Behavioral Interventions Scholars: 2017 Grantee Project Abstracts', 'December 2017 Pennsylvania Patient Safety Advisory, Volume 14, Number 4', 'The Effects of Home Visiting on Prenatal Health, Birth Outcomes, and Health Care Use in the First Year of Life: Final Implementation and Impact Findings from the Mother and Infant Home Visiting Program Evaluation-Strong Start', 'Behavioral Interventions Scholars: 2017 Grantee Project Abstracts', 'State Health Plan Certificate Of Need Standards And Criteria', 'State Letterhead-2']","['https://www.tn.gov/content/dam/tn/health/documents/2015_Edition_of_the_State_Health_Plan.pdf', 'http://patientsafety.pa.gov/ADVISORIES/Documents/201712_home.pdf', 'https://www.tn.gov/content/dam/tn/health/documents/Certificate_of_Need_Standards_and_Criteria_for_Neonatal_Intensive_Care_Units.pdf']","['869_6_state letterhead2.pdf', '869_2_december 2017 pennsylvania patient safety advisory volume 14 number 4.pdf', '869_5_state health plan certificate of need standards and criteria.pdf']",3,42.86,"['https://www.tn.gov/content/dam/tn/health/documents/2015_Edition_of_the_State_Health_Plan.pdf', 'http://patientsafety.pa.gov/ADVISORIES/Documents/201712_home.pdf', 'https://www.tn.gov/content/dam/tn/health/documents/Certificate_of_Need_Standards_and_Criteria_for_Neonatal_Intensive_Care_Units.pdf']","['869_6_state letterhead2.pdf', '869_2_december 2017 pennsylvania patient safety advisory volume 14 number 4.pdf', '869_5_state health plan certificate of need standards and criteria.pdf']","[0.215, 0.234, 0.243]","[0.5, 0.499, 0.515]","[0.598, 0.587, 0.612]","[0.137, 0.139, 0.172]","[0.153, 0.147, 0.202]","[0.12, 0.12, 0.166]","[0.722, 0.729, 0.73]","[0.622, 0.632, 0.636]","[0.573, 0.571, 0.584]","[0.668, 0.664, 0.678]","[0.779, 0.773, 0.781]","[0.71, 0.701, 0.719]","[0.607, 0.607, 0.618]","[0.909, 0.908, 0.914]","[0.821, 0.807, 0.833]","[0.741, 0.73, 0.753]","[0.775, 0.769, 0.781]","[0.763, 0.759, 0.772]",0.231,0.505,0.599,0.149,0.167,0.135,0.727,0.63,0.576,0.67,0.778,0.71,0.611,0.91,0.82,0.741,0.775,0.765
https://doi.org/10.1001/jamapediatrics.2015.1438,comparison of us birth weight references and the international fetal and newborn growth consortium for the 21st century standard,870_comparison of us birth weight references and the international fetal and newborn growth consortium for the 21st century standard.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710996/pdf'],"['Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710996/pdf'],['870_0_small for gestational age case definition  guidelines for data collection analysis and presentation of maternal immunisation safety data.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710996/pdf'],['870_0_small for gestational age case definition  guidelines for data collection analysis and presentation of maternal immunisation safety data.pdf'],[0.529],[0.508],[0.597],[0.169],[0.183],[0.147],[0.738],[0.645],[0.575],[0.702],[0.779],[0.707],[0.605],[0.911],[0.797],[0.743],[0.771],[0.766],0.529,0.508,0.597,0.169,0.183,0.147,0.738,0.645,0.575,0.702,0.779,0.707,0.605,0.911,0.797,0.743,0.771,0.766
https://doi.org/10.1001/jamapediatrics.2015.2731,parentadolescent sexual communication and adolescent safer sex behavior,873_parentadolescent sexual communication and adolescent safer sex behavior.pdf,5,"['https://www.dshs.texas.gov/chs/tshp/2018-School-Health-Profiles-School-Principal-Item-Rationale.pdf', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf', 'https://www.acf.hhs.gov/opre/report/conceptual-models-adulthood-preparation-subjects-within-personal-responsibility', 'https://mathematica.org/publications/conceptual-models-for-adulthood-preparation-subjects-within-the-prep', 'https://stacks.cdc.gov/view/cdc/82686']","['Item Rationale 2018 School Health Profiles School Principal Questionnaire', '2020 School Health Profiles Principal Item Rationale', 'Conceptual Models for Adulthood Preparation Subjects within the Personal Responsibility Education Program (PREP)', 'Conceptual Models for Adulthood Preparation Subjects within the Personal Responsibility Education Program (PREP)', 'School health profiles 2018 : characteristics of health programs among secondary schools']",['https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf'],['873_1_2020 school health profiles principal item rationale.pdf'],1,20.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1001/jamapediatrics.2015.3778,effect of a schoolbased water intervention on child body mass index and obesity,876_effect of a schoolbased water intervention on child body mass index and obesity.pdf,7,"['https://effectivehealthcare.ahrq.gov/products/obesity-research-methods/systematic-review', 'https://effectivehealthcare.ahrq.gov/products/obesity-research-methods/research-protocol', 'https://stacks.cdc.gov/view/cdc/86018', 'https://www.brookings.edu/blog/brown-center-chalkboard/2016/08/29/principal-not-food-experts-most-influential-in-the-school-cafeteria/', 'https://watermark.silverchair.com/jc.2016-2573.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsswggLHBgkqhkiG9w0BBwagggK4MIICtAIBADCCAq0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMjEyhggz68VFX5StCAgEQgIICfhsJrGvEOe9ZQeY8AipjL7vUD7MqyPeiql-uzZo2YRAeOOh9A8CmB3cfdMJgvga_wEF1755xgVi7IPq_Cq-QMDROPtlZfJc4Y7eeS6PNZCusRucYyl5eG0E_h6WLYYcT_TZV955A82zFPufWHcwAsptqPc-yhU70t7DmQ4lroVYr3ctkogC8sOkb6n7mNtBWKDzA_4CItsHyiv7X1mmcUWlEmv7pU2oscg4y3A21AmrtVVI-tgET_KqYxtZG1YhYNpF6crYIPP50k1WoAhc4IwJGcHBbhDFyNMgNxo0l4o93BxhMcpSTpwaZ1Xdh73yNdONnChugbXl2U-TYzzHtt0_ETcZ2Dt4cA4ZUf-hyX_eaMgmvg1Tqdg6S8WiTJRjlMjPSns3051CpZozPmwBgyv_hzyFQ4Gd16STQhaMJ17SYF2fM2-npz3aVTugzjtwn0BCpzNQAgrMGfi8aGcFF-TjF3UGkqhwEIJ3FjTSZIfvnYMkilBkNUIg0Q9plv85i_Ocio-qkspP4yeyMoJ295-euMAtWhhQIsUUVio5BtPG20AUpIJ9RxCV4cZBO3sqmktQbmbxxzo8VDYu5JKCTc4KIx1r3n89KxICrhGDbI9TEU4tr1PN4LIUiRCNHkQE6Uz6JoAnrAoTOvOPLt4X62GSewDpUqWBBSTpwyXBV0EtVTLxEJc8G_LODe6p5inw9bdG75uz9We7LMsFnX025i0lOnHBewdFIlCRJtTj8FPN-i4qOmjl1_8RgtWjVSQEFiMakoDVs1VE-5YozWUdRR5bmtcKvzAMFwCVdPRJ6TWIeo2kLnQj2gdaAZJL9F6Jp4npZqfX8o0x2E88Dilyx', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf', 'https://watermark.silverchair.com/jc.2016-2573.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsswggLHBgkqhkiG9w0BBwagggK4MIICtAIBADCCAq0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM-9NImvj5_LkwfszCAgEQgIICfpcBoEVespw-V4cHxlBd9LH2gf2e5-mnh5_bdPSTOm5QU9PrxMqiDkHlhgyAXIwTcZevFuphOPWVB73wSzAv-SZ2RR4SUAi-fb8sKwd6B3e1biRFmD4pATC7Y9-I5mlZkFjfgjc1Pv1YiQcCff_-bYwq4fJC0gk54VlZzaV1PK_Klgs9m95Lg4wTpVMOP01FDO4U2etXN1l2XMv15zZuBxEl9Q5MqehpM83dtoUUP-CvrlulgwS9eDVJU-jXwu3GNsGoT5Sn7yuXMXiZ9tx459Yyt7Fah1zOM4XHfpS9MAO5Me9_dBkBmuT8SW_mBrpTcnVpSfW50OtYf72c8OPVVxi18g8ZFhIcoKOFjIfV8YmffRgNE0fF9CrXDMwI-Cqbh_ek-Kg6YCkAEBBsZ881IwzOye41gevs29poLE6lyGTLETjTBKX0Nq2oqvscKXeGhYWzjfgW4lUS91swvajynrvg5VKROID716_n9XA-4_OV4t0JhIVn4fyvawyvTL-wGAzl2QJsJkGf5DuCuxLs-bWNeC78eQBXYJsUMgMLJRVK6q1vRxYKrJiv3KKYhUFVUnQ7PmHfBpklmjhF3yuJOpPz_hLGF2vasHlotWCAnGc6dXHBOUy42JHFBn4ddvcJJssDMd2WpvBlhnBa7VLs6dCcwUIXd8_ZxERf93uIQtRNYLUz3DmeI5PefJB-rwcYCOgR4jWmdFH3OTIXHwXAtJQ1blQzvAWSD_71Vuz8E6oEnLT-Ay1WRfYMo15o0LWbEUgpmqgU4MdskP8pcWoYpY7vV18rZd9uhSD3UkZkML11wmrF-V3Q7oYQfcVzfsQ698mp3YCj639AxpADTbJP']","['Methods for Evaluating Natural Experiments in Obesity: A Systematic Evidence Review', 'Obesity Prevention and Control', 'Lack of in-home piped water and reported consumption of sugar-sweetened beverages among adults in rural Alaska', 'Principal, not food experts, most influential in the school cafeteria', 'Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline', 'Environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health', 'Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf'],['876_5_environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health.pdf'],1,14.29,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf'],['876_5_environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health.pdf'],[0.368],[0.499],[0.592],[0.152],[0.158],[0.129],[0.727],[0.628],[0.569],[0.695],[0.767],[0.699],[0.591],[0.895],[0.804],[0.705],[0.766],[0.734],0.368,0.499,0.592,0.152,0.158,0.129,0.727,0.628,0.569,0.695,0.767,0.699,0.591,0.895,0.804,0.705,0.766,0.734
https://doi.org/10.1001/jamapediatrics.2016.0114,effect of oxygen desaturations on subsequent medical visits in infants discharged from the emergency department with bronchiolitis,878_effect of oxygen desaturations on subsequent medical visits in infants discharged from the emergency department with bronchiolitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397733/pdf'],['Cardiorespiratory and Pulse Oximetry Monitoring in Hospitalized Children: A Delphi Process'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397733/pdf'],['878_0_cardiorespiratory and pulse oximetry monitoring in hospitalized children a delphi process.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397733/pdf'],['878_0_cardiorespiratory and pulse oximetry monitoring in hospitalized children a delphi process.pdf'],[0.304],[0.516],[0.601],[0.165],[0.173],[0.131],[0.737],[0.642],[0.583],[0.685],[0.781],[0.705],[0.601],[0.898],[0.792],[0.716],[0.774],[0.742],0.304,0.516,0.601,0.165,0.173,0.131,0.737,0.642,0.583,0.685,0.781,0.705,0.601,0.898,0.792,0.716,0.774,0.742
https://doi.org/10.1001/jamapediatrics.2016.0445,effect of the insight responsive parenting intervention on rapid infant weight gain and overweight status at age 1 year,879_effect of the insight responsive parenting intervention on rapid infant weight gain and overweight status at age 1 year.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf']","['Interventions for preventing obesity in children', 'Educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf']","['879_0_interventions for preventing obesity in children.pdf', '879_1_educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf']","['879_0_interventions for preventing obesity in children.pdf', '879_1_educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.pdf']","[0.399, 0.443]","[0.51, 0.501]","[0.599, 0.59]","[0.164, 0.161]","[0.162, 0.164]","[0.142, 0.141]","[0.732, 0.733]","[0.637, 0.637]","[0.58, 0.569]","[0.702, 0.697]","[0.771, 0.766]","[0.687, 0.69]","[0.581, 0.583]","[0.91, 0.898]","[0.811, 0.791]","[0.718, 0.708]","[0.764, 0.759]","[0.752, 0.737]",0.421,0.506,0.595,0.163,0.163,0.141,0.732,0.637,0.575,0.7,0.768,0.689,0.582,0.904,0.801,0.713,0.762,0.744
https://doi.org/10.1001/jamapediatrics.2016.1559,capitalizing on advances in science to reduce the health consequences of early childhood adversity,880_capitalizing on advances in science to reduce the health consequences of early childhood adversity.pdf,4,"['https://nam.edu/accountable-communities-for-health-for-children-and-families-approaches-for-catalyzing-and-accelerating-success/', 'https://stacks.cdc.gov/view/cdc/82319', 'https://www.urban.org/research/publication/father-reentry-and-child-outcomes', 'https://erdc.wa.gov/file/650/download?token=KQMKxYax']","['Accountable Communities for Health for Children and Families: Approaches for Catalyzing and Accelerating Success', 'Vital Signs: Estimated proportion of adult health problems attributable to adverse childhood experiences and implications for prevention — 25 states, 2015–2017', 'Father Reentry and Child Outcomes', 'Christopher Blodgett, Ph. D. Myah Houghten, MSLA, MPA Washington State University']",['https://erdc.wa.gov/file/650/download?token=KQMKxYax'],['880_3_christopher blodgett ph d myah houghten msla mpa washington state university.pdf'],1,25.0,['https://erdc.wa.gov/file/650/download?token=KQMKxYax'],['880_3_christopher blodgett ph d myah houghten msla mpa washington state university.pdf'],[0.257],[0.516],[0.613],[0.155],[0.16],[0.125],[0.728],[0.636],[0.6],[0.679],[0.794],[0.733],[0.604],[0.913],[0.818],[0.751],[0.786],[0.774],0.257,0.516,0.613,0.155,0.16,0.125,0.728,0.636,0.6,0.679,0.794,0.733,0.604,0.913,0.818,0.751,0.786,0.774
https://doi.org/10.1001/jamapediatrics.2016.3982,characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians,882_characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689094/pdf', 'https://www.congress.gov/event/115th-congress/house-event/106020', 'https://www.nj.gov/health/cd/documents/topics/zika/mmwr_oct192017.pdf', 'https://health.hawaii.gov/docd/files/2017/01/MMWR_Zika_interim_guidelines-AUG102018.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790753/pdf']","['Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection — United States, October 2017', 'U.S. Public Health Response to the Zika Virus: Continuing Challenges', 'Morbidity and Mortality Weekly Report, Volume 66, Issue Number 41', 'Vital Signs Zika Guidance August 2018 mm6731e2', 'International consensus recommendations on the diagnostic work-up for malformations of cortical development']","['https://www.nj.gov/health/cd/documents/topics/zika/mmwr_oct192017.pdf', 'https://health.hawaii.gov/docd/files/2017/01/MMWR_Zika_interim_guidelines-AUG102018.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689094/pdf']","['882_2_morbidity and mortality weekly report volume 66 issue number 41.pdf', '882_3_vital signs zika guidance august 2018 mm6731e2.pdf', '882_0_update interim guidance for the diagnosis evaluation and management of infants with possible congenital zika virus infection — united states october 2017.pdf']",3,60.0,"['https://www.nj.gov/health/cd/documents/topics/zika/mmwr_oct192017.pdf', 'https://health.hawaii.gov/docd/files/2017/01/MMWR_Zika_interim_guidelines-AUG102018.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689094/pdf']","['882_2_morbidity and mortality weekly report volume 66 issue number 41.pdf', '882_3_vital signs zika guidance august 2018 mm6731e2.pdf', '882_0_update interim guidance for the diagnosis evaluation and management of infants with possible congenital zika virus infection — united states october 2017.pdf']","[0.64, 0.64, 0.33]","[0.547, 0.535, 0.547]","[0.632, 0.615, 0.632]","[0.189, 0.155, 0.189]","[0.204, 0.158, 0.204]","[0.163, 0.134, 0.163]","[0.756, 0.747, 0.756]","[0.663, 0.655, 0.663]","[0.615, 0.607, 0.615]","[0.649, 0.632, 0.649]","[0.799, 0.803, 0.799]","[0.721, 0.728, 0.721]","[0.607, 0.599, 0.607]","[0.911, 0.907, 0.911]","[0.826, 0.822, 0.826]","[0.76, 0.756, 0.76]","[0.788, 0.788, 0.788]","[0.785, 0.783, 0.785]",0.537,0.543,0.626,0.178,0.189,0.153,0.753,0.66,0.612,0.643,0.8,0.723,0.604,0.91,0.825,0.759,0.788,0.784
https://doi.org/10.1001/jamapediatrics.2016.4529,differenceindifferences analysis of the association between state samesex marriage policies and adolescent suicide attempts,883_differenceindifferences analysis of the association between state samesex marriage policies and adolescent suicide attempts.pdf,9,"['https://www.aclu.org/legal-document/grimm-v-gloucester-county-brief-national-pta-et-al', 'https://www.aclu.org/legal-document/doe-v-boyertown-area-school-district-national-pta-et-al', 'https://www.brookings.edu/research/rebalancing-children-first/', 'https://www.aei.org/research-products/report/rebalancing-children-first/', 'https://www.aclu.org/legal-document/fulton-v-city-philadelphia-lgbt-youth-service-orgs-amicus-brief', 'https://www.aclu.org/legal-document/gg-v-gloucester-county-school-board-national-pta-glsen-et-al', 'https://www.aclu.org/legal-document/parents-privacy-v-dallas-school-district-no-2-glsen', 'https://www.michigan.gov/documents/ag/Updegrove_v._Herring_amicus_brief_of_Massachusetts_et_al._--_as_filed_733974_7.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Brief%20of%20Massachusetts%20et%20al.%20in%20No.%2021-476.pdf']","['Grimm v. Gloucester County - Brief of the National PTA et al.', 'Doe v. Boyertown Area School District - National PTA, et al.', 'Rebalancing: Children first', 'Rebalancing: Children first - AEI', 'Fulton v. City of Philadelphia - LGBT youth service orgs Amicus Brief', 'G.G. v. Gloucester County School Board - The National PTA, GLSEN, et al.', 'Parents for Privacy v. Dallas School District No. 2 - GLSEN', 'In The United States Court Of Appeals For The Fourth Circuit', 'No. 21-476']","['https://www.michigan.gov/documents/ag/Updegrove_v._Herring_amicus_brief_of_Massachusetts_et_al._--_as_filed_733974_7.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Brief%20of%20Massachusetts%20et%20al.%20in%20No.%2021-476.pdf']","['883_7_in the united states court of appeals for the fourth circuit.pdf', '883_8_no 21476.pdf']",2,22.22,"['https://www.michigan.gov/documents/ag/Updegrove_v._Herring_amicus_brief_of_Massachusetts_et_al._--_as_filed_733974_7.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Brief%20of%20Massachusetts%20et%20al.%20in%20No.%2021-476.pdf']","['883_7_in the united states court of appeals for the fourth circuit.pdf', '883_8_no 21476.pdf']","[0.16, 0.176]","[0.454, 0.468]","[0.553, 0.565]","[0.108, 0.103]","[0.125, 0.126]","[0.107, 0.107]","[0.724, 0.722]","[0.626, 0.624]","[0.522, 0.537]","[0.69, 0.681]","[0.759, 0.767]","[0.627, 0.666]","[0.584, 0.588]","[0.894, 0.897]","[0.798, 0.795]","[0.701, 0.715]","[0.74, 0.749]","[0.734, 0.742]",0.168,0.461,0.559,0.105,0.126,0.107,0.723,0.625,0.53,0.685,0.763,0.647,0.586,0.895,0.796,0.708,0.744,0.738
https://doi.org/10.1001/jamapediatrics.2017.0206,effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life,884_effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517261/pdf']","['Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline', 'Recombinant growth hormone therapy for cystic fibrosis in children and young adults', 'Recombinant growth hormone therapy for cystic fibrosis in children and young adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517261/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542104/pdf']","['884_1_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf', '884_2_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf', '884_0_academy of nutrition and dietetics 2020 cystic fibrosis evidence analysis center evidencebased nutrition practice guideline.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517261/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542104/pdf']","['884_1_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf', '884_2_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf', '884_0_academy of nutrition and dietetics 2020 cystic fibrosis evidence analysis center evidencebased nutrition practice guideline.pdf']","[0.407, 0.363, 0.361]","[0.489, 0.49, 0.484]","[0.574, 0.574, 0.578]","[0.148, 0.149, 0.155]","[0.139, 0.141, 0.166]","[0.123, 0.124, 0.125]","[0.738, 0.738, 0.734]","[0.642, 0.64, 0.638]","[0.557, 0.555, 0.564]","[0.711, 0.71, 0.687]","[0.752, 0.753, 0.759]","[0.684, 0.677, 0.686]","[0.581, 0.578, 0.576]","[0.882, 0.881, 0.889]","[0.765, 0.766, 0.776]","[0.68, 0.68, 0.689]","[0.741, 0.743, 0.752]","[0.711, 0.71, 0.726]",0.377,0.488,0.575,0.151,0.149,0.124,0.737,0.64,0.559,0.703,0.755,0.682,0.578,0.884,0.769,0.683,0.745,0.716
https://doi.org/10.1001/jamapediatrics.2017.0910,motor vehicle crash risk among adolescents and young adults with attentiondeficithyperactivity disorder,885_motor vehicle crash risk among adolescents and young adults with attentiondeficithyperactivity disorder.pdf,5,"['http://jchc.virginia.gov/4.%20Staff%20Report.%20ADHD%20Study.%20HB1500(A)%20(2017)%20-%209.17.17.pdf', 'http://jchc.virginia.gov/JCHC%202017%20Annual%20Report.pdf', 'https://nam.edu/transportation-equity-health-and-aging-a-novel-approach-to-healthy-longevity-with-benefits-across-the-life-span/', 'https://stacks.cdc.gov/view/cdc/81836', 'https://www.nj.gov/oag/hts/downloads/NJ-Young-Drivers-2013-2017.pdf']","['ADHD prevalence and Risks of ADHD Medications in Virginia', 'JCHC%202017%20Annual%20Report', 'Transportation Equity, Health, and Aging: A Novel Approach to Healthy Longevity with Benefits Across the Life Span', 'LINCS : Linking Information for Nonfatal Crash Surveillance : a guide for integrating motor vehicle crash data to help keep Americans safe on the road', 'Young']","['https://www.nj.gov/oag/hts/downloads/NJ-Young-Drivers-2013-2017.pdf', 'http://jchc.virginia.gov/4.%20Staff%20Report.%20ADHD%20Study.%20HB1500(A)%20(2017)%20-%209.17.17.pdf', 'http://jchc.virginia.gov/JCHC%202017%20Annual%20Report.pdf']","['885_4_young.pdf', '885_0_adhd prevalence and risks of adhd medications in virginia.pdf', '885_1_jchc20201720annual20report.pdf']",3,60.0,"['https://www.nj.gov/oag/hts/downloads/NJ-Young-Drivers-2013-2017.pdf', 'http://jchc.virginia.gov/4.%20Staff%20Report.%20ADHD%20Study.%20HB1500(A)%20(2017)%20-%209.17.17.pdf', 'http://jchc.virginia.gov/JCHC%202017%20Annual%20Report.pdf']","['885_4_young.pdf', '885_0_adhd prevalence and risks of adhd medications in virginia.pdf', '885_1_jchc20201720annual20report.pdf']","[0.361, 0.282, 0.389]","[0.507, 0.493, 0.499]","[0.594, 0.592, 0.597]","[0.166, 0.158, 0.135]","[0.183, 0.163, 0.14]","[0.151, 0.133, 0.113]","[0.738, 0.736, 0.723]","[0.642, 0.643, 0.625]","[0.569, 0.565, 0.569]","[0.697, 0.683, 0.662]","[0.773, 0.782, 0.79]","[0.718, 0.685, 0.711]","[0.604, 0.585, 0.594]","[0.912, 0.911, 0.909]","[0.814, 0.787, 0.808]","[0.741, 0.724, 0.741]","[0.776, 0.765, 0.78]","[0.764, 0.759, 0.767]",0.344,0.5,0.594,0.153,0.162,0.132,0.732,0.637,0.568,0.681,0.782,0.705,0.594,0.911,0.803,0.735,0.774,0.763
https://doi.org/10.1001/jamapediatrics.2017.1284,effect of a babyled approach to complementary feeding on infant growth and overweight,886_effect of a babyled approach to complementary feeding on infant growth and overweight.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf']","['Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants', 'Interventions for preventing obesity in children', 'Educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf']","['886_1_interventions for preventing obesity in children.pdf', '886_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf', '886_2_educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494551/pdf']","['886_1_interventions for preventing obesity in children.pdf', '886_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf', '886_2_educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under.pdf']","[0.564, 0.354, 0.575]","[0.503, 0.506, 0.5]","[0.586, 0.589, 0.584]","[0.158, 0.171, 0.166]","[0.156, 0.173, 0.168]","[0.136, 0.153, 0.147]","[0.734, 0.738, 0.738]","[0.636, 0.641, 0.641]","[0.566, 0.565, 0.562]","[0.705, 0.709, 0.705]","[0.757, 0.757, 0.755]","[0.673, 0.681, 0.68]","[0.581, 0.588, 0.589]","[0.894, 0.888, 0.886]","[0.793, 0.785, 0.779]","[0.697, 0.695, 0.693]","[0.757, 0.753, 0.754]","[0.732, 0.726, 0.721]",0.498,0.503,0.586,0.165,0.166,0.145,0.737,0.639,0.564,0.706,0.756,0.678,0.586,0.889,0.786,0.695,0.755,0.726
https://doi.org/10.1001/jamapediatrics.2017.1919,global prevalence of fetal alcohol spectrum disorder among children and youth,887_global prevalence of fetal alcohol spectrum disorder among children and youth.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405816/pdf'],"['The Standardization of Diagnostic Criteria for Fetal Alcohol Spectrum Disorder (FASD): Implications for Research, Clinical Practice and Population Health']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405816/pdf'],['887_0_the standardization of diagnostic criteria for fetal alcohol spectrum disorder fasd implications for research clinical practice and population health.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405816/pdf'],['887_0_the standardization of diagnostic criteria for fetal alcohol spectrum disorder fasd implications for research clinical practice and population health.pdf'],[0.662],[0.522],[0.612],[0.172],[0.194],[0.144],[0.738],[0.648],[0.595],[0.704],[0.799],[0.723],[0.605],[0.916],[0.829],[0.754],[0.797],[0.784],0.662,0.522,0.612,0.172,0.194,0.144,0.738,0.648,0.595,0.704,0.799,0.723,0.605,0.916,0.829,0.754,0.797,0.784
https://doi.org/10.1001/jamapediatrics.2017.2536,association of cigarette price differentials with infant mortality in 23 european union countries,888_association of cigarette price differentials with infant mortality in 23 european union countries.pdf,1,['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%236%20-%20English%20Translation.pdf'],"['Bedsharing and Breastfeeding: The Academy of Breastfeeding Medicine Protocol #6, Revision 2019']",['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%236%20-%20English%20Translation.pdf'],['888_0_bedsharing and breastfeeding the academy of breastfeeding medicine protocol 6 revision 2019.pdf'],1,100.0,['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%236%20-%20English%20Translation.pdf'],['888_0_bedsharing and breastfeeding the academy of breastfeeding medicine protocol 6 revision 2019.pdf'],[0.234],[0.493],[0.587],[0.114],[0.114],[0.1],[0.722],[0.618],[0.576],[0.643],[0.779],[0.698],[0.605],[0.903],[0.81],[0.724],[0.778],[0.741],0.234,0.493,0.587,0.114,0.114,0.1,0.722,0.618,0.576,0.643,0.779,0.698,0.605,0.903,0.81,0.724,0.778,0.741
https://doi.org/10.1001/jamapediatrics.2017.3438,use of exome sequencing for infants in intensive care units,889_use of exome sequencing for infants in intensive care units.pdf,3,"['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf', 'https://www.acmg.net/PDFLibrary/Systematic%20evidence-based%20review%20outcomes%20from%20exome%20and%20genome%20sequencing%20for%20pediatric%20patients%20with%20congenital%20anomalies%20or%20intellectual%20disability.pdf', 'https://www.acmg.net/PDFLibrary/Exome_and_genome_sequencing_pediatric_patients.pdf']","['Whole Exome Sequencing Final evidence report', 'Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability', 'Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidencebased clinical guideline of the American College of Medical Genetics and Genomics (ACMG)']","['https://www.acmg.net/PDFLibrary/Systematic%20evidence-based%20review%20outcomes%20from%20exome%20and%20genome%20sequencing%20for%20pediatric%20patients%20with%20congenital%20anomalies%20or%20intellectual%20disability.pdf', 'https://www.acmg.net/PDFLibrary/Exome_and_genome_sequencing_pediatric_patients.pdf', 'https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf']","['889_1_systematic evidencebased review outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.pdf', '889_2_exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability an evidencebas.pdf', '889_0_whole exome sequencing final evidence report.pdf']",3,100.0,"['https://www.acmg.net/PDFLibrary/Systematic%20evidence-based%20review%20outcomes%20from%20exome%20and%20genome%20sequencing%20for%20pediatric%20patients%20with%20congenital%20anomalies%20or%20intellectual%20disability.pdf', 'https://www.acmg.net/PDFLibrary/Exome_and_genome_sequencing_pediatric_patients.pdf', 'https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf']","['889_1_systematic evidencebased review outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.pdf', '889_2_exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability an evidencebas.pdf', '889_0_whole exome sequencing final evidence report.pdf']","[0.542, 0.413, 0.517]","[0.547, 0.503, 0.503]","[0.619, 0.594, 0.59]","[0.193, 0.168, 0.16]","[0.205, 0.19, 0.185]","[0.162, 0.15, 0.155]","[0.749, 0.74, 0.745]","[0.662, 0.653, 0.657]","[0.607, 0.565, 0.57]","[0.685, 0.71, 0.71]","[0.798, 0.78, 0.772]","[0.721, 0.678, 0.676]","[0.633, 0.613, 0.607]","[0.91, 0.911, 0.892]","[0.83, 0.793, 0.809]","[0.761, 0.733, 0.697]","[0.796, 0.761, 0.769]","[0.783, 0.756, 0.758]",0.491,0.518,0.601,0.174,0.193,0.156,0.745,0.657,0.581,0.702,0.783,0.692,0.618,0.904,0.811,0.73,0.775,0.766
https://doi.org/10.1001/jamapediatrics.2017.4005,association of childhood blood lead levels with criminal offending,890_association of childhood blood lead levels with criminal offending.pdf,5,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://stacks.cdc.gov/view/cdc/78185', 'https://purl.fdlp.gov/GPO/gpo144830']","['2015-Lead-Poisoning', 'Toxicological Profile for Lead, Draft for Public Comment', 'Toxicological profile for lead: draft for public comment.', 'Toxicological profile for lead : draft for public comment', 'Toxicological profile for lead /']","['https://purl.fdlp.gov/GPO/gpo144830', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://purl.fdlp.gov/GPO/gpo132915']","['890_4_toxicological profile for lead .pdf', '890_1_toxicological profile for lead draft for public comment.pdf', '890_0_2015leadpoisoning.pdf', '890_2_toxicological profile for lead draft for public comment.pdf']",4,80.0,"['https://purl.fdlp.gov/GPO/gpo144830', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://purl.fdlp.gov/GPO/gpo132915']","['890_4_toxicological profile for lead .pdf', '890_1_toxicological profile for lead draft for public comment.pdf', '890_0_2015leadpoisoning.pdf', '890_2_toxicological profile for lead draft for public comment.pdf']","[0.528, 0.422, 0.422, 0.437]","[0.477, 0.48, 0.482, 0.48]","[0.575, 0.576, 0.578, 0.576]","[0.13, 0.129, 0.132, 0.129]","[0.129, 0.127, 0.13, 0.127]","[0.107, 0.106, 0.109, 0.106]","[0.73, 0.729, 0.729, 0.729]","[0.636, 0.636, 0.635, 0.636]","[0.547, 0.55, 0.551, 0.55]","[0.692, 0.691, 0.69, 0.691]","[0.769, 0.77, 0.77, 0.77]","[0.664, 0.667, 0.669, 0.667]","[0.589, 0.591, 0.593, 0.591]","[0.903, 0.904, 0.904, 0.904]","[0.78, 0.783, 0.786, 0.783]","[0.717, 0.719, 0.72, 0.719]","[0.755, 0.758, 0.759, 0.758]","[0.746, 0.747, 0.748, 0.747]",0.452,0.48,0.576,0.13,0.128,0.107,0.729,0.636,0.55,0.691,0.77,0.667,0.591,0.904,0.783,0.719,0.757,0.747
https://doi.org/10.1001/jamapediatrics.2017.4173,association of noncigarette tobacco product use with future cigarette smoking among youth in the population assessment of tobacco and health path study 20132015,891_association of noncigarette tobacco product use with future cigarette smoking among youth in the population assessment of tobacco and health path study 20132015.pdf,1,['https://www.tn.gov/content/dam/tn/health/healthprofboards/health-advisory/Health_Advisory_Electronic_Cigarettes_12-18.pdf'],['Tdh Public Health Advisory'],['https://www.tn.gov/content/dam/tn/health/healthprofboards/health-advisory/Health_Advisory_Electronic_Cigarettes_12-18.pdf'],['891_0_tdh public health advisory.pdf'],1,100.0,['https://www.tn.gov/content/dam/tn/health/healthprofboards/health-advisory/Health_Advisory_Electronic_Cigarettes_12-18.pdf'],['891_0_tdh public health advisory.pdf'],[0.514],[0.503],[0.582],[0.188],[0.208],[0.178],[0.742],[0.652],[0.569],[0.701],[0.791],[0.698],[0.6],[0.909],[0.807],[0.736],[0.785],[0.772],0.514,0.503,0.582,0.188,0.208,0.178,0.742,0.652,0.569,0.701,0.791,0.698,0.6,0.909,0.807,0.736,0.785,0.772
https://doi.org/10.1001/jamapediatrics.2017.4673,a multicomponent preschool to third grade preventive intervention and educational attainment at 35 years of age,892_a multicomponent preschool to third grade preventive intervention and educational attainment at 35 years of age.pdf,7,"['https://www.lrl.mn.gov/docs/2018/other/180481.pdf', 'https://www.urban.org/research/publication/boosting-upward-mobility-exemplars', 'https://www.urban.org/research/publication/parents-are-struggling-provide-their-families-during-pandemic', 'https://www.americanprogress.org/issues/early-childhood/reports/2021/04/30/499026/building-back-better-investing-improving-schools-creating-jobs-strengthening-families-economy/', 'https://www.congress.gov/event/117th-congress/house-event/112511', 'https://www.leg.mn.gov/docs/2018/other/180481.pdf', 'https://www.manhattan-institute.org/drawbacks-universal-pre-k-review-evidence']","['Early Childhood Programs', 'Boosting Upward Mobility: Exemplars', 'Parents Are Struggling to Provide for Their Families during the Pandemic', 'Building Back Better: Investing in Improving Schools, Creating Jobs, and Strengthening Families and Our Economy - Center for American Progress', 'Building Back Better: Investing in Improving Schools, Creating Jobs, and Strengthening Families and our Economy', 'Early Childhood Programs', 'The Drawbacks of Universal Pre-K: A Review of the Evidence']","['https://www.lrl.mn.gov/docs/2018/other/180481.pdf', 'https://www.leg.mn.gov/docs/2018/other/180481.pdf']","['892_0_early childhood programs.pdf', '892_5_early childhood programs.pdf']",2,28.57,"['https://www.lrl.mn.gov/docs/2018/other/180481.pdf', 'https://www.leg.mn.gov/docs/2018/other/180481.pdf']","['892_0_early childhood programs.pdf', '892_5_early childhood programs.pdf']","[0.478, 0.478]","[0.467, 0.467]","[0.561, 0.561]","[0.156, 0.156]","[0.167, 0.167]","[0.139, 0.139]","[0.725, 0.725]","[0.62, 0.62]","[0.536, 0.536]","[0.691, 0.691]","[0.753, 0.753]","[0.697, 0.697]","[0.618, 0.618]","[0.878, 0.878]","[0.779, 0.779]","[0.682, 0.682]","[0.761, 0.761]","[0.698, 0.698]",0.478,0.467,0.561,0.156,0.167,0.139,0.725,0.62,0.536,0.691,0.753,0.697,0.618,0.878,0.779,0.682,0.761,0.698
https://doi.org/10.1001/jamapediatrics.2017.5314,prevalence of multiple forms of sexting behavior among youth,894_prevalence of multiple forms of sexting behavior among youth.pdf,2,"['http://mgaleg.maryland.gov/cmte_testimony/2020/jud/3855_02272020_94218-792.pdf', 'https://www.americanprogress.org/issues/education-k-12/reports/2019/05/29/469886/momentum-building-modernize-sex-education/']","['Working to end sexual violence in', 'Momentum Is Building to Modernize Sex Education - Center for American Progress']",['http://mgaleg.maryland.gov/cmte_testimony/2020/jud/3855_02272020_94218-792.pdf'],['894_0_working to end sexual violence in.pdf'],1,50.0,['http://mgaleg.maryland.gov/cmte_testimony/2020/jud/3855_02272020_94218-792.pdf'],['894_0_working to end sexual violence in.pdf'],[0.242],[0.485],[0.582],[0.134],[0.143],[0.128],[0.719],[0.628],[0.554],[0.662],[0.787],[0.701],[0.605],[0.909],[0.812],[0.736],[0.777],[0.762],0.242,0.485,0.582,0.134,0.143,0.128,0.719,0.628,0.554,0.662,0.787,0.701,0.605,0.909,0.812,0.736,0.777,0.762
https://doi.org/10.1001/jamapediatrics.2017.5621,effect of including alcohol and cannabis content in a sexual riskreduction intervention on the incidence of sexually transmitted infections in adolescents,895_effect of including alcohol and cannabis content in a sexual riskreduction intervention on the incidence of sexually transmitted infections in adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf', 'https://effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research']","['Sexually Transmitted Infections Treatment Guidelines, 2021', 'Interventions for Substance Use Disorders in Adolescents: A Systematic Review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],['895_0_sexually transmitted infections treatment guidelines 2021.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],['895_0_sexually transmitted infections treatment guidelines 2021.pdf'],[0.222],[0.504],[0.593],[0.134],[0.142],[0.12],[0.735],[0.64],[0.583],[0.631],[0.788],[0.7],[0.57],[0.903],[0.809],[0.717],[0.78],[0.766],0.222,0.504,0.593,0.134,0.142,0.12,0.735,0.64,0.583,0.631,0.788,0.7,0.57,0.903,0.809,0.717,0.78,0.766
https://doi.org/10.1001/jamapediatrics.2018.0016,effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination,896_effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination.pdf,4,"['https://www.aspeninstitute.org/publications/meeting-the-challenge-of-vaccination-hesitancy/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://stacks.cdc.gov/view/cdc/109668', 'https://stacks.cdc.gov/view/cdc/109667']","['Meeting the Challenge of Vaccination Hesitancy - The Aspen Institute', 'Improving vaccination uptake among adolescents', '12 COVID-19 vaccination strategies for your community : a guide to support the work of health departments and community organizations across the United States', 'COVID-19 vaccination field guide : 12 strategies for your community']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['896_1_improving vaccination uptake among adolescents.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['896_1_improving vaccination uptake among adolescents.pdf'],[0.546],[0.523],[0.605],[0.194],[0.196],[0.17],[0.743],[0.652],[0.591],[0.703],[0.778],[0.701],[0.58],[0.913],[0.813],[0.725],[0.77],[0.751],0.546,0.523,0.605,0.194,0.196,0.17,0.743,0.652,0.591,0.703,0.778,0.701,0.58,0.913,0.813,0.725,0.77,0.751
https://doi.org/10.1001/jamapediatrics.2018.1785,comparison of health development maternal bonding and poverty among children born after denial of abortion vs after pregnancies subsequent to an abortion,897_comparison of health development maternal bonding and poverty among children born after denial of abortion vs after pregnancies subsequent to an abortion.pdf,8,"['https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://ag.ny.gov/sites/default/files/01_-_complaint.pdf', 'https://oag.dc.gov/sites/default/files/2020-07/Section-1557-ACA-Discrimination-Complaint.pdf', 'https://www.nj.gov/oag/newsreleases20/072020-Complaint.pdf', 'https://iwpr.org/publications/economic-effects-abortion-access-report/', 'https://data.nber.org/papers/w26662', 'https://www.guttmacher.org/gpr/2020/01/gestational-age-bans-harmful-any-stage-pregnancy', 'https://www.congress.gov/event/116th-congress/house-event/110504']","['THE STATE OF CALIFORNIA', 'United States District Court Southern District Of New York', 'United States District Court Southern District Of New York', 'United States District Court Southern District Of New York', 'The Economic Effects of Abortion Access: A Review of the Evidence', 'The Economic Consequences of Being Denied an Abortion', 'Gestational Age Bans: Harmful at Any Stage of Pregnancy', '""Protecting Women\'s Access to Reproductive Health Care""']","['https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://ag.ny.gov/sites/default/files/01_-_complaint.pdf', 'https://www.nj.gov/oag/newsreleases20/072020-Complaint.pdf', 'https://oag.dc.gov/sites/default/files/2020-07/Section-1557-ACA-Discrimination-Complaint.pdf']","['897_0_the state of california.pdf', '897_1_united states district court southern district of new york.pdf', '897_3_united states district court southern district of new york.pdf', '897_2_united states district court southern district of new york.pdf']",4,50.0,"['https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://ag.ny.gov/sites/default/files/01_-_complaint.pdf', 'https://www.nj.gov/oag/newsreleases20/072020-Complaint.pdf', 'https://oag.dc.gov/sites/default/files/2020-07/Section-1557-ACA-Discrimination-Complaint.pdf']","['897_0_the state of california.pdf', '897_1_united states district court southern district of new york.pdf', '897_3_united states district court southern district of new york.pdf', '897_2_united states district court southern district of new york.pdf']","[0.158, 0.136, 0.136, 0.136]","[0.475, 0.477, 0.477, 0.477]","[0.567, 0.568, 0.568, 0.568]","[0.108, 0.102, 0.102, 0.102]","[0.12, 0.113, 0.113, 0.113]","[0.108, 0.099, 0.099, 0.099]","[0.721, 0.72, 0.72, 0.72]","[0.621, 0.621, 0.621, 0.621]","[0.541, 0.541, 0.541, 0.541]","[0.678, 0.665, 0.665, 0.665]","[0.749, 0.756, 0.756, 0.756]","[0.666, 0.663, 0.663, 0.663]","[0.599, 0.597, 0.597, 0.597]","[0.906, 0.904, 0.904, 0.904]","[0.782, 0.789, 0.789, 0.789]","[0.706, 0.712, 0.712, 0.712]","[0.752, 0.753, 0.753, 0.753]","[0.736, 0.738, 0.738, 0.738]",0.142,0.476,0.568,0.103,0.115,0.101,0.72,0.621,0.541,0.668,0.754,0.664,0.597,0.904,0.787,0.71,0.753,0.737
https://doi.org/10.1001/jamapediatrics.2018.1915,association of plate design with consumption of fruits and vegetables among preschool children,898_association of plate design with consumption of fruits and vegetables among preschool children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['898_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '898_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['898_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '898_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.472, 0.469]","[0.52, 0.519]","[0.612, 0.61]","[0.184, 0.184]","[0.194, 0.194]","[0.163, 0.163]","[0.733, 0.733]","[0.636, 0.635]","[0.593, 0.591]","[0.704, 0.704]","[0.779, 0.779]","[0.682, 0.678]","[0.575, 0.575]","[0.923, 0.922]","[0.833, 0.831]","[0.737, 0.736]","[0.782, 0.78]","[0.771, 0.77]",0.47,0.52,0.611,0.184,0.194,0.163,0.733,0.635,0.592,0.704,0.779,0.68,0.575,0.923,0.832,0.736,0.781,0.77
https://doi.org/10.1001/jamapediatrics.2018.2143,receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder,899_receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902443/pdf', 'https://aspe.hhs.gov/reports/models-medication-assisted-treatment-opioid-use-disorder-retention-continuity-care', 'https://www.urban.org/research/publication/improving-substance-use-services-youth', 'https://www.urban.org/research/publication/characteristics-medicaid-enrolled-adolescents-unhealthy-opioid-or-other-substance-use', 'https://nam.edu/improving-access-to-evidence-based-medical-treatment-for-opioid-use-disorder-strategies-to-address-key-barriers-within-the-treatment-system/', 'https://effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research', 'https://www1.nyc.gov/assets/doh/downloads/pdf/basas/opioid-child-pamphlet-sp.pdf', 'https://www.urban.org/research/publication/evidence-based-interventions-adolescent-opioid-use-disorder']","['Medication for Adolescents and Young Adults with Opioid Use Disorder', 'Models for Medication-Assisted Treatment for Opioid Use Disorder, Retention, and Continuity of Care', 'Improving Substance Use Services for Youth', 'Characteristics of Medicaid-Enrolled Adolescents with Unhealthy Opioid or Other Substance Use', 'Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System', 'Interventions for Substance Use Disorders in Adolescents: A Systematic Review', 'Analgésicos Recetados O Heroína?', 'Evidence-Based Interventions for Adolescent Opioid Use Disorder']","['https://www1.nyc.gov/assets/doh/downloads/pdf/basas/opioid-child-pamphlet-sp.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902443/pdf']","['899_6_analgésicos recetados o heroína.pdf', '899_0_medication for adolescents and young adults with opioid use disorder.pdf']",2,25.0,"['https://www1.nyc.gov/assets/doh/downloads/pdf/basas/opioid-child-pamphlet-sp.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902443/pdf']","['899_6_analgésicos recetados o heroína.pdf', '899_0_medication for adolescents and young adults with opioid use disorder.pdf']","[0.611, 0.03]","[0.38, 0.507]","[0.518, 0.603]","[0.135, 0.184]","[0.188, 0.214]","[0.145, 0.172]","[0.727, 0.739]","[0.644, 0.649]","[0.482, 0.576]","[0.669, 0.695]","[0.782, 0.783]","[0.635, 0.693]","[0.539, 0.571]","[0.872, 0.91]","[0.784, 0.818]","[0.675, 0.734]","[0.73, 0.777]","[0.703, 0.768]",0.321,0.444,0.56,0.16,0.201,0.158,0.733,0.647,0.529,0.682,0.782,0.664,0.555,0.891,0.801,0.705,0.754,0.736
https://doi.org/10.1001/jamapediatrics.2018.2537,prevalence of adverse childhood experiences from the 20112014 behavioral risk factor surveillance system in 23 states,900_prevalence of adverse childhood experiences from the 20112014 behavioral risk factor surveillance system in 23 states.pdf,10,"['https://stacks.cdc.gov/view/cdc/82319', 'https://www.congress.gov/committee-print/116th-congress/house-committee-print/46456', 'https://www.congress.gov/committee-print/117th-congress/house-committee-print/46456', 'https://www.congress.gov/event/116th-congress/house-event/109762', 'https://stacks.cdc.gov/view/cdc/82316', 'https://osg.ca.gov/wp-content/uploads/sites/266/2021/10/CA-OSG-News-Release-ACEs-Equity-Act.pdf', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Overview-of-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=04f7d5']","['Vital Signs: Estimated proportion of adult health problems attributable to adverse childhood experiences and implications for prevention — 25 states, 2015–2017', 'ADDENDUM 1 TO HEARING HELD JANUARY 28, 2020', 'ADDENDUM 1 TO HEARING HELD JANUARY 28, 2020', 'Identifying, Preventing, and Treating Childhood Trauma: A Pervasive Public Health Issue that Needs Greater Federal Attention', 'Preventing adverse childhood experiences (ACEs) : leveraging the best available evidence', 'New ACEs Equity Act Significantly Expands ACE Screening in California', 'Executive Summary – Findings from Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'Public Health Sector', 'Roadmap for Resilience', 'ACEs and Toxic Stress : A Public Health Crisis']","['https://osg.ca.gov/wp-content/uploads/sites/266/2021/10/CA-OSG-News-Release-ACEs-Equity-Act.pdf', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Overview-of-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=04f7d5', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44']","['900_5_new aces equity act significantly expands ace screening in california.pdf', '900_9_aces and toxic stress  a public health crisis.pdf', '900_8_roadmap for resilience.pdf', '900_7_public health sector.pdf', '900_6_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']",5,50.0,"['https://osg.ca.gov/wp-content/uploads/sites/266/2021/10/CA-OSG-News-Release-ACEs-Equity-Act.pdf', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Overview-of-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=04f7d5', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44']","['900_5_new aces equity act significantly expands ace screening in california.pdf', '900_9_aces and toxic stress  a public health crisis.pdf', '900_8_roadmap for resilience.pdf', '900_7_public health sector.pdf', '900_6_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']","[0.185, 0.408, 0.406, 0.275, 0.45]","[0.46, 0.481, 0.47, 0.477, 0.475]","[0.569, 0.583, 0.566, 0.581, 0.58]","[0.127, 0.157, 0.143, 0.153, 0.154]","[0.134, 0.171, 0.147, 0.169, 0.166]","[0.101, 0.133, 0.116, 0.133, 0.127]","[0.716, 0.739, 0.731, 0.732, 0.732]","[0.623, 0.647, 0.638, 0.642, 0.641]","[0.519, 0.546, 0.536, 0.54, 0.539]","[0.686, 0.702, 0.694, 0.697, 0.69]","[0.778, 0.763, 0.76, 0.768, 0.767]","[0.689, 0.675, 0.665, 0.675, 0.676]","[0.591, 0.583, 0.586, 0.587, 0.594]","[0.896, 0.907, 0.903, 0.903, 0.904]","[0.796, 0.79, 0.782, 0.792, 0.789]","[0.731, 0.727, 0.72, 0.727, 0.729]","[0.767, 0.759, 0.755, 0.768, 0.763]","[0.753, 0.753, 0.746, 0.755, 0.753]",0.345,0.473,0.576,0.147,0.157,0.122,0.73,0.638,0.536,0.694,0.767,0.676,0.588,0.903,0.79,0.727,0.762,0.752
https://doi.org/10.1001/jamapediatrics.2018.4595,changes in flavored tobacco product use among current youth tobacco users in the united states 20142017,902_changes in flavored tobacco product use among current youth tobacco users in the united states 20142017.pdf,4,"['https://www.michigan.gov/documents/mdhhs/Finding_of_Emergency_MDHHS_665031_7.pdf', 'https://reason.org/commentary/the-public-health-case-for-e-cigarette-flavors/', 'https://www.michigan.gov/documents/lara/Protection_of_Youth_from_Nicotine_Product_Addiction_666131_7.pdf', 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents/modifications-compliance-policy-certain-deemed-tobacco-products']","['DHS Central Office Lthd', 'The Public Health Case for E-Cigarette Flavors', 'Protection Of Youth From Nicotine Product Addiction Emergency Rules', 'Modifications to Compliance Policy for Certain Deemed Tobacco Products']","['https://www.michigan.gov/documents/mdhhs/Finding_of_Emergency_MDHHS_665031_7.pdf', 'https://www.michigan.gov/documents/lara/Protection_of_Youth_from_Nicotine_Product_Addiction_666131_7.pdf']","['902_0_dhs central office lthd.pdf', '902_2_protection of youth from nicotine product addiction emergency rules.pdf']",2,50.0,"['https://www.michigan.gov/documents/mdhhs/Finding_of_Emergency_MDHHS_665031_7.pdf', 'https://www.michigan.gov/documents/lara/Protection_of_Youth_from_Nicotine_Product_Addiction_666131_7.pdf']","['902_0_dhs central office lthd.pdf', '902_2_protection of youth from nicotine product addiction emergency rules.pdf']","[0.505, 0.415]","[0.407, 0.427]","[0.521, 0.532]","[0.131, 0.122]","[0.142, 0.13]","[0.123, 0.135]","[0.738, 0.739]","[0.64, 0.641]","[0.453, 0.458]","[0.677, 0.695]","[0.682, 0.677]","[0.611, 0.613]","[0.56, 0.571]","[0.798, 0.8]","[0.68, 0.686]","[0.53, 0.547]","[0.682, 0.683]","[0.565, 0.574]",0.46,0.417,0.526,0.127,0.136,0.129,0.738,0.641,0.456,0.686,0.679,0.612,0.566,0.799,0.683,0.538,0.683,0.569
https://doi.org/10.1001/jamapediatrics.2019.0392,association of in vitro fertilization with childhood cancer in the united states,904_association of in vitro fertilization with childhood cancer in the united states.pdf,5,"['https://www.dshs.texas.gov/legislative/2020-Reports/Texas-Cancer-Registry-Report-2020.pdf', 'https://dph.illinois.gov/sites/default/files/publications/fy19-ihhsr-annual-report-final-draft-11-6-19.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/fy19-ihhsr-annual-report-final-draft-11-6-19.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/fy20ihhsrannualreport112320final.pdf', 'https://dshs.texas.gov/legislative/2020-Reports/Texas-Cancer-Registry-Report-2020.pdf']","['Texas Cancer Registry Annual Report 2020', 'Annual Report', '2019 Illinois Health and Hazardous Substances Registry Annual Report', '2020 Illinois Health and Hazardous Substances Registry Annual Report', 'Texas Cancer Registry Annual Report 2020']","['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/fy19-ihhsr-annual-report-final-draft-11-6-19.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/fy20ihhsrannualreport112320final.pdf']","['904_2_2019 illinois health and hazardous substances registry annual report.pdf', '904_3_2020 illinois health and hazardous substances registry annual report.pdf']",2,40.0,"['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/fy19-ihhsr-annual-report-final-draft-11-6-19.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/fy20ihhsrannualreport112320final.pdf']","['904_2_2019 illinois health and hazardous substances registry annual report.pdf', '904_3_2020 illinois health and hazardous substances registry annual report.pdf']","[0.464, 0.447]","[0.526, 0.524]","[0.61, 0.607]","[0.152, 0.143]","[0.167, 0.158]","[0.13, 0.122]","[0.734, 0.731]","[0.638, 0.634]","[0.591, 0.59]","[0.68, 0.674]","[0.787, 0.79]","[0.708, 0.709]","[0.62, 0.616]","[0.909, 0.912]","[0.824, 0.822]","[0.749, 0.748]","[0.792, 0.793]","[0.776, 0.776]",0.456,0.525,0.609,0.147,0.163,0.126,0.732,0.636,0.591,0.677,0.788,0.708,0.618,0.911,0.823,0.748,0.792,0.776
https://doi.org/10.1001/jamapediatrics.2019.1078,association of increased safe household firearm storage with firearm suicide and unintentional death among us youths,905_association of increased safe household firearm storage with firearm suicide and unintentional death among us youths.pdf,6,"['https://www.congress.gov/congressional-report/117th-congress/house-report/346/1', 'https://www.congress.gov/event/117th-congress/house-event/114874', 'https://www.pccd.pa.gov/criminaljustice/GunViolence/Documents/Special%20Council%20on%20Gun%20Violence%20Report%20of%20Findings%20Recommendations%20%20Action%20Steps%20-%20March%202020.pdf', 'https://www.pccd.pa.gov/criminaljustice/GunViolence/Documents/Report%20of%20Initial%20Findings%20and%20Workgroup%20Recommendations%20for%20SCGV%201-22-2020.pdf', 'https://www.congress.gov/event/117th-congress/house-event/112672', 'https://www.rand.org/pubs/research_reports/RR2088-1.html']","['H. Rept. 117-346 - PROTECTING OUR KIDS ACT', 'H.R. 2377—Federal Extreme Risk Protection Order Act of 2021; H.R. 7910—Protecting Our Kids Act', 'Report of Findings, Recommendations & Action Steps', 'REPORT OF INITIAL FINDINGS & WORKGROUP RECOMMENDATIONS Prepared for Consideration by the Special Council on Gun Violence', 'An Unending Crisis: Essential Steps to Reducing Gun Violence and Mass Shootings', 'The Science of Gun Policy: Second Edition']","['https://www.pccd.pa.gov/criminaljustice/GunViolence/Documents/Special%20Council%20on%20Gun%20Violence%20Report%20of%20Findings%20Recommendations%20%20Action%20Steps%20-%20March%202020.pdf', 'https://www.pccd.pa.gov/criminaljustice/GunViolence/Documents/Report%20of%20Initial%20Findings%20and%20Workgroup%20Recommendations%20for%20SCGV%201-22-2020.pdf']","['905_2_report of findings recommendations  action steps.pdf', '905_3_report of initial findings  workgroup recommendations prepared for consideration by the special council on gun violence.pdf']",2,33.33,"['https://www.pccd.pa.gov/criminaljustice/GunViolence/Documents/Special%20Council%20on%20Gun%20Violence%20Report%20of%20Findings%20Recommendations%20%20Action%20Steps%20-%20March%202020.pdf', 'https://www.pccd.pa.gov/criminaljustice/GunViolence/Documents/Report%20of%20Initial%20Findings%20and%20Workgroup%20Recommendations%20for%20SCGV%201-22-2020.pdf']","['905_2_report of findings recommendations  action steps.pdf', '905_3_report of initial findings  workgroup recommendations prepared for consideration by the special council on gun violence.pdf']","[0.286, 0.267]","[0.518, 0.527]","[0.611, 0.617]","[0.172, 0.167]","[0.187, 0.189]","[0.151, 0.149]","[0.733, 0.734]","[0.64, 0.639]","[0.602, 0.611]","[0.667, 0.66]","[0.806, 0.809]","[0.74, 0.74]","[0.614, 0.615]","[0.92, 0.92]","[0.846, 0.848]","[0.76, 0.765]","[0.803, 0.807]","[0.789, 0.791]",0.276,0.522,0.614,0.169,0.188,0.15,0.734,0.639,0.607,0.663,0.808,0.74,0.615,0.92,0.847,0.762,0.805,0.79
https://doi.org/10.1001/jamapediatrics.2019.1720,association of marijuana laws with teen marijuana use,907_association of marijuana laws with teen marijuana use.pdf,10,"['https://www.rstreet.org/2019/09/12/reviewed-work-association-of-marijuana-laws-with-teen-marijuana-use-new-estimates-from-the-youth-risk-behavior-surveys/', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-2.pdf', 'https://www.governor.virginia.gov/media/governorvirginiagov/governor-of-virginia/pdf/Final-Report-on-Marijuana-Legalization-11.30.20.pdf', 'https://www.rand.org/pubs/research_reports/RR4431.html', 'https://mathematica.org/publications/marijuana-legalization-public-health-safety-and-economic-factors-for-states-to-consider', 'https://www.nber.org/papers/w29038', 'https://www.nber.org/papers/w28647', 'https://www.nber.org/papers/w29087']","['Reviewed Work: Association of marijuana laws with teen marijuana use: New estimates from the youth risk behavior surveys.', 'Report to the Governor and the General Assembly of Virginia', 'Report to the Governor and the General Assembly of Virginia', 'Report to the Governor and the General Assembly of Virginia', 'Report to the Virginia General Assembly and Governor of Virginia', ""An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies"", 'Marijuana Legalization: Public Health, Safety, and Economic Factors for States to Consider', 'Is Recreational Marijuana a Gateway to Harder Drug Use and Crime?', 'The Public Health Effects of Legalizing Marijuana', 'Recreational Marijuana Laws and the Use of Opioids: Evidence from NSDUH Microdata']","['http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf']","['907_2_report to the governor and the general assembly of virginia.pdf', '907_3_report to the governor and the general assembly of virginia.pdf', '907_1_report to the governor and the general assembly of virginia.pdf']",3,30.0,"['http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf']","['907_2_report to the governor and the general assembly of virginia.pdf', '907_3_report to the governor and the general assembly of virginia.pdf', '907_1_report to the governor and the general assembly of virginia.pdf']","[0.529, 0.533, 0.497]","[0.53, 0.537, 0.526]","[0.612, 0.617, 0.609]","[0.151, 0.155, 0.149]","[0.169, 0.172, 0.168]","[0.146, 0.15, 0.144]","[0.72, 0.719, 0.72]","[0.622, 0.622, 0.622]","[0.593, 0.6, 0.589]","[0.655, 0.652, 0.656]","[0.792, 0.795, 0.79]","[0.718, 0.725, 0.716]","[0.607, 0.612, 0.605]","[0.915, 0.916, 0.914]","[0.825, 0.828, 0.824]","[0.757, 0.762, 0.754]","[0.793, 0.796, 0.791]","[0.774, 0.777, 0.773]",0.52,0.531,0.613,0.152,0.17,0.147,0.72,0.622,0.594,0.654,0.792,0.72,0.608,0.915,0.826,0.758,0.793,0.775
https://doi.org/10.1001/jamapediatrics.2019.3007,positive childhood experiences and adult mental and relational health in a statewide sample,910_positive childhood experiences and adult mental and relational health in a statewide sample.pdf,2,"['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/What-Lies-Ahead_CA_OSG-Report_12092020.pdf?emrc=988f3b']","['COVID-19 and the Massachusetts Juvenile Justice System', 'What Lies Ahead? – Findings from Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health']","['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/What-Lies-Ahead_CA_OSG-Report_12092020.pdf?emrc=988f3b']","['910_0_covid19 and the massachusetts juvenile justice system.pdf', '910_1_what lies ahead – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']",2,100.0,"['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/What-Lies-Ahead_CA_OSG-Report_12092020.pdf?emrc=988f3b']","['910_0_covid19 and the massachusetts juvenile justice system.pdf', '910_1_what lies ahead – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']","[0.25, 0.402]","[0.5, 0.515]","[0.593, 0.625]","[0.14, 0.181]","[0.153, 0.204]","[0.125, 0.158]","[0.727, 0.744]","[0.629, 0.657]","[0.564, 0.584]","[0.66, 0.677]","[0.781, 0.795]","[0.705, 0.718]","[0.606, 0.613]","[0.91, 0.924]","[0.803, 0.827]","[0.738, 0.758]","[0.782, 0.803]","[0.762, 0.787]",0.326,0.508,0.609,0.161,0.178,0.142,0.736,0.643,0.574,0.669,0.788,0.712,0.609,0.917,0.815,0.748,0.792,0.774
https://doi.org/10.1001/jamapediatrics.2019.3553,efficacy and safety of varenicline for adolescent smoking cessation,913_efficacy and safety of varenicline for adolescent smoking cessation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493442/pdf'],['Interventions for preventing weight gain after smoking cessation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493442/pdf'],['913_0_interventions for preventing weight gain after smoking cessation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493442/pdf'],['913_0_interventions for preventing weight gain after smoking cessation.pdf'],[0.495],[0.509],[0.591],[0.179],[0.178],[0.153],[0.742],[0.65],[0.585],[0.71],[0.777],[0.695],[0.576],[0.913],[0.803],[0.728],[0.771],[0.759],0.495,0.509,0.591,0.179,0.178,0.153,0.742,0.65,0.585,0.71,0.777,0.695,0.576,0.913,0.803,0.728,0.771,0.759
https://doi.org/10.1001/jamapediatrics.2020.0153,assessment of evidence about common infant symptoms and cow’s milk allergy,914_assessment of evidence about common infant symptoms and cow’s milk allergy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['914_0_skin care interventions in infants for preventing eczema and food allergy.pdf', '914_1_skin care interventions in infants for preventing eczema and food allergy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['914_0_skin care interventions in infants for preventing eczema and food allergy.pdf', '914_1_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.286, 0.282]","[0.519, 0.521]","[0.605, 0.607]","[0.147, 0.15]","[0.156, 0.157]","[0.122, 0.125]","[0.736, 0.737]","[0.642, 0.642]","[0.591, 0.594]","[0.665, 0.663]","[0.783, 0.784]","[0.7, 0.699]","[0.585, 0.588]","[0.906, 0.905]","[0.814, 0.817]","[0.731, 0.732]","[0.777, 0.778]","[0.76, 0.761]",0.284,0.52,0.606,0.148,0.157,0.123,0.736,0.642,0.593,0.664,0.784,0.7,0.587,0.905,0.815,0.732,0.778,0.76
https://doi.org/10.1001/jamapediatrics.2020.0878,neonatal earlyonset infection with sarscov2 in 33 neonates born to mothers with covid19 in wuhan china,915_neonatal earlyonset infection with sarscov2 in 33 neonates born to mothers with covid19 in wuhan china.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900664/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340735/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502967/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273948/pdf', 'https://www.americanprogress.org/issues/women/reports/2020/07/15/487429/toward-equitable-treatments-womens-health-coronavirus-beyond/', 'https://stacks.cdc.gov/view/cdc/88194']","['COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper', 'Perinatal-Neonatal Management of COVID-19 Infection — Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP)', 'Management strategies for children with COVID-19: ESPR practical recommendations', 'Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019', 'Considerations for Pediatric Heart Programs During COVID-19: Recommendations From the Congenital Cardiac Anesthesia Society', 'Toward Equitable Treatments for Women’s Health During Coronavirus and Beyond - Center for American Progress', 'Evaluation and management considerations for neonates at risk for COVID-19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900664/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502967/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['915_0_covid19 faqs in paediatric and congenital cardiology aepc position paper.pdf', '915_3_saudi society of maternalfetal medicine guidance on pregnancy and coronavirus disease 2019.pdf', '915_4_considerations for pediatric heart programs during covid19 recommendations from the congenital cardiac anesthesia society.pdf', '915_2_management strategies for children with covid19 espr practical recommendations.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900664/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502967/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['915_0_covid19 faqs in paediatric and congenital cardiology aepc position paper.pdf', '915_3_saudi society of maternalfetal medicine guidance on pregnancy and coronavirus disease 2019.pdf', '915_4_considerations for pediatric heart programs during covid19 recommendations from the congenital cardiac anesthesia society.pdf', '915_2_management strategies for children with covid19 espr practical recommendations.pdf']","[0.312, 0.323, 0.367, 0.293]","[0.553, 0.533, 0.544, 0.538]","[0.639, 0.627, 0.629, 0.632]","[0.183, 0.18, 0.175, 0.187]","[0.203, 0.199, 0.183, 0.19]","[0.145, 0.151, 0.135, 0.147]","[0.737, 0.738, 0.735, 0.739]","[0.647, 0.647, 0.645, 0.647]","[0.627, 0.606, 0.618, 0.618]","[0.629, 0.626, 0.626, 0.629]","[0.793, 0.783, 0.785, 0.793]","[0.738, 0.705, 0.728, 0.714]","[0.598, 0.589, 0.582, 0.583]","[0.913, 0.913, 0.912, 0.914]","[0.83, 0.823, 0.818, 0.837]","[0.768, 0.756, 0.759, 0.765]","[0.794, 0.785, 0.787, 0.797]","[0.785, 0.775, 0.778, 0.782]",0.324,0.542,0.632,0.181,0.194,0.144,0.737,0.647,0.617,0.627,0.789,0.721,0.588,0.913,0.827,0.762,0.791,0.78
https://doi.org/10.1001/jamapediatrics.2020.1346,screening and severity of coronavirus disease 2019 covid19 in children in madrid spain,916_screening and severity of coronavirus disease 2019 covid19 in children in madrid spain.pdf,8,"['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444177/pdf']","['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings', 'American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1', 'Infection par le SARS-CoV-2 chez les femmes enceintes. Actualisation de l’état des connaissances et de la proposition de prise en charge. CNGOF', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'Antibody tests for identification of current and past infection with SARS‐CoV‐2', 'European Resuscitation Council COVID-19 guidelines executive summary', 'Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19\xa0– 3.\xa0Version - S1-Leitlinie']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444177/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['916_1_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf', '916_0_coronavirus disease 2019 covid19 treatment guidelines.pdf', '916_2_american college of rheumatology clinical guidance for pediatric patients with multisystem inflammatory syndrome in ch.pdf', '916_7_empfehlungen zur intensivmedizinischen therapie von patienten mit covid19\xa0– 3\xa0version  s1leitlinie.pdf', '916_3_infection par le sarscov2 chez les femmes enceintes actualisation de létat des connaissances et de la proposition de prise en charge cngof.pdf', '916_6_european resuscitation council covid19 guidelines executive summary.pdf', '916_5_antibody tests for identification of current and past infection with sars‐cov‐2.pdf', '916_4_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf']",8,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444177/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['916_1_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf', '916_0_coronavirus disease 2019 covid19 treatment guidelines.pdf', '916_2_american college of rheumatology clinical guidance for pediatric patients with multisystem inflammatory syndrome in ch.pdf', '916_7_empfehlungen zur intensivmedizinischen therapie von patienten mit covid19\xa0– 3\xa0version  s1leitlinie.pdf', '916_3_infection par le sarscov2 chez les femmes enceintes actualisation de létat des connaissances et de la proposition de prise en charge cngof.pdf', '916_6_european resuscitation council covid19 guidelines executive summary.pdf', '916_5_antibody tests for identification of current and past infection with sars‐cov‐2.pdf', '916_4_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf']","[0.336, 0.402, 0.333, 0.271, 0.32, 0.239, 0.255, 0.089]","[0.523, 0.505, 0.518, 0.443, 0.468, 0.524, 0.519, 0.515]","[0.598, 0.582, 0.601, 0.549, 0.557, 0.6, 0.591, 0.592]","[0.162, 0.142, 0.154, 0.129, 0.121, 0.14, 0.143, 0.147]","[0.177, 0.16, 0.167, 0.149, 0.152, 0.155, 0.152, 0.167]","[0.139, 0.125, 0.124, 0.108, 0.11, 0.116, 0.124, 0.134]","[0.734, 0.733, 0.735, 0.729, 0.731, 0.726, 0.73, 0.734]","[0.645, 0.641, 0.643, 0.643, 0.643, 0.629, 0.637, 0.641]","[0.577, 0.568, 0.58, 0.522, 0.522, 0.58, 0.575, 0.575]","[0.663, 0.655, 0.65, 0.622, 0.657, 0.627, 0.702, 0.652]","[0.778, 0.765, 0.775, 0.762, 0.759, 0.781, 0.762, 0.775]","[0.688, 0.665, 0.69, 0.626, 0.64, 0.698, 0.682, 0.69]","[0.601, 0.572, 0.598, 0.537, 0.546, 0.6, 0.577, 0.587]","[0.906, 0.891, 0.907, 0.882, 0.881, 0.911, 0.902, 0.909]","[0.832, 0.804, 0.833, 0.817, 0.812, 0.826, 0.824, 0.827]","[0.739, 0.729, 0.741, 0.681, 0.692, 0.748, 0.715, 0.729]","[0.777, 0.765, 0.775, 0.719, 0.744, 0.784, 0.766, 0.775]","[0.769, 0.762, 0.767, 0.698, 0.721, 0.772, 0.75, 0.767]",0.281,0.502,0.584,0.142,0.16,0.122,0.732,0.64,0.562,0.653,0.77,0.672,0.577,0.899,0.822,0.722,0.763,0.751
https://doi.org/10.1001/jamapediatrics.2020.1456,coronavirus disease 2019 covid19 and mental health for children and adolescents,917_coronavirus disease 2019 covid19 and mental health for children and adolescents.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483317/pdf', 'https://www.wested.org/resources/improving-coordination-and-access-to-ca-school-based-mental-health-services/', 'https://www.wested.org/resources/region-2-cc-addresses-education-personnel-shortages-brief/', 'https://nam.edu/patients-families-and-communities-covid-19-impact-assessment-lessons-learned-and-compelling-needs/', 'https://news.maryland.gov/msde/wp-content/uploads/sites/12/2020/10/News-Release-October-26-2020-Board-Meeting-Return-to-In-Person-Instruction.pdf', 'https://www.brookings.edu/blog/brown-center-chalkboard/2021/06/08/why-some-parents-are-sticking-with-remote-learning-even-as-schools-reopen/']","['Measures implemented in the school setting to contain the COVID‐19 pandemic', 'Measures implemented in the school setting to contain the COVID‐19 pandemic: a rapid scoping review', 'Guidelines for the prevention and management of children and adolescents with COVID-19', 'Improving Coordination and Access to Comprehensive School-Based Mental Health Services in California', 'Special Issues Brief: How Region 2 States Are Leveraging Innovative Strategies to Address Critical Shortages of Education Personnel', 'Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs', 'For Immediate Release :', 'Why some parents are sticking with remote learning—even as schools reopen']","['https://news.maryland.gov/msde/wp-content/uploads/sites/12/2020/10/News-Release-October-26-2020-Board-Meeting-Return-to-In-Person-Instruction.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483317/pdf']","['917_6_for immediate release .pdf', '917_1_measures implemented in the school setting to contain the covid‐19 pandemic a rapid scoping review.pdf', '917_0_measures implemented in the school setting to contain the covid‐19 pandemic.pdf', '917_2_guidelines for the prevention and management of children and adolescents with covid19.pdf']",4,50.0,"['https://news.maryland.gov/msde/wp-content/uploads/sites/12/2020/10/News-Release-October-26-2020-Board-Meeting-Return-to-In-Person-Instruction.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483317/pdf']","['917_6_for immediate release .pdf', '917_1_measures implemented in the school setting to contain the covid‐19 pandemic a rapid scoping review.pdf', '917_0_measures implemented in the school setting to contain the covid‐19 pandemic.pdf', '917_2_guidelines for the prevention and management of children and adolescents with covid19.pdf']","[0.22, 0.258, 0.219, 0.313]","[0.586, 0.534, 0.518, 0.476]","[0.657, 0.629, 0.609, 0.574]","[0.226, 0.175, 0.167, 0.136]","[0.232, 0.184, 0.173, 0.143]","[0.191, 0.155, 0.147, 0.128]","[0.737, 0.732, 0.731, 0.732]","[0.647, 0.641, 0.637, 0.636]","[0.679, 0.616, 0.598, 0.552]","[0.677, 0.681, 0.681, 0.657]","[0.837, 0.802, 0.789, 0.769]","[0.785, 0.726, 0.711, 0.689]","[0.647, 0.593, 0.593, 0.572]","[0.928, 0.925, 0.908, 0.892]","[0.865, 0.847, 0.823, 0.779]","[0.802, 0.754, 0.732, 0.702]","[0.831, 0.791, 0.776, 0.748]","[0.818, 0.783, 0.758, 0.726]",0.253,0.528,0.617,0.176,0.183,0.155,0.733,0.64,0.611,0.674,0.799,0.728,0.601,0.913,0.829,0.748,0.786,0.771
https://doi.org/10.1001/jamapediatrics.2020.1619,mental health status among children in home confinement during the coronavirus disease 2019 outbreak in hubei province china,918_mental health status among children in home confinement during the coronavirus disease 2019 outbreak in hubei province china.pdf,7,"['https://nam.edu/patients-families-and-communities-covid-19-impact-assessment-lessons-learned-and-compelling-needs/', 'https://www.americanprogress.org/issues/disability/reports/2020/09/10/490221/mental-health-care-severely-inequitable-came-coronavirus-crisis/', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates-06032020.pdf', 'https://tea.texas.gov/sites/default/files/HB-906-Mental-Health-Task-Force-Year-1-Report.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://www.nber.org/papers/w28930', 'https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf']","['Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs', 'Mental Health Care Was Severely Inequitable, Then Came the Coronavirus Crisis - Center for American Progress', 'COVID-19 Updates', 'Mental Health Task Force Report 2020', '173ÿ67172', 'The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality', 'California State Evaluation and Learning Support (Cal SEALS) for SB 82 Triage Grants']","['https://tea.texas.gov/sites/default/files/HB-906-Mental-Health-Task-Force-Year-1-Report.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates-06032020.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf']","['918_3_mental health task force report 2020.pdf', '918_2_covid19 updates.pdf', '918_4_173ÿ67172.pdf', '918_6_california state evaluation and learning support cal seals for sb 82 triage grants.pdf']",4,57.14,"['https://tea.texas.gov/sites/default/files/HB-906-Mental-Health-Task-Force-Year-1-Report.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates-06032020.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf']","['918_3_mental health task force report 2020.pdf', '918_2_covid19 updates.pdf', '918_4_173ÿ67172.pdf', '918_6_california state evaluation and learning support cal seals for sb 82 triage grants.pdf']","[0.211, 0.23, 0.298, 0.075]","[0.426, 0.438, 0.467, 0.437]","[0.533, 0.551, 0.54, 0.548]","[0.116, 0.111, 0.12, 0.099]","[0.132, 0.109, 0.125, 0.117]","[0.103, 0.09, 0.159, 0.09]","[0.719, 0.723, 0.755, 0.712]","[0.616, 0.626, 0.662, 0.61]","[0.488, 0.5, 0.515, 0.492]","[0.656, 0.664, 0.76, 0.673]","[0.723, 0.729, 0.678, 0.719]","[0.663, 0.661, 0.61, 0.662]","[0.568, 0.556, 0.572, 0.566]","[0.858, 0.858, 0.858, 0.857]","[0.756, 0.753, 0.693, 0.757]","[0.638, 0.627, 0.653, 0.638]","[0.732, 0.727, 0.683, 0.727]","[0.657, 0.66, 0.669, 0.656]",0.203,0.442,0.543,0.111,0.121,0.11,0.727,0.628,0.499,0.688,0.712,0.649,0.566,0.858,0.74,0.639,0.717,0.661
https://doi.org/10.1001/jamapediatrics.2020.3345,data collection practices of mobile applications played by preschoolaged children,920_data collection practices of mobile applications played by preschoolaged children.pdf,3,"['https://cppa.ca.gov/regulations/pdf/preliminary_rulemaking_comments_4.pdf', 'https://www.congress.gov/event/117th-congress/house-event/111298', 'https://www.congress.gov/event/117th-congress/house-event/114134']","['Preliminary Rulemaking Written Comments - 09/22/2021-11/08/2021 - Part 4', '“Kids Online During COVID: Child Safety in an Increasingly Digital Age”', '""Enhancing Public Health: Legislation to Protect Children and Families""']",['https://cppa.ca.gov/regulations/pdf/preliminary_rulemaking_comments_4.pdf'],['920_0_preliminary rulemaking written comments  0922202111082021  part 4.pdf'],1,33.33,['https://cppa.ca.gov/regulations/pdf/preliminary_rulemaking_comments_4.pdf'],['920_0_preliminary rulemaking written comments  0922202111082021  part 4.pdf'],[0.253],[0.507],[0.61],[0.119],[0.125],[0.117],[0.72],[0.625],[0.579],[0.683],[0.786],[0.697],[0.609],[0.91],[0.826],[0.752],[0.785],[0.774],0.253,0.507,0.61,0.119,0.125,0.117,0.72,0.625,0.579,0.683,0.786,0.697,0.609,0.91,0.826,0.752,0.785,0.774
https://doi.org/10.1001/jamapediatrics.2020.5052,assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the united states,921_assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the united states.pdf,6,"['https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://stacks.cdc.gov/view/cdc/103403', 'https://stacks.cdc.gov/view/cdc/103106', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf', 'https://www.asecho.org/wp-content/uploads/2022/10/PIIS0894731721000274.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'COVID-19 science update ; Edition 2021-02-26 (78)', 'COVID-19 science update ; Edition 2021-02-19 (77)', 'Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19', 'ASE Statement on Adapting Pediatric, Fetal, and Congenital Heart Disease Echocardiographic Services to the Evolving COVID-19 Pandemic']","['https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.asecho.org/wp-content/uploads/2022/10/PIIS0894731721000274.pdf']","['921_0_master question list for covid19 caused by sarscov2.pdf', '921_4_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf', '921_1_master question list for covid19 caused by sarscov2.pdf', '921_5_ase statement on adapting pediatric fetal and congenital heart disease echocardiographic services to the evolving covid19 pandemic.pdf']",4,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.asecho.org/wp-content/uploads/2022/10/PIIS0894731721000274.pdf']","['921_4_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf', '921_1_master question list for covid19 caused by sarscov2.pdf', '921_5_ase statement on adapting pediatric fetal and congenital heart disease echocardiographic services to the evolving covid19 pandemic.pdf']","[0.413, 0.458, 0.439]","[0.513, 0.502, 0.511]","[0.592, 0.594, 0.598]","[0.171, 0.162, 0.179]","[0.162, 0.15, 0.171]","[0.138, 0.125, 0.131]","[0.741, 0.743, 0.742]","[0.647, 0.653, 0.652]","[0.568, 0.564, 0.574]","[0.718, 0.66, 0.639]","[0.769, 0.785, 0.79]","[0.679, 0.684, 0.692]","[0.591, 0.606, 0.604]","[0.91, 0.91, 0.91]","[0.798, 0.798, 0.801]","[0.726, 0.744, 0.75]","[0.769, 0.781, 0.785]","[0.753, 0.769, 0.772]",0.437,0.509,0.595,0.171,0.161,0.131,0.742,0.651,0.569,0.672,0.781,0.685,0.6,0.91,0.799,0.74,0.778,0.765
https://doi.org/10.1001/jamapsychiatry.2013.1176,performance of evidencebased youth psychotherapies compared with usual clinical care,932_performance of evidencebased youth psychotherapies compared with usual clinical care.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155022/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513116/pdf', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/Mental%20Health/QMP.pdf']","['Clinician Use of Standardized Assessments Following a Common Elements Psychotherapy Training and Consultation Program', 'Client feedback in psychological therapy for children and adolescents with mental health problems', 'Quality Management Plan Wraparound with Intensive Services']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513116/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155022/pdf', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/Mental%20Health/QMP.pdf']","['932_1_client feedback in psychological therapy for children and adolescents with mental health problems.pdf', '932_0_clinician use of standardized assessments following a common elements psychotherapy training and consultation program.pdf', '932_2_quality management plan wraparound with intensive services.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513116/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155022/pdf', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/Mental%20Health/QMP.pdf']","['932_1_client feedback in psychological therapy for children and adolescents with mental health problems.pdf', '932_0_clinician use of standardized assessments following a common elements psychotherapy training and consultation program.pdf', '932_2_quality management plan wraparound with intensive services.pdf']","[0.333, 0.339, 0.238]","[0.517, 0.523, 0.521]","[0.598, 0.608, 0.603]","[0.173, 0.171, 0.145]","[0.183, 0.184, 0.167]","[0.152, 0.15, 0.132]","[0.735, 0.735, 0.725]","[0.643, 0.645, 0.629]","[0.578, 0.585, 0.586]","[0.722, 0.711, 0.692]","[0.771, 0.784, 0.784]","[0.698, 0.717, 0.736]","[0.58, 0.596, 0.611]","[0.905, 0.916, 0.91]","[0.802, 0.807, 0.826]","[0.713, 0.734, 0.746]","[0.775, 0.785, 0.798]","[0.744, 0.758, 0.763]",0.303,0.52,0.603,0.163,0.178,0.145,0.732,0.639,0.583,0.708,0.78,0.717,0.596,0.91,0.812,0.731,0.786,0.755
https://doi.org/10.1001/jamapsychiatry.2013.2053,antipsychotics and the risk of type 2 diabetes mellitus in children and youth,933_antipsychotics and the risk of type 2 diabetes mellitus in children and youth.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521365/pdf', 'https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf', 'https://effectivehealthcare.ahrq.gov/products/asd-interventions/research-2017', 'https://effectivehealthcare.ahrq.gov/products/asd-medical/research-2017']","['Physical Health and Drug Safety in Individuals with Schizophrenia', 'Aripiprazole for autism spectrum disorders (ASD)', 'ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents', 'Psychotropic Medication Utilization Parameters for Children and Youth', 'Interventions Targeting Sensory Challenges in Children with Autism Spectrum Disorder - An Update', 'Medical Therapies for Children with Autism Spectrum Disorder — An Update']","['https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521365/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120220/pdf']","['933_3_psychotropic medication utilization parameters for children and youth.pdf', '933_0_physical health and drug safety in individuals with schizophrenia.pdf', '933_2_ispad clinical practice consensus guidelines 2018 definition epidemiology and classification of diabetes in children and adolescents.pdf', '933_1_aripiprazole for autism spectrum disorders asd.pdf']",4,66.67,"['https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521365/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120220/pdf']","['933_3_psychotropic medication utilization parameters for children and youth.pdf', '933_0_physical health and drug safety in individuals with schizophrenia.pdf', '933_2_ispad clinical practice consensus guidelines 2018 definition epidemiology and classification of diabetes in children and adolescents.pdf', '933_1_aripiprazole for autism spectrum disorders asd.pdf']","[0.473, 0.303, 0.432, 0.309]","[0.543, 0.533, 0.492, 0.519]","[0.631, 0.619, 0.604, 0.613]","[0.199, 0.198, 0.176, 0.183]","[0.209, 0.214, 0.18, 0.183]","[0.177, 0.178, 0.145, 0.151]","[0.748, 0.746, 0.742, 0.738]","[0.653, 0.653, 0.65, 0.643]","[0.611, 0.601, 0.579, 0.588]","[0.679, 0.697, 0.686, 0.697]","[0.809, 0.805, 0.775, 0.785]","[0.725, 0.716, 0.664, 0.701]","[0.605, 0.607, 0.584, 0.584]","[0.928, 0.925, 0.918, 0.911]","[0.82, 0.813, 0.799, 0.805]","[0.768, 0.763, 0.736, 0.731]","[0.806, 0.802, 0.768, 0.78]","[0.791, 0.785, 0.761, 0.759]",0.379,0.522,0.617,0.189,0.197,0.163,0.743,0.65,0.595,0.69,0.794,0.702,0.595,0.921,0.809,0.75,0.789,0.774
https://doi.org/10.1001/jamapsychiatry.2013.295,prevention of depression in atrisk adolescents,936_prevention of depression in atrisk adolescents.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'http://vcoy.virginia.gov/documents/collection/015%20Depressive%20disorders%20final3.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf']","['Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents', 'DEPRESSIVE DISORDERS', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs']","['http://vcoy.virginia.gov/documents/collection/015%20Depressive%20disorders%20final3.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf']","['936_1_depressive disorders.pdf', '936_0_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf', '936_2_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf']",3,100.0,"['http://vcoy.virginia.gov/documents/collection/015%20Depressive%20disorders%20final3.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf']","['936_1_depressive disorders.pdf', '936_0_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf', '936_2_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf']","[0.467, 0.406, 0.383]","[0.508, 0.508, 0.508]","[0.602, 0.588, 0.597]","[0.193, 0.176, 0.166]","[0.21, 0.183, 0.178]","[0.185, 0.158, 0.152]","[0.739, 0.739, 0.734]","[0.647, 0.647, 0.639]","[0.573, 0.57, 0.574]","[0.701, 0.72, 0.685]","[0.783, 0.764, 0.781]","[0.707, 0.676, 0.71]","[0.604, 0.579, 0.604]","[0.912, 0.902, 0.911]","[0.806, 0.798, 0.803]","[0.737, 0.702, 0.737]","[0.789, 0.765, 0.789]","[0.763, 0.739, 0.761]",0.419,0.508,0.596,0.178,0.19,0.165,0.737,0.644,0.572,0.702,0.776,0.698,0.596,0.908,0.802,0.725,0.781,0.754
https://doi.org/10.1001/jamapsychiatry.2013.504,adult psychiatric outcomes of bullying and being bullied by peers in childhood and adolescence,937_adult psychiatric outcomes of bullying and being bullied by peers in childhood and adolescence.pdf,6,"['https://purl.fdlp.gov/GPO/gpo137529', 'https://purl.fdlp.gov/GPO/gpo122468', 'https://schoolsafety.dbs.idaho.gov/wp-content/uploads/sites/106/2020/03/bullying-suicide-translation-final-a.pdf', 'https://purl.fdlp.gov/GPO/gpo88107', 'https://stacks.cdc.gov/view/cdc/34163', 'https://stacks.cdc.gov/view/cdc/55995']","['Bullying prevention in Indian country.', 'Bullying (United States. Office of Juvenile Justice and Delinquency Prevention)', 'The Relationship Between Bullying and Suicide: What We Know and What it Means for Schools', 'The relationship between bullying and suicide :\xa0what we know and what it means for schools.', 'The Relationship between bullying and suicide : what we know ad what it means for schools', 'Youth Risk Behavior Survey : data summary & trends report 2007-2017']","['https://purl.fdlp.gov/GPO/gpo137529', 'https://purl.fdlp.gov/GPO/gpo122468', 'https://purl.fdlp.gov/GPO/gpo88107']","['937_0_bullying prevention in indian country.pdf', '937_1_bullying united states office of juvenile justice and delinquency prevention.pdf', '937_3_the relationship between bullying and suicide \xa0what we know and what it means for schools.pdf']",3,50.0,"['https://purl.fdlp.gov/GPO/gpo137529', 'https://purl.fdlp.gov/GPO/gpo122468', 'https://purl.fdlp.gov/GPO/gpo88107']","['937_0_bullying prevention in indian country.pdf', '937_1_bullying united states office of juvenile justice and delinquency prevention.pdf', '937_3_the relationship between bullying and suicide \xa0what we know and what it means for schools.pdf']","[0.245, 0.379, 0.271]","[0.516, 0.529, 0.521]","[0.61, 0.615, 0.613]","[0.173, 0.19, 0.193]","[0.207, 0.222, 0.227]","[0.172, 0.179, 0.187]","[0.735, 0.736, 0.741]","[0.642, 0.645, 0.651]","[0.58, 0.595, 0.605]","[0.684, 0.704, 0.699]","[0.791, 0.801, 0.799]","[0.734, 0.736, 0.734]","[0.6, 0.623, 0.593]","[0.911, 0.917, 0.915]","[0.82, 0.817, 0.825]","[0.76, 0.761, 0.765]","[0.794, 0.799, 0.801]","[0.779, 0.784, 0.783]",0.298,0.522,0.613,0.185,0.219,0.179,0.737,0.646,0.593,0.696,0.797,0.735,0.605,0.914,0.821,0.762,0.798,0.782
https://doi.org/10.1001/jamapsychiatry.2013.651,effectiveness of a selective personalitytargeted prevention program for adolescent alcohol use and misuse,938_effectiveness of a selective personalitytargeted prevention program for adolescent alcohol use and misuse.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119449/pdf', 'https://www.acf.hhs.gov/opre/report/self-regulation-and-toxic-stress-report-3-comprehensive-review-self-regulation', 'https://effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research', 'https://purl.fdlp.gov/GPO/gpo75951']","['Brief school‐based interventions and behavioural outcomes for substance‐using adolescents', 'Self-Regulation and Toxic Stress Report 3: A Comprehensive Review of Self-Regulation Interventions from Birth Through Young Adulthood', 'Interventions for Substance Use Disorders in Adolescents: A Systematic Review', 'Facing addiction in America :\xa0the Surgeon General’s report on alcohol, drugs and heath.']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119449/pdf', 'https://purl.fdlp.gov/GPO/gpo75951']","['938_0_brief school‐based interventions and behavioural outcomes for substance‐using adolescents.pdf', '938_3_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119449/pdf', 'https://purl.fdlp.gov/GPO/gpo75951']","['938_0_brief school‐based interventions and behavioural outcomes for substance‐using adolescents.pdf', '938_3_facing addiction in america \xa0the surgeon generals report on alcohol drugs and heath.pdf']","[0.437, 0.377]","[0.503, 0.5]","[0.581, 0.588]","[0.165, 0.158]","[0.172, 0.177]","[0.146, 0.146]","[0.736, 0.732]","[0.643, 0.64]","[0.559, 0.559]","[0.713, 0.681]","[0.759, 0.775]","[0.673, 0.694]","[0.576, 0.6]","[0.904, 0.912]","[0.779, 0.787]","[0.707, 0.736]","[0.752, 0.77]","[0.735, 0.757]",0.407,0.502,0.585,0.162,0.174,0.146,0.734,0.641,0.559,0.697,0.767,0.683,0.588,0.908,0.783,0.722,0.761,0.746
https://doi.org/10.1001/jamapsychiatry.2014.3008,prediction of autism by translation and immuneinflammation coexpressed genes in toddlers from pediatric community practices,939_prediction of autism by translation and immuneinflammation coexpressed genes in toddlers from pediatric community practices.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102276/pdf'],"['Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102276/pdf'],['939_0_phenotyping etiological factors and biomarkers toward precision medicine in autism spectrum disorders.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102276/pdf'],['939_0_phenotyping etiological factors and biomarkers toward precision medicine in autism spectrum disorders.pdf'],[0.464],[0.521],[0.611],[0.166],[0.177],[0.138],[0.741],[0.656],[0.592],[0.701],[0.789],[0.73],[0.601],[0.912],[0.81],[0.748],[0.778],[0.771],0.464,0.521,0.611,0.166,0.177,0.138,0.741,0.656,0.592,0.701,0.789,0.73,0.601,0.912,0.81,0.748,0.778,0.771
https://doi.org/10.1001/jamapsychiatry.2015.1131,early cannabis use polygenic risk score for schizophrenia and brain maturation in adolescence,943_early cannabis use polygenic risk score for schizophrenia and brain maturation in adolescence.pdf,2,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1g95HajlMV5u85Z8C5ac07AGxmofLyP8i.pdf', 'https://legislature.idaho.gov/wp-content/uploads/budget/committee/mill/2016/2.Applications%20and%20Forms/02.Member%20Packet%20Day%202.pdf']","['The Problem with the current high Potency thc marijuana', 'Agenda Revised']","['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1g95HajlMV5u85Z8C5ac07AGxmofLyP8i.pdf', 'https://legislature.idaho.gov/wp-content/uploads/budget/committee/mill/2016/2.Applications%20and%20Forms/02.Member%20Packet%20Day%202.pdf']","['943_0_the problem with the current high potency thc marijuana.pdf', '943_1_agenda revised.pdf']",2,100.0,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1g95HajlMV5u85Z8C5ac07AGxmofLyP8i.pdf', 'https://legislature.idaho.gov/wp-content/uploads/budget/committee/mill/2016/2.Applications%20and%20Forms/02.Member%20Packet%20Day%202.pdf']","['943_0_the problem with the current high potency thc marijuana.pdf', '943_1_agenda revised.pdf']","[0.455, 0.127]","[0.503, 0.477]","[0.601, 0.568]","[0.168, 0.086]","[0.187, 0.095]","[0.155, 0.077]","[0.735, 0.716]","[0.647, 0.618]","[0.573, 0.557]","[0.675, 0.647]","[0.788, 0.773]","[0.714, 0.704]","[0.607, 0.595]","[0.912, 0.911]","[0.8, 0.799]","[0.742, 0.728]","[0.775, 0.764]","[0.766, 0.751]",0.291,0.49,0.585,0.127,0.141,0.116,0.726,0.633,0.565,0.661,0.78,0.709,0.601,0.911,0.8,0.735,0.77,0.758
https://doi.org/10.1001/jamapsychiatry.2015.2094,incidence of suicide among persons who had a parent who died during their childhood,944_incidence of suicide among persons who had a parent who died during their childhood.pdf,1,['https://www.omh.ny.gov/omhweb/resources/publications/suicde-prevention-plan.pdf'],['1700 Too Many - NY Suicide Prevention Plan'],['https://www.omh.ny.gov/omhweb/resources/publications/suicde-prevention-plan.pdf'],['944_0_1700 too many  ny suicide prevention plan.pdf'],1,100.0,['https://www.omh.ny.gov/omhweb/resources/publications/suicde-prevention-plan.pdf'],['944_0_1700 too many  ny suicide prevention plan.pdf'],[0.409],[0.501],[0.587],[0.153],[0.178],[0.152],[0.731],[0.633],[0.576],[0.694],[0.788],[0.7],[0.603],[0.901],[0.827],[0.74],[0.777],[0.769],0.409,0.501,0.587,0.153,0.178,0.152,0.731,0.633,0.576,0.694,0.788,0.7,0.603,0.901,0.827,0.74,0.777,0.769
https://doi.org/10.1001/jamapsychiatry.2015.2146,effects of group psychotherapy individual counseling methylphenidate and placebo in the treatment of adult attentiondeficithyperactivity disorder,945_effects of group psychotherapy individual counseling methylphenidate and placebo in the treatment of adult attentiondeficithyperactivity disorder.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494390/pdf'],['Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494390/pdf'],['945_0_cognitive‐behavioural interventions for attention deficit hyperactivity disorder adhd in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494390/pdf'],['945_0_cognitive‐behavioural interventions for attention deficit hyperactivity disorder adhd in adults.pdf'],[0.394],[0.473],[0.563],[0.156],[0.164],[0.136],[0.736],[0.642],[0.544],[0.736],[0.738],[0.664],[0.561],[0.865],[0.766],[0.653],[0.732],[0.679],0.394,0.473,0.563,0.156,0.164,0.136,0.736,0.642,0.544,0.736,0.738,0.664,0.561,0.865,0.766,0.653,0.732,0.679
https://doi.org/10.1001/jamapsychiatry.2016.0465,evaluation of the persistence remission and emergence of attentiondeficithyperactivity disorder in young adulthood,947_evaluation of the persistence remission and emergence of attentiondeficithyperactivity disorder in young adulthood.pdf,2,"['https://www.rand.org/pubs/research_reports/RR4431.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092481/pdf']","[""An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies"", 'Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092481/pdf'],['947_1_immediate‐release methylphenidate for attention deficit hyperactivity disorder adhd in adults.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092481/pdf'],['947_1_immediate‐release methylphenidate for attention deficit hyperactivity disorder adhd in adults.pdf'],[0.304],[0.5],[0.587],[0.155],[0.16],[0.134],[0.732],[0.635],[0.57],[0.708],[0.77],[0.69],[0.575],[0.91],[0.793],[0.726],[0.764],[0.754],0.304,0.5,0.587,0.155,0.16,0.134,0.732,0.635,0.57,0.708,0.77,0.69,0.575,0.91,0.793,0.726,0.764,0.754
https://doi.org/10.1001/jamapsychiatry.2016.2729,effect of group vs individual cognitive processing therapy in activeduty military seeking treatment for posttraumatic stress disorder,948_effect of group vs individual cognitive processing therapy in activeduty military seeking treatment for posttraumatic stress disorder.pdf,8,"['https://www.rand.org/pubs/research_reports/RR4191.html', 'http://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/PTSD-MTG2021.pdf', 'https://effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update/research-2018', 'https://effectivehealthcare.ahrq.gov/products/ptsd-pharm-treatment/research', 'https://effectivehealthcare.ahrq.gov/products/ptsd-repository-expanded/research', 'https://purl.fdlp.gov/GPO/gpo115018', 'https://www.congress.gov/event/115th-congress/senate-event/LC60401/text', 'https://purl.fdlp.gov/GPO/gpo111368']","['Predictors of PTSD Treatment Retention and Response', 'Post-Traumatic Stess Disorder and Acute Stress Disorder', 'Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update', 'Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder', 'Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder', 'VA/DoD clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.', 'S.Hrg. 115-336 — #BETHERE: WHAT MORE CAN BE DONE TO PREVENT SUICIDE?', '#Bethere :\xa0what more can be done to prevent suicide? : hearing before the Committee on Veterans’ Affairs, United States Senate, One Hundred Fifteenth Congress, first session, September 27, 2017.']","['https://purl.fdlp.gov/GPO/gpo115018', 'https://purl.fdlp.gov/GPO/gpo111368', 'http://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/PTSD-MTG2021.pdf']","['948_5_vadod clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.pdf', '948_7_bethere \xa0what more can be done to prevent suicide  hearing before the committee on veterans affairs united states senate one hundred fifteenth congress first session september 27 2017.pdf', '948_1_posttraumatic stess disorder and acute stress disorder.pdf']",3,37.5,"['https://purl.fdlp.gov/GPO/gpo115018', 'https://purl.fdlp.gov/GPO/gpo111368', 'http://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/PTSD-MTG2021.pdf']","['948_5_vadod clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder.pdf', '948_7_bethere \xa0what more can be done to prevent suicide  hearing before the committee on veterans affairs united states senate one hundred fifteenth congress first session september 27 2017.pdf', '948_1_posttraumatic stess disorder and acute stress disorder.pdf']","[0.622, 0.485, 0.21]","[0.521, 0.482, 0.5]","[0.609, 0.571, 0.585]","[0.185, 0.113, 0.175]","[0.197, 0.134, 0.176]","[0.16, 0.108, 0.147]","[0.738, 0.721, 0.739]","[0.651, 0.624, 0.652]","[0.589, 0.552, 0.563]","[0.7, 0.692, 0.714]","[0.789, 0.764, 0.773]","[0.708, 0.681, 0.683]","[0.602, 0.597, 0.591]","[0.917, 0.904, 0.912]","[0.816, 0.81, 0.786]","[0.748, 0.71, 0.725]","[0.782, 0.76, 0.762]","[0.773, 0.735, 0.751]",0.439,0.501,0.588,0.158,0.169,0.138,0.733,0.642,0.568,0.702,0.775,0.691,0.597,0.911,0.804,0.728,0.768,0.753
https://doi.org/10.1001/jamapsychiatry.2016.3478,women’s mental health and wellbeing 5 years after receiving or being denied an abortion,949_women’s mental health and wellbeing 5 years after receiving or being denied an abortion.pdf,6,"['https://www.congress.gov/event/116th-congress/house-event/110504', 'https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://data.nber.org/papers/w26662', 'https://www.hrw.org/report/2019/06/18/i-felt-world-was-falling-down-me/adolescent-girls-sexual-and-reproductive-health', 'https://www.aclu.org/legal-document/planned-parenthood-south-atlantic-et-al-v-moore-et-al-complaint', 'https://www.aclu.org/legal-document/emw-womens-surgical-center-v-meier-amicus-brief-apha']","['""Protecting Women\'s Access to Reproductive Health Care""', 'THE STATE OF CALIFORNIA', 'The Economic Consequences of Being Denied an Abortion', 'Adolescent Girlsâ\x80\x99 Sexual and Reproductive Health and Rights in the', 'Planned Parenthood South Atlantic et al v. Moore et al Complaint', 'EMW Women’s Surgical Center v. Meier: Amicus Brief for APHA']",['https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf'],['949_1_the state of california.pdf'],1,16.67,['https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf'],['949_1_the state of california.pdf'],[0.191],[0.458],[0.559],[0.099],[0.116],[0.117],[0.729],[0.631],[0.519],[0.711],[0.717],[0.66],[0.588],[0.851],[0.736],[0.628],[0.715],[0.651],0.191,0.458,0.559,0.099,0.116,0.117,0.729,0.631,0.519,0.711,0.717,0.66,0.588,0.851,0.736,0.628,0.715,0.651
https://doi.org/10.1001/jamapsychiatry.2017.0660,trajectories of depressive symptoms before diagnosis of dementia,950_trajectories of depressive symptoms before diagnosis of dementia.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574768/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995075/pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000367?download=true']","['Multi‐domain interventions for the prevention of dementia and cognitive decline', 'A Primary Care Agenda for Brain Health - A Scientific Statement From the American Heart Association', 'A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574768/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995075/pdf']","['950_0_multi‐domain interventions for the prevention of dementia and cognitive decline.pdf', '950_1_a primary care agenda for brain health  a scientific statement from the american heart association.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574768/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995075/pdf']","['950_0_multi‐domain interventions for the prevention of dementia and cognitive decline.pdf', '950_1_a primary care agenda for brain health  a scientific statement from the american heart association.pdf']","[0.301, 0.295]","[0.501, 0.479]","[0.588, 0.58]","[0.165, 0.158]","[0.162, 0.159]","[0.134, 0.128]","[0.735, 0.738]","[0.643, 0.648]","[0.568, 0.562]","[0.716, 0.709]","[0.768, 0.764]","[0.671, 0.663]","[0.566, 0.565]","[0.904, 0.906]","[0.808, 0.804]","[0.72, 0.722]","[0.76, 0.757]","[0.748, 0.753]",0.298,0.49,0.584,0.162,0.161,0.131,0.736,0.645,0.565,0.712,0.766,0.667,0.565,0.905,0.806,0.721,0.758,0.75
https://doi.org/10.1001/jamapsychiatry.2018.0335,association of cannabis with cognitive functioning in adolescents and young adults,951_association of cannabis with cognitive functioning in adolescents and young adults.pdf,6,"['https://www.rand.org/pubs/research_reports/RR4431.html', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf']","[""An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies"", 'Report to the Governor and the General Assembly of Virginia', 'Report to the Governor and the General Assembly of Virginia', 'Appendixes', 'Assessment Of The Potential Impact Of Regulated Marijuana In New York State', 'Executive Summary']","['http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf']","['951_3_appendixes.pdf', '951_4_assessment of the potential impact of regulated marijuana in new york state.pdf', '951_1_report to the governor and the general assembly of virginia.pdf', '951_2_report to the governor and the general assembly of virginia.pdf', '951_5_executive summary.pdf']",5,83.33,"['http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf']","['951_3_appendixes.pdf', '951_4_assessment of the potential impact of regulated marijuana in new york state.pdf', '951_1_report to the governor and the general assembly of virginia.pdf', '951_2_report to the governor and the general assembly of virginia.pdf', '951_5_executive summary.pdf']","[0.154, 0.156, 0.21, 0.342, 0.235]","[0.482, 0.494, 0.488, 0.492, 0.493]","[0.578, 0.591, 0.581, 0.584, 0.592]","[0.118, 0.161, 0.114, 0.115, 0.161]","[0.124, 0.171, 0.118, 0.119, 0.176]","[0.108, 0.146, 0.103, 0.104, 0.15]","[0.719, 0.731, 0.715, 0.715, 0.731]","[0.625, 0.64, 0.62, 0.62, 0.642]","[0.562, 0.564, 0.569, 0.572, 0.566]","[0.633, 0.659, 0.615, 0.614, 0.649]","[0.784, 0.778, 0.788, 0.789, 0.785]","[0.713, 0.71, 0.725, 0.728, 0.721]","[0.587, 0.594, 0.593, 0.595, 0.597]","[0.911, 0.908, 0.914, 0.915, 0.912]","[0.806, 0.794, 0.807, 0.808, 0.799]","[0.73, 0.727, 0.737, 0.739, 0.734]","[0.776, 0.774, 0.781, 0.783, 0.779]","[0.753, 0.749, 0.756, 0.758, 0.756]",0.219,0.49,0.585,0.134,0.142,0.122,0.722,0.629,0.567,0.634,0.785,0.719,0.593,0.912,0.803,0.733,0.779,0.754
https://doi.org/10.1001/jamapsychiatry.2018.4358,association of the youthnominated support team intervention for suicidal adolescents with 11 to 14year mortality outcomes,952_association of the youthnominated support team intervention for suicidal adolescents with 11 to 14year mortality outcomes.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['952_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['952_0_interventions for self‐harm in children and adolescents.pdf'],[0.489],[0.51],[0.589],[0.17],[0.179],[0.147],[0.735],[0.641],[0.575],[0.704],[0.774],[0.686],[0.578],[0.913],[0.804],[0.723],[0.771],[0.755],0.489,0.51,0.589,0.17,0.179,0.147,0.735,0.641,0.575,0.704,0.774,0.686,0.578,0.913,0.804,0.723,0.771,0.755
https://doi.org/10.1001/jamapsychiatry.2018.4500,association of cannabis use in adolescence and risk of depression anxiety and suicidality in young adulthood,953_association of cannabis use in adolescence and risk of depression anxiety and suicidality in young adulthood.pdf,2,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1fOpawhzqjMPW_Y8mEMyaqLSfh7rYh_2R.pdf']","['Oppose HB0032 Cannabis - Legalization and Regulation (Inclusion, Restoration and Rehabilitation Act of 2021)', 'INFORMATIONAL TESTIMONY Bill No .:']","['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1fOpawhzqjMPW_Y8mEMyaqLSfh7rYh_2R.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf']","['953_1_informational testimony bill no .pdf', '953_0_oppose hb0032 cannabis  legalization and regulation inclusion restoration and rehabilitation act of 2021.pdf']",2,100.0,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1fOpawhzqjMPW_Y8mEMyaqLSfh7rYh_2R.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf']","['953_1_informational testimony bill no .pdf', '953_0_oppose hb0032 cannabis  legalization and regulation inclusion restoration and rehabilitation act of 2021.pdf']","[0.558, 0.656]","[0.501, 0.502]","[0.597, 0.6]","[0.198, 0.177]","[0.222, 0.198]","[0.188, 0.165]","[0.752, 0.738]","[0.667, 0.65]","[0.563, 0.566]","[0.7, 0.687]","[0.779, 0.786]","[0.688, 0.71]","[0.589, 0.596]","[0.899, 0.908]","[0.793, 0.802]","[0.723, 0.731]","[0.768, 0.778]","[0.748, 0.755]",0.607,0.502,0.599,0.188,0.21,0.176,0.745,0.659,0.565,0.694,0.782,0.699,0.593,0.903,0.798,0.727,0.773,0.752
https://doi.org/10.1001/jamasurg.2014.514,rouxeny gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes,958_rouxeny gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes.pdf,6,"['https://www.hca.wa.gov/assets/program/bariatric_final_rpt_040315[1].pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214495/pdf', 'https://www.asge.org/docs/default-source/education/practice_guidelines/doc-position_statement_endoscopic_bariatric_therapies.pdf?sfvrsn=63c94951_6', 'https://watermark.silverchair.com/dc22s008.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAr8wggK7BgkqhkiG9w0BBwagggKsMIICqAIBADCCAqEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMKBwq4m_2ZbQdyeY_AgEQgIICcg_f-diMPUluztdcWsvfR86Wwzm5E7yTOUqyjxZNbBxs6EaUSmHhjKPzKwORaUYgqp29dAOBJn7DmDCsu2MOURY3OBrC4t8CygK7R1RCpaRBPEzllz7Spur7WtvW1HvmURQR4i4UYwF5zv-R3LHPFz8iIMC2_8jTCSAcI6cS2EY1fonRj_D-p-W3qgwRALXvPnBjYEvBOMnLAzyU9Q2L5rgFZClWM3NjFn-0UdNmVIOfe4ki8gaAEZP7KLdF-B4B7Ze8tjbPoQQSRF9k-BBWCnVDQlLkCzqokg20YEhP5is8UWMPzS1C8A4Qq92XJqlgj-Rds5L0WdtW_5ZCSm_hD5hnvKoSKmyvr-BmQmvbuvMVOzChm6MlaXKkDQA4xJzGAUr3VkRTAx0RrOqtny5l4f9Qb8t2UuFw_oNLxrnyqKTjyKfFU-WfNrsD7OAXvhUY2o0hAXkPnHbmTv0KP58MPw5ucspICz3NWIofBxNUajMIKoxjn2-qn1ZChTjl0Pj2srXaDKeUFRvQPYd0sFL19Dr55RRP_uggMABPwuWqAReBwDUzcoGGuVTP6_cfsu90nTJCJ8XzhUs8qFJEv_61yrDnbIvj4AckgvP_0zpOD25BlW6ufBhM97S9IHKjQs3cxU2fmIHmH7qKGcxGE4kbQP5m3CVc3gck7AJ7ggg8iE2BTSCSf0tCuCGPvK30YpxBnodkWr9Z6nmmWrqRz-3mdNM9J65IZ92JBg8oWzq5qkrs34zd_Jnd0tHlkzlNJ6V_ycR6bR3cAwhRBn5CGn7MHBJBIjaprfaPVNwNP7NL9AAEqmdSXEFBm3Xf5a8nN3t55FMO', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2942802-2', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2944630-0']","['Bariatric Surgery', 'Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP', 'ASGE position statement on endoscopic bariatric therapies in clinical practice', '8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022', 'Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists*', 'American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity']","['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2944630-0', 'https://www.hca.wa.gov/assets/program/bariatric_final_rpt_040315[1].pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214495/pdf', 'https://www.asge.org/docs/default-source/education/practice_guidelines/doc-position_statement_endoscopic_bariatric_therapies.pdf?sfvrsn=63c94951_6']","['958_5_american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.pdf', '958_0_bariatric surgery.pdf', '958_1_clinical practice guidelines of the european association for endoscopic surgery eaes on bariatric surgery update 2020 endorsed by ifsoec easo and espcop.pdf', '958_2_asge position statement on endoscopic bariatric therapies in clinical practice.pdf']",4,66.67,"['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2944630-0', 'https://www.hca.wa.gov/assets/program/bariatric_final_rpt_040315[1].pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214495/pdf', 'https://www.asge.org/docs/default-source/education/practice_guidelines/doc-position_statement_endoscopic_bariatric_therapies.pdf?sfvrsn=63c94951_6']","['958_5_american association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.pdf', '958_0_bariatric surgery.pdf', '958_1_clinical practice guidelines of the european association for endoscopic surgery eaes on bariatric surgery update 2020 endorsed by ifsoec easo and espcop.pdf', '958_2_asge position statement on endoscopic bariatric therapies in clinical practice.pdf']","[0.546, 0.408, 0.415, 0.292]","[0.489, 0.511, 0.498, 0.519]","[0.577, 0.596, 0.587, 0.604]","[0.152, 0.173, 0.161, 0.174]","[0.151, 0.174, 0.162, 0.182]","[0.122, 0.139, 0.133, 0.144]","[0.738, 0.738, 0.739, 0.742]","[0.644, 0.642, 0.646, 0.646]","[0.557, 0.576, 0.563, 0.59]","[0.686, 0.683, 0.685, 0.678]","[0.765, 0.772, 0.762, 0.783]","[0.679, 0.704, 0.705, 0.721]","[0.59, 0.607, 0.591, 0.603]","[0.888, 0.889, 0.877, 0.894]","[0.781, 0.786, 0.763, 0.797]","[0.7, 0.707, 0.684, 0.716]","[0.752, 0.763, 0.751, 0.776]","[0.713, 0.726, 0.703, 0.737]",0.415,0.504,0.591,0.165,0.167,0.135,0.739,0.644,0.572,0.683,0.77,0.702,0.598,0.887,0.782,0.702,0.76,0.72
https://doi.org/10.1001/jamasurg.2017.5083,incidence and prognosis of primary gastrinomas in the hepatobiliary tract,959_incidence and prognosis of primary gastrinomas in the hepatobiliary tract.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718045/pdf'],['Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718045/pdf'],['959_0_surgical management of zollingerellison syndrome classical considerations and current controversies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718045/pdf'],['959_0_surgical management of zollingerellison syndrome classical considerations and current controversies.pdf'],[0.615],[0.581],[0.668],[0.213],[0.221],[0.175],[0.76],[0.67],[0.641],[0.669],[0.817],[0.763],[0.641],[0.922],[0.839],[0.791],[0.814],[0.807],0.615,0.581,0.668,0.213,0.221,0.175,0.76,0.67,0.641,0.669,0.817,0.763,0.641,0.922,0.839,0.791,0.814,0.807
https://doi.org/10.1001/journalofethics.2016.18.4.msoc1-1604,reproductive rights and access to reproductive services for women with disabilities,961_reproductive rights and access to reproductive services for women with disabilities.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838962/pdf', 'https://www.guttmacher.org/gpr/2017/01/real-life-federal-restrictions-abortion-coverage-and-women-they-impact']","['Sexual health and education guidelines for the care of people with spina bifida', 'In Real Life: Federal Restrictions on Abortion Coverage and the Women They Impact']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838962/pdf'],['961_0_sexual health and education guidelines for the care of people with spina bifida.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838962/pdf'],['961_0_sexual health and education guidelines for the care of people with spina bifida.pdf'],[0.29],[0.531],[0.62],[0.159],[0.178],[0.15],[0.739],[0.641],[0.583],[0.654],[0.792],[0.709],[0.61],[0.925],[0.813],[0.744],[0.794],[0.775],0.29,0.531,0.62,0.159,0.178,0.15,0.739,0.641,0.583,0.654,0.792,0.709,0.61,0.925,0.813,0.744,0.794,0.775
https://doi.org/10.1001/virtualmentor.2006.8.8.msoc1-0608,the influence of controllable lifestyle on medical student specialty choice,962_the influence of controllable lifestyle on medical student specialty choice.pdf,1,['https://www.cchpca.org/sites/default/files/2018-09/Tele-Dermatology%20in%20Medi-Cal%20Issue%20Brief%2010-11.pdf'],['Tele-Dermatology in Medi-Cal: Findings from the Field and Challenges for the Future'],['https://www.cchpca.org/sites/default/files/2018-09/Tele-Dermatology%20in%20Medi-Cal%20Issue%20Brief%2010-11.pdf'],['962_0_teledermatology in medical findings from the field and challenges for the future.pdf'],1,100.0,['https://www.cchpca.org/sites/default/files/2018-09/Tele-Dermatology%20in%20Medi-Cal%20Issue%20Brief%2010-11.pdf'],['962_0_teledermatology in medical findings from the field and challenges for the future.pdf'],[0.241],[0.553],[0.652],[0.171],[0.197],[0.158],[0.739],[0.641],[0.611],[0.668],[0.819],[0.748],[0.654],[0.925],[0.849],[0.77],[0.816],[0.795],0.241,0.553,0.652,0.171,0.197,0.158,0.739,0.641,0.611,0.668,0.819,0.748,0.654,0.925,0.849,0.77,0.816,0.795
https://doi.org/10.1002/(sici)1096-8652(200001)63:1<57::aid-ajh13>3.0.co;2-5,advanced hodgkins disease in a pregnant hiv seropositive woman favorable mother and baby outcome following combined anticancer and antiretroviral therapy,964_advanced hodgkins disease in a pregnant hiv seropositive woman favorable mother and baby outcome following combined anticancer and antiretroviral therapy.pdf,2,"['https://ntp.niehs.nih.gov/ntp/ohat/cancer_chemo_preg/chemopregnancy_monofinal_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/cancer_chemo_preg/cancerchemo_appendfinal_508.pdf']","['Cancer Chemotherapy Use during Pregnancy', 'Cancer Chemotherapy Use during Pregnancy']","['https://ntp.niehs.nih.gov/ntp/ohat/cancer_chemo_preg/chemopregnancy_monofinal_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/cancer_chemo_preg/cancerchemo_appendfinal_508.pdf']","['964_0_cancer chemotherapy use during pregnancy.pdf', '964_1_cancer chemotherapy use during pregnancy.pdf']",2,100.0,"['https://ntp.niehs.nih.gov/ntp/ohat/cancer_chemo_preg/chemopregnancy_monofinal_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/cancer_chemo_preg/cancerchemo_appendfinal_508.pdf']","['964_0_cancer chemotherapy use during pregnancy.pdf', '964_1_cancer chemotherapy use during pregnancy.pdf']","[0.2, 0.156]","[0.579, 0.552]","[0.655, 0.631]","[0.176, 0.184]","[0.181, 0.196]","[0.135, 0.146]","[0.743, 0.738]","[0.649, 0.646]","[0.645, 0.621]","[0.6, 0.617]","[0.818, 0.802]","[0.75, 0.74]","[0.647, 0.623]","[0.918, 0.923]","[0.823, 0.818]","[0.777, 0.763]","[0.812, 0.799]","[0.796, 0.785]",0.178,0.566,0.643,0.18,0.189,0.141,0.74,0.647,0.633,0.609,0.81,0.745,0.635,0.921,0.821,0.77,0.806,0.79
https://doi.org/10.1002/(sici)1098-2280(2000)35:3<206::aid-em8>3.0.co;2-j,single cell gelcomet assay guidelines for in vitro and in vivo genetic toxicology testing,968_single cell gelcomet assay guidelines for in vitro and in vivo genetic toxicology testing.pdf,8,"['https://ntp.niehs.nih.gov/go/tr590abs', 'https://ntp.niehs.nih.gov/go/tr595abs', 'https://ntp.niehs.nih.gov/go/tr596abs', 'https://ntp.niehs.nih.gov/go/tr592abs', 'https://ntp.niehs.nih.gov/go/tr599abs', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16e.pdf', 'https://ntp.niehs.nih.gov/go/tr579abs']","['Toxicology and Carcinogenesis Studies of Antimony Trioxide in Wistar Han [Crl:WI (Han)] Rats and B6C3F1/N Mice (Inhalation Studies)', 'Toxicology and Carcinogenesis Studies in Hsd:Sprague Dawley SD Rats Exposed to Whole-body Radio Frequency Radiation at a Frequency (900 MHz) and Modulations (GSM and CDMA) Used by Cell Phones', 'Toxicology and Carcinogenesis Studies in B6C3F1/N Mice Exposed to Whole-Body Radio Frequency Radiation at a Frequency (1,900 MHz) and Modulations (GSM and CDMA) Used by Cell Phones', 'Toxicology and Carcinogenesis Study of Dietary Zinc[1] in Sprague Dawley Rats (Hsd:Sprague Dawley SD) (Feed Study)', 'Toxicology and Carcinogenesis Studies of Sodium Tungstate Dihydrate in Sprague Dawley (Hsd:Sprague Dawley SD) Rats and B6C3F1/N Mice (Drinking Water Studies)', 'Martin Blank, PhD Columbia University New York, NY 10032 email : mb32 @ cumc. columbia. edu', 'Massachusetts General Hospital', 'Toxicology and Carcinogenesis Studies of N,N-Dimethyl-p-Toluidine in F344/N Rats and B6C3F1/N Mice (Gavage Studies)']","['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16e.pdf']","['968_5_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf', '968_6_massachusetts general hospital.pdf']",2,25.0,"['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16e.pdf']","['968_5_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf', '968_6_massachusetts general hospital.pdf']","[0.54, 0.51]","[0.542, 0.526]","[0.629, 0.618]","[0.139, 0.132]","[0.137, 0.125]","[0.105, 0.097]","[0.733, 0.733]","[0.638, 0.638]","[0.617, 0.6]","[0.677, 0.67]","[0.806, 0.801]","[0.73, 0.715]","[0.654, 0.644]","[0.912, 0.909]","[0.824, 0.814]","[0.779, 0.77]","[0.809, 0.801]","[0.795, 0.788]",0.525,0.534,0.623,0.136,0.131,0.101,0.733,0.638,0.609,0.673,0.804,0.722,0.649,0.911,0.819,0.774,0.805,0.792
https://doi.org/10.1002/(sici)1099-0496(200003)29:3<182::aid-ppul5>3.0.co;2-t,bronchiectasis in alaska native children causes and clinical courses,974_bronchiectasis in alaska native children causes and clinical courses.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389290/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483665/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491127/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494510/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513042/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483496/pdf', 'https://stacks.cdc.gov/view/cdc/36155', 'http://dhss.alaska.gov/dph/Documents/HA2010/24_Respiratory_Disease.pdf']","['Influenza vaccine for children and adults with bronchiectasis', 'Pneumococcal vaccines for children and adults with bronchiectasis', 'Self‐management for bronchiectasis', 'Oral versus inhaled antibiotics for bronchiectasis', 'Inhaled corticosteroids for bronchiectasis', 'Head‐to‐head trials of antibiotics for bronchiectasis', 'Combination inhaled corticosteroids and long‐acting beta‐agonists for children and adults with bronchiectasis', 'Lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general United States child population', '24_Respiratory_Disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483496/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494510/pdf', 'http://dhss.alaska.gov/dph/Documents/HA2010/24_Respiratory_Disease.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483665/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389290/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513042/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491127/pdf']","['974_6_combination inhaled corticosteroids and long‐acting beta‐agonists for children and adults with bronchiectasis.pdf', '974_4_inhaled corticosteroids for bronchiectasis.pdf', '974_8_24respiratorydisease.pdf', '974_1_pneumococcal vaccines for children and adults with bronchiectasis.pdf', '974_0_influenza vaccine for children and adults with bronchiectasis.pdf', '974_5_head‐to‐head trials of antibiotics for bronchiectasis.pdf', '974_3_oral versus inhaled antibiotics for bronchiectasis.pdf', '974_2_self‐management for bronchiectasis.pdf']",8,88.89,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483496/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494510/pdf', 'http://dhss.alaska.gov/dph/Documents/HA2010/24_Respiratory_Disease.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483665/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389290/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513042/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491127/pdf']","['974_6_combination inhaled corticosteroids and long‐acting beta‐agonists for children and adults with bronchiectasis.pdf', '974_4_inhaled corticosteroids for bronchiectasis.pdf', '974_8_24respiratorydisease.pdf', '974_1_pneumococcal vaccines for children and adults with bronchiectasis.pdf', '974_0_influenza vaccine for children and adults with bronchiectasis.pdf', '974_5_head‐to‐head trials of antibiotics for bronchiectasis.pdf', '974_3_oral versus inhaled antibiotics for bronchiectasis.pdf', '974_2_self‐management for bronchiectasis.pdf']","[0.369, 0.327, 0.296, 0.302, 0.27, 0.282, 0.295, 0.345]","[0.536, 0.541, 0.561, 0.54, 0.541, 0.544, 0.549, 0.525]","[0.614, 0.616, 0.636, 0.621, 0.622, 0.621, 0.632, 0.602]","[0.178, 0.175, 0.205, 0.193, 0.191, 0.181, 0.183, 0.166]","[0.184, 0.179, 0.219, 0.201, 0.202, 0.186, 0.198, 0.164]","[0.146, 0.139, 0.17, 0.161, 0.162, 0.144, 0.155, 0.127]","[0.737, 0.734, 0.749, 0.743, 0.74, 0.736, 0.738, 0.735]","[0.636, 0.634, 0.65, 0.645, 0.641, 0.637, 0.638, 0.633]","[0.607, 0.611, 0.622, 0.61, 0.614, 0.617, 0.627, 0.588]","[0.649, 0.65, 0.654, 0.651, 0.651, 0.65, 0.652, 0.641]","[0.796, 0.798, 0.82, 0.8, 0.802, 0.801, 0.809, 0.787]","[0.724, 0.727, 0.735, 0.719, 0.723, 0.729, 0.737, 0.704]","[0.618, 0.617, 0.646, 0.624, 0.627, 0.612, 0.621, 0.599]","[0.915, 0.916, 0.919, 0.922, 0.927, 0.917, 0.928, 0.912]","[0.823, 0.829, 0.838, 0.83, 0.835, 0.828, 0.838, 0.815]","[0.746, 0.751, 0.775, 0.757, 0.762, 0.752, 0.768, 0.736]","[0.792, 0.798, 0.822, 0.797, 0.803, 0.799, 0.811, 0.787]","[0.77, 0.775, 0.803, 0.782, 0.785, 0.775, 0.794, 0.76]",0.311,0.542,0.621,0.184,0.192,0.151,0.739,0.639,0.612,0.65,0.802,0.725,0.62,0.919,0.829,0.756,0.801,0.78
https://doi.org/10.1002/(sici)1099-0496(200004)29:4<270::aid-ppul6>3.0.co;2-q,effects of endotracheal suctioning in highfrequency oscillatory and conventionally ventilated low birth weight neonates on cerebral hemodynamics observed by near infrared spectroscopy nirs,976_effects of endotracheal suctioning in highfrequency oscillatory and conventionally ventilated low birth weight neonates on cerebral hemodynamics observed by near infrared spectroscopy nirs.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478281/pdf'],['Routine oro/nasopharyngeal suction versus no suction at birth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478281/pdf'],['976_0_routine oronasopharyngeal suction versus no suction at birth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478281/pdf'],['976_0_routine oronasopharyngeal suction versus no suction at birth.pdf'],[0.25],[0.545],[0.63],[0.169],[0.163],[0.126],[0.737],[0.641],[0.618],[0.653],[0.792],[0.734],[0.614],[0.925],[0.822],[0.758],[0.8],[0.776],0.25,0.545,0.63,0.169,0.163,0.126,0.737,0.641,0.618,0.653,0.792,0.734,0.614,0.925,0.822,0.758,0.8,0.776
https://doi.org/10.1002/(sici)1099-0496(200006)29:6<452::aid-ppul7>3.0.co;2-h,sweat testing following newborn screening for cystic fibrosis,977_sweat testing following newborn screening for cystic fibrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810958/pdf'],['Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810958/pdf'],['977_0_guidelines for diagnosis of cystic fibrosis in newborns through older adults cystic fibrosis foundation consensus report.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810958/pdf'],['977_0_guidelines for diagnosis of cystic fibrosis in newborns through older adults cystic fibrosis foundation consensus report.pdf'],[0.455],[0.543],[0.644],[0.209],[0.234],[0.178],[0.742],[0.651],[0.629],[0.687],[0.804],[0.731],[0.633],[0.926],[0.842],[0.769],[0.801],[0.797],0.455,0.543,0.644,0.209,0.234,0.178,0.742,0.651,0.629,0.687,0.804,0.731,0.633,0.926,0.842,0.769,0.801,0.797
https://doi.org/10.1002/(sici)1099-0968(200002)8:1<19::aid-erv329>3.0.co;2-k,body awareness therapy in teenage anorexia nervosa outcome after 2 years,978_body awareness therapy in teenage anorexia nervosa outcome after 2 years.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf', 'https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf']","['Family therapy approaches for anorexia nervosa', 'Family therapy approaches for anorexia nervosa', 'The American Psychiatric Association Practice Guideline for the Treatment of Patients with Eating Disorders']","['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf']","['978_2_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf', '978_1_family therapy approaches for anorexia nervosa.pdf', '978_0_family therapy approaches for anorexia nervosa.pdf']",3,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1002/(sici)1520-6661(200001/02)9:1<83::aid-mfm17>3.0.co;2-o,effect of diabetes in pregnancy on offspring followup research in the pima indians,980_effect of diabetes in pregnancy on offspring followup research in the pima indians.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170990/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486032/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164477/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485334/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483546/pdf']","['Interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria', 'Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus', 'Exercise for pregnant women with pre‐existing diabetes for improving maternal and fetal outcomes', 'Different intensities of glycaemic control for pregnant women with pre‐existing diabetes', 'Different intensities of glycaemic control for pregnant women with pre-existing diabetes', 'Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes', 'Planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants', 'Different strategies for diagnosing gestational diabetes to improve maternal and infant health']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164477/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485334/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486032/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170990/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486104/pdf']","['980_0_interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria.pdf', '980_4_different intensities of glycaemic control for pregnant women with preexisting diabetes.pdf', '980_5_oral anti‐diabetic agents for women with established diabetesimpaired glucose tolerance or previous gestational diabetes planning pregnancy or pregnant women with pre‐existing diabetes.pdf', '980_7_different strategies for diagnosing gestational diabetes to improve maternal and infant health.pdf', '980_2_exercise for pregnant women with pre‐existing diabetes for improving maternal and fetal outcomes.pdf', '980_6_planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants.pdf', '980_1_oral antidiabetic agents for women with preexisting diabetes mellitusimpaired glucose tolerance or previous gestational diabetes mellitus.pdf', '980_3_different intensities of glycaemic control for pregnant women with pre‐existing diabetes.pdf']",8,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164477/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485334/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486032/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170990/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486104/pdf']","['980_0_interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria.pdf', '980_4_different intensities of glycaemic control for pregnant women with preexisting diabetes.pdf', '980_5_oral anti‐diabetic agents for women with established diabetesimpaired glucose tolerance or previous gestational diabetes planning pregnancy or pregnant women with pre‐existing diabetes.pdf', '980_7_different strategies for diagnosing gestational diabetes to improve maternal and infant health.pdf', '980_2_exercise for pregnant women with pre‐existing diabetes for improving maternal and fetal outcomes.pdf', '980_6_planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants.pdf', '980_1_oral antidiabetic agents for women with preexisting diabetes mellitusimpaired glucose tolerance or previous gestational diabetes mellitus.pdf', '980_3_different intensities of glycaemic control for pregnant women with pre‐existing diabetes.pdf']","[0.379, 0.492, 0.442, 0.258, 0.271, 0.404, 0.424, 0.352]","[0.533, 0.501, 0.544, 0.533, 0.547, 0.556, 0.529, 0.494]","[0.624, 0.599, 0.631, 0.624, 0.638, 0.645, 0.631, 0.595]","[0.189, 0.163, 0.21, 0.187, 0.191, 0.198, 0.195, 0.158]","[0.188, 0.171, 0.208, 0.189, 0.193, 0.204, 0.206, 0.156]","[0.161, 0.137, 0.179, 0.163, 0.17, 0.176, 0.173, 0.13]","[0.738, 0.734, 0.745, 0.735, 0.737, 0.737, 0.739, 0.736]","[0.641, 0.637, 0.647, 0.636, 0.635, 0.638, 0.642, 0.633]","[0.593, 0.562, 0.604, 0.597, 0.613, 0.621, 0.602, 0.554]","[0.662, 0.666, 0.664, 0.67, 0.662, 0.66, 0.665, 0.662]","[0.783, 0.758, 0.79, 0.785, 0.794, 0.798, 0.788, 0.755]","[0.713, 0.693, 0.721, 0.715, 0.733, 0.738, 0.716, 0.68]","[0.602, 0.584, 0.601, 0.601, 0.613, 0.615, 0.6, 0.587]","[0.907, 0.892, 0.908, 0.911, 0.922, 0.921, 0.919, 0.892]","[0.814, 0.793, 0.818, 0.817, 0.826, 0.828, 0.812, 0.788]","[0.745, 0.714, 0.747, 0.747, 0.76, 0.765, 0.759, 0.704]","[0.786, 0.761, 0.789, 0.79, 0.796, 0.8, 0.788, 0.758]","[0.765, 0.737, 0.77, 0.768, 0.782, 0.785, 0.779, 0.726]",0.378,0.53,0.623,0.186,0.189,0.161,0.738,0.639,0.593,0.664,0.781,0.714,0.6,0.909,0.812,0.743,0.784,0.764
https://doi.org/10.1002/0470846399.ch5,classification of ulcers and its relevance to management,981_classification of ulcers and its relevance to management.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144817/pdf'],['Debridement of diabetic foot ulcers'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144817/pdf'],['981_0_debridement of diabetic foot ulcers.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144817/pdf'],['981_0_debridement of diabetic foot ulcers.pdf'],[0.098],[0.444],[0.535],[0.113],[0.116],[0.127],[0.725],[0.626],[0.5],[0.71],[0.764],[0.616],[0.57],[0.905],[0.787],[0.67],[0.742],[0.746],0.098,0.444,0.535,0.113,0.116,0.127,0.725,0.626,0.5,0.71,0.764,0.616,0.57,0.905,0.787,0.67,0.742,0.746
https://doi.org/10.1002/1096-8628(20001009)96:5<671::aid-ajmg14>3.0.co;2-w,genetic and environmental influences on adolescent substance use and abuse,982_genetic and environmental influences on adolescent substance use and abuse.pdf,5,"['https://www.ncbi.nlm.nih.gov/books/n/rptsmokedis/', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'http://vcsc.virginia.gov/2008AnnualReport.pdf', 'http://www.vcsc.virginia.gov/2008AnnualReport.pdf', 'https://stacks.cdc.gov/view/cdc/6067']","['How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease', 'Preventing Tobacco Use Among Youth and Young Adults', '2008 Annual Report', 'singlecover', 'How tobacco smoke causes disease; the biology and behavioral basis for smoking-attributable disease : a report of the Surgeon General']","['http://vcsc.virginia.gov/2008AnnualReport.pdf', 'http://www.vcsc.virginia.gov/2008AnnualReport.pdf']","['982_2_2008 annual report.pdf', '982_3_singlecover.pdf']",2,40.0,"['http://vcsc.virginia.gov/2008AnnualReport.pdf', 'http://www.vcsc.virginia.gov/2008AnnualReport.pdf']","['982_2_2008 annual report.pdf', '982_3_singlecover.pdf']","[0.222, 0.222]","[0.521, 0.521]","[0.605, 0.605]","[0.14, 0.14]","[0.143, 0.143]","[0.126, 0.126]","[0.719, 0.719]","[0.621, 0.621]","[0.582, 0.582]","[0.668, 0.668]","[0.796, 0.796]","[0.726, 0.726]","[0.629, 0.629]","[0.917, 0.917]","[0.808, 0.808]","[0.756, 0.756]","[0.797, 0.797]","[0.778, 0.778]",0.222,0.521,0.605,0.14,0.143,0.126,0.719,0.621,0.582,0.668,0.796,0.726,0.629,0.917,0.808,0.756,0.797,0.778
https://doi.org/10.1002/1096-9098(200009)75:1<24::aid-jso5>3.0.co;2-l,effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer,985_effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457850/pdf'],['Surgical cytoreduction for recurrent epithelial ovarian cancer'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457850/pdf'],['985_0_surgical cytoreduction for recurrent epithelial ovarian cancer.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457850/pdf'],['985_0_surgical cytoreduction for recurrent epithelial ovarian cancer.pdf'],[0.589],[0.551],[0.625],[0.196],[0.196],[0.166],[0.747],[0.654],[0.617],[0.672],[0.792],[0.716],[0.62],[0.921],[0.811],[0.763],[0.794],[0.782],0.589,0.551,0.625,0.196,0.196,0.166,0.747,0.654,0.617,0.672,0.792,0.716,0.62,0.921,0.811,0.763,0.794,0.782
https://doi.org/10.1002/1096-9926(200012)62:6<429::aid-tera10>3.0.co;2-i,neonatal thyroidstimulating hormone level and perchlorate in drinking water,987_neonatal thyroidstimulating hormone level and perchlorate in drinking water.pdf,3,"['https://stacks.cdc.gov/view/cdc/6997', 'https://www.waterboards.ca.gov/losangeles/water_issues/programs/remediation/perchlorate/05_0114_perchlorate%20nas.pdf', 'https://www.waterboards.ca.gov/losangeles/water_issues/programs/remediation/perchlorate/04_0123_ucpercpeer.pdf']","['Toxicological profile for perchlorates', 'Health Implications of Perchlorate Ingestion', '(in alphabetical order)']","['https://www.waterboards.ca.gov/losangeles/water_issues/programs/remediation/perchlorate/04_0123_ucpercpeer.pdf', 'https://www.waterboards.ca.gov/losangeles/water_issues/programs/remediation/perchlorate/05_0114_perchlorate%20nas.pdf']","['987_2_in alphabetical order.pdf', '987_1_health implications of perchlorate ingestion.pdf']",2,66.67,"['https://www.waterboards.ca.gov/losangeles/water_issues/programs/remediation/perchlorate/04_0123_ucpercpeer.pdf', 'https://www.waterboards.ca.gov/losangeles/water_issues/programs/remediation/perchlorate/05_0114_perchlorate%20nas.pdf']","['987_2_in alphabetical order.pdf', '987_1_health implications of perchlorate ingestion.pdf']","[0.403, 0.393]","[0.56, 0.524]","[0.643, 0.616]","[0.191, 0.168]","[0.192, 0.167]","[0.146, 0.128]","[0.726, 0.729]","[0.63, 0.633]","[0.632, 0.59]","[0.676, 0.667]","[0.817, 0.799]","[0.744, 0.698]","[0.672, 0.647]","[0.917, 0.908]","[0.848, 0.822]","[0.791, 0.76]","[0.822, 0.796]","[0.808, 0.783]",0.398,0.542,0.629,0.179,0.179,0.137,0.728,0.631,0.611,0.671,0.808,0.721,0.659,0.913,0.835,0.776,0.809,0.796
https://doi.org/10.1002/1097-0142(20000915)89:6<1322::aid-cncr18>3.0.co;2-d,quality of life changes during conformal radiation therapy for prostate carcinoma,989_quality of life changes during conformal radiation therapy for prostate carcinoma.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499710/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465265/pdf']","['Cancer-Related Fatigue, Version 2.2015 - Clinical Practice Guidelines in Oncology', 'Survivorship: Fatigue, Version 1.2014 - Clinical Practice Guidelines in Oncology']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465265/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499710/pdf']","['989_1_survivorship fatigue version 12014  clinical practice guidelines in oncology.pdf', '989_0_cancerrelated fatigue version 22015  clinical practice guidelines in oncology.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465265/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499710/pdf']","['989_1_survivorship fatigue version 12014  clinical practice guidelines in oncology.pdf', '989_0_cancerrelated fatigue version 22015  clinical practice guidelines in oncology.pdf']","[0.446, 0.302]","[0.492, 0.51]","[0.604, 0.617]","[0.16, 0.168]","[0.184, 0.189]","[0.143, 0.149]","[0.742, 0.74]","[0.655, 0.652]","[0.568, 0.586]","[0.694, 0.688]","[0.764, 0.774]","[0.67, 0.688]","[0.573, 0.589]","[0.912, 0.916]","[0.803, 0.812]","[0.717, 0.732]","[0.762, 0.777]","[0.757, 0.769]",0.374,0.501,0.611,0.164,0.186,0.146,0.741,0.653,0.577,0.691,0.769,0.679,0.581,0.914,0.808,0.724,0.77,0.763
https://doi.org/10.1002/1097-0142(20001215)89:12<2547::aid-cncr5>3.0.co;2-v,delayed18ffluoro2deoxydglucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas,990_delayed18ffluoro2deoxydglucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478242/pdf', 'https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=21']","['Imaging modalities for characterising focal pancreatic lesions', 'Positron Emission Testing For Six Cancers (Brain, Cervical, Small Cell Lung, Ovarian, Pancreatic and Testicular)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478242/pdf'],['990_0_imaging modalities for characterising focal pancreatic lesions.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478242/pdf'],['990_0_imaging modalities for characterising focal pancreatic lesions.pdf'],[0.283],[0.543],[0.621],[0.17],[0.175],[0.14],[0.74],[0.641],[0.605],[0.678],[0.782],[0.71],[0.624],[0.912],[0.822],[0.743],[0.789],[0.77],0.283,0.543,0.621,0.17,0.175,0.14,0.74,0.641,0.605,0.678,0.782,0.71,0.624,0.912,0.822,0.743,0.789,0.77
https://doi.org/10.1002/1097-0142(20011215)92:12<2999::aid-cncr10145>3.0.co;2-1,does histology influence prognosis in patients with earlystage cervical carcinoma,991_does histology influence prognosis in patients with earlystage cervical carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387233/pdf'],['Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387233/pdf'],['991_0_primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387233/pdf'],['991_0_primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.pdf'],[0.411],[0.552],[0.635],[0.193],[0.211],[0.168],[0.751],[0.659],[0.612],[0.677],[0.801],[0.73],[0.623],[0.924],[0.823],[0.753],[0.79],[0.784],0.411,0.552,0.635,0.193,0.211,0.168,0.751,0.659,0.612,0.677,0.801,0.73,0.623,0.924,0.823,0.753,0.79,0.784
https://doi.org/10.1002/1097-0215(200002)9999:9999<::aid-ijc1097>3.0.co;2-d,residential magnetic fields as a risk factor for childhood acute leukaemia results from a german populationbased casecontrol study,992_residential magnetic fields as a risk factor for childhood acute leukaemia results from a german populationbased casecontrol study.pdf,6,"['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf', 'https://www.mass.gov/doc/evaluation-of-environmental-concerns-and-cancer-incidence-in-belmont-and-surrounding-0/download', 'https://www.mass.gov/doc/leukemia/download', 'https://www.mass.gov/doc/evaluation-of-cancer-incidence-in-census-tracts-3114-and-3116-in-lowell-massachusetts-1982-0/download', 'https://www.mass.gov/doc/evaluation-of-health-outcome-data-in-northampton-and-easthampton-ma-and-among-neighborhoods-in/download', 'https://www.mass.gov/doc/appendix-a-e-assessment-of-cancer-incidence-in-belmont-massachusetts-and-surrounding-0/download']","['Martin Blank, PhD Columbia University New York, NY 10032 email : mb32 @ cumc. columbia. edu', 'Evaluation of Environmental Concerns and Cancer', 'Risk Factor Information for Selected Cancer Types - Leukemia', 'Evaluation of Cancer Incidence in Census Tracts 3114 and 3116 in Lowell, Massachusetts, 1982-2001', 'Evaluation of Health Outcome Data in Northampton and Easthampton, MA and among Neighborhoods in Closest Proximity to the Northampton Regional Landfill', 'Appendix A']","['https://www.mass.gov/doc/evaluation-of-health-outcome-data-in-northampton-and-easthampton-ma-and-among-neighborhoods-in/download', 'https://www.mass.gov/doc/evaluation-of-environmental-concerns-and-cancer-incidence-in-belmont-and-surrounding-0/download', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf', 'https://www.mass.gov/doc/appendix-a-e-assessment-of-cancer-incidence-in-belmont-massachusetts-and-surrounding-0/download', 'https://www.mass.gov/doc/leukemia/download', 'https://www.mass.gov/doc/evaluation-of-cancer-incidence-in-census-tracts-3114-and-3116-in-lowell-massachusetts-1982-0/download']","['992_4_evaluation of health outcome data in northampton and easthampton ma and among neighborhoods in closest proximity to the northampton regional landfill.pdf', '992_1_evaluation of environmental concerns and cancer.pdf', '992_0_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf', '992_5_appendix a.pdf', '992_2_risk factor information for selected cancer types  leukemia.pdf', '992_3_evaluation of cancer incidence in census tracts 3114 and 3116 in lowell massachusetts 19822001.pdf']",6,100.0,"['https://www.mass.gov/doc/evaluation-of-health-outcome-data-in-northampton-and-easthampton-ma-and-among-neighborhoods-in/download', 'https://www.mass.gov/doc/evaluation-of-environmental-concerns-and-cancer-incidence-in-belmont-and-surrounding-0/download', 'http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf', 'https://www.mass.gov/doc/appendix-a-e-assessment-of-cancer-incidence-in-belmont-massachusetts-and-surrounding-0/download', 'https://www.mass.gov/doc/leukemia/download', 'https://www.mass.gov/doc/evaluation-of-cancer-incidence-in-census-tracts-3114-and-3116-in-lowell-massachusetts-1982-0/download']","['992_4_evaluation of health outcome data in northampton and easthampton ma and among neighborhoods in closest proximity to the northampton regional landfill.pdf', '992_1_evaluation of environmental concerns and cancer.pdf', '992_0_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf', '992_5_appendix a.pdf', '992_2_risk factor information for selected cancer types  leukemia.pdf', '992_3_evaluation of cancer incidence in census tracts 3114 and 3116 in lowell massachusetts 19822001.pdf']","[0.356, 0.226, 0.29, 0.254, 0.239, 0.193]","[0.533, 0.525, 0.54, 0.516, 0.545, 0.533]","[0.622, 0.612, 0.622, 0.605, 0.632, 0.624]","[0.157, 0.144, 0.139, 0.139, 0.175, 0.153]","[0.156, 0.145, 0.125, 0.141, 0.175, 0.155]","[0.113, 0.106, 0.095, 0.102, 0.133, 0.109]","[0.728, 0.726, 0.729, 0.725, 0.733, 0.727]","[0.633, 0.631, 0.635, 0.63, 0.635, 0.632]","[0.605, 0.593, 0.619, 0.584, 0.623, 0.608]","[0.69, 0.692, 0.675, 0.696, 0.688, 0.688]","[0.802, 0.798, 0.803, 0.792, 0.812, 0.804]","[0.734, 0.727, 0.732, 0.726, 0.75, 0.735]","[0.636, 0.628, 0.643, 0.618, 0.635, 0.633]","[0.913, 0.911, 0.911, 0.911, 0.908, 0.912]","[0.828, 0.831, 0.832, 0.827, 0.839, 0.832]","[0.762, 0.753, 0.768, 0.747, 0.772, 0.763]","[0.807, 0.802, 0.806, 0.798, 0.815, 0.808]","[0.786, 0.782, 0.785, 0.778, 0.795, 0.787]",0.26,0.532,0.62,0.151,0.149,0.11,0.728,0.633,0.605,0.688,0.802,0.734,0.632,0.911,0.832,0.761,0.806,0.785
https://doi.org/10.1002/1097-0215(20000915)87:6<874::aid-ijc18>3.0.co;2-l,rectal cancer and occupational risk factors a hypothesisgenerating exposurebased casecontrol study,993_rectal cancer and occupational risk factors a hypothesisgenerating exposurebased casecontrol study.pdf,5,"['https://purl.fdlp.gov/GPO/gpo132710', 'https://oehha.ca.gov/media/downloads/water/chemicals/phg/122810styrene_0.pdf', 'https://stacks.cdc.gov/view/cdc/79528', 'https://www.epa.gov/sites/default/files/2017-06/documents/ccl4_comp_bib_0.pdf', 'https://stacks.cdc.gov/view/cdc/7000']","['Toxicological profile for trichloroethylene.', 'Styrene', 'Toxicological profile for trichloroethylene (TCE)', 'Carbon Tetrachloride (CASRN : 56‐23‐5) Bibliography : Supplemental File for the TSCA Scope Document', 'Toxicological profile for carbon tetrachloride']","['https://purl.fdlp.gov/GPO/gpo132710', 'https://www.epa.gov/sites/default/files/2017-06/documents/ccl4_comp_bib_0.pdf', 'https://oehha.ca.gov/media/downloads/water/chemicals/phg/122810styrene_0.pdf']","['993_0_toxicological profile for trichloroethylene.pdf', '993_3_carbon tetrachloride casrn  56‐23‐5 bibliography  supplemental file for the tsca scope document.pdf', '993_1_styrene.pdf']",3,60.0,"['https://purl.fdlp.gov/GPO/gpo132710', 'https://www.epa.gov/sites/default/files/2017-06/documents/ccl4_comp_bib_0.pdf', 'https://oehha.ca.gov/media/downloads/water/chemicals/phg/122810styrene_0.pdf']","['993_0_toxicological profile for trichloroethylene.pdf', '993_3_carbon tetrachloride casrn  56‐23‐5 bibliography  supplemental file for the tsca scope document.pdf', '993_1_styrene.pdf']","[0.367, 0.42, 0.121]","[0.505, 0.47, 0.515]","[0.606, 0.572, 0.608]","[0.153, 0.09, 0.156]","[0.166, 0.102, 0.169]","[0.122, 0.079, 0.124]","[0.737, 0.733, 0.737]","[0.645, 0.636, 0.644]","[0.571, 0.549, 0.58]","[0.681, 0.65, 0.682]","[0.794, 0.777, 0.794]","[0.68, 0.673, 0.687]","[0.627, 0.586, 0.637]","[0.909, 0.909, 0.907]","[0.804, 0.789, 0.801]","[0.747, 0.726, 0.752]","[0.788, 0.772, 0.787]","[0.775, 0.761, 0.774]",0.303,0.497,0.595,0.133,0.146,0.108,0.736,0.642,0.567,0.671,0.788,0.68,0.617,0.908,0.798,0.742,0.782,0.77
https://doi.org/10.1002/1097-0215(20001220)90:6<351::aid-ijc7>3.0.co;2-j,normal tissue complication probability ntcp calculations as a means to compare proton and photon plans and evaluation of clinical appropriateness of calculated values,995_normal tissue complication probability ntcp calculations as a means to compare proton and photon plans and evaluation of clinical appropriateness of calculated values.pdf,2,"['https://www.hca.wa.gov/assets/program/htcc-srs-sbrt-20121116.pdf', 'https://www.hca.wa.gov/assets/program/intensity-modulated-radiation-therapy-20120921.pdf']","['Meeting Name (PEBB Board Meeting)', 'CURRICULUM VITAE']","['https://www.hca.wa.gov/assets/program/intensity-modulated-radiation-therapy-20120921.pdf', 'https://www.hca.wa.gov/assets/program/htcc-srs-sbrt-20121116.pdf']","['995_1_curriculum vitae.pdf', '995_0_meeting name pebb board meeting.pdf']",2,100.0,"['https://www.hca.wa.gov/assets/program/intensity-modulated-radiation-therapy-20120921.pdf', 'https://www.hca.wa.gov/assets/program/htcc-srs-sbrt-20121116.pdf']","['995_1_curriculum vitae.pdf', '995_0_meeting name pebb board meeting.pdf']","[0.296, 0.274]","[0.554, 0.545]","[0.635, 0.631]","[0.165, 0.164]","[0.18, 0.179]","[0.148, 0.146]","[0.746, 0.748]","[0.657, 0.66]","[0.626, 0.616]","[0.673, 0.677]","[0.815, 0.813]","[0.743, 0.734]","[0.646, 0.641]","[0.929, 0.926]","[0.837, 0.83]","[0.781, 0.771]","[0.82, 0.815]","[0.806, 0.801]",0.285,0.55,0.633,0.165,0.179,0.147,0.747,0.659,0.621,0.675,0.814,0.738,0.643,0.927,0.833,0.776,0.817,0.804
https://doi.org/10.1002/1097-0223(200007)20:7<571::aid-pd879>3.0.co;2-n,clinical application of preimplantation genetic diagnosis for cystic fibrosis,997_clinical application of preimplantation genetic diagnosis for cystic fibrosis.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929885/pdf', 'https://www.hca.wa.gov/assets/pebb/regence-ump-preauthreqs-genetic-testing.pdf']","['The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus', 'Genetic Testing']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929885/pdf'],['997_0_the improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis toward an international consensus.pdf'],1,50.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1002/1097-0223(200102)21:2<146::aid-pd3>3.0.co;2-m,use of videotapes for viewing at home to inform choice in down syndrome screening a randomised controlled trial,998_use of videotapes for viewing at home to inform choice in down syndrome screening a randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478132/pdf'],['Decision aids for people facing health treatment or screening decisions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478132/pdf'],['998_0_decision aids for people facing health treatment or screening decisions.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1002/1097-0258(20001215)19:23<3275::aid-sim626>3.0.co;2-m,statistics in medical journals some recent trends,999_statistics in medical journals some recent trends.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438775/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409283/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666144/pdf']","['Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury', 'Mind and body therapy for fibromyalgia', 'Vapocoolants (cold spray) for pain treatment during intravenous cannulation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409283/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438775/pdf']","['999_2_vapocoolants cold spray for pain treatment during intravenous cannulation.pdf', '999_1_mind and body therapy for fibromyalgia.pdf', '999_0_oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409283/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438775/pdf']","['999_2_vapocoolants cold spray for pain treatment during intravenous cannulation.pdf', '999_1_mind and body therapy for fibromyalgia.pdf', '999_0_oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury.pdf']","[0.343, 0.319, 0.331]","[0.514, 0.502, 0.518]","[0.614, 0.598, 0.619]","[0.17, 0.167, 0.177]","[0.18, 0.175, 0.185]","[0.147, 0.145, 0.148]","[0.733, 0.737, 0.733]","[0.635, 0.639, 0.637]","[0.581, 0.565, 0.593]","[0.732, 0.741, 0.729]","[0.782, 0.768, 0.788]","[0.702, 0.697, 0.716]","[0.597, 0.577, 0.594]","[0.92, 0.9, 0.919]","[0.823, 0.808, 0.825]","[0.731, 0.71, 0.739]","[0.776, 0.761, 0.782]","[0.763, 0.74, 0.769]",0.331,0.511,0.61,0.171,0.18,0.147,0.734,0.637,0.58,0.734,0.779,0.705,0.589,0.913,0.819,0.727,0.773,0.757
https://doi.org/10.1002/1097-0258(20001230)19:24<3325::aid-sim827>3.0.co;2-d,assessing the potential for bias in metaanalysis due to selective reporting of subgroup analyses within studies,1000_assessing the potential for bias in metaanalysis due to selective reporting of subgroup analyses within studies.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711080/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390503/pdf', 'https://www.rti.org/publication/comparative-effectiveness-review-methods', 'https://effectivehealthcare.ahrq.gov/products/clinical-heterogeneity-methods/research', 'https://effectivehealthcare.ahrq.gov/products/treatment-effects-bias/research']","['Interventions for helping people recognise early signs of recurrence in bipolar disorder', 'Bile acids for viral hepatitis', 'The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration', 'Comparison of protocols and registry entries to published reports for randomised controlled trials', 'Comparative effectiveness review methods', 'Comparative Effectiveness Review Methods: Clinical Heterogeneity', 'The Empirical Evidence of Bias in Trials Measuring Treatment Differences']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711080/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390503/pdf']","['1000_0_interventions for helping people recognise early signs of recurrence in bipolar disorder.pdf', '1000_1_bile acids for viral hepatitis.pdf', '1000_2_the prisma statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions explanation and elaboration.pdf', '1000_3_comparison of protocols and registry entries to published reports for randomised controlled trials.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711080/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390503/pdf']","['1000_0_interventions for helping people recognise early signs of recurrence in bipolar disorder.pdf', '1000_1_bile acids for viral hepatitis.pdf', '1000_2_the prisma statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions explanation and elaboration.pdf', '1000_3_comparison of protocols and registry entries to published reports for randomised controlled trials.pdf']","[0.318, 0.227, 0.512, 0.427]","[0.512, 0.502, 0.559, 0.544]","[0.605, 0.598, 0.647, 0.637]","[0.154, 0.145, 0.193, 0.199]","[0.168, 0.152, 0.22, 0.23]","[0.148, 0.131, 0.18, 0.196]","[0.733, 0.729, 0.739, 0.739]","[0.638, 0.629, 0.645, 0.647]","[0.576, 0.576, 0.629, 0.613]","[0.737, 0.721, 0.766, 0.769]","[0.777, 0.773, 0.801, 0.791]","[0.682, 0.685, 0.741, 0.719]","[0.589, 0.587, 0.629, 0.605]","[0.916, 0.912, 0.924, 0.925]","[0.81, 0.805, 0.84, 0.843]","[0.726, 0.724, 0.767, 0.749]","[0.768, 0.77, 0.802, 0.788]","[0.758, 0.753, 0.781, 0.778]",0.371,0.529,0.622,0.173,0.193,0.164,0.735,0.64,0.599,0.748,0.785,0.707,0.603,0.919,0.825,0.742,0.782,0.768
https://doi.org/10.1002/1097-0258(20010215)20:3<401::aid-sim801>3.0.co;2-1,methodological considerations on the design and analysis of an equivalence stratified cluster randomization trial,1001_methodological considerations on the design and analysis of an equivalence stratified cluster randomization trial.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061257/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164448/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465187/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676908/pdf']","['Alternative versus standard packages of antenatal care for low‐risk pregnancy', 'Alternative versus standard packages of antenatal care for low-risk pregnancy', 'Specialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomes', 'Group versus conventional antenatal care for women', 'Health system and community level interventions for improving antenatal care coverage and health outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164448/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061257/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465187/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676908/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084921/pdf']","['1001_1_alternative versus standard packages of antenatal care for lowrisk pregnancy.pdf', '1001_0_alternative versus standard packages of antenatal care for low‐risk pregnancy.pdf', '1001_3_group versus conventional antenatal care for women.pdf', '1001_4_health system and community level interventions for improving antenatal care coverage and health outcomes.pdf', '1001_2_specialised antenatal clinics for women with a pregnancy at high risk of preterm birth excluding multiple pregnancy to improve maternal and infant outcomes.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164448/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061257/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465187/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676908/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084921/pdf']","['1001_1_alternative versus standard packages of antenatal care for lowrisk pregnancy.pdf', '1001_0_alternative versus standard packages of antenatal care for low‐risk pregnancy.pdf', '1001_3_group versus conventional antenatal care for women.pdf', '1001_4_health system and community level interventions for improving antenatal care coverage and health outcomes.pdf', '1001_2_specialised antenatal clinics for women with a pregnancy at high risk of preterm birth excluding multiple pregnancy to improve maternal and infant outcomes.pdf']","[0.344, 0.313, 0.318, 0.307, 0.432]","[0.539, 0.512, 0.53, 0.532, 0.537]","[0.628, 0.603, 0.616, 0.617, 0.631]","[0.177, 0.174, 0.177, 0.176, 0.174]","[0.197, 0.185, 0.193, 0.198, 0.194]","[0.153, 0.15, 0.152, 0.153, 0.149]","[0.735, 0.737, 0.736, 0.735, 0.736]","[0.644, 0.644, 0.643, 0.643, 0.644]","[0.605, 0.572, 0.595, 0.597, 0.607]","[0.72, 0.729, 0.715, 0.731, 0.715]","[0.791, 0.782, 0.788, 0.789, 0.791]","[0.731, 0.687, 0.717, 0.718, 0.732]","[0.586, 0.596, 0.606, 0.598, 0.591]","[0.916, 0.911, 0.911, 0.918, 0.921]","[0.82, 0.805, 0.818, 0.822, 0.815]","[0.744, 0.726, 0.737, 0.74, 0.75]","[0.79, 0.777, 0.786, 0.789, 0.788]","[0.773, 0.758, 0.763, 0.767, 0.774]",0.343,0.53,0.619,0.176,0.193,0.151,0.736,0.644,0.595,0.722,0.788,0.717,0.595,0.915,0.816,0.739,0.786,0.767
https://doi.org/10.1002/1097-0274(200012)38:6<609::aid-ajim1>3.0.co;2-4,occupational risk factors for renal cell carcinoma in montreal,1002_occupational risk factors for renal cell carcinoma in montreal.pdf,3,"['https://stacks.cdc.gov/view/cdc/38281', 'https://stacks.cdc.gov/view/cdc/45159', 'https://oehha.ca.gov/media/downloads/water/chemicals/phg/122810styrene_0.pdf']","['Draft toxicological profile for JP-5, JP-8, and jet A fuels', 'Toxicological profile for JP-5, JP-8, and jet A fuels', 'Styrene']",['https://oehha.ca.gov/media/downloads/water/chemicals/phg/122810styrene_0.pdf'],['1002_2_styrene.pdf'],1,33.33,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1002/1097-0355(200007)21:3<156::aid-imhj2>3.0.co;2-d,prediction of childhood problems at three years in children experiencing disorders of regulation during infancy,1005_prediction of childhood problems at three years in children experiencing disorders of regulation during infancy.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685508/pdf']","['Group‐based parent training programmes for improving emotional and behavioural adjustment in young children', 'Massage for promoting mental and physical health in typically developing infants under the age of six months', 'The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants', 'Parent‐infant psychotherapy for improving parental and infant mental health']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494209/pdf']","['1005_1_massage for promoting mental and physical health in typically developing infants under the age of six months.pdf', '1005_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf', '1005_3_parent‐infant psychotherapy for improving parental and infant mental health.pdf', '1005_2_the neonatal behavioral assessment scale nbas and newborn behavioral observations nbo system for supporting caregivers and improving outcomes in caregivers and their infants.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494209/pdf']","['1005_1_massage for promoting mental and physical health in typically developing infants under the age of six months.pdf', '1005_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf', '1005_3_parent‐infant psychotherapy for improving parental and infant mental health.pdf', '1005_2_the neonatal behavioral assessment scale nbas and newborn behavioral observations nbo system for supporting caregivers and improving outcomes in caregivers and their infants.pdf']","[0.353, 0.274, 0.344, 0.362]","[0.505, 0.511, 0.513, 0.537]","[0.587, 0.594, 0.595, 0.616]","[0.155, 0.162, 0.167, 0.176]","[0.149, 0.163, 0.165, 0.188]","[0.124, 0.137, 0.138, 0.15]","[0.73, 0.732, 0.734, 0.732]","[0.632, 0.636, 0.638, 0.636]","[0.559, 0.567, 0.565, 0.592]","[0.698, 0.706, 0.702, 0.696]","[0.763, 0.768, 0.768, 0.782]","[0.671, 0.678, 0.676, 0.709]","[0.581, 0.59, 0.595, 0.603]","[0.903, 0.907, 0.907, 0.917]","[0.797, 0.807, 0.8, 0.821]","[0.714, 0.724, 0.728, 0.744]","[0.765, 0.769, 0.769, 0.786]","[0.739, 0.747, 0.75, 0.767]",0.333,0.516,0.598,0.165,0.166,0.137,0.732,0.636,0.571,0.7,0.77,0.684,0.592,0.909,0.806,0.728,0.772,0.751
https://doi.org/10.1002/1097-0355(200101/04)22:1<201::aid-imhj8>3.0.co;2-9,the effects of early relational trauma on right brain development affect regulation and infant mental health,1006_the effects of early relational trauma on right brain development affect regulation and infant mental health.pdf,2,"['https://www.colorado.gov/pacific/sites/default/files/PF_WIC_Handout-Colorado-MotherKnowsBreast-Carothers.pdf', 'http://purl.fdlp.gov/GPO/gpo70861']","['Bringing Baby Back to Breast', 'Childhood trauma and its effects :\xa0implications for police /']",['http://purl.fdlp.gov/GPO/gpo70861'],['1006_1_childhood trauma and its effects \xa0implications for police .pdf'],1,50.0,['http://purl.fdlp.gov/GPO/gpo70861'],['1006_1_childhood trauma and its effects \xa0implications for police .pdf'],[0.393],[0.486],[0.585],[0.142],[0.152],[0.135],[0.735],[0.644],[0.54],[0.683],[0.767],[0.675],[0.611],[0.899],[0.788],[0.733],[0.771],[0.756],0.393,0.486,0.585,0.142,0.152,0.135,0.735,0.644,0.54,0.683,0.767,0.675,0.611,0.899,0.788,0.733,0.771,0.756
https://doi.org/10.1002/1097-4679(200009)56:9<1131::aid-jclp3>3.0.co;2-8,youth suicidal behavior assessment and intervention,1008_youth suicidal behavior assessment and intervention.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786270/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786270/pdf'],['1008_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786270/pdf'],['1008_0_interventions for self‐harm in children and adolescents.pdf'],[0.52],[0.509],[0.598],[0.163],[0.176],[0.147],[0.733],[0.64],[0.563],[0.699],[0.775],[0.684],[0.579],[0.916],[0.793],[0.723],[0.773],[0.755],0.52,0.509,0.598,0.163,0.176,0.147,0.733,0.64,0.563,0.699,0.775,0.684,0.579,0.916,0.793,0.723,0.773,0.755
https://doi.org/10.1002/1098-108x(200012)28:4<470::aid-eat18>3.0.co;2-1,enteric feeding in severe adolescent anorexia nervosa a report of four cases,1011_enteric feeding in severe adolescent anorexia nervosa a report of four cases.pdf,1,['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['The American Psychiatric Association Practice Guideline for the Treatment of Patients with Eating Disorders'],['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['1011_0_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf'],1,100.0,['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['1011_0_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf'],[0.403],[0.529],[0.63],[0.171],[0.181],[0.15],[0.732],[0.637],[0.604],[0.651],[0.802],[0.729],[0.619],[0.923],[0.819],[0.771],[0.801],[0.785],0.403,0.529,0.63,0.171,0.181,0.15,0.732,0.637,0.604,0.651,0.802,0.729,0.619,0.923,0.819,0.771,0.801,0.785
https://doi.org/10.1002/1098-2396(20001215)38:4<432::aid-syn8>3.0.co;2-q,synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor,1012_synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782603/pdf'],['Tobacco Smoking in Individuals with Attention-Deficit/Hyperactivity Disorder: Epidemiology and Pharmacological Approaches to Cessation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782603/pdf'],['1012_0_tobacco smoking in individuals with attentiondeficithyperactivity disorder epidemiology and pharmacological approaches to cessation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782603/pdf'],['1012_0_tobacco smoking in individuals with attentiondeficithyperactivity disorder epidemiology and pharmacological approaches to cessation.pdf'],[0.229],[0.48],[0.601],[0.171],[0.179],[0.15],[0.74],[0.651],[0.577],[0.679],[0.782],[0.665],[0.58],[0.912],[0.804],[0.728],[0.776],[0.769],0.229,0.48,0.601,0.171,0.179,0.15,0.74,0.651,0.577,0.679,0.782,0.665,0.58,0.912,0.804,0.728,0.776,0.769
https://doi.org/10.1002/1098-240x(200012)23:6<435::aid-nur3>3.0.co;2-p,physiologic and behavioral effects of gentle human touch on preterm infants,1013_physiologic and behavioral effects of gentle human touch on preterm infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956667/pdf']","['Non‐pharmacological management of infant and young child procedural pain', 'Massage for promoting growth and development of preterm and/or low birth‐weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf']","['1013_1_massage for promoting growth and development of preterm andor low birth‐weight infants.pdf', '1013_0_non‐pharmacological management of infant and young child procedural pain.pdf']",2,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1002/1099-0496(200009)30:3<257::aid-ppul10>3.0.co;2-r,inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease,1014_inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483532/pdf']","['Palliative drug treatments for breathlessness in cystic fibrosis', 'Palliative drug treatments for breathlessness in cystic fibrosis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483532/pdf']","['1014_0_palliative drug treatments for breathlessness in cystic fibrosis.pdf', '1014_1_palliative drug treatments for breathlessness in cystic fibrosis.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483532/pdf']","['1014_0_palliative drug treatments for breathlessness in cystic fibrosis.pdf', '1014_1_palliative drug treatments for breathlessness in cystic fibrosis.pdf']","[0.241, 0.245]","[0.546, 0.545]","[0.624, 0.624]","[0.171, 0.171]","[0.188, 0.187]","[0.14, 0.14]","[0.733, 0.734]","[0.634, 0.635]","[0.622, 0.621]","[0.652, 0.652]","[0.801, 0.801]","[0.744, 0.742]","[0.615, 0.614]","[0.928, 0.928]","[0.83, 0.829]","[0.766, 0.765]","[0.808, 0.807]","[0.792, 0.791]",0.243,0.546,0.624,0.171,0.188,0.14,0.734,0.635,0.621,0.652,0.801,0.743,0.615,0.928,0.829,0.766,0.808,0.792
https://doi.org/10.1002/1099-0496(200010)30:4<350::aid-ppul13>3.0.co;2-2,status asthmaticus treated by highfrequency oscillatory ventilation,1015_status asthmaticus treated by highfrequency oscillatory ventilation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717127/pdf'],['Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717127/pdf'],['1015_0_recommendations for mechanical ventilation of critically ill children from the paediatric mechanical ventilation consensus conference pemvecc.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717127/pdf'],['1015_0_recommendations for mechanical ventilation of critically ill children from the paediatric mechanical ventilation consensus conference pemvecc.pdf'],[0.361],[0.564],[0.638],[0.208],[0.207],[0.155],[0.741],[0.649],[0.626],[0.665],[0.813],[0.743],[0.641],[0.919],[0.836],[0.784],[0.817],[0.803],0.361,0.564,0.638,0.208,0.207,0.155,0.741,0.649,0.626,0.665,0.813,0.743,0.641,0.919,0.836,0.784,0.817,0.803
https://doi.org/10.1002/1099-0852(200007/08)9:4<235::aid-car626>3.0.co;2-4,parental substance misuse and child protection in a british sample a survey of children on the child protection register in an inner london district office,1017_parental substance misuse and child protection in a british sample a survey of children on the child protection register in an inner london district office.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf'],['Effectiveness of psychosocial interventions for reducing parental substance misuse'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf'],['1017_0_effectiveness of psychosocial interventions for reducing parental substance misuse.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf'],['1017_0_effectiveness of psychosocial interventions for reducing parental substance misuse.pdf'],[0.401],[0.526],[0.611],[0.179],[0.188],[0.161],[0.729],[0.631],[0.583],[0.685],[0.786],[0.705],[0.601],[0.917],[0.826],[0.736],[0.785],[0.766],0.401,0.526,0.611,0.179,0.188,0.161,0.729,0.631,0.583,0.685,0.786,0.705,0.601,0.917,0.826,0.736,0.785,0.766
https://doi.org/10.1002/1099-0968(200010)8:5<369::aid-erv375>3.0.co;2-6,the eating disorder inventory as an instrument to explore change in adolescents in family therapy for anorexia nervosa,1018_the eating disorder inventory as an instrument to explore change in adolescents in family therapy for anorexia nervosa.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf']","['Family therapy approaches for anorexia nervosa', 'Family therapy approaches for anorexia nervosa']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf']","['1018_0_family therapy approaches for anorexia nervosa.pdf', '1018_1_family therapy approaches for anorexia nervosa.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf']","['1018_0_family therapy approaches for anorexia nervosa.pdf', '1018_1_family therapy approaches for anorexia nervosa.pdf']","[0.468, 0.469]","[0.514, 0.513]","[0.601, 0.6]","[0.171, 0.175]","[0.182, 0.186]","[0.154, 0.158]","[0.738, 0.74]","[0.643, 0.645]","[0.567, 0.567]","[0.718, 0.719]","[0.769, 0.773]","[0.682, 0.688]","[0.592, 0.595]","[0.912, 0.907]","[0.801, 0.8]","[0.721, 0.727]","[0.764, 0.765]","[0.752, 0.753]",0.469,0.514,0.601,0.173,0.184,0.156,0.739,0.644,0.567,0.718,0.771,0.685,0.593,0.909,0.8,0.724,0.764,0.752
https://doi.org/10.1002/1099-1050(200006)9:4<319::aid-hec521>3.0.co;2-3,mothers willingness to pay for her own and her childs health a contingent valuation study in taiwan,1019_mothers willingness to pay for her own and her childs health a contingent valuation study in taiwan.pdf,5,"['https://www.rff.org/publications/working-papers/economic-uncertainties-in-valuing-reductions-in-children039s-environmental-health-risks/', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/IncomeElasticityUpdate_Recommendationswithappendices.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/Income%20Elasticity%20Update_Recommendations_noAppD.pdf', 'https://www.epa.gov/sites/default/files/2017-09/documents/ee-0475_all.pdf', 'https://papers.nber.org/papers/W10011']","[""Economic Uncertainties in Valuing Reductions in Children's Environmental Health Risks"", 'MEMORANDUM | March 31, 2012', 'MEMORANDUM | March 30, 2012', 'Valuing Environmental Health Risk Reductions to Children', 'Valuation of the Risk of SARS in Taiwan']","['https://www.epa.gov/sites/default/files/2017-09/documents/ee-0475_all.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/IncomeElasticityUpdate_Recommendationswithappendices.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/Income%20Elasticity%20Update_Recommendations_noAppD.pdf']","['1019_3_valuing environmental health risk reductions to children.pdf', '1019_1_memorandum  march 31 2012.pdf', '1019_2_memorandum  march 30 2012.pdf']",3,60.0,"['https://www.epa.gov/sites/default/files/2017-09/documents/ee-0475_all.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/IncomeElasticityUpdate_Recommendationswithappendices.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/Income%20Elasticity%20Update_Recommendations_noAppD.pdf']","['1019_3_valuing environmental health risk reductions to children.pdf', '1019_1_memorandum  march 31 2012.pdf', '1019_2_memorandum  march 30 2012.pdf']","[0.333, 0.343, 0.506]","[0.542, 0.535, 0.533]","[0.625, 0.622, 0.62]","[0.14, 0.142, 0.143]","[0.153, 0.151, 0.154]","[0.125, 0.124, 0.125]","[0.725, 0.725, 0.726]","[0.627, 0.628, 0.629]","[0.609, 0.601, 0.598]","[0.699, 0.712, 0.715]","[0.797, 0.797, 0.796]","[0.728, 0.724, 0.721]","[0.652, 0.648, 0.647]","[0.915, 0.916, 0.916]","[0.84, 0.836, 0.835]","[0.769, 0.762, 0.76]","[0.805, 0.804, 0.802]","[0.788, 0.786, 0.785]",0.394,0.537,0.622,0.142,0.153,0.125,0.725,0.628,0.603,0.709,0.797,0.724,0.649,0.916,0.837,0.764,0.804,0.786
https://doi.org/10.1002/1099-1557(200011)9:6<457::aid-pds529>3.0.co;2-r,development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials,1023_development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf']","['Vaccines for measles, mumps, rubella, and varicella in children', 'Vaccines for measles, mumps, rubella, and varicella in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf']","['1023_0_vaccines for measles mumps rubella and varicella in children.pdf', '1023_1_vaccines for measles mumps rubella and varicella in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf']","['1023_0_vaccines for measles mumps rubella and varicella in children.pdf', '1023_1_vaccines for measles mumps rubella and varicella in children.pdf']","[0.33, 0.331]","[0.549, 0.55]","[0.622, 0.623]","[0.195, 0.196]","[0.187, 0.187]","[0.161, 0.161]","[0.746, 0.746]","[0.655, 0.654]","[0.597, 0.597]","[0.665, 0.665]","[0.783, 0.783]","[0.71, 0.711]","[0.624, 0.624]","[0.896, 0.897]","[0.819, 0.819]","[0.737, 0.737]","[0.79, 0.791]","[0.753, 0.753]",0.331,0.55,0.623,0.196,0.187,0.161,0.746,0.655,0.597,0.665,0.783,0.71,0.624,0.897,0.819,0.737,0.79,0.753
https://doi.org/10.1002/14651858.cd000020.pub2,antid administration in pregnancy for preventing rhesus alloimmunisation,1024_antid administration in pregnancy for preventing rhesus alloimmunisation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061251/pdf'],['Anti‐D administration in pregnancy for preventing Rhesus alloimmunisation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061251/pdf'],['1024_0_anti‐d administration in pregnancy for preventing rhesus alloimmunisation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061251/pdf'],['1024_0_anti‐d administration in pregnancy for preventing rhesus alloimmunisation.pdf'],[0.943],[0.546],[0.631],[0.208],[0.213],[0.174],[0.742],[0.649],[0.603],[0.688],[0.79],[0.712],[0.609],[0.909],[0.819],[0.732],[0.783],[0.758],0.943,0.546,0.631,0.208,0.213,0.174,0.742,0.649,0.603,0.688,0.79,0.712,0.609,0.909,0.819,0.732,0.783,0.758
https://doi.org/10.1002/14651858.cd000020.pub3,antid administration in pregnancy for preventing rhesus alloimmunisation,1025_antid administration in pregnancy for preventing rhesus alloimmunisation.pdf,3,"['https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2822%2900197-4', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Society of Family Planning committee consensus on Rh testing in early pregnancy', 'FIGO/ICM guidelines for preventing Rhesus disease: A call to action', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2822%2900197-4']","['1025_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1025_1_figoicm guidelines for preventing rhesus disease a call to action.pdf', '1025_0_society of family planning committee consensus on rh testing in early pregnancy.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2822%2900197-4']","['1025_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1025_1_figoicm guidelines for preventing rhesus disease a call to action.pdf', '1025_0_society of family planning committee consensus on rh testing in early pregnancy.pdf']","[0.255, 0.352, 0.437]","[0.501, 0.548, 0.546]","[0.592, 0.628, 0.627]","[0.169, 0.204, 0.193]","[0.166, 0.207, 0.196]","[0.145, 0.163, 0.157]","[0.737, 0.742, 0.737]","[0.644, 0.647, 0.641]","[0.555, 0.603, 0.607]","[0.688, 0.65, 0.646]","[0.761, 0.797, 0.8]","[0.69, 0.725, 0.727]","[0.592, 0.614, 0.616]","[0.884, 0.91, 0.912]","[0.769, 0.813, 0.819]","[0.682, 0.749, 0.747]","[0.754, 0.788, 0.789]","[0.707, 0.771, 0.773]",0.348,0.532,0.616,0.189,0.19,0.155,0.739,0.644,0.588,0.661,0.786,0.714,0.607,0.902,0.8,0.726,0.777,0.75
https://doi.org/10.1002/14651858.cd000025,magnesium sulphate and other anticonvulsants for women with preeclampsia,1026_magnesium sulphate and other anticonvulsants for women with preeclampsia.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865522/pdf']","['Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia', 'Magnesium sulphate versus lytic cocktail for eclampsia', 'Magnesium sulphate versus diazepam for eclampsia', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Chinese herbal medicines for treating pre‐eclampsia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865522/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061250/pdf']","['1026_2_magnesium sulphate versus diazepam for eclampsia.pdf', '1026_4_chinese herbal medicines for treating pre‐eclampsia.pdf', '1026_1_magnesium sulphate versus lytic cocktail for eclampsia.pdf', '1026_3_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1026_0_magnesium sulphate and other anticonvulsants for women with pre‐eclampsia.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865522/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061250/pdf']","['1026_2_magnesium sulphate versus diazepam for eclampsia.pdf', '1026_4_chinese herbal medicines for treating pre‐eclampsia.pdf', '1026_1_magnesium sulphate versus lytic cocktail for eclampsia.pdf', '1026_3_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1026_0_magnesium sulphate and other anticonvulsants for women with pre‐eclampsia.pdf']","[0.967, 0.68, 0.826, 0.09, 0.272]","[0.502, 0.493, 0.499, 0.513, 0.509]","[0.589, 0.585, 0.588, 0.604, 0.591]","[0.181, 0.148, 0.173, 0.181, 0.194]","[0.171, 0.142, 0.167, 0.14, 0.179]","[0.16, 0.13, 0.152, 0.126, 0.172]","[0.744, 0.734, 0.741, 0.738, 0.748]","[0.657, 0.641, 0.652, 0.642, 0.661]","[0.573, 0.565, 0.568, 0.567, 0.574]","[0.691, 0.676, 0.68, 0.657, 0.692]","[0.777, 0.77, 0.773, 0.794, 0.776]","[0.662, 0.662, 0.664, 0.684, 0.658]","[0.586, 0.569, 0.586, 0.606, 0.591]","[0.896, 0.899, 0.896, 0.901, 0.894]","[0.778, 0.792, 0.781, 0.797, 0.776]","[0.714, 0.712, 0.714, 0.745, 0.717]","[0.767, 0.763, 0.765, 0.785, 0.766]","[0.746, 0.744, 0.745, 0.762, 0.746]",0.567,0.503,0.591,0.175,0.16,0.148,0.741,0.651,0.569,0.679,0.778,0.666,0.588,0.897,0.785,0.72,0.769,0.749
https://doi.org/10.1002/14651858.cd000032.pub3,antenatal dietary education and supplementation to increase energy and protein intake,1027_antenatal dietary education and supplementation to increase energy and protein intake.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443020/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676908/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf']","['Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Support during pregnancy for women at increased risk of low birthweight babies', 'Antiplatelet agents for preventing pre‐eclampsia and its complications', 'Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Community‐based supplementary feeding for food insecure, vulnerable and malnourished populations – an overview of systematic reviews', 'Health system and community level interventions for improving antenatal care coverage and health outcomes', 'Epidural therapy for the treatment of severe pre‐eclampsia in non labouring women']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443020/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676908/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf']","['1027_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1027_7_epidural therapy for the treatment of severe pre‐eclampsia in non labouring women.pdf', '1027_1_support during pregnancy for women at increased risk of low birthweight babies.pdf', '1027_5_community‐based supplementary feeding for food insecure vulnerable and malnourished populations – an overview of systematic reviews.pdf', '1027_6_health system and community level interventions for improving antenatal care coverage and health outcomes.pdf', '1027_2_antiplatelet agents for preventing pre‐eclampsia and its complications.pdf', '1027_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1027_3_lipid‐based nutrient supplements for maternal birth and infant developmental outcomes.pdf']",8,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443020/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676908/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf']","['1027_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1027_7_epidural therapy for the treatment of severe pre‐eclampsia in non labouring women.pdf', '1027_1_support during pregnancy for women at increased risk of low birthweight babies.pdf', '1027_5_community‐based supplementary feeding for food insecure vulnerable and malnourished populations – an overview of systematic reviews.pdf', '1027_6_health system and community level interventions for improving antenatal care coverage and health outcomes.pdf', '1027_2_antiplatelet agents for preventing pre‐eclampsia and its complications.pdf', '1027_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1027_3_lipid‐based nutrient supplements for maternal birth and infant developmental outcomes.pdf']","[0.522, 0.627, 0.538, 0.623, 0.442, 0.498, 0.581, 0.434]","[0.515, 0.521, 0.531, 0.511, 0.525, 0.498, 0.503, 0.511]","[0.611, 0.617, 0.617, 0.599, 0.608, 0.585, 0.589, 0.601]","[0.169, 0.167, 0.19, 0.177, 0.177, 0.163, 0.177, 0.187]","[0.174, 0.163, 0.184, 0.176, 0.172, 0.147, 0.171, 0.179]","[0.144, 0.132, 0.157, 0.147, 0.143, 0.128, 0.148, 0.153]","[0.732, 0.731, 0.736, 0.738, 0.735, 0.735, 0.738, 0.741]","[0.638, 0.635, 0.642, 0.643, 0.641, 0.641, 0.646, 0.647]","[0.593, 0.593, 0.594, 0.576, 0.586, 0.569, 0.566, 0.576]","[0.694, 0.671, 0.697, 0.706, 0.701, 0.693, 0.704, 0.709]","[0.778, 0.778, 0.779, 0.764, 0.774, 0.77, 0.758, 0.764]","[0.687, 0.699, 0.697, 0.679, 0.69, 0.661, 0.684, 0.672]","[0.592, 0.591, 0.592, 0.582, 0.584, 0.581, 0.588, 0.583]","[0.911, 0.911, 0.906, 0.894, 0.905, 0.898, 0.883, 0.892]","[0.803, 0.807, 0.813, 0.795, 0.803, 0.79, 0.767, 0.797]","[0.722, 0.73, 0.727, 0.706, 0.722, 0.705, 0.686, 0.713]","[0.777, 0.779, 0.781, 0.768, 0.778, 0.765, 0.757, 0.764]","[0.759, 0.758, 0.758, 0.733, 0.75, 0.744, 0.713, 0.742]",0.533,0.514,0.603,0.176,0.171,0.144,0.736,0.642,0.582,0.697,0.771,0.684,0.587,0.9,0.797,0.714,0.771,0.745
https://doi.org/10.1002/14651858.cd000033.pub2,barbiturates for acute traumatic brain injury,1028_barbiturates for acute traumatic brain injury.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953357/pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf', 'https://www.colorado.gov/pacific/sites/default/files/Rule_17_Exhibit_2B_Referenced.pdf']","['Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury', 'Rule 17, Exhibit 2b', 'RULE 17, EXHIBIT 2B']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953357/pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf']","['1028_0_decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury.pdf', '1028_1_rule 17 exhibit 2b.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953357/pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf']","['1028_0_decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury.pdf', '1028_1_rule 17 exhibit 2b.pdf']","[0.567, 0.279]","[0.524, 0.53]","[0.611, 0.618]","[0.182, 0.156]","[0.188, 0.163]","[0.147, 0.123]","[0.742, 0.735]","[0.648, 0.635]","[0.593, 0.601]","[0.686, 0.654]","[0.783, 0.786]","[0.705, 0.725]","[0.602, 0.598]","[0.907, 0.915]","[0.816, 0.817]","[0.732, 0.748]","[0.78, 0.788]","[0.757, 0.766]",0.423,0.527,0.615,0.169,0.175,0.135,0.738,0.641,0.597,0.67,0.784,0.715,0.6,0.911,0.817,0.74,0.784,0.762
https://doi.org/10.1002/14651858.cd000051.pub2,cephalic version by postural management for breech presentation,1029_cephalic version by postural management for breech presentation.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171393/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188447/pdf']","['External cephalic version for breech presentation at term', 'Interventions for helping to turn term breech babies to head first presentation when using external cephalic version', 'External cephalic version for breech presentation before term']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188447/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171393/pdf']","['1029_0_external cephalic version for breech presentation at term.pdf', '1029_2_external cephalic version for breech presentation before term.pdf', '1029_1_interventions for helping to turn term breech babies to head first presentation when using external cephalic version.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188447/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171393/pdf']","['1029_0_external cephalic version for breech presentation at term.pdf', '1029_2_external cephalic version for breech presentation before term.pdf', '1029_1_interventions for helping to turn term breech babies to head first presentation when using external cephalic version.pdf']","[0.811, 0.564, 0.766]","[0.521, 0.523, 0.524]","[0.601, 0.602, 0.604]","[0.183, 0.189, 0.186]","[0.182, 0.187, 0.176]","[0.157, 0.164, 0.147]","[0.738, 0.74, 0.739]","[0.644, 0.646, 0.645]","[0.587, 0.587, 0.59]","[0.705, 0.711, 0.696]","[0.776, 0.775, 0.776]","[0.697, 0.696, 0.701]","[0.584, 0.585, 0.563]","[0.907, 0.905, 0.91]","[0.804, 0.804, 0.801]","[0.72, 0.717, 0.729]","[0.775, 0.773, 0.777]","[0.749, 0.745, 0.756]",0.714,0.523,0.602,0.186,0.182,0.156,0.739,0.645,0.588,0.704,0.776,0.698,0.577,0.907,0.803,0.722,0.775,0.75
https://doi.org/10.1002/14651858.cd000078,elective caesarean section versus expectant management for delivery of the small baby,1030_elective caesarean section versus expectant management for delivery of the small baby.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052739/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164504/pdf']","['Caesarean section versus vaginal delivery for preterm birth in singletons', 'Techniques for caesarean section', 'Caesarean section versus vaginal delivery for preterm birth in singletons']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052739/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164504/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['1030_0_caesarean section versus vaginal delivery for preterm birth in singletons.pdf', '1030_2_caesarean section versus vaginal delivery for preterm birth in singletons.pdf', '1030_1_techniques for caesarean section.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052739/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164504/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['1030_0_caesarean section versus vaginal delivery for preterm birth in singletons.pdf', '1030_2_caesarean section versus vaginal delivery for preterm birth in singletons.pdf', '1030_1_techniques for caesarean section.pdf']","[0.626, 0.52, 0.446]","[0.529, 0.525, 0.514]","[0.606, 0.606, 0.592]","[0.187, 0.168, 0.154]","[0.185, 0.176, 0.155]","[0.161, 0.151, 0.131]","[0.741, 0.734, 0.736]","[0.647, 0.637, 0.638]","[0.594, 0.592, 0.583]","[0.684, 0.686, 0.671]","[0.777, 0.767, 0.771]","[0.693, 0.704, 0.687]","[0.589, 0.556, 0.591]","[0.913, 0.914, 0.914]","[0.811, 0.809, 0.803]","[0.726, 0.723, 0.72]","[0.776, 0.771, 0.773]","[0.752, 0.752, 0.749]",0.531,0.523,0.601,0.17,0.172,0.148,0.737,0.641,0.59,0.68,0.772,0.695,0.579,0.914,0.808,0.723,0.773,0.751
https://doi.org/10.1002/14651858.cd000078.pub2,caesarean section versus vaginal delivery for preterm birth in singletons,1031_caesarean section versus vaginal delivery for preterm birth in singletons.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052739/pdf']","['Middle-East OBGYN Graduate Education (MOGGE) Foundation Practice Guidelines: Prelabor rupture of membranes; Practice guideline No. 01-O-19', 'Caesarean section versus vaginal delivery for preterm birth in singletons']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052739/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf']","['1031_1_caesarean section versus vaginal delivery for preterm birth in singletons.pdf', '1031_0_middleeast obgyn graduate education mogge foundation practice guidelines prelabor rupture of membranes practice guideline no 01o19.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052739/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf']","['1031_1_caesarean section versus vaginal delivery for preterm birth in singletons.pdf', '1031_0_middleeast obgyn graduate education mogge foundation practice guidelines prelabor rupture of membranes practice guideline no 01o19.pdf']","[0.362, 0.857]","[0.531, 0.538]","[0.611, 0.612]","[0.219, 0.177]","[0.207, 0.182]","[0.184, 0.14]","[0.745, 0.734]","[0.651, 0.636]","[0.587, 0.6]","[0.702, 0.656]","[0.776, 0.791]","[0.697, 0.712]","[0.586, 0.586]","[0.902, 0.91]","[0.802, 0.807]","[0.713, 0.732]","[0.77, 0.78]","[0.739, 0.754]",0.609,0.534,0.611,0.198,0.195,0.162,0.74,0.643,0.593,0.679,0.784,0.704,0.586,0.906,0.804,0.722,0.775,0.746
https://doi.org/10.1002/14651858.cd000078.pub3,caesarean section versus vaginal delivery for preterm birth in singletons,1032_caesarean section versus vaginal delivery for preterm birth in singletons.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf'],['Middle-East OBGYN Graduate Education (MOGGE) Foundation Practice Guidelines: Prelabor rupture of membranes; Practice guideline No. 01-O-19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf'],['1032_0_middleeast obgyn graduate education mogge foundation practice guidelines prelabor rupture of membranes practice guideline no 01o19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf'],['1032_0_middleeast obgyn graduate education mogge foundation practice guidelines prelabor rupture of membranes practice guideline no 01o19.pdf'],[0.295],[0.509],[0.589],[0.168],[0.166],[0.138],[0.738],[0.64],[0.574],[0.647],[0.778],[0.67],[0.574],[0.903],[0.787],[0.718],[0.761],[0.742],0.295,0.509,0.589,0.168,0.166,0.138,0.738,0.64,0.574,0.647,0.778,0.67,0.574,0.903,0.787,0.718,0.761,0.742
https://doi.org/10.1002/14651858.cd000082.pub2,expedited versus conservative approaches for vaginal delivery in breech presentation,1033_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf'],['Expedited versus conservative approaches for vaginal delivery in breech presentation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf'],['1033_0_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf'],['1033_0_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf'],[0.78],[0.545],[0.633],[0.185],[0.204],[0.179],[0.738],[0.642],[0.612],[0.706],[0.786],[0.712],[0.588],[0.931],[0.847],[0.744],[0.785],[0.775],0.78,0.545,0.633,0.185,0.204,0.179,0.738,0.642,0.612,0.706,0.786,0.712,0.588,0.931,0.847,0.744,0.785,0.775
https://doi.org/10.1002/14651858.cd000082.pub3,expedited versus conservative approaches for vaginal delivery in breech presentation,1034_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf'],['Expedited versus conservative approaches for vaginal delivery in breech presentation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf'],['1034_0_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf'],['1034_0_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf'],[0.959],[0.558],[0.644],[0.191],[0.207],[0.179],[0.74],[0.645],[0.625],[0.714],[0.796],[0.729],[0.6],[0.934],[0.846],[0.753],[0.795],[0.781],0.959,0.558,0.644,0.191,0.207,0.179,0.74,0.645,0.625,0.714,0.796,0.729,0.6,0.934,0.846,0.753,0.795,0.781
https://doi.org/10.1002/14651858.cd000085.pub2,extraabdominal versus intraabdominal repair of the uterine incision at caesarean section,1035_extraabdominal versus intraabdominal repair of the uterine incision at caesarean section.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988900/pdf']","['Techniques for caesarean section', 'Techniques and materials for skin closure in caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988900/pdf']","['1035_0_techniques for caesarean section.pdf', '1035_1_techniques and materials for skin closure in caesarean section.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988900/pdf']","['1035_0_techniques for caesarean section.pdf', '1035_1_techniques and materials for skin closure in caesarean section.pdf']","[0.631, 0.512]","[0.502, 0.518]","[0.588, 0.601]","[0.169, 0.183]","[0.164, 0.173]","[0.141, 0.144]","[0.743, 0.744]","[0.648, 0.649]","[0.564, 0.579]","[0.668, 0.664]","[0.768, 0.776]","[0.678, 0.692]","[0.59, 0.591]","[0.903, 0.904]","[0.796, 0.809]","[0.715, 0.728]","[0.765, 0.773]","[0.744, 0.754]",0.572,0.51,0.595,0.176,0.168,0.142,0.744,0.649,0.571,0.666,0.772,0.685,0.591,0.903,0.802,0.722,0.769,0.749
https://doi.org/10.1002/14651858.cd000098,antibiotics for gonorrhoea in pregnancy,1036_antibiotics for gonorrhoea in pregnancy.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491276/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498019/pdf']","['Antibiotics for treating gonorrhoea in pregnancy', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498019/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491276/pdf']","['1036_2_antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.pdf', '1036_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1036_0_antibiotics for treating gonorrhoea in pregnancy.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498019/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491276/pdf']","['1036_2_antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.pdf', '1036_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1036_0_antibiotics for treating gonorrhoea in pregnancy.pdf']","[0.676, 0.197, 0.465]","[0.523, 0.561, 0.522]","[0.617, 0.643, 0.617]","[0.172, 0.18, 0.175]","[0.178, 0.163, 0.187]","[0.153, 0.14, 0.158]","[0.738, 0.739, 0.738]","[0.643, 0.641, 0.642]","[0.591, 0.625, 0.594]","[0.679, 0.661, 0.684]","[0.778, 0.805, 0.779]","[0.704, 0.747, 0.703]","[0.586, 0.625, 0.592]","[0.913, 0.917, 0.913]","[0.808, 0.829, 0.814]","[0.729, 0.771, 0.732]","[0.771, 0.805, 0.773]","[0.755, 0.786, 0.759]",0.446,0.535,0.626,0.176,0.176,0.15,0.738,0.642,0.603,0.675,0.787,0.718,0.601,0.914,0.817,0.744,0.783,0.767
https://doi.org/10.1002/14651858.cd000111.pub2,immersion in water in pregnancy labour and birth,1037_immersion in water in pregnancy labour and birth.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494420/pdf']","['Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period', 'Immersion in water during labour and birth']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494420/pdf']","['1037_0_paracetamolacetaminophen single administration for perineal pain in the early postpartum period.pdf', '1037_1_immersion in water during labour and birth.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494420/pdf']","['1037_0_paracetamolacetaminophen single administration for perineal pain in the early postpartum period.pdf', '1037_1_immersion in water during labour and birth.pdf']","[0.347, 0.833]","[0.521, 0.517]","[0.612, 0.599]","[0.151, 0.179]","[0.157, 0.177]","[0.118, 0.15]","[0.732, 0.738]","[0.633, 0.643]","[0.586, 0.569]","[0.666, 0.681]","[0.78, 0.769]","[0.705, 0.688]","[0.594, 0.595]","[0.917, 0.898]","[0.813, 0.796]","[0.732, 0.716]","[0.783, 0.771]","[0.759, 0.742]",0.59,0.519,0.605,0.165,0.167,0.134,0.735,0.638,0.577,0.673,0.774,0.696,0.595,0.907,0.804,0.724,0.777,0.75
https://doi.org/10.1002/14651858.cd000121,interventions for leg cramps in pregnancy,1038_interventions for leg cramps in pregnancy.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094374/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025716/pdf']","['Interventions for leg cramps in pregnancy', 'Non‐drug therapies for lower limb muscle cramps', 'Magnesium for skeletal muscle cramps']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025716/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094374/pdf']","['1038_2_magnesium for skeletal muscle cramps.pdf', '1038_1_non‐drug therapies for lower limb muscle cramps.pdf', '1038_0_interventions for leg cramps in pregnancy.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025716/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094374/pdf']","['1038_2_magnesium for skeletal muscle cramps.pdf', '1038_1_non‐drug therapies for lower limb muscle cramps.pdf', '1038_0_interventions for leg cramps in pregnancy.pdf']","[0.699, 0.464, 0.507]","[0.528, 0.53, 0.522]","[0.602, 0.61, 0.596]","[0.17, 0.16, 0.169]","[0.184, 0.181, 0.181]","[0.152, 0.142, 0.15]","[0.733, 0.731, 0.733]","[0.637, 0.632, 0.635]","[0.591, 0.602, 0.583]","[0.707, 0.687, 0.709]","[0.776, 0.785, 0.772]","[0.695, 0.72, 0.698]","[0.604, 0.606, 0.594]","[0.912, 0.918, 0.906]","[0.829, 0.834, 0.818]","[0.734, 0.747, 0.719]","[0.777, 0.788, 0.772]","[0.76, 0.769, 0.747]",0.557,0.527,0.603,0.166,0.182,0.148,0.732,0.635,0.592,0.701,0.778,0.704,0.601,0.912,0.827,0.733,0.779,0.759
https://doi.org/10.1002/14651858.cd000133,maternal dietary antigen avoidance during pregnancy andor lactation for preventing or treating atopic disease in the child,1039_maternal dietary antigen avoidance during pregnancy andor lactation for preventing or treating atopic disease in the child.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045459/pdf'],"['Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045459/pdf'],['1039_0_maternal dietary antigen avoidance during pregnancy or lactation or both for preventing or treating atopic disease in the child.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045459/pdf'],['1039_0_maternal dietary antigen avoidance during pregnancy or lactation or both for preventing or treating atopic disease in the child.pdf'],[0.736],[0.534],[0.626],[0.192],[0.197],[0.174],[0.749],[0.655],[0.591],[0.677],[0.778],[0.685],[0.598],[0.91],[0.804],[0.729],[0.776],[0.755],0.736,0.534,0.626,0.192,0.197,0.174,0.749,0.655,0.591,0.677,0.778,0.685,0.598,0.91,0.804,0.729,0.776,0.755
https://doi.org/10.1002/14651858.cd000145,interventions for nausea and vomiting in early pregnancy,1040_interventions for nausea and vomiting in early pregnancy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196889/pdf'],['Interventions for nausea and vomiting in early pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196889/pdf'],['1040_0_interventions for nausea and vomiting in early pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196889/pdf'],['1040_0_interventions for nausea and vomiting in early pregnancy.pdf'],[0.756],[0.538],[0.616],[0.177],[0.189],[0.153],[0.738],[0.647],[0.596],[0.697],[0.782],[0.703],[0.605],[0.911],[0.821],[0.743],[0.785],[0.765],0.756,0.538,0.616,0.177,0.189,0.153,0.738,0.647,0.596,0.697,0.782,0.703,0.605,0.911,0.821,0.743,0.785,0.765
https://doi.org/10.1002/14651858.cd000169,drugs for preventing malariarelated illness in pregnant women and death in the newborn,1041_drugs for preventing malariarelated illness in pregnant women and death in the newborn.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532581/pdf']","['Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment', 'Insecticide‐treated nets for preventing malaria in pregnancy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498495/pdf']","['1041_1_insecticide‐treated nets for preventing malaria in pregnancy.pdf', '1041_0_drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or no treatment.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498495/pdf']","['1041_1_insecticide‐treated nets for preventing malaria in pregnancy.pdf', '1041_0_drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or no treatment.pdf']","[0.646, 0.535]","[0.5, 0.506]","[0.582, 0.585]","[0.18, 0.188]","[0.171, 0.169]","[0.154, 0.154]","[0.744, 0.745]","[0.651, 0.652]","[0.563, 0.565]","[0.695, 0.708]","[0.768, 0.766]","[0.663, 0.653]","[0.597, 0.581]","[0.885, 0.89]","[0.773, 0.776]","[0.71, 0.705]","[0.762, 0.763]","[0.738, 0.737]",0.591,0.503,0.583,0.184,0.17,0.154,0.744,0.651,0.564,0.702,0.767,0.658,0.589,0.887,0.774,0.708,0.762,0.738
https://doi.org/10.1002/14651858.cd000169.pub2,drugs for preventing malaria in pregnant women,1042_drugs for preventing malaria in pregnant women.pdf,8,"['http://www.ifpri.org/publication/operational-evidence-base-delivering-direct-nutrition-interventions-india-desk-review', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/127860', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532702/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532683/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf']","['The operational evidence base for delivering direct nutrition', 'The operational evidence base for delivering direct nutrition interventions in India: A desk review', 'Larvivorous fish for preventing malaria transmission', 'Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment', 'Intermittent preventive treatment regimens for malaria in HIV‐positive pregnant women', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Drugs for treating uncomplicated malaria in pregnant women', 'Intermittent preventive treatment for malaria in children living in areas with seasonal transmission']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532683/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532702/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf']","['1042_6_drugs for treating uncomplicated malaria in pregnant women.pdf', '1042_7_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf', '1042_3_drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or no treatment.pdf', '1042_5_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1042_4_intermittent preventive treatment regimens for malaria in hiv‐positive pregnant women.pdf', '1042_2_larvivorous fish for preventing malaria transmission.pdf']",6,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532683/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532702/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf']","['1042_6_drugs for treating uncomplicated malaria in pregnant women.pdf', '1042_7_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf', '1042_3_drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or no treatment.pdf', '1042_5_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1042_4_intermittent preventive treatment regimens for malaria in hiv‐positive pregnant women.pdf', '1042_2_larvivorous fish for preventing malaria transmission.pdf']","[0.191, 0.695, 0.493, 0.125, 0.601, 0.452]","[0.508, 0.504, 0.507, 0.532, 0.502, 0.501]","[0.59, 0.588, 0.59, 0.617, 0.587, 0.59]","[0.19, 0.187, 0.194, 0.2, 0.19, 0.151]","[0.174, 0.167, 0.174, 0.166, 0.171, 0.125]","[0.156, 0.147, 0.155, 0.142, 0.156, 0.105]","[0.747, 0.743, 0.746, 0.742, 0.747, 0.732]","[0.654, 0.651, 0.654, 0.646, 0.655, 0.638]","[0.567, 0.566, 0.565, 0.582, 0.566, 0.572]","[0.687, 0.693, 0.705, 0.666, 0.693, 0.657]","[0.767, 0.77, 0.766, 0.794, 0.767, 0.775]","[0.673, 0.669, 0.663, 0.704, 0.658, 0.683]","[0.587, 0.59, 0.584, 0.619, 0.593, 0.583]","[0.891, 0.899, 0.897, 0.904, 0.895, 0.903]","[0.782, 0.782, 0.778, 0.806, 0.773, 0.796]","[0.711, 0.715, 0.71, 0.754, 0.708, 0.718]","[0.761, 0.765, 0.765, 0.79, 0.76, 0.774]","[0.737, 0.742, 0.738, 0.767, 0.735, 0.748]",0.426,0.509,0.594,0.185,0.163,0.143,0.743,0.65,0.57,0.683,0.773,0.675,0.593,0.898,0.786,0.719,0.769,0.744
https://doi.org/10.1002/14651858.cd000169.pub3,drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or no treatment,1043_drugs for preventing malaria in pregnant women in endemic areas any drug regimen versus placebo or no treatment.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875065/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453882/pdf']","['Mefloquine for preventing malaria during travel to endemic areas', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Mefloquine for preventing malaria in pregnant women', 'Mefloquine for preventing malaria in pregnant women', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Adding rapid diagnostic tests to community‐based programmes for treating malaria']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453882/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875065/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/pdf']","['1043_5_adding rapid diagnostic tests to community‐based programmes for treating malaria.pdf', '1043_3_mefloquine for preventing malaria in pregnant women.pdf', '1043_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1043_4_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1043_0_mefloquine for preventing malaria during travel to endemic areas.pdf', '1043_2_mefloquine for preventing malaria in pregnant women.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453882/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875065/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/pdf']","['1043_5_adding rapid diagnostic tests to community‐based programmes for treating malaria.pdf', '1043_3_mefloquine for preventing malaria in pregnant women.pdf', '1043_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1043_4_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1043_0_mefloquine for preventing malaria during travel to endemic areas.pdf', '1043_2_mefloquine for preventing malaria in pregnant women.pdf']","[0.554, 0.483, 0.629, 0.61, 0.511, 0.5]","[0.541, 0.511, 0.53, 0.508, 0.518, 0.511]","[0.62, 0.597, 0.618, 0.592, 0.602, 0.598]","[0.193, 0.193, 0.185, 0.187, 0.19, 0.19]","[0.188, 0.191, 0.192, 0.183, 0.18, 0.187]","[0.152, 0.158, 0.156, 0.154, 0.152, 0.155]","[0.737, 0.743, 0.734, 0.738, 0.738, 0.742]","[0.643, 0.651, 0.64, 0.646, 0.646, 0.649]","[0.597, 0.561, 0.6, 0.561, 0.573, 0.564]","[0.706, 0.703, 0.704, 0.707, 0.71, 0.702]","[0.78, 0.767, 0.785, 0.761, 0.772, 0.766]","[0.716, 0.687, 0.705, 0.696, 0.693, 0.686]","[0.59, 0.578, 0.592, 0.585, 0.581, 0.576]","[0.911, 0.887, 0.917, 0.886, 0.905, 0.894]","[0.815, 0.782, 0.812, 0.771, 0.792, 0.786]","[0.727, 0.707, 0.728, 0.686, 0.714, 0.705]","[0.787, 0.766, 0.788, 0.764, 0.776, 0.767]","[0.751, 0.726, 0.761, 0.708, 0.739, 0.728]",0.548,0.52,0.604,0.19,0.187,0.154,0.739,0.646,0.576,0.705,0.772,0.697,0.584,0.9,0.793,0.711,0.775,0.735
https://doi.org/10.1002/14651858.cd000184.pub2,interventions to help external cephalic version for breech presentation at term,1044_interventions to help external cephalic version for breech presentation at term.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171393/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505736/pdf']","['Interventions for helping to turn term breech babies to head first presentation when using external cephalic version', 'Planned caesarean section for term breech delivery']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505736/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171393/pdf']","['1044_1_planned caesarean section for term breech delivery.pdf', '1044_0_interventions for helping to turn term breech babies to head first presentation when using external cephalic version.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505736/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171393/pdf']","['1044_1_planned caesarean section for term breech delivery.pdf', '1044_0_interventions for helping to turn term breech babies to head first presentation when using external cephalic version.pdf']","[0.541, 0.446]","[0.524, 0.545]","[0.607, 0.625]","[0.192, 0.204]","[0.192, 0.194]","[0.157, 0.155]","[0.741, 0.741]","[0.648, 0.649]","[0.581, 0.608]","[0.665, 0.668]","[0.781, 0.791]","[0.7, 0.72]","[0.597, 0.577]","[0.907, 0.92]","[0.805, 0.817]","[0.726, 0.748]","[0.778, 0.792]","[0.75, 0.773]",0.494,0.534,0.616,0.198,0.193,0.156,0.741,0.649,0.595,0.667,0.786,0.71,0.587,0.913,0.811,0.737,0.785,0.762
https://doi.org/10.1002/14651858.cd000184.pub3,interventions for helping to turn term breech babies to head first presentation when using external cephalic version,1045_interventions for helping to turn term breech babies to head first presentation when using external cephalic version.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf']","['External cephalic version for breech presentation at term', 'Expedited versus conservative approaches for vaginal delivery in breech presentation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505738/pdf']","['1045_1_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf', '1045_0_external cephalic version for breech presentation at term.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505640/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505738/pdf']","['1045_1_expedited versus conservative approaches for vaginal delivery in breech presentation.pdf', '1045_0_external cephalic version for breech presentation at term.pdf']","[0.675, 0.457]","[0.526, 0.523]","[0.607, 0.6]","[0.184, 0.195]","[0.173, 0.179]","[0.15, 0.156]","[0.738, 0.741]","[0.641, 0.647]","[0.591, 0.585]","[0.688, 0.688]","[0.779, 0.777]","[0.694, 0.691]","[0.579, 0.584]","[0.914, 0.902]","[0.813, 0.799]","[0.727, 0.723]","[0.776, 0.775]","[0.759, 0.751]",0.566,0.524,0.603,0.19,0.176,0.153,0.74,0.644,0.588,0.688,0.778,0.692,0.581,0.908,0.806,0.725,0.776,0.755
https://doi.org/10.1002/14651858.cd000184.pub4,interventions for helping to turn term breech babies to head first presentation when using external cephalic version,1046_interventions for helping to turn term breech babies to head first presentation when using external cephalic version.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188447/pdf'],['External cephalic version for breech presentation before term'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188447/pdf'],['1046_0_external cephalic version for breech presentation before term.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188447/pdf'],['1046_0_external cephalic version for breech presentation before term.pdf'],[0.695],[0.522],[0.6],[0.198],[0.183],[0.159],[0.742],[0.649],[0.581],[0.69],[0.774],[0.692],[0.587],[0.896],[0.795],[0.715],[0.772],[0.74],0.695,0.522,0.6,0.198,0.183,0.159,0.742,0.649,0.581,0.69,0.774,0.692,0.587,0.896,0.795,0.715,0.772,0.74
https://doi.org/10.1002/14651858.cd000198.pub2,support during pregnancy for women at increased risk of low birthweight babies,1047_support during pregnancy for women at increased risk of low birthweight babies.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443020/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464057/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.hca.wa.gov/assets/program/toolkit_for_reducing_caeserean_sections.pdf']","['Risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes', 'Delivery arrangements for health systems in low‐income countries: an overview of systematic reviews', 'Support during pregnancy for women at increased risk of low birthweight babies', 'Home uterine monitoring for detecting preterm labour', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Improving Maternal& Neonatal Outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464057/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443020/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388653/pdf', 'https://www.hca.wa.gov/assets/program/toolkit_for_reducing_caeserean_sections.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1047_3_home uterine monitoring for detecting preterm labour.pdf', '1047_2_support during pregnancy for women at increased risk of low birthweight babies.pdf', '1047_1_delivery arrangements for health systems in low‐income countries an overview of systematic reviews.pdf', '1047_0_risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes.pdf', '1047_5_improving maternal neonatal outcomes.pdf', '1047_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464057/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443020/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388653/pdf', 'https://www.hca.wa.gov/assets/program/toolkit_for_reducing_caeserean_sections.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1047_3_home uterine monitoring for detecting preterm labour.pdf', '1047_2_support during pregnancy for women at increased risk of low birthweight babies.pdf', '1047_1_delivery arrangements for health systems in low‐income countries an overview of systematic reviews.pdf', '1047_0_risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes.pdf', '1047_5_improving maternal neonatal outcomes.pdf', '1047_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.586, 0.426, 0.9, 0.644, 0.527, 0.389]","[0.548, 0.553, 0.546, 0.56, 0.539, 0.533]","[0.626, 0.631, 0.632, 0.645, 0.621, 0.622]","[0.2, 0.206, 0.179, 0.203, 0.18, 0.179]","[0.205, 0.215, 0.184, 0.214, 0.194, 0.191]","[0.174, 0.185, 0.153, 0.182, 0.155, 0.163]","[0.736, 0.736, 0.734, 0.736, 0.729, 0.731]","[0.644, 0.645, 0.641, 0.641, 0.637, 0.637]","[0.609, 0.616, 0.611, 0.625, 0.608, 0.609]","[0.705, 0.716, 0.704, 0.713, 0.678, 0.703]","[0.789, 0.795, 0.794, 0.8, 0.794, 0.793]","[0.719, 0.722, 0.718, 0.732, 0.728, 0.706]","[0.607, 0.609, 0.605, 0.612, 0.611, 0.605]","[0.913, 0.917, 0.926, 0.923, 0.914, 0.924]","[0.821, 0.834, 0.832, 0.837, 0.817, 0.824]","[0.739, 0.747, 0.75, 0.758, 0.75, 0.741]","[0.791, 0.797, 0.797, 0.801, 0.797, 0.792]","[0.768, 0.777, 0.779, 0.786, 0.774, 0.778]",0.579,0.546,0.63,0.191,0.201,0.169,0.734,0.641,0.613,0.703,0.794,0.721,0.608,0.92,0.828,0.747,0.796,0.777
https://doi.org/10.1002/14651858.cd000198.pub3,support during pregnancy for women at increased risk of low birthweight babies,1048_support during pregnancy for women at increased risk of low birthweight babies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf'],"['Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf'],['1048_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf'],['1048_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf'],[0.583],[0.507],[0.593],[0.182],[0.183],[0.161],[0.736],[0.644],[0.563],[0.708],[0.763],[0.689],[0.592],[0.89],[0.778],[0.688],[0.761],[0.717],0.583,0.507,0.593,0.182,0.183,0.161,0.736,0.644,0.563,0.708,0.763,0.689,0.592,0.89,0.778,0.688,0.761,0.717
https://doi.org/10.1002/14651858.cd000222.pub2,ursodeoxycholic acid for cystic fibrosisrelated liver disease,1049_ursodeoxycholic acid for cystic fibrosisrelated liver disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['Ursodeoxycholic acid for cystic fibrosis‐related liver disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['1049_0_ursodeoxycholic acid for cystic fibrosis‐related liver disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['1049_0_ursodeoxycholic acid for cystic fibrosis‐related liver disease.pdf'],[0.937],[0.551],[0.631],[0.208],[0.216],[0.166],[0.745],[0.653],[0.62],[0.711],[0.801],[0.725],[0.614],[0.913],[0.835],[0.754],[0.794],[0.78],0.937,0.551,0.631,0.208,0.216,0.166,0.745,0.653,0.62,0.711,0.801,0.725,0.614,0.913,0.835,0.754,0.794,0.78
https://doi.org/10.1002/14651858.cd000222.pub3,ursodeoxycholic acid for cystic fibrosisrelated liver disease,1050_ursodeoxycholic acid for cystic fibrosisrelated liver disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['Ursodeoxycholic acid for cystic fibrosis‐related liver disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['1050_0_ursodeoxycholic acid for cystic fibrosis‐related liver disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['1050_0_ursodeoxycholic acid for cystic fibrosis‐related liver disease.pdf'],[0.932],[0.56],[0.64],[0.21],[0.222],[0.167],[0.743],[0.651],[0.631],[0.71],[0.806],[0.734],[0.619],[0.919],[0.84],[0.764],[0.801],[0.787],0.932,0.56,0.64,0.21,0.222,0.167,0.743,0.651,0.631,0.71,0.806,0.734,0.619,0.919,0.84,0.764,0.801,0.787
https://doi.org/10.1002/14651858.cd000222.pub4,ursodeoxycholic acid for cystic fibrosisrelated liver disease,1051_ursodeoxycholic acid for cystic fibrosisrelated liver disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['Ursodeoxycholic acid for cystic fibrosis‐related liver disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['1051_0_ursodeoxycholic acid for cystic fibrosis‐related liver disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483662/pdf'],['1051_0_ursodeoxycholic acid for cystic fibrosis‐related liver disease.pdf'],[0.964],[0.551],[0.633],[0.207],[0.216],[0.165],[0.745],[0.654],[0.619],[0.712],[0.799],[0.725],[0.614],[0.914],[0.833],[0.754],[0.793],[0.779],0.964,0.551,0.633,0.207,0.216,0.165,0.745,0.654,0.619,0.712,0.799,0.725,0.614,0.914,0.833,0.754,0.793,0.779
https://doi.org/10.1002/14651858.cd000498.pub2,intraventricular streptokinase after intraventricular hemorrhage in newborn infants,1074_intraventricular streptokinase after intraventricular hemorrhage in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061244/pdf'],['Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061244/pdf'],['1074_0_postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061244/pdf'],['1074_0_postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants.pdf'],[0.515],[0.509],[0.611],[0.17],[0.161],[0.135],[0.744],[0.65],[0.576],[0.669],[0.775],[0.681],[0.595],[0.903],[0.795],[0.714],[0.766],[0.743],0.515,0.509,0.611,0.17,0.161,0.135,0.744,0.65,0.576,0.669,0.775,0.681,0.595,0.903,0.795,0.714,0.766,0.743
https://doi.org/10.1002/14651858.cd000500,endotracheal intubation at birth for preventing morbidity and mortality in vigorous meconiumstained infants born at term,1075_endotracheal intubation at birth for preventing morbidity and mortality in vigorous meconiumstained infants born at term.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823264/pdf']","['Tracheal suction at birth in non‐vigorous neonates born through meconium‐stained amniotic fluid', 'Routine oro/nasopharyngeal suction versus no suction at birth', 'Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207961/pdf']","['1075_1_routine oronasopharyngeal suction versus no suction at birth.pdf', '1075_2_antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections.pdf', '1075_0_tracheal suction at birth in non‐vigorous neonates born through meconium‐stained amniotic fluid.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207961/pdf']","['1075_1_routine oronasopharyngeal suction versus no suction at birth.pdf', '1075_2_antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections.pdf', '1075_0_tracheal suction at birth in non‐vigorous neonates born through meconium‐stained amniotic fluid.pdf']","[0.598, 0.533, 0.406]","[0.529, 0.525, 0.527]","[0.616, 0.611, 0.614]","[0.196, 0.173, 0.2]","[0.182, 0.163, 0.191]","[0.153, 0.138, 0.165]","[0.741, 0.738, 0.741]","[0.653, 0.647, 0.654]","[0.59, 0.59, 0.587]","[0.674, 0.665, 0.679]","[0.779, 0.782, 0.78]","[0.693, 0.697, 0.695]","[0.602, 0.597, 0.603]","[0.91, 0.91, 0.903]","[0.803, 0.806, 0.799]","[0.732, 0.731, 0.725]","[0.777, 0.776, 0.775]","[0.756, 0.759, 0.751]",0.512,0.527,0.614,0.19,0.179,0.152,0.74,0.651,0.589,0.673,0.78,0.695,0.601,0.908,0.803,0.729,0.776,0.755
https://doi.org/10.1002/14651858.cd000546.pub2,aversive smoking for smoking cessation,1076_aversive smoking for smoking cessation.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372978/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816175/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464070/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://stacks.cdc.gov/view/cdc/43466']","['Interventions for promoting smoking cessation during pregnancy', 'Relapse prevention interventions for smoking cessation', 'Relapse prevention interventions for smoking cessation', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Group behaviour therapy programmes for smoking cessation', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Promoting quitting among adults and young people: outcome indicators for comprehensive tobacco control programs—2015']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816175/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372978/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464070/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1076_2_relapse prevention interventions for smoking cessation.pdf', '1076_0_interventions for promoting smoking cessation during pregnancy.pdf', '1076_1_relapse prevention interventions for smoking cessation.pdf', '1076_5_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1076_4_group behaviour therapy programmes for smoking cessation.pdf', '1076_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816175/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372978/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464070/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1076_2_relapse prevention interventions for smoking cessation.pdf', '1076_0_interventions for promoting smoking cessation during pregnancy.pdf', '1076_1_relapse prevention interventions for smoking cessation.pdf', '1076_5_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1076_4_group behaviour therapy programmes for smoking cessation.pdf', '1076_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.51, 0.578, 0.557, 0.53, 0.618, 0.466]","[0.536, 0.528, 0.541, 0.524, 0.542, 0.532]","[0.614, 0.613, 0.618, 0.609, 0.616, 0.606]","[0.201, 0.169, 0.209, 0.177, 0.201, 0.184]","[0.214, 0.18, 0.222, 0.183, 0.213, 0.183]","[0.186, 0.155, 0.19, 0.156, 0.184, 0.162]","[0.745, 0.732, 0.746, 0.736, 0.742, 0.738]","[0.654, 0.639, 0.657, 0.644, 0.652, 0.645]","[0.596, 0.599, 0.603, 0.589, 0.603, 0.592]","[0.729, 0.713, 0.729, 0.714, 0.729, 0.716]","[0.785, 0.782, 0.792, 0.776, 0.791, 0.782]","[0.699, 0.712, 0.717, 0.701, 0.711, 0.696]","[0.592, 0.587, 0.599, 0.575, 0.6, 0.589]","[0.915, 0.919, 0.913, 0.912, 0.92, 0.914]","[0.814, 0.816, 0.815, 0.803, 0.824, 0.81]","[0.74, 0.747, 0.752, 0.737, 0.749, 0.738]","[0.785, 0.788, 0.792, 0.779, 0.794, 0.785]","[0.768, 0.769, 0.773, 0.761, 0.776, 0.765]",0.543,0.534,0.613,0.19,0.199,0.172,0.74,0.649,0.597,0.722,0.785,0.706,0.59,0.915,0.814,0.744,0.787,0.769
https://doi.org/10.1002/14651858.cd000950,carnitine supplementation of parenterally fed neonates,1077_carnitine supplementation of parenterally fed neonates.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826756/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795370/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390060/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752126/pdf']","['Carnitine supplementation for preterm infants with recurrent apnoea', 'Neonatology/Paediatrics – Guidelines on Parenteral Nutrition, Chapter 13', 'Carnitine supplementation for inborn errors of metabolism', 'Nutritional support in children and young people with cancer undergoing chemotherapy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390060/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795370/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826756/pdf']","['1077_2_carnitine supplementation for inborn errors of metabolism.pdf', '1077_3_nutritional support in children and young people with cancer undergoing chemotherapy.pdf', '1077_1_neonatologypaediatrics – guidelines on parenteral nutrition chapter 13.pdf', '1077_0_carnitine supplementation for preterm infants with recurrent apnoea.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390060/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795370/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826756/pdf']","['1077_2_carnitine supplementation for inborn errors of metabolism.pdf', '1077_3_nutritional support in children and young people with cancer undergoing chemotherapy.pdf', '1077_1_neonatologypaediatrics – guidelines on parenteral nutrition chapter 13.pdf', '1077_0_carnitine supplementation for preterm infants with recurrent apnoea.pdf']","[0.515, 0.374, 0.454, 0.445]","[0.532, 0.518, 0.533, 0.541]","[0.616, 0.605, 0.615, 0.62]","[0.171, 0.172, 0.177, 0.18]","[0.183, 0.17, 0.183, 0.195]","[0.151, 0.145, 0.151, 0.169]","[0.734, 0.738, 0.736, 0.734]","[0.637, 0.643, 0.642, 0.642]","[0.607, 0.584, 0.605, 0.612]","[0.681, 0.682, 0.67, 0.68]","[0.792, 0.773, 0.795, 0.795]","[0.71, 0.692, 0.704, 0.708]","[0.604, 0.601, 0.619, 0.608]","[0.909, 0.902, 0.911, 0.919]","[0.831, 0.808, 0.817, 0.83]","[0.75, 0.724, 0.752, 0.754]","[0.788, 0.773, 0.79, 0.792]","[0.779, 0.752, 0.78, 0.782]",0.447,0.531,0.614,0.175,0.183,0.154,0.736,0.641,0.602,0.678,0.789,0.704,0.608,0.91,0.822,0.745,0.786,0.773
https://doi.org/10.1002/14651858.cd000979,orthodontic treatment for posterior crossbites,1078_orthodontic treatment for posterior crossbites.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709729/pdf'],['Orthodontic treatment for posterior crossbites'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709729/pdf'],['1078_0_orthodontic treatment for posterior crossbites.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709729/pdf'],['1078_0_orthodontic treatment for posterior crossbites.pdf'],[0.685],[0.532],[0.613],[0.179],[0.187],[0.156],[0.743],[0.648],[0.596],[0.693],[0.787],[0.704],[0.609],[0.92],[0.817],[0.746],[0.787],[0.771],0.685,0.532,0.613,0.179,0.187,0.156,0.743,0.648,0.596,0.693,0.787,0.704,0.609,0.92,0.817,0.746,0.787,0.771
https://doi.org/10.1002/14651858.cd001006.pub2,mass media interventions for preventing smoking in young people,1079_mass media interventions for preventing smoking in young people.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773732/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486186/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://stacks.cdc.gov/view/cdc/60890', 'https://stacks.cdc.gov/view/cdc/46304', 'https://stacks.cdc.gov/view/cdc/81586']","['Mass media interventions for reducing mental health‐related stigma', 'Interventions for tobacco use prevention in Indigenous youth', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Health communication science digest searchable archive', 'Health communication science digest searchable archive', 'Health communication science digest searchable archive']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773732/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1079_0_mass media interventions for reducing mental health‐related stigma.pdf', '1079_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",2,33.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773732/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1079_0_mass media interventions for reducing mental health‐related stigma.pdf', '1079_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.626, 0.62]","[0.535, 0.533]","[0.625, 0.613]","[0.181, 0.188]","[0.182, 0.184]","[0.155, 0.159]","[0.733, 0.736]","[0.64, 0.642]","[0.597, 0.592]","[0.711, 0.704]","[0.783, 0.784]","[0.71, 0.705]","[0.612, 0.6]","[0.916, 0.915]","[0.833, 0.82]","[0.738, 0.737]","[0.788, 0.788]","[0.769, 0.767]",0.623,0.534,0.619,0.184,0.183,0.157,0.734,0.641,0.595,0.708,0.784,0.708,0.606,0.915,0.827,0.738,0.788,0.768
https://doi.org/10.1002/14651858.cd001006.pub3,mass media interventions for preventing smoking in young people,1080_mass media interventions for preventing smoking in young people.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481498/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf', 'https://www.rand.org/pubs/research_reports/RRA766-1.html', 'https://stacks.cdc.gov/view/cdc/60890', 'https://stacks.cdc.gov/view/cdc/81586']","['Mass media interventions for smoking cessation in adults', 'Incentives for preventing smoking in children and adolescents', 'Tobacco cessation interventions for young people', 'Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population', 'Do National Security Communication Campaigns Work?', 'Health communication science digest searchable archive', 'Health communication science digest searchable archive']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481498/pdf']","['1080_3_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf', '1080_2_tobacco cessation interventions for young people.pdf', '1080_0_mass media interventions for smoking cessation in adults.pdf', '1080_1_incentives for preventing smoking in children and adolescents.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481498/pdf']","['1080_3_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf', '1080_2_tobacco cessation interventions for young people.pdf', '1080_0_mass media interventions for smoking cessation in adults.pdf', '1080_1_incentives for preventing smoking in children and adolescents.pdf']","[0.849, 0.716, 0.722, 0.63]","[0.534, 0.542, 0.538, 0.545]","[0.62, 0.625, 0.62, 0.626]","[0.177, 0.205, 0.2, 0.207]","[0.176, 0.213, 0.212, 0.217]","[0.154, 0.184, 0.176, 0.185]","[0.733, 0.741, 0.736, 0.737]","[0.638, 0.649, 0.642, 0.643]","[0.596, 0.604, 0.602, 0.608]","[0.712, 0.717, 0.72, 0.723]","[0.784, 0.791, 0.791, 0.793]","[0.712, 0.723, 0.726, 0.725]","[0.602, 0.613, 0.619, 0.62]","[0.917, 0.918, 0.916, 0.919]","[0.831, 0.832, 0.832, 0.833]","[0.738, 0.746, 0.742, 0.747]","[0.784, 0.795, 0.798, 0.796]","[0.771, 0.777, 0.774, 0.776]",0.729,0.54,0.623,0.197,0.204,0.175,0.737,0.643,0.603,0.718,0.79,0.722,0.613,0.917,0.832,0.743,0.793,0.774
https://doi.org/10.1002/14651858.cd001027.pub2,cognitive behaviour therapy for chronic fatigue syndrome in adults,1081_cognitive behaviour therapy for chronic fatigue syndrome in adults.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473631/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599861/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457695/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419524/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953363/pdf']","['Exercise therapy for chronic fatigue syndrome', 'Psychological interventions for symptomatic management of non‐specific chest pain in patients with normal coronary anatomy', 'Interventions for fatigue in inflammatory bowel disease', 'Cognitive behavioural therapy (CBT) for adults and adolescents with asthma', 'Exercise therapy for chronic fatigue syndrome', 'Exercise therapy for chronic fatigue syndrome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953363/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457695/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419524/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473631/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599861/pdf']","['1081_5_exercise therapy for chronic fatigue syndrome.pdf', '1081_2_interventions for fatigue in inflammatory bowel disease.pdf', '1081_3_cognitive behavioural therapy cbt for adults and adolescents with asthma.pdf', '1081_4_exercise therapy for chronic fatigue syndrome.pdf', '1081_0_exercise therapy for chronic fatigue syndrome.pdf', '1081_1_psychological interventions for symptomatic management of non‐specific chest pain in patients with normal coronary anatomy.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953363/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457695/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419524/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473631/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599861/pdf']","['1081_5_exercise therapy for chronic fatigue syndrome.pdf', '1081_2_interventions for fatigue in inflammatory bowel disease.pdf', '1081_3_cognitive behavioural therapy cbt for adults and adolescents with asthma.pdf', '1081_4_exercise therapy for chronic fatigue syndrome.pdf', '1081_0_exercise therapy for chronic fatigue syndrome.pdf', '1081_1_psychological interventions for symptomatic management of non‐specific chest pain in patients with normal coronary anatomy.pdf']","[0.766, 0.552, 0.615, 0.695, 0.765, 0.752]","[0.524, 0.532, 0.53, 0.523, 0.523, 0.53]","[0.604, 0.607, 0.61, 0.604, 0.603, 0.612]","[0.197, 0.193, 0.192, 0.201, 0.202, 0.188]","[0.193, 0.187, 0.193, 0.197, 0.196, 0.186]","[0.165, 0.158, 0.159, 0.166, 0.166, 0.152]","[0.743, 0.742, 0.741, 0.744, 0.744, 0.74]","[0.65, 0.65, 0.647, 0.651, 0.652, 0.648]","[0.579, 0.592, 0.587, 0.58, 0.579, 0.592]","[0.739, 0.72, 0.732, 0.737, 0.737, 0.725]","[0.771, 0.777, 0.778, 0.774, 0.773, 0.777]","[0.69, 0.695, 0.692, 0.699, 0.699, 0.689]","[0.591, 0.588, 0.591, 0.593, 0.593, 0.589]","[0.898, 0.903, 0.906, 0.891, 0.891, 0.908]","[0.805, 0.812, 0.809, 0.804, 0.803, 0.814]","[0.717, 0.724, 0.725, 0.72, 0.719, 0.728]","[0.771, 0.776, 0.777, 0.773, 0.773, 0.776]","[0.745, 0.753, 0.754, 0.744, 0.743, 0.756]",0.691,0.527,0.607,0.196,0.192,0.161,0.742,0.65,0.585,0.732,0.775,0.694,0.591,0.9,0.808,0.722,0.774,0.749
https://doi.org/10.1002/14651858.cd001055.pub4,psychosocial interventions for supporting women to stop smoking in pregnancy,1082_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464359/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf']","['Individual behavioural counselling for smoking cessation', 'Competitions for smoking cessation', 'Prenatal education for congenital toxoplasmosis', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Assessment and support during early labour for improving birth outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464359/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1082_0_individual behavioural counselling for smoking cessation.pdf', '1082_4_assessment and support during early labour for improving birth outcomes.pdf', '1082_1_competitions for smoking cessation.pdf', '1082_2_prenatal education for congenital toxoplasmosis.pdf', '1082_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464359/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1082_0_individual behavioural counselling for smoking cessation.pdf', '1082_4_assessment and support during early labour for improving birth outcomes.pdf', '1082_1_competitions for smoking cessation.pdf', '1082_2_prenatal education for congenital toxoplasmosis.pdf', '1082_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.745, 0.704, 0.539, 0.974, 0.637]","[0.529, 0.525, 0.529, 0.514, 0.527]","[0.608, 0.604, 0.609, 0.608, 0.602]","[0.194, 0.188, 0.188, 0.161, 0.199]","[0.188, 0.179, 0.185, 0.149, 0.188]","[0.167, 0.161, 0.162, 0.132, 0.175]","[0.743, 0.738, 0.737, 0.736, 0.743]","[0.652, 0.647, 0.645, 0.641, 0.652]","[0.591, 0.577, 0.591, 0.578, 0.586]","[0.715, 0.698, 0.714, 0.685, 0.717]","[0.781, 0.77, 0.783, 0.771, 0.777]","[0.693, 0.689, 0.702, 0.681, 0.683]","[0.591, 0.586, 0.595, 0.589, 0.591]","[0.911, 0.896, 0.914, 0.911, 0.907]","[0.808, 0.789, 0.812, 0.8, 0.797]","[0.726, 0.707, 0.733, 0.721, 0.724]","[0.779, 0.769, 0.785, 0.77, 0.777]","[0.759, 0.735, 0.763, 0.75, 0.753]",0.72,0.525,0.606,0.186,0.178,0.159,0.739,0.647,0.585,0.706,0.776,0.69,0.59,0.908,0.801,0.722,0.776,0.752
https://doi.org/10.1002/14651858.cd001069.pub2,sucrose for analgesia in newborn infants undergoing painful procedures,1083_sucrose for analgesia in newborn infants undergoing painful procedures.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf', 'https://stacks.cdc.gov/view/cdc/41566']","['Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version', 'Sweet‐tasting solutions for needle‐related procedural pain in infants one month to one year of age', 'Sucrose for analgesia in newborn infants undergoing painful procedures', 'WHO guidelines on drawing blood : best practices in phlebotomy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['1083_1_sweet‐tasting solutions for needle‐related procedural pain in infants one month to one year of age.pdf', '1083_0_evidence and consensus based guideline for the management of delirium analgesia and sedation in intensive care medicine revision 2015 dasguideline 2015 – short version.pdf', '1083_2_sucrose for analgesia in newborn infants undergoing painful procedures.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['1083_1_sweet‐tasting solutions for needle‐related procedural pain in infants one month to one year of age.pdf', '1083_0_evidence and consensus based guideline for the management of delirium analgesia and sedation in intensive care medicine revision 2015 dasguideline 2015 – short version.pdf', '1083_2_sucrose for analgesia in newborn infants undergoing painful procedures.pdf']","[0.116, 0.606, 0.757]","[0.537, 0.484, 0.518]","[0.617, 0.574, 0.601]","[0.186, 0.142, 0.194]","[0.194, 0.146, 0.194]","[0.152, 0.111, 0.161]","[0.74, 0.735, 0.745]","[0.646, 0.64, 0.652]","[0.604, 0.55, 0.577]","[0.684, 0.663, 0.693]","[0.787, 0.779, 0.775]","[0.716, 0.666, 0.695]","[0.619, 0.587, 0.61]","[0.921, 0.906, 0.901]","[0.824, 0.803, 0.81]","[0.747, 0.715, 0.724]","[0.792, 0.762, 0.774]","[0.776, 0.749, 0.755]",0.493,0.513,0.597,0.174,0.178,0.141,0.74,0.646,0.577,0.68,0.78,0.692,0.605,0.909,0.812,0.729,0.776,0.76
https://doi.org/10.1002/14651858.cd001069.pub3,sucrose for analgesia in newborn infants undergoing painful procedures,1084_sucrose for analgesia in newborn infants undergoing painful procedures.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984677/pdf']","['Sucrose for analgesia in newborn infants undergoing painful procedures', 'Venepuncture versus heel lance for blood sampling in term neonates']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984677/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['1084_1_venepuncture versus heel lance for blood sampling in term neonates.pdf', '1084_0_sucrose for analgesia in newborn infants undergoing painful procedures.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984677/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['1084_1_venepuncture versus heel lance for blood sampling in term neonates.pdf', '1084_0_sucrose for analgesia in newborn infants undergoing painful procedures.pdf']","[0.811, 0.529]","[0.542, 0.531]","[0.616, 0.608]","[0.169, 0.183]","[0.177, 0.188]","[0.142, 0.156]","[0.735, 0.739]","[0.641, 0.648]","[0.601, 0.59]","[0.688, 0.697]","[0.782, 0.776]","[0.712, 0.7]","[0.601, 0.601]","[0.914, 0.905]","[0.82, 0.816]","[0.744, 0.732]","[0.792, 0.784]","[0.771, 0.76]",0.67,0.536,0.612,0.176,0.182,0.149,0.737,0.645,0.595,0.692,0.779,0.706,0.601,0.909,0.818,0.738,0.788,0.766
https://doi.org/10.1002/14651858.cd001069.pub4,sucrose for analgesia in newborn infants undergoing painful procedures,1085_sucrose for analgesia in newborn infants undergoing painful procedures.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779143/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['Skin‐to‐skin care for procedural pain in neonates', 'Sweet tasting solutions for reduction of needle‐related procedural pain in children aged one to 16 years', 'Sucrose for analgesia in newborn infants undergoing painful procedures']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779143/pdf']","['1085_0_skin‐to‐skin care for procedural pain in neonates.pdf', '1085_2_sucrose for analgesia in newborn infants undergoing painful procedures.pdf', '1085_1_sweet tasting solutions for reduction of needle‐related procedural pain in children aged one to 16 years.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779143/pdf']","['1085_0_skin‐to‐skin care for procedural pain in neonates.pdf', '1085_2_sucrose for analgesia in newborn infants undergoing painful procedures.pdf', '1085_1_sweet tasting solutions for reduction of needle‐related procedural pain in children aged one to 16 years.pdf']","[0.632, 0.623, 0.908]","[0.518, 0.516, 0.524]","[0.595, 0.597, 0.604]","[0.173, 0.194, 0.184]","[0.168, 0.189, 0.186]","[0.135, 0.16, 0.147]","[0.741, 0.746, 0.74]","[0.647, 0.654, 0.646]","[0.579, 0.574, 0.583]","[0.687, 0.695, 0.691]","[0.774, 0.77, 0.775]","[0.687, 0.691, 0.7]","[0.61, 0.609, 0.604]","[0.907, 0.897, 0.909]","[0.804, 0.801, 0.806]","[0.724, 0.717, 0.724]","[0.777, 0.772, 0.777]","[0.756, 0.748, 0.755]",0.721,0.519,0.599,0.184,0.181,0.147,0.742,0.649,0.579,0.691,0.773,0.693,0.608,0.904,0.804,0.722,0.775,0.753
https://doi.org/10.1002/14651858.cd001069.pub5,sucrose for analgesia in newborn infants undergoing painful procedures,1086_sucrose for analgesia in newborn infants undergoing painful procedures.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326795/pdf', 'https://effectivehealthcare.ahrq.gov/products/acute-pain-treatment/technical-brief', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461192/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143321/pdf']","['Consensus Guidelines for Perioperative Care in Neonatal Intestinal Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations', 'Treatment for Acute Pain: An Evidence Map', 'Breastfeeding for procedural pain in infants beyond the neonatal period', 'Infant pacifiers for reduction in risk of sudden infant death syndrome', 'Clonidine for pain in non‐ventilated infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326795/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461192/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143321/pdf']","['1086_0_consensus guidelines for perioperative care in neonatal intestinal surgery enhanced recovery after surgery eras society recommendations.pdf', '1086_2_breastfeeding for procedural pain in infants beyond the neonatal period.pdf', '1086_3_infant pacifiers for reduction in risk of sudden infant death syndrome.pdf', '1086_4_clonidine for pain in non‐ventilated infants.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326795/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461192/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143321/pdf']","['1086_0_consensus guidelines for perioperative care in neonatal intestinal surgery enhanced recovery after surgery eras society recommendations.pdf', '1086_2_breastfeeding for procedural pain in infants beyond the neonatal period.pdf', '1086_3_infant pacifiers for reduction in risk of sudden infant death syndrome.pdf', '1086_4_clonidine for pain in non‐ventilated infants.pdf']","[0.214, 0.607, 0.42, 0.428]","[0.524, 0.524, 0.512, 0.514]","[0.604, 0.608, 0.602, 0.604]","[0.169, 0.184, 0.155, 0.171]","[0.16, 0.176, 0.161, 0.174]","[0.125, 0.141, 0.125, 0.135]","[0.737, 0.739, 0.737, 0.739]","[0.639, 0.645, 0.64, 0.645]","[0.592, 0.585, 0.584, 0.583]","[0.645, 0.693, 0.681, 0.684]","[0.784, 0.775, 0.774, 0.774]","[0.714, 0.695, 0.693, 0.694]","[0.605, 0.601, 0.595, 0.598]","[0.899, 0.899, 0.9, 0.899]","[0.804, 0.811, 0.799, 0.805]","[0.732, 0.723, 0.717, 0.724]","[0.781, 0.775, 0.773, 0.774]","[0.756, 0.752, 0.748, 0.754]",0.417,0.518,0.605,0.17,0.168,0.132,0.738,0.642,0.586,0.676,0.777,0.699,0.6,0.899,0.805,0.724,0.776,0.753
https://doi.org/10.1002/14651858.cd001071.pub3,nonnutritive sucking for increasing physiologic stability and nutrition in preterm infants,1087_nonnutritive sucking for increasing physiologic stability and nutrition in preterm infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf']","['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews', 'Infant pacifiers for reduction in risk of sudden infant death syndrome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","['1087_1_infant pacifiers for reduction in risk of sudden infant death syndrome.pdf', '1087_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","['1087_1_infant pacifiers for reduction in risk of sudden infant death syndrome.pdf', '1087_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']","[0.494, 0.594]","[0.537, 0.53]","[0.632, 0.623]","[0.169, 0.178]","[0.189, 0.186]","[0.15, 0.148]","[0.738, 0.741]","[0.643, 0.647]","[0.61, 0.596]","[0.689, 0.692]","[0.787, 0.775]","[0.712, 0.708]","[0.606, 0.603]","[0.915, 0.897]","[0.82, 0.799]","[0.743, 0.715]","[0.789, 0.777]","[0.77, 0.74]",0.544,0.534,0.627,0.173,0.188,0.149,0.74,0.645,0.603,0.69,0.781,0.71,0.605,0.906,0.809,0.729,0.783,0.755
https://doi.org/10.1002/14651858.cd001095.pub2,shortcourse antibiotics for acute otitis media,1088_shortcourse antibiotics for acute otitis media.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/pdf']","['Systematic Review of Evidence-Based Guidelines on Medication Therapy for Upper Respiratory Tract Infection in Children with AGREE Instrument', 'Influenza vaccines for preventing acute otitis media in infants and children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/pdf']","['1088_0_systematic review of evidencebased guidelines on medication therapy for upper respiratory tract infection in children with agree instrument.pdf', '1088_1_influenza vaccines for preventing acute otitis media in infants and children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/pdf']","['1088_0_systematic review of evidencebased guidelines on medication therapy for upper respiratory tract infection in children with agree instrument.pdf', '1088_1_influenza vaccines for preventing acute otitis media in infants and children.pdf']","[0.231, 0.449]","[0.503, 0.51]","[0.587, 0.589]","[0.175, 0.176]","[0.162, 0.157]","[0.137, 0.144]","[0.737, 0.743]","[0.639, 0.651]","[0.565, 0.57]","[0.694, 0.698]","[0.767, 0.766]","[0.676, 0.667]","[0.583, 0.583]","[0.899, 0.894]","[0.806, 0.793]","[0.725, 0.713]","[0.764, 0.759]","[0.747, 0.74]",0.34,0.506,0.588,0.175,0.16,0.141,0.74,0.645,0.567,0.696,0.766,0.671,0.583,0.897,0.8,0.719,0.762,0.744
https://doi.org/10.1002/14651858.cd001139,interventions for preventing and treating pelvic and back pain in pregnancy,1089_interventions for preventing and treating pelvic and back pain in pregnancy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053516/pdf'],['Interventions for preventing and treating low‐back and pelvic pain during pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053516/pdf'],['1089_0_interventions for preventing and treating low‐back and pelvic pain during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053516/pdf'],['1089_0_interventions for preventing and treating low‐back and pelvic pain during pregnancy.pdf'],[0.622],[0.546],[0.622],[0.183],[0.192],[0.16],[0.738],[0.643],[0.6],[0.697],[0.78],[0.701],[0.609],[0.91],[0.831],[0.746],[0.786],[0.763],0.622,0.546,0.622,0.183,0.192,0.16,0.738,0.643,0.6,0.697,0.78,0.701,0.609,0.91,0.831,0.746,0.786,0.763
https://doi.org/10.1002/14651858.cd001141.pub3,support for breastfeeding mothers,1090_support for breastfeeding mothers.pdf,9,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164447/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161489/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Pain management for women in labour: an overview of systematic reviews', 'Antenatal breastfeeding education for increasing breastfeeding duration', 'Support for healthy breastfeeding mothers with healthy term babies', 'Antenatal breastfeeding education for increasing breastfeeding duration', 'Treatments for breast engorgement during lactation', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Peer support telephone calls for improving health', 'Support for healthy breastfeeding mothers with healthy term babies']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164447/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161489/pdf']","['1090_8_support for healthy breastfeeding mothers with healthy term babies.pdf', '1090_3_support for healthy breastfeeding mothers with healthy term babies.pdf', '1090_7_peer support telephone calls for improving health.pdf', '1090_6_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1090_1_pain management for women in labour an overview of systematic reviews.pdf', '1090_4_antenatal breastfeeding education for increasing breastfeeding duration.pdf', '1090_2_antenatal breastfeeding education for increasing breastfeeding duration.pdf', '1090_5_treatments for breast engorgement during lactation.pdf']",8,88.89,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164447/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161489/pdf']","['1090_8_support for healthy breastfeeding mothers with healthy term babies.pdf', '1090_3_support for healthy breastfeeding mothers with healthy term babies.pdf', '1090_7_peer support telephone calls for improving health.pdf', '1090_6_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1090_1_pain management for women in labour an overview of systematic reviews.pdf', '1090_4_antenatal breastfeeding education for increasing breastfeeding duration.pdf', '1090_2_antenatal breastfeeding education for increasing breastfeeding duration.pdf', '1090_5_treatments for breast engorgement during lactation.pdf']","[0.389, 0.699, 0.849, 0.629, 0.464, 0.173, 0.547, 0.759]","[0.546, 0.545, 0.537, 0.579, 0.508, 0.535, 0.537, 0.54]","[0.629, 0.618, 0.617, 0.651, 0.591, 0.617, 0.615, 0.623]","[0.21, 0.203, 0.168, 0.206, 0.162, 0.185, 0.201, 0.181]","[0.221, 0.205, 0.172, 0.181, 0.153, 0.198, 0.205, 0.188]","[0.18, 0.176, 0.141, 0.157, 0.133, 0.164, 0.177, 0.159]","[0.74, 0.738, 0.728, 0.739, 0.731, 0.734, 0.74, 0.732]","[0.652, 0.65, 0.636, 0.645, 0.637, 0.644, 0.648, 0.641]","[0.61, 0.604, 0.6, 0.639, 0.565, 0.604, 0.596, 0.605]","[0.709, 0.709, 0.7, 0.674, 0.686, 0.707, 0.707, 0.697]","[0.787, 0.792, 0.784, 0.816, 0.765, 0.784, 0.786, 0.788]","[0.715, 0.699, 0.712, 0.757, 0.695, 0.714, 0.703, 0.724]","[0.593, 0.603, 0.603, 0.634, 0.587, 0.576, 0.599, 0.588]","[0.92, 0.922, 0.92, 0.929, 0.89, 0.918, 0.914, 0.917]","[0.824, 0.827, 0.824, 0.841, 0.772, 0.82, 0.814, 0.823]","[0.751, 0.746, 0.739, 0.786, 0.695, 0.742, 0.735, 0.746]","[0.793, 0.794, 0.79, 0.824, 0.768, 0.791, 0.787, 0.792]","[0.774, 0.773, 0.763, 0.801, 0.719, 0.767, 0.761, 0.767]",0.564,0.541,0.62,0.19,0.19,0.161,0.735,0.644,0.603,0.699,0.788,0.715,0.598,0.916,0.818,0.742,0.792,0.766
https://doi.org/10.1002/14651858.cd001141.pub4,support for healthy breastfeeding mothers with healthy term babies,1091_support for healthy breastfeeding mothers with healthy term babies.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Interventions for promoting the initiation of breastfeeding', 'Support for healthy breastfeeding mothers with healthy term babies', 'Barriers Perceived by Managers and Clinical Professionals Related to the Implementation of Clinical Practice Guidelines for Breastfeeding through the Best Practice Spotlight Organization Program']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf']","['1091_2_support for healthy breastfeeding mothers with healthy term babies.pdf', '1091_1_interventions for promoting the initiation of breastfeeding.pdf', '1091_3_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guidelin.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf']","['1091_2_support for healthy breastfeeding mothers with healthy term babies.pdf', '1091_1_interventions for promoting the initiation of breastfeeding.pdf', '1091_3_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guidelin.pdf']","[0.848, 0.953, 0.262]","[0.536, 0.543, 0.497]","[0.608, 0.621, 0.58]","[0.205, 0.214, 0.14]","[0.199, 0.213, 0.136]","[0.175, 0.182, 0.123]","[0.74, 0.739, 0.724]","[0.652, 0.649, 0.631]","[0.592, 0.602, 0.565]","[0.715, 0.711, 0.694]","[0.788, 0.793, 0.776]","[0.687, 0.705, 0.681]","[0.6, 0.605, 0.583]","[0.915, 0.917, 0.902]","[0.819, 0.825, 0.817]","[0.737, 0.745, 0.726]","[0.786, 0.793, 0.778]","[0.766, 0.772, 0.757]",0.688,0.525,0.603,0.186,0.183,0.16,0.734,0.644,0.586,0.707,0.786,0.691,0.596,0.911,0.82,0.736,0.786,0.765
https://doi.org/10.1002/14651858.cd001141.pub5,support for healthy breastfeeding mothers with healthy term babies,1092_support for healthy breastfeeding mothers with healthy term babies.pdf,7,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/ABM%20Protocol%20%232bfm.2022.29203.aeh.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants', 'Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese', 'Breastfeeding education and support for women with twins or higher order multiples', 'Academy of Breastfeeding Medicine Clinical Protocol #2: Guidelines for Birth Hospitalization Discharge of Breastfeeding Dyads, Revised 2022', 'Targeted client communication via mobile devices for improving maternal, neonatal, and child health', 'Barriers Perceived by Managers and Clinical Professionals Related to the Implementation of Clinical Practice Guidelines for Breastfeeding through the Best Practice Spotlight Organization Program']","['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/ABM%20Protocol%20%232bfm.2022.29203.aeh.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf']","['1092_4_academy of breastfeeding medicine clinical protocol 2 guidelines for birth hospitalization discharge of breastfeeding dyads revised 2022.pdf', '1092_6_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guidelin.pdf', '1092_3_breastfeeding education and support for women with twins or higher order multiples.pdf', '1092_5_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '1092_1_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf', '1092_2_interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.pdf']",6,85.71,"['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/ABM%20Protocol%20%232bfm.2022.29203.aeh.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf']","['1092_4_academy of breastfeeding medicine clinical protocol 2 guidelines for birth hospitalization discharge of breastfeeding dyads revised 2022.pdf', '1092_6_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guidelin.pdf', '1092_3_breastfeeding education and support for women with twins or higher order multiples.pdf', '1092_5_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '1092_1_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf', '1092_2_interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.pdf']","[0.616, 0.833, 0.832, 0.561, 0.568, 0.286]","[0.546, 0.502, 0.556, 0.537, 0.525, 0.532]","[0.624, 0.585, 0.632, 0.616, 0.605, 0.608]","[0.203, 0.142, 0.215, 0.186, 0.187, 0.21]","[0.211, 0.141, 0.216, 0.179, 0.18, 0.203]","[0.175, 0.127, 0.185, 0.157, 0.159, 0.182]","[0.743, 0.725, 0.739, 0.737, 0.737, 0.742]","[0.657, 0.634, 0.651, 0.649, 0.647, 0.655]","[0.609, 0.57, 0.617, 0.592, 0.582, 0.589]","[0.686, 0.691, 0.705, 0.704, 0.706, 0.713]","[0.797, 0.78, 0.799, 0.786, 0.778, 0.782]","[0.715, 0.685, 0.719, 0.702, 0.69, 0.686]","[0.599, 0.588, 0.612, 0.597, 0.6, 0.597]","[0.923, 0.904, 0.92, 0.915, 0.906, 0.91]","[0.832, 0.824, 0.838, 0.819, 0.808, 0.81]","[0.756, 0.732, 0.755, 0.736, 0.723, 0.735]","[0.793, 0.782, 0.8, 0.786, 0.775, 0.78]","[0.778, 0.764, 0.782, 0.763, 0.753, 0.762]",0.616,0.533,0.612,0.191,0.188,0.164,0.737,0.649,0.593,0.701,0.787,0.7,0.599,0.913,0.822,0.74,0.786,0.767
https://doi.org/10.1002/14651858.cd001142,interventions for treating constipation in pregnancy,1093_interventions for treating constipation in pregnancy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958874/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465073/pdf']","['Interventions for treating constipation in pregnancy', 'Pharmacological treatment for antipsychotic‐related constipation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958874/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465073/pdf']","['1093_0_interventions for treating constipation in pregnancy.pdf', '1093_1_pharmacological treatment for antipsychotic‐related constipation.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958874/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465073/pdf']","['1093_0_interventions for treating constipation in pregnancy.pdf', '1093_1_pharmacological treatment for antipsychotic‐related constipation.pdf']","[0.732, 0.582]","[0.526, 0.52]","[0.613, 0.613]","[0.187, 0.172]","[0.199, 0.181]","[0.163, 0.148]","[0.741, 0.736]","[0.645, 0.639]","[0.589, 0.589]","[0.695, 0.698]","[0.779, 0.778]","[0.695, 0.694]","[0.594, 0.591]","[0.909, 0.911]","[0.813, 0.812]","[0.731, 0.731]","[0.775, 0.774]","[0.758, 0.758]",0.657,0.523,0.613,0.179,0.19,0.155,0.738,0.642,0.589,0.696,0.778,0.694,0.593,0.91,0.812,0.731,0.774,0.758
https://doi.org/10.1002/14651858.cd001144,moderately early 714 days postnatal corticosteroids for preventing chronic lung disease in preterm infants,1094_moderately early 714 days postnatal corticosteroids for preventing chronic lung disease in preterm infants.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580679/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464844/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485683/pdf', 'https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf', 'https://effectivehealthcare.ahrq.gov/products/cerebral-palsy-issues/white-paper']","['Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants', 'Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants', 'Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews', 'Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants', 'Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants', 'Guidelines for Perinatal Care', 'Developmental Disabilities Issues Exploration Forum: Cerebral Palsy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485683/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464844/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580679/pdf', 'https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf']","['1094_1_late  7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_4_early  8 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_2_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1094_3_systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_0_late ≥ 7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_5_guidelines for perinatal care.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485683/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464844/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580679/pdf', 'https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf']","['1094_1_late  7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_4_early  8 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_2_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1094_3_systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_0_late ≥ 7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1094_5_guidelines for perinatal care.pdf']","[0.813, 0.84, 0.466, 0.616, 0.83, 0.244]","[0.521, 0.516, 0.519, 0.519, 0.519, 0.512]","[0.595, 0.589, 0.603, 0.597, 0.595, 0.599]","[0.185, 0.186, 0.177, 0.192, 0.185, 0.143]","[0.169, 0.167, 0.16, 0.17, 0.163, 0.135]","[0.147, 0.144, 0.137, 0.145, 0.144, 0.107]","[0.745, 0.745, 0.745, 0.747, 0.744, 0.729]","[0.654, 0.654, 0.653, 0.656, 0.652, 0.627]","[0.585, 0.58, 0.584, 0.584, 0.587, 0.578]","[0.704, 0.706, 0.699, 0.699, 0.708, 0.615]","[0.772, 0.771, 0.77, 0.773, 0.773, 0.78]","[0.676, 0.667, 0.682, 0.666, 0.678, 0.687]","[0.59, 0.59, 0.591, 0.591, 0.586, 0.584]","[0.896, 0.894, 0.891, 0.899, 0.899, 0.906]","[0.791, 0.78, 0.783, 0.789, 0.793, 0.796]","[0.72, 0.716, 0.703, 0.723, 0.718, 0.738]","[0.763, 0.761, 0.762, 0.765, 0.764, 0.774]","[0.747, 0.742, 0.731, 0.748, 0.747, 0.76]",0.635,0.518,0.596,0.178,0.161,0.137,0.743,0.649,0.583,0.689,0.773,0.676,0.589,0.897,0.789,0.72,0.765,0.746
https://doi.org/10.1002/14651858.cd001145,delayed 3 weeks postnatal corticosteroids for chronic lung disease in preterm infants,1095_delayed 3 weeks postnatal corticosteroids for chronic lung disease in preterm infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580679/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485440/pdf']","['Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants', 'Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580679/pdf']","['1095_1_late  7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1095_0_late ≥ 7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580679/pdf']","['1095_1_late  7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf', '1095_0_late ≥ 7 days systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.pdf']","[0.645, 0.67]","[0.506, 0.504]","[0.584, 0.584]","[0.173, 0.171]","[0.16, 0.152]","[0.136, 0.134]","[0.741, 0.739]","[0.648, 0.647]","[0.571, 0.573]","[0.698, 0.702]","[0.776, 0.777]","[0.682, 0.685]","[0.594, 0.584]","[0.905, 0.908]","[0.78, 0.78]","[0.715, 0.712]","[0.764, 0.764]","[0.739, 0.739]",0.657,0.505,0.584,0.172,0.156,0.135,0.74,0.647,0.572,0.7,0.776,0.683,0.589,0.907,0.78,0.714,0.764,0.739
https://doi.org/10.1002/14651858.cd001290.pub2,interventions for educating children who are at risk of asthmarelated emergency department attendance,1096_interventions for educating children who are at risk of asthmarelated emergency department attendance.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353176/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486323/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406701/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972064/pdf']","['School‐based self‐management interventions for asthma in children and adolescents: a mixed methods systematic review', 'Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews', 'Smartphone and tablet self management apps for asthma', 'Interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings', 'Home‐based educational interventions for children with asthma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486323/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353176/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406701/pdf']","['1096_2_smartphone and tablet self management apps for asthma.pdf', '1096_4_home‐based educational interventions for children with asthma.pdf', '1096_0_school‐based self‐management interventions for asthma in children and adolescents a mixed methods systematic review.pdf', '1096_1_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf', '1096_3_interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486323/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353176/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406701/pdf']","['1096_2_smartphone and tablet self management apps for asthma.pdf', '1096_4_home‐based educational interventions for children with asthma.pdf', '1096_0_school‐based self‐management interventions for asthma in children and adolescents a mixed methods systematic review.pdf', '1096_1_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf', '1096_3_interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings.pdf']","[0.738, 0.408, 0.653, 0.522, 0.817]","[0.531, 0.541, 0.524, 0.529, 0.54]","[0.608, 0.618, 0.603, 0.617, 0.619]","[0.189, 0.204, 0.191, 0.186, 0.192]","[0.193, 0.208, 0.188, 0.171, 0.183]","[0.163, 0.176, 0.162, 0.152, 0.154]","[0.741, 0.747, 0.746, 0.738, 0.74]","[0.648, 0.657, 0.655, 0.648, 0.65]","[0.593, 0.599, 0.584, 0.601, 0.601]","[0.71, 0.704, 0.712, 0.7, 0.697]","[0.787, 0.79, 0.778, 0.789, 0.785]","[0.71, 0.702, 0.682, 0.708, 0.705]","[0.597, 0.594, 0.59, 0.6, 0.598]","[0.906, 0.917, 0.91, 0.915, 0.916]","[0.813, 0.82, 0.81, 0.821, 0.823]","[0.734, 0.739, 0.726, 0.733, 0.739]","[0.783, 0.787, 0.774, 0.782, 0.788]","[0.759, 0.77, 0.759, 0.764, 0.768]",0.628,0.533,0.613,0.192,0.189,0.161,0.742,0.652,0.596,0.705,0.786,0.701,0.596,0.913,0.817,0.734,0.783,0.764
https://doi.org/10.1002/14651858.cd001291.pub2,community interventions for preventing smoking in young people,1097_community interventions for preventing smoking in young people.pdf,10,"['https://stacks.cdc.gov/view/cdc/21569', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmoke50/', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486186/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20122014MasterPlanSavingLivesSavingMoney.pdf']","['The Health consequences of smoking—50 years of progress : a report of the Surgeon General', 'The Health Consequences of Smoking—50 Years of Progress', 'Preventing Tobacco Use Among Youth and Young Adults', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Family‐based programmes for preventing smoking by children and adolescents', 'Tobacco cessation interventions for young people', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Interventions for tobacco use prevention in Indigenous youth', 'Interventions for promoting smoking cessation during pregnancy', 'Saving Lives, Saving Money']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20122014MasterPlanSavingLivesSavingMoney.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1097_5_tobacco cessation interventions for young people.pdf', '1097_4_family‐based programmes for preventing smoking by children and adolescents.pdf', '1097_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1097_8_interventions for promoting smoking cessation during pregnancy.pdf', '1097_9_saving lives saving money.pdf', '1097_6_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",6,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/TEROC/MasterPlan/20122014MasterPlanSavingLivesSavingMoney.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1097_5_tobacco cessation interventions for young people.pdf', '1097_4_family‐based programmes for preventing smoking by children and adolescents.pdf', '1097_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1097_8_interventions for promoting smoking cessation during pregnancy.pdf', '1097_9_saving lives saving money.pdf', '1097_6_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.656, 0.816, 0.809, 0.727, 0.584, 0.332]","[0.532, 0.542, 0.519, 0.52, 0.513, 0.527]","[0.612, 0.618, 0.604, 0.606, 0.603, 0.602]","[0.207, 0.214, 0.184, 0.172, 0.18, 0.195]","[0.209, 0.216, 0.181, 0.175, 0.2, 0.182]","[0.183, 0.184, 0.155, 0.151, 0.173, 0.163]","[0.743, 0.741, 0.736, 0.73, 0.732, 0.739]","[0.653, 0.651, 0.645, 0.639, 0.635, 0.647]","[0.592, 0.603, 0.583, 0.591, 0.581, 0.586]","[0.725, 0.72, 0.714, 0.714, 0.692, 0.717]","[0.781, 0.79, 0.77, 0.774, 0.79, 0.776]","[0.702, 0.717, 0.692, 0.701, 0.71, 0.688]","[0.604, 0.61, 0.581, 0.591, 0.607, 0.596]","[0.91, 0.912, 0.905, 0.911, 0.912, 0.907]","[0.82, 0.826, 0.801, 0.813, 0.822, 0.808]","[0.734, 0.749, 0.727, 0.735, 0.74, 0.729]","[0.782, 0.793, 0.772, 0.779, 0.79, 0.778]","[0.767, 0.775, 0.756, 0.763, 0.772, 0.76]",0.654,0.525,0.608,0.192,0.194,0.168,0.737,0.645,0.589,0.714,0.78,0.702,0.598,0.91,0.815,0.736,0.782,0.765
https://doi.org/10.1002/14651858.cd001332,antispasticity agents for multiple sclerosis,1098_antispasticity agents for multiple sclerosis.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516893/pdf']","['Interventions for managing skeletal muscle spasticity following traumatic brain injury', 'Non‐pharmacological interventions for chronic pain in multiple sclerosis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516893/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486165/pdf']","['1098_1_non‐pharmacological interventions for chronic pain in multiple sclerosis.pdf', '1098_0_interventions for managing skeletal muscle spasticity following traumatic brain injury.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516893/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486165/pdf']","['1098_1_non‐pharmacological interventions for chronic pain in multiple sclerosis.pdf', '1098_0_interventions for managing skeletal muscle spasticity following traumatic brain injury.pdf']","[0.614, 0.452]","[0.551, 0.547]","[0.648, 0.639]","[0.211, 0.201]","[0.209, 0.202]","[0.162, 0.156]","[0.746, 0.742]","[0.655, 0.652]","[0.622, 0.618]","[0.703, 0.697]","[0.8, 0.802]","[0.723, 0.713]","[0.615, 0.613]","[0.932, 0.926]","[0.837, 0.835]","[0.761, 0.764]","[0.8, 0.8]","[0.79, 0.789]",0.533,0.549,0.643,0.206,0.206,0.159,0.744,0.653,0.62,0.7,0.801,0.718,0.614,0.929,0.836,0.762,0.8,0.79
https://doi.org/10.1002/14651858.cd001340.pub2,extracorporeal membrane oxygenation for severe respiratory failure in newborn infants,1099_extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823268/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353247/pdf']","['Milrinone for persistent pulmonary hypertension of the newborn', 'Extracorporeal membrane oxygenation for critically ill adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353247/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823268/pdf']","['1099_1_extracorporeal membrane oxygenation for critically ill adults.pdf', '1099_0_milrinone for persistent pulmonary hypertension of the newborn.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353247/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823268/pdf']","['1099_1_extracorporeal membrane oxygenation for critically ill adults.pdf', '1099_0_milrinone for persistent pulmonary hypertension of the newborn.pdf']","[0.323, 0.526]","[0.527, 0.536]","[0.608, 0.616]","[0.182, 0.171]","[0.184, 0.17]","[0.153, 0.14]","[0.736, 0.734]","[0.647, 0.644]","[0.589, 0.597]","[0.696, 0.687]","[0.78, 0.787]","[0.714, 0.718]","[0.608, 0.614]","[0.908, 0.913]","[0.806, 0.812]","[0.728, 0.738]","[0.782, 0.786]","[0.752, 0.763]",0.424,0.532,0.612,0.176,0.177,0.147,0.735,0.645,0.593,0.692,0.784,0.716,0.611,0.911,0.809,0.733,0.784,0.758
https://doi.org/10.1002/14651858.cd001402.pub2,newborn screening for cystic fibrosis,1100_newborn screening for cystic fibrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513589/pdf'],['Bronchoscopy‐guided antimicrobial therapy for cystic fibrosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513589/pdf'],['1100_0_bronchoscopy‐guided antimicrobial therapy for cystic fibrosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513589/pdf'],['1100_0_bronchoscopy‐guided antimicrobial therapy for cystic fibrosis.pdf'],[0.541],[0.542],[0.625],[0.194],[0.192],[0.151],[0.742],[0.645],[0.608],[0.694],[0.787],[0.724],[0.613],[0.91],[0.819],[0.739],[0.785],[0.765],0.541,0.542,0.625,0.194,0.192,0.151,0.742,0.645,0.608,0.694,0.787,0.724,0.613,0.91,0.819,0.739,0.785,0.765
https://doi.org/10.1002/14651858.cd001449,drugs for treatment of very high blood pressure during pregnancy,1101_drugs for treatment of very high blood pressure during pregnancy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073408/pdf'],['Drugs for treatment of very high blood pressure during pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073408/pdf'],['1101_0_drugs for treatment of very high blood pressure during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073408/pdf'],['1101_0_drugs for treatment of very high blood pressure during pregnancy.pdf'],[0.833],[0.524],[0.612],[0.195],[0.187],[0.161],[0.745],[0.652],[0.598],[0.685],[0.788],[0.682],[0.591],[0.903],[0.816],[0.741],[0.783],[0.769],0.833,0.524,0.612,0.195,0.187,0.161,0.745,0.652,0.598,0.685,0.788,0.682,0.591,0.903,0.816,0.741,0.783,0.769
https://doi.org/10.1002/14651858.cd001449.pub2,drugs for treatment of very high blood pressure during pregnancy,1102_drugs for treatment of very high blood pressure during pregnancy.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073408/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia', 'Drugs for treatment of very high blood pressure during pregnancy', 'Magnesium sulphate versus lytic cocktail for eclampsia', 'Magnesium sulphate versus diazepam for eclampsia', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073408/pdf']","['1102_0_magnesium sulphate and other anticonvulsants for women with pre‐eclampsia.pdf', '1102_2_magnesium sulphate versus lytic cocktail for eclampsia.pdf', '1102_4_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1102_3_magnesium sulphate versus diazepam for eclampsia.pdf', '1102_1_drugs for treatment of very high blood pressure during pregnancy.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073408/pdf']","['1102_0_magnesium sulphate and other anticonvulsants for women with pre‐eclampsia.pdf', '1102_2_magnesium sulphate versus lytic cocktail for eclampsia.pdf', '1102_4_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1102_3_magnesium sulphate versus diazepam for eclampsia.pdf', '1102_1_drugs for treatment of very high blood pressure during pregnancy.pdf']","[0.591, 0.804, 0.559, 0.525, 0.162]","[0.519, 0.527, 0.59, 0.516, 0.535]","[0.606, 0.617, 0.665, 0.607, 0.622]","[0.184, 0.179, 0.212, 0.176, 0.199]","[0.178, 0.183, 0.188, 0.173, 0.197]","[0.149, 0.147, 0.151, 0.142, 0.16]","[0.737, 0.734, 0.74, 0.735, 0.74]","[0.648, 0.644, 0.645, 0.644, 0.65]","[0.585, 0.598, 0.657, 0.588, 0.605]","[0.675, 0.67, 0.658, 0.673, 0.681]","[0.785, 0.79, 0.826, 0.788, 0.795]","[0.687, 0.713, 0.779, 0.696, 0.711]","[0.591, 0.598, 0.631, 0.589, 0.593]","[0.911, 0.916, 0.932, 0.914, 0.915]","[0.797, 0.809, 0.84, 0.801, 0.817]","[0.735, 0.743, 0.797, 0.733, 0.747]","[0.782, 0.79, 0.833, 0.786, 0.793]","[0.759, 0.769, 0.811, 0.763, 0.773]",0.528,0.537,0.623,0.19,0.184,0.15,0.737,0.646,0.607,0.671,0.797,0.717,0.6,0.918,0.813,0.751,0.797,0.775
https://doi.org/10.1002/14651858.cd001449.pub3,drugs for treatment of very high blood pressure during pregnancy,1103_drugs for treatment of very high blood pressure during pregnancy.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017474/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487386/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517196/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.jacc.org/doi/pdf/10.1016/j.jacc.2017.11.006?_gl=1*ewjwn3*_ga*Njk2NjM3OTIuMTY2Mjk3ODAwMw..*_ga_2V8VW4Y237*MTY2MzE3Mjg4NS4yLjAuMTY2MzE3Mjg4OC41Ny4wLjA.&_ga=2.252528333.578092439.1663172885-69663792.1662978003']","['Antihypertensive drug therapy for mild to moderate hypertension during pregnancy', 'An evaluation of the influence of the publication of the UK National Institute for health and Care Excellence’s guidance on hypertension in pregnancy: a retrospective analysis of clinical practice', 'Guided imagery for treating hypertension in pregnancy', ""Interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks' gestation"", 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', '2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517196/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017474/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487386/pdf']","['1103_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1103_3_interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks gestation.pdf', '1103_1_an evaluation of the influence of the publication of the uk national institute for health and care excellences guidan.pdf', '1103_0_antihypertensive drug therapy for mild to moderate hypertension during pregnancy.pdf', '1103_5_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1103_2_guided imagery for treating hypertension in pregnancy.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517196/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017474/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487386/pdf']","['1103_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1103_3_interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks gestation.pdf', '1103_1_an evaluation of the influence of the publication of the uk national institute for health and care excellences guidan.pdf', '1103_0_antihypertensive drug therapy for mild to moderate hypertension during pregnancy.pdf', '1103_5_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1103_2_guided imagery for treating hypertension in pregnancy.pdf']","[0.739, 0.26, 0.572, 0.611, 0.333, 0.431]","[0.508, 0.512, 0.522, 0.505, 0.506, 0.516]","[0.606, 0.602, 0.615, 0.591, 0.601, 0.611]","[0.163, 0.188, 0.182, 0.182, 0.168, 0.184]","[0.157, 0.171, 0.177, 0.165, 0.148, 0.172]","[0.131, 0.145, 0.144, 0.142, 0.126, 0.145]","[0.732, 0.74, 0.734, 0.742, 0.737, 0.737]","[0.636, 0.647, 0.641, 0.65, 0.644, 0.643]","[0.59, 0.579, 0.59, 0.582, 0.579, 0.589]","[0.683, 0.685, 0.673, 0.694, 0.677, 0.685]","[0.781, 0.775, 0.785, 0.775, 0.774, 0.781]","[0.682, 0.682, 0.699, 0.667, 0.688, 0.695]","[0.582, 0.586, 0.577, 0.583, 0.579, 0.581]","[0.911, 0.896, 0.903, 0.9, 0.897, 0.907]","[0.801, 0.799, 0.808, 0.787, 0.785, 0.811]","[0.725, 0.72, 0.743, 0.716, 0.711, 0.731]","[0.775, 0.769, 0.782, 0.768, 0.767, 0.777]","[0.761, 0.749, 0.764, 0.744, 0.739, 0.759]",0.491,0.511,0.604,0.178,0.165,0.139,0.737,0.643,0.585,0.683,0.779,0.686,0.581,0.902,0.799,0.724,0.773,0.753
https://doi.org/10.1002/14651858.cd001450.pub4,fetal and umbilical doppler ultrasound in normal pregnancy,1104_fetal and umbilical doppler ultrasound in normal pregnancy.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481396/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510058/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644109/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Use of biochemical tests of placental function for improving pregnancy outcome', 'Fetal movement counting for assessment of fetal wellbeing', 'Fetal and umbilical Doppler ultrasound in high‐risk pregnancies', 'Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small‐for‐gestational‐age infants', 'Antenatal cardiotocography for fetal assessment', ""Routine ultrasound in late pregnancy (after 24 weeks' gestation)"", 'Multidisciplinary consensus on screening for, diagnosis and management of fetal growth restriction in the Netherlands', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481396/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510058/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644109/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860184/pdf']","['1104_4_biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small‐for‐gestational‐age infants.pdf', '1104_6_routine ultrasound in late pregnancy after 24 weeks gestation.pdf', '1104_3_fetal and umbilical doppler ultrasound in high‐risk pregnancies.pdf', '1104_8_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1104_2_fetal movement counting for assessment of fetal wellbeing.pdf', '1104_5_antenatal cardiotocography for fetal assessment.pdf', '1104_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1104_7_multidisciplinary consensus on screening for diagnosis and management of fetal growth restriction in the netherlands.pdf', '1104_1_use of biochemical tests of placental function for improving pregnancy outcome.pdf']",9,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481396/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510058/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644109/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860184/pdf']","['1104_4_biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small‐for‐gestational‐age infants.pdf', '1104_6_routine ultrasound in late pregnancy after 24 weeks gestation.pdf', '1104_3_fetal and umbilical doppler ultrasound in high‐risk pregnancies.pdf', '1104_8_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1104_2_fetal movement counting for assessment of fetal wellbeing.pdf', '1104_5_antenatal cardiotocography for fetal assessment.pdf', '1104_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1104_7_multidisciplinary consensus on screening for diagnosis and management of fetal growth restriction in the netherlands.pdf', '1104_1_use of biochemical tests of placental function for improving pregnancy outcome.pdf']","[0.45, 0.607, 0.574, 0.861, 0.344, 0.703, 0.696, 0.175, 0.345]","[0.511, 0.509, 0.512, 0.499, 0.512, 0.519, 0.498, 0.506, 0.514]","[0.598, 0.589, 0.592, 0.592, 0.594, 0.603, 0.581, 0.596, 0.6]","[0.179, 0.196, 0.204, 0.162, 0.189, 0.202, 0.173, 0.173, 0.197]","[0.171, 0.179, 0.184, 0.161, 0.176, 0.186, 0.161, 0.174, 0.183]","[0.149, 0.163, 0.173, 0.144, 0.156, 0.168, 0.15, 0.149, 0.164]","[0.74, 0.744, 0.747, 0.734, 0.742, 0.741, 0.741, 0.733, 0.742]","[0.643, 0.649, 0.654, 0.635, 0.644, 0.645, 0.647, 0.633, 0.646]","[0.575, 0.573, 0.575, 0.58, 0.575, 0.579, 0.562, 0.57, 0.573]","[0.706, 0.716, 0.717, 0.699, 0.711, 0.714, 0.709, 0.681, 0.711]","[0.769, 0.769, 0.772, 0.775, 0.769, 0.778, 0.76, 0.783, 0.769]","[0.682, 0.679, 0.677, 0.679, 0.688, 0.693, 0.681, 0.691, 0.687]","[0.586, 0.587, 0.587, 0.586, 0.588, 0.587, 0.584, 0.579, 0.589]","[0.897, 0.89, 0.894, 0.908, 0.895, 0.902, 0.881, 0.907, 0.896]","[0.796, 0.79, 0.782, 0.791, 0.793, 0.797, 0.76, 0.802, 0.793]","[0.709, 0.708, 0.709, 0.711, 0.711, 0.716, 0.682, 0.728, 0.708]","[0.766, 0.763, 0.765, 0.768, 0.767, 0.772, 0.753, 0.776, 0.764]","[0.742, 0.738, 0.738, 0.75, 0.739, 0.747, 0.709, 0.755, 0.737]",0.528,0.509,0.594,0.186,0.175,0.157,0.74,0.644,0.574,0.707,0.772,0.684,0.586,0.897,0.789,0.709,0.766,0.739
https://doi.org/10.1002/14651858.cd001457,glutamine supplementation for prevention of morbidity in preterm infants,1105_glutamine supplementation for prevention of morbidity in preterm infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055588/pdf'],['Glutamine supplementation to prevent morbidity and mortality in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055588/pdf'],['1105_0_glutamine supplementation to prevent morbidity and mortality in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055588/pdf'],['1105_0_glutamine supplementation to prevent morbidity and mortality in preterm infants.pdf'],[0.669],[0.505],[0.599],[0.175],[0.179],[0.154],[0.739],[0.65],[0.577],[0.698],[0.778],[0.685],[0.592],[0.91],[0.81],[0.726],[0.769],[0.759],0.669,0.505,0.599,0.175,0.179,0.154,0.739,0.65,0.577,0.698,0.778,0.685,0.592,0.91,0.81,0.726,0.769,0.759
https://doi.org/10.1002/14651858.cd001497.pub2,interventions for preventing tobacco sales to minors,1106_interventions for preventing tobacco sales to minors.pdf,8,"['https://www.mercatus.org/publication/deeming-tobacco-products-be-subject-federal-food-drug-and-cosmetic-act', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.tn.gov/content/dam/tn/health/documents/Tennessee_Youth_Tobacco_Survey_Summary.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://stacks.cdc.gov/view/cdc/42440']","['Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act', 'Interventions for promoting smoking cessation during pregnancy', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Tobacco cessation interventions for young people', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Prevalence of Tobacco Use', 'Preventing Tobacco Use Among Youth and Young Adults', 'Preventing initiation of tobacco use : outcome indicators for comprehensive tobacco control programs–2014']","['https://www.tn.gov/content/dam/tn/health/documents/Tennessee_Youth_Tobacco_Survey_Summary.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1106_5_prevalence of tobacco use.pdf', '1106_3_tobacco cessation interventions for young people.pdf', '1106_4_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1106_1_interventions for promoting smoking cessation during pregnancy.pdf', '1106_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",5,62.5,"['https://www.tn.gov/content/dam/tn/health/documents/Tennessee_Youth_Tobacco_Survey_Summary.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1106_5_prevalence of tobacco use.pdf', '1106_3_tobacco cessation interventions for young people.pdf', '1106_4_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1106_1_interventions for promoting smoking cessation during pregnancy.pdf', '1106_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.354, 0.432, 0.53, 0.379, 0.422]","[0.53, 0.548, 0.529, 0.534, 0.535]","[0.61, 0.622, 0.611, 0.616, 0.607]","[0.192, 0.196, 0.17, 0.163, 0.174]","[0.213, 0.201, 0.173, 0.17, 0.169]","[0.183, 0.175, 0.144, 0.143, 0.148]","[0.73, 0.734, 0.726, 0.721, 0.727]","[0.632, 0.641, 0.632, 0.628, 0.632]","[0.598, 0.61, 0.596, 0.607, 0.595]","[0.69, 0.695, 0.682, 0.682, 0.681]","[0.789, 0.797, 0.784, 0.79, 0.787]","[0.727, 0.732, 0.718, 0.729, 0.711]","[0.633, 0.619, 0.59, 0.602, 0.603]","[0.918, 0.924, 0.919, 0.926, 0.92]","[0.838, 0.841, 0.82, 0.834, 0.826]","[0.753, 0.755, 0.744, 0.755, 0.744]","[0.795, 0.802, 0.791, 0.8, 0.795]","[0.775, 0.784, 0.771, 0.779, 0.772]",0.423,0.535,0.613,0.179,0.185,0.159,0.728,0.633,0.601,0.686,0.789,0.723,0.609,0.921,0.832,0.75,0.797,0.776
https://doi.org/10.1002/14651858.cd001531,safety education of pedestrians for injury prevention,1107_safety education of pedestrians for injury prevention.pdf,2,"['http://purl.fdlp.gov/GPO/gpo74731', 'https://www.congress.gov/event/111th-congress/senate-event/LC56944/text?s=1&r=12971']","['Opportunities to improve transportation safety :\xa0hearing before the Committee on Environment and Public Works, United States Senate, One Hundred Eleventh Congress, second session, April 14, 2010.', 'S.Hrg. 111-1234 — OPPORTUNITIES TO IMPROVE TRANSPORTATION SAFETY']",['http://purl.fdlp.gov/GPO/gpo74731'],['1107_0_opportunities to improve transportation safety \xa0hearing before the committee on environment and public works united states senate one hundred eleventh congress second session april 14 2010.pdf'],1,50.0,['http://purl.fdlp.gov/GPO/gpo74731'],['1107_0_opportunities to improve transportation safety \xa0hearing before the committee on environment and public works united states senate one hundred eleventh congress second session april 14 2010.pdf'],[0.229],[0.483],[0.575],[0.119],[0.123],[0.112],[0.714],[0.608],[0.55],[0.689],[0.77],[0.714],[0.609],[0.889],[0.811],[0.696],[0.774],[0.718],0.229,0.483,0.575,0.119,0.123,0.112,0.714,0.608,0.55,0.689,0.77,0.714,0.609,0.889,0.811,0.696,0.774,0.718
https://doi.org/10.1002/14651858.cd001688.pub3,interventions for promoting the initiation of breastfeeding,1108_interventions for promoting the initiation of breastfeeding.pdf,7,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://stacks.cdc.gov/view/cdc/76249', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'CDC Worksite Health ScoreCard scoring methodology : evidence and impact ratings and supporting citations', 'Barriers Perceived by Managers and Clinical Professionals Related to the Implementation of Clinical Practice Guidelines for Breastfeeding through the Best Practice Spotlight Organization Program', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese', 'Breastfeeding education and support for women with twins or higher order multiples', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf']","['1108_2_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guidelin.pdf', '1108_6_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1108_3_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1108_5_breastfeeding education and support for women with twins or higher order multiples.pdf', '1108_4_interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.pdf']",5,71.43,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf']","['1108_2_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guidelin.pdf', '1108_6_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1108_3_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1108_5_breastfeeding education and support for women with twins or higher order multiples.pdf', '1108_4_interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.pdf']","[0.303, 0.386, 0.783, 0.803, 0.392]","[0.513, 0.504, 0.54, 0.581, 0.543]","[0.601, 0.594, 0.632, 0.658, 0.624]","[0.151, 0.179, 0.187, 0.235, 0.219]","[0.154, 0.177, 0.192, 0.243, 0.218]","[0.134, 0.152, 0.162, 0.205, 0.19]","[0.724, 0.734, 0.732, 0.742, 0.742]","[0.632, 0.642, 0.64, 0.654, 0.653]","[0.585, 0.557, 0.609, 0.642, 0.597]","[0.685, 0.694, 0.693, 0.706, 0.708]","[0.786, 0.765, 0.797, 0.81, 0.786]","[0.701, 0.694, 0.708, 0.744, 0.699]","[0.599, 0.596, 0.612, 0.626, 0.606]","[0.906, 0.889, 0.925, 0.925, 0.912]","[0.833, 0.777, 0.827, 0.851, 0.818]","[0.743, 0.696, 0.749, 0.774, 0.744]","[0.792, 0.764, 0.796, 0.815, 0.787]","[0.772, 0.72, 0.783, 0.796, 0.769]",0.533,0.536,0.622,0.194,0.197,0.169,0.735,0.644,0.598,0.697,0.789,0.709,0.608,0.911,0.821,0.741,0.791,0.768
https://doi.org/10.1002/14651858.cd001746.pub3,family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke,1109_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf']","[""Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke"", 'Interventions for promoting smoking cessation during pregnancy', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Psychosocial interventions for supporting women to stop smoking in pregnancy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf']","['1109_0_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf', '1109_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1109_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1109_1_interventions for promoting smoking cessation during pregnancy.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf']","['1109_0_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf', '1109_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1109_3_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1109_1_interventions for promoting smoking cessation during pregnancy.pdf']","[0.965, 0.618, 0.729, 0.682]","[0.55, 0.538, 0.532, 0.535]","[0.628, 0.613, 0.616, 0.62]","[0.227, 0.203, 0.196, 0.187]","[0.225, 0.191, 0.196, 0.193]","[0.197, 0.169, 0.165, 0.163]","[0.746, 0.74, 0.739, 0.733]","[0.655, 0.648, 0.648, 0.642]","[0.604, 0.592, 0.591, 0.601]","[0.711, 0.704, 0.704, 0.705]","[0.788, 0.782, 0.778, 0.783]","[0.716, 0.701, 0.707, 0.718]","[0.62, 0.602, 0.589, 0.6]","[0.914, 0.911, 0.91, 0.915]","[0.822, 0.811, 0.805, 0.818]","[0.742, 0.736, 0.735, 0.745]","[0.792, 0.786, 0.781, 0.79]","[0.769, 0.762, 0.759, 0.767]",0.748,0.539,0.619,0.203,0.201,0.174,0.74,0.648,0.597,0.706,0.783,0.71,0.603,0.913,0.814,0.74,0.787,0.764
https://doi.org/10.1002/14651858.cd001801.pub3,grommets ventilation tubes for hearing loss associated with otitis media with effusion in children,1110_grommets ventilation tubes for hearing loss associated with otitis media with effusion in children.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829244/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170417/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117560/pdf']","['Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children', 'Antihistamines and/or decongestants for otitis media with effusion (OME) in children', 'Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review', 'Antibiotics for otitis media with effusion in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829244/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170417/pdf']","['1110_2_diagnosis monitoring and treatment of primary ciliary dyskinesia pcd foundation consensus recommendations based on state of the art review.pdf', '1110_0_oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.pdf', '1110_3_antibiotics for otitis media with effusion in children.pdf', '1110_1_antihistamines andor decongestants for otitis media with effusion ome in children.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829244/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170417/pdf']","['1110_2_diagnosis monitoring and treatment of primary ciliary dyskinesia pcd foundation consensus recommendations based on state of the art review.pdf', '1110_0_oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.pdf', '1110_3_antibiotics for otitis media with effusion in children.pdf', '1110_1_antihistamines andor decongestants for otitis media with effusion ome in children.pdf']","[0.63, 0.555, 0.185, 0.605]","[0.548, 0.535, 0.533, 0.518]","[0.629, 0.618, 0.615, 0.606]","[0.15, 0.188, 0.189, 0.182]","[0.156, 0.182, 0.176, 0.169]","[0.107, 0.159, 0.154, 0.146]","[0.736, 0.74, 0.741, 0.741]","[0.637, 0.649, 0.652, 0.651]","[0.626, 0.593, 0.593, 0.577]","[0.625, 0.681, 0.681, 0.678]","[0.802, 0.784, 0.785, 0.777]","[0.742, 0.707, 0.701, 0.688]","[0.616, 0.608, 0.601, 0.599]","[0.921, 0.908, 0.913, 0.902]","[0.817, 0.805, 0.807, 0.795]","[0.766, 0.73, 0.734, 0.725]","[0.8, 0.779, 0.779, 0.77]","[0.785, 0.758, 0.764, 0.753]",0.494,0.534,0.617,0.177,0.171,0.142,0.74,0.647,0.597,0.666,0.787,0.71,0.606,0.911,0.806,0.739,0.782,0.765
https://doi.org/10.1002/14651858.cd001807,antibiotics for prelabour rupture of membranes at or near term,1111_antibiotics for prelabour rupture of membranes at or near term.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1111_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1111_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],[0.154],[0.554],[0.634],[0.197],[0.17],[0.138],[0.746],[0.648],[0.606],[0.656],[0.802],[0.725],[0.622],[0.904],[0.812],[0.759],[0.8],[0.774],0.154,0.554,0.634,0.197,0.17,0.138,0.746,0.648,0.606,0.656,0.802,0.725,0.622,0.904,0.812,0.759,0.8,0.774
https://doi.org/10.1002/14651858.cd001807.pub2,antibiotics for prelabour rupture of membranes at or near term,1112_antibiotics for prelabour rupture of membranes at or near term.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464808/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485695/pdf']","['Middle-East OBGYN Graduate Education (MOGGE) Foundation Practice Guidelines: Prelabor rupture of membranes; Practice guideline No. 01-O-19', 'Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)', 'Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus', 'Induction of labour for improving birth outcomes for women at or beyond term', ""Induction of labour at or beyond 37 weeks' gestation"", 'Combined diet and exercise interventions for preventing gestational diabetes mellitus', 'Different methods and settings for glucose monitoring for gestational diabetes during pregnancy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485695/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464808/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf']","['1112_5_combined diet and exercise interventions for preventing gestational diabetes mellitus.pdf', '1112_6_different methods and settings for glucose monitoring for gestational diabetes during pregnancy.pdf', '1112_4_induction of labour at or beyond 37 weeks gestation.pdf', '1112_1_planned early birth versus expectant management waiting for prelabour rupture of membranes at term 37 weeks or more.pdf', '1112_2_dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.pdf', '1112_3_induction of labour for improving birth outcomes for women at or beyond term.pdf', '1112_0_middleeast obgyn graduate education mogge foundation practice guidelines prelabor rupture of membranes practice guideline no 01o19.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485695/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464808/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125938/pdf']","['1112_5_combined diet and exercise interventions for preventing gestational diabetes mellitus.pdf', '1112_6_different methods and settings for glucose monitoring for gestational diabetes during pregnancy.pdf', '1112_4_induction of labour at or beyond 37 weeks gestation.pdf', '1112_1_planned early birth versus expectant management waiting for prelabour rupture of membranes at term 37 weeks or more.pdf', '1112_2_dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.pdf', '1112_3_induction of labour for improving birth outcomes for women at or beyond term.pdf', '1112_0_middleeast obgyn graduate education mogge foundation practice guidelines prelabor rupture of membranes practice guideline no 01o19.pdf']","[0.416, 0.569, 0.35, 0.505, 0.5, 0.388, 0.403]","[0.512, 0.515, 0.516, 0.52, 0.515, 0.518, 0.523]","[0.596, 0.599, 0.602, 0.601, 0.6, 0.599, 0.603]","[0.166, 0.17, 0.184, 0.195, 0.172, 0.183, 0.172]","[0.144, 0.147, 0.169, 0.178, 0.154, 0.17, 0.176]","[0.12, 0.124, 0.142, 0.151, 0.125, 0.142, 0.134]","[0.736, 0.74, 0.741, 0.744, 0.739, 0.741, 0.739]","[0.64, 0.645, 0.649, 0.652, 0.643, 0.648, 0.643]","[0.572, 0.571, 0.576, 0.575, 0.575, 0.577, 0.584]","[0.671, 0.679, 0.693, 0.684, 0.672, 0.691, 0.655]","[0.768, 0.766, 0.771, 0.774, 0.767, 0.773, 0.785]","[0.679, 0.683, 0.686, 0.68, 0.686, 0.682, 0.694]","[0.583, 0.58, 0.583, 0.592, 0.584, 0.584, 0.594]","[0.895, 0.887, 0.898, 0.896, 0.89, 0.897, 0.9]","[0.788, 0.784, 0.792, 0.786, 0.788, 0.791, 0.795]","[0.709, 0.702, 0.708, 0.713, 0.706, 0.711, 0.725]","[0.765, 0.76, 0.763, 0.766, 0.764, 0.766, 0.769]","[0.737, 0.73, 0.739, 0.74, 0.733, 0.74, 0.748]",0.447,0.517,0.6,0.177,0.163,0.134,0.74,0.646,0.576,0.678,0.772,0.684,0.586,0.895,0.789,0.711,0.765,0.738
https://doi.org/10.1002/14651858.cd001814,developmental care for promoting development and preventing morbidity in preterm infants,1113_developmental care for promoting development and preventing morbidity in preterm infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612699/pdf']","['Developmental care for promoting development and preventing morbidity in preterm infants', 'Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612699/pdf']","['1113_0_developmental care for promoting development and preventing morbidity in preterm infants.pdf', '1113_1_early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612699/pdf']","['1113_0_developmental care for promoting development and preventing morbidity in preterm infants.pdf', '1113_1_early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.pdf']","[0.924, 0.645]","[0.517, 0.515]","[0.6, 0.596]","[0.189, 0.184]","[0.175, 0.171]","[0.158, 0.155]","[0.741, 0.74]","[0.648, 0.649]","[0.581, 0.576]","[0.722, 0.717]","[0.773, 0.771]","[0.668, 0.669]","[0.59, 0.595]","[0.91, 0.907]","[0.793, 0.793]","[0.723, 0.722]","[0.771, 0.769]","[0.754, 0.751]",0.784,0.516,0.598,0.186,0.173,0.157,0.74,0.649,0.579,0.72,0.772,0.669,0.593,0.909,0.793,0.722,0.77,0.752
https://doi.org/10.1002/14651858.cd001814.pub2,developmental care for promoting development and preventing morbidity in preterm infants,1114_developmental care for promoting development and preventing morbidity in preterm infants.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568376/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464252/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464533/pdf']","['Responsive versus scheduled feeding for preterm infants', 'Cycled light in the intensive care unit for preterm and low birth weight infants', 'Co‐bedding in neonatal nursery for promoting growth and neurodevelopment in stable preterm twins']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464252/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568376/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464533/pdf']","['1114_1_cycled light in the intensive care unit for preterm and low birth weight infants.pdf', '1114_0_responsive versus scheduled feeding for preterm infants.pdf', '1114_2_co‐bedding in neonatal nursery for promoting growth and neurodevelopment in stable preterm twins.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464252/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568376/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464533/pdf']","['1114_1_cycled light in the intensive care unit for preterm and low birth weight infants.pdf', '1114_0_responsive versus scheduled feeding for preterm infants.pdf', '1114_2_co‐bedding in neonatal nursery for promoting growth and neurodevelopment in stable preterm twins.pdf']","[0.574, 0.497, 0.498]","[0.533, 0.558, 0.557]","[0.616, 0.638, 0.64]","[0.195, 0.213, 0.209]","[0.19, 0.21, 0.205]","[0.155, 0.173, 0.166]","[0.738, 0.737, 0.739]","[0.646, 0.646, 0.646]","[0.591, 0.619, 0.622]","[0.707, 0.704, 0.709]","[0.781, 0.791, 0.796]","[0.71, 0.725, 0.726]","[0.602, 0.611, 0.615]","[0.905, 0.925, 0.923]","[0.821, 0.832, 0.835]","[0.737, 0.758, 0.76]","[0.783, 0.798, 0.8]","[0.761, 0.782, 0.783]",0.523,0.549,0.631,0.206,0.202,0.165,0.738,0.646,0.611,0.707,0.789,0.72,0.609,0.918,0.829,0.752,0.794,0.775
https://doi.org/10.1002/14651858.cd001816.pub3,oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates,1115_oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464658/pdf'],['Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464658/pdf'],['1115_0_oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464658/pdf'],['1115_0_oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates.pdf'],[0.971],[0.506],[0.594],[0.18],[0.19],[0.166],[0.743],[0.651],[0.569],[0.701],[0.763],[0.679],[0.59],[0.891],[0.776],[0.699],[0.757],[0.723],0.971,0.506,0.594,0.18,0.19,0.166,0.743,0.651,0.569,0.701,0.763,0.679,0.59,0.891,0.776,0.699,0.757,0.723
https://doi.org/10.1002/14651858.cd001830.pub5,pit and fissure sealants for preventing dental decay in permanent teeth,1116_pit and fissure sealants for preventing dental decay in permanent teeth.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308902/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832104/pdf']","['Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents', 'Sealants for preventing dental caries in primary teeth']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308902/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832104/pdf']","['1116_0_pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents.pdf', '1116_1_sealants for preventing dental caries in primary teeth.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308902/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832104/pdf']","['1116_0_pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents.pdf', '1116_1_sealants for preventing dental caries in primary teeth.pdf']","[0.852, 0.889]","[0.532, 0.538]","[0.61, 0.613]","[0.189, 0.202]","[0.183, 0.198]","[0.16, 0.171]","[0.743, 0.744]","[0.652, 0.652]","[0.592, 0.598]","[0.695, 0.699]","[0.786, 0.787]","[0.713, 0.72]","[0.614, 0.613]","[0.906, 0.907]","[0.802, 0.805]","[0.731, 0.732]","[0.786, 0.789]","[0.758, 0.758]",0.871,0.535,0.611,0.196,0.191,0.166,0.744,0.652,0.595,0.697,0.786,0.716,0.613,0.907,0.804,0.732,0.788,0.758
https://doi.org/10.1002/14651858.cd001871.pub4,interventions for preventing obesity in children,1117_interventions for preventing obesity in children.pdf,3,"['https://www.urban.org/research/publication/obesity-across-america', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf']","['Obesity across America', ""Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors"", 'Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf']","['1117_2_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf', '1117_1_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf']","['1117_2_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf', '1117_1_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf']","[0.715, 0.697]","[0.534, 0.534]","[0.617, 0.619]","[0.197, 0.196]","[0.197, 0.197]","[0.173, 0.171]","[0.74, 0.741]","[0.649, 0.647]","[0.587, 0.592]","[0.718, 0.722]","[0.77, 0.774]","[0.685, 0.685]","[0.603, 0.603]","[0.914, 0.913]","[0.822, 0.83]","[0.716, 0.723]","[0.777, 0.778]","[0.753, 0.759]",0.706,0.534,0.618,0.197,0.197,0.172,0.74,0.648,0.589,0.72,0.772,0.685,0.603,0.913,0.826,0.72,0.778,0.756
https://doi.org/10.1002/14651858.cd001872.pub2,interventions for treating obesity in children,1118_interventions for treating obesity in children.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028049/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761478/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486279/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472619/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481371/pdf', 'https://stacks.cdc.gov/view/cdc/53646']","['Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years', 'Surgery for weight loss in adults', 'Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years', 'How useful are clinical guidelines for the management of obesity in general practice?', ""Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors"", 'Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years', 'Nutritional interventions for survivors of childhood cancer', 'Drug interventions for the treatment of obesity in children and adolescents', 'Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years', 'The Childhood Obesity Research Demonstration (CORD) Project']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472619/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486279/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028049/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761478/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf']","['1118_8_diet physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.pdf', '1118_5_diet physical activity and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years.pdf', '1118_4_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf', '1118_7_drug interventions for the treatment of obesity in children and adolescents.pdf', '1118_6_nutritional interventions for survivors of childhood cancer.pdf', '1118_1_surgery for weight loss in adults.pdf', '1118_2_parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years.pdf', '1118_3_how useful are clinical guidelines for the management of obesity in general practice.pdf', '1118_0_diet physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.pdf']",9,90.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669248/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472619/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486279/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028049/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761478/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481885/pdf']","['1118_8_diet physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years.pdf', '1118_5_diet physical activity and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years.pdf', '1118_4_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf', '1118_7_drug interventions for the treatment of obesity in children and adolescents.pdf', '1118_6_nutritional interventions for survivors of childhood cancer.pdf', '1118_1_surgery for weight loss in adults.pdf', '1118_2_parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years.pdf', '1118_3_how useful are clinical guidelines for the management of obesity in general practice.pdf', '1118_0_diet physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.pdf']","[0.804, 0.453, 0.786, 0.373, 0.69, 0.801, 0.573, 0.685, 0.753]","[0.528, 0.533, 0.546, 0.523, 0.53, 0.522, 0.531, 0.558, 0.532]","[0.613, 0.614, 0.626, 0.61, 0.616, 0.609, 0.614, 0.642, 0.616]","[0.188, 0.195, 0.197, 0.177, 0.182, 0.174, 0.187, 0.204, 0.193]","[0.189, 0.199, 0.2, 0.179, 0.183, 0.17, 0.194, 0.211, 0.196]","[0.16, 0.162, 0.164, 0.146, 0.152, 0.139, 0.165, 0.166, 0.164]","[0.739, 0.739, 0.737, 0.736, 0.734, 0.737, 0.737, 0.736, 0.74]","[0.643, 0.645, 0.641, 0.639, 0.637, 0.64, 0.641, 0.641, 0.644]","[0.588, 0.594, 0.609, 0.585, 0.59, 0.586, 0.591, 0.633, 0.591]","[0.706, 0.712, 0.704, 0.695, 0.697, 0.675, 0.709, 0.696, 0.707]","[0.777, 0.78, 0.787, 0.777, 0.774, 0.773, 0.778, 0.807, 0.779]","[0.689, 0.702, 0.712, 0.689, 0.705, 0.701, 0.696, 0.751, 0.692]","[0.605, 0.608, 0.613, 0.603, 0.602, 0.603, 0.608, 0.619, 0.605]","[0.916, 0.909, 0.915, 0.916, 0.914, 0.909, 0.916, 0.928, 0.919]","[0.824, 0.821, 0.834, 0.816, 0.814, 0.806, 0.823, 0.843, 0.826]","[0.735, 0.744, 0.747, 0.737, 0.729, 0.726, 0.738, 0.768, 0.74]","[0.781, 0.784, 0.793, 0.779, 0.779, 0.776, 0.784, 0.81, 0.784]","[0.763, 0.763, 0.771, 0.762, 0.755, 0.75, 0.765, 0.791, 0.766]",0.658,0.534,0.618,0.189,0.191,0.158,0.737,0.641,0.596,0.7,0.781,0.704,0.607,0.916,0.823,0.74,0.786,0.765
https://doi.org/10.1002/14651858.cd001904.pub3,carbamazepine versus phenobarbitone monotherapy for epilepsy an individual participant data review,1119_carbamazepine versus phenobarbitone monotherapy for epilepsy an individual participant data review.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481892/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517155/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486134/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513029/pdf']","['Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data', 'Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review', 'Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data', 'Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486134/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481892/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513029/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517155/pdf']","['1119_2_antiepileptic drug monotherapy for epilepsy a network meta‐analysis of individual participant data.pdf', '1119_0_antiepileptic drug monotherapy for epilepsy a network meta‐analysis of individual participant data.pdf', '1119_3_lamotrigine versus carbamazepine monotherapy for epilepsy an individual participant data review.pdf', '1119_1_carbamazepine versus phenobarbitone monotherapy for epilepsy an individual participant data review.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486134/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481892/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513029/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517155/pdf']","['1119_2_antiepileptic drug monotherapy for epilepsy a network meta‐analysis of individual participant data.pdf', '1119_0_antiepileptic drug monotherapy for epilepsy a network meta‐analysis of individual participant data.pdf', '1119_3_lamotrigine versus carbamazepine monotherapy for epilepsy an individual participant data review.pdf', '1119_1_carbamazepine versus phenobarbitone monotherapy for epilepsy an individual participant data review.pdf']","[0.837, 0.923, 0.816, 0.853]","[0.496, 0.498, 0.498, 0.499]","[0.6, 0.601, 0.602, 0.603]","[0.183, 0.189, 0.197, 0.203]","[0.182, 0.189, 0.19, 0.198]","[0.156, 0.16, 0.163, 0.168]","[0.743, 0.745, 0.747, 0.746]","[0.655, 0.658, 0.659, 0.658]","[0.552, 0.553, 0.557, 0.557]","[0.735, 0.737, 0.731, 0.738]","[0.75, 0.753, 0.762, 0.761]","[0.679, 0.692, 0.677, 0.678]","[0.591, 0.598, 0.595, 0.598]","[0.88, 0.873, 0.892, 0.89]","[0.769, 0.763, 0.773, 0.77]","[0.672, 0.674, 0.696, 0.694]","[0.744, 0.746, 0.753, 0.752]","[0.698, 0.694, 0.723, 0.719]",0.857,0.498,0.601,0.193,0.19,0.162,0.745,0.658,0.555,0.735,0.757,0.681,0.596,0.884,0.769,0.684,0.749,0.708
https://doi.org/10.1002/14651858.cd001912.pub2,prophylactic antistaphylococcal antibiotics for cystic fibrosis,1120_prophylactic antistaphylococcal antibiotics for cystic fibrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513196/pdf'],['Treatment for chronic methicillin‐sensitive pulmonary infection in people with cystic fibrosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513196/pdf'],['1120_0_treatment for chronic methicillin‐sensitive pulmonary infection in people with cystic fibrosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513196/pdf'],['1120_0_treatment for chronic methicillin‐sensitive pulmonary infection in people with cystic fibrosis.pdf'],[0.499],[0.525],[0.614],[0.189],[0.187],[0.15],[0.74],[0.645],[0.6],[0.7],[0.783],[0.69],[0.599],[0.917],[0.811],[0.736],[0.775],[0.762],0.499,0.525,0.614,0.189,0.187,0.15,0.74,0.645,0.6,0.7,0.783,0.69,0.599,0.917,0.811,0.736,0.775,0.762
https://doi.org/10.1002/14651858.cd001919.pub3,information provision for stroke patients and their caregivers,1121_information provision for stroke patients and their caregivers.pdf,4,"['https://www.nj.gov/health/healthcarequality/documents/aphasia_report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516056/pdf', 'https://www.aan.com/Guidelines/home/GetGuidelineContent/744', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610078/pdf']","['Final Report', 'Telephone interventions, delivered by healthcare professionals, for providing education and psychosocial support for informal caregivers of adults with diagnosed illnesses', 'Guidelines for Adult Stroke Rehabilitation and Recovery', 'Information provision for stroke survivors and their carers']","['https://www.aan.com/Guidelines/home/GetGuidelineContent/744', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516056/pdf', 'https://www.nj.gov/health/healthcarequality/documents/aphasia_report.pdf']","['1121_2_guidelines for adult stroke rehabilitation and recovery.pdf', '1121_3_information provision for stroke survivors and their carers.pdf', '1121_1_telephone interventions delivered by healthcare professionals for providing education and psychosocial support for informal caregivers of adults with diagnosed illnesses.pdf', '1121_0_final report.pdf']",4,100.0,"['https://www.aan.com/Guidelines/home/GetGuidelineContent/744', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516056/pdf', 'https://www.nj.gov/health/healthcarequality/documents/aphasia_report.pdf']","['1121_2_guidelines for adult stroke rehabilitation and recovery.pdf', '1121_3_information provision for stroke survivors and their carers.pdf', '1121_1_telephone interventions delivered by healthcare professionals for providing education and psychosocial support for informal caregivers of adults with diagnosed illnesses.pdf', '1121_0_final report.pdf']","[0.213, 0.609, 0.575, 0.865]","[0.498, 0.516, 0.513, 0.492]","[0.588, 0.594, 0.591, 0.593]","[0.166, 0.192, 0.175, 0.156]","[0.17, 0.186, 0.167, 0.155]","[0.146, 0.168, 0.149, 0.128]","[0.745, 0.746, 0.74, 0.733]","[0.654, 0.658, 0.651, 0.636]","[0.561, 0.568, 0.567, 0.549]","[0.678, 0.722, 0.713, 0.679]","[0.77, 0.761, 0.763, 0.772]","[0.69, 0.685, 0.681, 0.698]","[0.599, 0.6, 0.599, 0.612]","[0.91, 0.904, 0.906, 0.905]","[0.796, 0.802, 0.803, 0.804]","[0.714, 0.707, 0.71, 0.72]","[0.765, 0.763, 0.763, 0.77]","[0.744, 0.739, 0.742, 0.744]",0.565,0.505,0.591,0.172,0.17,0.148,0.741,0.65,0.561,0.698,0.766,0.689,0.602,0.906,0.801,0.713,0.765,0.742
https://doi.org/10.1002/14651858.cd001930.pub2,cognitivebehavioural interventions for children who have been sexually abused,1122_cognitivebehavioural interventions for children who have been sexually abused.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf', 'https://stacks.cdc.gov/view/cdc/30582', 'https://stacks.cdc.gov/view/cdc/39320']","['Cognitive‐behavioural interventions for children who have been sexually abused', 'Violence against children in Haiti : findings from a national survey 2012', 'Enquête sur la violence contre les enfants en Haïti : résultats d’une enquête nationale réalisée en 2012']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf'],['1122_0_cognitive‐behavioural interventions for children who have been sexually abused.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf'],['1122_0_cognitive‐behavioural interventions for children who have been sexually abused.pdf'],[0.94],[0.532],[0.614],[0.194],[0.198],[0.173],[0.739],[0.646],[0.591],[0.728],[0.786],[0.691],[0.595],[0.917],[0.827],[0.738],[0.787],[0.77],0.94,0.532,0.614,0.194,0.198,0.173,0.739,0.646,0.591,0.728,0.786,0.691,0.595,0.917,0.827,0.738,0.787,0.77
https://doi.org/10.1002/14651858.cd001930.pub3,cognitivebehavioural interventions for children who have been sexually abused,1123_cognitivebehavioural interventions for children who have been sexually abused.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.rand.org/pubs/research_reports/RR1728.html']","['Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises', 'Psychological therapies for children and adolescents exposed to trauma', 'Improving Outcomes for Children Exposed to Violence']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf']","['1123_1_psychological therapies for children and adolescents exposed to trauma.pdf', '1123_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf']","['1123_1_psychological therapies for children and adolescents exposed to trauma.pdf', '1123_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf']","[0.519, 0.687]","[0.506, 0.52]","[0.592, 0.607]","[0.174, 0.163]","[0.171, 0.165]","[0.15, 0.142]","[0.74, 0.732]","[0.647, 0.64]","[0.563, 0.58]","[0.729, 0.72]","[0.767, 0.779]","[0.662, 0.688]","[0.581, 0.583]","[0.908, 0.912]","[0.801, 0.817]","[0.716, 0.727]","[0.763, 0.778]","[0.748, 0.761]",0.603,0.513,0.599,0.168,0.168,0.146,0.736,0.643,0.571,0.724,0.773,0.675,0.582,0.91,0.809,0.722,0.77,0.754
https://doi.org/10.1002/14651858.cd001992.pub3,cyclooxygenase cox inhibitors for treating preterm labour,1125_cyclooxygenase cox inhibitors for treating preterm labour.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676064/pdf']","['Ethanol for preventing preterm birth in threatened preterm labor', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Techniques for assisting difficult delivery at caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676064/pdf']","['1125_0_ethanol for preventing preterm birth in threatened preterm labor.pdf', '1125_1_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1125_2_techniques for assisting difficult delivery at caesarean section.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676064/pdf']","['1125_0_ethanol for preventing preterm birth in threatened preterm labor.pdf', '1125_1_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1125_2_techniques for assisting difficult delivery at caesarean section.pdf']","[0.611, 0.394, 0.437]","[0.517, 0.507, 0.515]","[0.6, 0.599, 0.603]","[0.191, 0.175, 0.183]","[0.18, 0.162, 0.166]","[0.149, 0.133, 0.142]","[0.74, 0.74, 0.741]","[0.648, 0.648, 0.65]","[0.581, 0.577, 0.581]","[0.692, 0.683, 0.674]","[0.775, 0.773, 0.775]","[0.688, 0.689, 0.687]","[0.587, 0.586, 0.587]","[0.895, 0.892, 0.895]","[0.789, 0.776, 0.792]","[0.715, 0.703, 0.716]","[0.768, 0.764, 0.767]","[0.742, 0.729, 0.741]",0.481,0.513,0.601,0.183,0.169,0.141,0.74,0.649,0.58,0.683,0.774,0.688,0.587,0.894,0.786,0.711,0.766,0.737
https://doi.org/10.1002/14651858.cd002003.pub5,betablockers for hypertension,1126_betablockers for hypertension.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570410/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755267/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761481/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483478/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483466/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550717/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464701/pdf', 'https://www.rti.org/publication/comparative-effectiveness-review-methods']","['Beta‐blockers in patients without heart failure after myocardial infarction', 'Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery', 'First‐line combination therapy versus first‐line monotherapy for primary hypertension', 'Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery', 'Blood pressure targets for hypertension in older adults', 'Pharmacotherapy for hypertension in adults aged 18 to 59 years', 'First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension', 'Pharmacotherapy for hypertension in adults 60 years or older', 'Eplerenone for hypertension', 'Comparative effectiveness review methods']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550717/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761481/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483478/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570410/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464701/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483466/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755267/pdf']","['1126_7_pharmacotherapy for hypertension in adults 60 years or older.pdf', '1126_3_perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery.pdf', '1126_4_blood pressure targets for hypertension in older adults.pdf', '1126_0_beta‐blockers in patients without heart failure after myocardial infarction.pdf', '1126_8_eplerenone for hypertension.pdf', '1126_5_pharmacotherapy for hypertension in adults aged 18 to 59 years.pdf', '1126_6_first‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension.pdf', '1126_2_first‐line combination therapy versus first‐line monotherapy for primary hypertension.pdf', '1126_1_perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery.pdf']",9,90.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550717/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761481/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483478/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570410/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464701/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483466/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755267/pdf']","['1126_7_pharmacotherapy for hypertension in adults 60 years or older.pdf', '1126_3_perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery.pdf', '1126_4_blood pressure targets for hypertension in older adults.pdf', '1126_0_beta‐blockers in patients without heart failure after myocardial infarction.pdf', '1126_8_eplerenone for hypertension.pdf', '1126_5_pharmacotherapy for hypertension in adults aged 18 to 59 years.pdf', '1126_6_first‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension.pdf', '1126_2_first‐line combination therapy versus first‐line monotherapy for primary hypertension.pdf', '1126_1_perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery.pdf']","[0.664, 0.651, 0.621, 0.645, 0.583, 0.757, 0.747, 0.736, 0.571]","[0.512, 0.506, 0.503, 0.51, 0.506, 0.518, 0.504, 0.502, 0.504]","[0.599, 0.596, 0.591, 0.601, 0.594, 0.603, 0.592, 0.593, 0.593]","[0.19, 0.186, 0.185, 0.188, 0.178, 0.192, 0.188, 0.185, 0.186]","[0.197, 0.179, 0.187, 0.19, 0.182, 0.202, 0.192, 0.189, 0.181]","[0.159, 0.15, 0.153, 0.154, 0.144, 0.16, 0.155, 0.152, 0.151]","[0.746, 0.745, 0.744, 0.744, 0.741, 0.742, 0.748, 0.744, 0.745]","[0.655, 0.654, 0.655, 0.654, 0.648, 0.651, 0.658, 0.656, 0.654]","[0.574, 0.569, 0.566, 0.577, 0.572, 0.58, 0.566, 0.568, 0.564]","[0.717, 0.712, 0.713, 0.719, 0.715, 0.716, 0.715, 0.704, 0.715]","[0.774, 0.766, 0.768, 0.774, 0.769, 0.777, 0.763, 0.769, 0.764]","[0.677, 0.668, 0.669, 0.675, 0.677, 0.687, 0.669, 0.671, 0.664]","[0.589, 0.58, 0.578, 0.578, 0.582, 0.59, 0.577, 0.578, 0.581]","[0.904, 0.902, 0.897, 0.906, 0.906, 0.907, 0.893, 0.904, 0.9]","[0.792, 0.791, 0.784, 0.791, 0.79, 0.8, 0.784, 0.792, 0.783]","[0.718, 0.704, 0.707, 0.714, 0.712, 0.724, 0.702, 0.71, 0.702]","[0.765, 0.757, 0.758, 0.762, 0.763, 0.771, 0.754, 0.758, 0.755]","[0.742, 0.736, 0.734, 0.742, 0.739, 0.749, 0.731, 0.738, 0.733]",0.664,0.507,0.596,0.186,0.189,0.153,0.744,0.654,0.571,0.714,0.769,0.673,0.581,0.902,0.79,0.71,0.76,0.738
https://doi.org/10.1002/14651858.cd002006.pub2,position in the second stage of labour for women without epidural anaesthesia,1127_position in the second stage of labour for women without epidural anaesthesia.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484432/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf']","['Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period', 'Position in the second stage of labour for women with epidural anaesthesia', 'Position in the second stage of labour for women without epidural anaesthesia', 'Pain management for women in labour: an overview of systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484432/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464234/pdf']","['1127_0_paracetamolacetaminophen single administration for perineal pain in the early postpartum period.pdf', '1127_2_position in the second stage of labour for women without epidural anaesthesia.pdf', '1127_3_pain management for women in labour an overview of systematic reviews.pdf', '1127_1_position in the second stage of labour for women with epidural anaesthesia.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484432/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464234/pdf']","['1127_0_paracetamolacetaminophen single administration for perineal pain in the early postpartum period.pdf', '1127_2_position in the second stage of labour for women without epidural anaesthesia.pdf', '1127_3_pain management for women in labour an overview of systematic reviews.pdf', '1127_1_position in the second stage of labour for women with epidural anaesthesia.pdf']","[0.371, 0.835, 0.823, 0.511]","[0.516, 0.519, 0.502, 0.536]","[0.608, 0.597, 0.585, 0.615]","[0.153, 0.184, 0.165, 0.195]","[0.167, 0.194, 0.175, 0.213]","[0.126, 0.16, 0.142, 0.169]","[0.733, 0.74, 0.736, 0.737]","[0.636, 0.644, 0.639, 0.643]","[0.582, 0.577, 0.555, 0.595]","[0.664, 0.685, 0.678, 0.688]","[0.778, 0.771, 0.758, 0.784]","[0.702, 0.688, 0.693, 0.721]","[0.595, 0.591, 0.59, 0.61]","[0.917, 0.908, 0.889, 0.915]","[0.808, 0.8, 0.765, 0.808]","[0.731, 0.721, 0.689, 0.74]","[0.782, 0.776, 0.762, 0.788]","[0.757, 0.746, 0.711, 0.76]",0.635,0.518,0.601,0.174,0.187,0.149,0.736,0.641,0.577,0.679,0.773,0.701,0.596,0.907,0.795,0.72,0.777,0.744
https://doi.org/10.1002/14651858.cd002006.pub3,position in the second stage of labour for women without epidural anaesthesia,1128_position in the second stage of labour for women without epidural anaesthesia.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464399/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464699/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484432/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf']","['Fundal pressure during the second stage of labour', 'Pushing/bearing down methods for the second stage of labour', 'Position in the second stage of labour for women without epidural anaesthesia', 'Perineal techniques during the second stage of labour for reducing perineal trauma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464699/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464399/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484432/pdf']","['1128_1_pushingbearing down methods for the second stage of labour.pdf', '1128_0_fundal pressure during the second stage of labour.pdf', '1128_3_perineal techniques during the second stage of labour for reducing perineal trauma.pdf', '1128_2_position in the second stage of labour for women without epidural anaesthesia.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464699/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464399/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484432/pdf']","['1128_1_pushingbearing down methods for the second stage of labour.pdf', '1128_0_fundal pressure during the second stage of labour.pdf', '1128_3_perineal techniques during the second stage of labour for reducing perineal trauma.pdf', '1128_2_position in the second stage of labour for women without epidural anaesthesia.pdf']","[0.665, 0.652, 0.948, 0.637]","[0.513, 0.514, 0.517, 0.513]","[0.591, 0.594, 0.597, 0.589]","[0.18, 0.183, 0.18, 0.184]","[0.172, 0.176, 0.174, 0.181]","[0.148, 0.149, 0.147, 0.16]","[0.74, 0.741, 0.742, 0.744]","[0.645, 0.644, 0.647, 0.648]","[0.572, 0.571, 0.572, 0.573]","[0.698, 0.695, 0.68, 0.7]","[0.768, 0.769, 0.77, 0.767]","[0.67, 0.684, 0.684, 0.675]","[0.584, 0.586, 0.589, 0.581]","[0.896, 0.895, 0.895, 0.896]","[0.793, 0.797, 0.795, 0.793]","[0.713, 0.713, 0.715, 0.713]","[0.767, 0.768, 0.769, 0.767]","[0.741, 0.741, 0.743, 0.742]",0.726,0.514,0.593,0.182,0.176,0.151,0.742,0.646,0.572,0.693,0.768,0.678,0.585,0.895,0.795,0.714,0.768,0.742
https://doi.org/10.1002/14651858.cd002006.pub4,position in the second stage of labour for women without epidural anaesthesia,1129_position in the second stage of labour for women without epidural anaesthesia.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517130/pdf', 'https://effectivehealthcare.ahrq.gov/products/labor-dystocia/research']","['Maternal position in the second stage of labour for women with epidural anaesthesia', 'Labor Dystocia']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517130/pdf'],['1129_0_maternal position in the second stage of labour for women with epidural anaesthesia.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517130/pdf'],['1129_0_maternal position in the second stage of labour for women with epidural anaesthesia.pdf'],[0.863],[0.512],[0.593],[0.184],[0.182],[0.159],[0.742],[0.647],[0.571],[0.697],[0.766],[0.676],[0.586],[0.9],[0.791],[0.709],[0.765],[0.739],0.863,0.512,0.593,0.184,0.182,0.159,0.742,0.647,0.571,0.697,0.766,0.676,0.586,0.9,0.791,0.709,0.765,0.739
https://doi.org/10.1002/14651858.cd002018,antidepressant treatment for postnatal depression,1130_antidepressant treatment for postnatal depression.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094614/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf', 'https://effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/research']","['Antidepressant treatment for postnatal depression', 'Antenatal psychosocial assessment for reducing perinatal mental health morbidity', 'Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094614/pdf']","['1130_1_antenatal psychosocial assessment for reducing perinatal mental health morbidity.pdf', '1130_0_antidepressant treatment for postnatal depression.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094614/pdf']","['1130_1_antenatal psychosocial assessment for reducing perinatal mental health morbidity.pdf', '1130_0_antidepressant treatment for postnatal depression.pdf']","[0.701, 0.514]","[0.522, 0.525]","[0.627, 0.615]","[0.189, 0.191]","[0.211, 0.2]","[0.175, 0.171]","[0.737, 0.737]","[0.644, 0.643]","[0.588, 0.584]","[0.706, 0.713]","[0.784, 0.783]","[0.708, 0.706]","[0.591, 0.595]","[0.925, 0.918]","[0.816, 0.819]","[0.744, 0.735]","[0.782, 0.78]","[0.773, 0.766]",0.607,0.524,0.621,0.19,0.206,0.173,0.737,0.643,0.586,0.71,0.784,0.707,0.593,0.921,0.817,0.74,0.781,0.77
https://doi.org/10.1002/14651858.cd002020.pub2,parenttraining programmes for improving maternal psychosocial health,1132_parenttraining programmes for improving maternal psychosocial health.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1132_0_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf', '1132_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1132_0_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf', '1132_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']","[0.746, 0.147]","[0.549, 0.59]","[0.625, 0.652]","[0.213, 0.181]","[0.204, 0.146]","[0.176, 0.138]","[0.74, 0.733]","[0.65, 0.636]","[0.603, 0.66]","[0.724, 0.653]","[0.787, 0.824]","[0.716, 0.777]","[0.605, 0.637]","[0.914, 0.935]","[0.834, 0.852]","[0.746, 0.801]","[0.791, 0.832]","[0.774, 0.815]",0.447,0.57,0.639,0.197,0.175,0.157,0.736,0.643,0.631,0.689,0.805,0.746,0.621,0.925,0.843,0.774,0.811,0.794
https://doi.org/10.1002/14651858.cd002020.pub4,groupbased parent training programmes for improving parental psychosocial health,1133_groupbased parent training programmes for improving parental psychosocial health.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf']","['Group‐based parent training programmes for improving emotional and behavioural adjustment in young children', 'Group-based parent-training programmes for improving emotional and behavioural adjustment in children from birth to three years old', 'Antenatal psychosocial assessment for reducing perinatal mental health morbidity']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf']","['1133_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf', '1133_1_groupbased parenttraining programmes for improving emotional and behavioural adjustment in children from birth to three years old.pdf', '1133_2_antenatal psychosocial assessment for reducing perinatal mental health morbidity.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf']","['1133_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf', '1133_1_groupbased parenttraining programmes for improving emotional and behavioural adjustment in children from birth to three years old.pdf', '1133_2_antenatal psychosocial assessment for reducing perinatal mental health morbidity.pdf']","[0.831, 0.696, 0.406]","[0.527, 0.532, 0.52]","[0.606, 0.612, 0.614]","[0.191, 0.192, 0.177]","[0.187, 0.197, 0.181]","[0.163, 0.163, 0.147]","[0.741, 0.738, 0.733]","[0.649, 0.646, 0.641]","[0.576, 0.585, 0.584]","[0.738, 0.737, 0.714]","[0.774, 0.778, 0.776]","[0.68, 0.703, 0.696]","[0.59, 0.581, 0.578]","[0.908, 0.907, 0.916]","[0.813, 0.814, 0.811]","[0.723, 0.735, 0.73]","[0.772, 0.776, 0.775]","[0.751, 0.76, 0.76]",0.644,0.526,0.611,0.187,0.188,0.158,0.737,0.645,0.582,0.73,0.776,0.693,0.583,0.91,0.813,0.729,0.774,0.757
https://doi.org/10.1002/14651858.cd002053,sedatives for opiate withdrawal in newborn infants,1134_sedatives for opiate withdrawal in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf'],['Sedatives for opioid withdrawal in newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf'],['1134_0_sedatives for opioid withdrawal in newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf'],['1134_0_sedatives for opioid withdrawal in newborn infants.pdf'],[0.673],[0.518],[0.604],[0.18],[0.18],[0.157],[0.736],[0.643],[0.582],[0.693],[0.779],[0.694],[0.583],[0.909],[0.806],[0.724],[0.774],[0.755],0.673,0.518,0.604,0.18,0.18,0.157,0.736,0.643,0.582,0.693,0.779,0.694,0.583,0.909,0.806,0.724,0.774,0.755
https://doi.org/10.1002/14651858.cd002053.pub2,sedatives for opiate withdrawal in newborn infants,1135_sedatives for opiate withdrawal in newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf']","['Sedatives for opioid withdrawal in newborn infants', 'Home visits during pregnancy and after birth for women with an alcohol or drug problem']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf']","['1135_0_sedatives for opioid withdrawal in newborn infants.pdf', '1135_1_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf']","['1135_0_sedatives for opioid withdrawal in newborn infants.pdf', '1135_1_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf']","[0.778, 0.362]","[0.533, 0.527]","[0.614, 0.605]","[0.2, 0.188]","[0.192, 0.164]","[0.17, 0.151]","[0.741, 0.737]","[0.648, 0.644]","[0.59, 0.581]","[0.703, 0.687]","[0.779, 0.777]","[0.696, 0.683]","[0.592, 0.579]","[0.905, 0.901]","[0.812, 0.795]","[0.732, 0.726]","[0.781, 0.776]","[0.758, 0.752]",0.57,0.53,0.609,0.194,0.178,0.161,0.739,0.646,0.585,0.695,0.778,0.69,0.585,0.903,0.804,0.729,0.778,0.755
https://doi.org/10.1002/14651858.cd002053.pub3,sedatives for opiate withdrawal in newborn infants,1136_sedatives for opiate withdrawal in newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf']","['Sedatives for opioid withdrawal in newborn infants', 'Non‐pharmacological care for opioid withdrawal in newborns']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf']","['1136_0_sedatives for opioid withdrawal in newborn infants.pdf', '1136_1_non‐pharmacological care for opioid withdrawal in newborns.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf']","['1136_0_sedatives for opioid withdrawal in newborn infants.pdf', '1136_1_non‐pharmacological care for opioid withdrawal in newborns.pdf']","[0.789, 0.635]","[0.53, 0.526]","[0.612, 0.61]","[0.196, 0.186]","[0.19, 0.183]","[0.167, 0.16]","[0.74, 0.737]","[0.648, 0.644]","[0.589, 0.585]","[0.706, 0.691]","[0.777, 0.776]","[0.693, 0.694]","[0.591, 0.598]","[0.904, 0.906]","[0.811, 0.81]","[0.73, 0.733]","[0.779, 0.78]","[0.755, 0.759]",0.712,0.528,0.611,0.191,0.186,0.164,0.738,0.646,0.587,0.698,0.776,0.694,0.595,0.905,0.81,0.732,0.78,0.757
https://doi.org/10.1002/14651858.cd002059,opiate treatment for opiate withdrawal in newborn infants,1137_opiate treatment for opiate withdrawal in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261830/pdf'],['Opioid treatment for opioid withdrawal in newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261830/pdf'],['1137_0_opioid treatment for opioid withdrawal in newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261830/pdf'],['1137_0_opioid treatment for opioid withdrawal in newborn infants.pdf'],[0.695],[0.527],[0.6],[0.187],[0.183],[0.16],[0.739],[0.647],[0.584],[0.7],[0.774],[0.675],[0.589],[0.906],[0.804],[0.73],[0.777],[0.754],0.695,0.527,0.6,0.187,0.183,0.16,0.739,0.647,0.584,0.7,0.774,0.675,0.589,0.906,0.804,0.73,0.777,0.754
https://doi.org/10.1002/14651858.cd002059.pub2,opiate treatment for opiate withdrawal in newborn infants,1138_opiate treatment for opiate withdrawal in newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261830/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf']","['Opioid treatment for opioid withdrawal in newborn infants', 'Home visits during pregnancy and after birth for women with an alcohol or drug problem']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261830/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf']","['1138_0_opioid treatment for opioid withdrawal in newborn infants.pdf', '1138_1_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261830/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf']","['1138_0_opioid treatment for opioid withdrawal in newborn infants.pdf', '1138_1_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf']","[0.703, 0.334]","[0.532, 0.53]","[0.607, 0.604]","[0.198, 0.192]","[0.19, 0.168]","[0.165, 0.151]","[0.739, 0.736]","[0.648, 0.645]","[0.586, 0.581]","[0.698, 0.688]","[0.778, 0.777]","[0.693, 0.682]","[0.594, 0.582]","[0.903, 0.899]","[0.806, 0.793]","[0.733, 0.728]","[0.781, 0.778]","[0.759, 0.753]",0.518,0.531,0.605,0.195,0.179,0.158,0.738,0.647,0.583,0.693,0.778,0.688,0.588,0.901,0.8,0.73,0.78,0.756
https://doi.org/10.1002/14651858.cd002060,fibreoptic phototherapy for neonatal jaundice,1140_fibreoptic phototherapy for neonatal jaundice.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885069/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483308/pdf']","['Light‐emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates', 'Fluid supplementation for neonatal unconjugated hyperbilirubinaemia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483308/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885069/pdf']","['1140_1_fluid supplementation for neonatal unconjugated hyperbilirubinaemia.pdf', '1140_0_light‐emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483308/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885069/pdf']","['1140_1_fluid supplementation for neonatal unconjugated hyperbilirubinaemia.pdf', '1140_0_light‐emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates.pdf']","[0.598, 0.38]","[0.509, 0.514]","[0.592, 0.591]","[0.164, 0.186]","[0.143, 0.168]","[0.122, 0.154]","[0.742, 0.752]","[0.648, 0.659]","[0.579, 0.578]","[0.687, 0.703]","[0.767, 0.768]","[0.674, 0.671]","[0.586, 0.599]","[0.9, 0.895]","[0.795, 0.795]","[0.72, 0.721]","[0.765, 0.763]","[0.747, 0.745]",0.489,0.512,0.591,0.175,0.155,0.138,0.747,0.653,0.579,0.695,0.768,0.673,0.593,0.897,0.795,0.72,0.764,0.746
https://doi.org/10.1002/14651858.cd002238.pub2,drugs for nocturnal enuresis in children other than desmopressin and tricyclics,1143_drugs for nocturnal enuresis in children other than desmopressin and tricyclics.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741207/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf']","['Alarm interventions for nocturnal enuresis in children', 'Tricyclic and related drugs for nocturnal enuresis in children', 'Conservative interventions for treating functional daytime urinary incontinence in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741207/pdf']","['1143_2_conservative interventions for treating functional daytime urinary incontinence in children.pdf', '1143_0_alarm interventions for nocturnal enuresis in children.pdf', '1143_1_tricyclic and related drugs for nocturnal enuresis in children.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741207/pdf']","['1143_2_conservative interventions for treating functional daytime urinary incontinence in children.pdf', '1143_0_alarm interventions for nocturnal enuresis in children.pdf', '1143_1_tricyclic and related drugs for nocturnal enuresis in children.pdf']","[0.755, 0.907, 0.58]","[0.514, 0.5, 0.511]","[0.609, 0.594, 0.606]","[0.174, 0.176, 0.19]","[0.17, 0.169, 0.184]","[0.147, 0.151, 0.161]","[0.741, 0.744, 0.745]","[0.649, 0.653, 0.655]","[0.579, 0.563, 0.573]","[0.688, 0.7, 0.701]","[0.78, 0.77, 0.78]","[0.688, 0.679, 0.687]","[0.593, 0.582, 0.591]","[0.912, 0.905, 0.909]","[0.79, 0.781, 0.79]","[0.723, 0.706, 0.718]","[0.773, 0.76, 0.771]","[0.75, 0.737, 0.749]",0.747,0.508,0.603,0.18,0.174,0.153,0.743,0.652,0.572,0.696,0.777,0.685,0.589,0.909,0.787,0.716,0.768,0.745
https://doi.org/10.1002/14651858.cd002243.pub4,corticosteroids for treating sepsis in children and adults,1144_corticosteroids for treating sepsis in children and adults.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957233/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/pdf']","['Pragmatic Recommendations for the Management of COVID-19 Patients with Shock in Low- and Middle-Income Countries', 'Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957233/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/pdf']","['1144_0_pragmatic recommendations for the management of covid19 patients with shock in low and middleincome countries.pdf', '1144_1_pragmatic recommendations for therapeutics of hospitalized covid19 patients in low and middleincome countries.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957233/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/pdf']","['1144_0_pragmatic recommendations for the management of covid19 patients with shock in low and middleincome countries.pdf', '1144_1_pragmatic recommendations for therapeutics of hospitalized covid19 patients in low and middleincome countries.pdf']","[0.34, 0.301]","[0.516, 0.513]","[0.602, 0.6]","[0.163, 0.159]","[0.164, 0.167]","[0.127, 0.133]","[0.738, 0.738]","[0.643, 0.645]","[0.581, 0.579]","[0.672, 0.672]","[0.779, 0.782]","[0.679, 0.679]","[0.601, 0.6]","[0.914, 0.915]","[0.808, 0.808]","[0.727, 0.728]","[0.773, 0.775]","[0.755, 0.757]",0.321,0.514,0.601,0.161,0.166,0.13,0.738,0.644,0.58,0.672,0.78,0.679,0.601,0.915,0.808,0.728,0.774,0.756
https://doi.org/10.1002/14651858.cd002251.pub2,techniques for preventing hypotension during spinal anaesthesia for caesarean section,1146_techniques for preventing hypotension during spinal anaesthesia for caesarean section.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483677/pdf']","['Techniques for caesarean section', 'Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section', 'Techniques for preventing hypotension during spinal anaesthesia for caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483677/pdf']","['1146_1_interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.pdf', '1146_0_techniques for caesarean section.pdf', '1146_2_techniques for preventing hypotension during spinal anaesthesia for caesarean section.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483677/pdf']","['1146_1_interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.pdf', '1146_0_techniques for caesarean section.pdf', '1146_2_techniques for preventing hypotension during spinal anaesthesia for caesarean section.pdf']","[0.514, 0.602, 0.811]","[0.525, 0.515, 0.525]","[0.6, 0.592, 0.601]","[0.181, 0.16, 0.188]","[0.161, 0.149, 0.175]","[0.13, 0.121, 0.145]","[0.741, 0.737, 0.744]","[0.649, 0.641, 0.652]","[0.595, 0.58, 0.585]","[0.673, 0.66, 0.672]","[0.781, 0.775, 0.778]","[0.691, 0.689, 0.692]","[0.59, 0.585, 0.59]","[0.909, 0.91, 0.904]","[0.808, 0.801, 0.804]","[0.734, 0.721, 0.721]","[0.78, 0.777, 0.776]","[0.757, 0.748, 0.748]",0.642,0.522,0.598,0.176,0.162,0.132,0.741,0.647,0.587,0.668,0.778,0.691,0.588,0.908,0.804,0.725,0.778,0.751
https://doi.org/10.1002/14651858.cd002251.pub3,techniques for preventing hypotension during spinal anaesthesia for caesarean section,1147_techniques for preventing hypotension during spinal anaesthesia for caesarean section.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130052/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786885/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387232/pdf']","['Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section', 'Combined spinal‐epidural versus spinal anaesthesia for caesarean section', 'Techniques for preventing hypotension during spinal anaesthesia for caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387232/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130052/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786885/pdf']","['1147_2_techniques for preventing hypotension during spinal anaesthesia for caesarean section.pdf', '1147_0_interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.pdf', '1147_1_combined spinal‐epidural versus spinal anaesthesia for caesarean section.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387232/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130052/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786885/pdf']","['1147_2_techniques for preventing hypotension during spinal anaesthesia for caesarean section.pdf', '1147_0_interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section.pdf', '1147_1_combined spinal‐epidural versus spinal anaesthesia for caesarean section.pdf']","[0.77, 0.738, 0.96]","[0.515, 0.51, 0.514]","[0.599, 0.594, 0.598]","[0.196, 0.181, 0.188]","[0.174, 0.156, 0.171]","[0.153, 0.136, 0.147]","[0.75, 0.744, 0.743]","[0.661, 0.655, 0.65]","[0.575, 0.577, 0.571]","[0.686, 0.687, 0.676]","[0.771, 0.772, 0.771]","[0.681, 0.675, 0.685]","[0.585, 0.582, 0.59]","[0.893, 0.896, 0.895]","[0.79, 0.79, 0.796]","[0.702, 0.707, 0.711]","[0.761, 0.763, 0.764]","[0.734, 0.737, 0.739]",0.823,0.513,0.597,0.188,0.167,0.145,0.746,0.655,0.574,0.683,0.771,0.68,0.586,0.895,0.792,0.707,0.763,0.737
https://doi.org/10.1002/14651858.cd002284.pub2,fluoride mouthrinses for preventing dental caries in children and adolescents,1149_fluoride mouthrinses for preventing dental caries in children and adolescents.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516798/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494221/pdf', 'https://publichealth.nc.gov/oralhealth/docs/OralHealth-Newsletter-092418-WEB.pdf']","['Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment', 'Fluoride toothpastes of different concentrations for preventing dental caries', 'One‐to‐one oral hygiene advice provided in a dental setting for oral health', 'Fluoride supplementation (with tablets, drops, lozenges or chewing gum) in pregnant women for preventing dental caries in the primary teeth of their children', 'Slow‐release fluoride devices for the control of dental decay', 'The road to Oral Health Equity in NC']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516798/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494221/pdf']","['1149_3_fluoride supplementation with tablets drops lozenges or chewing gum in pregnant women for preventing dental caries in the primary teeth of their children.pdf', '1149_2_one‐to‐one oral hygiene advice provided in a dental setting for oral health.pdf', '1149_1_fluoride toothpastes of different concentrations for preventing dental caries.pdf', '1149_0_fluorides for preventing early tooth decay demineralised lesions during fixed brace treatment.pdf', '1149_4_slow‐release fluoride devices for the control of dental decay.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516798/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494221/pdf']","['1149_3_fluoride supplementation with tablets drops lozenges or chewing gum in pregnant women for preventing dental caries in the primary teeth of their children.pdf', '1149_2_one‐to‐one oral hygiene advice provided in a dental setting for oral health.pdf', '1149_1_fluoride toothpastes of different concentrations for preventing dental caries.pdf', '1149_0_fluorides for preventing early tooth decay demineralised lesions during fixed brace treatment.pdf', '1149_4_slow‐release fluoride devices for the control of dental decay.pdf']","[0.687, 0.793, 0.611, 0.647, 0.642]","[0.522, 0.536, 0.51, 0.531, 0.535]","[0.61, 0.624, 0.598, 0.618, 0.62]","[0.192, 0.193, 0.188, 0.197, 0.194]","[0.2, 0.199, 0.184, 0.197, 0.199]","[0.17, 0.17, 0.159, 0.17, 0.171]","[0.744, 0.744, 0.745, 0.746, 0.742]","[0.651, 0.652, 0.657, 0.655, 0.65]","[0.587, 0.6, 0.571, 0.593, 0.6]","[0.716, 0.719, 0.723, 0.718, 0.724]","[0.786, 0.791, 0.777, 0.789, 0.791]","[0.7, 0.713, 0.688, 0.705, 0.709]","[0.599, 0.607, 0.602, 0.61, 0.606]","[0.903, 0.905, 0.902, 0.903, 0.91]","[0.816, 0.827, 0.813, 0.817, 0.822]","[0.739, 0.744, 0.733, 0.74, 0.745]","[0.783, 0.793, 0.777, 0.787, 0.789]","[0.765, 0.771, 0.755, 0.766, 0.771]",0.676,0.527,0.614,0.193,0.196,0.168,0.744,0.653,0.59,0.72,0.787,0.703,0.605,0.905,0.819,0.74,0.786,0.766
https://doi.org/10.1002/14651858.cd002761,drugs for preventing migraine headaches in children,1152_drugs for preventing migraine headaches in children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221229/pdf']","['Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults', 'Topiramate for the prophylaxis of episodic migraine in adults', 'Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388931/pdf']","['1152_2_antiepileptics other than gabapentin pregabalin topiramate and valproate for the prophylaxis of episodic migraine in adults.pdf', '1152_0_gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.pdf', '1152_1_topiramate for the prophylaxis of episodic migraine in adults.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388931/pdf']","['1152_2_antiepileptics other than gabapentin pregabalin topiramate and valproate for the prophylaxis of episodic migraine in adults.pdf', '1152_0_gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.pdf', '1152_1_topiramate for the prophylaxis of episodic migraine in adults.pdf']","[0.519, 0.494, 0.65]","[0.523, 0.521, 0.513]","[0.604, 0.603, 0.589]","[0.181, 0.179, 0.175]","[0.189, 0.183, 0.175]","[0.157, 0.152, 0.151]","[0.738, 0.735, 0.738]","[0.646, 0.643, 0.646]","[0.584, 0.586, 0.572]","[0.715, 0.716, 0.712]","[0.771, 0.774, 0.766]","[0.704, 0.7, 0.68]","[0.602, 0.604, 0.597]","[0.902, 0.904, 0.902]","[0.818, 0.814, 0.802]","[0.726, 0.733, 0.723]","[0.775, 0.779, 0.771]","[0.753, 0.759, 0.75]",0.554,0.519,0.599,0.178,0.182,0.153,0.737,0.645,0.581,0.714,0.77,0.695,0.601,0.903,0.811,0.727,0.775,0.754
https://doi.org/10.1002/14651858.cd002770,mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease,1153_mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1153_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1153_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.516],[0.529],[0.615],[0.185],[0.188],[0.154],[0.744],[0.651],[0.589],[0.708],[0.774],[0.701],[0.599],[0.901],[0.796],[0.715],[0.775],[0.743],0.516,0.529,0.615,0.185,0.188,0.154,0.744,0.651,0.589,0.708,0.774,0.701,0.599,0.901,0.796,0.715,0.775,0.743
https://doi.org/10.1002/14651858.cd002771.pub3,kangaroo mother care to reduce morbidity and mortality in low birthweight infants,1156_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf']","['Skin‐to‐skin care for procedural pain in neonates', 'Kangaroo mother care to reduce morbidity and mortality in low birthweight infants', 'Early skin‐to‐skin contact for mothers and their healthy newborn infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf']","['1156_2_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf', '1156_0_skin‐to‐skin care for procedural pain in neonates.pdf', '1156_1_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf']","['1156_2_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf', '1156_0_skin‐to‐skin care for procedural pain in neonates.pdf', '1156_1_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf']","[0.619, 0.962, 0.7]","[0.517, 0.51, 0.512]","[0.595, 0.586, 0.589]","[0.19, 0.183, 0.205]","[0.172, 0.156, 0.174]","[0.15, 0.138, 0.166]","[0.741, 0.742, 0.749]","[0.647, 0.648, 0.657]","[0.574, 0.57, 0.571]","[0.705, 0.703, 0.726]","[0.774, 0.77, 0.769]","[0.675, 0.664, 0.66]","[0.59, 0.588, 0.586]","[0.9, 0.899, 0.895]","[0.793, 0.786, 0.778]","[0.72, 0.714, 0.707]","[0.771, 0.765, 0.761]","[0.747, 0.743, 0.736]",0.76,0.513,0.59,0.193,0.167,0.151,0.744,0.651,0.572,0.711,0.771,0.666,0.588,0.898,0.786,0.714,0.766,0.742
https://doi.org/10.1002/14651858.cd002771.pub4,kangaroo mother care to reduce morbidity and mortality in low birthweight infants,1157_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf,9,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.cgdev.org/publication/structuring-funding-development-impact-bonds-for-health-nine-lessons', 'https://www.fhi360.org/resource/lego-nurturing-care-and-covid-19-research-briefs', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094920/pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Structuring and Funding Development Impact Bonds for Health: Nine Lessons from Cameroon and Beyond', 'LEGO Nurturing Care and COVID-19: Research Briefs', 'Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants', 'Breastfeeding education and support for women with twins or higher order multiples', 'Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants', 'Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews', 'Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants', 'Early full enteral feeding for preterm or low birth weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094920/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf']","['1157_6_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1157_3_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf', '1157_5_interventions to prevent hypothermia at birth in preterm andor low birth weight infants.pdf', '1157_7_slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.pdf', '1157_8_early full enteral feeding for preterm or low birth weight infants.pdf', '1157_4_breastfeeding education and support for women with twins or higher order multiples.pdf']",6,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094920/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf']","['1157_6_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1157_3_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf', '1157_5_interventions to prevent hypothermia at birth in preterm andor low birth weight infants.pdf', '1157_7_slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.pdf', '1157_8_early full enteral feeding for preterm or low birth weight infants.pdf', '1157_4_breastfeeding education and support for women with twins or higher order multiples.pdf']","[0.545, 0.459, 0.606, 0.531, 0.523, 0.532]","[0.507, 0.508, 0.513, 0.508, 0.507, 0.514]","[0.594, 0.591, 0.59, 0.591, 0.59, 0.596]","[0.176, 0.181, 0.193, 0.179, 0.176, 0.179]","[0.158, 0.159, 0.165, 0.161, 0.154, 0.17]","[0.141, 0.15, 0.15, 0.149, 0.143, 0.149]","[0.744, 0.743, 0.745, 0.743, 0.74, 0.733]","[0.65, 0.65, 0.653, 0.65, 0.647, 0.639]","[0.572, 0.572, 0.569, 0.57, 0.573, 0.571]","[0.709, 0.711, 0.697, 0.71, 0.707, 0.693]","[0.767, 0.771, 0.77, 0.769, 0.769, 0.773]","[0.673, 0.67, 0.674, 0.672, 0.672, 0.677]","[0.587, 0.582, 0.59, 0.582, 0.578, 0.586]","[0.888, 0.899, 0.893, 0.899, 0.9, 0.901]","[0.771, 0.785, 0.776, 0.784, 0.784, 0.797]","[0.691, 0.705, 0.707, 0.703, 0.708, 0.717]","[0.759, 0.761, 0.765, 0.76, 0.762, 0.769]","[0.72, 0.74, 0.734, 0.736, 0.739, 0.745]",0.533,0.51,0.592,0.181,0.161,0.147,0.741,0.648,0.571,0.704,0.77,0.673,0.584,0.897,0.783,0.705,0.763,0.736
https://doi.org/10.1002/14651858.cd002776,prophylactic vitamin k for vitamin k deficiency bleeding in neonates,1158_prophylactic vitamin k for vitamin k deficiency bleeding in neonates.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491307/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605977/pdf']","['Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates', 'Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605977/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491307/pdf']","['1158_1_pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.pdf', '1158_0_prophylactic vitamin k for the prevention of vitamin k deficiency bleeding in preterm neonates.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605977/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491307/pdf']","['1158_1_pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.pdf', '1158_0_prophylactic vitamin k for the prevention of vitamin k deficiency bleeding in preterm neonates.pdf']","[0.737, 0.358]","[0.527, 0.53]","[0.61, 0.603]","[0.172, 0.193]","[0.162, 0.186]","[0.135, 0.164]","[0.736, 0.746]","[0.64, 0.655]","[0.592, 0.583]","[0.688, 0.692]","[0.779, 0.777]","[0.682, 0.681]","[0.595, 0.61]","[0.911, 0.896]","[0.8, 0.802]","[0.737, 0.735]","[0.776, 0.778]","[0.759, 0.756]",0.547,0.528,0.607,0.182,0.174,0.15,0.741,0.647,0.587,0.69,0.778,0.681,0.603,0.903,0.801,0.736,0.777,0.758
https://doi.org/10.1002/14651858.cd002856.pub3,giving women their own case notes to carry during pregnancy,1163_giving women their own case notes to carry during pregnancy.pdf,3,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Provision and uptake of routine antenatal services: a qualitative evidence synthesis', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564082/pdf']","['1163_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1163_1_provision and uptake of routine antenatal services a qualitative evidence synthesis.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564082/pdf']","['1163_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1163_1_provision and uptake of routine antenatal services a qualitative evidence synthesis.pdf']","[0.417, 0.512]","[0.505, 0.53]","[0.589, 0.618]","[0.181, 0.179]","[0.179, 0.19]","[0.156, 0.16]","[0.737, 0.733]","[0.644, 0.639]","[0.558, 0.589]","[0.719, 0.713]","[0.758, 0.778]","[0.691, 0.707]","[0.586, 0.586]","[0.882, 0.906]","[0.768, 0.823]","[0.681, 0.725]","[0.753, 0.778]","[0.703, 0.752]",0.465,0.518,0.603,0.18,0.184,0.158,0.735,0.641,0.574,0.716,0.768,0.699,0.586,0.894,0.795,0.703,0.766,0.728
https://doi.org/10.1002/14651858.cd002891,interventions for preventing eating disorders in children and adolescents,1166_interventions for preventing eating disorders in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353082/pdf'],"['Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353082/pdf'],['1166_0_inpatient versus outpatient care partial hospitalisation and waiting list for people with eating disorders.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353082/pdf'],['1166_0_inpatient versus outpatient care partial hospitalisation and waiting list for people with eating disorders.pdf'],[0.504],[0.534],[0.625],[0.197],[0.196],[0.169],[0.741],[0.646],[0.596],[0.707],[0.784],[0.7],[0.597],[0.908],[0.819],[0.734],[0.783],[0.763],0.504,0.534,0.625,0.197,0.196,0.169,0.741,0.646,0.596,0.707,0.784,0.7,0.597,0.908,0.819,0.734,0.783,0.763
https://doi.org/10.1002/14651858.cd002959.pub2,vaccines for women to prevent neonatal tetanus,1167_vaccines for women to prevent neonatal tetanus.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Vaccines for women for preventing neonatal tetanus', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1167_0_vaccines for women for preventing neonatal tetanus.pdf', '1167_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1167_0_vaccines for women for preventing neonatal tetanus.pdf', '1167_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']","[0.924, 0.175]","[0.525, 0.552]","[0.609, 0.636]","[0.196, 0.183]","[0.197, 0.161]","[0.167, 0.142]","[0.742, 0.739]","[0.648, 0.643]","[0.583, 0.607]","[0.695, 0.66]","[0.779, 0.804]","[0.693, 0.73]","[0.602, 0.633]","[0.909, 0.917]","[0.804, 0.822]","[0.719, 0.761]","[0.777, 0.805]","[0.749, 0.781]",0.549,0.538,0.623,0.19,0.179,0.154,0.74,0.645,0.595,0.677,0.792,0.712,0.617,0.913,0.813,0.74,0.791,0.765
https://doi.org/10.1002/14651858.cd002959.pub3,vaccines for women to prevent neonatal tetanus,1168_vaccines for women to prevent neonatal tetanus.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138051/pdf'],['Vaccines for women for preventing neonatal tetanus'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138051/pdf'],['1168_0_vaccines for women for preventing neonatal tetanus.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138051/pdf'],['1168_0_vaccines for women for preventing neonatal tetanus.pdf'],[0.931],[0.529],[0.614],[0.201],[0.202],[0.169],[0.743],[0.649],[0.59],[0.7],[0.785],[0.706],[0.604],[0.908],[0.809],[0.727],[0.782],[0.754],0.931,0.529,0.614,0.201,0.202,0.169,0.743,0.649,0.59,0.7,0.785,0.706,0.604,0.908,0.809,0.727,0.782,0.754
https://doi.org/10.1002/14651858.cd002959.pub4,vaccines for women for preventing neonatal tetanus,1169_vaccines for women for preventing neonatal tetanus.pdf,3,"['https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1169_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1169_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1169_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1169_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.377, 0.422]","[0.501, 0.522]","[0.587, 0.613]","[0.164, 0.163]","[0.159, 0.165]","[0.137, 0.138]","[0.736, 0.731]","[0.643, 0.636]","[0.557, 0.596]","[0.69, 0.684]","[0.76, 0.785]","[0.69, 0.699]","[0.594, 0.602]","[0.886, 0.917]","[0.766, 0.807]","[0.683, 0.726]","[0.757, 0.783]","[0.707, 0.761]",0.399,0.512,0.6,0.164,0.162,0.138,0.734,0.639,0.577,0.687,0.772,0.694,0.598,0.901,0.786,0.705,0.77,0.734
https://doi.org/10.1002/14651858.cd002964,individual and groupbased parenting programmes for improving psychosocial outcomes for teenage parents and their children,1170_individual and groupbased parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf'],['Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf'],['1170_0_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf'],['1170_0_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf'],[0.861],[0.539],[0.618],[0.206],[0.201],[0.175],[0.741],[0.649],[0.589],[0.717],[0.781],[0.709],[0.598],[0.905],[0.824],[0.737],[0.782],[0.765],0.861,0.539,0.618,0.206,0.201,0.175,0.741,0.649,0.589,0.717,0.781,0.709,0.598,0.905,0.824,0.737,0.782,0.765
https://doi.org/10.1002/14651858.cd002964.pub2,individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children,1171_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950520/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research']","['Fifty years of preventing and treating childhood behaviour disorders: a systematic review to inform policy and practice', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950520/pdf'],['1171_0_fifty years of preventing and treating childhood behaviour disorders a systematic review to inform policy and practice.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950520/pdf'],['1171_0_fifty years of preventing and treating childhood behaviour disorders a systematic review to inform policy and practice.pdf'],[0.399],[0.527],[0.605],[0.18],[0.175],[0.148],[0.73],[0.639],[0.592],[0.709],[0.784],[0.712],[0.592],[0.908],[0.827],[0.743],[0.786],[0.766],0.399,0.527,0.605,0.18,0.175,0.148,0.73,0.639,0.592,0.709,0.784,0.712,0.592,0.908,0.827,0.743,0.786,0.766
https://doi.org/10.1002/14651858.cd002973,tracheal gas insufflation for the prevention of morbidity and mortality in mechanically ventilated newborn infants,1172_tracheal gas insufflation for the prevention of morbidity and mortality in mechanically ventilated newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1172_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1172_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.411],[0.529],[0.616],[0.184],[0.17],[0.141],[0.746],[0.652],[0.59],[0.693],[0.773],[0.699],[0.594],[0.892],[0.793],[0.706],[0.771],[0.734],0.411,0.529,0.616,0.184,0.17,0.141,0.746,0.652,0.59,0.693,0.773,0.699,0.594,0.892,0.793,0.706,0.771,0.734
https://doi.org/10.1002/14651858.cd003015,family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 1017,1173_family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 1017.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],"['Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],['1173_0_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],['1173_0_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf'],[0.593],[0.506],[0.589],[0.179],[0.178],[0.155],[0.74],[0.647],[0.558],[0.715],[0.761],[0.674],[0.589],[0.893],[0.788],[0.7],[0.753],[0.731],0.593,0.506,0.589,0.179,0.178,0.155,0.74,0.647,0.558,0.715,0.761,0.674,0.589,0.893,0.788,0.7,0.753,0.731
https://doi.org/10.1002/14651858.cd003018.pub3,parent training interventions for attention deficit hyperactivity disorder adhd in children aged 5 to 18 years,1174_parent training interventions for attention deficit hyperactivity disorder adhd in children aged 5 to 18 years.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf']","['Parent‐mediated interventions for promoting communication and language development in young children with Down syndrome', 'Parenting interventions for the prevention of unintentional injuries in childhood', 'Parent training programmes for managing infantile colic']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf']","['1174_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf', '1174_2_parent training programmes for managing infantile colic.pdf', '1174_0_parent‐mediated interventions for promoting communication and language development in young children with down syndrome.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf']","['1174_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf', '1174_2_parent training programmes for managing infantile colic.pdf', '1174_0_parent‐mediated interventions for promoting communication and language development in young children with down syndrome.pdf']","[0.666, 0.595, 0.602]","[0.534, 0.529, 0.542]","[0.614, 0.615, 0.625]","[0.178, 0.171, 0.19]","[0.177, 0.175, 0.19]","[0.152, 0.151, 0.168]","[0.735, 0.733, 0.738]","[0.639, 0.638, 0.643]","[0.595, 0.597, 0.604]","[0.71, 0.703, 0.712]","[0.785, 0.784, 0.793]","[0.713, 0.712, 0.721]","[0.585, 0.598, 0.605]","[0.917, 0.918, 0.918]","[0.819, 0.824, 0.829]","[0.735, 0.743, 0.75]","[0.788, 0.787, 0.795]","[0.767, 0.772, 0.78]",0.621,0.535,0.618,0.18,0.181,0.157,0.735,0.64,0.599,0.708,0.787,0.715,0.596,0.918,0.824,0.743,0.79,0.773
https://doi.org/10.1002/14651858.cd003020.pub3,universal schoolbased prevention for illicit drug use,1175_universal schoolbased prevention for illicit drug use.pdf,3,"['https://www.opensocietyfoundations.org/publications/prevention-drug-use-and-problematic-use', 'https://www.urban.org/research/publication/evidence-based-interventions-adolescent-opioid-use-disorder', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf']","['Prevention of Drug Use and Problematic Use', 'Evidence-Based Interventions for Adolescent Opioid Use Disorder', 'Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],['1175_2_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],['1175_2_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf'],[0.707],[0.517],[0.599],[0.189],[0.19],[0.165],[0.742],[0.648],[0.574],[0.721],[0.766],[0.691],[0.594],[0.9],[0.804],[0.711],[0.767],[0.742],0.707,0.517,0.599,0.189,0.19,0.165,0.742,0.648,0.574,0.721,0.766,0.691,0.594,0.9,0.804,0.711,0.767,0.742
https://doi.org/10.1002/14651858.cd003024.pub2,primary prevention for alcohol misuse in young people,1176_primary prevention for alcohol misuse in young people.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362433/pdf', 'http://wtsc.wa.gov/wp-content/uploads/dlm_uploads/2019/05/School-Based-Prevention-Programs_May2014.pdf', 'http://wtsc.wa.gov/wp-content/uploads/2016/05/School-Based-Prevention-Programs_May2014.pdf']","['Strategies to improve the implementation of workplace‐based policies or practices targeting tobacco, alcohol, diet, physical activity and obesity', 'Effectiveness of School-based Alcohol Misuse and Drinking / Driving Programs', 'Research and Data Division May 2014']","['http://wtsc.wa.gov/wp-content/uploads/dlm_uploads/2019/05/School-Based-Prevention-Programs_May2014.pdf', 'http://wtsc.wa.gov/wp-content/uploads/2016/05/School-Based-Prevention-Programs_May2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362433/pdf']","['1176_1_effectiveness of schoolbased alcohol misuse and drinking  driving programs.pdf', '1176_2_research and data division may 2014.pdf', '1176_0_strategies to improve the implementation of workplace‐based policies or practices targeting tobacco alcohol diet physical activity and obesity.pdf']",3,100.0,"['http://wtsc.wa.gov/wp-content/uploads/dlm_uploads/2019/05/School-Based-Prevention-Programs_May2014.pdf', 'http://wtsc.wa.gov/wp-content/uploads/2016/05/School-Based-Prevention-Programs_May2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362433/pdf']","['1176_1_effectiveness of schoolbased alcohol misuse and drinking  driving programs.pdf', '1176_2_research and data division may 2014.pdf', '1176_0_strategies to improve the implementation of workplace‐based policies or practices targeting tobacco alcohol diet physical activity and obesity.pdf']","[0.221, 0.189, 0.189]","[0.463, 0.463, 0.488]","[0.584, 0.584, 0.599]","[0.145, 0.145, 0.147]","[0.165, 0.165, 0.151]","[0.145, 0.145, 0.141]","[0.72, 0.72, 0.734]","[0.626, 0.626, 0.641]","[0.541, 0.541, 0.559]","[0.705, 0.705, 0.727]","[0.765, 0.765, 0.769]","[0.649, 0.649, 0.654]","[0.558, 0.558, 0.557]","[0.92, 0.92, 0.917]","[0.827, 0.827, 0.828]","[0.696, 0.696, 0.694]","[0.755, 0.755, 0.76]","[0.744, 0.744, 0.751]",0.2,0.471,0.589,0.146,0.16,0.144,0.725,0.631,0.547,0.712,0.766,0.651,0.558,0.919,0.827,0.695,0.757,0.746
https://doi.org/10.1002/14651858.cd003032,ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents,1177_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367681/pdf']","['Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents', 'Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367681/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf']","['1177_1_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf', '1177_0_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367681/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf']","['1177_1_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf', '1177_0_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf']","[0.819, 0.835]","[0.543, 0.544]","[0.627, 0.628]","[0.219, 0.218]","[0.232, 0.229]","[0.185, 0.183]","[0.742, 0.741]","[0.651, 0.65]","[0.608, 0.609]","[0.699, 0.7]","[0.788, 0.789]","[0.709, 0.711]","[0.603, 0.603]","[0.914, 0.916]","[0.818, 0.819]","[0.75, 0.75]","[0.788, 0.789]","[0.769, 0.769]",0.827,0.544,0.627,0.218,0.231,0.184,0.742,0.651,0.609,0.7,0.788,0.71,0.603,0.915,0.819,0.75,0.788,0.769
https://doi.org/10.1002/14651858.cd003032.pub2,ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents,1178_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf'],"['Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf'],['1178_0_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf'],['1178_0_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf'],[0.869],[0.55],[0.634],[0.224],[0.236],[0.187],[0.741],[0.651],[0.616],[0.701],[0.796],[0.726],[0.609],[0.918],[0.825],[0.752],[0.795],[0.775],0.869,0.55,0.634,0.224,0.236,0.187,0.741,0.651,0.616,0.701,0.796,0.726,0.609,0.918,0.825,0.752,0.795,0.775
https://doi.org/10.1002/14651858.cd003032.pub3,ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents,1179_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367681/pdf']","['Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents', 'Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367681/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf']","['1179_1_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf', '1179_0_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367681/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf']","['1179_1_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf', '1179_0_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf']","[0.946, 0.952]","[0.548, 0.548]","[0.629, 0.63]","[0.226, 0.225]","[0.233, 0.231]","[0.186, 0.184]","[0.744, 0.743]","[0.655, 0.654]","[0.614, 0.615]","[0.701, 0.701]","[0.794, 0.794]","[0.722, 0.724]","[0.6, 0.6]","[0.915, 0.916]","[0.821, 0.823]","[0.747, 0.747]","[0.792, 0.793]","[0.772, 0.773]",0.949,0.548,0.629,0.226,0.232,0.185,0.744,0.655,0.615,0.701,0.794,0.723,0.6,0.915,0.822,0.747,0.792,0.772
https://doi.org/10.1002/14651858.cd003032.pub4,ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents,1180_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937601/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf']","['Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update', 'Lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures', 'Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937601/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387132/pdf']","['1180_2_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf', '1180_0_recommendations for the treatment of epilepsy in adult and pediatric patients in belgium 2020 update.pdf', '1180_1_lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095003/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937601/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387132/pdf']","['1180_2_ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents.pdf', '1180_0_recommendations for the treatment of epilepsy in adult and pediatric patients in belgium 2020 update.pdf', '1180_1_lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures.pdf']","[0.402, 0.773, 0.993]","[0.545, 0.53, 0.535]","[0.628, 0.62, 0.621]","[0.218, 0.196, 0.201]","[0.223, 0.197, 0.206]","[0.181, 0.161, 0.169]","[0.742, 0.743, 0.739]","[0.652, 0.652, 0.648]","[0.61, 0.601, 0.6]","[0.703, 0.682, 0.709]","[0.788, 0.79, 0.782]","[0.711, 0.709, 0.704]","[0.598, 0.59, 0.597]","[0.919, 0.919, 0.916]","[0.824, 0.818, 0.812]","[0.74, 0.742, 0.731]","[0.789, 0.782, 0.782]","[0.769, 0.762, 0.759]",0.723,0.537,0.623,0.205,0.209,0.17,0.741,0.651,0.604,0.698,0.787,0.708,0.595,0.918,0.818,0.738,0.784,0.763
https://doi.org/10.1002/14651858.cd003064,furosemide for transient tachypnea of the newborn,1181_furosemide for transient tachypnea of the newborn.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144734/pdf'],['Diuretics for transient tachypnoea of the newborn'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144734/pdf'],['1181_0_diuretics for transient tachypnoea of the newborn.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144734/pdf'],['1181_0_diuretics for transient tachypnoea of the newborn.pdf'],[0.7],[0.529],[0.608],[0.169],[0.181],[0.145],[0.735],[0.641],[0.593],[0.687],[0.776],[0.704],[0.598],[0.908],[0.82],[0.729],[0.774],[0.758],0.7,0.529,0.608,0.169,0.181,0.145,0.735,0.641,0.593,0.687,0.776,0.704,0.598,0.908,0.82,0.729,0.774,0.758
https://doi.org/10.1002/14651858.cd003064.pub2,furosemide for transient tachypnoea of the newborn,1182_furosemide for transient tachypnoea of the newborn.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144734/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520752/pdf']","['Diuretics for transient tachypnoea of the newborn', 'Epinephrine for transient tachypnea of the newborn']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520752/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144734/pdf']","['1182_1_epinephrine for transient tachypnea of the newborn.pdf', '1182_0_diuretics for transient tachypnoea of the newborn.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520752/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144734/pdf']","['1182_1_epinephrine for transient tachypnea of the newborn.pdf', '1182_0_diuretics for transient tachypnoea of the newborn.pdf']","[0.94, 0.617]","[0.525, 0.525]","[0.612, 0.607]","[0.168, 0.17]","[0.176, 0.178]","[0.139, 0.143]","[0.736, 0.737]","[0.64, 0.642]","[0.589, 0.584]","[0.704, 0.705]","[0.774, 0.773]","[0.706, 0.699]","[0.597, 0.597]","[0.91, 0.902]","[0.811, 0.811]","[0.727, 0.722]","[0.774, 0.77]","[0.754, 0.751]",0.778,0.525,0.609,0.169,0.177,0.141,0.736,0.641,0.587,0.704,0.774,0.702,0.597,0.906,0.811,0.724,0.772,0.752
https://doi.org/10.1002/14651858.cd003064.pub3,diuretics for transient tachypnoea of the newborn,1183_diuretics for transient tachypnoea of the newborn.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094231/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094737/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164572/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076329/pdf']","['Salbutamol for transient tachypnea of the newborn', 'Fluid restriction in the management of transient tachypnea of the newborn', 'Non‐invasive respiratory support for the management of transient tachypnea of the newborn', 'Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews', 'Postnatal corticosteroids for transient tachypnoea of the newborn']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094737/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164572/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094231/pdf']","['1183_1_fluid restriction in the management of transient tachypnea of the newborn.pdf', '1183_3_airway clearance techniques for cystic fibrosis an overview of cochrane systematic reviews.pdf', '1183_4_postnatal corticosteroids for transient tachypnoea of the newborn.pdf', '1183_2_non‐invasive respiratory support for the management of transient tachypnea of the newborn.pdf', '1183_0_salbutamol for transient tachypnea of the newborn.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094737/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164572/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094231/pdf']","['1183_1_fluid restriction in the management of transient tachypnea of the newborn.pdf', '1183_3_airway clearance techniques for cystic fibrosis an overview of cochrane systematic reviews.pdf', '1183_4_postnatal corticosteroids for transient tachypnoea of the newborn.pdf', '1183_2_non‐invasive respiratory support for the management of transient tachypnea of the newborn.pdf', '1183_0_salbutamol for transient tachypnea of the newborn.pdf']","[0.611, 0.64, 0.604, 0.398, 0.677]","[0.526, 0.523, 0.527, 0.523, 0.517]","[0.61, 0.61, 0.615, 0.608, 0.603]","[0.169, 0.162, 0.167, 0.167, 0.161]","[0.172, 0.169, 0.177, 0.172, 0.164]","[0.137, 0.131, 0.136, 0.137, 0.129]","[0.734, 0.734, 0.734, 0.735, 0.735]","[0.64, 0.638, 0.639, 0.64, 0.64]","[0.587, 0.585, 0.594, 0.587, 0.581]","[0.701, 0.707, 0.701, 0.706, 0.698]","[0.774, 0.774, 0.779, 0.772, 0.77]","[0.7, 0.697, 0.701, 0.696, 0.694]","[0.6, 0.599, 0.599, 0.593, 0.595]","[0.904, 0.9, 0.909, 0.906, 0.905]","[0.808, 0.806, 0.816, 0.808, 0.801]","[0.725, 0.716, 0.729, 0.722, 0.722]","[0.773, 0.77, 0.776, 0.773, 0.769]","[0.753, 0.744, 0.758, 0.751, 0.75]",0.586,0.523,0.609,0.165,0.171,0.134,0.734,0.639,0.587,0.703,0.774,0.698,0.597,0.905,0.808,0.723,0.772,0.751
https://doi.org/10.1002/14651858.cd003110,areawide traffic calming for preventing traffic related injuries,1184_areawide traffic calming for preventing traffic related injuries.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387238/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/environmental/active-design-community-guide.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/environmental/promoting-safety.pdf']","['Organisational travel plans for improving health', 'Guide for Community Groups', 'Active design supplement']","['https://www1.nyc.gov/assets/doh/downloads/pdf/environmental/promoting-safety.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387238/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/environmental/active-design-community-guide.pdf']","['1184_2_active design supplement.pdf', '1184_0_organisational travel plans for improving health.pdf', '1184_1_guide for community groups.pdf']",3,100.0,"['https://www1.nyc.gov/assets/doh/downloads/pdf/environmental/promoting-safety.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387238/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/environmental/active-design-community-guide.pdf']","['1184_2_active design supplement.pdf', '1184_0_organisational travel plans for improving health.pdf', '1184_1_guide for community groups.pdf']","[0.265, 0.122, 0.311]","[0.508, 0.508, 0.499]","[0.602, 0.595, 0.597]","[0.147, 0.15, 0.116]","[0.163, 0.153, 0.121]","[0.132, 0.129, 0.104]","[0.73, 0.727, 0.72]","[0.633, 0.632, 0.617]","[0.574, 0.582, 0.576]","[0.698, 0.712, 0.67]","[0.776, 0.768, 0.787]","[0.714, 0.692, 0.711]","[0.618, 0.591, 0.616]","[0.91, 0.905, 0.911]","[0.819, 0.821, 0.827]","[0.731, 0.715, 0.735]","[0.785, 0.773, 0.792]","[0.755, 0.744, 0.757]",0.233,0.505,0.598,0.138,0.146,0.122,0.726,0.627,0.577,0.693,0.777,0.706,0.608,0.909,0.822,0.727,0.783,0.752
https://doi.org/10.1002/14651858.cd003161,cognitive behavioural interventions for sleep problems in adults aged 60,1185_cognitive behavioural interventions for sleep problems in adults aged 60.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517220/pdf', 'https://jcsm.aasm.org/doi/epdf/10.5664/jcsm.6470', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428876/pdf']","['Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline', 'Non‐pharmacological interventions for sleep promotion in the intensive care unit', 'Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline', 'Psychosocial interventions for the prevention of disability following traumatic physical injury']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428876/pdf']","['1185_0_clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults an american academy of sleep medicine clinical practice guideline.pdf', '1185_1_non‐pharmacological interventions for sleep promotion in the intensive care unit.pdf', '1185_3_psychosocial interventions for the prevention of disability following traumatic physical injury.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428876/pdf']","['1185_0_clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults an american academy of sleep medicine clinical practice guideline.pdf', '1185_1_non‐pharmacological interventions for sleep promotion in the intensive care unit.pdf', '1185_3_psychosocial interventions for the prevention of disability following traumatic physical injury.pdf']","[0.598, 0.626, 0.334]","[0.527, 0.525, 0.523]","[0.609, 0.617, 0.607]","[0.196, 0.19, 0.166]","[0.209, 0.194, 0.168]","[0.176, 0.169, 0.142]","[0.737, 0.741, 0.735]","[0.645, 0.651, 0.644]","[0.585, 0.587, 0.579]","[0.724, 0.719, 0.711]","[0.783, 0.78, 0.777]","[0.702, 0.688, 0.679]","[0.611, 0.6, 0.586]","[0.907, 0.913, 0.912]","[0.802, 0.814, 0.805]","[0.735, 0.727, 0.725]","[0.779, 0.774, 0.768]","[0.758, 0.759, 0.758]",0.519,0.525,0.611,0.184,0.19,0.162,0.738,0.647,0.584,0.718,0.78,0.69,0.599,0.911,0.807,0.729,0.774,0.758
https://doi.org/10.1002/14651858.cd003180.pub2,interventions for promoting physical activity,1186_interventions for promoting physical activity.pdf,9,"['https://effectivehealthcare.ahrq.gov/products/grades-predictive-values/white-paper-2015', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481891/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769154/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475768/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142076/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062985/pdf']","['Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence', 'Remote and web 2.0 interventions for promoting physical activity', 'Computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease', 'School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18', 'Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults', 'Face‐to‐face versus remote and web 2.0 interventions for promoting physical activity', 'Interventions for promoting physical activity in people with neuromuscular disease', 'Community wide interventions for increasing physical activity', 'Interventions for promoting physical activity in people with cystic fibrosis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142076/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062985/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481891/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769154/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475768/pdf']","['1186_6_interventions for promoting physical activity in people with neuromuscular disease.pdf', '1186_1_remote and web 20 interventions for promoting physical activity.pdf', '1186_7_community wide interventions for increasing physical activity.pdf', '1186_8_interventions for promoting physical activity in people with cystic fibrosis.pdf', '1186_2_computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease.pdf', '1186_3_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '1186_4_interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.pdf', '1186_5_face‐to‐face versus remote and web 20 interventions for promoting physical activity.pdf']",8,88.89,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142076/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508615/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062985/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481891/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769154/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475768/pdf']","['1186_6_interventions for promoting physical activity in people with neuromuscular disease.pdf', '1186_1_remote and web 20 interventions for promoting physical activity.pdf', '1186_7_community wide interventions for increasing physical activity.pdf', '1186_8_interventions for promoting physical activity in people with cystic fibrosis.pdf', '1186_2_computer and mobile technology interventions for self‐management in chronic obstructive pulmonary disease.pdf', '1186_3_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf', '1186_4_interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.pdf', '1186_5_face‐to‐face versus remote and web 20 interventions for promoting physical activity.pdf']","[0.649, 0.405, 0.601, 0.333, 0.638, 0.614, 0.557, 0.539]","[0.523, 0.51, 0.526, 0.507, 0.521, 0.523, 0.514, 0.519]","[0.622, 0.614, 0.627, 0.605, 0.624, 0.625, 0.617, 0.624]","[0.207, 0.2, 0.211, 0.195, 0.188, 0.208, 0.191, 0.21]","[0.213, 0.209, 0.226, 0.196, 0.192, 0.222, 0.2, 0.223]","[0.189, 0.182, 0.193, 0.174, 0.167, 0.189, 0.169, 0.191]","[0.738, 0.741, 0.739, 0.74, 0.736, 0.739, 0.738, 0.74]","[0.647, 0.65, 0.649, 0.648, 0.645, 0.647, 0.645, 0.651]","[0.592, 0.579, 0.597, 0.572, 0.591, 0.595, 0.583, 0.59]","[0.737, 0.741, 0.738, 0.734, 0.73, 0.729, 0.726, 0.741]","[0.778, 0.769, 0.782, 0.765, 0.778, 0.781, 0.77, 0.777]","[0.698, 0.684, 0.7, 0.679, 0.7, 0.699, 0.693, 0.693]","[0.589, 0.58, 0.593, 0.576, 0.592, 0.591, 0.585, 0.585]","[0.912, 0.91, 0.918, 0.904, 0.914, 0.917, 0.912, 0.917]","[0.824, 0.814, 0.828, 0.803, 0.813, 0.823, 0.81, 0.822]","[0.711, 0.704, 0.717, 0.695, 0.712, 0.719, 0.713, 0.715]","[0.774, 0.765, 0.778, 0.758, 0.772, 0.777, 0.768, 0.774]","[0.742, 0.736, 0.751, 0.727, 0.741, 0.752, 0.742, 0.749]",0.542,0.518,0.62,0.201,0.21,0.182,0.739,0.648,0.587,0.735,0.775,0.693,0.586,0.913,0.817,0.711,0.771,0.742
https://doi.org/10.1002/14651858.cd003201,schoolbased driver education for the prevention of traffic crashes,1187_schoolbased driver education for the prevention of traffic crashes.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf', 'https://www.wri.org/publication/sustainable-and-safe-vision-and-guidance-zero-road-deaths', 'https://www.colorado.gov/pacific/sites/default/files/ISVP_%20MVS_highway-safety-countermeasure-guide1.pdf']","['Mobility management to prevent, reduce, or delay driving a car in teenagers', 'Sustainable and Safe: A Vision and Guidance for Zero Road Deaths', 'Countermeasures That Work:']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf'],['1187_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf'],['1187_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf'],[0.424],[0.523],[0.613],[0.174],[0.183],[0.166],[0.736],[0.638],[0.584],[0.711],[0.777],[0.703],[0.598],[0.912],[0.831],[0.725],[0.779],[0.756],0.424,0.523,0.613,0.174,0.183,0.166,0.736,0.638,0.584,0.711,0.777,0.703,0.598,0.912,0.831,0.725,0.779,0.756
https://doi.org/10.1002/14651858.cd003211,feed thickener for newborn infants with gastrooesophageal reflux,1188_feed thickener for newborn infants with gastrooesophageal reflux.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485971/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752126/pdf']","['Feed thickener for infants up to six months of age with gastro‐oesophageal reflux', 'Nutritional support in children and young people with cancer undergoing chemotherapy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485971/pdf']","['1188_1_nutritional support in children and young people with cancer undergoing chemotherapy.pdf', '1188_0_feed thickener for infants up to six months of age with gastro‐oesophageal reflux.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752126/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485971/pdf']","['1188_1_nutritional support in children and young people with cancer undergoing chemotherapy.pdf', '1188_0_feed thickener for infants up to six months of age with gastro‐oesophageal reflux.pdf']","[0.781, 0.356]","[0.513, 0.533]","[0.605, 0.62]","[0.155, 0.18]","[0.162, 0.194]","[0.126, 0.147]","[0.733, 0.735]","[0.635, 0.639]","[0.583, 0.603]","[0.67, 0.682]","[0.771, 0.785]","[0.698, 0.708]","[0.599, 0.611]","[0.911, 0.922]","[0.8, 0.81]","[0.724, 0.742]","[0.773, 0.787]","[0.749, 0.766]",0.569,0.523,0.613,0.167,0.178,0.137,0.734,0.637,0.593,0.676,0.778,0.703,0.605,0.917,0.805,0.733,0.78,0.758
https://doi.org/10.1002/14651858.cd003214.pub3,bronchodilators for the prevention and treatment of chronic lung disease in preterm infants,1189_bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463958/pdf'],['Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463958/pdf'],['1189_0_bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463958/pdf'],['1189_0_bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.pdf'],[0.959],[0.516],[0.607],[0.183],[0.191],[0.158],[0.739],[0.648],[0.576],[0.705],[0.769],[0.695],[0.592],[0.893],[0.786],[0.709],[0.763],[0.737],0.959,0.516,0.607,0.183,0.191,0.158,0.739,0.648,0.576,0.705,0.769,0.695,0.592,0.893,0.786,0.709,0.763,0.737
https://doi.org/10.1002/14651858.cd003215.pub2,base administration or fluid bolus for preventing morbidity and mortality in preterm infants with metabolic acidosis,1190_base administration or fluid bolus for preventing morbidity and mortality in preterm infants with metabolic acidosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1190_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1190_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.475],[0.528],[0.617],[0.177],[0.181],[0.144],[0.742],[0.649],[0.592],[0.692],[0.775],[0.7],[0.601],[0.897],[0.791],[0.706],[0.773],[0.734],0.475,0.528,0.617,0.177,0.181,0.144,0.742,0.649,0.592,0.692,0.775,0.7,0.601,0.897,0.791,0.706,0.773,0.734
https://doi.org/10.1002/14651858.cd003248.pub2,early versus delayed umbilical cord clamping in preterm infants,1191_early versus delayed umbilical cord clamping in preterm infants.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026059/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060023/pdf']","['Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes', 'Active versus expectant management for women in the third stage of labour', 'Placental cord drainage after vaginal delivery as part of the management of the third stage of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060023/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026059/pdf']","['1191_0_effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.pdf', '1191_2_placental cord drainage after vaginal delivery as part of the management of the third stage of labour.pdf', '1191_1_active versus expectant management for women in the third stage of labour.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060023/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026059/pdf']","['1191_0_effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.pdf', '1191_2_placental cord drainage after vaginal delivery as part of the management of the third stage of labour.pdf', '1191_1_active versus expectant management for women in the third stage of labour.pdf']","[0.558, 0.344, 0.479]","[0.528, 0.539, 0.531]","[0.607, 0.619, 0.615]","[0.19, 0.191, 0.177]","[0.187, 0.198, 0.175]","[0.164, 0.161, 0.141]","[0.742, 0.738, 0.734]","[0.652, 0.646, 0.642]","[0.582, 0.594, 0.592]","[0.682, 0.675, 0.672]","[0.777, 0.786, 0.779]","[0.702, 0.718, 0.72]","[0.585, 0.61, 0.578]","[0.905, 0.911, 0.907]","[0.806, 0.815, 0.808]","[0.722, 0.736, 0.733]","[0.774, 0.785, 0.783]","[0.75, 0.76, 0.757]",0.46,0.533,0.614,0.186,0.187,0.155,0.738,0.647,0.589,0.676,0.781,0.713,0.591,0.908,0.81,0.73,0.781,0.756
https://doi.org/10.1002/14651858.cd003248.pub3,effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes,1192_effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544813/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494179/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464177/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372362/pdf']","['Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes', 'Stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants', 'Daily oral iron supplementation during pregnancy', 'Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes', 'Provision of respiratory support compared to no respiratory support before cord clamping for preterm infants', 'Controlled cord traction for the third stage of labour', 'Active versus expectant management for women in the third stage of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372362/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464177/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544813/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494179/pdf']","['1192_6_active versus expectant management for women in the third stage of labour.pdf', '1192_2_daily oral iron supplementation during pregnancy.pdf', '1192_1_stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants.pdf', '1192_5_controlled cord traction for the third stage of labour.pdf', '1192_0_effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.pdf', '1192_3_effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.pdf', '1192_4_provision of respiratory support compared to no respiratory support before cord clamping for preterm infants.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372362/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464177/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544813/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494179/pdf']","['1192_6_active versus expectant management for women in the third stage of labour.pdf', '1192_2_daily oral iron supplementation during pregnancy.pdf', '1192_1_stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants.pdf', '1192_5_controlled cord traction for the third stage of labour.pdf', '1192_0_effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes.pdf', '1192_3_effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.pdf', '1192_4_provision of respiratory support compared to no respiratory support before cord clamping for preterm infants.pdf']","[0.497, 0.312, 0.174, 0.642, 0.475, 0.4, 0.264]","[0.518, 0.503, 0.524, 0.502, 0.522, 0.515, 0.526]","[0.61, 0.599, 0.62, 0.599, 0.608, 0.609, 0.616]","[0.171, 0.145, 0.154, 0.167, 0.188, 0.182, 0.188]","[0.166, 0.141, 0.165, 0.17, 0.187, 0.186, 0.196]","[0.141, 0.118, 0.128, 0.143, 0.17, 0.161, 0.164]","[0.736, 0.731, 0.737, 0.736, 0.743, 0.74, 0.741]","[0.645, 0.64, 0.649, 0.645, 0.656, 0.65, 0.655]","[0.578, 0.566, 0.588, 0.562, 0.574, 0.575, 0.58]","[0.662, 0.646, 0.648, 0.666, 0.674, 0.667, 0.665]","[0.779, 0.769, 0.778, 0.77, 0.772, 0.777, 0.772]","[0.694, 0.676, 0.701, 0.678, 0.688, 0.684, 0.7]","[0.589, 0.588, 0.592, 0.588, 0.581, 0.599, 0.599]","[0.896, 0.895, 0.906, 0.892, 0.894, 0.898, 0.894]","[0.805, 0.794, 0.806, 0.793, 0.804, 0.799, 0.801]","[0.711, 0.706, 0.721, 0.701, 0.705, 0.712, 0.708]","[0.772, 0.76, 0.773, 0.758, 0.763, 0.769, 0.767]","[0.74, 0.735, 0.747, 0.73, 0.736, 0.74, 0.735]",0.395,0.516,0.609,0.171,0.173,0.146,0.738,0.649,0.575,0.661,0.774,0.689,0.591,0.896,0.8,0.709,0.766,0.738
https://doi.org/10.1002/14651858.cd003277,treatment of lennoxgastaut syndrome,1193_treatment of lennoxgastaut syndrome.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095011/pdf'],['Anti‐seizure medications for Lennox‐Gastaut syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095011/pdf'],['1193_0_anti‐seizure medications for lennox‐gastaut syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095011/pdf'],['1193_0_anti‐seizure medications for lennox‐gastaut syndrome.pdf'],[0.754],[0.531],[0.611],[0.201],[0.194],[0.17],[0.748],[0.661],[0.589],[0.712],[0.778],[0.702],[0.6],[0.894],[0.804],[0.724],[0.776],[0.752],0.754,0.531,0.611,0.201,0.194,0.17,0.748,0.661,0.589,0.712,0.778,0.702,0.6,0.894,0.804,0.724,0.776,0.752
https://doi.org/10.1002/14651858.cd003277.pub3,treatment of lennoxgastaut syndrome,1194_treatment of lennoxgastaut syndrome.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095011/pdf']","['Lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures', 'Anti‐seizure medications for Lennox‐Gastaut syndrome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387132/pdf']","['1194_1_anti‐seizure medications for lennox‐gastaut syndrome.pdf', '1194_0_lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387132/pdf']","['1194_1_anti‐seizure medications for lennox‐gastaut syndrome.pdf', '1194_0_lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures.pdf']","[0.638, 0.785]","[0.529, 0.523]","[0.609, 0.609]","[0.198, 0.19]","[0.19, 0.19]","[0.166, 0.162]","[0.745, 0.741]","[0.658, 0.651]","[0.589, 0.586]","[0.717, 0.718]","[0.775, 0.775]","[0.704, 0.702]","[0.6, 0.597]","[0.892, 0.895]","[0.807, 0.804]","[0.724, 0.725]","[0.772, 0.769]","[0.751, 0.749]",0.712,0.526,0.609,0.194,0.19,0.164,0.743,0.655,0.587,0.718,0.775,0.703,0.599,0.893,0.806,0.724,0.77,0.75
https://doi.org/10.1002/14651858.cd003284.pub3,steroid hormone treatment for kawasaki disease in children,1195_steroid hormone treatment for kawasaki disease in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464937/pdf'],['Corticosteroids for the treatment of Kawasaki disease in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464937/pdf'],['1195_0_corticosteroids for the treatment of kawasaki disease in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464937/pdf'],['1195_0_corticosteroids for the treatment of kawasaki disease in children.pdf'],[0.31],[0.494],[0.59],[0.146],[0.152],[0.13],[0.733],[0.639],[0.562],[0.712],[0.764],[0.669],[0.564],[0.916],[0.829],[0.708],[0.752],[0.751],0.31,0.494,0.59,0.146,0.152,0.13,0.733,0.639,0.562,0.712,0.764,0.669,0.564,0.916,0.829,0.708,0.752,0.751
https://doi.org/10.1002/14651858.cd003289.pub4,tobacco cessation interventions for young people,1196_tobacco cessation interventions for young people.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf'],['Tobacco cessation interventions for young people'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf'],['1196_0_tobacco cessation interventions for young people.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf'],['1196_0_tobacco cessation interventions for young people.pdf'],[0.893],[0.553],[0.629],[0.221],[0.234],[0.2],[0.746],[0.656],[0.61],[0.727],[0.797],[0.73],[0.616],[0.917],[0.834],[0.752],[0.799],[0.779],0.893,0.553,0.629,0.221,0.234,0.2,0.746,0.656,0.61,0.727,0.797,0.73,0.616,0.917,0.834,0.752,0.799,0.779
https://doi.org/10.1002/14651858.cd003289.pub5,tobacco cessation interventions for young people,1197_tobacco cessation interventions for young people.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464070/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://stacks.cdc.gov/view/cdc/84557']","['Interventions for promoting smoking cessation during pregnancy', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Group behaviour therapy programmes for smoking cessation', 'Tobacco cessation interventions for young people', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'Smoking Cessation', 'Smoking cessation: a report of the Surgeon General.', 'Smoking cessation : a report of the Surgeon General']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464070/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['1197_0_interventions for promoting smoking cessation during pregnancy.pdf', '1197_3_tobacco cessation interventions for young people.pdf', '1197_7_smoking cessation a report of the surgeon general.pdf', '1197_1_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1197_4_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1197_2_group behaviour therapy programmes for smoking cessation.pdf', '1197_5_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']",7,77.78,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464070/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['1197_0_interventions for promoting smoking cessation during pregnancy.pdf', '1197_3_tobacco cessation interventions for young people.pdf', '1197_7_smoking cessation a report of the surgeon general.pdf', '1197_1_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1197_4_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf', '1197_2_group behaviour therapy programmes for smoking cessation.pdf', '1197_5_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']","[0.643, 0.776, 0.742, 0.958, 0.711, 0.557, 0.557]","[0.533, 0.546, 0.525, 0.537, 0.53, 0.546, 0.525]","[0.617, 0.623, 0.613, 0.61, 0.614, 0.62, 0.613]","[0.181, 0.22, 0.192, 0.198, 0.191, 0.21, 0.192]","[0.189, 0.228, 0.199, 0.191, 0.194, 0.216, 0.199]","[0.164, 0.198, 0.165, 0.172, 0.166, 0.186, 0.165]","[0.734, 0.747, 0.739, 0.741, 0.739, 0.744, 0.739]","[0.642, 0.657, 0.648, 0.648, 0.647, 0.654, 0.648]","[0.601, 0.603, 0.589, 0.593, 0.592, 0.605, 0.589]","[0.716, 0.728, 0.705, 0.717, 0.716, 0.726, 0.705]","[0.785, 0.792, 0.792, 0.785, 0.78, 0.793, 0.792]","[0.717, 0.719, 0.709, 0.702, 0.707, 0.716, 0.709]","[0.594, 0.608, 0.603, 0.598, 0.583, 0.605, 0.603]","[0.914, 0.913, 0.913, 0.909, 0.908, 0.915, 0.913]","[0.823, 0.831, 0.817, 0.816, 0.81, 0.83, 0.817]","[0.747, 0.746, 0.747, 0.738, 0.737, 0.748, 0.747]","[0.79, 0.793, 0.787, 0.787, 0.782, 0.795, 0.787]","[0.77, 0.774, 0.771, 0.765, 0.762, 0.775, 0.771]",0.706,0.535,0.616,0.198,0.202,0.174,0.74,0.649,0.596,0.716,0.788,0.711,0.599,0.912,0.821,0.744,0.789,0.77
https://doi.org/10.1002/14651858.cd003289.pub6,tobacco cessation interventions for young people,1198_tobacco cessation interventions for young people.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353172/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470854/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543670/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009295/pdf', 'https://www.federalregister.gov/documents/2018/12/18/2018-27352/eliminating-youth-electronic-cigarette-and-other-tobacco-product-use-the-role-for-drug-therapies-new', 'https://www.federalregister.gov/documents/2018/11/05/2018-24126/eliminating-youth-electronic-cigarette-and-other-tobacco-product-use-the-role-for-drug-therapies']","['Nicotine replacement therapy versus control for smoking cessation', 'Competitions for smoking cessation', 'Print‐based self‐help interventions for smoking cessation', 'Incentives for smoking cessation', 'Telephone counselling for smoking cessation', 'Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation', 'Strategies to improve smoking cessation rates in primary care', 'Mindfulness for smoking cessation', 'Eliminating Youth Electronic Cigarette and Other Tobacco Product Use: The Role for Drug Therapies; New Date for Public Hearing; Request for Comments', 'Eliminating Youth Electronic Cigarette and Other Tobacco Product Use: The Role for Drug Therapies; Public Hearing; Request for Comments']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470854/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353172/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009295/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543670/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112723/pdf']","['1198_5_different doses durations and modes of delivery of nicotine replacement therapy for smoking cessation.pdf', '1198_0_nicotine replacement therapy versus control for smoking cessation.pdf', '1198_4_telephone counselling for smoking cessation.pdf', '1198_3_incentives for smoking cessation.pdf', '1198_7_mindfulness for smoking cessation.pdf', '1198_1_competitions for smoking cessation.pdf', '1198_6_strategies to improve smoking cessation rates in primary care.pdf', '1198_2_print‐based self‐help interventions for smoking cessation.pdf']",8,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470854/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353172/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6496404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009295/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953205/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543670/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112723/pdf']","['1198_5_different doses durations and modes of delivery of nicotine replacement therapy for smoking cessation.pdf', '1198_0_nicotine replacement therapy versus control for smoking cessation.pdf', '1198_4_telephone counselling for smoking cessation.pdf', '1198_3_incentives for smoking cessation.pdf', '1198_7_mindfulness for smoking cessation.pdf', '1198_1_competitions for smoking cessation.pdf', '1198_6_strategies to improve smoking cessation rates in primary care.pdf', '1198_2_print‐based self‐help interventions for smoking cessation.pdf']","[0.737, 0.758, 0.798, 0.766, 0.798, 0.67, 0.752, 0.769]","[0.53, 0.53, 0.534, 0.539, 0.529, 0.546, 0.54, 0.528]","[0.609, 0.612, 0.612, 0.618, 0.613, 0.623, 0.622, 0.613]","[0.196, 0.204, 0.201, 0.197, 0.197, 0.205, 0.211, 0.201]","[0.201, 0.211, 0.207, 0.201, 0.2, 0.213, 0.212, 0.209]","[0.173, 0.179, 0.177, 0.172, 0.171, 0.176, 0.183, 0.181]","[0.743, 0.746, 0.744, 0.741, 0.743, 0.74, 0.745, 0.745]","[0.653, 0.655, 0.654, 0.65, 0.652, 0.65, 0.657, 0.655]","[0.587, 0.589, 0.593, 0.602, 0.584, 0.61, 0.599, 0.587]","[0.721, 0.723, 0.723, 0.72, 0.733, 0.723, 0.722, 0.728]","[0.782, 0.785, 0.787, 0.792, 0.78, 0.794, 0.788, 0.781]","[0.706, 0.702, 0.71, 0.716, 0.708, 0.728, 0.709, 0.7]","[0.596, 0.6, 0.603, 0.603, 0.589, 0.608, 0.603, 0.598]","[0.908, 0.914, 0.914, 0.916, 0.911, 0.92, 0.914, 0.909]","[0.813, 0.817, 0.818, 0.829, 0.811, 0.833, 0.824, 0.811]","[0.732, 0.735, 0.738, 0.744, 0.729, 0.751, 0.738, 0.727]","[0.78, 0.783, 0.786, 0.791, 0.779, 0.797, 0.786, 0.779]","[0.76, 0.767, 0.768, 0.774, 0.756, 0.778, 0.769, 0.76]",0.756,0.534,0.615,0.202,0.207,0.176,0.743,0.653,0.594,0.724,0.786,0.71,0.6,0.913,0.819,0.737,0.785,0.766
https://doi.org/10.1002/14651858.cd003300.pub2,graduated driver licensing for reducing motor vehicle crashes among young drivers,1199_graduated driver licensing for reducing motor vehicle crashes among young drivers.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf', 'https://www.rand.org/pubs/technical_reports/TR403.html']","['Mobility management to prevent, reduce, or delay driving a car in teenagers', 'Preventing Underage Drinking: Using Getting To Outcomesâ\x84¢ with the SAMHSA Strategic Prevention Framework to Achieve Results']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf'],['1199_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf'],['1199_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf'],[0.441],[0.547],[0.627],[0.175],[0.185],[0.156],[0.728],[0.632],[0.617],[0.718],[0.793],[0.732],[0.616],[0.926],[0.852],[0.753],[0.801],[0.782],0.441,0.547,0.627,0.175,0.185,0.156,0.728,0.632,0.617,0.718,0.793,0.732,0.616,0.926,0.852,0.753,0.801,0.782
https://doi.org/10.1002/14651858.cd003300.pub3,graduated driver licensing for reducing motor vehicle crashes among young drivers,1200_graduated driver licensing for reducing motor vehicle crashes among young drivers.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf', 'https://www.colorado.gov/pacific/sites/default/files/ISVP_%20MVS_highway-safety-countermeasure-guide1.pdf']","['Mobility management to prevent, reduce, or delay driving a car in teenagers', 'Countermeasures That Work:']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf'],['1200_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094927/pdf'],['1200_0_mobility management to prevent reduce or delay driving a car in teenagers.pdf'],[0.435],[0.54],[0.622],[0.177],[0.185],[0.16],[0.731],[0.636],[0.611],[0.72],[0.789],[0.725],[0.61],[0.923],[0.849],[0.747],[0.796],[0.778],0.435,0.54,0.622,0.177,0.185,0.16,0.731,0.636,0.611,0.72,0.789,0.725,0.61,0.923,0.849,0.747,0.796,0.778
https://doi.org/10.1002/14651858.cd003311,cooling for newborns with hypoxic ischaemic encephalopathy,1201_cooling for newborns with hypoxic ischaemic encephalopathy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003568/pdf'],['Cooling for newborns with hypoxic ischaemic encephalopathy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003568/pdf'],['1201_0_cooling for newborns with hypoxic ischaemic encephalopathy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003568/pdf'],['1201_0_cooling for newborns with hypoxic ischaemic encephalopathy.pdf'],[0.693],[0.503],[0.595],[0.194],[0.182],[0.156],[0.751],[0.661],[0.569],[0.686],[0.777],[0.678],[0.596],[0.903],[0.776],[0.714],[0.761],[0.738],0.693,0.503,0.595,0.194,0.182,0.156,0.751,0.661,0.569,0.686,0.777,0.678,0.596,0.903,0.776,0.714,0.761,0.738
https://doi.org/10.1002/14651858.cd003311.pub2,cooling for newborns with hypoxic ischaemic encephalopathy,1202_cooling for newborns with hypoxic ischaemic encephalopathy.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003568/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517232/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885036/pdf', 'https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf']","['Cooling for newborns with hypoxic ischaemic encephalopathy', 'Hypothermia for neuroprotection in children after cardiopulmonary arrest', 'Acupuncture for hypoxic ischemic encephalopathy in neonates', 'Guidelines for Perinatal Care']","['https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003568/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517232/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885036/pdf']","['1202_3_guidelines for perinatal care.pdf', '1202_0_cooling for newborns with hypoxic ischaemic encephalopathy.pdf', '1202_1_hypothermia for neuroprotection in children after cardiopulmonary arrest.pdf', '1202_2_acupuncture for hypoxic ischemic encephalopathy in neonates.pdf']",4,100.0,"['https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003568/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517232/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885036/pdf']","['1202_3_guidelines for perinatal care.pdf', '1202_0_cooling for newborns with hypoxic ischaemic encephalopathy.pdf', '1202_1_hypothermia for neuroprotection in children after cardiopulmonary arrest.pdf', '1202_2_acupuncture for hypoxic ischemic encephalopathy in neonates.pdf']","[0.884, 0.464, 0.406, 0.284]","[0.508, 0.511, 0.511, 0.505]","[0.6, 0.595, 0.604, 0.6]","[0.138, 0.208, 0.189, 0.164]","[0.133, 0.188, 0.183, 0.158]","[0.105, 0.164, 0.147, 0.13]","[0.73, 0.754, 0.746, 0.739]","[0.628, 0.664, 0.652, 0.642]","[0.572, 0.578, 0.578, 0.577]","[0.61, 0.695, 0.683, 0.674]","[0.78, 0.774, 0.774, 0.776]","[0.682, 0.668, 0.677, 0.681]","[0.588, 0.601, 0.594, 0.592]","[0.91, 0.897, 0.906, 0.912]","[0.785, 0.777, 0.789, 0.795]","[0.742, 0.721, 0.727, 0.73]","[0.775, 0.769, 0.769, 0.772]","[0.759, 0.739, 0.748, 0.753]",0.509,0.509,0.6,0.175,0.166,0.137,0.742,0.646,0.576,0.665,0.776,0.677,0.594,0.906,0.786,0.73,0.771,0.75
https://doi.org/10.1002/14651858.cd003380.pub3,psychological and educational interventions for preventing depression in children and adolescents,1203_psychological and educational interventions for preventing depression in children and adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf']","['Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents', 'Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf']","['1203_1_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf', '1203_0_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407360/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf']","['1203_1_cognitive behavioural therapy cbt third‐wave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf', '1203_0_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf']","[0.605, 0.828]","[0.51, 0.502]","[0.588, 0.592]","[0.171, 0.168]","[0.168, 0.169]","[0.151, 0.147]","[0.739, 0.736]","[0.647, 0.644]","[0.572, 0.564]","[0.743, 0.719]","[0.76, 0.764]","[0.653, 0.656]","[0.587, 0.586]","[0.903, 0.906]","[0.799, 0.8]","[0.705, 0.712]","[0.759, 0.762]","[0.744, 0.748]",0.716,0.506,0.59,0.17,0.169,0.149,0.738,0.645,0.568,0.731,0.762,0.655,0.587,0.905,0.8,0.708,0.76,0.746
https://doi.org/10.1002/14651858.cd003380.pub4,cognitive behavioural therapy cbt thirdwave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents,1204_cognitive behavioural therapy cbt thirdwave cbt and interpersonal therapy ipt based interventions for preventing depression in children and adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', 'E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['1204_1_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '1204_0_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['1204_1_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '1204_0_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']","[0.678, 0.657]","[0.508, 0.508]","[0.597, 0.595]","[0.175, 0.177]","[0.171, 0.175]","[0.15, 0.154]","[0.741, 0.745]","[0.65, 0.652]","[0.567, 0.568]","[0.733, 0.738]","[0.765, 0.763]","[0.678, 0.67]","[0.589, 0.587]","[0.898, 0.901]","[0.799, 0.802]","[0.708, 0.707]","[0.761, 0.761]","[0.741, 0.744]",0.667,0.508,0.596,0.176,0.173,0.152,0.743,0.651,0.567,0.736,0.764,0.674,0.588,0.899,0.8,0.708,0.761,0.742
https://doi.org/10.1002/14651858.cd003402.pub2,marine oil and other prostaglandin precursor supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction,1205_marine oil and other prostaglandin precursor supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf']","['Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood', 'Magnesium sulphate versus diazepam for eclampsia', 'Magnesium sulphate versus lytic cocktail for eclampsia', 'Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes', 'Omega‐3 fatty acid addition during pregnancy', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus', 'Epidural therapy for the treatment of severe pre‐eclampsia in non labouring women']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf']","['1205_4_omega‐3 fatty acid addition during pregnancy.pdf', '1205_0_maternal prenatal andor postnatal n‐3 long chain polyunsaturated fatty acids lcpufa supplementation for preventing allergies in early childhood.pdf', '1205_3_lipid‐based nutrient supplements for maternal birth and infant developmental outcomes.pdf', '1205_5_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1205_6_dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.pdf', '1205_2_magnesium sulphate versus lytic cocktail for eclampsia.pdf', '1205_1_magnesium sulphate versus diazepam for eclampsia.pdf', '1205_7_epidural therapy for the treatment of severe pre‐eclampsia in non labouring women.pdf']",8,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138041/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045443/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf']","['1205_4_omega‐3 fatty acid addition during pregnancy.pdf', '1205_0_maternal prenatal andor postnatal n‐3 long chain polyunsaturated fatty acids lcpufa supplementation for preventing allergies in early childhood.pdf', '1205_3_lipid‐based nutrient supplements for maternal birth and infant developmental outcomes.pdf', '1205_5_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1205_6_dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.pdf', '1205_2_magnesium sulphate versus lytic cocktail for eclampsia.pdf', '1205_1_magnesium sulphate versus diazepam for eclampsia.pdf', '1205_7_epidural therapy for the treatment of severe pre‐eclampsia in non labouring women.pdf']","[0.575, 0.418, 0.352, 0.414, 0.552, 0.287, 0.414, 0.309]","[0.5, 0.5, 0.496, 0.49, 0.501, 0.491, 0.496, 0.487]","[0.58, 0.58, 0.582, 0.583, 0.587, 0.58, 0.582, 0.585]","[0.181, 0.166, 0.171, 0.15, 0.173, 0.152, 0.163, 0.153]","[0.158, 0.151, 0.151, 0.146, 0.159, 0.143, 0.145, 0.144]","[0.148, 0.133, 0.134, 0.129, 0.137, 0.125, 0.131, 0.12]","[0.748, 0.744, 0.744, 0.734, 0.744, 0.737, 0.74, 0.733]","[0.656, 0.649, 0.649, 0.639, 0.648, 0.644, 0.649, 0.637]","[0.574, 0.568, 0.564, 0.569, 0.569, 0.563, 0.57, 0.556]","[0.706, 0.685, 0.698, 0.685, 0.686, 0.673, 0.684, 0.667]","[0.767, 0.766, 0.759, 0.769, 0.762, 0.766, 0.77, 0.765]","[0.639, 0.644, 0.644, 0.648, 0.65, 0.649, 0.649, 0.647]","[0.591, 0.587, 0.585, 0.588, 0.587, 0.588, 0.587, 0.582]","[0.9, 0.897, 0.891, 0.909, 0.893, 0.899, 0.9, 0.905]","[0.778, 0.779, 0.782, 0.785, 0.783, 0.781, 0.778, 0.788]","[0.71, 0.706, 0.705, 0.705, 0.704, 0.708, 0.709, 0.707]","[0.761, 0.76, 0.755, 0.761, 0.761, 0.76, 0.763, 0.759]","[0.746, 0.74, 0.74, 0.749, 0.738, 0.745, 0.746, 0.744]",0.415,0.495,0.582,0.164,0.15,0.132,0.74,0.646,0.567,0.685,0.766,0.646,0.587,0.899,0.782,0.707,0.76,0.743
https://doi.org/10.1002/14651858.cd003403,bright light therapy for sleep problems in adults aged 60,1206_bright light therapy for sleep problems in adults aged 60.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017641/pdf']","['Non‐pharmacological interventions for sleep promotion in the intensive care unit', 'Physical exercise for sleep problems in adults aged 60+']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017641/pdf']","['1206_0_non‐pharmacological interventions for sleep promotion in the intensive care unit.pdf', '1206_1_physical exercise for sleep problems in adults aged 60.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017641/pdf']","['1206_0_non‐pharmacological interventions for sleep promotion in the intensive care unit.pdf', '1206_1_physical exercise for sleep problems in adults aged 60.pdf']","[0.611, 0.859]","[0.528, 0.536]","[0.628, 0.64]","[0.176, 0.191]","[0.201, 0.226]","[0.169, 0.188]","[0.738, 0.743]","[0.646, 0.65]","[0.592, 0.596]","[0.715, 0.728]","[0.783, 0.791]","[0.698, 0.706]","[0.606, 0.616]","[0.925, 0.93]","[0.819, 0.82]","[0.733, 0.746]","[0.777, 0.783]","[0.765, 0.776]",0.735,0.532,0.634,0.183,0.214,0.178,0.74,0.648,0.594,0.722,0.787,0.702,0.611,0.927,0.819,0.74,0.78,0.77
https://doi.org/10.1002/14651858.cd003452.pub2,orthodontic treatment for prominent upper front teeth in children,1208_orthodontic treatment for prominent upper front teeth in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494411/pdf'],['Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494411/pdf'],['1208_0_orthodontic treatment for prominent upper front teeth class ii malocclusion in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494411/pdf'],['1208_0_orthodontic treatment for prominent upper front teeth class ii malocclusion in children and adolescents.pdf'],[0.838],[0.505],[0.597],[0.173],[0.177],[0.15],[0.746],[0.653],[0.575],[0.71],[0.776],[0.678],[0.595],[0.911],[0.797],[0.716],[0.77],[0.751],0.838,0.505,0.597,0.173,0.177,0.15,0.746,0.653,0.575,0.71,0.776,0.678,0.595,0.911,0.797,0.716,0.77,0.751
https://doi.org/10.1002/14651858.cd003452.pub3,orthodontic treatment for prominent upper front teeth class ii malocclusion in children,1209_orthodontic treatment for prominent upper front teeth class ii malocclusion in children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491166/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494411/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485795/pdf']","['Orthodontic treatment for deep bite and retroclined upper front teeth in children', 'Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents', 'Orthodontic treatment for deep bite and retroclined upper front teeth in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494411/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491166/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485795/pdf']","['1209_1_orthodontic treatment for prominent upper front teeth class ii malocclusion in children and adolescents.pdf', '1209_0_orthodontic treatment for deep bite and retroclined upper front teeth in children.pdf', '1209_2_orthodontic treatment for deep bite and retroclined upper front teeth in children.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494411/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491166/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485795/pdf']","['1209_1_orthodontic treatment for prominent upper front teeth class ii malocclusion in children and adolescents.pdf', '1209_0_orthodontic treatment for deep bite and retroclined upper front teeth in children.pdf', '1209_2_orthodontic treatment for deep bite and retroclined upper front teeth in children.pdf']","[0.638, 0.959, 0.647]","[0.498, 0.498, 0.496]","[0.589, 0.595, 0.594]","[0.174, 0.165, 0.166]","[0.169, 0.172, 0.176]","[0.148, 0.15, 0.152]","[0.747, 0.742, 0.744]","[0.654, 0.647, 0.649]","[0.566, 0.567, 0.562]","[0.714, 0.703, 0.703]","[0.767, 0.77, 0.773]","[0.668, 0.672, 0.678]","[0.59, 0.585, 0.586]","[0.899, 0.906, 0.904]","[0.784, 0.79, 0.788]","[0.703, 0.706, 0.711]","[0.76, 0.76, 0.76]","[0.737, 0.743, 0.744]",0.748,0.497,0.593,0.168,0.172,0.15,0.744,0.65,0.565,0.707,0.77,0.673,0.587,0.903,0.787,0.707,0.76,0.741
https://doi.org/10.1002/14651858.cd003469.pub4,botulinum toxin a as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy update,1210_botulinum toxin a as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy update.pdf,6,"['https://effectivehealthcare.ahrq.gov/products/grades-predictive-values/white-paper-2015', 'https://effectivehealthcare.ahrq.gov/products/cerebral-palsy-issues/white-paper', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-medication-covered-under-medical.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481584/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442500/pdf']","['Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence', 'Developmental Disabilities Issues Exploration Forum: Cerebral Palsy', 'Medications Covered Under Medical', 'Interventions for managing skeletal muscle spasticity following traumatic brain injury', 'Pharmacological interventions for pain in children and adolescents with life‐limiting conditions', 'Constraint‐induced movement therapy in children with unilateral cerebral palsy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442500/pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-medication-covered-under-medical.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481584/pdf']","['1210_5_constraint‐induced movement therapy in children with unilateral cerebral palsy.pdf', '1210_2_medications covered under medical.pdf', '1210_3_interventions for managing skeletal muscle spasticity following traumatic brain injury.pdf', '1210_4_pharmacological interventions for pain in children and adolescents with life‐limiting conditions.pdf']",4,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442500/pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-medication-covered-under-medical.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486165/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481584/pdf']","['1210_5_constraint‐induced movement therapy in children with unilateral cerebral palsy.pdf', '1210_2_medications covered under medical.pdf', '1210_3_interventions for managing skeletal muscle spasticity following traumatic brain injury.pdf', '1210_4_pharmacological interventions for pain in children and adolescents with life‐limiting conditions.pdf']","[0.234, 0.399, 0.412, 0.586]","[0.521, 0.499, 0.524, 0.515]","[0.603, 0.58, 0.607, 0.602]","[0.172, 0.122, 0.168, 0.155]","[0.171, 0.109, 0.167, 0.151]","[0.146, 0.098, 0.134, 0.119]","[0.74, 0.727, 0.737, 0.736]","[0.648, 0.63, 0.642, 0.64]","[0.579, 0.567, 0.582, 0.576]","[0.71, 0.647, 0.697, 0.684]","[0.777, 0.776, 0.779, 0.778]","[0.678, 0.685, 0.674, 0.689]","[0.602, 0.586, 0.6, 0.6]","[0.905, 0.905, 0.909, 0.901]","[0.811, 0.802, 0.814, 0.8]","[0.725, 0.727, 0.735, 0.729]","[0.773, 0.766, 0.775, 0.772]","[0.753, 0.758, 0.762, 0.752]",0.408,0.515,0.598,0.154,0.15,0.124,0.735,0.64,0.576,0.684,0.777,0.681,0.597,0.905,0.807,0.729,0.772,0.756
https://doi.org/10.1002/14651858.cd003483,naloxone for opiateexposed newborn infants,1211_naloxone for opiateexposed newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169/pdf'],['Naloxone for opioid‐exposed newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169/pdf'],['1211_0_naloxone for opioid‐exposed newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169/pdf'],['1211_0_naloxone for opioid‐exposed newborn infants.pdf'],[0.801],[0.512],[0.606],[0.181],[0.187],[0.161],[0.741],[0.649],[0.575],[0.711],[0.776],[0.667],[0.59],[0.922],[0.816],[0.726],[0.772],[0.761],0.801,0.512,0.606,0.181,0.187,0.161,0.741,0.649,0.575,0.711,0.776,0.667,0.59,0.922,0.816,0.726,0.772,0.761
https://doi.org/10.1002/14651858.cd003483.pub2,naloxone for opiateexposed newborn infants,1212_naloxone for opiateexposed newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169/pdf']","['Singapore Neonatal Resuscitation Guidelines 2016', 'Naloxone for opioid‐exposed newborn infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523090/pdf']","['1212_1_naloxone for opioid‐exposed newborn infants.pdf', '1212_0_singapore neonatal resuscitation guidelines 2016.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517169/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523090/pdf']","['1212_1_naloxone for opioid‐exposed newborn infants.pdf', '1212_0_singapore neonatal resuscitation guidelines 2016.pdf']","[0.288, 0.893]","[0.509, 0.531]","[0.599, 0.611]","[0.177, 0.162]","[0.184, 0.168]","[0.158, 0.124]","[0.74, 0.736]","[0.649, 0.643]","[0.574, 0.599]","[0.705, 0.627]","[0.78, 0.799]","[0.682, 0.718]","[0.589, 0.608]","[0.917, 0.924]","[0.813, 0.816]","[0.728, 0.759]","[0.773, 0.795]","[0.762, 0.779]",0.591,0.52,0.605,0.169,0.176,0.141,0.738,0.646,0.587,0.666,0.79,0.7,0.599,0.921,0.815,0.744,0.784,0.77
https://doi.org/10.1002/14651858.cd003484,dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia,1214_dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","[""Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia"", 'Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","['1214_0_naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks gestation with suspected perinatal asphyxia.pdf', '1214_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","['1214_0_naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks gestation with suspected perinatal asphyxia.pdf', '1214_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']","[0.636, 0.501]","[0.548, 0.535]","[0.634, 0.62]","[0.198, 0.193]","[0.211, 0.194]","[0.168, 0.156]","[0.74, 0.743]","[0.649, 0.651]","[0.609, 0.595]","[0.68, 0.688]","[0.789, 0.776]","[0.707, 0.7]","[0.612, 0.603]","[0.924, 0.9]","[0.821, 0.793]","[0.751, 0.715]","[0.788, 0.774]","[0.777, 0.741]",0.569,0.542,0.627,0.196,0.203,0.162,0.742,0.65,0.602,0.684,0.782,0.704,0.607,0.912,0.807,0.733,0.781,0.759
https://doi.org/10.1002/14651858.cd003485,steroid therapy for meconium aspiration syndrome in newborn infants,1215_steroid therapy for meconium aspiration syndrome in newborn infants.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483527/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485718/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027383/pdf']","['Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections', 'Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews', 'Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates', 'Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants', 'Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates', 'Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants', 'Surfactant for meconium aspiration syndrome in term and late preterm infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485718/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027383/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483527/pdf']","['1215_4_inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.pdf', '1215_2_early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.pdf', '1215_5_inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.pdf', '1215_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1215_6_surfactant for meconium aspiration syndrome in term and late preterm infants.pdf', '1215_0_antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections.pdf', '1215_3_late ≥ 7 days inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485718/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027383/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483527/pdf']","['1215_4_inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.pdf', '1215_2_early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.pdf', '1215_5_inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.pdf', '1215_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1215_6_surfactant for meconium aspiration syndrome in term and late preterm infants.pdf', '1215_0_antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections.pdf', '1215_3_late ≥ 7 days inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.pdf']","[0.398, 0.344, 0.498, 0.495, 0.502, 0.528, 0.595]","[0.525, 0.519, 0.524, 0.529, 0.534, 0.531, 0.536]","[0.61, 0.602, 0.609, 0.617, 0.618, 0.616, 0.622]","[0.178, 0.18, 0.183, 0.173, 0.187, 0.167, 0.19]","[0.176, 0.165, 0.176, 0.166, 0.178, 0.162, 0.184]","[0.148, 0.143, 0.149, 0.136, 0.151, 0.13, 0.155]","[0.74, 0.738, 0.739, 0.741, 0.739, 0.735, 0.74]","[0.646, 0.644, 0.645, 0.647, 0.647, 0.641, 0.647]","[0.587, 0.578, 0.584, 0.59, 0.6, 0.595, 0.6]","[0.685, 0.686, 0.687, 0.683, 0.682, 0.678, 0.687]","[0.774, 0.77, 0.774, 0.775, 0.784, 0.782, 0.781]","[0.692, 0.688, 0.693, 0.699, 0.701, 0.703, 0.697]","[0.593, 0.59, 0.594, 0.598, 0.604, 0.596, 0.597]","[0.904, 0.899, 0.906, 0.9, 0.911, 0.915, 0.913]","[0.8, 0.789, 0.799, 0.794, 0.808, 0.813, 0.812]","[0.724, 0.715, 0.722, 0.711, 0.737, 0.734, 0.735]","[0.769, 0.765, 0.77, 0.771, 0.78, 0.778, 0.778]","[0.749, 0.74, 0.748, 0.738, 0.762, 0.762, 0.762]",0.48,0.528,0.613,0.18,0.172,0.145,0.739,0.645,0.591,0.684,0.777,0.696,0.596,0.907,0.802,0.725,0.773,0.752
https://doi.org/10.1002/14651858.cd003486,therapeutic lung lavage for meconium aspiration syndrome in newborn infants,1216_therapeutic lung lavage for meconium aspiration syndrome in newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057030/pdf']","['Surfactant for pulmonary haemorrhage in neonates', 'Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057030/pdf']","['1216_0_surfactant for pulmonary haemorrhage in neonates.pdf', '1216_1_early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996938/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057030/pdf']","['1216_0_surfactant for pulmonary haemorrhage in neonates.pdf', '1216_1_early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.pdf']","[0.461, 0.311]","[0.532, 0.49]","[0.622, 0.58]","[0.172, 0.154]","[0.173, 0.14]","[0.144, 0.124]","[0.739, 0.738]","[0.647, 0.645]","[0.612, 0.555]","[0.679, 0.669]","[0.8, 0.774]","[0.717, 0.675]","[0.613, 0.583]","[0.928, 0.899]","[0.826, 0.766]","[0.748, 0.697]","[0.793, 0.762]","[0.779, 0.729]",0.386,0.511,0.601,0.163,0.157,0.134,0.738,0.646,0.584,0.674,0.787,0.696,0.598,0.913,0.796,0.722,0.778,0.754
https://doi.org/10.1002/14651858.cd003486.pub2,lung lavage for meconium aspiration syndrome in newborn infants,1217_lung lavage for meconium aspiration syndrome in newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027383/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210808/pdf']","['Surfactant for meconium aspiration syndrome in term and late preterm infants', 'Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027383/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210808/pdf']","['1217_0_surfactant for meconium aspiration syndrome in term and late preterm infants.pdf', '1217_1_animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027383/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210808/pdf']","['1217_0_surfactant for meconium aspiration syndrome in term and late preterm infants.pdf', '1217_1_animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.pdf']","[0.842, 0.576]","[0.532, 0.495]","[0.614, 0.582]","[0.19, 0.161]","[0.188, 0.156]","[0.154, 0.132]","[0.74, 0.737]","[0.651, 0.645]","[0.598, 0.552]","[0.694, 0.694]","[0.784, 0.761]","[0.705, 0.675]","[0.61, 0.595]","[0.908, 0.892]","[0.806, 0.763]","[0.736, 0.698]","[0.783, 0.759]","[0.758, 0.72]",0.709,0.514,0.598,0.175,0.172,0.143,0.738,0.648,0.575,0.694,0.772,0.69,0.603,0.9,0.784,0.717,0.771,0.739
https://doi.org/10.1002/14651858.cd003510.pub2,antiretrovirals for reducing the risk of mothertochild transmission of hiv infection,1218_antiretrovirals for reducing the risk of mothertochild transmission of hiv infection.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498019/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery', 'Techniques for caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498019/pdf']","['1218_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1218_2_techniques for caesarean section.pdf', '1218_1_antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498019/pdf']","['1218_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1218_2_techniques for caesarean section.pdf', '1218_1_antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.pdf']","[0.149, 0.391, 0.356]","[0.534, 0.495, 0.507]","[0.618, 0.58, 0.599]","[0.182, 0.147, 0.167]","[0.162, 0.141, 0.168]","[0.139, 0.128, 0.142]","[0.738, 0.737, 0.736]","[0.643, 0.641, 0.642]","[0.58, 0.554, 0.565]","[0.659, 0.668, 0.679]","[0.792, 0.759, 0.765]","[0.732, 0.681, 0.698]","[0.622, 0.583, 0.585]","[0.892, 0.887, 0.892]","[0.789, 0.765, 0.772]","[0.732, 0.688, 0.694]","[0.79, 0.758, 0.76]","[0.742, 0.713, 0.717]",0.299,0.512,0.599,0.165,0.157,0.136,0.737,0.642,0.566,0.669,0.772,0.704,0.597,0.89,0.775,0.705,0.769,0.724
https://doi.org/10.1002/14651858.cd003510.pub3,antiretrovirals for reducing the risk of mothertochild transmission of hiv infection,1219_antiretrovirals for reducing the risk of mothertochild transmission of hiv infection.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026368/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://effectivehealthcare.ahrq.gov/products/global-health-evidence-evaluation-framework/white-paper', 'https://effectivehealthcare.ahrq.gov/products/mixed-treatment-comparisons/research']","['Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Global Health Evidence Evaluation Framework', 'Use of Mixed Treatment Comparisons in Systematic Reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026368/pdf']","['1219_2_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1219_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1219_0_antiretroviral therapy for prevention of hiv transmission in hivdiscordant couples.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026368/pdf']","['1219_2_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1219_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1219_0_antiretroviral therapy for prevention of hiv transmission in hivdiscordant couples.pdf']","[0.409, 0.296, 0.402]","[0.507, 0.506, 0.51]","[0.596, 0.598, 0.597]","[0.163, 0.158, 0.17]","[0.155, 0.161, 0.171]","[0.132, 0.135, 0.147]","[0.74, 0.733, 0.737]","[0.648, 0.64, 0.646]","[0.566, 0.575, 0.562]","[0.678, 0.68, 0.691]","[0.767, 0.772, 0.764]","[0.695, 0.688, 0.695]","[0.597, 0.594, 0.574]","[0.885, 0.897, 0.889]","[0.773, 0.786, 0.78]","[0.692, 0.702, 0.7]","[0.76, 0.766, 0.757]","[0.716, 0.735, 0.723]",0.369,0.508,0.597,0.164,0.162,0.138,0.737,0.645,0.568,0.683,0.768,0.693,0.588,0.89,0.78,0.698,0.761,0.725
https://doi.org/10.1002/14651858.cd003519,early skintoskin contact for mothers and their healthy newborn infants,1220_early skintoskin contact for mothers and their healthy newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf'],['Early skin‐to‐skin contact for mothers and their healthy newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf'],['1220_0_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf'],['1220_0_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf'],[0.782],[0.536],[0.613],[0.192],[0.192],[0.161],[0.743],[0.65],[0.591],[0.695],[0.778],[0.702],[0.606],[0.903],[0.813],[0.735],[0.785],[0.76],0.782,0.536,0.613,0.192,0.192,0.161,0.743,0.65,0.591,0.695,0.778,0.702,0.606,0.903,0.813,0.735,0.785,0.76
https://doi.org/10.1002/14651858.cd003519.pub2,early skintoskin contact for mothers and their healthy newborn infants,1221_early skintoskin contact for mothers and their healthy newborn infants.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['Early skin‐to‐skin contact for mothers and their healthy newborn infants', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Techniques for caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['1221_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1221_0_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf', '1221_2_techniques for caesarean section.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['1221_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1221_0_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf', '1221_2_techniques for caesarean section.pdf']","[0.82, 0.136, 0.321]","[0.576, 0.546, 0.507]","[0.649, 0.625, 0.592]","[0.191, 0.202, 0.149]","[0.168, 0.203, 0.138]","[0.144, 0.167, 0.121]","[0.737, 0.742, 0.733]","[0.641, 0.65, 0.635]","[0.642, 0.605, 0.571]","[0.655, 0.692, 0.66]","[0.818, 0.79, 0.772]","[0.771, 0.72, 0.69]","[0.641, 0.614, 0.595]","[0.923, 0.913, 0.907]","[0.835, 0.822, 0.796]","[0.785, 0.746, 0.72]","[0.826, 0.796, 0.776]","[0.797, 0.768, 0.746]",0.426,0.543,0.622,0.181,0.17,0.144,0.737,0.642,0.606,0.669,0.793,0.727,0.617,0.914,0.818,0.75,0.799,0.77
https://doi.org/10.1002/14651858.cd003519.pub3,early skintoskin contact for mothers and their healthy newborn infants,1222_early skintoskin contact for mothers and their healthy newborn infants.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168801/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.opensocietyfoundations.org/publications/expecting-better-improving-health-and-rights-pregnant-women-who-use-drugs']","['Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding', 'Skin‐to‐skin care for procedural pain in neonates', ': the presence of a companion favors the use of best practices in delivery care in the South region of Brazil', 'Kangaroo mother care to reduce morbidity and mortality in low birthweight infants', 'Early skin‐to‐skin contact for mothers and their healthy newborn infants', 'Interventions for promoting the initiation of breastfeeding', 'Expecting Better: Improving Health and Rights for Pregnant Women Who Use Drugs']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168801/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf']","['1222_5_interventions for promoting the initiation of breastfeeding.pdf', '1222_3_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf', '1222_4_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf', '1222_0_rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding.pdf', '1222_1_skin‐to‐skin care for procedural pain in neonates.pdf', '1222_2_ the presence of a companion favors the use of best practices in delivery care in the south region of brazil.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168801/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf']","['1222_5_interventions for promoting the initiation of breastfeeding.pdf', '1222_3_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf', '1222_4_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf', '1222_0_rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding.pdf', '1222_1_skin‐to‐skin care for procedural pain in neonates.pdf', '1222_2_ the presence of a companion favors the use of best practices in delivery care in the south region of brazil.pdf']","[0.717, 0.669, 0.219, 0.734, 0.932, 0.618]","[0.553, 0.513, 0.546, 0.558, 0.527, 0.51]","[0.632, 0.597, 0.624, 0.637, 0.606, 0.59]","[0.209, 0.189, 0.206, 0.215, 0.181, 0.16]","[0.207, 0.171, 0.203, 0.216, 0.173, 0.158]","[0.174, 0.152, 0.168, 0.178, 0.144, 0.129]","[0.739, 0.742, 0.744, 0.742, 0.74, 0.735]","[0.648, 0.649, 0.652, 0.65, 0.647, 0.639]","[0.611, 0.565, 0.601, 0.615, 0.582, 0.568]","[0.695, 0.701, 0.697, 0.698, 0.691, 0.666]","[0.795, 0.769, 0.788, 0.796, 0.778, 0.776]","[0.718, 0.671, 0.711, 0.729, 0.689, 0.668]","[0.614, 0.59, 0.612, 0.623, 0.607, 0.601]","[0.913, 0.897, 0.908, 0.913, 0.904, 0.903]","[0.828, 0.797, 0.823, 0.832, 0.811, 0.814]","[0.752, 0.717, 0.745, 0.754, 0.733, 0.732]","[0.797, 0.766, 0.791, 0.798, 0.779, 0.774]","[0.777, 0.743, 0.77, 0.777, 0.76, 0.755]",0.648,0.534,0.614,0.193,0.188,0.158,0.74,0.648,0.59,0.691,0.784,0.698,0.608,0.906,0.818,0.739,0.784,0.764
https://doi.org/10.1002/14651858.cd003519.pub4,early skintoskin contact for mothers and their healthy newborn infants,1223_early skintoskin contact for mothers and their healthy newborn infants.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513033/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127543/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www1.nyc.gov/assets/doh/downloads/pdf/tcny/community-health-assessment-plan.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/tcny/tcny-2020-annual-report.pdf']","['SBA 2020: Regional anesthesia guideline for using anticoagulants update', 'Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants', 'Parenteral opioids for maternal pain management in labour', 'Oral dextrose gel to prevent hypoglycaemia in at‐risk neonates', 'Breastfeeding education and support for women with twins or higher order multiples', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'New york city department of health and mental hygiene', '1 St Annual Update']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513033/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/tcny/tcny-2020-annual-report.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/tcny/community-health-assessment-plan.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127543/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf']","['1223_0_sba 2020 regional anesthesia guideline for using anticoagulants update.pdf', '1223_4_breastfeeding education and support for women with twins or higher order multiples.pdf', '1223_2_parenteral opioids for maternal pain management in labour.pdf', '1223_7_1 st annual update.pdf', '1223_6_new york city department of health and mental hygiene.pdf', '1223_3_oral dextrose gel to prevent hypoglycaemia in at‐risk neonates.pdf', '1223_1_interventions to prevent hypothermia at birth in preterm andor low birth weight infants.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513033/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/tcny/tcny-2020-annual-report.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/tcny/community-health-assessment-plan.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127543/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf']","['1223_0_sba 2020 regional anesthesia guideline for using anticoagulants update.pdf', '1223_4_breastfeeding education and support for women with twins or higher order multiples.pdf', '1223_2_parenteral opioids for maternal pain management in labour.pdf', '1223_7_1 st annual update.pdf', '1223_6_new york city department of health and mental hygiene.pdf', '1223_3_oral dextrose gel to prevent hypoglycaemia in at‐risk neonates.pdf', '1223_1_interventions to prevent hypothermia at birth in preterm andor low birth weight infants.pdf']","[0.168, 0.571, 0.485, 0.471, 0.629, 0.153, 0.126]","[0.523, 0.558, 0.518, 0.512, 0.507, 0.528, 0.526]","[0.604, 0.635, 0.602, 0.613, 0.6, 0.614, 0.607]","[0.124, 0.202, 0.175, 0.125, 0.119, 0.174, 0.188]","[0.111, 0.2, 0.158, 0.124, 0.11, 0.162, 0.174]","[0.078, 0.167, 0.134, 0.105, 0.089, 0.138, 0.146]","[0.726, 0.738, 0.736, 0.716, 0.719, 0.738, 0.742]","[0.628, 0.646, 0.644, 0.619, 0.618, 0.645, 0.649]","[0.599, 0.618, 0.576, 0.588, 0.579, 0.589, 0.578]","[0.603, 0.69, 0.676, 0.652, 0.661, 0.684, 0.682]","[0.794, 0.796, 0.775, 0.8, 0.786, 0.779, 0.776]","[0.717, 0.723, 0.689, 0.722, 0.705, 0.7, 0.693]","[0.601, 0.613, 0.589, 0.598, 0.602, 0.597, 0.601]","[0.912, 0.916, 0.896, 0.915, 0.905, 0.905, 0.901]","[0.808, 0.833, 0.798, 0.829, 0.814, 0.809, 0.797]","[0.749, 0.754, 0.722, 0.747, 0.729, 0.727, 0.725]","[0.793, 0.799, 0.774, 0.8, 0.79, 0.778, 0.778]","[0.772, 0.779, 0.749, 0.772, 0.761, 0.753, 0.75]",0.372,0.525,0.611,0.158,0.148,0.122,0.731,0.636,0.59,0.664,0.787,0.707,0.6,0.907,0.813,0.736,0.787,0.762
https://doi.org/10.1002/14651858.cd003523.pub2,electromagnetic fields for treating osteoarthritis,1224_electromagnetic fields for treating osteoarthritis.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/nonpharma-treatment-pain/research-2018', 'https://effectivehealthcare.ahrq.gov/products/noninvasive-nonpharm-pain-update/research', 'https://cdle.colorado.gov/sites/cdle/files/Ex6_LEI_Referenced_Version_with_Bibliography.pdf', 'https://www.colorado.gov/pacific/sites/default/files/Ex6_LEI_Referenced_Version_with_Bibliography.pdf']","['Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review', 'Noninvasive Nonpharmacological Treatment for Chronic Pain', '08/06/12 – Draft Updated', '08/06/12 – Draft Updated']",['https://cdle.colorado.gov/sites/cdle/files/Ex6_LEI_Referenced_Version_with_Bibliography.pdf'],['1224_2_080612 – draft updated.pdf'],1,25.0,['https://cdle.colorado.gov/sites/cdle/files/Ex6_LEI_Referenced_Version_with_Bibliography.pdf'],['1224_2_080612 – draft updated.pdf'],[0.398],[0.546],[0.634],[0.159],[0.168],[0.124],[0.737],[0.634],[0.622],[0.654],[0.798],[0.745],[0.615],[0.927],[0.822],[0.763],[0.804],[0.783],0.398,0.546,0.634,0.159,0.168,0.124,0.737,0.634,0.622,0.654,0.798,0.745,0.615,0.927,0.822,0.763,0.804,0.783
https://doi.org/10.1002/14651858.cd003615.pub2,oxcarbazepine versus phenytoin monotherapy for epilepsy,1226_oxcarbazepine versus phenytoin monotherapy for epilepsy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516888/pdf'],['Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516888/pdf'],['1226_0_oxcarbazepine versus phenytoin monotherapy for epilepsy an individual participant data review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516888/pdf'],['1226_0_oxcarbazepine versus phenytoin monotherapy for epilepsy an individual participant data review.pdf'],[0.776],[0.509],[0.606],[0.197],[0.199],[0.172],[0.745],[0.651],[0.568],[0.72],[0.765],[0.688],[0.604],[0.898],[0.782],[0.702],[0.759],[0.729],0.776,0.509,0.606,0.197,0.199,0.172,0.745,0.651,0.568,0.72,0.765,0.688,0.604,0.898,0.782,0.702,0.759,0.729
https://doi.org/10.1002/14651858.cd003650.pub3,micronutrient supplementation in children and adults with hiv infection,1227_micronutrient supplementation in children and adults with hiv infection.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981643/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458097/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464706/pdf']","['Inpatient management of children with severe acute malnutrition: a review of WHO guidelines', 'Nutritional supplements for people being treated for active tuberculosis', 'Micronutrient supplementation in adults with HIV infection', 'Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464706/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458097/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981643/pdf']","['1227_3_vitamin a supplementation for preventing morbidity and mortality in children from six months to five years of age.pdf', '1227_0_inpatient management of children with severe acute malnutrition a review of who guidelines.pdf', '1227_2_micronutrient supplementation in adults with hiv infection.pdf', '1227_1_nutritional supplements for people being treated for active tuberculosis.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464706/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458097/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981643/pdf']","['1227_3_vitamin a supplementation for preventing morbidity and mortality in children from six months to five years of age.pdf', '1227_0_inpatient management of children with severe acute malnutrition a review of who guidelines.pdf', '1227_2_micronutrient supplementation in adults with hiv infection.pdf', '1227_1_nutritional supplements for people being treated for active tuberculosis.pdf']","[0.254, 0.663, 0.719, 0.668]","[0.531, 0.519, 0.533, 0.518]","[0.615, 0.61, 0.62, 0.603]","[0.195, 0.173, 0.199, 0.18]","[0.19, 0.182, 0.196, 0.168]","[0.163, 0.146, 0.169, 0.149]","[0.748, 0.742, 0.749, 0.746]","[0.654, 0.647, 0.657, 0.651]","[0.589, 0.577, 0.588, 0.579]","[0.702, 0.679, 0.704, 0.698]","[0.781, 0.786, 0.78, 0.777]","[0.692, 0.698, 0.692, 0.675]","[0.598, 0.585, 0.592, 0.584]","[0.904, 0.897, 0.906, 0.903]","[0.815, 0.822, 0.817, 0.809]","[0.73, 0.718, 0.726, 0.726]","[0.779, 0.78, 0.777, 0.774]","[0.758, 0.764, 0.755, 0.757]",0.576,0.525,0.612,0.187,0.184,0.157,0.746,0.652,0.583,0.696,0.781,0.689,0.59,0.903,0.816,0.725,0.778,0.759
https://doi.org/10.1002/14651858.cd003664.pub5,infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy,1228_infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485330/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517017/pdf']","['Protein hydrolysate versus standard formula for preterm infants', 'Infant formulas containing hydrolysed protein for prevention of allergic disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485330/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517017/pdf']","['1228_0_protein hydrolysate versus standard formula for preterm infants.pdf', '1228_1_infant formulas containing hydrolysed protein for prevention of allergic disease.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485330/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517017/pdf']","['1228_0_protein hydrolysate versus standard formula for preterm infants.pdf', '1228_1_infant formulas containing hydrolysed protein for prevention of allergic disease.pdf']","[0.357, 0.417]","[0.491, 0.487]","[0.592, 0.581]","[0.167, 0.159]","[0.168, 0.159]","[0.144, 0.144]","[0.737, 0.735]","[0.647, 0.642]","[0.564, 0.555]","[0.703, 0.702]","[0.769, 0.759]","[0.669, 0.658]","[0.561, 0.556]","[0.904, 0.903]","[0.819, 0.79]","[0.709, 0.691]","[0.761, 0.751]","[0.75, 0.736]",0.387,0.489,0.587,0.163,0.164,0.144,0.736,0.645,0.559,0.702,0.764,0.663,0.558,0.903,0.804,0.7,0.756,0.743
https://doi.org/10.1002/14651858.cd003666.pub2,volumetargeted versus pressurelimited ventilation in the neonate,1229_volumetargeted versus pressurelimited ventilation in the neonate.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457606/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485452/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182138/pdf']","['Pressure‐controlled versus volume‐controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS)', 'Volume‐targeted versus pressure‐limited ventilation in neonates', 'Intra‐amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182138/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457606/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485452/pdf']","['1229_2_intra‐amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns.pdf', '1229_0_pressure‐controlled versus volume‐controlled ventilation for acute respiratory failure due to acute lung injury ali or acute respiratory distress syndrome ards.pdf', '1229_1_volume‐targeted versus pressure‐limited ventilation in neonates.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182138/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457606/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485452/pdf']","['1229_2_intra‐amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns.pdf', '1229_0_pressure‐controlled versus volume‐controlled ventilation for acute respiratory failure due to acute lung injury ali or acute respiratory distress syndrome ards.pdf', '1229_1_volume‐targeted versus pressure‐limited ventilation in neonates.pdf']","[0.462, 0.797, 0.323]","[0.513, 0.519, 0.517]","[0.603, 0.6, 0.588]","[0.163, 0.181, 0.198]","[0.167, 0.177, 0.174]","[0.13, 0.144, 0.152]","[0.734, 0.739, 0.741]","[0.641, 0.649, 0.652]","[0.595, 0.588, 0.584]","[0.678, 0.701, 0.708]","[0.783, 0.774, 0.774]","[0.693, 0.688, 0.672]","[0.592, 0.594, 0.593]","[0.914, 0.908, 0.899]","[0.803, 0.805, 0.793]","[0.739, 0.731, 0.727]","[0.781, 0.775, 0.775]","[0.768, 0.759, 0.753]",0.527,0.516,0.597,0.181,0.173,0.142,0.738,0.647,0.589,0.696,0.777,0.684,0.593,0.907,0.8,0.732,0.777,0.76
https://doi.org/10.1002/14651858.cd003667.pub2,intramuscular penicillin for the prevention of early onset group b streptococcal infection in newborn infants,1230_intramuscular penicillin for the prevention of early onset group b streptococcal infection in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1230_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1230_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.428],[0.53],[0.622],[0.181],[0.18],[0.144],[0.742],[0.649],[0.593],[0.686],[0.781],[0.706],[0.604],[0.901],[0.797],[0.717],[0.776],[0.743],0.428,0.53,0.622,0.181,0.18,0.144,0.742,0.649,0.593,0.686,0.781,0.706,0.604,0.901,0.797,0.717,0.776,0.743
https://doi.org/10.1002/14651858.cd003668.pub2,infant position in neonates receiving mechanical ventilation,1231_infant position in neonates receiving mechanical ventilation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144689/pdf'],['Positioning for acute respiratory distress in hospitalised infants and children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144689/pdf'],['1231_0_positioning for acute respiratory distress in hospitalised infants and children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144689/pdf'],['1231_0_positioning for acute respiratory distress in hospitalised infants and children.pdf'],[0.696],[0.504],[0.58],[0.175],[0.171],[0.147],[0.744],[0.65],[0.563],[0.717],[0.759],[0.678],[0.588],[0.886],[0.794],[0.699],[0.757],[0.733],0.696,0.504,0.58,0.175,0.171,0.147,0.744,0.65,0.563,0.717,0.759,0.678,0.588,0.886,0.794,0.699,0.757,0.733
https://doi.org/10.1002/14651858.cd003670,gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality,1232_gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026606/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134414/pdf']","['Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units', 'Gloves, gowns and masks for reducing the transmission of meticillin‐resistant Staphylococcus aureus (MRSA) in the hospital setting', 'epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134414/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026606/pdf']","['1232_2_epic2 national evidencebased guidelines for preventing healthcareassociated infections in nhs hospitals in england.pdf', '1232_0_patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units.pdf', '1232_1_gloves gowns and masks for reducing the transmission of meticillin‐resistant staphylococcus aureus mrsa in the hospital setting.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134414/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026606/pdf']","['1232_2_epic2 national evidencebased guidelines for preventing healthcareassociated infections in nhs hospitals in england.pdf', '1232_0_patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units.pdf', '1232_1_gloves gowns and masks for reducing the transmission of meticillin‐resistant staphylococcus aureus mrsa in the hospital setting.pdf']","[0.453, 0.518, 0.299]","[0.541, 0.533, 0.531]","[0.623, 0.616, 0.617]","[0.153, 0.168, 0.166]","[0.162, 0.178, 0.172]","[0.115, 0.142, 0.135]","[0.726, 0.733, 0.729]","[0.629, 0.637, 0.634]","[0.618, 0.602, 0.604]","[0.65, 0.687, 0.707]","[0.801, 0.789, 0.789]","[0.737, 0.713, 0.712]","[0.619, 0.598, 0.597]","[0.919, 0.918, 0.918]","[0.819, 0.817, 0.82]","[0.762, 0.741, 0.742]","[0.806, 0.79, 0.79]","[0.782, 0.771, 0.771]",0.423,0.535,0.619,0.162,0.171,0.131,0.729,0.633,0.608,0.681,0.793,0.721,0.605,0.918,0.819,0.748,0.795,0.775
https://doi.org/10.1002/14651858.cd003671,ward reduction without general anaesthesia versus reduction and repair under general anaesthesia for gastroschisis in newborn infants,1233_ward reduction without general anaesthesia versus reduction and repair under general anaesthesia for gastroschisis in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1233_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1233_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.355],[0.532],[0.623],[0.173],[0.178],[0.151],[0.741],[0.643],[0.594],[0.681],[0.777],[0.712],[0.602],[0.908],[0.803],[0.718],[0.779],[0.746],0.355,0.532,0.623,0.173,0.178,0.151,0.741,0.643,0.594,0.681,0.777,0.712,0.602,0.908,0.803,0.718,0.779,0.746
https://doi.org/10.1002/14651858.cd003680,groupbased parenttraining programmes for improving emotional and behavioural adjustment in 03 year old children,1234_groupbased parenttraining programmes for improving emotional and behavioural adjustment in 03 year old children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf']","['Group‐based parent training programmes for improving emotional and behavioural adjustment in young children', 'Parenting interventions for the prevention of unintentional injuries in childhood']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf']","['1234_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf', '1234_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf']","['1234_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf', '1234_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf']","[0.808, 0.513]","[0.55, 0.532]","[0.624, 0.613]","[0.19, 0.195]","[0.19, 0.195]","[0.158, 0.168]","[0.734, 0.74]","[0.641, 0.648]","[0.609, 0.59]","[0.71, 0.725]","[0.793, 0.782]","[0.726, 0.697]","[0.583, 0.586]","[0.923, 0.914]","[0.828, 0.821]","[0.747, 0.735]","[0.796, 0.782]","[0.776, 0.763]",0.661,0.541,0.619,0.193,0.193,0.163,0.737,0.645,0.599,0.718,0.788,0.712,0.585,0.919,0.825,0.741,0.789,0.77
https://doi.org/10.1002/14651858.cd003680.pub2,groupbased parenttraining programmes for improving emotional and behavioural adjustment in children from birth to three years old,1235_groupbased parenttraining programmes for improving emotional and behavioural adjustment in children from birth to three years old.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457882/pdf']","['Group‐based parent training programmes for improving emotional and behavioural adjustment in young children', 'Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children', 'Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457882/pdf']","['1235_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf', '1235_1_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf', '1235_2_interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164375/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457882/pdf']","['1235_0_group‐based parent training programmes for improving emotional and behavioural adjustment in young children.pdf', '1235_1_individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children.pdf', '1235_2_interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.pdf']","[0.873, 0.741, 0.493]","[0.524, 0.533, 0.53]","[0.604, 0.611, 0.608]","[0.193, 0.206, 0.179]","[0.193, 0.198, 0.176]","[0.17, 0.173, 0.149]","[0.742, 0.742, 0.736]","[0.649, 0.651, 0.641]","[0.575, 0.585, 0.584]","[0.737, 0.732, 0.719]","[0.772, 0.778, 0.774]","[0.681, 0.699, 0.695]","[0.588, 0.595, 0.591]","[0.904, 0.901, 0.907]","[0.81, 0.819, 0.817]","[0.722, 0.73, 0.728]","[0.77, 0.776, 0.776]","[0.748, 0.756, 0.753]",0.702,0.529,0.608,0.193,0.189,0.164,0.74,0.647,0.581,0.729,0.775,0.692,0.591,0.904,0.815,0.727,0.774,0.752
https://doi.org/10.1002/14651858.cd003680.pub3,groupbased parent training programmes for improving emotional and behavioural adjustment in young children,1236_groupbased parent training programmes for improving emotional and behavioural adjustment in young children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf', 'https://www.brookings.edu/research/the-power-of-love-why-maternal-depression-is-an-economic-mobility-issue/']","['Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight', 'Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight', 'The Power of Love: Why maternal depression is an economic mobility issue']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf']","['1236_0_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf', '1236_1_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf']","['1236_0_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf', '1236_1_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf']","[0.537, 0.54]","[0.518, 0.517]","[0.601, 0.601]","[0.171, 0.165]","[0.169, 0.165]","[0.142, 0.141]","[0.736, 0.736]","[0.643, 0.641]","[0.578, 0.576]","[0.714, 0.719]","[0.774, 0.77]","[0.694, 0.69]","[0.598, 0.588]","[0.901, 0.906]","[0.805, 0.807]","[0.727, 0.721]","[0.774, 0.771]","[0.747, 0.746]",0.538,0.518,0.601,0.168,0.167,0.141,0.736,0.642,0.577,0.716,0.772,0.692,0.593,0.903,0.806,0.724,0.772,0.746
https://doi.org/10.1002/14651858.cd003742,oral immunoglobulin for the treatment of rotavirus diarrhoea in low birth weight infants,1238_oral immunoglobulin for the treatment of rotavirus diarrhoea in low birth weight infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133785/pdf'],['Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133785/pdf'],['1238_0_oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133785/pdf'],['1238_0_oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.pdf'],[0.906],[0.568],[0.658],[0.228],[0.243],[0.208],[0.749],[0.658],[0.631],[0.68],[0.802],[0.72],[0.618],[0.937],[0.832],[0.762],[0.802],[0.793],0.906,0.568,0.658,0.228,0.243,0.208,0.749,0.658,0.631,0.68,0.802,0.72,0.618,0.937,0.832,0.762,0.802,0.793
https://doi.org/10.1002/14651858.cd003742.pub2,oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants,1239_oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133785/pdf'],['Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133785/pdf'],['1239_0_oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133785/pdf'],['1239_0_oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants.pdf'],[0.983],[0.572],[0.659],[0.227],[0.245],[0.207],[0.747],[0.657],[0.637],[0.685],[0.808],[0.734],[0.622],[0.938],[0.832],[0.772],[0.808],[0.797],0.983,0.572,0.659,0.227,0.245,0.207,0.747,0.657,0.637,0.685,0.808,0.734,0.622,0.938,0.832,0.772,0.808,0.797
https://doi.org/10.1002/14651858.cd003756,antimalarial drugs given at regular intervals for preventing clinical malaria and severe anaemia in preschool children,1240_antimalarial drugs given at regular intervals for preventing clinical malaria and severe anaemia in preschool children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf']","['Intermittent preventive treatment for malaria in infants', 'Intermittent preventive treatment for malaria in children living in areas with seasonal transmission', 'Intermittent preventive treatment for malaria in infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf']","['1240_2_intermittent preventive treatment for malaria in infants.pdf', '1240_0_intermittent preventive treatment for malaria in infants.pdf', '1240_1_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf']","['1240_2_intermittent preventive treatment for malaria in infants.pdf', '1240_0_intermittent preventive treatment for malaria in infants.pdf', '1240_1_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf']","[0.317, 0.368, 0.319]","[0.498, 0.501, 0.5]","[0.586, 0.592, 0.591]","[0.147, 0.148, 0.155]","[0.145, 0.146, 0.152]","[0.132, 0.132, 0.136]","[0.737, 0.736, 0.738]","[0.638, 0.639, 0.643]","[0.561, 0.566, 0.567]","[0.682, 0.682, 0.681]","[0.768, 0.768, 0.772]","[0.664, 0.672, 0.663]","[0.586, 0.585, 0.589]","[0.904, 0.904, 0.907]","[0.795, 0.801, 0.798]","[0.707, 0.708, 0.715]","[0.766, 0.767, 0.769]","[0.741, 0.744, 0.751]",0.335,0.5,0.59,0.15,0.148,0.133,0.737,0.64,0.565,0.682,0.769,0.666,0.587,0.905,0.798,0.71,0.767,0.745
https://doi.org/10.1002/14651858.cd003756.pub2,chemoprophylaxis and intermittent treatment for preventing malaria in children,1241_chemoprophylaxis and intermittent treatment for preventing malaria in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf']","['Intermittent preventive treatment for malaria in infants', 'Intermittent preventive treatment for malaria in infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf']","['1241_1_intermittent preventive treatment for malaria in infants.pdf', '1241_0_intermittent preventive treatment for malaria in infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf']","['1241_1_intermittent preventive treatment for malaria in infants.pdf', '1241_0_intermittent preventive treatment for malaria in infants.pdf']","[0.557, 0.559]","[0.496, 0.499]","[0.589, 0.595]","[0.168, 0.169]","[0.173, 0.175]","[0.146, 0.146]","[0.741, 0.74]","[0.646, 0.647]","[0.558, 0.562]","[0.693, 0.693]","[0.771, 0.771]","[0.686, 0.696]","[0.584, 0.584]","[0.899, 0.9]","[0.781, 0.786]","[0.701, 0.702]","[0.766, 0.768]","[0.727, 0.73]",0.558,0.497,0.592,0.169,0.174,0.146,0.74,0.647,0.56,0.693,0.771,0.691,0.584,0.899,0.784,0.702,0.767,0.728
https://doi.org/10.1002/14651858.cd003756.pub3,chemoprophylaxis and intermittent treatment for preventing malaria in children,1242_chemoprophylaxis and intermittent treatment for preventing malaria in children.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532579/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686653/pdf']","['Intermittent preventive treatment for malaria in infants', 'Intermittent preventive treatment for malaria in children living in areas with seasonal transmission', 'Home‐ or community‐based programmes for treating malaria', 'Intermittent preventive treatment for malaria in infants', 'Oral iron supplements for children in malaria‐endemic areas', 'Mefloquine for preventing malaria during travel to endemic areas']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532579/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf']","['1242_5_mefloquine for preventing malaria during travel to endemic areas.pdf', '1242_4_oral iron supplements for children in malaria‐endemic areas.pdf', '1242_1_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf', '1242_2_home‐ or community‐based programmes for treating malaria.pdf', '1242_3_intermittent preventive treatment for malaria in infants.pdf', '1242_0_intermittent preventive treatment for malaria in infants.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532713/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532579/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf']","['1242_5_mefloquine for preventing malaria during travel to endemic areas.pdf', '1242_4_oral iron supplements for children in malaria‐endemic areas.pdf', '1242_1_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf', '1242_2_home‐ or community‐based programmes for treating malaria.pdf', '1242_3_intermittent preventive treatment for malaria in infants.pdf', '1242_0_intermittent preventive treatment for malaria in infants.pdf']","[0.73, 0.766, 0.56, 0.729, 0.636, 0.518]","[0.502, 0.505, 0.505, 0.502, 0.505, 0.507]","[0.589, 0.592, 0.591, 0.586, 0.588, 0.593]","[0.18, 0.173, 0.188, 0.178, 0.184, 0.184]","[0.168, 0.169, 0.179, 0.168, 0.175, 0.176]","[0.15, 0.139, 0.154, 0.138, 0.152, 0.152]","[0.743, 0.743, 0.745, 0.741, 0.744, 0.743]","[0.653, 0.65, 0.656, 0.648, 0.651, 0.651]","[0.568, 0.573, 0.572, 0.573, 0.568, 0.571]","[0.704, 0.7, 0.698, 0.693, 0.702, 0.702]","[0.771, 0.773, 0.774, 0.778, 0.771, 0.77]","[0.674, 0.676, 0.674, 0.683, 0.676, 0.684]","[0.585, 0.588, 0.592, 0.598, 0.589, 0.587]","[0.904, 0.906, 0.905, 0.902, 0.902, 0.903]","[0.782, 0.79, 0.788, 0.794, 0.786, 0.791]","[0.713, 0.721, 0.719, 0.724, 0.712, 0.712]","[0.768, 0.771, 0.769, 0.773, 0.766, 0.767]","[0.741, 0.747, 0.747, 0.748, 0.738, 0.74]",0.656,0.504,0.59,0.181,0.172,0.148,0.743,0.651,0.571,0.7,0.773,0.678,0.59,0.904,0.789,0.717,0.769,0.743
https://doi.org/10.1002/14651858.cd003756.pub4,intermittent preventive treatment for malaria in children living in areas with seasonal transmission,1243_intermittent preventive treatment for malaria in children living in areas with seasonal transmission.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468924/pdf']","['Larvivorous fish for preventing malaria transmission', 'Intermittent preventive treatment for malaria in infants', 'Intermittent preventive treatment for malaria in infants', 'Intermittent preventive antimalarial treatment for children with anaemia', 'Larvivorous fish for preventing malaria transmission']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468924/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf']","['1243_3_intermittent preventive antimalarial treatment for children with anaemia.pdf', '1243_1_intermittent preventive treatment for malaria in infants.pdf', '1243_0_larvivorous fish for preventing malaria transmission.pdf', '1243_4_larvivorous fish for preventing malaria transmission.pdf', '1243_2_intermittent preventive treatment for malaria in infants.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887842/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468924/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406727/pdf']","['1243_3_intermittent preventive antimalarial treatment for children with anaemia.pdf', '1243_1_intermittent preventive treatment for malaria in infants.pdf', '1243_0_larvivorous fish for preventing malaria transmission.pdf', '1243_4_larvivorous fish for preventing malaria transmission.pdf', '1243_2_intermittent preventive treatment for malaria in infants.pdf']","[0.336, 0.762, 0.759, 0.723, 0.339]","[0.512, 0.508, 0.51, 0.51, 0.511]","[0.595, 0.588, 0.597, 0.597, 0.594]","[0.185, 0.183, 0.152, 0.153, 0.183]","[0.18, 0.177, 0.138, 0.138, 0.178]","[0.147, 0.152, 0.113, 0.109, 0.153]","[0.741, 0.742, 0.731, 0.731, 0.741]","[0.649, 0.649, 0.64, 0.639, 0.649]","[0.572, 0.567, 0.582, 0.583, 0.57]","[0.7, 0.71, 0.674, 0.667, 0.71]","[0.78, 0.771, 0.781, 0.785, 0.771]","[0.683, 0.678, 0.695, 0.703, 0.686]","[0.593, 0.589, 0.588, 0.588, 0.588]","[0.906, 0.904, 0.912, 0.907, 0.904]","[0.787, 0.785, 0.803, 0.802, 0.79]","[0.726, 0.711, 0.725, 0.731, 0.712]","[0.772, 0.766, 0.781, 0.784, 0.767]","[0.75, 0.739, 0.756, 0.759, 0.741]",0.584,0.51,0.594,0.171,0.162,0.135,0.737,0.645,0.575,0.692,0.778,0.689,0.589,0.907,0.793,0.721,0.774,0.749
https://doi.org/10.1002/14651858.cd003759.pub3,homebased support for disadvantaged adult mothers,1245_homebased support for disadvantaged adult mothers.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research']","['Schedules for home visits in the early postpartum period', 'Schedules for home visits in the early postpartum period', 'Home safety education and provision of safety equipment for injury prevention', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf']","['1245_0_schedules for home visits in the early postpartum period.pdf', '1245_1_schedules for home visits in the early postpartum period.pdf', '1245_2_home safety education and provision of safety equipment for injury prevention.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf']","['1245_0_schedules for home visits in the early postpartum period.pdf', '1245_1_schedules for home visits in the early postpartum period.pdf', '1245_2_home safety education and provision of safety equipment for injury prevention.pdf']","[0.368, 0.293, 0.355]","[0.529, 0.527, 0.499]","[0.621, 0.62, 0.598]","[0.185, 0.184, 0.158]","[0.19, 0.189, 0.164]","[0.163, 0.162, 0.142]","[0.729, 0.73, 0.725]","[0.636, 0.636, 0.627]","[0.595, 0.592, 0.562]","[0.712, 0.71, 0.715]","[0.786, 0.785, 0.764]","[0.711, 0.708, 0.69]","[0.595, 0.591, 0.597]","[0.919, 0.917, 0.901]","[0.831, 0.826, 0.802]","[0.735, 0.736, 0.7]","[0.787, 0.787, 0.765]","[0.769, 0.768, 0.734]",0.339,0.518,0.613,0.176,0.181,0.156,0.728,0.633,0.583,0.712,0.778,0.703,0.594,0.912,0.82,0.724,0.78,0.757
https://doi.org/10.1002/14651858.cd003809.pub3,fluorides for the prevention of early tooth decay demineralised white lesions during fixed brace treatment,1246_fluorides for the prevention of early tooth decay demineralised white lesions during fixed brace treatment.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833909/pdf']","['Fluorides for preventing early tooth decay (demineralised lesions) during fixed brace treatment', 'Effectiveness of a clinical guideline to improve dental health among orthodontically treated patients: study protocol for a cluster randomized controlled trial']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833909/pdf']","['1246_0_fluorides for preventing early tooth decay demineralised lesions during fixed brace treatment.pdf', '1246_1_effectiveness of a clinical guideline to improve dental health among orthodontically treated patients study protocol for a cluster randomized controlled trial.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833909/pdf']","['1246_0_fluorides for preventing early tooth decay demineralised lesions during fixed brace treatment.pdf', '1246_1_effectiveness of a clinical guideline to improve dental health among orthodontically treated patients study protocol for a cluster randomized controlled trial.pdf']","[0.893, 0.437]","[0.546, 0.585]","[0.634, 0.663]","[0.208, 0.208]","[0.217, 0.228]","[0.184, 0.175]","[0.749, 0.746]","[0.656, 0.652]","[0.612, 0.657]","[0.708, 0.693]","[0.796, 0.822]","[0.722, 0.766]","[0.62, 0.643]","[0.916, 0.932]","[0.815, 0.832]","[0.745, 0.788]","[0.793, 0.824]","[0.773, 0.807]",0.665,0.566,0.649,0.208,0.223,0.179,0.748,0.654,0.635,0.7,0.809,0.744,0.631,0.924,0.823,0.766,0.808,0.79
https://doi.org/10.1002/14651858.cd003819.pub2,iodine supplementation for preventing iodine deficiency disorders in children,1247_iodine supplementation for preventing iodine deficiency disorders in children.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783742/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464647/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby', 'Iodine supplementation for women during the preconception, pregnancy and postpartum period', 'Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders', 'Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464647/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783742/pdf']","['1247_3_home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.pdf', '1247_2_iodine fortification of foods and condiments other than salt for preventing iodine deficiency disorders.pdf', '1247_4_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1247_1_iodine supplementation for women during the preconception pregnancy and postpartum period.pdf', '1247_0_supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464647/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783742/pdf']","['1247_3_home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.pdf', '1247_2_iodine fortification of foods and condiments other than salt for preventing iodine deficiency disorders.pdf', '1247_4_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1247_1_iodine supplementation for women during the preconception pregnancy and postpartum period.pdf', '1247_0_supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.pdf']","[0.396, 0.716, 0.715, 0.448, 0.13]","[0.513, 0.52, 0.567, 0.527, 0.535]","[0.596, 0.604, 0.64, 0.607, 0.623]","[0.169, 0.192, 0.178, 0.212, 0.176]","[0.163, 0.192, 0.153, 0.205, 0.182]","[0.128, 0.153, 0.116, 0.168, 0.138]","[0.736, 0.737, 0.731, 0.742, 0.732]","[0.642, 0.646, 0.636, 0.653, 0.636]","[0.574, 0.587, 0.634, 0.586, 0.608]","[0.695, 0.706, 0.648, 0.703, 0.681]","[0.774, 0.78, 0.813, 0.78, 0.79]","[0.666, 0.684, 0.744, 0.688, 0.704]","[0.605, 0.609, 0.636, 0.609, 0.612]","[0.906, 0.91, 0.921, 0.899, 0.916]","[0.807, 0.817, 0.834, 0.812, 0.822]","[0.729, 0.735, 0.781, 0.732, 0.75]","[0.771, 0.778, 0.813, 0.777, 0.791]","[0.756, 0.761, 0.794, 0.757, 0.775]",0.481,0.532,0.614,0.185,0.179,0.141,0.736,0.643,0.598,0.687,0.787,0.697,0.614,0.91,0.818,0.745,0.786,0.769
https://doi.org/10.1002/14651858.cd003849,epinephrine for the resuscitation of apparently stillborn or extremely bradycardic newborn infants,1248_epinephrine for the resuscitation of apparently stillborn or extremely bradycardic newborn infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1248_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1248_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1248_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1248_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']","[0.435, 0.202]","[0.528, 0.583]","[0.624, 0.664]","[0.179, 0.191]","[0.175, 0.176]","[0.138, 0.142]","[0.74, 0.74]","[0.646, 0.645]","[0.592, 0.649]","[0.685, 0.659]","[0.777, 0.818]","[0.708, 0.769]","[0.604, 0.645]","[0.905, 0.932]","[0.799, 0.844]","[0.715, 0.792]","[0.774, 0.822]","[0.741, 0.806]",0.319,0.555,0.644,0.185,0.175,0.14,0.74,0.645,0.621,0.672,0.797,0.738,0.625,0.919,0.822,0.754,0.798,0.774
https://doi.org/10.1002/14651858.cd003859.pub2,disclosing to parents newborn carrier status identified by routine blood spot screening,1249_disclosing to parents newborn carrier status identified by routine blood spot screening.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464902/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386923/pdf']","['Policy interventions implemented through sporting organisations for promoting healthy behaviour change', ""Interventions for improving patients' trust in doctors and groups of doctors""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386923/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464902/pdf']","['1249_1_interventions for improving patients trust in doctors and groups of doctors.pdf', '1249_0_policy interventions implemented through sporting organisations for promoting healthy behaviour change.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386923/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464902/pdf']","['1249_1_interventions for improving patients trust in doctors and groups of doctors.pdf', '1249_0_policy interventions implemented through sporting organisations for promoting healthy behaviour change.pdf']","[0.266, 0.222]","[0.556, 0.549]","[0.636, 0.641]","[0.181, 0.161]","[0.173, 0.154]","[0.144, 0.132]","[0.735, 0.733]","[0.636, 0.632]","[0.62, 0.614]","[0.682, 0.657]","[0.796, 0.798]","[0.735, 0.733]","[0.617, 0.624]","[0.922, 0.926]","[0.844, 0.846]","[0.755, 0.763]","[0.802, 0.801]","[0.778, 0.784]",0.244,0.552,0.639,0.171,0.163,0.138,0.734,0.634,0.617,0.669,0.797,0.734,0.621,0.924,0.845,0.759,0.802,0.781
https://doi.org/10.1002/14651858.cd003877.pub5,sedation of children undergoing dental treatment,1250_sedation of children undergoing dental treatment.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045283/pdf'],['Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045283/pdf'],['1250_0_interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045283/pdf'],['1250_0_interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment.pdf'],[0.662],[0.512],[0.599],[0.179],[0.165],[0.147],[0.74],[0.647],[0.576],[0.691],[0.771],[0.685],[0.603],[0.913],[0.814],[0.719],[0.771],[0.755],0.662,0.512,0.599,0.179,0.165,0.147,0.74,0.647,0.576,0.691,0.771,0.685,0.603,0.913,0.814,0.719,0.771,0.755
https://doi.org/10.1002/14651858.cd003928.pub2,cephalic version by moxibustion for breech presentation,1251_cephalic version by moxibustion for breech presentation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1251_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1251_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],[0.147],[0.56],[0.636],[0.192],[0.165],[0.144],[0.739],[0.639],[0.626],[0.662],[0.809],[0.752],[0.629],[0.912],[0.825],[0.768],[0.81],[0.783],0.147,0.56,0.636,0.192,0.165,0.144,0.739,0.639,0.626,0.662,0.809,0.752,0.629,0.912,0.825,0.768,0.81,0.783
https://doi.org/10.1002/14651858.cd003934.pub2,maternal positions and mobility during first stage labour,1252_maternal positions and mobility during first stage labour.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf']","['Pain management for women in labour: an overview of systematic reviews', ': the presence of a companion favors the use of best practices in delivery care in the South region of Brazil', 'Position in the second stage of labour for women with epidural anaesthesia', 'Parenteral opioids for maternal pain management in labour', 'Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464234/pdf']","['1252_3_parenteral opioids for maternal pain management in labour.pdf', '1252_1_ the presence of a companion favors the use of best practices in delivery care in the south region of brazil.pdf', '1252_0_pain management for women in labour an overview of systematic reviews.pdf', '1252_4_paracetamolacetaminophen single administration for perineal pain in the early postpartum period.pdf', '1252_2_position in the second stage of labour for women with epidural anaesthesia.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233118/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094229/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464234/pdf']","['1252_3_parenteral opioids for maternal pain management in labour.pdf', '1252_1_ the presence of a companion favors the use of best practices in delivery care in the south region of brazil.pdf', '1252_0_pain management for women in labour an overview of systematic reviews.pdf', '1252_4_paracetamolacetaminophen single administration for perineal pain in the early postpartum period.pdf', '1252_2_position in the second stage of labour for women with epidural anaesthesia.pdf']","[0.571, 0.261, 0.792, 0.477, 0.42]","[0.504, 0.496, 0.497, 0.503, 0.516]","[0.594, 0.578, 0.58, 0.598, 0.6]","[0.164, 0.157, 0.163, 0.153, 0.181]","[0.165, 0.158, 0.16, 0.158, 0.186]","[0.134, 0.131, 0.136, 0.122, 0.153]","[0.734, 0.734, 0.736, 0.733, 0.735]","[0.642, 0.637, 0.64, 0.639, 0.64]","[0.57, 0.56, 0.556, 0.574, 0.58]","[0.686, 0.671, 0.695, 0.678, 0.693]","[0.765, 0.767, 0.757, 0.775, 0.776]","[0.69, 0.656, 0.682, 0.687, 0.701]","[0.561, 0.581, 0.58, 0.588, 0.598]","[0.903, 0.906, 0.884, 0.91, 0.908]","[0.795, 0.806, 0.765, 0.807, 0.803]","[0.722, 0.719, 0.687, 0.726, 0.73]","[0.761, 0.764, 0.756, 0.773, 0.775]","[0.745, 0.743, 0.712, 0.752, 0.751]",0.504,0.503,0.59,0.164,0.165,0.135,0.734,0.64,0.568,0.685,0.768,0.683,0.582,0.902,0.795,0.717,0.766,0.741
https://doi.org/10.1002/14651858.cd003934.pub3,maternal positions and mobility during first stage labour,1253_maternal positions and mobility during first stage labour.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120324/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513033/pdf']","['Assessment and support during early labour for improving birth outcomes', 'Hypnosis for pain management during labour and childbirth', 'Parenteral opioids for maternal pain management in labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513033/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120324/pdf']","['1253_0_assessment and support during early labour for improving birth outcomes.pdf', '1253_2_parenteral opioids for maternal pain management in labour.pdf', '1253_1_hypnosis for pain management during labour and childbirth.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513033/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120324/pdf']","['1253_0_assessment and support during early labour for improving birth outcomes.pdf', '1253_2_parenteral opioids for maternal pain management in labour.pdf', '1253_1_hypnosis for pain management during labour and childbirth.pdf']","[0.606, 0.566, 0.597]","[0.514, 0.504, 0.509]","[0.595, 0.588, 0.593]","[0.193, 0.184, 0.189]","[0.18, 0.166, 0.165]","[0.157, 0.142, 0.146]","[0.742, 0.743, 0.745]","[0.648, 0.65, 0.65]","[0.569, 0.568, 0.565]","[0.7, 0.689, 0.705]","[0.77, 0.772, 0.771]","[0.678, 0.672, 0.67]","[0.581, 0.581, 0.585]","[0.894, 0.893, 0.894]","[0.787, 0.785, 0.781]","[0.705, 0.711, 0.71]","[0.763, 0.765, 0.763]","[0.735, 0.742, 0.74]",0.59,0.509,0.592,0.189,0.17,0.148,0.743,0.649,0.567,0.698,0.771,0.673,0.582,0.894,0.784,0.709,0.764,0.739
https://doi.org/10.1002/14651858.cd003935,repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease,1254_repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388653/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104525/pdf']","['Risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes', 'Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104525/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388653/pdf']","['1254_1_repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.pdf', '1254_0_risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104525/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388653/pdf']","['1254_1_repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.pdf', '1254_0_risk‐scoring systems for predicting preterm birth with the aim of reducing associated adverse outcomes.pdf']","[0.489, 0.623]","[0.518, 0.558]","[0.604, 0.649]","[0.203, 0.204]","[0.196, 0.21]","[0.179, 0.175]","[0.744, 0.742]","[0.654, 0.65]","[0.578, 0.621]","[0.694, 0.697]","[0.78, 0.8]","[0.68, 0.723]","[0.594, 0.62]","[0.909, 0.927]","[0.795, 0.831]","[0.714, 0.757]","[0.768, 0.796]","[0.742, 0.78]",0.556,0.538,0.627,0.204,0.203,0.177,0.743,0.652,0.599,0.696,0.79,0.702,0.607,0.918,0.813,0.736,0.782,0.761
https://doi.org/10.1002/14651858.cd003941.pub3,patient reminder and recall interventions to improve immunization rates,1255_patient reminder and recall interventions to improve immunization rates.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329401/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6']","['Improving vaccination uptake among adolescents', 'Nudge strategies to improve healthcare providers’ implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within Cochrane systematic reviews', ""Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis"", 'American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329401/pdf']","['1255_0_improving vaccination uptake among adolescents.pdf', '1255_3_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf', '1255_2_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf', '1255_1_nudge strategies to improve healthcare providers implementation of evidencebased guidelines policies and practices a systematic review of trials included within cochrane systematic reviews.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329401/pdf']","['1255_0_improving vaccination uptake among adolescents.pdf', '1255_3_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf', '1255_2_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf', '1255_1_nudge strategies to improve healthcare providers implementation of evidencebased guidelines policies and practices a systematic review of trials included within cochrane systematic reviews.pdf']","[0.62, 0.582, 0.448, 0.271]","[0.536, 0.517, 0.536, 0.526]","[0.619, 0.6, 0.625, 0.621]","[0.207, 0.14, 0.202, 0.183]","[0.213, 0.136, 0.21, 0.188]","[0.181, 0.107, 0.176, 0.149]","[0.747, 0.737, 0.744, 0.742]","[0.656, 0.639, 0.652, 0.652]","[0.592, 0.582, 0.597, 0.592]","[0.723, 0.652, 0.708, 0.707]","[0.775, 0.778, 0.781, 0.783]","[0.709, 0.706, 0.718, 0.718]","[0.6, 0.593, 0.605, 0.605]","[0.905, 0.907, 0.907, 0.909]","[0.81, 0.796, 0.82, 0.814]","[0.726, 0.738, 0.736, 0.739]","[0.779, 0.779, 0.786, 0.787]","[0.752, 0.758, 0.764, 0.764]",0.48,0.529,0.616,0.183,0.187,0.153,0.742,0.65,0.591,0.698,0.779,0.713,0.601,0.907,0.81,0.735,0.783,0.76
https://doi.org/10.1002/14651858.cd003953.pub3,antifungal therapy for newborn infants with invasive fungal infection,1256_antifungal therapy for newborn infants with invasive fungal infection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1256_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1256_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.472],[0.53],[0.623],[0.162],[0.164],[0.131],[0.744],[0.65],[0.596],[0.667],[0.779],[0.712],[0.597],[0.901],[0.784],[0.713],[0.775],[0.738],0.472,0.53,0.623,0.162,0.164,0.131,0.744,0.65,0.596,0.667,0.779,0.712,0.597,0.901,0.784,0.713,0.775,0.738
https://doi.org/10.1002/14651858.cd003955.pub2,naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks gestation with suspected perinatal asphyxia,1257_naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks gestation with suspected perinatal asphyxia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1257_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1257_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.428],[0.533],[0.629],[0.184],[0.193],[0.153],[0.743],[0.653],[0.595],[0.688],[0.781],[0.709],[0.607],[0.908],[0.799],[0.717],[0.778],[0.745],0.428,0.533,0.629,0.184,0.193,0.153,0.743,0.653,0.595,0.688,0.781,0.709,0.607,0.908,0.799,0.717,0.778,0.745
https://doi.org/10.1002/14651858.cd003968.pub3,psychological therapies for the management of chronic and recurrent pain in children and adolescents,1258_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257251/pdf'],['Psychological therapies for the management of chronic and recurrent pain in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257251/pdf'],['1258_0_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257251/pdf'],['1258_0_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf'],[0.921],[0.515],[0.6],[0.177],[0.182],[0.153],[0.744],[0.65],[0.569],[0.737],[0.754],[0.675],[0.584],[0.901],[0.787],[0.707],[0.755],[0.74],0.921,0.515,0.6,0.177,0.182,0.153,0.744,0.65,0.569,0.737,0.754,0.675,0.584,0.901,0.787,0.707,0.755,0.74
https://doi.org/10.1002/14651858.cd003968.pub5,psychological therapies for the management of chronic and recurrent pain in children and adolescents,1259_psychological therapies for the management of chronic and recurrent pain in children and adolescents.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437545/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf']","['Psychological therapies for the management of chronic pain (excluding headache) in adults', 'Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological interventions for parents of children and adolescents with chronic illness']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437545/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['1259_0_psychological therapies for the management of chronic pain excluding headache in adults.pdf', '1259_2_psychological interventions for parents of children and adolescents with chronic illness.pdf', '1259_1_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437545/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['1259_0_psychological therapies for the management of chronic pain excluding headache in adults.pdf', '1259_2_psychological interventions for parents of children and adolescents with chronic illness.pdf', '1259_1_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']","[0.882, 0.709, 0.773]","[0.515, 0.516, 0.51]","[0.598, 0.6, 0.596]","[0.176, 0.171, 0.168]","[0.178, 0.168, 0.168]","[0.157, 0.149, 0.147]","[0.743, 0.742, 0.744]","[0.651, 0.649, 0.649]","[0.568, 0.573, 0.567]","[0.741, 0.735, 0.737]","[0.755, 0.758, 0.755]","[0.671, 0.673, 0.661]","[0.586, 0.584, 0.585]","[0.907, 0.909, 0.905]","[0.789, 0.79, 0.792]","[0.698, 0.703, 0.701]","[0.751, 0.753, 0.754]","[0.737, 0.74, 0.739]",0.788,0.514,0.598,0.172,0.171,0.151,0.743,0.65,0.569,0.738,0.756,0.668,0.585,0.907,0.79,0.701,0.753,0.739
https://doi.org/10.1002/14651858.cd003988.pub2,combined hormonal versus nonhormonal versus progestinonly contraception in lactation,1260_combined hormonal versus nonhormonal versus progestinonly contraception in lactation.pdf,2,"['https://www1.nyc.gov/assets/doh/downloads/pdf/ms/breastfeeding-birth-control-postpartum-poster.pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/providers/health/women/texas-larc-toolkit.pdf']","['Birth Control', 'The Texas Long-Acting Reversible Contraception Toolkit']","['https://www.hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/providers/health/women/texas-larc-toolkit.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ms/breastfeeding-birth-control-postpartum-poster.pdf']","['1260_1_the texas longacting reversible contraception toolkit.pdf', '1260_0_birth control.pdf']",2,100.0,"['https://www.hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/providers/health/women/texas-larc-toolkit.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ms/breastfeeding-birth-control-postpartum-poster.pdf']","['1260_1_the texas longacting reversible contraception toolkit.pdf', '1260_0_birth control.pdf']","[0.287, 0.297]","[0.54, 0.541]","[0.62, 0.627]","[0.168, 0.189]","[0.179, 0.204]","[0.161, 0.175]","[0.73, 0.737]","[0.631, 0.642]","[0.603, 0.604]","[0.634, 0.648]","[0.798, 0.798]","[0.731, 0.73]","[0.617, 0.617]","[0.918, 0.924]","[0.818, 0.828]","[0.763, 0.762]","[0.801, 0.8]","[0.784, 0.788]",0.292,0.54,0.623,0.178,0.192,0.168,0.734,0.637,0.603,0.641,0.798,0.73,0.617,0.921,0.823,0.762,0.8,0.786
https://doi.org/10.1002/14651858.cd004068.pub3,postnatal parental education for optimizing infant general health and parentinfant relationships,1261_postnatal parental education for optimizing infant general health and parentinfant relationships.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828589/pdf'],['Community‐based maternal and newborn educational care packages for improving neonatal health and survival in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828589/pdf'],['1261_0_community‐based maternal and newborn educational care packages for improving neonatal health and survival in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828589/pdf'],['1261_0_community‐based maternal and newborn educational care packages for improving neonatal health and survival in low‐ and middle‐income countries.pdf'],[0.518],[0.518],[0.595],[0.172],[0.168],[0.153],[0.736],[0.644],[0.576],[0.714],[0.771],[0.673],[0.59],[0.901],[0.799],[0.712],[0.767],[0.745],0.518,0.518,0.595,0.172,0.168,0.153,0.736,0.644,0.576,0.714,0.771,0.673,0.59,0.901,0.799,0.712,0.767,0.745
https://doi.org/10.1002/14651858.cd004068.pub4,postnatal parental education for optimizing infant general health and parentinfant relationships,1262_postnatal parental education for optimizing infant general health and parentinfant relationships.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf'],['Parent training programmes for managing infantile colic'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf'],['1262_0_parent training programmes for managing infantile colic.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf'],['1262_0_parent training programmes for managing infantile colic.pdf'],[0.619],[0.536],[0.614],[0.178],[0.184],[0.153],[0.733],[0.64],[0.6],[0.704],[0.783],[0.709],[0.591],[0.913],[0.823],[0.739],[0.785],[0.767],0.619,0.536,0.614,0.178,0.184,0.153,0.733,0.64,0.6,0.704,0.783,0.709,0.591,0.913,0.823,0.739,0.785,0.767
https://doi.org/10.1002/14651858.cd004069.pub3,vitamin e supplementation in pregnancy,1263_vitamin e supplementation in pregnancy.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1263_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1263_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1263_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1263_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1263_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1263_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']","[0.451, 0.38, 0.462]","[0.502, 0.503, 0.501]","[0.594, 0.591, 0.581]","[0.16, 0.164, 0.172]","[0.159, 0.151, 0.161]","[0.139, 0.13, 0.148]","[0.735, 0.74, 0.742]","[0.639, 0.645, 0.65]","[0.579, 0.569, 0.562]","[0.696, 0.691, 0.707]","[0.774, 0.767, 0.757]","[0.671, 0.676, 0.674]","[0.588, 0.586, 0.587]","[0.911, 0.896, 0.883]","[0.79, 0.775, 0.759]","[0.715, 0.702, 0.685]","[0.767, 0.76, 0.752]","[0.752, 0.731, 0.711]",0.431,0.502,0.589,0.165,0.157,0.139,0.739,0.645,0.57,0.698,0.766,0.674,0.587,0.897,0.775,0.701,0.76,0.731
https://doi.org/10.1002/14651858.cd004072.pub3,vitamin c supplementation in pregnancy,1264_vitamin c supplementation in pregnancy.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513179/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092533/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Vitamin supplementation for preventing miscarriage', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews', 'Intermittent oral iron supplementation during pregnancy', 'Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092533/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513179/pdf']","['1264_4_intermittent oral iron supplementation during pregnancy.pdf', '1264_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1264_2_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1264_1_vitamin supplementation for preventing miscarriage.pdf', '1264_5_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1264_6_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1264_3_treatments for women with gestational diabetes mellitus an overview of cochrane systematic reviews.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092533/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104220/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513179/pdf']","['1264_4_intermittent oral iron supplementation during pregnancy.pdf', '1264_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1264_2_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1264_1_vitamin supplementation for preventing miscarriage.pdf', '1264_5_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1264_6_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1264_3_treatments for women with gestational diabetes mellitus an overview of cochrane systematic reviews.pdf']","[0.372, 0.84, 0.437, 0.382, 0.605, 0.386, 0.465]","[0.512, 0.499, 0.5, 0.515, 0.502, 0.5, 0.503]","[0.592, 0.592, 0.589, 0.595, 0.584, 0.579, 0.586]","[0.191, 0.16, 0.165, 0.19, 0.177, 0.175, 0.165]","[0.167, 0.154, 0.146, 0.176, 0.158, 0.158, 0.151]","[0.153, 0.136, 0.128, 0.157, 0.145, 0.148, 0.136]","[0.745, 0.734, 0.74, 0.743, 0.744, 0.743, 0.74]","[0.651, 0.64, 0.646, 0.649, 0.65, 0.651, 0.643]","[0.572, 0.576, 0.567, 0.575, 0.559, 0.561, 0.567]","[0.699, 0.696, 0.691, 0.699, 0.707, 0.707, 0.699]","[0.771, 0.774, 0.768, 0.77, 0.758, 0.759, 0.762]","[0.663, 0.667, 0.672, 0.67, 0.665, 0.671, 0.67]","[0.589, 0.585, 0.583, 0.586, 0.584, 0.584, 0.578]","[0.9, 0.911, 0.897, 0.901, 0.883, 0.883, 0.892]","[0.79, 0.789, 0.773, 0.792, 0.761, 0.758, 0.773]","[0.719, 0.713, 0.701, 0.721, 0.69, 0.686, 0.695]","[0.767, 0.766, 0.76, 0.768, 0.755, 0.753, 0.759]","[0.752, 0.752, 0.731, 0.751, 0.718, 0.712, 0.725]",0.498,0.504,0.588,0.175,0.159,0.143,0.741,0.647,0.568,0.7,0.766,0.668,0.584,0.895,0.777,0.704,0.761,0.734
https://doi.org/10.1002/14651858.cd004073.pub4,vitamin supplementation for preventing miscarriage,1265_vitamin supplementation for preventing miscarriage.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464743/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Medical treatments for incomplete miscarriage', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464743/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1265_0_medical treatments for incomplete miscarriage.pdf', '1265_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1265_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464743/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1265_0_medical treatments for incomplete miscarriage.pdf', '1265_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1265_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.52, 0.397, 0.527]","[0.525, 0.503, 0.518]","[0.612, 0.588, 0.612]","[0.182, 0.172, 0.167]","[0.179, 0.171, 0.176]","[0.157, 0.15, 0.148]","[0.742, 0.741, 0.735]","[0.649, 0.647, 0.639]","[0.587, 0.562, 0.594]","[0.665, 0.696, 0.689]","[0.775, 0.757, 0.78]","[0.683, 0.681, 0.686]","[0.588, 0.587, 0.593]","[0.904, 0.884, 0.913]","[0.802, 0.768, 0.809]","[0.726, 0.69, 0.73]","[0.773, 0.756, 0.779]","[0.753, 0.714, 0.765]",0.481,0.515,0.604,0.174,0.175,0.152,0.739,0.645,0.581,0.683,0.771,0.683,0.589,0.9,0.793,0.715,0.769,0.744
https://doi.org/10.1002/14651858.cd004089.pub2,perioperative buffered versus nonbuffered fluid administration for surgery in adults,1266_perioperative buffered versus nonbuffered fluid administration for surgery in adults.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839829/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483610/pdf']","['Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons', 'Perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483610/pdf'],['1266_1_perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483610/pdf'],['1266_1_perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.pdf'],[0.6],[0.508],[0.592],[0.176],[0.164],[0.139],[0.741],[0.649],[0.573],[0.709],[0.771],[0.68],[0.605],[0.902],[0.801],[0.72],[0.769],[0.749],0.6,0.508,0.592,0.176,0.164,0.139,0.741,0.649,0.573,0.709,0.771,0.68,0.605,0.902,0.801,0.72,0.769,0.749
https://doi.org/10.1002/14651858.cd004106.pub4,combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children,1267_combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015852/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949777/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053857/pdf']","['Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events', 'Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events', 'Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children', 'Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949777/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053857/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015852/pdf']","['1267_0_regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma serious adverse events.pdf', '1267_2_combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.pdf', '1267_3_combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.pdf', '1267_1_regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma serious adverse events.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949777/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053857/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015852/pdf']","['1267_0_regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma serious adverse events.pdf', '1267_2_combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.pdf', '1267_3_combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.pdf', '1267_1_regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma serious adverse events.pdf']","[0.705, 0.582, 0.712, 0.545]","[0.508, 0.514, 0.52, 0.514]","[0.598, 0.594, 0.605, 0.599]","[0.186, 0.189, 0.186, 0.189]","[0.189, 0.193, 0.201, 0.202]","[0.156, 0.161, 0.163, 0.159]","[0.746, 0.747, 0.743, 0.745]","[0.656, 0.656, 0.654, 0.654]","[0.581, 0.581, 0.59, 0.582]","[0.701, 0.703, 0.699, 0.701]","[0.772, 0.777, 0.78, 0.776]","[0.675, 0.679, 0.695, 0.687]","[0.583, 0.591, 0.583, 0.569]","[0.9, 0.9, 0.897, 0.899]","[0.791, 0.79, 0.79, 0.779]","[0.71, 0.721, 0.725, 0.72]","[0.762, 0.768, 0.771, 0.763]","[0.74, 0.747, 0.746, 0.742]",0.636,0.514,0.599,0.188,0.196,0.16,0.745,0.655,0.583,0.701,0.776,0.684,0.581,0.899,0.787,0.719,0.766,0.744
https://doi.org/10.1002/14651858.cd004170.pub3,multidisciplinary rehabilitation for acquired brain injury in adults of working age,1268_multidisciplinary rehabilitation for acquired brain injury in adults of working age.pdf,6,"['https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf', 'https://cdle.colorado.gov/sites/cdle/files/TBI_Evidence_Summary_and_Table.pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2A_Referenced.pdf', 'https://www.colorado.gov/pacific/sites/default/files/Rule_17_Exhibit_2B_Referenced.pdf', 'https://www.colorado.gov/pacific/sites/default/files/Rule_17_Exhibit_2A_Referenced.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095062/pdf']","['Rule 17, Exhibit 2b', 'Evidence Summary Traumatic Brain Injury Medical Treatment Guideline 2019 Revision', 'Rule 17, Exhibit 2a', 'RULE 17, EXHIBIT 2B', 'RULE 17, EXHIBIT 2A', 'Implementation interventions to promote the uptake of evidence‐based practices in stroke rehabilitation']","['https://cdle.colorado.gov/sites/cdle/files/TBI_Evidence_Summary_and_Table.pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2A_Referenced.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095062/pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf']","['1268_1_evidence summary traumatic brain injury medical treatment guideline 2019 revision.pdf', '1268_2_rule 17 exhibit 2a.pdf', '1268_5_implementation interventions to promote the uptake of evidence‐based practices in stroke rehabilitation.pdf', '1268_0_rule 17 exhibit 2b.pdf']",4,66.67,"['https://cdle.colorado.gov/sites/cdle/files/TBI_Evidence_Summary_and_Table.pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2A_Referenced.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095062/pdf', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf']","['1268_1_evidence summary traumatic brain injury medical treatment guideline 2019 revision.pdf', '1268_2_rule 17 exhibit 2a.pdf', '1268_5_implementation interventions to promote the uptake of evidence‐based practices in stroke rehabilitation.pdf', '1268_0_rule 17 exhibit 2b.pdf']","[0.447, 0.331, 0.423, 0.619]","[0.519, 0.569, 0.531, 0.572]","[0.623, 0.65, 0.619, 0.652]","[0.171, 0.183, 0.191, 0.186]","[0.185, 0.196, 0.189, 0.199]","[0.149, 0.16, 0.16, 0.161]","[0.74, 0.74, 0.736, 0.739]","[0.65, 0.644, 0.644, 0.643]","[0.584, 0.644, 0.592, 0.65]","[0.702, 0.676, 0.717, 0.671]","[0.789, 0.809, 0.779, 0.811]","[0.712, 0.758, 0.702, 0.763]","[0.602, 0.626, 0.598, 0.627]","[0.924, 0.935, 0.916, 0.935]","[0.822, 0.843, 0.828, 0.845]","[0.748, 0.782, 0.736, 0.786]","[0.782, 0.816, 0.781, 0.819]","[0.777, 0.8, 0.763, 0.803]",0.455,0.548,0.636,0.183,0.192,0.158,0.739,0.645,0.617,0.692,0.797,0.734,0.613,0.927,0.835,0.763,0.799,0.786
https://doi.org/10.1002/14651858.cd004212.pub2,opioids for neonates receiving mechanical ventilation,1269_opioids for neonates receiving mechanical ventilation.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388902/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf']","['Opioids for neonates receiving mechanical ventilation', 'Opioids for newborn infants receiving mechanical ventilation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388902/pdf']","['1269_1_opioids for newborn infants receiving mechanical ventilation.pdf', '1269_0_opioids for neonates receiving mechanical ventilation.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388902/pdf']","['1269_1_opioids for newborn infants receiving mechanical ventilation.pdf', '1269_0_opioids for neonates receiving mechanical ventilation.pdf']","[0.926, 0.759]","[0.521, 0.53]","[0.603, 0.608]","[0.19, 0.192]","[0.18, 0.181]","[0.152, 0.151]","[0.741, 0.741]","[0.65, 0.648]","[0.578, 0.587]","[0.701, 0.699]","[0.769, 0.772]","[0.686, 0.688]","[0.59, 0.598]","[0.903, 0.908]","[0.793, 0.796]","[0.713, 0.72]","[0.77, 0.775]","[0.74, 0.745]",0.843,0.526,0.605,0.191,0.18,0.151,0.741,0.649,0.583,0.7,0.77,0.687,0.594,0.905,0.794,0.716,0.772,0.742
https://doi.org/10.1002/14651858.cd004212.pub3,opioids for neonates receiving mechanical ventilation,1270_opioids for neonates receiving mechanical ventilation.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481534/pdf', 'https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf']","['Opioids for newborn infants receiving mechanical ventilation', 'Clonidine for sedation and analgesia for neonates receiving mechanical ventilation', 'Guidelines for Perinatal Care', 'Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care – short version', 'Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version']","['https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830566/pdf']","['1270_2_guidelines for perinatal care.pdf', '1270_1_clonidine for sedation and analgesia for neonates receiving mechanical ventilation.pdf', '1270_4_evidence and consensus based guideline for the management of delirium analgesia and sedation in intensive care medicine revision 2015 dasguideline 2015 – short version.pdf', '1270_0_opioids for newborn infants receiving mechanical ventilation.pdf', '1270_3_evidence and consensusbased german guidelines for the management of analgesia sedation and delirium in intensive care – short version.pdf']",5,100.0,"['https://countycare.com/wp-content/uploads/GuidelinesforPerinatalCare-7thed.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830566/pdf']","['1270_2_guidelines for perinatal care.pdf', '1270_1_clonidine for sedation and analgesia for neonates receiving mechanical ventilation.pdf', '1270_4_evidence and consensus based guideline for the management of delirium analgesia and sedation in intensive care medicine revision 2015 dasguideline 2015 – short version.pdf', '1270_0_opioids for newborn infants receiving mechanical ventilation.pdf', '1270_3_evidence and consensusbased german guidelines for the management of analgesia sedation and delirium in intensive care – short version.pdf']","[0.793, 0.627, 0.296, 0.203, 0.222]","[0.562, 0.552, 0.488, 0.535, 0.491]","[0.637, 0.631, 0.574, 0.616, 0.581]","[0.163, 0.191, 0.138, 0.198, 0.145]","[0.163, 0.202, 0.145, 0.19, 0.159]","[0.128, 0.155, 0.11, 0.156, 0.117]","[0.727, 0.736, 0.73, 0.738, 0.731]","[0.626, 0.644, 0.635, 0.646, 0.637]","[0.633, 0.613, 0.55, 0.588, 0.562]","[0.627, 0.692, 0.668, 0.697, 0.668]","[0.801, 0.786, 0.768, 0.773, 0.77]","[0.739, 0.717, 0.664, 0.7, 0.667]","[0.613, 0.607, 0.57, 0.595, 0.573]","[0.923, 0.918, 0.901, 0.907, 0.905]","[0.818, 0.819, 0.795, 0.806, 0.797]","[0.763, 0.743, 0.707, 0.723, 0.711]","[0.807, 0.792, 0.759, 0.778, 0.763]","[0.78, 0.764, 0.734, 0.747, 0.737]",0.428,0.526,0.608,0.167,0.172,0.133,0.732,0.638,0.589,0.67,0.78,0.697,0.592,0.911,0.807,0.729,0.78,0.752
https://doi.org/10.1002/14651858.cd004217.pub2,pain relief for neonatal circumcision,1271_pain relief for neonatal circumcision.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004245/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984663/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611486/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464546/pdf']","['Non‐pharmacological management of infant and young child procedural pain', 'Caudal epidural block versus other methods of postoperative pain relief for circumcision in boys', 'Paracetamol (acetaminophen) for prevention or treatment of pain in newborns', 'Paracetamol (acetaminophen) for prevention or treatment of pain in newborns', 'Topical anaesthesia for needle‐related pain in newborn infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004245/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611486/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984663/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464546/pdf']","['1271_1_caudal epidural block versus other methods of postoperative pain relief for circumcision in boys.pdf', '1271_3_paracetamol acetaminophen for prevention or treatment of pain in newborns.pdf', '1271_0_non‐pharmacological management of infant and young child procedural pain.pdf', '1271_2_paracetamol acetaminophen for prevention or treatment of pain in newborns.pdf', '1271_4_topical anaesthesia for needle‐related pain in newborn infants.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004245/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611486/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483553/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984663/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464546/pdf']","['1271_1_caudal epidural block versus other methods of postoperative pain relief for circumcision in boys.pdf', '1271_3_paracetamol acetaminophen for prevention or treatment of pain in newborns.pdf', '1271_0_non‐pharmacological management of infant and young child procedural pain.pdf', '1271_2_paracetamol acetaminophen for prevention or treatment of pain in newborns.pdf', '1271_4_topical anaesthesia for needle‐related pain in newborn infants.pdf']","[0.448, 0.515, 0.535, 0.549, 0.56]","[0.507, 0.507, 0.512, 0.506, 0.513]","[0.585, 0.597, 0.597, 0.596, 0.597]","[0.173, 0.182, 0.172, 0.175, 0.178]","[0.165, 0.167, 0.162, 0.163, 0.165]","[0.141, 0.144, 0.139, 0.14, 0.135]","[0.744, 0.745, 0.74, 0.744, 0.74]","[0.648, 0.65, 0.644, 0.648, 0.644]","[0.572, 0.569, 0.577, 0.569, 0.576]","[0.686, 0.686, 0.697, 0.688, 0.685]","[0.773, 0.773, 0.768, 0.768, 0.773]","[0.671, 0.682, 0.678, 0.68, 0.691]","[0.587, 0.588, 0.583, 0.585, 0.59]","[0.899, 0.888, 0.902, 0.891, 0.899]","[0.787, 0.792, 0.804, 0.795, 0.796]","[0.72, 0.724, 0.718, 0.717, 0.729]","[0.768, 0.767, 0.769, 0.764, 0.774]","[0.749, 0.748, 0.751, 0.746, 0.753]",0.521,0.509,0.594,0.176,0.164,0.14,0.743,0.647,0.573,0.688,0.771,0.68,0.587,0.896,0.795,0.722,0.768,0.749
https://doi.org/10.1002/14651858.cd004219.pub2,percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates,1272_percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250057/pdf'],['Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250057/pdf'],['1272_0_percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250057/pdf'],['1272_0_percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.pdf'],[0.864],[0.539],[0.627],[0.191],[0.198],[0.169],[0.743],[0.65],[0.603],[0.679],[0.776],[0.684],[0.611],[0.917],[0.816],[0.735],[0.775],[0.759],0.864,0.539,0.627,0.191,0.198,0.169,0.743,0.65,0.603,0.679,0.776,0.684,0.611,0.917,0.816,0.735,0.775,0.759
https://doi.org/10.1002/14651858.cd004228.pub2,psychological andor educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy,1273_psychological andor educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy.pdf,6,"['https://www.rand.org/pubs/research_reports/RR2178.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164828/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Gender Differences in Response to Alcohol Use Disorder Treatment', 'Alcohol intake reduction for controlling hypertension', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Routine pre-pregnancy health promotion for improving pregnancy outcomes', 'Targeted client communication via mobile devices for improving maternal, neonatal, and child health', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164828/pdf']","['1273_4_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '1273_1_alcohol intake reduction for controlling hypertension.pdf', '1273_5_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1273_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1273_3_routine prepregnancy health promotion for improving pregnancy outcomes.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164828/pdf']","['1273_4_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '1273_1_alcohol intake reduction for controlling hypertension.pdf', '1273_5_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1273_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1273_3_routine prepregnancy health promotion for improving pregnancy outcomes.pdf']","[0.644, 0.479, 0.599, 0.464, 0.494]","[0.541, 0.527, 0.499, 0.532, 0.554]","[0.627, 0.617, 0.588, 0.625, 0.639]","[0.172, 0.177, 0.159, 0.165, 0.19]","[0.174, 0.188, 0.159, 0.175, 0.206]","[0.145, 0.153, 0.136, 0.147, 0.172]","[0.734, 0.733, 0.733, 0.732, 0.734]","[0.64, 0.639, 0.639, 0.637, 0.641]","[0.598, 0.59, 0.556, 0.603, 0.617]","[0.689, 0.705, 0.69, 0.685, 0.699]","[0.785, 0.778, 0.76, 0.791, 0.791]","[0.716, 0.707, 0.691, 0.705, 0.74]","[0.596, 0.597, 0.588, 0.605, 0.594]","[0.917, 0.911, 0.888, 0.923, 0.915]","[0.823, 0.816, 0.773, 0.822, 0.83]","[0.74, 0.729, 0.689, 0.742, 0.755]","[0.79, 0.779, 0.76, 0.792, 0.798]","[0.765, 0.756, 0.715, 0.776, 0.773]",0.536,0.531,0.619,0.173,0.18,0.151,0.733,0.639,0.593,0.694,0.781,0.712,0.596,0.911,0.813,0.731,0.784,0.757
https://doi.org/10.1002/14651858.cd004265.pub3,hand washing promotion for preventing diarrhoea,1275_hand washing promotion for preventing diarrhoea.pdf,6,"['https://www.cgdev.org/publication/management-supervision-and-healthcare-field-experiment', 'https://www.nber.org/papers/w23749?sy=749', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094449/pdf', 'https://www.icrw.org/publications/impact-of-p-a-c-e-on-wash-behaviors-program-evaluation-in-madhya-pradesh/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192094/pdf']","['Management, Supervision, and Healthcare: A Field Experiment', 'Management, Supervision, and Health Care: A Field Experiment', 'Hand‐washing promotion for preventing diarrhoea', 'Impact of P.A.C.E. on WASH Behaviors: Program Evaluation in Madhya Pradesh', 'Rinse‐free hand wash for reducing absenteeism among preschool and school children', 'Hand cleaning with ash for reducing the spread of viral and bacterial infections: a rapid review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192094/pdf']","['1275_4_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf', '1275_2_hand‐washing promotion for preventing diarrhoea.pdf', '1275_5_hand cleaning with ash for reducing the spread of viral and bacterial infections a rapid review.pdf']",3,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192094/pdf']","['1275_4_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf', '1275_2_hand‐washing promotion for preventing diarrhoea.pdf', '1275_5_hand cleaning with ash for reducing the spread of viral and bacterial infections a rapid review.pdf']","[0.926, 0.68, 0.62]","[0.525, 0.52, 0.525]","[0.614, 0.61, 0.61]","[0.181, 0.184, 0.168]","[0.19, 0.2, 0.181]","[0.15, 0.16, 0.145]","[0.737, 0.742, 0.734]","[0.643, 0.65, 0.64]","[0.583, 0.577, 0.58]","[0.706, 0.721, 0.724]","[0.779, 0.775, 0.777]","[0.7, 0.696, 0.7]","[0.599, 0.596, 0.6]","[0.915, 0.912, 0.913]","[0.812, 0.809, 0.813]","[0.73, 0.723, 0.73]","[0.779, 0.775, 0.78]","[0.755, 0.748, 0.754]",0.742,0.523,0.611,0.178,0.19,0.152,0.738,0.644,0.58,0.717,0.777,0.699,0.598,0.913,0.811,0.728,0.778,0.752
https://doi.org/10.1002/14651858.cd004274.pub4,interactive health communication applications for people with chronic disease,1276_interactive health communication applications for people with chronic disease.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464831/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871105/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973635/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011343/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486319/pdf', 'https://aspe.hhs.gov/reports/consumer-use-computerized-applications-address-health-health-care-needs', 'https://aspe.hhs.gov/reports/consumer-use-computerized-applications-address-health-health-care-needs-0']","[""Interventions for enhancing consumers' online health literacy"", 'Adult patient access to electronic health records', 'Interventions for promoting information and communication technologies adoption in healthcare professionals', 'Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people', 'Consumers attitudes and beliefs towards the receipt of antenatal corticosteroids and use of clinical practice guidelines', 'Personalised care planning for adults with chronic or long‐term health conditions', 'Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews', 'Computer‐based diabetes self‐management interventions for adults with type 2 diabetes mellitus', 'Consumer Use of Computerized Applications to Address Health and Health Care Needs', 'Consumer Use of Computerized Applications to Address Health and Health Care Needs']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011343/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486319/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871105/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464831/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973635/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf']","['1276_4_consumers attitudes and beliefs towards the receipt of antenatal corticosteroids and use of clinical practice guidelines.pdf', '1276_3_interactive computerbased interventions for weight loss or weight maintenance in overweight or obese people.pdf', '1276_7_computer‐based diabetes self‐management interventions for adults with type 2 diabetes mellitus.pdf', '1276_1_adult patient access to electronic health records.pdf', '1276_0_interventions for enhancing consumers online health literacy.pdf', '1276_2_interventions for promoting information and communication technologies adoption in healthcare professionals.pdf', '1276_5_personalised care planning for adults with chronic or long‐term health conditions.pdf', '1276_6_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf']",8,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011343/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996838/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486319/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871105/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464831/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973635/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486144/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf']","['1276_4_consumers attitudes and beliefs towards the receipt of antenatal corticosteroids and use of clinical practice guidelines.pdf', '1276_3_interactive computerbased interventions for weight loss or weight maintenance in overweight or obese people.pdf', '1276_7_computer‐based diabetes self‐management interventions for adults with type 2 diabetes mellitus.pdf', '1276_1_adult patient access to electronic health records.pdf', '1276_0_interventions for enhancing consumers online health literacy.pdf', '1276_2_interventions for promoting information and communication technologies adoption in healthcare professionals.pdf', '1276_5_personalised care planning for adults with chronic or long‐term health conditions.pdf', '1276_6_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf']","[0.607, 0.65, 0.445, 0.417, 0.374, 0.622, 0.481, 0.661]","[0.556, 0.511, 0.52, 0.545, 0.532, 0.526, 0.549, 0.543]","[0.635, 0.605, 0.603, 0.629, 0.617, 0.623, 0.631, 0.636]","[0.164, 0.162, 0.169, 0.19, 0.173, 0.171, 0.195, 0.189]","[0.176, 0.17, 0.173, 0.195, 0.177, 0.181, 0.2, 0.187]","[0.141, 0.139, 0.142, 0.161, 0.15, 0.148, 0.164, 0.16]","[0.729, 0.731, 0.732, 0.735, 0.734, 0.732, 0.737, 0.734]","[0.634, 0.639, 0.639, 0.643, 0.641, 0.641, 0.647, 0.645]","[0.629, 0.574, 0.578, 0.611, 0.598, 0.6, 0.615, 0.619]","[0.684, 0.716, 0.709, 0.714, 0.716, 0.716, 0.718, 0.705]","[0.807, 0.769, 0.776, 0.792, 0.789, 0.787, 0.797, 0.801]","[0.752, 0.695, 0.692, 0.723, 0.722, 0.719, 0.733, 0.736]","[0.624, 0.587, 0.61, 0.617, 0.61, 0.6, 0.613, 0.626]","[0.917, 0.911, 0.915, 0.923, 0.914, 0.923, 0.918, 0.925]","[0.844, 0.805, 0.817, 0.836, 0.829, 0.822, 0.83, 0.839]","[0.771, 0.726, 0.733, 0.749, 0.746, 0.748, 0.756, 0.751]","[0.815, 0.766, 0.777, 0.796, 0.792, 0.787, 0.8, 0.797]","[0.795, 0.752, 0.759, 0.774, 0.77, 0.773, 0.778, 0.778]",0.532,0.535,0.622,0.177,0.182,0.151,0.733,0.641,0.603,0.71,0.79,0.722,0.611,0.918,0.828,0.748,0.791,0.772
https://doi.org/10.1002/14651858.cd004338.pub2,prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants,1277_prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815293/pdf'],['Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815293/pdf'],['1277_0_prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815293/pdf'],['1277_0_prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.pdf'],[0.925],[0.567],[0.648],[0.224],[0.231],[0.194],[0.745],[0.651],[0.624],[0.695],[0.797],[0.716],[0.617],[0.932],[0.846],[0.757],[0.795],[0.786],0.925,0.567,0.648,0.224,0.231,0.194,0.745,0.651,0.624,0.695,0.797,0.716,0.617,0.932,0.846,0.757,0.795,0.786
https://doi.org/10.1002/14651858.cd004338.pub3,prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants,1278_prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1278_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1278_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.471],[0.541],[0.627],[0.186],[0.186],[0.148],[0.742],[0.648],[0.6],[0.69],[0.781],[0.717],[0.602],[0.904],[0.807],[0.722],[0.78],[0.747],0.471,0.541,0.627,0.186,0.186,0.148,0.742,0.648,0.6,0.69,0.781,0.717,0.602,0.904,0.807,0.722,0.78,0.747
https://doi.org/10.1002/14651858.cd004360.pub4,noninvasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma,1279_noninvasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457810/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103936/pdf']","['Non‐invasive positive pressure ventilation for acute asthma in children', 'Brazilian recommendations of mechanical ventilation 2013. Part I']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457810/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103936/pdf']","['1279_0_non‐invasive positive pressure ventilation for acute asthma in children.pdf', '1279_1_brazilian recommendations of mechanical ventilation 2013 part i.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457810/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103936/pdf']","['1279_0_non‐invasive positive pressure ventilation for acute asthma in children.pdf', '1279_1_brazilian recommendations of mechanical ventilation 2013 part i.pdf']","[0.731, 0.38]","[0.531, 0.529]","[0.617, 0.606]","[0.19, 0.168]","[0.203, 0.18]","[0.163, 0.134]","[0.738, 0.741]","[0.644, 0.644]","[0.594, 0.592]","[0.712, 0.67]","[0.785, 0.79]","[0.712, 0.717]","[0.6, 0.608]","[0.911, 0.911]","[0.812, 0.81]","[0.735, 0.748]","[0.781, 0.789]","[0.762, 0.77]",0.555,0.53,0.611,0.179,0.192,0.149,0.74,0.644,0.593,0.691,0.788,0.714,0.604,0.911,0.811,0.742,0.785,0.766
https://doi.org/10.1002/14651858.cd004363.pub2,antidepressant prevention of postnatal depression,1280_antidepressant prevention of postnatal depression.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/research', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf']","['Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions', 'TennCare II Demonstration', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Antenatal psychosocial assessment for reducing perinatal mental health morbidity']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['1280_2_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1280_3_antenatal psychosocial assessment for reducing perinatal mental health morbidity.pdf', '1280_1_tenncare ii demonstration.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171384/pdf', 'https://www.tn.gov/content/dam/tn/tenncare/documents2/Amendment38.pdf']","['1280_2_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1280_3_antenatal psychosocial assessment for reducing perinatal mental health morbidity.pdf', '1280_1_tenncare ii demonstration.pdf']","[0.167, 0.198, 0.543]","[0.584, 0.525, 0.521]","[0.659, 0.626, 0.611]","[0.187, 0.187, 0.111]","[0.169, 0.213, 0.121]","[0.149, 0.173, 0.101]","[0.737, 0.736, 0.713]","[0.641, 0.644, 0.613]","[0.647, 0.592, 0.601]","[0.66, 0.703, 0.654]","[0.821, 0.784, 0.801]","[0.767, 0.706, 0.732]","[0.639, 0.588, 0.595]","[0.925, 0.916, 0.918]","[0.84, 0.813, 0.825]","[0.793, 0.744, 0.754]","[0.825, 0.782, 0.798]","[0.808, 0.771, 0.777]",0.303,0.543,0.632,0.162,0.168,0.141,0.729,0.633,0.613,0.672,0.802,0.735,0.607,0.92,0.826,0.764,0.802,0.785
https://doi.org/10.1002/14651858.cd004371.pub4,interventions to improve adherence to lipidlowering medication,1282_interventions to improve adherence to lipidlowering medication.pdf,2,"['https://www.jacc.org/doi/pdf/10.1016/j.jacc.2018.11.003?_gl=1*ewjwn3*_ga*Njk2NjM3OTIuMTY2Mjk3ODAwMw..*_ga_2V8VW4Y237*MTY2MzE3Mjg4NS4yLjAuMTY2MzE3Mjg4OC41Ny4wLjA.&_ga=2.252528333.578092439.1663172885-69663792.1662978003', 'https://cdn.ymaws.com/scct.org/resource/resmgr/docs/guidelines/2018_Guideline_on_the_Manage.pdf']","['2018 AHA/ACC/AACVPR/AAPA/ ABC/ACPM/ADA/AGS/APhA/ASPC/ NLA/PCNA Guideline on the Management of Blood Cholesterol', '2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol']",['https://cdn.ymaws.com/scct.org/resource/resmgr/docs/guidelines/2018_Guideline_on_the_Manage.pdf'],['1282_1_2018 ahaaccaacvpraapaabcacpmadaagsaphaaspcnlapcna guideline on the management of blood cholesterol.pdf'],1,50.0,['https://cdn.ymaws.com/scct.org/resource/resmgr/docs/guidelines/2018_Guideline_on_the_Manage.pdf'],['1282_1_2018 ahaaccaacvpraapaabcacpmadaagsaphaaspcnlapcna guideline on the management of blood cholesterol.pdf'],[0.4],[0.512],[0.596],[0.171],[0.177],[0.133],[0.735],[0.646],[0.569],[0.687],[0.766],[0.662],[0.603],[0.891],[0.791],[0.719],[0.771],[0.75],0.4,0.512,0.596,0.171,0.177,0.133,0.735,0.646,0.569,0.687,0.766,0.662,0.603,0.891,0.791,0.719,0.771,0.75
https://doi.org/10.1002/14651858.cd004372.pub2,psychological interventions for depression in adolescent and adult congenital heart disease,1283_psychological interventions for depression in adolescent and adult congenital heart disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf']","['E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions', 'Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['1283_1_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '1283_0_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513202/pdf']","['1283_1_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '1283_0_e‐health interventions for anxiety and depression in children and adolescents with long‐term physical conditions.pdf']","[0.409, 0.421]","[0.51, 0.514]","[0.599, 0.603]","[0.164, 0.164]","[0.159, 0.16]","[0.136, 0.135]","[0.74, 0.739]","[0.645, 0.644]","[0.572, 0.574]","[0.711, 0.708]","[0.767, 0.769]","[0.671, 0.681]","[0.582, 0.586]","[0.908, 0.905]","[0.813, 0.811]","[0.717, 0.72]","[0.764, 0.766]","[0.75, 0.749]",0.415,0.512,0.601,0.164,0.16,0.136,0.74,0.645,0.573,0.71,0.768,0.676,0.584,0.907,0.812,0.718,0.765,0.75
https://doi.org/10.1002/14651858.cd004380.pub3,schoolbased education programmes for the prevention of child sexual abuse,1284_schoolbased education programmes for the prevention of child sexual abuse.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],"['School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],['1284_0_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],['1284_0_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf'],[0.537],[0.524],[0.605],[0.175],[0.175],[0.156],[0.734],[0.639],[0.58],[0.715],[0.777],[0.696],[0.589],[0.909],[0.811],[0.727],[0.778],[0.756],0.537,0.524,0.605,0.175,0.175,0.156,0.734,0.639,0.58,0.715,0.777,0.696,0.589,0.909,0.811,0.727,0.778,0.756
https://doi.org/10.1002/14651858.cd004407.pub3,vaccines for measles mumps and rubella in children,1285_vaccines for measles mumps and rubella in children.pdf,4,"['https://www.nber.org/papers/w19807', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf']","['Special Interests and the Media: Theory and an Application to Climate Change', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Vaccines for measles, mumps, rubella, and varicella in children', 'Vaccines for measles, mumps, rubella, and varicella in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf']","['1285_3_vaccines for measles mumps rubella and varicella in children.pdf', '1285_2_vaccines for measles mumps rubella and varicella in children.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169657/pdf']","['1285_3_vaccines for measles mumps rubella and varicella in children.pdf', '1285_2_vaccines for measles mumps rubella and varicella in children.pdf']","[0.871, 0.87]","[0.522, 0.521]","[0.605, 0.605]","[0.201, 0.201]","[0.191, 0.191]","[0.167, 0.167]","[0.749, 0.749]","[0.66, 0.661]","[0.577, 0.577]","[0.697, 0.697]","[0.77, 0.77]","[0.7, 0.699]","[0.611, 0.611]","[0.886, 0.885]","[0.793, 0.792]","[0.696, 0.696]","[0.77, 0.77]","[0.722, 0.722]",0.871,0.522,0.605,0.201,0.191,0.167,0.749,0.661,0.577,0.697,0.77,0.7,0.611,0.885,0.792,0.696,0.77,0.722
https://doi.org/10.1002/14651858.cd004434.pub2,endothelin receptor antagonists for pulmonary arterial hypertension,1286_endothelin receptor antagonists for pulmonary arterial hypertension.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094512/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956416/pdf']","['Endothelin receptor antagonists for pulmonary arterial hypertension', 'Endothelin receptor antagonists for pulmonary arterial hypertension']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094512/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956416/pdf']","['1286_0_endothelin receptor antagonists for pulmonary arterial hypertension.pdf', '1286_1_endothelin receptor antagonists for pulmonary arterial hypertension.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094512/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956416/pdf']","['1286_0_endothelin receptor antagonists for pulmonary arterial hypertension.pdf', '1286_1_endothelin receptor antagonists for pulmonary arterial hypertension.pdf']","[0.737, 0.748]","[0.506, 0.507]","[0.589, 0.587]","[0.167, 0.166]","[0.163, 0.16]","[0.131, 0.128]","[0.741, 0.74]","[0.647, 0.645]","[0.58, 0.581]","[0.713, 0.702]","[0.771, 0.771]","[0.675, 0.675]","[0.585, 0.585]","[0.902, 0.903]","[0.792, 0.793]","[0.714, 0.719]","[0.768, 0.77]","[0.742, 0.743]",0.742,0.506,0.588,0.167,0.162,0.13,0.74,0.646,0.581,0.708,0.771,0.675,0.585,0.903,0.792,0.716,0.769,0.742
https://doi.org/10.1002/14651858.cd004434.pub3,endothelin receptor antagonists for pulmonary arterial hypertension,1287_endothelin receptor antagonists for pulmonary arterial hypertension.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094512/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956416/pdf']","['Endothelin receptor antagonists for pulmonary arterial hypertension', 'Endothelin receptor antagonists for pulmonary arterial hypertension']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956416/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094512/pdf']","['1287_1_endothelin receptor antagonists for pulmonary arterial hypertension.pdf', '1287_0_endothelin receptor antagonists for pulmonary arterial hypertension.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956416/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094512/pdf']","['1287_1_endothelin receptor antagonists for pulmonary arterial hypertension.pdf', '1287_0_endothelin receptor antagonists for pulmonary arterial hypertension.pdf']","[0.726, 0.811]","[0.522, 0.518]","[0.6, 0.599]","[0.177, 0.176]","[0.17, 0.172]","[0.131, 0.132]","[0.738, 0.739]","[0.643, 0.644]","[0.594, 0.589]","[0.695, 0.703]","[0.781, 0.779]","[0.701, 0.7]","[0.595, 0.592]","[0.908, 0.907]","[0.812, 0.809]","[0.733, 0.726]","[0.782, 0.778]","[0.756, 0.752]",0.768,0.52,0.599,0.176,0.171,0.132,0.738,0.643,0.591,0.699,0.78,0.7,0.593,0.907,0.81,0.73,0.78,0.754
https://doi.org/10.1002/14651858.cd004451.pub2,diuretics for preventing preeclampsia,1288_diuretics for preventing preeclampsia.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487386/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Epidural therapy for the treatment of severe pre‐eclampsia in non labouring women', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Guided imagery for treating hypertension in pregnancy', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Antihypertensive drug therapy for mild to moderate hypertension during pregnancy', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487386/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1288_2_guided imagery for treating hypertension in pregnancy.pdf', '1288_4_antihypertensive drug therapy for mild to moderate hypertension during pregnancy.pdf', '1288_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1288_3_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1288_0_epidural therapy for the treatment of severe pre‐eclampsia in non labouring women.pdf', '1288_5_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487386/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1288_2_guided imagery for treating hypertension in pregnancy.pdf', '1288_4_antihypertensive drug therapy for mild to moderate hypertension during pregnancy.pdf', '1288_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1288_3_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1288_0_epidural therapy for the treatment of severe pre‐eclampsia in non labouring women.pdf', '1288_5_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']","[0.636, 0.463, 0.624, 0.183, 0.509, 0.532]","[0.534, 0.5, 0.522, 0.571, 0.54, 0.496]","[0.622, 0.586, 0.615, 0.648, 0.63, 0.583]","[0.188, 0.165, 0.172, 0.202, 0.189, 0.169]","[0.194, 0.162, 0.185, 0.185, 0.196, 0.168]","[0.16, 0.134, 0.15, 0.155, 0.162, 0.142]","[0.733, 0.732, 0.73, 0.736, 0.733, 0.732]","[0.641, 0.64, 0.636, 0.642, 0.64, 0.64]","[0.608, 0.577, 0.601, 0.638, 0.615, 0.561]","[0.687, 0.687, 0.686, 0.665, 0.679, 0.688]","[0.787, 0.769, 0.785, 0.811, 0.79, 0.757]","[0.72, 0.676, 0.701, 0.759, 0.723, 0.692]","[0.599, 0.584, 0.599, 0.63, 0.605, 0.589]","[0.917, 0.906, 0.92, 0.92, 0.921, 0.888]","[0.821, 0.789, 0.812, 0.832, 0.821, 0.769]","[0.742, 0.711, 0.733, 0.778, 0.749, 0.683]","[0.791, 0.768, 0.786, 0.818, 0.794, 0.757]","[0.766, 0.737, 0.766, 0.792, 0.772, 0.707]",0.491,0.527,0.614,0.181,0.182,0.151,0.733,0.64,0.6,0.682,0.783,0.712,0.601,0.912,0.807,0.733,0.786,0.757
https://doi.org/10.1002/14651858.cd004483.pub2,dental fillings for the treatment of caries in the primary dentition,1289_dental fillings for the treatment of caries in the primary dentition.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387869/pdf'],['Preformed crowns for decayed primary molar teeth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387869/pdf'],['1289_0_preformed crowns for decayed primary molar teeth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387869/pdf'],['1289_0_preformed crowns for decayed primary molar teeth.pdf'],[0.703],[0.545],[0.62],[0.202],[0.211],[0.175],[0.744],[0.65],[0.604],[0.698],[0.785],[0.717],[0.612],[0.909],[0.811],[0.741],[0.787],[0.764],0.703,0.545,0.62,0.202,0.211,0.175,0.744,0.65,0.604,0.698,0.785,0.717,0.612,0.909,0.811,0.741,0.787,0.764
https://doi.org/10.1002/14651858.cd004493.pub3,familybased programmes for preventing smoking by children and adolescents,1290_familybased programmes for preventing smoking by children and adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf']","['Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1290_1_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf', '1290_0_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1290_1_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf', '1290_0_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.69, 0.799]","[0.528, 0.539]","[0.606, 0.614]","[0.19, 0.194]","[0.196, 0.186]","[0.165, 0.161]","[0.738, 0.736]","[0.645, 0.643]","[0.582, 0.597]","[0.714, 0.705]","[0.775, 0.786]","[0.698, 0.706]","[0.6, 0.595]","[0.911, 0.916]","[0.814, 0.818]","[0.724, 0.74]","[0.779, 0.79]","[0.754, 0.767]",0.744,0.534,0.61,0.192,0.191,0.163,0.737,0.644,0.589,0.71,0.78,0.702,0.597,0.913,0.816,0.732,0.784,0.76
https://doi.org/10.1002/14651858.cd004498.pub2,multiple versus single lumen umbilical venous catheters for newborn infants,1291_multiple versus single lumen umbilical venous catheters for newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464939/pdf'],['Antimicrobial dressings for the prevention of catheter‐related infections in newborn infants with central venous catheters'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464939/pdf'],['1291_0_antimicrobial dressings for the prevention of catheter‐related infections in newborn infants with central venous catheters.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464939/pdf'],['1291_0_antimicrobial dressings for the prevention of catheter‐related infections in newborn infants with central venous catheters.pdf'],[0.537],[0.523],[0.614],[0.177],[0.178],[0.144],[0.741],[0.648],[0.586],[0.674],[0.78],[0.705],[0.6],[0.908],[0.802],[0.731],[0.778],[0.758],0.537,0.523,0.614,0.177,0.178,0.144,0.741,0.648,0.586,0.674,0.78,0.705,0.6,0.908,0.802,0.731,0.778,0.758
https://doi.org/10.1002/14651858.cd004501.pub2,antibiotic regimens for suspected late onset sepsis in newborn infants,1292_antibiotic regimens for suspected late onset sepsis in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127057/pdf'],['Antibiotic regimens for late‐onset neonatal sepsis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127057/pdf'],['1292_0_antibiotic regimens for late‐onset neonatal sepsis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127057/pdf'],['1292_0_antibiotic regimens for late‐onset neonatal sepsis.pdf'],[0.64],[0.537],[0.622],[0.193],[0.206],[0.173],[0.739],[0.648],[0.602],[0.691],[0.784],[0.715],[0.597],[0.908],[0.812],[0.736],[0.783],[0.761],0.64,0.537,0.622,0.193,0.206,0.173,0.739,0.648,0.602,0.691,0.784,0.715,0.597,0.908,0.812,0.736,0.783,0.761
https://doi.org/10.1002/14651858.cd004503.pub2,long versus short inspiratory times in neonates receiving mechanical ventilation,1293_long versus short inspiratory times in neonates receiving mechanical ventilation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1293_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1293_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.36],[0.517],[0.6],[0.168],[0.159],[0.129],[0.739],[0.646],[0.583],[0.702],[0.769],[0.685],[0.596],[0.895],[0.786],[0.708],[0.769],[0.734],0.36,0.517,0.6,0.168,0.159,0.129,0.739,0.646,0.583,0.702,0.769,0.685,0.596,0.895,0.786,0.708,0.769,0.734
https://doi.org/10.1002/14651858.cd004534.pub3,educational and skillsbased interventions for preventing relationship and dating violence in adolescents and young adults,1294_educational and skillsbased interventions for preventing relationship and dating violence in adolescents and young adults.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390063/pdf', 'https://stacks.cdc.gov/view/cdc/31482']","['School‐based education programmes for the prevention of child sexual abuse', 'Psychological therapies for women who experience intimate partner violence', 'THRIVES : a global technical package to prevent violence against children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390063/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805791/pdf']","['1294_1_psychological therapies for women who experience intimate partner violence.pdf', '1294_0_school‐based education programmes for the prevention of child sexual abuse.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390063/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805791/pdf']","['1294_1_psychological therapies for women who experience intimate partner violence.pdf', '1294_0_school‐based education programmes for the prevention of child sexual abuse.pdf']","[0.611, 0.603]","[0.539, 0.539]","[0.62, 0.618]","[0.186, 0.186]","[0.181, 0.187]","[0.158, 0.165]","[0.733, 0.733]","[0.642, 0.641]","[0.596, 0.596]","[0.715, 0.718]","[0.784, 0.785]","[0.709, 0.707]","[0.595, 0.597]","[0.916, 0.913]","[0.829, 0.826]","[0.74, 0.74]","[0.788, 0.789]","[0.769, 0.768]",0.607,0.539,0.619,0.186,0.184,0.162,0.733,0.641,0.596,0.716,0.784,0.708,0.596,0.915,0.827,0.74,0.788,0.768
https://doi.org/10.1002/14651858.cd004592.pub2,single versus double volume exchange transfusion in jaundiced newborn infants,1295_single versus double volume exchange transfusion in jaundiced newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1295_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1295_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.234],[0.528],[0.616],[0.161],[0.157],[0.123],[0.739],[0.643],[0.594],[0.643],[0.778],[0.708],[0.601],[0.905],[0.792],[0.715],[0.778],[0.742],0.234,0.528,0.616,0.161,0.157,0.123,0.739,0.643,0.594,0.643,0.778,0.708,0.601,0.905,0.792,0.715,0.778,0.742
https://doi.org/10.1002/14651858.cd004595.pub2,screening programmes for developmental dysplasia of the hip in newborn infants,1296_screening programmes for developmental dysplasia of the hip in newborn infants.pdf,1,['https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/pddhcpg.pdf'],['Detection and Nonoperative Management of Pediatric Developmental Dysplasia of the Hip in Infants up to Six Months of Age'],['https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/pddhcpg.pdf'],['1296_0_detection and nonoperative management of pediatric developmental dysplasia of the hip in infants up to six months of age.pdf'],1,100.0,['https://www.aaos.org/globalassets/quality-and-practice-resources/pddh/pddhcpg.pdf'],['1296_0_detection and nonoperative management of pediatric developmental dysplasia of the hip in infants up to six months of age.pdf'],[0.624],[0.543],[0.624],[0.205],[0.218],[0.177],[0.749],[0.654],[0.595],[0.689],[0.785],[0.716],[0.614],[0.909],[0.8],[0.74],[0.787],[0.762],0.624,0.543,0.624,0.205,0.218,0.177,0.749,0.654,0.595,0.689,0.785,0.716,0.614,0.909,0.8,0.74,0.787,0.762
https://doi.org/10.1002/14651858.cd004606.pub2,schoolbased secondary prevention programmes for preventing violence,1297_schoolbased secondary prevention programmes for preventing violence.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473192/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805791/pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast', 'https://www.rti.org/publication/design-options-impact-evaluation-schoolwide-positive-behavior-supports']","['School‐based education programmes for the prevention of unintentional injuries in children and young people', 'Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people', 'School‐based education programmes for the prevention of child sexual abuse', 'Vol6_WebCover.indd', 'Design options for an impact evaluation of schoolwide positive behavior supports']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast']","['1297_2_school‐based education programmes for the prevention of child sexual abuse.pdf', '1297_1_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf', '1297_3_vol6webcoverindd.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast']","['1297_2_school‐based education programmes for the prevention of child sexual abuse.pdf', '1297_1_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf', '1297_3_vol6webcoverindd.pdf']","[0.645, 0.554, 0.336]","[0.505, 0.499, 0.477]","[0.592, 0.584, 0.573]","[0.168, 0.167, 0.131]","[0.171, 0.17, 0.14]","[0.154, 0.151, 0.124]","[0.735, 0.739, 0.731]","[0.642, 0.647, 0.634]","[0.562, 0.557, 0.542]","[0.727, 0.729, 0.699]","[0.768, 0.759, 0.76]","[0.672, 0.665, 0.663]","[0.589, 0.588, 0.578]","[0.904, 0.901, 0.904]","[0.8, 0.788, 0.776]","[0.715, 0.702, 0.712]","[0.766, 0.756, 0.756]","[0.748, 0.735, 0.743]",0.512,0.494,0.583,0.155,0.16,0.143,0.735,0.641,0.554,0.718,0.762,0.667,0.585,0.903,0.788,0.71,0.759,0.742
https://doi.org/10.1002/14651858.cd004609.pub3,hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury,1298_hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury.pdf,4,"['https://purl.fdlp.gov/GPO/gpo76920', 'https://www.gao.gov/products/GAO-16-154', 'https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf', 'https://www.colorado.gov/pacific/sites/default/files/Rule_17_Exhibit_2B_Referenced.pdf']","['Defense health care, research on hyperbaric oxygen therapy to treat traumatic brain injury and post-traumatic stress disorder : report to congressional committees.', 'Defense Health Care: Research on Hyperbaric Oxygen Therapy to Treat Traumatic Brain Injury and Post-Traumatic Stress Disorder', 'Rule 17, Exhibit 2b', 'RULE 17, EXHIBIT 2B']","['https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf', 'https://purl.fdlp.gov/GPO/gpo76920']","['1298_2_rule 17 exhibit 2b.pdf', '1298_0_defense health care research on hyperbaric oxygen therapy to treat traumatic brain injury and posttraumatic stress disorder  report to congressional committees.pdf']",2,50.0,"['https://cdle.colorado.gov/sites/cdle/files/Rule_17_Exhibit_2B_Referenced.pdf', 'https://purl.fdlp.gov/GPO/gpo76920']","['1298_2_rule 17 exhibit 2b.pdf', '1298_0_defense health care research on hyperbaric oxygen therapy to treat traumatic brain injury and posttraumatic stress disorder  report to congressional committees.pdf']","[0.551, 0.369]","[0.524, 0.51]","[0.61, 0.601]","[0.151, 0.17]","[0.157, 0.17]","[0.125, 0.147]","[0.736, 0.741]","[0.637, 0.649]","[0.589, 0.572]","[0.658, 0.699]","[0.781, 0.774]","[0.715, 0.683]","[0.606, 0.604]","[0.91, 0.901]","[0.811, 0.811]","[0.743, 0.73]","[0.784, 0.77]","[0.763, 0.756]",0.46,0.517,0.605,0.161,0.164,0.136,0.738,0.643,0.581,0.678,0.778,0.699,0.605,0.905,0.811,0.736,0.777,0.76
https://doi.org/10.1002/14651858.cd004621.pub2,extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children,1299_extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf'],"['Interventions for promoting the eruption of palatally displaced permanent canine teeth, without the need for surgical exposure, in children aged 9 to 14 years']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf'],['1299_0_interventions for promoting the eruption of palatally displaced permanent canine teeth without the need for surgical exposure in children aged 9 to 14 years.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf'],['1299_0_interventions for promoting the eruption of palatally displaced permanent canine teeth without the need for surgical exposure in children aged 9 to 14 years.pdf'],[0.728],[0.548],[0.629],[0.188],[0.194],[0.168],[0.739],[0.644],[0.61],[0.696],[0.794],[0.729],[0.624],[0.917],[0.829],[0.753],[0.794],[0.777],0.728,0.548,0.629,0.188,0.194,0.168,0.739,0.644,0.61,0.696,0.794,0.729,0.624,0.917,0.829,0.753,0.794,0.777
https://doi.org/10.1002/14651858.cd004621.pub3,extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children,1300_extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_oralsurgery.pdf']","['Interventions for promoting the eruption of palatally displaced permanent canine teeth, without the need for surgical exposure, in children aged 9 to 14 years', 'Management Considerations for Pediatric Oral Surgery and Oral Pathology']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_oralsurgery.pdf']","['1300_0_interventions for promoting the eruption of palatally displaced permanent canine teeth without the need for surgical exposure in children aged 9 to 14 years.pdf', '1300_1_management considerations for pediatric oral surgery and oral pathology.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_oralsurgery.pdf']","['1300_0_interventions for promoting the eruption of palatally displaced permanent canine teeth without the need for surgical exposure in children aged 9 to 14 years.pdf', '1300_1_management considerations for pediatric oral surgery and oral pathology.pdf']","[0.798, 0.298]","[0.546, 0.528]","[0.629, 0.613]","[0.195, 0.155]","[0.198, 0.165]","[0.169, 0.133]","[0.739, 0.735]","[0.646, 0.635]","[0.61, 0.602]","[0.696, 0.646]","[0.794, 0.795]","[0.725, 0.737]","[0.62, 0.612]","[0.916, 0.925]","[0.827, 0.813]","[0.751, 0.758]","[0.793, 0.798]","[0.775, 0.782]",0.548,0.537,0.621,0.175,0.181,0.151,0.737,0.641,0.606,0.671,0.794,0.731,0.616,0.921,0.82,0.754,0.796,0.778
https://doi.org/10.1002/14651858.cd004621.pub4,extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children,1301_extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494250/pdf'],['Extraction of primary (baby) teeth for unerupted palatally displaced permanent canine teeth in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494250/pdf'],['1301_0_extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494250/pdf'],['1301_0_extraction of primary baby teeth for unerupted palatally displaced permanent canine teeth in children.pdf'],[1.0],[0.492],[0.6],[0.183],[0.182],[0.206],[0.76],[0.673],[0.55],[0.716],[0.759],[0.621],[0.581],[0.92],[0.826],[0.688],[0.735],[0.744],1.0,0.492,0.6,0.183,0.182,0.206,0.76,0.673,0.55,0.716,0.759,0.621,0.581,0.92,0.826,0.688,0.735,0.744
https://doi.org/10.1002/14651858.cd004660.pub2,caesarean section for nonmedical reasons at term,1303_caesarean section for nonmedical reasons at term.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf'],['Techniques for caesarean section'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf'],['1303_0_techniques for caesarean section.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf'],['1303_0_techniques for caesarean section.pdf'],[0.502],[0.503],[0.595],[0.163],[0.168],[0.144],[0.738],[0.639],[0.569],[0.659],[0.771],[0.683],[0.588],[0.913],[0.799],[0.718],[0.768],[0.748],0.502,0.503,0.595,0.163,0.168,0.144,0.738,0.639,0.569,0.659,0.771,0.683,0.588,0.913,0.799,0.718,0.768,0.748
https://doi.org/10.1002/14651858.cd004660.pub3,caesarean section for nonmedical reasons at term,1304_caesarean section for nonmedical reasons at term.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110647/pdf']","['Planned caesarean section for women with a twin pregnancy', 'Planned caesarean section for women with a twin pregnancy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110647/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507501/pdf']","['1304_1_planned caesarean section for women with a twin pregnancy.pdf', '1304_0_planned caesarean section for women with a twin pregnancy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110647/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507501/pdf']","['1304_1_planned caesarean section for women with a twin pregnancy.pdf', '1304_0_planned caesarean section for women with a twin pregnancy.pdf']","[0.751, 0.619]","[0.527, 0.533]","[0.629, 0.626]","[0.186, 0.204]","[0.207, 0.218]","[0.171, 0.186]","[0.739, 0.744]","[0.643, 0.65]","[0.591, 0.589]","[0.678, 0.68]","[0.78, 0.781]","[0.709, 0.713]","[0.587, 0.597]","[0.924, 0.913]","[0.809, 0.809]","[0.741, 0.731]","[0.78, 0.778]","[0.767, 0.755]",0.685,0.53,0.627,0.195,0.212,0.178,0.742,0.647,0.59,0.679,0.78,0.711,0.592,0.919,0.809,0.736,0.779,0.761
https://doi.org/10.1002/14651858.cd004690.pub4,cognitive behavioural therapy for anxiety disorders in children and adolescents,1305_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513116/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457876/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf']","['Client feedback in psychological therapy for children and adolescents with mental health problems', 'Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults', 'Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises', 'Cognitive behavioural therapy for anxiety disorders in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513116/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457876/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf']","['1305_3_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf', '1305_0_client feedback in psychological therapy for children and adolescents with mental health problems.pdf', '1305_1_psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.pdf', '1305_2_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513116/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457876/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf']","['1305_3_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf', '1305_0_client feedback in psychological therapy for children and adolescents with mental health problems.pdf', '1305_1_psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.pdf', '1305_2_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf']","[0.53, 0.537, 0.595, 0.892]","[0.518, 0.526, 0.509, 0.499]","[0.604, 0.61, 0.596, 0.584]","[0.185, 0.184, 0.18, 0.163]","[0.184, 0.186, 0.178, 0.155]","[0.157, 0.157, 0.153, 0.134]","[0.743, 0.739, 0.742, 0.742]","[0.653, 0.645, 0.649, 0.648]","[0.574, 0.577, 0.565, 0.557]","[0.732, 0.728, 0.726, 0.736]","[0.77, 0.77, 0.767, 0.761]","[0.676, 0.689, 0.677, 0.651]","[0.579, 0.583, 0.578, 0.578]","[0.907, 0.907, 0.902, 0.905]","[0.802, 0.807, 0.79, 0.793]","[0.712, 0.72, 0.708, 0.708]","[0.767, 0.774, 0.766, 0.76]","[0.75, 0.752, 0.74, 0.744]",0.639,0.513,0.599,0.178,0.176,0.15,0.742,0.649,0.568,0.73,0.767,0.673,0.579,0.905,0.798,0.712,0.767,0.746
https://doi.org/10.1002/14651858.cd004691.pub2,exercise in prevention and treatment of anxiety and depression among children and young people,1306_exercise in prevention and treatment of anxiety and depression among children and young people.pdf,2,"['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761477/pdf']","['Vol6_WebCover.indd', 'Non‐pharmacological interventions for depression in adults and children with traumatic brain injury']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761477/pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast']","['1306_1_non‐pharmacological interventions for depression in adults and children with traumatic brain injury.pdf', '1306_0_vol6webcoverindd.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761477/pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast']","['1306_1_non‐pharmacological interventions for depression in adults and children with traumatic brain injury.pdf', '1306_0_vol6webcoverindd.pdf']","[0.267, 0.612]","[0.512, 0.484]","[0.598, 0.575]","[0.173, 0.125]","[0.175, 0.129]","[0.152, 0.113]","[0.736, 0.726]","[0.644, 0.628]","[0.57, 0.549]","[0.727, 0.692]","[0.764, 0.762]","[0.685, 0.675]","[0.591, 0.575]","[0.899, 0.903]","[0.802, 0.782]","[0.714, 0.714]","[0.763, 0.759]","[0.739, 0.74]",0.44,0.498,0.587,0.149,0.152,0.133,0.731,0.636,0.559,0.71,0.763,0.68,0.583,0.901,0.792,0.714,0.761,0.74
https://doi.org/10.1002/14651858.cd004694.pub3,tiagabine for acute affective episodes in bipolar disorder,1307_tiagabine for acute affective episodes in bipolar disorder.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457604/pdf', 'https://effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018', 'https://www.rti.org/publication/nonpharmacologic-interventions-treatment-resistant-depression-adults-comparative']","['Topiramate for acute affective episodes in bipolar disorder in adults', 'Treatment for Bipolar Disorder in Adults: A Systematic Review', 'Nonpharmacologic interventions for treatment-resistant depression in adults. Comparative Effectiveness Review Number 33. AHRQ Publication No. 11-EHC056-EF']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457604/pdf'],['1307_0_topiramate for acute affective episodes in bipolar disorder in adults.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457604/pdf'],['1307_0_topiramate for acute affective episodes in bipolar disorder in adults.pdf'],[0.673],[0.549],[0.631],[0.196],[0.213],[0.171],[0.74],[0.649],[0.615],[0.713],[0.796],[0.729],[0.608],[0.921],[0.823],[0.753],[0.794],[0.778],0.673,0.549,0.631,0.196,0.213,0.171,0.74,0.649,0.615,0.713,0.796,0.729,0.608,0.921,0.823,0.753,0.794,0.778
https://doi.org/10.1002/14651858.cd004696.pub5,nutrientenriched formula versus standard formula for preterm infants following hospital discharge,1308_nutrientenriched formula versus standard formula for preterm infants following hospital discharge.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","['Nutrient‐enriched formula versus standard formula for preterm infants', 'Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636703/pdf']","['1308_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1308_0_nutrient‐enriched formula versus standard formula for preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636703/pdf']","['1308_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1308_0_nutrient‐enriched formula versus standard formula for preterm infants.pdf']","[0.86, 0.452]","[0.515, 0.51]","[0.602, 0.588]","[0.168, 0.181]","[0.168, 0.175]","[0.138, 0.159]","[0.742, 0.743]","[0.65, 0.65]","[0.583, 0.577]","[0.708, 0.723]","[0.769, 0.765]","[0.685, 0.67]","[0.587, 0.58]","[0.899, 0.907]","[0.782, 0.793]","[0.703, 0.714]","[0.767, 0.765]","[0.731, 0.745]",0.656,0.512,0.595,0.174,0.171,0.149,0.742,0.65,0.58,0.716,0.767,0.677,0.583,0.903,0.788,0.708,0.766,0.738
https://doi.org/10.1002/14651858.cd004704.pub2,mass media interventions for smoking cessation in adults,1309_mass media interventions for smoking cessation in adults.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773732/pdf', 'https://stacks.cdc.gov/view/cdc/43466', 'https://www.rand.org/pubs/technical_reports/TR780.html']","['Mass media interventions for reducing mental health‐related stigma', 'Promoting quitting among adults and young people: outcome indicators for comprehensive tobacco control programs—2015', 'How the Department of Health Influences Healthy Living']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773732/pdf'],['1309_0_mass media interventions for reducing mental health‐related stigma.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773732/pdf'],['1309_0_mass media interventions for reducing mental health‐related stigma.pdf'],[0.512],[0.524],[0.61],[0.162],[0.161],[0.137],[0.728],[0.635],[0.589],[0.713],[0.779],[0.702],[0.607],[0.913],[0.825],[0.73],[0.785],[0.763],0.512,0.524,0.61,0.162,0.161,0.137,0.728,0.635,0.589,0.713,0.779,0.702,0.607,0.913,0.825,0.73,0.785,0.763
https://doi.org/10.1002/14651858.cd004704.pub3,mass media interventions for smoking cessation in adults,1310_mass media interventions for smoking cessation in adults.pdf,6,"['https://stacks.cdc.gov/view/cdc/76024', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464363/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481357/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/127860', 'http://www.ifpri.org/publication/operational-evidence-base-delivering-direct-nutrition-interventions-india-desk-review']","['Best practices user guide : health communications in tobacco prevention and control', 'Targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult, ethnic minorities', 'Psychosocial interventions for supporting women to stop smoking in pregnancy', 'Mass media interventions for preventing smoking in young people', 'The operational evidence base for delivering direct nutrition interventions in India: A desk review', 'The operational evidence base for delivering direct nutrition']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481357/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464363/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1310_3_mass media interventions for preventing smoking in young people.pdf', '1310_1_targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult ethnic minorities.pdf', '1310_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']",3,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481357/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464363/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472671/pdf']","['1310_3_mass media interventions for preventing smoking in young people.pdf', '1310_1_targeted mass media interventions promoting healthy behaviours to reduce risk of non‐communicable diseases in adult ethnic minorities.pdf', '1310_2_psychosocial interventions for supporting women to stop smoking in pregnancy.pdf']","[0.686, 0.639, 0.842]","[0.533, 0.532, 0.524]","[0.616, 0.62, 0.6]","[0.198, 0.182, 0.175]","[0.209, 0.19, 0.172]","[0.175, 0.158, 0.149]","[0.737, 0.73, 0.733]","[0.643, 0.638, 0.64]","[0.597, 0.6, 0.585]","[0.722, 0.72, 0.711]","[0.786, 0.788, 0.779]","[0.72, 0.724, 0.699]","[0.618, 0.614, 0.595]","[0.912, 0.915, 0.908]","[0.829, 0.829, 0.809]","[0.736, 0.733, 0.724]","[0.794, 0.795, 0.784]","[0.769, 0.766, 0.755]",0.722,0.53,0.612,0.185,0.19,0.161,0.733,0.64,0.594,0.718,0.784,0.714,0.609,0.912,0.822,0.731,0.791,0.763
https://doi.org/10.1002/14651858.cd004704.pub4,mass media interventions for smoking cessation in adults,1311_mass media interventions for smoking cessation in adults.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164549/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf']","['Interventions for increasing solid organ donor registration', 'Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164549/pdf']","['1311_1_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf', '1311_0_interventions for increasing solid organ donor registration.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164549/pdf']","['1311_1_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf', '1311_0_interventions for increasing solid organ donor registration.pdf']","[0.396, 0.567]","[0.527, 0.526]","[0.61, 0.606]","[0.166, 0.162]","[0.166, 0.161]","[0.144, 0.132]","[0.731, 0.73]","[0.637, 0.636]","[0.59, 0.586]","[0.715, 0.693]","[0.78, 0.775]","[0.707, 0.702]","[0.597, 0.598]","[0.912, 0.909]","[0.823, 0.816]","[0.726, 0.719]","[0.781, 0.781]","[0.76, 0.754]",0.481,0.526,0.608,0.164,0.164,0.138,0.73,0.637,0.588,0.704,0.778,0.704,0.597,0.911,0.819,0.722,0.781,0.757
https://doi.org/10.1002/14651858.cd004735.pub3,planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks gestation for improving pregnancy outcome,1312_planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks gestation for improving pregnancy outcome.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf'],['Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf'],['1312_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf'],['1312_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.392],[0.506],[0.592],[0.167],[0.157],[0.135],[0.739],[0.645],[0.57],[0.674],[0.765],[0.678],[0.589],[0.895],[0.772],[0.702],[0.76],[0.729],0.392,0.506,0.592,0.167,0.157,0.135,0.739,0.645,0.57,0.674,0.765,0.678,0.589,0.895,0.772,0.702,0.76,0.729
https://doi.org/10.1002/14651858.cd004735.pub4,planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks gestation for improving pregnancy outcome,1313_planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks gestation for improving pregnancy outcome.pdf,6,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://stacks.cdc.gov/view/cdc/84557', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf']","['Smoking cessation: a report of the Surgeon General.', 'Smoking cessation : a report of the Surgeon General', 'Smoking Cessation', 'Planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants', 'Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants']","['https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf']","['1313_4_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf', '1313_3_planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants.pdf', '1313_0_smoking cessation a report of the surgeon general.pdf', '1313_5_planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.pdf']",4,66.67,"['https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf']","['1313_4_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf', '1313_3_planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants.pdf', '1313_0_smoking cessation a report of the surgeon general.pdf', '1313_5_planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.pdf']","[0.139, 0.521, 0.139, 0.674]","[0.491, 0.505, 0.491, 0.51]","[0.581, 0.597, 0.581, 0.597]","[0.13, 0.176, 0.13, 0.186]","[0.117, 0.17, 0.117, 0.176]","[0.105, 0.149, 0.105, 0.157]","[0.73, 0.738, 0.73, 0.741]","[0.636, 0.641, 0.636, 0.646]","[0.556, 0.57, 0.556, 0.571]","[0.65, 0.679, 0.65, 0.68]","[0.772, 0.771, 0.772, 0.77]","[0.667, 0.677, 0.667, 0.677]","[0.571, 0.581, 0.571, 0.582]","[0.901, 0.903, 0.901, 0.899]","[0.777, 0.791, 0.777, 0.787]","[0.712, 0.713, 0.712, 0.71]","[0.758, 0.762, 0.758, 0.762]","[0.739, 0.744, 0.739, 0.739]",0.368,0.499,0.589,0.155,0.145,0.129,0.735,0.64,0.563,0.665,0.771,0.672,0.576,0.901,0.783,0.712,0.76,0.74
https://doi.org/10.1002/14651858.cd004790.pub2,hepatitis b immunisation for newborn infants of hepatitis b surface antigenpositive mothers,1314_hepatitis b immunisation for newborn infants of hepatitis b surface antigenpositive mothers.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589939/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154826/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B', 'Booster dose vaccination for preventing hepatitis B', 'Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589939/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154826/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1314_0_radix sophorae flavescentis versus other drugs or herbs for chronic hepatitis b.pdf', '1314_1_booster dose vaccination for preventing hepatitis b.pdf', '1314_2_hepatitis b immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis b virus.pdf', '1314_3_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589939/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154826/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1314_0_radix sophorae flavescentis versus other drugs or herbs for chronic hepatitis b.pdf', '1314_1_booster dose vaccination for preventing hepatitis b.pdf', '1314_2_hepatitis b immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis b virus.pdf', '1314_3_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']","[0.504, 0.58, 0.633, 0.109]","[0.507, 0.509, 0.515, 0.526]","[0.594, 0.597, 0.595, 0.609]","[0.166, 0.176, 0.178, 0.165]","[0.147, 0.17, 0.161, 0.125]","[0.137, 0.152, 0.146, 0.12]","[0.741, 0.743, 0.737, 0.737]","[0.648, 0.65, 0.645, 0.64]","[0.576, 0.573, 0.581, 0.581]","[0.697, 0.699, 0.705, 0.661]","[0.775, 0.772, 0.773, 0.795]","[0.664, 0.671, 0.665, 0.698]","[0.587, 0.587, 0.585, 0.61]","[0.908, 0.912, 0.911, 0.913]","[0.792, 0.797, 0.798, 0.808]","[0.719, 0.722, 0.717, 0.754]","[0.769, 0.767, 0.77, 0.792]","[0.751, 0.752, 0.75, 0.771]",0.457,0.514,0.599,0.171,0.151,0.139,0.74,0.646,0.578,0.691,0.779,0.674,0.592,0.911,0.799,0.728,0.774,0.756
https://doi.org/10.1002/14651858.cd004796.pub2,manipulative therapies for infantile colic,1316_manipulative therapies for infantile colic.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457752/pdf']","['Parent training programmes for managing infantile colic', 'Pain‐relieving agents for infantile colic']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457752/pdf']","['1316_0_parent training programmes for managing infantile colic.pdf', '1316_1_pain‐relieving agents for infantile colic.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457752/pdf']","['1316_0_parent training programmes for managing infantile colic.pdf', '1316_1_pain‐relieving agents for infantile colic.pdf']","[0.761, 0.775]","[0.517, 0.515]","[0.606, 0.601]","[0.162, 0.166]","[0.169, 0.167]","[0.139, 0.137]","[0.731, 0.732]","[0.637, 0.638]","[0.584, 0.58]","[0.704, 0.707]","[0.774, 0.775]","[0.696, 0.692]","[0.599, 0.596]","[0.912, 0.908]","[0.811, 0.81]","[0.731, 0.726]","[0.775, 0.775]","[0.76, 0.757]",0.768,0.516,0.603,0.164,0.168,0.138,0.732,0.637,0.582,0.706,0.774,0.694,0.597,0.91,0.81,0.728,0.775,0.758
https://doi.org/10.1002/14651858.cd004797.pub4,multisystemic therapy for social emotional and behavioral problems in youth aged 1017,1318_multisystemic therapy for social emotional and behavioral problems in youth aged 1017.pdf,6,"['https://www.nber.org/papers/w21206', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885060/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483473/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014676/pdf', 'https://bscc.ca.gov/wp-content/uploads/JOJJVol2_Iss1.pdf']","['Causal Effects of Mental Health Treatment on Education Outcomes for Youth in the Justice System', 'Cognitive‐behavioral treatment for antisocial behavior in youth in residential treatment', 'Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour', 'Atypical antipsychotics for disruptive behaviour disorders in children and youths', 'Alternatives to inpatient mental health care for children and young people', 'Journal of Juvenile Justice']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885060/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014676/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483473/pdf']","['1318_1_cognitive‐behavioral treatment for antisocial behavior in youth in residential treatment.pdf', '1318_2_cognitive‐behavioural therapy cbt interventions for young people aged 10 to 18 with harmful sexual behaviour.pdf', '1318_4_alternatives to inpatient mental health care for children and young people.pdf', '1318_3_atypical antipsychotics for disruptive behaviour disorders in children and youths.pdf']",4,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885060/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014676/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483473/pdf']","['1318_1_cognitive‐behavioral treatment for antisocial behavior in youth in residential treatment.pdf', '1318_2_cognitive‐behavioural therapy cbt interventions for young people aged 10 to 18 with harmful sexual behaviour.pdf', '1318_4_alternatives to inpatient mental health care for children and young people.pdf', '1318_3_atypical antipsychotics for disruptive behaviour disorders in children and youths.pdf']","[0.692, 0.521, 0.477, 0.512]","[0.523, 0.524, 0.487, 0.515]","[0.601, 0.602, 0.569, 0.599]","[0.173, 0.171, 0.15, 0.163]","[0.178, 0.175, 0.155, 0.166]","[0.145, 0.151, 0.135, 0.139]","[0.734, 0.735, 0.737, 0.733]","[0.64, 0.64, 0.642, 0.638]","[0.582, 0.583, 0.544, 0.583]","[0.723, 0.712, 0.727, 0.7]","[0.782, 0.779, 0.751, 0.781]","[0.692, 0.699, 0.676, 0.699]","[0.595, 0.587, 0.573, 0.589]","[0.912, 0.907, 0.89, 0.912]","[0.815, 0.818, 0.765, 0.813]","[0.735, 0.725, 0.69, 0.733]","[0.78, 0.778, 0.748, 0.781]","[0.765, 0.76, 0.721, 0.763]",0.55,0.512,0.593,0.164,0.169,0.143,0.735,0.64,0.573,0.716,0.773,0.692,0.586,0.905,0.803,0.721,0.772,0.752
https://doi.org/10.1002/14651858.cd004822.pub2,antibiotics for prolonged moist cough in children,1319_antibiotics for prolonged moist cough in children.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086475/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513288/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619877/pdf']","['Antibiotics for persistent cough or wheeze following acute bronchiolitis in children', 'Interventions for bronchiectasis: an overview of Cochrane systematic reviews', 'Antibiotics for prolonged wet cough in children', 'Prolonged cough in children: a summary of the Belgian primary care clinical guideline']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513288/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086475/pdf']","['1319_2_antibiotics for prolonged wet cough in children.pdf', '1319_3_prolonged cough in children a summary of the belgian primary care clinical guideline.pdf', '1319_0_antibiotics for persistent cough or wheeze following acute bronchiolitis in children.pdf', '1319_1_interventions for bronchiectasis an overview of cochrane systematic reviews.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513288/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086475/pdf']","['1319_2_antibiotics for prolonged wet cough in children.pdf', '1319_3_prolonged cough in children a summary of the belgian primary care clinical guideline.pdf', '1319_0_antibiotics for persistent cough or wheeze following acute bronchiolitis in children.pdf', '1319_1_interventions for bronchiectasis an overview of cochrane systematic reviews.pdf']","[0.711, 0.478, 0.906, 0.569]","[0.536, 0.535, 0.532, 0.526]","[0.609, 0.605, 0.609, 0.604]","[0.193, 0.173, 0.189, 0.181]","[0.2, 0.187, 0.193, 0.19]","[0.162, 0.143, 0.157, 0.147]","[0.738, 0.733, 0.739, 0.735]","[0.643, 0.636, 0.643, 0.641]","[0.595, 0.6, 0.592, 0.585]","[0.706, 0.683, 0.699, 0.703]","[0.781, 0.787, 0.778, 0.775]","[0.703, 0.725, 0.697, 0.699]","[0.612, 0.617, 0.606, 0.607]","[0.912, 0.916, 0.912, 0.906]","[0.814, 0.818, 0.812, 0.801]","[0.74, 0.752, 0.733, 0.721]","[0.783, 0.787, 0.778, 0.776]","[0.766, 0.771, 0.762, 0.746]",0.666,0.532,0.607,0.184,0.193,0.152,0.736,0.641,0.593,0.698,0.78,0.706,0.611,0.912,0.811,0.737,0.781,0.761
https://doi.org/10.1002/14651858.cd004827.pub4,probiotics for the prevention of pediatric antibioticassociated diarrhea,1320_probiotics for the prevention of pediatric antibioticassociated diarrhea.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091175/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486212/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490796/pdf']","['A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands', 'Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children', 'Probiotics for people with cystic fibrosis', 'Probiotics for the prevention of pediatric antibiotic‐associated diarrhea']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490796/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091175/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486212/pdf']","['1320_3_probiotics for the prevention of pediatric antibiotic‐associated diarrhea.pdf', '1320_2_probiotics for people with cystic fibrosis.pdf', '1320_0_a practical guide for probiotics applied to the case of antibioticassociated diarrhea in the netherlands.pdf', '1320_1_probiotics for the prevention of clostridium difficile‐associated diarrhea in adults and children.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490796/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091175/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486212/pdf']","['1320_3_probiotics for the prevention of pediatric antibiotic‐associated diarrhea.pdf', '1320_2_probiotics for people with cystic fibrosis.pdf', '1320_0_a practical guide for probiotics applied to the case of antibioticassociated diarrhea in the netherlands.pdf', '1320_1_probiotics for the prevention of clostridium difficile‐associated diarrhea in adults and children.pdf']","[0.554, 0.817, 0.606, 0.948]","[0.504, 0.507, 0.501, 0.5]","[0.587, 0.588, 0.596, 0.584]","[0.179, 0.164, 0.169, 0.179]","[0.168, 0.156, 0.172, 0.166]","[0.151, 0.134, 0.151, 0.149]","[0.748, 0.741, 0.746, 0.747]","[0.659, 0.646, 0.657, 0.659]","[0.566, 0.572, 0.566, 0.566]","[0.722, 0.722, 0.699, 0.726]","[0.767, 0.769, 0.776, 0.772]","[0.656, 0.671, 0.674, 0.663]","[0.593, 0.588, 0.595, 0.593]","[0.897, 0.901, 0.902, 0.896]","[0.774, 0.79, 0.782, 0.776]","[0.708, 0.711, 0.724, 0.715]","[0.757, 0.763, 0.766, 0.76]","[0.74, 0.741, 0.752, 0.746]",0.731,0.503,0.589,0.173,0.166,0.146,0.745,0.655,0.567,0.717,0.771,0.666,0.592,0.899,0.78,0.714,0.762,0.745
https://doi.org/10.1002/14651858.cd004851.pub3,newer generation antidepressants for depressive disorders in children and adolescents,1321_newer generation antidepressants for depressive disorders in children and adolescents.pdf,7,"['https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093893/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888928/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf']","['Psychotropic Medication Utilization Parameters for Children and Youth', 'New generation antidepressants for depression in children and adolescents: a network meta‐analysis', 'Tricyclic drugs for depression in children and adolescents', 'The Treatment of Depressive Disorders in Children and Adolescents', 'Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents', 'Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents', 'Interventions for self‐harm in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf', 'https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888928/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093893/pdf']","['1321_1_new generation antidepressants for depression in children and adolescents a network meta‐analysis.pdf', '1321_6_interventions for self‐harm in children and adolescents.pdf', '1321_4_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf', '1321_0_psychotropic medication utilization parameters for children and youth.pdf', '1321_5_psychological therapies versus antidepressant medication alone and in combination for depression in children and adolescents.pdf', '1321_3_the treatment of depressive disorders in children and adolescents.pdf', '1321_2_tricyclic drugs for depression in children and adolescents.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978530/pdf', 'https://hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888928/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093893/pdf']","['1321_1_new generation antidepressants for depression in children and adolescents a network meta‐analysis.pdf', '1321_6_interventions for self‐harm in children and adolescents.pdf', '1321_4_interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.pdf', '1321_0_psychotropic medication utilization parameters for children and youth.pdf', '1321_5_psychological therapies versus antidepressant medication alone and in combination for depression in children and adolescents.pdf', '1321_3_the treatment of depressive disorders in children and adolescents.pdf', '1321_2_tricyclic drugs for depression in children and adolescents.pdf']","[0.344, 0.852, 0.707, 0.468, 0.73, 0.668, 0.674]","[0.503, 0.507, 0.513, 0.508, 0.507, 0.508, 0.503]","[0.592, 0.594, 0.606, 0.604, 0.598, 0.605, 0.594]","[0.182, 0.176, 0.19, 0.178, 0.193, 0.194, 0.184]","[0.186, 0.176, 0.198, 0.189, 0.199, 0.207, 0.19]","[0.162, 0.153, 0.17, 0.156, 0.175, 0.17, 0.167]","[0.742, 0.739, 0.743, 0.741, 0.746, 0.742, 0.742]","[0.652, 0.647, 0.651, 0.648, 0.655, 0.65, 0.65]","[0.567, 0.569, 0.573, 0.576, 0.565, 0.575, 0.563]","[0.727, 0.72, 0.722, 0.682, 0.726, 0.705, 0.726]","[0.769, 0.775, 0.775, 0.786, 0.77, 0.789, 0.769]","[0.682, 0.685, 0.685, 0.695, 0.678, 0.702, 0.682]","[0.596, 0.593, 0.597, 0.593, 0.595, 0.587, 0.591]","[0.899, 0.906, 0.906, 0.912, 0.897, 0.906, 0.899]","[0.791, 0.795, 0.798, 0.799, 0.792, 0.806, 0.789]","[0.704, 0.715, 0.72, 0.732, 0.71, 0.725, 0.706]","[0.763, 0.77, 0.771, 0.781, 0.765, 0.777, 0.762]","[0.735, 0.748, 0.752, 0.762, 0.742, 0.752, 0.74]",0.635,0.507,0.599,0.185,0.192,0.165,0.742,0.65,0.57,0.715,0.776,0.687,0.593,0.904,0.796,0.716,0.77,0.747
https://doi.org/10.1002/14651858.cd004879.pub2,vaccines for preventing influenza in healthy children,1323_vaccines for preventing influenza in healthy children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf'],['Vaccines for preventing influenza in healthy children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf'],['1323_0_vaccines for preventing influenza in healthy children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf'],['1323_0_vaccines for preventing influenza in healthy children.pdf'],[0.844],[0.53],[0.601],[0.209],[0.203],[0.175],[0.748],[0.656],[0.591],[0.692],[0.778],[0.687],[0.615],[0.907],[0.814],[0.738],[0.784],[0.761],0.844,0.53,0.601,0.209,0.203,0.175,0.748,0.656,0.591,0.692,0.778,0.687,0.615,0.907,0.814,0.738,0.784,0.761
https://doi.org/10.1002/14651858.cd004879.pub3,vaccines for preventing influenza in healthy children,1324_vaccines for preventing influenza in healthy children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf']","['Physical interventions to interrupt or reduce the spread of respiratory viruses', 'Vaccines for preventing influenza in healthy children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993921/pdf']","['1324_1_vaccines for preventing influenza in healthy children.pdf', '1324_0_physical interventions to interrupt or reduce the spread of respiratory viruses.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993921/pdf']","['1324_1_vaccines for preventing influenza in healthy children.pdf', '1324_0_physical interventions to interrupt or reduce the spread of respiratory viruses.pdf']","[0.468, 0.873]","[0.547, 0.551]","[0.613, 0.625]","[0.217, 0.193]","[0.214, 0.185]","[0.181, 0.153]","[0.745, 0.737]","[0.653, 0.643]","[0.605, 0.618]","[0.686, 0.667]","[0.787, 0.794]","[0.708, 0.723]","[0.628, 0.629]","[0.908, 0.908]","[0.824, 0.829]","[0.75, 0.753]","[0.797, 0.804]","[0.77, 0.775]",0.67,0.549,0.619,0.205,0.2,0.167,0.741,0.648,0.611,0.677,0.79,0.716,0.629,0.908,0.827,0.752,0.8,0.772
https://doi.org/10.1002/14651858.cd004879.pub4,vaccines for preventing influenza in healthy children,1325_vaccines for preventing influenza in healthy children.pdf,10,"['https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481390/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491101/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093890/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749450/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504984/pdf']","['Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Vaccines for preventing influenza in healthy children', 'Vaccines for the common cold', 'Influenza vaccines for preventing acute otitis media in infants and children', 'Vaccines for preventing influenza in the elderly', 'Vaccines for preventing influenza in healthy adults', 'Amantadine and rimantadine for influenza A in children and the elderly', 'Vaccines for the common cold', 'Industry sponsorship and research outcome', 'Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093890/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749450/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481390/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504984/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491101/pdf']","['1325_5_vaccines for preventing influenza in healthy adults.pdf', '1325_1_vaccines for preventing influenza in healthy children.pdf', '1325_6_amantadine and rimantadine for influenza a in children and the elderly.pdf', '1325_8_industry sponsorship and research outcome.pdf', '1325_7_vaccines for the common cold.pdf', '1325_3_influenza vaccines for preventing acute otitis media in infants and children.pdf', '1325_2_vaccines for the common cold.pdf', '1325_9_influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions.pdf', '1325_4_vaccines for preventing influenza in the elderly.pdf']",9,90.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093890/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749450/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485791/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481390/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504984/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491101/pdf']","['1325_5_vaccines for preventing influenza in healthy adults.pdf', '1325_1_vaccines for preventing influenza in healthy children.pdf', '1325_6_amantadine and rimantadine for influenza a in children and the elderly.pdf', '1325_8_industry sponsorship and research outcome.pdf', '1325_7_vaccines for the common cold.pdf', '1325_3_influenza vaccines for preventing acute otitis media in infants and children.pdf', '1325_2_vaccines for the common cold.pdf', '1325_9_influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐term care institutions.pdf', '1325_4_vaccines for preventing influenza in the elderly.pdf']","[0.965, 0.589, 0.804, 0.791, 0.854, 0.535, 0.588, 0.479, 0.542]","[0.523, 0.527, 0.509, 0.512, 0.514, 0.53, 0.515, 0.525, 0.528]","[0.594, 0.597, 0.588, 0.59, 0.6, 0.602, 0.598, 0.599, 0.6]","[0.203, 0.207, 0.177, 0.154, 0.185, 0.2, 0.188, 0.2, 0.206]","[0.193, 0.199, 0.157, 0.138, 0.18, 0.194, 0.186, 0.191, 0.192]","[0.17, 0.175, 0.14, 0.125, 0.161, 0.17, 0.163, 0.168, 0.171]","[0.747, 0.748, 0.742, 0.735, 0.743, 0.745, 0.742, 0.744, 0.746]","[0.656, 0.658, 0.651, 0.64, 0.654, 0.655, 0.65, 0.654, 0.658]","[0.58, 0.582, 0.57, 0.575, 0.584, 0.586, 0.583, 0.583, 0.586]","[0.698, 0.702, 0.687, 0.698, 0.697, 0.701, 0.697, 0.701, 0.707]","[0.774, 0.775, 0.77, 0.765, 0.774, 0.776, 0.775, 0.775, 0.777]","[0.688, 0.687, 0.68, 0.678, 0.691, 0.694, 0.692, 0.694, 0.694]","[0.609, 0.614, 0.599, 0.592, 0.588, 0.607, 0.596, 0.606, 0.601]","[0.901, 0.9, 0.895, 0.899, 0.908, 0.902, 0.908, 0.899, 0.905]","[0.806, 0.809, 0.797, 0.797, 0.812, 0.805, 0.808, 0.807, 0.813]","[0.728, 0.728, 0.719, 0.712, 0.728, 0.727, 0.726, 0.721, 0.729]","[0.776, 0.777, 0.768, 0.769, 0.773, 0.776, 0.774, 0.776, 0.778]","[0.753, 0.753, 0.745, 0.741, 0.755, 0.752, 0.755, 0.747, 0.756]",0.683,0.52,0.596,0.191,0.181,0.16,0.744,0.653,0.581,0.699,0.773,0.689,0.601,0.902,0.806,0.724,0.774,0.751
https://doi.org/10.1002/14651858.cd004879.pub5,vaccines for preventing influenza in healthy children,1326_vaccines for preventing influenza in healthy children.pdf,4,"['https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094623/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580359/pdf', 'https://health.mo.gov/living/wellness/immunizations/pdf/flu-presentation.pdf']","['Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Physical interventions to interrupt or reduce the spread of respiratory viruses', 'Probiotics for preventing acute otitis media in children', 'Microsoft PowerPoint - Flu Presentation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094623/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580359/pdf', 'https://health.mo.gov/living/wellness/immunizations/pdf/flu-presentation.pdf']","['1326_1_physical interventions to interrupt or reduce the spread of respiratory viruses.pdf', '1326_2_probiotics for preventing acute otitis media in children.pdf', '1326_3_microsoft powerpoint  flu presentation.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094623/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580359/pdf', 'https://health.mo.gov/living/wellness/immunizations/pdf/flu-presentation.pdf']","['1326_1_physical interventions to interrupt or reduce the spread of respiratory viruses.pdf', '1326_2_probiotics for preventing acute otitis media in children.pdf', '1326_3_microsoft powerpoint  flu presentation.pdf']","[0.534, 0.56, 0.286]","[0.524, 0.524, 0.499]","[0.599, 0.602, 0.568]","[0.173, 0.178, 0.149]","[0.161, 0.161, 0.148]","[0.139, 0.138, 0.144]","[0.737, 0.739, 0.732]","[0.645, 0.647, 0.639]","[0.586, 0.585, 0.565]","[0.683, 0.689, 0.695]","[0.776, 0.775, 0.753]","[0.696, 0.687, 0.679]","[0.61, 0.595, 0.597]","[0.904, 0.905, 0.882]","[0.811, 0.808, 0.81]","[0.73, 0.723, 0.724]","[0.78, 0.776, 0.765]","[0.755, 0.75, 0.737]",0.46,0.516,0.59,0.167,0.157,0.14,0.736,0.644,0.579,0.689,0.768,0.687,0.601,0.897,0.81,0.726,0.774,0.747
https://doi.org/10.1002/14651858.cd004903,pneumococcal vaccination during pregnancy for preventing infant infection,1327_pneumococcal vaccination during pregnancy for preventing infant infection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf'],['Pneumococcal vaccination during pregnancy for preventing infant infection'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf'],['1327_0_pneumococcal vaccination during pregnancy for preventing infant infection.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf'],['1327_0_pneumococcal vaccination during pregnancy for preventing infant infection.pdf'],[0.701],[0.516],[0.615],[0.18],[0.19],[0.161],[0.738],[0.642],[0.579],[0.703],[0.774],[0.702],[0.59],[0.912],[0.8],[0.711],[0.765],[0.739],0.701,0.516,0.615,0.18,0.19,0.161,0.738,0.642,0.579,0.703,0.774,0.702,0.59,0.912,0.8,0.711,0.765,0.739
https://doi.org/10.1002/14651858.cd004903.pub2,pneumococcal vaccination during pregnancy for preventing infant infection,1328_pneumococcal vaccination during pregnancy for preventing infant infection.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf']","['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Pneumococcal vaccination during pregnancy for preventing infant infection']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf']","['1328_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1328_1_pneumococcal vaccination during pregnancy for preventing infant infection.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf']","['1328_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1328_1_pneumococcal vaccination during pregnancy for preventing infant infection.pdf']","[0.179, 0.851]","[0.575, 0.525]","[0.653, 0.614]","[0.194, 0.197]","[0.173, 0.201]","[0.149, 0.173]","[0.739, 0.741]","[0.642, 0.645]","[0.634, 0.582]","[0.663, 0.702]","[0.811, 0.773]","[0.762, 0.697]","[0.64, 0.597]","[0.92, 0.905]","[0.824, 0.791]","[0.774, 0.713]","[0.813, 0.767]","[0.785, 0.735]",0.515,0.55,0.633,0.196,0.187,0.161,0.74,0.643,0.608,0.682,0.792,0.73,0.619,0.913,0.807,0.744,0.79,0.76
https://doi.org/10.1002/14651858.cd004903.pub3,pneumococcal vaccination during pregnancy for preventing infant infection,1329_pneumococcal vaccination during pregnancy for preventing infant infection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf'],['Pneumococcal vaccination during pregnancy for preventing infant infection'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf'],['1329_0_pneumococcal vaccination during pregnancy for preventing infant infection.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436174/pdf'],['1329_0_pneumococcal vaccination during pregnancy for preventing infant infection.pdf'],[0.955],[0.526],[0.615],[0.195],[0.197],[0.168],[0.742],[0.648],[0.583],[0.713],[0.772],[0.694],[0.592],[0.907],[0.791],[0.716],[0.768],[0.737],0.955,0.526,0.615,0.195,0.197,0.168,0.742,0.648,0.583,0.713,0.772,0.694,0.592,0.907,0.791,0.716,0.768,0.737
https://doi.org/10.1002/14651858.cd004905.pub5,multiplemicronutrient supplementation for women during pregnancy,1330_multiplemicronutrient supplementation for women during pregnancy.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418471/pdf', 'https://mathematica.org/publications/mcc-indonesia-nutrition-project-impact-evaluation-design', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf']","['Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low‐ and middle‐income countries (LMIC)', 'Multiple‐micronutrient supplementation for women during pregnancy', 'MCC Indonesia Nutrition Project Impact Evaluation Design', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes', 'Preconception lifestyle advice for people with infertility', 'Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418471/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1330_4_lipid‐based nutrient supplements for maternal birth and infant developmental outcomes.pdf', '1330_6_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1330_0_nutritional interventions for preventing stunting in children birth to 59 months living in urban slums in low‐ and middle‐income countries lmic.pdf', '1330_5_preconception lifestyle advice for people with infertility.pdf', '1330_1_multiple‐micronutrient supplementation for women during pregnancy.pdf', '1330_3_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418471/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1330_4_lipid‐based nutrient supplements for maternal birth and infant developmental outcomes.pdf', '1330_6_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1330_0_nutritional interventions for preventing stunting in children birth to 59 months living in urban slums in low‐ and middle‐income countries lmic.pdf', '1330_5_preconception lifestyle advice for people with infertility.pdf', '1330_1_multiple‐micronutrient supplementation for women during pregnancy.pdf', '1330_3_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.557, 0.956, 0.475, 0.682, 0.467, 0.605]","[0.505, 0.502, 0.523, 0.524, 0.515, 0.514]","[0.597, 0.59, 0.609, 0.612, 0.604, 0.61]","[0.179, 0.176, 0.175, 0.174, 0.185, 0.161]","[0.177, 0.175, 0.175, 0.169, 0.19, 0.17]","[0.15, 0.151, 0.144, 0.147, 0.163, 0.144]","[0.742, 0.741, 0.733, 0.739, 0.743, 0.733]","[0.647, 0.648, 0.637, 0.644, 0.649, 0.639]","[0.569, 0.558, 0.587, 0.587, 0.578, 0.589]","[0.708, 0.708, 0.702, 0.69, 0.707, 0.695]","[0.765, 0.758, 0.778, 0.775, 0.774, 0.781]","[0.669, 0.674, 0.694, 0.689, 0.679, 0.684]","[0.589, 0.596, 0.604, 0.594, 0.598, 0.6]","[0.897, 0.888, 0.914, 0.907, 0.911, 0.919]","[0.799, 0.771, 0.819, 0.809, 0.804, 0.807]","[0.718, 0.694, 0.734, 0.727, 0.729, 0.729]","[0.763, 0.758, 0.78, 0.777, 0.773, 0.777]","[0.747, 0.722, 0.763, 0.757, 0.758, 0.766]",0.624,0.514,0.604,0.175,0.176,0.15,0.739,0.644,0.578,0.702,0.772,0.682,0.597,0.906,0.802,0.722,0.771,0.752
https://doi.org/10.1002/14651858.cd004905.pub6,multiplemicronutrient supplementation for women during pregnancy,1331_multiplemicronutrient supplementation for women during pregnancy.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094617/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['Zinc supplementation for improving pregnancy and infant outcome', 'Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094617/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1331_1_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1331_0_zinc supplementation for improving pregnancy and infant outcome.pdf', '1331_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094617/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1331_1_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1331_0_zinc supplementation for improving pregnancy and infant outcome.pdf', '1331_2_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']","[0.727, 0.644, 0.583]","[0.504, 0.518, 0.5]","[0.59, 0.6, 0.584]","[0.174, 0.177, 0.166]","[0.176, 0.173, 0.165]","[0.152, 0.153, 0.145]","[0.741, 0.741, 0.738]","[0.648, 0.648, 0.646]","[0.562, 0.581, 0.562]","[0.712, 0.711, 0.707]","[0.757, 0.77, 0.757]","[0.67, 0.678, 0.676]","[0.594, 0.59, 0.592]","[0.89, 0.911, 0.889]","[0.772, 0.809, 0.768]","[0.691, 0.719, 0.685]","[0.759, 0.771, 0.756]","[0.721, 0.754, 0.714]",0.651,0.507,0.591,0.172,0.171,0.15,0.74,0.647,0.568,0.71,0.761,0.675,0.592,0.897,0.783,0.698,0.762,0.73
https://doi.org/10.1002/14651858.cd004909.pub2,fetal movement counting for assessment of fetal wellbeing,1332_fetal movement counting for assessment of fetal wellbeing.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464774/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf']","['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Fetal and umbilical Doppler ultrasound in normal pregnancy', 'Fetal movement counting for assessment of fetal wellbeing']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464774/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1332_2_fetal movement counting for assessment of fetal wellbeing.pdf', '1332_1_fetal and umbilical doppler ultrasound in normal pregnancy.pdf', '1332_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464774/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['1332_2_fetal movement counting for assessment of fetal wellbeing.pdf', '1332_1_fetal and umbilical doppler ultrasound in normal pregnancy.pdf', '1332_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf']","[0.129, 0.461, 0.911]","[0.529, 0.511, 0.549]","[0.605, 0.593, 0.626]","[0.199, 0.181, 0.175]","[0.207, 0.174, 0.155]","[0.173, 0.151, 0.134]","[0.742, 0.737, 0.737]","[0.645, 0.64, 0.636]","[0.588, 0.575, 0.614]","[0.721, 0.707, 0.662]","[0.774, 0.771, 0.801]","[0.707, 0.687, 0.746]","[0.597, 0.584, 0.627]","[0.902, 0.902, 0.914]","[0.81, 0.796, 0.829]","[0.72, 0.712, 0.765]","[0.776, 0.767, 0.805]","[0.747, 0.742, 0.78]",0.5,0.53,0.608,0.185,0.179,0.153,0.739,0.64,0.592,0.697,0.782,0.713,0.603,0.906,0.812,0.732,0.783,0.756
https://doi.org/10.1002/14651858.cd004909.pub3,fetal movement counting for assessment of fetal wellbeing,1333_fetal movement counting for assessment of fetal wellbeing.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464914/pdf']","['Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464914/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1333_1_cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing.pdf', '1333_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464914/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1333_1_cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing.pdf', '1333_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']","[0.401, 0.504]","[0.532, 0.503]","[0.612, 0.588]","[0.198, 0.173]","[0.197, 0.168]","[0.163, 0.146]","[0.74, 0.737]","[0.644, 0.643]","[0.593, 0.561]","[0.703, 0.713]","[0.776, 0.756]","[0.707, 0.695]","[0.597, 0.592]","[0.898, 0.881]","[0.807, 0.771]","[0.718, 0.684]","[0.776, 0.755]","[0.745, 0.708]",0.453,0.518,0.6,0.185,0.182,0.154,0.738,0.643,0.577,0.708,0.766,0.701,0.595,0.889,0.789,0.701,0.766,0.726
https://doi.org/10.1002/14651858.cd004916.pub3,interventions to slow progression of myopia in children,1334_interventions to slow progression of myopia in children.pdf,6,"['https://www.optometry.ca.gov/meetings/materials/20170608_3a3.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739548/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984636/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491194/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584039/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032141/pdf']","['Board of Optometry - Meeting Materials', 'Update in pediatric myopia treatment strategies', 'Interventions to slow progression of myopia in children', 'Vision screening for correctable visual acuity deficits in school‐age children and adolescents', 'The quality of systematic reviews about interventions for refractive error can be improved: a review of systematic reviews', 'Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia']","['https://www.optometry.ca.gov/meetings/materials/20170608_3a3.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032141/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491194/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984636/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584039/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739548/pdf']","['1334_0_board of optometry  meeting materials.pdf', '1334_5_laserassisted subepithelial keratectomy lasek versus photorefractive keratectomy prk for correction of myopia.pdf', '1334_3_vision screening for correctable visual acuity deficits in school‐age children and adolescents.pdf', '1334_2_interventions to slow progression of myopia in children.pdf', '1334_4_the quality of systematic reviews about interventions for refractive error can be improved a review of systematic reviews.pdf', '1334_1_update in pediatric myopia treatment strategies.pdf']",6,100.0,"['https://www.optometry.ca.gov/meetings/materials/20170608_3a3.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032141/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491194/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984636/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584039/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739548/pdf']","['1334_0_board of optometry  meeting materials.pdf', '1334_5_laserassisted subepithelial keratectomy lasek versus photorefractive keratectomy prk for correction of myopia.pdf', '1334_3_vision screening for correctable visual acuity deficits in school‐age children and adolescents.pdf', '1334_2_interventions to slow progression of myopia in children.pdf', '1334_4_the quality of systematic reviews about interventions for refractive error can be improved a review of systematic reviews.pdf', '1334_1_update in pediatric myopia treatment strategies.pdf']","[0.394, 0.625, 0.91, 0.614, 0.475, 0.603]","[0.506, 0.515, 0.521, 0.52, 0.524, 0.523]","[0.594, 0.605, 0.605, 0.608, 0.618, 0.616]","[0.173, 0.178, 0.176, 0.194, 0.195, 0.209]","[0.182, 0.176, 0.179, 0.194, 0.2, 0.224]","[0.161, 0.148, 0.15, 0.166, 0.164, 0.187]","[0.753, 0.746, 0.743, 0.751, 0.745, 0.753]","[0.661, 0.65, 0.648, 0.658, 0.651, 0.66]","[0.577, 0.583, 0.587, 0.588, 0.595, 0.59]","[0.693, 0.703, 0.703, 0.704, 0.703, 0.697]","[0.784, 0.776, 0.78, 0.784, 0.795, 0.799]","[0.703, 0.688, 0.702, 0.695, 0.715, 0.719]","[0.606, 0.604, 0.61, 0.614, 0.611, 0.632]","[0.906, 0.899, 0.906, 0.905, 0.914, 0.912]","[0.797, 0.789, 0.798, 0.797, 0.799, 0.797]","[0.736, 0.724, 0.729, 0.731, 0.746, 0.748]","[0.779, 0.773, 0.78, 0.782, 0.788, 0.793]","[0.764, 0.749, 0.755, 0.759, 0.771, 0.774]",0.604,0.518,0.608,0.188,0.192,0.163,0.748,0.655,0.587,0.7,0.786,0.704,0.613,0.907,0.796,0.736,0.783,0.762
https://doi.org/10.1002/14651858.cd004944.pub2,tocolysis for assisting delivery at caesarean section,1335_tocolysis for assisting delivery at caesarean section.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513259/pdf']","['Techniques for assisting difficult delivery at caesarean section', 'Acute tocolysis for uterine tachysystole or suspected fetal distress']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513259/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676064/pdf']","['1335_1_acute tocolysis for uterine tachysystole or suspected fetal distress.pdf', '1335_0_techniques for assisting difficult delivery at caesarean section.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513259/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676064/pdf']","['1335_1_acute tocolysis for uterine tachysystole or suspected fetal distress.pdf', '1335_0_techniques for assisting difficult delivery at caesarean section.pdf']","[0.699, 0.489]","[0.526, 0.533]","[0.613, 0.619]","[0.182, 0.191]","[0.192, 0.195]","[0.157, 0.166]","[0.738, 0.742]","[0.645, 0.649]","[0.591, 0.6]","[0.668, 0.673]","[0.781, 0.785]","[0.71, 0.714]","[0.595, 0.598]","[0.909, 0.918]","[0.813, 0.822]","[0.726, 0.737]","[0.776, 0.782]","[0.753, 0.764]",0.594,0.53,0.616,0.186,0.194,0.162,0.74,0.647,0.595,0.671,0.783,0.712,0.597,0.913,0.817,0.732,0.779,0.758
https://doi.org/10.1002/14651858.cd004944.pub3,techniques for assisting difficult delivery at caesarean section,1336_techniques for assisting difficult delivery at caesarean section.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf'],['Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf'],['1336_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf'],['1336_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.442],[0.519],[0.609],[0.173],[0.166],[0.142],[0.739],[0.644],[0.584],[0.677],[0.776],[0.706],[0.594],[0.901],[0.794],[0.713],[0.771],[0.74],0.442,0.519,0.609,0.173,0.166,0.142,0.739,0.644,0.584,0.677,0.776,0.706,0.594,0.901,0.794,0.713,0.771,0.74
https://doi.org/10.1002/14651858.cd004945.pub2,induction of labour for improving birth outcomes for women at or beyond term,1337_induction of labour for improving birth outcomes for women at or beyond term.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf']","[""Induction of labour at or beyond 37 weeks' gestation"", 'Induction of labour for improving birth outcomes for women at or beyond term']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf']","['1337_1_induction of labour for improving birth outcomes for women at or beyond term.pdf', '1337_0_induction of labour at or beyond 37 weeks gestation.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf']","['1337_1_induction of labour for improving birth outcomes for women at or beyond term.pdf', '1337_0_induction of labour at or beyond 37 weeks gestation.pdf']","[0.842, 0.86]","[0.537, 0.533]","[0.617, 0.618]","[0.204, 0.202]","[0.21, 0.207]","[0.175, 0.173]","[0.74, 0.739]","[0.649, 0.649]","[0.6, 0.598]","[0.682, 0.682]","[0.786, 0.783]","[0.703, 0.706]","[0.59, 0.588]","[0.918, 0.918]","[0.81, 0.81]","[0.734, 0.731]","[0.788, 0.784]","[0.761, 0.759]",0.851,0.535,0.617,0.203,0.208,0.174,0.74,0.649,0.599,0.682,0.784,0.704,0.589,0.918,0.81,0.732,0.786,0.76
https://doi.org/10.1002/14651858.cd004945.pub3,induction of labour for improving birth outcomes for women at or beyond term,1338_induction of labour for improving birth outcomes for women at or beyond term.pdf,10,"['https://www.hca.wa.gov/assets/program/toolkit_for_reducing_caeserean_sections.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464767/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464808/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241469/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138281/pdf']","['Improving Maternal& Neonatal Outcomes', ""Induction of labour at or beyond 37 weeks' gestation"", 'Ultrasound for fetal assessment in early pregnancy', 'Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)', 'Planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants', 'Pharmacological and mechanical interventions for labour induction in outpatient settings', 'Induction of labour for improving birth outcomes for women at or beyond term', 'Different methods for the induction of labour in outpatient settings', 'Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants', 'Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241469/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464808/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483740/pdf', 'https://www.hca.wa.gov/assets/program/toolkit_for_reducing_caeserean_sections.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464767/pdf']","['1338_7_different methods for the induction of labour in outpatient settings.pdf', '1338_9_vaginal prostaglandin pge2 and pgf2a for induction of labour at term.pdf', '1338_8_planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.pdf', '1338_1_induction of labour at or beyond 37 weeks gestation.pdf', '1338_4_planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants.pdf', '1338_6_induction of labour for improving birth outcomes for women at or beyond term.pdf', '1338_3_planned early birth versus expectant management waiting for prelabour rupture of membranes at term 37 weeks or more.pdf', '1338_5_pharmacological and mechanical interventions for labour induction in outpatient settings.pdf', '1338_0_improving maternal neonatal outcomes.pdf', '1338_2_ultrasound for fetal assessment in early pregnancy.pdf']",10,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241469/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491338/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494436/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464808/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483740/pdf', 'https://www.hca.wa.gov/assets/program/toolkit_for_reducing_caeserean_sections.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464767/pdf']","['1338_7_different methods for the induction of labour in outpatient settings.pdf', '1338_9_vaginal prostaglandin pge2 and pgf2a for induction of labour at term.pdf', '1338_8_planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.pdf', '1338_1_induction of labour at or beyond 37 weeks gestation.pdf', '1338_4_planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants.pdf', '1338_6_induction of labour for improving birth outcomes for women at or beyond term.pdf', '1338_3_planned early birth versus expectant management waiting for prelabour rupture of membranes at term 37 weeks or more.pdf', '1338_5_pharmacological and mechanical interventions for labour induction in outpatient settings.pdf', '1338_0_improving maternal neonatal outcomes.pdf', '1338_2_ultrasound for fetal assessment in early pregnancy.pdf']","[0.385, 0.92, 0.612, 0.71, 0.557, 0.761, 0.954, 0.601, 0.708, 0.679]","[0.513, 0.514, 0.516, 0.517, 0.512, 0.519, 0.519, 0.516, 0.508, 0.518]","[0.596, 0.586, 0.602, 0.598, 0.604, 0.596, 0.596, 0.594, 0.593, 0.591]","[0.172, 0.186, 0.181, 0.191, 0.173, 0.192, 0.198, 0.188, 0.168, 0.188]","[0.178, 0.166, 0.18, 0.184, 0.176, 0.188, 0.186, 0.178, 0.178, 0.178]","[0.151, 0.152, 0.154, 0.165, 0.147, 0.167, 0.164, 0.156, 0.149, 0.156]","[0.737, 0.746, 0.738, 0.744, 0.735, 0.744, 0.745, 0.744, 0.734, 0.741]","[0.645, 0.654, 0.644, 0.652, 0.638, 0.652, 0.653, 0.652, 0.641, 0.648]","[0.579, 0.575, 0.581, 0.582, 0.582, 0.583, 0.581, 0.579, 0.573, 0.578]","[0.685, 0.691, 0.681, 0.696, 0.68, 0.695, 0.686, 0.69, 0.673, 0.696]","[0.764, 0.765, 0.773, 0.771, 0.775, 0.773, 0.774, 0.769, 0.777, 0.772]","[0.681, 0.631, 0.678, 0.671, 0.679, 0.667, 0.665, 0.67, 0.681, 0.67]","[0.568, 0.581, 0.583, 0.579, 0.583, 0.581, 0.589, 0.584, 0.589, 0.586]","[0.911, 0.903, 0.912, 0.911, 0.916, 0.911, 0.91, 0.899, 0.909, 0.906]","[0.79, 0.786, 0.793, 0.792, 0.799, 0.792, 0.786, 0.787, 0.791, 0.789]","[0.721, 0.722, 0.722, 0.717, 0.727, 0.72, 0.721, 0.716, 0.732, 0.721]","[0.76, 0.761, 0.77, 0.768, 0.771, 0.771, 0.77, 0.768, 0.776, 0.77]","[0.745, 0.742, 0.748, 0.748, 0.754, 0.75, 0.749, 0.742, 0.754, 0.749]",0.689,0.515,0.596,0.184,0.179,0.156,0.741,0.648,0.579,0.687,0.771,0.669,0.582,0.909,0.79,0.722,0.769,0.748
https://doi.org/10.1002/14651858.cd004945.pub4,induction of labour for improving birth outcomes for women at or beyond term,1339_induction of labour for improving birth outcomes for women at or beyond term.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044809/pdf']","[""Induction of labour at or beyond 37 weeks' gestation"", ""Routine ultrasound for fetal assessment before 24 weeks' gestation"", 'Membrane sweeping for induction of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044809/pdf']","['1339_0_induction of labour at or beyond 37 weeks gestation.pdf', '1339_1_routine ultrasound for fetal assessment before 24 weeks gestation.pdf', '1339_2_membrane sweeping for induction of labour.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407184/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044809/pdf']","['1339_0_induction of labour at or beyond 37 weeks gestation.pdf', '1339_1_routine ultrasound for fetal assessment before 24 weeks gestation.pdf', '1339_2_membrane sweeping for induction of labour.pdf']","[0.927, 0.612, 0.706]","[0.52, 0.528, 0.519]","[0.603, 0.605, 0.596]","[0.201, 0.2, 0.189]","[0.191, 0.189, 0.18]","[0.172, 0.169, 0.156]","[0.745, 0.742, 0.742]","[0.654, 0.65, 0.649]","[0.581, 0.586, 0.581]","[0.694, 0.693, 0.688]","[0.772, 0.775, 0.771]","[0.68, 0.691, 0.682]","[0.579, 0.587, 0.582]","[0.907, 0.905, 0.907]","[0.797, 0.798, 0.796]","[0.715, 0.72, 0.717]","[0.769, 0.773, 0.769]","[0.747, 0.747, 0.745]",0.748,0.522,0.601,0.197,0.187,0.166,0.743,0.651,0.583,0.692,0.773,0.684,0.583,0.906,0.797,0.717,0.77,0.746
https://doi.org/10.1002/14651858.cd004971.pub2,different powered toothbrushes for plaque control and gingival health,1340_different powered toothbrushes for plaque control and gingival health.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133541/pdf', 'https://effectivehealthcare.ahrq.gov/products/mixed-treatment-comparisons/research']","['Powered versus manual toothbrushing for oral health', 'Use of Mixed Treatment Comparisons in Systematic Reviews']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133541/pdf'],['1340_0_powered versus manual toothbrushing for oral health.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133541/pdf'],['1340_0_powered versus manual toothbrushing for oral health.pdf'],[0.833],[0.515],[0.599],[0.167],[0.174],[0.153],[0.743],[0.651],[0.586],[0.729],[0.779],[0.692],[0.588],[0.917],[0.814],[0.73],[0.78],[0.761],0.833,0.515,0.599,0.167,0.174,0.153,0.743,0.651,0.586,0.729,0.779,0.692,0.588,0.917,0.814,0.73,0.78,0.761
https://doi.org/10.1002/14651858.cd005000.pub2,aripiprazole alone or in combination for acute mania,1341_aripiprazole alone or in combination for acute mania.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353063/pdf', 'https://effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018']","['Immunonutrition for acute respiratory distress syndrome (ARDS) in adults', 'Treatment for Bipolar Disorder in Adults: A Systematic Review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353063/pdf'],['1341_0_immunonutrition for acute respiratory distress syndrome ards in adults.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353063/pdf'],['1341_0_immunonutrition for acute respiratory distress syndrome ards in adults.pdf'],[0.43],[0.497],[0.586],[0.164],[0.143],[0.122],[0.738],[0.647],[0.571],[0.697],[0.765],[0.677],[0.581],[0.899],[0.771],[0.705],[0.758],[0.735],0.43,0.497,0.586,0.164,0.143,0.122,0.738,0.647,0.571,0.697,0.765,0.677,0.581,0.899,0.771,0.705,0.758,0.735
https://doi.org/10.1002/14651858.cd005014.pub3,home safety education and provision of safety equipment for injury prevention,1342_home safety education and provision of safety equipment for injury prevention.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438817/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf']","['First aid interventions by laypeople for acute oral poisoning', 'Parenting interventions for the prevention of unintentional injuries in childhood']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438817/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf']","['1342_0_first aid interventions by laypeople for acute oral poisoning.pdf', '1342_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438817/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf']","['1342_0_first aid interventions by laypeople for acute oral poisoning.pdf', '1342_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf']","[0.503, 0.762]","[0.507, 0.516]","[0.592, 0.597]","[0.164, 0.173]","[0.159, 0.174]","[0.138, 0.147]","[0.734, 0.734]","[0.64, 0.639]","[0.561, 0.571]","[0.703, 0.72]","[0.758, 0.764]","[0.689, 0.699]","[0.6, 0.585]","[0.887, 0.896]","[0.787, 0.791]","[0.693, 0.701]","[0.762, 0.769]","[0.722, 0.73]",0.633,0.512,0.595,0.168,0.166,0.143,0.734,0.639,0.566,0.712,0.761,0.694,0.593,0.891,0.789,0.697,0.766,0.726
https://doi.org/10.1002/14651858.cd005020.pub3,vision screening for amblyopia in childhood,1343_vision screening for amblyopia in childhood.pdf,3,"['https://effectivehealthcare.ahrq.gov/products/methods-decision-simulation-modeling/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819728/pdf']","['Decision and Simulation Modeling in Systematic Reviews', 'Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years', 'Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819728/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718221/pdf']","['1343_2_binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.pdf', '1343_1_binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819728/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718221/pdf']","['1343_2_binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.pdf', '1343_1_binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.pdf']","[0.559, 0.58]","[0.543, 0.537]","[0.632, 0.626]","[0.199, 0.19]","[0.214, 0.206]","[0.189, 0.183]","[0.748, 0.748]","[0.649, 0.65]","[0.613, 0.611]","[0.708, 0.702]","[0.796, 0.799]","[0.721, 0.729]","[0.623, 0.619]","[0.923, 0.924]","[0.817, 0.811]","[0.75, 0.756]","[0.79, 0.793]","[0.774, 0.778]",0.57,0.54,0.629,0.195,0.21,0.186,0.748,0.649,0.612,0.705,0.798,0.725,0.621,0.923,0.814,0.753,0.792,0.776
https://doi.org/10.1002/14651858.cd005030.pub2,interventions for prevention of drug use by young people delivered in nonschool settings,1344_interventions for prevention of drug use by young people delivered in nonschool settings.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://www.acf.hhs.gov/opre/report/conceptual-models-adulthood-preparation-subjects-within-personal-responsibility', 'https://mathematica.org/publications/conceptual-models-for-adulthood-preparation-subjects-within-the-prep', 'https://www.opensocietyfoundations.org/publications/prevention-drug-use-and-problematic-use', 'https://www.rand.org/pubs/technical_reports/TR795.html', 'https://www.opensocietyfoundations.org/publications/drug-production-and-trafficking-counterdrug-policies-and-security-and-governance-afghanistan']","['Family‐based prevention programmes for alcohol use in young people', 'Conceptual Models for Adulthood Preparation Subjects within the Personal Responsibility Education Program (PREP)', 'Conceptual Models for Adulthood Preparation Subjects within the Personal Responsibility Education Program (PREP)', 'Prevention of Drug Use and Problematic Use', 'Assessing the Evidence Base of the New UK Drugs Strategy', 'Drug Production and Trafficking, Counterdrug Policies, and Security and Governance in Afghanistan']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf'],['1344_0_family‐based prevention programmes for alcohol use in young people.pdf'],1,16.67,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf'],['1344_0_family‐based prevention programmes for alcohol use in young people.pdf'],[0.674],[0.523],[0.604],[0.184],[0.191],[0.166],[0.736],[0.645],[0.581],[0.722],[0.773],[0.693],[0.591],[0.907],[0.81],[0.718],[0.772],[0.746],0.674,0.523,0.604,0.184,0.191,0.166,0.736,0.645,0.581,0.722,0.773,0.693,0.591,0.907,0.81,0.718,0.772,0.746
https://doi.org/10.1002/14651858.cd005038.pub2,massage intervention for promoting mental and physical health in infants aged under six months,1345_massage intervention for promoting mental and physical health in infants aged under six months.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078453/pdf'],['Massage for promoting mental and physical health in typically developing infants under the age of six months'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078453/pdf'],['1345_0_massage for promoting mental and physical health in typically developing infants under the age of six months.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078453/pdf'],['1345_0_massage for promoting mental and physical health in typically developing infants under the age of six months.pdf'],[0.806],[0.511],[0.594],[0.177],[0.173],[0.148],[0.74],[0.646],[0.564],[0.724],[0.762],[0.68],[0.592],[0.891],[0.794],[0.7],[0.764],[0.728],0.806,0.511,0.594,0.177,0.173,0.148,0.74,0.646,0.564,0.724,0.762,0.68,0.592,0.891,0.794,0.7,0.764,0.728
https://doi.org/10.1002/14651858.cd005038.pub3,massage for promoting mental and physical health in typically developing infants under the age of six months,1346_massage for promoting mental and physical health in typically developing infants under the age of six months.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496070/pdf'],['Addressing child under nutrition: can traditional practices offer a solution?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496070/pdf'],['1346_0_addressing child under nutrition can traditional practices offer a solution.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496070/pdf'],['1346_0_addressing child under nutrition can traditional practices offer a solution.pdf'],[0.338],[0.494],[0.584],[0.145],[0.151],[0.116],[0.727],[0.629],[0.564],[0.687],[0.772],[0.696],[0.58],[0.889],[0.794],[0.699],[0.771],[0.726],0.338,0.494,0.584,0.145,0.151,0.116,0.727,0.629,0.564,0.687,0.772,0.696,0.58,0.889,0.794,0.699,0.771,0.726
https://doi.org/10.1002/14651858.cd005041.pub2,immediaterelease methylphenidate for attention deficit hyperactivity disorder adhd in adults,1347_immediaterelease methylphenidate for attention deficit hyperactivity disorder adhd in adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763351/pdf'],['Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763351/pdf'],['1347_0_methylphenidate for children and adolescents with attention deficit hyperactivity disorder adhd.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763351/pdf'],['1347_0_methylphenidate for children and adolescents with attention deficit hyperactivity disorder adhd.pdf'],[0.753],[0.512],[0.602],[0.185],[0.19],[0.163],[0.74],[0.644],[0.577],[0.724],[0.773],[0.683],[0.591],[0.908],[0.802],[0.719],[0.771],[0.748],0.753,0.512,0.602,0.185,0.19,0.163,0.74,0.644,0.577,0.724,0.773,0.683,0.591,0.908,0.802,0.719,0.771,0.748
https://doi.org/10.1002/14651858.cd005043.pub3,advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial wellbeing of women who experience intimate partner abuse,1348_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial wellbeing of women who experience intimate partner abuse.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.acf.hhs.gov/opre/report/impacts-family-outcomes-evidence-based-early-childhood-home-visiting-results-mother-and', 'https://www.acf.hhs.gov/opre/resource/impacts-family-outcomes-evidence-based-early-childhood-home-visiting-results-mother-infant-home-visiting-program-evaluation']","['A realist review of which advocacy interventions work for which abused women under what circumstances', 'Impacts on Family Outcomes of Evidence-Based Early Childhood Home Visiting: Results from the Mother and Infant Home Visiting Program Evaluation', 'Impacts on Family Outcomes of Evidence-Based Early Childhood Home Visiting: Results from the Mother and Infant Home Visiting Program Evaluation']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf'],['1348_0_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf'],['1348_0_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf'],[0.761],[0.532],[0.609],[0.178],[0.183],[0.159],[0.732],[0.639],[0.586],[0.709],[0.78],[0.703],[0.601],[0.905],[0.823],[0.73],[0.783],[0.76],0.761,0.532,0.609,0.178,0.183,0.159,0.732,0.639,0.586,0.709,0.78,0.703,0.601,0.905,0.823,0.73,0.783,0.76
https://doi.org/10.1002/14651858.cd005092.pub2,cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed,1349_cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464444/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464444/pdf']","['1349_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1349_0_cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464444/pdf']","['1349_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1349_0_cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed.pdf']","[0.955, 0.142]","[0.574, 0.543]","[0.648, 0.625]","[0.205, 0.235]","[0.187, 0.251]","[0.157, 0.216]","[0.739, 0.748]","[0.644, 0.66]","[0.639, 0.602]","[0.663, 0.71]","[0.81, 0.78]","[0.76, 0.714]","[0.638, 0.611]","[0.92, 0.906]","[0.836, 0.816]","[0.785, 0.737]","[0.818, 0.783]","[0.8, 0.761]",0.548,0.558,0.637,0.22,0.219,0.186,0.744,0.652,0.621,0.686,0.795,0.737,0.625,0.913,0.826,0.761,0.8,0.78
https://doi.org/10.1002/14651858.cd005092.pub3,cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed,1350_cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully breastfeed.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf']","['Avoidance of bottles during the establishment of breastfeeds in preterm infants', 'ABM Clinical Protocol #3: Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2017']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf']","['1350_0_avoidance of bottles during the establishment of breastfeeds in preterm infants.pdf', '1350_1_abm clinical protocol 3 supplementary feedings in the healthy term breastfed neonate revised 2017.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf']","['1350_0_avoidance of bottles during the establishment of breastfeeds in preterm infants.pdf', '1350_1_abm clinical protocol 3 supplementary feedings in the healthy term breastfed neonate revised 2017.pdf']","[0.808, 0.465]","[0.532, 0.558]","[0.615, 0.633]","[0.21, 0.214]","[0.214, 0.236]","[0.183, 0.187]","[0.743, 0.744]","[0.653, 0.654]","[0.591, 0.617]","[0.712, 0.678]","[0.775, 0.794]","[0.712, 0.744]","[0.597, 0.622]","[0.903, 0.913]","[0.807, 0.823]","[0.723, 0.757]","[0.775, 0.8]","[0.748, 0.778]",0.637,0.545,0.624,0.212,0.225,0.185,0.744,0.653,0.604,0.695,0.784,0.728,0.609,0.908,0.815,0.74,0.788,0.763
https://doi.org/10.1002/14651858.cd005103.pub2,continuous subcutaneous insulin infusion csii versus multiple insulin injections for type 1 diabetes mellitus,1351_continuous subcutaneous insulin infusion csii versus multiple insulin injections for type 1 diabetes mellitus.pdf,7,"['https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-final-rpt-20171221.pdf', 'https://www.hca.wa.gov/assets/program/glucose_monitoring_final%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464609/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486147/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223534/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6']","['Continuous glucose monitoring – update Final evidence report', 'Glucose Monitoring:', 'Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews', 'Different insulin types and regimens for pregnant women with pre‐existing diabetes', 'Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus', 'Diabetes in Aging: Pathways for Developing the Evidence-Base for Clinical Guidance', 'American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update']","['https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-final-rpt-20171221.pdf', 'https://www.hca.wa.gov/assets/program/glucose_monitoring_final%5B1%5D.pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464609/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486147/pdf']","['1351_0_continuous glucose monitoring – update final evidence report.pdf', '1351_1_glucose monitoring.pdf', '1351_6_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf', '1351_3_different insulin types and regimens for pregnant women with pre‐existing diabetes.pdf', '1351_5_diabetes in aging pathways for developing the evidencebase for clinical guidance.pdf', '1351_2_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf', '1351_4_intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.pdf']",7,100.0,"['https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-final-rpt-20171221.pdf', 'https://www.hca.wa.gov/assets/program/glucose_monitoring_final%5B1%5D.pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464609/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486147/pdf']","['1351_0_continuous glucose monitoring – update final evidence report.pdf', '1351_1_glucose monitoring.pdf', '1351_6_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf', '1351_3_different insulin types and regimens for pregnant women with pre‐existing diabetes.pdf', '1351_5_diabetes in aging pathways for developing the evidencebase for clinical guidance.pdf', '1351_2_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf', '1351_4_intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.pdf']","[0.489, 0.54, 0.293, 0.666, 0.59, 0.325, 0.418]","[0.537, 0.568, 0.536, 0.533, 0.519, 0.539, 0.532]","[0.617, 0.644, 0.619, 0.62, 0.624, 0.631, 0.62]","[0.191, 0.202, 0.175, 0.195, 0.188, 0.173, 0.192]","[0.194, 0.216, 0.186, 0.19, 0.209, 0.173, 0.197]","[0.154, 0.169, 0.142, 0.16, 0.163, 0.141, 0.16]","[0.739, 0.739, 0.738, 0.742, 0.738, 0.73, 0.741]","[0.646, 0.644, 0.643, 0.649, 0.647, 0.637, 0.647]","[0.593, 0.632, 0.605, 0.595, 0.602, 0.616, 0.595]","[0.716, 0.703, 0.685, 0.702, 0.703, 0.7, 0.716]","[0.779, 0.801, 0.794, 0.779, 0.781, 0.791, 0.782]","[0.719, 0.749, 0.729, 0.711, 0.696, 0.73, 0.706]","[0.608, 0.625, 0.596, 0.597, 0.577, 0.606, 0.601]","[0.906, 0.924, 0.923, 0.905, 0.918, 0.922, 0.917]","[0.805, 0.836, 0.82, 0.818, 0.823, 0.832, 0.816]","[0.728, 0.768, 0.757, 0.727, 0.741, 0.74, 0.733]","[0.782, 0.807, 0.794, 0.78, 0.782, 0.791, 0.783]","[0.746, 0.783, 0.771, 0.752, 0.765, 0.767, 0.761]",0.474,0.538,0.625,0.188,0.195,0.156,0.738,0.645,0.605,0.704,0.787,0.72,0.601,0.916,0.821,0.742,0.788,0.764
https://doi.org/10.1002/14651858.cd005126.pub2,chinese herbal medicines for treating preeclampsia,1352_chinese herbal medicines for treating preeclampsia.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf']","['Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['1352_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1352_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['1352_1_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1352_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']","[0.31, 0.161]","[0.587, 0.516]","[0.664, 0.612]","[0.196, 0.156]","[0.181, 0.157]","[0.161, 0.133]","[0.742, 0.734]","[0.647, 0.641]","[0.661, 0.59]","[0.665, 0.676]","[0.825, 0.783]","[0.774, 0.712]","[0.634, 0.593]","[0.929, 0.909]","[0.854, 0.806]","[0.792, 0.721]","[0.83, 0.78]","[0.811, 0.75]",0.235,0.551,0.638,0.176,0.169,0.147,0.738,0.644,0.625,0.671,0.804,0.743,0.613,0.919,0.83,0.756,0.805,0.78
https://doi.org/10.1002/14651858.cd005149.pub4,intranasal steroids for acute sinusitis,1353_intranasal steroids for acute sinusitis.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494494/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517045/pdf', 'https://www.allergyparameters.org/app/download/9038725370/2014+Rhinosinusitis.pdf?t=1515165992', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734596/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193118/pdf']","['extract for acute sinusitis', 'Corticosteroids for septic arthritis in children', 'Diagnosis and management of rhinosinusitis: a practice parameter update', 'Corticosteroids for the common cold', 'Corticosteroids as standalone or add‐on treatment for sore throat']","['https://www.allergyparameters.org/app/download/9038725370/2014+Rhinosinusitis.pdf?t=1515165992', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734596/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494494/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517045/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193118/pdf']","['1353_2_diagnosis and management of rhinosinusitis a practice parameter update.pdf', '1353_3_corticosteroids for the common cold.pdf', '1353_0_extract for acute sinusitis.pdf', '1353_1_corticosteroids for septic arthritis in children.pdf', '1353_4_corticosteroids as standalone or add‐on treatment for sore throat.pdf']",5,100.0,"['https://www.allergyparameters.org/app/download/9038725370/2014+Rhinosinusitis.pdf?t=1515165992', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734596/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494494/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517045/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193118/pdf']","['1353_2_diagnosis and management of rhinosinusitis a practice parameter update.pdf', '1353_3_corticosteroids for the common cold.pdf', '1353_0_extract for acute sinusitis.pdf', '1353_1_corticosteroids for septic arthritis in children.pdf', '1353_4_corticosteroids as standalone or add‐on treatment for sore throat.pdf']","[0.708, 0.58, 0.455, 0.615, 0.607]","[0.538, 0.531, 0.529, 0.527, 0.521]","[0.621, 0.622, 0.618, 0.612, 0.611]","[0.168, 0.182, 0.178, 0.172, 0.169]","[0.173, 0.187, 0.181, 0.168, 0.17]","[0.136, 0.152, 0.153, 0.135, 0.138]","[0.741, 0.74, 0.741, 0.738, 0.738]","[0.644, 0.646, 0.647, 0.639, 0.643]","[0.611, 0.605, 0.601, 0.6, 0.592]","[0.652, 0.693, 0.692, 0.692, 0.696]","[0.797, 0.787, 0.785, 0.787, 0.777]","[0.724, 0.71, 0.708, 0.711, 0.694]","[0.606, 0.604, 0.598, 0.599, 0.592]","[0.912, 0.913, 0.91, 0.904, 0.905]","[0.809, 0.821, 0.814, 0.81, 0.808]","[0.75, 0.738, 0.734, 0.737, 0.724]","[0.793, 0.783, 0.782, 0.78, 0.773]","[0.776, 0.767, 0.763, 0.761, 0.753]",0.593,0.529,0.617,0.174,0.176,0.143,0.74,0.644,0.602,0.685,0.787,0.709,0.6,0.909,0.812,0.737,0.782,0.764
https://doi.org/10.1002/14651858.cd005170.pub2,pharmacotherapy for anxiety disorders in children and adolescents,1354_pharmacotherapy for anxiety disorders in children and adolescents.pdf,5,"['https://effectivehealthcare.ahrq.gov/products/anxiety-children/research-protocol', 'https://effectivehealthcare.ahrq.gov/products/anxiety-children/research-2017', 'https://www.rti.org/publication/nonpharmacologic-interventions-treatment-resistant-depression-adults-comparative', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491167/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360927/pdf']","['Anxiety in Children', 'Anxiety in Children', 'Nonpharmacologic interventions for treatment-resistant depression in adults. Comparative Effectiveness Review Number 33. AHRQ Publication No. 11-EHC056-EF', 'Cognitive behavioural therapy for anxiety disorders in children and adolescents', 'Pharmacotherapy for social anxiety disorder (SAnD)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360927/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491167/pdf']","['1354_4_pharmacotherapy for social anxiety disorder sand.pdf', '1354_3_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf']",2,40.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360927/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491167/pdf']","['1354_4_pharmacotherapy for social anxiety disorder sand.pdf', '1354_3_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf']","[0.734, 0.707]","[0.514, 0.513]","[0.599, 0.6]","[0.189, 0.176]","[0.186, 0.176]","[0.16, 0.147]","[0.744, 0.742]","[0.652, 0.648]","[0.574, 0.575]","[0.724, 0.721]","[0.779, 0.777]","[0.675, 0.679]","[0.594, 0.582]","[0.908, 0.912]","[0.799, 0.801]","[0.724, 0.722]","[0.773, 0.774]","[0.755, 0.757]",0.72,0.514,0.599,0.182,0.181,0.153,0.743,0.65,0.575,0.722,0.778,0.677,0.588,0.91,0.8,0.723,0.774,0.756
https://doi.org/10.1002/14651858.cd005173.pub3,tiagabine in the maintenance treatment of bipolar disorder,1355_tiagabine in the maintenance treatment of bipolar disorder.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388918/pdf', 'https://effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/final-report-2018', 'https://www.rti.org/publication/nonpharmacologic-interventions-treatment-resistant-depression-adults-comparative']","['Tiagabine for acute affective episodes in bipolar disorder', 'Treatment for Bipolar Disorder in Adults: A Systematic Review', 'Nonpharmacologic interventions for treatment-resistant depression in adults. Comparative Effectiveness Review Number 33. AHRQ Publication No. 11-EHC056-EF']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388918/pdf'],['1355_0_tiagabine for acute affective episodes in bipolar disorder.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388918/pdf'],['1355_0_tiagabine for acute affective episodes in bipolar disorder.pdf'],[0.887],[0.544],[0.625],[0.197],[0.219],[0.183],[0.738],[0.646],[0.617],[0.715],[0.801],[0.727],[0.612],[0.93],[0.826],[0.76],[0.799],[0.79],0.887,0.544,0.625,0.197,0.219,0.183,0.738,0.646,0.617,0.715,0.801,0.727,0.612,0.93,0.826,0.76,0.799,0.79
https://doi.org/10.1002/14651858.cd005189.pub3,antibiotics for bronchiolitis in children,1356_antibiotics for bronchiolitis in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464822/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483479/pdf']","['Chest radiographs for acute lower respiratory tract infections', 'Antibiotics for persistent cough or wheeze following acute bronchiolitis in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464822/pdf']","['1356_1_antibiotics for persistent cough or wheeze following acute bronchiolitis in children.pdf', '1356_0_chest radiographs for acute lower respiratory tract infections.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464822/pdf']","['1356_1_antibiotics for persistent cough or wheeze following acute bronchiolitis in children.pdf', '1356_0_chest radiographs for acute lower respiratory tract infections.pdf']","[0.446, 0.717]","[0.51, 0.511]","[0.592, 0.593]","[0.177, 0.168]","[0.178, 0.172]","[0.145, 0.137]","[0.742, 0.736]","[0.647, 0.638]","[0.569, 0.57]","[0.7, 0.697]","[0.763, 0.765]","[0.675, 0.687]","[0.588, 0.592]","[0.902, 0.906]","[0.788, 0.796]","[0.71, 0.715]","[0.756, 0.761]","[0.742, 0.744]",0.582,0.51,0.593,0.172,0.175,0.141,0.739,0.643,0.569,0.698,0.764,0.681,0.59,0.904,0.792,0.712,0.758,0.743
https://doi.org/10.1002/14651858.cd005189.pub4,antibiotics for bronchiolitis in children under two years of age,1357_antibiotics for bronchiolitis in children under two years of age.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354031/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635777/pdf']","['Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO‐defined non‐severe pneumonia and wheeze', 'Surfactant therapy for bronchiolitis in critically ill infants', 'Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old', 'Continuous positive airway pressure (CPAP) for acute bronchiolitis in children', 'Parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635777/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354031/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104667/pdf']","['1357_4_parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis.pdf', '1357_2_chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.pdf', '1357_0_antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with who‐defined non‐severe pneumonia and wheeze.pdf', '1357_3_continuous positive airway pressure cpap for acute bronchiolitis in children.pdf', '1357_1_surfactant therapy for bronchiolitis in critically ill infants.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635777/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092454/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354031/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104667/pdf']","['1357_4_parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis.pdf', '1357_2_chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.pdf', '1357_0_antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with who‐defined non‐severe pneumonia and wheeze.pdf', '1357_3_continuous positive airway pressure cpap for acute bronchiolitis in children.pdf', '1357_1_surfactant therapy for bronchiolitis in critically ill infants.pdf']","[0.488, 0.565, 0.525, 0.55, 0.515]","[0.506, 0.51, 0.513, 0.512, 0.504]","[0.593, 0.599, 0.601, 0.594, 0.59]","[0.17, 0.178, 0.182, 0.174, 0.169]","[0.162, 0.178, 0.185, 0.174, 0.163]","[0.13, 0.139, 0.15, 0.136, 0.132]","[0.739, 0.739, 0.741, 0.738, 0.738]","[0.645, 0.644, 0.648, 0.644, 0.643]","[0.567, 0.573, 0.576, 0.577, 0.57]","[0.693, 0.702, 0.706, 0.705, 0.706]","[0.763, 0.769, 0.771, 0.769, 0.765]","[0.677, 0.683, 0.678, 0.683, 0.677]","[0.588, 0.596, 0.59, 0.589, 0.587]","[0.9, 0.904, 0.904, 0.904, 0.899]","[0.785, 0.795, 0.799, 0.792, 0.79]","[0.707, 0.716, 0.717, 0.713, 0.708]","[0.757, 0.765, 0.764, 0.765, 0.758]","[0.733, 0.742, 0.745, 0.743, 0.736]",0.529,0.509,0.595,0.175,0.172,0.137,0.739,0.645,0.573,0.702,0.767,0.68,0.59,0.902,0.792,0.712,0.762,0.74
https://doi.org/10.1002/14651858.cd005215.pub3,interventions for preventing unintended pregnancies among adolescents,1358_interventions for preventing unintended pregnancies among adolescents.pdf,7,"['https://docs.gatesfoundation.org/documents/supportingtransitions.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409381/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472521/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092487/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239532/pdf']","['supportingtransitions', 'Targeted client communication via mobile devices for improving sexual and reproductive health', 'Theory‐based interventions for contraception', 'Behavioral interventions for improving contraceptive use among women living with HIV', 'Strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception', 'School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents', 'School‐based interventions for improving contraceptive use in adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472521/pdf', 'https://docs.gatesfoundation.org/documents/supportingtransitions.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409381/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092487/pdf']","['1358_5_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf', '1358_2_theory‐based interventions for contraception.pdf', '1358_0_supportingtransitions.pdf', '1358_1_targeted client communication via mobile devices for improving sexual and reproductive health.pdf', '1358_4_strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception.pdf', '1358_6_school‐based interventions for improving contraceptive use in adolescents.pdf', '1358_3_behavioral interventions for improving contraceptive use among women living with hiv.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472521/pdf', 'https://docs.gatesfoundation.org/documents/supportingtransitions.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409381/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092487/pdf']","['1358_5_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf', '1358_2_theory‐based interventions for contraception.pdf', '1358_0_supportingtransitions.pdf', '1358_1_targeted client communication via mobile devices for improving sexual and reproductive health.pdf', '1358_4_strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception.pdf', '1358_6_school‐based interventions for improving contraceptive use in adolescents.pdf', '1358_3_behavioral interventions for improving contraceptive use among women living with hiv.pdf']","[0.361, 0.65, 0.76, 0.58, 0.509, 0.74, 0.74]","[0.524, 0.522, 0.521, 0.532, 0.531, 0.525, 0.526]","[0.608, 0.601, 0.614, 0.616, 0.615, 0.603, 0.606]","[0.195, 0.199, 0.174, 0.189, 0.202, 0.203, 0.203]","[0.196, 0.2, 0.181, 0.188, 0.2, 0.211, 0.201]","[0.172, 0.176, 0.15, 0.162, 0.176, 0.186, 0.18]","[0.743, 0.745, 0.731, 0.74, 0.743, 0.745, 0.744]","[0.651, 0.653, 0.639, 0.649, 0.651, 0.653, 0.652]","[0.581, 0.579, 0.585, 0.587, 0.587, 0.581, 0.575]","[0.715, 0.713, 0.668, 0.71, 0.703, 0.708, 0.704]","[0.773, 0.768, 0.791, 0.776, 0.775, 0.767, 0.769]","[0.691, 0.692, 0.711, 0.7, 0.695, 0.695, 0.689]","[0.588, 0.594, 0.603, 0.59, 0.593, 0.598, 0.596]","[0.903, 0.894, 0.907, 0.905, 0.905, 0.892, 0.894]","[0.803, 0.799, 0.82, 0.812, 0.806, 0.803, 0.796]","[0.719, 0.711, 0.742, 0.721, 0.72, 0.709, 0.709]","[0.773, 0.768, 0.789, 0.776, 0.773, 0.769, 0.768]","[0.749, 0.74, 0.766, 0.752, 0.75, 0.738, 0.739]",0.62,0.526,0.609,0.195,0.197,0.172,0.742,0.65,0.582,0.703,0.774,0.696,0.595,0.9,0.806,0.719,0.774,0.748
https://doi.org/10.1002/14651858.cd005230.pub2,complementary and miscellaneous interventions for nocturnal enuresis in children,1359_complementary and miscellaneous interventions for nocturnal enuresis in children.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741207/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100585/pdf']","['Conservative interventions for treating functional daytime urinary incontinence in children', 'Tricyclic and related drugs for nocturnal enuresis in children', 'Alarm interventions for nocturnal enuresis in children', 'Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741207/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100585/pdf']","['1359_1_tricyclic and related drugs for nocturnal enuresis in children.pdf', '1359_2_alarm interventions for nocturnal enuresis in children.pdf', '1359_0_conservative interventions for treating functional daytime urinary incontinence in children.pdf', '1359_3_drugs for nocturnal enuresis in children other than desmopressin and tricyclics.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741207/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100585/pdf']","['1359_1_tricyclic and related drugs for nocturnal enuresis in children.pdf', '1359_2_alarm interventions for nocturnal enuresis in children.pdf', '1359_0_conservative interventions for treating functional daytime urinary incontinence in children.pdf', '1359_3_drugs for nocturnal enuresis in children other than desmopressin and tricyclics.pdf']","[0.552, 0.716, 0.729, 0.752]","[0.518, 0.512, 0.527, 0.515]","[0.607, 0.598, 0.615, 0.608]","[0.185, 0.179, 0.178, 0.186]","[0.176, 0.174, 0.177, 0.179]","[0.156, 0.155, 0.151, 0.16]","[0.743, 0.743, 0.741, 0.744]","[0.652, 0.652, 0.649, 0.652]","[0.577, 0.568, 0.588, 0.577]","[0.7, 0.705, 0.694, 0.695]","[0.781, 0.771, 0.782, 0.783]","[0.697, 0.69, 0.701, 0.691]","[0.594, 0.588, 0.601, 0.595]","[0.906, 0.902, 0.909, 0.908]","[0.798, 0.79, 0.801, 0.798]","[0.72, 0.709, 0.727, 0.723]","[0.775, 0.765, 0.779, 0.773]","[0.752, 0.741, 0.755, 0.754]",0.687,0.518,0.607,0.182,0.176,0.155,0.743,0.651,0.578,0.698,0.779,0.695,0.595,0.906,0.797,0.72,0.773,0.75
https://doi.org/10.1002/14651858.cd005249.pub2,push versus gravity for intermittent bolus gavage tube feeding of premature and low birth weight infants,1360_push versus gravity for intermittent bolus gavage tube feeding of premature and low birth weight infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407337/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407046/pdf']","['Continuous versus bolus intermittent intragastric tube feeding for preterm and low birth weight infants with gastro‐oesophageal reflux disease', 'Push versus gravity for intermittent bolus gavage tube feeding of preterm and low birth weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407337/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407046/pdf']","['1360_0_continuous versus bolus intermittent intragastric tube feeding for preterm and low birth weight infants with gastro‐oesophageal reflux disease.pdf', '1360_1_push versus gravity for intermittent bolus gavage tube feeding of preterm and low birth weight infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407337/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407046/pdf']","['1360_0_continuous versus bolus intermittent intragastric tube feeding for preterm and low birth weight infants with gastro‐oesophageal reflux disease.pdf', '1360_1_push versus gravity for intermittent bolus gavage tube feeding of preterm and low birth weight infants.pdf']","[0.657, 0.934]","[0.525, 0.524]","[0.618, 0.603]","[0.169, 0.177]","[0.185, 0.192]","[0.149, 0.157]","[0.738, 0.741]","[0.642, 0.645]","[0.593, 0.582]","[0.691, 0.702]","[0.774, 0.766]","[0.706, 0.698]","[0.596, 0.596]","[0.916, 0.912]","[0.811, 0.808]","[0.737, 0.729]","[0.778, 0.772]","[0.761, 0.756]",0.796,0.524,0.611,0.173,0.189,0.153,0.74,0.643,0.587,0.696,0.77,0.702,0.596,0.914,0.81,0.733,0.775,0.758
https://doi.org/10.1002/14651858.cd005252.pub3,avoidance of bottles during the establishment of breast feeds in preterm infants,1361_avoidance of bottles during the establishment of breast feeds in preterm infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf'],['Avoidance of bottles during the establishment of breastfeeds in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf'],['1361_0_avoidance of bottles during the establishment of breastfeeds in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf'],['1361_0_avoidance of bottles during the establishment of breastfeeds in preterm infants.pdf'],[0.842],[0.526],[0.604],[0.205],[0.197],[0.17],[0.743],[0.653],[0.583],[0.713],[0.774],[0.698],[0.596],[0.905],[0.798],[0.72],[0.772],[0.749],0.842,0.526,0.604,0.205,0.197,0.17,0.743,0.653,0.583,0.713,0.774,0.698,0.596,0.905,0.798,0.72,0.772,0.749
https://doi.org/10.1002/14651858.cd005252.pub4,avoidance of bottles during the establishment of breast feeds in preterm infants,1362_avoidance of bottles during the establishment of breast feeds in preterm infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf']","['Avoidance of bottles during the establishment of breastfeeds in preterm infants', 'Breastfeeding education and support for women with twins or higher order multiples']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf']","['1362_0_avoidance of bottles during the establishment of breastfeeds in preterm infants.pdf', '1362_1_breastfeeding education and support for women with twins or higher order multiples.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464508/pdf']","['1362_0_avoidance of bottles during the establishment of breastfeeds in preterm infants.pdf', '1362_1_breastfeeding education and support for women with twins or higher order multiples.pdf']","[0.843, 0.471]","[0.526, 0.539]","[0.604, 0.618]","[0.205, 0.2]","[0.197, 0.196]","[0.17, 0.167]","[0.743, 0.737]","[0.653, 0.645]","[0.583, 0.597]","[0.713, 0.694]","[0.774, 0.785]","[0.698, 0.711]","[0.596, 0.604]","[0.905, 0.91]","[0.798, 0.815]","[0.72, 0.737]","[0.772, 0.785]","[0.748, 0.763]",0.657,0.532,0.611,0.203,0.197,0.169,0.74,0.649,0.59,0.704,0.78,0.704,0.6,0.907,0.806,0.728,0.778,0.756
https://doi.org/10.1002/14651858.cd005257.pub2,interventions for nonoliguric hyperkalaemia in preterm neonates,1363_interventions for nonoliguric hyperkalaemia in preterm neonates.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984658/pdf'],['Interventions for non‐oliguric hyperkalaemia in preterm neonates'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984658/pdf'],['1363_0_interventions for non‐oliguric hyperkalaemia in preterm neonates.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984658/pdf'],['1363_0_interventions for non‐oliguric hyperkalaemia in preterm neonates.pdf'],[0.935],[0.515],[0.601],[0.189],[0.184],[0.155],[0.745],[0.652],[0.573],[0.684],[0.771],[0.678],[0.597],[0.897],[0.795],[0.722],[0.767],[0.745],0.935,0.515,0.601,0.189,0.184,0.155,0.745,0.652,0.573,0.684,0.771,0.678,0.597,0.897,0.795,0.722,0.767,0.745
https://doi.org/10.1002/14651858.cd005299.pub3,symphysiotomy for fetopelvic disproportion,1364_symphysiotomy for fetopelvic disproportion.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505736/pdf'],['Planned caesarean section for term breech delivery'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505736/pdf'],['1364_0_planned caesarean section for term breech delivery.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505736/pdf'],['1364_0_planned caesarean section for term breech delivery.pdf'],[0.454],[0.511],[0.603],[0.171],[0.178],[0.151],[0.739],[0.638],[0.567],[0.654],[0.773],[0.694],[0.587],[0.907],[0.799],[0.724],[0.772],[0.747],0.454,0.511,0.603,0.171,0.178,0.151,0.739,0.638,0.567,0.654,0.773,0.694,0.587,0.907,0.799,0.724,0.772,0.747
https://doi.org/10.1002/14651858.cd005300.pub4,specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes,1365_specialised antenatal clinics for women with a multiple pregnancy for improving maternal and infant outcomes.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research']","['Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1365_1_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1365_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1365_1_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1365_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.493, 0.491]","[0.526, 0.53]","[0.616, 0.623]","[0.181, 0.183]","[0.181, 0.198]","[0.157, 0.169]","[0.74, 0.737]","[0.646, 0.643]","[0.59, 0.602]","[0.699, 0.705]","[0.777, 0.786]","[0.709, 0.703]","[0.595, 0.596]","[0.9, 0.915]","[0.792, 0.811]","[0.713, 0.729]","[0.772, 0.782]","[0.738, 0.763]",0.492,0.528,0.619,0.182,0.19,0.163,0.738,0.645,0.596,0.702,0.782,0.706,0.595,0.907,0.802,0.721,0.777,0.75
https://doi.org/10.1002/14651858.cd005436.pub5,oral zinc for treating diarrhoea in children,1366_oral zinc for treating diarrhoea in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494641/pdf']","['Zinc supplementation for the treatment of measles in children', 'Smectite for acute infectious diarrhoea in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494641/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361/pdf']","['1366_1_smectite for acute infectious diarrhoea in children.pdf', '1366_0_zinc supplementation for the treatment of measles in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494641/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361/pdf']","['1366_1_smectite for acute infectious diarrhoea in children.pdf', '1366_0_zinc supplementation for the treatment of measles in children.pdf']","[0.728, 0.709]","[0.518, 0.506]","[0.603, 0.594]","[0.173, 0.167]","[0.179, 0.18]","[0.148, 0.152]","[0.742, 0.737]","[0.651, 0.645]","[0.577, 0.57]","[0.728, 0.728]","[0.779, 0.768]","[0.684, 0.678]","[0.575, 0.577]","[0.906, 0.91]","[0.802, 0.804]","[0.725, 0.716]","[0.771, 0.765]","[0.747, 0.746]",0.718,0.512,0.599,0.17,0.179,0.15,0.74,0.648,0.573,0.728,0.774,0.681,0.576,0.908,0.803,0.72,0.768,0.746
https://doi.org/10.1002/14651858.cd005455.pub2,choice of instruments for assisted vaginal delivery,1367_choice of instruments for assisted vaginal delivery.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf']","['Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries', 'Instruments for assisted vaginal birth', 'Perineal techniques during the second stage of labour for reducing perineal trauma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133539/pdf']","['1367_1_instruments for assisted vaginal birth.pdf', '1367_2_perineal techniques during the second stage of labour for reducing perineal trauma.pdf', '1367_0_oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133539/pdf']","['1367_1_instruments for assisted vaginal birth.pdf', '1367_2_perineal techniques during the second stage of labour for reducing perineal trauma.pdf', '1367_0_oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.pdf']","[0.41, 0.817, 0.466]","[0.517, 0.52, 0.509]","[0.594, 0.6, 0.598]","[0.171, 0.166, 0.157]","[0.163, 0.165, 0.158]","[0.15, 0.14, 0.136]","[0.744, 0.74, 0.737]","[0.65, 0.645, 0.639]","[0.58, 0.578, 0.575]","[0.701, 0.68, 0.684]","[0.763, 0.767, 0.766]","[0.681, 0.687, 0.681]","[0.589, 0.595, 0.589]","[0.897, 0.898, 0.9]","[0.797, 0.801, 0.799]","[0.711, 0.719, 0.717]","[0.764, 0.769, 0.765]","[0.742, 0.745, 0.742]",0.564,0.515,0.597,0.165,0.162,0.142,0.74,0.645,0.578,0.688,0.765,0.683,0.591,0.898,0.799,0.716,0.766,0.743
https://doi.org/10.1002/14651858.cd005458.pub2,antibiotics for mastitis in breastfeeding women,1368_antibiotics for mastitis in breastfeeding women.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025440/pdf'],['Interventions for impetigo'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025440/pdf'],['1368_0_interventions for impetigo.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025440/pdf'],['1368_0_interventions for impetigo.pdf'],[0.426],[0.535],[0.618],[0.176],[0.17],[0.134],[0.732],[0.638],[0.601],[0.669],[0.789],[0.716],[0.608],[0.92],[0.829],[0.75],[0.792],[0.774],0.426,0.535,0.618,0.176,0.17,0.134,0.732,0.638,0.601,0.669,0.789,0.716,0.608,0.92,0.829,0.75,0.792,0.774
https://doi.org/10.1002/14651858.cd005458.pub3,antibiotics for mastitis in breastfeeding women,1369_antibiotics for mastitis in breastfeeding women.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094918/pdf'],['Interventions for preventing mastitis after childbirth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094918/pdf'],['1369_0_interventions for preventing mastitis after childbirth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094918/pdf'],['1369_0_interventions for preventing mastitis after childbirth.pdf'],[0.722],[0.543],[0.628],[0.192],[0.199],[0.162],[0.739],[0.647],[0.6],[0.687],[0.785],[0.717],[0.605],[0.912],[0.823],[0.74],[0.786],[0.764],0.722,0.543,0.628,0.192,0.199,0.162,0.739,0.647,0.6,0.687,0.785,0.717,0.605,0.912,0.823,0.74,0.786,0.764
https://doi.org/10.1002/14651858.cd005463.pub2,individual and groupbased parenting programmes for the treatment of physical child abuse and neglect,1371_individual and groupbased parenting programmes for the treatment of physical child abuse and neglect.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.rand.org/pubs/research_reports/RR1728.html']","['Parenting interventions for the prevention of unintentional injuries in childhood', 'Improving Outcomes for Children Exposed to Violence']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf'],['1371_0_parenting interventions for the prevention of unintentional injuries in childhood.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf'],['1371_0_parenting interventions for the prevention of unintentional injuries in childhood.pdf'],[0.569],[0.549],[0.627],[0.195],[0.198],[0.171],[0.732],[0.639],[0.603],[0.714],[0.785],[0.727],[0.59],[0.917],[0.825],[0.735],[0.79],[0.763],0.569,0.549,0.627,0.195,0.198,0.171,0.732,0.639,0.603,0.714,0.785,0.727,0.59,0.917,0.825,0.735,0.79,0.763
https://doi.org/10.1002/14651858.cd005530.pub3,combined dtphbvhib vaccine versus separately administered dtphbv and hib vaccines for primary prevention of diphtheria tetanus pertussis hepatitis b and haemophilus influenzae b hib,1372_combined dtphbvhib vaccine versus separately administered dtphbv and hib vaccines for primary prevention of diphtheria tetanus pertussis hepatitis b and haemophilus influenzae b hib.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513245/pdf', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research']","['Needle size for vaccination procedures in children and adolescents', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513245/pdf'],['1372_0_needle size for vaccination procedures in children and adolescents.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513245/pdf'],['1372_0_needle size for vaccination procedures in children and adolescents.pdf'],[0.511],[0.524],[0.608],[0.191],[0.188],[0.157],[0.743],[0.651],[0.576],[0.692],[0.766],[0.71],[0.614],[0.891],[0.79],[0.711],[0.772],[0.733],0.511,0.524,0.608,0.191,0.188,0.157,0.743,0.651,0.576,0.692,0.766,0.71,0.614,0.891,0.79,0.711,0.772,0.733
https://doi.org/10.1002/14651858.cd005545.pub3,trial of instrumental delivery in theatre versus immediate caesarean section for anticipated difficult assisted births,1374_trial of instrumental delivery in theatre versus immediate caesarean section for anticipated difficult assisted births.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf', 'https://effectivehealthcare.ahrq.gov/products/labor-dystocia/research']","['Instruments for assisted vaginal birth', 'Labor Dystocia']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf'],['1374_0_instruments for assisted vaginal birth.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf'],['1374_0_instruments for assisted vaginal birth.pdf'],[0.408],[0.509],[0.6],[0.17],[0.168],[0.145],[0.735],[0.637],[0.569],[0.675],[0.77],[0.69],[0.579],[0.912],[0.803],[0.713],[0.763],[0.743],0.408,0.509,0.6,0.17,0.168,0.145,0.735,0.637,0.569,0.675,0.77,0.69,0.579,0.912,0.803,0.713,0.763,0.743
https://doi.org/10.1002/14651858.cd005546.pub2,caesarean section versus vaginal delivery for preventing mother to infant hepatitis c virus transmission,1375_caesarean section versus vaginal delivery for preventing mother to infant hepatitis c virus transmission.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1375_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1375_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],[0.203],[0.589],[0.667],[0.2],[0.181],[0.163],[0.745],[0.647],[0.648],[0.662],[0.821],[0.764],[0.641],[0.93],[0.849],[0.786],[0.819],[0.802],0.203,0.589,0.667,0.2,0.181,0.163,0.745,0.647,0.648,0.662,0.821,0.764,0.641,0.93,0.849,0.786,0.819,0.802
https://doi.org/10.1002/14651858.cd005563.pub3,interventions for preventing delirium in hospitalised nonicu patients,1377_interventions for preventing delirium in hospitalised nonicu patients.pdf,9,"['https://effectivehealthcare.ahrq.gov/products/antipsychotics/research', 'https://www.mass.gov/doc/recommendations-from-the-alzheimers-and-related-dementias-acute-care-advisory-committee-2017/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513030/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047222/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494561/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623130/pdf']","['Antipsychotics for the Prevention and Treatment of Delirium', 'Recommendations from the Alzheimer’s and Related Dementias Acute Care Advisory Committee', 'Interventions for preventing intensive care unit delirium in adults', 'Cholinesterase inhibitors for the treatment of delirium in non‐ICU settings', 'The Scottish Intercollegiate Guidelines Network (SIGN) 157: Guidelines on Risk Reduction and Management of Delirium', 'Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit', 'Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non‐cardiac and non‐neurosurgical procedures in adults', 'Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients', 'Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients']","['https://www.mass.gov/doc/recommendations-from-the-alzheimers-and-related-dementias-acute-care-advisory-committee-2017/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047222/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513030/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494561/pdf']","['1377_1_recommendations from the alzheimers and related dementias acute care advisory committee.pdf', '1377_7_non‐pharmacological interventions for preventing delirium in hospitalised non‐icu patients.pdf', '1377_5_benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.pdf', '1377_2_interventions for preventing intensive care unit delirium in adults.pdf', '1377_4_the scottish intercollegiate guidelines network sign 157 guidelines on risk reduction and management of delirium.pdf', '1377_3_cholinesterase inhibitors for the treatment of delirium in non‐icu settings.pdf', '1377_8_non‐pharmacological interventions for preventing delirium in hospitalised non‐icu patients.pdf', '1377_6_processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cogniti.pdf']",8,88.89,"['https://www.mass.gov/doc/recommendations-from-the-alzheimers-and-related-dementias-acute-care-advisory-committee-2017/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047222/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373634/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513030/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494561/pdf']","['1377_1_recommendations from the alzheimers and related dementias acute care advisory committee.pdf', '1377_7_non‐pharmacological interventions for preventing delirium in hospitalised non‐icu patients.pdf', '1377_5_benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit.pdf', '1377_2_interventions for preventing intensive care unit delirium in adults.pdf', '1377_4_the scottish intercollegiate guidelines network sign 157 guidelines on risk reduction and management of delirium.pdf', '1377_3_cholinesterase inhibitors for the treatment of delirium in non‐icu settings.pdf', '1377_8_non‐pharmacological interventions for preventing delirium in hospitalised non‐icu patients.pdf', '1377_6_processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cogniti.pdf']","[0.256, 0.744, 0.62, 0.32, 0.639, 0.59, 0.874, 0.874]","[0.501, 0.523, 0.507, 0.517, 0.51, 0.514, 0.523, 0.515]","[0.586, 0.603, 0.595, 0.598, 0.592, 0.597, 0.603, 0.599]","[0.148, 0.194, 0.182, 0.186, 0.167, 0.179, 0.194, 0.183]","[0.148, 0.175, 0.172, 0.177, 0.157, 0.17, 0.175, 0.169]","[0.127, 0.158, 0.148, 0.152, 0.132, 0.143, 0.157, 0.148]","[0.737, 0.743, 0.74, 0.74, 0.736, 0.74, 0.743, 0.742]","[0.64, 0.653, 0.648, 0.649, 0.64, 0.648, 0.653, 0.65]","[0.564, 0.581, 0.571, 0.576, 0.566, 0.577, 0.581, 0.577]","[0.679, 0.708, 0.702, 0.706, 0.687, 0.697, 0.708, 0.71]","[0.767, 0.771, 0.769, 0.766, 0.769, 0.773, 0.771, 0.77]","[0.676, 0.687, 0.684, 0.687, 0.692, 0.686, 0.687, 0.684]","[0.566, 0.589, 0.58, 0.591, 0.582, 0.585, 0.589, 0.592]","[0.897, 0.895, 0.895, 0.893, 0.895, 0.895, 0.895, 0.895]","[0.802, 0.802, 0.799, 0.797, 0.802, 0.805, 0.802, 0.804]","[0.715, 0.713, 0.709, 0.71, 0.718, 0.713, 0.713, 0.712]","[0.768, 0.769, 0.765, 0.766, 0.769, 0.768, 0.769, 0.768]","[0.744, 0.744, 0.742, 0.738, 0.749, 0.746, 0.744, 0.742]",0.615,0.514,0.597,0.179,0.168,0.146,0.74,0.648,0.574,0.7,0.77,0.685,0.584,0.895,0.802,0.713,0.768,0.744
https://doi.org/10.1002/14651858.cd005570.pub4,wound drains after incisional hernia repair,1378_wound drains after incisional hernia repair.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465115/pdf'],['Wound drainage for lower limb arterial surgery'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465115/pdf'],['1378_0_wound drainage for lower limb arterial surgery.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465115/pdf'],['1378_0_wound drainage for lower limb arterial surgery.pdf'],[0.673],[0.552],[0.627],[0.179],[0.193],[0.158],[0.735],[0.636],[0.616],[0.699],[0.795],[0.732],[0.616],[0.927],[0.838],[0.76],[0.8],[0.784],0.673,0.552,0.627,0.179,0.193,0.158,0.735,0.636,0.616,0.699,0.795,0.732,0.616,0.927,0.838,0.76,0.8,0.784
https://doi.org/10.1002/14651858.cd005947.pub4,glutamine supplementation for young infants with severe gastrointestinal disease,1379_glutamine supplementation for young infants with severe gastrointestinal disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055588/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf']","['Glutamine supplementation to prevent morbidity and mortality in preterm infants', 'Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055588/pdf']","['1379_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1379_0_glutamine supplementation to prevent morbidity and mortality in preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055588/pdf']","['1379_1_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1379_0_glutamine supplementation to prevent morbidity and mortality in preterm infants.pdf']","[0.785, 0.46]","[0.53, 0.516]","[0.622, 0.607]","[0.176, 0.179]","[0.177, 0.188]","[0.145, 0.162]","[0.742, 0.739]","[0.649, 0.649]","[0.594, 0.583]","[0.687, 0.698]","[0.777, 0.775]","[0.712, 0.691]","[0.604, 0.593]","[0.902, 0.913]","[0.793, 0.806]","[0.712, 0.725]","[0.777, 0.773]","[0.737, 0.752]",0.623,0.523,0.615,0.177,0.182,0.153,0.74,0.649,0.589,0.693,0.776,0.702,0.599,0.907,0.8,0.718,0.775,0.744
https://doi.org/10.1002/14651858.cd005949,higher versus lower amino acid intake in parenteral nutrition for newborn infants,1380_higher versus lower amino acid intake in parenteral nutrition for newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1380_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1380_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.378],[0.529],[0.626],[0.171],[0.172],[0.14],[0.741],[0.646],[0.593],[0.69],[0.776],[0.707],[0.596],[0.909],[0.795],[0.718],[0.776],[0.744],0.378,0.529,0.626,0.171,0.172,0.14,0.741,0.646,0.593,0.69,0.776,0.707,0.596,0.909,0.795,0.718,0.776,0.744
https://doi.org/10.1002/14651858.cd005949.pub2,higher versus lower amino acid intake in parenteral nutrition for newborn infants,1381_higher versus lower amino acid intake in parenteral nutrition for newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078205/pdf'],['Branched‐chain amino acid supplementation for improving growth and development in term and preterm neonates'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078205/pdf'],['1381_0_branched‐chain amino acid supplementation for improving growth and development in term and preterm neonates.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078205/pdf'],['1381_0_branched‐chain amino acid supplementation for improving growth and development in term and preterm neonates.pdf'],[0.448],[0.488],[0.577],[0.162],[0.149],[0.135],[0.736],[0.641],[0.56],[0.696],[0.762],[0.654],[0.57],[0.897],[0.781],[0.707],[0.759],[0.737],0.448,0.488,0.577,0.162,0.149,0.135,0.736,0.641,0.56,0.696,0.762,0.654,0.57,0.897,0.781,0.707,0.759,0.737
https://doi.org/10.1002/14651858.cd005954.pub2,exercise therapy in juvenile idiopathic arthritis,1382_exercise therapy in juvenile idiopathic arthritis.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461882/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565560/pdf']","['Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews', 'Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews', 'A Systematic Critical Appraisal of Clinical Practice Guidelines in Juvenile Idiopathic Arthritis Using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461882/pdf']","['1382_2_a systematic critical appraisal of clinical practice guidelines in juvenile idiopathic arthritis using the appraisal of guidelines for research and evaluation ii agree ii instrument.pdf', '1382_1_physical activity and exercise for chronic pain in adults an overview of cochrane reviews.pdf', '1382_0_physical activity and exercise for chronic pain in adults an overview of cochrane reviews.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461882/pdf']","['1382_2_a systematic critical appraisal of clinical practice guidelines in juvenile idiopathic arthritis using the appraisal of guidelines for research and evaluation ii agree ii instrument.pdf', '1382_1_physical activity and exercise for chronic pain in adults an overview of cochrane reviews.pdf', '1382_0_physical activity and exercise for chronic pain in adults an overview of cochrane reviews.pdf']","[0.523, 0.534, 0.195]","[0.519, 0.502, 0.504]","[0.608, 0.596, 0.599]","[0.157, 0.174, 0.168]","[0.166, 0.184, 0.18]","[0.133, 0.154, 0.151]","[0.729, 0.737, 0.735]","[0.628, 0.637, 0.635]","[0.584, 0.568, 0.565]","[0.692, 0.723, 0.723]","[0.782, 0.767, 0.763]","[0.708, 0.7, 0.692]","[0.608, 0.599, 0.592]","[0.908, 0.896, 0.902]","[0.819, 0.786, 0.791]","[0.726, 0.7, 0.701]","[0.782, 0.763, 0.761]","[0.761, 0.727, 0.728]",0.417,0.508,0.601,0.166,0.177,0.146,0.734,0.633,0.572,0.713,0.771,0.7,0.6,0.902,0.799,0.709,0.769,0.739
https://doi.org/10.1002/14651858.cd005956.pub2,interventions to improve adherence to exercise for chronic musculoskeletal pain in adults,1383_interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494515/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461882/pdf']","['Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review', 'Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461882/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494515/pdf']","['1383_1_physical activity and exercise for chronic pain in adults an overview of cochrane reviews.pdf', '1383_0_exercise interventions and patient beliefs for people with hip knee or hip and knee osteoarthritis a mixed methods review.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461882/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494515/pdf']","['1383_1_physical activity and exercise for chronic pain in adults an overview of cochrane reviews.pdf', '1383_0_exercise interventions and patient beliefs for people with hip knee or hip and knee osteoarthritis a mixed methods review.pdf']","[0.71, 0.675]","[0.513, 0.52]","[0.606, 0.61]","[0.178, 0.176]","[0.192, 0.183]","[0.155, 0.148]","[0.74, 0.735]","[0.645, 0.638]","[0.576, 0.59]","[0.724, 0.715]","[0.763, 0.772]","[0.693, 0.707]","[0.598, 0.603]","[0.901, 0.903]","[0.79, 0.811]","[0.714, 0.734]","[0.768, 0.782]","[0.738, 0.755]",0.693,0.516,0.608,0.177,0.188,0.151,0.738,0.641,0.583,0.72,0.768,0.7,0.601,0.902,0.8,0.724,0.775,0.746
https://doi.org/10.1002/14651858.cd005967.pub4,artesunate versus quinine for treating severe malaria,1384_artesunate versus quinine for treating severe malaria.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537457/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580442/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470355/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463986/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455227/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468924/pdf']","['Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age', 'Larvivorous fish for preventing malaria transmission', 'Artemether for severe malaria', 'Dihydroartemisinin‐piperaquine for treating uncomplicated malaria', 'Pre‐referral rectal artesunate for severe malaria', 'Artemether for severe malaria', 'Larvivorous fish for preventing malaria transmission']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537457/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580442/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468924/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470355/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463986/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455227/pdf']","['1384_0_ready‐to‐use therapeutic food rutf for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age.pdf', '1384_2_artemether for severe malaria.pdf', '1384_6_larvivorous fish for preventing malaria transmission.pdf', '1384_3_dihydroartemisinin‐piperaquine for treating uncomplicated malaria.pdf', '1384_4_pre‐referral rectal artesunate for severe malaria.pdf', '1384_1_larvivorous fish for preventing malaria transmission.pdf', '1384_5_artemether for severe malaria.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537457/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580442/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468924/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470355/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463986/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455227/pdf']","['1384_0_ready‐to‐use therapeutic food rutf for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age.pdf', '1384_2_artemether for severe malaria.pdf', '1384_6_larvivorous fish for preventing malaria transmission.pdf', '1384_3_dihydroartemisinin‐piperaquine for treating uncomplicated malaria.pdf', '1384_4_pre‐referral rectal artesunate for severe malaria.pdf', '1384_1_larvivorous fish for preventing malaria transmission.pdf', '1384_5_artemether for severe malaria.pdf']","[0.417, 0.305, 0.783, 0.582, 0.698, 0.768, 0.306]","[0.503, 0.512, 0.505, 0.505, 0.506, 0.505, 0.512]","[0.585, 0.595, 0.593, 0.585, 0.59, 0.593, 0.591]","[0.151, 0.168, 0.136, 0.169, 0.173, 0.134, 0.165]","[0.148, 0.174, 0.118, 0.165, 0.176, 0.118, 0.174]","[0.118, 0.145, 0.101, 0.138, 0.149, 0.104, 0.143]","[0.734, 0.74, 0.728, 0.742, 0.74, 0.729, 0.739]","[0.64, 0.648, 0.634, 0.651, 0.647, 0.634, 0.65]","[0.57, 0.58, 0.583, 0.569, 0.568, 0.584, 0.576]","[0.685, 0.703, 0.656, 0.697, 0.692, 0.664, 0.7]","[0.768, 0.776, 0.784, 0.777, 0.773, 0.781, 0.775]","[0.67, 0.676, 0.701, 0.67, 0.681, 0.693, 0.671]","[0.594, 0.583, 0.588, 0.589, 0.593, 0.588, 0.588]","[0.903, 0.91, 0.906, 0.901, 0.9, 0.911, 0.905]","[0.792, 0.792, 0.804, 0.786, 0.786, 0.805, 0.796]","[0.716, 0.718, 0.728, 0.722, 0.715, 0.722, 0.719]","[0.766, 0.771, 0.781, 0.767, 0.766, 0.778, 0.77]","[0.742, 0.745, 0.754, 0.742, 0.737, 0.752, 0.741]",0.551,0.507,0.59,0.157,0.153,0.128,0.736,0.643,0.576,0.685,0.776,0.68,0.589,0.905,0.794,0.72,0.771,0.745
https://doi.org/10.1002/14651858.cd005974.pub3,homeopathic remedies for preventing and treating acute respiratory tract infections in children,1385_homeopathic remedies for preventing and treating acute respiratory tract infections in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513540/pdf']","['Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children', 'Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513633/pdf']","['1385_1_homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.pdf', '1385_0_homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513540/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513633/pdf']","['1385_1_homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.pdf', '1385_0_homeopathic medicinal products for preventing and treating acute respiratory tract infections in children.pdf']","[0.707, 0.69]","[0.533, 0.536]","[0.625, 0.627]","[0.18, 0.185]","[0.196, 0.199]","[0.159, 0.16]","[0.736, 0.738]","[0.642, 0.644]","[0.602, 0.608]","[0.709, 0.708]","[0.791, 0.796]","[0.705, 0.714]","[0.613, 0.616]","[0.919, 0.916]","[0.835, 0.834]","[0.747, 0.755]","[0.791, 0.796]","[0.776, 0.78]",0.698,0.534,0.626,0.182,0.198,0.16,0.737,0.643,0.605,0.708,0.794,0.71,0.615,0.917,0.835,0.751,0.794,0.778
https://doi.org/10.1002/14651858.cd005975.pub3,oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age,1386_oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age.pdf,1,['https://www.aarc.org/wp-content/uploads/2021/08/management-of-pediatric-patients-with-oxygen-in-the-acute-setting.pdf'],['AARC Clinical Practice Guideline: Management of Pediatric Patients With Oxygen in the Acute Care Setting'],['https://www.aarc.org/wp-content/uploads/2021/08/management-of-pediatric-patients-with-oxygen-in-the-acute-setting.pdf'],['1386_0_aarc clinical practice guideline management of pediatric patients with oxygen in the acute care setting.pdf'],1,100.0,['https://www.aarc.org/wp-content/uploads/2021/08/management-of-pediatric-patients-with-oxygen-in-the-acute-setting.pdf'],['1386_0_aarc clinical practice guideline management of pediatric patients with oxygen in the acute care setting.pdf'],[0.475],[0.575],[0.644],[0.212],[0.221],[0.178],[0.744],[0.651],[0.645],[0.687],[0.81],[0.757],[0.652],[0.918],[0.835],[0.777],[0.82],[0.794],0.475,0.575,0.644,0.212,0.221,0.178,0.744,0.651,0.645,0.687,0.81,0.757,0.652,0.918,0.835,0.777,0.82,0.794
https://doi.org/10.1002/14651858.cd005978.pub2,zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months,1387_zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000651/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043363/pdf']","['Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age', 'Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months', 'Zinc supplementation for improving pregnancy and infant outcome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000651/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043363/pdf']","['1387_1_zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.pdf', '1387_0_zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age.pdf', '1387_2_zinc supplementation for improving pregnancy and infant outcome.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000651/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043363/pdf']","['1387_1_zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.pdf', '1387_0_zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age.pdf', '1387_2_zinc supplementation for improving pregnancy and infant outcome.pdf']","[0.876, 0.952, 0.656]","[0.54, 0.529, 0.523]","[0.623, 0.615, 0.606]","[0.205, 0.194, 0.189]","[0.217, 0.206, 0.189]","[0.183, 0.175, 0.162]","[0.743, 0.743, 0.74]","[0.652, 0.652, 0.647]","[0.605, 0.593, 0.583]","[0.714, 0.712, 0.704]","[0.79, 0.785, 0.78]","[0.718, 0.706, 0.697]","[0.608, 0.603, 0.593]","[0.917, 0.914, 0.912]","[0.825, 0.821, 0.814]","[0.745, 0.738, 0.733]","[0.791, 0.782, 0.781]","[0.771, 0.766, 0.761]",0.828,0.531,0.615,0.196,0.204,0.173,0.742,0.65,0.594,0.71,0.785,0.707,0.601,0.914,0.82,0.739,0.785,0.766
https://doi.org/10.1002/14651858.cd005978.pub3,zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months,1388_zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094617/pdf']","['Zinc supplementation for the treatment of measles in children', 'Zinc supplementation for improving pregnancy and infant outcome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094617/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361/pdf']","['1388_1_zinc supplementation for improving pregnancy and infant outcome.pdf', '1388_0_zinc supplementation for the treatment of measles in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094617/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481361/pdf']","['1388_1_zinc supplementation for improving pregnancy and infant outcome.pdf', '1388_0_zinc supplementation for the treatment of measles in children.pdf']","[0.804, 0.628]","[0.519, 0.521]","[0.603, 0.608]","[0.181, 0.182]","[0.177, 0.196]","[0.157, 0.166]","[0.738, 0.737]","[0.645, 0.645]","[0.581, 0.589]","[0.706, 0.718]","[0.776, 0.778]","[0.694, 0.703]","[0.588, 0.595]","[0.911, 0.916]","[0.815, 0.82]","[0.724, 0.73]","[0.776, 0.779]","[0.757, 0.76]",0.716,0.52,0.605,0.181,0.186,0.162,0.738,0.645,0.585,0.712,0.777,0.698,0.591,0.913,0.817,0.727,0.778,0.758
https://doi.org/10.1002/14651858.cd005982.pub2,low molecular weight heparin for prevention of central venous catheterizationrelated thrombosis in children,1389_low molecular weight heparin for prevention of central venous catheterizationrelated thrombosis in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390480/pdf'],['Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390480/pdf'],['1389_0_low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390480/pdf'],['1389_0_low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children.pdf'],[0.898],[0.538],[0.624],[0.208],[0.205],[0.17],[0.747],[0.657],[0.598],[0.696],[0.785],[0.71],[0.606],[0.91],[0.827],[0.736],[0.782],[0.762],0.898,0.538,0.624,0.208,0.205,0.17,0.747,0.657,0.598,0.696,0.785,0.71,0.606,0.91,0.827,0.736,0.782,0.762
https://doi.org/10.1002/14651858.cd005992,smoking bans for reducing smoking prevalence and tobacco consumption,1390_smoking bans for reducing smoking prevalence and tobacco consumption.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf'],['Interventions for promoting smoking cessation during pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf'],['1390_0_interventions for promoting smoking cessation during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090746/pdf'],['1390_0_interventions for promoting smoking cessation during pregnancy.pdf'],[0.405],[0.521],[0.622],[0.171],[0.185],[0.157],[0.729],[0.635],[0.595],[0.711],[0.787],[0.717],[0.591],[0.922],[0.828],[0.743],[0.79],[0.773],0.405,0.521,0.622,0.171,0.185,0.157,0.729,0.635,0.595,0.711,0.787,0.717,0.591,0.922,0.828,0.743,0.79,0.773
https://doi.org/10.1002/14651858.cd006037.pub3,psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions,1391_psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517179/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.rand.org/pubs/research_reports/RRA858-1.html', 'https://www.rand.org/pubs/research_reports/RR2178.html']","['Effectiveness of psychosocial interventions for reducing parental substance misuse', 'Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Examining Interventions to Address Infant Mortality in Allegheny County, Pennsylvania', 'Gender Differences in Response to Alcohol Use Disorder Treatment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517179/pdf']","['1391_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1391_0_effectiveness of psychosocial interventions for reducing parental substance misuse.pdf', '1391_1_psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517179/pdf']","['1391_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1391_0_effectiveness of psychosocial interventions for reducing parental substance misuse.pdf', '1391_1_psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.pdf']","[0.703, 0.687, 0.415]","[0.514, 0.523, 0.526]","[0.602, 0.599, 0.605]","[0.153, 0.175, 0.184]","[0.155, 0.173, 0.184]","[0.131, 0.149, 0.158]","[0.728, 0.733, 0.736]","[0.631, 0.639, 0.642]","[0.59, 0.579, 0.581]","[0.681, 0.706, 0.708]","[0.782, 0.773, 0.773]","[0.692, 0.693, 0.698]","[0.592, 0.586, 0.588]","[0.916, 0.908, 0.904]","[0.809, 0.81, 0.811]","[0.726, 0.724, 0.722]","[0.78, 0.773, 0.774]","[0.764, 0.754, 0.752]",0.602,0.521,0.602,0.171,0.171,0.146,0.732,0.637,0.583,0.698,0.776,0.694,0.589,0.909,0.81,0.724,0.776,0.757
https://doi.org/10.1002/14651858.cd006047.pub4,household interventions for preventing domestic lead exposure in children,1392_household interventions for preventing domestic lead exposure in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461195/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094406/pdf']","['Household interventions for preventing domestic lead exposure in children', 'Household interventions for secondary prevention of domestic lead exposure in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461195/pdf']","['1392_1_household interventions for secondary prevention of domestic lead exposure in children.pdf', '1392_0_household interventions for preventing domestic lead exposure in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461195/pdf']","['1392_1_household interventions for secondary prevention of domestic lead exposure in children.pdf', '1392_0_household interventions for preventing domestic lead exposure in children.pdf']","[0.728, 0.715]","[0.505, 0.503]","[0.583, 0.584]","[0.177, 0.181]","[0.174, 0.179]","[0.161, 0.165]","[0.732, 0.734]","[0.638, 0.641]","[0.562, 0.56]","[0.721, 0.722]","[0.767, 0.765]","[0.67, 0.665]","[0.585, 0.587]","[0.893, 0.891]","[0.787, 0.785]","[0.695, 0.692]","[0.76, 0.758]","[0.726, 0.724]",0.722,0.504,0.583,0.179,0.176,0.163,0.733,0.639,0.561,0.722,0.766,0.667,0.586,0.892,0.786,0.694,0.759,0.725
https://doi.org/10.1002/14651858.cd006066,continuous cardiotocography ctg as a form of electronic fetal monitoring efm for fetal assessment during labour,1393_continuous cardiotocography ctg as a form of electronic fetal monitoring efm for fetal assessment during labour.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050610/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045457/pdf']","['Fetal movement counting for assessment of fetal wellbeing', ""Operative versus conservative management for 'fetal distress' in labour"", 'Fetal electrocardiogram (ECG) for fetal monitoring during labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050610/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045457/pdf']","['1393_0_fetal movement counting for assessment of fetal wellbeing.pdf', '1393_1_operative versus conservative management for fetal distress in labour.pdf', '1393_2_fetal electrocardiogram ecg for fetal monitoring during labour.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050610/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045457/pdf']","['1393_0_fetal movement counting for assessment of fetal wellbeing.pdf', '1393_1_operative versus conservative management for fetal distress in labour.pdf', '1393_2_fetal electrocardiogram ecg for fetal monitoring during labour.pdf']","[0.392, 0.384, 0.582]","[0.502, 0.498, 0.502]","[0.581, 0.579, 0.582]","[0.18, 0.171, 0.18]","[0.161, 0.155, 0.16]","[0.146, 0.142, 0.141]","[0.739, 0.738, 0.739]","[0.646, 0.644, 0.648]","[0.564, 0.565, 0.564]","[0.708, 0.689, 0.708]","[0.764, 0.762, 0.77]","[0.667, 0.654, 0.666]","[0.588, 0.578, 0.585]","[0.894, 0.897, 0.898]","[0.786, 0.787, 0.788]","[0.704, 0.697, 0.705]","[0.762, 0.755, 0.765]","[0.737, 0.739, 0.742]",0.453,0.501,0.581,0.177,0.159,0.143,0.739,0.646,0.564,0.702,0.765,0.662,0.584,0.896,0.787,0.702,0.761,0.739
https://doi.org/10.1002/14651858.cd006066.pub2,continuous cardiotocography ctg as a form of electronic fetal monitoring efm for fetal assessment during labour,1394_continuous cardiotocography ctg as a form of electronic fetal monitoring efm for fetal assessment during labour.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104297/pdf']","['Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Fetal pulse oximetry for fetal assessment in labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104297/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['1394_1_fetal pulse oximetry for fetal assessment in labour.pdf', '1394_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104297/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['1394_1_fetal pulse oximetry for fetal assessment in labour.pdf', '1394_0_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']","[0.419, 0.633]","[0.507, 0.492]","[0.585, 0.576]","[0.188, 0.159]","[0.168, 0.139]","[0.151, 0.123]","[0.74, 0.736]","[0.647, 0.643]","[0.569, 0.562]","[0.703, 0.698]","[0.776, 0.767]","[0.664, 0.662]","[0.584, 0.581]","[0.904, 0.898]","[0.792, 0.775]","[0.713, 0.696]","[0.768, 0.758]","[0.749, 0.731]",0.526,0.499,0.581,0.173,0.154,0.137,0.738,0.645,0.566,0.7,0.772,0.663,0.583,0.901,0.784,0.704,0.763,0.74
https://doi.org/10.1002/14651858.cd006066.pub3,continuous cardiotocography ctg as a form of electronic fetal monitoring efm for fetal assessment during labour,1395_continuous cardiotocography ctg as a form of electronic fetal monitoring efm for fetal assessment during labour.pdf,2,"['https://effectivehealthcare.ahrq.gov/products/labor-dystocia/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464556/pdf']","['Labor Dystocia', 'Intermittent auscultation (IA) of fetal heart rate in labour for fetal well‐being']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464556/pdf'],['1395_1_intermittent auscultation ia of fetal heart rate in labour for fetal well‐being.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464556/pdf'],['1395_1_intermittent auscultation ia of fetal heart rate in labour for fetal well‐being.pdf'],[0.692],[0.504],[0.581],[0.18],[0.165],[0.146],[0.738],[0.644],[0.564],[0.706],[0.767],[0.667],[0.584],[0.898],[0.785],[0.705],[0.762],[0.739],0.692,0.504,0.581,0.18,0.165,0.146,0.738,0.644,0.564,0.706,0.767,0.667,0.584,0.898,0.785,0.705,0.762,0.739
https://doi.org/10.1002/14651858.cd006095.pub4,probiotics for the prevention of clostridium difficileassociated diarrhea in adults and children,1396_probiotics for the prevention of clostridium difficileassociated diarrhea in adults and children.pdf,1,['https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2820%2934729-6'],['AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders'],['https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2820%2934729-6'],['1396_0_aga clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders.pdf'],1,100.0,['https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2820%2934729-6'],['1396_0_aga clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders.pdf'],[0.346],[0.508],[0.596],[0.173],[0.172],[0.141],[0.736],[0.645],[0.568],[0.69],[0.775],[0.679],[0.601],[0.903],[0.792],[0.724],[0.768],[0.749],0.346,0.508,0.596,0.173,0.172,0.141,0.736,0.645,0.568,0.69,0.775,0.679,0.601,0.903,0.792,0.724,0.768,0.749
https://doi.org/10.1002/14651858.cd006167.pub3,amniotomy for shortening spontaneous labour,1397_amniotomy for shortening spontaneous labour.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf'],[': the presence of a companion favors the use of best practices in delivery care in the South region of Brazil'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf'],['1397_0_ the presence of a companion favors the use of best practices in delivery care in the south region of brazil.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772405/pdf'],['1397_0_ the presence of a companion favors the use of best practices in delivery care in the south region of brazil.pdf'],[0.233],[0.489],[0.575],[0.157],[0.157],[0.131],[0.735],[0.637],[0.552],[0.667],[0.768],[0.649],[0.578],[0.901],[0.793],[0.713],[0.76],[0.738],0.233,0.489,0.575,0.157,0.157,0.131,0.735,0.637,0.552,0.667,0.768,0.649,0.578,0.901,0.793,0.713,0.76,0.738
https://doi.org/10.1002/14651858.cd006173.pub2,timing of prophylactic uterotonics for the third stage of labour after vaginal birth,1399_timing of prophylactic uterotonics for the third stage of labour after vaginal birth.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236306/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060023/pdf']","['Intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour', 'Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour', 'Placental cord drainage after vaginal delivery as part of the management of the third stage of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236306/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060023/pdf']","['1399_1_intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.pdf', '1399_0_intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour.pdf', '1399_2_placental cord drainage after vaginal delivery as part of the management of the third stage of labour.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513632/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236306/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060023/pdf']","['1399_1_intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.pdf', '1399_0_intravenous versus intramuscular prophylactic oxytocin for reducing blood loss in the third stage of labour.pdf', '1399_2_placental cord drainage after vaginal delivery as part of the management of the third stage of labour.pdf']","[0.699, 0.774, 0.731]","[0.535, 0.527, 0.536]","[0.625, 0.617, 0.618]","[0.205, 0.193, 0.195]","[0.204, 0.185, 0.198]","[0.17, 0.159, 0.162]","[0.742, 0.738, 0.741]","[0.652, 0.647, 0.65]","[0.594, 0.586, 0.587]","[0.689, 0.692, 0.69]","[0.787, 0.778, 0.78]","[0.714, 0.704, 0.705]","[0.613, 0.604, 0.612]","[0.901, 0.902, 0.903]","[0.807, 0.806, 0.809]","[0.733, 0.721, 0.728]","[0.78, 0.775, 0.776]","[0.751, 0.745, 0.751]",0.735,0.533,0.62,0.198,0.196,0.164,0.74,0.65,0.589,0.69,0.782,0.708,0.61,0.902,0.807,0.727,0.777,0.749
https://doi.org/10.1002/14651858.cd006176.pub2,umbilical vein injection for the routine management of third stage of labour,1400_umbilical vein injection for the routine management of third stage of labour.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407481/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487388/pdf']","['Mechanical and surgical interventions for treating primary postpartum haemorrhage', 'Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407481/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487388/pdf']","['1400_0_mechanical and surgical interventions for treating primary postpartum haemorrhage.pdf', '1400_1_prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407481/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487388/pdf']","['1400_0_mechanical and surgical interventions for treating primary postpartum haemorrhage.pdf', '1400_1_prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.pdf']","[0.511, 0.742]","[0.52, 0.511]","[0.611, 0.601]","[0.189, 0.193]","[0.182, 0.18]","[0.151, 0.154]","[0.741, 0.742]","[0.647, 0.65]","[0.583, 0.575]","[0.675, 0.687]","[0.78, 0.777]","[0.692, 0.677]","[0.596, 0.59]","[0.905, 0.906]","[0.808, 0.8]","[0.727, 0.721]","[0.776, 0.772]","[0.753, 0.75]",0.627,0.516,0.606,0.191,0.181,0.152,0.742,0.649,0.579,0.681,0.778,0.684,0.593,0.905,0.804,0.724,0.774,0.752
https://doi.org/10.1002/14651858.cd006177.pub2,interventions in the workplace to support breastfeeding for women in employment,1401_interventions in the workplace to support breastfeeding for women in employment.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1401_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1401_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],[0.237],[0.569],[0.648],[0.185],[0.162],[0.147],[0.738],[0.642],[0.63],[0.66],[0.816],[0.747],[0.637],[0.928],[0.847],[0.782],[0.82],[0.803],0.237,0.569,0.648,0.185,0.162,0.147,0.738,0.642,0.63,0.66,0.816,0.747,0.637,0.928,0.847,0.782,0.82,0.803
https://doi.org/10.1002/14651858.cd006178.pub3,antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery,1403_antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094629/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458027/pdf']","['Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Cervical stitch (cerclage) in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews', 'Antibiotic treatment for the sexual partners of women with bacterial vaginosis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094629/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458027/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1403_1_cervical stitch cerclage in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies.pdf', '1403_3_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1403_4_antibiotic treatment for the sexual partners of women with bacterial vaginosis.pdf', '1403_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1403_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094629/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458027/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1403_1_cervical stitch cerclage in combination with other treatments for preventing spontaneous preterm birth in singleton pregnancies.pdf', '1403_3_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '1403_4_antibiotic treatment for the sexual partners of women with bacterial vaginosis.pdf', '1403_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1403_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.446, 0.466, 0.523, 0.522, 0.53]","[0.546, 0.524, 0.516, 0.497, 0.533]","[0.638, 0.619, 0.607, 0.59, 0.629]","[0.189, 0.171, 0.173, 0.167, 0.177]","[0.197, 0.169, 0.168, 0.168, 0.187]","[0.165, 0.142, 0.144, 0.143, 0.158]","[0.742, 0.739, 0.738, 0.736, 0.737]","[0.651, 0.646, 0.644, 0.643, 0.643]","[0.612, 0.592, 0.582, 0.556, 0.605]","[0.673, 0.681, 0.687, 0.689, 0.689]","[0.793, 0.78, 0.774, 0.759, 0.79]","[0.726, 0.711, 0.689, 0.691, 0.705]","[0.603, 0.596, 0.586, 0.585, 0.601]","[0.92, 0.91, 0.909, 0.889, 0.926]","[0.813, 0.792, 0.795, 0.764, 0.814]","[0.743, 0.719, 0.72, 0.683, 0.738]","[0.788, 0.775, 0.768, 0.752, 0.787]","[0.769, 0.745, 0.747, 0.708, 0.772]",0.497,0.523,0.617,0.175,0.178,0.15,0.738,0.645,0.589,0.684,0.779,0.704,0.594,0.911,0.796,0.721,0.774,0.748
https://doi.org/10.1002/14651858.cd006202.pub2,homebased chemicallyinduced whitening bleaching of teeth in adults,1404_homebased chemicallyinduced whitening bleaching of teeth in adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517292/pdf'],['Home‐based chemically‐induced whitening (bleaching) of teeth in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517292/pdf'],['1404_0_home‐based chemically‐induced whitening bleaching of teeth in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517292/pdf'],['1404_0_home‐based chemically‐induced whitening bleaching of teeth in adults.pdf'],[0.999],[0.537],[0.614],[0.189],[0.193],[0.177],[0.75],[0.659],[0.596],[0.724],[0.777],[0.688],[0.605],[0.913],[0.827],[0.728],[0.785],[0.766],0.999,0.537,0.614,0.189,0.193,0.177,0.75,0.659,0.596,0.724,0.777,0.688,0.605,0.913,0.827,0.728,0.785,0.766
https://doi.org/10.1002/14651858.cd006245.pub2,care delivery and selfmanagement strategies for children with epilepsy,1405_care delivery and selfmanagement strategies for children with epilepsy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494414/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf']","['Care delivery and self‐management strategies for children with epilepsy', 'Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494414/pdf']","['1405_1_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf', '1405_0_care delivery and self‐management strategies for children with epilepsy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494414/pdf']","['1405_1_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf', '1405_0_care delivery and self‐management strategies for children with epilepsy.pdf']","[0.832, 0.366]","[0.51, 0.523]","[0.597, 0.601]","[0.158, 0.183]","[0.15, 0.186]","[0.135, 0.166]","[0.727, 0.737]","[0.632, 0.641]","[0.584, 0.579]","[0.694, 0.71]","[0.78, 0.771]","[0.709, 0.703]","[0.615, 0.619]","[0.921, 0.914]","[0.824, 0.82]","[0.725, 0.725]","[0.772, 0.77]","[0.758, 0.752]",0.599,0.516,0.599,0.17,0.168,0.151,0.732,0.637,0.581,0.702,0.776,0.706,0.617,0.917,0.822,0.725,0.771,0.755
https://doi.org/10.1002/14651858.cd006245.pub3,care delivery and self management strategies for children with epilepsy,1406_care delivery and self management strategies for children with epilepsy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390263/pdf'],['Care delivery and self management strategies for adults with epilepsy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390263/pdf'],['1406_0_care delivery and self management strategies for adults with epilepsy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390263/pdf'],['1406_0_care delivery and self management strategies for adults with epilepsy.pdf'],[0.77],[0.553],[0.634],[0.208],[0.219],[0.185],[0.736],[0.646],[0.604],[0.717],[0.785],[0.718],[0.627],[0.909],[0.827],[0.736],[0.786],[0.761],0.77,0.553,0.634,0.208,0.219,0.185,0.736,0.646,0.604,0.717,0.785,0.718,0.627,0.909,0.827,0.736,0.786,0.761
https://doi.org/10.1002/14651858.cd006275.pub2,nonpharmacological management of infant and young child procedural pain,1407_nonpharmacological management of infant and young child procedural pain.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935979/pdf'],['Non‐pharmacological interventions for assisting the induction of anaesthesia in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935979/pdf'],['1407_0_non‐pharmacological interventions for assisting the induction of anaesthesia in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935979/pdf'],['1407_0_non‐pharmacological interventions for assisting the induction of anaesthesia in children.pdf'],[0.477],[0.517],[0.6],[0.179],[0.169],[0.147],[0.741],[0.648],[0.573],[0.709],[0.765],[0.681],[0.592],[0.897],[0.804],[0.716],[0.77],[0.742],0.477,0.517,0.6,0.179,0.169,0.147,0.741,0.648,0.573,0.709,0.765,0.681,0.592,0.897,0.804,0.716,0.77,0.742
https://doi.org/10.1002/14651858.cd006275.pub3,nonpharmacological management of infant and young child procedural pain,1408_nonpharmacological management of infant and young child procedural pain.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143321/pdf']","['Opioids for newborn infants receiving mechanical ventilation', 'Skin‐to‐skin care for procedural pain in neonates', 'Infant pacifiers for reduction in risk of sudden infant death syndrome', 'Sucrose for analgesia in newborn infants undergoing painful procedures', 'Psychological interventions for needle‐related procedural pain and distress in children and adolescents', 'Clonidine for pain in non‐ventilated infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143321/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['1408_1_skin‐to‐skin care for procedural pain in neonates.pdf', '1408_5_clonidine for pain in non‐ventilated infants.pdf', '1408_0_opioids for newborn infants receiving mechanical ventilation.pdf', '1408_2_infant pacifiers for reduction in risk of sudden infant death syndrome.pdf', '1408_4_psychological interventions for needle‐related procedural pain and distress in children and adolescents.pdf', '1408_3_sucrose for analgesia in newborn infants undergoing painful procedures.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464258/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143321/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517234/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457867/pdf']","['1408_1_skin‐to‐skin care for procedural pain in neonates.pdf', '1408_5_clonidine for pain in non‐ventilated infants.pdf', '1408_0_opioids for newborn infants receiving mechanical ventilation.pdf', '1408_2_infant pacifiers for reduction in risk of sudden infant death syndrome.pdf', '1408_4_psychological interventions for needle‐related procedural pain and distress in children and adolescents.pdf', '1408_3_sucrose for analgesia in newborn infants undergoing painful procedures.pdf']","[0.657, 0.68, 0.521, 0.631, 0.72, 0.577]","[0.525, 0.536, 0.523, 0.534, 0.528, 0.517]","[0.605, 0.628, 0.611, 0.626, 0.615, 0.602]","[0.181, 0.183, 0.184, 0.164, 0.183, 0.179]","[0.179, 0.197, 0.179, 0.181, 0.18, 0.179]","[0.147, 0.157, 0.15, 0.143, 0.151, 0.145]","[0.741, 0.741, 0.74, 0.738, 0.739, 0.742]","[0.649, 0.649, 0.648, 0.643, 0.647, 0.648]","[0.583, 0.603, 0.58, 0.603, 0.588, 0.574]","[0.703, 0.696, 0.703, 0.692, 0.707, 0.7]","[0.773, 0.783, 0.769, 0.783, 0.771, 0.765]","[0.691, 0.712, 0.697, 0.71, 0.7, 0.692]","[0.605, 0.608, 0.591, 0.605, 0.599, 0.6]","[0.906, 0.914, 0.903, 0.915, 0.91, 0.896]","[0.81, 0.822, 0.805, 0.815, 0.813, 0.804]","[0.729, 0.743, 0.721, 0.736, 0.728, 0.718]","[0.776, 0.787, 0.772, 0.785, 0.775, 0.768]","[0.756, 0.77, 0.748, 0.764, 0.758, 0.745]",0.631,0.527,0.614,0.179,0.182,0.149,0.74,0.647,0.588,0.7,0.774,0.7,0.601,0.907,0.812,0.729,0.777,0.757
https://doi.org/10.1002/14651858.cd006281.pub3,drug treatment for spinal muscular atrophy type i,1409_drug treatment for spinal muscular atrophy type i.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905354/pdf'],['Drug treatment for spinal muscular atrophy type I'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905354/pdf'],['1409_0_drug treatment for spinal muscular atrophy type i.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905354/pdf'],['1409_0_drug treatment for spinal muscular atrophy type i.pdf'],[0.83],[0.534],[0.628],[0.174],[0.186],[0.146],[0.742],[0.643],[0.601],[0.698],[0.793],[0.718],[0.613],[0.92],[0.822],[0.748],[0.792],[0.773],0.83,0.534,0.628,0.174,0.186,0.146,0.742,0.643,0.601,0.698,0.793,0.718,0.613,0.92,0.822,0.748,0.792,0.773
https://doi.org/10.1002/14651858.cd006281.pub5,drug treatment for spinal muscular atrophy type i,1410_drug treatment for spinal muscular atrophy type i.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995983/pdf'],['Drug treatment for spinal muscular atrophy types II and III'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995983/pdf'],['1410_0_drug treatment for spinal muscular atrophy types ii and iii.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995983/pdf'],['1410_0_drug treatment for spinal muscular atrophy types ii and iii.pdf'],[0.843],[0.529],[0.618],[0.166],[0.175],[0.137],[0.739],[0.644],[0.596],[0.703],[0.784],[0.704],[0.605],[0.912],[0.822],[0.729],[0.785],[0.759],0.843,0.529,0.618,0.166,0.175,0.137,0.739,0.644,0.596,0.703,0.784,0.704,0.605,0.912,0.822,0.729,0.785,0.759
https://doi.org/10.1002/14651858.cd006285.pub2,autoinflation for hearing loss associated with otitis media with effusion,1411_autoinflation for hearing loss associated with otitis media with effusion.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117560/pdf'],['Antibiotics for otitis media with effusion in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117560/pdf'],['1411_0_antibiotics for otitis media with effusion in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117560/pdf'],['1411_0_antibiotics for otitis media with effusion in children.pdf'],[0.688],[0.516],[0.603],[0.182],[0.167],[0.144],[0.74],[0.649],[0.58],[0.686],[0.774],[0.689],[0.59],[0.905],[0.794],[0.719],[0.771],[0.751],0.688,0.516,0.603,0.182,0.167,0.144,0.74,0.649,0.58,0.686,0.774,0.689,0.59,0.905,0.794,0.719,0.771,0.751
https://doi.org/10.1002/14651858.cd006309.pub2,psychosocial and psychological interventions for treating antenatal depression,1412_psychosocial and psychological interventions for treating antenatal depression.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928931/pdf']","['Assessment and support during early labour for improving birth outcomes', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?', 'Dance movement therapy for depression']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1412_2_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1412_0_assessment and support during early labour for improving birth outcomes.pdf', '1412_3_dance movement therapy for depression.pdf', '1412_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928931/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1412_2_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf', '1412_0_assessment and support during early labour for improving birth outcomes.pdf', '1412_3_dance movement therapy for depression.pdf', '1412_1_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.48, 0.447, 0.215, 0.615]","[0.575, 0.525, 0.535, 0.527]","[0.653, 0.611, 0.625, 0.621]","[0.186, 0.177, 0.17, 0.166]","[0.169, 0.185, 0.183, 0.175]","[0.149, 0.153, 0.15, 0.148]","[0.741, 0.735, 0.732, 0.732]","[0.645, 0.64, 0.637, 0.637]","[0.636, 0.581, 0.601, 0.599]","[0.665, 0.692, 0.705, 0.689]","[0.815, 0.773, 0.787, 0.787]","[0.758, 0.7, 0.719, 0.699]","[0.637, 0.585, 0.603, 0.602]","[0.93, 0.904, 0.92, 0.927]","[0.842, 0.805, 0.83, 0.819]","[0.785, 0.715, 0.743, 0.736]","[0.821, 0.774, 0.791, 0.787]","[0.802, 0.744, 0.773, 0.774]",0.439,0.541,0.627,0.175,0.178,0.15,0.735,0.64,0.604,0.688,0.79,0.719,0.607,0.92,0.824,0.745,0.793,0.773
https://doi.org/10.1002/14651858.cd006316.pub3,pneumococcal vaccines for children and adults with bronchiectasis,1413_pneumococcal vaccines for children and adults with bronchiectasis.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422320/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086475/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457746/pdf']","['Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease', 'Interventions for bronchiectasis: an overview of Cochrane systematic reviews', 'Pneumococcal vaccines for cystic fibrosis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422320/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086475/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457746/pdf']","['1413_0_pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.pdf', '1413_1_interventions for bronchiectasis an overview of cochrane systematic reviews.pdf', '1413_2_pneumococcal vaccines for cystic fibrosis.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422320/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086475/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457746/pdf']","['1413_0_pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.pdf', '1413_1_interventions for bronchiectasis an overview of cochrane systematic reviews.pdf', '1413_2_pneumococcal vaccines for cystic fibrosis.pdf']","[0.739, 0.498, 0.629]","[0.511, 0.513, 0.532]","[0.601, 0.604, 0.626]","[0.185, 0.177, 0.187]","[0.191, 0.186, 0.205]","[0.159, 0.15, 0.166]","[0.746, 0.741, 0.745]","[0.654, 0.649, 0.652]","[0.574, 0.578, 0.596]","[0.698, 0.693, 0.697]","[0.775, 0.775, 0.788]","[0.687, 0.692, 0.705]","[0.594, 0.602, 0.606]","[0.907, 0.906, 0.92]","[0.8, 0.8, 0.821]","[0.717, 0.715, 0.74]","[0.766, 0.769, 0.777]","[0.746, 0.743, 0.767]",0.622,0.519,0.61,0.183,0.194,0.158,0.744,0.652,0.583,0.696,0.779,0.695,0.601,0.911,0.807,0.724,0.771,0.752
https://doi.org/10.1002/14651858.cd006318.pub3,maintenance agonist treatments for opiatedependent pregnant women,1414_maintenance agonist treatments for opiatedependent pregnant women.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027221/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910124/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'http://www.floridahealth.gov/programs-and-services/womens-health/pregnancy/14_2015-title-v-brief-substance-exposed-newborns-final-11-06-2014.pdf', 'https://www.rand.org/pubs/research_reports/RRA858-1.html', 'https://www.rand.org/pubs/research_reports/RR1823.html', 'https://www.rand.org/pubs/working_papers/WR1263.html']","['Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders', 'Interventions for female drug‐using offenders', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Neonatal Abstinence Syndrome', 'Examining Interventions to Address Infant Mortality in Allegheny County, Pennsylvania', 'Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016', 'Evidence on the Effectiveness of Heroin-Assisted Treatment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910124/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027221/pdf', 'http://www.floridahealth.gov/programs-and-services/womens-health/pregnancy/14_2015-title-v-brief-substance-exposed-newborns-final-11-06-2014.pdf']","['1414_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1414_1_interventions for female drug‐using offenders.pdf', '1414_0_dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.pdf', '1414_3_neonatal abstinence syndrome.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910124/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027221/pdf', 'http://www.floridahealth.gov/programs-and-services/womens-health/pregnancy/14_2015-title-v-brief-substance-exposed-newborns-final-11-06-2014.pdf']","['1414_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1414_1_interventions for female drug‐using offenders.pdf', '1414_0_dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.pdf', '1414_3_neonatal abstinence syndrome.pdf']","[0.712, 0.675, 0.407, 0.225]","[0.51, 0.515, 0.516, 0.511]","[0.6, 0.597, 0.602, 0.597]","[0.159, 0.174, 0.182, 0.162]","[0.168, 0.175, 0.189, 0.177]","[0.14, 0.152, 0.161, 0.146]","[0.73, 0.735, 0.737, 0.73]","[0.635, 0.641, 0.645, 0.635]","[0.582, 0.57, 0.572, 0.575]","[0.685, 0.695, 0.699, 0.658]","[0.775, 0.767, 0.769, 0.78]","[0.685, 0.692, 0.691, 0.701]","[0.597, 0.584, 0.593, 0.602]","[0.914, 0.899, 0.904, 0.91]","[0.8, 0.796, 0.797, 0.816]","[0.719, 0.711, 0.716, 0.737]","[0.771, 0.766, 0.766, 0.782]","[0.756, 0.742, 0.746, 0.765]",0.505,0.513,0.599,0.169,0.177,0.15,0.733,0.639,0.575,0.684,0.773,0.692,0.594,0.907,0.802,0.721,0.771,0.752
https://doi.org/10.1002/14651858.cd006404,pyronaridine for treating uncomplicated malaria,1415_pyronaridine for treating uncomplicated malaria.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353203/pdf']","['Pyronaridine‐artesunate for treating uncomplicated malaria', 'Pyronaridine‐artesunate for treating uncomplicated malaria']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353203/pdf']","['1415_0_pyronaridine‐artesunate for treating uncomplicated malaria.pdf', '1415_1_pyronaridine‐artesunate for treating uncomplicated malaria.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353203/pdf']","['1415_0_pyronaridine‐artesunate for treating uncomplicated malaria.pdf', '1415_1_pyronaridine‐artesunate for treating uncomplicated malaria.pdf']","[0.498, 0.469]","[0.504, 0.496]","[0.604, 0.595]","[0.157, 0.154]","[0.163, 0.162]","[0.139, 0.138]","[0.738, 0.738]","[0.642, 0.643]","[0.576, 0.568]","[0.695, 0.693]","[0.774, 0.774]","[0.688, 0.681]","[0.584, 0.589]","[0.921, 0.917]","[0.815, 0.805]","[0.717, 0.715]","[0.77, 0.769]","[0.75, 0.748]",0.483,0.5,0.599,0.155,0.163,0.139,0.738,0.643,0.572,0.694,0.774,0.684,0.587,0.919,0.81,0.716,0.77,0.749
https://doi.org/10.1002/14651858.cd006410.pub2,alternatives to inpatient mental health care for children and young people,1416_alternatives to inpatient mental health care for children and young people.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204394/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052814/pdf']","['Crisis intervention for people with severe mental illnesses', 'Hospital at home early discharge', 'Crisis intervention for people with severe mental illnesses']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052814/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204394/pdf']","['1416_1_hospital at home early discharge.pdf', '1416_2_crisis intervention for people with severe mental illnesses.pdf', '1416_0_crisis intervention for people with severe mental illnesses.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175532/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052814/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204394/pdf']","['1416_1_hospital at home early discharge.pdf', '1416_2_crisis intervention for people with severe mental illnesses.pdf', '1416_0_crisis intervention for people with severe mental illnesses.pdf']","[0.514, 0.484, 0.557]","[0.5, 0.5, 0.494]","[0.575, 0.573, 0.572]","[0.161, 0.159, 0.154]","[0.155, 0.156, 0.159]","[0.154, 0.146, 0.142]","[0.75, 0.74, 0.736]","[0.658, 0.645, 0.642]","[0.556, 0.555, 0.548]","[0.738, 0.732, 0.731]","[0.738, 0.753, 0.75]","[0.678, 0.677, 0.684]","[0.589, 0.582, 0.573]","[0.88, 0.89, 0.885]","[0.744, 0.767, 0.766]","[0.672, 0.685, 0.684]","[0.734, 0.752, 0.748]","[0.699, 0.717, 0.714]",0.518,0.498,0.573,0.158,0.157,0.147,0.742,0.648,0.553,0.734,0.747,0.68,0.581,0.885,0.759,0.68,0.745,0.71
https://doi.org/10.1002/14651858.cd006417,schoolbased interventions to postpone sexual intercourse and promote condom use among adolescents,1417_schoolbased interventions to postpone sexual intercourse and promote condom use among adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],"['School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],['1417_0_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461872/pdf'],['1417_0_school‐based interventions for preventing hiv sexually transmitted infections and pregnancy in adolescents.pdf'],[0.6],[0.522],[0.613],[0.187],[0.203],[0.175],[0.74],[0.644],[0.581],[0.703],[0.782],[0.702],[0.59],[0.914],[0.821],[0.73],[0.776],[0.759],0.6,0.522,0.613,0.187,0.203,0.175,0.74,0.644,0.581,0.703,0.782,0.702,0.59,0.914,0.821,0.73,0.776,0.759
https://doi.org/10.1002/14651858.cd006418.pub2,impact of tuberculosis preventive therapy on tuberculosis and mortality in hivinfected children,1418_impact of tuberculosis preventive therapy on tuberculosis and mortality in hivinfected children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618450/pdf'],['Isoniazid for preventing tuberculosis in HIV‐infected children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618450/pdf'],['1418_0_isoniazid for preventing tuberculosis in hiv‐infected children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618450/pdf'],['1418_0_isoniazid for preventing tuberculosis in hiv‐infected children.pdf'],[0.732],[0.546],[0.631],[0.212],[0.226],[0.189],[0.746],[0.649],[0.608],[0.693],[0.79],[0.718],[0.604],[0.924],[0.825],[0.744],[0.788],[0.767],0.732,0.546,0.631,0.212,0.226,0.189,0.746,0.649,0.608,0.693,0.79,0.718,0.604,0.924,0.825,0.744,0.788,0.767
https://doi.org/10.1002/14651858.cd006462.pub4,early additional food and fluids for healthy breastfed fullterm infants,1419_early additional food and fluids for healthy breastfed fullterm infants.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127543/pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/131440']","['Oral dextrose gel to prevent hypoglycaemia in at‐risk neonates', 'ABM Clinical Protocol #3: Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2017', 'Study of the determinants of chronic malnutrition in northern Nigeria: Qualitative evidence from Kebbi and Bauchi states']","['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127543/pdf']","['1419_1_abm clinical protocol 3 supplementary feedings in the healthy term breastfed neonate revised 2017.pdf', '1419_0_oral dextrose gel to prevent hypoglycaemia in at‐risk neonates.pdf']",2,66.67,"['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127543/pdf']","['1419_1_abm clinical protocol 3 supplementary feedings in the healthy term breastfed neonate revised 2017.pdf', '1419_0_oral dextrose gel to prevent hypoglycaemia in at‐risk neonates.pdf']","[0.48, 0.59]","[0.559, 0.526]","[0.632, 0.613]","[0.206, 0.177]","[0.219, 0.17]","[0.178, 0.142]","[0.743, 0.737]","[0.654, 0.645]","[0.62, 0.591]","[0.674, 0.688]","[0.8, 0.779]","[0.738, 0.704]","[0.623, 0.595]","[0.917, 0.904]","[0.825, 0.805]","[0.764, 0.724]","[0.806, 0.778]","[0.785, 0.749]",0.535,0.542,0.623,0.192,0.195,0.16,0.74,0.649,0.605,0.681,0.79,0.721,0.609,0.911,0.815,0.744,0.792,0.767
https://doi.org/10.1002/14651858.cd006475.pub2,probiotics in infants for prevention of allergic disease and food hypersensitivity,1420_probiotics in infants for prevention of allergic disease and food hypersensitivity.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517242/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464137/pdf', 'https://www.allergyparameters.org/app/download/9033341870/2014+Food+Allergy.pdf?t=1626362304']","['Probiotics for treating eczema', 'Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy', 'Food allergy: A practice parameter update—2014']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517242/pdf', 'https://www.allergyparameters.org/app/download/9033341870/2014+Food+Allergy.pdf?t=1626362304', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464137/pdf']","['1420_0_probiotics for treating eczema.pdf', '1420_2_food allergy a practice parameter update—2014.pdf', '1420_1_polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517242/pdf', 'https://www.allergyparameters.org/app/download/9033341870/2014+Food+Allergy.pdf?t=1626362304', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464137/pdf']","['1420_0_probiotics for treating eczema.pdf', '1420_2_food allergy a practice parameter update—2014.pdf', '1420_1_polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.pdf']","[0.532, 0.669, 0.317]","[0.544, 0.577, 0.519]","[0.625, 0.649, 0.602]","[0.186, 0.189, 0.181]","[0.183, 0.199, 0.176]","[0.152, 0.158, 0.152]","[0.739, 0.741, 0.742]","[0.643, 0.641, 0.647]","[0.605, 0.64, 0.575]","[0.682, 0.658, 0.682]","[0.789, 0.809, 0.771]","[0.703, 0.747, 0.678]","[0.596, 0.595, 0.582]","[0.918, 0.93, 0.905]","[0.807, 0.823, 0.775]","[0.742, 0.774, 0.714]","[0.787, 0.812, 0.766]","[0.768, 0.796, 0.735]",0.506,0.547,0.625,0.185,0.186,0.154,0.741,0.644,0.607,0.674,0.79,0.709,0.591,0.918,0.802,0.743,0.788,0.766
https://doi.org/10.1002/14651858.cd006519.pub3,polymerbased oral rehydration solution for treating acute watery diarrhoea,1421_polymerbased oral rehydration solution for treating acute watery diarrhoea.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875065/pdf']","['Probiotics for treating acute infectious diarrhoea', 'Mefloquine for preventing malaria in pregnant women', 'Mefloquine for preventing malaria in pregnant women']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875065/pdf']","['1421_0_probiotics for treating acute infectious diarrhoea.pdf', '1421_1_mefloquine for preventing malaria in pregnant women.pdf', '1421_2_mefloquine for preventing malaria in pregnant women.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166250/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875065/pdf']","['1421_0_probiotics for treating acute infectious diarrhoea.pdf', '1421_1_mefloquine for preventing malaria in pregnant women.pdf', '1421_2_mefloquine for preventing malaria in pregnant women.pdf']","[0.715, 0.405, 0.374]","[0.512, 0.494, 0.495]","[0.606, 0.586, 0.585]","[0.168, 0.155, 0.158]","[0.172, 0.155, 0.155]","[0.138, 0.119, 0.12]","[0.747, 0.743, 0.744]","[0.655, 0.649, 0.651]","[0.574, 0.554, 0.552]","[0.709, 0.687, 0.686]","[0.773, 0.763, 0.765]","[0.666, 0.66, 0.662]","[0.581, 0.572, 0.574]","[0.909, 0.893, 0.886]","[0.799, 0.77, 0.766]","[0.721, 0.705, 0.707]","[0.769, 0.756, 0.756]","[0.75, 0.728, 0.726]",0.498,0.5,0.592,0.16,0.161,0.126,0.745,0.652,0.56,0.694,0.767,0.663,0.576,0.896,0.778,0.711,0.76,0.735
https://doi.org/10.1002/14651858.cd006546.pub3,kinship care for the safety permanency and wellbeing of children removed from the home for maltreatment,1422_kinship care for the safety permanency and wellbeing of children removed from the home for maltreatment.pdf,9,"['https://stacks.cdc.gov/view/cdc/40392', 'https://www.leg.mn.gov/docs/2018/other/181026.pdf', 'https://mn.gov/mmb-stat/results-first/child-welfare-report.pdf', 'https://dcs.az.gov/sites/default/files/DCS-Reports/AZ-Evaluation%20Plan_0-2-29-2016.pdf', 'https://www.acf.hhs.gov/opre/report/conceptual-model-judicial-decision-making-and-hearing-quality-child-welfare', 'https://www.acf.hhs.gov/opre/report/child-welfare-reasonable-efforts-findings-study-refs-understanding-study-design', 'https://www.governor.ny.gov/sites/default/files/atoms/files/2020StateoftheStateBook.pdf', 'https://www1.nyc.gov/assets/acs/pdf/testimony/2018/TaskForceReport.pdf', 'https://www.governor.ny.gov/sites/governor.ny.gov/files/atoms/files/2020StateoftheStateBook.pdf?utm_source=NYSAR+Master+List&utm_campaign=a34fbe5db0-EMAIL_CAMPAIGN_BROKER_AUG2018_COPY_01&utm_medium=email&utm_term=0_f1e488a523-a34fbe5db0-']","['INSPIRE : seven strategies for ending violence against children', 'Child Welfare Inventory and Benefit-Cost Analysis', 'Child Welfare Inventory and Benefit-Cost Analysis', 'Using National Core Indicators (NCI) Data for Quality Improvement Initiatives', 'Conceptual Model of Judicial Decision-Making and Hearing Quality in Child Welfare', 'The Child Welfare Reasonable Efforts Findings Study (REFS): Understanding the Study Design', 'New York State', 'March 2018', 'New York State']","['https://www.leg.mn.gov/docs/2018/other/181026.pdf', 'https://www1.nyc.gov/assets/acs/pdf/testimony/2018/TaskForceReport.pdf', 'https://dcs.az.gov/sites/default/files/DCS-Reports/AZ-Evaluation%20Plan_0-2-29-2016.pdf', 'https://www.governor.ny.gov/sites/governor.ny.gov/files/atoms/files/2020StateoftheStateBook.pdf?utm_source=NYSAR+Master+List&utm_campaign=a34fbe5db0-EMAIL_CAMPAIGN_BROKER_AUG2018_COPY_01&utm_medium=email&utm_term=0_f1e488a523-a34fbe5db0-', 'https://www.governor.ny.gov/sites/default/files/atoms/files/2020StateoftheStateBook.pdf']","['1422_1_child welfare inventory and benefitcost analysis.pdf', '1422_7_march 2018.pdf', '1422_3_using national core indicators nci data for quality improvement initiatives.pdf', '1422_8_new york state.pdf', '1422_6_new york state.pdf']",5,55.56,"['https://www.leg.mn.gov/docs/2018/other/181026.pdf', 'https://www1.nyc.gov/assets/acs/pdf/testimony/2018/TaskForceReport.pdf', 'https://dcs.az.gov/sites/default/files/DCS-Reports/AZ-Evaluation%20Plan_0-2-29-2016.pdf', 'https://www.governor.ny.gov/sites/governor.ny.gov/files/atoms/files/2020StateoftheStateBook.pdf?utm_source=NYSAR+Master+List&utm_campaign=a34fbe5db0-EMAIL_CAMPAIGN_BROKER_AUG2018_COPY_01&utm_medium=email&utm_term=0_f1e488a523-a34fbe5db0-', 'https://www.governor.ny.gov/sites/default/files/atoms/files/2020StateoftheStateBook.pdf']","['1422_1_child welfare inventory and benefitcost analysis.pdf', '1422_7_march 2018.pdf', '1422_3_using national core indicators nci data for quality improvement initiatives.pdf', '1422_8_new york state.pdf', '1422_6_new york state.pdf']","[0.482, 0.435, 0.119, 0.514, 0.119]","[0.539, 0.532, 0.521, 0.495, 0.495]","[0.631, 0.626, 0.615, 0.599, 0.599]","[0.184, 0.199, 0.156, 0.102, 0.102]","[0.209, 0.23, 0.175, 0.104, 0.104]","[0.173, 0.192, 0.148, 0.089, 0.089]","[0.732, 0.735, 0.727, 0.706, 0.706]","[0.638, 0.646, 0.631, 0.61, 0.61]","[0.592, 0.585, 0.573, 0.555, 0.555]","[0.696, 0.693, 0.695, 0.636, 0.636]","[0.793, 0.794, 0.778, 0.786, 0.786]","[0.721, 0.719, 0.704, 0.704, 0.704]","[0.626, 0.628, 0.609, 0.612, 0.612]","[0.909, 0.905, 0.904, 0.905, 0.905]","[0.808, 0.805, 0.8, 0.796, 0.796]","[0.724, 0.72, 0.712, 0.704, 0.704]","[0.794, 0.789, 0.778, 0.776, 0.776]","[0.745, 0.741, 0.733, 0.727, 0.727]",0.334,0.516,0.614,0.149,0.164,0.138,0.721,0.627,0.572,0.671,0.787,0.71,0.617,0.906,0.801,0.713,0.783,0.735
https://doi.org/10.1002/14651858.cd006589.pub4,oral iron supplements for children in malariaendemic areas,1423_oral iron supplements for children in malariaendemic areas.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046492/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805585/pdf']","['Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age', 'Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age', 'Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805585/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046492/pdf']","['1423_0_point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age.pdf', '1423_2_folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.pdf', '1423_1_home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805585/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046492/pdf']","['1423_0_point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age.pdf', '1423_2_folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.pdf', '1423_1_home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.pdf']","[0.707, 0.683, 0.404]","[0.514, 0.515, 0.512]","[0.597, 0.61, 0.596]","[0.174, 0.165, 0.174]","[0.177, 0.171, 0.176]","[0.143, 0.135, 0.145]","[0.739, 0.735, 0.74]","[0.645, 0.639, 0.647]","[0.576, 0.58, 0.57]","[0.707, 0.708, 0.711]","[0.776, 0.776, 0.773]","[0.678, 0.684, 0.668]","[0.592, 0.581, 0.591]","[0.908, 0.911, 0.906]","[0.801, 0.814, 0.797]","[0.73, 0.722, 0.725]","[0.776, 0.769, 0.77]","[0.756, 0.753, 0.752]",0.598,0.514,0.601,0.171,0.175,0.141,0.738,0.644,0.575,0.709,0.775,0.677,0.588,0.908,0.804,0.726,0.772,0.754
https://doi.org/10.1002/14651858.cd006641.pub2,separate care for new mother and infant versus roomingin for increasing the duration of breastfeeding,1424_separate care for new mother and infant versus roomingin for increasing the duration of breastfeeding.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168801/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research']","['Rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168801/pdf'],['1424_0_rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168801/pdf'],['1424_0_rooming‐in for new mother and infant versus separate care for increasing the duration of breastfeeding.pdf'],[0.956],[0.578],[0.659],[0.231],[0.248],[0.202],[0.744],[0.655],[0.64],[0.707],[0.81],[0.753],[0.636],[0.926],[0.849],[0.773],[0.812],[0.795],0.956,0.578,0.659,0.231,0.248,0.202,0.744,0.655,0.64,0.707,0.81,0.753,0.636,0.926,0.849,0.773,0.812,0.795
https://doi.org/10.1002/14651858.cd006641.pub3,roomingin for new mother and infant versus separate care for increasing the duration of breastfeeding,1425_roomingin for new mother and infant versus separate care for increasing the duration of breastfeeding.pdf,2,"['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research']","['ABM Clinical Protocol #3: Supplementary Feedings in the Healthy Term Breastfed Neonate, Revised 2017', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries']",['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf'],['1425_0_abm clinical protocol 3 supplementary feedings in the healthy term breastfed neonate revised 2017.pdf'],1,50.0,['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/3-supplementation-protocol-english.pdf'],['1425_0_abm clinical protocol 3 supplementary feedings in the healthy term breastfed neonate revised 2017.pdf'],[0.47],[0.579],[0.652],[0.207],[0.223],[0.178],[0.74],[0.649],[0.643],[0.668],[0.811],[0.764],[0.636],[0.927],[0.844],[0.783],[0.819],[0.802],0.47,0.579,0.652,0.207,0.223,0.178,0.74,0.649,0.643,0.668,0.811,0.764,0.636,0.927,0.844,0.783,0.819,0.802
https://doi.org/10.1002/14651858.cd006669.pub2,highdose chemotherapy for children and young adults with stage iv rhabdomyosarcoma,1426_highdose chemotherapy for children and young adults with stage iv rhabdomyosarcoma.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478255/pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-transplants.pdf', 'https://www.hca.wa.gov/assets/pebb/regence-ump-preauthreqs-transplants.pdf']","['Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas', 'Transplants, Ventricular Assist Devices, and Utilization Management', 'Transplants, Ventricular Assist Devices, and Utilization Management']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478255/pdf'],['1426_0_autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478255/pdf'],['1426_0_autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.pdf'],[0.618],[0.538],[0.626],[0.188],[0.188],[0.151],[0.743],[0.648],[0.608],[0.697],[0.791],[0.721],[0.602],[0.924],[0.828],[0.744],[0.787],[0.774],0.618,0.538,0.626,0.188,0.188,0.151,0.743,0.648,0.608,0.697,0.791,0.721,0.602,0.924,0.828,0.744,0.787,0.774
https://doi.org/10.1002/14651858.cd006674.pub3,dietary advice interventions in pregnancy for preventing gestational diabetes mellitus,1427_dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485334/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516997/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf']","['Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes', 'Care prior to and during subsequent pregnancies following stillbirth for improving outcomes', 'Probiotics for preventing gestational diabetes', 'Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Different strategies for diagnosing gestational diabetes to improve maternal and infant health', 'Combined diet and exercise interventions for preventing gestational diabetes mellitus']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485334/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516997/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf']","['1427_5_different strategies for diagnosing gestational diabetes to improve maternal and infant health.pdf', '1427_0_oral anti‐diabetic agents for women with established diabetesimpaired glucose tolerance or previous gestational diabetes planning pregnancy or pregnant women with pre‐existing diabetes.pdf', '1427_1_care prior to and during subsequent pregnancies following stillbirth for improving outcomes.pdf', '1427_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1427_3_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '1427_6_combined diet and exercise interventions for preventing gestational diabetes mellitus.pdf', '1427_2_probiotics for preventing gestational diabetes.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483546/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485334/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516997/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485974/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf']","['1427_5_different strategies for diagnosing gestational diabetes to improve maternal and infant health.pdf', '1427_0_oral anti‐diabetic agents for women with established diabetesimpaired glucose tolerance or previous gestational diabetes planning pregnancy or pregnant women with pre‐existing diabetes.pdf', '1427_1_care prior to and during subsequent pregnancies following stillbirth for improving outcomes.pdf', '1427_4_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1427_3_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '1427_6_combined diet and exercise interventions for preventing gestational diabetes mellitus.pdf', '1427_2_probiotics for preventing gestational diabetes.pdf']","[0.554, 0.483, 0.61, 0.624, 0.435, 0.595, 0.702]","[0.52, 0.524, 0.516, 0.513, 0.511, 0.518, 0.52]","[0.608, 0.615, 0.605, 0.609, 0.604, 0.605, 0.608]","[0.192, 0.206, 0.197, 0.174, 0.187, 0.199, 0.194]","[0.185, 0.193, 0.178, 0.179, 0.187, 0.187, 0.178]","[0.161, 0.165, 0.155, 0.152, 0.158, 0.163, 0.156]","[0.741, 0.747, 0.747, 0.736, 0.742, 0.745, 0.743]","[0.647, 0.652, 0.654, 0.642, 0.648, 0.651, 0.65]","[0.586, 0.587, 0.572, 0.591, 0.58, 0.582, 0.587]","[0.7, 0.689, 0.692, 0.693, 0.698, 0.703, 0.707]","[0.771, 0.774, 0.763, 0.776, 0.769, 0.768, 0.771]","[0.689, 0.691, 0.68, 0.686, 0.686, 0.677, 0.686]","[0.588, 0.591, 0.584, 0.593, 0.589, 0.59, 0.587]","[0.897, 0.894, 0.88, 0.906, 0.897, 0.896, 0.894]","[0.801, 0.799, 0.793, 0.8, 0.792, 0.797, 0.798]","[0.717, 0.716, 0.704, 0.717, 0.712, 0.715, 0.711]","[0.774, 0.772, 0.76, 0.774, 0.768, 0.771, 0.77]","[0.744, 0.744, 0.73, 0.753, 0.74, 0.742, 0.741]",0.572,0.517,0.608,0.193,0.184,0.159,0.743,0.649,0.584,0.697,0.77,0.685,0.589,0.895,0.797,0.713,0.77,0.742
https://doi.org/10.1002/14651858.cd006689.pub2,intermittent preventive treatment regimens for malaria in hivpositive pregnant women,1428_intermittent preventive treatment regimens for malaria in hivpositive pregnant women.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf'],['Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf'],['1428_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf'],['1428_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf'],[0.315],[0.497],[0.59],[0.154],[0.15],[0.133],[0.734],[0.639],[0.576],[0.686],[0.773],[0.67],[0.592],[0.91],[0.781],[0.706],[0.764],[0.744],0.315,0.497,0.59,0.154,0.15,0.133,0.734,0.639,0.576,0.686,0.773,0.67,0.592,0.91,0.781,0.706,0.764,0.744
https://doi.org/10.1002/14651858.cd006723.pub2,homebased support for disadvantaged teenage mothers,1429_homebased support for disadvantaged teenage mothers.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483560/pdf']","['Schedules for home visits in the early postpartum period', 'Schedules for home visits in the early postpartum period']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf']","['1429_1_schedules for home visits in the early postpartum period.pdf', '1429_0_schedules for home visits in the early postpartum period.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483560/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407336/pdf']","['1429_1_schedules for home visits in the early postpartum period.pdf', '1429_0_schedules for home visits in the early postpartum period.pdf']","[0.369, 0.296]","[0.525, 0.527]","[0.618, 0.618]","[0.181, 0.181]","[0.186, 0.188]","[0.158, 0.16]","[0.731, 0.73]","[0.637, 0.636]","[0.588, 0.592]","[0.71, 0.712]","[0.782, 0.783]","[0.702, 0.706]","[0.591, 0.595]","[0.915, 0.917]","[0.823, 0.829]","[0.734, 0.733]","[0.783, 0.783]","[0.766, 0.767]",0.333,0.526,0.618,0.181,0.187,0.159,0.73,0.637,0.59,0.711,0.782,0.704,0.593,0.916,0.826,0.734,0.783,0.766
https://doi.org/10.1002/14651858.cd006726.pub2,psychological therapies for the treatment of posttraumatic stress disorder in children and adolescents,1430_psychological therapies for the treatment of posttraumatic stress disorder in children and adolescents.pdf,8,"['https://dir.ca.gov/chswc/Reports/2018/PTSD_September_2018.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991463/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516951/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782594/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136365/pdf']","['Overview of the Behavioral Health of First Responders in California Using PTSD-Related Workers’ Compensation Claims Data', 'Couple and family therapies for post‐traumatic stress disorder (PTSD)', 'Psychological therapies for chronic post‐traumatic stress disorder (PTSD) in adults', 'Psychological therapies for children and adolescents exposed to trauma', 'Internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder (PTSD) in adults', 'Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises', 'Psychological therapies for post‐traumatic stress disorder and comorbid substance use disorder', 'Internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder (PTSD) in adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782594/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516951/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991463/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136365/pdf']","['1430_6_psychological therapies for post‐traumatic stress disorder and comorbid substance use disorder.pdf', '1430_5_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf', '1430_4_internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder ptsd in adults.pdf', '1430_3_psychological therapies for children and adolescents exposed to trauma.pdf', '1430_1_couple and family therapies for post‐traumatic stress disorder ptsd.pdf', '1430_2_psychological therapies for chronic post‐traumatic stress disorder ptsd in adults.pdf', '1430_7_internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder ptsd in adults.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782594/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513488/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516951/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890534/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991463/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136365/pdf']","['1430_6_psychological therapies for post‐traumatic stress disorder and comorbid substance use disorder.pdf', '1430_5_psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises.pdf', '1430_4_internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder ptsd in adults.pdf', '1430_3_psychological therapies for children and adolescents exposed to trauma.pdf', '1430_1_couple and family therapies for post‐traumatic stress disorder ptsd.pdf', '1430_2_psychological therapies for chronic post‐traumatic stress disorder ptsd in adults.pdf', '1430_7_internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder ptsd in adults.pdf']","[0.602, 0.715, 0.859, 0.638, 0.747, 0.698, 0.649]","[0.508, 0.505, 0.507, 0.511, 0.507, 0.512, 0.507]","[0.589, 0.584, 0.591, 0.589, 0.592, 0.588, 0.591]","[0.182, 0.175, 0.175, 0.185, 0.178, 0.184, 0.174]","[0.178, 0.164, 0.173, 0.175, 0.177, 0.175, 0.171]","[0.156, 0.149, 0.153, 0.156, 0.153, 0.155, 0.151]","[0.743, 0.748, 0.74, 0.749, 0.743, 0.745, 0.741]","[0.652, 0.657, 0.65, 0.657, 0.651, 0.654, 0.651]","[0.565, 0.567, 0.567, 0.572, 0.564, 0.569, 0.567]","[0.734, 0.751, 0.733, 0.745, 0.727, 0.747, 0.732]","[0.766, 0.761, 0.768, 0.763, 0.762, 0.766, 0.768]","[0.68, 0.654, 0.679, 0.666, 0.68, 0.675, 0.677]","[0.584, 0.587, 0.582, 0.583, 0.579, 0.585, 0.582]","[0.891, 0.893, 0.894, 0.894, 0.89, 0.891, 0.895]","[0.798, 0.79, 0.802, 0.793, 0.801, 0.799, 0.802]","[0.709, 0.705, 0.706, 0.705, 0.706, 0.709, 0.708]","[0.762, 0.754, 0.76, 0.755, 0.759, 0.762, 0.76]","[0.738, 0.739, 0.74, 0.738, 0.738, 0.738, 0.741]",0.701,0.508,0.589,0.179,0.173,0.153,0.744,0.653,0.567,0.738,0.765,0.673,0.583,0.893,0.798,0.707,0.759,0.739
https://doi.org/10.1002/14651858.cd006732.pub2,interventions for improving the adoption of shared decision making by healthcare professionals,1431_interventions for improving the adoption of shared decision making by healthcare professionals.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663950/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621088/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513543/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf']","['Implementing Clinical Practice Guidelines About Health Promotion and Disease Prevention Through Shared Decision Making', 'Implementation strategies for health systems in low‐income countries: an overview of systematic reviews', 'Randomised controlled trials as part of clinical care: A seven‐step routinisation framework proposal', 'Interventions for increasing the use of shared decision making by healthcare professionals', 'Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513543/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663950/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621088/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf']","['1431_3_interventions for increasing the use of shared decision making by healthcare professionals.pdf', '1431_2_randomised controlled trials as part of clinical care a seven‐step routinisation framework proposal.pdf', '1431_0_implementing clinical practice guidelines about health promotion and disease prevention through shared decision making.pdf', '1431_1_implementation strategies for health systems in low‐income countries an overview of systematic reviews.pdf', '1431_4_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513543/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663950/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621088/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491214/pdf']","['1431_3_interventions for increasing the use of shared decision making by healthcare professionals.pdf', '1431_2_randomised controlled trials as part of clinical care a seven‐step routinisation framework proposal.pdf', '1431_0_implementing clinical practice guidelines about health promotion and disease prevention through shared decision making.pdf', '1431_1_implementation strategies for health systems in low‐income countries an overview of systematic reviews.pdf', '1431_4_interventions to improve safe and effective medicines use by consumers an overview of systematic reviews.pdf']","[0.457, 0.543, 0.404, 0.81, 0.502]","[0.539, 0.551, 0.567, 0.55, 0.544]","[0.616, 0.626, 0.646, 0.635, 0.635]","[0.21, 0.19, 0.225, 0.206, 0.213]","[0.216, 0.208, 0.253, 0.218, 0.213]","[0.184, 0.169, 0.202, 0.187, 0.186]","[0.746, 0.738, 0.749, 0.744, 0.74]","[0.656, 0.647, 0.66, 0.654, 0.652]","[0.589, 0.617, 0.628, 0.612, 0.614]","[0.733, 0.712, 0.722, 0.726, 0.718]","[0.768, 0.79, 0.797, 0.786, 0.787]","[0.702, 0.74, 0.749, 0.725, 0.73]","[0.611, 0.633, 0.63, 0.621, 0.628]","[0.904, 0.916, 0.929, 0.928, 0.922]","[0.828, 0.848, 0.851, 0.842, 0.843]","[0.721, 0.761, 0.765, 0.752, 0.744]","[0.776, 0.797, 0.806, 0.794, 0.788]","[0.735, 0.767, 0.774, 0.763, 0.757]",0.543,0.55,0.632,0.209,0.222,0.186,0.743,0.654,0.612,0.722,0.786,0.729,0.625,0.92,0.842,0.749,0.792,0.759
https://doi.org/10.1002/14651858.cd006733.pub2,interventions for improving the psychosocial wellbeing of children affected by hiv and aids,1432_interventions for improving the psychosocial wellbeing of children affected by hiv and aids.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1432_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091544/pdf'],['1432_0_evidence for perinatal and child health care guidelines in crisis settings can cochrane help.pdf'],[0.267],[0.585],[0.664],[0.192],[0.166],[0.148],[0.742],[0.644],[0.651],[0.664],[0.821],[0.764],[0.648],[0.926],[0.858],[0.794],[0.828],[0.813],0.267,0.585,0.664,0.192,0.166,0.148,0.742,0.644,0.651,0.664,0.821,0.764,0.648,0.926,0.858,0.794,0.828,0.813
https://doi.org/10.1002/14651858.cd006748.pub4,social norms information for alcohol misuse in university and college students,1433_social norms information for alcohol misuse in university and college students.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457858/pdf', 'https://mn.gov/mmb-stat/results-first/sud-prevention-inventory.pdf', 'https://mn.gov/mmb-stat/results-first/substance-use-report.pdf', 'https://www.rand.org/pubs/research_reports/RR2178.html', 'https://www.congress.gov/event/116th-congress/house-event/109109', 'https://www.rand.org/pubs/research_reports/RR1352.html']","['Alcohol intake reduction for controlling hypertension', 'Motivational interviewing for the prevention of alcohol misuse in young adults', 'Substance Use Disorder Prevention Inventory', 'Adult and Youth Substance Use Benefit-Cost Analysis', 'Gender Differences in Response to Alcohol Use Disorder Treatment', '“Enhancing Vehicle Technology to Prevent Drunk Driving”', 'Improving Oversight and Coordination of Department of Defense Programs That Address Problematic Behaviors Among Military Personnel']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf']","['1433_1_motivational interviewing for the prevention of alcohol misuse in young adults.pdf', '1433_0_alcohol intake reduction for controlling hypertension.pdf']",2,28.57,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf']","['1433_1_motivational interviewing for the prevention of alcohol misuse in young adults.pdf', '1433_0_alcohol intake reduction for controlling hypertension.pdf']","[0.566, 0.842]","[0.511, 0.507]","[0.596, 0.595]","[0.174, 0.166]","[0.178, 0.168]","[0.152, 0.14]","[0.742, 0.735]","[0.65, 0.642]","[0.575, 0.575]","[0.748, 0.727]","[0.761, 0.765]","[0.681, 0.69]","[0.583, 0.583]","[0.908, 0.907]","[0.803, 0.802]","[0.711, 0.711]","[0.763, 0.764]","[0.741, 0.74]",0.704,0.509,0.595,0.17,0.173,0.146,0.738,0.646,0.575,0.738,0.763,0.685,0.583,0.907,0.802,0.711,0.764,0.74
https://doi.org/10.1002/14651858.cd006780,antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction,1434_antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092635/pdf'],['Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092635/pdf'],['1434_0_venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092635/pdf'],['1434_0_venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.pdf'],[0.503],[0.521],[0.618],[0.17],[0.176],[0.145],[0.739],[0.646],[0.587],[0.682],[0.779],[0.691],[0.578],[0.92],[0.819],[0.727],[0.774],[0.758],0.503,0.521,0.618,0.17,0.176,0.145,0.739,0.646,0.587,0.682,0.779,0.691,0.578,0.92,0.819,0.727,0.774,0.758
https://doi.org/10.1002/14651858.cd006795.pub3,interventions other than pharmacological psychosocial or psychological for treating antenatal depression,1435_interventions other than pharmacological psychosocial or psychological for treating antenatal depression.pdf,5,"['https://effectivehealthcare.ahrq.gov/products/mental-health-pregnancy/research', 'https://www.rand.org/pubs/research_reports/RR1135.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321518/pdf']","['Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions', 'Acupuncture for Major Depressive Disorder', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Omega‐3 fatty acids for the treatment of dementia', 'Omega‐3 fatty acids for depression in adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1435_3_omega‐3 fatty acids for the treatment of dementia.pdf', '1435_4_omega‐3 fatty acids for depression in adults.pdf', '1435_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf']","['1435_3_omega‐3 fatty acids for the treatment of dementia.pdf', '1435_4_omega‐3 fatty acids for depression in adults.pdf', '1435_2_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf']","[0.363, 0.53, 0.649]","[0.518, 0.52, 0.517]","[0.606, 0.608, 0.61]","[0.175, 0.189, 0.169]","[0.17, 0.186, 0.171]","[0.141, 0.16, 0.144]","[0.737, 0.742, 0.734]","[0.641, 0.65, 0.637]","[0.58, 0.578, 0.587]","[0.703, 0.719, 0.693]","[0.775, 0.778, 0.782]","[0.7, 0.698, 0.695]","[0.59, 0.595, 0.596]","[0.895, 0.892, 0.905]","[0.805, 0.796, 0.801]","[0.717, 0.719, 0.719]","[0.773, 0.772, 0.776]","[0.745, 0.741, 0.754]",0.514,0.518,0.608,0.178,0.176,0.148,0.738,0.643,0.582,0.705,0.778,0.698,0.594,0.897,0.801,0.718,0.774,0.747
https://doi.org/10.1002/14651858.cd006822.pub4,heliox for croup in children,1437_heliox for croup in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516979/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406495/pdf']","['Heliox for croup in children', 'Heliox for croup in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516979/pdf']","['1437_1_heliox for croup in children.pdf', '1437_0_heliox for croup in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406495/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516979/pdf']","['1437_1_heliox for croup in children.pdf', '1437_0_heliox for croup in children.pdf']","[0.932, 0.933]","[0.513, 0.514]","[0.597, 0.598]","[0.182, 0.186]","[0.189, 0.194]","[0.151, 0.154]","[0.74, 0.741]","[0.646, 0.648]","[0.581, 0.58]","[0.707, 0.708]","[0.776, 0.775]","[0.705, 0.702]","[0.6, 0.599]","[0.901, 0.898]","[0.809, 0.81]","[0.725, 0.725]","[0.775, 0.774]","[0.755, 0.754]",0.933,0.514,0.597,0.184,0.192,0.152,0.74,0.647,0.581,0.708,0.776,0.704,0.599,0.899,0.81,0.725,0.774,0.754
https://doi.org/10.1002/14651858.cd006883.pub2,antifibrinolytic agents for reducing blood loss in scoliosis surgery in children,1438_antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429347/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838155/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464927/pdf']","['Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis', 'Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders', 'Antifibrinolytic therapy to reduce haemoptysis from any cause']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429347/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464927/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838155/pdf']","['1438_0_tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.pdf', '1438_2_antifibrinolytic therapy to reduce haemoptysis from any cause.pdf', '1438_1_antifibrinolytics lysine analogues for the prevention of bleeding in people with haematological disorders.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429347/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464927/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838155/pdf']","['1438_0_tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.pdf', '1438_2_antifibrinolytic therapy to reduce haemoptysis from any cause.pdf', '1438_1_antifibrinolytics lysine analogues for the prevention of bleeding in people with haematological disorders.pdf']","[0.525, 0.495, 0.48]","[0.553, 0.538, 0.553]","[0.634, 0.627, 0.637]","[0.176, 0.181, 0.192]","[0.187, 0.183, 0.197]","[0.137, 0.143, 0.152]","[0.743, 0.739, 0.739]","[0.652, 0.643, 0.644]","[0.626, 0.607, 0.62]","[0.653, 0.672, 0.674]","[0.807, 0.792, 0.794]","[0.734, 0.719, 0.727]","[0.622, 0.617, 0.616]","[0.922, 0.918, 0.922]","[0.828, 0.823, 0.83]","[0.769, 0.748, 0.752]","[0.806, 0.79, 0.793]","[0.787, 0.77, 0.776]",0.5,0.548,0.633,0.183,0.189,0.144,0.74,0.646,0.618,0.666,0.798,0.727,0.618,0.921,0.827,0.756,0.796,0.778
https://doi.org/10.1002/14651858.cd006901.pub2,nitric oxide donors for cervical ripening and induction of labour,1439_nitric oxide donors for cervical ripening and induction of labour.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513439/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463948/pdf']","['Oral misoprostol for induction of labour', 'Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term', 'Castor oil, bath and/or enema for cervical priming and induction of labour', 'Nitric oxide donors for cervical ripening and induction of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513439/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138266/pdf']","['1439_1_vaginal prostaglandin pge2 and pgf2a for induction of labour at term.pdf', '1439_3_nitric oxide donors for cervical ripening and induction of labour.pdf', '1439_0_oral misoprostol for induction of labour.pdf', '1439_2_castor oil bath andor enema for cervical priming and induction of labour.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138281/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513439/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138266/pdf']","['1439_1_vaginal prostaglandin pge2 and pgf2a for induction of labour at term.pdf', '1439_3_nitric oxide donors for cervical ripening and induction of labour.pdf', '1439_0_oral misoprostol for induction of labour.pdf', '1439_2_castor oil bath andor enema for cervical priming and induction of labour.pdf']","[0.518, 0.599, 0.489, 0.942]","[0.526, 0.528, 0.515, 0.512]","[0.599, 0.601, 0.597, 0.595]","[0.213, 0.236, 0.208, 0.193]","[0.171, 0.197, 0.169, 0.166]","[0.167, 0.196, 0.165, 0.148]","[0.757, 0.765, 0.757, 0.747]","[0.667, 0.677, 0.665, 0.653]","[0.584, 0.589, 0.584, 0.574]","[0.686, 0.692, 0.675, 0.688]","[0.762, 0.763, 0.765, 0.762]","[0.607, 0.609, 0.627, 0.634]","[0.589, 0.599, 0.588, 0.578]","[0.892, 0.888, 0.895, 0.896]","[0.793, 0.79, 0.789, 0.793]","[0.727, 0.728, 0.723, 0.719]","[0.757, 0.759, 0.757, 0.754]","[0.74, 0.741, 0.739, 0.738]",0.637,0.52,0.598,0.212,0.176,0.169,0.756,0.666,0.583,0.685,0.763,0.619,0.588,0.893,0.791,0.724,0.757,0.739
https://doi.org/10.1002/14651858.cd006901.pub3,nitric oxide donors for cervical ripening and induction of labour,1440_nitric oxide donors for cervical ripening and induction of labour.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953318/pdf']","['Pharmacological and mechanical interventions for labour induction in outpatient settings', 'Acupuncture or acupressure for induction of labour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953318/pdf']","['1440_0_pharmacological and mechanical interventions for labour induction in outpatient settings.pdf', '1440_1_acupuncture or acupressure for induction of labour.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483740/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953318/pdf']","['1440_0_pharmacological and mechanical interventions for labour induction in outpatient settings.pdf', '1440_1_acupuncture or acupressure for induction of labour.pdf']","[0.593, 0.517]","[0.515, 0.508]","[0.595, 0.587]","[0.207, 0.197]","[0.172, 0.16]","[0.158, 0.151]","[0.753, 0.749]","[0.661, 0.656]","[0.577, 0.57]","[0.682, 0.686]","[0.761, 0.762]","[0.637, 0.634]","[0.586, 0.583]","[0.885, 0.889]","[0.788, 0.78]","[0.714, 0.713]","[0.759, 0.758]","[0.731, 0.73]",0.555,0.512,0.591,0.202,0.166,0.154,0.751,0.659,0.573,0.684,0.762,0.635,0.585,0.887,0.784,0.714,0.758,0.73
https://doi.org/10.1002/14651858.cd006922.pub4,inhaled steroids with and without regular salmeterol for asthma serious adverse events,1441_inhaled steroids with and without regular salmeterol for asthma serious adverse events.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095067/pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item4a.pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item4d.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760886/pdf']","['Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events', 'Glucocorticoids, Inhaled Review', 'Glucocorticoids, Inhaled Review', 'Inhaled steroids with and without regular formoterol for asthma: serious adverse events']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760886/pdf']","['1441_0_regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma serious adverse events.pdf', '1441_3_inhaled steroids with and without regular formoterol for asthma serious adverse events.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760886/pdf']","['1441_0_regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma serious adverse events.pdf', '1441_3_inhaled steroids with and without regular formoterol for asthma serious adverse events.pdf']","[0.843, 0.804]","[0.508, 0.518]","[0.602, 0.601]","[0.188, 0.189]","[0.193, 0.191]","[0.161, 0.159]","[0.747, 0.744]","[0.657, 0.653]","[0.579, 0.588]","[0.699, 0.7]","[0.778, 0.785]","[0.678, 0.685]","[0.585, 0.589]","[0.907, 0.909]","[0.795, 0.8]","[0.713, 0.725]","[0.767, 0.778]","[0.746, 0.757]",0.824,0.513,0.601,0.189,0.192,0.16,0.746,0.655,0.583,0.7,0.782,0.681,0.587,0.908,0.798,0.719,0.772,0.752
https://doi.org/10.1002/14651858.cd006946.pub2,treatments for breast engorgement during lactation,1442_treatments for breast engorgement during lactation.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388926/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226721/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094412/pdf']","['Treatments for breast engorgement during lactation', 'Treatments for breast abscesses in breastfeeding women', 'Treatments for breast engorgement during lactation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226721/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388926/pdf']","['1442_2_treatments for breast engorgement during lactation.pdf', '1442_1_treatments for breast abscesses in breastfeeding women.pdf', '1442_0_treatments for breast engorgement during lactation.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094412/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226721/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388926/pdf']","['1442_2_treatments for breast engorgement during lactation.pdf', '1442_1_treatments for breast abscesses in breastfeeding women.pdf', '1442_0_treatments for breast engorgement during lactation.pdf']","[0.914, 0.725, 0.849]","[0.544, 0.55, 0.555]","[0.626, 0.631, 0.634]","[0.198, 0.187, 0.204]","[0.204, 0.192, 0.213]","[0.175, 0.158, 0.178]","[0.737, 0.732, 0.737]","[0.647, 0.638, 0.646]","[0.6, 0.612, 0.613]","[0.701, 0.682, 0.703]","[0.785, 0.792, 0.793]","[0.719, 0.73, 0.732]","[0.609, 0.616, 0.618]","[0.912, 0.918, 0.914]","[0.824, 0.832, 0.834]","[0.736, 0.752, 0.751]","[0.788, 0.796, 0.797]","[0.76, 0.773, 0.771]",0.829,0.55,0.63,0.196,0.203,0.17,0.735,0.644,0.608,0.695,0.79,0.727,0.614,0.915,0.83,0.746,0.794,0.768
https://doi.org/10.1002/14651858.cd006968.pub2,local interventions for the management of alveolar osteitis dry socket,1443_local interventions for the management of alveolar osteitis dry socket.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094158/pdf'],['Antibiotics to prevent complications following tooth extractions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094158/pdf'],['1443_0_antibiotics to prevent complications following tooth extractions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094158/pdf'],['1443_0_antibiotics to prevent complications following tooth extractions.pdf'],[0.724],[0.528],[0.615],[0.176],[0.17],[0.14],[0.741],[0.647],[0.595],[0.686],[0.78],[0.698],[0.592],[0.917],[0.818],[0.734],[0.783],[0.762],0.724,0.528,0.615,0.176,0.17,0.14,0.741,0.647,0.595,0.686,0.78,0.698,0.592,0.917,0.818,0.734,0.783,0.762
https://doi.org/10.1002/14651858.cd006975.pub4,vaccines for preventing invasive salmonella infections in people with sickle cell disease,1444_vaccines for preventing invasive salmonella infections in people with sickle cell disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517230/pdf'],['Vaccines for preventing invasive salmonella infections in people with sickle cell disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517230/pdf'],['1444_0_vaccines for preventing invasive salmonella infections in people with sickle cell disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517230/pdf'],['1444_0_vaccines for preventing invasive salmonella infections in people with sickle cell disease.pdf'],[0.978],[0.55],[0.646],[0.184],[0.19],[0.168],[0.743],[0.645],[0.616],[0.699],[0.796],[0.721],[0.622],[0.928],[0.834],[0.757],[0.792],[0.784],0.978,0.55,0.646,0.184,0.19,0.168,0.743,0.645,0.616,0.699,0.796,0.721,0.622,0.928,0.834,0.757,0.792,0.784
https://doi.org/10.1002/14651858.cd006980.pub3,neonatal vitamin a supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries,1445_neonatal vitamin a supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509778/pdf'],['Fortification of staple foods with vitamin A for vitamin A deficiency'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509778/pdf'],['1445_0_fortification of staple foods with vitamin a for vitamin a deficiency.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509778/pdf'],['1445_0_fortification of staple foods with vitamin a for vitamin a deficiency.pdf'],[0.604],[0.51],[0.597],[0.18],[0.181],[0.149],[0.738],[0.643],[0.573],[0.693],[0.771],[0.678],[0.601],[0.902],[0.796],[0.717],[0.771],[0.746],0.604,0.51,0.597,0.18,0.181,0.149,0.738,0.643,0.573,0.693,0.771,0.678,0.601,0.902,0.796,0.717,0.771,0.746
https://doi.org/10.1002/14651858.cd006997.pub2,tricyclic antidepressants for attention deficit hyperactivity disorder adhd in children and adolescents,1446_tricyclic antidepressants for attention deficit hyperactivity disorder adhd in children and adolescents.pdf,3,"['http://jchc.virginia.gov/4.%20Staff%20Report.%20ADHD%20Study.%20HB1500(A)%20(2017)%20-%209.17.17.pdf', 'http://jchc.virginia.gov/JCHC%202017%20Annual%20Report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513464/pdf']","['ADHD prevalence and Risks of ADHD Medications in Virginia', 'JCHC%202017%20Annual%20Report', 'Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults']","['http://jchc.virginia.gov/JCHC%202017%20Annual%20Report.pdf', 'http://jchc.virginia.gov/4.%20Staff%20Report.%20ADHD%20Study.%20HB1500(A)%20(2017)%20-%209.17.17.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513464/pdf']","['1446_1_jchc20201720annual20report.pdf', '1446_0_adhd prevalence and risks of adhd medications in virginia.pdf', '1446_2_amphetamines for attention deficit hyperactivity disorder adhd in adults.pdf']",3,100.0,"['http://jchc.virginia.gov/JCHC%202017%20Annual%20Report.pdf', 'http://jchc.virginia.gov/4.%20Staff%20Report.%20ADHD%20Study.%20HB1500(A)%20(2017)%20-%209.17.17.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513464/pdf']","['1446_1_jchc20201720annual20report.pdf', '1446_0_adhd prevalence and risks of adhd medications in virginia.pdf', '1446_2_amphetamines for attention deficit hyperactivity disorder adhd in adults.pdf']","[0.285, 0.147, 0.601]","[0.492, 0.497, 0.51]","[0.589, 0.594, 0.594]","[0.129, 0.173, 0.185]","[0.123, 0.171, 0.173]","[0.104, 0.146, 0.15]","[0.721, 0.74, 0.742]","[0.625, 0.65, 0.65]","[0.565, 0.569, 0.578]","[0.661, 0.702, 0.726]","[0.784, 0.781, 0.777]","[0.704, 0.683, 0.684]","[0.579, 0.575, 0.588]","[0.909, 0.908, 0.903]","[0.806, 0.787, 0.801]","[0.731, 0.719, 0.723]","[0.773, 0.763, 0.767]","[0.757, 0.754, 0.752]",0.344,0.5,0.592,0.162,0.156,0.133,0.734,0.642,0.571,0.696,0.781,0.69,0.581,0.907,0.798,0.724,0.768,0.754
https://doi.org/10.1002/14651858.cd007007.pub3,screening women for intimate partner violence in healthcare settings,1447_screening women for intimate partner violence in healthcare settings.pdf,7,"['https://www.acf.hhs.gov/opre/resource/state-of-the-evidence-evidence-on-recognizing-and-addressing-intimate-partner-violence-in-healthy-relationship-programs', 'https://www.cgdev.org/publication/pandemics-and-violence-against-women-and-children', 'https://www.acf.hhs.gov/opre/report/state-evidence-evidence-recognizing-and-addressing-intimate-partner-violence-healthy', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390063/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf']","['State of the Evidence: Evidence on Recognizing and Addressing Intimate Partner Violence in Healthy Relationship Programs', 'Pandemics and Violence Against Women and Children', 'State of the Evidence: Evidence on Recognizing and Addressing Intimate Partner Violence in Healthy Relationship Programs', 'Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'Training healthcare providers to respond to intimate partner violence against women', 'Psychological therapies for women who experience intimate partner violence', 'Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390063/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166264/pdf']","['1447_5_psychological therapies for women who experience intimate partner violence.pdf', '1447_3_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1447_6_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse.pdf', '1447_4_training healthcare providers to respond to intimate partner violence against women.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390063/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166264/pdf']","['1447_5_psychological therapies for women who experience intimate partner violence.pdf', '1447_3_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1447_6_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse.pdf', '1447_4_training healthcare providers to respond to intimate partner violence against women.pdf']","[0.436, 0.741, 0.692, 0.751]","[0.542, 0.527, 0.53, 0.554]","[0.621, 0.616, 0.608, 0.63]","[0.192, 0.16, 0.186, 0.197]","[0.188, 0.161, 0.187, 0.198]","[0.163, 0.135, 0.163, 0.17]","[0.735, 0.729, 0.735, 0.737]","[0.645, 0.635, 0.644, 0.647]","[0.597, 0.601, 0.581, 0.609]","[0.707, 0.686, 0.711, 0.702]","[0.786, 0.791, 0.779, 0.79]","[0.711, 0.705, 0.7, 0.715]","[0.604, 0.606, 0.598, 0.614]","[0.912, 0.918, 0.904, 0.91]","[0.828, 0.82, 0.816, 0.832]","[0.739, 0.736, 0.724, 0.741]","[0.789, 0.789, 0.779, 0.794]","[0.768, 0.772, 0.754, 0.768]",0.655,0.538,0.619,0.184,0.183,0.158,0.734,0.643,0.597,0.702,0.786,0.708,0.605,0.911,0.824,0.735,0.788,0.766
https://doi.org/10.1002/14651858.cd007025.pub4,motivational interviewing for the prevention of alcohol misuse in young adults,1448_motivational interviewing for the prevention of alcohol misuse in young adults.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699669/pdf', 'https://www.rand.org/pubs/research_reports/RR2178.html', 'https://www2.illinois.gov/dcfs/aboutus/Documents/Illinois_DCFS_Title_IV-E_Family_First_Prevention_Plan_102621.pdf']","['Alcohol intake reduction for controlling hypertension', 'Motivational interviewing for smoking cessation', 'Gender Differences in Response to Alcohol Use Disorder Treatment', 'Marc D. Smith, Acting Director']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699669/pdf']","['1448_0_alcohol intake reduction for controlling hypertension.pdf', '1448_1_motivational interviewing for smoking cessation.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699669/pdf']","['1448_0_alcohol intake reduction for controlling hypertension.pdf', '1448_1_motivational interviewing for smoking cessation.pdf']","[0.598, 0.613]","[0.505, 0.516]","[0.595, 0.597]","[0.17, 0.175]","[0.171, 0.174]","[0.144, 0.147]","[0.736, 0.737]","[0.644, 0.646]","[0.57, 0.575]","[0.732, 0.733]","[0.761, 0.769]","[0.687, 0.688]","[0.583, 0.587]","[0.901, 0.905]","[0.799, 0.806]","[0.706, 0.718]","[0.76, 0.768]","[0.734, 0.746]",0.605,0.51,0.596,0.172,0.172,0.145,0.736,0.645,0.573,0.732,0.765,0.688,0.585,0.903,0.802,0.712,0.764,0.74
https://doi.org/10.1002/14651858.cd007122.pub4,different strategies for diagnosing gestational diabetes to improve maternal and infant health,1452_different strategies for diagnosing gestational diabetes to improve maternal and infant health.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485695/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf', 'https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6']","['Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews', 'ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus', 'Different methods and settings for glucose monitoring for gestational diabetes during pregnancy', 'Implications of the introduction of new criteria for the diagnosis of gestational diabetes: a health outcome and cost of care analysis', 'Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants', 'American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update']","['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485695/pdf']","['1452_5_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf', '1452_3_implications of the introduction of new criteria for the diagnosis of gestational diabetes a health outcome and cost of care analysis.pdf', '1452_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1452_1_endocrinology in the time of covid19 diagnosis and management of gestational diabetes mellitus.pdf', '1452_4_planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.pdf', '1452_2_different methods and settings for glucose monitoring for gestational diabetes during pregnancy.pdf']",6,100.0,"['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326329/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938017/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491311/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485695/pdf']","['1452_5_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf', '1452_3_implications of the introduction of new criteria for the diagnosis of gestational diabetes a health outcome and cost of care analysis.pdf', '1452_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf', '1452_1_endocrinology in the time of covid19 diagnosis and management of gestational diabetes mellitus.pdf', '1452_4_planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.pdf', '1452_2_different methods and settings for glucose monitoring for gestational diabetes during pregnancy.pdf']","[0.428, 0.524, 0.67, 0.532, 0.679, 0.37]","[0.516, 0.526, 0.517, 0.543, 0.525, 0.516]","[0.604, 0.618, 0.612, 0.632, 0.617, 0.604]","[0.163, 0.18, 0.163, 0.203, 0.189, 0.188]","[0.16, 0.189, 0.17, 0.206, 0.187, 0.177]","[0.129, 0.157, 0.145, 0.176, 0.163, 0.157]","[0.737, 0.732, 0.732, 0.741, 0.737, 0.742]","[0.641, 0.64, 0.635, 0.648, 0.643, 0.648]","[0.583, 0.593, 0.594, 0.607, 0.589, 0.577]","[0.67, 0.687, 0.697, 0.68, 0.685, 0.703]","[0.784, 0.777, 0.781, 0.794, 0.777, 0.767]","[0.704, 0.71, 0.693, 0.732, 0.704, 0.685]","[0.587, 0.597, 0.596, 0.607, 0.591, 0.583]","[0.912, 0.905, 0.916, 0.917, 0.908, 0.895]","[0.802, 0.811, 0.807, 0.816, 0.806, 0.797]","[0.741, 0.739, 0.727, 0.755, 0.726, 0.711]","[0.782, 0.783, 0.781, 0.8, 0.778, 0.769]","[0.76, 0.758, 0.762, 0.775, 0.751, 0.74]",0.534,0.524,0.615,0.181,0.181,0.154,0.737,0.642,0.59,0.687,0.78,0.705,0.594,0.909,0.806,0.733,0.782,0.758
https://doi.org/10.1002/14651858.cd007776,preconception care for diabetic women to improve maternal and infant health,1480_preconception care for diabetic women to improve maternal and infant health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164828/pdf'],['Routine pre-pregnancy health promotion for improving pregnancy outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164828/pdf'],['1480_0_routine prepregnancy health promotion for improving pregnancy outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164828/pdf'],['1480_0_routine prepregnancy health promotion for improving pregnancy outcomes.pdf'],[0.519],[0.556],[0.645],[0.185],[0.199],[0.166],[0.733],[0.635],[0.621],[0.692],[0.795],[0.747],[0.595],[0.921],[0.83],[0.759],[0.799],[0.778],0.519,0.556,0.645,0.185,0.199,0.166,0.733,0.635,0.621,0.692,0.795,0.747,0.595,0.921,0.83,0.759,0.799,0.778
https://doi.org/10.1002/14651858.cd007813.pub3,amphetamines for attention deficit hyperactivity disorder adhd in adults,1489_amphetamines for attention deficit hyperactivity disorder adhd in adults.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092481/pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item3cc.pdf']","['Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults', 'Stimulants and Related Agents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092481/pdf'],['1489_0_immediate‐release methylphenidate for attention deficit hyperactivity disorder adhd in adults.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092481/pdf'],['1489_0_immediate‐release methylphenidate for attention deficit hyperactivity disorder adhd in adults.pdf'],[0.644],[0.5],[0.591],[0.179],[0.173],[0.155],[0.742],[0.65],[0.569],[0.727],[0.769],[0.673],[0.587],[0.905],[0.796],[0.718],[0.763],[0.748],0.644,0.5,0.591,0.179,0.173,0.155,0.742,0.65,0.569,0.727,0.769,0.673,0.587,0.905,0.796,0.718,0.763,0.748
https://doi.org/10.1002/14651858.cd007879.pub2,hepatitis b vaccination during pregnancy for preventing infant infection,1491_hepatitis b vaccination during pregnancy for preventing infant infection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185858/pdf'],['Hepatitis B vaccination during pregnancy for preventing infant infection'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185858/pdf'],['1491_0_hepatitis b vaccination during pregnancy for preventing infant infection.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185858/pdf'],['1491_0_hepatitis b vaccination during pregnancy for preventing infant infection.pdf'],[0.936],[0.554],[0.648],[0.197],[0.209],[0.18],[0.744],[0.645],[0.622],[0.691],[0.803],[0.731],[0.611],[0.932],[0.833],[0.759],[0.797],[0.786],0.936,0.554,0.648,0.197,0.209,0.18,0.744,0.645,0.622,0.691,0.803,0.731,0.611,0.932,0.833,0.759,0.797,0.786
https://doi.org/10.1002/14651858.cd007892.pub7,vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections,1498_vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386833/pdf'],['Skin preparation for preventing infection following caesarean section'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386833/pdf'],['1498_0_skin preparation for preventing infection following caesarean section.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386833/pdf'],['1498_0_skin preparation for preventing infection following caesarean section.pdf'],[0.761],[0.529],[0.615],[0.186],[0.183],[0.159],[0.74],[0.648],[0.594],[0.687],[0.783],[0.696],[0.595],[0.917],[0.814],[0.724],[0.779],[0.755],0.761,0.529,0.615,0.186,0.183,0.159,0.74,0.648,0.594,0.687,0.783,0.696,0.595,0.917,0.814,0.724,0.779,0.755
https://doi.org/10.1002/14651858.cd007939.pub2,single herbal medicine for diabetic retinopathy,1502_single herbal medicine for diabetic retinopathy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517038/pdf'],['Single herbal medicine for diabetic retinopathy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517038/pdf'],['1502_0_single herbal medicine for diabetic retinopathy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517038/pdf'],['1502_0_single herbal medicine for diabetic retinopathy.pdf'],[0.963],[0.534],[0.624],[0.187],[0.189],[0.153],[0.739],[0.645],[0.603],[0.715],[0.788],[0.705],[0.6],[0.916],[0.826],[0.737],[0.784],[0.762],0.963,0.534,0.624,0.187,0.189,0.153,0.739,0.645,0.603,0.715,0.788,0.705,0.6,0.916,0.826,0.737,0.784,0.762
https://doi.org/10.1002/14651858.cd008521.pub4,vaccines for preventing rotavirus diarrhoea vaccines in use,1535_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf'],['Vaccines for preventing rotavirus diarrhoea: vaccines in use'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf'],['1535_0_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf'],['1535_0_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf'],[0.832],[0.513],[0.598],[0.187],[0.174],[0.156],[0.748],[0.661],[0.58],[0.719],[0.773],[0.676],[0.585],[0.912],[0.796],[0.718],[0.77],[0.746],0.832,0.513,0.598,0.187,0.174,0.156,0.748,0.661,0.58,0.719,0.773,0.676,0.585,0.912,0.796,0.718,0.77,0.746
https://doi.org/10.1002/14651858.cd008552.pub6,interventions for increasing fruit and vegetable consumption in children aged five years and under,1542_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['1542_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['1542_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.997],[0.552],[0.64],[0.224],[0.226],[0.198],[0.747],[0.655],[0.61],[0.717],[0.79],[0.698],[0.611],[0.928],[0.841],[0.743],[0.793],[0.781],0.997,0.552,0.64,0.224,0.226,0.198,0.747,0.655,0.61,0.717,0.79,0.698,0.611,0.928,0.841,0.743,0.793,0.781
https://doi.org/10.1002/14651858.cd008888,inhaled corticosteroids for subacute cough in children,1556_inhaled corticosteroids for subacute cough in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934584/pdf'],['Inhaled corticosteroids for subacute and chronic cough in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934584/pdf'],['1556_0_inhaled corticosteroids for subacute and chronic cough in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934584/pdf'],['1556_0_inhaled corticosteroids for subacute and chronic cough in adults.pdf'],[0.559],[0.517],[0.6],[0.165],[0.172],[0.14],[0.733],[0.636],[0.583],[0.71],[0.776],[0.684],[0.584],[0.919],[0.816],[0.724],[0.777],[0.761],0.559,0.517,0.6,0.165,0.172,0.14,0.733,0.636,0.583,0.71,0.776,0.684,0.584,0.919,0.816,0.724,0.777,0.761
https://doi.org/10.1002/14651858.cd008898,restorative justice conferencing for reducing recidivism in young offenders,1559_restorative justice conferencing for reducing recidivism in young offenders.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],"['Individual‐, family‐, and school‐level interventions targeting multiple risk behaviours in young people']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],['1559_0_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517301/pdf'],['1559_0_individual‐ family‐ and school‐level interventions targeting multiple risk behaviours in young people.pdf'],[0.502],[0.511],[0.602],[0.154],[0.168],[0.141],[0.733],[0.636],[0.57],[0.703],[0.771],[0.681],[0.594],[0.912],[0.813],[0.711],[0.769],[0.749],0.502,0.511,0.602,0.154,0.168,0.141,0.733,0.636,0.57,0.703,0.771,0.681,0.594,0.912,0.813,0.711,0.769,0.749
https://doi.org/10.1002/14651858.cd008901.pub4,recombinant growth hormone therapy for cystic fibrosis in children and young adults,1560_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf'],['Recombinant growth hormone therapy for cystic fibrosis in children and young adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf'],['1560_0_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf'],['1560_0_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf'],[0.988],[0.506],[0.587],[0.181],[0.17],[0.152],[0.747],[0.652],[0.565],[0.741],[0.758],[0.672],[0.594],[0.888],[0.79],[0.696],[0.755],[0.731],0.988,0.506,0.587,0.181,0.17,0.152,0.747,0.652,0.565,0.741,0.758,0.672,0.594,0.888,0.79,0.696,0.755,0.731
https://doi.org/10.1002/14651858.cd008959.pub3,home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age,1564_home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf'],['Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf'],['1564_0_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf'],['1564_0_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf'],[0.59],[0.505],[0.589],[0.175],[0.172],[0.151],[0.741],[0.651],[0.56],[0.716],[0.757],[0.661],[0.596],[0.887],[0.772],[0.69],[0.756],[0.72],0.59,0.505,0.589,0.175,0.172,0.151,0.741,0.651,0.56,0.716,0.757,0.661,0.596,0.887,0.772,0.69,0.756,0.72
https://doi.org/10.1002/14651858.cd009197.pub4,periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis,1584_periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953391/pdf'],['Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953391/pdf'],['1584_0_periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953391/pdf'],['1584_0_periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.pdf'],[0.999],[0.539],[0.64],[0.2],[0.213],[0.177],[0.746],[0.657],[0.607],[0.705],[0.79],[0.706],[0.598],[0.924],[0.824],[0.738],[0.786],[0.771],0.999,0.539,0.64,0.2,0.213,0.177,0.746,0.657,0.607,0.705,0.79,0.706,0.598,0.924,0.824,0.738,0.786,0.771
https://doi.org/10.1002/14651858.cd010008.pub4,topiramate for juvenile myoclonic epilepsy,1636_topiramate for juvenile myoclonic epilepsy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612308/pdf'],['Topiramate for juvenile myoclonic epilepsy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612308/pdf'],['1636_0_topiramate for juvenile myoclonic epilepsy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612308/pdf'],['1636_0_topiramate for juvenile myoclonic epilepsy.pdf'],[0.947],[0.523],[0.61],[0.212],[0.203],[0.181],[0.745],[0.656],[0.592],[0.719],[0.777],[0.698],[0.58],[0.899],[0.807],[0.723],[0.772],[0.75],0.947,0.523,0.61,0.212,0.203,0.181,0.745,0.656,0.592,0.719,0.777,0.698,0.58,0.899,0.807,0.723,0.772,0.75
https://doi.org/10.1002/14651858.cd010187.pub2,fortification of maize flour with iron for controlling anaemia and iron deficiency in populations,1645_fortification of maize flour with iron for controlling anaemia and iron deficiency in populations.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599881/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814158/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/134483']","['Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews', 'Wheat flour fortification with iron for reducing anaemia and improving iron status in populations', 'Fortification of wheat and maize flour with folic acid for population health outcomes', 'Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations', 'Fortification of rice with vitamins and minerals for addressing micronutrient malnutrition', 'Hidden hunger: Understanding dietary adequacy in urban and rural food consumption in Senegal']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814158/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599881/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf']","['1645_3_wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.pdf', '1645_4_fortification of rice with vitamins and minerals for addressing micronutrient malnutrition.pdf', '1645_2_fortification of wheat and maize flour with folic acid for population health outcomes.pdf', '1645_0_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1645_1_wheat flour fortification with iron for reducing anaemia and improving iron status in populations.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814158/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599881/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf']","['1645_3_wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.pdf', '1645_4_fortification of rice with vitamins and minerals for addressing micronutrient malnutrition.pdf', '1645_2_fortification of wheat and maize flour with folic acid for population health outcomes.pdf', '1645_0_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1645_1_wheat flour fortification with iron for reducing anaemia and improving iron status in populations.pdf']","[0.635, 0.827, 0.669, 0.872, 0.626]","[0.527, 0.522, 0.54, 0.504, 0.521]","[0.614, 0.608, 0.62, 0.591, 0.607]","[0.182, 0.175, 0.182, 0.175, 0.179]","[0.193, 0.183, 0.194, 0.18, 0.184]","[0.155, 0.143, 0.153, 0.149, 0.149]","[0.738, 0.734, 0.733, 0.736, 0.737]","[0.644, 0.639, 0.638, 0.644, 0.642]","[0.596, 0.591, 0.609, 0.561, 0.588]","[0.699, 0.693, 0.69, 0.697, 0.699]","[0.785, 0.783, 0.791, 0.761, 0.781]","[0.699, 0.695, 0.714, 0.68, 0.693]","[0.61, 0.608, 0.617, 0.604, 0.6]","[0.912, 0.91, 0.913, 0.889, 0.91]","[0.821, 0.815, 0.829, 0.778, 0.813]","[0.734, 0.734, 0.746, 0.696, 0.729]","[0.787, 0.787, 0.797, 0.766, 0.782]","[0.765, 0.764, 0.772, 0.724, 0.759]",0.726,0.523,0.608,0.179,0.187,0.15,0.736,0.641,0.589,0.696,0.78,0.696,0.608,0.907,0.811,0.728,0.784,0.757
https://doi.org/10.1002/14651858.cd010211,interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes,1646_interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483533/pdf'],['Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483533/pdf'],['1646_0_interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483533/pdf'],['1646_0_interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes.pdf'],[0.926],[0.559],[0.658],[0.212],[0.232],[0.195],[0.748],[0.655],[0.627],[0.697],[0.802],[0.726],[0.611],[0.935],[0.837],[0.759],[0.801],[0.79],0.926,0.559,0.658,0.212,0.232,0.195,0.748,0.655,0.627,0.697,0.802,0.726,0.611,0.935,0.837,0.759,0.801,0.79
https://doi.org/10.1002/14651858.cd010248,interleukin2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission,1652_interleukin2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783743/pdf'],['Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783743/pdf'],['1652_0_interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783743/pdf'],['1652_0_interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.pdf'],[0.756],[0.505],[0.598],[0.169],[0.172],[0.151],[0.739],[0.645],[0.572],[0.72],[0.765],[0.673],[0.58],[0.915],[0.798],[0.714],[0.761],[0.75],0.756,0.505,0.598,0.169,0.172,0.151,0.739,0.645,0.572,0.72,0.765,0.673,0.58,0.915,0.798,0.714,0.761,0.75
https://doi.org/10.1002/14651858.cd010331.pub2,topical anaesthesia for needlerelated pain in newborn infants,1654_topical anaesthesia for needlerelated pain in newborn infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1654_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf'],['1654_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf'],[0.539],[0.526],[0.614],[0.173],[0.171],[0.139],[0.74],[0.643],[0.589],[0.686],[0.769],[0.701],[0.598],[0.9],[0.793],[0.704],[0.773],[0.733],0.539,0.526,0.614,0.173,0.171,0.139,0.74,0.643,0.589,0.686,0.769,0.701,0.598,0.9,0.793,0.704,0.773,0.733
https://doi.org/10.1002/14651858.cd010403.pub3,maxillary distraction osteogenesis versus orthognathic surgery for cleft lip and palate patients,1657_maxillary distraction osteogenesis versus orthognathic surgery for cleft lip and palate patients.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513261/pdf'],['Maxillary distraction osteogenesis versus orthognathic surgery for cleft lip and palate patients'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513261/pdf'],['1657_0_maxillary distraction osteogenesis versus orthognathic surgery for cleft lip and palate patients.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513261/pdf'],['1657_0_maxillary distraction osteogenesis versus orthognathic surgery for cleft lip and palate patients.pdf'],[0.991],[0.529],[0.621],[0.188],[0.193],[0.165],[0.748],[0.653],[0.599],[0.689],[0.779],[0.708],[0.603],[0.908],[0.825],[0.731],[0.782],[0.76],0.991,0.529,0.621,0.188,0.193,0.165,0.748,0.653,0.599,0.689,0.779,0.708,0.603,0.908,0.825,0.731,0.782,0.76
https://doi.org/10.1002/14651858.cd010534,parentinfant psychotherapy for improving parental and infant mental health,1660_parentinfant psychotherapy for improving parental and infant mental health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685508/pdf'],['Parent‐infant psychotherapy for improving parental and infant mental health'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685508/pdf'],['1660_0_parent‐infant psychotherapy for improving parental and infant mental health.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685508/pdf'],['1660_0_parent‐infant psychotherapy for improving parental and infant mental health.pdf'],[0.769],[0.512],[0.602],[0.175],[0.179],[0.16],[0.741],[0.647],[0.559],[0.718],[0.765],[0.657],[0.578],[0.914],[0.788],[0.714],[0.757],[0.748],0.769,0.512,0.602,0.175,0.179,0.16,0.741,0.647,0.559,0.718,0.765,0.657,0.578,0.914,0.788,0.714,0.757,0.748
https://doi.org/10.1002/14651858.cd010537.pub5,assisted reproductive technology an overview of cochrane reviews,1663_assisted reproductive technology an overview of cochrane reviews.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf'],['Interventions during pregnancy to prevent preterm birth: an overview of Cochrane systematic reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf'],['1663_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516886/pdf'],['1663_0_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf'],[0.496],[0.508],[0.6],[0.173],[0.169],[0.144],[0.735],[0.641],[0.593],[0.68],[0.772],[0.701],[0.603],[0.894],[0.782],[0.677],[0.769],[0.717],0.496,0.508,0.6,0.173,0.169,0.144,0.735,0.641,0.593,0.68,0.772,0.701,0.603,0.894,0.782,0.677,0.769,0.717
https://doi.org/10.1002/14651858.cd010734.pub2,iodine fortification of foods and condiments other than salt for preventing iodine deficiency disorders,1669_iodine fortification of foods and condiments other than salt for preventing iodine deficiency disorders.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf']","['Wheat flour fortification with iron for reducing anaemia and improving iron status in populations', 'Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf']","['1669_1_wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.pdf', '1669_0_wheat flour fortification with iron for reducing anaemia and improving iron status in populations.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf']","['1669_1_wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.pdf', '1669_0_wheat flour fortification with iron for reducing anaemia and improving iron status in populations.pdf']","[0.512, 0.534]","[0.517, 0.515]","[0.609, 0.605]","[0.172, 0.175]","[0.169, 0.167]","[0.132, 0.133]","[0.738, 0.738]","[0.643, 0.643]","[0.584, 0.579]","[0.712, 0.717]","[0.777, 0.775]","[0.683, 0.68]","[0.6, 0.594]","[0.911, 0.909]","[0.814, 0.808]","[0.723, 0.719]","[0.774, 0.772]","[0.755, 0.751]",0.523,0.516,0.607,0.173,0.168,0.133,0.738,0.643,0.581,0.714,0.776,0.681,0.597,0.91,0.811,0.721,0.773,0.753
https://doi.org/10.1002/14651858.cd011118.pub3,psychological therapies remotely delivered for the management of chronic and recurrent pain in children and adolescents,1682_psychological therapies remotely delivered for the management of chronic and recurrent pain in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437545/pdf'],['Psychological therapies for the management of chronic pain (excluding headache) in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437545/pdf'],['1682_0_psychological therapies for the management of chronic pain excluding headache in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437545/pdf'],['1682_0_psychological therapies for the management of chronic pain excluding headache in adults.pdf'],[0.849],[0.52],[0.602],[0.179],[0.181],[0.159],[0.741],[0.648],[0.571],[0.736],[0.76],[0.688],[0.592],[0.908],[0.805],[0.706],[0.758],[0.744],0.849,0.52,0.602,0.179,0.181,0.159,0.741,0.648,0.571,0.736,0.76,0.688,0.592,0.908,0.805,0.706,0.758,0.744
https://doi.org/10.1002/14651858.cd011400.pub2,food fortification with multiple micronutrients impact on health outcomes in general population,1691_food fortification with multiple micronutrients impact on health outcomes in general population.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/134540', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf']","['Wheat flour fortification with iron for reducing anaemia and improving iron status in populations', 'Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews', 'Rice fortification in Bangladesh: Technical feasibility and regulatory requirement for introducing rice fortification in public modern storage/distribution of fortified rice through PFDS channels', 'Wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf']","['1691_3_wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.pdf', '1691_1_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1691_0_wheat flour fortification with iron for reducing anaemia and improving iron status in populations.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407500/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503748/pdf']","['1691_3_wheat flour fortification with iron and other micronutrients for reducing anaemia and improving iron status in populations.pdf', '1691_1_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf', '1691_0_wheat flour fortification with iron for reducing anaemia and improving iron status in populations.pdf']","[0.639, 0.508, 0.683]","[0.519, 0.507, 0.518]","[0.61, 0.594, 0.606]","[0.181, 0.182, 0.181]","[0.181, 0.181, 0.177]","[0.149, 0.154, 0.148]","[0.741, 0.741, 0.74]","[0.647, 0.65, 0.646]","[0.584, 0.565, 0.582]","[0.717, 0.72, 0.721]","[0.773, 0.756, 0.772]","[0.68, 0.671, 0.678]","[0.596, 0.594, 0.59]","[0.911, 0.889, 0.909]","[0.81, 0.774, 0.804]","[0.72, 0.689, 0.717]","[0.773, 0.759, 0.771]","[0.753, 0.72, 0.75]",0.61,0.515,0.603,0.181,0.18,0.15,0.741,0.648,0.577,0.719,0.767,0.676,0.593,0.903,0.796,0.709,0.768,0.741
https://doi.org/10.1002/14651858.cd011737.pub2,reduction in saturated fat intake for cardiovascular disease,1707_reduction in saturated fat intake for cardiovascular disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092457/pdf']","['High versus low‐added sugar consumption for the primary prevention of cardiovascular disease', 'Reduction in saturated fat intake for cardiovascular disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092457/pdf']","['1707_0_high versus low‐added sugar consumption for the primary prevention of cardiovascular disease.pdf', '1707_1_reduction in saturated fat intake for cardiovascular disease.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092457/pdf']","['1707_0_high versus low‐added sugar consumption for the primary prevention of cardiovascular disease.pdf', '1707_1_reduction in saturated fat intake for cardiovascular disease.pdf']","[0.661, 1.0]","[0.511, 0.516]","[0.599, 0.601]","[0.186, 0.193]","[0.17, 0.178]","[0.155, 0.163]","[0.748, 0.75]","[0.66, 0.664]","[0.58, 0.591]","[0.737, 0.734]","[0.764, 0.774]","[0.662, 0.671]","[0.577, 0.578]","[0.91, 0.912]","[0.788, 0.799]","[0.704, 0.71]","[0.758, 0.768]","[0.744, 0.75]",0.831,0.514,0.6,0.19,0.174,0.159,0.749,0.662,0.585,0.736,0.769,0.667,0.577,0.911,0.794,0.707,0.763,0.747
https://doi.org/10.1002/14651858.cd012089.pub2,parentmediated interventions for promoting communication and language development in young children with down syndrome,1735_parentmediated interventions for promoting communication and language development in young children with down syndrome.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf'],['Parent‐mediated interventions for promoting communication and language development in young children with Down syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf'],['1735_0_parent‐mediated interventions for promoting communication and language development in young children with down syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf'],['1735_0_parent‐mediated interventions for promoting communication and language development in young children with down syndrome.pdf'],[0.982],[0.565],[0.644],[0.21],[0.225],[0.193],[0.739],[0.648],[0.625],[0.72],[0.801],[0.737],[0.621],[0.922],[0.84],[0.767],[0.803],[0.791],0.982,0.565,0.644,0.21,0.225,0.193,0.739,0.648,0.625,0.72,0.801,0.737,0.621,0.922,0.84,0.767,0.803,0.791
https://doi.org/10.1002/14651858.cd012203.pub2,care prior to and during subsequent pregnancies following stillbirth for improving outcomes,1747_care prior to and during subsequent pregnancies following stillbirth for improving outcomes.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf'],['Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf'],['1747_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf'],['1747_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf'],[0.506],[0.508],[0.599],[0.172],[0.167],[0.144],[0.74],[0.646],[0.567],[0.69],[0.762],[0.677],[0.579],[0.891],[0.793],[0.702],[0.759],[0.732],0.506,0.508,0.599,0.172,0.167,0.144,0.74,0.646,0.567,0.69,0.762,0.677,0.579,0.891,0.793,0.702,0.759,0.732
https://doi.org/10.1002/14651858.cd012278.pub2,computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife,1751_computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415132/pdf'],['Computerised cognitive training for preventing dementia in people with mild cognitive impairment'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415132/pdf'],['1751_0_computerised cognitive training for preventing dementia in people with mild cognitive impairment.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415132/pdf'],['1751_0_computerised cognitive training for preventing dementia in people with mild cognitive impairment.pdf'],[0.898],[0.524],[0.613],[0.187],[0.198],[0.165],[0.744],[0.653],[0.594],[0.728],[0.783],[0.701],[0.592],[0.916],[0.817],[0.73],[0.777],[0.761],0.898,0.524,0.613,0.187,0.198,0.165,0.744,0.653,0.594,0.728,0.783,0.701,0.592,0.916,0.817,0.73,0.777,0.761
https://doi.org/10.1002/14651858.cd012378.pub2,inositol for subfertile women with polycystic ovary syndrome,1755_inositol for subfertile women with polycystic ovary syndrome.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094745/pdf']","['Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews', 'Antioxidants for female subfertility']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094745/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf']","['1755_1_antioxidants for female subfertility.pdf', '1755_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094745/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf']","['1755_1_antioxidants for female subfertility.pdf', '1755_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf']","[0.577, 0.772]","[0.521, 0.516]","[0.614, 0.61]","[0.19, 0.17]","[0.185, 0.17]","[0.152, 0.137]","[0.744, 0.738]","[0.652, 0.643]","[0.585, 0.582]","[0.683, 0.674]","[0.776, 0.775]","[0.688, 0.693]","[0.599, 0.597]","[0.907, 0.908]","[0.798, 0.793]","[0.723, 0.723]","[0.77, 0.771]","[0.751, 0.749]",0.674,0.518,0.612,0.18,0.177,0.145,0.741,0.647,0.583,0.679,0.776,0.69,0.598,0.907,0.796,0.723,0.77,0.75
https://doi.org/10.1002/14651858.cd012394.pub3,interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews,1757_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['Probiotics for preventing gestational diabetes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['1757_0_probiotics for preventing gestational diabetes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['1757_0_probiotics for preventing gestational diabetes.pdf'],[0.626],[0.515],[0.607],[0.173],[0.169],[0.146],[0.739],[0.644],[0.584],[0.704],[0.771],[0.685],[0.585],[0.907],[0.799],[0.712],[0.769],[0.744],0.626,0.515,0.607,0.173,0.169,0.146,0.739,0.644,0.584,0.704,0.771,0.685,0.585,0.907,0.799,0.712,0.769,0.744
https://doi.org/10.1002/14651858.cd012459.pub2,parent training programmes for managing infantile colic,1759_parent training programmes for managing infantile colic.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf'],['Parent training programmes for managing infantile colic'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf'],['1759_0_parent training programmes for managing infantile colic.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890412/pdf'],['1759_0_parent training programmes for managing infantile colic.pdf'],[1.0],[0.536],[0.623],[0.174],[0.193],[0.161],[0.733],[0.64],[0.603],[0.707],[0.779],[0.707],[0.606],[0.924],[0.83],[0.743],[0.783],[0.772],1.0,0.536,0.623,0.174,0.193,0.161,0.733,0.64,0.603,0.707,0.779,0.707,0.606,0.924,0.83,0.743,0.783,0.772
https://doi.org/10.1002/14651858.cd012505.pub2,interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews,1763_interventions during pregnancy to prevent preterm birth an overview of cochrane systematic reviews.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.rand.org/pubs/research_reports/RR4340.html', 'https://www.congress.gov/event/117th-congress/house-event/111387']","['Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews', 'Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Pregnancy research review', 'Addressing the Maternal Health Crisis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1763_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '1763_1_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf']","['1763_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '1763_1_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf']","[0.746, 0.73]","[0.518, 0.499]","[0.612, 0.589]","[0.167, 0.171]","[0.18, 0.18]","[0.152, 0.154]","[0.735, 0.736]","[0.642, 0.644]","[0.592, 0.572]","[0.694, 0.705]","[0.78, 0.764]","[0.69, 0.685]","[0.605, 0.6]","[0.921, 0.894]","[0.805, 0.771]","[0.722, 0.684]","[0.777, 0.759]","[0.759, 0.719]",0.738,0.508,0.601,0.169,0.18,0.153,0.736,0.643,0.582,0.7,0.772,0.688,0.603,0.907,0.788,0.703,0.768,0.739
https://doi.org/10.1002/14651858.cd012519.pub2,maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants,1766_maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516999/pdf'],['Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516999/pdf'],['1766_0_maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516999/pdf'],['1766_0_maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.pdf'],[0.999],[0.557],[0.645],[0.222],[0.225],[0.199],[0.752],[0.665],[0.615],[0.693],[0.786],[0.705],[0.601],[0.909],[0.819],[0.737],[0.787],[0.766],0.999,0.557,0.645,0.222,0.225,0.199,0.752,0.665,0.615,0.693,0.786,0.705,0.601,0.909,0.819,0.737,0.787,0.766
https://doi.org/10.1002/14651858.cd012527.pub2,psychological interventions to foster resilience in healthcare professionals,1767_psychological interventions to foster resilience in healthcare professionals.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647095/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388680/pdf']","['Pre‐deployment programmes for building resilience in military and frontline emergency service personnel', 'Psychological interventions to foster resilience in healthcare students']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647095/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388680/pdf']","['1767_0_pre‐deployment programmes for building resilience in military and frontline emergency service personnel.pdf', '1767_1_psychological interventions to foster resilience in healthcare students.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647095/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388680/pdf']","['1767_0_pre‐deployment programmes for building resilience in military and frontline emergency service personnel.pdf', '1767_1_psychological interventions to foster resilience in healthcare students.pdf']","[0.714, 0.939]","[0.515, 0.521]","[0.604, 0.611]","[0.173, 0.18]","[0.173, 0.18]","[0.147, 0.159]","[0.737, 0.743]","[0.649, 0.655]","[0.57, 0.575]","[0.721, 0.731]","[0.767, 0.767]","[0.686, 0.682]","[0.583, 0.585]","[0.911, 0.91]","[0.815, 0.816]","[0.715, 0.718]","[0.767, 0.763]","[0.75, 0.758]",0.827,0.518,0.607,0.176,0.176,0.153,0.74,0.652,0.573,0.726,0.767,0.684,0.584,0.911,0.815,0.716,0.765,0.754
https://doi.org/10.1002/14651858.cd012547.pub2,caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors,1773_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf'],"[""Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf'],['1773_0_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf'],['1773_0_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf'],[1.0],[0.542],[0.628],[0.204],[0.208],[0.176],[0.741],[0.647],[0.601],[0.723],[0.78],[0.698],[0.611],[0.91],[0.837],[0.731],[0.784],[0.763],1.0,0.542,0.628,0.204,0.208,0.176,0.741,0.647,0.601,0.723,0.78,0.698,0.611,0.91,0.837,0.731,0.784,0.763
https://doi.org/10.1002/14651858.cd012566.pub2,rinsefree hand wash for reducing absenteeism among preschool and school children,1778_rinsefree hand wash for reducing absenteeism among preschool and school children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['Rinse‐free hand wash for reducing absenteeism among preschool and school children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['1778_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['1778_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],[1.0],[0.536],[0.625],[0.194],[0.202],[0.164],[0.739],[0.645],[0.596],[0.698],[0.781],[0.705],[0.61],[0.921],[0.819],[0.734],[0.782],[0.763],1.0,0.536,0.625,0.194,0.202,0.164,0.739,0.645,0.596,0.698,0.781,0.705,0.61,0.921,0.819,0.734,0.782,0.763
https://doi.org/10.1002/14651858.cd012610.pub2,lipidbased nutrient supplements for maternal birth and infant developmental outcomes,1781_lipidbased nutrient supplements for maternal birth and infant developmental outcomes.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497129/pdf']","['Antenatal interventions for preventing stillbirth, fetal loss and perinatal death: an overview of Cochrane systematic reviews', 'Nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews', 'Preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497129/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf']","['1781_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1781_2_preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health nutrition and developmental outcomes.pdf', '1781_1_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078228/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497129/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464655/pdf']","['1781_0_antenatal interventions for preventing stillbirth fetal loss and perinatal death an overview of cochrane systematic reviews.pdf', '1781_2_preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health nutrition and developmental outcomes.pdf', '1781_1_nutrition‐specific interventions for preventing and controlling anaemia throughout the life cycle an overview of systematic reviews.pdf']","[0.504, 0.459, 0.831]","[0.499, 0.506, 0.501]","[0.583, 0.589, 0.588]","[0.168, 0.178, 0.173]","[0.16, 0.168, 0.167]","[0.142, 0.147, 0.145]","[0.739, 0.742, 0.741]","[0.647, 0.648, 0.649]","[0.562, 0.571, 0.561]","[0.713, 0.726, 0.715]","[0.752, 0.759, 0.75]","[0.672, 0.659, 0.666]","[0.587, 0.587, 0.588]","[0.881, 0.895, 0.881]","[0.767, 0.792, 0.771]","[0.681, 0.708, 0.686]","[0.75, 0.756, 0.752]","[0.709, 0.739, 0.715]",0.598,0.502,0.587,0.173,0.165,0.145,0.741,0.648,0.565,0.718,0.754,0.666,0.587,0.886,0.777,0.692,0.753,0.721
https://doi.org/10.1002/14651858.cd012622.pub2,nonpharmacological interventions for chronic pain in multiple sclerosis,1783_nonpharmacological interventions for chronic pain in multiple sclerosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803560/pdf'],['Palliative care interventions for people with multiple sclerosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803560/pdf'],['1783_0_palliative care interventions for people with multiple sclerosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803560/pdf'],['1783_0_palliative care interventions for people with multiple sclerosis.pdf'],[0.497],[0.538],[0.635],[0.193],[0.199],[0.162],[0.743],[0.65],[0.602],[0.721],[0.781],[0.698],[0.601],[0.924],[0.828],[0.734],[0.782],[0.768],0.497,0.538,0.635,0.193,0.199,0.162,0.743,0.65,0.602,0.721,0.781,0.698,0.601,0.924,0.828,0.734,0.782,0.768
https://doi.org/10.1002/14651858.cd012681.pub2,severe fatigue after treatment for childhood cancer,1785_severe fatigue after treatment for childhood cancer.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059965/pdf'],['Severe fatigue after treatment for childhood cancer'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059965/pdf'],['1785_0_severe fatigue after treatment for childhood cancer.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059965/pdf'],['1785_0_severe fatigue after treatment for childhood cancer.pdf'],[1.0],[0.51],[0.591],[0.176],[0.164],[0.156],[0.747],[0.655],[0.56],[0.736],[0.748],[0.672],[0.594],[0.902],[0.78],[0.689],[0.748],[0.726],1.0,0.51,0.591,0.176,0.164,0.156,0.747,0.655,0.56,0.736,0.748,0.672,0.594,0.902,0.78,0.689,0.748,0.726
https://doi.org/10.1002/14651858.cd012689,insecticide space spraying for preventing malaria transmission,1786_insecticide space spraying for preventing malaria transmission.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516806/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf']","['Insecticide space spraying for preventing malaria transmission', 'Larvivorous fish for preventing malaria transmission']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516806/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf']","['1786_0_insecticide space spraying for preventing malaria transmission.pdf', '1786_1_larvivorous fish for preventing malaria transmission.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516806/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741835/pdf']","['1786_0_insecticide space spraying for preventing malaria transmission.pdf', '1786_1_larvivorous fish for preventing malaria transmission.pdf']","[0.817, 0.431]","[0.536, 0.533]","[0.63, 0.627]","[0.169, 0.152]","[0.172, 0.15]","[0.139, 0.115]","[0.734, 0.728]","[0.64, 0.635]","[0.608, 0.61]","[0.704, 0.69]","[0.796, 0.798]","[0.737, 0.732]","[0.618, 0.611]","[0.925, 0.925]","[0.834, 0.835]","[0.75, 0.751]","[0.799, 0.802]","[0.779, 0.781]",0.624,0.534,0.629,0.161,0.161,0.127,0.731,0.637,0.609,0.697,0.797,0.734,0.615,0.925,0.835,0.75,0.8,0.78
https://doi.org/10.1002/14651858.cd012742.pub2,subconjunctival draining minimallyinvasive glaucoma devices for medically uncontrolled glaucoma,1789_subconjunctival draining minimallyinvasive glaucoma devices for medically uncontrolled glaucoma.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094917/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006956/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388466/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437719/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061024/pdf']","['Ab interno trabecular bypass surgery with Trabectome for open‐angle glaucoma', 'Ab interno supraciliary microstent surgery for open‐angle glaucoma', 'Acupuncture for glaucoma', 'Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure', 'Ab interno trabecular bypass surgery with iStent for open‐angle glaucoma', 'Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006956/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388466/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437719/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061024/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094917/pdf']","['1789_1_ab interno supraciliary microstent surgery for open‐angle glaucoma.pdf', '1789_2_acupuncture for glaucoma.pdf', '1789_3_endoscopic cyclophotocoagulation ecp for open angle glaucoma and primary angle closure.pdf', '1789_4_ab interno trabecular bypass surgery with istent for open‐angle glaucoma.pdf', '1789_5_ab interno trabecular bypass surgery with schlemm´s canal microstent hydrus for open angle glaucoma.pdf', '1789_0_ab interno trabecular bypass surgery with trabectome for open‐angle glaucoma.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006956/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388466/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437719/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061024/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094917/pdf']","['1789_1_ab interno supraciliary microstent surgery for open‐angle glaucoma.pdf', '1789_2_acupuncture for glaucoma.pdf', '1789_3_endoscopic cyclophotocoagulation ecp for open angle glaucoma and primary angle closure.pdf', '1789_4_ab interno trabecular bypass surgery with istent for open‐angle glaucoma.pdf', '1789_5_ab interno trabecular bypass surgery with schlemm´s canal microstent hydrus for open angle glaucoma.pdf', '1789_0_ab interno trabecular bypass surgery with trabectome for open‐angle glaucoma.pdf']","[0.724, 0.735, 0.705, 0.832, 0.64, 0.664]","[0.514, 0.503, 0.523, 0.515, 0.512, 0.518]","[0.614, 0.607, 0.623, 0.613, 0.609, 0.617]","[0.168, 0.161, 0.178, 0.168, 0.168, 0.169]","[0.184, 0.18, 0.194, 0.18, 0.176, 0.186]","[0.148, 0.146, 0.157, 0.15, 0.147, 0.154]","[0.743, 0.739, 0.744, 0.743, 0.744, 0.743]","[0.65, 0.647, 0.653, 0.651, 0.652, 0.65]","[0.586, 0.578, 0.596, 0.587, 0.581, 0.588]","[0.701, 0.705, 0.704, 0.702, 0.702, 0.707]","[0.781, 0.776, 0.79, 0.781, 0.78, 0.783]","[0.694, 0.693, 0.699, 0.692, 0.692, 0.698]","[0.603, 0.598, 0.606, 0.593, 0.599, 0.603]","[0.916, 0.911, 0.921, 0.917, 0.913, 0.916]","[0.809, 0.801, 0.82, 0.807, 0.808, 0.813]","[0.727, 0.717, 0.742, 0.728, 0.726, 0.73]","[0.774, 0.77, 0.782, 0.773, 0.771, 0.775]","[0.758, 0.748, 0.773, 0.759, 0.758, 0.761]",0.717,0.514,0.614,0.169,0.183,0.15,0.743,0.65,0.586,0.704,0.782,0.695,0.6,0.916,0.81,0.728,0.774,0.759
https://doi.org/10.1002/14651858.cd012767.pub2,perioperative restrictive versus goaldirected fluid therapy for adults undergoing major noncardiac surgery,1790_perioperative restrictive versus goaldirected fluid therapy for adults undergoing major noncardiac surgery.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953415/pdf'],['Perioperative restrictive versus goal‐directed fluid therapy for adults undergoing major non‐cardiac surgery'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953415/pdf'],['1790_0_perioperative restrictive versus goal‐directed fluid therapy for adults undergoing major non‐cardiac surgery.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953415/pdf'],['1790_0_perioperative restrictive versus goal‐directed fluid therapy for adults undergoing major non‐cardiac surgery.pdf'],[0.998],[0.529],[0.612],[0.185],[0.188],[0.157],[0.741],[0.645],[0.594],[0.695],[0.776],[0.694],[0.599],[0.915],[0.818],[0.727],[0.778],[0.757],0.998,0.529,0.612,0.185,0.188,0.157,0.741,0.645,0.594,0.695,0.776,0.694,0.599,0.915,0.818,0.727,0.778,0.757
https://doi.org/10.1002/14651858.cd013836.pub2,antibiotic regimens for lateonset neonatal sepsis,1816_antibiotic regimens for lateonset neonatal sepsis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['Antibiotics for hospital‐acquired pneumonia in neonates and children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['1816_0_antibiotics for hospital‐acquired pneumonia in neonates and children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['1816_0_antibiotics for hospital‐acquired pneumonia in neonates and children.pdf'],[0.694],[0.535],[0.623],[0.18],[0.187],[0.158],[0.739],[0.646],[0.602],[0.704],[0.782],[0.708],[0.586],[0.917],[0.819],[0.732],[0.781],[0.764],0.694,0.535,0.623,0.18,0.187,0.158,0.739,0.646,0.602,0.704,0.782,0.708,0.586,0.917,0.819,0.732,0.781,0.764
https://doi.org/10.1002/14651858.cd013837.pub2,antibiotic regimens for earlyonset neonatal sepsis,1817_antibiotic regimens for earlyonset neonatal sepsis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['Antibiotics for hospital‐acquired pneumonia in neonates and children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['1817_0_antibiotics for hospital‐acquired pneumonia in neonates and children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['1817_0_antibiotics for hospital‐acquired pneumonia in neonates and children.pdf'],[0.687],[0.535],[0.626],[0.18],[0.187],[0.157],[0.738],[0.645],[0.603],[0.703],[0.784],[0.708],[0.587],[0.919],[0.819],[0.734],[0.782],[0.765],0.687,0.535,0.626,0.18,0.187,0.157,0.738,0.645,0.603,0.703,0.784,0.708,0.587,0.919,0.819,0.734,0.782,0.765
https://doi.org/10.1002/14651858.mr000051,monitoring strategies for clinical intervention studies,1821_monitoring strategies for clinical intervention studies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653423/pdf'],['Monitoring strategies for clinical intervention studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653423/pdf'],['1821_0_monitoring strategies for clinical intervention studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653423/pdf'],['1821_0_monitoring strategies for clinical intervention studies.pdf'],[0.927],[0.569],[0.651],[0.223],[0.242],[0.209],[0.743],[0.656],[0.626],[0.76],[0.793],[0.724],[0.627],[0.931],[0.846],[0.754],[0.802],[0.784],0.927,0.569,0.651,0.223,0.242,0.209,0.743,0.656,0.626,0.76,0.793,0.724,0.627,0.931,0.846,0.754,0.802,0.784
https://doi.org/10.1002/9780470767603.ch6,youth civic engagement in mexico,1871_youth civic engagement in mexico.pdf,3,"['https://www.in.gov/icsb/files/phalen-leadership-academies-complete-state-application-final.pdf', 'https://www.doe.in.gov/sites/default/files/grants/phalen-leadership-academies-far-eastside-c3-application.pdf', 'https://www.doe.in.gov/sites/default/files/grants/jrphalen-2018-application.pdf']","['Charter School Application', 'Quality Counts : Indiana Charter School Program Grant Application', 'Quality Counts : Indiana Charter School Program Grant Application']",['https://www.in.gov/icsb/files/phalen-leadership-academies-complete-state-application-final.pdf'],['1871_0_charter school application.pdf'],1,33.33,['https://www.in.gov/icsb/files/phalen-leadership-academies-complete-state-application-final.pdf'],['1871_0_charter school application.pdf'],[0.236],[0.512],[0.615],[0.106],[0.12],[0.101],[0.71],[0.604],[0.583],[0.67],[0.799],[0.71],[0.646],[0.919],[0.839],[0.756],[0.799],[0.78],0.236,0.512,0.615,0.106,0.12,0.101,0.71,0.604,0.583,0.67,0.799,0.71,0.646,0.919,0.839,0.756,0.799,0.78
https://doi.org/10.1002/ajcp.12306,policing education an empirical review of the challenges and impact of the work of school police officers,1964_policing education an empirical review of the challenges and impact of the work of school police officers.pdf,4,"['https://www.brookings.edu/multi-chapter-report/a-better-path-forward-for-criminal-justice/', 'https://www.aei.org/research-products/report/a-better-path-forward-for-criminal-justice/', 'https://www.brookings.edu/research/a-better-path-forward-for-criminal-justice-reconsidering-police-in-schools/', 'https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf']","['A better path forward for criminal justice', 'A better path forward for criminal justice - AEI', 'A better path forward for criminal justice: Reconsidering police in schools', '2023 RIPA Board Annual Report - Racial and Identity Profiling Advisory Board - California Department of Justice']",['https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf'],['1964_3_2023 ripa board annual report  racial and identity profiling advisory board  california department of justice.pdf'],1,25.0,['https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf'],['1964_3_2023 ripa board annual report  racial and identity profiling advisory board  california department of justice.pdf'],[0.281],[0.534],[0.618],[0.159],[0.173],[0.144],[0.729],[0.633],[0.598],[0.685],[0.792],[0.726],[0.651],[0.915],[0.839],[0.76],[0.798],[0.779],0.281,0.534,0.618,0.159,0.173,0.144,0.729,0.633,0.598,0.685,0.792,0.726,0.651,0.915,0.839,0.76,0.798,0.779
https://doi.org/10.1002/ajcp.12382,population health and trauma‐informed practice implications for programs systems and policies,1966_population health and trauma‐informed practice implications for programs systems and policies.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['1966_1_well and thriving prevention and early intervention in california  second public draft.pdf', '1966_0_well and thriving prevention and early intervention in california first public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['1966_1_well and thriving prevention and early intervention in california  second public draft.pdf', '1966_0_well and thriving prevention and early intervention in california first public draft.pdf']","[0.63, 0.631]","[0.535, 0.534]","[0.635, 0.636]","[0.175, 0.176]","[0.191, 0.192]","[0.155, 0.156]","[0.736, 0.736]","[0.647, 0.648]","[0.59, 0.59]","[0.699, 0.699]","[0.802, 0.802]","[0.724, 0.724]","[0.629, 0.629]","[0.925, 0.925]","[0.831, 0.83]","[0.763, 0.762]","[0.808, 0.808]","[0.792, 0.791]",0.631,0.534,0.635,0.175,0.192,0.155,0.736,0.647,0.59,0.699,0.802,0.724,0.629,0.925,0.831,0.762,0.808,0.792
https://doi.org/10.1002/ajcp.12487,applying community‐based participatory approaches to addressing health disparities and promoting health equity,1968_applying community‐based participatory approaches to addressing health disparities and promoting health equity.pdf,2,"['https://charlottenc.gov/safecharlotte/Documents/Alternative-Response-Research-Report.pdf', 'https://www.rand.org/pubs/research_reports/RRA1355-1.html']","['Pre-publication Copy', 'SAFE Charlotte']",['https://charlottenc.gov/safecharlotte/Documents/Alternative-Response-Research-Report.pdf'],['1968_0_prepublication copy.pdf'],1,50.0,['https://charlottenc.gov/safecharlotte/Documents/Alternative-Response-Research-Report.pdf'],['1968_0_prepublication copy.pdf'],[0.21],[0.5],[0.596],[0.125],[0.143],[0.109],[0.723],[0.626],[0.565],[0.698],[0.782],[0.681],[0.609],[0.916],[0.826],[0.74],[0.781],[0.762],0.21,0.5,0.596,0.125,0.143,0.109,0.723,0.626,0.565,0.698,0.782,0.681,0.609,0.916,0.826,0.74,0.781,0.762
https://doi.org/10.1002/ajh.25809,covid ‐19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient,1977_covid ‐19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361751/pdf'],['COVID‐19 and thalassaemia: A position statement of the Thalassaemia International Federation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361751/pdf'],['1977_0_covid‐19 and thalassaemia a position statement of the thalassaemia international federation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361751/pdf'],['1977_0_covid‐19 and thalassaemia a position statement of the thalassaemia international federation.pdf'],[0.574],[0.572],[0.647],[0.21],[0.21],[0.168],[0.749],[0.653],[0.637],[0.637],[0.811],[0.762],[0.636],[0.92],[0.845],[0.78],[0.82],[0.791],0.574,0.572,0.647,0.21,0.21,0.168,0.749,0.653,0.637,0.637,0.811,0.762,0.636,0.92,0.845,0.78,0.82,0.791
https://doi.org/10.1002/ajmg.a.61102,parents perspective on having a child with down syndrome in france,2029_parents perspective on having a child with down syndrome in france.pdf,1,['https://law.georgia.gov/document/document/2021-05-13-rutledge-v-little-rock-family-planning-states-amicus-brief-pdf/download'],['In the Supreme Court of the United States'],['https://law.georgia.gov/document/document/2021-05-13-rutledge-v-little-rock-family-planning-states-amicus-brief-pdf/download'],['2029_0_in the supreme court of the united states.pdf'],1,100.0,['https://law.georgia.gov/document/document/2021-05-13-rutledge-v-little-rock-family-planning-states-amicus-brief-pdf/download'],['2029_0_in the supreme court of the united states.pdf'],[0.275],[0.486],[0.578],[0.12],[0.128],[0.115],[0.719],[0.62],[0.544],[0.675],[0.773],[0.675],[0.622],[0.901],[0.817],[0.735],[0.766],[0.754],0.275,0.486,0.578,0.12,0.128,0.115,0.719,0.62,0.544,0.675,0.773,0.675,0.622,0.901,0.817,0.735,0.766,0.754
https://doi.org/10.1002/ajmg.a.61165,expansions and contractions of the fmr1 cgg repeat in 5508 transmissions of normal intermediate and premutation alleles,2030_expansions and contractions of the fmr1 cgg repeat in 5508 transmissions of normal intermediate and premutation alleles.pdf,4,"['https://opwdd.ny.gov/system/files/documents/2019/12/2019-staff-publications_7-29-2019.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf', 'https://www.acmg.net/PDFLibrary/Laboratory-testing-for-fragile-X-2021-revision.pdf', 'https://fr.opwdd.ny.gov/system/files/documents/2019/12/2019-staff-publications_7-29-2019.pdf']","['2019 Staff Publications', '2019 Ibr Staff Publications', 'Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)', '2019 Staff Publications']","['https://opwdd.ny.gov/system/files/documents/2019/12/2019-staff-publications_7-29-2019.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf', 'https://www.acmg.net/PDFLibrary/Laboratory-testing-for-fragile-X-2021-revision.pdf', 'https://fr.opwdd.ny.gov/system/files/documents/2019/12/2019-staff-publications_7-29-2019.pdf']","['2030_0_2019 staff publications.pdf', '2030_1_2019 ibr staff publications.pdf', '2030_2_laboratory testing for fragile x 2021 revision a technical standard of the american college of medical genetics and genomics acmg.pdf', '2030_3_2019 staff publications.pdf']",4,100.0,"['https://opwdd.ny.gov/system/files/documents/2019/12/2019-staff-publications_7-29-2019.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf', 'https://www.acmg.net/PDFLibrary/Laboratory-testing-for-fragile-X-2021-revision.pdf', 'https://fr.opwdd.ny.gov/system/files/documents/2019/12/2019-staff-publications_7-29-2019.pdf']","['2030_0_2019 staff publications.pdf', '2030_1_2019 ibr staff publications.pdf', '2030_2_laboratory testing for fragile x 2021 revision a technical standard of the american college of medical genetics and genomics acmg.pdf', '2030_3_2019 staff publications.pdf']","[0.095, 0.125, 0.633, 0.095]","[0.491, 0.492, 0.521, 0.491]","[0.575, 0.576, 0.61, 0.575]","[0.117, 0.119, 0.174, 0.117]","[0.114, 0.118, 0.198, 0.114]","[0.104, 0.105, 0.16, 0.104]","[0.74, 0.741, 0.745, 0.74]","[0.642, 0.643, 0.651, 0.642]","[0.55, 0.551, 0.576, 0.55]","[0.695, 0.688, 0.712, 0.695]","[0.765, 0.77, 0.785, 0.765]","[0.668, 0.673, 0.721, 0.668]","[0.599, 0.602, 0.642, 0.599]","[0.908, 0.909, 0.913, 0.908]","[0.785, 0.782, 0.794, 0.785]","[0.724, 0.725, 0.758, 0.724]","[0.759, 0.766, 0.784, 0.759]","[0.75, 0.76, 0.776, 0.75]",0.237,0.499,0.584,0.132,0.136,0.118,0.742,0.645,0.557,0.697,0.771,0.683,0.611,0.91,0.787,0.733,0.767,0.759
https://doi.org/10.1002/art.40865,treatment to target using recombinant interleukin‐1 receptor antagonist as first‐line monotherapy in new‐onset systemic juvenile idiopathic arthritis results from a five‐year follow‐up study,2142_treatment to target using recombinant interleukin‐1 receptor antagonist as first‐line monotherapy in new‐onset systemic juvenile idiopathic arthritis results from a five‐year follow‐up study.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.rheumatology.org/Portals/0/Files/ACR-JIA%20Guideline-Oligo-TMJ-sJIA-EarlyView.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf']","['American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', '2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis', 'American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['2142_0_american college of rheumatology clinical guidance for pediatric patients with multisystem inflammatory syndrome in c.pdf', '2142_3_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '2142_1_coronavirus disease 2019 covid19 treatment guidelines.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['2142_0_american college of rheumatology clinical guidance for pediatric patients with multisystem inflammatory syndrome in c.pdf', '2142_3_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '2142_1_coronavirus disease 2019 covid19 treatment guidelines.pdf']","[0.325, 0.296, 0.329]","[0.574, 0.534, 0.542]","[0.648, 0.626, 0.619]","[0.183, 0.18, 0.161]","[0.181, 0.188, 0.16]","[0.129, 0.132, 0.121]","[0.746, 0.745, 0.742]","[0.649, 0.65, 0.645]","[0.635, 0.606, 0.599]","[0.649, 0.658, 0.648]","[0.813, 0.794, 0.794]","[0.751, 0.71, 0.707]","[0.63, 0.597, 0.598]","[0.93, 0.924, 0.905]","[0.836, 0.823, 0.801]","[0.778, 0.753, 0.756]","[0.813, 0.79, 0.791]","[0.799, 0.782, 0.78]",0.317,0.55,0.631,0.175,0.176,0.127,0.744,0.648,0.613,0.652,0.8,0.723,0.608,0.92,0.82,0.762,0.798,0.787
https://doi.org/10.1002/aur.2095,meeting the 24‐hr movement guidelines an update on us youth with autism spectrum disorder from the 2016 national survey of childrens health,2168_meeting the 24‐hr movement guidelines an update on us youth with autism spectrum disorder from the 2016 national survey of childrens health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['2168_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['2168_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.52],[0.533],[0.626],[0.18],[0.199],[0.164],[0.737],[0.646],[0.587],[0.716],[0.788],[0.719],[0.619],[0.922],[0.813],[0.757],[0.787],[0.774],0.52,0.533,0.626,0.18,0.199,0.164,0.737,0.646,0.587,0.716,0.788,0.719,0.619,0.922,0.813,0.757,0.787,0.774
https://doi.org/10.1002/bin.1684,effects of a handwashing intervention package on handwashing in preschool children,2216_effects of a handwashing intervention package on handwashing in preschool children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['Rinse‐free hand wash for reducing absenteeism among preschool and school children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['2216_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['2216_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],[0.371],[0.539],[0.63],[0.18],[0.197],[0.15],[0.734],[0.638],[0.599],[0.69],[0.791],[0.723],[0.623],[0.922],[0.827],[0.752],[0.794],[0.775],0.371,0.539,0.63,0.18,0.197,0.15,0.734,0.638,0.599,0.69,0.791,0.723,0.623,0.922,0.827,0.752,0.794,0.775
https://doi.org/10.1002/bjs.10961,longterm outcomes of endovenous laser ablation and conventional surgery for great saphenous varicose veins,2225_longterm outcomes of endovenous laser ablation and conventional surgery for great saphenous varicose veins.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407488/pdf'],['Interventions for great saphenous vein incompetence'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407488/pdf'],['2225_0_interventions for great saphenous vein incompetence.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407488/pdf'],['2225_0_interventions for great saphenous vein incompetence.pdf'],[0.474],[0.525],[0.609],[0.168],[0.17],[0.132],[0.737],[0.645],[0.595],[0.665],[0.783],[0.712],[0.598],[0.916],[0.816],[0.735],[0.785],[0.764],0.474,0.525,0.609,0.168,0.17,0.132,0.737,0.645,0.595,0.665,0.783,0.712,0.598,0.916,0.816,0.735,0.785,0.764
https://doi.org/10.1002/cbl.30342,teen cannabis vaping and edible use increased in highdensity dispensary states,2309_teen cannabis vaping and edible use increased in highdensity dispensary states.pdf,1,['https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg4_publiccomments_6.25.20.pdf'],['The ravaging ellacts'],['https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg4_publiccomments_6.25.20.pdf'],['2309_0_the ravaging ellacts.pdf'],1,100.0,['https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg4_publiccomments_6.25.20.pdf'],['2309_0_the ravaging ellacts.pdf'],[0.204],[0.576],[0.64],[0.166],[0.172],[0.15],[0.721],[0.626],[0.659],[0.641],[0.823],[0.788],[0.675],[0.921],[0.859],[0.79],[0.834],[0.801],0.204,0.576,0.64,0.166,0.172,0.15,0.721,0.626,0.659,0.641,0.823,0.788,0.675,0.921,0.859,0.79,0.834,0.801
https://doi.org/10.1002/cl2.1120,interventions for reducing violence against children in low‐ and middle‐income countries an evidence and gap map,2354_interventions for reducing violence against children in low‐ and middle‐income countries an evidence and gap map.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['How effects on health equity are assessed in systematic reviews of interventions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['2354_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['2354_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],[0.53],[0.562],[0.651],[0.19],[0.197],[0.163],[0.734],[0.643],[0.623],[0.715],[0.8],[0.728],[0.622],[0.928],[0.847],[0.764],[0.807],[0.789],0.53,0.562,0.651,0.19,0.197,0.163,0.734,0.643,0.623,0.715,0.8,0.728,0.622,0.928,0.847,0.764,0.807,0.789
https://doi.org/10.1002/cl2.28,protocol mentoring interventions to affect juvenile delinquency and associated problems,2355_protocol mentoring interventions to affect juvenile delinquency and associated problems.pdf,2,"['https://purl.fdlp.gov/GPO/gpo76784', 'https://purl.fdlp.gov/GPO/gpo89610']","['An evaluation of advocacy-based mentoring as a treatment intervention for chronic delinquency /', 'Prediction and prevention of premature closures of mentoring relationships :\xa0the Study To Analyze Relationships (STAR Project) /']","['https://purl.fdlp.gov/GPO/gpo89610', 'https://purl.fdlp.gov/GPO/gpo76784']","['2355_1_prediction and prevention of premature closures of mentoring relationships \xa0the study to analyze relationships star project .pdf', '2355_0_an evaluation of advocacybased mentoring as a treatment intervention for chronic delinquency .pdf']",2,100.0,"['https://purl.fdlp.gov/GPO/gpo89610', 'https://purl.fdlp.gov/GPO/gpo76784']","['2355_1_prediction and prevention of premature closures of mentoring relationships \xa0the study to analyze relationships star project .pdf', '2355_0_an evaluation of advocacybased mentoring as a treatment intervention for chronic delinquency .pdf']","[0.373, 0.225]","[0.549, 0.549]","[0.631, 0.627]","[0.141, 0.141]","[0.159, 0.162]","[0.13, 0.13]","[0.724, 0.725]","[0.63, 0.629]","[0.607, 0.611]","[0.703, 0.71]","[0.795, 0.792]","[0.745, 0.735]","[0.634, 0.633]","[0.923, 0.923]","[0.843, 0.847]","[0.772, 0.775]","[0.807, 0.805]","[0.789, 0.789]",0.299,0.549,0.629,0.141,0.161,0.13,0.724,0.629,0.609,0.706,0.794,0.74,0.633,0.923,0.845,0.774,0.806,0.789
https://doi.org/10.1002/cl2.46,protocol effectiveness of early familyparent training programs in preventing antisocial behavior  delinquency,2356_protocol effectiveness of early familyparent training programs in preventing antisocial behavior  delinquency.pdf,3,"['http://www.governor.wa.gov/sites/default/files/documents/BRCCF_20160614_ReadingMaterials_can-prevention-technical-package.pdf', 'https://purl.fdlp.gov/GPO/gpo105865', 'https://stacks.cdc.gov/view/cdc/38864']","['Preventing Child Abuse and Neglect: A Technical Package for Policy, Norm, and Programmatic Activities', 'Preventing child abuse and neglect :\xa0a technical package for policy, norm, and programmatic activities /', 'Preventing child abuse and neglect : a technical package for policy, norm, and programmatic activities']","['https://purl.fdlp.gov/GPO/gpo105865', 'http://www.governor.wa.gov/sites/default/files/documents/BRCCF_20160614_ReadingMaterials_can-prevention-technical-package.pdf']","['2356_1_preventing child abuse and neglect \xa0a technical package for policy norm and programmatic activities .pdf', '2356_0_preventing child abuse and neglect a technical package for policy norm and programmatic activities.pdf']",2,66.67,"['https://purl.fdlp.gov/GPO/gpo105865', 'http://www.governor.wa.gov/sites/default/files/documents/BRCCF_20160614_ReadingMaterials_can-prevention-technical-package.pdf']","['2356_1_preventing child abuse and neglect \xa0a technical package for policy norm and programmatic activities .pdf', '2356_0_preventing child abuse and neglect a technical package for policy norm and programmatic activities.pdf']","[0.362, 0.362]","[0.536, 0.536]","[0.633, 0.633]","[0.165, 0.165]","[0.176, 0.176]","[0.148, 0.148]","[0.724, 0.724]","[0.628, 0.628]","[0.602, 0.602]","[0.684, 0.684]","[0.79, 0.79]","[0.713, 0.713]","[0.619, 0.619]","[0.918, 0.918]","[0.828, 0.828]","[0.761, 0.761]","[0.796, 0.796]","[0.782, 0.782]",0.362,0.536,0.633,0.165,0.176,0.148,0.724,0.628,0.602,0.684,0.79,0.713,0.619,0.918,0.828,0.761,0.796,0.782
https://doi.org/10.1002/cpt.1909,prioritization of anti‐sars‐cov‐2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human pharmacokinetics,2424_prioritization of anti‐sars‐cov‐2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human pharmacokinetics.pdf,1,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines'],['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['2424_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,100.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['2424_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.327],[0.506],[0.6],[0.144],[0.155],[0.123],[0.74],[0.652],[0.575],[0.648],[0.78],[0.679],[0.587],[0.899],[0.781],[0.736],[0.766],[0.759],0.327,0.506,0.6,0.144,0.155,0.123,0.74,0.652,0.575,0.648,0.78,0.679,0.587,0.899,0.781,0.736,0.766,0.759
https://doi.org/10.1002/eap.1880,warm dry winters truncate timing and size distribution of seaward‐migrating salmon across a large regulated watershed,2497_warm dry winters truncate timing and size distribution of seaward‐migrating salmon across a large regulated watershed.pdf,1,['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['Indicators of climate change in california'],['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['2497_0_indicators of climate change in california.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['2497_0_indicators of climate change in california.pdf'],[0.461],[0.508],[0.602],[0.15],[0.138],[0.124],[0.732],[0.636],[0.574],[0.687],[0.789],[0.711],[0.63],[0.901],[0.813],[0.744],[0.769],[0.767],0.461,0.508,0.602,0.15,0.138,0.124,0.732,0.636,0.574,0.687,0.789,0.711,0.63,0.901,0.813,0.744,0.769,0.767
https://doi.org/10.1002/ece3.4366,estimating age‐dependent survival when juveniles resemble females invasive ring‐necked parakeets as an example,2516_estimating age‐dependent survival when juveniles resemble females invasive ring‐necked parakeets as an example.pdf,1,['https://dlnr.hawaii.gov/hisc/files/2019/12/Shiels-and-Kalodimos-2019-RRP-review-Pac-Sci.pdf'],['Biology and Impacts of Pacific Island Invasive Species. 15.'],['https://dlnr.hawaii.gov/hisc/files/2019/12/Shiels-and-Kalodimos-2019-RRP-review-Pac-Sci.pdf'],['2516_0_biology and impacts of pacific island invasive species 15.pdf'],1,100.0,['https://dlnr.hawaii.gov/hisc/files/2019/12/Shiels-and-Kalodimos-2019-RRP-review-Pac-Sci.pdf'],['2516_0_biology and impacts of pacific island invasive species 15.pdf'],[0.229],[0.49],[0.584],[0.118],[0.122],[0.109],[0.727],[0.634],[0.555],[0.676],[0.778],[0.681],[0.634],[0.888],[0.812],[0.75],[0.776],[0.772],0.229,0.49,0.584,0.118,0.122,0.109,0.727,0.634,0.555,0.676,0.778,0.681,0.634,0.888,0.812,0.75,0.776,0.772
https://doi.org/10.1002/ecs2.3198,potential wildfire and carbon stability in frequent‐fire forests in the sierra nevada trade‐offs from a long‐term study,2519_potential wildfire and carbon stability in frequent‐fire forests in the sierra nevada trade‐offs from a long‐term study.pdf,1,['https://ww2.arb.ca.gov/sites/default/files/2022-05/2022-draft-sp-appendix-i-nwl-modeling.pdf'],['Appendix I - Natural and Working Lands Technical Support Document'],['https://ww2.arb.ca.gov/sites/default/files/2022-05/2022-draft-sp-appendix-i-nwl-modeling.pdf'],['2519_0_appendix i  natural and working lands technical support document.pdf'],1,100.0,['https://ww2.arb.ca.gov/sites/default/files/2022-05/2022-draft-sp-appendix-i-nwl-modeling.pdf'],['2519_0_appendix i  natural and working lands technical support document.pdf'],[0.487],[0.54],[0.624],[0.167],[0.165],[0.138],[0.734],[0.644],[0.603],[0.701],[0.805],[0.73],[0.652],[0.919],[0.831],[0.778],[0.812],[0.795],0.487,0.54,0.624,0.167,0.165,0.138,0.734,0.644,0.603,0.701,0.805,0.73,0.652,0.919,0.831,0.778,0.812,0.795
https://doi.org/10.1002/ejhf.1924,angiotensin‐converting enzyme inhibitors and angiotensin ii receptor blockers are not associated with severe covid‐19 infection in a multi‐site uk acute hospital trust,2522_angiotensin‐converting enzyme inhibitors and angiotensin ii receptor blockers are not associated with severe covid‐19 infection in a multi‐site uk acute hospital trust.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['2522_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['2522_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.404],[0.491],[0.582],[0.152],[0.158],[0.13],[0.739],[0.646],[0.556],[0.686],[0.759],[0.687],[0.59],[0.906],[0.789],[0.71],[0.736],[0.734],0.404,0.491,0.582,0.152,0.158,0.13,0.739,0.646,0.556,0.686,0.759,0.687,0.59,0.906,0.789,0.71,0.736,0.734
https://doi.org/10.1002/epi4.12311,a home‐based primary‐care model for epilepsy care in india basis and design,2531_a home‐based primary‐care model for epilepsy care in india basis and design.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092477/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409429/pdf']","['Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy', 'Psychological treatments for people with epilepsy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409429/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092477/pdf']","['2531_1_psychological treatments for people with epilepsy.pdf', '2531_0_strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409429/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092477/pdf']","['2531_1_psychological treatments for people with epilepsy.pdf', '2531_0_strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.pdf']","[0.465, 0.494]","[0.534, 0.531]","[0.619, 0.619]","[0.179, 0.179]","[0.192, 0.195]","[0.156, 0.159]","[0.739, 0.738]","[0.647, 0.645]","[0.589, 0.588]","[0.688, 0.693]","[0.793, 0.788]","[0.716, 0.712]","[0.615, 0.614]","[0.922, 0.922]","[0.833, 0.823]","[0.741, 0.736]","[0.795, 0.789]","[0.774, 0.768]",0.48,0.532,0.619,0.179,0.194,0.158,0.738,0.646,0.589,0.69,0.79,0.714,0.615,0.922,0.828,0.738,0.792,0.771
https://doi.org/10.1002/etc.4293,behavioral effects of copper on larval white sturgeon,2540_behavioral effects of copper on larval white sturgeon.pdf,1,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['Antifouling Paints in Washington State Report and Recommendations'],['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['2540_0_antifouling paints in washington state report and recommendations.pdf'],1,100.0,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['2540_0_antifouling paints in washington state report and recommendations.pdf'],[0.221],[0.499],[0.589],[0.129],[0.132],[0.109],[0.729],[0.635],[0.573],[0.675],[0.788],[0.683],[0.618],[0.914],[0.816],[0.75],[0.794],[0.779],0.221,0.499,0.589,0.129,0.132,0.109,0.729,0.635,0.573,0.675,0.788,0.683,0.618,0.914,0.816,0.75,0.794,0.779
https://doi.org/10.1002/ijc.32158,neonatal phototherapy and future risk of childhood cancer,2738_neonatal phototherapy and future risk of childhood cancer.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390477/pdf'],['Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390477/pdf'],['2738_0_use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390477/pdf'],['2738_0_use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia.pdf'],[0.333],[0.547],[0.635],[0.176],[0.168],[0.131],[0.734],[0.636],[0.615],[0.674],[0.793],[0.726],[0.609],[0.927],[0.829],[0.753],[0.797],[0.778],0.333,0.547,0.635,0.176,0.168,0.131,0.734,0.636,0.615,0.674,0.793,0.726,0.609,0.927,0.829,0.753,0.797,0.778
https://doi.org/10.1002/ijc.32757,maternal diabetes and risk of childhood cancer in the offspring,2739_maternal diabetes and risk of childhood cancer in the offspring.pdf,1,['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CDSRB/CDPH%20Document%20Library/CCCP/CA_Comprehensive_Cancer_Control_Plan_2021_2025_ADA.pdf'],"['California’s Comprehensive Cancer Control Plan, 2021–2025']",['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CDSRB/CDPH%20Document%20Library/CCCP/CA_Comprehensive_Cancer_Control_Plan_2021_2025_ADA.pdf'],['2739_0_californias comprehensive cancer control plan 2021–2025.pdf'],1,100.0,['https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CDSRB/CDPH%20Document%20Library/CCCP/CA_Comprehensive_Cancer_Control_Plan_2021_2025_ADA.pdf'],['2739_0_californias comprehensive cancer control plan 2021–2025.pdf'],[0.469],[0.525],[0.615],[0.144],[0.156],[0.124],[0.734],[0.635],[0.59],[0.661],[0.789],[0.713],[0.62],[0.914],[0.81],[0.751],[0.791],[0.772],0.469,0.525,0.615,0.144,0.156,0.124,0.734,0.635,0.59,0.661,0.789,0.713,0.62,0.914,0.81,0.751,0.791,0.772
https://doi.org/10.1002/ijgo.13146,expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus  covid ‐19 infection,2743_expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus  covid ‐19 infection.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820999/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf']","['Considerations for Pediatric Heart Programs During COVID-19: Recommendations From the Congenital Cardiac Anesthesia Society', 'Recomendaciones y manejo práctico de la gestante con COVID-19:', 'COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review', 'Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce', 'Adapting obstetric and neonatal services during the COVID-19 pandemic: a scoping review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820999/pdf']","['2743_2_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf', '2743_0_considerations for pediatric heart programs during covid19 recommendations from the congenital cardiac anesthesia society.pdf', '2743_4_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf', '2743_1_recomendaciones y manejo práctico de la gestante con covid19.pdf', '2743_3_clinical care of pregnant and postpartum women with covid‐19 living recommendations from the national covid‐19 clinical evidence taskforce.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273948/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820999/pdf']","['2743_2_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf', '2743_0_considerations for pediatric heart programs during covid19 recommendations from the congenital cardiac anesthesia society.pdf', '2743_4_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf', '2743_1_recomendaciones y manejo práctico de la gestante con covid19.pdf', '2743_3_clinical care of pregnant and postpartum women with covid‐19 living recommendations from the national covid‐19 clinical evidence taskforce.pdf']","[0.348, 0.099, 0.517, 0.494, 0.503]","[0.514, 0.561, 0.547, 0.451, 0.57]","[0.609, 0.639, 0.631, 0.567, 0.651]","[0.158, 0.173, 0.179, 0.152, 0.192]","[0.176, 0.183, 0.204, 0.189, 0.217]","[0.137, 0.132, 0.153, 0.135, 0.158]","[0.739, 0.74, 0.745, 0.736, 0.745]","[0.65, 0.649, 0.657, 0.651, 0.658]","[0.575, 0.623, 0.608, 0.532, 0.63]","[0.627, 0.614, 0.629, 0.615, 0.629]","[0.785, 0.802, 0.803, 0.787, 0.812]","[0.69, 0.737, 0.727, 0.678, 0.748]","[0.609, 0.617, 0.62, 0.569, 0.632]","[0.912, 0.927, 0.922, 0.884, 0.934]","[0.801, 0.821, 0.83, 0.797, 0.836]","[0.739, 0.773, 0.77, 0.71, 0.78]","[0.779, 0.805, 0.803, 0.754, 0.815]","[0.767, 0.792, 0.792, 0.732, 0.8]",0.392,0.529,0.619,0.171,0.194,0.143,0.741,0.653,0.594,0.623,0.798,0.716,0.609,0.916,0.817,0.754,0.791,0.777
https://doi.org/10.1002/ijgo.13331,prevention of noncommunicable diseases by interventions in the preconception period a figo position paper for action by healthcare practitioners,2744_prevention of noncommunicable diseases by interventions in the preconception period a figo position paper for action by healthcare practitioners.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf'],"['Quality Appraisal of Nutritional Guidelines to Prevent, Diagnose, and Treat Malnutrition in All Its Forms during Pregnancy']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf'],['2744_0_quality appraisal of nutritional guidelines to prevent diagnose and treat malnutrition in all its forms during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf'],['2744_0_quality appraisal of nutritional guidelines to prevent diagnose and treat malnutrition in all its forms during pregnancy.pdf'],[0.536],[0.493],[0.601],[0.141],[0.154],[0.132],[0.737],[0.646],[0.554],[0.658],[0.77],[0.657],[0.6],[0.908],[0.801],[0.727],[0.768],[0.758],0.536,0.493,0.601,0.141,0.154,0.132,0.737,0.646,0.554,0.658,0.77,0.657,0.6,0.908,0.801,0.727,0.768,0.758
https://doi.org/10.1002/imhj.21865,early childhood mental health consultation care providers’ experiences of the consultative relationship,2889_early childhood mental health consultation care providers’ experiences of the consultative relationship.pdf,3,"['https://www.dshs.texas.gov/ECI_Library_Matters_september20.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['September 2020', 'Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['2889_1_well and thriving prevention and early intervention in california first public draft.pdf', '2889_2_well and thriving prevention and early intervention in california  second public draft.pdf']",2,66.67,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['2889_1_well and thriving prevention and early intervention in california first public draft.pdf', '2889_2_well and thriving prevention and early intervention in california  second public draft.pdf']","[0.364, 0.367]","[0.52, 0.52]","[0.629, 0.629]","[0.143, 0.143]","[0.159, 0.159]","[0.12, 0.119]","[0.723, 0.722]","[0.628, 0.627]","[0.589, 0.59]","[0.676, 0.676]","[0.797, 0.798]","[0.725, 0.727]","[0.615, 0.615]","[0.911, 0.911]","[0.836, 0.837]","[0.758, 0.759]","[0.803, 0.804]","[0.781, 0.782]",0.365,0.52,0.629,0.143,0.159,0.119,0.722,0.627,0.589,0.676,0.798,0.726,0.615,0.911,0.837,0.758,0.804,0.782
https://doi.org/10.1002/imhj.21889,the role of consultative alliance in infant and early childhood mental health consultation child teacher and classroom outcomes,2897_the role of consultative alliance in infant and early childhood mental health consultation child teacher and classroom outcomes.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['2897_0_well and thriving prevention and early intervention in california first public draft.pdf', '2897_1_well and thriving prevention and early intervention in california  second public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['2897_0_well and thriving prevention and early intervention in california first public draft.pdf', '2897_1_well and thriving prevention and early intervention in california  second public draft.pdf']","[0.345, 0.346]","[0.512, 0.512]","[0.611, 0.611]","[0.135, 0.135]","[0.147, 0.147]","[0.116, 0.116]","[0.723, 0.723]","[0.628, 0.627]","[0.575, 0.575]","[0.679, 0.679]","[0.789, 0.79]","[0.713, 0.714]","[0.619, 0.62]","[0.923, 0.923]","[0.82, 0.82]","[0.75, 0.751]","[0.796, 0.797]","[0.776, 0.777]",0.345,0.512,0.611,0.135,0.147,0.116,0.723,0.627,0.575,0.679,0.79,0.714,0.619,0.923,0.82,0.75,0.796,0.776
https://doi.org/10.1002/j.2379-3988.2001.tb00015.x,strategic frame analysis reframing americas youth,2948_strategic frame analysis reframing americas youth.pdf,2,"['https://www.ccf.ny.gov/files/5813/8262/0204/ResourceGuideSection2DataInformTellStory.pdf', 'https://www.ccf.ny.gov/files/2713/8262/0297/Resource20Guide20FULL.pdf']","['Session Two : Using Data To Inform Andtella Story', 'Using Data to Build Comprehensive Systems for Infants and Families']","['https://www.ccf.ny.gov/files/2713/8262/0297/Resource20Guide20FULL.pdf', 'https://www.ccf.ny.gov/files/5813/8262/0204/ResourceGuideSection2DataInformTellStory.pdf']","['2948_1_using data to build comprehensive systems for infants and families.pdf', '2948_0_session two  using data to inform andtella story.pdf']",2,100.0,"['https://www.ccf.ny.gov/files/2713/8262/0297/Resource20Guide20FULL.pdf', 'https://www.ccf.ny.gov/files/5813/8262/0204/ResourceGuideSection2DataInformTellStory.pdf']","['2948_1_using data to build comprehensive systems for infants and families.pdf', '2948_0_session two  using data to inform andtella story.pdf']","[0.514, 0.472]","[0.562, 0.564]","[0.65, 0.652]","[0.138, 0.138]","[0.154, 0.154]","[0.132, 0.132]","[0.719, 0.718]","[0.62, 0.62]","[0.634, 0.635]","[0.692, 0.694]","[0.815, 0.817]","[0.773, 0.774]","[0.663, 0.665]","[0.925, 0.924]","[0.86, 0.864]","[0.788, 0.79]","[0.828, 0.83]","[0.807, 0.809]",0.493,0.563,0.651,0.138,0.154,0.132,0.718,0.62,0.635,0.693,0.816,0.774,0.664,0.925,0.862,0.789,0.829,0.808
https://doi.org/10.1002/j.2379-3988.2006.tb00048.x,understanding and facilitating the youth mentoring movement,2953_understanding and facilitating the youth mentoring movement.pdf,2,"['https://purl.fdlp.gov/GPO/gpo83961', 'https://purl.fdlp.gov/GPO/gpo89610']","['Mentoring children of incarcerated parents :\xa0a synthesis of research and input from the Listening Session held by the Office of Juvenile Justice and Delinquency Prevention and the White House Domestic Policy Council and Office of Public Engagement.', 'Prediction and prevention of premature closures of mentoring relationships :\xa0the Study To Analyze Relationships (STAR Project) /']",['https://purl.fdlp.gov/GPO/gpo89610'],['2953_1_prediction and prevention of premature closures of mentoring relationships \xa0the study to analyze relationships star project .pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo89610'],['2953_1_prediction and prevention of premature closures of mentoring relationships \xa0the study to analyze relationships star project .pdf'],[0.52],[0.534],[0.62],[0.153],[0.181],[0.149],[0.727],[0.632],[0.591],[0.708],[0.79],[0.742],[0.633],[0.916],[0.837],[0.763],[0.801],[0.783],0.52,0.534,0.62,0.153,0.181,0.149,0.727,0.632,0.591,0.708,0.79,0.742,0.633,0.916,0.837,0.763,0.801,0.783
https://doi.org/10.1002/j.2379-3988.2006.tb00049.x,organized activity participation positive youth development and the overscheduling hypothesis,2954_organized activity participation positive youth development and the overscheduling hypothesis.pdf,3,"['https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://www.nber.org/papers/w15284', 'https://dyrs.dc.gov/sites/default/files/dc/sites/dyrs/publication/attachments/PYJ%20Final%20-%20Butts.pdf']","['Preventing Tobacco Use Among Youth and Young Adults', 'The Rug Rat Race', 'Positive Youth Justice']",['https://dyrs.dc.gov/sites/default/files/dc/sites/dyrs/publication/attachments/PYJ%20Final%20-%20Butts.pdf'],['2954_2_positive youth justice.pdf'],1,33.33,['https://dyrs.dc.gov/sites/default/files/dc/sites/dyrs/publication/attachments/PYJ%20Final%20-%20Butts.pdf'],['2954_2_positive youth justice.pdf'],[0.532],[0.558],[0.647],[0.199],[0.219],[0.191],[0.735],[0.64],[0.621],[0.69],[0.808],[0.757],[0.651],[0.928],[0.845],[0.782],[0.819],[0.802],0.532,0.558,0.647,0.199,0.219,0.191,0.735,0.64,0.621,0.69,0.808,0.757,0.651,0.928,0.845,0.782,0.819,0.802
https://doi.org/10.1002/j.2379-3988.2008.tb00054.x,mathematics education for young children what it is and how to promote it,2955_mathematics education for young children what it is and how to promote it.pdf,10,"['https://www.michigan.gov/documents/mde/K-12_MI_Math_Standards_REV_470033_7_550413_7.pdf?amp;preview=1', 'https://www.sde.idaho.gov/academic/shared/math/ICS-Mathematics.pdf', 'https://www.sri.com/work/publications/preschool-teachers-can-use-pbs-kids-transmedia-curriculum-supplement-support-young', 'https://www.sri.com/work/publications/supporting-parent-child-experiences-pegcat-early-math-concepts-report-cpb-pbs', 'https://mdk12.msde.maryland.gov/INSTRUCTION/ccr_conferences/Documents/index/Math_MS_Coherence_CCSSI_Math%20Standards.pdf', 'https://www.brookings.edu/research/the-evaluation-roadmap-for-optimizing-pre-k-programs/', 'https://boardofed.idaho.gov/meetings/board/Administrative%20Rules/Incorporated%20by%20Reference%20Documents/08.02.03.004.01.h.%20ICS-Mathematics-0816.pdf', 'https://www.nj.gov/education/cccs/2016/math/standards.pdf?fbclid=IwAR0qDVRD2efrZsmk5WvugxTS83km1if7XKChGXPisYopWcSEMBPcvGELcXA', 'https://dese.mo.gov/sites/default/files/CCSSI_Math%20Standards.pdf', 'https://www.sri.com/work/publications/2012-preschool-pilot-study-pbs-kids-transmedia-mathematics-content-report-cpb-pbs']","['Michigan Math Standards', 'Techincal Document', 'Preschool Teachers Can Use a PBS KIDS Transmedia Curriculum Supplement to Support Young Children’s Mathematics Learning: Results of a Randomized Controlled Trial International', 'Supporting Parent-Child Experiences with PEG+CAT Early Math Concepts: Report to the CPB-PBS Ready To Learn Initiative', 'Math Standards.indb', 'The evaluation roadmap for optimizing pre-K programs', 'Math Standards.indb', 'New Jersey Student Learning Standards for Mathematics', 'Math Standards.indb', '2012 Preschool Pilot Study of PBS KIDS Transmedia Mathematics Content: A Report to the CPB-PBS ""Ready to Learn Initiative"" International']","['https://www.michigan.gov/documents/mde/K-12_MI_Math_Standards_REV_470033_7_550413_7.pdf?amp;preview=1', 'https://www.sde.idaho.gov/academic/shared/math/ICS-Mathematics.pdf', 'https://boardofed.idaho.gov/meetings/board/Administrative%20Rules/Incorporated%20by%20Reference%20Documents/08.02.03.004.01.h.%20ICS-Mathematics-0816.pdf']","['2955_0_michigan math standards.pdf', '2955_1_techincal document.pdf', '2955_6_math standardsindb.pdf']",3,30.0,"['https://www.michigan.gov/documents/mde/K-12_MI_Math_Standards_REV_470033_7_550413_7.pdf?amp;preview=1', 'https://www.sde.idaho.gov/academic/shared/math/ICS-Mathematics.pdf', 'https://boardofed.idaho.gov/meetings/board/Administrative%20Rules/Incorporated%20by%20Reference%20Documents/08.02.03.004.01.h.%20ICS-Mathematics-0816.pdf']","['2955_0_michigan math standards.pdf', '2955_1_techincal document.pdf', '2955_6_math standardsindb.pdf']","[0.259, 0.24, 0.26]","[0.52, 0.521, 0.521]","[0.614, 0.614, 0.614]","[0.115, 0.113, 0.116]","[0.133, 0.132, 0.133]","[0.112, 0.109, 0.113]","[0.728, 0.728, 0.727]","[0.625, 0.626, 0.624]","[0.602, 0.603, 0.603]","[0.701, 0.7, 0.701]","[0.792, 0.793, 0.794]","[0.747, 0.748, 0.747]","[0.636, 0.637, 0.637]","[0.923, 0.922, 0.923]","[0.837, 0.839, 0.839]","[0.771, 0.771, 0.771]","[0.808, 0.81, 0.809]","[0.788, 0.789, 0.789]",0.253,0.521,0.614,0.115,0.133,0.111,0.728,0.625,0.603,0.701,0.793,0.747,0.637,0.923,0.838,0.771,0.809,0.789
https://doi.org/10.1002/j.2379-3988.2011.tb00066.x,evidencebased interventions for juvenile offenders and juvenile justice policies that support them and commentaries,2958_evidencebased interventions for juvenile offenders and juvenile justice policies that support them and commentaries.pdf,9,"['https://www.urban.org/research/publication/evaluation-report-nycs-advocate-intervene-mentor-program', 'https://www1.nyc.gov/assets/opportunity/pdf/evidence/AIM_Final_2018.pdf', 'http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf', 'https://www.tn.gov/content/dam/tn/tccy/documents/pb/pb-jj-ta-0215.pdf', 'https://www.urban.org/research/publication/bridging-research-and-practice-juvenile-probation', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'https://bscc.ca.gov/wp-content/uploads/JOJJVol1_Iss2.pdf', 'https://mathematica.org/publications/oakland-unite-2017-2018-strategy-evaluation-life-coaching-and-employment-and-education-support', 'https://bscc.ca.gov/wp-content/uploads/JOJJVol2_Iss1.pdf']","[""Evaluation Report on NYC's Advocate, Intervene, Mentor Program"", 'Justice Policy Center', 'JUVENILE OFFENDING', 'Policy Brief', 'Bridging Research and Practice in Juvenile Probation', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'OJJDP Journal of Juvenile Justice, Volume 1, Issue 2, Spring 2012', 'Oakland Unite 2017-2018 Strategy Evaluation: Life Coaching and Employment and Education Support for Youth at Risk of Violence', 'Journal of Juvenile Justice']","['https://www.tn.gov/content/dam/tn/tccy/documents/pb/pb-jj-ta-0215.pdf', 'https://www1.nyc.gov/assets/opportunity/pdf/evidence/AIM_Final_2018.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf']","['2958_3_policy brief.pdf', '2958_1_justice policy center.pdf', '2958_5_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '2958_2_juvenile offending.pdf']",4,44.44,"['https://www.tn.gov/content/dam/tn/tccy/documents/pb/pb-jj-ta-0215.pdf', 'https://www1.nyc.gov/assets/opportunity/pdf/evidence/AIM_Final_2018.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf']","['2958_3_policy brief.pdf', '2958_1_justice policy center.pdf', '2958_5_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '2958_2_juvenile offending.pdf']","[0.412, 0.645, 0.683, 0.427]","[0.586, 0.572, 0.553, 0.575]","[0.671, 0.656, 0.648, 0.663]","[0.229, 0.186, 0.163, 0.22]","[0.254, 0.213, 0.17, 0.242]","[0.205, 0.168, 0.142, 0.197]","[0.739, 0.727, 0.727, 0.739]","[0.65, 0.635, 0.63, 0.648]","[0.649, 0.639, 0.627, 0.64]","[0.697, 0.685, 0.664, 0.686]","[0.825, 0.816, 0.814, 0.82]","[0.767, 0.761, 0.757, 0.765]","[0.671, 0.658, 0.646, 0.657]","[0.933, 0.927, 0.927, 0.925]","[0.86, 0.853, 0.837, 0.844]","[0.798, 0.79, 0.785, 0.79]","[0.837, 0.828, 0.824, 0.832]","[0.817, 0.807, 0.805, 0.811]",0.542,0.571,0.659,0.2,0.22,0.178,0.733,0.641,0.639,0.683,0.819,0.763,0.658,0.928,0.848,0.791,0.83,0.81
https://doi.org/10.1002/jat.3733,chronic exposure to perfluorononanoic acid impairs spermatogenesis steroidogenesis and fertility in male mice,2983_chronic exposure to perfluorononanoic acid impairs spermatogenesis steroidogenesis and fertility in male mice.pdf,1,['https://apps.ecology.wa.gov/publications/documents/2104048.pdf'],['Per- and Polyfluoroalkyl Substances Chemical Action Plan'],['https://apps.ecology.wa.gov/publications/documents/2104048.pdf'],['2983_0_per and polyfluoroalkyl substances chemical action plan.pdf'],1,100.0,['https://apps.ecology.wa.gov/publications/documents/2104048.pdf'],['2983_0_per and polyfluoroalkyl substances chemical action plan.pdf'],[0.19],[0.514],[0.606],[0.118],[0.116],[0.09],[0.727],[0.632],[0.598],[0.62],[0.797],[0.703],[0.622],[0.916],[0.819],[0.762],[0.798],[0.783],0.19,0.514,0.606,0.118,0.116,0.09,0.727,0.632,0.598,0.62,0.797,0.703,0.622,0.916,0.819,0.762,0.798,0.783
https://doi.org/10.1002/jia2.25422,viral load assay performs comparably to early infant diagnosis assay to diagnose infants with hiv in mozambique a prospective observational study,3036_viral load assay performs comparably to early infant diagnosis assay to diagnose infants with hiv in mozambique a prospective observational study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['3036_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['3036_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],[0.504],[0.52],[0.607],[0.176],[0.181],[0.149],[0.738],[0.645],[0.576],[0.692],[0.769],[0.694],[0.607],[0.897],[0.811],[0.71],[0.776],[0.735],0.504,0.52,0.607,0.176,0.181,0.149,0.738,0.645,0.576,0.692,0.769,0.694,0.607,0.897,0.811,0.71,0.776,0.735
https://doi.org/10.1002/jia2.25556,preventing mental health conditions in adolescents living with hiv an urgent need for evidence,3038_preventing mental health conditions in adolescents living with hiv an urgent need for evidence.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496797/pdf'],['Future directions for HIV service delivery research: Research gaps identified through WHO guideline development'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496797/pdf'],['3038_0_future directions for hiv service delivery research research gaps identified through who guideline development.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496797/pdf'],['3038_0_future directions for hiv service delivery research research gaps identified through who guideline development.pdf'],[0.526],[0.523],[0.62],[0.189],[0.19],[0.164],[0.746],[0.659],[0.563],[0.682],[0.793],[0.698],[0.61],[0.901],[0.813],[0.736],[0.788],[0.765],0.526,0.523,0.62,0.189,0.19,0.164,0.746,0.659,0.563,0.682,0.793,0.698,0.61,0.901,0.813,0.736,0.788,0.765
https://doi.org/10.1002/jimd.12110,a novel phosphoglucomutase‐deficient mouse model reveals aberrant glycosylation and early embryonic lethality,3048_a novel phosphoglucomutase‐deficient mouse model reveals aberrant glycosylation and early embryonic lethality.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268/pdf'],"['International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268/pdf'],['3048_0_international consensus guidelines for phosphoglucomutase 1 deficiency pgm1cdg diagnosis followup and management.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268/pdf'],['3048_0_international consensus guidelines for phosphoglucomutase 1 deficiency pgm1cdg diagnosis followup and management.pdf'],[0.284],[0.531],[0.624],[0.146],[0.148],[0.109],[0.738],[0.641],[0.613],[0.634],[0.791],[0.712],[0.609],[0.904],[0.815],[0.758],[0.795],[0.783],0.284,0.531,0.624,0.146,0.148,0.109,0.738,0.641,0.613,0.634,0.791,0.712,0.609,0.904,0.815,0.758,0.795,0.783
https://doi.org/10.1002/jimd.12143,liver neoplasms in methylmalonic aciduria an emerging complication,3049_liver neoplasms in methylmalonic aciduria an emerging complication.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3049_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3049_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.499],[0.565],[0.646],[0.164],[0.173],[0.118],[0.748],[0.65],[0.637],[0.633],[0.812],[0.755],[0.63],[0.925],[0.835],[0.776],[0.809],[0.79],0.499,0.565,0.646,0.164,0.173,0.118,0.748,0.65,0.637,0.633,0.812,0.755,0.63,0.925,0.835,0.776,0.809,0.79
https://doi.org/10.1002/jimd.12193,retrospective evaluation of the dutch pre‐newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia what to aim expect and evaluate from newborn screening,3050_retrospective evaluation of the dutch pre‐newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia what to aim expect and evaluate from newborn screening.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3050_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3050_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.568],[0.544],[0.622],[0.165],[0.178],[0.121],[0.738],[0.644],[0.609],[0.664],[0.797],[0.731],[0.62],[0.926],[0.833],[0.768],[0.801],[0.786],0.568,0.544,0.622,0.165,0.178,0.121,0.738,0.644,0.609,0.664,0.797,0.731,0.62,0.926,0.833,0.768,0.801,0.786
https://doi.org/10.1002/jimd.12287,plasma methylcitric acid and its correlations with other disease biomarkers the impact in the follow up of patients with propionic and methylmalonic acidemia,3051_plasma methylcitric acid and its correlations with other disease biomarkers the impact in the follow up of patients with propionic and methylmalonic acidemia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3051_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3051_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.666],[0.54],[0.621],[0.162],[0.174],[0.121],[0.742],[0.646],[0.611],[0.657],[0.801],[0.736],[0.624],[0.918],[0.821],[0.766],[0.801],[0.785],0.666,0.54,0.621,0.162,0.174,0.121,0.742,0.646,0.611,0.657,0.801,0.736,0.624,0.918,0.821,0.766,0.801,0.785
https://doi.org/10.1002/jmd2.12053,domino liver transplantation for select metabolic disorders expanding the living donor pool,3053_domino liver transplantation for select metabolic disorders expanding the living donor pool.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3053_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['3053_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.536],[0.554],[0.626],[0.163],[0.18],[0.13],[0.74],[0.641],[0.619],[0.637],[0.802],[0.738],[0.628],[0.918],[0.826],[0.769],[0.802],[0.784],0.536,0.554,0.626,0.163,0.18,0.13,0.74,0.641,0.619,0.637,0.802,0.738,0.628,0.918,0.826,0.769,0.802,0.784
https://doi.org/10.1002/jmv.25807,covid‐19 epidemic disease characteristics in children,3075_covid‐19 epidemic disease characteristics in children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906345/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975298/pdf']","['A primer for pediatric radiologists on infection control in an era of COVID-19', 'Consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID‐19–related illness', 'Turkish IBD Organization’s Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975298/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906345/pdf']","['3075_2_turkish ibd organizations position statement on inflammatory bowel disease management recommendations during covid19 pandemic.pdf', '3075_0_a primer for pediatric radiologists on infection control in an era of covid19.pdf', '3075_1_consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for covid‐19–related illness.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975298/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906345/pdf']","['3075_2_turkish ibd organizations position statement on inflammatory bowel disease management recommendations during covid19 pandemic.pdf', '3075_0_a primer for pediatric radiologists on infection control in an era of covid19.pdf', '3075_1_consensus‐based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for covid‐19–related illness.pdf']","[0.435, 0.378, 0.445]","[0.532, 0.547, 0.575]","[0.62, 0.633, 0.654]","[0.163, 0.174, 0.194]","[0.177, 0.178, 0.192]","[0.149, 0.139, 0.155]","[0.742, 0.743, 0.747]","[0.652, 0.648, 0.657]","[0.586, 0.627, 0.638]","[0.644, 0.626, 0.627]","[0.803, 0.815, 0.821]","[0.687, 0.743, 0.761]","[0.622, 0.635, 0.628]","[0.909, 0.914, 0.907]","[0.821, 0.842, 0.847]","[0.757, 0.778, 0.775]","[0.797, 0.817, 0.821]","[0.781, 0.793, 0.796]",0.419,0.551,0.636,0.177,0.182,0.148,0.744,0.652,0.617,0.632,0.813,0.73,0.628,0.91,0.837,0.77,0.812,0.79
https://doi.org/10.1002/jum.15284,is there a role for lung ultrasound during the covid19 pandemic,3117_is there a role for lung ultrasound during the covid19 pandemic.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732472/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138384/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233395/pdf']","['An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting', 'The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society', 'The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138384/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732472/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233395/pdf']","['3117_1_the role of chest imaging in patient management during the covid19 pandemic a multinational consensus statement from the fleischner society.pdf', '3117_0_an italian guidance model for the management of suspected or confirmed covid19 patients in the primary care setting.pdf', '3117_2_the role of chest imaging in patient management during the covid19 pandemic a multinational consensus statement from the fleischner society.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138384/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732472/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233395/pdf']","['3117_1_the role of chest imaging in patient management during the covid19 pandemic a multinational consensus statement from the fleischner society.pdf', '3117_0_an italian guidance model for the management of suspected or confirmed covid19 patients in the primary care setting.pdf', '3117_2_the role of chest imaging in patient management during the covid19 pandemic a multinational consensus statement from the fleischner society.pdf']","[0.333, 0.362, 0.325]","[0.577, 0.548, 0.579]","[0.643, 0.623, 0.647]","[0.185, 0.156, 0.193]","[0.198, 0.157, 0.201]","[0.154, 0.12, 0.16]","[0.752, 0.746, 0.755]","[0.662, 0.653, 0.665]","[0.648, 0.613, 0.649]","[0.657, 0.631, 0.66]","[0.817, 0.803, 0.814]","[0.781, 0.738, 0.769]","[0.652, 0.64, 0.661]","[0.933, 0.92, 0.933]","[0.851, 0.825, 0.849]","[0.793, 0.77, 0.79]","[0.828, 0.809, 0.822]","[0.811, 0.792, 0.808]",0.34,0.568,0.638,0.178,0.185,0.145,0.751,0.66,0.637,0.649,0.811,0.763,0.651,0.929,0.842,0.784,0.82,0.804
https://doi.org/10.1002/jum.15285,proposal for international standardization of the use of lung ultrasound for patients with covid ‐19,3118_proposal for international standardization of the use of lung ultrasound for patients with covid ‐19.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109458/pdf']","['Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries', 'Thoracic imaging tests for the diagnosis of COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf']","['3118_1_thoracic imaging tests for the diagnosis of covid‐19.pdf', '3118_0_pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe covid19 in low and middleincome countries.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf']","['3118_1_thoracic imaging tests for the diagnosis of covid‐19.pdf', '3118_0_pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe covid19 in low and middleincome countries.pdf']","[0.419, 0.18]","[0.544, 0.55]","[0.614, 0.623]","[0.149, 0.154]","[0.149, 0.159]","[0.116, 0.12]","[0.733, 0.741]","[0.636, 0.647]","[0.619, 0.635]","[0.69, 0.654]","[0.799, 0.804]","[0.746, 0.754]","[0.641, 0.648]","[0.926, 0.922]","[0.841, 0.842]","[0.762, 0.785]","[0.81, 0.813]","[0.784, 0.799]",0.299,0.547,0.619,0.151,0.154,0.118,0.737,0.641,0.627,0.672,0.802,0.75,0.645,0.924,0.841,0.774,0.811,0.792
https://doi.org/10.1002/jwmg.21782,lifetime sex‐specific moose mortality during an intentional population reduction,3120_lifetime sex‐specific moose mortality during an intentional population reduction.pdf,1,['https://adfg.alaska.gov/static/home/subsistence/pdfs/Paragi_Frye_2020_per_capita_moose_harvest_among_regions_of_Alaska_1990-2018.pdf'],['Estimated moose harvest per capita among regions of Alaska during 1990-2018'],['https://adfg.alaska.gov/static/home/subsistence/pdfs/Paragi_Frye_2020_per_capita_moose_harvest_among_regions_of_Alaska_1990-2018.pdf'],['3120_0_estimated moose harvest per capita among regions of alaska during 19902018.pdf'],1,100.0,['https://adfg.alaska.gov/static/home/subsistence/pdfs/Paragi_Frye_2020_per_capita_moose_harvest_among_regions_of_Alaska_1990-2018.pdf'],['3120_0_estimated moose harvest per capita among regions of alaska during 19902018.pdf'],[0.284],[0.515],[0.594],[0.167],[0.174],[0.147],[0.731],[0.637],[0.581],[0.695],[0.792],[0.699],[0.644],[0.901],[0.824],[0.756],[0.795],[0.779],0.284,0.515,0.594,0.167,0.174,0.147,0.731,0.637,0.581,0.695,0.792,0.699,0.644,0.901,0.824,0.756,0.795,0.779
https://doi.org/10.1002/lt.26258,anticancer effect of statins in patients undergoing liver transplantation for hepatocellular carcinoma,3124_anticancer effect of statins in patients undergoing liver transplantation for hepatocellular carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['3124_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['3124_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.476],[0.523],[0.605],[0.168],[0.169],[0.121],[0.745],[0.658],[0.585],[0.647],[0.792],[0.691],[0.627],[0.914],[0.802],[0.754],[0.784],[0.772],0.476,0.523,0.605,0.168,0.169,0.121,0.745,0.658,0.585,0.647,0.792,0.691,0.627,0.914,0.802,0.754,0.784,0.772
https://doi.org/10.1002/mcf2.10035,juvenile chinook salmon and forage fish use of eelgrass habitats in a diked and channelized puget sound river delta,3127_juvenile chinook salmon and forage fish use of eelgrass habitats in a diked and channelized puget sound river delta.pdf,2,"['https://purl.fdlp.gov/GPO/gpo119711', 'http://www.seattle.gov/light/skagit/Relicensing/cs/groups/secure/@scl.skagit.team/documents/document/cm9k/njiy/~edisp/prod622570.pdf']","['Contaminant baselines and sediment provenance along the Puget Sound energy transport corridor, 2015 /', 'Om-01 Operations Model Revised Study Plan']","['https://purl.fdlp.gov/GPO/gpo119711', 'http://www.seattle.gov/light/skagit/Relicensing/cs/groups/secure/@scl.skagit.team/documents/document/cm9k/njiy/~edisp/prod622570.pdf']","['3127_0_contaminant baselines and sediment provenance along the puget sound energy transport corridor 2015 .pdf', '3127_1_om01 operations model revised study plan.pdf']",2,100.0,"['https://purl.fdlp.gov/GPO/gpo119711', 'http://www.seattle.gov/light/skagit/Relicensing/cs/groups/secure/@scl.skagit.team/documents/document/cm9k/njiy/~edisp/prod622570.pdf']","['3127_0_contaminant baselines and sediment provenance along the puget sound energy transport corridor 2015 .pdf', '3127_1_om01 operations model revised study plan.pdf']","[0.148, 0.202]","[0.513, 0.535]","[0.601, 0.616]","[0.143, 0.132]","[0.125, 0.135]","[0.101, 0.113]","[0.73, 0.726]","[0.638, 0.633]","[0.583, 0.608]","[0.668, 0.672]","[0.8, 0.804]","[0.71, 0.736]","[0.633, 0.642]","[0.9, 0.908]","[0.806, 0.838]","[0.765, 0.774]","[0.801, 0.811]","[0.784, 0.791]",0.175,0.524,0.609,0.138,0.13,0.107,0.728,0.635,0.595,0.67,0.802,0.723,0.637,0.904,0.822,0.77,0.806,0.788
https://doi.org/10.1002/mrdd.20075,assessment of executive function in preschoolaged children,3157_assessment of executive function in preschoolaged children.pdf,2,"['https://www.acf.hhs.gov/opre/report/executive-function-mapping-project-measures-compendium-resource-selecting-measures', 'http://purl.fdlp.gov/GPO/gpo81368']","['Executive Function Mapping Project Measures Compendium: A Resource for Selecting Measures Related to Executive Function and Other Regulation-related Skills in Early Childhood', 'Executive function: implications for education /']",['http://purl.fdlp.gov/GPO/gpo81368'],['3157_1_executive function implications for education .pdf'],1,50.0,['http://purl.fdlp.gov/GPO/gpo81368'],['3157_1_executive function implications for education .pdf'],[0.57],[0.516],[0.607],[0.173],[0.192],[0.163],[0.737],[0.649],[0.567],[0.731],[0.787],[0.692],[0.62],[0.908],[0.807],[0.748],[0.787],[0.773],0.57,0.516,0.607,0.173,0.192,0.163,0.737,0.649,0.567,0.731,0.787,0.692,0.62,0.908,0.807,0.748,0.787,0.773
https://doi.org/10.1002/nafm.10036,juvenile and adult striped bass mortality and distribution in an unrecovered coastal population,3175_juvenile and adult striped bass mortality and distribution in an unrecovered coastal population.pdf,2,"['https://deq.nc.gov/media/21332/download', 'https://deq.nc.gov/media/19799/download']","['Appendix 3 : Achieving Sustainable Harvest For The Tar-pamlico And Neuse Striped Bass Stocks', 'Central Southern Management Area Striped Bass Stocks in North Carolina, 2020']","['https://deq.nc.gov/media/21332/download', 'https://deq.nc.gov/media/19799/download']","['3175_0_appendix 3  achieving sustainable harvest for the tarpamlico and neuse striped bass stocks.pdf', '3175_1_central southern management area striped bass stocks in north carolina 2020.pdf']",2,100.0,"['https://deq.nc.gov/media/21332/download', 'https://deq.nc.gov/media/19799/download']","['3175_0_appendix 3  achieving sustainable harvest for the tarpamlico and neuse striped bass stocks.pdf', '3175_1_central southern management area striped bass stocks in north carolina 2020.pdf']","[0.57, 0.68]","[0.52, 0.516]","[0.6, 0.6]","[0.185, 0.169]","[0.195, 0.177]","[0.163, 0.15]","[0.733, 0.731]","[0.645, 0.641]","[0.587, 0.586]","[0.697, 0.703]","[0.794, 0.786]","[0.717, 0.714]","[0.645, 0.639]","[0.906, 0.904]","[0.812, 0.81]","[0.753, 0.749]","[0.776, 0.77]","[0.773, 0.765]",0.625,0.518,0.6,0.177,0.186,0.157,0.732,0.643,0.587,0.7,0.79,0.716,0.642,0.905,0.811,0.751,0.773,0.769
https://doi.org/10.1002/ncp.10244,impact of feeding interval on time to achieve full oral feeding in preterm infants a randomized trial,3180_impact of feeding interval on time to achieve full oral feeding in preterm infants a randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407504/pdf'],['Short versus long feeding interval for bolus feedings in very preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407504/pdf'],['3180_0_short versus long feeding interval for bolus feedings in very preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407504/pdf'],['3180_0_short versus long feeding interval for bolus feedings in very preterm infants.pdf'],[0.652],[0.56],[0.641],[0.206],[0.212],[0.175],[0.737],[0.643],[0.627],[0.681],[0.788],[0.73],[0.613],[0.925],[0.834],[0.755],[0.796],[0.78],0.652,0.56,0.641,0.206,0.212,0.175,0.737,0.643,0.627,0.681,0.788,0.73,0.613,0.925,0.834,0.755,0.796,0.78
https://doi.org/10.1002/pam.22008,the case for limiting federal student aid to forprofit colleges,3242_the case for limiting federal student aid to forprofit colleges.pdf,6,"['https://www.brookings.edu/blog/brown-center-chalkboard/2020/11/02/the-alarming-rise-in-for-profit-college-enrollment/', 'https://www.brookings.edu/blog/how-we-rise/2021/01/12/the-for-profit-college-system-is-broken-and-the-biden-administration-needs-to-fix-it/', 'https://www.urban.org/research/publication/profit-college-policy-crossroads', 'https://www.congress.gov/congressional-report/116th-congress/house-report/700/1', 'https://www1.nyc.gov/assets/dca/downloads/pdf/about/PublicComments-DeceptiveAdvertisingbyForProfitSchools.pdf', 'https://www.brookings.edu/research/where-have-all-the-gi-bill-dollars-gone/']","['The alarming rise in for-profit college enrollment', 'The for-profit college system is broken and the Biden administration needs to fix it', 'For-Profit College Policy at the Crossroads', 'H. Rept. 116-700 - COLLEGE AFFORDABILITY ACT', 'Comments Received on Deceptive Advertising by For-Profit Educational Institutions', 'Where have all the GI Bill dollars gone?']",['https://www1.nyc.gov/assets/dca/downloads/pdf/about/PublicComments-DeceptiveAdvertisingbyForProfitSchools.pdf'],['3242_4_comments received on deceptive advertising by forprofit educational institutions.pdf'],1,16.67,['https://www1.nyc.gov/assets/dca/downloads/pdf/about/PublicComments-DeceptiveAdvertisingbyForProfitSchools.pdf'],['3242_4_comments received on deceptive advertising by forprofit educational institutions.pdf'],[0.632],[0.555],[0.645],[0.192],[0.204],[0.181],[0.727],[0.633],[0.633],[0.708],[0.817],[0.74],[0.654],[0.923],[0.859],[0.785],[0.824],[0.805],0.632,0.555,0.645,0.192,0.204,0.181,0.727,0.633,0.633,0.708,0.817,0.74,0.654,0.923,0.859,0.785,0.824,0.805
https://doi.org/10.1002/pam.22171,how local economic conditions affect school finances teacher quality and student achievement evidence from the texas shale boom,3251_how local economic conditions affect school finances teacher quality and student achievement evidence from the texas shale boom.pdf,4,"['https://www.whitehouse.gov/wp-content/uploads/2019/10/The-Value-of-U.S.-Energy-Innovation-and-Policies-Supporting-the-Shale-Revolution.pdf', 'https://purl.fdlp.gov/GPO/gpo129413', 'https://www.congress.gov/event/117th-congress/house-event/112462', 'https://www.whitehouse.gov/wp-content/uploads/2020/02/2020-Economic-Report-of-the-President-WHCEA.pdf']","['The Value of U.S. Energy Innovation and Policies Supporting the Shale Revolution', 'The value of U.S. energy innovation and policies supporting the shale revolution /', '""Generating Equity: Deploying a Just and Clean Energy Future""', 'Economic Report of the President']",['https://purl.fdlp.gov/GPO/gpo129413'],['3251_1_the value of us energy innovation and policies supporting the shale revolution .pdf'],1,25.0,['https://purl.fdlp.gov/GPO/gpo129413'],['3251_1_the value of us energy innovation and policies supporting the shale revolution .pdf'],[0.326],[0.55],[0.631],[0.169],[0.164],[0.135],[0.721],[0.622],[0.628],[0.681],[0.813],[0.762],[0.679],[0.932],[0.849],[0.787],[0.823],[0.804],0.326,0.55,0.631,0.169,0.164,0.135,0.721,0.622,0.628,0.681,0.813,0.762,0.679,0.932,0.849,0.787,0.823,0.804
https://doi.org/10.1002/pan3.10194,the role of western‐based scientific indigenous and local knowledge in wildlife management and conservation,3255_the role of western‐based scientific indigenous and local knowledge in wildlife management and conservation.pdf,2,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8gubd3v4q_LIVING_WITH_TIGERS_high_res_.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/7y451dcmjv_living_with_tigers_110622__june_13_.pdf']","['Living with Tigers: How to manage coexistence for the benefit of people and tigers', 'Living with Tigers: How to manage coexistence for the benefit of people and tigers']",['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8gubd3v4q_LIVING_WITH_TIGERS_high_res_.pdf'],['3255_0_living with tigers how to manage coexistence for the benefit of people and tigers.pdf'],1,50.0,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8gubd3v4q_LIVING_WITH_TIGERS_high_res_.pdf'],['3255_0_living with tigers how to manage coexistence for the benefit of people and tigers.pdf'],[0.297],[0.522],[0.622],[0.145],[0.156],[0.133],[0.728],[0.637],[0.581],[0.68],[0.793],[0.714],[0.635],[0.911],[0.834],[0.759],[0.797],[0.782],0.297,0.522,0.622,0.145,0.156,0.133,0.728,0.637,0.581,0.68,0.793,0.714,0.635,0.911,0.834,0.759,0.797,0.782
https://doi.org/10.1002/pbc.28409,the covid‐19 pandemic a rapid global response for children with cancer from siop cog siop‐e siop‐podc ipso pros cci and st jude global,3329_the covid‐19 pandemic a rapid global response for children with cancer from siop cog siop‐e siop‐podc ipso pros cci and st jude global.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951944/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['3329_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '3329_2_coronavirus disease 2019 covid19 treatment guidelines.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['3329_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '3329_2_coronavirus disease 2019 covid19 treatment guidelines.pdf']","[0.581, 0.54]","[0.561, 0.553]","[0.639, 0.625]","[0.178, 0.171]","[0.186, 0.172]","[0.155, 0.141]","[0.747, 0.745]","[0.658, 0.654]","[0.623, 0.615]","[0.628, 0.637]","[0.815, 0.803]","[0.749, 0.718]","[0.632, 0.612]","[0.922, 0.902]","[0.841, 0.814]","[0.768, 0.769]","[0.818, 0.802]","[0.798, 0.789]",0.56,0.557,0.632,0.174,0.179,0.148,0.746,0.656,0.619,0.633,0.809,0.734,0.622,0.912,0.827,0.768,0.81,0.794
https://doi.org/10.1002/phar.1649,a review of antibiotic use in pregnancy,3344_a review of antibiotic use in pregnancy.pdf,1,['https://www.idsociety.org/contentassets/7ab3d1e72a9d4868be6d6c2c2553818e/adult_oi.pdf'],['Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV'],['https://www.idsociety.org/contentassets/7ab3d1e72a9d4868be6d6c2c2553818e/adult_oi.pdf'],['3344_0_guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with hiv.pdf'],1,100.0,['https://www.idsociety.org/contentassets/7ab3d1e72a9d4868be6d6c2c2553818e/adult_oi.pdf'],['3344_0_guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with hiv.pdf'],[0.37],[0.574],[0.646],[0.159],[0.15],[0.125],[0.742],[0.646],[0.633],[0.607],[0.81],[0.722],[0.615],[0.91],[0.799],[0.779],[0.806],[0.794],0.37,0.574,0.646,0.159,0.15,0.125,0.742,0.646,0.633,0.607,0.81,0.722,0.615,0.91,0.799,0.779,0.806,0.794
https://doi.org/10.1002/pon.4989,longterm issues and supportive care needs of adolescent and young adult childhood brain tumour survivors and their caregivers a systematic review,3386_longterm issues and supportive care needs of adolescent and young adult childhood brain tumour survivors and their caregivers a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059965/pdf', 'https://effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/research']","['Severe fatigue after treatment for childhood cancer', 'Disparities and Barriers to Pediatric Cancer Survivorship Care']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059965/pdf'],['3386_0_severe fatigue after treatment for childhood cancer.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059965/pdf'],['3386_0_severe fatigue after treatment for childhood cancer.pdf'],[0.394],[0.503],[0.591],[0.151],[0.161],[0.137],[0.736],[0.641],[0.56],[0.697],[0.765],[0.693],[0.59],[0.911],[0.801],[0.705],[0.763],[0.736],0.394,0.503,0.591,0.151,0.161,0.137,0.736,0.641,0.56,0.697,0.765,0.693,0.59,0.911,0.801,0.705,0.763,0.736
https://doi.org/10.1002/rmv.1801,mothertochild transmission of hbv review of current clinical management and prevention strategies,3470_mothertochild transmission of hbv review of current clinical management and prevention strategies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464495/pdf'],['Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464495/pdf'],['3470_0_hepatitis b immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis b virus.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464495/pdf'],['3470_0_hepatitis b immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis b virus.pdf'],[0.438],[0.533],[0.622],[0.176],[0.168],[0.139],[0.734],[0.642],[0.605],[0.639],[0.791],[0.693],[0.595],[0.921],[0.819],[0.735],[0.787],[0.769],0.438,0.533,0.622,0.176,0.168,0.139,0.734,0.642,0.605,0.639,0.791,0.693,0.595,0.921,0.819,0.735,0.787,0.769
https://doi.org/10.1002/rra.3634,tributary confluences are dynamic thermal refuges for a juvenile salmonid in a warming river network,3480_tributary confluences are dynamic thermal refuges for a juvenile salmonid in a warming river network.pdf,1,['https://www.waterboards.ca.gov/santaana/board_info/agendas/2021/dec102021/item_15.pdf'],['20210928_Staff Report_V2_Final'],['https://www.waterboards.ca.gov/santaana/board_info/agendas/2021/dec102021/item_15.pdf'],['3480_0_20210928staff reportv2final.pdf'],1,100.0,['https://www.waterboards.ca.gov/santaana/board_info/agendas/2021/dec102021/item_15.pdf'],['3480_0_20210928staff reportv2final.pdf'],[0.095],[0.528],[0.615],[0.132],[0.121],[0.102],[0.721],[0.624],[0.606],[0.662],[0.806],[0.75],[0.656],[0.915],[0.838],[0.781],[0.818],[0.798],0.095,0.528,0.615,0.132,0.121,0.102,0.721,0.624,0.606,0.662,0.806,0.75,0.656,0.915,0.838,0.781,0.818,0.798
https://doi.org/10.1002/smi.2922,exposures to structural racism and racial discrimination among pregnant and early post‐partum black women living in oakland california,3514_exposures to structural racism and racial discrimination among pregnant and early post‐partum black women living in oakland california.pdf,2,"['https://www.aspeninstitute.org/publications/reversing-the-u-s-maternal-mortality-crisis/', 'https://www1.nyc.gov/assets/doh/downloads/pdf/csi/strategies-for-community-engagement-raising-awareness-severe-maternal-morbidity.pdf']","['Reversing the U.S. Maternal Mortality Crisis - The Aspen Institute', 'Raising Awareness to Reduce Severe Maternal Morbidity']",['https://www1.nyc.gov/assets/doh/downloads/pdf/csi/strategies-for-community-engagement-raising-awareness-severe-maternal-morbidity.pdf'],['3514_1_raising awareness to reduce severe maternal morbidity.pdf'],1,50.0,['https://www1.nyc.gov/assets/doh/downloads/pdf/csi/strategies-for-community-engagement-raising-awareness-severe-maternal-morbidity.pdf'],['3514_1_raising awareness to reduce severe maternal morbidity.pdf'],[0.299],[0.482],[0.597],[0.131],[0.159],[0.125],[0.726],[0.633],[0.542],[0.67],[0.77],[0.682],[0.61],[0.903],[0.799],[0.727],[0.762],[0.743],0.299,0.482,0.597,0.131,0.159,0.125,0.726,0.633,0.542,0.67,0.77,0.682,0.61,0.903,0.799,0.727,0.762,0.743
https://doi.org/10.1002/smi.2976,a lifestyle intervention randomized controlled trial in obese women with infertility improved body composition among those who experienced childhood adversity,3515_a lifestyle intervention randomized controlled trial in obese women with infertility improved body composition among those who experienced childhood adversity.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf'],['Preconception lifestyle advice for people with infertility'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf'],['3515_0_preconception lifestyle advice for people with infertility.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf'],['3515_0_preconception lifestyle advice for people with infertility.pdf'],[0.463],[0.503],[0.598],[0.153],[0.159],[0.134],[0.735],[0.639],[0.56],[0.688],[0.754],[0.685],[0.583],[0.894],[0.779],[0.694],[0.757],[0.718],0.463,0.503,0.598,0.153,0.159,0.134,0.735,0.639,0.56,0.688,0.754,0.685,0.583,0.894,0.779,0.694,0.757,0.718
https://doi.org/10.1002/tpg2.20101,an anchored chromosome‐scale genome assembly of spinach improves annotation and reveals extensive gene rearrangements in euasterids,3573_an anchored chromosome‐scale genome assembly of spinach improves annotation and reveals extensive gene rearrangements in euasterids.pdf,1,['https://www.cdfa.ca.gov/plant/meetings/docs/sab/ho1_seed_biotechnology_center_report.pdf'],['SBC Team'],['https://www.cdfa.ca.gov/plant/meetings/docs/sab/ho1_seed_biotechnology_center_report.pdf'],['3573_0_sbc team.pdf'],1,100.0,['https://www.cdfa.ca.gov/plant/meetings/docs/sab/ho1_seed_biotechnology_center_report.pdf'],['3573_0_sbc team.pdf'],[0.188],[0.523],[0.625],[0.153],[0.162],[0.138],[0.748],[0.662],[0.599],[0.683],[0.796],[0.702],[0.624],[0.908],[0.824],[0.764],[0.795],[0.784],0.188,0.523,0.625,0.153,0.162,0.138,0.748,0.662,0.599,0.683,0.796,0.702,0.624,0.908,0.824,0.764,0.795,0.784
https://doi.org/10.1002/uog.22014,coronavirus in pregnancy and delivery rapid review,3579_coronavirus in pregnancy and delivery rapid review.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755429/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516367/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf']","['Management strategies for children with COVID-19: ESPR practical recommendations', ""Women's sexual/reproductive health and access challenges amid COVID-19 pandemic"", 'Aktualisierte Empfehlungen zu SARS-CoV-2/COVID-19 und Schwangerschaft, Geburt und Wochenbett', 'Recomendaciones y manejo práctico de la gestante con COVID-19:', 'COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516367/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755429/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['3579_2_aktualisierte empfehlungen zu sarscov2covid19 und schwangerschaft geburt und wochenbett.pdf', '3579_4_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf', '3579_3_recomendaciones y manejo práctico de la gestante con covid19.pdf', '3579_1_womens sexualreproductive health and access challenges amid covid19 pandemic.pdf', '3579_0_management strategies for children with covid19 espr practical recommendations.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516367/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755429/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['3579_2_aktualisierte empfehlungen zu sarscov2covid19 und schwangerschaft geburt und wochenbett.pdf', '3579_4_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf', '3579_3_recomendaciones y manejo práctico de la gestante con covid19.pdf', '3579_1_womens sexualreproductive health and access challenges amid covid19 pandemic.pdf', '3579_0_management strategies for children with covid19 espr practical recommendations.pdf']","[0.31, 0.469, 0.17, 0.078, 0.554]","[0.49, 0.523, 0.461, 0.56, 0.565]","[0.585, 0.611, 0.569, 0.64, 0.643]","[0.145, 0.175, 0.165, 0.186, 0.191]","[0.185, 0.196, 0.206, 0.205, 0.184]","[0.13, 0.157, 0.153, 0.168, 0.149]","[0.73, 0.734, 0.73, 0.738, 0.734]","[0.652, 0.646, 0.647, 0.646, 0.642]","[0.565, 0.58, 0.537, 0.625, 0.639]","[0.615, 0.629, 0.619, 0.612, 0.606]","[0.784, 0.783, 0.781, 0.802, 0.812]","[0.696, 0.697, 0.682, 0.743, 0.732]","[0.578, 0.608, 0.564, 0.618, 0.616]","[0.898, 0.912, 0.883, 0.922, 0.93]","[0.817, 0.801, 0.798, 0.825, 0.838]","[0.717, 0.74, 0.708, 0.776, 0.78]","[0.755, 0.776, 0.748, 0.801, 0.815]","[0.729, 0.765, 0.727, 0.786, 0.795]",0.316,0.52,0.61,0.172,0.195,0.151,0.733,0.647,0.589,0.616,0.792,0.71,0.597,0.909,0.816,0.744,0.779,0.76
https://doi.org/10.1007/0-306-47147-7_6,cultural adjustment and hispanic adolescent drug use,3766_cultural adjustment and hispanic adolescent drug use.pdf,1,['https://purl.fdlp.gov/GPO/gpo59896'],['Substance abuse :\xa0clinical issues in intensive outpatient treatment /'],['https://purl.fdlp.gov/GPO/gpo59896'],['3766_0_substance abuse \xa0clinical issues in intensive outpatient treatment .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo59896'],['3766_0_substance abuse \xa0clinical issues in intensive outpatient treatment .pdf'],[0.237],[0.563],[0.648],[0.124],[0.147],[0.12],[0.718],[0.616],[0.637],[0.663],[0.821],[0.769],[0.663],[0.925],[0.851],[0.792],[0.831],[0.808],0.237,0.563,0.648,0.124,0.147,0.12,0.718,0.616,0.637,0.663,0.821,0.769,0.663,0.925,0.851,0.792,0.831,0.808
https://doi.org/10.1007/978-0-306-48544-2_12,fostering resilience among youth in the juvenile justice system,3795_fostering resilience among youth in the juvenile justice system.pdf,2,"['http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf']","['Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'JUVENILE OFFENDING']","['http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf']","['3795_1_juvenile offending.pdf', '3795_0_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf']",2,100.0,"['http://vcoy.virginia.gov/documents/collection/026%20Juvenille%20offending2.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf']","['3795_1_juvenile offending.pdf', '3795_0_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf']","[0.532, 0.796]","[0.524, 0.508]","[0.616, 0.604]","[0.195, 0.149]","[0.219, 0.161]","[0.183, 0.137]","[0.739, 0.729]","[0.647, 0.631]","[0.584, 0.575]","[0.684, 0.675]","[0.795, 0.791]","[0.724, 0.718]","[0.627, 0.62]","[0.915, 0.916]","[0.815, 0.81]","[0.759, 0.756]","[0.802, 0.795]","[0.786, 0.781]",0.664,0.516,0.61,0.172,0.19,0.16,0.734,0.639,0.579,0.679,0.793,0.721,0.623,0.915,0.812,0.758,0.798,0.784
https://doi.org/10.1007/978-1-0716-1339-9_18,infant rabbit model for studying shiga toxinproducing escherichia coli,3805_infant rabbit model for studying shiga toxinproducing escherichia coli.pdf,2,"['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/EpiSummariesofSelectedCommDiseasesinCA2013-2019.pdf', 'https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/STECHUSEpiSummary2013-2019.pdf']","['CDPH-IDB Epidemiologic Summaries of Selected Communicable Diseases in California, 2013-2019', 'Epidemiologic Summary of Shiga Toxin-producing E. coli (STEC) Infections and Hemolytic Uremic Syndrome (HUS) in California, 2013-2019']","['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/EpiSummariesofSelectedCommDiseasesinCA2013-2019.pdf', 'https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/STECHUSEpiSummary2013-2019.pdf']","['3805_0_cdphidb epidemiologic summaries of selected communicable diseases in california 20132019.pdf', '3805_1_epidemiologic summary of shiga toxinproducing e coli stec infections and hemolytic uremic syndrome hus in california 20132019.pdf']",2,100.0,"['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/EpiSummariesofSelectedCommDiseasesinCA2013-2019.pdf', 'https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/STECHUSEpiSummary2013-2019.pdf']","['3805_0_cdphidb epidemiologic summaries of selected communicable diseases in california 20132019.pdf', '3805_1_epidemiologic summary of shiga toxinproducing e coli stec infections and hemolytic uremic syndrome hus in california 20132019.pdf']","[0.123, 0.131]","[0.502, 0.503]","[0.59, 0.586]","[0.094, 0.1]","[0.091, 0.1]","[0.058, 0.065]","[0.724, 0.723]","[0.626, 0.626]","[0.596, 0.593]","[0.634, 0.645]","[0.8, 0.796]","[0.693, 0.696]","[0.6, 0.605]","[0.908, 0.907]","[0.827, 0.827]","[0.75, 0.751]","[0.803, 0.804]","[0.786, 0.787]",0.127,0.502,0.588,0.097,0.096,0.061,0.724,0.626,0.595,0.639,0.798,0.694,0.603,0.907,0.827,0.75,0.804,0.786
https://doi.org/10.1007/s00128-020-02971-1,evaluation of juvenile freshwater mussel sensitivity to multiple forms of florpyrauxifenbenzyl,4057_evaluation of juvenile freshwater mussel sensitivity to multiple forms of florpyrauxifenbenzyl.pdf,1,['https://www.dec.ny.gov/docs/lands_forests_pdf/peconicludwigiamanagementplan.pdf'],['Peconic Ludwigia peploides Control Project Five-Year Management Plan'],['https://www.dec.ny.gov/docs/lands_forests_pdf/peconicludwigiamanagementplan.pdf'],['4057_0_peconic ludwigia peploides control project fiveyear management plan.pdf'],1,100.0,['https://www.dec.ny.gov/docs/lands_forests_pdf/peconicludwigiamanagementplan.pdf'],['4057_0_peconic ludwigia peploides control project fiveyear management plan.pdf'],[0.252],[0.576],[0.649],[0.186],[0.189],[0.153],[0.737],[0.652],[0.658],[0.654],[0.833],[0.767],[0.674],[0.923],[0.851],[0.808],[0.84],[0.824],0.252,0.576,0.649,0.186,0.189,0.153,0.737,0.652,0.658,0.654,0.833,0.767,0.674,0.923,0.851,0.808,0.84,0.824
https://doi.org/10.1007/s00204-018-2350-5,anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders,4139_anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders.pdf,1,['https://purl.fdlp.gov/GPO/gpo144829'],['Toxicological profile for glyphosate.'],['https://purl.fdlp.gov/GPO/gpo144829'],['4139_0_toxicological profile for glyphosate.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo144829'],['4139_0_toxicological profile for glyphosate.pdf'],[0.405],[0.493],[0.605],[0.148],[0.15],[0.114],[0.743],[0.655],[0.563],[0.673],[0.784],[0.669],[0.61],[0.906],[0.794],[0.731],[0.767],[0.755],0.405,0.493,0.605,0.148,0.15,0.114,0.743,0.655,0.563,0.673,0.784,0.669,0.61,0.906,0.794,0.731,0.767,0.755
https://doi.org/10.1007/s00204-019-02540-4,association of plasma folate vitamin b12 levels and arsenic methylation capacity with developmental delay in preschool children in taiwan,4140_association of plasma folate vitamin b12 levels and arsenic methylation capacity with developmental delay in preschool children in taiwan.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['Provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['4140_0_provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['4140_0_provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults.pdf'],[0.402],[0.538],[0.634],[0.179],[0.176],[0.138],[0.739],[0.644],[0.605],[0.662],[0.789],[0.714],[0.634],[0.912],[0.809],[0.751],[0.792],[0.769],0.402,0.538,0.634,0.179,0.176,0.138,0.739,0.644,0.605,0.662,0.789,0.714,0.634,0.912,0.809,0.751,0.792,0.769
https://doi.org/10.1007/s00204-020-02715-4,internal exposure to perfluoroalkyl substances pfass and biological markers in 101 healthy 1yearold children associations between levels of perfluorooctanoic acid pfoa and vaccine response,4142_internal exposure to perfluoroalkyl substances pfass and biological markers in 101 healthy 1yearold children associations between levels of perfluorooctanoic acid pfoa and vaccine response.pdf,3,"['https://stacks.cdc.gov/view/cdc/114926', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf']","['Evaluation of per-and polyfluoroalkyl substances (PFAS) detected in private residential drinking water wells located within 1 mile of the Pease International Tradeport : PEASE AIR FORCE BASE PORTSMOUTH, NEWINGTON, AND GREENLAND, NEW HAMPSHIRE EPA FACILITY ID: NH7570024847', 'Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft', 'Per- and Polyfluoroalkyl Substances Chemical Action Plan']","['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf']","['4142_1_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '4142_2_per and polyfluoroalkyl substances chemical action plan.pdf']",2,66.67,"['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf']","['4142_1_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '4142_2_per and polyfluoroalkyl substances chemical action plan.pdf']","[0.553, 0.278]","[0.535, 0.53]","[0.62, 0.614]","[0.163, 0.139]","[0.152, 0.127]","[0.119, 0.098]","[0.739, 0.728]","[0.647, 0.633]","[0.602, 0.611]","[0.663, 0.63]","[0.797, 0.803]","[0.706, 0.721]","[0.639, 0.641]","[0.911, 0.918]","[0.819, 0.822]","[0.765, 0.771]","[0.797, 0.805]","[0.782, 0.79]",0.416,0.532,0.617,0.151,0.14,0.108,0.734,0.64,0.607,0.647,0.8,0.714,0.64,0.915,0.821,0.768,0.801,0.786
https://doi.org/10.1007/s00204-020-02745-y,combined effect of polymorphisms of mthfr and mtr and arsenic methylation capacity on developmental delay in preschool children in taiwan,4143_combined effect of polymorphisms of mthfr and mtr and arsenic methylation capacity on developmental delay in preschool children in taiwan.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['Provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['4143_0_provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['4143_0_provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults.pdf'],[0.3],[0.515],[0.605],[0.154],[0.149],[0.122],[0.74],[0.647],[0.58],[0.674],[0.775],[0.688],[0.613],[0.907],[0.8],[0.73],[0.771],[0.757],0.3,0.515,0.605,0.154,0.149,0.122,0.74,0.647,0.58,0.674,0.775,0.688,0.613,0.907,0.8,0.73,0.771,0.757
https://doi.org/10.1007/s00267-019-01146-x,stream conditions after 18 years of passive riparian restoration in small fishbearing watersheds,4282_stream conditions after 18 years of passive riparian restoration in small fishbearing watersheds.pdf,4,"['https://www.dnr.wa.gov/publications/lm_trust_land_hcp_annual_rprt_2019.pdf', 'https://www.dnr.wa.gov/sites/default/files/publications/lm_tl_hcp_arpt_2020.pdf', 'https://www.dnr.wa.gov/publications/lm_oesf_may_2019_newsletter.pdf', 'https://www.dnr.wa.gov/publications/lm_oesf_rvmp_2019_annual_report.pdf']","['2019 Annual Report', 'Trust Lands Habitat Conservation Plan Annual Report', 'Learning Forest', 'Riparian Validation Monitoring Program (RVMP) 2019 Annual Report']","['https://www.dnr.wa.gov/publications/lm_oesf_may_2019_newsletter.pdf', 'https://www.dnr.wa.gov/publications/lm_trust_land_hcp_annual_rprt_2019.pdf', 'https://www.dnr.wa.gov/sites/default/files/publications/lm_tl_hcp_arpt_2020.pdf', 'https://www.dnr.wa.gov/publications/lm_oesf_rvmp_2019_annual_report.pdf']","['4282_2_learning forest.pdf', '4282_0_2019 annual report.pdf', '4282_1_trust lands habitat conservation plan annual report.pdf', '4282_3_riparian validation monitoring program rvmp 2019 annual report.pdf']",4,100.0,"['https://www.dnr.wa.gov/publications/lm_oesf_may_2019_newsletter.pdf', 'https://www.dnr.wa.gov/publications/lm_trust_land_hcp_annual_rprt_2019.pdf', 'https://www.dnr.wa.gov/sites/default/files/publications/lm_tl_hcp_arpt_2020.pdf', 'https://www.dnr.wa.gov/publications/lm_oesf_rvmp_2019_annual_report.pdf']","['4282_2_learning forest.pdf', '4282_0_2019 annual report.pdf', '4282_1_trust lands habitat conservation plan annual report.pdf', '4282_3_riparian validation monitoring program rvmp 2019 annual report.pdf']","[0.437, 0.421, 0.616, 0.588]","[0.6, 0.584, 0.588, 0.554]","[0.664, 0.653, 0.656, 0.631]","[0.232, 0.204, 0.208, 0.219]","[0.221, 0.203, 0.207, 0.211]","[0.196, 0.171, 0.174, 0.181]","[0.748, 0.742, 0.742, 0.746]","[0.659, 0.653, 0.654, 0.658]","[0.661, 0.652, 0.655, 0.609]","[0.72, 0.707, 0.711, 0.713]","[0.832, 0.829, 0.83, 0.811]","[0.779, 0.77, 0.773, 0.734]","[0.69, 0.683, 0.683, 0.665]","[0.926, 0.927, 0.93, 0.91]","[0.867, 0.864, 0.864, 0.84]","[0.812, 0.81, 0.812, 0.786]","[0.844, 0.844, 0.844, 0.822]","[0.825, 0.823, 0.824, 0.804]",0.515,0.581,0.651,0.216,0.21,0.18,0.745,0.656,0.644,0.713,0.826,0.764,0.68,0.923,0.859,0.805,0.839,0.819
https://doi.org/10.1007/s00296-019-04498-z,drug reactions in children with rheumatic diseases receiving parenteral therapies 9 years’ experience of a tertiary pediatric rheumatology center,4302_drug reactions in children with rheumatic diseases receiving parenteral therapies 9 years’ experience of a tertiary pediatric rheumatology center.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['4302_0_diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['4302_0_diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19.pdf'],[0.439],[0.56],[0.634],[0.182],[0.199],[0.152],[0.749],[0.655],[0.626],[0.638],[0.808],[0.733],[0.626],[0.925],[0.826],[0.771],[0.807],[0.791],0.439,0.56,0.634,0.182,0.199,0.152,0.749,0.655,0.626,0.638,0.808,0.733,0.626,0.925,0.826,0.771,0.807,0.791
https://doi.org/10.1007/s00330-020-07229-2,extended application of subtraction arterial phase imaging in lirads version 2018 a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium–enhanced mri,4310_extended application of subtraction arterial phase imaging in lirads version 2018 a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium–enhanced mri.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['4310_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['4310_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.31],[0.557],[0.625],[0.157],[0.158],[0.127],[0.746],[0.655],[0.623],[0.642],[0.802],[0.723],[0.638],[0.917],[0.827],[0.773],[0.806],[0.786],0.31,0.557,0.625,0.157,0.158,0.127,0.746,0.655,0.623,0.642,0.802,0.723,0.638,0.917,0.827,0.773,0.806,0.786
https://doi.org/10.1007/s00330-021-07908-8,diagnostic performance of adultbased ata and acrtirads ultrasound risk stratification systems in pediatric thyroid nodules a systematic review and metaanalysis,4311_diagnostic performance of adultbased ata and acrtirads ultrasound risk stratification systems in pediatric thyroid nodules a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716393/pdf'],['2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716393/pdf'],['4311_0_2022 european thyroid association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716393/pdf'],['4311_0_2022 european thyroid association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.pdf'],[0.454],[0.543],[0.619],[0.182],[0.168],[0.134],[0.742],[0.643],[0.608],[0.671],[0.795],[0.704],[0.625],[0.914],[0.823],[0.764],[0.797],[0.782],0.454,0.543,0.619,0.182,0.168,0.134,0.742,0.643,0.608,0.671,0.795,0.704,0.625,0.914,0.823,0.764,0.797,0.782
https://doi.org/10.1007/s00382-018-4585-5,the added value of the multisystem spread information for ocean heat content and steric sea level investigations in the cmems grep ensemble reanalysis product,4324_the added value of the multisystem spread information for ocean heat content and steric sea level investigations in the cmems grep ensemble reanalysis product.pdf,1,['https://wdfw.wa.gov/sites/default/files/2021-07/cheng2021_upperoceantemperatures2020.pdf'],['Upper Ocean Temperatures Hit Record High in 2020'],['https://wdfw.wa.gov/sites/default/files/2021-07/cheng2021_upperoceantemperatures2020.pdf'],['4324_0_upper ocean temperatures hit record high in 2020.pdf'],1,100.0,['https://wdfw.wa.gov/sites/default/files/2021-07/cheng2021_upperoceantemperatures2020.pdf'],['4324_0_upper ocean temperatures hit record high in 2020.pdf'],[0.519],[0.522],[0.625],[0.182],[0.174],[0.161],[0.741],[0.653],[0.577],[0.734],[0.801],[0.719],[0.67],[0.915],[0.822],[0.763],[0.794],[0.784],0.519,0.522,0.625,0.182,0.174,0.161,0.741,0.653,0.577,0.734,0.801,0.719,0.67,0.915,0.822,0.763,0.794,0.784
https://doi.org/10.1007/s00383-019-04461-w,adolescent gallstones—need for early intervention in symptomatic idiopathic gallstones,4336_adolescent gallstones—need for early intervention in symptomatic idiopathic gallstones.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061037/pdf'],['Cholelithiasis and cholecystitis in children and adolescents: Does this increasing diagnosis require a common guideline for pediatricians and pediatric surgeons?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061037/pdf'],['4336_0_cholelithiasis and cholecystitis in children and adolescents does this increasing diagnosis require a common guideline for pediatricians and pediatric surgeons.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061037/pdf'],['4336_0_cholelithiasis and cholecystitis in children and adolescents does this increasing diagnosis require a common guideline for pediatricians and pediatric surgeons.pdf'],[0.412],[0.566],[0.649],[0.195],[0.201],[0.159],[0.74],[0.645],[0.637],[0.657],[0.81],[0.749],[0.643],[0.919],[0.836],[0.777],[0.815],[0.795],0.412,0.566,0.649,0.195,0.201,0.159,0.74,0.645,0.637,0.657,0.81,0.749,0.643,0.919,0.836,0.777,0.815,0.795
https://doi.org/10.1007/s00384-019-03253-x,associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics,4339_associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094278/pdf'],['Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094278/pdf'],['4339_0_risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094278/pdf'],['4339_0_risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.pdf'],[0.452],[0.527],[0.607],[0.185],[0.179],[0.146],[0.744],[0.651],[0.588],[0.665],[0.776],[0.675],[0.603],[0.905],[0.813],[0.73],[0.778],[0.757],0.452,0.527,0.607,0.185,0.179,0.146,0.744,0.651,0.588,0.665,0.776,0.675,0.603,0.905,0.813,0.73,0.778,0.757
https://doi.org/10.1007/s00404-018-4929-8,doubleballoon catheter versus dinoprostone insert for labour induction a metaanalysis,4360_doubleballoon catheter versus dinoprostone insert for labour induction a metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953206/pdf'],['Mechanical methods for induction of labour'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953206/pdf'],['4360_0_mechanical methods for induction of labour.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953206/pdf'],['4360_0_mechanical methods for induction of labour.pdf'],[0.502],[0.505],[0.592],[0.184],[0.183],[0.156],[0.741],[0.644],[0.565],[0.672],[0.771],[0.68],[0.593],[0.903],[0.783],[0.715],[0.767],[0.739],0.502,0.505,0.592,0.184,0.183,0.156,0.741,0.644,0.565,0.672,0.771,0.68,0.593,0.903,0.783,0.715,0.767,0.739
https://doi.org/10.1007/s00405-020-05965-1,olfactory and gustatory dysfunctions as a clinical presentation of mildtomoderate forms of the coronavirus disease covid19 a multicenter european study,4361_olfactory and gustatory dysfunctions as a clinical presentation of mildtomoderate forms of the coronavirus disease covid19 a multicenter european study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406942/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406518/pdf']","['Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction', 'Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406942/pdf']","['4361_1_interventions for the prevention of persistent post‐covid‐19 olfactory dysfunction.pdf', '4361_0_interventions for the treatment of persistent post‐covid‐19 olfactory dysfunction.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406518/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406942/pdf']","['4361_1_interventions for the prevention of persistent post‐covid‐19 olfactory dysfunction.pdf', '4361_0_interventions for the treatment of persistent post‐covid‐19 olfactory dysfunction.pdf']","[0.46, 0.45]","[0.532, 0.532]","[0.624, 0.624]","[0.177, 0.179]","[0.182, 0.184]","[0.142, 0.143]","[0.738, 0.739]","[0.641, 0.642]","[0.605, 0.605]","[0.67, 0.669]","[0.79, 0.79]","[0.703, 0.702]","[0.617, 0.618]","[0.915, 0.916]","[0.821, 0.822]","[0.748, 0.75]","[0.791, 0.791]","[0.774, 0.775]",0.455,0.532,0.624,0.178,0.183,0.142,0.738,0.641,0.605,0.669,0.79,0.702,0.617,0.915,0.821,0.749,0.791,0.774
https://doi.org/10.1007/s00406-019-00981-7,agerelated differences in the impact of cannabis use on the brain and cognition a systematic review,4363_agerelated differences in the impact of cannabis use on the brain and cognition a systematic review.pdf,3,"['http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf']","['Report to the Governor and the General Assembly of Virginia', 'Report to the Governor and the General Assembly of Virginia', 'Appendixes']","['http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf']","['4363_0_report to the governor and the general assembly of virginia.pdf', '4363_2_appendixes.pdf', '4363_1_report to the governor and the general assembly of virginia.pdf']",3,100.0,"['http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf']","['4363_0_report to the governor and the general assembly of virginia.pdf', '4363_2_appendixes.pdf', '4363_1_report to the governor and the general assembly of virginia.pdf']","[0.125, 0.125, 0.177]","[0.535, 0.518, 0.542]","[0.618, 0.608, 0.623]","[0.127, 0.129, 0.129]","[0.123, 0.127, 0.126]","[0.109, 0.111, 0.112]","[0.714, 0.716, 0.714]","[0.618, 0.621, 0.619]","[0.63, 0.608, 0.637]","[0.6, 0.617, 0.6]","[0.818, 0.809, 0.821]","[0.763, 0.741, 0.768]","[0.637, 0.626, 0.639]","[0.928, 0.922, 0.929]","[0.84, 0.835, 0.842]","[0.778, 0.765, 0.782]","[0.818, 0.807, 0.821]","[0.793, 0.784, 0.796]",0.142,0.532,0.616,0.128,0.125,0.111,0.715,0.619,0.625,0.606,0.816,0.757,0.634,0.926,0.839,0.775,0.815,0.791
https://doi.org/10.1007/s00431-019-03329-4,preliminary study on bisphenol a levels and possible exposure history of mother and exclusively breastfed infant pairs,4438_preliminary study on bisphenol a levels and possible exposure history of mother and exclusively breastfed infant pairs.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['4438_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['4438_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.278],[0.523],[0.608],[0.137],[0.143],[0.103],[0.732],[0.639],[0.592],[0.649],[0.79],[0.687],[0.616],[0.908],[0.813],[0.755],[0.787],[0.772],0.278,0.523,0.608,0.137,0.143,0.103,0.732,0.639,0.592,0.649,0.79,0.687,0.616,0.908,0.813,0.755,0.787,0.772
https://doi.org/10.1007/s00431-019-03420-w,cigarette smoking ecigarette use and sexual identity among high school students in the usa,4439_cigarette smoking ecigarette use and sexual identity among high school students in the usa.pdf,2,"['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['PM0000529', 'PM0000551']","['https://www.fda.gov/media/153017/download', 'https://www.fda.gov/media/158754/download']","['4439_1_pm0000551.pdf', '4439_0_pm0000529.pdf']",2,100.0,"['https://www.fda.gov/media/153017/download', 'https://www.fda.gov/media/158754/download']","['4439_1_pm0000551.pdf', '4439_0_pm0000529.pdf']","[0.26, 0.366]","[0.538, 0.55]","[0.613, 0.622]","[0.175, 0.172]","[0.176, 0.17]","[0.143, 0.138]","[0.738, 0.732]","[0.639, 0.635]","[0.599, 0.613]","[0.675, 0.662]","[0.798, 0.802]","[0.729, 0.744]","[0.635, 0.644]","[0.916, 0.922]","[0.817, 0.826]","[0.762, 0.776]","[0.803, 0.809]","[0.785, 0.791]",0.313,0.544,0.617,0.173,0.173,0.141,0.735,0.637,0.606,0.669,0.8,0.736,0.639,0.919,0.821,0.769,0.806,0.788
https://doi.org/10.1007/s00431-019-03457-x,a digital movement in the world of inactive children favourable outcomes of playing active video games in a pilot randomized trial,4440_a digital movement in the world of inactive children favourable outcomes of playing active video games in a pilot randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['4440_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['4440_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.427],[0.523],[0.61],[0.173],[0.186],[0.15],[0.733],[0.635],[0.588],[0.696],[0.775],[0.701],[0.608],[0.919],[0.817],[0.734],[0.781],[0.764],0.427,0.523,0.61,0.173,0.186,0.15,0.733,0.635,0.588,0.696,0.775,0.701,0.608,0.919,0.817,0.734,0.781,0.764
https://doi.org/10.1007/s00431-019-03511-8,experts’ opinion for improving global adolescent vaccination rates a call to action,4441_experts’ opinion for improving global adolescent vaccination rates a call to action.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693/pdf'],['COVID Vaccines in Adolescents and Young Adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693/pdf'],['4441_0_covid vaccines in adolescents and young adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114693/pdf'],['4441_0_covid vaccines in adolescents and young adults.pdf'],[0.514],[0.594],[0.669],[0.275],[0.286],[0.246],[0.762],[0.67],[0.661],[0.682],[0.836],[0.766],[0.651],[0.926],[0.854],[0.805],[0.839],[0.82],0.514,0.594,0.669,0.275,0.286,0.246,0.762,0.67,0.661,0.682,0.836,0.766,0.651,0.926,0.854,0.805,0.839,0.82
https://doi.org/10.1007/s00431-020-03684-7,sarscov2 infection in children and newborns a systematic review,4442_sarscov2 infection in children and newborns a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf'],['Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf'],['4442_0_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf'],['4442_0_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf'],[0.224],[0.552],[0.623],[0.191],[0.191],[0.155],[0.745],[0.654],[0.611],[0.656],[0.799],[0.71],[0.635],[0.912],[0.829],[0.763],[0.8],[0.783],0.224,0.552,0.623,0.191,0.191,0.155,0.745,0.654,0.611,0.656,0.799,0.71,0.635,0.912,0.829,0.763,0.8,0.783
https://doi.org/10.1007/s00431-021-03999-z,a crosssectional study of screening for coronavirus disease 2019 covid19 at the pediatric emergency department in vilnius during the first wave of the pandemic,4446_a crosssectional study of screening for coronavirus disease 2019 covid19 at the pediatric emergency department in vilnius during the first wave of the pandemic.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['4446_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['4446_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],[0.409],[0.543],[0.618],[0.187],[0.182],[0.147],[0.735],[0.639],[0.601],[0.679],[0.786],[0.719],[0.62],[0.918],[0.828],[0.747],[0.796],[0.773],0.409,0.543,0.618,0.187,0.182,0.147,0.735,0.639,0.601,0.679,0.786,0.719,0.62,0.918,0.828,0.747,0.796,0.773
https://doi.org/10.1007/s00432-020-03138-5,clinical characteristics and outcomes of sdhbrelated pheochromocytoma and paraganglioma in children and adolescents,4460_clinical characteristics and outcomes of sdhbrelated pheochromocytoma and paraganglioma in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390422/pdf'],"['Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390422/pdf'],['4460_0_multidisciplinary practice guidelines for the diagnosis genetic counseling and treatment of pheochromocytomas and paragangliomas.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390422/pdf'],['4460_0_multidisciplinary practice guidelines for the diagnosis genetic counseling and treatment of pheochromocytomas and paragangliomas.pdf'],[0.65],[0.539],[0.627],[0.169],[0.176],[0.133],[0.746],[0.654],[0.607],[0.666],[0.794],[0.705],[0.627],[0.908],[0.81],[0.756],[0.79],[0.776],0.65,0.539,0.627,0.169,0.176,0.133,0.746,0.654,0.607,0.666,0.794,0.705,0.627,0.908,0.81,0.756,0.79,0.776
https://doi.org/10.1007/s00439-003-1018-1,evidence of a founder effect for the 235delc mutation of gjb2 connexin�26 in east asians,4464_evidence of a founder effect for the 235delc mutation of gjb2 connexin�26 in east asians.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798855/pdf'],['EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798855/pdf'],['4464_0_emqn best practice guidelines for diagnostic testing of mutations causing nonsyndromic hearing impairment at the dfnb1 locus.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798855/pdf'],['4464_0_emqn best practice guidelines for diagnostic testing of mutations causing nonsyndromic hearing impairment at the dfnb1 locus.pdf'],[0.614],[0.552],[0.645],[0.191],[0.229],[0.176],[0.753],[0.666],[0.627],[0.694],[0.814],[0.748],[0.646],[0.914],[0.824],[0.769],[0.806],[0.787],0.614,0.552,0.645,0.191,0.229,0.176,0.753,0.666,0.627,0.694,0.814,0.748,0.646,0.914,0.824,0.769,0.806,0.787
https://doi.org/10.1007/s00442-019-04361-9,dazed confused and then hungry pesticides alter predator–prey interactions of estuarine organisms,4481_dazed confused and then hungry pesticides alter predator–prey interactions of estuarine organisms.pdf,1,['https://files.nc.gov/ncdeq/Marine-Fisheries/fisheries-management/blue-crab/05-2020-NC-Blue-Crab-FMP-Amendment-3-Final.pdf'],[') Fishery Management Plan Amendment 3'],['https://files.nc.gov/ncdeq/Marine-Fisheries/fisheries-management/blue-crab/05-2020-NC-Blue-Crab-FMP-Amendment-3-Final.pdf'],['4481_0_ fishery management plan amendment 3.pdf'],1,100.0,['https://files.nc.gov/ncdeq/Marine-Fisheries/fisheries-management/blue-crab/05-2020-NC-Blue-Crab-FMP-Amendment-3-Final.pdf'],['4481_0_ fishery management plan amendment 3.pdf'],[0.246],[0.511],[0.596],[0.132],[0.121],[0.103],[0.725],[0.631],[0.586],[0.669],[0.795],[0.713],[0.638],[0.907],[0.821],[0.766],[0.801],[0.786],0.246,0.511,0.596,0.132,0.121,0.103,0.725,0.631,0.586,0.669,0.795,0.713,0.638,0.907,0.821,0.766,0.801,0.786
https://doi.org/10.1007/s00442-020-04655-3,sizedependent vulnerability to herbivory in a coastal foundation species,4482_sizedependent vulnerability to herbivory in a coastal foundation species.pdf,2,"['https://dlnr.hawaii.gov/wp-content/uploads/2020/05/F-2T.pdf', 'http://oeqc2.doh.hawaii.gov/EA_EIS_Library/2021-06-08-HA-Revised-FEIS-Hawaii-Island-Commercial-Aquarium-Permits.pdf']","['Kailua Kona HI 96745', 'Transmittal of Revised Final Environmental Impact Statement']",['https://dlnr.hawaii.gov/wp-content/uploads/2020/05/F-2T.pdf'],['4482_0_kailua kona hi 96745.pdf'],1,50.0,['https://dlnr.hawaii.gov/wp-content/uploads/2020/05/F-2T.pdf'],['4482_0_kailua kona hi 96745.pdf'],[0.242],[0.527],[0.613],[0.132],[0.125],[0.114],[0.717],[0.62],[0.607],[0.678],[0.805],[0.749],[0.653],[0.908],[0.839],[0.774],[0.811],[0.79],0.242,0.527,0.613,0.132,0.125,0.114,0.717,0.62,0.607,0.678,0.805,0.749,0.653,0.908,0.839,0.774,0.811,0.79
https://doi.org/10.1007/s00520-019-04741-0,promoting assessment and management of function through navigation opportunities to bridge oncology and rehabilitation systems of care,4552_promoting assessment and management of function through navigation opportunities to bridge oncology and rehabilitation systems of care.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988887/pdf'],['A Systematic Review of Rehabilitation and Exercise Recommendations in Oncology Guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988887/pdf'],['4552_0_a systematic review of rehabilitation and exercise recommendations in oncology guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988887/pdf'],['4552_0_a systematic review of rehabilitation and exercise recommendations in oncology guidelines.pdf'],[0.645],[0.537],[0.645],[0.218],[0.243],[0.204],[0.758],[0.677],[0.612],[0.687],[0.79],[0.71],[0.61],[0.923],[0.832],[0.755],[0.793],[0.784],0.645,0.537,0.645,0.218,0.243,0.204,0.758,0.677,0.612,0.687,0.79,0.71,0.61,0.923,0.832,0.755,0.793,0.784
https://doi.org/10.1007/s00592-019-01300-1,a randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps,4577_a randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps.pdf,1,['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6'],['American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update'],['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6'],['4577_0_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf'],1,100.0,['https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2822%2900576-6'],['4577_0_american association of clinical endocrinology clinical practice guideline developing a diabetes mellitus comprehensive care plan—2022 update.pdf'],[0.426],[0.547],[0.63],[0.189],[0.201],[0.154],[0.743],[0.649],[0.607],[0.682],[0.8],[0.736],[0.621],[0.929],[0.818],[0.774],[0.799],[0.783],0.426,0.547,0.63,0.189,0.201,0.154,0.743,0.649,0.607,0.682,0.8,0.736,0.621,0.929,0.818,0.774,0.799,0.783
https://doi.org/10.1007/s00787-013-0375-0,diagnostic procedures in autism spectrum disorders a systematic literature review,4661_diagnostic procedures in autism spectrum disorders a systematic literature review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513463/pdf'],['Diagnostic tests for autism spectrum disorder (ASD) in preschool children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513463/pdf'],['4661_0_diagnostic tests for autism spectrum disorder asd in preschool children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513463/pdf'],['4661_0_diagnostic tests for autism spectrum disorder asd in preschool children.pdf'],[0.631],[0.512],[0.603],[0.193],[0.21],[0.174],[0.741],[0.654],[0.553],[0.755],[0.762],[0.68],[0.586],[0.901],[0.79],[0.704],[0.758],[0.731],0.631,0.512,0.603,0.193,0.21,0.174,0.741,0.654,0.553,0.755,0.762,0.68,0.586,0.901,0.79,0.704,0.758,0.731
https://doi.org/10.1007/s00787-019-01388-4,seeking and accessing professional support for child anxiety in a community sample,4693_seeking and accessing professional support for child anxiety in a community sample.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['Cognitive behavioural therapy for anxiety disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['4693_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['4693_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],[0.453],[0.517],[0.604],[0.174],[0.178],[0.158],[0.736],[0.642],[0.573],[0.698],[0.771],[0.678],[0.586],[0.909],[0.81],[0.717],[0.769],[0.749],0.453,0.517,0.604,0.174,0.178,0.158,0.736,0.642,0.573,0.698,0.771,0.678,0.586,0.909,0.81,0.717,0.769,0.749
https://doi.org/10.1007/s00787-020-01478-8,cooccurring obsessive–compulsive disorder and autism spectrum disorder in young people prevalence clinical characteristics and outcomes,4694_cooccurring obsessive–compulsive disorder and autism spectrum disorder in young people prevalence clinical characteristics and outcomes.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543671/pdf'],['Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543671/pdf'],['4694_0_behavioural and cognitive behavioural therapy for obsessive compulsive disorder ocd in individuals with autism spectrum disorder asd.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543671/pdf'],['4694_0_behavioural and cognitive behavioural therapy for obsessive compulsive disorder ocd in individuals with autism spectrum disorder asd.pdf'],[0.555],[0.541],[0.632],[0.203],[0.213],[0.178],[0.743],[0.65],[0.598],[0.7],[0.787],[0.715],[0.598],[0.915],[0.821],[0.744],[0.79],[0.771],0.555,0.541,0.632,0.203,0.213,0.178,0.743,0.65,0.598,0.7,0.787,0.715,0.598,0.915,0.821,0.744,0.79,0.771
https://doi.org/10.1007/s00787-020-01490-y,comparison of suicide risk and other outcomes among boys and girls who selfharm,4695_comparison of suicide risk and other outcomes among boys and girls who selfharm.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['4695_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['4695_0_interventions for self‐harm in children and adolescents.pdf'],[0.404],[0.529],[0.614],[0.187],[0.193],[0.152],[0.737],[0.644],[0.59],[0.69],[0.79],[0.713],[0.596],[0.915],[0.819],[0.738],[0.789],[0.769],0.404,0.529,0.614,0.187,0.193,0.152,0.737,0.644,0.59,0.69,0.79,0.713,0.596,0.915,0.819,0.738,0.789,0.769
https://doi.org/10.1007/s00787-020-01541-4,prevalence and sociodemographic correlates of psychological health problems in chinese adolescents during the outbreak of covid19,4696_prevalence and sociodemographic correlates of psychological health problems in chinese adolescents during the outbreak of covid19.pdf,2,"['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/134878']","['IL PANDAS-PANS Advisory Council Report - 2020', 'COVID-19 school closures and mental health of adolescent students: Evidence from rural Mozambique']",['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf'],['4696_0_il pandaspans advisory council report  2020.pdf'],1,50.0,['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf'],['4696_0_il pandaspans advisory council report  2020.pdf'],[0.248],[0.511],[0.605],[0.135],[0.148],[0.126],[0.733],[0.639],[0.579],[0.665],[0.788],[0.709],[0.616],[0.909],[0.819],[0.738],[0.788],[0.767],0.248,0.511,0.605,0.135,0.148,0.126,0.733,0.639,0.579,0.665,0.788,0.709,0.616,0.909,0.819,0.738,0.788,0.767
https://doi.org/10.1007/s10067-020-05073-9,rheumatologists’ perspective on coronavirus disease 19 covid19 and potential therapeutic targets,4720_rheumatologists’ perspective on coronavirus disease 19 covid19 and potential therapeutic targets.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['COVID-19 PICU guidelines: for high- and limited-resource settings'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['4720_0_covid19 picu guidelines for high and limitedresource settings.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['4720_0_covid19 picu guidelines for high and limitedresource settings.pdf'],[0.584],[0.532],[0.623],[0.174],[0.175],[0.135],[0.744],[0.649],[0.603],[0.628],[0.798],[0.711],[0.62],[0.922],[0.808],[0.758],[0.794],[0.776],0.584,0.532,0.623,0.174,0.175,0.135,0.744,0.649,0.603,0.628,0.798,0.711,0.62,0.922,0.808,0.758,0.794,0.776
https://doi.org/10.1007/s10096-002-0774-5,cluster of neonatal infections in jerusalem due to unusual biochemical variant of enterobacter sakazakii,4725_cluster of neonatal infections in jerusalem due to unusual biochemical variant of enterobacter sakazakii.pdf,1,['https://www.epa.gov/sites/default/files/2014-03/documents/guidelines_for_drinking_water_quality_3v.pdf'],['Guidelines for Drinking-water Quality'],['https://www.epa.gov/sites/default/files/2014-03/documents/guidelines_for_drinking_water_quality_3v.pdf'],['4725_0_guidelines for drinkingwater quality.pdf'],1,100.0,['https://www.epa.gov/sites/default/files/2014-03/documents/guidelines_for_drinking_water_quality_3v.pdf'],['4725_0_guidelines for drinkingwater quality.pdf'],[0.114],[0.584],[0.663],[0.147],[0.149],[0.117],[0.726],[0.631],[0.679],[0.593],[0.833],[0.785],[0.65],[0.916],[0.831],[0.811],[0.842],[0.823],0.114,0.584,0.663,0.147,0.149,0.117,0.726,0.631,0.679,0.593,0.833,0.785,0.65,0.916,0.831,0.811,0.842,0.823
https://doi.org/10.1007/s10461-019-02721-3,crystal clear with active visualization understanding medication adherence among youth living with hiv,4794_crystal clear with active visualization understanding medication adherence among youth living with hiv.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['4794_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['4794_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.423],[0.525],[0.605],[0.178],[0.167],[0.15],[0.739],[0.65],[0.579],[0.684],[0.779],[0.71],[0.61],[0.925],[0.812],[0.728],[0.779],[0.753],0.423,0.525,0.605,0.178,0.167,0.15,0.739,0.65,0.579,0.684,0.779,0.71,0.61,0.925,0.812,0.728,0.779,0.753
https://doi.org/10.1007/s10560-020-00665-5,economic burden of known cases of child maltreatment from 2018 in each state,5031_economic burden of known cases of child maltreatment from 2018 in each state.pdf,1,['https://www.tn.gov/content/dam/tn/tccy/documents/Second%20Look%20Commission%20Report%20Summary.pdf'],['Second Look Commission Report Summary'],['https://www.tn.gov/content/dam/tn/tccy/documents/Second%20Look%20Commission%20Report%20Summary.pdf'],['5031_0_second look commission report summary.pdf'],1,100.0,['https://www.tn.gov/content/dam/tn/tccy/documents/Second%20Look%20Commission%20Report%20Summary.pdf'],['5031_0_second look commission report summary.pdf'],[0.508],[0.605],[0.68],[0.234],[0.266],[0.22],[0.737],[0.645],[0.671],[0.707],[0.825],[0.795],[0.675],[0.936],[0.86],[0.806],[0.838],[0.82],0.508,0.605,0.68,0.234,0.266,0.22,0.737,0.645,0.671,0.707,0.825,0.795,0.675,0.936,0.86,0.806,0.838,0.82
https://doi.org/10.1007/s10567-021-00344-6,risk and resilience factors for mental health among transgender and gender nonconforming tgnc youth a systematic review,5100_risk and resilience factors for mental health among transgender and gender nonconforming tgnc youth a systematic review.pdf,1,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['Report & Recommendations For Fiscal Year 2022'],['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['5100_0_report  recommendations for fiscal year 2022.pdf'],1,100.0,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['5100_0_report  recommendations for fiscal year 2022.pdf'],[0.396],[0.56],[0.648],[0.178],[0.187],[0.156],[0.733],[0.639],[0.62],[0.665],[0.819],[0.753],[0.646],[0.925],[0.845],[0.782],[0.825],[0.801],0.396,0.56,0.648,0.178,0.187,0.156,0.733,0.639,0.62,0.665,0.819,0.753,0.646,0.925,0.845,0.782,0.825,0.801
https://doi.org/10.1007/s10578-019-00923-3,a pilot study of familybased exposurefocused treatment for youth with autism spectrum disorder and anxiety,5134_a pilot study of familybased exposurefocused treatment for youth with autism spectrum disorder and anxiety.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf']","['Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD)', 'Cognitive behavioural therapy for anxiety disorders in children and adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf']","['5134_0_behavioural and cognitive behavioural therapy for obsessive compulsive disorder ocd in individuals with autism spectrum disorder asd.pdf', '5134_1_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543671/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf']","['5134_0_behavioural and cognitive behavioural therapy for obsessive compulsive disorder ocd in individuals with autism spectrum disorder asd.pdf', '5134_1_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf']","[0.577, 0.58]","[0.549, 0.524]","[0.631, 0.607]","[0.198, 0.188]","[0.209, 0.191]","[0.175, 0.162]","[0.739, 0.739]","[0.648, 0.649]","[0.607, 0.579]","[0.706, 0.71]","[0.795, 0.779]","[0.731, 0.69]","[0.601, 0.586]","[0.92, 0.914]","[0.83, 0.814]","[0.748, 0.722]","[0.797, 0.775]","[0.776, 0.757]",0.579,0.536,0.619,0.193,0.2,0.168,0.739,0.649,0.593,0.708,0.787,0.71,0.593,0.917,0.822,0.735,0.786,0.766
https://doi.org/10.1007/s10641-018-0821-4,an assessment of juvenile sand tiger carcharias taurus activity patterns in a seasonal nursery using accelerometer transmitters,5192_an assessment of juvenile sand tiger carcharias taurus activity patterns in a seasonal nursery using accelerometer transmitters.pdf,1,['https://www.mass.gov/doc/2018-dmf-annual-report/download'],['Massachusetts Division of Marine Fisheries 2018 Annual Report'],['https://www.mass.gov/doc/2018-dmf-annual-report/download'],['5192_0_massachusetts division of marine fisheries 2018 annual report.pdf'],1,100.0,['https://www.mass.gov/doc/2018-dmf-annual-report/download'],['5192_0_massachusetts division of marine fisheries 2018 annual report.pdf'],[0.206],[0.55],[0.628],[0.144],[0.139],[0.116],[0.726],[0.633],[0.636],[0.662],[0.819],[0.762],[0.677],[0.918],[0.849],[0.794],[0.827],[0.808],0.206,0.55,0.628,0.144,0.139,0.116,0.726,0.633,0.636,0.662,0.819,0.762,0.677,0.918,0.849,0.794,0.827,0.808
https://doi.org/10.1007/s10641-019-00907-1,golfo dulce critical habitat and nursery area for juvenile scalloped hammerhead sharks sphyrna lewini in the eastern tropical pacific seascape,5193_golfo dulce critical habitat and nursery area for juvenile scalloped hammerhead sharks sphyrna lewini in the eastern tropical pacific seascape.pdf,1,['https://purl.fdlp.gov/GPO/gpo143144'],['Scalloped hammerhead shark (Sphyrna lewini) 5 year review :\xa0summary and evaluation.'],['https://purl.fdlp.gov/GPO/gpo143144'],['5193_0_scalloped hammerhead shark sphyrna lewini 5 year review \xa0summary and evaluation.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo143144'],['5193_0_scalloped hammerhead shark sphyrna lewini 5 year review \xa0summary and evaluation.pdf'],[0.541],[0.536],[0.62],[0.179],[0.179],[0.14],[0.737],[0.653],[0.602],[0.677],[0.808],[0.73],[0.665],[0.894],[0.839],[0.78],[0.815],[0.795],0.541,0.536,0.62,0.179,0.179,0.14,0.737,0.653,0.602,0.677,0.808,0.73,0.665,0.894,0.839,0.78,0.815,0.795
https://doi.org/10.1007/s10643-019-00987-9,quality of life and meeting 24h who guidelines among preschool children in singapore,5241_quality of life and meeting 24h who guidelines among preschool children in singapore.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['5241_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['5241_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.49],[0.547],[0.634],[0.179],[0.201],[0.162],[0.734],[0.643],[0.605],[0.717],[0.794],[0.732],[0.632],[0.924],[0.831],[0.762],[0.794],[0.778],0.49,0.547,0.634,0.179,0.201,0.162,0.734,0.643,0.605,0.717,0.794,0.732,0.632,0.924,0.831,0.762,0.794,0.778
https://doi.org/10.1007/s10648-015-9319-1,school climate a review of the construct measurement and impact on student outcomes,5259_school climate a review of the construct measurement and impact on student outcomes.pdf,3,"['https://www.rand.org/pubs/research_reports/RR2483.html', 'https://www.rand.org/pubs/research_reports/RR4259.html', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_14.pdf']","['Will School Renovations Impact Students, Teachers, and Communities?', 'Measuring School and Classroom Climate', 'School Climate, Student Engagement, and Academic Achievement: A Latent Variable, Multilevel Multi-Informant Examination']",['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_14.pdf'],['5259_2_school climate student engagement and academic achievement a latent variable multilevel multiinformant examination.pdf'],1,33.33,['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_14.pdf'],['5259_2_school climate student engagement and academic achievement a latent variable multilevel multiinformant examination.pdf'],[0.903],[0.53],[0.623],[0.204],[0.233],[0.204],[0.745],[0.653],[0.589],[0.73],[0.78],[0.707],[0.632],[0.915],[0.812],[0.75],[0.79],[0.771],0.903,0.53,0.623,0.204,0.233,0.204,0.745,0.653,0.589,0.73,0.78,0.707,0.632,0.915,0.812,0.75,0.79,0.771
https://doi.org/10.1007/s10654-020-00675-8,mistrust in biomedical research and vaccine hesitancy the forefront challenge in the battle against covid19 in italy,5274_mistrust in biomedical research and vaccine hesitancy the forefront challenge in the battle against covid19 in italy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528734/pdf'],['Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528734/pdf'],['5274_0_vaccine hesitancy among maltese healthcare workers toward influenza and novel covid19 vaccination.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528734/pdf'],['5274_0_vaccine hesitancy among maltese healthcare workers toward influenza and novel covid19 vaccination.pdf'],[0.192],[0.506],[0.592],[0.167],[0.179],[0.144],[0.726],[0.632],[0.592],[0.668],[0.798],[0.739],[0.605],[0.918],[0.809],[0.711],[0.781],[0.745],0.192,0.506,0.592,0.167,0.179,0.144,0.726,0.632,0.592,0.668,0.798,0.739,0.605,0.918,0.809,0.711,0.781,0.745
https://doi.org/10.1007/s10654-020-00698-1,assessing the age specificity of infection fatality rates for covid19 systematic review metaanalysis and public policy implications,5275_assessing the age specificity of infection fatality rates for covid19 systematic review metaanalysis and public policy implications.pdf,6,"['https://www.nber.org/papers/w28925', 'https://www.nber.org/papers/w28601', 'https://www.nber.org/papers/w28519', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.cgdev.org/publication/three-new-estimates-indias-all-cause-excess-mortality-during-covid-19-pandemic']","['The Intergenerational Mortality Tradeoff of COVID-19 Lockdown Policies', 'Addressing the COVID-19 Pandemic: Comparing Alternative Value Frameworks', 'The Trade-off Between Prioritization and Vaccination Speed Depends on Mitigation Measures', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Three New Estimates of India’s All-Cause Excess Mortality during the COVID-19 Pandemic']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['5275_3_master question list for covid19 caused by sarscov2.pdf', '5275_4_master question list for covid19 caused by sarscov2.pdf']",2,33.33,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf'],['5275_3_master question list for covid19 caused by sarscov2.pdf'],[0.495],[0.54],[0.631],[0.188],[0.186],[0.155],[0.743],[0.657],[0.611],[0.674],[0.806],[0.74],[0.639],[0.918],[0.838],[0.765],[0.807],[0.791],0.495,0.54,0.631,0.188,0.186,0.155,0.743,0.657,0.611,0.674,0.806,0.74,0.639,0.918,0.838,0.765,0.807,0.791
https://doi.org/10.1007/s10654-021-00728-6,covid19 vaccine acceptance among pregnant women and mothers of young children results of a survey in 16 countries,5276_covid19 vaccine acceptance among pregnant women and mothers of young children results of a survey in 16 countries.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192261/pdf'],['Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192261/pdf'],['5276_0_maternal vaccines during the covid19 pandemica qualitative interview study with uk pregnant women.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192261/pdf'],['5276_0_maternal vaccines during the covid19 pandemica qualitative interview study with uk pregnant women.pdf'],[0.643],[0.538],[0.62],[0.195],[0.215],[0.186],[0.737],[0.649],[0.599],[0.675],[0.795],[0.715],[0.618],[0.908],[0.832],[0.762],[0.797],[0.779],0.643,0.538,0.62,0.195,0.215,0.186,0.737,0.649,0.599,0.675,0.795,0.715,0.618,0.908,0.832,0.762,0.797,0.779
https://doi.org/10.1007/s10661-019-7716-5,did changes in western federal land management policies improve salmonid habitat in streams on public lands within the interior columbia river basin,5280_did changes in western federal land management policies improve salmonid habitat in streams on public lands within the interior columbia river basin.pdf,1,['https://purl.fdlp.gov/GPO/gpo141860'],['Bioregional assessment of Northwest forests.'],['https://purl.fdlp.gov/GPO/gpo141860'],['5280_0_bioregional assessment of northwest forests.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo141860'],['5280_0_bioregional assessment of northwest forests.pdf'],[0.314],[0.528],[0.619],[0.161],[0.167],[0.146],[0.737],[0.645],[0.585],[0.701],[0.793],[0.722],[0.648],[0.917],[0.834],[0.771],[0.802],[0.788],0.314,0.528,0.619,0.161,0.167,0.146,0.737,0.645,0.585,0.701,0.793,0.722,0.648,0.917,0.834,0.771,0.802,0.788
https://doi.org/10.1007/s10750-019-04034-x,response of juvenile salmonids to large wood placement in columbia river tributaries,5298_response of juvenile salmonids to large wood placement in columbia river tributaries.pdf,1,['https://rco.wa.gov/wp-content/uploads/2020/05/SRFB-Meeting-2020June.pdf'],['Salmon Recovery Funding Board Meeting Agenda'],['https://rco.wa.gov/wp-content/uploads/2020/05/SRFB-Meeting-2020June.pdf'],['5298_0_salmon recovery funding board meeting agenda.pdf'],1,100.0,['https://rco.wa.gov/wp-content/uploads/2020/05/SRFB-Meeting-2020June.pdf'],['5298_0_salmon recovery funding board meeting agenda.pdf'],[0.42],[0.497],[0.592],[0.134],[0.141],[0.116],[0.728],[0.635],[0.553],[0.68],[0.784],[0.702],[0.633],[0.91],[0.816],[0.751],[0.79],[0.774],0.42,0.497,0.592,0.134,0.141,0.116,0.728,0.635,0.553,0.68,0.784,0.702,0.633,0.91,0.816,0.751,0.79,0.774
https://doi.org/10.1007/s10802-019-00518-5,family burden of raising a child with adhd,5390_family burden of raising a child with adhd.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250955/pdf', 'https://effectivehealthcare.ahrq.gov/products/learning-health-systems-pilot-adhd/methods-report']","['Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed Guidelines', 'Facilitating the Implementation of EPC Reports in Learning Health Systems Engaged in Quality Initiatives: an EPC Pilot Project on ADHD']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250955/pdf'],['5390_0_neurofeedback and attentiondeficithyperactivitydisorder adhd in children rating the evidence and proposed guidelines.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250955/pdf'],['5390_0_neurofeedback and attentiondeficithyperactivitydisorder adhd in children rating the evidence and proposed guidelines.pdf'],[0.381],[0.515],[0.614],[0.142],[0.152],[0.129],[0.727],[0.636],[0.582],[0.695],[0.784],[0.712],[0.609],[0.917],[0.804],[0.748],[0.78],[0.767],0.381,0.515,0.614,0.142,0.152,0.129,0.727,0.636,0.582,0.695,0.784,0.712,0.609,0.917,0.804,0.748,0.78,0.767
https://doi.org/10.1007/s10802-019-00558-x,effects of groupbased cbt on postevent processing in children with social anxiety disorder following an experimental social stressor,5391_effects of groupbased cbt on postevent processing in children with social anxiety disorder following an experimental social stressor.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['Cognitive behavioural therapy for anxiety disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['5391_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['5391_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],[0.431],[0.501],[0.587],[0.168],[0.164],[0.142],[0.739],[0.647],[0.557],[0.729],[0.758],[0.661],[0.578],[0.903],[0.776],[0.708],[0.756],[0.741],0.431,0.501,0.587,0.168,0.164,0.142,0.739,0.647,0.557,0.729,0.758,0.661,0.578,0.903,0.776,0.708,0.756,0.741
https://doi.org/10.1007/s10802-019-00596-5,schoolbased treatment for anxiety research study stars a randomized controlled effectiveness trial,5392_schoolbased treatment for anxiety research study stars a randomized controlled effectiveness trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['Cognitive behavioural therapy for anxiety disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['5392_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['5392_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],[0.568],[0.516],[0.603],[0.175],[0.177],[0.154],[0.739],[0.647],[0.569],[0.715],[0.765],[0.676],[0.585],[0.913],[0.792],[0.718],[0.766],[0.75],0.568,0.516,0.603,0.175,0.177,0.154,0.739,0.647,0.569,0.715,0.765,0.676,0.585,0.913,0.792,0.718,0.766,0.75
https://doi.org/10.1007/s10826-019-01522-5,the assessment of the attitudes and behaviors about physically abused children a survey of mental health professionals,5672_the assessment of the attitudes and behaviors about physically abused children a survey of mental health professionals.pdf,1,['https://www.bbs.ca.gov/pdf/agen_notice/2022/20220121_pa_v.pdf'],['Presentation on Request to Add Coursework in Parent Alienation to the'],['https://www.bbs.ca.gov/pdf/agen_notice/2022/20220121_pa_v.pdf'],['5672_0_presentation on request to add coursework in parent alienation to the.pdf'],1,100.0,['https://www.bbs.ca.gov/pdf/agen_notice/2022/20220121_pa_v.pdf'],['5672_0_presentation on request to add coursework in parent alienation to the.pdf'],[0.473],[0.536],[0.626],[0.18],[0.201],[0.171],[0.734],[0.634],[0.586],[0.705],[0.787],[0.732],[0.641],[0.918],[0.82],[0.759],[0.792],[0.776],0.473,0.536,0.626,0.18,0.201,0.171,0.734,0.634,0.586,0.705,0.787,0.732,0.641,0.918,0.82,0.759,0.792,0.776
https://doi.org/10.1007/s10862-019-09782-7,comparison of discriminant validity indices of parent teacher and multiinformant reports of behavioral problems in elementary schoolers,5686_comparison of discriminant validity indices of parent teacher and multiinformant reports of behavioral problems in elementary schoolers.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978163/pdf'],['Conduct Problems and Adherence to COVID-19 Guidelines: A Developmental Psychopathology-Informed Approach'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978163/pdf'],['5686_0_conduct problems and adherence to covid19 guidelines a developmental psychopathologyinformed approach.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978163/pdf'],['5686_0_conduct problems and adherence to covid19 guidelines a developmental psychopathologyinformed approach.pdf'],[0.353],[0.518],[0.607],[0.162],[0.182],[0.146],[0.734],[0.638],[0.567],[0.711],[0.779],[0.71],[0.618],[0.907],[0.798],[0.741],[0.778],[0.758],0.353,0.518,0.607,0.162,0.182,0.146,0.734,0.638,0.567,0.711,0.779,0.71,0.618,0.907,0.798,0.741,0.778,0.758
https://doi.org/10.1007/s10896-019-00070-2,evaluating the effects of an adolescent family violence intervention program on recidivism among courtinvolved youth,5744_evaluating the effects of an adolescent family violence intervention program on recidivism among courtinvolved youth.pdf,3,"['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf', 'https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/1/Wsipp_BenefitCost_ProgramDetails_Juvenile-Justice']","['Qe UNC CHARLOTTE UrbanInstitute ai', 'CMPD Youth Program Assessment', 'Washington State Institute for Public Policy']","['https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/1/Wsipp_BenefitCost_ProgramDetails_Juvenile-Justice', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf']","['5744_2_washington state institute for public policy.pdf', '5744_1_cmpd youth program assessment.pdf', '5744_0_qe unc charlotte urbaninstitute ai.pdf']",3,100.0,"['https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/1/Wsipp_BenefitCost_ProgramDetails_Juvenile-Justice', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf']","['5744_2_washington state institute for public policy.pdf', '5744_1_cmpd youth program assessment.pdf', '5744_0_qe unc charlotte urbaninstitute ai.pdf']","[0.452, 0.425, 0.317]","[0.561, 0.551, 0.563]","[0.645, 0.642, 0.653]","[0.156, 0.174, 0.188]","[0.188, 0.21, 0.22]","[0.15, 0.163, 0.171]","[0.723, 0.73, 0.734]","[0.627, 0.634, 0.639]","[0.618, 0.613, 0.618]","[0.695, 0.68, 0.686]","[0.799, 0.802, 0.807]","[0.737, 0.736, 0.737]","[0.652, 0.644, 0.647]","[0.932, 0.926, 0.926]","[0.828, 0.832, 0.834]","[0.773, 0.773, 0.779]","[0.811, 0.811, 0.814]","[0.79, 0.791, 0.794]",0.398,0.558,0.647,0.173,0.206,0.161,0.729,0.633,0.616,0.687,0.803,0.737,0.648,0.928,0.831,0.775,0.812,0.792
https://doi.org/10.1007/s10903-019-00880-y,lead exposure in newly resettled pediatric refugees in syracuse ny,5797_lead exposure in newly resettled pediatric refugees in syracuse ny.pdf,1,['https://ag.ny.gov/sites/default/files/008397_2021_the_people_of_the_stat_v_the_people_of_the_stat_summons_complaint_1.pdf'],['Filed : Onondaga County Clerk 09 / 30 / 2021 05:14 Pm'],['https://ag.ny.gov/sites/default/files/008397_2021_the_people_of_the_stat_v_the_people_of_the_stat_summons_complaint_1.pdf'],['5797_0_filed  onondaga county clerk 09  30  2021 0514 pm.pdf'],1,100.0,['https://ag.ny.gov/sites/default/files/008397_2021_the_people_of_the_stat_v_the_people_of_the_stat_summons_complaint_1.pdf'],['5797_0_filed  onondaga county clerk 09  30  2021 0514 pm.pdf'],[0.418],[0.486],[0.573],[0.125],[0.128],[0.107],[0.727],[0.63],[0.555],[0.659],[0.781],[0.653],[0.637],[0.908],[0.83],[0.733],[0.77],[0.763],0.418,0.486,0.573,0.125,0.128,0.107,0.727,0.63,0.555,0.659,0.781,0.653,0.637,0.908,0.83,0.733,0.77,0.763
https://doi.org/10.1007/s10928-019-09642-7,towards regulatory endorsement of drug development tools to promote the application of modelinformed drug development in duchenne muscular dystrophy,5800_towards regulatory endorsement of drug development tools to promote the application of modelinformed drug development in duchenne muscular dystrophy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877853/pdf'],['Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington’s Disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877853/pdf'],['5800_0_standardized data structures in rare diseases cdisc user guides for duchenne muscular dystrophy and huntingtons disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877853/pdf'],['5800_0_standardized data structures in rare diseases cdisc user guides for duchenne muscular dystrophy and huntingtons disease.pdf'],[0.677],[0.582],[0.668],[0.204],[0.213],[0.171],[0.75],[0.661],[0.648],[0.698],[0.814],[0.752],[0.654],[0.925],[0.852],[0.789],[0.82],[0.805],0.677,0.582,0.668,0.204,0.213,0.171,0.75,0.661,0.648,0.698,0.814,0.752,0.654,0.925,0.852,0.789,0.82,0.805
https://doi.org/10.1007/s10964-019-01072-5,risk factors for school absenteeism and dropout a metaanalytic review,6048_risk factors for school absenteeism and dropout a metaanalytic review.pdf,2,"['https://www.brookings.edu/blog/education-plus-development/2020/11/23/does-reopening-schools-lead-to-increased-life-expectancy-the-data-arent-so-simple/', 'https://www1.nyc.gov/assets/youthemployment/downloads/pdf/dytf-connecting-our-future-report.pdf']","['Does reopening schools lead to increased life expectancy? The data aren’t so simple.', 'Connecting Our Future']",['https://www1.nyc.gov/assets/youthemployment/downloads/pdf/dytf-connecting-our-future-report.pdf'],['6048_1_connecting our future.pdf'],1,50.0,['https://www1.nyc.gov/assets/youthemployment/downloads/pdf/dytf-connecting-our-future-report.pdf'],['6048_1_connecting our future.pdf'],[0.234],[0.486],[0.59],[0.118],[0.142],[0.12],[0.718],[0.619],[0.547],[0.682],[0.763],[0.704],[0.62],[0.909],[0.8],[0.738],[0.769],[0.751],0.234,0.486,0.59,0.118,0.142,0.12,0.718,0.619,0.547,0.682,0.763,0.704,0.62,0.909,0.8,0.738,0.769,0.751
https://doi.org/10.1007/s10964-020-01391-y,social support and internalizing psychopathology in transgender youth,6054_social support and internalizing psychopathology in transgender youth.pdf,2,"['https://www.aclu.org/legal-document/brandt-et-al-v-rutledge-et-al-amicus-brief-california-and-20-other-states', 'https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf']","['Brandt et al v. Rutledge et al - Amicus Brief of California and 20 Other States', 'In The United States Court Of Appeals For The Eleventh Circuit']",['https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf'],['6054_1_in the united states court of appeals for the eleventh circuit.pdf'],1,50.0,['https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf'],['6054_1_in the united states court of appeals for the eleventh circuit.pdf'],[0.331],[0.478],[0.57],[0.132],[0.143],[0.126],[0.733],[0.638],[0.541],[0.68],[0.761],[0.669],[0.598],[0.915],[0.784],[0.72],[0.754],[0.739],0.331,0.478,0.57,0.132,0.143,0.126,0.733,0.638,0.541,0.68,0.761,0.669,0.598,0.915,0.784,0.72,0.754,0.739
https://doi.org/10.1007/s10995-014-1557-1,reasons for mother–infant bedsharing a systematic narrative synthesis of the literature and implications for future research,6175_reasons for mother–infant bedsharing a systematic narrative synthesis of the literature and implications for future research.pdf,1,['https://phpa.health.maryland.gov/mch/Documents/Nocturnal%20Video%20Assessment%20of%20Sleep%20Environment%20(Peds%202016).pdf'],['Nocturnal Video Assessment of Infant Sleep Environments'],['https://phpa.health.maryland.gov/mch/Documents/Nocturnal%20Video%20Assessment%20of%20Sleep%20Environment%20(Peds%202016).pdf'],['6175_0_nocturnal video assessment of infant sleep environments.pdf'],1,100.0,['https://phpa.health.maryland.gov/mch/Documents/Nocturnal%20Video%20Assessment%20of%20Sleep%20Environment%20(Peds%202016).pdf'],['6175_0_nocturnal video assessment of infant sleep environments.pdf'],[0.645],[0.545],[0.632],[0.194],[0.222],[0.174],[0.737],[0.646],[0.609],[0.682],[0.804],[0.739],[0.627],[0.921],[0.834],[0.766],[0.803],[0.784],0.645,0.545,0.632,0.194,0.222,0.174,0.737,0.646,0.609,0.682,0.804,0.739,0.627,0.921,0.834,0.766,0.803,0.784
https://doi.org/10.1007/s10995-016-2201-z,vaccination coverage and timelines among children 0–6 months in kinshasa the democratic republic of congo a prospective cohort study,6197_vaccination coverage and timelines among children 0–6 months in kinshasa the democratic republic of congo a prospective cohort study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607275/pdf', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research']","['Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607275/pdf'],['6197_0_arresting vertical transmission of hepatitis b virus averthbv in pregnant women and their neonates in the democratic republic of the congo a feasibility study.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607275/pdf'],['6197_0_arresting vertical transmission of hepatitis b virus averthbv in pregnant women and their neonates in the democratic republic of the congo a feasibility study.pdf'],[0.273],[0.504],[0.601],[0.172],[0.185],[0.148],[0.734],[0.643],[0.568],[0.661],[0.767],[0.663],[0.601],[0.905],[0.798],[0.724],[0.766],[0.752],0.273,0.504,0.601,0.172,0.185,0.148,0.734,0.643,0.568,0.661,0.767,0.663,0.601,0.905,0.798,0.724,0.766,0.752
https://doi.org/10.1007/s10995-018-02706-z,social support during pregnancy modifies the association between maternal adverse childhood experiences and infant birth size,6210_social support during pregnancy modifies the association between maternal adverse childhood experiences and infant birth size.pdf,1,['https://www.dhs.wisconsin.gov/publications/p02500.pdf'],['Wisconsin PRAMS 2016-2017 Surveillance Report'],['https://www.dhs.wisconsin.gov/publications/p02500.pdf'],['6210_0_wisconsin prams 20162017 surveillance report.pdf'],1,100.0,['https://www.dhs.wisconsin.gov/publications/p02500.pdf'],['6210_0_wisconsin prams 20162017 surveillance report.pdf'],[0.319],[0.519],[0.615],[0.148],[0.159],[0.14],[0.728],[0.628],[0.578],[0.663],[0.779],[0.712],[0.612],[0.913],[0.803],[0.745],[0.785],[0.767],0.319,0.519,0.615,0.148,0.159,0.14,0.728,0.628,0.578,0.663,0.779,0.712,0.612,0.913,0.803,0.745,0.785,0.767
https://doi.org/10.1007/s10995-018-02726-9,conditions of poverty parent–child interactions and toddlers’ early language skills in lowincome families,6212_conditions of poverty parent–child interactions and toddlers’ early language skills in lowincome families.pdf,3,"['https://www.bakerinstitute.org/research/americas-children-responding-to-the-crisis-now-with-the-future-in-mind/', 'https://www.bakerinstitute.org/research/impact-covid-19-vulnerable-families/', 'http://www.houstontx.gov/education/baker-institute-crisis-covid-19.pdf']","['Americaâ\x80\x99s Children: Responding to the Crisis Now', 'The Impact of Covid-19 on Vulnerable Families', 'America’s Children: Responding to the Crisis Now with the Future in Mind']",['http://www.houstontx.gov/education/baker-institute-crisis-covid-19.pdf'],['6212_2_americas children responding to the crisis now with the future in mind.pdf'],1,33.33,['http://www.houstontx.gov/education/baker-institute-crisis-covid-19.pdf'],['6212_2_americas children responding to the crisis now with the future in mind.pdf'],[0.483],[0.543],[0.633],[0.167],[0.179],[0.154],[0.734],[0.637],[0.597],[0.674],[0.797],[0.736],[0.644],[0.915],[0.819],[0.77],[0.802],[0.783],0.483,0.543,0.633,0.167,0.179,0.154,0.734,0.637,0.597,0.674,0.797,0.736,0.644,0.915,0.819,0.77,0.802,0.783
https://doi.org/10.1007/s10995-019-02805-5,the impact of an mhealth voice message service mmitra on infant care knowledge and practices among lowincome women in india findings from a pseudorandomized controlled trial,6217_the impact of an mhealth voice message service mmitra on infant care knowledge and practices among lowincome women in india findings from a pseudorandomized controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf']","['Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants', 'Targeted client communication via mobile devices for improving maternal, neonatal, and child health']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf']","['6217_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf', '6217_1_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf']","['6217_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf', '6217_1_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf']","[0.515, 0.493]","[0.527, 0.54]","[0.611, 0.623]","[0.18, 0.182]","[0.185, 0.187]","[0.159, 0.157]","[0.731, 0.731]","[0.637, 0.639]","[0.579, 0.591]","[0.685, 0.684]","[0.774, 0.783]","[0.692, 0.705]","[0.617, 0.609]","[0.906, 0.915]","[0.809, 0.821]","[0.729, 0.745]","[0.775, 0.787]","[0.751, 0.763]",0.504,0.534,0.617,0.181,0.186,0.158,0.731,0.638,0.585,0.685,0.778,0.698,0.613,0.911,0.815,0.737,0.781,0.757
https://doi.org/10.1007/s11096-018-0734-5,factors influencing the recruitment of lactating women in a clinical trial involving direct oral anticoagulants a qualitative study,6250_factors influencing the recruitment of lactating women in a clinical trial involving direct oral anticoagulants a qualitative study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078544/pdf'],['Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078544/pdf'],['6250_0_factors that impact on recruitment to randomised trials in health care a qualitative evidence synthesis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078544/pdf'],['6250_0_factors that impact on recruitment to randomised trials in health care a qualitative evidence synthesis.pdf'],[0.373],[0.556],[0.639],[0.171],[0.184],[0.153],[0.732],[0.637],[0.62],[0.677],[0.799],[0.735],[0.624],[0.928],[0.846],[0.761],[0.804],[0.789],0.373,0.556,0.639,0.171,0.184,0.153,0.732,0.637,0.62,0.677,0.799,0.735,0.624,0.928,0.846,0.761,0.804,0.789
https://doi.org/10.1007/s11121-018-0964-8,effects of home visiting program implementation on preventive health care access and utilization results from a randomized trial of healthy families oregon,6368_effects of home visiting program implementation on preventive health care access and utilization results from a randomized trial of healthy families oregon.pdf,1,['https://humanservices.hawaii.gov/wp-content/uploads/2021/10/Family-First-Hawaii_FFPSA-Plan_Final-May21_PDF-2.pdf'],['Title IV-E Prevention Plan'],['https://humanservices.hawaii.gov/wp-content/uploads/2021/10/Family-First-Hawaii_FFPSA-Plan_Final-May21_PDF-2.pdf'],['6368_0_title ive prevention plan.pdf'],1,100.0,['https://humanservices.hawaii.gov/wp-content/uploads/2021/10/Family-First-Hawaii_FFPSA-Plan_Final-May21_PDF-2.pdf'],['6368_0_title ive prevention plan.pdf'],[0.544],[0.544],[0.625],[0.168],[0.197],[0.154],[0.727],[0.633],[0.604],[0.688],[0.799],[0.735],[0.651],[0.912],[0.83],[0.768],[0.805],[0.784],0.544,0.544,0.625,0.168,0.197,0.154,0.727,0.633,0.604,0.688,0.799,0.735,0.651,0.912,0.83,0.768,0.805,0.784
https://doi.org/10.1007/s11121-019-01018-0,effectiveness of facebook groups to boost participation in a parenting intervention,6370_effectiveness of facebook groups to boost participation in a parenting intervention.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],"['Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],['6370_0_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],['6370_0_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf'],[0.389],[0.519],[0.614],[0.152],[0.16],[0.14],[0.727],[0.631],[0.574],[0.702],[0.776],[0.694],[0.585],[0.918],[0.815],[0.732],[0.772],[0.762],0.389,0.519,0.614,0.152,0.16,0.14,0.727,0.631,0.574,0.702,0.776,0.694,0.585,0.918,0.815,0.732,0.772,0.762
https://doi.org/10.1007/s11121-019-01048-8,scaling up evidencebased interventions in us public systems to prevent behavioral health problems challenges and opportunities,6371_scaling up evidencebased interventions in us public systems to prevent behavioral health problems challenges and opportunities.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['Well and Thriving: Prevention and Early Intervention in California - Second Public Draft', 'Well and Thriving: Prevention and Early Intervention in California, First Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['6371_1_well and thriving prevention and early intervention in california first public draft.pdf', '6371_0_well and thriving prevention and early intervention in california  second public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['6371_1_well and thriving prevention and early intervention in california first public draft.pdf', '6371_0_well and thriving prevention and early intervention in california  second public draft.pdf']","[0.515, 0.513]","[0.524, 0.524]","[0.632, 0.632]","[0.161, 0.161]","[0.182, 0.181]","[0.143, 0.143]","[0.728, 0.727]","[0.638, 0.638]","[0.586, 0.586]","[0.695, 0.694]","[0.801, 0.801]","[0.72, 0.721]","[0.626, 0.627]","[0.924, 0.924]","[0.829, 0.829]","[0.759, 0.76]","[0.804, 0.805]","[0.788, 0.788]",0.514,0.524,0.632,0.161,0.181,0.143,0.728,0.638,0.586,0.694,0.801,0.72,0.627,0.924,0.829,0.76,0.804,0.788
https://doi.org/10.1007/s11126-020-09843-1,the effect of covid19 pandemic and social restrictions on depression rates and maternal attachment in immediate postpartum women a preliminary study,6385_the effect of covid19 pandemic and social restrictions on depression rates and maternal attachment in immediate postpartum women a preliminary study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf'],['Infection par le SARS-CoV-2 chez les femmes enceintes. Actualisation de l’état des connaissances et de la proposition de prise en charge. CNGOF'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf'],['6385_0_infection par le sarscov2 chez les femmes enceintes actualisation de létat des connaissances et de la proposition de prise en charge cngof.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf'],['6385_0_infection par le sarscov2 chez les femmes enceintes actualisation de létat des connaissances et de la proposition de prise en charge cngof.pdf'],[0.051],[0.478],[0.571],[0.112],[0.149],[0.113],[0.729],[0.64],[0.536],[0.624],[0.774],[0.688],[0.568],[0.879],[0.816],[0.72],[0.77],[0.74],0.051,0.478,0.571,0.112,0.149,0.113,0.729,0.64,0.536,0.624,0.774,0.688,0.568,0.879,0.816,0.72,0.77,0.74
https://doi.org/10.1007/s11136-017-1682-6,impact of monitoring healthrelated quality of life in clinical practice in children with type 1 diabetes mellitus,6407_impact of monitoring healthrelated quality of life in clinical practice in children with type 1 diabetes mellitus.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509115/pdf'],['Routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509115/pdf'],['6407_0_routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509115/pdf'],['6407_0_routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice.pdf'],[0.402],[0.542],[0.625],[0.18],[0.186],[0.144],[0.735],[0.641],[0.598],[0.704],[0.777],[0.707],[0.594],[0.922],[0.832],[0.74],[0.784],[0.767],0.402,0.542,0.625,0.18,0.186,0.144,0.735,0.641,0.598,0.704,0.777,0.707,0.594,0.922,0.832,0.74,0.784,0.767
https://doi.org/10.1007/s11192-021-03900-7,daytoday discovery of preprint–publication links,6472_daytoday discovery of preprint–publication links.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791232/pdf']","['Efficacy and safety of COVID‐19 vaccines', 'Interleukin‐1 blocking agents for treating COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791232/pdf']","['6472_0_efficacy and safety of covid‐19 vaccines.pdf', '6472_1_interleukin‐1 blocking agents for treating covid‐19.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791232/pdf']","['6472_0_efficacy and safety of covid‐19 vaccines.pdf', '6472_1_interleukin‐1 blocking agents for treating covid‐19.pdf']","[0.148, 0.183]","[0.494, 0.508]","[0.587, 0.599]","[0.119, 0.128]","[0.128, 0.13]","[0.123, 0.121]","[0.732, 0.73]","[0.638, 0.636]","[0.56, 0.577]","[0.728, 0.717]","[0.76, 0.771]","[0.69, 0.694]","[0.59, 0.601]","[0.892, 0.901]","[0.803, 0.825]","[0.704, 0.721]","[0.757, 0.766]","[0.732, 0.751]",0.165,0.501,0.593,0.123,0.129,0.122,0.731,0.637,0.569,0.722,0.766,0.692,0.595,0.897,0.814,0.712,0.762,0.742
https://doi.org/10.1007/s11199-019-01026-y,characteristics of preschool gender enforcers and peers who associate with them,6484_characteristics of preschool gender enforcers and peers who associate with them.pdf,1,['https://www.nj.gov/oag/dcr/downloads/2020-ybtf-report.pdf'],['Anti-bias'],['https://www.nj.gov/oag/dcr/downloads/2020-ybtf-report.pdf'],['6484_0_antibias.pdf'],1,100.0,['https://www.nj.gov/oag/dcr/downloads/2020-ybtf-report.pdf'],['6484_0_antibias.pdf'],[0.144],[0.543],[0.643],[0.162],[0.183],[0.153],[0.742],[0.643],[0.616],[0.662],[0.769],[0.743],[0.626],[0.87],[0.82],[0.777],[0.783],[0.783],0.144,0.543,0.643,0.162,0.183,0.153,0.742,0.643,0.616,0.662,0.769,0.743,0.626,0.87,0.82,0.777,0.783,0.783
https://doi.org/10.1007/s11356-017-9799-2,low blood lead levels and attentiondeficit hyperactivity disorder in children a systematic review and metaanalysis,6533_low blood lead levels and attentiondeficit hyperactivity disorder in children a systematic review and metaanalysis.pdf,1,['https://purl.fdlp.gov/GPO/gpo144830'],['Toxicological profile for lead /'],['https://purl.fdlp.gov/GPO/gpo144830'],['6533_0_toxicological profile for lead .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo144830'],['6533_0_toxicological profile for lead .pdf'],[0.672],[0.503],[0.602],[0.163],[0.165],[0.131],[0.736],[0.643],[0.561],[0.7],[0.788],[0.677],[0.619],[0.909],[0.798],[0.738],[0.772],[0.76],0.672,0.503,0.602,0.163,0.165,0.131,0.736,0.643,0.561,0.7,0.788,0.677,0.619,0.909,0.798,0.738,0.772,0.76
https://doi.org/10.1007/s11356-019-06478-z,fracking and infant mortality fresh evidence from oklahoma,6534_fracking and infant mortality fresh evidence from oklahoma.pdf,1,['https://www.gov.ca.gov/wp-content/uploads/2021/10/Public-Health-Panel-Memo.pdf'],['RE : Response to CalGEM Questions for the California Oil and Gas Public Health Rulemaking Scientific Advisory Panel'],['https://www.gov.ca.gov/wp-content/uploads/2021/10/Public-Health-Panel-Memo.pdf'],['6534_0_re  response to calgem questions for the california oil and gas public health rulemaking scientific advisory panel.pdf'],1,100.0,['https://www.gov.ca.gov/wp-content/uploads/2021/10/Public-Health-Panel-Memo.pdf'],['6534_0_re  response to calgem questions for the california oil and gas public health rulemaking scientific advisory panel.pdf'],[0.423],[0.518],[0.62],[0.152],[0.162],[0.122],[0.728],[0.635],[0.577],[0.684],[0.784],[0.706],[0.621],[0.924],[0.81],[0.749],[0.781],[0.766],0.423,0.518,0.62,0.152,0.162,0.122,0.728,0.635,0.577,0.684,0.784,0.706,0.621,0.924,0.81,0.749,0.781,0.766
https://doi.org/10.1007/s11423-019-09700-4,open educational resources student efficacy and user perceptions a synthesis of research published between 2015 and 2018,6566_open educational resources student efficacy and user perceptions a synthesis of research published between 2015 and 2018.pdf,3,"['https://highered.colorado.gov/sites/highered/files/2020-03/oer-handout.pdf', 'https://masterplan.highered.colorado.gov/wp-content/uploads/2020/10/FINAL_OER_Report_2020_9_29_20.pdf', 'https://highered.colorado.gov/Publications/Reports/Legislative/OER/OER_Report_2019_Final.pdf']","['Are OER?', 'Equcation Practices', '2 Transforming colorado Equcation Practices']","['https://highered.colorado.gov/sites/highered/files/2020-03/oer-handout.pdf', 'https://highered.colorado.gov/Publications/Reports/Legislative/OER/OER_Report_2019_Final.pdf']","['6566_0_are oer.pdf', '6566_2_2 transforming colorado equcation practices.pdf']",2,66.67,"['https://highered.colorado.gov/sites/highered/files/2020-03/oer-handout.pdf', 'https://highered.colorado.gov/Publications/Reports/Legislative/OER/OER_Report_2019_Final.pdf']","['6566_0_are oer.pdf', '6566_2_2 transforming colorado equcation practices.pdf']","[0.46, 0.368]","[0.547, 0.571]","[0.64, 0.658]","[0.162, 0.183]","[0.165, 0.203]","[0.173, 0.186]","[0.728, 0.733]","[0.64, 0.642]","[0.625, 0.656]","[0.732, 0.717]","[0.805, 0.822]","[0.754, 0.785]","[0.641, 0.663]","[0.919, 0.929]","[0.848, 0.87]","[0.772, 0.798]","[0.812, 0.835]","[0.795, 0.814]",0.414,0.559,0.649,0.172,0.184,0.179,0.73,0.641,0.641,0.724,0.814,0.77,0.652,0.924,0.859,0.785,0.824,0.804
https://doi.org/10.1007/s11423-020-09744-x,academic communities of engagement an expansive lens for examining support structures in blended and online learning,6567_academic communities of engagement an expansive lens for examining support structures in blended and online learning.pdf,1,['https://www.cde.ca.gov/ci/cr/dl/documents/dlintegrationstdsguide.pdf'],['CA Digital Learning Integration & Stds. Guidance - Distance Learning (CA Dept of Education)'],['https://www.cde.ca.gov/ci/cr/dl/documents/dlintegrationstdsguide.pdf'],['6567_0_ca digital learning integration  stds guidance  distance learning ca dept of education.pdf'],1,100.0,['https://www.cde.ca.gov/ci/cr/dl/documents/dlintegrationstdsguide.pdf'],['6567_0_ca digital learning integration  stds guidance  distance learning ca dept of education.pdf'],[0.514],[0.565],[0.65],[0.18],[0.192],[0.18],[0.743],[0.649],[0.629],[0.71],[0.808],[0.752],[0.654],[0.925],[0.843],[0.787],[0.818],[0.8],0.514,0.565,0.65,0.18,0.192,0.18,0.743,0.649,0.629,0.71,0.808,0.752,0.654,0.925,0.843,0.787,0.818,0.8
https://doi.org/10.1007/s11596-010-0647-6,shortterm impact of cognitionmotivationemotional intelligenceresistance skills program on drug use prevention for school students in wuhan china,6597_shortterm impact of cognitionmotivationemotional intelligenceresistance skills program on drug use prevention for school students in wuhan china.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf'],['Universal school‐based prevention for illicit drug use'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf'],['6597_0_universal school‐based prevention for illicit drug use.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf'],['6597_0_universal school‐based prevention for illicit drug use.pdf'],[0.591],[0.536],[0.615],[0.2],[0.215],[0.189],[0.739],[0.645],[0.592],[0.696],[0.781],[0.712],[0.607],[0.913],[0.837],[0.739],[0.784],[0.765],0.591,0.536,0.615,0.2,0.215,0.189,0.739,0.645,0.592,0.696,0.781,0.712,0.607,0.913,0.837,0.739,0.784,0.765
https://doi.org/10.1007/s11596-020-2172-6,clinical characteristics of children with coronavirus disease 2019 in hubei china,6598_clinical characteristics of children with coronavirus disease 2019 in hubei china.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283678/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364349/pdf']","['Managing ICU surge during the COVID-19 crisis: rapid guidelines', 'Practical Guide for Pediatric Pulmonologists on Imaging Management of Pediatric Patients with COVID‐19', 'Management of liver diseases during the pandemic of coronavirus disease-19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283678/pdf']","['6598_2_management of liver diseases during the pandemic of coronavirus disease19.pdf', '6598_0_managing icu surge during the covid19 crisis rapid guidelines.pdf', '6598_1_practical guide for pediatric pulmonologists on imaging management of pediatric patients with covid‐19.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283678/pdf']","['6598_2_management of liver diseases during the pandemic of coronavirus disease19.pdf', '6598_0_managing icu surge during the covid19 crisis rapid guidelines.pdf', '6598_1_practical guide for pediatric pulmonologists on imaging management of pediatric patients with covid‐19.pdf']","[0.363, 0.475, 0.475]","[0.571, 0.539, 0.569]","[0.642, 0.617, 0.644]","[0.188, 0.159, 0.203]","[0.203, 0.166, 0.212]","[0.152, 0.128, 0.165]","[0.743, 0.737, 0.752]","[0.651, 0.643, 0.659]","[0.639, 0.617, 0.643]","[0.63, 0.641, 0.651]","[0.808, 0.799, 0.814]","[0.741, 0.734, 0.752]","[0.642, 0.619, 0.633]","[0.923, 0.915, 0.916]","[0.844, 0.838, 0.842]","[0.783, 0.765, 0.781]","[0.816, 0.807, 0.819]","[0.795, 0.782, 0.799]",0.438,0.56,0.634,0.183,0.194,0.148,0.744,0.651,0.633,0.641,0.807,0.742,0.631,0.918,0.841,0.776,0.814,0.792
https://doi.org/10.1007/s11605-020-04555-0,surgical outcomes of spontaneously ruptured hepatocellular carcinoma,6601_surgical outcomes of spontaneously ruptured hepatocellular carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['6601_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['6601_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.605],[0.54],[0.617],[0.17],[0.172],[0.132],[0.749],[0.658],[0.594],[0.643],[0.783],[0.681],[0.636],[0.906],[0.802],[0.751],[0.78],[0.765],0.605,0.54,0.617,0.17,0.172,0.132,0.749,0.658,0.594,0.643,0.783,0.681,0.636,0.906,0.802,0.751,0.78,0.765
https://doi.org/10.1007/s11739-020-02432-x,covid19 coagulopathy and venous thromboembolism more questions than answers,6633_covid19 coagulopathy and venous thromboembolism more questions than answers.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833273/pdf'],['Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833273/pdf'],['6633_0_therapeutic strategies for severe covid19 a position paper from the italian society of infectious and tropical diseases simit.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833273/pdf'],['6633_0_therapeutic strategies for severe covid19 a position paper from the italian society of infectious and tropical diseases simit.pdf'],[0.599],[0.562],[0.641],[0.215],[0.214],[0.167],[0.756],[0.672],[0.623],[0.67],[0.81],[0.739],[0.628],[0.916],[0.824],[0.769],[0.802],[0.787],0.599,0.562,0.641,0.215,0.214,0.167,0.756,0.672,0.623,0.67,0.81,0.739,0.628,0.916,0.824,0.769,0.802,0.787
https://doi.org/10.1007/s12020-019-01843-x,comparison among tirads acr tirads and kwak tirads and 2015 ata guidelines in the diagnostic efficiency of thyroid nodules,6724_comparison among tirads acr tirads and kwak tirads and 2015 ata guidelines in the diagnostic efficiency of thyroid nodules.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578891/pdf']","['Discordance Between ATA and ACR Guideline Systems for Thyroid Nodule Biopsy', 'Explore the Diagnostic Efficiency of Chinese Thyroid Imaging Reporting and Data Systems by Comparing With the Other Four Systems (ACR TI-RADS, Kwak-TIRADS, KSThR-TIRADS, and EU-TIRADS): A Single-Center Study']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578891/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541514/pdf']","['6724_1_explore the diagnostic efficiency of chinese thyroid imaging reporting and data systems by comparing with the other f.pdf', '6724_0_discordance between ata and acr guideline systems for thyroid nodule biopsy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578891/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541514/pdf']","['6724_1_explore the diagnostic efficiency of chinese thyroid imaging reporting and data systems by comparing with the other f.pdf', '6724_0_discordance between ata and acr guideline systems for thyroid nodule biopsy.pdf']","[0.569, 0.664]","[0.506, 0.495]","[0.582, 0.58]","[0.177, 0.171]","[0.168, 0.172]","[0.152, 0.144]","[0.746, 0.74]","[0.653, 0.647]","[0.555, 0.55]","[0.726, 0.718]","[0.764, 0.758]","[0.659, 0.653]","[0.63, 0.598]","[0.904, 0.903]","[0.786, 0.784]","[0.734, 0.721]","[0.771, 0.757]","[0.758, 0.75]",0.617,0.5,0.581,0.174,0.17,0.148,0.743,0.65,0.552,0.722,0.761,0.656,0.614,0.903,0.785,0.728,0.764,0.754
https://doi.org/10.1007/s12035-019-1498-1,socioeconomic deprivation adverse childhood experiences and medical disorders in adulthood mechanisms and associations,6727_socioeconomic deprivation adverse childhood experiences and medical disorders in adulthood mechanisms and associations.pdf,3,"['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Overview-of-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=04f7d5', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f']","['ACEs and Toxic Stress : A Public Health Crisis', 'Executive Summary – Findings from Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'Public Health Sector']","['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Overview-of-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=04f7d5', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44']","['6727_0_aces and toxic stress  a public health crisis.pdf', '6727_2_public health sector.pdf', '6727_1_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']",3,100.0,"['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Overview-of-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=04f7d5', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44']","['6727_0_aces and toxic stress  a public health crisis.pdf', '6727_2_public health sector.pdf', '6727_1_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']","[0.279, 0.288, 0.238]","[0.55, 0.548, 0.56]","[0.646, 0.647, 0.65]","[0.154, 0.145, 0.147]","[0.145, 0.144, 0.139]","[0.113, 0.107, 0.103]","[0.75, 0.743, 0.744]","[0.663, 0.655, 0.656]","[0.632, 0.637, 0.643]","[0.661, 0.655, 0.652]","[0.813, 0.821, 0.823]","[0.736, 0.745, 0.748]","[0.623, 0.63, 0.639]","[0.932, 0.927, 0.932]","[0.843, 0.846, 0.845]","[0.778, 0.78, 0.785]","[0.815, 0.827, 0.826]","[0.803, 0.807, 0.81]",0.268,0.553,0.648,0.149,0.143,0.108,0.746,0.658,0.637,0.656,0.819,0.743,0.631,0.93,0.845,0.781,0.823,0.807
https://doi.org/10.1007/s12072-021-10234-2,impact of tenofovir alafenamide vs entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis b,6730_impact of tenofovir alafenamide vs entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis b.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['6730_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['6730_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.58],[0.51],[0.589],[0.158],[0.161],[0.123],[0.747],[0.657],[0.57],[0.647],[0.777],[0.683],[0.626],[0.897],[0.805],[0.741],[0.76],[0.757],0.58,0.51,0.589,0.158,0.161,0.123,0.747,0.657,0.57,0.647,0.777,0.683,0.626,0.897,0.805,0.741,0.76,0.757
https://doi.org/10.1007/s12519-020-00343-7,diagnosis treatment and prevention of 2019 novel coronavirus infection in children experts’ consensus statement,6855_diagnosis treatment and prevention of 2019 novel coronavirus infection in children experts’ consensus statement.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315111/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090514/pdf']","['Best practice for infection prevention in pediatric respiratory clinics during the COVID-19 epidemic', 'Management strategies for children with COVID-19: ESPR practical recommendations', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315111/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['6855_0_best practice for infection prevention in pediatric respiratory clinics during the covid19 epidemic.pdf', '6855_3_pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.pdf', '6855_2_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '6855_1_management strategies for children with covid19 espr practical recommendations.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315111/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['6855_0_best practice for infection prevention in pediatric respiratory clinics during the covid19 epidemic.pdf', '6855_3_pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.pdf', '6855_2_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '6855_1_management strategies for children with covid19 espr practical recommendations.pdf']","[0.563, 0.414, 0.298, 0.352]","[0.589, 0.557, 0.546, 0.556]","[0.665, 0.627, 0.627, 0.638]","[0.203, 0.172, 0.163, 0.187]","[0.218, 0.183, 0.18, 0.188]","[0.164, 0.14, 0.139, 0.145]","[0.75, 0.741, 0.743, 0.745]","[0.654, 0.645, 0.651, 0.651]","[0.657, 0.631, 0.612, 0.633]","[0.635, 0.621, 0.625, 0.627]","[0.817, 0.809, 0.802, 0.813]","[0.772, 0.75, 0.737, 0.731]","[0.659, 0.633, 0.623, 0.624]","[0.934, 0.932, 0.928, 0.931]","[0.836, 0.824, 0.827, 0.841]","[0.795, 0.775, 0.758, 0.779]","[0.825, 0.811, 0.806, 0.82]","[0.81, 0.795, 0.789, 0.799]",0.407,0.562,0.639,0.181,0.192,0.147,0.745,0.65,0.633,0.627,0.81,0.747,0.635,0.931,0.832,0.777,0.816,0.798
https://doi.org/10.1007/s12519-020-00345-5,diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus,6856_diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013412/pdf']","['Management strategies for children with COVID-19: ESPR practical recommendations', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013412/pdf']","['6856_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '6856_0_management strategies for children with covid19 espr practical recommendations.pdf', '6856_2_consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of covid‐19.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013412/pdf']","['6856_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '6856_0_management strategies for children with covid19 espr practical recommendations.pdf', '6856_2_consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of covid‐19.pdf']","[0.397, 0.271, 0.282]","[0.553, 0.571, 0.554]","[0.631, 0.65, 0.634]","[0.163, 0.193, 0.182]","[0.179, 0.196, 0.197]","[0.135, 0.149, 0.145]","[0.742, 0.746, 0.739]","[0.649, 0.653, 0.648]","[0.62, 0.651, 0.632]","[0.612, 0.618, 0.639]","[0.801, 0.815, 0.8]","[0.738, 0.736, 0.744]","[0.626, 0.633, 0.635]","[0.918, 0.924, 0.922]","[0.833, 0.849, 0.833]","[0.763, 0.789, 0.775]","[0.808, 0.826, 0.809]","[0.789, 0.802, 0.789]",0.317,0.559,0.638,0.179,0.191,0.143,0.742,0.65,0.634,0.623,0.805,0.739,0.631,0.921,0.838,0.776,0.814,0.793
https://doi.org/10.1007/s12671-019-01273-w,feasibility of a smartphone app with mindfulness training for adolescent smoking cessation craving to quit c2qteen,6884_feasibility of a smartphone app with mindfulness training for adolescent smoking cessation craving to quit c2qteen.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009295/pdf'],['Mindfulness for smoking cessation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009295/pdf'],['6884_0_mindfulness for smoking cessation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009295/pdf'],['6884_0_mindfulness for smoking cessation.pdf'],[0.4],[0.507],[0.602],[0.158],[0.168],[0.143],[0.735],[0.641],[0.569],[0.717],[0.769],[0.696],[0.573],[0.911],[0.801],[0.719],[0.768],[0.746],0.4,0.507,0.602,0.158,0.168,0.143,0.735,0.641,0.569,0.717,0.769,0.696,0.573,0.911,0.801,0.719,0.768,0.746
https://doi.org/10.1007/s13178-019-00387-z,supporting lgbtq foster teens development of a relationshipfocusedselfguided curriculum for foster families,6907_supporting lgbtq foster teens development of a relationshipfocusedselfguided curriculum for foster families.pdf,1,['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf'],['Disproportionality and Disparities'],['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf'],['6907_0_disproportionality and disparities.pdf'],1,100.0,['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf'],['6907_0_disproportionality and disparities.pdf'],[0.592],[0.519],[0.612],[0.166],[0.2],[0.17],[0.739],[0.646],[0.593],[0.678],[0.788],[0.716],[0.619],[0.912],[0.823],[0.759],[0.793],[0.777],0.592,0.519,0.612,0.166,0.2,0.17,0.739,0.646,0.593,0.678,0.788,0.716,0.619,0.912,0.823,0.759,0.793,0.777
https://doi.org/10.1007/s13312-019-1517-3,early aggressive enteral feeding in neonates weighing 750–1250 grams a randomized controlled trial,6935_early aggressive enteral feeding in neonates weighing 750–1250 grams a randomized controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf']","['Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants', 'Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf']","['6935_1_slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.pdf', '6935_0_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf']","['6935_1_slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.pdf', '6935_0_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf']","[0.486, 0.49]","[0.536, 0.536]","[0.618, 0.619]","[0.195, 0.198]","[0.195, 0.195]","[0.165, 0.168]","[0.741, 0.742]","[0.647, 0.647]","[0.602, 0.604]","[0.659, 0.661]","[0.791, 0.793]","[0.712, 0.707]","[0.591, 0.591]","[0.92, 0.92]","[0.82, 0.821]","[0.73, 0.732]","[0.783, 0.784]","[0.763, 0.767]",0.488,0.536,0.619,0.197,0.195,0.167,0.742,0.647,0.603,0.66,0.792,0.71,0.591,0.92,0.821,0.731,0.784,0.765
https://doi.org/10.1007/s13312-020-1819-5,coronavirus disease 2019 covid19 in children  what we know so far and what we do not,6936_coronavirus disease 2019 covid19 in children  what we know so far and what we do not.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['COVID-19 PICU guidelines: for high- and limited-resource settings'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['6936_0_covid19 picu guidelines for high and limitedresource settings.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['6936_0_covid19 picu guidelines for high and limitedresource settings.pdf'],[0.659],[0.523],[0.612],[0.167],[0.167],[0.131],[0.742],[0.648],[0.592],[0.639],[0.79],[0.702],[0.623],[0.91],[0.804],[0.749],[0.788],[0.768],0.659,0.523,0.612,0.167,0.167,0.131,0.742,0.648,0.592,0.639,0.79,0.702,0.623,0.91,0.804,0.749,0.788,0.768
https://doi.org/10.1007/s13524-018-0748-6,the timing of teenage births estimating the effect on high school graduation and laterlife outcomes,7001_the timing of teenage births estimating the effect on high school graduation and laterlife outcomes.pdf,7,"['https://www.census.gov/content/census/en/library/publications/2019/adrm/2018-ces-annual-report.html', 'https://www.sanantonio.gov/Portals/0/Files/health/News/Reports/StatusOfWomen/StatusOfWomen-Full.pdf', 'https://www.census.gov/content/census/en/library/publications/2019/adrm/2018-ces-selected-publications-and-working-papers.html', 'https://www.census.gov/content/census/en/library/publications/2020/adrm/2019-ces-annual-report.html', 'https://www.census.gov/library/publications/2019/adrm/2018-ces-annual-report.html', 'https://www.census.gov/library/publications/2019/adrm/2018-ces-selected-publications-and-working-papers.html', 'https://www.census.gov/content/census/en/library/publications/2020/adrm/2019-ces-selected-publications-and-working-papers.html']","['CES and Research Data Centers Research Report: 2018', 'The Status Of Women In San Antonio', '2018 CES Selected Publications and Working Papers', 'Center for Economic Studies Research Report: 2019', 'CES and Research Data Centers Research Report: 2018', '2018 CES Selected Publications and Working Papers', '2019 CES Staff Publications and Working Papers']",['https://www.sanantonio.gov/Portals/0/Files/health/News/Reports/StatusOfWomen/StatusOfWomen-Full.pdf'],['7001_1_the status of women in san antonio.pdf'],1,14.29,['https://www.sanantonio.gov/Portals/0/Files/health/News/Reports/StatusOfWomen/StatusOfWomen-Full.pdf'],['7001_1_the status of women in san antonio.pdf'],[0.295],[0.525],[0.62],[0.154],[0.175],[0.138],[0.725],[0.62],[0.595],[0.709],[0.79],[0.723],[0.649],[0.916],[0.839],[0.755],[0.794],[0.778],0.295,0.525,0.62,0.154,0.175,0.138,0.725,0.62,0.595,0.709,0.79,0.723,0.649,0.916,0.839,0.755,0.794,0.778
https://doi.org/10.1007/s13524-018-0753-9,misreporting month of birth diagnosis and implications for research on nutrition and early childhood in developing countries,7002_misreporting month of birth diagnosis and implications for research on nutrition and early childhood in developing countries.pdf,2,"['http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133446', 'https://purl.fdlp.gov/GPO/gpo131383']","['Agriculture and undernutrition through the lens of economics', 'Evaluation of indicators to monitor quality of anthropometry data during fieldwork /']",['https://purl.fdlp.gov/GPO/gpo131383'],['7002_1_evaluation of indicators to monitor quality of anthropometry data during fieldwork .pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo131383'],['7002_1_evaluation of indicators to monitor quality of anthropometry data during fieldwork .pdf'],[0.294],[0.536],[0.621],[0.148],[0.162],[0.135],[0.733],[0.634],[0.602],[0.734],[0.788],[0.717],[0.652],[0.915],[0.836],[0.772],[0.808],[0.79],0.294,0.536,0.621,0.148,0.162,0.135,0.733,0.634,0.602,0.734,0.788,0.717,0.652,0.915,0.836,0.772,0.808,0.79
https://doi.org/10.1007/s13524-019-00793-3,the impact of childcare on poor urban women’s economic empowerment in africa,7006_the impact of childcare on poor urban women’s economic empowerment in africa.pdf,9,"['https://www.rand.org/blog/2020/05/economic-recovery-in-egypt-should-include-women.html', 'https://www.cgdev.org/publication/review-multilateral-development-banks-investments-childcare', 'https://www.rand.org/pubs/research_reports/RR2868.html', 'https://www.icrw.org/publications/weprosper-research-salon-brief-childcare/', 'https://www.icrw.org/publications/global-assessment-of-care-services-current-status-impact-and-policy-recommendations/', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/135938', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133551', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_french.pdf', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_english.pdf']","['Economic Recovery in Egypt Should Include Women', 'A Review of Multilateral Development Banks’ Investments in Childcare', 'Women in Egypt Face Barriers to Employment', 'WeProsper Research Salon Brief: Childcare', 'Global Assessment of Care Services: Current Status, Impact, and Policy Recommendations', 'Cash transfers and intimate partner violence: A research view on design and implementation for risk mitigation and prevention', 'Towards gender equality: A review of evidence on social safety nets in Africa', 'Examen Des Données Probantes Relatives à La Crise Mondiale Des Services De Garde D’enfants Et De La Voie à Suivre Pour La Reprise Et La Résilience Après La Covid-19', 'Evidence Review Of The Global Childcare Crisis And The Road For Post-covid-19 Recovery And Resilience']","['https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_french.pdf', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_english.pdf']","['7006_7_examen des données probantes relatives à la crise mondiale des services de garde denfants et de la voie à suivre pour la reprise et la résilience après la covid19.pdf', '7006_8_evidence review of the global childcare crisis and the road for postcovid19 recovery and resilience.pdf']",2,22.22,"['https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_french.pdf', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_english.pdf']","['7006_7_examen des données probantes relatives à la crise mondiale des services de garde denfants et de la voie à suivre pour la reprise et la résilience après la covid19.pdf', '7006_8_evidence review of the global childcare crisis and the road for postcovid19 recovery and resilience.pdf']","[0.079, 0.414]","[0.447, 0.524]","[0.56, 0.625]","[0.12, 0.166]","[0.15, 0.175]","[0.118, 0.15]","[0.724, 0.724]","[0.627, 0.625]","[0.51, 0.592]","[0.673, 0.677]","[0.759, 0.8]","[0.645, 0.713]","[0.546, 0.634]","[0.868, 0.913]","[0.801, 0.835]","[0.695, 0.762]","[0.74, 0.8]","[0.706, 0.78]",0.246,0.486,0.593,0.143,0.162,0.134,0.724,0.626,0.551,0.675,0.78,0.679,0.59,0.891,0.818,0.728,0.77,0.743
https://doi.org/10.1007/s40120-018-0118-8,patient power revolution in multiple sclerosis navigating the new frontier,7027_patient power revolution in multiple sclerosis navigating the new frontier.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822792/pdf'],['Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822792/pdf'],['7027_0_joint healthcare professional and patient development of communication tools to improve the standard of ms care.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822792/pdf'],['7027_0_joint healthcare professional and patient development of communication tools to improve the standard of ms care.pdf'],[0.633],[0.581],[0.66],[0.224],[0.237],[0.194],[0.751],[0.662],[0.648],[0.707],[0.82],[0.769],[0.639],[0.923],[0.863],[0.784],[0.829],[0.812],0.633,0.581,0.66,0.224,0.237,0.194,0.751,0.662,0.648,0.707,0.82,0.769,0.639,0.923,0.863,0.784,0.829,0.812
https://doi.org/10.1007/s40263-019-00680-w,adverse events associated with melatonin for the treatment of primary or secondary sleep disorders a systematic review,7038_adverse events associated with melatonin for the treatment of primary or secondary sleep disorders a systematic review.pdf,1,['https://wa.kaiserpermanente.org/static/pdf/public/guidelines/insomnia.pdf'],['Insomnia Guideline'],['https://wa.kaiserpermanente.org/static/pdf/public/guidelines/insomnia.pdf'],['7038_0_insomnia guideline.pdf'],1,100.0,['https://wa.kaiserpermanente.org/static/pdf/public/guidelines/insomnia.pdf'],['7038_0_insomnia guideline.pdf'],[0.411],[0.533],[0.625],[0.184],[0.207],[0.165],[0.739],[0.646],[0.609],[0.689],[0.804],[0.722],[0.62],[0.927],[0.826],[0.766],[0.806],[0.792],0.411,0.533,0.625,0.184,0.207,0.165,0.739,0.646,0.609,0.689,0.804,0.722,0.62,0.927,0.826,0.766,0.806,0.792
https://doi.org/10.1007/s40265-018-1046-8,emapalumab first global approval,7041_emapalumab first global approval.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340087/pdf'],['Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340087/pdf'],['7041_0_challenges in the diagnosis of hemophagocytic lymphohistiocytosis recommendations from the north american consortium for histiocytosis nacho.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340087/pdf'],['7041_0_challenges in the diagnosis of hemophagocytic lymphohistiocytosis recommendations from the north american consortium for histiocytosis nacho.pdf'],[0.312],[0.497],[0.611],[0.181],[0.186],[0.133],[0.743],[0.651],[0.587],[0.656],[0.772],[0.671],[0.598],[0.91],[0.811],[0.731],[0.768],[0.758],0.312,0.497,0.611,0.181,0.186,0.133,0.743,0.651,0.587,0.656,0.772,0.671,0.598,0.91,0.811,0.731,0.768,0.758
https://doi.org/10.1007/s40272-019-00362-6,treatment withdrawal following remission in juvenile idiopathic arthritis a systematic review of the literature,7045_treatment withdrawal following remission in juvenile idiopathic arthritis a systematic review of the literature.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 1'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['7045_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['7045_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],[0.354],[0.582],[0.65],[0.184],[0.19],[0.146],[0.748],[0.655],[0.638],[0.665],[0.817],[0.746],[0.632],[0.925],[0.839],[0.785],[0.817],[0.802],0.354,0.582,0.65,0.184,0.19,0.146,0.748,0.655,0.638,0.665,0.817,0.746,0.632,0.925,0.839,0.785,0.817,0.802
https://doi.org/10.1007/s40719-019-00180-8,a review of gun buybacks,7075_a review of gun buybacks.pdf,1,['https://abgt.assembly.ca.gov/sites/abgt.assembly.ca.gov/files/Feb%2028%20-%20Sub.%205%20agenda%20CDCR.pdf'],['Agenda'],['https://abgt.assembly.ca.gov/sites/abgt.assembly.ca.gov/files/Feb%2028%20-%20Sub.%205%20agenda%20CDCR.pdf'],['7075_0_agenda.pdf'],1,100.0,['https://abgt.assembly.ca.gov/sites/abgt.assembly.ca.gov/files/Feb%2028%20-%20Sub.%205%20agenda%20CDCR.pdf'],['7075_0_agenda.pdf'],[0.178],[0.515],[0.6],[0.138],[0.147],[0.117],[0.714],[0.614],[0.592],[0.671],[0.812],[0.733],[0.648],[0.925],[0.852],[0.763],[0.82],[0.795],0.178,0.515,0.6,0.138,0.147,0.117,0.714,0.614,0.592,0.671,0.812,0.733,0.648,0.925,0.852,0.763,0.82,0.795
https://doi.org/10.1016/b978-0-444-63459-7.00007-5,the analysis of field choice in college and graduate school,7105_the analysis of field choice in college and graduate school.pdf,5,"['https://www.brookings.edu/research/community-college-program-choices-in-the-wake-of-local-job-losses/', 'https://www.federalreserve.gov/econres/feds/files/2019015pap.pdf', 'https://www.rand.org/pubs/working_papers/WRA1060-1-v2.html', 'https://www.nber.org/papers/w23029?sy=029', 'https://www.rand.org/pubs/working_papers/WRA1060-1.html']","['Community college program choices in the wake of local job losses', 'Who Values Access to College?', 'When Sarah Meets Lawrence', 'The Costs of and Net Returns to College Major', 'When Sarah Meets Lawrence']",['https://www.federalreserve.gov/econres/feds/files/2019015pap.pdf'],['7105_1_who values access to college.pdf'],1,20.0,['https://www.federalreserve.gov/econres/feds/files/2019015pap.pdf'],['7105_1_who values access to college.pdf'],[0.447],[0.549],[0.632],[0.177],[0.198],[0.168],[0.731],[0.635],[0.61],[0.725],[0.795],[0.724],[0.664],[0.916],[0.842],[0.769],[0.801],[0.784],0.447,0.549,0.632,0.177,0.198,0.168,0.731,0.635,0.61,0.725,0.795,0.724,0.664,0.916,0.842,0.769,0.801,0.784
https://doi.org/10.1016/b978-012657951-2/50002-9,understanding attempted suicide in adolescence,7111_understanding attempted suicide in adolescence.pdf,5,"['http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/025%20Nonsuicidal%20self%20injury2.pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Non-Suicidal%20Self-Injurious%20Behavior_0.pdf', 'http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'https://rga.lis.virginia.gov/Published/2010/HD9/PDF']","['Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'NONSUICIDAL SELF-INJURY', 'Microsoft Word - Non-Suicidal Self-Injurious Behavior_0.doc', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs, 4th Edition']","['http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Non-Suicidal%20Self-Injurious%20Behavior_0.pdf', 'http://vcoy.virginia.gov/documents/collection/025%20Nonsuicidal%20self%20injury2.pdf']","['7111_3_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '7111_0_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '7111_2_microsoft word  nonsuicidal selfinjurious behavior0doc.pdf', '7111_1_nonsuicidal selfinjury.pdf']",4,80.0,"['http://vcoy.virginia.gov/pdf/Collection_HouseDoc7041513withcover.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/pdf/documents/collection/Non-Suicidal%20Self-Injurious%20Behavior_0.pdf', 'http://vcoy.virginia.gov/documents/collection/025%20Nonsuicidal%20self%20injury2.pdf']","['7111_3_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '7111_0_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '7111_2_microsoft word  nonsuicidal selfinjurious behavior0doc.pdf', '7111_1_nonsuicidal selfinjury.pdf']","[0.434, 0.571, 0.615, 0.431]","[0.55, 0.558, 0.545, 0.557]","[0.644, 0.653, 0.638, 0.651]","[0.174, 0.182, 0.206, 0.228]","[0.195, 0.202, 0.231, 0.25]","[0.163, 0.17, 0.193, 0.21]","[0.738, 0.739, 0.746, 0.75]","[0.64, 0.642, 0.651, 0.655]","[0.602, 0.612, 0.597, 0.609]","[0.689, 0.69, 0.709, 0.709]","[0.8, 0.807, 0.797, 0.804]","[0.727, 0.74, 0.725, 0.735]","[0.628, 0.634, 0.623, 0.634]","[0.919, 0.924, 0.907, 0.919]","[0.828, 0.831, 0.834, 0.836]","[0.767, 0.778, 0.762, 0.778]","[0.809, 0.817, 0.801, 0.815]","[0.794, 0.801, 0.791, 0.802]",0.513,0.552,0.647,0.197,0.22,0.184,0.743,0.647,0.605,0.699,0.802,0.732,0.63,0.917,0.832,0.771,0.81,0.797
https://doi.org/10.1016/b978-155860915-0/50038-x,lifelines using visualization to enhance navigation and analysis of patient records,7120_lifelines using visualization to enhance navigation and analysis of patient records.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858819/pdf'],['Visualization Methods to Support Guideline-Based Care Management'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858819/pdf'],['7120_0_visualization methods to support guidelinebased care management.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858819/pdf'],['7120_0_visualization methods to support guidelinebased care management.pdf'],[0.251],[0.563],[0.655],[0.159],[0.184],[0.163],[0.744],[0.651],[0.632],[0.702],[0.808],[0.756],[0.64],[0.929],[0.855],[0.78],[0.818],[0.807],0.251,0.563,0.655,0.159,0.184,0.163,0.744,0.651,0.632,0.702,0.808,0.756,0.64,0.929,0.855,0.78,0.818,0.807
https://doi.org/10.1016/j.aap.2017.07.012,automobiledependency as a barrier to vision zero evidence from the states in the usa,7147_automobiledependency as a barrier to vision zero evidence from the states in the usa.pdf,2,"['https://www.portland.gov/sites/default/files/council-documents/2021/exhibit-a-the-way-to-go-plan-reportv.1.pdf', 'https://www.portland.gov/sites/default/files/2020-04/pbot_e-scooter_01152019.pdf']","['The Way to Go Plan : Moving People in Portland', '2018 E-Scooter Findings Report']","['https://www.portland.gov/sites/default/files/council-documents/2021/exhibit-a-the-way-to-go-plan-reportv.1.pdf', 'https://www.portland.gov/sites/default/files/2020-04/pbot_e-scooter_01152019.pdf']","['7147_0_the way to go plan  moving people in portland.pdf', '7147_1_2018 escooter findings report.pdf']",2,100.0,"['https://www.portland.gov/sites/default/files/council-documents/2021/exhibit-a-the-way-to-go-plan-reportv.1.pdf', 'https://www.portland.gov/sites/default/files/2020-04/pbot_e-scooter_01152019.pdf']","['7147_0_the way to go plan  moving people in portland.pdf', '7147_1_2018 escooter findings report.pdf']","[0.167, 0.132]","[0.542, 0.542]","[0.633, 0.626]","[0.148, 0.152]","[0.158, 0.153]","[0.129, 0.122]","[0.722, 0.716]","[0.622, 0.615]","[0.618, 0.615]","[0.677, 0.681]","[0.809, 0.806]","[0.743, 0.746]","[0.663, 0.673]","[0.912, 0.915]","[0.851, 0.852]","[0.779, 0.78]","[0.815, 0.814]","[0.789, 0.787]",0.15,0.542,0.629,0.15,0.155,0.126,0.719,0.619,0.617,0.679,0.808,0.744,0.668,0.913,0.851,0.78,0.815,0.788
https://doi.org/10.1016/j.aca.2017.08.016,identification of novel nonionic cationic zwitterionic and anionic polyfluoroalkyl substances using uplc–tof–mse highresolution parent ion search,7152_identification of novel nonionic cationic zwitterionic and anionic polyfluoroalkyl substances using uplc–tof–mse highresolution parent ion search.pdf,1,['https://www.michigan.gov/documents/pfasresponse/Science_Advisory_Board_Report_641294_7.pdf?link_id=15&can_id=0e9c68c5b3095f0fdca05cf3f9a58935&source=email-the-million-parts-per-trillion-tour&email_referrer=email_508214&email_subject=the-million-parts-per-trillion-tour'],['Scientific Evidence and Recommendations for .Managing PFAS Contamination .in Michigan'],['https://www.michigan.gov/documents/pfasresponse/Science_Advisory_Board_Report_641294_7.pdf?link_id=15&can_id=0e9c68c5b3095f0fdca05cf3f9a58935&source=email-the-million-parts-per-trillion-tour&email_referrer=email_508214&email_subject=the-million-parts-per-trillion-tour'],['7152_0_scientific evidence and recommendations for managing pfas contamination in michigan.pdf'],1,100.0,['https://www.michigan.gov/documents/pfasresponse/Science_Advisory_Board_Report_641294_7.pdf?link_id=15&can_id=0e9c68c5b3095f0fdca05cf3f9a58935&source=email-the-million-parts-per-trillion-tour&email_referrer=email_508214&email_subject=the-million-parts-per-trillion-tour'],['7152_0_scientific evidence and recommendations for managing pfas contamination in michigan.pdf'],[0.274],[0.489],[0.594],[0.154],[0.14],[0.119],[0.738],[0.651],[0.567],[0.661],[0.788],[0.676],[0.625],[0.903],[0.805],[0.744],[0.786],[0.771],0.274,0.489,0.594,0.154,0.14,0.119,0.738,0.651,0.567,0.661,0.788,0.676,0.625,0.903,0.805,0.744,0.786,0.771
https://doi.org/10.1016/j.acap.2013.08.002,use of interrupted time series analysis in evaluating health care quality improvements,7175_use of interrupted time series analysis in evaluating health care quality improvements.pdf,8,"['https://www.aclu.org/legal-document/wikimedia-v-nsa-declaration-jonathon-penney', 'https://www.brookings.edu/research/profiles-in-patient-privacy-protection/', 'https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/validity-time-series', 'https://www.nber.org/papers/w26080', 'https://www.dhs.wisconsin.gov/seniorcare/scwaiver-1315-opib-eval.pdf', 'https://www.acf.hhs.gov/opre/report/final-report-descriptive-study-unaccompanied-refugee-minors-program-service-provision', 'https://mathematica.org/publications/project-evaluation-activity-in-support-of-partnership-for-patients-interim-appendices', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318526/pdf']","['WIKIMEDIA V. NSA -DECLARATION OF Jonathon Penney', 'Profiles in patient privacy protection', 'Testing the Validity of the Single Interrupted Time Series Design', 'Testing the Validity of the Single Interrupted Time Series Design', 'EVALUATION REPORT FOR THE WISCONSIN SENIORCARE SECTION 1115 PHARMACEUTICAL BENEFIT DEMONSTRATION', 'Final Report of the Descriptive Study of the Unaccompanied Refugee Minors Program: Service Provision, Trends, and Evaluation Recommendations', 'Project Evaluation Activity in Support of Partnership for Patients: Interim Evaluation Report, Appendices', 'Impact of the SIGN head injury guidelines and NHS 4-hour emergency target on hospital admissions for head injury in Scotland: an interrupted times series']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318526/pdf', 'https://www.dhs.wisconsin.gov/seniorcare/scwaiver-1315-opib-eval.pdf']","['7175_7_impact of the sign head injury guidelines and nhs 4hour emergency target on hospital admissions for head injury in scotland an interrupted times series.pdf', '7175_4_evaluation report for the wisconsin seniorcare section 1115 pharmaceutical benefit demonstration.pdf']",2,25.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318526/pdf', 'https://www.dhs.wisconsin.gov/seniorcare/scwaiver-1315-opib-eval.pdf']","['7175_7_impact of the sign head injury guidelines and nhs 4hour emergency target on hospital admissions for head injury in scotland an interrupted times series.pdf', '7175_4_evaluation report for the wisconsin seniorcare section 1115 pharmaceutical benefit demonstration.pdf']","[0.278, 0.27]","[0.467, 0.536]","[0.563, 0.618]","[0.117, 0.138]","[0.127, 0.144]","[0.106, 0.119]","[0.726, 0.719]","[0.628, 0.621]","[0.517, 0.604]","[0.707, 0.7]","[0.748, 0.796]","[0.672, 0.735]","[0.607, 0.642]","[0.884, 0.924]","[0.756, 0.838]","[0.674, 0.763]","[0.747, 0.803]","[0.698, 0.784]",0.274,0.502,0.591,0.128,0.136,0.112,0.722,0.625,0.56,0.704,0.772,0.704,0.625,0.904,0.797,0.719,0.775,0.741
https://doi.org/10.1016/j.addbeh.2021.106912,a systematic review of randomized controlled trials and network metaanalysis of ecigarettes for smoking cessation,7289_a systematic review of randomized controlled trials and network metaanalysis of ecigarettes for smoking cessation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438601/pdf'],['Electronic cigarettes for smoking cessation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438601/pdf'],['7289_0_electronic cigarettes for smoking cessation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438601/pdf'],['7289_0_electronic cigarettes for smoking cessation.pdf'],[0.573],[0.523],[0.616],[0.208],[0.219],[0.183],[0.742],[0.656],[0.588],[0.72],[0.793],[0.705],[0.596],[0.915],[0.822],[0.742],[0.783],[0.771],0.573,0.523,0.616,0.208,0.219,0.183,0.742,0.656,0.588,0.72,0.793,0.705,0.596,0.915,0.822,0.742,0.783,0.771
https://doi.org/10.1016/j.adolescence.2018.09.009,groupbased trajectories of parentchild communication and parental knowledge between sexual minority and heterosexual girls and their associations with substance use,7396_groupbased trajectories of parentchild communication and parental knowledge between sexual minority and heterosexual girls and their associations with substance use.pdf,1,['https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf'],['1'],['https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf'],['7396_0_1.pdf'],1,100.0,['https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf'],['7396_0_1.pdf'],[0.188],[0.512],[0.615],[0.137],[0.156],[0.13],[0.727],[0.627],[0.577],[0.665],[0.793],[0.719],[0.62],[0.918],[0.818],[0.75],[0.794],[0.774],0.188,0.512,0.615,0.137,0.156,0.13,0.727,0.627,0.577,0.665,0.793,0.719,0.62,0.918,0.818,0.75,0.794,0.774
https://doi.org/10.1016/j.ajem.2018.12.029,utility of applying white blood cell cutoffs to nondiagnostic mri and ultrasound studies for suspected pediatric appendicitis,7421_utility of applying white blood cell cutoffs to nondiagnostic mri and ultrasound studies for suspected pediatric appendicitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670723/pdf'],['Magnetic resonance imaging (MRI) for diagnosis of acute appendicitis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670723/pdf'],['7421_0_magnetic resonance imaging mri for diagnosis of acute appendicitis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670723/pdf'],['7421_0_magnetic resonance imaging mri for diagnosis of acute appendicitis.pdf'],[0.429],[0.54],[0.619],[0.191],[0.186],[0.153],[0.741],[0.644],[0.603],[0.687],[0.785],[0.706],[0.626],[0.917],[0.822],[0.739],[0.789],[0.768],0.429,0.54,0.619,0.191,0.186,0.153,0.741,0.644,0.603,0.687,0.785,0.706,0.626,0.917,0.822,0.739,0.789,0.768
https://doi.org/10.1016/j.ajhg.2019.06.015,de novo missense variants in wdr37 cause a severe multisystemic syndrome,7428_de novo missense variants in wdr37 cause a severe multisystemic syndrome.pdf,1,['https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf'],['2019 Ibr Staff Publications'],['https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf'],['7428_0_2019 ibr staff publications.pdf'],1,100.0,['https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf'],['7428_0_2019 ibr staff publications.pdf'],[0.169],[0.495],[0.586],[0.129],[0.127],[0.114],[0.748],[0.655],[0.559],[0.682],[0.781],[0.668],[0.61],[0.906],[0.799],[0.727],[0.779],[0.763],0.169,0.495,0.586,0.129,0.127,0.114,0.748,0.655,0.559,0.682,0.781,0.668,0.61,0.906,0.799,0.727,0.779,0.763
https://doi.org/10.1016/j.ajic.2020.07.005,clinical characteristics outcomes and prognosticators in adult patients hospitalized with covid19,7435_clinical characteristics outcomes and prognosticators in adult patients hospitalized with covid19.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['7435_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['7435_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.315],[0.514],[0.592],[0.152],[0.154],[0.122],[0.737],[0.642],[0.576],[0.687],[0.768],[0.694],[0.607],[0.915],[0.813],[0.734],[0.776],[0.759],0.315,0.514,0.592,0.152,0.154,0.122,0.737,0.642,0.576,0.687,0.768,0.694,0.607,0.915,0.813,0.734,0.776,0.759
https://doi.org/10.1016/j.ajog.2004.10.593,maternalperinatal morbidity and mortality associated with adolescent pregnancy in latin america crosssectional study,7474_maternalperinatal morbidity and mortality associated with adolescent pregnancy in latin america crosssectional study.pdf,3,"['https://datapopalliance.org/publications/socioeconomic-impact-assessment-of-covid-19-in-equatorial-guinea/', 'https://purl.fdlp.gov/GPO/gpo115465', 'https://www.cgdev.org/publication/adolescent-fertility-low-and-middle-income-countries-effects-and-solutions-working-paper']","['Socioeconomic Impact Assessment of COVID-19 in Equatorial Guinea', 'Sexual and reproductive health in early and later adolescence :\xa0DHS data on yourth age 10-19 /', 'Adolescent Fertility in Low- and Middle-Income Countries: Effects and Solutions - Working Paper 295']",['https://purl.fdlp.gov/GPO/gpo115465'],['7474_1_sexual and reproductive health in early and later adolescence \xa0dhs data on yourth age 1019 .pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo115465'],['7474_1_sexual and reproductive health in early and later adolescence \xa0dhs data on yourth age 1019 .pdf'],[0.407],[0.518],[0.609],[0.17],[0.181],[0.152],[0.733],[0.629],[0.579],[0.659],[0.786],[0.674],[0.637],[0.908],[0.819],[0.743],[0.783],[0.772],0.407,0.518,0.609,0.17,0.181,0.152,0.733,0.629,0.579,0.659,0.786,0.674,0.637,0.908,0.819,0.743,0.783,0.772
https://doi.org/10.1016/j.ajog.2012.08.033,noninvasive prenatal testing for fetal trisomies in a routinely screened firsttrimester population,7503_noninvasive prenatal testing for fetal trisomies in a routinely screened firsttrimester population.pdf,3,"['https://www.hca.wa.gov/assets/program/cfdna-draft-key-qs-comment-response-complete-v2-20190826.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486016/pdf', 'https://www.acmg.net/PDFLibrary/Fetal-Aneuploidy-Noninvasive-Prenatal-Screening.pdf']","['Cell-free DNA Prenatal Screening for Chromosomal Aneuploidies', 'Genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women', 'ACMG statement on noninvasive prenatal screening for fetal aneuploidy']","['https://www.acmg.net/PDFLibrary/Fetal-Aneuploidy-Noninvasive-Prenatal-Screening.pdf', 'https://www.hca.wa.gov/assets/program/cfdna-draft-key-qs-comment-response-complete-v2-20190826.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486016/pdf']","['7503_2_acmg statement on noninvasive prenatal screening for fetal aneuploidy.pdf', '7503_0_cellfree dna prenatal screening for chromosomal aneuploidies.pdf', '7503_1_genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.pdf']",3,100.0,"['https://www.acmg.net/PDFLibrary/Fetal-Aneuploidy-Noninvasive-Prenatal-Screening.pdf', 'https://www.hca.wa.gov/assets/program/cfdna-draft-key-qs-comment-response-complete-v2-20190826.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486016/pdf']","['7503_2_acmg statement on noninvasive prenatal screening for fetal aneuploidy.pdf', '7503_0_cellfree dna prenatal screening for chromosomal aneuploidies.pdf', '7503_1_genomics‐based non‐invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.pdf']","[0.68, 0.407, 0.466]","[0.566, 0.54, 0.526]","[0.641, 0.617, 0.604]","[0.203, 0.184, 0.171]","[0.237, 0.214, 0.183]","[0.186, 0.169, 0.15]","[0.751, 0.746, 0.74]","[0.66, 0.657, 0.648]","[0.639, 0.607, 0.597]","[0.671, 0.676, 0.677]","[0.809, 0.797, 0.781]","[0.725, 0.693, 0.68]","[0.653, 0.642, 0.626]","[0.907, 0.902, 0.9]","[0.838, 0.816, 0.817]","[0.776, 0.749, 0.731]","[0.81, 0.795, 0.784]","[0.791, 0.775, 0.757]",0.518,0.544,0.621,0.186,0.211,0.168,0.746,0.655,0.614,0.675,0.796,0.699,0.64,0.903,0.824,0.752,0.796,0.774
https://doi.org/10.1016/j.ajog.2019.01.223,maternal and newborn outcomes with elective induction of labor at term,7518_maternal and newborn outcomes with elective induction of labor at term.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf'],"[""Induction of labour at or beyond 37 weeks' gestation""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf'],['7518_0_induction of labour at or beyond 37 weeks gestation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf'],['7518_0_induction of labour at or beyond 37 weeks gestation.pdf'],[0.499],[0.513],[0.597],[0.178],[0.188],[0.156],[0.739],[0.646],[0.57],[0.671],[0.762],[0.685],[0.584],[0.9],[0.786],[0.713],[0.755],[0.742],0.499,0.513,0.597,0.178,0.188,0.156,0.739,0.646,0.57,0.671,0.762,0.685,0.584,0.9,0.786,0.713,0.755,0.742
https://doi.org/10.1016/j.ajog.2019.03.003,effect of antenatal dietary interventions in maternal obesity on pregnancy weightgain and birthweight healthy mums and babies humba randomized trial,7519_effect of antenatal dietary interventions in maternal obesity on pregnancy weightgain and birthweight healthy mums and babies humba randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['Probiotics for preventing gestational diabetes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['7519_0_probiotics for preventing gestational diabetes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['7519_0_probiotics for preventing gestational diabetes.pdf'],[0.525],[0.501],[0.591],[0.167],[0.156],[0.136],[0.738],[0.643],[0.561],[0.698],[0.761],[0.673],[0.576],[0.896],[0.777],[0.707],[0.755],[0.733],0.525,0.501,0.591,0.167,0.156,0.136,0.738,0.643,0.561,0.698,0.761,0.673,0.576,0.896,0.777,0.707,0.755,0.733
https://doi.org/10.1016/j.ajog.2019.05.019,the continuing burden of rh disease 50 years after the introduction of antirhd immunoglobin prophylaxis call to action,7520_the continuing burden of rh disease 50 years after the introduction of antirhd immunoglobin prophylaxis call to action.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700/pdf'],['FIGO/ICM guidelines for preventing Rhesus disease: A call to action'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700/pdf'],['7520_0_figoicm guidelines for preventing rhesus disease a call to action.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700/pdf'],['7520_0_figoicm guidelines for preventing rhesus disease a call to action.pdf'],[0.632],[0.581],[0.662],[0.246],[0.243],[0.191],[0.745],[0.652],[0.642],[0.643],[0.826],[0.753],[0.66],[0.909],[0.836],[0.784],[0.815],[0.809],0.632,0.581,0.662,0.246,0.243,0.191,0.745,0.652,0.642,0.643,0.826,0.753,0.66,0.909,0.836,0.784,0.815,0.809
https://doi.org/10.1016/j.ajog.2020.02.017,coronavirus disease 2019 covid19 and pregnancy what obstetricians need to know,7521_coronavirus disease 2019 covid19 and pregnancy what obstetricians need to know.pdf,10,"['https://stacks.cdc.gov/view/cdc/91103', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212945/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820999/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849424/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665491/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151284/pdf']","['Overview of COVID-19 disease', 'Post-natal follow-up for women and neonates during the COVID-19 pandemic: French National Authority for Health recommendations', 'COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review', 'Recomendaciones y manejo práctico de la gestante con COVID-19:', 'Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement', 'Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce', 'Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients', 'Adapting obstetric and neonatal services during the COVID-19 pandemic: a scoping review', 'The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic', 'Thoracic Anesthesia of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection: Preliminary Recommendations for Airway Management by the European Association of Cardiothoracic Anaesthesiology Thoracic Subspecialty Committee']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820999/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665491/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212945/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849424/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf']","['7521_5_clinical care of pregnant and postpartum women with covid‐19 living recommendations from the national covid‐19 clinical evidence taskforce.pdf', '7521_4_update on the management of multiple sclerosis during the covid19 pandemic and post pandemic an international consensus statement.pdf', '7521_8_the calm after the storm restarting art treatments safely in the wake of the covid19 pandemic.pdf', '7521_1_postnatal followup for women and neonates during the covid19 pandemic french national authority for health recommendations.pdf', '7521_3_recomendaciones y manejo práctico de la gestante con covid19.pdf', '7521_7_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf', '7521_6_professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.pdf', '7521_2_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf']",8,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820999/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665491/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212945/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231730/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849424/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf']","['7521_5_clinical care of pregnant and postpartum women with covid‐19 living recommendations from the national covid‐19 clinical evidence taskforce.pdf', '7521_4_update on the management of multiple sclerosis during the covid19 pandemic and post pandemic an international consensus statement.pdf', '7521_8_the calm after the storm restarting art treatments safely in the wake of the covid19 pandemic.pdf', '7521_1_postnatal followup for women and neonates during the covid19 pandemic french national authority for health recommendations.pdf', '7521_3_recomendaciones y manejo práctico de la gestante con covid19.pdf', '7521_7_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf', '7521_6_professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.pdf', '7521_2_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf']","[0.354, 0.621, 0.094, 0.443, 0.48, 0.499, 0.509, 0.49]","[0.583, 0.515, 0.574, 0.567, 0.465, 0.555, 0.594, 0.524]","[0.65, 0.603, 0.647, 0.644, 0.567, 0.63, 0.662, 0.61]","[0.199, 0.144, 0.188, 0.187, 0.161, 0.184, 0.216, 0.169]","[0.215, 0.147, 0.203, 0.204, 0.199, 0.203, 0.23, 0.185]","[0.16, 0.116, 0.156, 0.16, 0.145, 0.156, 0.188, 0.146]","[0.741, 0.733, 0.739, 0.74, 0.734, 0.741, 0.744, 0.737]","[0.652, 0.641, 0.648, 0.648, 0.648, 0.65, 0.654, 0.647]","[0.652, 0.578, 0.646, 0.638, 0.544, 0.621, 0.665, 0.586]","[0.624, 0.617, 0.62, 0.618, 0.619, 0.626, 0.626, 0.632]","[0.823, 0.792, 0.818, 0.82, 0.797, 0.812, 0.83, 0.794]","[0.771, 0.702, 0.758, 0.75, 0.696, 0.745, 0.778, 0.706]","[0.638, 0.62, 0.649, 0.636, 0.579, 0.626, 0.648, 0.617]","[0.931, 0.912, 0.926, 0.925, 0.881, 0.918, 0.928, 0.91]","[0.842, 0.807, 0.839, 0.839, 0.805, 0.835, 0.848, 0.807]","[0.789, 0.75, 0.789, 0.783, 0.72, 0.778, 0.799, 0.748]","[0.829, 0.789, 0.823, 0.82, 0.766, 0.814, 0.833, 0.79]","[0.811, 0.776, 0.805, 0.804, 0.742, 0.801, 0.816, 0.776]",0.436,0.547,0.627,0.181,0.198,0.153,0.739,0.649,0.616,0.623,0.811,0.738,0.627,0.916,0.828,0.77,0.808,0.791
https://doi.org/10.1016/j.ajog.2021.03.023,coronavirus disease 2019 vaccine response in pregnant and lactating women a cohort study,7524_coronavirus disease 2019 vaccine response in pregnant and lactating women a cohort study.pdf,7,"['https://stacks.cdc.gov/view/cdc/113922', 'https://stacks.cdc.gov/view/cdc/110583', 'https://stacks.cdc.gov/view/cdc/115012', 'https://stacks.cdc.gov/view/cdc/118109', 'https://stacks.cdc.gov/view/cdc/117410', 'https://stacks.cdc.gov/view/cdc/119137', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['COVID-19 vaccines while pregnant or breastfeeding', 'How to increase COVID-19 vaccination upon discharge from hospitals, emergency departments & urgent care facilities', 'COVID-19 vaccines while pregnant or breastfeeding', 'COVID-19 vaccines while pregnant or breastfeeding', 'COVID-19 vaccines while pregnant or breastfeeding', 'COVID-19 vaccines while pregnant or breastfeeding', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines']",['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['7524_6_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,14.29,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['7524_6_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.303],[0.542],[0.615],[0.158],[0.157],[0.12],[0.739],[0.646],[0.601],[0.62],[0.786],[0.701],[0.601],[0.899],[0.795],[0.755],[0.788],[0.775],0.303,0.542,0.615,0.158,0.157,0.12,0.739,0.646,0.601,0.62,0.786,0.701,0.601,0.899,0.795,0.755,0.788,0.775
https://doi.org/10.1016/j.amepre.2019.07.024,shortterm impact of a flavored tobacco restriction changes in youth tobacco use in a massachusetts community,7666_shortterm impact of a flavored tobacco restriction changes in youth tobacco use in a massachusetts community.pdf,4,"['https://www.federalregister.gov/documents/2022/05/04/2022-08994/tobacco-product-standard-for-menthol-in-cigarettes', 'https://www.federalregister.gov/documents/2022/05/04/2022-08993/tobacco-product-standard-for-characterizing-flavors-in-cigars', 'https://www.in.gov/health/tpc/files/2025-IN-Tobacco-Control-Strategic-Plan.pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/Policy/FlavoredTobaccoAndMenthol/ChallengesinEnforcing_LocalFlavoredTobaccoRestrictions.pdf']","['Tobacco Product Standard for Menthol in Cigarettes', 'Tobacco Product Standard for Characterizing Flavors in Cigars', '2025 Strategic Plan', 'Challenges in Enforcing Local Flavored Tobacco Restrictions']","['https://www.in.gov/health/tpc/files/2025-IN-Tobacco-Control-Strategic-Plan.pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/Policy/FlavoredTobaccoAndMenthol/ChallengesinEnforcing_LocalFlavoredTobaccoRestrictions.pdf']","['7666_2_2025 strategic plan.pdf', '7666_3_challenges in enforcing local flavored tobacco restrictions.pdf']",2,50.0,"['https://www.in.gov/health/tpc/files/2025-IN-Tobacco-Control-Strategic-Plan.pdf', 'https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/Policy/FlavoredTobaccoAndMenthol/ChallengesinEnforcing_LocalFlavoredTobaccoRestrictions.pdf']","['7666_2_2025 strategic plan.pdf', '7666_3_challenges in enforcing local flavored tobacco restrictions.pdf']","[0.562, 0.661]","[0.538, 0.523]","[0.626, 0.606]","[0.209, 0.19]","[0.235, 0.208]","[0.192, 0.183]","[0.74, 0.735]","[0.637, 0.637]","[0.607, 0.586]","[0.677, 0.678]","[0.803, 0.792]","[0.732, 0.72]","[0.639, 0.642]","[0.924, 0.915]","[0.825, 0.821]","[0.768, 0.757]","[0.81, 0.793]","[0.786, 0.776]",0.612,0.53,0.616,0.2,0.221,0.188,0.738,0.637,0.597,0.677,0.798,0.726,0.641,0.919,0.823,0.762,0.802,0.781
https://doi.org/10.1016/j.amepre.2019.10.005,active children through individual vouchers evaluation a mixedmethod rct,7669_active children through individual vouchers evaluation a mixedmethod rct.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['7669_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['7669_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.508],[0.519],[0.605],[0.18],[0.189],[0.147],[0.737],[0.641],[0.59],[0.705],[0.786],[0.699],[0.588],[0.918],[0.822],[0.738],[0.788],[0.772],0.508,0.519,0.605,0.18,0.189,0.147,0.737,0.641,0.59,0.705,0.786,0.699,0.588,0.918,0.822,0.738,0.788,0.772
https://doi.org/10.1016/j.amepre.2019.12.024,impact of the centers for disease control and prevention recommendation and state law on birth cohort hepatitis c screening of new york city medicaid recipients,7671_impact of the centers for disease control and prevention recommendation and state law on birth cohort hepatitis c screening of new york city medicaid recipients.pdf,1,['https://www.dhs.wisconsin.gov/publications/p00440-2019.pdf'],['Hepatitis C in Wisconsin -- Wisconsin Hepatitis C Virus Surveillance Annual Review 2019'],['https://www.dhs.wisconsin.gov/publications/p00440-2019.pdf'],['7671_0_hepatitis c in wisconsin  wisconsin hepatitis c virus surveillance annual review 2019.pdf'],1,100.0,['https://www.dhs.wisconsin.gov/publications/p00440-2019.pdf'],['7671_0_hepatitis c in wisconsin  wisconsin hepatitis c virus surveillance annual review 2019.pdf'],[0.361],[0.536],[0.628],[0.195],[0.206],[0.178],[0.738],[0.644],[0.599],[0.685],[0.792],[0.719],[0.651],[0.92],[0.834],[0.752],[0.797],[0.775],0.361,0.536,0.628,0.195,0.206,0.178,0.738,0.644,0.599,0.685,0.792,0.719,0.651,0.92,0.834,0.752,0.797,0.775
https://doi.org/10.1016/j.amj.2018.10.002,uncuffed endotracheal tubes not appropriate for pediatric critical care transport,7674_uncuffed endotracheal tubes not appropriate for pediatric critical care transport.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786207/pdf'],['Cuffed versus uncuffed endotracheal tubes for neonates'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786207/pdf'],['7674_0_cuffed versus uncuffed endotracheal tubes for neonates.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786207/pdf'],['7674_0_cuffed versus uncuffed endotracheal tubes for neonates.pdf'],[0.366],[0.537],[0.619],[0.198],[0.196],[0.157],[0.739],[0.646],[0.594],[0.649],[0.785],[0.719],[0.614],[0.907],[0.804],[0.739],[0.783],[0.761],0.366,0.537,0.619,0.198,0.196,0.157,0.739,0.646,0.594,0.649,0.785,0.719,0.614,0.907,0.804,0.739,0.783,0.761
https://doi.org/10.1016/j.amjms.2021.01.007,policy interventions social distancing and sarscov2 transmission in the united states a retrospective statelevel analysis,7685_policy interventions social distancing and sarscov2 transmission in the united states a retrospective statelevel analysis.pdf,2,"['https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['7685_1_master question list for covid19 caused by sarscov2.pdf', '7685_0_master question list for covid19 caused by sarscov2.pdf']",2,100.0,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf'],['7685_1_master question list for covid19 caused by sarscov2.pdf'],[0.318],[0.495],[0.595],[0.13],[0.123],[0.103],[0.729],[0.639],[0.56],[0.663],[0.775],[0.706],[0.626],[0.893],[0.797],[0.708],[0.775],[0.731],0.318,0.495,0.595,0.13,0.123,0.103,0.729,0.639,0.56,0.663,0.775,0.706,0.626,0.893,0.797,0.708,0.775,0.731
https://doi.org/10.1016/j.annepidem.2011.06.001,adolescent marijuana use from 2002 to 2008 higher in states with medical marijuana laws cause still unclear,7715_adolescent marijuana use from 2002 to 2008 higher in states with medical marijuana laws cause still unclear.pdf,5,"['https://www.dmv.ca.gov/portal/file/changes-in-driver-cannabinoid-prevalence-associated-with-implementing-medical-marijuana-laws-in-14-u-s-states/', 'https://www.nber.org/papers/w20085?sy=085', 'https://www.nber.org/papers/w20332?sy=332', 'http://jchc.virginia.gov/4.%20Cannabis%20Study.pdf', 'https://www.rand.org/pubs/rgs_dissertations/RGSD424.html']","['Changes in Driver Cannabinoid Prevalence Associated with Implementing Medical Marijuana Law in 14 U.S. States', 'The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use', 'Medical Marijuana Laws and Teen Marijuana Use', 'ADHD prevalence and Risks of ADHD Medications in Virginia', 'The Criminal Justice System and More Lenient Drug Policy']","['https://www.dmv.ca.gov/portal/file/changes-in-driver-cannabinoid-prevalence-associated-with-implementing-medical-marijuana-laws-in-14-u-s-states/', 'http://jchc.virginia.gov/4.%20Cannabis%20Study.pdf']","['7715_0_changes in driver cannabinoid prevalence associated with implementing medical marijuana law in 14 us states.pdf', '7715_3_adhd prevalence and risks of adhd medications in virginia.pdf']",2,40.0,"['https://www.dmv.ca.gov/portal/file/changes-in-driver-cannabinoid-prevalence-associated-with-implementing-medical-marijuana-laws-in-14-u-s-states/', 'http://jchc.virginia.gov/4.%20Cannabis%20Study.pdf']","['7715_0_changes in driver cannabinoid prevalence associated with implementing medical marijuana law in 14 us states.pdf', '7715_3_adhd prevalence and risks of adhd medications in virginia.pdf']","[0.407, 0.565]","[0.515, 0.499]","[0.607, 0.596]","[0.192, 0.188]","[0.223, 0.216]","[0.182, 0.178]","[0.745, 0.746]","[0.653, 0.659]","[0.57, 0.553]","[0.694, 0.692]","[0.783, 0.783]","[0.694, 0.683]","[0.622, 0.603]","[0.914, 0.909]","[0.811, 0.798]","[0.74, 0.732]","[0.776, 0.765]","[0.768, 0.764]",0.486,0.507,0.601,0.19,0.22,0.18,0.746,0.656,0.561,0.693,0.783,0.689,0.613,0.911,0.804,0.736,0.77,0.766
https://doi.org/10.1016/j.apnr.2018.10.007,hf app to support selfcare among community dwelling adults with hf a feasibility study,7755_hf app to support selfcare among community dwelling adults with hf a feasibility study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390434/pdf'],['mHealth education interventions in heart failure'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390434/pdf'],['7755_0_mhealth education interventions in heart failure.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390434/pdf'],['7755_0_mhealth education interventions in heart failure.pdf'],[0.554],[0.545],[0.63],[0.185],[0.203],[0.165],[0.74],[0.646],[0.603],[0.707],[0.793],[0.723],[0.608],[0.925],[0.828],[0.751],[0.795],[0.779],0.554,0.545,0.63,0.185,0.203,0.165,0.74,0.646,0.603,0.707,0.793,0.723,0.608,0.925,0.828,0.751,0.795,0.779
https://doi.org/10.1016/j.appdev.2020.101218,adverse childhood experiences and childrens development in early care and education programs,7800_adverse childhood experiences and childrens development in early care and education programs.pdf,3,"['https://mathematica.org/publications/education-to-workforce-indicator-framework-using-data-to-promote-equity-and-economic-security', 'https://www.newamerica.org/education-policy/reports/reducing-exclusionary-discipline-practices-in-early-childhood-education/', 'https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf']","['Education-to-Workforce Indicator Framework: Using Data to Promote Equity and Economic Security for All', 'Reducing Exclusionary Discipline Practices in Early Childhood Education', 'Supporting Child and Student Social, Emotional, Behavioral, and Mental Health Needs (PDF)']",['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['7800_2_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],1,33.33,['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['7800_2_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],[0.391],[0.534],[0.629],[0.173],[0.191],[0.157],[0.735],[0.642],[0.597],[0.676],[0.796],[0.728],[0.625],[0.922],[0.825],[0.768],[0.8],[0.785],0.391,0.534,0.629,0.173,0.191,0.157,0.735,0.642,0.597,0.676,0.796,0.728,0.625,0.922,0.825,0.768,0.8,0.785
https://doi.org/10.1016/j.appet.2014.03.030,involving children in meal preparation effects on food intake,7819_involving children in meal preparation effects on food intake.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930971/pdf'],['Meal planning values impacted by the cancer experience in families with school-aged survivors- a qualitative exploration and recommendations for intervention development'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930971/pdf'],['7819_0_meal planning values impacted by the cancer experience in families with schoolaged survivors a qualitative exploration and recommendations for intervention development.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930971/pdf'],['7819_0_meal planning values impacted by the cancer experience in families with schoolaged survivors a qualitative exploration and recommendations for intervention development.pdf'],[0.435],[0.498],[0.598],[0.158],[0.181],[0.162],[0.735],[0.638],[0.557],[0.688],[0.755],[0.668],[0.599],[0.906],[0.794],[0.722],[0.755],[0.747],0.435,0.498,0.598,0.158,0.181,0.162,0.735,0.638,0.557,0.688,0.755,0.668,0.599,0.906,0.794,0.722,0.755,0.747
https://doi.org/10.1016/j.appet.2018.05.215,effects of congruent and incongruent experiential learning on intake of a novel vegetable in preschool children a cluster randomized trial,7839_effects of congruent and incongruent experiential learning on intake of a novel vegetable in preschool children a cluster randomized trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['7839_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '7839_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['7839_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '7839_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.316, 0.317]","[0.557, 0.555]","[0.65, 0.647]","[0.18, 0.179]","[0.187, 0.186]","[0.166, 0.165]","[0.734, 0.734]","[0.633, 0.632]","[0.628, 0.625]","[0.673, 0.673]","[0.802, 0.801]","[0.736, 0.73]","[0.617, 0.616]","[0.929, 0.928]","[0.85, 0.847]","[0.756, 0.755]","[0.811, 0.809]","[0.788, 0.786]",0.317,0.556,0.649,0.179,0.186,0.166,0.734,0.633,0.627,0.673,0.802,0.733,0.617,0.929,0.849,0.756,0.81,0.787
https://doi.org/10.1016/j.aquatox.2018.10.019,constant exposure to environmental concentrations of the antifouling biocide seanine retards growth and reduces acetylcholinesterase activity in a marine mysid,7883_constant exposure to environmental concentrations of the antifouling biocide seanine retards growth and reduces acetylcholinesterase activity in a marine mysid.pdf,1,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['Antifouling Paints in Washington State Report and Recommendations'],['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['7883_0_antifouling paints in washington state report and recommendations.pdf'],1,100.0,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['7883_0_antifouling paints in washington state report and recommendations.pdf'],[0.216],[0.476],[0.566],[0.112],[0.11],[0.1],[0.733],[0.64],[0.547],[0.676],[0.774],[0.652],[0.611],[0.908],[0.794],[0.73],[0.772],[0.765],0.216,0.476,0.566,0.112,0.11,0.1,0.733,0.64,0.547,0.676,0.774,0.652,0.611,0.908,0.794,0.73,0.772,0.765
https://doi.org/10.1016/j.aquatox.2019.105231,an urban stormwater runoff mortality syndrome in juvenile coho salmon,7884_an urban stormwater runoff mortality syndrome in juvenile coho salmon.pdf,1,['https://wsdot.wa.gov/sites/default/files/2021-11/I405-SR522-SR527-EA-AppendixI-Ecosystems.pdf'],"['I-405, SR 522 Vicinity to SR 527 Express Toll Lanes Improvement Project Environmental Assessment, Appendix I, Ecosystems Discipline Report']",['https://wsdot.wa.gov/sites/default/files/2021-11/I405-SR522-SR527-EA-AppendixI-Ecosystems.pdf'],['7884_0_i405 sr 522 vicinity to sr 527 express toll lanes improvement project environmental assessment appendix i ecosystems discipline report.pdf'],1,100.0,['https://wsdot.wa.gov/sites/default/files/2021-11/I405-SR522-SR527-EA-AppendixI-Ecosystems.pdf'],['7884_0_i405 sr 522 vicinity to sr 527 express toll lanes improvement project environmental assessment appendix i ecosystems discipline report.pdf'],[0.183],[0.492],[0.574],[0.123],[0.114],[0.103],[0.723],[0.627],[0.555],[0.656],[0.782],[0.698],[0.643],[0.91],[0.805],[0.748],[0.788],[0.772],0.183,0.492,0.574,0.123,0.114,0.103,0.723,0.627,0.555,0.656,0.782,0.698,0.643,0.91,0.805,0.748,0.788,0.772
https://doi.org/10.1016/j.atmosenv.2019.06.047,experimental measurements of black carbon emission factors to estimate the global impact of uncontrolled burning of waste,7922_experimental measurements of black carbon emission factors to estimate the global impact of uncontrolled burning of waste.pdf,1,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8mie6esklg_Crimes_that_Affect_the_Environment_and_Climate_Change.pdf'],['Crimes that Affect the Environment and Climate Change'],['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8mie6esklg_Crimes_that_Affect_the_Environment_and_Climate_Change.pdf'],['7922_0_crimes that affect the environment and climate change.pdf'],1,100.0,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8mie6esklg_Crimes_that_Affect_the_Environment_and_Climate_Change.pdf'],['7922_0_crimes that affect the environment and climate change.pdf'],[0.182],[0.479],[0.586],[0.116],[0.107],[0.094],[0.724],[0.627],[0.55],[0.653],[0.779],[0.685],[0.623],[0.904],[0.802],[0.743],[0.782],[0.767],0.182,0.479,0.586,0.116,0.107,0.094,0.724,0.627,0.55,0.653,0.779,0.685,0.623,0.904,0.802,0.743,0.782,0.767
https://doi.org/10.1016/j.bbadis.2020.165821,interplay between hormones and exercise on hippocampal plasticity across the lifespan,7954_interplay between hormones and exercise on hippocampal plasticity across the lifespan.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802999/pdf'],['Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802999/pdf'],['7954_0_exercisephysical activity in individuals with type 2 diabetes a consensus statement from the american college of sports medicine.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802999/pdf'],['7954_0_exercisephysical activity in individuals with type 2 diabetes a consensus statement from the american college of sports medicine.pdf'],[0.319],[0.471],[0.575],[0.138],[0.127],[0.118],[0.744],[0.652],[0.543],[0.688],[0.762],[0.633],[0.574],[0.891],[0.772],[0.701],[0.761],[0.751],0.319,0.471,0.575,0.138,0.127,0.118,0.744,0.652,0.543,0.688,0.762,0.633,0.574,0.891,0.772,0.701,0.761,0.751
https://doi.org/10.1016/j.bbi.2020.03.028,impact on mental health and perceptions of psychological care among medical and nursing staff in wuhan during the 2019 novel coronavirus disease outbreak a crosssectional study,7962_impact on mental health and perceptions of psychological care among medical and nursing staff in wuhan during the 2019 novel coronavirus disease outbreak a crosssectional study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435262/pdf'],['Mental health care of health workers during Covid-19: Recommendations based on evidence and expert consensus'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435262/pdf'],['7962_0_mental health care of health workers during covid19 recommendations based on evidence and expert consensus.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435262/pdf'],['7962_0_mental health care of health workers during covid19 recommendations based on evidence and expert consensus.pdf'],[0.494],[0.488],[0.593],[0.158],[0.184],[0.149],[0.739],[0.654],[0.543],[0.693],[0.765],[0.664],[0.603],[0.905],[0.794],[0.725],[0.756],[0.743],0.494,0.488,0.593,0.158,0.184,0.149,0.739,0.654,0.543,0.693,0.765,0.664,0.603,0.905,0.794,0.725,0.756,0.743
https://doi.org/10.1016/j.biocon.2020.108409,broadscale impacts of an invasive native predator on a sensitive native prey species within the shifting avian community of the north american great basin,8031_broadscale impacts of an invasive native predator on a sensitive native prey species within the shifting avian community of the north american great basin.pdf,1,['https://wdfw.wa.gov/sites/default/files/publications/02210/draft_wdfw02210.pdf'],['DRAFT Periodic Status Review for the Ferruginous Hawk'],['https://wdfw.wa.gov/sites/default/files/publications/02210/draft_wdfw02210.pdf'],['8031_0_draft periodic status review for the ferruginous hawk.pdf'],1,100.0,['https://wdfw.wa.gov/sites/default/files/publications/02210/draft_wdfw02210.pdf'],['8031_0_draft periodic status review for the ferruginous hawk.pdf'],[0.365],[0.48],[0.572],[0.136],[0.138],[0.117],[0.734],[0.642],[0.535],[0.691],[0.77],[0.651],[0.618],[0.9],[0.783],[0.734],[0.768],[0.76],0.365,0.48,0.572,0.136,0.138,0.117,0.734,0.642,0.535,0.691,0.77,0.651,0.618,0.9,0.783,0.734,0.768,0.76
https://doi.org/10.1016/j.bjid.2019.07.004,hivinfected youths transitioning from pediatric to adult outpatient care in a teaching tertiary care hospital in são paulo city brazil,8066_hivinfected youths transitioning from pediatric to adult outpatient care in a teaching tertiary care hospital in são paulo city brazil.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['8066_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['8066_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.388],[0.554],[0.633],[0.19],[0.189],[0.165],[0.744],[0.652],[0.618],[0.667],[0.8],[0.732],[0.596],[0.928],[0.838],[0.753],[0.796],[0.777],0.388,0.554,0.633,0.19,0.189,0.165,0.744,0.652,0.618,0.667,0.8,0.732,0.596,0.928,0.838,0.753,0.796,0.777
https://doi.org/10.1016/j.bone.2020.115648,bone health in young adult survivors born extremely preterm or extremely low birthweight in the post surfactant era,8082_bone health in young adult survivors born extremely preterm or extremely low birthweight in the post surfactant era.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146348/pdf'],['Update on Calcium and Phosphorus Requirements of Preterm Infants and Recommendations for Enteral Mineral Intake'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146348/pdf'],['8082_0_update on calcium and phosphorus requirements of preterm infants and recommendations for enteral mineral intake.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146348/pdf'],['8082_0_update on calcium and phosphorus requirements of preterm infants and recommendations for enteral mineral intake.pdf'],[0.336],[0.491],[0.586],[0.144],[0.138],[0.13],[0.738],[0.646],[0.557],[0.69],[0.772],[0.662],[0.609],[0.909],[0.787],[0.732],[0.767],[0.756],0.336,0.491,0.586,0.144,0.138,0.13,0.738,0.646,0.557,0.69,0.772,0.662,0.609,0.909,0.787,0.732,0.767,0.756
https://doi.org/10.1016/j.brat.2019.103466,tasksharing of psychological treatment for antenatal depression in khayelitsha south africa effects on antenatal and postnatal outcomes in an individual randomised controlled trial,8154_tasksharing of psychological treatment for antenatal depression in khayelitsha south africa effects on antenatal and postnatal outcomes in an individual randomised controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.nber.org/papers/w28106']","['Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries', 'The Comparative Impact of Cash Transfers and a Psychotherapy Program on Psychological and Economic Well-being']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['8154_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['8154_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf'],[0.618],[0.515],[0.603],[0.157],[0.165],[0.139],[0.733],[0.64],[0.569],[0.708],[0.77],[0.692],[0.589],[0.911],[0.806],[0.722],[0.773],[0.749],0.618,0.515,0.603,0.157,0.165,0.139,0.733,0.64,0.569,0.708,0.77,0.692,0.589,0.911,0.806,0.722,0.773,0.749
https://doi.org/10.1016/j.burns.2017.07.018,use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury a retrospective chart review,8166_use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury a retrospective chart review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703676/pdf'],"['American Burn Association Guidelines on the Management of Acute Pain in the Adult Burn Patient: A Review of the Literature, a Compilation of Expert Opinion, and Next Steps']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703676/pdf'],['8166_0_american burn association guidelines on the management of acute pain in the adult burn patient a review of the literature a compilation of expert opinion and next steps.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703676/pdf'],['8166_0_american burn association guidelines on the management of acute pain in the adult burn patient a review of the literature a compilation of expert opinion and next steps.pdf'],[0.325],[0.53],[0.601],[0.162],[0.174],[0.149],[0.733],[0.643],[0.597],[0.659],[0.797],[0.711],[0.625],[0.935],[0.824],[0.762],[0.794],[0.786],0.325,0.53,0.601,0.162,0.174,0.149,0.733,0.643,0.597,0.659,0.797,0.711,0.625,0.935,0.824,0.762,0.794,0.786
https://doi.org/10.1016/j.cbd.2019.01.010,pacific geoduck panopea generosa resilience to natural ph variation,8181_pacific geoduck panopea generosa resilience to natural ph variation.pdf,3,"['https://www.dnr.wa.gov/publications/aqr_resv_fb_mgmt_plan_0619.pdf', 'https://www.dnr.wa.gov/publications/aqr_resv_fb_draft_mgmt_plan_0619.pdf', 'https://www.dnr.wa.gov/publications/em_climaterresilienceplan_feb2020.pdf']","['Fidalgo Bay Aquatic Reserve Management Plan', 'Fidalgo Bay Aquatic Reserve Management Plan', 'Dnr ’ S Plan For Climate Resilience']","['https://www.dnr.wa.gov/publications/aqr_resv_fb_mgmt_plan_0619.pdf', 'https://www.dnr.wa.gov/publications/aqr_resv_fb_draft_mgmt_plan_0619.pdf', 'https://www.dnr.wa.gov/publications/em_climaterresilienceplan_feb2020.pdf']","['8181_0_fidalgo bay aquatic reserve management plan.pdf', '8181_1_fidalgo bay aquatic reserve management plan.pdf', '8181_2_dnr  s plan for climate resilience.pdf']",3,100.0,"['https://www.dnr.wa.gov/publications/aqr_resv_fb_mgmt_plan_0619.pdf', 'https://www.dnr.wa.gov/publications/aqr_resv_fb_draft_mgmt_plan_0619.pdf', 'https://www.dnr.wa.gov/publications/em_climaterresilienceplan_feb2020.pdf']","['8181_0_fidalgo bay aquatic reserve management plan.pdf', '8181_1_fidalgo bay aquatic reserve management plan.pdf', '8181_2_dnr  s plan for climate resilience.pdf']","[0.28, 0.276, 0.218]","[0.471, 0.471, 0.47]","[0.57, 0.57, 0.573]","[0.109, 0.109, 0.092]","[0.104, 0.104, 0.08]","[0.088, 0.088, 0.076]","[0.724, 0.724, 0.721]","[0.633, 0.633, 0.627]","[0.537, 0.537, 0.536]","[0.643, 0.643, 0.642]","[0.784, 0.784, 0.781]","[0.681, 0.682, 0.674]","[0.629, 0.629, 0.612]","[0.903, 0.903, 0.91]","[0.794, 0.794, 0.788]","[0.741, 0.742, 0.732]","[0.782, 0.783, 0.777]","[0.77, 0.77, 0.763]",0.258,0.471,0.571,0.103,0.096,0.084,0.723,0.631,0.537,0.643,0.783,0.679,0.623,0.905,0.792,0.738,0.781,0.768
https://doi.org/10.1016/j.cca.2019.03.1519,reducing the viral load and early infant diagnosis results’ turnaround time in northwestern province zambia,8203_reducing the viral load and early infant diagnosis results’ turnaround time in northwestern province zambia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['8203_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['8203_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],[0.247],[0.539],[0.608],[0.158],[0.152],[0.119],[0.732],[0.635],[0.608],[0.645],[0.793],[0.729],[0.629],[0.914],[0.835],[0.749],[0.803],[0.771],0.247,0.539,0.608,0.158,0.152,0.119,0.732,0.635,0.608,0.645,0.793,0.729,0.629,0.914,0.835,0.749,0.803,0.771
https://doi.org/10.1016/j.ccell.2018.09.010,actionable activating oncogenic erbb2her2 transmembrane and juxtamembrane domain mutations,8206_actionable activating oncogenic erbb2her2 transmembrane and juxtamembrane domain mutations.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260262/pdf'],['Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260262/pdf'],['8206_0_updated guidelines for predictive biomarker testing in advanced nonsmallcell lung cancer a national consensus of the spanish society of pathology and the spanish society of medical oncology.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260262/pdf'],['8206_0_updated guidelines for predictive biomarker testing in advanced nonsmallcell lung cancer a national consensus of the spanish society of pathology and the spanish society of medical oncology.pdf'],[0.508],[0.496],[0.59],[0.136],[0.136],[0.112],[0.74],[0.653],[0.568],[0.665],[0.786],[0.694],[0.603],[0.903],[0.802],[0.732],[0.78],[0.764],0.508,0.496,0.59,0.136,0.136,0.112,0.74,0.653,0.568,0.665,0.786,0.694,0.603,0.903,0.802,0.732,0.78,0.764
https://doi.org/10.1016/j.ccell.2021.06.014,highly variable sarscov2 spike antibody responses to two doses of covid19 rna vaccination in patients with multiple myeloma,8207_highly variable sarscov2 spike antibody responses to two doses of covid19 rna vaccination in patients with multiple myeloma.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/pdf', 'https://stacks.cdc.gov/view/cdc/107873']","['COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network', 'COVID-19 science update ; Edition 2021-07-09 (97)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/pdf'],['8207_0_covid19 vaccination in patients with multiple myeloma a consensus of the european myeloma network.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/pdf'],['8207_0_covid19 vaccination in patients with multiple myeloma a consensus of the european myeloma network.pdf'],[0.584],[0.529],[0.615],[0.196],[0.201],[0.161],[0.749],[0.66],[0.592],[0.669],[0.8],[0.708],[0.624],[0.914],[0.816],[0.755],[0.796],[0.781],0.584,0.529,0.615,0.196,0.201,0.161,0.749,0.66,0.592,0.669,0.8,0.708,0.624,0.914,0.816,0.755,0.796,0.781
https://doi.org/10.1016/j.cct.2018.02.010,design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus hpv vaccine,8236_design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus hpv vaccine.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf'],['Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf'],['8236_0_comparison of different human papillomavirus hpv vaccine types and dose schedules for prevention of hpv‐related disease in females and males.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf'],['8236_0_comparison of different human papillomavirus hpv vaccine types and dose schedules for prevention of hpv‐related disease in females and males.pdf'],[0.388],[0.522],[0.609],[0.17],[0.178],[0.148],[0.74],[0.645],[0.578],[0.699],[0.769],[0.703],[0.603],[0.9],[0.801],[0.722],[0.777],[0.737],0.388,0.522,0.609,0.17,0.178,0.148,0.74,0.645,0.578,0.699,0.769,0.703,0.603,0.9,0.801,0.722,0.777,0.737
https://doi.org/10.1016/j.cct.2018.10.006,icancope with sickle cell pain design of a randomized controlled trial of a smartphone and webbased pain selfmanagement program for youth with sickle cell disease,8238_icancope with sickle cell pain design of a randomized controlled trial of a smartphone and webbased pain selfmanagement program for youth with sickle cell disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078570/pdf'],['Digital behavioural interventions for people with sickle cell disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078570/pdf'],['8238_0_digital behavioural interventions for people with sickle cell disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078570/pdf'],['8238_0_digital behavioural interventions for people with sickle cell disease.pdf'],[0.407],[0.526],[0.615],[0.155],[0.167],[0.136],[0.736],[0.642],[0.589],[0.696],[0.783],[0.702],[0.608],[0.92],[0.812],[0.742],[0.785],[0.771],0.407,0.526,0.615,0.155,0.167,0.136,0.736,0.642,0.589,0.696,0.783,0.702,0.608,0.92,0.812,0.742,0.785,0.771
https://doi.org/10.1016/j.cct.2018.10.008,“wellness champions for change” a multilevel intervention to improve schoollevel implementation of local wellness policies study protocol for a cluster randomized trial,8239_“wellness champions for change” a multilevel intervention to improve schoollevel implementation of local wellness policies study protocol for a cluster randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['8239_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['8239_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.502],[0.511],[0.602],[0.171],[0.175],[0.149],[0.739],[0.644],[0.575],[0.697],[0.778],[0.687],[0.601],[0.91],[0.813],[0.728],[0.778],[0.762],0.502,0.511,0.602,0.171,0.175,0.149,0.739,0.644,0.575,0.697,0.778,0.687,0.601,0.91,0.813,0.728,0.778,0.762
https://doi.org/10.1016/j.cct.2019.105822,targeting pregnancyrelated weight gain to reduce disparities in obesity baseline results from the healthy babies trial,8240_targeting pregnancyrelated weight gain to reduce disparities in obesity baseline results from the healthy babies trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf', 'https://nam.edu/the-current-understanding-of-gestational-weight-gain-among-women-with-obesity-and-the-need-for-future-research/']","['Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population', 'The Current Understanding of Gestational Weight Gain Among Women with Obesity and the Need for Future Research']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],['8240_0_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],['8240_0_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf'],[0.376],[0.524],[0.621],[0.16],[0.162],[0.129],[0.727],[0.631],[0.595],[0.683],[0.784],[0.71],[0.584],[0.924],[0.827],[0.739],[0.784],[0.771],0.376,0.524,0.621,0.16,0.162,0.129,0.727,0.631,0.595,0.683,0.784,0.71,0.584,0.924,0.827,0.739,0.784,0.771
https://doi.org/10.1016/j.cct.2019.105849,champ a cluster randomizedcontrol trial to prevent obesity in child care centers,8241_champ a cluster randomizedcontrol trial to prevent obesity in child care centers.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', ""Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['8241_1_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf', '8241_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['8241_1_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf', '8241_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.516, 0.583]","[0.542, 0.547]","[0.628, 0.635]","[0.175, 0.181]","[0.188, 0.189]","[0.155, 0.159]","[0.734, 0.735]","[0.634, 0.637]","[0.605, 0.61]","[0.698, 0.691]","[0.786, 0.792]","[0.716, 0.718]","[0.609, 0.608]","[0.919, 0.93]","[0.831, 0.835]","[0.746, 0.752]","[0.795, 0.8]","[0.773, 0.783]",0.549,0.544,0.631,0.178,0.189,0.157,0.734,0.635,0.607,0.694,0.789,0.717,0.609,0.925,0.833,0.749,0.798,0.778
https://doi.org/10.1016/j.cell.2018.11.021,organoid modeling of the tumor immune microenvironment,8252_organoid modeling of the tumor immune microenvironment.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589088/pdf'],['Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589088/pdf'],['8252_0_exploration of feasible immune biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma treatment in real world clinical practice.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589088/pdf'],['8252_0_exploration of feasible immune biomarkers for immune checkpoint inhibitors in head and neck squamous cell carcinoma treatment in real world clinical practice.pdf'],[0.492],[0.482],[0.576],[0.133],[0.124],[0.114],[0.747],[0.665],[0.551],[0.703],[0.77],[0.64],[0.606],[0.902],[0.782],[0.727],[0.764],[0.758],0.492,0.482,0.576,0.133,0.124,0.114,0.747,0.665,0.551,0.703,0.77,0.64,0.606,0.902,0.782,0.727,0.764,0.758
https://doi.org/10.1016/j.cell.2019.03.028,polygenic prediction of weight and obesity trajectories from birth to adulthood,8253_polygenic prediction of weight and obesity trajectories from birth to adulthood.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098277/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612115/pdf']","['OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions', 'A guide to performing Polygenic Risk Score analyses']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098277/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612115/pdf']","['8253_0_obedis core variables project european expert guidelines on a minimal core set of variables to include in randomized controlled clinical trials of obesity interventions.pdf', '8253_1_a guide to performing polygenic risk score analyses.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098277/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612115/pdf']","['8253_0_obedis core variables project european expert guidelines on a minimal core set of variables to include in randomized controlled clinical trials of obesity interventions.pdf', '8253_1_a guide to performing polygenic risk score analyses.pdf']","[0.377, 0.451]","[0.488, 0.488]","[0.586, 0.589]","[0.134, 0.131]","[0.143, 0.16]","[0.114, 0.127]","[0.733, 0.736]","[0.641, 0.648]","[0.551, 0.558]","[0.716, 0.744]","[0.778, 0.768]","[0.676, 0.662]","[0.61, 0.6]","[0.899, 0.901]","[0.796, 0.789]","[0.721, 0.719]","[0.769, 0.767]","[0.752, 0.755]",0.414,0.488,0.587,0.133,0.151,0.12,0.734,0.645,0.554,0.73,0.773,0.669,0.605,0.9,0.792,0.72,0.768,0.754
https://doi.org/10.1016/j.cell.2020.02.058,structure function and antigenicity of the sarscov2 spike glycoprotein,8254_structure function and antigenicity of the sarscov2 spike glycoprotein.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316371/pdf']","['AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories', 'Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf']","['8254_1_principles of care for patients with liver disease during the coronavirus disease 2019 covid19 pandemic position stat.pdf', '8254_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf']","['8254_1_principles of care for patients with liver disease during the coronavirus disease 2019 covid19 pandemic position stat.pdf', '8254_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf']","[0.329, 0.295]","[0.477, 0.481]","[0.573, 0.586]","[0.105, 0.111]","[0.114, 0.115]","[0.092, 0.088]","[0.733, 0.733]","[0.642, 0.645]","[0.544, 0.544]","[0.647, 0.669]","[0.778, 0.771]","[0.671, 0.676]","[0.597, 0.617]","[0.908, 0.902]","[0.796, 0.802]","[0.728, 0.732]","[0.767, 0.771]","[0.758, 0.759]",0.312,0.479,0.579,0.108,0.115,0.09,0.733,0.643,0.544,0.658,0.774,0.673,0.607,0.905,0.799,0.73,0.769,0.758
https://doi.org/10.1016/j.cell.2020.09.034,mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children misc,8256_mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children misc.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['8256_0_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['8256_0_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf'],[0.477],[0.496],[0.595],[0.147],[0.145],[0.107],[0.741],[0.653],[0.575],[0.655],[0.778],[0.678],[0.587],[0.909],[0.811],[0.735],[0.773],[0.767],0.477,0.496,0.595,0.147,0.145,0.107,0.741,0.653,0.575,0.655,0.778,0.678,0.587,0.909,0.811,0.735,0.773,0.767
https://doi.org/10.1016/j.cgh.2020.06.017,characteristics of liver function in patients with sarscov2 and chronic hbv coinfection,8272_characteristics of liver function in patients with sarscov2 and chronic hbv coinfection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['8272_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['8272_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.384],[0.512],[0.59],[0.151],[0.157],[0.122],[0.74],[0.643],[0.571],[0.668],[0.764],[0.675],[0.604],[0.909],[0.803],[0.73],[0.769],[0.756],0.384,0.512,0.59,0.151,0.157,0.122,0.74,0.643,0.571,0.668,0.764,0.675,0.604,0.909,0.803,0.73,0.769,0.756
https://doi.org/10.1016/j.chemosphere.2018.10.079,an epithelium is not just an epithelium effects of na cl and ph on olfaction andor copperinduced olfactory deficits,8351_an epithelium is not just an epithelium effects of na cl and ph on olfaction andor copperinduced olfactory deficits.pdf,1,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['Antifouling Paints in Washington State Report and Recommendations'],['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['8351_0_antifouling paints in washington state report and recommendations.pdf'],1,100.0,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['8351_0_antifouling paints in washington state report and recommendations.pdf'],[0.237],[0.473],[0.566],[0.119],[0.122],[0.112],[0.734],[0.64],[0.543],[0.682],[0.77],[0.638],[0.607],[0.905],[0.799],[0.726],[0.77],[0.764],0.237,0.473,0.566,0.119,0.122,0.112,0.734,0.64,0.543,0.682,0.77,0.638,0.607,0.905,0.799,0.726,0.77,0.764
https://doi.org/10.1016/j.chemosphere.2018.11.018,persistent endocrinedisrupting chemicals found in human follicular fluid stimulate the proliferation of granulosa tumor spheroids via gpr30 and igf1r but not via the classic estrogen receptors,8352_persistent endocrinedisrupting chemicals found in human follicular fluid stimulate the proliferation of granulosa tumor spheroids via gpr30 and igf1r but not via the classic estrogen receptors.pdf,1,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft'],['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['8352_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,100.0,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['8352_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.331],[0.485],[0.584],[0.127],[0.121],[0.099],[0.739],[0.646],[0.557],[0.673],[0.775],[0.667],[0.615],[0.905],[0.795],[0.736],[0.771],[0.762],0.331,0.485,0.584,0.127,0.121,0.099,0.739,0.646,0.557,0.673,0.775,0.667,0.615,0.905,0.795,0.736,0.771,0.762
https://doi.org/10.1016/j.chemosphere.2019.03.093,associations between prenatal exposure to bisphenol a and neonatal outcomes in a taiwanese cohort study mediated through oxidative stress,8353_associations between prenatal exposure to bisphenol a and neonatal outcomes in a taiwanese cohort study mediated through oxidative stress.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['8353_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['8353_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.666],[0.491],[0.596],[0.139],[0.144],[0.114],[0.739],[0.65],[0.556],[0.674],[0.781],[0.653],[0.612],[0.901],[0.784],[0.734],[0.763],[0.755],0.666,0.491,0.596,0.139,0.144,0.114,0.739,0.65,0.556,0.674,0.781,0.653,0.612,0.901,0.784,0.734,0.763,0.755
https://doi.org/10.1016/j.chemosphere.2019.05.129,a pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol a in rats,8354_a pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol a in rats.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['8354_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['8354_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.684],[0.494],[0.595],[0.144],[0.141],[0.113],[0.742],[0.651],[0.564],[0.674],[0.78],[0.658],[0.613],[0.9],[0.798],[0.737],[0.773],[0.761],0.684,0.494,0.595,0.144,0.141,0.113,0.742,0.651,0.564,0.674,0.78,0.658,0.613,0.9,0.798,0.737,0.773,0.761
https://doi.org/10.1016/j.chest.2018.10.041,air pollution and noncommunicable diseases,8357_air pollution and noncommunicable diseases.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970621/pdf', 'https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2930325-1']","['Taking a Stand Against Air Pollution—The Impact on Cardiovascular Disease - A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology', 'Managing Chronic Cough as a Symptom in Children and Management Algorithms CHEST Guideline and Expert Panel Report']",['https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2930325-1'],['8357_1_managing chronic cough as a symptom in children and management algorithms chest guideline and expert panel report.pdf'],1,50.0,['https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2930325-1'],['8357_1_managing chronic cough as a symptom in children and management algorithms chest guideline and expert panel report.pdf'],[0.266],[0.535],[0.623],[0.145],[0.148],[0.114],[0.738],[0.637],[0.605],[0.651],[0.804],[0.728],[0.606],[0.919],[0.812],[0.756],[0.799],[0.782],0.266,0.535,0.623,0.145,0.148,0.114,0.738,0.637,0.605,0.651,0.804,0.728,0.606,0.919,0.812,0.756,0.799,0.782
https://doi.org/10.1016/j.chest.2019.07.010,preedit,8358_preedit.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173736/pdf'],['Interventions for the management of malignant pleural effusions: a network meta‐analysis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173736/pdf'],['8358_0_interventions for the management of malignant pleural effusions a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173736/pdf'],['8358_0_interventions for the management of malignant pleural effusions a network meta‐analysis.pdf'],[0.324],[0.504],[0.588],[0.155],[0.152],[0.117],[0.733],[0.637],[0.565],[0.672],[0.765],[0.688],[0.587],[0.893],[0.792],[0.702],[0.768],[0.723],0.324,0.504,0.588,0.155,0.152,0.117,0.733,0.637,0.565,0.672,0.765,0.688,0.587,0.893,0.792,0.702,0.768,0.723
https://doi.org/10.1016/j.chest.2020.04.043,cardiorespiratory progression over 5 years and role of corticosteroids in duchenne muscular dystrophy,8359_cardiorespiratory progression over 5 years and role of corticosteroids in duchenne muscular dystrophy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673515/pdf'],['Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular Dystrophy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673515/pdf'],['8359_0_adult north star network ansn consensus guideline for the standard of care of adults with duchenne muscular dystrophy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673515/pdf'],['8359_0_adult north star network ansn consensus guideline for the standard of care of adults with duchenne muscular dystrophy.pdf'],[0.406],[0.541],[0.621],[0.153],[0.16],[0.115],[0.733],[0.633],[0.613],[0.631],[0.804],[0.735],[0.625],[0.919],[0.817],[0.767],[0.806],[0.788],0.406,0.541,0.621,0.153,0.16,0.115,0.733,0.633,0.613,0.631,0.804,0.735,0.625,0.919,0.817,0.767,0.806,0.788
https://doi.org/10.1016/j.chiabu.2019.01.005,are sexual minority youth overrepresented in foster care child welfare and outofhome placement findings from nationally representative data,8554_are sexual minority youth overrepresented in foster care child welfare and outofhome placement findings from nationally representative data.pdf,3,"['https://www.aclu.org/legal-document/fulton-v-city-philadelphia-amicus-brief-american-psychological-association-et-al', 'https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf', 'https://www.mass.gov/doc/commission-report-on-dcf/download']","['Fulton v City of Philadelphia - Amicus Brief of American Psychological Association et al', 'Disproportionality and Disparities', 'Dark Pink Photos Company Annual Report']","['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf', 'https://www.mass.gov/doc/commission-report-on-dcf/download']","['8554_1_disproportionality and disparities.pdf', '8554_2_dark pink photos company annual report.pdf']",2,66.67,"['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf', 'https://www.mass.gov/doc/commission-report-on-dcf/download']","['8554_1_disproportionality and disparities.pdf', '8554_2_dark pink photos company annual report.pdf']","[0.617, 0.607]","[0.501, 0.52]","[0.601, 0.617]","[0.174, 0.184]","[0.215, 0.219]","[0.175, 0.175]","[0.742, 0.733]","[0.65, 0.639]","[0.569, 0.579]","[0.687, 0.677]","[0.772, 0.79]","[0.696, 0.716]","[0.615, 0.634]","[0.903, 0.913]","[0.8, 0.818]","[0.739, 0.749]","[0.773, 0.794]","[0.756, 0.774]",0.612,0.51,0.609,0.179,0.217,0.175,0.738,0.645,0.574,0.682,0.781,0.706,0.625,0.908,0.809,0.744,0.784,0.765
https://doi.org/10.1016/j.chiabu.2019.01.008,the development of the protective factors survey 2nd edition a selfreport measure of protective factors against child maltreatment,8555_the development of the protective factors survey 2nd edition a selfreport measure of protective factors against child maltreatment.pdf,1,['https://dcyf.wa.gov/sites/default/files/pdf/reports/DCYFBaselinePerformanceAssessment-measures.pdf'],"['Capacity Assessment and Integration Support for the Washington State Department of Children, Youth, and Families']",['https://dcyf.wa.gov/sites/default/files/pdf/reports/DCYFBaselinePerformanceAssessment-measures.pdf'],['8555_0_capacity assessment and integration support for the washington state department of children youth and families.pdf'],1,100.0,['https://dcyf.wa.gov/sites/default/files/pdf/reports/DCYFBaselinePerformanceAssessment-measures.pdf'],['8555_0_capacity assessment and integration support for the washington state department of children youth and families.pdf'],[0.335],[0.578],[0.647],[0.157],[0.188],[0.139],[0.724],[0.627],[0.647],[0.681],[0.815],[0.768],[0.642],[0.924],[0.866],[0.796],[0.834],[0.811],0.335,0.578,0.647,0.157,0.188,0.139,0.724,0.627,0.647,0.681,0.815,0.768,0.642,0.924,0.866,0.796,0.834,0.811
https://doi.org/10.1016/j.chiabu.2020.104890,adverse childhood experiences and trajectories of internalizing externalizing and prosocial behaviors from childhood to adolescence,8570_adverse childhood experiences and trajectories of internalizing externalizing and prosocial behaviors from childhood to adolescence.pdf,1,['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],"['Supporting Child and Student Social, Emotional, Behavioral, and Mental Health Needs (PDF)']",['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['8570_0_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],1,100.0,['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['8570_0_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],[0.308],[0.518],[0.616],[0.145],[0.161],[0.132],[0.727],[0.632],[0.581],[0.662],[0.785],[0.714],[0.614],[0.916],[0.82],[0.764],[0.792],[0.776],0.308,0.518,0.616,0.145,0.161,0.132,0.727,0.632,0.581,0.662,0.785,0.714,0.614,0.916,0.82,0.764,0.792,0.776
https://doi.org/10.1016/j.childyouth.2012.08.009,resilience in children and youth a review,8803_resilience in children and youth a review.pdf,6,"['https://www.rand.org/pubs/research_reports/RRA554-1.html', 'https://www.rand.org/pubs/research_reports/RRA554-2.html', 'https://www.michigan.gov/documents/mdhhs/youth_transition_507738_7.pdf', 'https://www.rand.org/pubs/research_reports/RR2670.html', 'https://www.urban.org/research/publication/arts-infusion-initiative-2010-15-evaluation-report', 'https://www.rand.org/pubs/research_reports/RR1683.html']","['Assessing the Association Between Airmen Participation in Force Support Squadron Programs and Unit Cohesion', 'Assessing the Association Between Airmen Participation in Force Support Squadron Programs and Unit Cohesion', 'Helping Youth Transition to Adulthood: Guidance for Foster Parents', 'Air Force Morale, Welfare, and Recreation Programs and Services', 'Arts Infusion Initiative, 2010â\x80\x9315: Evaluation Report', 'An Agenda to Advance Integrative Resilience Research and Practice']",['https://www.michigan.gov/documents/mdhhs/youth_transition_507738_7.pdf'],['8803_2_helping youth transition to adulthood guidance for foster parents.pdf'],1,16.67,['https://www.michigan.gov/documents/mdhhs/youth_transition_507738_7.pdf'],['8803_2_helping youth transition to adulthood guidance for foster parents.pdf'],[0.321],[0.548],[0.63],[0.162],[0.185],[0.169],[0.735],[0.637],[0.623],[0.678],[0.809],[0.754],[0.629],[0.923],[0.844],[0.778],[0.817],[0.8],0.321,0.548,0.63,0.162,0.185,0.169,0.735,0.637,0.623,0.678,0.809,0.754,0.629,0.923,0.844,0.778,0.817,0.8
https://doi.org/10.1016/j.childyouth.2017.08.011,connectedness to family school peers and community in socially vulnerable adolescents,8933_connectedness to family school peers and community in socially vulnerable adolescents.pdf,2,"['https://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20(Late).pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20%28Late%29.pdf']","['312345678', '312345678']","['https://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20(Late).pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20%28Late%29.pdf']","['8933_0_312345678.pdf', '8933_1_312345678.pdf']",2,100.0,"['https://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20(Late).pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20%28Late%29.pdf']","['8933_0_312345678.pdf', '8933_1_312345678.pdf']","[0.306, 0.306]","[0.433, 0.433]","[0.541, 0.541]","[0.126, 0.126]","[0.127, 0.127]","[0.119, 0.119]","[0.738, 0.738]","[0.643, 0.643]","[0.481, 0.481]","[0.696, 0.696]","[0.701, 0.701]","[0.613, 0.613]","[0.572, 0.572]","[0.896, 0.896]","[0.723, 0.723]","[0.678, 0.678]","[0.701, 0.701]","[0.699, 0.699]",0.306,0.433,0.541,0.126,0.127,0.119,0.738,0.643,0.481,0.696,0.701,0.613,0.572,0.896,0.723,0.678,0.701,0.699
https://doi.org/10.1016/j.childyouth.2018.02.015,the effects of placement and school stability on academic growth trajectories of students in foster care,8947_the effects of placement and school stability on academic growth trajectories of students in foster care.pdf,1,['http://council.nyc.gov/data/wp-content/uploads/sites/73/2020/01/FINAL-PAPER.pdf'],['FINAL PAPER'],['http://council.nyc.gov/data/wp-content/uploads/sites/73/2020/01/FINAL-PAPER.pdf'],['8947_0_final paper.pdf'],1,100.0,['http://council.nyc.gov/data/wp-content/uploads/sites/73/2020/01/FINAL-PAPER.pdf'],['8947_0_final paper.pdf'],[0.16],[0.536],[0.615],[0.144],[0.156],[0.116],[0.72],[0.623],[0.611],[0.647],[0.803],[0.733],[0.648],[0.926],[0.848],[0.773],[0.804],[0.787],0.16,0.536,0.615,0.144,0.156,0.116,0.72,0.623,0.611,0.647,0.803,0.733,0.648,0.926,0.848,0.773,0.804,0.787
https://doi.org/10.1016/j.childyouth.2018.12.007,socialemotional wellbeing among youth living in outofhome care,8965_socialemotional wellbeing among youth living in outofhome care.pdf,2,"['https://dcs.az.gov/file/14124/download?token=gDeB0nYG', 'https://dcs.az.gov/file/14991/download?token=3EyWWPi5']","['IV-E WAIVER DEMONSTRATIONS', 'Arizona Waiver Demonstration Project Final Evaluation Report']","['https://dcs.az.gov/file/14124/download?token=gDeB0nYG', 'https://dcs.az.gov/file/14991/download?token=3EyWWPi5']","['8965_0_ive waiver demonstrations.pdf', '8965_1_arizona waiver demonstration project final evaluation report.pdf']",2,100.0,"['https://dcs.az.gov/file/14124/download?token=gDeB0nYG', 'https://dcs.az.gov/file/14991/download?token=3EyWWPi5']","['8965_0_ive waiver demonstrations.pdf', '8965_1_arizona waiver demonstration project final evaluation report.pdf']","[0.433, 0.682]","[0.569, 0.546]","[0.636, 0.625]","[0.171, 0.169]","[0.198, 0.195]","[0.152, 0.165]","[0.721, 0.728]","[0.621, 0.631]","[0.63, 0.596]","[0.686, 0.701]","[0.807, 0.788]","[0.763, 0.725]","[0.66, 0.64]","[0.915, 0.913]","[0.855, 0.838]","[0.785, 0.767]","[0.823, 0.799]","[0.799, 0.783]",0.557,0.557,0.631,0.17,0.197,0.159,0.724,0.626,0.613,0.694,0.798,0.744,0.65,0.914,0.847,0.776,0.811,0.791
https://doi.org/10.1016/j.childyouth.2018.12.022,human trafficking victimization among youth who run away from foster care,8967_human trafficking victimization among youth who run away from foster care.pdf,4,"['https://www.acf.hhs.gov/opre/report/survey-youth-currently-and-formerly-foster-care-risk-human-trafficking-final-report', 'https://www.acf.hhs.gov/opre/report/examining-link-foster-care-runaway-episodes-and-human-trafficking', 'https://www.rti.org/publication/examining-link', 'https://www.dhss.delaware.gov/dhss/admin/files/htfinal2020report.pdf']","['Survey of Youth Currently and Formerly in Foster Care at Risk for Human Trafficking: Final Report', 'Examining the Link: Foster Care Runaway Episodes and Human Trafficking', 'Examining the link', 'Estimating the Prevalence of Human Trafficking in Delaware']",['https://www.dhss.delaware.gov/dhss/admin/files/htfinal2020report.pdf'],['8967_3_estimating the prevalence of human trafficking in delaware.pdf'],1,25.0,['https://www.dhss.delaware.gov/dhss/admin/files/htfinal2020report.pdf'],['8967_3_estimating the prevalence of human trafficking in delaware.pdf'],[0.199],[0.533],[0.625],[0.161],[0.177],[0.14],[0.724],[0.63],[0.597],[0.665],[0.793],[0.723],[0.641],[0.908],[0.832],[0.765],[0.802],[0.787],0.199,0.533,0.625,0.161,0.177,0.14,0.724,0.63,0.597,0.665,0.793,0.723,0.641,0.908,0.832,0.765,0.802,0.787
https://doi.org/10.1016/j.childyouth.2019.03.021,who benefits head start directors views of coordination with elementary schools to support the transition to kindergarten,8972_who benefits head start directors views of coordination with elementary schools to support the transition to kindergarten.pdf,3,"['https://www.acf.hhs.gov/opre/report/understanding-cross-systems-transitions-head-start-kindergarten-review-knowledge-base', 'https://www.acf.hhs.gov/opre/report/design-options-head-start-kindergarten-transitions-descriptive-study', 'https://www.dcyf.wa.gov/sites/default/files/pubs/EL_0018.pdf']","['Understanding Cross-Systems Transitions from Head Start to Kindergarten: A Review of the Knowledge Base and a Theory of Change', 'Design Options for Head Start to Kindergarten Transitions Descriptive Study', 'EL_0018 Strengthening Transitions']",['https://www.dcyf.wa.gov/sites/default/files/pubs/EL_0018.pdf'],['8972_2_el0018 strengthening transitions.pdf'],1,33.33,['https://www.dcyf.wa.gov/sites/default/files/pubs/EL_0018.pdf'],['8972_2_el0018 strengthening transitions.pdf'],[0.658],[0.6],[0.674],[0.232],[0.261],[0.214],[0.745],[0.655],[0.662],[0.712],[0.822],[0.789],[0.678],[0.925],[0.872],[0.801],[0.835],[0.814],0.658,0.6,0.674,0.232,0.261,0.214,0.745,0.655,0.662,0.712,0.822,0.789,0.678,0.925,0.872,0.801,0.835,0.814
https://doi.org/10.1016/j.childyouth.2019.06.001,“how am i doing” narratives of youth living in congregate care on their socialemotional wellbeing,8979_“how am i doing” narratives of youth living in congregate care on their socialemotional wellbeing.pdf,1,['https://dcs.az.gov/file/14124/download?token=gDeB0nYG'],['IV-E WAIVER DEMONSTRATIONS'],['https://dcs.az.gov/file/14124/download?token=gDeB0nYG'],['8979_0_ive waiver demonstrations.pdf'],1,100.0,['https://dcs.az.gov/file/14124/download?token=gDeB0nYG'],['8979_0_ive waiver demonstrations.pdf'],[0.391],[0.601],[0.665],[0.166],[0.207],[0.156],[0.722],[0.625],[0.674],[0.683],[0.829],[0.793],[0.672],[0.923],[0.876],[0.806],[0.846],[0.82],0.391,0.601,0.665,0.166,0.207,0.156,0.722,0.625,0.674,0.683,0.829,0.793,0.672,0.923,0.876,0.806,0.846,0.82
https://doi.org/10.1016/j.cjca.2018.02.022,hypertension canada’s 2018 guidelines for diagnosis risk assessment prevention and treatment of hypertension in adults and children,9017_hypertension canada’s 2018 guidelines for diagnosis risk assessment prevention and treatment of hypertension in adults and children.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094237/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093137/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347316/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513382/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO_BP_Exec_Summary_final.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836998/pdf']","['Long‐term effects of weight‐reducing drugs in people with hypertension', 'Alcohol intake reduction for controlling hypertension', 'Long‐term effects of weight‐reducing diets in people with hypertension', 'Blood pressure targets for the treatment of people with hypertension and cardiovascular disease', 'First‐line combination therapy versus first‐line monotherapy for primary hypertension', 'Diabetes Canada 2018 clinical practice guidelines - Key messages for family physicians caring for patients living with type 2 diabetes', 'Blood pressure targets for the treatment of people with hypertension and cardiovascular disease', 'KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease', 'Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease', 'Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094237/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513382/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093137/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347316/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO_BP_Exec_Summary_final.pdf']","['9017_0_long‐term effects of weight‐reducing drugs in people with hypertension.pdf', '9017_1_alcohol intake reduction for controlling hypertension.pdf', '9017_3_blood pressure targets for the treatment of people with hypertension and cardiovascular disease.pdf', '9017_4_first‐line combination therapy versus first‐line monotherapy for primary hypertension.pdf', '9017_9_recomendaciones preventivas cardiovasculares actualización papps 2018.pdf', '9017_6_blood pressure targets for the treatment of people with hypertension and cardiovascular disease.pdf', '9017_2_long‐term effects of weight‐reducing diets in people with hypertension.pdf', '9017_7_kdigo 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.pdf', '9017_5_diabetes canada 2018 clinical practice guidelines  key messages for family physicians caring for patients living with type 2 diabetes.pdf', '9017_8_executive summary of the kdigo 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.pdf']",10,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094237/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094445/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513382/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093137/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347316/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO_BP_Exec_Summary_final.pdf']","['9017_0_long‐term effects of weight‐reducing drugs in people with hypertension.pdf', '9017_1_alcohol intake reduction for controlling hypertension.pdf', '9017_3_blood pressure targets for the treatment of people with hypertension and cardiovascular disease.pdf', '9017_4_first‐line combination therapy versus first‐line monotherapy for primary hypertension.pdf', '9017_9_recomendaciones preventivas cardiovasculares actualización papps 2018.pdf', '9017_6_blood pressure targets for the treatment of people with hypertension and cardiovascular disease.pdf', '9017_2_long‐term effects of weight‐reducing diets in people with hypertension.pdf', '9017_7_kdigo 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.pdf', '9017_5_diabetes canada 2018 clinical practice guidelines  key messages for family physicians caring for patients living with type 2 diabetes.pdf', '9017_8_executive summary of the kdigo 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.pdf']","[0.287, 0.283, 0.3, 0.386, 0.305, 0.394, 0.39, 0.562, 0.551, 0.114]","[0.536, 0.528, 0.555, 0.534, 0.488, 0.551, 0.541, 0.574, 0.608, 0.597]","[0.621, 0.617, 0.638, 0.622, 0.593, 0.635, 0.629, 0.654, 0.678, 0.669]","[0.18, 0.175, 0.21, 0.19, 0.182, 0.211, 0.19, 0.212, 0.213, 0.241]","[0.186, 0.181, 0.216, 0.195, 0.211, 0.221, 0.199, 0.221, 0.222, 0.249]","[0.139, 0.141, 0.167, 0.147, 0.149, 0.17, 0.156, 0.168, 0.16, 0.191]","[0.738, 0.734, 0.744, 0.742, 0.745, 0.746, 0.739, 0.745, 0.751, 0.75]","[0.648, 0.644, 0.656, 0.656, 0.662, 0.658, 0.652, 0.657, 0.664, 0.665]","[0.603, 0.593, 0.619, 0.603, 0.565, 0.612, 0.603, 0.642, 0.678, 0.665]","[0.658, 0.657, 0.672, 0.66, 0.653, 0.674, 0.668, 0.666, 0.662, 0.676]","[0.789, 0.784, 0.798, 0.789, 0.798, 0.794, 0.789, 0.817, 0.824, 0.826]","[0.709, 0.71, 0.726, 0.707, 0.712, 0.715, 0.713, 0.756, 0.785, 0.777]","[0.604, 0.6, 0.61, 0.595, 0.58, 0.613, 0.604, 0.639, 0.657, 0.66]","[0.924, 0.918, 0.925, 0.922, 0.89, 0.921, 0.926, 0.934, 0.939, 0.936]","[0.826, 0.817, 0.833, 0.823, 0.82, 0.828, 0.832, 0.838, 0.86, 0.854]","[0.747, 0.734, 0.755, 0.741, 0.729, 0.751, 0.749, 0.788, 0.808, 0.803]","[0.787, 0.781, 0.796, 0.783, 0.772, 0.792, 0.788, 0.82, 0.835, 0.83]","[0.771, 0.757, 0.776, 0.765, 0.749, 0.772, 0.773, 0.803, 0.816, 0.815]",0.357,0.551,0.636,0.2,0.21,0.159,0.743,0.656,0.618,0.665,0.801,0.731,0.616,0.923,0.833,0.76,0.798,0.78
https://doi.org/10.1016/j.clnu.2020.05.051,the modified nutric score can be used for nutritional risk assessment as well as prognosis prediction in critically ill covid19 patients,9059_the modified nutric score can be used for nutritional risk assessment as well as prognosis prediction in critically ill covid19 patients.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['9059_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['9059_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.394],[0.524],[0.605],[0.167],[0.173],[0.135],[0.741],[0.646],[0.578],[0.675],[0.77],[0.7],[0.608],[0.914],[0.806],[0.739],[0.777],[0.762],0.394,0.524,0.605,0.167,0.173,0.135,0.741,0.646,0.578,0.675,0.77,0.7,0.608,0.914,0.806,0.739,0.777,0.762
https://doi.org/10.1016/j.clp.2020.05.007,patent ductus arteriosus—time for a definitive trial,9078_patent ductus arteriosus—time for a definitive trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095061/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812277/pdf']","['Indomethacin for symptomatic patent ductus arteriosus in preterm infants', 'Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095061/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812277/pdf']","['9078_0_indomethacin for symptomatic patent ductus arteriosus in preterm infants.pdf', '9078_1_early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095061/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812277/pdf']","['9078_0_indomethacin for symptomatic patent ductus arteriosus in preterm infants.pdf', '9078_1_early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.pdf']","[0.568, 0.541]","[0.527, 0.507]","[0.616, 0.599]","[0.185, 0.171]","[0.179, 0.162]","[0.146, 0.137]","[0.738, 0.737]","[0.647, 0.644]","[0.59, 0.568]","[0.669, 0.669]","[0.784, 0.774]","[0.716, 0.701]","[0.596, 0.59]","[0.91, 0.901]","[0.797, 0.782]","[0.731, 0.713]","[0.779, 0.767]","[0.757, 0.736]",0.554,0.517,0.607,0.178,0.17,0.142,0.738,0.645,0.579,0.669,0.779,0.708,0.593,0.905,0.79,0.722,0.773,0.746
https://doi.org/10.1016/j.cmi.2017.08.008,the relationship between gramnegative colonization and bloodstream infections in neonates a systematic review and metaanalysis,9083_the relationship between gramnegative colonization and bloodstream infections in neonates a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449086/pdf'],['Sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multi-drug resistant organisms'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449086/pdf'],['9083_0_sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multidrug resistant organisms.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449086/pdf'],['9083_0_sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multidrug resistant organisms.pdf'],[0.391],[0.537],[0.616],[0.176],[0.195],[0.155],[0.735],[0.643],[0.604],[0.679],[0.79],[0.726],[0.6],[0.917],[0.803],[0.751],[0.793],[0.772],0.391,0.537,0.616,0.176,0.195,0.155,0.735,0.643,0.604,0.679,0.79,0.726,0.6,0.917,0.803,0.751,0.793,0.772
https://doi.org/10.1016/j.cmi.2020.03.034,association of covid19 with pregnancy outcomes in healthcare workers and general women,9084_association of covid19 with pregnancy outcomes in healthcare workers and general women.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900664/pdf'],['COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900664/pdf'],['9084_0_covid19 faqs in paediatric and congenital cardiology aepc position paper.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900664/pdf'],['9084_0_covid19 faqs in paediatric and congenital cardiology aepc position paper.pdf'],[0.327],[0.587],[0.658],[0.19],[0.206],[0.149],[0.737],[0.648],[0.652],[0.61],[0.816],[0.759],[0.641],[0.915],[0.844],[0.788],[0.814],[0.803],0.327,0.587,0.658,0.19,0.206,0.149,0.737,0.648,0.652,0.61,0.816,0.759,0.641,0.915,0.844,0.788,0.814,0.803
https://doi.org/10.1016/j.contraception.2018.10.007,support for and interest in alternative models of medication abortion provision among a national probability sample of us women,9154_support for and interest in alternative models of medication abortion provision among a national probability sample of us women.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193989/pdf'],['Medical abortion offered in pharmacy versus clinic‐based settings'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193989/pdf'],['9154_0_medical abortion offered in pharmacy versus clinic‐based settings.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193989/pdf'],['9154_0_medical abortion offered in pharmacy versus clinic‐based settings.pdf'],[0.429],[0.527],[0.612],[0.18],[0.206],[0.17],[0.734],[0.643],[0.587],[0.668],[0.786],[0.707],[0.609],[0.922],[0.828],[0.736],[0.784],[0.774],0.429,0.527,0.612,0.18,0.206,0.17,0.734,0.643,0.587,0.668,0.786,0.707,0.609,0.922,0.828,0.736,0.784,0.774
https://doi.org/10.1016/j.contraception.2018.10.008,the effect of immediate postpartum levonorgestrel contraceptive implant use on breastfeeding and infant growth a randomized controlled trial,9155_the effect of immediate postpartum levonorgestrel contraceptive implant use on breastfeeding and infant growth a randomized controlled trial.pdf,1,['https://www.in.gov/health/laboroflove/files/Breastfeeding-Guidance.pdf'],['Breastfeeding and Reproductive Planning Guidance Document'],['https://www.in.gov/health/laboroflove/files/Breastfeeding-Guidance.pdf'],['9155_0_breastfeeding and reproductive planning guidance document.pdf'],1,100.0,['https://www.in.gov/health/laboroflove/files/Breastfeeding-Guidance.pdf'],['9155_0_breastfeeding and reproductive planning guidance document.pdf'],[0.456],[0.528],[0.616],[0.177],[0.188],[0.171],[0.738],[0.64],[0.584],[0.658],[0.776],[0.695],[0.621],[0.906],[0.809],[0.734],[0.779],[0.754],0.456,0.528,0.616,0.177,0.188,0.171,0.738,0.64,0.584,0.658,0.776,0.695,0.621,0.906,0.809,0.734,0.779,0.754
https://doi.org/10.1016/j.contraception.2019.02.008,foregoing rh testing and antid immunoglobulin for women presenting for early abortion a recommendation from the national abortion federations clinical policies committee,9156_foregoing rh testing and antid immunoglobulin for women presenting for early abortion a recommendation from the national abortion federations clinical policies committee.pdf,2,"['https://www.heritage.org/life/report/chemical-abortion-review', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161512/pdf']","['Chemical Abortion: A Review', 'Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161512/pdf'],['9156_1_commentary notest medication abortion a sample protocol for increasing access during a pandemic and beyond.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161512/pdf'],['9156_1_commentary notest medication abortion a sample protocol for increasing access during a pandemic and beyond.pdf'],[0.471],[0.558],[0.625],[0.211],[0.231],[0.187],[0.749],[0.653],[0.607],[0.643],[0.809],[0.718],[0.652],[0.93],[0.806],[0.768],[0.796],[0.795],0.471,0.558,0.625,0.211,0.231,0.187,0.749,0.653,0.607,0.643,0.809,0.718,0.652,0.93,0.806,0.768,0.796,0.795
https://doi.org/10.1016/j.cpr.2019.101783,prevalence and correlates of nonsuicidal selfinjury among lesbian gay bisexual and transgender individuals a systematic review and metaanalysis,9216_prevalence and correlates of nonsuicidal selfinjury among lesbian gay bisexual and transgender individuals a systematic review and metaanalysis.pdf,2,"['https://wmc.wa.gov/sites/default/files/public/Newsletter/WMCUpdateFall2020.pdf', 'https://wmc.wa.gov/sites/default/files/public/Newsletter/6.WPHPReport.pdf']","['Update!', 'WPHP Report']","['https://wmc.wa.gov/sites/default/files/public/Newsletter/6.WPHPReport.pdf', 'https://wmc.wa.gov/sites/default/files/public/Newsletter/WMCUpdateFall2020.pdf']","['9216_1_wphp report.pdf', '9216_0_update.pdf']",2,100.0,"['https://wmc.wa.gov/sites/default/files/public/Newsletter/6.WPHPReport.pdf', 'https://wmc.wa.gov/sites/default/files/public/Newsletter/WMCUpdateFall2020.pdf']","['9216_1_wphp report.pdf', '9216_0_update.pdf']","[0.233, 0.053]","[0.524, 0.523]","[0.611, 0.613]","[0.107, 0.125]","[0.126, 0.141]","[0.095, 0.114]","[0.707, 0.722]","[0.616, 0.624]","[0.589, 0.581]","[0.674, 0.669]","[0.801, 0.79]","[0.745, 0.731]","[0.614, 0.609]","[0.923, 0.918]","[0.842, 0.812]","[0.766, 0.757]","[0.807, 0.79]","[0.782, 0.772]",0.143,0.524,0.612,0.116,0.134,0.105,0.714,0.62,0.585,0.671,0.796,0.738,0.611,0.921,0.827,0.762,0.798,0.777
https://doi.org/10.1016/j.critrevonc.2019.03.010,european recommendations for female fertility preservation eurefer a joint collaboration between oncologists and fertility specialists,9220_european recommendations for female fertility preservation eurefer a joint collaboration between oncologists and fertility specialists.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519169/pdf'],['The Oncology Association of Bosnia and Herzegovina’s recommendations for fertility preservation in oncologic patients'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519169/pdf'],['9220_0_the oncology association of bosnia and herzegovinas recommendations for fertility preservation in oncologic patients.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519169/pdf'],['9220_0_the oncology association of bosnia and herzegovinas recommendations for fertility preservation in oncologic patients.pdf'],[0.766],[0.502],[0.594],[0.183],[0.2],[0.171],[0.754],[0.665],[0.558],[0.657],[0.774],[0.666],[0.614],[0.907],[0.779],[0.725],[0.761],[0.747],0.766,0.502,0.594,0.183,0.2,0.171,0.754,0.665,0.558,0.657,0.774,0.666,0.614,0.907,0.779,0.725,0.761,0.747
https://doi.org/10.1016/j.cub.2020.07.044,enduring behavioral effects induced by birth by caesarean section in the mouse,9242_enduring behavioral effects induced by birth by caesarean section in the mouse.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489962/pdf'],['Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489962/pdf'],['9242_0_guidelines for reporting on animal fecal transplantation graft studies recommendations from a systematic review of murine transplantation protocols.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489962/pdf'],['9242_0_guidelines for reporting on animal fecal transplantation graft studies recommendations from a systematic review of murine transplantation protocols.pdf'],[0.288],[0.494],[0.58],[0.121],[0.118],[0.093],[0.727],[0.635],[0.561],[0.676],[0.77],[0.694],[0.614],[0.907],[0.805],[0.745],[0.778],[0.763],0.288,0.494,0.58,0.121,0.118,0.093,0.727,0.635,0.561,0.676,0.77,0.694,0.614,0.907,0.805,0.745,0.778,0.763
https://doi.org/10.1016/j.dcn.2019.100700,neuroimaging predictors of onset and course of depression in childhood and adolescence a systematic review of longitudinal studies,9262_neuroimaging predictors of onset and course of depression in childhood and adolescence a systematic review of longitudinal studies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505307/pdf'],['Critical appraisal of clinical practice guidelines for depression in children and adolescents - A protocol for systematic review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505307/pdf'],['9262_0_critical appraisal of clinical practice guidelines for depression in children and adolescents  a protocol for systematic review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505307/pdf'],['9262_0_critical appraisal of clinical practice guidelines for depression in children and adolescents  a protocol for systematic review.pdf'],[0.369],[0.465],[0.568],[0.129],[0.133],[0.118],[0.731],[0.639],[0.526],[0.713],[0.756],[0.66],[0.568],[0.905],[0.781],[0.708],[0.75],[0.736],0.369,0.465,0.568,0.129,0.133,0.118,0.731,0.639,0.526,0.713,0.756,0.66,0.568,0.905,0.781,0.708,0.75,0.736
https://doi.org/10.1016/j.ddmod.2019.08.002,without a bug’s life germfree rodents to interrogate microbiotagutneuroimmune interactions,9263_without a bug’s life germfree rodents to interrogate microbiotagutneuroimmune interactions.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489962/pdf'],['Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489962/pdf'],['9263_0_guidelines for reporting on animal fecal transplantation graft studies recommendations from a systematic review of murine transplantation protocols.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489962/pdf'],['9263_0_guidelines for reporting on animal fecal transplantation graft studies recommendations from a systematic review of murine transplantation protocols.pdf'],[0.333],[0.526],[0.612],[0.131],[0.14],[0.103],[0.731],[0.639],[0.604],[0.667],[0.794],[0.734],[0.617],[0.913],[0.829],[0.762],[0.798],[0.782],0.333,0.526,0.612,0.131,0.14,0.103,0.731,0.639,0.604,0.667,0.794,0.734,0.617,0.913,0.829,0.762,0.798,0.782
https://doi.org/10.1016/j.drugalcdep.2019.04.011,the rise of ecigarettes pod mod devices and juul among youth factors influencing use health implications and downstream effects,9362_the rise of ecigarettes pod mod devices and juul among youth factors influencing use health implications and downstream effects.pdf,1,['https://ag.ny.gov/sites/default/files/11-18-2019_juul_complaint_-_final_dated_and_signed_correct.pdf'],['Complaint'],['https://ag.ny.gov/sites/default/files/11-18-2019_juul_complaint_-_final_dated_and_signed_correct.pdf'],['9362_0_complaint.pdf'],1,100.0,['https://ag.ny.gov/sites/default/files/11-18-2019_juul_complaint_-_final_dated_and_signed_correct.pdf'],['9362_0_complaint.pdf'],[0.365],[0.456],[0.573],[0.149],[0.156],[0.139],[0.734],[0.644],[0.517],[0.668],[0.772],[0.664],[0.606],[0.895],[0.796],[0.725],[0.768],[0.758],0.365,0.456,0.573,0.149,0.156,0.139,0.734,0.644,0.517,0.668,0.772,0.664,0.606,0.895,0.796,0.725,0.768,0.758
https://doi.org/10.1016/j.earlhumdev.2019.05.015,historical aspects of probiotic use to prevent necrotising enterocolitis in preterm babies,9434_historical aspects of probiotic use to prevent necrotising enterocolitis in preterm babies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf'],['Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf'],['9434_0_probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf'],['9434_0_probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.pdf'],[0.453],[0.492],[0.59],[0.17],[0.171],[0.155],[0.744],[0.66],[0.558],[0.7],[0.778],[0.649],[0.577],[0.906],[0.767],[0.712],[0.746],[0.744],0.453,0.492,0.59,0.17,0.171,0.155,0.744,0.66,0.558,0.7,0.778,0.649,0.577,0.906,0.767,0.712,0.746,0.744
https://doi.org/10.1016/j.earlhumdev.2019.05.016,addressing safety concerns of probiotic use in preterm babies,9435_addressing safety concerns of probiotic use in preterm babies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf'],['Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf'],['9435_0_probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf'],['9435_0_probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.pdf'],[0.379],[0.485],[0.59],[0.155],[0.158],[0.147],[0.742],[0.653],[0.545],[0.678],[0.768],[0.653],[0.569],[0.904],[0.751],[0.708],[0.738],[0.738],0.379,0.485,0.59,0.155,0.158,0.147,0.742,0.653,0.545,0.678,0.768,0.653,0.569,0.904,0.751,0.708,0.738,0.738
https://doi.org/10.1016/j.ebiom.2020.102951,sarscov2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical electron microscopy and molecular analyses of placenta,9441_sarscov2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical electron microscopy and molecular analyses of placenta.pdf,5,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['Master Question List for COVID-19 (caused by SARS-Cov-2)', 'For Public Release', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['9441_1_for public release.pdf', '9441_4_master question list for covid19 caused by sarscov2.pdf', '9441_2_master question list for covid19 caused by sarscov2.pdf', '9441_0_master question list for covid19 caused by sarscov2.pdf', '9441_3_master question list for covid19 caused by sarscov2.pdf']",5,100.0,"['https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['9441_1_for public release.pdf', '9441_4_master question list for covid19 caused by sarscov2.pdf', '9441_2_master question list for covid19 caused by sarscov2.pdf', '9441_0_master question list for covid19 caused by sarscov2.pdf', '9441_3_master question list for covid19 caused by sarscov2.pdf']","[0.466, 0.463, 0.49, 0.482, 0.48]","[0.557, 0.559, 0.559, 0.563, 0.56]","[0.641, 0.642, 0.643, 0.645, 0.643]","[0.171, 0.173, 0.173, 0.174, 0.174]","[0.168, 0.168, 0.17, 0.17, 0.17]","[0.134, 0.134, 0.135, 0.135, 0.136]","[0.747, 0.747, 0.748, 0.748, 0.748]","[0.657, 0.658, 0.658, 0.658, 0.658]","[0.633, 0.634, 0.635, 0.638, 0.636]","[0.618, 0.617, 0.618, 0.618, 0.617]","[0.808, 0.81, 0.809, 0.81, 0.81]","[0.746, 0.745, 0.747, 0.751, 0.747]","[0.633, 0.634, 0.633, 0.636, 0.634]","[0.909, 0.91, 0.91, 0.909, 0.91]","[0.828, 0.828, 0.829, 0.829, 0.828]","[0.776, 0.777, 0.776, 0.779, 0.777]","[0.811, 0.812, 0.812, 0.813, 0.813]","[0.796, 0.797, 0.797, 0.798, 0.798]",0.476,0.56,0.643,0.173,0.169,0.135,0.748,0.658,0.635,0.618,0.809,0.747,0.634,0.91,0.828,0.777,0.812,0.797
https://doi.org/10.1016/j.ebiom.2021.103355,increased viral variants in children and young adults with impaired humoral immunity and persistent sarscov2 infection a consecutive case series,9442_increased viral variants in children and young adults with impaired humoral immunity and persistent sarscov2 infection a consecutive case series.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf', 'https://stacks.cdc.gov/view/cdc/105945']","['Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents', 'COVID-19 science update ; Edition 2021-04-07 (88)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf'],['9442_0_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf'],['9442_0_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf'],[0.353],[0.541],[0.614],[0.165],[0.166],[0.126],[0.739],[0.647],[0.609],[0.635],[0.797],[0.721],[0.622],[0.918],[0.817],[0.766],[0.798],[0.782],0.353,0.541,0.614,0.165,0.166,0.126,0.739,0.647,0.609,0.635,0.797,0.721,0.622,0.918,0.817,0.766,0.798,0.782
https://doi.org/10.1016/j.echo.2020.05.030,echocardiographic findings in patients with covid19 with significant myocardial injury,9447_echocardiographic findings in patients with covid19 with significant myocardial injury.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['9447_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['9447_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.414],[0.521],[0.604],[0.179],[0.18],[0.128],[0.747],[0.656],[0.582],[0.664],[0.774],[0.718],[0.603],[0.917],[0.815],[0.735],[0.777],[0.759],0.414,0.521,0.604,0.179,0.18,0.128,0.747,0.656,0.582,0.664,0.774,0.718,0.603,0.917,0.815,0.735,0.777,0.759
https://doi.org/10.1016/j.eclinm.2018.10.004,what works in youth suicide prevention a systematic review and metaanalysis,9452_what works in youth suicide prevention a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830632/pdf'],['Policy addressing suicidality in children and young people: an international scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830632/pdf'],['9452_0_policy addressing suicidality in children and young people an international scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830632/pdf'],['9452_0_policy addressing suicidality in children and young people an international scoping review.pdf'],[0.321],[0.526],[0.602],[0.172],[0.18],[0.149],[0.732],[0.641],[0.589],[0.705],[0.793],[0.716],[0.604],[0.92],[0.83],[0.744],[0.792],[0.776],0.321,0.526,0.602,0.172,0.18,0.149,0.732,0.641,0.589,0.705,0.793,0.716,0.604,0.92,0.83,0.744,0.792,0.776
https://doi.org/10.1016/j.eclinm.2020.100404,the impact of ethnicity on clinical outcomes in covid19 a systematic review,9453_the impact of ethnicity on clinical outcomes in covid19 a systematic review.pdf,8,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'For Public Release', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['9453_4_master question list for covid19 caused by sarscov2.pdf', '9453_2_for public release.pdf', '9453_0_master question list for covid19 caused by sarscov2.pdf', '9453_6_master question list for covid19 caused by sarscov2.pdf', '9453_7_master question list for covid19 caused by sarscov2.pdf', '9453_3_master question list for covid19 caused by sarscov2.pdf', '9453_1_master question list for covid19 caused by sarscov2.pdf', '9453_5_master question list for covid19 caused by sarscov2.pdf']",8,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['9453_4_master question list for covid19 caused by sarscov2.pdf', '9453_2_for public release.pdf', '9453_0_master question list for covid19 caused by sarscov2.pdf', '9453_6_master question list for covid19 caused by sarscov2.pdf', '9453_7_master question list for covid19 caused by sarscov2.pdf', '9453_3_master question list for covid19 caused by sarscov2.pdf', '9453_1_master question list for covid19 caused by sarscov2.pdf']","[0.442, 0.458, 0.452, 0.45, 0.454, 0.444, 0.461]","[0.542, 0.539, 0.54, 0.54, 0.542, 0.54, 0.541]","[0.628, 0.626, 0.625, 0.626, 0.628, 0.624, 0.627]","[0.164, 0.162, 0.16, 0.165, 0.164, 0.161, 0.164]","[0.164, 0.162, 0.16, 0.165, 0.165, 0.161, 0.163]","[0.134, 0.133, 0.132, 0.137, 0.136, 0.132, 0.134]","[0.739, 0.739, 0.737, 0.74, 0.74, 0.738, 0.739]","[0.645, 0.644, 0.643, 0.646, 0.646, 0.644, 0.645]","[0.609, 0.607, 0.608, 0.607, 0.609, 0.607, 0.608]","[0.654, 0.655, 0.655, 0.659, 0.657, 0.655, 0.654]","[0.811, 0.808, 0.808, 0.809, 0.81, 0.808, 0.811]","[0.734, 0.733, 0.735, 0.733, 0.734, 0.735, 0.732]","[0.625, 0.624, 0.625, 0.625, 0.624, 0.625, 0.625]","[0.92, 0.919, 0.919, 0.92, 0.92, 0.919, 0.92]","[0.837, 0.837, 0.837, 0.838, 0.838, 0.837, 0.838]","[0.76, 0.758, 0.76, 0.757, 0.759, 0.759, 0.759]","[0.814, 0.811, 0.812, 0.812, 0.813, 0.812, 0.813]","[0.794, 0.792, 0.791, 0.792, 0.793, 0.791, 0.793]",0.452,0.541,0.626,0.163,0.163,0.134,0.739,0.645,0.608,0.656,0.809,0.734,0.625,0.92,0.837,0.759,0.812,0.792
https://doi.org/10.1016/j.eclinm.2020.100433,covid19 in 7780 pediatric patients a systematic review,9454_covid19 in 7780 pediatric patients a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf']","['9454_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '9454_0_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf']","['9454_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '9454_0_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf']","[0.311, 0.277]","[0.531, 0.54]","[0.613, 0.618]","[0.155, 0.18]","[0.167, 0.186]","[0.134, 0.145]","[0.741, 0.743]","[0.646, 0.651]","[0.588, 0.595]","[0.645, 0.657]","[0.788, 0.793]","[0.703, 0.704]","[0.614, 0.623]","[0.919, 0.917]","[0.821, 0.826]","[0.746, 0.759]","[0.789, 0.792]","[0.773, 0.776]",0.294,0.536,0.615,0.167,0.176,0.14,0.742,0.649,0.591,0.651,0.79,0.704,0.619,0.918,0.823,0.752,0.79,0.774
https://doi.org/10.1016/j.eclinm.2020.100527,multisystem inflammatory syndrome in children a systematic review,9456_multisystem inflammatory syndrome in children a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078022/pdf']","['Clinical care of children and adolescents with COVID‐19: recommendations from the National COVID‐19 Clinical Evidence Taskforce', 'Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078022/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['9456_1_extracorporeal membrane oxygenation for covid19 updated 2021 guidelines from the extracorporeal life support organization.pdf', '9456_0_clinical care of children and adolescents with covid‐19 recommendations from the national covid‐19 clinical evidence taskforce.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078022/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['9456_1_extracorporeal membrane oxygenation for covid19 updated 2021 guidelines from the extracorporeal life support organization.pdf', '9456_0_clinical care of children and adolescents with covid‐19 recommendations from the national covid‐19 clinical evidence taskforce.pdf']","[0.443, 0.403]","[0.569, 0.54]","[0.637, 0.625]","[0.181, 0.181]","[0.179, 0.189]","[0.125, 0.14]","[0.741, 0.74]","[0.653, 0.649]","[0.636, 0.609]","[0.638, 0.668]","[0.814, 0.804]","[0.744, 0.725]","[0.626, 0.614]","[0.921, 0.92]","[0.834, 0.83]","[0.778, 0.758]","[0.811, 0.803]","[0.795, 0.786]",0.423,0.554,0.631,0.181,0.184,0.133,0.74,0.651,0.623,0.653,0.809,0.734,0.62,0.921,0.832,0.768,0.807,0.79
https://doi.org/10.1016/j.eclinm.2020.100547,an openlabel randomized trial of the combination of ifnκ plus tff2 with standard care in the treatment of patients with moderate covid19,9457_an openlabel randomized trial of the combination of ifnκ plus tff2 with standard care in the treatment of patients with moderate covid19.pdf,2,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['9457_0_master question list for covid19 caused by sarscov2.pdf', '9457_1_master question list for covid19 caused by sarscov2.pdf']",2,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['9457_0_master question list for covid19 caused by sarscov2.pdf', '9457_1_master question list for covid19 caused by sarscov2.pdf']","[0.446, 0.442]","[0.561, 0.562]","[0.641, 0.642]","[0.183, 0.185]","[0.174, 0.175]","[0.136, 0.137]","[0.745, 0.746]","[0.652, 0.653]","[0.638, 0.639]","[0.64, 0.641]","[0.813, 0.813]","[0.753, 0.756]","[0.628, 0.628]","[0.925, 0.926]","[0.838, 0.838]","[0.777, 0.777]","[0.817, 0.817]","[0.797, 0.798]",0.444,0.562,0.641,0.184,0.174,0.137,0.746,0.653,0.639,0.641,0.813,0.754,0.628,0.925,0.838,0.777,0.817,0.798
https://doi.org/10.1016/j.eclinm.2020.100683,mediumterm effects of sarscov2 infection on multiple vital organs exercise capacity cognition quality of life and mental health posthospital discharge,9458_mediumterm effects of sarscov2 infection on multiple vital organs exercise capacity cognition quality of life and mental health posthospital discharge.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849856/pdf', 'https://www.congress.gov/event/117th-congress/house-event/112514']","['ESCMID rapid guidelines for assessment and management of long COVID', '“The Long Haul: Forging a Path through the Lingering Effects of COVID-19”']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849856/pdf'],['9458_0_escmid rapid guidelines for assessment and management of long covid.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849856/pdf'],['9458_0_escmid rapid guidelines for assessment and management of long covid.pdf'],[0.624],[0.55],[0.631],[0.179],[0.188],[0.134],[0.748],[0.659],[0.61],[0.673],[0.802],[0.724],[0.62],[0.918],[0.816],[0.76],[0.796],[0.78],0.624,0.55,0.631,0.179,0.188,0.134,0.748,0.659,0.61,0.673,0.802,0.724,0.62,0.918,0.816,0.76,0.796,0.78
https://doi.org/10.1016/j.ecolecon.2019.106496,french attitudes on climate change carbon taxation and other climate policies,9482_french attitudes on climate change carbon taxation and other climate policies.pdf,3,"['https://files.hawaii.gov/tax/stats/trc/docs2022/Appendix_A.pdf', 'https://files.hawaii.gov/tax/stats/trc/docs2022/sup_211215/UHERO_Carbon_Tax_Study.pdf', 'https://www.rff.org/publications/working-papers/understanding-the-resistance-to-carbon-taxes-a-case-study-of-sweden/']","['Appendix A :', 'Hawaiʻi Carbon Pricing Study Additional Scenarios & Administrative Considerations', 'Understanding the Resistance to Carbon Taxes: A Case Study of Sweden']","['https://files.hawaii.gov/tax/stats/trc/docs2022/Appendix_A.pdf', 'https://files.hawaii.gov/tax/stats/trc/docs2022/sup_211215/UHERO_Carbon_Tax_Study.pdf']","['9482_0_appendix a .pdf', '9482_1_hawaiʻi carbon pricing study additional scenarios  administrative considerations.pdf']",2,66.67,"['https://files.hawaii.gov/tax/stats/trc/docs2022/Appendix_A.pdf', 'https://files.hawaii.gov/tax/stats/trc/docs2022/sup_211215/UHERO_Carbon_Tax_Study.pdf']","['9482_0_appendix a .pdf', '9482_1_hawaiʻi carbon pricing study additional scenarios  administrative considerations.pdf']","[0.472, 0.472]","[0.515, 0.515]","[0.612, 0.612]","[0.143, 0.143]","[0.146, 0.146]","[0.129, 0.129]","[0.721, 0.721]","[0.624, 0.624]","[0.585, 0.585]","[0.684, 0.684]","[0.793, 0.793]","[0.706, 0.706]","[0.643, 0.643]","[0.914, 0.914]","[0.826, 0.827]","[0.756, 0.756]","[0.792, 0.792]","[0.779, 0.779]",0.472,0.515,0.612,0.143,0.146,0.129,0.721,0.624,0.585,0.684,0.793,0.706,0.643,0.914,0.827,0.756,0.792,0.779
https://doi.org/10.1016/j.ecresq.2019.06.009,ece quality indicators and child outcomes analyses of six large child care studies,9799_ece quality indicators and child outcomes analyses of six large child care studies.pdf,5,"['https://www.acf.hhs.gov/opre/report/does-classroom-quality-promote-preschoolers-learning-conceptual-framework-evaluating', 'https://mathematica.org/publications/exploring-the-associations-of-the-pre-k-class-with-childrens-school-readiness-in-faces-2014', 'https://mathematica.org/publications/how-much-does-the-pre-k-class-relate-to-childrens-readiness-for-school-skills', 'https://www.rand.org/pubs/research_reports/RRA252-1.html', 'https://www.michigan.gov/documents/mde/MRS_Final_Report_ADA_726867_7.pdf']","['Does Classroom Quality Promote Preschoolers’ Learning? A Conceptual Framework for Evaluating the Impact of Classroom Quality on Child Outcomes', 'Exploring the Associations of the Pre-K CLASS with Children’s School Readiness in FACES 2014: Associations for Subgroups and Thresholds of Quality', ""How Much Does the Pre-K CLASS Relate to Children's Readiness for School Skills?"", 'What Is the Cost of High-Quality Publicly Funded Pre-K?', 'Michigan’s Child Care Market Rates']",['https://www.michigan.gov/documents/mde/MRS_Final_Report_ADA_726867_7.pdf'],['9799_4_michigans child care market rates.pdf'],1,20.0,['https://www.michigan.gov/documents/mde/MRS_Final_Report_ADA_726867_7.pdf'],['9799_4_michigans child care market rates.pdf'],[0.343],[0.545],[0.619],[0.145],[0.156],[0.126],[0.722],[0.628],[0.607],[0.686],[0.797],[0.73],[0.649],[0.926],[0.834],[0.766],[0.804],[0.788],0.343,0.545,0.619,0.145,0.156,0.126,0.722,0.628,0.607,0.686,0.797,0.73,0.649,0.926,0.834,0.766,0.804,0.788
https://doi.org/10.1016/j.ehb.2011.02.004,exposure to food advertising on television associations with childrens fast food and soft drink consumption and obesity,9857_exposure to food advertising on television associations with childrens fast food and soft drink consumption and obesity.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf', 'https://www.nber.org/papers/w18087', 'https://www.nber.org/papers/w18640']","['Environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health', 'The Heterogeneity of the Cigarette Price Effect on Body Mass Index', 'Fast-Food Restaurant Advertising on Television and Its Influence on Youth Body Composition']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf'],['9857_0_environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6564085/pdf'],['9857_0_environmental interventions to reduce the consumption of sugar‐sweetened beverages and their effects on health.pdf'],[0.233],[0.517],[0.61],[0.15],[0.159],[0.132],[0.726],[0.625],[0.58],[0.701],[0.777],[0.701],[0.608],[0.919],[0.814],[0.736],[0.783],[0.765],0.233,0.517,0.61,0.15,0.159,0.132,0.726,0.625,0.58,0.701,0.777,0.701,0.608,0.919,0.814,0.736,0.783,0.765
https://doi.org/10.1016/j.ejca.2007.06.007,a systematic review of the effectiveness of magnetic resonance imaging mri as an addition to mammography and ultrasound in screening young women at high risk of breast cancer,9887_a systematic review of the effectiveness of magnetic resonance imaging mri as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257601/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636525/pdf', 'https://effectivehealthcare.ahrq.gov/products/diagnostic-tests-reviews/research', 'https://www.hca.wa.gov/assets/program/bmri_appendices_draft%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/breast_imaging_final_report_120814%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/breast_mri_072310_final%5B1%5D.pdf']","['Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group', 'Recommendations for Breast Cancer Surveillance for Female Childhood, Adolescent and Young Adult Cancer Survivors Treated with Chest Radiation: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group', 'Breast MRI: EUSOBI recommendations for women’s information', 'Comprehensive Overview of Methods and Reporting of Meta-Analyses of Test Accuracy', 'HTA Draft Appendices: Breast MRI', 'Appropriate Imaging for Breast Cancer Screening in Special Populations', 'HTA Report : Breast MRI']","['https://www.hca.wa.gov/assets/program/breast_mri_072310_final%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf', 'https://www.hca.wa.gov/assets/program/bmri_appendices_draft%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/breast_imaging_final_report_120814%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636525/pdf']","['9887_6_hta report  breast mri.pdf', '9887_0_updated breast cancer surveillance recommendations for female survivors of childhood adolescent and young adult cancer from the international guideline harmonization group.pdf', '9887_4_hta draft appendices breast mri.pdf', '9887_5_appropriate imaging for breast cancer screening in special populations.pdf', '9887_2_breast mri eusobi recommendations for womens information.pdf']",5,71.43,"['https://www.hca.wa.gov/assets/program/breast_mri_072310_final%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf', 'https://www.hca.wa.gov/assets/program/bmri_appendices_draft%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/breast_imaging_final_report_120814%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636525/pdf']","['9887_6_hta report  breast mri.pdf', '9887_0_updated breast cancer surveillance recommendations for female survivors of childhood adolescent and young adult cancer from the international guideline harmonization group.pdf', '9887_4_hta draft appendices breast mri.pdf', '9887_5_appropriate imaging for breast cancer screening in special populations.pdf', '9887_2_breast mri eusobi recommendations for womens information.pdf']","[0.51, 0.518, 0.747, 0.742, 0.71]","[0.585, 0.605, 0.582, 0.596, 0.611]","[0.66, 0.678, 0.658, 0.669, 0.672]","[0.257, 0.26, 0.255, 0.275, 0.249]","[0.265, 0.26, 0.259, 0.288, 0.248]","[0.22, 0.222, 0.213, 0.239, 0.21]","[0.759, 0.761, 0.758, 0.759, 0.755]","[0.676, 0.68, 0.675, 0.677, 0.669]","[0.63, 0.66, 0.629, 0.645, 0.671]","[0.734, 0.726, 0.73, 0.745, 0.704]","[0.799, 0.823, 0.802, 0.814, 0.826]","[0.758, 0.785, 0.756, 0.768, 0.793]","[0.649, 0.648, 0.643, 0.665, 0.656]","[0.912, 0.923, 0.913, 0.926, 0.93]","[0.825, 0.844, 0.827, 0.845, 0.853]","[0.759, 0.79, 0.763, 0.789, 0.8]","[0.81, 0.828, 0.811, 0.824, 0.833]","[0.774, 0.804, 0.778, 0.803, 0.813]",0.645,0.596,0.667,0.259,0.264,0.221,0.758,0.675,0.647,0.728,0.813,0.772,0.652,0.921,0.839,0.78,0.821,0.794
https://doi.org/10.1016/j.ejca.2020.03.021,flash survey on severe acute respiratory syndrome coronavirus2 infections in paediatric patients on anticancer treatment,9894_flash survey on severe acute respiratory syndrome coronavirus2 infections in paediatric patients on anticancer treatment.pdf,2,"['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951944/pdf']","['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)']",['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['9894_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,50.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['9894_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.468],[0.533],[0.615],[0.168],[0.176],[0.139],[0.738],[0.646],[0.596],[0.642],[0.791],[0.7],[0.601],[0.9],[0.805],[0.752],[0.786],[0.774],0.468,0.533,0.615,0.168,0.176,0.139,0.738,0.646,0.596,0.642,0.791,0.7,0.601,0.9,0.805,0.752,0.786,0.774
https://doi.org/10.1016/j.ejca.2020.09.012,effect of urea cream on sorafenibassociated hand–foot skin reaction in patients with hepatocellular carcinoma a multicenter randomised doubleblind controlled study,9895_effect of urea cream on sorafenibassociated hand–foot skin reaction in patients with hepatocellular carcinoma a multicenter randomised doubleblind controlled study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['9895_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['9895_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.485],[0.545],[0.618],[0.174],[0.167],[0.13],[0.743],[0.652],[0.611],[0.638],[0.798],[0.72],[0.63],[0.923],[0.813],[0.759],[0.794],[0.78],0.485,0.545,0.618,0.174,0.167,0.13,0.743,0.652,0.611,0.638,0.798,0.72,0.63,0.923,0.813,0.759,0.794,0.78
https://doi.org/10.1016/j.ejim.2021.02.019,the efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis b virus–related hepatocellular carcinoma,9903_the efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis b virus–related hepatocellular carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['9903_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['9903_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.626],[0.531],[0.606],[0.174],[0.173],[0.132],[0.746],[0.657],[0.594],[0.657],[0.789],[0.68],[0.629],[0.919],[0.821],[0.76],[0.784],[0.776],0.626,0.531,0.606,0.174,0.173,0.132,0.746,0.657,0.594,0.657,0.789,0.68,0.629,0.919,0.821,0.76,0.784,0.776
https://doi.org/10.1016/j.ekir.2020.08.022,cohort study of outpatient hemodialysis management strategies for covid19 in northwest london,9954_cohort study of outpatient hemodialysis management strategies for covid19 in northwest london.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653213/pdf'],['COVID-19 and maintenance hemodialysis: a systematic scoping review of practice guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653213/pdf'],['9954_0_covid19 and maintenance hemodialysis a systematic scoping review of practice guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653213/pdf'],['9954_0_covid19 and maintenance hemodialysis a systematic scoping review of practice guidelines.pdf'],[0.469],[0.541],[0.617],[0.172],[0.188],[0.148],[0.734],[0.639],[0.612],[0.653],[0.8],[0.747],[0.617],[0.92],[0.82],[0.772],[0.808],[0.788],0.469,0.541,0.617,0.172,0.188,0.148,0.734,0.639,0.612,0.653,0.8,0.747,0.617,0.92,0.82,0.772,0.808,0.788
https://doi.org/10.1016/j.envint.2006.05.002,ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems a global assessment,9986_ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems a global assessment.pdf,7,"['https://www.ucsusa.org/resources/subsidizing-waste', 'https://www.ucsusa.org/resources/reviving-dead-zone', 'https://purl.fdlp.gov/GPO/gpo106600', 'http://purl.fdlp.gov/GPO/gpo81314', 'https://www.epa.gov/sites/default/files/2015-07/documents/feb10_ecologicalres_draft.pdf', 'https://www.epa.gov/sites/production/files/2015-08/documents/aquatic-life-ambient-water-quality-criteria-for-ammonia-freshwater-2013.pdf', 'https://www.rand.org/pubs/research_reports/RR2695.html']","['Subsidizing Waste', 'Reviving the Dead Zone', 'Agriculture--a river runs through it :\xa0the connections between agriculture and water quality /', 'Effects of wastewater effluent discharge and treatment facility upgrades on environmental and biological conditions of the upper Blue River, Johnson County, Kansas and Jackson County, Missouri, January 2003 through March 2009 /', 'Effects of Air Pollutants on Ecological Resources : Literature Review and Case Studies', '2013 Freshwater Aquatic Life Ambient Water Quality Criteria for Ammonia', 'Impact of ammonia emissions from agriculture on biodiversity']","['https://www.epa.gov/sites/default/files/2015-07/documents/feb10_ecologicalres_draft.pdf', 'https://www.epa.gov/sites/production/files/2015-08/documents/aquatic-life-ambient-water-quality-criteria-for-ammonia-freshwater-2013.pdf', 'https://purl.fdlp.gov/GPO/gpo106600']","['9986_4_effects of air pollutants on ecological resources  literature review and case studies.pdf', '9986_5_2013 freshwater aquatic life ambient water quality criteria for ammonia.pdf', '9986_2_agriculturea river runs through it \xa0the connections between agriculture and water quality .pdf']",3,42.86,"['https://www.epa.gov/sites/default/files/2015-07/documents/feb10_ecologicalres_draft.pdf', 'https://www.epa.gov/sites/production/files/2015-08/documents/aquatic-life-ambient-water-quality-criteria-for-ammonia-freshwater-2013.pdf', 'https://purl.fdlp.gov/GPO/gpo106600']","['9986_4_effects of air pollutants on ecological resources  literature review and case studies.pdf', '9986_5_2013 freshwater aquatic life ambient water quality criteria for ammonia.pdf', '9986_2_agriculturea river runs through it \xa0the connections between agriculture and water quality .pdf']","[0.256, 0.446, 0.489]","[0.482, 0.483, 0.479]","[0.583, 0.58, 0.582]","[0.133, 0.138, 0.12]","[0.123, 0.135, 0.1]","[0.11, 0.122, 0.089]","[0.735, 0.743, 0.729]","[0.644, 0.654, 0.633]","[0.55, 0.554, 0.551]","[0.68, 0.693, 0.648]","[0.784, 0.781, 0.786]","[0.654, 0.642, 0.673]","[0.612, 0.615, 0.62]","[0.899, 0.896, 0.899]","[0.786, 0.788, 0.792]","[0.735, 0.736, 0.748]","[0.776, 0.77, 0.785]","[0.77, 0.768, 0.772]",0.397,0.481,0.582,0.13,0.119,0.107,0.736,0.644,0.552,0.674,0.784,0.656,0.616,0.898,0.789,0.74,0.777,0.77
https://doi.org/10.1016/j.envint.2016.10.015,exposure to perfluoroalkyl substances and thyroid function in pregnant women and children a systematic review of epidemiologic studies,10020_exposure to perfluoroalkyl substances and thyroid function in pregnant women and children a systematic review of epidemiologic studies.pdf,7,"['https://stacks.cdc.gov/view/cdc/84242', 'https://www.ezview.wa.gov/Portals/_1962/Documents/PFAS/Health-091917.pdf', 'https://www.ezview.wa.gov/Portals/_1962/Documents/PFAS/HealthChapter-FCComments2017-1019.pdf', 'https://files.nc.gov/ncdeq/sab/Blake-et-al.-2020.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://mde.maryland.gov/PublicHealth/Documents/MDH_PFHxS%20Advisory%20Fact%20Sheet.pdf', 'https://www.michigan.gov/documents/pfasresponse/Science_Advisory_Board_Report_641294_7.pdf?link_id=15&can_id=0e9c68c5b3095f0fdca05cf3f9a58935&source=email-the-million-parts-per-trillion-tour&email_referrer=email_508214&email_subject=the-million-parts-per-trillion-tour']","['PFAS : an overview of the science and guidance for clinicians on per- and polyfluoroalkyl substances (PFAS)', 'Submit comments, suggestions, and questions to Kara Steward at kara. steward@ ecy. wa. gov.', 'Submit comments, suggestions, and questions to Kara Steward at kara. steward@ ecy. wa. gov.', 'Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (P', 'Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Maryland Department of Health Health Advisory on Perfluorohexane Sulfonic Acid (PFHxS) in Drinking Water', 'Scientific Evidence and Recommendations for .Managing PFAS Contamination .in Michigan']","['https://www.ezview.wa.gov/Portals/_1962/Documents/PFAS/Health-091917.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://files.nc.gov/ncdeq/sab/Blake-et-al.-2020.pdf', 'https://www.michigan.gov/documents/pfasresponse/Science_Advisory_Board_Report_641294_7.pdf?link_id=15&can_id=0e9c68c5b3095f0fdca05cf3f9a58935&source=email-the-million-parts-per-trillion-tour&email_referrer=email_508214&email_subject=the-million-parts-per-trillion-tour', 'https://mde.maryland.gov/PublicHealth/Documents/MDH_PFHxS%20Advisory%20Fact%20Sheet.pdf', 'https://www.ezview.wa.gov/Portals/_1962/Documents/PFAS/HealthChapter-FCComments2017-1019.pdf']","['10020_1_submit comments suggestions and questions to kara steward at kara steward ecy wa gov.pdf', '10020_4_per and polyfluoroalkyl substances chemical action plan.pdf', '10020_3_evaluation of maternal embryo and placental effects in cd1 mice following gestational exposure to perfluorooctanoic acid p.pdf', '10020_6_scientific evidence and recommendations for managing pfas contamination in michigan.pdf', '10020_5_maryland department of health health advisory on perfluorohexane sulfonic acid pfhxs in drinking water.pdf', '10020_2_submit comments suggestions and questions to kara steward at kara steward ecy wa gov.pdf']",6,85.71,"['https://www.ezview.wa.gov/Portals/_1962/Documents/PFAS/Health-091917.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://files.nc.gov/ncdeq/sab/Blake-et-al.-2020.pdf', 'https://www.michigan.gov/documents/pfasresponse/Science_Advisory_Board_Report_641294_7.pdf?link_id=15&can_id=0e9c68c5b3095f0fdca05cf3f9a58935&source=email-the-million-parts-per-trillion-tour&email_referrer=email_508214&email_subject=the-million-parts-per-trillion-tour', 'https://mde.maryland.gov/PublicHealth/Documents/MDH_PFHxS%20Advisory%20Fact%20Sheet.pdf', 'https://www.ezview.wa.gov/Portals/_1962/Documents/PFAS/HealthChapter-FCComments2017-1019.pdf']","['10020_1_submit comments suggestions and questions to kara steward at kara steward ecy wa gov.pdf', '10020_4_per and polyfluoroalkyl substances chemical action plan.pdf', '10020_3_evaluation of maternal embryo and placental effects in cd1 mice following gestational exposure to perfluorooctanoic acid p.pdf', '10020_6_scientific evidence and recommendations for managing pfas contamination in michigan.pdf', '10020_5_maryland department of health health advisory on perfluorohexane sulfonic acid pfhxs in drinking water.pdf', '10020_2_submit comments suggestions and questions to kara steward at kara steward ecy wa gov.pdf']","[0.609, 0.609, 0.46, 0.429, 0.169, 0.513]","[0.484, 0.479, 0.503, 0.484, 0.477, 0.484]","[0.586, 0.581, 0.605, 0.595, 0.59, 0.587]","[0.147, 0.126, 0.156, 0.142, 0.137, 0.147]","[0.148, 0.124, 0.146, 0.136, 0.138, 0.148]","[0.123, 0.102, 0.112, 0.11, 0.105, 0.123]","[0.735, 0.729, 0.739, 0.733, 0.729, 0.735]","[0.647, 0.638, 0.652, 0.645, 0.642, 0.647]","[0.555, 0.55, 0.564, 0.556, 0.546, 0.556]","[0.685, 0.66, 0.668, 0.666, 0.655, 0.687]","[0.79, 0.785, 0.79, 0.787, 0.792, 0.79]","[0.663, 0.668, 0.675, 0.674, 0.671, 0.663]","[0.601, 0.61, 0.614, 0.612, 0.604, 0.602]","[0.907, 0.909, 0.901, 0.903, 0.896, 0.907]","[0.801, 0.805, 0.813, 0.806, 0.804, 0.802]","[0.736, 0.74, 0.748, 0.743, 0.739, 0.737]","[0.773, 0.772, 0.778, 0.774, 0.778, 0.773]","[0.766, 0.766, 0.768, 0.766, 0.771, 0.766]",0.465,0.485,0.591,0.143,0.14,0.112,0.733,0.645,0.554,0.67,0.789,0.669,0.607,0.904,0.805,0.74,0.775,0.767
https://doi.org/10.1016/j.envint.2018.09.013,phthalates and organophosphates in settled dust and hvac filter dust of us lowincome homes association with season building characteristics and childhood asthma,10031_phthalates and organophosphates in settled dust and hvac filter dust of us lowincome homes association with season building characteristics and childhood asthma.pdf,1,['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['Draft Regulatory Determinations: Report to the Legislature'],['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['10031_0_draft regulatory determinations report to the legislature.pdf'],1,100.0,['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['10031_0_draft regulatory determinations report to the legislature.pdf'],[0.158],[0.466],[0.566],[0.117],[0.121],[0.101],[0.731],[0.64],[0.528],[0.683],[0.765],[0.641],[0.608],[0.905],[0.788],[0.723],[0.759],[0.754],0.158,0.466,0.566,0.117,0.121,0.101,0.731,0.64,0.528,0.683,0.765,0.641,0.608,0.905,0.788,0.723,0.759,0.754
https://doi.org/10.1016/j.envint.2018.10.043,prenatal concurrent and sexspecific associations between blood lead concentrations and iq in preschool canadian children,10033_prenatal concurrent and sexspecific associations between blood lead concentrations and iq in preschool canadian children.pdf,1,['https://purl.fdlp.gov/GPO/gpo144830'],['Toxicological profile for lead /'],['https://purl.fdlp.gov/GPO/gpo144830'],['10033_0_toxicological profile for lead .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo144830'],['10033_0_toxicological profile for lead .pdf'],[0.712],[0.481],[0.581],[0.143],[0.15],[0.128],[0.738],[0.648],[0.548],[0.703],[0.773],[0.659],[0.603],[0.908],[0.774],[0.722],[0.752],[0.749],0.712,0.481,0.581,0.143,0.15,0.128,0.738,0.648,0.548,0.703,0.773,0.659,0.603,0.908,0.774,0.722,0.752,0.749
https://doi.org/10.1016/j.envint.2018.12.041,maternal levels of perfluoroalkyl substances pfass during pregnancy and childhood allergy and asthma related outcomes and infections in the norwegian mother and child moba cohort,10034_maternal levels of perfluoroalkyl substances pfass during pregnancy and childhood allergy and asthma related outcomes and infections in the norwegian mother and child moba cohort.pdf,2,"['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf']","['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft', 'Per- and Polyfluoroalkyl Substances Chemical Action Plan']","['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf']","['10034_1_per and polyfluoroalkyl substances chemical action plan.pdf', '10034_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf']",2,100.0,"['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf']","['10034_1_per and polyfluoroalkyl substances chemical action plan.pdf', '10034_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf']","[0.547, 0.314]","[0.485, 0.497]","[0.582, 0.592]","[0.123, 0.139]","[0.12, 0.14]","[0.096, 0.114]","[0.725, 0.735]","[0.63, 0.644]","[0.557, 0.564]","[0.649, 0.684]","[0.784, 0.784]","[0.681, 0.673]","[0.615, 0.619]","[0.911, 0.908]","[0.806, 0.806]","[0.743, 0.743]","[0.779, 0.778]","[0.768, 0.766]",0.43,0.491,0.587,0.131,0.13,0.105,0.73,0.637,0.56,0.667,0.784,0.677,0.617,0.909,0.806,0.743,0.778,0.767
https://doi.org/10.1016/j.envint.2019.03.041,traffic related air pollution and the burden of childhood asthma in the contiguous united states in 2000 and 2010,10035_traffic related air pollution and the burden of childhood asthma in the contiguous united states in 2000 and 2010.pdf,3,"['https://www.federalregister.gov/documents/2022/03/28/2022-04934/control-of-air-pollution-from-new-motor-vehicles-heavy-duty-engine-and-vehicle-standards', 'https://www.sanjoseca.gov/Home/ShowDocument?id=59127', 'https://www.dec.ny.gov/docs/air_pdf/albanysouthendreport.pdf']","['Control of Air Pollution From New Motor Vehicles: Heavy-Duty Engine and Vehicle Standards', 'Draft Environmental Impact Report', 'Albany South End Community Air Quality Study']","['https://www.sanjoseca.gov/Home/ShowDocument?id=59127', 'https://www.dec.ny.gov/docs/air_pdf/albanysouthendreport.pdf']","['10035_1_draft environmental impact report.pdf', '10035_2_albany south end community air quality study.pdf']",2,66.67,"['https://www.sanjoseca.gov/Home/ShowDocument?id=59127', 'https://www.dec.ny.gov/docs/air_pdf/albanysouthendreport.pdf']","['10035_1_draft environmental impact report.pdf', '10035_2_albany south end community air quality study.pdf']","[0.173, 0.316]","[0.503, 0.5]","[0.591, 0.595]","[0.119, 0.138]","[0.123, 0.141]","[0.094, 0.117]","[0.713, 0.729]","[0.612, 0.632]","[0.575, 0.564]","[0.681, 0.707]","[0.789, 0.779]","[0.704, 0.693]","[0.642, 0.635]","[0.912, 0.907]","[0.828, 0.814]","[0.751, 0.739]","[0.794, 0.782]","[0.777, 0.767]",0.244,0.502,0.593,0.129,0.132,0.106,0.721,0.622,0.569,0.694,0.784,0.698,0.639,0.909,0.821,0.745,0.788,0.772
https://doi.org/10.1016/j.envint.2019.104921,reduction of hazardous chemicals in swedish preschool dust through article substitution actions,10036_reduction of hazardous chemicals in swedish preschool dust through article substitution actions.pdf,1,['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['Draft Regulatory Determinations: Report to the Legislature'],['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['10036_0_draft regulatory determinations report to the legislature.pdf'],1,100.0,['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['10036_0_draft regulatory determinations report to the legislature.pdf'],[0.25],[0.485],[0.578],[0.134],[0.141],[0.115],[0.731],[0.641],[0.551],[0.68],[0.774],[0.669],[0.625],[0.907],[0.803],[0.744],[0.773],[0.766],0.25,0.485,0.578,0.134,0.141,0.115,0.731,0.641,0.551,0.68,0.774,0.669,0.625,0.907,0.803,0.744,0.773,0.766
https://doi.org/10.1016/j.envint.2019.104983,prenatal exposure to per and polyfluoroalkyl substances and infant growth and adiposity the healthy start study,10037_prenatal exposure to per and polyfluoroalkyl substances and infant growth and adiposity the healthy start study.pdf,1,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft'],['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['10037_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,100.0,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['10037_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.641],[0.49],[0.59],[0.147],[0.145],[0.122],[0.739],[0.651],[0.557],[0.693],[0.787],[0.661],[0.608],[0.909],[0.792],[0.737],[0.772],[0.761],0.641,0.49,0.59,0.147,0.145,0.122,0.739,0.651,0.557,0.693,0.787,0.661,0.608,0.909,0.792,0.737,0.772,0.761
https://doi.org/10.1016/j.envint.2019.105259,perfluoroalkyl substances airways infections allergy and asthma related health outcomes – implications of gender exposure period and study design,10038_perfluoroalkyl substances airways infections allergy and asthma related health outcomes – implications of gender exposure period and study design.pdf,1,['https://apps.ecology.wa.gov/publications/documents/2104048.pdf'],['Per- and Polyfluoroalkyl Substances Chemical Action Plan'],['https://apps.ecology.wa.gov/publications/documents/2104048.pdf'],['10038_0_per and polyfluoroalkyl substances chemical action plan.pdf'],1,100.0,['https://apps.ecology.wa.gov/publications/documents/2104048.pdf'],['10038_0_per and polyfluoroalkyl substances chemical action plan.pdf'],[0.31],[0.492],[0.58],[0.134],[0.132],[0.107],[0.728],[0.633],[0.563],[0.656],[0.788],[0.673],[0.616],[0.91],[0.813],[0.742],[0.78],[0.768],0.31,0.492,0.58,0.134,0.132,0.107,0.728,0.633,0.563,0.656,0.788,0.673,0.616,0.91,0.813,0.742,0.78,0.768
https://doi.org/10.1016/j.envint.2020.106104,effects of prenatal exposure and coexposure to metallic or metalloid elements on early infant neurodevelopmental outcomes in areas with smallscale gold mining activities in northern tanzania,10041_effects of prenatal exposure and coexposure to metallic or metalloid elements on early infant neurodevelopmental outcomes in areas with smallscale gold mining activities in northern tanzania.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['Provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['10041_0_provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522704/pdf'],['10041_0_provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults.pdf'],[0.392],[0.49],[0.59],[0.145],[0.149],[0.122],[0.736],[0.644],[0.553],[0.688],[0.77],[0.669],[0.595],[0.9],[0.79],[0.708],[0.762],[0.747],0.392,0.49,0.59,0.145,0.149,0.122,0.736,0.644,0.553,0.688,0.77,0.669,0.595,0.9,0.79,0.708,0.762,0.747
https://doi.org/10.1016/j.envint.2020.106204,hexafluoropropylene oxidedimer acid hfpoda or genx alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality low birthweight and hepatomegaly in the spraguedawley rat,10042_hexafluoropropylene oxidedimer acid hfpoda or genx alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality low birthweight and hepatomegaly in the spraguedawley rat.pdf,3,"['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.epa.gov/system/files/documents/2021-10/genx-chemicals-toxicity-assessment_tech-edited_oct-21-508.pdf', 'https://files.nc.gov/ncdeq/sab/FINAL-SAB-April-2021-Meeting-Minutes.pdf']","['Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Human Health Toxicity Values for Hexafluoropropylene Oxide Dimer Acid and Its Ammonium Salt, Also Known as “GenX Chemicals”', 'Secretaries ’ Science Advisory Board']","['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.epa.gov/system/files/documents/2021-10/genx-chemicals-toxicity-assessment_tech-edited_oct-21-508.pdf', 'https://files.nc.gov/ncdeq/sab/FINAL-SAB-April-2021-Meeting-Minutes.pdf']","['10042_0_per and polyfluoroalkyl substances chemical action plan.pdf', '10042_1_human health toxicity values for hexafluoropropylene oxide dimer acid and its ammonium salt also known as “genx chemicals”.pdf', '10042_2_secretaries  science advisory board.pdf']",3,100.0,"['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.epa.gov/system/files/documents/2021-10/genx-chemicals-toxicity-assessment_tech-edited_oct-21-508.pdf', 'https://files.nc.gov/ncdeq/sab/FINAL-SAB-April-2021-Meeting-Minutes.pdf']","['10042_0_per and polyfluoroalkyl substances chemical action plan.pdf', '10042_1_human health toxicity values for hexafluoropropylene oxide dimer acid and its ammonium salt also known as “genx chemicals”.pdf', '10042_2_secretaries  science advisory board.pdf']","[0.328, 0.482, 0.088]","[0.481, 0.5, 0.471]","[0.581, 0.596, 0.567]","[0.117, 0.152, 0.102]","[0.116, 0.145, 0.1]","[0.096, 0.117, 0.079]","[0.727, 0.734, 0.715]","[0.634, 0.641, 0.617]","[0.555, 0.566, 0.541]","[0.648, 0.673, 0.646]","[0.781, 0.784, 0.783]","[0.668, 0.667, 0.681]","[0.619, 0.633, 0.603]","[0.91, 0.904, 0.907]","[0.797, 0.808, 0.813]","[0.739, 0.746, 0.729]","[0.774, 0.782, 0.774]","[0.765, 0.771, 0.754]",0.299,0.484,0.581,0.124,0.12,0.097,0.725,0.631,0.554,0.656,0.783,0.672,0.618,0.907,0.806,0.738,0.777,0.763
https://doi.org/10.1016/j.envpol.2016.12.013,a first overview of textile fibers including microplastics in indoor and outdoor environments,10069_a first overview of textile fibers including microplastics in indoor and outdoor environments.pdf,6,"['https://stacks.cdc.gov/view/cdc/116530', 'https://www.pacificresearch.org/a-little-truth-about-microplastics/', 'https://www.congress.gov/event/116th-congress/house-event/110151', 'https://www.congress.gov/event/116th-congress/house-event/LC64690/text', 'https://www.ciel.org/reports/plastic-health-the-hidden-costs-of-a-plastic-planet-february-2019/', 'https://www.epa.gov/sites/default/files/2018-03/documents/microplastics_expert_workshop_report_final_12-4-17.pdf']","['NCEH/ATSDR Microplastic Scoping Review EndNote Library of all abstracts', 'A Little Truth About Microplastics - Pacific Research Institute', 'A Sea of Problems: Impacts of Plastic Pollution on Oceans and Wildlife', 'House Hearing, 116th Congress — OVERSIGHT HEARING ON A SEA OF PROBLEMS: IMPACTS OF PLASTIC POLLUTION ON OCEANS AND WILDLIFE', 'Plastic & Health: The Hidden Costs of a Plastic Planet (February 2019)', 'Microplastics Expert Workshop Report']",['https://www.epa.gov/sites/default/files/2018-03/documents/microplastics_expert_workshop_report_final_12-4-17.pdf'],['10069_5_microplastics expert workshop report.pdf'],1,16.67,['https://www.epa.gov/sites/default/files/2018-03/documents/microplastics_expert_workshop_report_final_12-4-17.pdf'],['10069_5_microplastics expert workshop report.pdf'],[0.288],[0.502],[0.591],[0.147],[0.144],[0.129],[0.738],[0.64],[0.561],[0.692],[0.778],[0.682],[0.629],[0.897],[0.811],[0.738],[0.781],[0.771],0.288,0.502,0.591,0.147,0.144,0.129,0.738,0.64,0.561,0.692,0.778,0.682,0.629,0.897,0.811,0.738,0.781,0.771
https://doi.org/10.1016/j.envpol.2020.114465,can atmospheric pollution be considered a cofactor in extremely high level of sarscov2 lethality in northern italy,10079_can atmospheric pollution be considered a cofactor in extremely high level of sarscov2 lethality in northern italy.pdf,2,"['https://wildlandfire.az.gov/sites/default/files/USFS_WildfireSmoke-Covid19.pdf', 'https://stacks.cdc.gov/view/cdc/88968']","['Wildfire Smoke and COVID-19 Fact Sheet', 'Wildfire smoke and COVID-19 : frequently asked questions and resources for air resource advisors and other environmental health professionals']",['https://wildlandfire.az.gov/sites/default/files/USFS_WildfireSmoke-Covid19.pdf'],['10079_0_wildfire smoke and covid19 fact sheet.pdf'],1,50.0,['https://wildlandfire.az.gov/sites/default/files/USFS_WildfireSmoke-Covid19.pdf'],['10079_0_wildfire smoke and covid19 fact sheet.pdf'],[0.2],[0.479],[0.585],[0.128],[0.149],[0.113],[0.733],[0.637],[0.547],[0.658],[0.783],[0.689],[0.6],[0.905],[0.811],[0.737],[0.78],[0.769],0.2,0.479,0.585,0.128,0.149,0.113,0.733,0.637,0.547,0.658,0.783,0.689,0.6,0.905,0.811,0.737,0.78,0.769
https://doi.org/10.1016/j.envpol.2021.116619,associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections recent findings from nhanes 1999–2016,10080_associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections recent findings from nhanes 1999–2016.pdf,1,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft'],['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['10080_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,100.0,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['10080_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.611],[0.488],[0.591],[0.14],[0.136],[0.114],[0.739],[0.648],[0.551],[0.689],[0.778],[0.648],[0.613],[0.905],[0.794],[0.731],[0.766],[0.757],0.611,0.488,0.591,0.14,0.136,0.114,0.739,0.648,0.551,0.689,0.778,0.648,0.613,0.905,0.794,0.731,0.766,0.757
https://doi.org/10.1016/j.envres.2014.07.004,nonylphenol in pregnant women and their matching fetuses placental transfer and potential risks of infants,10120_nonylphenol in pregnant women and their matching fetuses placental transfer and potential risks of infants.pdf,2,"['https://www.ezview.wa.gov/Portals/_1962/Documents/saferproducts/Priority%20Consumer%20Products%20%E2%80%93%20Report%20to%20the%20Legislature.pdf', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf']","['Priority Consumer Products – Report to the Legislature', 'Draft Priority Product Report, Safer Products for Washington']","['https://www.ezview.wa.gov/Portals/_1962/Documents/saferproducts/Priority%20Consumer%20Products%20%E2%80%93%20Report%20to%20the%20Legislature.pdf', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf']","['10120_0_priority consumer products – report to the legislature.pdf', '10120_1_draft priority product report safer products for washington.pdf']",2,100.0,"['https://www.ezview.wa.gov/Portals/_1962/Documents/saferproducts/Priority%20Consumer%20Products%20%E2%80%93%20Report%20to%20the%20Legislature.pdf', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf']","['10120_0_priority consumer products – report to the legislature.pdf', '10120_1_draft priority product report safer products for washington.pdf']","[0.311, 0.348]","[0.468, 0.47]","[0.565, 0.568]","[0.11, 0.112]","[0.115, 0.117]","[0.098, 0.097]","[0.732, 0.731]","[0.639, 0.638]","[0.534, 0.535]","[0.663, 0.657]","[0.768, 0.771]","[0.623, 0.626]","[0.601, 0.605]","[0.895, 0.894]","[0.783, 0.786]","[0.72, 0.725]","[0.757, 0.76]","[0.753, 0.754]",0.33,0.469,0.567,0.111,0.116,0.098,0.732,0.639,0.534,0.66,0.77,0.625,0.603,0.895,0.784,0.722,0.758,0.754
https://doi.org/10.1016/j.envres.2017.07.051,phthalate and bisphenol a exposure during in utero windows of susceptibility in relation to reproductive hormones and pubertal development in girls,10140_phthalate and bisphenol a exposure during in utero windows of susceptibility in relation to reproductive hormones and pubertal development in girls.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['10140_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['10140_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.557],[0.477],[0.579],[0.136],[0.132],[0.112],[0.74],[0.65],[0.543],[0.688],[0.778],[0.645],[0.606],[0.9],[0.781],[0.729],[0.762],[0.756],0.557,0.477,0.579,0.136,0.132,0.112,0.74,0.65,0.543,0.688,0.778,0.645,0.606,0.9,0.781,0.729,0.762,0.756
https://doi.org/10.1016/j.envres.2019.03.060,wildland firefighter smoke exposure and risk of lung cancer and cardiovascular disease mortality,10150_wildland firefighter smoke exposure and risk of lung cancer and cardiovascular disease mortality.pdf,2,"['https://stacks.cdc.gov/view/cdc/121301', 'https://purl.fdlp.gov/GPO/gpo141809']","['National Firefighter Registry (NFR) protocol', 'Final human health and ecological risk assessment for carbaryl Rangeland grasshopper and Mormon cricket suppression applications.']",['https://purl.fdlp.gov/GPO/gpo141809'],['10150_1_final human health and ecological risk assessment for carbaryl rangeland grasshopper and mormon cricket suppression applications.pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo141809'],['10150_1_final human health and ecological risk assessment for carbaryl rangeland grasshopper and mormon cricket suppression applications.pdf'],[0.317],[0.486],[0.577],[0.126],[0.122],[0.1],[0.731],[0.642],[0.543],[0.673],[0.774],[0.65],[0.624],[0.901],[0.785],[0.731],[0.767],[0.755],0.317,0.486,0.577,0.126,0.122,0.1,0.731,0.642,0.543,0.673,0.774,0.65,0.624,0.901,0.785,0.731,0.767,0.755
https://doi.org/10.1016/j.envres.2019.108643,early childhood lead exposure and the persistence of educational consequences into adolescence,10153_early childhood lead exposure and the persistence of educational consequences into adolescence.pdf,1,['https://purl.fdlp.gov/GPO/gpo144830'],['Toxicological profile for lead /'],['https://purl.fdlp.gov/GPO/gpo144830'],['10153_0_toxicological profile for lead .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo144830'],['10153_0_toxicological profile for lead .pdf'],[0.457],[0.484],[0.586],[0.137],[0.137],[0.114],[0.731],[0.637],[0.55],[0.685],[0.773],[0.672],[0.609],[0.91],[0.789],[0.73],[0.765],[0.757],0.457,0.484,0.586,0.137,0.137,0.114,0.731,0.637,0.55,0.685,0.773,0.672,0.609,0.91,0.789,0.73,0.765,0.757
https://doi.org/10.1016/j.eururo.2019.04.026,oncologic outcomes following partial nephrectomy and percutaneous ablation for ct1 renal masses,10214_oncologic outcomes following partial nephrectomy and percutaneous ablation for ct1 renal masses.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246015/pdf'],['Asian Conference on Tumor Ablation guidelines for renal cell carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246015/pdf'],['10214_0_asian conference on tumor ablation guidelines for renal cell carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246015/pdf'],['10214_0_asian conference on tumor ablation guidelines for renal cell carcinoma.pdf'],[0.45],[0.534],[0.611],[0.179],[0.174],[0.132],[0.743],[0.651],[0.589],[0.663],[0.793],[0.663],[0.624],[0.909],[0.82],[0.758],[0.792],[0.778],0.45,0.534,0.611,0.179,0.174,0.132,0.743,0.651,0.589,0.663,0.793,0.663,0.624,0.909,0.82,0.758,0.792,0.778
https://doi.org/10.1016/j.fertnstert.2018.07.455,a randomized pilot trial update an internetbased mindbody intervention to mitigate distress in women experiencing infertility,10290_a randomized pilot trial update an internetbased mindbody intervention to mitigate distress in women experiencing infertility.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf'],['Preconception lifestyle advice for people with infertility'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf'],['10290_0_preconception lifestyle advice for people with infertility.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092458/pdf'],['10290_0_preconception lifestyle advice for people with infertility.pdf'],[0.217],[0.531],[0.608],[0.169],[0.169],[0.139],[0.731],[0.632],[0.595],[0.672],[0.777],[0.701],[0.59],[0.906],[0.804],[0.73],[0.784],[0.755],0.217,0.531,0.608,0.169,0.169,0.139,0.731,0.632,0.595,0.672,0.777,0.701,0.59,0.906,0.804,0.73,0.784,0.755
https://doi.org/10.1016/j.fertnstert.2019.07.155,babies born following administration of nolasiban before embryo transfer et after ivf neonatal and infant development outcomes from a doubleblind placebocontrolled clinical trial,10291_babies born following administration of nolasiban before embryo transfer et after ivf neonatal and infant development outcomes from a doubleblind placebocontrolled clinical trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408576/pdf'],['Oxytocin antagonists for assisted reproduction'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408576/pdf'],['10291_0_oxytocin antagonists for assisted reproduction.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408576/pdf'],['10291_0_oxytocin antagonists for assisted reproduction.pdf'],[0.308],[0.52],[0.594],[0.165],[0.152],[0.124],[0.736],[0.639],[0.586],[0.659],[0.771],[0.688],[0.603],[0.907],[0.792],[0.718],[0.772],[0.746],0.308,0.52,0.594,0.165,0.152,0.124,0.736,0.639,0.586,0.659,0.771,0.688,0.603,0.907,0.792,0.718,0.772,0.746
https://doi.org/10.1016/j.fishres.2019.105350,growth survivorship and juvenile physiology of triploid steelhead oncorhynchus mykiss,10299_growth survivorship and juvenile physiology of triploid steelhead oncorhynchus mykiss.pdf,2,"['https://wdfw.wa.gov/sites/default/files/2020-01/marine_aquaculture_permit_justification.pdf', 'https://wdfw.wa.gov/sites/default/files/2020-01/marine_aquaculture_permit_justification-01-31-20.pdf']","['Justification for the Mitigated Determination of Non-Significance (MDNS) for Washington Department of Fish and Wildlife SEPA 19-056 and for the Approval of Cooke Aquaculture Pacific ’ s Marine Aquaculture Permit Application', 'Justification for the Mitigated Determination of Non-Significance (MDNS)']",['https://wdfw.wa.gov/sites/default/files/2020-01/marine_aquaculture_permit_justification-01-31-20.pdf'],['10299_1_justification for the mitigated determination of nonsignificance mdns.pdf'],1,50.0,['https://wdfw.wa.gov/sites/default/files/2020-01/marine_aquaculture_permit_justification-01-31-20.pdf'],['10299_1_justification for the mitigated determination of nonsignificance mdns.pdf'],[0.482],[0.499],[0.592],[0.143],[0.152],[0.122],[0.737],[0.646],[0.559],[0.667],[0.786],[0.676],[0.643],[0.897],[0.788],[0.749],[0.78],[0.774],0.482,0.499,0.592,0.143,0.152,0.122,0.737,0.646,0.559,0.667,0.786,0.676,0.643,0.897,0.788,0.749,0.78,0.774
https://doi.org/10.1016/j.fitote.2019.104281,steroidal alkaloid variation in veratrum californicum as determined by modern methods of analytical analysis,10300_steroidal alkaloid variation in veratrum californicum as determined by modern methods of analytical analysis.pdf,1,['https://boardofed.idaho.gov/wp-content/uploads/2021/09/Owen-McDougal-BSU-IGEM-FY22.pdf'],['7 / 1 / 2021 7 / 1 / 2024 Boise State University'],['https://boardofed.idaho.gov/wp-content/uploads/2021/09/Owen-McDougal-BSU-IGEM-FY22.pdf'],['10300_0_7  1  2021 7  1  2024 boise state university.pdf'],1,100.0,['https://boardofed.idaho.gov/wp-content/uploads/2021/09/Owen-McDougal-BSU-IGEM-FY22.pdf'],['10300_0_7  1  2021 7  1  2024 boise state university.pdf'],[0.115],[0.487],[0.584],[0.083],[0.073],[0.059],[0.722],[0.627],[0.569],[0.62],[0.793],[0.699],[0.631],[0.901],[0.815],[0.756],[0.799],[0.784],0.115,0.487,0.584,0.083,0.073,0.059,0.722,0.627,0.569,0.62,0.793,0.699,0.631,0.901,0.815,0.756,0.799,0.784
https://doi.org/10.1016/j.fsi.2018.10.053,copper nanoparticles induced oxidation stress cell apoptosis and immune response in the liver of juvenile takifugu fasciatus,10345_copper nanoparticles induced oxidation stress cell apoptosis and immune response in the liver of juvenile takifugu fasciatus.pdf,1,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['Antifouling Paints in Washington State Report and Recommendations'],['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['10345_0_antifouling paints in washington state report and recommendations.pdf'],1,100.0,['https://fortress.wa.gov/ecy/publications/documents/1904020.pdf'],['10345_0_antifouling paints in washington state report and recommendations.pdf'],[0.144],[0.479],[0.582],[0.108],[0.108],[0.093],[0.731],[0.636],[0.561],[0.653],[0.779],[0.662],[0.606],[0.908],[0.807],[0.736],[0.777],[0.768],0.144,0.479,0.582,0.108,0.108,0.093,0.731,0.636,0.561,0.653,0.779,0.662,0.606,0.908,0.807,0.736,0.777,0.768
https://doi.org/10.1016/j.fsigen.2019.06.012,the congenital disorder of glycosylation in pgm1 pgm1cdg can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood,10347_the congenital disorder of glycosylation in pgm1 pgm1cdg can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268/pdf'],"['International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268/pdf'],['10347_0_international consensus guidelines for phosphoglucomutase 1 deficiency pgm1cdg diagnosis followup and management.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268/pdf'],['10347_0_international consensus guidelines for phosphoglucomutase 1 deficiency pgm1cdg diagnosis followup and management.pdf'],[0.339],[0.512],[0.611],[0.163],[0.168],[0.118],[0.738],[0.64],[0.583],[0.642],[0.781],[0.693],[0.609],[0.911],[0.796],[0.745],[0.783],[0.771],0.339,0.512,0.611,0.163,0.168,0.118,0.738,0.64,0.583,0.642,0.781,0.693,0.609,0.911,0.796,0.745,0.783,0.771
https://doi.org/10.1016/j.gfs.2016.07.009,impact of cash transfer programs on food security and nutrition in subsaharan africa a crosscountry analysis,10388_impact of cash transfer programs on food security and nutrition in subsaharan africa a crosscountry analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486161/pdf'],['Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486161/pdf'],['10388_0_unconditional cash transfers for reducing poverty and vulnerabilities effect on use of health services and health outcomes in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486161/pdf'],['10388_0_unconditional cash transfers for reducing poverty and vulnerabilities effect on use of health services and health outcomes in low‐ and middle‐income countries.pdf'],[0.338],[0.525],[0.619],[0.153],[0.166],[0.128],[0.72],[0.624],[0.587],[0.704],[0.789],[0.704],[0.619],[0.913],[0.827],[0.737],[0.789],[0.766],0.338,0.525,0.619,0.153,0.166,0.128,0.72,0.624,0.587,0.704,0.789,0.704,0.619,0.913,0.827,0.737,0.789,0.766
https://doi.org/10.1016/j.ihj.2020.03.005,predictors of mortality strategies to reduce readmission and economic impact of acute decompensated heart failure results of the vellore heart failure registry,10493_predictors of mortality strategies to reduce readmission and economic impact of acute decompensated heart failure results of the vellore heart failure registry.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231859/pdf'],"['Predictors of mortality, strategies to reduce readmission, and economic impact of acute decompensated heart failure: Results of the Vellore Heart Failure Registry']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231859/pdf'],['10493_0_predictors of mortality strategies to reduce readmission and economic impact of acute decompensated heart failure results of the vellore heart failure registry.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231859/pdf'],['10493_0_predictors of mortality strategies to reduce readmission and economic impact of acute decompensated heart failure results of the vellore heart failure registry.pdf'],[1.0],[0.511],[0.586],[0.18],[0.19],[0.152],[0.742],[0.644],[0.56],[0.711],[0.764],[0.674],[0.617],[0.902],[0.805],[0.733],[0.769],[0.752],1.0,0.511,0.586,0.18,0.19,0.152,0.742,0.644,0.56,0.711,0.764,0.674,0.617,0.902,0.805,0.733,0.769,0.752
https://doi.org/10.1016/j.ijantimicag.2020.106179,emerging copathogens new delhi metallobetalactamase producing enterobacterales infections in new york city covid19 patients,10494_emerging copathogens new delhi metallobetalactamase producing enterobacterales infections in new york city covid19 patients.pdf,1,['http://healthcarereportcard.illinois.gov/files/pdf/CRAB_2020Report_FINAL.pdf'],['Illinois Carbapenem-Resistant'],['http://healthcarereportcard.illinois.gov/files/pdf/CRAB_2020Report_FINAL.pdf'],['10494_0_illinois carbapenemresistant.pdf'],1,100.0,['http://healthcarereportcard.illinois.gov/files/pdf/CRAB_2020Report_FINAL.pdf'],['10494_0_illinois carbapenemresistant.pdf'],[0.234],[0.559],[0.641],[0.19],[0.21],[0.161],[0.742],[0.656],[0.621],[0.672],[0.807],[0.738],[0.621],[0.923],[0.827],[0.77],[0.805],[0.794],0.234,0.559,0.641,0.19,0.21,0.161,0.742,0.656,0.621,0.672,0.807,0.738,0.621,0.923,0.827,0.77,0.805,0.794
https://doi.org/10.1016/j.ijedudev.2020.102326,modelling the longrun learning impact of the covid19 learning shock actions to more than mitigate loss,10526_modelling the longrun learning impact of the covid19 learning shock actions to more than mitigate loss.pdf,3,"['https://www.michigan.gov/documents/dtmb/MI_Blueprint_for_Comprehensive_Student_Recovery_725617_7.pdf', 'https://www.cgdev.org/publication/learning-loss-and-student-dropouts-during-covid-19-pandemic-review-evidence-two-years', 'https://www.rand.org/pubs/research_reports/RRA827-8.html']","['MI Blueprint', 'Learning Loss and Student Dropouts during the COVID-19 Pandemic: A Review of the Evidence Two Years after Schools Shut Down', 'One Year into the Pandemic, What Secondary Math Teachers Said About Challenges to Standards-Aligned Instruction and Skipping Content']",['https://www.michigan.gov/documents/dtmb/MI_Blueprint_for_Comprehensive_Student_Recovery_725617_7.pdf'],['10526_0_mi blueprint.pdf'],1,33.33,['https://www.michigan.gov/documents/dtmb/MI_Blueprint_for_Comprehensive_Student_Recovery_725617_7.pdf'],['10526_0_mi blueprint.pdf'],[0.293],[0.588],[0.663],[0.186],[0.197],[0.172],[0.732],[0.634],[0.674],[0.677],[0.834],[0.789],[0.667],[0.938],[0.872],[0.811],[0.846],[0.825],0.293,0.588,0.663,0.186,0.197,0.172,0.732,0.634,0.674,0.677,0.834,0.789,0.667,0.938,0.872,0.811,0.846,0.825
https://doi.org/10.1016/j.ijheh.2019.05.004,burden of disease from inadequate water sanitation and hygiene for selected adverse health outcomes an updated analysis with a focus on low and middleincome countries,10600_burden of disease from inadequate water sanitation and hygiene for selected adverse health outcomes an updated analysis with a focus on low and middleincome countries.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208960/pdf', 'https://www.nber.org/papers/w28394']","['Interventions to improve water, sanitation, and hygiene for preventing soil‐transmitted helminth infection', 'Housing Precarity & the COVID-19 Pandemic: Impacts of Utility Disconnection and Eviction Moratoria on Infections and Deaths Across US Counties']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208960/pdf'],['10600_0_interventions to improve water sanitation and hygiene for preventing soil‐transmitted helminth infection.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208960/pdf'],['10600_0_interventions to improve water sanitation and hygiene for preventing soil‐transmitted helminth infection.pdf'],[0.357],[0.493],[0.589],[0.15],[0.143],[0.123],[0.737],[0.648],[0.559],[0.713],[0.767],[0.666],[0.59],[0.91],[0.792],[0.716],[0.762],[0.746],0.357,0.493,0.589,0.15,0.143,0.123,0.737,0.648,0.559,0.713,0.767,0.666,0.59,0.91,0.792,0.716,0.762,0.746
https://doi.org/10.1016/j.ijheh.2019.09.003,estimated timevarying exposures to air emissions from animal feeding operations and childhood asthma,10601_estimated timevarying exposures to air emissions from animal feeding operations and childhood asthma.pdf,10,"['https://www.arb.ca.gov/lists/com-attach/937-tier2lcfspathways-ws-ATNda1NgB2ZSeVNj.pdf', 'https://www.arb.ca.gov/lists/com-attach/947-tier2lcfspathways-ws-WmgCNAEyWDkLIFdn.pdf', 'https://www.arb.ca.gov/lists/com-attach/938-tier2lcfspathways-ws-UGIBN1xvVDVRegIy.pdf', 'https://www.arb.ca.gov/lists/com-attach/949-tier2lcfspathways-ws-BzVTZVBjVTRVfgY2.pdf', 'https://www.arb.ca.gov/lists/com-attach/952-tier2lcfspathways-ws-UmBWYFRnVjcCKQMz.pdf', 'https://www.arb.ca.gov/lists/com-attach/950-tier2lcfspathways-ws-UmBVYwEyUTBWfQc3.pdf', 'https://www.arb.ca.gov/lists/com-attach/946-tier2lcfspathways-ws-Wmhda1BjVDVVfgMz.pdf', 'https://www.arb.ca.gov/lists/com-attach/939-tier2lcfspathways-ws-UmBRZ1RnBGVSeQk5.pdf', 'https://www.arb.ca.gov/lists/com-attach/951-tier2lcfspathways-ws-VmRdawQ3A2ICKVBg.pdf', 'https://www.arb.ca.gov/lists/com-attach/948-tier2lcfspathways-ws-WmhcalZlUDEAKwk5.pdf']","['July 25, 2022 Submitted via ca. gov', 'September 19, 2022 Submitted via ca. gov', 'July 26, 2022 Submitted via ca. gov', 'September 19, 2022 Submitted via ca. gov', 'September 26, 2022 Submitted via ca. gov', 'September 19, 2022 Submitted via ca. gov', 'September 19, 2022 Submitted via ca. gov', 'July 26, 2022 Submitted via ca. gov', 'September 26, 2022 Submitted via ca. gov', 'September 19, 2022 Submitted via ca. gov']","['https://www.arb.ca.gov/lists/com-attach/946-tier2lcfspathways-ws-Wmhda1BjVDVVfgMz.pdf', 'https://www.arb.ca.gov/lists/com-attach/937-tier2lcfspathways-ws-ATNda1NgB2ZSeVNj.pdf', 'https://www.arb.ca.gov/lists/com-attach/951-tier2lcfspathways-ws-VmRdawQ3A2ICKVBg.pdf', 'https://www.arb.ca.gov/lists/com-attach/948-tier2lcfspathways-ws-WmhcalZlUDEAKwk5.pdf', 'https://www.arb.ca.gov/lists/com-attach/952-tier2lcfspathways-ws-UmBWYFRnVjcCKQMz.pdf', 'https://www.arb.ca.gov/lists/com-attach/947-tier2lcfspathways-ws-WmgCNAEyWDkLIFdn.pdf', 'https://www.arb.ca.gov/lists/com-attach/950-tier2lcfspathways-ws-UmBVYwEyUTBWfQc3.pdf', 'https://www.arb.ca.gov/lists/com-attach/949-tier2lcfspathways-ws-BzVTZVBjVTRVfgY2.pdf', 'https://www.arb.ca.gov/lists/com-attach/939-tier2lcfspathways-ws-UmBRZ1RnBGVSeQk5.pdf', 'https://www.arb.ca.gov/lists/com-attach/938-tier2lcfspathways-ws-UGIBN1xvVDVRegIy.pdf']","['10601_6_september 19 2022 submitted via ca gov.pdf', '10601_0_july 25 2022 submitted via ca gov.pdf', '10601_8_september 26 2022 submitted via ca gov.pdf', '10601_9_september 19 2022 submitted via ca gov.pdf', '10601_4_september 26 2022 submitted via ca gov.pdf', '10601_1_september 19 2022 submitted via ca gov.pdf', '10601_5_september 19 2022 submitted via ca gov.pdf', '10601_3_september 19 2022 submitted via ca gov.pdf', '10601_7_july 26 2022 submitted via ca gov.pdf', '10601_2_july 26 2022 submitted via ca gov.pdf']",10,100.0,"['https://www.arb.ca.gov/lists/com-attach/946-tier2lcfspathways-ws-Wmhda1BjVDVVfgMz.pdf', 'https://www.arb.ca.gov/lists/com-attach/937-tier2lcfspathways-ws-ATNda1NgB2ZSeVNj.pdf', 'https://www.arb.ca.gov/lists/com-attach/951-tier2lcfspathways-ws-VmRdawQ3A2ICKVBg.pdf', 'https://www.arb.ca.gov/lists/com-attach/948-tier2lcfspathways-ws-WmhcalZlUDEAKwk5.pdf', 'https://www.arb.ca.gov/lists/com-attach/952-tier2lcfspathways-ws-UmBWYFRnVjcCKQMz.pdf', 'https://www.arb.ca.gov/lists/com-attach/947-tier2lcfspathways-ws-WmgCNAEyWDkLIFdn.pdf', 'https://www.arb.ca.gov/lists/com-attach/950-tier2lcfspathways-ws-UmBVYwEyUTBWfQc3.pdf', 'https://www.arb.ca.gov/lists/com-attach/949-tier2lcfspathways-ws-BzVTZVBjVTRVfgY2.pdf', 'https://www.arb.ca.gov/lists/com-attach/939-tier2lcfspathways-ws-UmBRZ1RnBGVSeQk5.pdf', 'https://www.arb.ca.gov/lists/com-attach/938-tier2lcfspathways-ws-UGIBN1xvVDVRegIy.pdf']","['10601_6_september 19 2022 submitted via ca gov.pdf', '10601_0_july 25 2022 submitted via ca gov.pdf', '10601_8_september 26 2022 submitted via ca gov.pdf', '10601_9_september 19 2022 submitted via ca gov.pdf', '10601_4_september 26 2022 submitted via ca gov.pdf', '10601_1_september 19 2022 submitted via ca gov.pdf', '10601_5_september 19 2022 submitted via ca gov.pdf', '10601_3_september 19 2022 submitted via ca gov.pdf', '10601_7_july 26 2022 submitted via ca gov.pdf', '10601_2_july 26 2022 submitted via ca gov.pdf']","[0.054, 0.054, 0.054, 0.054, 0.054, 0.054, 0.054, 0.054, 0.054, 0.054]","[0.472, 0.472, 0.471, 0.471, 0.472, 0.471, 0.471, 0.471, 0.472, 0.472]","[0.567, 0.567, 0.567, 0.567, 0.567, 0.567, 0.567, 0.567, 0.567, 0.567]","[0.115, 0.115, 0.115, 0.115, 0.115, 0.115, 0.115, 0.115, 0.115, 0.115]","[0.111, 0.111, 0.111, 0.111, 0.111, 0.111, 0.111, 0.111, 0.111, 0.111]","[0.095, 0.095, 0.095, 0.095, 0.095, 0.095, 0.095, 0.095, 0.095, 0.095]","[0.729, 0.729, 0.729, 0.729, 0.729, 0.729, 0.729, 0.729, 0.729, 0.729]","[0.636, 0.636, 0.636, 0.636, 0.636, 0.636, 0.636, 0.636, 0.636, 0.636]","[0.539, 0.539, 0.539, 0.539, 0.539, 0.539, 0.539, 0.539, 0.539, 0.539]","[0.675, 0.675, 0.675, 0.675, 0.675, 0.675, 0.675, 0.675, 0.675, 0.675]","[0.766, 0.766, 0.766, 0.766, 0.766, 0.766, 0.766, 0.766, 0.766, 0.766]","[0.661, 0.661, 0.661, 0.661, 0.661, 0.661, 0.661, 0.661, 0.661, 0.661]","[0.608, 0.608, 0.608, 0.608, 0.608, 0.608, 0.608, 0.608, 0.608, 0.608]","[0.901, 0.901, 0.901, 0.901, 0.901, 0.901, 0.901, 0.901, 0.901, 0.901]","[0.782, 0.782, 0.782, 0.782, 0.782, 0.782, 0.782, 0.782, 0.782, 0.782]","[0.72, 0.72, 0.72, 0.72, 0.72, 0.72, 0.72, 0.72, 0.72, 0.72]","[0.759, 0.759, 0.759, 0.759, 0.759, 0.759, 0.759, 0.759, 0.759, 0.759]","[0.75, 0.75, 0.75, 0.75, 0.75, 0.75, 0.75, 0.75, 0.75, 0.75]",0.054,0.471,0.567,0.115,0.111,0.095,0.729,0.636,0.539,0.675,0.766,0.661,0.608,0.901,0.782,0.72,0.759,0.75
https://doi.org/10.1016/j.ijid.2018.04.3941,implementation of early infant diagnosis of hiv in mbeya region tanzania,10605_implementation of early infant diagnosis of hiv in mbeya region tanzania.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['10605_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['10605_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],[0.405],[0.548],[0.625],[0.184],[0.168],[0.14],[0.743],[0.648],[0.611],[0.64],[0.796],[0.736],[0.627],[0.908],[0.818],[0.744],[0.804],[0.767],0.405,0.548,0.625,0.184,0.168,0.14,0.743,0.648,0.611,0.64,0.796,0.736,0.627,0.908,0.818,0.744,0.804,0.767
https://doi.org/10.1016/j.ijid.2020.11.163,severe covid19 infection and pediatric comorbidities a systematic review and metaanalysis,10607_severe covid19 infection and pediatric comorbidities a systematic review and metaanalysis.pdf,3,"['https://stacks.cdc.gov/view/cdc/106171', 'https://stacks.cdc.gov/view/cdc/114448', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821846/pdf']","['Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821846/pdf'],['10607_2_coronavirus disease 2019 covid19 vaccination for children position statement of indian academy of pediatrics advisory committee on vaccination and immunization practices.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821846/pdf'],['10607_2_coronavirus disease 2019 covid19 vaccination for children position statement of indian academy of pediatrics advisory committee on vaccination and immunization practices.pdf'],[0.457],[0.511],[0.604],[0.179],[0.203],[0.155],[0.737],[0.649],[0.566],[0.667],[0.792],[0.686],[0.617],[0.911],[0.802],[0.739],[0.769],[0.759],0.457,0.511,0.604,0.179,0.203,0.155,0.737,0.649,0.566,0.667,0.792,0.686,0.617,0.911,0.802,0.739,0.769,0.759
https://doi.org/10.1016/j.ijporl.2019.02.033,vestibular infant screening – flanders the implementation of a standard vestibular screening protocol for hearingimpaired children in flanders,10651_vestibular infant screening – flanders the implementation of a standard vestibular screening protocol for hearingimpaired children in flanders.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920012/pdf'],['Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Updated Clinical Practice Guideline From the Academy of Neurologic Physical Therapy of the American Physical Therapy Association'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920012/pdf'],['10651_0_vestibular rehabilitation for peripheral vestibular hypofunction an updated clinical practice guideline from the aca.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920012/pdf'],['10651_0_vestibular rehabilitation for peripheral vestibular hypofunction an updated clinical practice guideline from the aca.pdf'],[0.333],[0.52],[0.608],[0.16],[0.168],[0.139],[0.735],[0.644],[0.576],[0.666],[0.795],[0.703],[0.624],[0.916],[0.792],[0.75],[0.786],[0.776],0.333,0.52,0.608,0.16,0.168,0.139,0.735,0.644,0.576,0.666,0.795,0.703,0.624,0.916,0.792,0.75,0.786,0.776
https://doi.org/10.1016/j.ijporl.2019.05.044,effects of salivary gland botulinum toxina on drooling and respiratory morbidity in children with neurological dysfunction,10652_effects of salivary gland botulinum toxina on drooling and respiratory morbidity in children with neurological dysfunction.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818421/pdf'],['Prevention and management of respiratory disease in young people with cerebral palsy: consensus statement'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818421/pdf'],['10652_0_prevention and management of respiratory disease in young people with cerebral palsy consensus statement.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818421/pdf'],['10652_0_prevention and management of respiratory disease in young people with cerebral palsy consensus statement.pdf'],[0.405],[0.522],[0.608],[0.182],[0.182],[0.146],[0.739],[0.642],[0.578],[0.654],[0.795],[0.689],[0.622],[0.914],[0.803],[0.75],[0.795],[0.777],0.405,0.522,0.608,0.182,0.182,0.146,0.739,0.642,0.578,0.654,0.795,0.689,0.622,0.914,0.803,0.75,0.795,0.777
https://doi.org/10.1016/j.ijporl.2019.109683,auditory processing disorders in incarcerated youth a call for early detection and treatment,10653_auditory processing disorders in incarcerated youth a call for early detection and treatment.pdf,1,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['2021 : How Gender And Race'],['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['10653_0_2021  how gender and race.pdf'],1,100.0,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['10653_0_2021  how gender and race.pdf'],[0.163],[0.518],[0.602],[0.116],[0.112],[0.093],[0.721],[0.622],[0.585],[0.633],[0.786],[0.714],[0.629],[0.913],[0.801],[0.754],[0.788],[0.767],0.163,0.518,0.602,0.116,0.112,0.093,0.721,0.622,0.585,0.633,0.786,0.714,0.629,0.913,0.801,0.754,0.788,0.767
https://doi.org/10.1016/j.ijporl.2020.110030,practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the covid19 pandemic,10654_practical insights for paediatric otolaryngology surgical cases and performing microlaryngobronchoscopy during the covid19 pandemic.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843245/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['Bronchoscopy precautions and recommendations in the COVID-19 pandemic', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843245/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['10654_0_bronchoscopy precautions and recommendations in the covid19 pandemic.pdf', '10654_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843245/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['10654_0_bronchoscopy precautions and recommendations in the covid19 pandemic.pdf', '10654_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf']","[0.427, 0.401]","[0.566, 0.548]","[0.65, 0.629]","[0.203, 0.172]","[0.208, 0.182]","[0.157, 0.138]","[0.748, 0.744]","[0.655, 0.651]","[0.639, 0.615]","[0.633, 0.62]","[0.822, 0.81]","[0.754, 0.742]","[0.659, 0.637]","[0.922, 0.92]","[0.833, 0.832]","[0.789, 0.767]","[0.824, 0.811]","[0.805, 0.791]",0.414,0.557,0.639,0.188,0.195,0.148,0.746,0.653,0.627,0.627,0.816,0.748,0.648,0.921,0.833,0.778,0.818,0.798
https://doi.org/10.1016/j.ijporl.2021.110626,loss of smell and taste in covid19 infection in adolescents,10655_loss of smell and taste in covid19 infection in adolescents.pdf,2,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['10655_1_master question list for covid19 caused by sarscov2.pdf', '10655_0_master question list for covid19 caused by sarscov2.pdf']",2,100.0,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf'],['10655_0_master question list for covid19 caused by sarscov2.pdf'],[0.414],[0.512],[0.608],[0.156],[0.154],[0.125],[0.741],[0.648],[0.578],[0.636],[0.779],[0.7],[0.624],[0.908],[0.806],[0.745],[0.782],[0.766],0.414,0.512,0.608,0.156,0.154,0.125,0.741,0.648,0.578,0.636,0.779,0.7,0.624,0.908,0.806,0.745,0.782,0.766
https://doi.org/10.1016/j.ijrefrig.2009.09.018,review of secondary loop refrigeration systems,10658_review of secondary loop refrigeration systems.pdf,3,"['https://www.epa.gov/sites/default/files/2016-06/documents/mac_report_2013-iv_industrial.pdf', 'https://www.epa.gov/sites/default/files/2016-06/documents/mac_report_2013.pdf', 'https://ww2.arb.ca.gov/sites/default/files/2018-09/concept_paper.pdf']","['MAC Report 2013: IV Industrial Processes Sector', 'Global Mitigation of Non-CO2 Greenhouse Gases: 2010-2030', 'Short-Lived Climate Pollutant Reduction Strategy']","['https://www.epa.gov/sites/default/files/2016-06/documents/mac_report_2013.pdf', 'https://ww2.arb.ca.gov/sites/default/files/2018-09/concept_paper.pdf', 'https://www.epa.gov/sites/default/files/2016-06/documents/mac_report_2013-iv_industrial.pdf']","['10658_1_global mitigation of nonco2 greenhouse gases 20102030.pdf', '10658_2_shortlived climate pollutant reduction strategy.pdf', '10658_0_mac report 2013 iv industrial processes sector.pdf']",3,100.0,"['https://www.epa.gov/sites/default/files/2016-06/documents/mac_report_2013.pdf', 'https://ww2.arb.ca.gov/sites/default/files/2018-09/concept_paper.pdf', 'https://www.epa.gov/sites/default/files/2016-06/documents/mac_report_2013-iv_industrial.pdf']","['10658_1_global mitigation of nonco2 greenhouse gases 20102030.pdf', '10658_2_shortlived climate pollutant reduction strategy.pdf', '10658_0_mac report 2013 iv industrial processes sector.pdf']","[0.252, 0.219, 0.123]","[0.516, 0.511, 0.52]","[0.605, 0.607, 0.608]","[0.129, 0.119, 0.137]","[0.123, 0.118, 0.136]","[0.104, 0.1, 0.111]","[0.728, 0.723, 0.729]","[0.631, 0.626, 0.634]","[0.58, 0.59, 0.584]","[0.645, 0.627, 0.65]","[0.794, 0.804, 0.797]","[0.707, 0.724, 0.71]","[0.656, 0.65, 0.659]","[0.916, 0.919, 0.916]","[0.817, 0.818, 0.821]","[0.76, 0.768, 0.762]","[0.802, 0.808, 0.805]","[0.787, 0.79, 0.79]",0.198,0.516,0.607,0.128,0.126,0.105,0.727,0.63,0.585,0.641,0.798,0.714,0.655,0.917,0.819,0.763,0.805,0.789
https://doi.org/10.1016/j.immuni.2020.03.007,sarscov2 vaccines status report,10674_sarscov2 vaccines status report.pdf,8,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_21.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_07.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_14.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200512.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_05_05.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200526.pdf', 'https://www.americanprogress.org/issues/healthcare/reports/2020/07/28/488196/comprehensive-covid-19-vaccine-plan/', 'https://www.nber.org/papers/w28587']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Master Question List for COVID-19 (caused by SARs-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'A Comprehensive COVID-19 Vaccine Plan - Center for American Progress', 'The Repeated Setbacks of HIV Vaccine Development Laid the Groundwork for SARS-CoV-2 Vaccines']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_21.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200512.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_14.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_05_05.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_07.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200526.pdf']","['10674_0_master question list for covid19 caused by sarscov2.pdf', '10674_3_master question list for covid19 caused by sarscov2.pdf', '10674_2_master question list for covid19 caused by sarscov2.pdf', '10674_4_master question list for covid19 caused by sarscov2.pdf', '10674_1_master question list for covid19 caused by sarscov2.pdf', '10674_5_master question list for covid19 caused by sarscov2.pdf']",6,75.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_21.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200512.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_14.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_05_05.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_07.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200526.pdf']","['10674_0_master question list for covid19 caused by sarscov2.pdf', '10674_3_master question list for covid19 caused by sarscov2.pdf', '10674_2_master question list for covid19 caused by sarscov2.pdf', '10674_4_master question list for covid19 caused by sarscov2.pdf', '10674_1_master question list for covid19 caused by sarscov2.pdf', '10674_5_master question list for covid19 caused by sarscov2.pdf']","[0.362, 0.358, 0.352, 0.378, 0.38, 0.38]","[0.502, 0.502, 0.502, 0.502, 0.501, 0.5]","[0.598, 0.598, 0.597, 0.598, 0.596, 0.597]","[0.148, 0.15, 0.148, 0.149, 0.152, 0.148]","[0.152, 0.154, 0.153, 0.152, 0.157, 0.152]","[0.131, 0.133, 0.132, 0.131, 0.137, 0.13]","[0.738, 0.739, 0.738, 0.739, 0.741, 0.739]","[0.648, 0.65, 0.648, 0.648, 0.652, 0.649]","[0.564, 0.564, 0.565, 0.563, 0.562, 0.563]","[0.658, 0.658, 0.66, 0.659, 0.664, 0.659]","[0.788, 0.787, 0.788, 0.787, 0.786, 0.786]","[0.693, 0.691, 0.692, 0.691, 0.687, 0.691]","[0.629, 0.629, 0.628, 0.629, 0.626, 0.627]","[0.905, 0.905, 0.905, 0.905, 0.906, 0.906]","[0.805, 0.804, 0.804, 0.804, 0.804, 0.803]","[0.746, 0.746, 0.746, 0.746, 0.743, 0.745]","[0.783, 0.783, 0.783, 0.783, 0.78, 0.781]","[0.768, 0.768, 0.768, 0.768, 0.766, 0.767]",0.368,0.501,0.597,0.149,0.153,0.132,0.739,0.649,0.563,0.66,0.787,0.691,0.628,0.905,0.804,0.745,0.782,0.768
https://doi.org/10.1016/j.invent.2019.100254,assessing the efficacy and acceptability of an internetdelivered intervention for resilience among college students a pilot randomised control trial protocol,10729_assessing the efficacy and acceptability of an internetdelivered intervention for resilience among college students a pilot randomised control trial protocol.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388680/pdf'],['Psychological interventions to foster resilience in healthcare students'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388680/pdf'],['10729_0_psychological interventions to foster resilience in healthcare students.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388680/pdf'],['10729_0_psychological interventions to foster resilience in healthcare students.pdf'],[0.487],[0.503],[0.597],[0.153],[0.163],[0.143],[0.735],[0.646],[0.555],[0.725],[0.768],[0.677],[0.588],[0.907],[0.803],[0.72],[0.762],[0.755],0.487,0.503,0.597,0.153,0.163,0.143,0.735,0.646,0.555,0.725,0.768,0.677,0.588,0.907,0.803,0.72,0.762,0.755
https://doi.org/10.1016/j.jaac.2017.03.013,what is the maletofemale ratio in autism spectrum disorder a systematic review and metaanalysis,10828_what is the maletofemale ratio in autism spectrum disorder a systematic review and metaanalysis.pdf,2,"['https://mathematica.org/publications/promoting-readiness-of-minors-with-autism-spectrum-disorder-evidence-from-a-randomized-controlled', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094878/pdf']","['Promoting Readiness of Minors with Autism Spectrum Disorder: Evidence from a Randomized Controlled Trial', 'The effectiveness and adverse effects of D‐cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094878/pdf'],['10828_1_the effectiveness and adverse effects of d‐cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094878/pdf'],['10828_1_the effectiveness and adverse effects of d‐cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.pdf'],[0.432],[0.527],[0.614],[0.178],[0.186],[0.152],[0.736],[0.64],[0.591],[0.717],[0.787],[0.725],[0.589],[0.916],[0.819],[0.729],[0.787],[0.762],0.432,0.527,0.614,0.178,0.186,0.152,0.736,0.64,0.591,0.717,0.787,0.725,0.589,0.916,0.819,0.729,0.787,0.762
https://doi.org/10.1016/j.jaac.2018.05.030,master clinician review saving holden caulfield suicide prevention in children and adolescents,10842_master clinician review saving holden caulfield suicide prevention in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['10842_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['10842_0_interventions for self‐harm in children and adolescents.pdf'],[0.427],[0.523],[0.608],[0.173],[0.187],[0.151],[0.735],[0.644],[0.584],[0.693],[0.788],[0.711],[0.59],[0.919],[0.824],[0.736],[0.789],[0.769],0.427,0.523,0.608,0.173,0.187,0.151,0.735,0.644,0.584,0.693,0.788,0.711,0.59,0.919,0.824,0.736,0.789,0.769
https://doi.org/10.1016/j.jaac.2018.09.220,362 enhancing health among youth living with hiv using an iphone game,10850_362 enhancing health among youth living with hiv using an iphone game.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['10850_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['10850_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.229],[0.562],[0.638],[0.16],[0.136],[0.113],[0.733],[0.632],[0.636],[0.645],[0.805],[0.745],[0.617],[0.936],[0.845],[0.765],[0.812],[0.788],0.229,0.562,0.638,0.16,0.136,0.113,0.733,0.632,0.636,0.645,0.805,0.745,0.617,0.936,0.845,0.765,0.812,0.788
https://doi.org/10.1016/j.jaac.2018.11.013,doubleblind shamcontrolled pilot study of trigeminal nerve stimulation for attentiondeficithyperactivity disorder,10851_doubleblind shamcontrolled pilot study of trigeminal nerve stimulation for attentiondeficithyperactivity disorder.pdf,4,"['https://www.hca.wa.gov/sites/default/files/pebb/kaiser-washington-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/kaiser-washington-preauthreqs.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067282/pdf', 'https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1078222/peds_20192528.pdf']","['HCA website auth info draft_2017.docx', 'Kaiser Permanente Washington Pre-Authorization requirements :', 'Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents', 'Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents']","['https://www.hca.wa.gov/assets/pebb/kaiser-washington-preauthreqs.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067282/pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/kaiser-washington-preauthreqs.pdf']","['10851_1_kaiser permanente washington preauthorization requirements .pdf', '10851_2_clinical practice guideline for the diagnosis evaluation and treatment of attentiondeficithyperactivity disorder in children and adolescents.pdf', '10851_0_hca website auth info draft2017docx.pdf']",3,75.0,"['https://www.hca.wa.gov/assets/pebb/kaiser-washington-preauthreqs.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067282/pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/kaiser-washington-preauthreqs.pdf']","['10851_1_kaiser permanente washington preauthorization requirements .pdf', '10851_2_clinical practice guideline for the diagnosis evaluation and treatment of attentiondeficithyperactivity disorder in children and adolescents.pdf', '10851_0_hca website auth info draft2017docx.pdf']","[0.27, 0.27, 0.305]","[0.517, 0.499, 0.517]","[0.602, 0.597, 0.602]","[0.122, 0.151, 0.122]","[0.119, 0.165, 0.119]","[0.093, 0.13, 0.093]","[0.719, 0.729, 0.719]","[0.619, 0.635, 0.619]","[0.595, 0.583, 0.595]","[0.648, 0.689, 0.648]","[0.786, 0.772, 0.786]","[0.719, 0.684, 0.719]","[0.609, 0.578, 0.609]","[0.923, 0.913, 0.923]","[0.804, 0.8, 0.804]","[0.753, 0.734, 0.753]","[0.784, 0.777, 0.784]","[0.775, 0.767, 0.775]",0.282,0.511,0.6,0.132,0.134,0.105,0.722,0.624,0.591,0.662,0.781,0.707,0.599,0.92,0.803,0.747,0.782,0.772
https://doi.org/10.1016/j.jaac.2019.02.014,parentbased treatment as efficacious as cognitivebehavioral therapy for childhood anxiety a randomized noninferiority study of supportive parenting for anxious childhood emotions,10852_parentbased treatment as efficacious as cognitivebehavioral therapy for childhood anxiety a randomized noninferiority study of supportive parenting for anxious childhood emotions.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['Cognitive behavioural therapy for anxiety disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['10852_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['10852_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],[0.558],[0.519],[0.603],[0.179],[0.184],[0.158],[0.738],[0.646],[0.577],[0.708],[0.775],[0.689],[0.582],[0.915],[0.811],[0.723],[0.774],[0.756],0.558,0.519,0.603,0.179,0.184,0.158,0.738,0.646,0.577,0.708,0.775,0.689,0.582,0.915,0.811,0.723,0.774,0.756
https://doi.org/10.1016/j.jaac.2020.08.466,impact of covid19 pandemic on college student mental health and wellness,10857_impact of covid19 pandemic on college student mental health and wellness.pdf,1,['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],"['Supporting Child and Student Social, Emotional, Behavioral, and Mental Health Needs (PDF)']",['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['10857_0_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],1,100.0,['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['10857_0_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],[0.377],[0.522],[0.613],[0.151],[0.175],[0.141],[0.729],[0.634],[0.587],[0.669],[0.789],[0.72],[0.625],[0.921],[0.81],[0.758],[0.797],[0.775],0.377,0.522,0.613,0.151,0.175,0.141,0.729,0.634,0.587,0.669,0.789,0.72,0.625,0.921,0.81,0.758,0.797,0.775
https://doi.org/10.1016/j.jaac.2021.02.014,adverse effects of refeeding on the plasma lipidome in young individuals with anorexia nervosa,10858_adverse effects of refeeding on the plasma lipidome in young individuals with anorexia nervosa.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747364/pdf'],['To Improve the Initial Inpatient Management of Adolescents Admitted with Severe Anorexia Nervosa: A Narrative Review and a Convenient Protocol'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747364/pdf'],['10858_0_to improve the initial inpatient management of adolescents admitted with severe anorexia nervosa a narrative review and a convenient protocol.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747364/pdf'],['10858_0_to improve the initial inpatient management of adolescents admitted with severe anorexia nervosa a narrative review and a convenient protocol.pdf'],[0.329],[0.491],[0.589],[0.15],[0.148],[0.118],[0.737],[0.643],[0.563],[0.669],[0.772],[0.664],[0.605],[0.917],[0.793],[0.739],[0.773],[0.76],0.329,0.491,0.589,0.15,0.148,0.118,0.737,0.643,0.563,0.669,0.772,0.664,0.605,0.917,0.793,0.739,0.773,0.76
https://doi.org/10.1016/j.jaac.2021.02.022,systematic review and metaanalysis effectiveness of wraparound care coordination for children and adolescents,10859_systematic review and metaanalysis effectiveness of wraparound care coordination for children and adolescents.pdf,1,['https://yes.idaho.gov/wp-content/uploads/2021/07/Brief_Benchmarks.pdf'],['Care Benchmarks :'],['https://yes.idaho.gov/wp-content/uploads/2021/07/Brief_Benchmarks.pdf'],['10859_0_care benchmarks .pdf'],1,100.0,['https://yes.idaho.gov/wp-content/uploads/2021/07/Brief_Benchmarks.pdf'],['10859_0_care benchmarks .pdf'],[0.443],[0.541],[0.62],[0.168],[0.199],[0.152],[0.733],[0.644],[0.604],[0.703],[0.801],[0.731],[0.617],[0.923],[0.839],[0.764],[0.81],[0.786],0.443,0.541,0.62,0.168,0.199,0.152,0.733,0.644,0.604,0.703,0.801,0.731,0.617,0.923,0.839,0.764,0.81,0.786
https://doi.org/10.1016/j.jaad.2007.06.045,the prevalence of acne in adults 20 years and older,10872_the prevalence of acne in adults 20 years and older.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383843/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069546/pdf']","['Oral isotretinoin for acne', 'Interventions for acne scars']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383843/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069546/pdf']","['10872_0_oral isotretinoin for acne.pdf', '10872_1_interventions for acne scars.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383843/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069546/pdf']","['10872_0_oral isotretinoin for acne.pdf', '10872_1_interventions for acne scars.pdf']","[0.26, 0.283]","[0.507, 0.535]","[0.586, 0.615]","[0.139, 0.167]","[0.154, 0.183]","[0.144, 0.156]","[0.732, 0.733]","[0.633, 0.633]","[0.559, 0.587]","[0.672, 0.67]","[0.766, 0.785]","[0.682, 0.706]","[0.61, 0.617]","[0.883, 0.903]","[0.785, 0.813]","[0.693, 0.739]","[0.766, 0.787]","[0.714, 0.763]",0.271,0.521,0.601,0.153,0.168,0.15,0.732,0.633,0.573,0.671,0.776,0.694,0.613,0.893,0.799,0.716,0.776,0.738
https://doi.org/10.1016/j.jaad.2019.10.119,effects of emollient use on the developing infant skin microbiome,10877_effects of emollient use on the developing infant skin microbiome.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['10877_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '10877_0_skin care interventions in infants for preventing eczema and food allergy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['10877_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '10877_0_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.309, 0.313]","[0.558, 0.555]","[0.644, 0.642]","[0.169, 0.165]","[0.17, 0.168]","[0.139, 0.134]","[0.735, 0.734]","[0.636, 0.636]","[0.624, 0.619]","[0.643, 0.644]","[0.799, 0.797]","[0.739, 0.739]","[0.627, 0.623]","[0.915, 0.917]","[0.821, 0.818]","[0.761, 0.759]","[0.809, 0.807]","[0.784, 0.781]",0.311,0.556,0.643,0.167,0.169,0.137,0.734,0.636,0.621,0.643,0.798,0.739,0.625,0.916,0.819,0.76,0.808,0.782
https://doi.org/10.1016/j.jaad.2020.06.323,16294 evaluating prebiotic effects of glycerol moving toward enhancing the care of infant skin,10878_16294 evaluating prebiotic effects of glycerol moving toward enhancing the care of infant skin.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['Skin care interventions in infants for preventing eczema and food allergy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['10878_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1016/j.jacc.2018.10.031,children present a window of opportunity for promoting health,10912_children present a window of opportunity for promoting health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437845/pdf'],"['Cardiovascular events, diabetes and guidelines: the virtue of simplicity']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437845/pdf'],['10912_0_cardiovascular events diabetes and guidelines the virtue of simplicity.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437845/pdf'],['10912_0_cardiovascular events diabetes and guidelines the virtue of simplicity.pdf'],[0.308],[0.547],[0.631],[0.15],[0.154],[0.112],[0.733],[0.635],[0.626],[0.643],[0.815],[0.754],[0.618],[0.926],[0.847],[0.775],[0.816],[0.798],0.308,0.547,0.631,0.15,0.154,0.112,0.733,0.635,0.626,0.643,0.815,0.754,0.618,0.926,0.847,0.775,0.816,0.798
https://doi.org/10.1016/j.jacc.2020.08.041,anticoagulation mortality bleeding and pathology among patients hospitalized with covid19 a single health system study,10913_anticoagulation mortality bleeding and pathology among patients hospitalized with covid19 a single health system study.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442752/pdf', 'https://stacks.cdc.gov/view/cdc/93279', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763451/pdf']","['Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment', 'COVID-19 science update ; Edition 2020-09-08', 'For Public Release', 'Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', '2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442752/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763451/pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['10913_6_master question list for covid19 caused by sarscov2.pdf', '10913_0_nuts and bolts of covid19 associated coagulopathy the essentials for management and treatment.pdf', '10913_3_master question list for covid19 caused by sarscov2.pdf', '10913_7_2021 focused update consensus guidelines of the asia pacific heart rhythm society on stroke prevention in atrial fibrillation executive summary.pdf', '10913_2_for public release.pdf', '10913_5_master question list for covid19 caused by sarscov2.pdf', '10913_4_master question list for covid19 caused by sarscov2.pdf']",7,87.5,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442752/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763451/pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['10913_6_master question list for covid19 caused by sarscov2.pdf', '10913_0_nuts and bolts of covid19 associated coagulopathy the essentials for management and treatment.pdf', '10913_3_master question list for covid19 caused by sarscov2.pdf', '10913_7_2021 focused update consensus guidelines of the asia pacific heart rhythm society on stroke prevention in atrial fibrillation executive summary.pdf', '10913_2_for public release.pdf', '10913_5_master question list for covid19 caused by sarscov2.pdf', '10913_4_master question list for covid19 caused by sarscov2.pdf']","[0.469, 0.259, 0.262, 0.256, 0.255, 0.261, 0.291]","[0.549, 0.559, 0.552, 0.555, 0.546, 0.549, 0.549]","[0.632, 0.636, 0.633, 0.629, 0.629, 0.632, 0.631]","[0.154, 0.203, 0.154, 0.188, 0.152, 0.153, 0.152]","[0.14, 0.215, 0.139, 0.189, 0.138, 0.138, 0.137]","[0.117, 0.166, 0.116, 0.143, 0.115, 0.115, 0.115]","[0.741, 0.747, 0.741, 0.747, 0.74, 0.741, 0.74]","[0.645, 0.655, 0.645, 0.655, 0.644, 0.645, 0.644]","[0.619, 0.616, 0.621, 0.615, 0.617, 0.62, 0.619]","[0.628, 0.668, 0.626, 0.66, 0.627, 0.625, 0.625]","[0.798, 0.801, 0.799, 0.796, 0.797, 0.799, 0.799]","[0.74, 0.745, 0.744, 0.72, 0.739, 0.74, 0.738]","[0.616, 0.619, 0.619, 0.617, 0.616, 0.617, 0.617]","[0.921, 0.918, 0.92, 0.918, 0.92, 0.921, 0.92]","[0.82, 0.814, 0.82, 0.815, 0.819, 0.819, 0.819]","[0.762, 0.769, 0.764, 0.759, 0.761, 0.763, 0.762]","[0.804, 0.804, 0.805, 0.795, 0.803, 0.804, 0.804]","[0.786, 0.789, 0.786, 0.78, 0.784, 0.786, 0.785]",0.293,0.551,0.632,0.165,0.157,0.127,0.742,0.648,0.618,0.637,0.798,0.738,0.617,0.92,0.818,0.763,0.803,0.785
https://doi.org/10.1016/j.jacc.2020.08.069,characterization of myocardial injury in patients with covid19,10914_characterization of myocardial injury in patients with covid19.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['10914_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['10914_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.429],[0.506],[0.586],[0.16],[0.167],[0.127],[0.745],[0.652],[0.57],[0.681],[0.752],[0.686],[0.599],[0.911],[0.795],[0.725],[0.762],[0.742],0.429,0.506,0.586,0.16,0.167,0.127,0.745,0.652,0.57,0.681,0.752,0.686,0.599,0.911,0.795,0.725,0.762,0.742
https://doi.org/10.1016/j.jaci.2003.09.033,atopic dermatitis and the atopic march,10917_atopic dermatitis and the atopic march.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.jaad.org/action/showPdf?pii=S0190-9622%2822%2900080-9', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552896/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy', 'American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults', 'Phototherapy for atopic eczema', 'Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood']","['https://www.jaad.org/action/showPdf?pii=S0190-9622%2822%2900080-9', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552896/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['10917_2_american academy of dermatology guidelines awareness of comorbidities associated with atopic dermatitis in adults.pdf', '10917_3_phototherapy for atopic eczema.pdf', '10917_4_maternal prenatal andor postnatal n‐3 long chain polyunsaturated fatty acids lcpufa supplementation for preventing allergies in early childhood.pdf', '10917_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '10917_0_skin care interventions in infants for preventing eczema and food allergy.pdf']",5,100.0,"['https://www.jaad.org/action/showPdf?pii=S0190-9622%2822%2900080-9', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552896/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['10917_2_american academy of dermatology guidelines awareness of comorbidities associated with atopic dermatitis in adults.pdf', '10917_3_phototherapy for atopic eczema.pdf', '10917_4_maternal prenatal andor postnatal n‐3 long chain polyunsaturated fatty acids lcpufa supplementation for preventing allergies in early childhood.pdf', '10917_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '10917_0_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.27, 0.276, 0.58, 0.216, 0.205]","[0.564, 0.547, 0.525, 0.546, 0.542]","[0.646, 0.627, 0.609, 0.631, 0.628]","[0.188, 0.144, 0.138, 0.156, 0.151]","[0.2, 0.148, 0.144, 0.168, 0.165]","[0.166, 0.117, 0.115, 0.137, 0.132]","[0.75, 0.734, 0.736, 0.74, 0.738]","[0.654, 0.631, 0.634, 0.639, 0.638]","[0.623, 0.617, 0.587, 0.612, 0.607]","[0.654, 0.637, 0.626, 0.64, 0.641]","[0.815, 0.798, 0.785, 0.797, 0.795]","[0.748, 0.735, 0.694, 0.723, 0.724]","[0.628, 0.625, 0.599, 0.616, 0.612]","[0.926, 0.921, 0.912, 0.92, 0.921]","[0.824, 0.826, 0.804, 0.822, 0.818]","[0.777, 0.756, 0.736, 0.754, 0.752]","[0.815, 0.801, 0.784, 0.799, 0.797]","[0.798, 0.78, 0.759, 0.778, 0.775]",0.309,0.545,0.628,0.155,0.165,0.133,0.74,0.639,0.609,0.64,0.798,0.725,0.616,0.92,0.819,0.755,0.799,0.778
https://doi.org/10.1016/j.jaci.2018.08.037,direct infant uv light exposure is associated with eczema and immune development,10972_direct infant uv light exposure is associated with eczema and immune development.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf']","['Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health', 'Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf']","['10972_0_vitamin d supplementation for term breastfed infants to prevent vitamin d deficiency and improve bone health.pdf', '10972_1_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf']","['10972_0_vitamin d supplementation for term breastfed infants to prevent vitamin d deficiency and improve bone health.pdf', '10972_1_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf']","[0.445, 0.407]","[0.5, 0.512]","[0.593, 0.603]","[0.152, 0.144]","[0.145, 0.136]","[0.125, 0.116]","[0.744, 0.737]","[0.651, 0.644]","[0.561, 0.575]","[0.672, 0.67]","[0.765, 0.768]","[0.68, 0.689]","[0.583, 0.593]","[0.908, 0.918]","[0.797, 0.817]","[0.723, 0.738]","[0.763, 0.773]","[0.746, 0.761]",0.426,0.506,0.598,0.148,0.141,0.12,0.74,0.647,0.568,0.671,0.766,0.684,0.588,0.913,0.807,0.73,0.768,0.754
https://doi.org/10.1016/j.jaci.2020.12.488,risk factors associated with covid19 related anosmia and ageusia,10973_risk factors associated with covid19 related anosmia and ageusia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['10973_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['10973_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],[0.221],[0.519],[0.593],[0.155],[0.132],[0.102],[0.737],[0.634],[0.58],[0.686],[0.772],[0.691],[0.602],[0.906],[0.795],[0.729],[0.778],[0.756],0.221,0.519,0.593,0.155,0.132,0.102,0.737,0.634,0.58,0.686,0.772,0.691,0.602,0.906,0.795,0.729,0.778,0.756
https://doi.org/10.1016/j.jadohealth.2009.03.021,school bullying among adolescents in the united states physical verbal relational and cyber,11261_school bullying among adolescents in the united states physical verbal relational and cyber.pdf,6,"['https://stacks.cdc.gov/view/cdc/61176', 'https://purl.fdlp.gov/GPO/gpo86095', 'https://www.congress.gov/event/111th-congress/house-event/LC4951/text', 'https://www.dhs.wisconsin.gov/mch/earlychildhoodsystems/stueckslides.pdf', 'https://www.nj.gov/education/students/safety/behavior/hib/guidance.pdf', 'https://www.nj.gov/oag/dcr/downloads/Anti-Bullying_Bill-of-Rights.pdf']","[""America's children in brief : key national indicators of well-being, 2017"", 'The role of technology in youth harassment victimization /', 'House Hearing, 111th Congress — ENSURING STUDENT CYBER SAFETY', 'BRIGHT FUTURES', 'Guidance for Schools on Implementing the Anti-Bullying Bill of Rights Act', 'Guidance for Schools on Implementing the Anti-Bullying Bill of Rights Act']","['https://www.dhs.wisconsin.gov/mch/earlychildhoodsystems/stueckslides.pdf', 'https://purl.fdlp.gov/GPO/gpo86095']","['11261_3_bright futures.pdf', '11261_1_the role of technology in youth harassment victimization .pdf']",2,33.33,"['https://www.dhs.wisconsin.gov/mch/earlychildhoodsystems/stueckslides.pdf', 'https://purl.fdlp.gov/GPO/gpo86095']","['11261_3_bright futures.pdf', '11261_1_the role of technology in youth harassment victimization .pdf']","[0.25, 0.205]","[0.492, 0.53]","[0.594, 0.626]","[0.115, 0.204]","[0.125, 0.227]","[0.118, 0.196]","[0.72, 0.742]","[0.624, 0.65]","[0.571, 0.585]","[0.674, 0.706]","[0.765, 0.778]","[0.698, 0.722]","[0.589, 0.633]","[0.897, 0.909]","[0.816, 0.826]","[0.738, 0.761]","[0.775, 0.791]","[0.758, 0.773]",0.227,0.511,0.61,0.16,0.176,0.157,0.731,0.637,0.578,0.69,0.772,0.71,0.611,0.903,0.821,0.75,0.783,0.766
https://doi.org/10.1016/j.jadohealth.2012.05.004,postpartum contraceptive use among adolescent mothers in seven states,11349_postpartum contraceptive use among adolescent mothers in seven states.pdf,2,"['https://www.cdph.ca.gov/Programs/CFH/DMCAH/CDPH%20Document%20Library/Communications/AFLPStory-2018-02.pdf', 'https://www.cdph.ca.gov/Programs/CFH/DMCAH/CDPH%20Document%20Library/Communications/AFLPStory-2018-01.pdf']","['Teen Mom Gains Confidence and Breaks Out of Her Shell', 'Stories from the Adolescent Family Life Program, Meet Maria']","['https://www.cdph.ca.gov/Programs/CFH/DMCAH/CDPH%20Document%20Library/Communications/AFLPStory-2018-02.pdf', 'https://www.cdph.ca.gov/Programs/CFH/DMCAH/CDPH%20Document%20Library/Communications/AFLPStory-2018-01.pdf']","['11349_0_teen mom gains confidence and breaks out of her shell.pdf', '11349_1_stories from the adolescent family life program meet maria.pdf']",2,100.0,"['https://www.cdph.ca.gov/Programs/CFH/DMCAH/CDPH%20Document%20Library/Communications/AFLPStory-2018-02.pdf', 'https://www.cdph.ca.gov/Programs/CFH/DMCAH/CDPH%20Document%20Library/Communications/AFLPStory-2018-01.pdf']","['11349_0_teen mom gains confidence and breaks out of her shell.pdf', '11349_1_stories from the adolescent family life program meet maria.pdf']","[0.184, 0.226]","[0.512, 0.512]","[0.607, 0.603]","[0.133, 0.145]","[0.163, 0.177]","[0.129, 0.148]","[0.718, 0.724]","[0.623, 0.627]","[0.585, 0.579]","[0.628, 0.636]","[0.8, 0.799]","[0.713, 0.709]","[0.624, 0.621]","[0.915, 0.91]","[0.83, 0.827]","[0.76, 0.756]","[0.797, 0.796]","[0.782, 0.779]",0.205,0.512,0.605,0.139,0.17,0.139,0.721,0.625,0.582,0.632,0.8,0.711,0.623,0.913,0.829,0.758,0.796,0.78
https://doi.org/10.1016/j.jadohealth.2018.02.003,chosen name use is linked to reduced depressive symptoms suicidal ideation and suicidal behavior among transgender youth,11497_chosen name use is linked to reduced depressive symptoms suicidal ideation and suicidal behavior among transgender youth.pdf,8,"['https://townhall.virginia.gov/L/GetFile.cfm?File=C:\\TownHall\\docroot\\GuidanceDocs\\201\\GDoc_DOE_6968_v1.pdf&eType=EmailBlastContent&eId=accc37f1-8e04-4767-8c3a-be4aac9525a3', 'https://townhall.virginia.gov/l/GetFile.cfm?File=C:%5CTownHall%5Cdocroot%5CGuidanceDocs_Proposed%5C201%5CGDoc_DOE_4683_20201208.pdf&eType=EmailBlastContent&eId=c88e8b38-0b61-495c-b4b5-bad1b745bd0d&eType=EmailBlastContent&eId=ba2a2c32-3602-4793-a87a-c65e1e2bba9a', 'https://www.aclu.org/legal-document/doe-v-mmsd-amicus-brief-professors-psychology-and-human-development', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://www.aclu.org/legal-document/grimm-v-gloucester-county-brief-trevor-project', 'https://www.mass.gov/doc/commission-report-on-dcf/download', 'https://www.federalregister.gov/documents/2022/07/12/2022-13734/nondiscrimination-on-the-basis-of-sex-in-education-programs-or-activities-receiving-federal']","['Model Policies for the Treatment of Transgender Students in Virgiinia Public Schools', 'Model Policies for the Treatment of Transgender Students in Virgiinia Public Schools', 'Doe v. MMSD - Amicus Brief of Professors of Psychology and Human Development', 'Annual Report | 2019-2020', 'Annual Report | 2019-2020', 'Grimm v. Gloucester County - Brief of The Trevor Project', 'Dark Pink Photos Company Annual Report', 'Nondiscrimination on the Basis of Sex in Education Programs or Activities Receiving Federal Financial Assistance']","['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf', 'https://www.mass.gov/doc/commission-report-on-dcf/download', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://townhall.virginia.gov/L/GetFile.cfm?File=C:\\TownHall\\docroot\\GuidanceDocs\\201\\GDoc_DOE_6968_v1.pdf&eType=EmailBlastContent&eId=accc37f1-8e04-4767-8c3a-be4aac9525a3', 'https://townhall.virginia.gov/l/GetFile.cfm?File=C:%5CTownHall%5Cdocroot%5CGuidanceDocs_Proposed%5C201%5CGDoc_DOE_4683_20201208.pdf&eType=EmailBlastContent&eId=c88e8b38-0b61-495c-b4b5-bad1b745bd0d&eType=EmailBlastContent&eId=ba2a2c32-3602-4793-a87a-c65e1e2bba9a']","['11497_3_annual report  20192020.pdf', '11497_6_dark pink photos company annual report.pdf', '11497_4_annual report  20192020.pdf', '11497_0_model policies for the treatment of transgender students in virgiinia public schools.pdf', '11497_1_model policies for the treatment of transgender students in virgiinia public schools.pdf']",5,62.5,"['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf', 'https://www.mass.gov/doc/commission-report-on-dcf/download', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://townhall.virginia.gov/L/GetFile.cfm?File=C:\\TownHall\\docroot\\GuidanceDocs\\201\\GDoc_DOE_6968_v1.pdf&eType=EmailBlastContent&eId=accc37f1-8e04-4767-8c3a-be4aac9525a3', 'https://townhall.virginia.gov/l/GetFile.cfm?File=C:%5CTownHall%5Cdocroot%5CGuidanceDocs_Proposed%5C201%5CGDoc_DOE_4683_20201208.pdf&eType=EmailBlastContent&eId=c88e8b38-0b61-495c-b4b5-bad1b745bd0d&eType=EmailBlastContent&eId=ba2a2c32-3602-4793-a87a-c65e1e2bba9a']","['11497_3_annual report  20192020.pdf', '11497_6_dark pink photos company annual report.pdf', '11497_4_annual report  20192020.pdf', '11497_0_model policies for the treatment of transgender students in virgiinia public schools.pdf', '11497_1_model policies for the treatment of transgender students in virgiinia public schools.pdf']","[0.285, 0.277, 0.212, 0.212, 0.325]","[0.534, 0.523, 0.534, 0.531, 0.533]","[0.621, 0.609, 0.621, 0.614, 0.615]","[0.155, 0.158, 0.155, 0.17, 0.17]","[0.18, 0.184, 0.18, 0.202, 0.202]","[0.14, 0.157, 0.14, 0.166, 0.166]","[0.73, 0.731, 0.73, 0.742, 0.741]","[0.635, 0.632, 0.635, 0.645, 0.644]","[0.592, 0.58, 0.592, 0.589, 0.591]","[0.658, 0.673, 0.658, 0.653, 0.65]","[0.806, 0.796, 0.806, 0.798, 0.8]","[0.724, 0.709, 0.724, 0.715, 0.716]","[0.63, 0.619, 0.63, 0.619, 0.621]","[0.925, 0.92, 0.925, 0.922, 0.922]","[0.828, 0.82, 0.828, 0.821, 0.822]","[0.765, 0.748, 0.765, 0.759, 0.761]","[0.803, 0.792, 0.803, 0.795, 0.797]","[0.782, 0.773, 0.782, 0.777, 0.779]",0.262,0.531,0.616,0.162,0.19,0.154,0.735,0.638,0.589,0.658,0.801,0.718,0.624,0.923,0.824,0.76,0.798,0.779
https://doi.org/10.1016/j.jadohealth.2018.10.002,efficacy of a familybased intervention on parentadolescent discrepancies in positive parenting and substance use among hispanic youth,11502_efficacy of a familybased intervention on parentadolescent discrepancies in positive parenting and substance use among hispanic youth.pdf,1,['https://pl.ocfs.ny.gov/main/sppd/docs/FFPSA-Prevention-Plan-2022-07-29.pdf'],['New York State Family First Prevention Services Act (FFPSA) Prevention Plan'],['https://pl.ocfs.ny.gov/main/sppd/docs/FFPSA-Prevention-Plan-2022-07-29.pdf'],['11502_0_new york state family first prevention services act ffpsa prevention plan.pdf'],1,100.0,['https://pl.ocfs.ny.gov/main/sppd/docs/FFPSA-Prevention-Plan-2022-07-29.pdf'],['11502_0_new york state family first prevention services act ffpsa prevention plan.pdf'],[0.2],[0.526],[0.612],[0.153],[0.171],[0.139],[0.729],[0.634],[0.59],[0.663],[0.794],[0.713],[0.622],[0.922],[0.823],[0.763],[0.798],[0.779],0.2,0.526,0.612,0.153,0.171,0.139,0.729,0.634,0.59,0.663,0.794,0.713,0.622,0.922,0.823,0.763,0.798,0.779
https://doi.org/10.1016/j.jadohealth.2018.10.092,77 check yourself a randomized trial of electronic screening and personalized feedback for adolescent health risk behaviors in primary care,11503_77 check yourself a randomized trial of electronic screening and personalized feedback for adolescent health risk behaviors in primary care.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509115/pdf'],['Routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509115/pdf'],['11503_0_routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509115/pdf'],['11503_0_routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice.pdf'],[0.34],[0.554],[0.625],[0.185],[0.178],[0.156],[0.734],[0.64],[0.607],[0.689],[0.784],[0.721],[0.604],[0.922],[0.826],[0.739],[0.792],[0.767],0.34,0.554,0.625,0.185,0.178,0.156,0.734,0.64,0.607,0.689,0.784,0.721,0.604,0.922,0.826,0.739,0.792,0.767
https://doi.org/10.1016/j.jadohealth.2018.10.187,171 a process evaluation of a fitness curriculum to meet physical activity policy requirements a pilot study,11504_171 a process evaluation of a fitness curriculum to meet physical activity policy requirements a pilot study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['11504_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['11504_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.315],[0.544],[0.622],[0.175],[0.18],[0.146],[0.73],[0.63],[0.611],[0.674],[0.798],[0.729],[0.617],[0.921],[0.842],[0.75],[0.807],[0.781],0.315,0.544,0.622,0.175,0.18,0.146,0.73,0.63,0.611,0.674,0.798,0.729,0.617,0.921,0.842,0.75,0.807,0.781
https://doi.org/10.1016/j.jadohealth.2018.10.303,whats unique about lesbian gay bisexual and transgender lgbt youth and young adult suicides findings from the national violent death reporting system,11505_whats unique about lesbian gay bisexual and transgender lgbt youth and young adult suicides findings from the national violent death reporting system.pdf,1,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['Report & Recommendations For Fiscal Year 2022'],['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['11505_0_report  recommendations for fiscal year 2022.pdf'],1,100.0,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['11505_0_report  recommendations for fiscal year 2022.pdf'],[0.305],[0.56],[0.644],[0.179],[0.194],[0.158],[0.733],[0.637],[0.619],[0.663],[0.814],[0.755],[0.648],[0.924],[0.83],[0.778],[0.814],[0.796],0.305,0.56,0.644,0.179,0.194,0.158,0.733,0.637,0.619,0.663,0.814,0.755,0.648,0.924,0.83,0.778,0.814,0.796
https://doi.org/10.1016/j.jadohealth.2018.11.012,associations of lesbian gay bisexual transgender and questioning–inclusive sex education with mental health outcomes and schoolbased victimization in us high school students,11506_associations of lesbian gay bisexual transgender and questioning–inclusive sex education with mental health outcomes and schoolbased victimization in us high school students.pdf,3,"['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Teacher.pdf']","['Annual Report | 2019-2020', 'Annual Report | 2019-2020', '2020 School Health Profiles Teacher Item Rationale']","['https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Teacher.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf']","['11506_2_2020 school health profiles teacher item rationale.pdf', '11506_0_annual report  20192020.pdf', '11506_1_annual report  20192020.pdf']",3,100.0,"['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf']","['11506_0_annual report  20192020.pdf', '11506_1_annual report  20192020.pdf']","[0.311, 0.311]","[0.457, 0.457]","[0.564, 0.564]","[0.123, 0.123]","[0.147, 0.147]","[0.103, 0.103]","[0.726, 0.726]","[0.631, 0.631]","[0.468, 0.468]","[0.653, 0.653]","[0.744, 0.744]","[0.661, 0.661]","[0.6, 0.6]","[0.885, 0.885]","[0.738, 0.738]","[0.694, 0.694]","[0.731, 0.731]","[0.715, 0.715]",0.311,0.457,0.564,0.123,0.147,0.103,0.726,0.631,0.468,0.653,0.744,0.661,0.6,0.885,0.738,0.694,0.731,0.715
https://doi.org/10.1016/j.jadohealth.2018.11.023,the impact of age of transfer on outcomes in the transition from pediatric to adult health systems a systematic review of reviews,11509_the impact of age of transfer on outcomes in the transition from pediatric to adult health systems a systematic review of reviews.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056438/pdf'],['Health care transition from pediatric to adult care: an evidence-based guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056438/pdf'],['11509_0_health care transition from pediatric to adult care an evidencebased guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056438/pdf'],['11509_0_health care transition from pediatric to adult care an evidencebased guideline.pdf'],[0.595],[0.587],[0.656],[0.216],[0.231],[0.18],[0.743],[0.651],[0.649],[0.702],[0.817],[0.768],[0.633],[0.931],[0.854],[0.781],[0.815],[0.797],0.595,0.587,0.656,0.216,0.231,0.18,0.743,0.651,0.649,0.702,0.817,0.768,0.633,0.931,0.854,0.781,0.815,0.797
https://doi.org/10.1016/j.jadohealth.2018.12.006,a descriptive analysis of school and school shooter characteristics and the severity of school shootings in the united states 1999–2018,11510_a descriptive analysis of school and school shooter characteristics and the severity of school shootings in the united states 1999–2018.pdf,6,"['https://www.splcenter.org/20191010/safe-whom-how-msd-commission-putting-floridas-children-danger', 'https://www.nber.org/papers/w28311', 'https://civilrights.org/resource/invest-in-evidence-based-programs-through-the-bipartisan-safer-communities-act/', 'https://civilrights.org/resource/advance-safe-healthy-and-inclusive-school-climates-stronger-connections-grant-program-faqs/', 'https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf', 'https://oag.ca.gov/system/files/media/ripa-draft-2023-ripa-board-report-072822.pdf']","[""Safe For Whom? How the MSD Commission is putting Florida's Children in Danger"", ""Trauma at School: The Impacts of Shootings on Students' Human Capital and Economic Outcomes"", 'Invest in Evidence-Based Programs through the Bipartisan Safer Communities Act', 'Advance Safe, Healthy, and Inclusive School Climates: Stronger Connections Grant Program FAQs', '2023 RIPA Board Annual Report - Racial and Identity Profiling Advisory Board - California Department of Justice', 'DRAFT 2023 RIPA Board Report']","['https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf', 'https://oag.ca.gov/system/files/media/ripa-draft-2023-ripa-board-report-072822.pdf']","['11510_4_2023 ripa board annual report  racial and identity profiling advisory board  california department of justice.pdf', '11510_5_draft 2023 ripa board report.pdf']",2,33.33,"['https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf', 'https://oag.ca.gov/system/files/media/ripa-draft-2023-ripa-board-report-072822.pdf']","['11510_4_2023 ripa board annual report  racial and identity profiling advisory board  california department of justice.pdf', '11510_5_draft 2023 ripa board report.pdf']","[0.183, 0.143]","[0.502, 0.506]","[0.586, 0.591]","[0.13, 0.135]","[0.146, 0.153]","[0.125, 0.128]","[0.723, 0.722]","[0.622, 0.621]","[0.559, 0.564]","[0.687, 0.683]","[0.771, 0.782]","[0.711, 0.722]","[0.627, 0.632]","[0.91, 0.915]","[0.806, 0.813]","[0.737, 0.748]","[0.772, 0.786]","[0.758, 0.77]",0.163,0.504,0.589,0.133,0.149,0.127,0.722,0.621,0.561,0.685,0.776,0.716,0.629,0.913,0.809,0.742,0.779,0.764
https://doi.org/10.1016/j.jadohealth.2019.02.019,adolescents ecigarette use increases in frequency dependence and nicotine exposure over 12 months,11515_adolescents ecigarette use increases in frequency dependence and nicotine exposure over 12 months.pdf,1,['https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Hernandez-et-al-JAIP.pdf'],['Electronic Cigarettes and Their Impact on Allergic Respiratory Diseases: A Work Group Report of the AAAAI Environmental Exposures and Respiratory Health Committee'],['https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Hernandez-et-al-JAIP.pdf'],['11515_0_electronic cigarettes and their impact on allergic respiratory diseases a work group report of the aaaai environmental exposures and respiratory health committee.pdf'],1,100.0,['https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Hernandez-et-al-JAIP.pdf'],['11515_0_electronic cigarettes and their impact on allergic respiratory diseases a work group report of the aaaai environmental exposures and respiratory health committee.pdf'],[0.503],[0.543],[0.62],[0.189],[0.189],[0.151],[0.746],[0.655],[0.618],[0.667],[0.814],[0.751],[0.637],[0.919],[0.84],[0.781],[0.812],[0.795],0.503,0.543,0.62,0.189,0.189,0.151,0.746,0.655,0.618,0.667,0.814,0.751,0.637,0.919,0.84,0.781,0.812,0.795
https://doi.org/10.1016/j.jadohealth.2019.03.005,taking stock of dietary supplements harmful effects on children adolescents and young adults,11516_taking stock of dietary supplements harmful effects on children adolescents and young adults.pdf,3,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8051560&GUID=B03E9D17-00CE-4B96-9AFB-1E0F9B25A670', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8072840&GUID=57122B69-E181-40AA-975A-7A699DAA6512', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8072837&GUID=0C44B974-6C3F-4C85-BA55-50ED19A952C6']","['Testimony', '/View.ashx', 'Tilman A Ruff']","['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8051560&GUID=B03E9D17-00CE-4B96-9AFB-1E0F9B25A670', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8072837&GUID=0C44B974-6C3F-4C85-BA55-50ED19A952C6', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8072840&GUID=57122B69-E181-40AA-975A-7A699DAA6512']","['11516_0_testimony.pdf', '11516_2_tilman a ruff.pdf', '11516_1_viewashx.pdf']",3,100.0,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8051560&GUID=B03E9D17-00CE-4B96-9AFB-1E0F9B25A670', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8072837&GUID=0C44B974-6C3F-4C85-BA55-50ED19A952C6', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8072840&GUID=57122B69-E181-40AA-975A-7A699DAA6512']","['11516_0_testimony.pdf', '11516_2_tilman a ruff.pdf', '11516_1_viewashx.pdf']","[0.813, 0.089, 0.089]","[0.507, 0.43, 0.43]","[0.598, 0.518, 0.518]","[0.173, 0.09, 0.09]","[0.192, 0.096, 0.096]","[0.164, 0.104, 0.104]","[0.74, 0.736, 0.736]","[0.645, 0.637, 0.637]","[0.559, 0.465, 0.465]","[0.687, 0.703, 0.703]","[0.777, 0.675, 0.675]","[0.678, 0.533, 0.533]","[0.609, 0.602, 0.602]","[0.911, 0.868, 0.868]","[0.805, 0.72, 0.72]","[0.734, 0.61, 0.61]","[0.772, 0.672, 0.672]","[0.758, 0.628, 0.628]",0.33,0.456,0.545,0.118,0.128,0.124,0.737,0.64,0.496,0.698,0.709,0.581,0.604,0.882,0.748,0.651,0.705,0.671
https://doi.org/10.1016/j.jadohealth.2019.03.006,racerelated traumatic events online and mental health among adolescents of color,11517_racerelated traumatic events online and mental health among adolescents of color.pdf,2,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/1HEEcCfbVyWtGX6jNJQgqu5_0G0pm0TZW.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/402_02022021_154528-266.pdf']","['Testimony of Kristin Henning Director, Georgetown Juvenile Justice Initiative * Blume Professor of Law, Georgetown Juvenile Justice Clinic * Director, Mid-Atlantic Juvenile Defender Center * 600 New Jersey Ave NW Washington, DC 20001 * Titles and organizational affiliation for identification purposes only.', 'SB0136-Fav Testimony Voices Maryland-Juvenile Inte']",['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/402_02022021_154528-266.pdf'],['11517_1_sb0136fav testimony voices marylandjuvenile inte.pdf'],1,50.0,['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/402_02022021_154528-266.pdf'],['11517_1_sb0136fav testimony voices marylandjuvenile inte.pdf'],[0.155],[0.463],[0.563],[0.108],[0.126],[0.108],[0.721],[0.618],[0.516],[0.678],[0.739],[0.622],[0.606],[0.89],[0.773],[0.683],[0.737],[0.7],0.155,0.463,0.563,0.108,0.126,0.108,0.721,0.618,0.516,0.678,0.739,0.622,0.606,0.89,0.773,0.683,0.737,0.7
https://doi.org/10.1016/j.jadohealth.2019.03.013,tracking of physical activity and sedentary behavior from adolescence to young adulthood a systematic literature review,11518_tracking of physical activity and sedentary behavior from adolescence to young adulthood a systematic literature review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['11518_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['11518_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.477],[0.525],[0.616],[0.176],[0.195],[0.154],[0.733],[0.636],[0.589],[0.718],[0.78],[0.697],[0.609],[0.919],[0.825],[0.733],[0.78],[0.764],0.477,0.525,0.616,0.176,0.195,0.154,0.733,0.636,0.589,0.718,0.78,0.697,0.609,0.919,0.825,0.733,0.78,0.764
https://doi.org/10.1016/j.jadohealth.2019.05.022,effects of exposure to tobacco and electronic cigarette advertisements on tobacco use an analysis of the 2015 national youth tobacco survey,11520_effects of exposure to tobacco and electronic cigarette advertisements on tobacco use an analysis of the 2015 national youth tobacco survey.pdf,1,['https://www.in.gov/health/tpc/files/2025-IN-Tobacco-Control-Strategic-Plan.pdf'],['2025 Strategic Plan'],['https://www.in.gov/health/tpc/files/2025-IN-Tobacco-Control-Strategic-Plan.pdf'],['11520_0_2025 strategic plan.pdf'],1,100.0,['https://www.in.gov/health/tpc/files/2025-IN-Tobacco-Control-Strategic-Plan.pdf'],['11520_0_2025 strategic plan.pdf'],[0.549],[0.455],[0.558],[0.148],[0.172],[0.128],[0.738],[0.634],[0.46],[0.673],[0.726],[0.647],[0.587],[0.873],[0.716],[0.681],[0.717],[0.704],0.549,0.455,0.558,0.148,0.172,0.128,0.738,0.634,0.46,0.673,0.726,0.647,0.587,0.873,0.716,0.681,0.717,0.704
https://doi.org/10.1016/j.jadohealth.2019.05.027,police stops among atrisk youth repercussions for mental health,11521_police stops among atrisk youth repercussions for mental health.pdf,3,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/402_02022021_154528-266.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/1HEEcCfbVyWtGX6jNJQgqu5_0G0pm0TZW.pdf', 'https://tcf.org/content/report/reimagining-equitable-policing-public-safety-system-new-york-city/']","['SB0136-Fav Testimony Voices Maryland-Juvenile Inte', 'Testimony of Kristin Henning Director, Georgetown Juvenile Justice Initiative * Blume Professor of Law, Georgetown Juvenile Justice Clinic * Director, Mid-Atlantic Juvenile Defender Center * 600 New Jersey Ave NW Washington, DC 20001 * Titles and organizational affiliation for identification purposes only.', 'Reimagining a More Equitable Policing and Public Safety System in New York City']",['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/402_02022021_154528-266.pdf'],['11521_0_sb0136fav testimony voices marylandjuvenile inte.pdf'],1,33.33,['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/402_02022021_154528-266.pdf'],['11521_0_sb0136fav testimony voices marylandjuvenile inte.pdf'],[0.23],[0.478],[0.571],[0.133],[0.154],[0.134],[0.728],[0.629],[0.521],[0.689],[0.739],[0.629],[0.619],[0.893],[0.788],[0.686],[0.739],[0.698],0.23,0.478,0.571,0.133,0.154,0.134,0.728,0.629,0.521,0.689,0.739,0.629,0.619,0.893,0.788,0.686,0.739,0.698
https://doi.org/10.1016/j.jadohealth.2019.12.018,psychological functioning in transgender adolescents before and after genderaffirmative care compared with cisgender general population peers,11524_psychological functioning in transgender adolescents before and after genderaffirmative care compared with cisgender general population peers.pdf,4,"['https://www.aclu.org/legal-document/bpj-v-west-virginia-state-board-education-plaintiffs-daubert-motion-stephen-levine', 'https://www.aclu.org/legal-document/brandt-et-al-v-rutledge-et-al-supplemental-declaration-paul-w-hruz', 'https://www.aclu.org/legal-document/brandt-et-al-v-rutledge-et-al-amicus-brief-family-research-council', 'https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf']","[""B.P.J. v. West Virginia State Board of Education - Plaintiff's Daubert Motion for Stephen Levine"", 'Brandt et al v Rutledge et al - Supplemental Declaration of Paul W. Hruz', 'Brandt et al v Rutledge et al - Amicus Brief of Family Research Council', 'In The United States Court Of Appeals For The Eleventh Circuit']",['https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf'],['11524_3_in the united states court of appeals for the eleventh circuit.pdf'],1,25.0,['https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf'],['11524_3_in the united states court of appeals for the eleventh circuit.pdf'],[0.333],[0.488],[0.579],[0.134],[0.152],[0.13],[0.733],[0.637],[0.551],[0.665],[0.774],[0.675],[0.61],[0.913],[0.808],[0.73],[0.766],[0.746],0.333,0.488,0.579,0.134,0.152,0.13,0.733,0.637,0.551,0.665,0.774,0.675,0.61,0.913,0.808,0.73,0.766,0.746
https://doi.org/10.1016/j.jadohealth.2020.05.004,adolescents motivations to engage in social distancing during the covid19 pandemic associations with mental and social health,11526_adolescents motivations to engage in social distancing during the covid19 pandemic associations with mental and social health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259042/pdf'],"[""COVID-19 effects on women's home and work life, family violence and mental health from the Women's Health Expert Panel of the American Academy of Nursing""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259042/pdf'],['11526_0_covid19 effects on womens home and work life family violence and mental health from the womens health expert panel of the american academy of nursing.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259042/pdf'],['11526_0_covid19 effects on womens home and work life family violence and mental health from the womens health expert panel of the american academy of nursing.pdf'],[0.27],[0.53],[0.619],[0.148],[0.161],[0.132],[0.726],[0.628],[0.581],[0.673],[0.789],[0.717],[0.618],[0.92],[0.823],[0.758],[0.796],[0.773],0.27,0.53,0.619,0.148,0.161,0.132,0.726,0.628,0.581,0.673,0.789,0.717,0.618,0.92,0.823,0.758,0.796,0.773
https://doi.org/10.1016/j.jadohealth.2020.05.006,the covid19 pandemic and rapid implementation of adolescent and young adult telemedicine challenges and opportunities for innovation,11527_the covid19 pandemic and rapid implementation of adolescent and young adult telemedicine challenges and opportunities for innovation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['11527_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['11527_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.344],[0.56],[0.648],[0.16],[0.178],[0.141],[0.739],[0.648],[0.624],[0.643],[0.814],[0.753],[0.63],[0.93],[0.842],[0.767],[0.818],[0.797],0.344,0.56,0.648,0.16,0.178,0.141,0.739,0.648,0.624,0.643,0.814,0.753,0.63,0.93,0.842,0.767,0.818,0.797
https://doi.org/10.1016/j.jaip.2019.03.027,eculizumab hypersensitivity and desensitization in a toddler with atypical hemolytic uremic syndrome,11554_eculizumab hypersensitivity and desensitization in a toddler with atypical hemolytic uremic syndrome.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['11554_0_diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['11554_0_diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19.pdf'],[0.361],[0.573],[0.645],[0.194],[0.207],[0.157],[0.751],[0.658],[0.642],[0.646],[0.816],[0.736],[0.627],[0.92],[0.833],[0.778],[0.815],[0.797],0.361,0.573,0.645,0.194,0.207,0.157,0.751,0.658,0.642,0.646,0.816,0.736,0.627,0.92,0.833,0.778,0.815,0.797
https://doi.org/10.1016/j.jajs.2019.02.001,how effective is periarticular drug infiltration in providing pain relief following total knee replacement as compared to epidural analgesia,11556_how effective is periarticular drug infiltration in providing pain relief following total knee replacement as compared to epidural analgesia.pdf,1,['https://www.aaos.org/globalassets/quality-and-practice-resources/dod/painalleviationcpg.pdf'],"['Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery']",['https://www.aaos.org/globalassets/quality-and-practice-resources/dod/painalleviationcpg.pdf'],['11556_0_pharmacologic physical and cognitive pain alleviation for musculoskeletal extremitypelvis surgery.pdf'],1,100.0,['https://www.aaos.org/globalassets/quality-and-practice-resources/dod/painalleviationcpg.pdf'],['11556_0_pharmacologic physical and cognitive pain alleviation for musculoskeletal extremitypelvis surgery.pdf'],[0.361],[0.561],[0.649],[0.186],[0.205],[0.156],[0.742],[0.649],[0.63],[0.658],[0.809],[0.75],[0.632],[0.929],[0.826],[0.777],[0.809],[0.795],0.361,0.561,0.649,0.186,0.205,0.156,0.742,0.649,0.63,0.658,0.809,0.75,0.632,0.929,0.826,0.777,0.809,0.795
https://doi.org/10.1016/j.jamda.2020.10.028,evaluating the effect of covid19 pandemic lockdown on longterm care residents’ mental health a datadriven approach in new brunswick,11581_evaluating the effect of covid19 pandemic lockdown on longterm care residents’ mental health a datadriven approach in new brunswick.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442144/pdf', 'https://www.dhcs.ca.gov/dataandstats/reports/Documents/EQRTechRpt-Vol1.pdf']","['Non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent SARS‐CoV‐2 infections and their consequences: a rapid review', 'Medi-Cal Managed Care External Quality Review Technical Report']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442144/pdf', 'https://www.dhcs.ca.gov/dataandstats/reports/Documents/EQRTechRpt-Vol1.pdf']","['11581_0_non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent sars‐cov‐2 infections and their consequences a rapid review.pdf', '11581_1_medical managed care external quality review technical report.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442144/pdf', 'https://www.dhcs.ca.gov/dataandstats/reports/Documents/EQRTechRpt-Vol1.pdf']","['11581_0_non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent sars‐cov‐2 infections and their consequences a rapid review.pdf', '11581_1_medical managed care external quality review technical report.pdf']","[0.398, 0.303]","[0.549, 0.556]","[0.621, 0.633]","[0.164, 0.161]","[0.173, 0.179]","[0.14, 0.136]","[0.73, 0.725]","[0.639, 0.633]","[0.612, 0.63]","[0.693, 0.691]","[0.793, 0.807]","[0.724, 0.739]","[0.639, 0.653]","[0.911, 0.924]","[0.828, 0.843]","[0.752, 0.782]","[0.8, 0.816]","[0.771, 0.795]",0.351,0.552,0.627,0.163,0.176,0.138,0.728,0.636,0.621,0.692,0.8,0.732,0.646,0.917,0.835,0.767,0.808,0.783
https://doi.org/10.1016/j.jand.2018.11.001,contribution of wiceligible foods to the overall diet of 13 and 24monthold toddlers in the wic infant and toddler feeding practices study2,11617_contribution of wiceligible foods to the overall diet of 13 and 24monthold toddlers in the wic infant and toddler feeding practices study2.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['11617_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '11617_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['11617_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '11617_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.351, 0.347]","[0.533, 0.534]","[0.618, 0.62]","[0.187, 0.187]","[0.196, 0.197]","[0.163, 0.165]","[0.739, 0.739]","[0.64, 0.641]","[0.605, 0.608]","[0.692, 0.693]","[0.789, 0.79]","[0.705, 0.71]","[0.603, 0.604]","[0.922, 0.923]","[0.84, 0.843]","[0.745, 0.746]","[0.794, 0.796]","[0.782, 0.783]",0.349,0.534,0.619,0.187,0.197,0.164,0.739,0.641,0.607,0.692,0.79,0.708,0.603,0.923,0.841,0.746,0.795,0.782
https://doi.org/10.1016/j.jand.2019.05.012,taste exposure increases intake and nutrition education increases willingness to try an unfamiliar vegetable in preschool children a cluster randomized trial,11618_taste exposure increases intake and nutrition education increases willingness to try an unfamiliar vegetable in preschool children a cluster randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['11618_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['11618_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.592],[0.55],[0.629],[0.206],[0.22],[0.188],[0.738],[0.644],[0.614],[0.697],[0.794],[0.726],[0.612],[0.925],[0.838],[0.751],[0.799],[0.779],0.592,0.55,0.629,0.206,0.22,0.188,0.738,0.644,0.614,0.697,0.794,0.726,0.612,0.925,0.838,0.751,0.799,0.779
https://doi.org/10.1016/j.jand.2019.05.016,effects of an evidenceinformed healthy eating blog on dietary intakes and foodrelated behaviors of mothers of preschool and schoolaged children a randomized controlled trial,11619_effects of an evidenceinformed healthy eating blog on dietary intakes and foodrelated behaviors of mothers of preschool and schoolaged children a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['11619_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['11619_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.499],[0.543],[0.625],[0.183],[0.192],[0.163],[0.737],[0.642],[0.611],[0.698],[0.79],[0.715],[0.604],[0.921],[0.836],[0.743],[0.793],[0.776],0.499,0.543,0.625,0.183,0.192,0.163,0.737,0.642,0.611,0.698,0.79,0.715,0.604,0.921,0.836,0.743,0.793,0.776
https://doi.org/10.1016/j.jand.2019.05.017,increasing intake of an unfamiliar vegetable in preschool children through learning using storybooks and sensory play a cluster randomized trial,11620_increasing intake of an unfamiliar vegetable in preschool children through learning using storybooks and sensory play a cluster randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['11620_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['11620_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.516],[0.548],[0.627],[0.194],[0.204],[0.176],[0.738],[0.64],[0.61],[0.691],[0.79],[0.724],[0.615],[0.923],[0.835],[0.748],[0.793],[0.775],0.516,0.548,0.627,0.194,0.204,0.176,0.738,0.64,0.61,0.691,0.79,0.724,0.615,0.923,0.835,0.748,0.793,0.775
https://doi.org/10.1016/j.janxdis.2017.08.007,combining child social skills training with a parent early intervention program for inhibited preschool children,11630_combining child social skills training with a parent early intervention program for inhibited preschool children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['Cognitive behavioural therapy for anxiety disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['11630_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['11630_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],[0.552],[0.507],[0.599],[0.17],[0.176],[0.152],[0.736],[0.642],[0.559],[0.716],[0.762],[0.679],[0.583],[0.913],[0.79],[0.713],[0.76],[0.745],0.552,0.507,0.599,0.17,0.176,0.152,0.736,0.642,0.559,0.716,0.762,0.679,0.583,0.913,0.79,0.713,0.76,0.745
https://doi.org/10.1016/j.jaut.2020.102433,the epidemiology and pathogenesis of coronavirus disease covid19 outbreak,11640_the epidemiology and pathogenesis of coronavirus disease covid19 outbreak.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282404/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300825/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448735/pdf']","['Assessment of paediatric dental guidelines and caries management alternatives in the post COVID-19 period. A critical review and clinical recommendations', 'Best Practice Guidelines for the Management of Acute Craniomaxillofacial Trauma During the COVID-19 Pandemic', 'Safety guidelines for non‐surgical facial procedures during covid‐19 outbreak', 'International Society for Gynecologic Endoscopy (ISGE) guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the SARS-CoV-2 pandemic']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448735/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300825/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282404/pdf']","['11640_3_international society for gynecologic endoscopy isge guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the sarscov2 pandemic.pdf', '11640_0_assessment of paediatric dental guidelines and caries management alternatives in the post covid19 period a critical review and clinical recommendations.pdf', '11640_2_safety guidelines for non‐surgical facial procedures during covid‐19 outbreak.pdf', '11640_1_best practice guidelines for the management of acute craniomaxillofacial trauma during the covid19 pandemic.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448735/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300825/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282404/pdf']","['11640_3_international society for gynecologic endoscopy isge guidelines and recommendations on gynecological endoscopy during the evolutionary phases of the sarscov2 pandemic.pdf', '11640_0_assessment of paediatric dental guidelines and caries management alternatives in the post covid19 period a critical review and clinical recommendations.pdf', '11640_2_safety guidelines for non‐surgical facial procedures during covid‐19 outbreak.pdf', '11640_1_best practice guidelines for the management of acute craniomaxillofacial trauma during the covid19 pandemic.pdf']","[0.342, 0.463, 0.426, 0.346]","[0.497, 0.494, 0.488, 0.506]","[0.591, 0.588, 0.584, 0.595]","[0.122, 0.131, 0.131, 0.155]","[0.13, 0.132, 0.142, 0.162]","[0.102, 0.108, 0.121, 0.135]","[0.734, 0.738, 0.739, 0.741]","[0.638, 0.644, 0.646, 0.649]","[0.57, 0.558, 0.555, 0.572]","[0.601, 0.619, 0.637, 0.622]","[0.79, 0.79, 0.785, 0.791]","[0.699, 0.685, 0.689, 0.703]","[0.624, 0.62, 0.617, 0.615]","[0.912, 0.904, 0.908, 0.907]","[0.795, 0.782, 0.802, 0.8]","[0.745, 0.738, 0.737, 0.746]","[0.782, 0.774, 0.776, 0.782]","[0.767, 0.761, 0.764, 0.766]",0.394,0.496,0.589,0.135,0.142,0.116,0.738,0.644,0.564,0.62,0.789,0.694,0.619,0.908,0.795,0.742,0.778,0.764
https://doi.org/10.1016/j.jcf.2019.10.025,characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials,11679_characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629645/pdf'],['Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629645/pdf'],['11679_0_continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629645/pdf'],['11679_0_continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes.pdf'],[0.229],[0.563],[0.647],[0.173],[0.176],[0.135],[0.731],[0.635],[0.636],[0.685],[0.801],[0.743],[0.617],[0.923],[0.851],[0.764],[0.804],[0.788],0.229,0.563,0.647,0.173,0.176,0.135,0.731,0.635,0.636,0.685,0.801,0.743,0.617,0.923,0.851,0.764,0.804,0.788
https://doi.org/10.1016/j.jcjo.2020.01.009,surgical outcomes of plication versus resection in basic type of intermittent exotropia,11692_surgical outcomes of plication versus resection in basic type of intermittent exotropia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437222/pdf'],['Interventions for intermittent exotropia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437222/pdf'],['11692_0_interventions for intermittent exotropia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437222/pdf'],['11692_0_interventions for intermittent exotropia.pdf'],[0.413],[0.535],[0.608],[0.173],[0.175],[0.143],[0.737],[0.642],[0.6],[0.661],[0.79],[0.723],[0.611],[0.918],[0.808],[0.744],[0.793],[0.77],0.413,0.535,0.608,0.173,0.175,0.143,0.737,0.642,0.6,0.661,0.79,0.723,0.611,0.918,0.808,0.744,0.793,0.77
https://doi.org/10.1016/j.jcomdis.2019.02.002,an evaluation of an integrated fluency and resilience program for early developmental stuttering disorders,11723_an evaluation of an integrated fluency and resilience program for early developmental stuttering disorders.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428330/pdf'],['Non‐pharmacological interventions for stuttering in children six years and younger'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428330/pdf'],['11723_0_non‐pharmacological interventions for stuttering in children six years and younger.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428330/pdf'],['11723_0_non‐pharmacological interventions for stuttering in children six years and younger.pdf'],[0.497],[0.53],[0.621],[0.169],[0.178],[0.153],[0.729],[0.634],[0.586],[0.715],[0.78],[0.711],[0.615],[0.915],[0.813],[0.741],[0.784],[0.767],0.497,0.53,0.621,0.169,0.178,0.153,0.729,0.634,0.586,0.715,0.78,0.711,0.615,0.915,0.813,0.741,0.784,0.767
https://doi.org/10.1016/j.jcrs.2013.05.044,efficacy of surgical simulator training versus traditional wetlab training on operating room performance of ophthalmology residents during the capsulorhexis in cataract surgery,11748_efficacy of surgical simulator training versus traditional wetlab training on operating room performance of ophthalmology residents during the capsulorhexis in cataract surgery.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689714/pdf'],['Virtual reality training for cataract surgery operating performance in ophthalmology trainees'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689714/pdf'],['11748_0_virtual reality training for cataract surgery operating performance in ophthalmology trainees.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689714/pdf'],['11748_0_virtual reality training for cataract surgery operating performance in ophthalmology trainees.pdf'],[0.492],[0.528],[0.618],[0.17],[0.182],[0.151],[0.733],[0.641],[0.599],[0.682],[0.787],[0.718],[0.596],[0.923],[0.825],[0.734],[0.786],[0.763],0.492,0.528,0.618,0.17,0.182,0.151,0.733,0.641,0.599,0.682,0.787,0.718,0.596,0.923,0.825,0.734,0.786,0.763
https://doi.org/10.1016/j.jdcr.2019.03.024,palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis,11753_palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['11753_0_diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300843/pdf'],['11753_0_diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19.pdf'],[0.239],[0.563],[0.647],[0.177],[0.191],[0.152],[0.749],[0.656],[0.631],[0.629],[0.819],[0.734],[0.613],[0.925],[0.82],[0.769],[0.807],[0.79],0.239,0.563,0.647,0.177,0.191,0.152,0.749,0.656,0.631,0.629,0.819,0.734,0.613,0.925,0.82,0.769,0.807,0.79
https://doi.org/10.1016/j.jecp.2011.07.004,early literacy and early numeracy the value of including early literacy skills in the prediction of numeracy development,11870_early literacy and early numeracy the value of including early literacy skills in the prediction of numeracy development.pdf,2,"['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/09_05-2018_LetterWorkgroup3and4.pdf', 'https://www.brookings.edu/blog/education-plus-development/2021/08/10/what-if-teaching-mirrored-how-human-brains-learn/']","['Letter to Workgroup 3 and 4', 'What if teaching mirrored how human brains learn?']",['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/09_05-2018_LetterWorkgroup3and4.pdf'],['11870_0_letter to workgroup 3 and 4.pdf'],1,50.0,['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/09_05-2018_LetterWorkgroup3and4.pdf'],['11870_0_letter to workgroup 3 and 4.pdf'],[0.263],[0.517],[0.621],[0.182],[0.209],[0.173],[0.732],[0.64],[0.577],[0.715],[0.787],[0.728],[0.635],[0.915],[0.82],[0.766],[0.786],[0.779],0.263,0.517,0.621,0.182,0.209,0.173,0.732,0.64,0.577,0.715,0.787,0.728,0.635,0.915,0.82,0.766,0.786,0.779
https://doi.org/10.1016/j.jedc.2020.103858,do inflationtargeting central banks adjust inflation targets to meet the target,11893_do inflationtargeting central banks adjust inflation targets to meet the target.pdf,1,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2022/0418.pdf'],['Just Do IT? An Assessment of Inflation Targeting in a Global Comparative Case Study'],['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2022/0418.pdf'],['11893_0_just do it an assessment of inflation targeting in a global comparative case study.pdf'],1,100.0,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2022/0418.pdf'],['11893_0_just do it an assessment of inflation targeting in a global comparative case study.pdf'],[0.589],[0.497],[0.599],[0.157],[0.168],[0.156],[0.732],[0.637],[0.558],[0.74],[0.772],[0.674],[0.647],[0.912],[0.814],[0.743],[0.776],[0.763],0.589,0.497,0.599,0.157,0.168,0.156,0.732,0.637,0.558,0.74,0.772,0.674,0.647,0.912,0.814,0.743,0.776,0.763
https://doi.org/10.1016/j.jfineco.2021.05.037,should information be sold separately evidence from mifid ii,11973_should information be sold separately evidence from mifid ii.pdf,1,['https://www.sec.gov/files/staff-report-investment-research-small-issuers.pdf'],['Staff Report on the Issues Affecting the Provision of and Reliance Upon Investment Research Into Small Issuers'],['https://www.sec.gov/files/staff-report-investment-research-small-issuers.pdf'],['11973_0_staff report on the issues affecting the provision of and reliance upon investment research into small issuers.pdf'],1,100.0,['https://www.sec.gov/files/staff-report-investment-research-small-issuers.pdf'],['11973_0_staff report on the issues affecting the provision of and reliance upon investment research into small issuers.pdf'],[0.567],[0.543],[0.63],[0.179],[0.187],[0.165],[0.73],[0.632],[0.601],[0.719],[0.793],[0.714],[0.653],[0.917],[0.847],[0.768],[0.796],[0.782],0.567,0.543,0.63,0.179,0.187,0.165,0.73,0.632,0.601,0.719,0.793,0.714,0.653,0.917,0.847,0.768,0.796,0.782
https://doi.org/10.1016/j.jfineco.2021.07.013,retail shareholder participation in the proxy process monitoring engagement and voting,11975_retail shareholder participation in the proxy process monitoring engagement and voting.pdf,2,"['https://www.federalregister.gov/documents/2022/07/27/2022-15348/substantial-implementation-duplication-and-resubmission-of-shareholder-proposals-under-exchange-act', 'https://www.sec.gov/rules/proposed/2022/34-95267.pdf']","['Substantial Implementation, Duplication, and Resubmission of Shareholder Proposals Under Exchange Act Rule 14a-8', '34-95267']",['https://www.sec.gov/rules/proposed/2022/34-95267.pdf'],['11975_1_3495267.pdf'],1,50.0,['https://www.sec.gov/rules/proposed/2022/34-95267.pdf'],['11975_1_3495267.pdf'],[0.375],[0.56],[0.64],[0.173],[0.191],[0.164],[0.729],[0.635],[0.625],[0.717],[0.804],[0.736],[0.658],[0.92],[0.856],[0.78],[0.808],[0.79],0.375,0.56,0.64,0.173,0.191,0.164,0.729,0.635,0.625,0.717,0.804,0.736,0.658,0.92,0.856,0.78,0.808,0.79
https://doi.org/10.1016/j.jfma.2020.02.009,sarscov2 infection in children transmission dynamics and clinical characteristics,11980_sarscov2 infection in children transmission dynamics and clinical characteristics.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314347/pdf']","['Management strategies for children with COVID-19: ESPR practical recommendations', 'Cardiac imaging in congenital heart disease during the coronavirus disease-2019 pandemic: recommendations from the Working Group on Congenital Heart Disease of the Italian Society of Cardiology']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314347/pdf']","['11980_0_management strategies for children with covid19 espr practical recommendations.pdf', '11980_1_cardiac imaging in congenital heart disease during the coronavirus disease2019 pandemic recommendations from the working group on congenital heart disease of the italian society of cardiology.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314347/pdf']","['11980_0_management strategies for children with covid19 espr practical recommendations.pdf', '11980_1_cardiac imaging in congenital heart disease during the coronavirus disease2019 pandemic recommendations from the working group on congenital heart disease of the italian society of cardiology.pdf']","[0.409, 0.286]","[0.557, 0.54]","[0.636, 0.623]","[0.194, 0.159]","[0.196, 0.159]","[0.16, 0.129]","[0.739, 0.729]","[0.643, 0.632]","[0.637, 0.612]","[0.62, 0.611]","[0.818, 0.806]","[0.738, 0.741]","[0.628, 0.626]","[0.92, 0.914]","[0.848, 0.826]","[0.783, 0.764]","[0.824, 0.797]","[0.798, 0.785]",0.347,0.548,0.629,0.176,0.177,0.145,0.734,0.637,0.625,0.615,0.812,0.74,0.627,0.917,0.837,0.774,0.81,0.792
https://doi.org/10.1016/j.jhealeco.2018.09.011,impact and spillover effects of an asset transfer program on child undernutrition evidence from a randomized control trial in bangladesh,12109_impact and spillover effects of an asset transfer program on child undernutrition evidence from a randomized control trial in bangladesh.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/134593']","['Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Nutrition-sensitive social protection programs within food systems']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf']","['12109_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '12109_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf']","['12109_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '12109_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']","[0.37, 0.36]","[0.505, 0.506]","[0.591, 0.591]","[0.147, 0.152]","[0.151, 0.155]","[0.127, 0.13]","[0.727, 0.727]","[0.63, 0.63]","[0.558, 0.56]","[0.701, 0.7]","[0.771, 0.771]","[0.683, 0.681]","[0.606, 0.61]","[0.908, 0.908]","[0.796, 0.798]","[0.723, 0.723]","[0.771, 0.771]","[0.75, 0.75]",0.365,0.506,0.591,0.149,0.153,0.129,0.727,0.63,0.559,0.7,0.771,0.682,0.608,0.908,0.797,0.723,0.771,0.75
https://doi.org/10.1016/j.jhealeco.2019.102225,the impact of the philadelphia beverage tax on purchases and consumption by adults and children,12113_the impact of the philadelphia beverage tax on purchases and consumption by adults and children.pdf,5,"['http://www.seattle.gov/Documents/Departments/CityAuditor/auditreports/SBT_12MonthReport.pdf', 'https://www.nber.org/papers/w28960', 'https://www.rti.org/rti-press-publication/preventing-non-communicable-diseases-using-pricing-policies', 'https://mathematica.org/publications/how-retailers-responded-to-taxes-on-sweetened-beverages-a-tale-of-two-cities', 'https://mathematica.org/publications/multi-city-study-shows-beverage-taxes-raise-prices-reduce-and-shift-purchases']","['12 Month Report : Store Audits & Child Cohort', 'The Effect of Beverage Taxes on Youth Consumption and BMI: Evidence from Mauritius', 'Preventing non-communicable diseases using pricing policies', 'How Retailers Responded to Taxes on Sweetened Beverages: A Tale of Two Cities', 'Multi-City Study Shows Beverage Taxes Raise Prices, Reduce and Shift Purchases']",['http://www.seattle.gov/Documents/Departments/CityAuditor/auditreports/SBT_12MonthReport.pdf'],['12113_0_12 month report  store audits  child cohort.pdf'],1,20.0,['http://www.seattle.gov/Documents/Departments/CityAuditor/auditreports/SBT_12MonthReport.pdf'],['12113_0_12 month report  store audits  child cohort.pdf'],[0.687],[0.55],[0.637],[0.19],[0.223],[0.188],[0.737],[0.641],[0.612],[0.696],[0.797],[0.732],[0.668],[0.916],[0.838],[0.766],[0.804],[0.787],0.687,0.55,0.637,0.19,0.223,0.188,0.737,0.641,0.612,0.696,0.797,0.732,0.668,0.916,0.838,0.766,0.804,0.787
https://doi.org/10.1016/j.jhep.2016.01.029,impact of direct acting antiviral therapy in patients with chronic hepatitis c and decompensated cirrhosis,12130_impact of direct acting antiviral therapy in patients with chronic hepatitis c and decompensated cirrhosis.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529246/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166104/pdf']","['AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review', '2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529246/pdf']","['12130_1_2017 kasl clinical practice guidelines management of hepatitis c treatment of chronic hepatitis c.pdf', '12130_0_aga clinical practice update on interaction between oral directacting antivirals daas for chronic hepatitis c infection and hepatocellular carcinoma expert review.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166104/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529246/pdf']","['12130_1_2017 kasl clinical practice guidelines management of hepatitis c treatment of chronic hepatitis c.pdf', '12130_0_aga clinical practice update on interaction between oral directacting antivirals daas for chronic hepatitis c infection and hepatocellular carcinoma expert review.pdf']","[0.565, 0.735]","[0.594, 0.522]","[0.656, 0.608]","[0.246, 0.185]","[0.249, 0.204]","[0.205, 0.158]","[0.76, 0.743]","[0.675, 0.653]","[0.654, 0.586]","[0.649, 0.672]","[0.808, 0.774]","[0.734, 0.667]","[0.638, 0.591]","[0.93, 0.917]","[0.822, 0.794]","[0.781, 0.738]","[0.812, 0.772]","[0.792, 0.76]",0.65,0.558,0.632,0.215,0.226,0.181,0.752,0.664,0.62,0.661,0.791,0.701,0.615,0.923,0.808,0.76,0.792,0.776
https://doi.org/10.1016/j.jhep.2016.06.019,outcomes after successful directacting antiviral therapy for patients with chronic hepatitis c and decompensated cirrhosis,12133_outcomes after successful directacting antiviral therapy for patients with chronic hepatitis c and decompensated cirrhosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529246/pdf'],['AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529246/pdf'],['12133_0_aga clinical practice update on interaction between oral directacting antivirals daas for chronic hepatitis c infection and hepatocellular carcinoma expert review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529246/pdf'],['12133_0_aga clinical practice update on interaction between oral directacting antivirals daas for chronic hepatitis c infection and hepatocellular carcinoma expert review.pdf'],[0.604],[0.53],[0.616],[0.196],[0.221],[0.173],[0.745],[0.656],[0.592],[0.678],[0.782],[0.679],[0.599],[0.92],[0.808],[0.749],[0.781],[0.77],0.604,0.53,0.616,0.196,0.221,0.173,0.745,0.656,0.592,0.678,0.782,0.679,0.599,0.92,0.808,0.749,0.781,0.77
https://doi.org/10.1016/j.jhep.2019.03.028,a multicenter study of entecavir vs tenofovir on prognosis of treatmentnaïve chronic hepatitis b in south korea,12135_a multicenter study of entecavir vs tenofovir on prognosis of treatmentnaïve chronic hepatitis b in south korea.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['12135_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['12135_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.534],[0.504],[0.584],[0.151],[0.152],[0.117],[0.742],[0.654],[0.571],[0.647],[0.782],[0.645],[0.619],[0.911],[0.812],[0.747],[0.78],[0.767],0.534,0.504,0.584,0.151,0.152,0.117,0.742,0.654,0.571,0.647,0.782,0.645,0.619,0.911,0.812,0.747,0.78,0.767
https://doi.org/10.1016/j.jhep.2019.05.005,arterial subtraction images of gadoxetateenhanced mri improve diagnosis of earlystage hepatocellular carcinoma,12136_arterial subtraction images of gadoxetateenhanced mri improve diagnosis of earlystage hepatocellular carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['12136_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['12136_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.332],[0.556],[0.627],[0.167],[0.165],[0.128],[0.751],[0.661],[0.617],[0.646],[0.796],[0.719],[0.632],[0.924],[0.821],[0.763],[0.797],[0.78],0.332,0.556,0.627,0.167,0.165,0.128,0.751,0.661,0.617,0.646,0.796,0.719,0.632,0.924,0.821,0.763,0.797,0.78
https://doi.org/10.1016/j.jinf.2018.08.009,a hand hygiene intervention to decrease hand foot and mouth disease and absence due to sickness among kindergarteners in china a clusterrandomized controlled trial,12163_a hand hygiene intervention to decrease hand foot and mouth disease and absence due to sickness among kindergarteners in china a clusterrandomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['Rinse‐free hand wash for reducing absenteeism among preschool and school children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['12163_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['12163_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],[0.381],[0.501],[0.599],[0.16],[0.17],[0.133],[0.731],[0.635],[0.561],[0.683],[0.773],[0.683],[0.588],[0.91],[0.803],[0.729],[0.772],[0.757],0.381,0.501,0.599,0.16,0.17,0.133,0.731,0.635,0.561,0.683,0.773,0.683,0.588,0.91,0.803,0.729,0.772,0.757
https://doi.org/10.1016/j.jinf.2020.03.005,clinical features of covid19 in elderly patients a comparison with young and middleaged patients,12165_clinical features of covid19 in elderly patients a comparison with young and middleaged patients.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274119/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573453/pdf']","['Guidelines: Anaesthesia in the context of COVID-19 pandemic', 'Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings', 'What the COVID-19 pandemic entails for the management of patients with behavioral and psychological symptoms of dementia: experience in France']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274119/pdf']","['12165_1_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf', '12165_2_what the covid19 pandemic entails for the management of patients with behavioral and psychological symptoms of dementia experience in france.pdf', '12165_0_guidelines anaesthesia in the context of covid19 pandemic.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712344/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573453/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274119/pdf']","['12165_1_recommendations for use of antigenic tests in the diagnosis of acute sarscov2 infection in the second pandemic wave attitude in different clinical settings.pdf', '12165_2_what the covid19 pandemic entails for the management of patients with behavioral and psychological symptoms of dementia experience in france.pdf', '12165_0_guidelines anaesthesia in the context of covid19 pandemic.pdf']","[0.353, 0.32, 0.375]","[0.54, 0.519, 0.502]","[0.614, 0.609, 0.585]","[0.169, 0.149, 0.146]","[0.178, 0.157, 0.152]","[0.136, 0.123, 0.115]","[0.736, 0.731, 0.734]","[0.644, 0.639, 0.638]","[0.602, 0.58, 0.564]","[0.651, 0.644, 0.643]","[0.799, 0.789, 0.768]","[0.728, 0.699, 0.66]","[0.633, 0.625, 0.626]","[0.92, 0.917, 0.906]","[0.832, 0.819, 0.786]","[0.762, 0.753, 0.736]","[0.798, 0.784, 0.767]","[0.78, 0.766, 0.753]",0.349,0.52,0.603,0.155,0.162,0.125,0.734,0.64,0.582,0.646,0.785,0.696,0.628,0.914,0.812,0.75,0.783,0.766
https://doi.org/10.1016/j.jinf.2021.02.025,use of lateral flow devices allows rapid triage of patients with sarscov2 on admission to hospital,12166_use of lateral flow devices allows rapid triage of patients with sarscov2 on admission to hospital.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/pdf'],"['Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/pdf'],['12166_0_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/pdf'],['12166_0_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf'],[0.373],[0.508],[0.59],[0.14],[0.136],[0.112],[0.733],[0.639],[0.566],[0.701],[0.767],[0.683],[0.592],[0.902],[0.806],[0.711],[0.768],[0.743],0.373,0.508,0.59,0.14,0.136,0.112,0.733,0.639,0.566,0.701,0.767,0.683,0.592,0.902,0.806,0.711,0.768,0.743
https://doi.org/10.1016/j.jmoneco.2019.08.014,central bank announcements big news for little people,12240_central bank announcements big news for little people.pdf,6,"['https://www.nber.org/papers/w28592', 'https://www.clevelandfed.org/publications/working-paper/wp-2026r-average-inflation-targeting-and-household-expectations', 'https://www.clevelandfed.org/publications/working-paper/wp-2026-average-inflation-targeting-and-household--expectations', 'https://www.nber.org/papers/w28836', 'https://www.dallasfed.org/-/media/documents/research/papers/2019/wp1906r1.pdf', 'https://www.newyorkfed.org/research/staff_reports/sr897.html']","['The Voice of Monetary Policy', 'Average Inflation Targeting and Household Expectations', 'Average Inflation Targeting and Household Expectations', 'The Inflation Expectations of U.S. Firms: Evidence from a new survey', 'Do Monetary Policy Announcements Shift Household Expectations?', 'Do Monetary Policy Announcements Shift Household Expectations? - FEDERAL RESERVE BANK of NEW YORK']",['https://www.dallasfed.org/-/media/documents/research/papers/2019/wp1906r1.pdf'],['12240_4_do monetary policy announcements shift household expectations.pdf'],1,16.67,['https://www.dallasfed.org/-/media/documents/research/papers/2019/wp1906r1.pdf'],['12240_4_do monetary policy announcements shift household expectations.pdf'],[0.396],[0.561],[0.643],[0.185],[0.204],[0.166],[0.733],[0.642],[0.625],[0.739],[0.802],[0.739],[0.66],[0.926],[0.855],[0.777],[0.808],[0.795],0.396,0.561,0.643,0.185,0.204,0.166,0.733,0.642,0.625,0.739,0.802,0.739,0.66,0.926,0.855,0.777,0.808,0.795
https://doi.org/10.1016/j.jneb.2016.10.007,a communitybased positive deviancehearth infant and young child nutrition intervention in ecuador improved diet and reduced underweight,12283_a communitybased positive deviancehearth infant and young child nutrition intervention in ecuador improved diet and reduced underweight.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf']","['12283_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12283_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12283_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12283_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf']","['12283_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12283_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12283_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12283_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.477, 0.475, 0.474, 0.473]","[0.54, 0.538, 0.542, 0.543]","[0.619, 0.617, 0.618, 0.619]","[0.197, 0.196, 0.202, 0.203]","[0.201, 0.2, 0.207, 0.207]","[0.166, 0.165, 0.169, 0.17]","[0.738, 0.738, 0.738, 0.739]","[0.64, 0.64, 0.641, 0.642]","[0.607, 0.605, 0.609, 0.611]","[0.698, 0.697, 0.698, 0.698]","[0.794, 0.794, 0.799, 0.8]","[0.712, 0.707, 0.721, 0.722]","[0.608, 0.608, 0.616, 0.616]","[0.917, 0.916, 0.913, 0.914]","[0.834, 0.831, 0.826, 0.827]","[0.743, 0.742, 0.753, 0.755]","[0.796, 0.794, 0.8, 0.801]","[0.775, 0.774, 0.777, 0.778]",0.475,0.541,0.618,0.2,0.204,0.168,0.738,0.641,0.608,0.698,0.797,0.716,0.612,0.915,0.83,0.748,0.798,0.776
https://doi.org/10.1016/j.jneb.2018.09.001,the impact of a healthy weight intervention embedded in a homevisiting program on childrens weight and mothers’ feeding practices,12289_the impact of a healthy weight intervention embedded in a homevisiting program on childrens weight and mothers’ feeding practices.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['12289_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12289_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['12289_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '12289_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.501, 0.5]","[0.547, 0.549]","[0.626, 0.628]","[0.206, 0.206]","[0.214, 0.214]","[0.183, 0.184]","[0.742, 0.742]","[0.645, 0.645]","[0.607, 0.609]","[0.705, 0.706]","[0.794, 0.794]","[0.699, 0.703]","[0.613, 0.613]","[0.92, 0.921]","[0.831, 0.834]","[0.747, 0.748]","[0.793, 0.794]","[0.779, 0.781]",0.5,0.548,0.627,0.206,0.214,0.183,0.742,0.645,0.608,0.706,0.794,0.701,0.613,0.921,0.833,0.748,0.794,0.78
https://doi.org/10.1016/j.jneb.2019.04.002,efficacy of a homebased parent trainingfocused weight management intervention for preschool children the drive randomized controlled pilot trial,12290_efficacy of a homebased parent trainingfocused weight management intervention for preschool children the drive randomized controlled pilot trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['12290_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['12290_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.456],[0.535],[0.621],[0.19],[0.196],[0.165],[0.738],[0.642],[0.597],[0.698],[0.783],[0.695],[0.604],[0.924],[0.827],[0.739],[0.786],[0.772],0.456,0.535,0.621,0.19,0.196,0.165,0.738,0.642,0.597,0.698,0.783,0.695,0.604,0.924,0.827,0.739,0.786,0.772
https://doi.org/10.1016/j.jneb.2019.04.007,discover myplate nutrition education for kindergarten,12291_discover myplate nutrition education for kindergarten.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['12291_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['12291_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.227],[0.54],[0.621],[0.174],[0.2],[0.164],[0.737],[0.64],[0.606],[0.692],[0.793],[0.724],[0.608],[0.932],[0.848],[0.756],[0.796],[0.784],0.227,0.54,0.621,0.174,0.2,0.164,0.737,0.64,0.606,0.692,0.793,0.724,0.608,0.932,0.848,0.756,0.796,0.784
https://doi.org/10.1016/j.jneb.2019.07.016,access with education improves fruit and vegetable intake in preschool children,12292_access with education improves fruit and vegetable intake in preschool children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['12292_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['12292_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.526],[0.538],[0.612],[0.19],[0.196],[0.163],[0.735],[0.641],[0.6],[0.693],[0.788],[0.706],[0.609],[0.925],[0.833],[0.746],[0.791],[0.779],0.526,0.538,0.612,0.19,0.196,0.163,0.735,0.641,0.6,0.693,0.788,0.706,0.609,0.925,0.833,0.746,0.791,0.779
https://doi.org/10.1016/j.jnn.2020.06.005,covid19 in babies knowledge for neonatal care,12299_covid19 in babies knowledge for neonatal care.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12299_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12299_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.582],[0.525],[0.614],[0.157],[0.175],[0.144],[0.738],[0.644],[0.585],[0.634],[0.794],[0.715],[0.621],[0.911],[0.815],[0.75],[0.795],[0.779],0.582,0.525,0.614,0.157,0.175,0.144,0.738,0.644,0.585,0.634,0.794,0.715,0.621,0.911,0.815,0.75,0.795,0.779
https://doi.org/10.1016/j.jnn.2020.10.005,the implications of face masks for babies and families during the covid19 pandemic a discussion paper,12300_the implications of face masks for babies and families during the covid19 pandemic a discussion paper.pdf,3,"['https://mises.org/wire/unmask-america', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.pacificresearch.org/sally-pipes-quoted-in-ken-artzs-column-in-aprils-health-care-news-single-payer-health-care-stalls-in-california/']","['Unmask America', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'Sally Pipes Quoted in Ken Artz\'s Column in April\'s ""Health Care News"": ""Single-Payer Health Care Stalls in California"" - Pacific Research Institute']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12300_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12300_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.107],[0.575],[0.645],[0.116],[0.092],[0.073],[0.734],[0.632],[0.633],[0.591],[0.82],[0.758],[0.64],[0.925],[0.844],[0.778],[0.825],[0.803],0.107,0.575,0.645,0.116,0.092,0.073,0.734,0.632,0.633,0.591,0.82,0.758,0.64,0.925,0.844,0.778,0.825,0.803
https://doi.org/10.1016/j.jnn.2020.11.004,exploring modifiable riskfactors for premature birth in the context of covid19 mitigation measures a discussion paper,12301_exploring modifiable riskfactors for premature birth in the context of covid19 mitigation measures a discussion paper.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12301_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12301_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.332],[0.503],[0.596],[0.133],[0.139],[0.116],[0.736],[0.64],[0.557],[0.64],[0.783],[0.688],[0.609],[0.914],[0.798],[0.733],[0.776],[0.764],0.332,0.503,0.596,0.133,0.139,0.116,0.736,0.64,0.557,0.64,0.783,0.688,0.609,0.914,0.798,0.733,0.776,0.764
https://doi.org/10.1016/j.jogc.2018.05.042,a systematic review of barriers to vaccination during pregnancy in the canadian context,12316_a systematic review of barriers to vaccination during pregnancy in the canadian context.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849424/pdf', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/protocol']","['Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Safety of Vaccines Used for Routine Immunization in the United States']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849424/pdf'],['12316_0_professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849424/pdf'],['12316_0_professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients.pdf'],[0.482],[0.609],[0.67],[0.269],[0.295],[0.25],[0.756],[0.671],[0.668],[0.667],[0.835],[0.775],[0.653],[0.933],[0.856],[0.801],[0.835],[0.815],0.482,0.609,0.67,0.269,0.295,0.25,0.756,0.671,0.668,0.667,0.835,0.775,0.653,0.933,0.856,0.801,0.835,0.815
https://doi.org/10.1016/j.jogn.2019.03.004,systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome,12319_systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf', 'https://www.in.gov/health/laboroflove/files/breastfeeding-and-substance-use-final.pdf']","['Non‐pharmacological care for opioid withdrawal in newborns', 'Breastfeeding and Substance Use : Evidence-based Practices']","['https://www.in.gov/health/laboroflove/files/breastfeeding-and-substance-use-final.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf']","['12319_1_breastfeeding and substance use  evidencebased practices.pdf', '12319_0_non‐pharmacological care for opioid withdrawal in newborns.pdf']",2,100.0,"['https://www.in.gov/health/laboroflove/files/breastfeeding-and-substance-use-final.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf']","['12319_1_breastfeeding and substance use  evidencebased practices.pdf', '12319_0_non‐pharmacological care for opioid withdrawal in newborns.pdf']","[0.407, 0.415]","[0.527, 0.514]","[0.626, 0.608]","[0.178, 0.17]","[0.2, 0.185]","[0.17, 0.153]","[0.737, 0.733]","[0.651, 0.643]","[0.585, 0.568]","[0.659, 0.689]","[0.797, 0.778]","[0.714, 0.689]","[0.617, 0.605]","[0.921, 0.914]","[0.812, 0.799]","[0.758, 0.731]","[0.79, 0.769]","[0.779, 0.757]",0.411,0.52,0.617,0.174,0.193,0.162,0.735,0.647,0.577,0.674,0.788,0.702,0.611,0.917,0.806,0.744,0.78,0.768
https://doi.org/10.1016/j.jogn.2020.07.004,promotion of maternal–infant mental health and traumainformed care during the covid19 pandemic,12320_promotion of maternal–infant mental health and traumainformed care during the covid19 pandemic.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12320_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12320_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.543],[0.541],[0.628],[0.174],[0.195],[0.161],[0.747],[0.657],[0.595],[0.64],[0.799],[0.73],[0.618],[0.921],[0.826],[0.758],[0.798],[0.786],0.543,0.541,0.628,0.174,0.195,0.161,0.747,0.657,0.595,0.64,0.799,0.73,0.618,0.921,0.826,0.758,0.798,0.786
https://doi.org/10.1016/j.joule.2020.07.013,energy consumption of cryptocurrencies beyond bitcoin,12329_energy consumption of cryptocurrencies beyond bitcoin.pdf,1,['https://www.whitehouse.gov/wp-content/uploads/2022/09/09-2022-Crypto-Assets-and-Climate-Report.pdf'],['Climate And Energy Implications Of Crypto-assets In The United States'],['https://www.whitehouse.gov/wp-content/uploads/2022/09/09-2022-Crypto-Assets-and-Climate-Report.pdf'],['12329_0_climate and energy implications of cryptoassets in the united states.pdf'],1,100.0,['https://www.whitehouse.gov/wp-content/uploads/2022/09/09-2022-Crypto-Assets-and-Climate-Report.pdf'],['12329_0_climate and energy implications of cryptoassets in the united states.pdf'],[0.497],[0.511],[0.613],[0.16],[0.156],[0.141],[0.733],[0.646],[0.585],[0.694],[0.8],[0.719],[0.654],[0.908],[0.835],[0.762],[0.811],[0.79],0.497,0.511,0.613,0.16,0.156,0.141,0.733,0.646,0.585,0.694,0.8,0.719,0.654,0.908,0.835,0.762,0.811,0.79
https://doi.org/10.1016/j.jpag.2014.04.005,early initiation of postpartum contraception does it decrease rapid repeat pregnancy in adolescents,12363_early initiation of postpartum contraception does it decrease rapid repeat pregnancy in adolescents.pdf,4,"['https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2817%2930473-0', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154222/pdf', 'https://www.in.gov/health/laboroflove/files/Final-LARC-Guidance.pdf', 'https://www.in.gov/laboroflove/files/larc-tool-kit-w-appendices.pdf']","['Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices', 'Education for contraceptive use by women after childbirth', 'Long-Acting Reversible Contraception (LARC)', 'Long Acting reversible contraception (LARC)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154222/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2817%2930473-0', 'https://www.in.gov/health/laboroflove/files/Final-LARC-Guidance.pdf']","['12363_1_education for contraceptive use by women after childbirth.pdf', '12363_0_society of family planning guidelines postplacental insertion of intrauterine devices.pdf', '12363_2_longacting reversible contraception larc.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154222/pdf', 'https://www.contraceptionjournal.org/action/showPdf?pii=S0010-7824%2817%2930473-0', 'https://www.in.gov/health/laboroflove/files/Final-LARC-Guidance.pdf']","['12363_1_education for contraceptive use by women after childbirth.pdf', '12363_0_society of family planning guidelines postplacental insertion of intrauterine devices.pdf', '12363_2_longacting reversible contraception larc.pdf']","[0.283, 0.377, 0.488]","[0.529, 0.567, 0.559]","[0.603, 0.636, 0.644]","[0.182, 0.219, 0.213]","[0.198, 0.244, 0.238]","[0.172, 0.213, 0.212]","[0.738, 0.748, 0.745]","[0.641, 0.656, 0.649]","[0.587, 0.624, 0.618]","[0.66, 0.648, 0.658]","[0.779, 0.811, 0.805]","[0.703, 0.746, 0.736]","[0.605, 0.632, 0.639]","[0.904, 0.918, 0.915]","[0.811, 0.826, 0.83]","[0.738, 0.777, 0.776]","[0.782, 0.813, 0.812]","[0.764, 0.798, 0.795]",0.383,0.552,0.628,0.205,0.227,0.199,0.744,0.649,0.61,0.655,0.798,0.728,0.625,0.912,0.822,0.764,0.802,0.786
https://doi.org/10.1016/j.jpag.2019.06.005,a management protocol for gonad preservation in patients with androgen insensitivity syndrome,12383_a management protocol for gonad preservation in patients with androgen insensitivity syndrome.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['12383_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['12383_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.401],[0.61],[0.681],[0.21],[0.225],[0.183],[0.75],[0.652],[0.67],[0.652],[0.827],[0.75],[0.653],[0.933],[0.841],[0.801],[0.831],[0.815],0.401,0.61,0.681,0.21,0.225,0.183,0.75,0.652,0.67,0.652,0.827,0.75,0.653,0.933,0.841,0.801,0.831,0.815
https://doi.org/10.1016/j.jpeds.2017.12.061,prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents,12562_prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706/pdf'],['Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706/pdf'],['12562_0_management of congenital nephrotic syndrome consensus recommendations of the erknetespn working group.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706/pdf'],['12562_0_management of congenital nephrotic syndrome consensus recommendations of the erknetespn working group.pdf'],[0.322],[0.557],[0.635],[0.165],[0.154],[0.116],[0.742],[0.64],[0.615],[0.605],[0.8],[0.723],[0.627],[0.923],[0.789],[0.767],[0.793],[0.778],0.322,0.557,0.635,0.165,0.154,0.116,0.742,0.64,0.615,0.605,0.8,0.723,0.627,0.923,0.789,0.767,0.793,0.778
https://doi.org/10.1016/j.jpeds.2018.10.048,betahemolytic nongroup a streptococcal pharyngitis in children,12569_betahemolytic nongroup a streptococcal pharyngitis in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271976/pdf'],['Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271976/pdf'],['12569_0_efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271976/pdf'],['12569_0_efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat.pdf'],[0.332],[0.527],[0.599],[0.17],[0.168],[0.135],[0.739],[0.642],[0.584],[0.676],[0.771],[0.7],[0.609],[0.91],[0.803],[0.734],[0.777],[0.758],0.332,0.527,0.599,0.17,0.168,0.135,0.739,0.642,0.584,0.676,0.771,0.7,0.609,0.91,0.803,0.734,0.777,0.758
https://doi.org/10.1016/j.jpeds.2020.03.013,behavioral and emotional disorders in children during the covid19 epidemic,12574_behavioral and emotional disorders in children during the covid19 epidemic.pdf,4,"['https://www.congress.gov/event/117th-congress/house-event/111442', 'https://www.congress.gov/event/117th-congress/house-event/114071', 'https://www.rand.org/blog/2021/09/parenting-during-the-pandemic-communicating-with-children.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf']","['Meeting the Moment: Improving Access to Behavioral and Mental Health Care', 'Back to School: Highlighting Best Practices for Safely Reopening Schools', 'Parenting During the Pandemic: Communicating with Children About COVID-19', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12574_3_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['12574_3_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.449],[0.544],[0.631],[0.164],[0.184],[0.148],[0.742],[0.652],[0.61],[0.64],[0.808],[0.74],[0.627],[0.929],[0.839],[0.765],[0.809],[0.793],0.449,0.544,0.631,0.164,0.184,0.148,0.742,0.652,0.61,0.64,0.808,0.74,0.627,0.929,0.839,0.765,0.809,0.793
https://doi.org/10.1016/j.jpeds.2020.05.020,effects of the global coronavirus disease2019 pandemic on early childhood development short and longterm risks and mitigating program and policy actions,12575_effects of the global coronavirus disease2019 pandemic on early childhood development short and longterm risks and mitigating program and policy actions.pdf,7,"['https://www.urban.org/research/publication/stories-hardship-families-young-children-covid-19-pandemic-persists', 'https://tourism.az.gov/wp-content/uploads/2021/07/Department-of-Treasury-Coronavirus-State-and-Local-Fiscal-Recovery-Funds-Interim-Final-Rule-31-CRF-Part-35-.pdf', 'https://budget.delaware.gov/covid19/documents/arp-interim-final-rule-2021-10283.pdf', 'https://www.federalregister.gov/documents/2021/05/17/2021-10283/coronavirus-state-and-local-fiscal-recovery-funds', 'https://www.urban.org/research/publication/six-months-pandemic-40-percent-parents-young-children-have-experienced-economic-fallout', 'https://www.thedialogue.org/analysis/evaluating-the-impact-of-covid19-in-children-under-the-age-of-6-latina-america/', 'https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf']","['Stories of Hardship from Families with Young Children as the COVID-19 Pandemic Persists', 'Interim Final Rule', '26786 Federal Register', 'Coronavirus State and Local Fiscal Recovery Funds', 'Six Months into the Pandemic, 40 Percent of Parents with Young Children Have Experienced Economic Fallout', 'Measuring the Impact of Covid-19 on Children under Six in Latin America – Mapping Surveys in Progress and Systematizing Lessons Learned - The Dialogue', 'Supporting Child and Student Social, Emotional, Behavioral, and Mental Health Needs (PDF)']","['https://budget.delaware.gov/covid19/documents/arp-interim-final-rule-2021-10283.pdf', 'https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf', 'https://tourism.az.gov/wp-content/uploads/2021/07/Department-of-Treasury-Coronavirus-State-and-Local-Fiscal-Recovery-Funds-Interim-Final-Rule-31-CRF-Part-35-.pdf']","['12575_2_26786 federal register.pdf', '12575_6_supporting child and student social emotional behavioral and mental health needs pdf.pdf', '12575_1_interim final rule.pdf']",3,42.86,"['https://budget.delaware.gov/covid19/documents/arp-interim-final-rule-2021-10283.pdf', 'https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf', 'https://tourism.az.gov/wp-content/uploads/2021/07/Department-of-Treasury-Coronavirus-State-and-Local-Fiscal-Recovery-Funds-Interim-Final-Rule-31-CRF-Part-35-.pdf']","['12575_2_26786 federal register.pdf', '12575_6_supporting child and student social emotional behavioral and mental health needs pdf.pdf', '12575_1_interim final rule.pdf']","[0.279, 0.277, 0.497]","[0.54, 0.57, 0.548]","[0.628, 0.654, 0.634]","[0.123, 0.166, 0.125]","[0.128, 0.178, 0.131]","[0.099, 0.147, 0.1]","[0.721, 0.739, 0.721]","[0.626, 0.644, 0.626]","[0.632, 0.649, 0.639]","[0.641, 0.655, 0.638]","[0.815, 0.826, 0.819]","[0.746, 0.774, 0.76]","[0.645, 0.648, 0.648]","[0.927, 0.933, 0.928]","[0.85, 0.857, 0.852]","[0.788, 0.801, 0.793]","[0.816, 0.835, 0.824]","[0.798, 0.816, 0.804]",0.351,0.553,0.639,0.138,0.146,0.115,0.727,0.632,0.64,0.645,0.82,0.76,0.647,0.929,0.853,0.794,0.825,0.806
https://doi.org/10.1016/j.jpeds.2020.07.009,household transmission of severe acute respiratory syndrome coronavirus 2 from adults to children,12576_household transmission of severe acute respiratory syndrome coronavirus 2 from adults to children.pdf,3,"['https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf']","['For Public Release', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-Cov-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf']","['12576_1_master question list for covid19 caused by sarscov2.pdf', '12576_0_for public release.pdf', '12576_2_master question list for covid19 caused by sarscov2.pdf']",3,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf']","['12576_1_master question list for covid19 caused by sarscov2.pdf', '12576_0_for public release.pdf', '12576_2_master question list for covid19 caused by sarscov2.pdf']","[0.466, 0.454, 0.473]","[0.549, 0.549, 0.554]","[0.631, 0.632, 0.636]","[0.186, 0.189, 0.192]","[0.2, 0.203, 0.207]","[0.155, 0.158, 0.16]","[0.737, 0.738, 0.739]","[0.647, 0.649, 0.65]","[0.617, 0.616, 0.621]","[0.654, 0.655, 0.656]","[0.801, 0.802, 0.804]","[0.726, 0.724, 0.729]","[0.631, 0.63, 0.634]","[0.912, 0.913, 0.913]","[0.834, 0.834, 0.836]","[0.768, 0.767, 0.77]","[0.805, 0.805, 0.808]","[0.788, 0.789, 0.791]",0.464,0.551,0.633,0.189,0.203,0.158,0.738,0.649,0.618,0.655,0.802,0.726,0.632,0.913,0.835,0.768,0.806,0.789
https://doi.org/10.1016/j.jpeds.2020.08.037,pediatric severe acute respiratory syndrome coronavirus 2 sarscov2 clinical presentation infectivity and immune responses,12577_pediatric severe acute respiratory syndrome coronavirus 2 sarscov2 clinical presentation infectivity and immune responses.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf']","['Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19', 'Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'For Public Release', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-Cov-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf']","['12577_2_master question list for covid19 caused by sarscov2.pdf', '12577_7_master question list for covid19 caused by sarscov2.pdf', '12577_3_for public release.pdf', '12577_4_master question list for covid19 caused by sarscov2.pdf', '12577_6_master question list for covid19 caused by sarscov2.pdf', '12577_5_master question list for covid19 caused by sarscov2.pdf', '12577_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf', '12577_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '12577_8_master question list for covid19 caused by sarscov2.pdf']",9,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf']","['12577_2_master question list for covid19 caused by sarscov2.pdf', '12577_7_master question list for covid19 caused by sarscov2.pdf', '12577_3_for public release.pdf', '12577_4_master question list for covid19 caused by sarscov2.pdf', '12577_5_master question list for covid19 caused by sarscov2.pdf', '12577_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf', '12577_1_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '12577_8_master question list for covid19 caused by sarscov2.pdf']","[0.249, 0.289, 0.513, 0.494, 0.539, 0.52, 0.538, 0.495]","[0.556, 0.554, 0.554, 0.557, 0.557, 0.522, 0.529, 0.559]","[0.641, 0.64, 0.639, 0.642, 0.642, 0.607, 0.614, 0.643]","[0.193, 0.195, 0.191, 0.195, 0.195, 0.156, 0.152, 0.195]","[0.19, 0.192, 0.188, 0.192, 0.192, 0.134, 0.157, 0.192]","[0.159, 0.162, 0.157, 0.161, 0.161, 0.106, 0.124, 0.16]","[0.747, 0.747, 0.746, 0.748, 0.747, 0.735, 0.74, 0.747]","[0.656, 0.657, 0.656, 0.657, 0.657, 0.636, 0.645, 0.657]","[0.618, 0.617, 0.617, 0.619, 0.619, 0.578, 0.59, 0.621]","[0.653, 0.656, 0.654, 0.654, 0.653, 0.679, 0.63, 0.654]","[0.802, 0.8, 0.8, 0.801, 0.802, 0.771, 0.792, 0.801]","[0.735, 0.735, 0.735, 0.737, 0.737, 0.698, 0.717, 0.74]","[0.646, 0.645, 0.644, 0.645, 0.646, 0.609, 0.622, 0.648]","[0.923, 0.924, 0.922, 0.923, 0.923, 0.92, 0.923, 0.922]","[0.825, 0.825, 0.824, 0.825, 0.825, 0.808, 0.814, 0.825]","[0.775, 0.773, 0.774, 0.775, 0.776, 0.733, 0.752, 0.777]","[0.806, 0.805, 0.804, 0.805, 0.806, 0.779, 0.795, 0.806]","[0.79, 0.788, 0.788, 0.79, 0.79, 0.757, 0.778, 0.791]",0.455,0.548,0.634,0.184,0.18,0.149,0.745,0.653,0.61,0.654,0.796,0.729,0.638,0.923,0.821,0.767,0.801,0.784
https://doi.org/10.1016/j.jpeds.2020.10.025,outcomes after introduction of minimally invasive surfactant therapy in two australian tertiary neonatal units,12578_outcomes after introduction of minimally invasive surfactant therapy in two australian tertiary neonatal units.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109227/pdf'],['Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109227/pdf'],['12578_0_surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109227/pdf'],['12578_0_surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.pdf'],[0.453],[0.519],[0.6],[0.172],[0.169],[0.135],[0.735],[0.64],[0.586],[0.664],[0.769],[0.698],[0.598],[0.906],[0.796],[0.728],[0.776],[0.751],0.453,0.519,0.6,0.172,0.169,0.135,0.735,0.64,0.586,0.664,0.769,0.698,0.598,0.906,0.796,0.728,0.776,0.751
https://doi.org/10.1016/j.jpeds.2020.11.016,severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth,12579_severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth.pdf,4,"['https://stacks.cdc.gov/view/cdc/114448', 'https://stacks.cdc.gov/view/cdc/106171', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents']","['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['12579_2_coronavirus disease 2019 covid19 treatment guidelines.pdf', '12579_3_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf']",2,50.0,"['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['12579_2_coronavirus disease 2019 covid19 treatment guidelines.pdf', '12579_3_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf']","[0.537, 0.493]","[0.515, 0.531]","[0.597, 0.611]","[0.148, 0.17]","[0.158, 0.174]","[0.12, 0.131]","[0.737, 0.739]","[0.642, 0.645]","[0.582, 0.597]","[0.654, 0.655]","[0.774, 0.786]","[0.691, 0.721]","[0.589, 0.616]","[0.897, 0.915]","[0.789, 0.808]","[0.742, 0.752]","[0.776, 0.788]","[0.764, 0.77]",0.515,0.523,0.604,0.159,0.166,0.126,0.738,0.643,0.589,0.655,0.78,0.706,0.603,0.906,0.798,0.747,0.782,0.767
https://doi.org/10.1016/j.jpubeco.2020.104343,revenge of the experts will covid19 renew or diminish public trust in science,12702_revenge of the experts will covid19 renew or diminish public trust in science.pdf,2,"['https://www.nber.org/papers/w28593', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf']","['Experimental Evidence on the Effectiveness of Non-Experts for Improving Vaccine Demand', 'A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers’ perceptions in high and low- and middle-income countries']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf'],['12702_1_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf'],['12702_1_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf'],[0.125],[0.518],[0.607],[0.156],[0.166],[0.135],[0.728],[0.639],[0.577],[0.701],[0.782],[0.669],[0.603],[0.915],[0.838],[0.742],[0.78],[0.768],0.125,0.518,0.607,0.156,0.166,0.135,0.728,0.639,0.577,0.701,0.782,0.669,0.603,0.915,0.838,0.742,0.78,0.768
https://doi.org/10.1016/j.jsp.2018.11.001,are students with disabilities suspended more frequently than otherwise similar students without disabilities,12842_are students with disabilities suspended more frequently than otherwise similar students without disabilities.pdf,4,"['https://www.michigan.gov/documents/ag/School_Discipline_Multi-State_letter_Final_5.24.21_726121_7.pdf', 'https://www.mass.gov/doc/school-discipline-multistate-letter/download', 'https://www.congress.gov/event/116th-congress/house-event/109347', 'https://www.aei.org/research-products/testimony/statement-before-the-west-virginia-advisory-committee-to-the-u-s-commission-on-civil-rights-student-discipline/']","['May 24, 2021', 'May 24, 2021', '""Brown v. Board of Education at 65: A Promise Unfulfilled.""', 'Statement before the West Virginia Advisory Committee to The U.S. Commission on Civil Rights: Student Discipline - AEI']","['https://www.mass.gov/doc/school-discipline-multistate-letter/download', 'https://www.michigan.gov/documents/ag/School_Discipline_Multi-State_letter_Final_5.24.21_726121_7.pdf']","['12842_1_may 24 2021.pdf', '12842_0_may 24 2021.pdf']",2,50.0,"['https://www.mass.gov/doc/school-discipline-multistate-letter/download', 'https://www.michigan.gov/documents/ag/School_Discipline_Multi-State_letter_Final_5.24.21_726121_7.pdf']","['12842_1_may 24 2021.pdf', '12842_0_may 24 2021.pdf']","[0.508, 0.508]","[0.501, 0.501]","[0.596, 0.596]","[0.176, 0.176]","[0.188, 0.188]","[0.16, 0.16]","[0.733, 0.733]","[0.639, 0.639]","[0.569, 0.569]","[0.714, 0.714]","[0.78, 0.78]","[0.693, 0.693]","[0.625, 0.625]","[0.917, 0.917]","[0.816, 0.816]","[0.741, 0.741]","[0.777, 0.777]","[0.763, 0.763]",0.508,0.501,0.596,0.176,0.188,0.16,0.733,0.639,0.569,0.714,0.78,0.693,0.625,0.917,0.816,0.741,0.777,0.763
https://doi.org/10.1016/j.jsp.2019.05.007,safe and supportive schools for lgbt youth addressing educational inequities through inclusive policies and practices,12844_safe and supportive schools for lgbt youth addressing educational inequities through inclusive policies and practices.pdf,1,['https://townhall.virginia.gov/L/GetFile.cfm?File=C:\\TownHall\\docroot\\GuidanceDocs\\201\\GDoc_DOE_6968_v1.pdf&eType=EmailBlastContent&eId=accc37f1-8e04-4767-8c3a-be4aac9525a3'],['Model Policies for the Treatment of Transgender Students in Virgiinia Public Schools'],['https://townhall.virginia.gov/L/GetFile.cfm?File=C:\\TownHall\\docroot\\GuidanceDocs\\201\\GDoc_DOE_6968_v1.pdf&eType=EmailBlastContent&eId=accc37f1-8e04-4767-8c3a-be4aac9525a3'],['12844_0_model policies for the treatment of transgender students in virgiinia public schools.pdf'],1,100.0,['https://townhall.virginia.gov/L/GetFile.cfm?File=C:\\TownHall\\docroot\\GuidanceDocs\\201\\GDoc_DOE_6968_v1.pdf&eType=EmailBlastContent&eId=accc37f1-8e04-4767-8c3a-be4aac9525a3'],['12844_0_model policies for the treatment of transgender students in virgiinia public schools.pdf'],[0.579],[0.537],[0.627],[0.198],[0.232],[0.195],[0.743],[0.651],[0.602],[0.674],[0.8],[0.732],[0.637],[0.92],[0.828],[0.768],[0.804],[0.786],0.579,0.537,0.627,0.198,0.232,0.195,0.743,0.651,0.602,0.674,0.8,0.732,0.637,0.92,0.828,0.768,0.804,0.786
https://doi.org/10.1016/j.jspd.2019.01.011,bracing in adolescent idiopathic scoliosis trial braist development and validation of a prognostic model in untreated adolescent idiopathic scoliosis using the simplified skeletal maturity system,12847_bracing in adolescent idiopathic scoliosis trial braist development and validation of a prognostic model in untreated adolescent idiopathic scoliosis using the simplified skeletal maturity system.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201698/pdf'],['Network meta-analysis of short-term effects of different strategies in the conservative treatment of AIS'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201698/pdf'],['12847_0_network metaanalysis of shortterm effects of different strategies in the conservative treatment of ais.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201698/pdf'],['12847_0_network metaanalysis of shortterm effects of different strategies in the conservative treatment of ais.pdf'],[0.419],[0.549],[0.625],[0.153],[0.173],[0.126],[0.733],[0.634],[0.618],[0.696],[0.797],[0.732],[0.616],[0.923],[0.838],[0.77],[0.803],[0.787],0.419,0.549,0.625,0.153,0.173,0.126,0.733,0.634,0.618,0.696,0.797,0.732,0.616,0.923,0.838,0.77,0.803,0.787
https://doi.org/10.1016/j.jue.2019.01.002,new road infrastructure the effects on firms,12915_new road infrastructure the effects on firms.pdf,1,['https://www.tn.gov/content/dam/tn/tdot/long-range-planning/research/final-reports/res2020-final-reports/RES2020-01_Final_Report_Approved.pdf'],['Evaluating the Private Sector Returns to Transportation Investments in Tennessee'],['https://www.tn.gov/content/dam/tn/tdot/long-range-planning/research/final-reports/res2020-final-reports/RES2020-01_Final_Report_Approved.pdf'],['12915_0_evaluating the private sector returns to transportation investments in tennessee.pdf'],1,100.0,['https://www.tn.gov/content/dam/tn/tdot/long-range-planning/research/final-reports/res2020-final-reports/RES2020-01_Final_Report_Approved.pdf'],['12915_0_evaluating the private sector returns to transportation investments in tennessee.pdf'],[0.184],[0.469],[0.571],[0.122],[0.146],[0.119],[0.726],[0.629],[0.531],[0.724],[0.759],[0.673],[0.637],[0.889],[0.822],[0.718],[0.769],[0.755],0.184,0.469,0.571,0.122,0.146,0.119,0.726,0.629,0.531,0.724,0.759,0.673,0.637,0.889,0.822,0.718,0.769,0.755
https://doi.org/10.1016/j.juro.2018.07.001,accuracy of transperineal targeted prostate biopsies visual estimation and image fusion in men needing repeat biopsy in the picture trial,12935_accuracy of transperineal targeted prostate biopsies visual estimation and image fusion in men needing repeat biopsy in the picture trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483565/pdf'],"['Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483565/pdf'],['12935_0_prostate mri with or without mri‐targeted biopsy and systematic biopsy for detecting prostate cancer.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483565/pdf'],['12935_0_prostate mri with or without mri‐targeted biopsy and systematic biopsy for detecting prostate cancer.pdf'],[0.564],[0.515],[0.6],[0.178],[0.173],[0.157],[0.743],[0.652],[0.569],[0.692],[0.765],[0.698],[0.625],[0.887],[0.792],[0.689],[0.773],[0.713],0.564,0.515,0.6,0.178,0.173,0.157,0.743,0.652,0.569,0.692,0.765,0.698,0.625,0.887,0.792,0.689,0.773,0.713
https://doi.org/10.1016/j.jval.2018.07.752,patientreported outcomes and observerreported outcome assessment for childhood chronic kidney disease,12939_patientreported outcomes and observerreported outcome assessment for childhood chronic kidney disease.pdf,1,['https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/esrd/esrd-report.pdf'],['End Stage Renal Disease in the Medicare Population'],['https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/esrd/esrd-report.pdf'],['12939_0_end stage renal disease in the medicare population.pdf'],1,100.0,['https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/esrd/esrd-report.pdf'],['12939_0_end stage renal disease in the medicare population.pdf'],[0.258],[0.525],[0.608],[0.155],[0.151],[0.123],[0.732],[0.637],[0.578],[0.694],[0.77],[0.7],[0.633],[0.905],[0.785],[0.726],[0.775],[0.745],0.258,0.525,0.608,0.155,0.151,0.123,0.732,0.637,0.578,0.694,0.77,0.7,0.633,0.905,0.785,0.726,0.775,0.745
https://doi.org/10.1016/j.lanwpc.2020.100045,a study of breastfeeding practices sarscov2 and its antibodies in the breast milk of mothers confirmed with covid19,13013_a study of breastfeeding practices sarscov2 and its antibodies in the breast milk of mothers confirmed with covid19.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['13013_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['13013_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.359],[0.545],[0.623],[0.163],[0.183],[0.142],[0.738],[0.646],[0.603],[0.623],[0.803],[0.728],[0.62],[0.92],[0.83],[0.758],[0.807],[0.79],0.359,0.545,0.623,0.163,0.183,0.142,0.738,0.646,0.603,0.623,0.803,0.728,0.62,0.92,0.83,0.758,0.807,0.79
https://doi.org/10.1016/j.leukres.2020.106368,reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for all with pegasparaginase—a real world study,13024_reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for all with pegasparaginase—a real world study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831116/pdf'],['Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831116/pdf'],['13024_0_prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831116/pdf'],['13024_0_prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.pdf'],[0.504],[0.523],[0.609],[0.182],[0.175],[0.141],[0.739],[0.651],[0.586],[0.676],[0.784],[0.695],[0.614],[0.913],[0.812],[0.744],[0.785],[0.769],0.504,0.523,0.609,0.182,0.175,0.141,0.739,0.651,0.586,0.676,0.784,0.695,0.614,0.913,0.812,0.744,0.785,0.769
https://doi.org/10.1016/j.marpolbul.2016.05.006,a review of crustacean sensitivity to high amplitude underwater noise data needs for effective risk assessment in relation to uk commercial species,13063_a review of crustacean sensitivity to high amplitude underwater noise data needs for effective risk assessment in relation to uk commercial species.pdf,3,"['https://www.dos.ny.gov/opd/programs/pdfs/Consistency/F-2018-0209PN-Material.pdf', 'https://www.nj.gov/bpu/pdf/Draft_NJ_OWSP_Appendix_7-10-20.pdf', 'https://www.nj.gov/bpu/pdf/Final_NJ_OWSP_9-9-20.pdf']","['DEPARTMENT OF THE NAVY t ,. S. FLEET FORCES COII } I ,{ ND', 'Appendices', 'Strategic Plan']","['https://www.nj.gov/bpu/pdf/Final_NJ_OWSP_9-9-20.pdf', 'https://www.nj.gov/bpu/pdf/Draft_NJ_OWSP_Appendix_7-10-20.pdf']","['13063_2_strategic plan.pdf', '13063_1_appendices.pdf']",2,66.67,"['https://www.nj.gov/bpu/pdf/Final_NJ_OWSP_9-9-20.pdf', 'https://www.nj.gov/bpu/pdf/Draft_NJ_OWSP_Appendix_7-10-20.pdf']","['13063_2_strategic plan.pdf', '13063_1_appendices.pdf']","[0.186, 0.175]","[0.464, 0.466]","[0.562, 0.561]","[0.094, 0.093]","[0.09, 0.091]","[0.074, 0.076]","[0.721, 0.721]","[0.626, 0.625]","[0.524, 0.525]","[0.649, 0.652]","[0.772, 0.772]","[0.676, 0.676]","[0.63, 0.63]","[0.9, 0.9]","[0.797, 0.797]","[0.727, 0.727]","[0.772, 0.772]","[0.757, 0.757]",0.18,0.465,0.562,0.093,0.09,0.075,0.721,0.625,0.524,0.651,0.772,0.676,0.63,0.9,0.797,0.727,0.772,0.757
https://doi.org/10.1016/j.metabol.2018.12.001,childhood obesity increased risk for cardiometabolic disease and cancer in adulthood,13085_childhood obesity increased risk for cardiometabolic disease and cancer in adulthood.pdf,1,['https://health.maryland.gov/phpa/cancer/cancerplan/SiteAssets/Pages/publications/Cancer-MD-Maryland_FINAL%20-1.pdf'],['2021-2025 Maryland Comprehensive Cancer Control Plan'],['https://health.maryland.gov/phpa/cancer/cancerplan/SiteAssets/Pages/publications/Cancer-MD-Maryland_FINAL%20-1.pdf'],['13085_0_20212025 maryland comprehensive cancer control plan.pdf'],1,100.0,['https://health.maryland.gov/phpa/cancer/cancerplan/SiteAssets/Pages/publications/Cancer-MD-Maryland_FINAL%20-1.pdf'],['13085_0_20212025 maryland comprehensive cancer control plan.pdf'],[0.338],[0.525],[0.63],[0.137],[0.145],[0.104],[0.732],[0.633],[0.596],[0.657],[0.796],[0.713],[0.605],[0.922],[0.82],[0.749],[0.793],[0.777],0.338,0.525,0.63,0.137,0.145,0.104,0.732,0.633,0.596,0.657,0.796,0.713,0.605,0.922,0.82,0.749,0.793,0.777
https://doi.org/10.1016/j.midw.2007.08.002,‘soothing the ring of fire’ australian womens and midwives’ experiences of using perineal warm packs in the second stage of labour,13100_‘soothing the ring of fire’ australian womens and midwives’ experiences of using perineal warm packs in the second stage of labour.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf', 'https://effectivehealthcare.ahrq.gov/products/labor-dystocia/research']","['Perineal techniques during the second stage of labour for reducing perineal trauma', 'Labor Dystocia']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf'],['13100_0_perineal techniques during the second stage of labour for reducing perineal trauma.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481402/pdf'],['13100_0_perineal techniques during the second stage of labour for reducing perineal trauma.pdf'],[0.442],[0.507],[0.593],[0.156],[0.171],[0.139],[0.734],[0.642],[0.558],[0.663],[0.766],[0.676],[0.603],[0.905],[0.788],[0.716],[0.76],[0.74],0.442,0.507,0.593,0.156,0.171,0.139,0.734,0.642,0.558,0.663,0.766,0.676,0.603,0.905,0.788,0.716,0.76,0.74
https://doi.org/10.1016/j.mrrev.2019.02.001,exposure to glyphosatebased herbicides and risk for nonhodgkin lymphoma a metaanalysis and supporting evidence,13135_exposure to glyphosatebased herbicides and risk for nonhodgkin lymphoma a metaanalysis and supporting evidence.pdf,2,"['https://purl.fdlp.gov/GPO/gpo144829', 'https://www.wri.org/publication/creating-sustainable-food-future-final-report']","['Toxicological profile for glyphosate.', 'Creating a Sustainable Food Future']",['https://purl.fdlp.gov/GPO/gpo144829'],['13135_0_toxicological profile for glyphosate.pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo144829'],['13135_0_toxicological profile for glyphosate.pdf'],[0.64],[0.486],[0.589],[0.152],[0.151],[0.117],[0.737],[0.648],[0.552],[0.687],[0.776],[0.653],[0.617],[0.905],[0.793],[0.73],[0.767],[0.759],0.64,0.486,0.589,0.152,0.151,0.117,0.737,0.648,0.552,0.687,0.776,0.653,0.617,0.905,0.793,0.73,0.767,0.759
https://doi.org/10.1016/j.neuro.2019.09.006,prenatal lead exposure and childhood executive function and behavioral difficulties in project viva,13213_prenatal lead exposure and childhood executive function and behavioral difficulties in project viva.pdf,1,['https://purl.fdlp.gov/GPO/gpo144830'],['Toxicological profile for lead /'],['https://purl.fdlp.gov/GPO/gpo144830'],['13213_0_toxicological profile for lead .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo144830'],['13213_0_toxicological profile for lead .pdf'],[0.699],[0.481],[0.574],[0.136],[0.135],[0.12],[0.738],[0.647],[0.544],[0.699],[0.769],[0.642],[0.599],[0.903],[0.77],[0.719],[0.75],[0.744],0.699,0.481,0.574,0.136,0.135,0.12,0.738,0.647,0.544,0.699,0.769,0.642,0.599,0.903,0.77,0.719,0.75,0.744
https://doi.org/10.1016/j.neuroimage.2019.02.017,prenatal lead exposure impacts crosshemispheric and longrange connectivity in the human fetal brain,13221_prenatal lead exposure impacts crosshemispheric and longrange connectivity in the human fetal brain.pdf,1,['https://www.michigan.gov/documents/mdch/Dried_Blood_Spot_Research_Table_Public_Report_347898_7.pdf'],['Research Use of Michigan ’s Residual Newborn Screening Blood Spots'],['https://www.michigan.gov/documents/mdch/Dried_Blood_Spot_Research_Table_Public_Report_347898_7.pdf'],['13221_0_research use of michigan s residual newborn screening blood spots.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1016/j.nmd.2019.09.007,nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy interim efficacy and safety results from the phase 2 nurture study,13256_nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy interim efficacy and safety results from the phase 2 nurture study.pdf,3,"['https://www.dhs.pa.gov/docs/Publications/Documents/FORMS%20AND%20PUBS%20OMAP/MAB2020121504.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175931/pdf', 'https://www.dhs.pa.gov/providers/Pharmacy-Services/Documents/Clinical%20Guidelines%20Non-PDL/Spinraza%20010521.pdf']","['Medical Assistance Bulletin', 'Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2', 'Medical Assistance Bulletin']","['https://www.dhs.pa.gov/providers/Pharmacy-Services/Documents/Clinical%20Guidelines%20Non-PDL/Spinraza%20010521.pdf', 'https://www.dhs.pa.gov/docs/Publications/Documents/FORMS%20AND%20PUBS%20OMAP/MAB2020121504.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175931/pdf']","['13256_2_medical assistance bulletin.pdf', '13256_0_medical assistance bulletin.pdf', '13256_1_revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of smn2.pdf']",3,100.0,"['https://www.dhs.pa.gov/providers/Pharmacy-Services/Documents/Clinical%20Guidelines%20Non-PDL/Spinraza%20010521.pdf', 'https://www.dhs.pa.gov/docs/Publications/Documents/FORMS%20AND%20PUBS%20OMAP/MAB2020121504.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175931/pdf']","['13256_2_medical assistance bulletin.pdf', '13256_0_medical assistance bulletin.pdf', '13256_1_revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of smn2.pdf']","[0.123, 0.346, 0.123]","[0.542, 0.542, 0.56]","[0.616, 0.616, 0.641]","[0.161, 0.161, 0.187]","[0.168, 0.168, 0.194]","[0.122, 0.122, 0.136]","[0.737, 0.737, 0.734]","[0.637, 0.637, 0.641]","[0.608, 0.608, 0.632]","[0.651, 0.651, 0.67]","[0.803, 0.803, 0.809]","[0.729, 0.729, 0.75]","[0.624, 0.624, 0.63]","[0.908, 0.908, 0.931]","[0.836, 0.836, 0.838]","[0.769, 0.769, 0.778]","[0.811, 0.811, 0.816]","[0.791, 0.791, 0.796]",0.197,0.548,0.624,0.17,0.177,0.127,0.736,0.638,0.616,0.657,0.805,0.736,0.626,0.916,0.837,0.772,0.813,0.793
https://doi.org/10.1016/j.nmd.2019.10.008,longterm data with idebenone on respiratory function outcomes in patients with duchenne muscular dystrophy,13257_longterm data with idebenone on respiratory function outcomes in patients with duchenne muscular dystrophy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574769/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632644/pdf']","['Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline', 'Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632644/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574769/pdf']","['13257_1_antioxidants to prevent respiratory decline in people with duchenne muscular dystrophy and progressive respiratory decline.pdf', '13257_0_antioxidants to prevent respiratory decline in people with duchenne muscular dystrophy and progressive respiratory decline.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632644/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574769/pdf']","['13257_1_antioxidants to prevent respiratory decline in people with duchenne muscular dystrophy and progressive respiratory decline.pdf', '13257_0_antioxidants to prevent respiratory decline in people with duchenne muscular dystrophy and progressive respiratory decline.pdf']","[0.538, 0.538]","[0.532, 0.532]","[0.622, 0.622]","[0.176, 0.176]","[0.184, 0.183]","[0.142, 0.142]","[0.736, 0.736]","[0.643, 0.643]","[0.601, 0.6]","[0.683, 0.683]","[0.79, 0.789]","[0.719, 0.719]","[0.614, 0.614]","[0.919, 0.919]","[0.822, 0.822]","[0.748, 0.748]","[0.792, 0.792]","[0.772, 0.772]",0.538,0.532,0.622,0.176,0.183,0.142,0.736,0.643,0.601,0.683,0.79,0.719,0.614,0.919,0.822,0.748,0.792,0.772
https://doi.org/10.1016/j.nurpra.2020.09.014,perinatal anxiety and depression during covid19,13317_perinatal anxiety and depression during covid19.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['13317_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['13317_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.374],[0.546],[0.633],[0.156],[0.165],[0.135],[0.739],[0.646],[0.607],[0.634],[0.807],[0.732],[0.625],[0.918],[0.831],[0.76],[0.812],[0.791],0.374,0.546,0.633,0.156,0.165,0.135,0.739,0.646,0.607,0.634,0.807,0.732,0.625,0.918,0.831,0.76,0.812,0.791
https://doi.org/10.1016/j.pan.2018.11.004,autoimmune pancreatitis in children a single centre experience in diagnosis management and long term follow up,13420_autoimmune pancreatitis in children a single centre experience in diagnosis management and long term follow up.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437085/pdf'],['European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437085/pdf'],['13420_0_european guideline on igg4related digestive disease – ueg and sgf evidencebased recommendations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437085/pdf'],['13420_0_european guideline on igg4related digestive disease – ueg and sgf evidencebased recommendations.pdf'],[0.497],[0.613],[0.686],[0.216],[0.234],[0.171],[0.752],[0.654],[0.676],[0.65],[0.83],[0.782],[0.653],[0.927],[0.849],[0.806],[0.831],[0.817],0.497,0.613,0.686,0.216,0.234,0.171,0.752,0.654,0.676,0.65,0.83,0.782,0.653,0.927,0.849,0.806,0.831,0.817
https://doi.org/10.1016/j.parkreldis.2019.06.025,juvenile parkinsonism differential diagnosis genetics and treatment,13421_juvenile parkinsonism differential diagnosis genetics and treatment.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894329/pdf'],['Diagnostic approach to paediatric movement disorders: a clinical practice guide'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894329/pdf'],['13421_0_diagnostic approach to paediatric movement disorders a clinical practice guide.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894329/pdf'],['13421_0_diagnostic approach to paediatric movement disorders a clinical practice guide.pdf'],[0.447],[0.505],[0.601],[0.157],[0.158],[0.132],[0.745],[0.649],[0.576],[0.673],[0.787],[0.695],[0.623],[0.912],[0.794],[0.751],[0.789],[0.772],0.447,0.505,0.601,0.157,0.158,0.132,0.745,0.649,0.576,0.673,0.787,0.695,0.623,0.912,0.794,0.751,0.789,0.772
https://doi.org/10.1016/j.pcl.2011.06.004,developmental and psychosocial issues in cystic fibrosis,13447_developmental and psychosocial issues in cystic fibrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494281/pdf'],['Standard (head‐down tilt) versus modified (without head‐down tilt) postural drainage in infants and young children with cystic fibrosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494281/pdf'],['13447_0_standard head‐down tilt versus modified without head‐down tilt postural drainage in infants and young children with cystic fibrosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494281/pdf'],['13447_0_standard head‐down tilt versus modified without head‐down tilt postural drainage in infants and young children with cystic fibrosis.pdf'],[0.283],[0.555],[0.638],[0.169],[0.174],[0.133],[0.731],[0.633],[0.626],[0.648],[0.798],[0.749],[0.616],[0.927],[0.831],[0.758],[0.802],[0.78],0.283,0.555,0.638,0.169,0.174,0.133,0.731,0.633,0.626,0.648,0.798,0.749,0.616,0.927,0.831,0.758,0.802,0.78
https://doi.org/10.1016/j.pcl.2018.12.007,the current state of newborn screening in the united states,13464_the current state of newborn screening in the united states.pdf,1,['https://regulations.delaware.gov/documents/November2019c.pdf'],['Delaware Register'],['https://regulations.delaware.gov/documents/November2019c.pdf'],['13464_0_delaware register.pdf'],1,100.0,['https://regulations.delaware.gov/documents/November2019c.pdf'],['13464_0_delaware register.pdf'],[0.135],[0.528],[0.611],[0.098],[0.097],[0.077],[0.717],[0.613],[0.628],[0.613],[0.813],[0.746],[0.632],[0.935],[0.845],[0.78],[0.823],[0.801],0.135,0.528,0.611,0.098,0.097,0.077,0.717,0.613,0.628,0.613,0.813,0.746,0.632,0.935,0.845,0.78,0.823,0.801
https://doi.org/10.1016/j.pcl.2019.12.001,adverse childhood experiences outcomes and interventions,13465_adverse childhood experiences outcomes and interventions.pdf,4,"['https://stacks.cdc.gov/view/cdc/109052', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Healthcare-Sector-Brief_12092020.pdf?emrc=1f10ac', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab']","['Disparities in stressful life events among children aged 5–17 years : United States, 2019', 'From Adversity to Resilience in the Healthcare Sector – Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'Executive Summary – Findings from Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'Roadmap for Resilience']","['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Healthcare-Sector-Brief_12092020.pdf?emrc=1f10ac']","['13465_2_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '13465_3_roadmap for resilience.pdf', '13465_1_from adversity to resilience in the healthcare sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']",3,75.0,"['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Healthcare-Sector-Brief_12092020.pdf?emrc=1f10ac']","['13465_2_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '13465_3_roadmap for resilience.pdf', '13465_1_from adversity to resilience in the healthcare sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']","[0.614, 0.582, 0.545]","[0.588, 0.542, 0.585]","[0.672, 0.634, 0.668]","[0.202, 0.177, 0.211]","[0.212, 0.186, 0.23]","[0.172, 0.149, 0.19]","[0.747, 0.741, 0.753]","[0.662, 0.653, 0.669]","[0.651, 0.61, 0.643]","[0.681, 0.674, 0.686]","[0.825, 0.804, 0.817]","[0.77, 0.736, 0.763]","[0.648, 0.632, 0.643]","[0.937, 0.931, 0.938]","[0.858, 0.839, 0.853]","[0.798, 0.774, 0.795]","[0.834, 0.81, 0.83]","[0.817, 0.793, 0.812]",0.58,0.572,0.658,0.197,0.209,0.17,0.747,0.661,0.635,0.68,0.815,0.756,0.641,0.935,0.85,0.789,0.825,0.807
https://doi.org/10.1016/j.pec.2009.04.008,burnout prevention a review of intervention programs,13473_burnout prevention a review of intervention programs.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718215/pdf', 'https://www.pacificresearch.org/blame-the-regulatory-state-for-the-healthcare-burnout-crisis/', 'https://www.rand.org/pubs/research_reports/RRA428-1.html', 'https://nj.gov/health/ems/documents/ems-toolbox/supplementalresearchbulletin-firstresponders-may2018.pdf', 'https://www.brookings.edu/blog/brown-center-chalkboard/2022/02/08/how-much-do-teachers-struggle-with-stress-and-burnout/', 'https://purl.fdlp.gov/GPO/gpo106713', 'https://www.rand.org/pubs/research_reports/RR1952.html']","['Preventing occupational stress in healthcare workers', 'Blame The Regulatory State For The Healthcare Burnout Crisis - Pacific Research Institute', 'Assessing Burnout Among Military Health Care Providers', 'First Responders: Behavioral Health Concerns, Emergency Response, and Trauma', 'How much do teachers struggle with stress and burnout?', 'First responders: behavioral health concerns, emergency response, and trauma.', 'Programs Addressing Psychological Health and Resilience in the U.S. Department of Homeland Security']","['https://nj.gov/health/ems/documents/ems-toolbox/supplementalresearchbulletin-firstresponders-may2018.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718215/pdf', 'https://purl.fdlp.gov/GPO/gpo106713']","['13473_3_first responders behavioral health concerns emergency response and trauma.pdf', '13473_0_preventing occupational stress in healthcare workers.pdf', '13473_5_first responders behavioral health concerns emergency response and trauma.pdf']",3,42.86,"['https://nj.gov/health/ems/documents/ems-toolbox/supplementalresearchbulletin-firstresponders-may2018.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718215/pdf', 'https://purl.fdlp.gov/GPO/gpo106713']","['13473_3_first responders behavioral health concerns emergency response and trauma.pdf', '13473_0_preventing occupational stress in healthcare workers.pdf', '13473_5_first responders behavioral health concerns emergency response and trauma.pdf']","[0.513, 0.338, 0.338]","[0.545, 0.531, 0.545]","[0.632, 0.612, 0.632]","[0.175, 0.187, 0.175]","[0.187, 0.196, 0.187]","[0.147, 0.163, 0.147]","[0.728, 0.73, 0.728]","[0.641, 0.641, 0.641]","[0.595, 0.586, 0.595]","[0.694, 0.721, 0.694]","[0.795, 0.78, 0.795]","[0.732, 0.697, 0.732]","[0.626, 0.6, 0.626]","[0.922, 0.919, 0.922]","[0.835, 0.823, 0.835]","[0.766, 0.737, 0.766]","[0.802, 0.781, 0.802]","[0.785, 0.764, 0.785]",0.396,0.54,0.625,0.179,0.19,0.152,0.729,0.641,0.592,0.703,0.79,0.72,0.617,0.921,0.831,0.756,0.795,0.778
https://doi.org/10.1016/j.pedhc.2017.05.005,child care health consultation improves infant and toddler care,13502_child care health consultation improves infant and toddler care.pdf,1,['https://www.dcyf.wa.gov/sites/default/files/pdf/cchc-devtrain.pdf'],['Lane Harmon Final Capstone Report'],['https://www.dcyf.wa.gov/sites/default/files/pdf/cchc-devtrain.pdf'],['13502_0_lane harmon final capstone report.pdf'],1,100.0,['https://www.dcyf.wa.gov/sites/default/files/pdf/cchc-devtrain.pdf'],['13502_0_lane harmon final capstone report.pdf'],[0.623],[0.587],[0.66],[0.209],[0.229],[0.19],[0.738],[0.644],[0.652],[0.678],[0.824],[0.772],[0.674],[0.933],[0.864],[0.8],[0.835],[0.815],0.623,0.587,0.66,0.209,0.229,0.19,0.738,0.644,0.652,0.678,0.824,0.772,0.674,0.933,0.864,0.8,0.835,0.815
https://doi.org/10.1016/j.pediatrneurol.2007.08.014,effects of iron supplementation on attention deficit hyperactivity disorder in children,13512_effects of iron supplementation on attention deficit hyperactivity disorder in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353229/pdf']","['Iron for restless legs syndrome', 'Iron for the treatment of restless legs syndrome']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353229/pdf']","['13512_0_iron for restless legs syndrome.pdf', '13512_1_iron for the treatment of restless legs syndrome.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070449/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353229/pdf']","['13512_0_iron for restless legs syndrome.pdf', '13512_1_iron for the treatment of restless legs syndrome.pdf']","[0.393, 0.512]","[0.529, 0.513]","[0.62, 0.604]","[0.174, 0.173]","[0.19, 0.178]","[0.148, 0.147]","[0.731, 0.735]","[0.635, 0.637]","[0.591, 0.573]","[0.689, 0.692]","[0.776, 0.773]","[0.704, 0.685]","[0.592, 0.6]","[0.921, 0.915]","[0.799, 0.802]","[0.737, 0.723]","[0.772, 0.767]","[0.761, 0.753]",0.453,0.521,0.612,0.173,0.184,0.147,0.733,0.636,0.582,0.69,0.774,0.695,0.596,0.918,0.8,0.73,0.77,0.757
https://doi.org/10.1016/j.pedn.2008.03.002,breastfeeding experiences of urban adolescent mothers,13524_breastfeeding experiences of urban adolescent mothers.pdf,1,['https://dph.georgia.gov/sites/dph.georgia.gov/files/Breastshield%20Fitting%20and%20Size.pdf'],['Medela F'],['https://dph.georgia.gov/sites/dph.georgia.gov/files/Breastshield%20Fitting%20and%20Size.pdf'],['13524_0_medela f.pdf'],1,100.0,['https://dph.georgia.gov/sites/dph.georgia.gov/files/Breastshield%20Fitting%20and%20Size.pdf'],['13524_0_medela f.pdf'],[0.256],[0.568],[0.641],[0.198],[0.224],[0.2],[0.743],[0.651],[0.635],[0.643],[0.811],[0.761],[0.652],[0.924],[0.84],[0.787],[0.825],[0.806],0.256,0.568,0.641,0.198,0.224,0.2,0.743,0.651,0.635,0.643,0.811,0.761,0.652,0.924,0.84,0.787,0.825,0.806
https://doi.org/10.1016/j.pedn.2020.10.024,war on two fronts experience of children with cancer and their family during covid19 pandemic in iran,13542_war on two fronts experience of children with cancer and their family during covid19 pandemic in iran.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['13542_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['13542_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.55],[0.54],[0.619],[0.154],[0.178],[0.147],[0.729],[0.635],[0.605],[0.646],[0.797],[0.741],[0.629],[0.912],[0.84],[0.761],[0.809],[0.787],0.55,0.54,0.619,0.154,0.178,0.147,0.729,0.635,0.605,0.646,0.797,0.741,0.629,0.912,0.84,0.761,0.809,0.787
https://doi.org/10.1016/j.pmedr.2018.12.003,severe housingcost burden and obesity among preschoolaged lowincome children in los angeles county,13590_severe housingcost burden and obesity among preschoolaged lowincome children in los angeles county.pdf,2,"['https://dhr.ny.gov/sites/default/files/pdf/nys-disparate-impact-comments-10182019.pdf', 'https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/docs/2022/affordability-whitepaper-workshop3-nov2022.pdf']","['Division of', 'Potential Affordability Indicator Options for 2023 Needs Assessment']",['https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/docs/2022/affordability-whitepaper-workshop3-nov2022.pdf'],['13590_1_potential affordability indicator options for 2023 needs assessment.pdf'],1,50.0,['https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/docs/2022/affordability-whitepaper-workshop3-nov2022.pdf'],['13590_1_potential affordability indicator options for 2023 needs assessment.pdf'],[0.182],[0.499],[0.597],[0.128],[0.135],[0.107],[0.719],[0.622],[0.56],[0.68],[0.778],[0.688],[0.627],[0.907],[0.814],[0.736],[0.781],[0.762],0.182,0.499,0.597,0.128,0.135,0.107,0.719,0.622,0.56,0.68,0.778,0.688,0.627,0.907,0.814,0.736,0.781,0.762
https://doi.org/10.1016/j.pmedr.2019.100931,intervention effects of a kindergartenbased health promotion programme on obesity related behavioural outcomes and bmi percentiles,13591_intervention effects of a kindergartenbased health promotion programme on obesity related behavioural outcomes and bmi percentiles.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['13591_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '13591_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['13591_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '13591_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.54, 0.535]","[0.505, 0.504]","[0.597, 0.595]","[0.16, 0.16]","[0.169, 0.168]","[0.141, 0.14]","[0.731, 0.731]","[0.636, 0.635]","[0.571, 0.569]","[0.693, 0.694]","[0.774, 0.774]","[0.683, 0.679]","[0.589, 0.589]","[0.911, 0.91]","[0.816, 0.814]","[0.725, 0.724]","[0.772, 0.771]","[0.762, 0.761]",0.538,0.504,0.596,0.16,0.169,0.141,0.731,0.635,0.57,0.694,0.774,0.681,0.589,0.911,0.815,0.724,0.772,0.762
https://doi.org/10.1016/j.pmedr.2020.101094,correlates of youth vaping flavor preferences,13594_correlates of youth vaping flavor preferences.pdf,2,"['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['PM0000529', 'PM0000551']","['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['13594_0_pm0000529.pdf', '13594_1_pm0000551.pdf']",2,100.0,"['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['13594_0_pm0000529.pdf', '13594_1_pm0000551.pdf']","[0.4, 0.462]","[0.481, 0.483]","[0.57, 0.57]","[0.145, 0.149]","[0.153, 0.159]","[0.124, 0.132]","[0.727, 0.733]","[0.634, 0.639]","[0.532, 0.538]","[0.672, 0.685]","[0.769, 0.769]","[0.672, 0.668]","[0.619, 0.613]","[0.9, 0.897]","[0.788, 0.784]","[0.738, 0.732]","[0.771, 0.77]","[0.758, 0.759]",0.431,0.482,0.57,0.147,0.156,0.128,0.73,0.637,0.535,0.679,0.769,0.67,0.616,0.899,0.786,0.735,0.77,0.758
https://doi.org/10.1016/j.preteyeres.2004.06.002,the role of omega3 longchain polyunsaturated fatty acids in health and disease of the retina,13622_the role of omega3 longchain polyunsaturated fatty acids in health and disease of the retina.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087473/pdf', 'https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf']","['Omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration', 'DEVELOPMENT OF FISH CONTAMINANT GOALS AND ADVISORY TISSUE LEVELS (ATLs) FOR COMMON CONTAMINANTS IN CALIFORNIA SPORT FISH :']","['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087473/pdf']","['13622_1_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '13622_0_omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration.pdf']",2,100.0,"['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087473/pdf']","['13622_1_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '13622_0_omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration.pdf']","[0.293, 0.321]","[0.462, 0.465]","[0.571, 0.57]","[0.107, 0.108]","[0.102, 0.114]","[0.094, 0.091]","[0.738, 0.734]","[0.644, 0.639]","[0.542, 0.546]","[0.662, 0.675]","[0.768, 0.761]","[0.65, 0.655]","[0.608, 0.579]","[0.902, 0.9]","[0.772, 0.773]","[0.715, 0.698]","[0.755, 0.749]","[0.749, 0.732]",0.307,0.464,0.571,0.107,0.108,0.092,0.736,0.641,0.544,0.669,0.764,0.653,0.593,0.901,0.772,0.706,0.752,0.74
https://doi.org/10.1016/j.psychres.2018.12.050,exploration of no2 and pm25 air pollution and mental health problems using highresolution data in londonbased children from a uk longitudinal cohort study,13663_exploration of no2 and pm25 air pollution and mental health problems using highresolution data in londonbased children from a uk longitudinal cohort study.pdf,1,['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8814494&GUID=FC7DB5A7-940C-4D14-A893-97F185FA8653'],['Testimony of Carlos Castell Croke Associate for NYC Programs New York League of Conservation Voters'],['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8814494&GUID=FC7DB5A7-940C-4D14-A893-97F185FA8653'],['13663_0_testimony of carlos castell croke associate for nyc programs new york league of conservation voters.pdf'],1,100.0,['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8814494&GUID=FC7DB5A7-940C-4D14-A893-97F185FA8653'],['13663_0_testimony of carlos castell croke associate for nyc programs new york league of conservation voters.pdf'],[0.115],[0.458],[0.562],[0.088],[0.095],[0.087],[0.709],[0.61],[0.525],[0.666],[0.775],[0.681],[0.599],[0.91],[0.806],[0.724],[0.767],[0.75],0.115,0.458,0.562,0.088,0.095,0.087,0.709,0.61,0.525,0.666,0.775,0.681,0.599,0.91,0.806,0.724,0.767,0.75
https://doi.org/10.1016/j.psyneuen.2019.06.003,repeated stress leads to enhanced cortisol stress response in child social anxiety disorder but this effect can be prevented with cbt,13687_repeated stress leads to enhanced cortisol stress response in child social anxiety disorder but this effect can be prevented with cbt.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['Cognitive behavioural therapy for anxiety disorders in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['13687_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092480/pdf'],['13687_0_cognitive behavioural therapy for anxiety disorders in children and adolescents.pdf'],[0.346],[0.495],[0.587],[0.157],[0.15],[0.13],[0.736],[0.643],[0.557],[0.719],[0.761],[0.663],[0.583],[0.903],[0.775],[0.706],[0.751],[0.74],0.346,0.495,0.587,0.157,0.15,0.13,0.736,0.643,0.557,0.719,0.761,0.663,0.583,0.903,0.775,0.706,0.751,0.74
https://doi.org/10.1016/j.red.2019.03.010,financial frictions entry and growth a study of china,13771_financial frictions entry and growth a study of china.pdf,5,"['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2021/0411.pdf', 'https://www.minneapolisfed.org/research/staff-reports/firm-entry-and-exit-and-aggregate-growth', 'https://www.clevelandfed.org/publications/working-paper/wp-2124r-firm-dynamics-and-soe-transformation-during-chinas-economic-reform', 'https://www.clevelandfed.org/publications/working-paper/wp-2124-firm-dynamics-and-soe-transformation', 'https://www.atlantafed.org/research/publications/wp/2019/11/19/21-high-skilled-services-and-development-in-china.aspx']","['Firm Entry and Exit and Aggregate Growth', 'Firm Entry and Exit and Aggregate Growth', 'Firm Dynamics and SOE Transformation During China’s Economic Reform', ""Firm Dynamics and SOE Transformation During China's Economic Reform"", 'High-Skilled Services and Development in China']",['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2021/0411.pdf'],['13771_0_firm entry and exit and aggregate growth.pdf'],1,20.0,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2021/0411.pdf'],['13771_0_firm entry and exit and aggregate growth.pdf'],[0.549],[0.558],[0.65],[0.189],[0.207],[0.182],[0.728],[0.628],[0.623],[0.741],[0.802],[0.744],[0.679],[0.918],[0.849],[0.78],[0.816],[0.801],0.549,0.558,0.65,0.189,0.207,0.182,0.728,0.628,0.623,0.741,0.802,0.744,0.679,0.918,0.849,0.78,0.816,0.801
https://doi.org/10.1016/j.reprotox.2019.05.065,prenatal bisphenol a and phthalate exposure are risk factors for male reproductive system development and cord blood sex hormone levels,13810_prenatal bisphenol a and phthalate exposure are risk factors for male reproductive system development and cord blood sex hormone levels.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['13810_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['13810_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.432],[0.489],[0.587],[0.14],[0.132],[0.108],[0.739],[0.647],[0.555],[0.671],[0.781],[0.654],[0.613],[0.901],[0.781],[0.733],[0.772],[0.759],0.432,0.489,0.587,0.14,0.132,0.108,0.739,0.647,0.555,0.671,0.781,0.654,0.613,0.901,0.781,0.733,0.772,0.759
https://doi.org/10.1016/j.rmed.2018.01.012,airway clearance techniques in neuromuscular disorders a state of the art review,13936_airway clearance techniques in neuromuscular disorders a state of the art review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092569/pdf', 'https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=108']","['Cough augmentation techniques for people with chronic neuromuscular disorders', 'Noninvasive Positive Pressure Ventilation in the Home']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092569/pdf'],['13936_0_cough augmentation techniques for people with chronic neuromuscular disorders.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092569/pdf'],['13936_0_cough augmentation techniques for people with chronic neuromuscular disorders.pdf'],[0.406],[0.504],[0.588],[0.151],[0.154],[0.122],[0.733],[0.638],[0.564],[0.678],[0.775],[0.685],[0.609],[0.911],[0.798],[0.725],[0.778],[0.761],0.406,0.504,0.588,0.151,0.154,0.122,0.733,0.638,0.564,0.678,0.775,0.685,0.609,0.911,0.798,0.725,0.778,0.761
https://doi.org/10.1016/j.scitotenv.2005.10.007,occurrence of antibiotics in hospital residential and dairy effluent municipal wastewater and the rio grande in new mexico,13972_occurrence of antibiotics in hospital residential and dairy effluent municipal wastewater and the rio grande in new mexico.pdf,1,['https://purl.fdlp.gov/GPO/gpo140796'],['Prioritization of constituents for national- and regional-scale ambient monitoring of water and sediment in the United States /'],['https://purl.fdlp.gov/GPO/gpo140796'],['13972_0_prioritization of constituents for national and regionalscale ambient monitoring of water and sediment in the united states .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo140796'],['13972_0_prioritization of constituents for national and regionalscale ambient monitoring of water and sediment in the united states .pdf'],[0.207],[0.541],[0.633],[0.177],[0.167],[0.132],[0.738],[0.652],[0.608],[0.66],[0.811],[0.729],[0.649],[0.909],[0.817],[0.775],[0.805],[0.794],0.207,0.541,0.633,0.177,0.167,0.132,0.738,0.652,0.608,0.66,0.811,0.729,0.649,0.909,0.817,0.775,0.805,0.794
https://doi.org/10.1016/j.scitotenv.2009.09.043,is lowlevel environmental mercury exposure of concern to human health,13983_is lowlevel environmental mercury exposure of concern to human health.pdf,1,['https://purl.fdlp.gov/GPO/gpo140796'],['Prioritization of constituents for national- and regional-scale ambient monitoring of water and sediment in the United States /'],['https://purl.fdlp.gov/GPO/gpo140796'],['13983_0_prioritization of constituents for national and regionalscale ambient monitoring of water and sediment in the united states .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo140796'],['13983_0_prioritization of constituents for national and regionalscale ambient monitoring of water and sediment in the united states .pdf'],[0.192],[0.524],[0.615],[0.153],[0.145],[0.116],[0.735],[0.646],[0.602],[0.664],[0.805],[0.723],[0.639],[0.909],[0.821],[0.767],[0.803],[0.789],0.192,0.524,0.615,0.153,0.145,0.116,0.735,0.646,0.602,0.664,0.805,0.723,0.639,0.909,0.821,0.767,0.803,0.789
https://doi.org/10.1016/j.scitotenv.2017.08.094,perfluoroalkyl substances pfass in breast milk from korea timecourse trends influencing factors and infant exposure,14006_perfluoroalkyl substances pfass in breast milk from korea timecourse trends influencing factors and infant exposure.pdf,3,"['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2020/02/Final_Product-Chemical_Profile_Carpets_Rugs_PFASs_a.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/11/Product-Chemical-Profile-for-Treatments-with-PFASs.pdf']","['Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Procut-Chemical Profile for Carpets and Rugs Containing Perfluoroalkyl or Polyfluoroalkyl Substances', 'Product-Chemical Profile for Treatments Containing Perfluoroalkyl or Polyfluoroalkyl Substances for Use on Converted Textiles or Leathers']","['https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/11/Product-Chemical-Profile-for-Treatments-with-PFASs.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2020/02/Final_Product-Chemical_Profile_Carpets_Rugs_PFASs_a.pdf']","['14006_2_productchemical profile for treatments containing perfluoroalkyl or polyfluoroalkyl substances for use on converted textiles or leathers.pdf', '14006_0_per and polyfluoroalkyl substances chemical action plan.pdf', '14006_1_procutchemical profile for carpets and rugs containing perfluoroalkyl or polyfluoroalkyl substances.pdf']",3,100.0,"['https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/11/Product-Chemical-Profile-for-Treatments-with-PFASs.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2020/02/Final_Product-Chemical_Profile_Carpets_Rugs_PFASs_a.pdf']","['14006_2_productchemical profile for treatments containing perfluoroalkyl or polyfluoroalkyl substances for use on converted textiles or leathers.pdf', '14006_0_per and polyfluoroalkyl substances chemical action plan.pdf', '14006_1_procutchemical profile for carpets and rugs containing perfluoroalkyl or polyfluoroalkyl substances.pdf']","[0.388, 0.583, 0.565]","[0.48, 0.47, 0.48]","[0.587, 0.572, 0.587]","[0.152, 0.134, 0.153]","[0.144, 0.133, 0.146]","[0.124, 0.111, 0.125]","[0.743, 0.732, 0.741]","[0.657, 0.642, 0.656]","[0.551, 0.54, 0.551]","[0.677, 0.661, 0.673]","[0.78, 0.773, 0.785]","[0.646, 0.651, 0.651]","[0.611, 0.61, 0.616]","[0.904, 0.904, 0.903]","[0.795, 0.795, 0.799]","[0.736, 0.73, 0.737]","[0.768, 0.766, 0.771]","[0.762, 0.759, 0.763]",0.512,0.477,0.582,0.146,0.141,0.12,0.739,0.652,0.547,0.67,0.779,0.649,0.612,0.904,0.796,0.734,0.768,0.761
https://doi.org/10.1016/j.scitotenv.2019.01.325,prenatal exposure to perfluoroalkyl substances is associated with lower hand foot and mouth disease viruses antibody response in infancy findings from the guangzhou birth cohort study,14010_prenatal exposure to perfluoroalkyl substances is associated with lower hand foot and mouth disease viruses antibody response in infancy findings from the guangzhou birth cohort study.pdf,3,"['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://stacks.cdc.gov/view/cdc/114926', 'https://www.dhs.wisconsin.gov/publications/p02434v.pdf']","['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft', 'Evaluation of per-and polyfluoroalkyl substances (PFAS) detected in private residential drinking water wells located within 1 mile of the Pease International Tradeport : PEASE AIR FORCE BASE PORTSMOUTH, NEWINGTON, AND GREENLAND, NEW HAMPSHIRE EPA FACILITY ID: NH7570024847', 'Recommended Public Health Groundwater Quality Standards, P-02434V']",['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['14010_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,33.33,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['14010_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.614],[0.488],[0.587],[0.135],[0.134],[0.112],[0.741],[0.651],[0.557],[0.684],[0.782],[0.666],[0.612],[0.905],[0.802],[0.737],[0.771],[0.761],0.614,0.488,0.587,0.135,0.134,0.112,0.741,0.651,0.557,0.684,0.782,0.666,0.612,0.905,0.802,0.737,0.771,0.761
https://doi.org/10.1016/j.semperi.2020.151282,care of the covid19 exposed complex newborn infant,14032_care of the covid19 exposed complex newborn infant.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['14032_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['14032_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.523],[0.561],[0.637],[0.175],[0.193],[0.152],[0.742],[0.651],[0.621],[0.621],[0.811],[0.748],[0.637],[0.926],[0.835],[0.772],[0.817],[0.801],0.523,0.561,0.637,0.175,0.193,0.152,0.742,0.651,0.621,0.621,0.811,0.748,0.637,0.926,0.835,0.772,0.817,0.801
https://doi.org/10.1016/j.seppur.2009.10.020,palladium and palladium alloy membranes for hydrogen separation and production history fabrication strategies and current performance,14034_palladium and palladium alloy membranes for hydrogen separation and production history fabrication strategies and current performance.pdf,9,"['https://www.osti.gov/biblio/1599578', 'https://www.osti.gov/biblio/1659801', 'https://www.osti.gov/biblio/1031392', 'https://www.osti.gov/biblio/1566807', 'https://www.osti.gov/biblio/1031392-annual-progress-report-doe-hydrogen-fuel-cells-program-book', 'https://www.osti.gov/biblio/1599578-development-hydrogen-mitigation-nevada-solar-one-power-plant', 'https://www.osti.gov/biblio/1659801-acciona-power-plant-hydrogen-mitigation-project', 'https://www.osti.gov/biblio/1566807-abengoa-acciona-power-plant-hydrogen-mitigation-project-cooperative-research-development-final-report-crada-number-crd', 'https://purl.fdlp.gov/GPO/gpo143497']","['Development of Hydrogen Mitigation for the Nevada Solar One Power Plant', 'Acciona Power Plant Hydrogen Mitigation Project', '2011 Annual Progress Report: DOE Hydrogen and Fuel Cells Program (Book)', 'Abengoa/Acciona Power Plant Hydrogen Mitigation Project (Cooperative Research and Development Final Report, CRADA Number CRD-15-583)', '2011 Annual Progress Report: DOE Hydrogen and Fuel Cells Program (Book)', 'Development of Hydrogen Mitigation for the Nevada Solar One Power Plant', 'Acciona Power Plant Hydrogen Mitigation Project', 'Abengoa/Acciona Power Plant Hydrogen Mitigation Project (Cooperative Research and Development Final Report, CRADA Number CRD-15-583)', 'Acciona power plant hydrogen mitigation project /']",['https://purl.fdlp.gov/GPO/gpo143497'],['14034_8_acciona power plant hydrogen mitigation project .pdf'],1,11.11,['https://purl.fdlp.gov/GPO/gpo143497'],['14034_8_acciona power plant hydrogen mitigation project .pdf'],[0.329],[0.522],[0.602],[0.136],[0.135],[0.116],[0.739],[0.643],[0.566],[0.666],[0.784],[0.703],[0.668],[0.901],[0.816],[0.753],[0.798],[0.779],0.329,0.522,0.602,0.136,0.135,0.116,0.739,0.643,0.566,0.666,0.784,0.703,0.668,0.901,0.816,0.753,0.798,0.779
https://doi.org/10.1016/j.siny.2016.02.009,continuous positive airway pressure physiology and comparison of devices,14062_continuous positive airway pressure physiology and comparison of devices.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354031/pdf'],['Continuous positive airway pressure (CPAP) for acute bronchiolitis in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354031/pdf'],['14062_0_continuous positive airway pressure cpap for acute bronchiolitis in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354031/pdf'],['14062_0_continuous positive airway pressure cpap for acute bronchiolitis in children.pdf'],[0.447],[0.531],[0.614],[0.184],[0.183],[0.139],[0.737],[0.644],[0.602],[0.668],[0.791],[0.722],[0.613],[0.919],[0.809],[0.746],[0.791],[0.771],0.447,0.531,0.614,0.184,0.183,0.139,0.737,0.644,0.602,0.668,0.791,0.722,0.613,0.919,0.809,0.746,0.791,0.771
https://doi.org/10.1016/j.siny.2019.01.004,models of care for neonatal abstinence syndrome what works,14070_models of care for neonatal abstinence syndrome what works.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf', 'https://aspe.hhs.gov/reports/utilization-mental-health-services-among-children-diagnosed-neonatal-abstinence-syndrome-birth-issue', 'https://aspe.hhs.gov/reports/use-outpatient-pharmacological-treatment-among-infants-born-neonatal-abstinence-syndrome-medicaid', 'https://aspe.hhs.gov/reports/trends-hospital-readmission-emergency-department-visit-among-infants-born-neonatal-abstinence']","['Non‐pharmacological care for opioid withdrawal in newborns', 'Utilization of Mental Health Services among Children Diagnosed with Neonatal Abstinence Syndrome at Birth Issue Brief', 'Use of Outpatient Pharmacological Treatment Among Infants Born with Neonatal Abstinence Syndrome: Medicaid 2008-2017 Issue Brief', 'Trends in Hospital Readmission and Emergency Department Visit among Infants Born with Neonatal Abstinence Syndrome Issue Brief']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf'],['14070_0_non‐pharmacological care for opioid withdrawal in newborns.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130993/pdf'],['14070_0_non‐pharmacological care for opioid withdrawal in newborns.pdf'],[0.586],[0.528],[0.614],[0.177],[0.186],[0.159],[0.737],[0.645],[0.589],[0.668],[0.783],[0.709],[0.609],[0.912],[0.814],[0.735],[0.787],[0.764],0.586,0.528,0.614,0.177,0.186,0.159,0.737,0.645,0.589,0.668,0.783,0.709,0.609,0.912,0.814,0.735,0.787,0.764
https://doi.org/10.1016/j.smrv.2005.11.001,sleep loss learning capacity and academic performance,14085_sleep loss learning capacity and academic performance.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483483/pdf', 'https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf']","['Later school start times for supporting the education, health, and well‐being of high school students', 'Research & information']","['https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483483/pdf']","['14085_1_research  information.pdf', '14085_0_later school start times for supporting the education health and well‐being of high school students.pdf']",2,100.0,"['https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483483/pdf']","['14085_1_research  information.pdf', '14085_0_later school start times for supporting the education health and well‐being of high school students.pdf']","[0.367, 0.505]","[0.564, 0.55]","[0.64, 0.633]","[0.19, 0.19]","[0.21, 0.207]","[0.18, 0.169]","[0.734, 0.733]","[0.647, 0.646]","[0.639, 0.615]","[0.68, 0.688]","[0.817, 0.796]","[0.763, 0.731]","[0.653, 0.623]","[0.93, 0.923]","[0.847, 0.833]","[0.787, 0.756]","[0.82, 0.799]","[0.803, 0.782]",0.436,0.557,0.637,0.19,0.208,0.174,0.734,0.647,0.627,0.684,0.806,0.747,0.638,0.927,0.84,0.772,0.809,0.792
https://doi.org/10.1016/j.smrv.2018.10.007,the influence of bedsharing on infant physiology breastfeeding and behaviour a systematic review,14091_the influence of bedsharing on infant physiology breastfeeding and behaviour a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078207/pdf', 'https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%236%20-%20English%20Translation.pdf']","['Bed sharing versus no bed sharing for healthy term neonates', 'Bedsharing and Breastfeeding: The Academy of Breastfeeding Medicine Protocol #6, Revision 2019']","['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%236%20-%20English%20Translation.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078207/pdf']","['14091_1_bedsharing and breastfeeding the academy of breastfeeding medicine protocol 6 revision 2019.pdf', '14091_0_bed sharing versus no bed sharing for healthy term neonates.pdf']",2,100.0,"['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/Protocol%20%236%20-%20English%20Translation.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078207/pdf']","['14091_1_bedsharing and breastfeeding the academy of breastfeeding medicine protocol 6 revision 2019.pdf', '14091_0_bed sharing versus no bed sharing for healthy term neonates.pdf']","[0.46, 0.737]","[0.56, 0.559]","[0.641, 0.642]","[0.203, 0.191]","[0.222, 0.204]","[0.178, 0.166]","[0.743, 0.734]","[0.652, 0.642]","[0.639, 0.629]","[0.673, 0.686]","[0.813, 0.799]","[0.768, 0.741]","[0.632, 0.613]","[0.932, 0.929]","[0.846, 0.834]","[0.785, 0.765]","[0.822, 0.807]","[0.804, 0.79]",0.599,0.56,0.641,0.197,0.213,0.172,0.738,0.647,0.634,0.679,0.806,0.754,0.623,0.931,0.84,0.775,0.815,0.797
https://doi.org/10.1016/j.socscimed.2004.12.001,storylines of research in diffusion of innovation a metanarrative approach to systematic review,14117_storylines of research in diffusion of innovation a metanarrative approach to systematic review.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072935/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848005/pdf']","['How can we improve guideline use? A conceptual framework of implementability', 'Understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake: protocol for a realist review', 'The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration', 'Making sense of complex data: a mapping process for analyzing findings of a realist review on guideline implementability']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072935/pdf']","['14117_3_making sense of complex data a mapping process for analyzing findings of a realist review on guideline implementability.pdf', '14117_1_understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake protocol for a realist review.pdf', '14117_2_the prisma statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions explanation and elaboration.pdf', '14117_0_how can we improve guideline use a conceptual framework of implementability.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072935/pdf']","['14117_3_making sense of complex data a mapping process for analyzing findings of a realist review on guideline implementability.pdf', '14117_1_understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake protocol for a realist review.pdf', '14117_2_the prisma statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions explanation and elaboration.pdf', '14117_0_how can we improve guideline use a conceptual framework of implementability.pdf']","[0.387, 0.509, 0.489, 0.43]","[0.584, 0.594, 0.56, 0.561]","[0.672, 0.682, 0.649, 0.647]","[0.192, 0.206, 0.176, 0.182]","[0.203, 0.215, 0.184, 0.191]","[0.167, 0.181, 0.152, 0.161]","[0.74, 0.741, 0.736, 0.737]","[0.65, 0.65, 0.641, 0.646]","[0.648, 0.655, 0.629, 0.627]","[0.748, 0.743, 0.741, 0.729]","[0.817, 0.823, 0.802, 0.802]","[0.769, 0.78, 0.744, 0.749]","[0.648, 0.659, 0.629, 0.635]","[0.922, 0.929, 0.925, 0.926]","[0.863, 0.866, 0.845, 0.849]","[0.79, 0.795, 0.772, 0.773]","[0.826, 0.83, 0.807, 0.811]","[0.81, 0.814, 0.786, 0.79]",0.454,0.575,0.663,0.189,0.198,0.165,0.738,0.647,0.64,0.74,0.811,0.761,0.643,0.925,0.856,0.783,0.819,0.8
https://doi.org/10.1016/j.socscimed.2017.08.038,preventing genderbased violence victimization in adolescent girls in lowerincome countries systematic review of reviews,14269_preventing genderbased violence victimization in adolescent girls in lowerincome countries systematic review of reviews.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['How effects on health equity are assessed in systematic reviews of interventions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['14269_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['14269_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],[0.511],[0.548],[0.64],[0.177],[0.185],[0.153],[0.731],[0.639],[0.604],[0.708],[0.794],[0.717],[0.612],[0.925],[0.835],[0.752],[0.798],[0.78],0.511,0.548,0.64,0.177,0.185,0.153,0.731,0.639,0.604,0.708,0.794,0.717,0.612,0.925,0.835,0.752,0.798,0.78
https://doi.org/10.1016/j.ssmph.2021.100793,the legacy of structural racism associations between historic redlining current mortgage lending and health,14309_the legacy of structural racism associations between historic redlining current mortgage lending and health.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['14309_1_well and thriving prevention and early intervention in california  second public draft.pdf', '14309_0_well and thriving prevention and early intervention in california first public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['14309_1_well and thriving prevention and early intervention in california  second public draft.pdf', '14309_0_well and thriving prevention and early intervention in california first public draft.pdf']","[0.356, 0.358]","[0.503, 0.502]","[0.612, 0.612]","[0.133, 0.133]","[0.146, 0.145]","[0.115, 0.115]","[0.72, 0.721]","[0.626, 0.626]","[0.567, 0.567]","[0.678, 0.678]","[0.792, 0.792]","[0.708, 0.707]","[0.612, 0.612]","[0.922, 0.922]","[0.819, 0.819]","[0.746, 0.746]","[0.795, 0.794]","[0.775, 0.774]",0.357,0.502,0.612,0.133,0.145,0.115,0.72,0.626,0.567,0.678,0.792,0.708,0.612,0.922,0.819,0.746,0.794,0.774
https://doi.org/10.1016/j.ssresearch.2019.102364,raceethnicity human capital and the selection of young children into early childhood education,14340_raceethnicity human capital and the selection of young children into early childhood education.pdf,1,['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['State Of Washington'],['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['14340_0_state of washington.pdf'],1,100.0,['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['14340_0_state of washington.pdf'],[0.535],[0.502],[0.595],[0.152],[0.162],[0.144],[0.732],[0.636],[0.568],[0.682],[0.774],[0.695],[0.625],[0.909],[0.811],[0.737],[0.775],[0.76],0.535,0.502,0.595,0.152,0.162,0.144,0.732,0.636,0.568,0.682,0.774,0.695,0.625,0.909,0.811,0.737,0.775,0.76
https://doi.org/10.1016/j.survophthal.2019.01.010,interventions to improve functioning participation and quality of life in children with visual impairment a systematic review,14352_interventions to improve functioning participation and quality of life in children with visual impairment a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984642/pdf'],['Low vision rehabilitation for better quality of life in visually impaired adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984642/pdf'],['14352_0_low vision rehabilitation for better quality of life in visually impaired adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984642/pdf'],['14352_0_low vision rehabilitation for better quality of life in visually impaired adults.pdf'],[0.491],[0.535],[0.62],[0.181],[0.186],[0.158],[0.736],[0.644],[0.593],[0.711],[0.784],[0.709],[0.603],[0.923],[0.826],[0.745],[0.787],[0.772],0.491,0.535,0.62,0.181,0.186,0.158,0.736,0.644,0.593,0.711,0.784,0.709,0.603,0.923,0.826,0.745,0.787,0.772
https://doi.org/10.1016/j.sxmr.2018.03.005,role of androgens in female genitourinary tissue structure and function implications in the genitourinary syndrome of menopause,14353_role of androgens in female genitourinary tissue structure and function implications in the genitourinary syndrome of menopause.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064950/pdf'],"[""International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064950/pdf'],['14353_0_international society for the study of womens sexual health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064950/pdf'],['14353_0_international society for the study of womens sexual health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women.pdf'],[0.615],[0.62],[0.689],[0.249],[0.266],[0.225],[0.763],[0.671],[0.685],[0.663],[0.839],[0.791],[0.668],[0.933],[0.849],[0.815],[0.841],[0.827],0.615,0.62,0.689,0.249,0.266,0.225,0.763,0.671,0.685,0.663,0.839,0.791,0.668,0.933,0.849,0.815,0.841,0.827
https://doi.org/10.1016/j.therap.2020.05.002,“offlabel” use of hydroxychloroquine azithromycin lopinavirritonavir and chloroquine in covid19 a survey of cardiac adverse drug reactions by the french network of pharmacovigilance centers,14407_“offlabel” use of hydroxychloroquine azithromycin lopinavirritonavir and chloroquine in covid19 a survey of cardiac adverse drug reactions by the french network of pharmacovigilance centers.pdf,3,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'For Public Release', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf']","['14407_1_for public release.pdf', '14407_0_master question list for covid19 caused by sarscov2.pdf', '14407_2_master question list for covid19 caused by sarscov2.pdf']",3,100.0,"['https://www.dhs.gov/sites/default/files/publications/20200901_mql_sars-cov-2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200707.pdf']","['14407_1_for public release.pdf', '14407_0_master question list for covid19 caused by sarscov2.pdf', '14407_2_master question list for covid19 caused by sarscov2.pdf']","[0.373, 0.376, 0.368]","[0.539, 0.539, 0.54]","[0.62, 0.619, 0.619]","[0.156, 0.156, 0.155]","[0.139, 0.139, 0.138]","[0.117, 0.117, 0.116]","[0.74, 0.74, 0.739]","[0.649, 0.648, 0.648]","[0.616, 0.616, 0.617]","[0.634, 0.634, 0.634]","[0.798, 0.798, 0.798]","[0.731, 0.733, 0.733]","[0.632, 0.634, 0.634]","[0.919, 0.918, 0.918]","[0.824, 0.823, 0.823]","[0.761, 0.761, 0.762]","[0.803, 0.803, 0.804]","[0.784, 0.783, 0.783]",0.372,0.539,0.619,0.156,0.139,0.117,0.74,0.648,0.616,0.634,0.798,0.732,0.633,0.918,0.823,0.761,0.803,0.783
https://doi.org/10.1016/j.thromres.2020.02.015,thromboembolism prophylaxis during lasparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches,14413_thromboembolism prophylaxis during lasparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831116/pdf'],['Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831116/pdf'],['14413_0_prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831116/pdf'],['14413_0_prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.pdf'],[0.484],[0.515],[0.611],[0.174],[0.167],[0.132],[0.737],[0.649],[0.579],[0.674],[0.787],[0.682],[0.614],[0.916],[0.802],[0.738],[0.776],[0.767],0.484,0.515,0.611,0.174,0.167,0.132,0.737,0.649,0.579,0.674,0.787,0.682,0.614,0.916,0.802,0.738,0.776,0.767
https://doi.org/10.1016/j.tmaid.2020.101623,clinical laboratory and imaging features of covid19 a systematic review and metaanalysis,14424_clinical laboratory and imaging features of covid19 a systematic review and metaanalysis.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274119/pdf', 'https://www.dir.ca.gov/dwc/MTUS/ACOEM-Guideline-COVID-19.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430932/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275141/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276667/pdf']","['Guidelines: Anaesthesia in the context of COVID-19 pandemic', 'ACOEM COVID-19 Guideline', 'Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)', 'COVID-19 and the production of knowledge regarding recommendations during pregnancy: a scoping review', 'Assessment of knowledge, attitude and practices among dental practitioners on methods of infection control while carrying out dental procedures during novel coronavirus (COVID-19) pandemic', 'Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic', 'Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)', 'Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries', 'Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)', 'Managing ICU surge during the COVID-19 crisis: rapid guidelines']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/pdf', 'https://www.dir.ca.gov/dwc/MTUS/ACOEM-Guideline-COVID-19.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430932/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275141/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274119/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520406/pdf']","['14424_8_chemoprophylaxis diagnosis treatments and discharge management of covid19 an evidencebased clinical practice guideline updated version.pdf', '14424_1_acoem covid19 guideline.pdf', '14424_7_pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe covid19 in low and middleincome countries.pdf', '14424_6_surviving sepsis campaign guidelines on the management of critically ill adults with coronavirus disease 2019 covid19.pdf', '14424_3_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf', '14424_9_managing icu surge during the covid19 crisis rapid guidelines.pdf', '14424_2_head and neck radiotherapy amid the covid19 pandemic practice recommendations of the italian association of radiotherapy and clinical oncology airo.pdf', '14424_5_review of practical recommendations for otolaryngologists and head and neck surgeons during the covid19 pandemic.pdf', '14424_0_guidelines anaesthesia in the context of covid19 pandemic.pdf', '14424_4_assessment of knowledge attitude and practices among dental practitioners on methods of infection control while carrying out dental procedures during novel coronavirus covid19 pandemic.pdf']",10,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/pdf', 'https://www.dir.ca.gov/dwc/MTUS/ACOEM-Guideline-COVID-19.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176264/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319759/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276667/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430932/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275141/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274119/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520406/pdf']","['14424_8_chemoprophylaxis diagnosis treatments and discharge management of covid19 an evidencebased clinical practice guideline updated version.pdf', '14424_1_acoem covid19 guideline.pdf', '14424_7_pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe covid19 in low and middleincome countries.pdf', '14424_6_surviving sepsis campaign guidelines on the management of critically ill adults with coronavirus disease 2019 covid19.pdf', '14424_3_covid19 and the production of knowledge regarding recommendations during pregnancy a scoping review.pdf', '14424_9_managing icu surge during the covid19 crisis rapid guidelines.pdf', '14424_2_head and neck radiotherapy amid the covid19 pandemic practice recommendations of the italian association of radiotherapy and clinical oncology airo.pdf', '14424_5_review of practical recommendations for otolaryngologists and head and neck surgeons during the covid19 pandemic.pdf', '14424_0_guidelines anaesthesia in the context of covid19 pandemic.pdf', '14424_4_assessment of knowledge attitude and practices among dental practitioners on methods of infection control while carrying out dental procedures during novel coronavirus covid19 pandemic.pdf']","[0.399, 0.646, 0.243, 0.407, 0.304, 0.388, 0.438, 0.462, 0.579, 0.315]","[0.498, 0.492, 0.501, 0.494, 0.485, 0.494, 0.501, 0.497, 0.482, 0.485]","[0.586, 0.586, 0.596, 0.586, 0.58, 0.587, 0.593, 0.593, 0.572, 0.574]","[0.162, 0.149, 0.157, 0.163, 0.142, 0.146, 0.144, 0.147, 0.141, 0.13]","[0.172, 0.165, 0.168, 0.163, 0.156, 0.154, 0.153, 0.155, 0.156, 0.15]","[0.135, 0.127, 0.134, 0.132, 0.126, 0.123, 0.116, 0.113, 0.122, 0.117]","[0.736, 0.737, 0.739, 0.739, 0.735, 0.736, 0.733, 0.736, 0.738, 0.73]","[0.644, 0.645, 0.648, 0.646, 0.644, 0.642, 0.64, 0.639, 0.643, 0.637]","[0.561, 0.556, 0.562, 0.554, 0.546, 0.56, 0.562, 0.562, 0.542, 0.552]","[0.677, 0.678, 0.683, 0.672, 0.675, 0.673, 0.654, 0.631, 0.664, 0.676]","[0.782, 0.781, 0.779, 0.773, 0.77, 0.781, 0.784, 0.785, 0.762, 0.772]","[0.673, 0.674, 0.68, 0.681, 0.659, 0.683, 0.691, 0.684, 0.637, 0.68]","[0.609, 0.593, 0.605, 0.602, 0.59, 0.595, 0.604, 0.606, 0.607, 0.581]","[0.918, 0.918, 0.912, 0.9, 0.908, 0.916, 0.919, 0.916, 0.905, 0.92]","[0.796, 0.796, 0.805, 0.781, 0.781, 0.803, 0.805, 0.8, 0.768, 0.786]","[0.738, 0.731, 0.739, 0.714, 0.719, 0.732, 0.741, 0.741, 0.721, 0.725]","[0.773, 0.768, 0.77, 0.763, 0.756, 0.771, 0.777, 0.777, 0.752, 0.763]","[0.761, 0.759, 0.76, 0.736, 0.749, 0.756, 0.761, 0.766, 0.744, 0.753]",0.418,0.493,0.585,0.148,0.159,0.125,0.736,0.643,0.556,0.668,0.777,0.674,0.599,0.913,0.792,0.73,0.767,0.754
https://doi.org/10.1016/j.tox.2018.11.015,developmental perfluorooctane sulfonate exposure inhibits longterm potentiation by affecting ampa receptor trafficking,14442_developmental perfluorooctane sulfonate exposure inhibits longterm potentiation by affecting ampa receptor trafficking.pdf,2,"['https://www.dhs.wisconsin.gov/publications/p02434v.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf']","['Recommended Public Health Groundwater Quality Standards, P-02434V', 'Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft']",['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['14442_1_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,50.0,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['14442_1_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.462],[0.482],[0.585],[0.126],[0.125],[0.106],[0.74],[0.649],[0.552],[0.668],[0.774],[0.654],[0.617],[0.903],[0.786],[0.73],[0.765],[0.756],0.462,0.482,0.585,0.126,0.125,0.106,0.74,0.649,0.552,0.668,0.774,0.654,0.617,0.903,0.786,0.73,0.765,0.756
https://doi.org/10.1016/j.tra.2018.11.018,the who why and when of uber and other ridehailing trips an examination of a large sample household travel survey,14462_the who why and when of uber and other ridehailing trips an examination of a large sample household travel survey.pdf,3,"['https://www.congress.gov/event/116th-congress/house-event/LC65343/text', 'https://www.congress.gov/event/116th-congress/house-event/110062', 'https://www.tn.gov/content/dam/tn/tdot/long-range-planning/research/final-reports/res2020-final-reports/RES2020-20_Final_Report_approved.pdf']","['House Hearing, 116th Congress — EXAMINING THE FUTURE OF TRANSPORTATION NETWORK COMPANIES: CHALLENGES AND OPPORTUNITIES', '""Examining the Future of Transportation Network Companies: Challenges and Opportunities.""', 'Investigating the Service of App-Based Rideshare and Transportation Network Companies']",['https://www.tn.gov/content/dam/tn/tdot/long-range-planning/research/final-reports/res2020-final-reports/RES2020-20_Final_Report_approved.pdf'],['14462_2_investigating the service of appbased rideshare and transportation network companies.pdf'],1,33.33,['https://www.tn.gov/content/dam/tn/tdot/long-range-planning/research/final-reports/res2020-final-reports/RES2020-20_Final_Report_approved.pdf'],['14462_2_investigating the service of appbased rideshare and transportation network companies.pdf'],[0.359],[0.521],[0.618],[0.183],[0.193],[0.168],[0.735],[0.639],[0.589],[0.709],[0.778],[0.717],[0.65],[0.896],[0.836],[0.746],[0.788],[0.768],0.359,0.521,0.618,0.183,0.193,0.168,0.735,0.639,0.589,0.709,0.778,0.717,0.65,0.896,0.836,0.746,0.788,0.768
https://doi.org/10.1016/j.transci.2020.102866,first case of convalescent plasma transfusion in a child with covid19associated severe aplastic anemia,14466_first case of convalescent plasma transfusion in a child with covid19associated severe aplastic anemia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135693/pdf'],['Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135693/pdf'],['14466_0_convalescent plasma or hyperimmune immunoglobulin for people with covid‐19 a living systematic review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135693/pdf'],['14466_0_convalescent plasma or hyperimmune immunoglobulin for people with covid‐19 a living systematic review.pdf'],[0.357],[0.535],[0.625],[0.173],[0.177],[0.135],[0.738],[0.645],[0.606],[0.639],[0.781],[0.71],[0.595],[0.915],[0.828],[0.738],[0.786],[0.769],0.357,0.535,0.625,0.173,0.177,0.135,0.738,0.645,0.606,0.639,0.781,0.71,0.595,0.915,0.828,0.738,0.786,0.769
https://doi.org/10.1016/j.tre.2018.11.007,crude oil contango arbitrage and the floating storage decision,14474_crude oil contango arbitrage and the floating storage decision.pdf,1,['https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2015.pdf'],['A Quantitative Model of the Oil Tanker Market in the Arabian Gulf'],['https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2015.pdf'],['14474_0_a quantitative model of the oil tanker market in the arabian gulf.pdf'],1,100.0,['https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2015.pdf'],['14474_0_a quantitative model of the oil tanker market in the arabian gulf.pdf'],[0.451],[0.548],[0.629],[0.168],[0.185],[0.16],[0.728],[0.632],[0.612],[0.69],[0.807],[0.739],[0.692],[0.919],[0.849],[0.789],[0.819],[0.802],0.451,0.548,0.629,0.168,0.185,0.16,0.728,0.632,0.612,0.69,0.807,0.739,0.692,0.919,0.849,0.789,0.819,0.802
https://doi.org/10.1016/j.urology.2017.08.003,neurostimulation therapy for nonneurogenic overactive bladder in children a metaanalysis,14515_neurostimulation therapy for nonneurogenic overactive bladder in children a metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf'],['Conservative interventions for treating functional daytime urinary incontinence in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf'],['14515_0_conservative interventions for treating functional daytime urinary incontinence in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749940/pdf'],['14515_0_conservative interventions for treating functional daytime urinary incontinence in children.pdf'],[0.474],[0.519],[0.604],[0.167],[0.17],[0.142],[0.737],[0.645],[0.581],[0.689],[0.772],[0.706],[0.598],[0.903],[0.791],[0.722],[0.771],[0.748],0.474,0.519,0.604,0.167,0.17,0.142,0.737,0.645,0.581,0.689,0.772,0.706,0.598,0.903,0.791,0.722,0.771,0.748
https://doi.org/10.1016/j.urolonc.2017.07.025,predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma,14519_predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831701/pdf'],['Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831701/pdf'],['14519_0_management of penile cancer patients during the covid19 pandemic an eurogen accelerated delphi consensus study.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831701/pdf'],['14519_0_management of penile cancer patients during the covid19 pandemic an eurogen accelerated delphi consensus study.pdf'],[0.4],[0.534],[0.61],[0.168],[0.172],[0.141],[0.739],[0.646],[0.591],[0.658],[0.794],[0.711],[0.64],[0.92],[0.812],[0.763],[0.792],[0.783],0.4,0.534,0.61,0.168,0.172,0.141,0.739,0.646,0.591,0.658,0.794,0.711,0.64,0.92,0.812,0.763,0.792,0.783
https://doi.org/10.1016/j.vaccine.2011.08.096,reasons related to nonvaccination and undervaccination of children in low and middle income countries findings from a systematic review of the published literature 1999–2009,14596_reasons related to nonvaccination and undervaccination of children in low and middle income countries findings from a systematic review of the published literature 1999–2009.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://purl.fdlp.gov/GPO/gpo115968', 'https://www.cgdev.org/publication/global-immunization-and-gavi-five-priorities-next-five-years']","[""Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis"", 'Indicators of child deprivation in Sub-Saharan Africa :\xa0levels and trends from the Demographic and Health Surveys /', 'Global Immunization and Gavi: Five Priorities for the Next Five Years']","['https://purl.fdlp.gov/GPO/gpo115968', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf']","['14596_1_indicators of child deprivation in subsaharan africa \xa0levels and trends from the demographic and health surveys .pdf', '14596_0_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf']",2,66.67,"['https://purl.fdlp.gov/GPO/gpo115968', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf']","['14596_1_indicators of child deprivation in subsaharan africa \xa0levels and trends from the demographic and health surveys .pdf', '14596_0_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf']","[0.501, 0.18]","[0.475, 0.575]","[0.586, 0.662]","[0.143, 0.242]","[0.171, 0.263]","[0.119, 0.217]","[0.723, 0.747]","[0.625, 0.658]","[0.527, 0.637]","[0.681, 0.708]","[0.779, 0.805]","[0.644, 0.747]","[0.617, 0.633]","[0.912, 0.926]","[0.822, 0.854]","[0.703, 0.772]","[0.769, 0.809]","[0.758, 0.792]",0.341,0.525,0.624,0.193,0.217,0.168,0.735,0.641,0.582,0.695,0.792,0.696,0.625,0.919,0.838,0.738,0.789,0.775
https://doi.org/10.1016/j.vaccine.2017.04.015,varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment,14679_varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169786/pdf'],"['Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169786/pdf'],['14679_0_recommendations for vaccination in children with atopic dermatitis treated with dupilumab a consensus meeting 2020.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169786/pdf'],['14679_0_recommendations for vaccination in children with atopic dermatitis treated with dupilumab a consensus meeting 2020.pdf'],[0.532],[0.537],[0.614],[0.189],[0.194],[0.163],[0.746],[0.657],[0.595],[0.661],[0.789],[0.713],[0.626],[0.899],[0.815],[0.747],[0.773],[0.767],0.532,0.537,0.614,0.189,0.194,0.163,0.746,0.657,0.595,0.661,0.789,0.713,0.626,0.899,0.815,0.747,0.773,0.767
https://doi.org/10.1016/j.vaccine.2017.07.116,the effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine a randomized factorial design placebocontrolled study among indian infants,14689_the effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine a randomized factorial design placebocontrolled study among indian infants.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434239/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816010/pdf', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research']","['Vaccines for preventing rotavirus diarrhoea: vaccines in use', 'Vaccines for preventing rotavirus diarrhoea: vaccines in use', 'Vaccines for preventing rotavirus diarrhoea: vaccines in use', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434239/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf']","['14689_2_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf', '14689_1_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf', '14689_0_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816010/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434239/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf']","['14689_2_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf', '14689_1_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf', '14689_0_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf']","[0.502, 0.49, 0.468]","[0.508, 0.514, 0.516]","[0.589, 0.593, 0.602]","[0.169, 0.179, 0.171]","[0.163, 0.175, 0.168]","[0.14, 0.147, 0.145]","[0.742, 0.743, 0.742]","[0.652, 0.655, 0.651]","[0.57, 0.576, 0.58]","[0.676, 0.678, 0.676]","[0.774, 0.782, 0.774]","[0.679, 0.688, 0.685]","[0.59, 0.597, 0.585]","[0.91, 0.907, 0.912]","[0.782, 0.783, 0.785]","[0.731, 0.741, 0.728]","[0.77, 0.777, 0.771]","[0.751, 0.755, 0.75]",0.487,0.513,0.595,0.173,0.169,0.144,0.742,0.653,0.575,0.677,0.777,0.684,0.591,0.91,0.783,0.733,0.773,0.752
https://doi.org/10.1016/j.vaccine.2018.11.073,persistence and 4year boosting of the bactericidal response elicited by two and threedose schedules of menbfhbp a phase 3 extension study in adolescents,14713_persistence and 4year boosting of the bactericidal response elicited by two and threedose schedules of menbfhbp a phase 3 extension study in adolescents.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf', 'https://stacks.cdc.gov/view/cdc/95034']","['Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020', 'Meningococcal vaccination : 5ecommendations of the Advisory Committee on Immunization Practices, United States, 2020']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf'],['14713_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf'],['14713_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf'],[0.498],[0.577],[0.647],[0.222],[0.236],[0.201],[0.753],[0.666],[0.646],[0.669],[0.815],[0.737],[0.638],[0.918],[0.841],[0.785],[0.816],[0.801],0.498,0.577,0.647,0.222,0.236,0.201,0.753,0.666,0.646,0.669,0.815,0.737,0.638,0.918,0.841,0.785,0.816,0.801
https://doi.org/10.1016/j.vaccine.2018.12.017,variations in reason for intention not to vaccinate across time region and by raceethnicity nisteen 2008–2016,14714_variations in reason for intention not to vaccinate across time region and by raceethnicity nisteen 2008–2016.pdf,1,['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['Oversight Committee Meeting'],['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['14714_0_oversight committee meeting.pdf'],1,100.0,['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['14714_0_oversight committee meeting.pdf'],[0.228],[0.493],[0.582],[0.109],[0.116],[0.093],[0.721],[0.621],[0.567],[0.648],[0.783],[0.692],[0.599],[0.914],[0.809],[0.727],[0.775],[0.759],0.228,0.493,0.582,0.109,0.116,0.093,0.721,0.621,0.567,0.648,0.783,0.692,0.599,0.914,0.809,0.727,0.775,0.759
https://doi.org/10.1016/j.wneu.2019.08.183,pipeline embolization device for treatment of craniocervical internal carotid artery dissections report of 3 cases,14788_pipeline embolization device for treatment of craniocervical internal carotid artery dissections report of 3 cases.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807178/pdf'],['Endovascular treatment of blunt injury of the extracranial internal carotid artery: the prospect and dilemma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807178/pdf'],['14788_0_endovascular treatment of blunt injury of the extracranial internal carotid artery the prospect and dilemma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807178/pdf'],['14788_0_endovascular treatment of blunt injury of the extracranial internal carotid artery the prospect and dilemma.pdf'],[0.523],[0.554],[0.638],[0.205],[0.234],[0.184],[0.766],[0.676],[0.618],[0.648],[0.801],[0.731],[0.629],[0.919],[0.823],[0.755],[0.8],[0.787],0.523,0.554,0.638,0.205,0.234,0.184,0.766,0.676,0.618,0.648,0.801,0.731,0.629,0.919,0.823,0.755,0.8,0.787
https://doi.org/10.1016/j.worlddev.2019.02.012,improving the quality of early childhood care at scale the effects of “from zero to forever”,14838_improving the quality of early childhood care at scale the effects of “from zero to forever”.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.thedialogue.org/analysis/construyendo-un-paquete-basico-de-prestaciones-para-la-primera-infancia/', 'https://www.thedialogue.org/analysis/design-and-cost-of-an-early-childhood-care-services-package-the-case-of-colombia/', 'https://www.cgdev.org/publication/how-prioritize-early-childhood-note-recent-experience-colombia']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Construyendo un paquete básico de prestaciones para la primera infancia - The Dialogue', 'Design and Cost of an Early Childhood Care Services Package: The Case of Colombia - The Dialogue', 'How to Prioritize Early Childhood? A Note on the Recent Experience in Colombia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['14838_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '14838_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,40.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['14838_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '14838_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.383, 0.376]","[0.529, 0.528]","[0.619, 0.617]","[0.161, 0.161]","[0.162, 0.161]","[0.136, 0.136]","[0.728, 0.728]","[0.629, 0.628]","[0.597, 0.594]","[0.68, 0.68]","[0.785, 0.784]","[0.702, 0.697]","[0.605, 0.605]","[0.925, 0.924]","[0.833, 0.83]","[0.746, 0.745]","[0.792, 0.79]","[0.777, 0.776]",0.38,0.528,0.618,0.161,0.162,0.136,0.728,0.629,0.595,0.68,0.784,0.7,0.605,0.925,0.831,0.746,0.791,0.776
https://doi.org/10.1016/j.worlddev.2020.105131,the impact of climate vulnerability on firms’ cost of capital and access to finance,14841_the impact of climate vulnerability on firms’ cost of capital and access to finance.pdf,1,['https://docs.gatesfoundation.org/documents/bill_and_melinda_gates_foundation_investing_in_climate_change_adaptation_and_agricultural_innovation_is_essential_for_our_future.pdf'],['Investing In Climate Change Adaptation And Agricultural Innovation Is Essential For Our Future'],['https://docs.gatesfoundation.org/documents/bill_and_melinda_gates_foundation_investing_in_climate_change_adaptation_and_agricultural_innovation_is_essential_for_our_future.pdf'],['14841_0_investing in climate change adaptation and agricultural innovation is essential for our future.pdf'],1,100.0,['https://docs.gatesfoundation.org/documents/bill_and_melinda_gates_foundation_investing_in_climate_change_adaptation_and_agricultural_innovation_is_essential_for_our_future.pdf'],['14841_0_investing in climate change adaptation and agricultural innovation is essential for our future.pdf'],[0.411],[0.517],[0.622],[0.166],[0.158],[0.147],[0.729],[0.63],[0.582],[0.67],[0.798],[0.697],[0.629],[0.915],[0.827],[0.768],[0.805],[0.786],0.411,0.517,0.622,0.166,0.158,0.147,0.729,0.63,0.582,0.67,0.798,0.697,0.629,0.915,0.827,0.768,0.805,0.786
https://doi.org/10.1016/j.xinn.2020.04.001,epidemiological and clinical characteristics of covid19 in adolescents and young adults,14845_epidemiological and clinical characteristics of covid19 in adolescents and young adults.pdf,8,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.nber.org/papers/w27408', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.congress.gov/event/116th-congress/house-event/110912']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Black Lives Matter Protests, Social Distancing, and COVID-19', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Hybrid Hearing on “The Urgent Need for a National Plan to Contain the Coronavirus”']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['14845_5_master question list for covid19 caused by sarscov2.pdf', '14845_3_master question list for covid19 caused by sarscov2.pdf', '14845_2_master question list for covid19 caused by sarscov2.pdf', '14845_0_master question list for covid19 caused by sarscov2.pdf', '14845_6_master question list for covid19 caused by sarscov2.pdf', '14845_1_master question list for covid19 caused by sarscov2.pdf']",6,75.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['14845_5_master question list for covid19 caused by sarscov2.pdf', '14845_2_master question list for covid19 caused by sarscov2.pdf', '14845_0_master question list for covid19 caused by sarscov2.pdf', '14845_6_master question list for covid19 caused by sarscov2.pdf', '14845_1_master question list for covid19 caused by sarscov2.pdf']","[0.4, 0.392, 0.393, 0.36, 0.415]","[0.516, 0.519, 0.518, 0.52, 0.518]","[0.61, 0.612, 0.611, 0.614, 0.613]","[0.151, 0.153, 0.153, 0.155, 0.153]","[0.146, 0.147, 0.146, 0.149, 0.148]","[0.118, 0.118, 0.118, 0.12, 0.119]","[0.739, 0.739, 0.739, 0.74, 0.739]","[0.643, 0.644, 0.644, 0.644, 0.644]","[0.583, 0.585, 0.584, 0.585, 0.584]","[0.65, 0.647, 0.647, 0.648, 0.648]","[0.78, 0.781, 0.781, 0.781, 0.78]","[0.695, 0.697, 0.695, 0.699, 0.697]","[0.628, 0.629, 0.629, 0.631, 0.628]","[0.908, 0.907, 0.907, 0.906, 0.907]","[0.818, 0.817, 0.818, 0.818, 0.818]","[0.751, 0.753, 0.753, 0.754, 0.752]","[0.786, 0.787, 0.787, 0.787, 0.786]","[0.765, 0.767, 0.766, 0.767, 0.766]",0.392,0.518,0.612,0.153,0.147,0.119,0.739,0.644,0.584,0.648,0.781,0.697,0.629,0.907,0.818,0.753,0.787,0.766
https://doi.org/10.1016/j.ygyno.2019.10.018,human papillomavirus vaccination ongoing challenges and future directions,14871_human papillomavirus vaccination ongoing challenges and future directions.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838962/pdf'],['Sexual health and education guidelines for the care of people with spina bifida'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838962/pdf'],['14871_0_sexual health and education guidelines for the care of people with spina bifida.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838962/pdf'],['14871_0_sexual health and education guidelines for the care of people with spina bifida.pdf'],[0.113],[0.503],[0.599],[0.136],[0.139],[0.109],[0.735],[0.643],[0.557],[0.626],[0.787],[0.687],[0.607],[0.916],[0.79],[0.733],[0.774],[0.758],0.113,0.503,0.599,0.136,0.139,0.109,0.735,0.643,0.557,0.626,0.787,0.687,0.607,0.916,0.79,0.733,0.774,0.758
https://doi.org/10.1016/j.yhbeh.2013.04.003,pubertal timing and the development of psychopathology in adolescence and beyond,14878_pubertal timing and the development of psychopathology in adolescence and beyond.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf', 'https://www.acf.hhs.gov/opre/report/economic-benefits-delayed-sexual-activity', 'https://mathematica.org/publications/economic-benefits-of-delayed-sexual-activity']","['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline', 'Economic Benefits of Delayed Sexual Activity', 'Economic Benefits of Delayed Sexual Activity']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['14878_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['14878_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.337],[0.513],[0.61],[0.16],[0.157],[0.134],[0.738],[0.642],[0.573],[0.65],[0.781],[0.698],[0.615],[0.913],[0.783],[0.748],[0.782],[0.768],0.337,0.513,0.61,0.16,0.157,0.134,0.738,0.642,0.573,0.65,0.781,0.698,0.615,0.913,0.783,0.748,0.782,0.768
https://doi.org/10.1016/j.ymgme.2014.05.006,nutrition management guideline for maple syrup urine disease an evidence and consensusbased approach,14907_nutrition management guideline for maple syrup urine disease an evidence and consensusbased approach.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696316/pdf'],['Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696316/pdf'],['14907_0_review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696316/pdf'],['14907_0_review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders.pdf'],[0.379],[0.491],[0.583],[0.13],[0.135],[0.108],[0.731],[0.635],[0.552],[0.686],[0.775],[0.686],[0.613],[0.908],[0.796],[0.739],[0.778],[0.762],0.379,0.491,0.583,0.13,0.135,0.108,0.731,0.635,0.552,0.686,0.775,0.686,0.613,0.908,0.796,0.739,0.778,0.762
https://doi.org/10.1016/j.ymgme.2014.07.018,inborn error of metabolism iem screening in singapore by electrospray ionizationtandem mass spectrometry esimsms an 8year journey from pilot to current program,14909_inborn error of metabolism iem screening in singapore by electrospray ionizationtandem mass spectrometry esimsms an 8year journey from pilot to current program.pdf,1,['https://www.acmg.net/PDFLibrary/Lab-Analysis-of-Organic-Acids.pdf'],"['Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG)']",['https://www.acmg.net/PDFLibrary/Lab-Analysis-of-Organic-Acids.pdf'],['14909_0_laboratory analysis of organic acids 2018 update a technical standard of the american college of medical genetics and genomics acmg.pdf'],1,100.0,['https://www.acmg.net/PDFLibrary/Lab-Analysis-of-Organic-Acids.pdf'],['14909_0_laboratory analysis of organic acids 2018 update a technical standard of the american college of medical genetics and genomics acmg.pdf'],[0.435],[0.541],[0.626],[0.175],[0.188],[0.142],[0.737],[0.643],[0.618],[0.681],[0.801],[0.744],[0.648],[0.924],[0.832],[0.777],[0.808],[0.793],0.435,0.541,0.626,0.175,0.188,0.142,0.737,0.643,0.618,0.681,0.801,0.744,0.648,0.924,0.832,0.777,0.808,0.793
https://doi.org/10.1016/j.ymgme.2018.04.007,the effect of enzyme replacement therapy on clinical outcomes in paediatric patients with fabry disease – a systematic literature review by a european panel of experts,14917_the effect of enzyme replacement therapy on clinical outcomes in paediatric patients with fabry disease – a systematic literature review by a european panel of experts.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852597/pdf'],"['Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852597/pdf'],['14917_0_consensus recommendations for diagnosis management and treatment of fabry disease in paediatric patients.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852597/pdf'],['14917_0_consensus recommendations for diagnosis management and treatment of fabry disease in paediatric patients.pdf'],[0.439],[0.522],[0.598],[0.168],[0.162],[0.126],[0.738],[0.641],[0.585],[0.677],[0.79],[0.712],[0.623],[0.915],[0.791],[0.755],[0.783],[0.775],0.439,0.522,0.598,0.168,0.162,0.126,0.738,0.641,0.585,0.677,0.79,0.712,0.623,0.915,0.791,0.755,0.783,0.775
https://doi.org/10.1016/j.ymgme.2019.04.009,corrigendum to universal newborn screening a roadmap for action molecular genetics and metabolism 124 2018 177–183,14920_corrigendum to universal newborn screening a roadmap for action molecular genetics and metabolism 124 2018 177–183.pdf,5,"['https://opwdd.ny.gov/system/files/documents/2019/12/2018_ibr_staff_publications.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/01/ibr-published-works-2018.pdf', 'https://ar.opwdd.ny.gov/system/files?file=documents/2020/01/ibr-published-works-2018.pdf', 'https://fr.opwdd.ny.gov/system/files/documents/2019/12/2018_ibr_staff_publications.pdf']","['2018 Ibr Staff Publications', '2019 Ibr Staff Publications', '2018 Ibr Staff Publications', '2018 Ibr Staff Publications', '2018 Ibr Staff Publications']","['https://opwdd.ny.gov/system/files/documents/2019/12/2018_ibr_staff_publications.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/01/ibr-published-works-2018.pdf', 'https://ar.opwdd.ny.gov/system/files?file=documents/2020/01/ibr-published-works-2018.pdf', 'https://fr.opwdd.ny.gov/system/files/documents/2019/12/2018_ibr_staff_publications.pdf']","['14920_0_2018 ibr staff publications.pdf', '14920_1_2019 ibr staff publications.pdf', '14920_2_2018 ibr staff publications.pdf', '14920_3_2018 ibr staff publications.pdf', '14920_4_2018 ibr staff publications.pdf']",5,100.0,"['https://opwdd.ny.gov/system/files/documents/2019/12/2018_ibr_staff_publications.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf', 'https://opwdd.ny.gov/system/files/documents/2020/01/ibr-published-works-2018.pdf', 'https://ar.opwdd.ny.gov/system/files?file=documents/2020/01/ibr-published-works-2018.pdf', 'https://fr.opwdd.ny.gov/system/files/documents/2019/12/2018_ibr_staff_publications.pdf']","['14920_0_2018 ibr staff publications.pdf', '14920_1_2019 ibr staff publications.pdf', '14920_2_2018 ibr staff publications.pdf', '14920_3_2018 ibr staff publications.pdf', '14920_4_2018 ibr staff publications.pdf']","[0.035, 0.091, 0.035, 0.035, 0.035]","[0.478, 0.483, 0.478, 0.478, 0.478]","[0.574, 0.579, 0.575, 0.575, 0.574]","[0.104, 0.12, 0.104, 0.104, 0.104]","[0.109, 0.125, 0.108, 0.108, 0.109]","[0.092, 0.104, 0.092, 0.092, 0.092]","[0.733, 0.734, 0.733, 0.733, 0.733]","[0.643, 0.643, 0.643, 0.643, 0.643]","[0.541, 0.548, 0.541, 0.541, 0.541]","[0.678, 0.684, 0.677, 0.677, 0.678]","[0.779, 0.787, 0.779, 0.779, 0.779]","[0.656, 0.672, 0.656, 0.656, 0.656]","[0.602, 0.601, 0.602, 0.602, 0.602]","[0.909, 0.917, 0.909, 0.909, 0.909]","[0.795, 0.811, 0.795, 0.795, 0.795]","[0.714, 0.722, 0.714, 0.714, 0.714]","[0.764, 0.772, 0.764, 0.764, 0.764]","[0.752, 0.762, 0.752, 0.752, 0.752]",0.046,0.479,0.575,0.107,0.112,0.094,0.733,0.643,0.542,0.679,0.781,0.659,0.602,0.911,0.798,0.716,0.766,0.754
https://doi.org/10.1016/j.ymgme.2019.11.001,liver transplantation in propionic and methylmalonic acidemia a single center study with literature review,14921_liver transplantation in propionic and methylmalonic acidemia a single center study with literature review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['14921_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['14921_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.404],[0.527],[0.613],[0.167],[0.172],[0.124],[0.743],[0.648],[0.59],[0.649],[0.793],[0.71],[0.622],[0.918],[0.807],[0.754],[0.79],[0.774],0.404,0.527,0.613,0.167,0.172,0.124,0.743,0.648,0.59,0.649,0.793,0.71,0.622,0.918,0.807,0.754,0.79,0.774
https://doi.org/10.1016/j.ymgmr.2017.08.001,the prevalence of diseases caused by lysosomerelated genes in a cohort of undiagnosed patients,14924_the prevalence of diseases caused by lysosomerelated genes in a cohort of undiagnosed patients.pdf,1,['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf'],['Whole Exome Sequencing Final evidence report'],['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf'],['14924_0_whole exome sequencing final evidence report.pdf'],1,100.0,['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf'],['14924_0_whole exome sequencing final evidence report.pdf'],[0.377],[0.5],[0.599],[0.154],[0.172],[0.137],[0.74],[0.647],[0.559],[0.677],[0.778],[0.682],[0.607],[0.895],[0.809],[0.697],[0.777],[0.756],0.377,0.5,0.599,0.154,0.172,0.137,0.74,0.647,0.559,0.677,0.778,0.682,0.607,0.895,0.809,0.697,0.777,0.756
https://doi.org/10.1016/j.ypmed.2018.09.019,reduction in purchases of energydense nutrientpoor foods in mexico associated with the introduction of a tax in 2014,15009_reduction in purchases of energydense nutrientpoor foods in mexico associated with the introduction of a tax in 2014.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141932/pdf'],['Taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141932/pdf'],['15009_0_taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141932/pdf'],['15009_0_taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes.pdf'],[0.428],[0.494],[0.59],[0.135],[0.146],[0.122],[0.722],[0.623],[0.566],[0.708],[0.774],[0.68],[0.602],[0.91],[0.809],[0.724],[0.774],[0.755],0.428,0.494,0.59,0.135,0.146,0.122,0.722,0.623,0.566,0.708,0.774,0.68,0.602,0.91,0.809,0.724,0.774,0.755
https://doi.org/10.1016/j.ypmed.2019.02.026,violent death rates in the us compared to those of the other highincome countries 2015,15010_violent death rates in the us compared to those of the other highincome countries 2015.pdf,6,"['https://www.rti.org/rti-press-publication/2022-firearm-and-toolmarks-policy-and-practice-forum', 'https://www.aei.org/research-products/report/rebalancing-children-first/', 'https://www.brookings.edu/research/rebalancing-children-first/', 'https://purl.fdlp.gov/GPO/gpo130842', 'https://www.congress.gov/event/116th-congress/senate-event/LC64630/text?s=1&r=16607', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/victims/victims-services-news-special-edition-2020-dv.pdf']","['2022 Firearm and Toolmarks Policy and Practice Forum', 'Rebalancing: Children first - AEI', 'Rebalancing: Children first', 'Gun violence in America :\xa0understanding and reducing the costs of firearm injuries and deaths : hearing before the Joint Economic Committee, United States Senate, One Hundred Sixteenth Congress, first session, September 18, 2019.', 'S.Hrg. 116-100 — GUN VIOLENCE IN AMERICA: UNDERSTANDING AND REDUCING THE COSTS OF FIREARM INJURIES AND DEATHS', 'Domestic Violence Awareness Month Special Edition']",['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/victims/victims-services-news-special-edition-2020-dv.pdf'],['15010_5_domestic violence awareness month special edition.pdf'],1,16.67,['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/victims/victims-services-news-special-edition-2020-dv.pdf'],['15010_5_domestic violence awareness month special edition.pdf'],[0.101],[0.506],[0.601],[0.13],[0.15],[0.117],[0.715],[0.613],[0.565],[0.682],[0.791],[0.709],[0.642],[0.914],[0.83],[0.75],[0.797],[0.779],0.101,0.506,0.601,0.13,0.15,0.117,0.715,0.613,0.565,0.682,0.791,0.709,0.642,0.914,0.83,0.75,0.797,0.779
https://doi.org/10.1016/j.yrtph.2019.01.020,perfluorohexanoic acid toxicity part ii application of human health toxicity value for risk characterization,15027_perfluorohexanoic acid toxicity part ii application of human health toxicity value for risk characterization.pdf,6,"['https://www.congress.gov/event/116th-congress/house-event/110423', 'https://purl.fdlp.gov/GPO/gpo124530', 'https://www.congress.gov/event/116th-congress/senate-event/LC64043/text', 'https://dnr.wisconsin.gov/sites/default/files/topic/SurfaceWater/PFASScopeComments.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.dec.ny.gov/data/DecDocs/152263/Work%20Plan.HW.152263.2021-06-17.SC%20WP%20signed%20QAPP.pdf']","['“Improving Safety and Transparency in America’s Food and Drugs”', 'Examining legislation to address the risks associated with per- and polyfluoroalkyl substances (PFAS) :\xa0hearing before the Committee on Environment and Public Works, United States Senate, One Hundred Sixteenth Congress, first session, May 22, 2019.', 'S.Hrg. 116-35 — EXAMINING LEGISLATION TO ADDRESS THE RISKS ASSOCIATED WITH PER-AND POLYFLUOROALKYL SUBSTANCES (PFAS)', 'Tony Evers, Governor Preston D. Cole, Secretary', 'Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Site Characterization Workplan']","['https://dnr.wisconsin.gov/sites/default/files/topic/SurfaceWater/PFASScopeComments.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.dec.ny.gov/data/DecDocs/152263/Work%20Plan.HW.152263.2021-06-17.SC%20WP%20signed%20QAPP.pdf']","['15027_3_tony evers governor preston d cole secretary.pdf', '15027_4_per and polyfluoroalkyl substances chemical action plan.pdf', '15027_5_site characterization workplan.pdf']",3,50.0,"['https://dnr.wisconsin.gov/sites/default/files/topic/SurfaceWater/PFASScopeComments.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.dec.ny.gov/data/DecDocs/152263/Work%20Plan.HW.152263.2021-06-17.SC%20WP%20signed%20QAPP.pdf']","['15027_3_tony evers governor preston d cole secretary.pdf', '15027_4_per and polyfluoroalkyl substances chemical action plan.pdf', '15027_5_site characterization workplan.pdf']","[0.308, 0.43, 0.275]","[0.478, 0.488, 0.472]","[0.591, 0.591, 0.577]","[0.147, 0.15, 0.124]","[0.154, 0.152, 0.129]","[0.127, 0.13, 0.102]","[0.729, 0.733, 0.731]","[0.641, 0.646, 0.64]","[0.553, 0.557, 0.548]","[0.678, 0.672, 0.673]","[0.787, 0.788, 0.769]","[0.672, 0.672, 0.657]","[0.616, 0.625, 0.609]","[0.909, 0.913, 0.908]","[0.815, 0.809, 0.798]","[0.738, 0.742, 0.727]","[0.783, 0.782, 0.77]","[0.772, 0.773, 0.758]",0.338,0.479,0.586,0.14,0.145,0.12,0.731,0.642,0.553,0.674,0.781,0.667,0.617,0.91,0.807,0.736,0.778,0.768
https://doi.org/10.1016/s0002-8223(03)01076-9,national trends in soft drink consumption among children and adolescents age 6 to 17 years prevalence amounts and sources 19771978 to 19941998,15057_national trends in soft drink consumption among children and adolescents age 6 to 17 years prevalence amounts and sources 19771978 to 19941998.pdf,2,"['https://www.chicagofed.org/publications/profitwise-news-and-views/2005/pnv-october2005', 'http://purl.fdlp.gov/GPO/gpo63510']","['Towards Financial Literacy: Program Leaders Comment on Evaluation and Impact', 'Nutrition and health characteristics of low-income populations.\xa0Meal patterns, milk and soft drink consumption, and supplement use /']",['http://purl.fdlp.gov/GPO/gpo63510'],['15057_1_nutrition and health characteristics of lowincome populations\xa0meal patterns milk and soft drink consumption and supplement use .pdf'],1,50.0,['http://purl.fdlp.gov/GPO/gpo63510'],['15057_1_nutrition and health characteristics of lowincome populations\xa0meal patterns milk and soft drink consumption and supplement use .pdf'],[0.39],[0.569],[0.657],[0.231],[0.259],[0.213],[0.741],[0.635],[0.646],[0.721],[0.816],[0.772],[0.665],[0.932],[0.843],[0.787],[0.825],[0.807],0.39,0.569,0.657,0.231,0.259,0.213,0.741,0.635,0.646,0.721,0.816,0.772,0.665,0.932,0.843,0.787,0.825,0.807
https://doi.org/10.1016/s0020-7292(01)00496-9,gestational diabetes mellitus prevalence risk factors maternal and infant outcomes,15181_gestational diabetes mellitus prevalence risk factors maternal and infant outcomes.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2214247/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf']","['Managing diabetes during pregnancy. Guide for family physicians.', 'Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2214247/pdf']","['15181_1_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '15181_0_managing diabetes during pregnancy guide for family physicians.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2214247/pdf']","['15181_1_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '15181_0_managing diabetes during pregnancy guide for family physicians.pdf']","[0.455, 0.404]","[0.476, 0.475]","[0.573, 0.58]","[0.129, 0.138]","[0.134, 0.149]","[0.122, 0.128]","[0.732, 0.733]","[0.634, 0.632]","[0.543, 0.534]","[0.682, 0.635]","[0.735, 0.745]","[0.63, 0.631]","[0.59, 0.608]","[0.897, 0.899]","[0.745, 0.756]","[0.685, 0.701]","[0.728, 0.741]","[0.713, 0.724]",0.429,0.475,0.577,0.134,0.142,0.125,0.732,0.633,0.538,0.659,0.74,0.631,0.599,0.898,0.75,0.693,0.734,0.718
https://doi.org/10.1016/s0140-6736(00)04956-4,natural history of cervical human papillomavirus infection in young women a longitudinal cohort study,15473_natural history of cervical human papillomavirus infection in young women a longitudinal cohort study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457841/pdf', 'https://stacks.cdc.gov/view/cdc/6776']","['5‐FU for genital warts in non‐immunocompromised individuals', 'Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions', 'Treating opportunistic infections among HIV-exposed and infected children; recommendations from the Ceters for Disease Control and Prevention, the National Institutes of Health, and the Infectious Diseases Society of America']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457841/pdf']","['15473_0_5‐fu for genital warts in non‐immunocompromised individuals.pdf', '15473_1_human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206224/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457841/pdf']","['15473_0_5‐fu for genital warts in non‐immunocompromised individuals.pdf', '15473_1_human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.pdf']","[0.189, 0.328]","[0.521, 0.544]","[0.611, 0.629]","[0.158, 0.183]","[0.156, 0.211]","[0.131, 0.161]","[0.733, 0.736]","[0.645, 0.649]","[0.592, 0.61]","[0.652, 0.677]","[0.787, 0.798]","[0.71, 0.726]","[0.584, 0.62]","[0.919, 0.921]","[0.812, 0.82]","[0.737, 0.751]","[0.786, 0.803]","[0.767, 0.775]",0.259,0.532,0.62,0.17,0.183,0.146,0.734,0.647,0.601,0.665,0.792,0.718,0.602,0.92,0.816,0.744,0.794,0.771
https://doi.org/10.1016/s0140-6736(02)11767-3,low dose mifepristone and two regimens of levonorgestrel for emergency contraception a who multicentre randomised trial,15538_low dose mifepristone and two regimens of levonorgestrel for emergency contraception a who multicentre randomised trial.pdf,8,"['https://stacks.cdc.gov/view/cdc/40745', 'https://stacks.cdc.gov/view/cdc/40515', 'https://stacks.cdc.gov/view/cdc/13723', 'https://crsreports.congress.gov/product/pdf/download/RL/RL33728/RL33728.pdf/', 'https://www.cdc.gov/mmwr/pdf/rr/rr62e0614.pdf', 'https://www.rand.org/pubs/occasional_papers/OP382.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055045/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483633/pdf']","['Sexual identity, sex of sexual contacts, and health-related behaviors among students in grades 9–12 — United States and selected sites, 2015', 'U.S. selected practice recommendations for contraceptive use, 2016', 'U.S. selected practice recommendations for contraceptive use, 2013; adapted from the World Health Organization Selected practice recommendations for contraceptive use, 2nd edition', 'Emergency Contraception: Plan B', 'U.S. Selected Practice Recommendations for Contraceptive Use, 2013 Adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use, 2nd Edition', 'Physical and Psychological Health Following Military Sexual Assault: Recommendations for Care, Research, and Policy', 'Interventions for emergency contraception', 'Interventions for emergency contraception']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055045/pdf', 'https://www.cdc.gov/mmwr/pdf/rr/rr62e0614.pdf']","['15538_7_interventions for emergency contraception.pdf', '15538_6_interventions for emergency contraception.pdf', '15538_4_us selected practice recommendations for contraceptive use 2013 adapted from the world health organization selected practice recommendations for contraceptive use 2nd edition.pdf']",3,37.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483633/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055045/pdf', 'https://www.cdc.gov/mmwr/pdf/rr/rr62e0614.pdf']","['15538_7_interventions for emergency contraception.pdf', '15538_6_interventions for emergency contraception.pdf', '15538_4_us selected practice recommendations for contraceptive use 2013 adapted from the world health organization selected practice recommendations for contraceptive use 2nd edition.pdf']","[0.395, 0.464, 0.467]","[0.51, 0.51, 0.608]","[0.599, 0.6, 0.673]","[0.204, 0.199, 0.233]","[0.208, 0.205, 0.26]","[0.177, 0.172, 0.217]","[0.737, 0.735, 0.746]","[0.649, 0.647, 0.654]","[0.565, 0.563, 0.677]","[0.67, 0.666, 0.669]","[0.772, 0.771, 0.832]","[0.676, 0.674, 0.779]","[0.596, 0.597, 0.656]","[0.902, 0.907, 0.935]","[0.788, 0.793, 0.847]","[0.729, 0.726, 0.812]","[0.766, 0.765, 0.838]","[0.742, 0.743, 0.822]",0.442,0.543,0.624,0.212,0.224,0.189,0.739,0.65,0.602,0.668,0.792,0.71,0.616,0.915,0.809,0.756,0.79,0.769
https://doi.org/10.1016/s0140-6736(05)17702-2,induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children a prospective study,15608_induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children a prospective study.pdf,8,"['https://stacks.cdc.gov/view/cdc/91164', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821196/pdf', 'https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_FJCSurvivalGuide.pdf', 'https://stacks.cdc.gov/view/cdc/5390', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590850/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169043/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf', 'https://watermark.silverchair.com/ciw376.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsAwggK8BgkqhkiG9w0BBwagggKtMIICqQIBADCCAqIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMlQ40Hl6dzoyQ1m5KAgEQgIICc42dM43NHD11RHffRDHTEZms53zXNyJNZ6_hqEeaNrLIR9TQSPfhRtjc3GZw7o2qY3gaQOhvGnkHSRAlawFts28HU6GtoLapKlZ6DmEvrQjf5QdHKXZ-dw4eAsg7aj8ITC0ferNM1HN0UbxV9lISk2jweQRy0x5UIpJ-sjKg8aomQVvKtLD4JAU6J3F3VO7PHfNA5nbsTDDXH9Uphd1j7zfDw02oRQeAoAiN2TMykkWrUtKwpvYdl04g6_5WEWPXoTnfSmaTNDTYvO_9VNxLQ4zbX70z3nDsl6UjEu0fk6hNooptBf8jlKTGzeUn8jvIxScwNN_gJG5nU5_G7bOR1EVV0g1DeZzPWQFX-hzdwxh0UAyF73urxyQoolxvvXJQ0-43mTPN1dzUtmnNvTi0KmEkDK9yr6jU2tf13cI6YG1Oy218YC4tyvlhqTG1ZGYsvKAJTE754XY2ffTuouE97WOU9YjulgMexAlBU15wDFGKPf4UrbeRLsNadm3n0NsoOoaJnXSP8Z5xdyb_ABr2v3adYyeGG1hac-waZETallYv62JYVYZEGHBUWLK21qs8JZ6u29953ko9s5RTEvmpi4vBWw3TxM4shmUS9KaEn0k9ahtzfclrnZvbU8hgqtZ04qiNZCGFxKTqydSVfi8hKX0T9Ggo_3rT9X96RO7uUQtCe_maaVrhLYPaTxegL2DDN-DfW5Nts86eyQnUfvaaIK9zXg-AIS1IHrXJXvJUFMoyoGPxy0lllRAXeplIQDfXA3S-9ZzFdd0gzIaAN3O23AZMIpAR1poKyNOMOO-roebJ3aLSZit3zD2GijGKBn9cCAQnJw']","['Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis', 'Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics', 'Drug-Resistant Tuberculosis', 'Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children; recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics', 'Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis', 'Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children - Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics', 'Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children', 'Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis']","['https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_FJCSurvivalGuide.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590850/pdf']","['15608_2_drugresistant tuberculosis.pdf', '15608_6_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf', '15608_4_official american thoracic societycenters for disease control and preventioninfectious diseases society of america clinical practice guidelines treatment of drugsusceptible tuberculosis.pdf']",3,37.5,"['https://www.tn.gov/content/dam/tn/health/documents/tuberculosis_guidelines/TB_FJCSurvivalGuide.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590850/pdf']","['15608_2_drugresistant tuberculosis.pdf', '15608_6_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf', '15608_4_official american thoracic societycenters for disease control and preventioninfectious diseases society of america clinical practice guidelines treatment of drugsusceptible tuberculosis.pdf']","[0.226, 0.356, 0.298]","[0.58, 0.545, 0.613]","[0.65, 0.627, 0.672]","[0.189, 0.182, 0.213]","[0.179, 0.179, 0.205]","[0.144, 0.143, 0.168]","[0.744, 0.741, 0.753]","[0.644, 0.642, 0.656]","[0.672, 0.606, 0.689]","[0.612, 0.644, 0.629]","[0.822, 0.789, 0.832]","[0.768, 0.722, 0.789]","[0.628, 0.618, 0.652]","[0.928, 0.914, 0.933]","[0.837, 0.814, 0.84]","[0.797, 0.74, 0.813]","[0.834, 0.796, 0.842]","[0.811, 0.762, 0.827]",0.293,0.579,0.65,0.195,0.188,0.152,0.746,0.647,0.656,0.628,0.814,0.76,0.633,0.925,0.83,0.783,0.824,0.8
https://doi.org/10.1016/s0140-6736(06)69569-x,improvement of child survival in mexico the diagonal approach,15676_improvement of child survival in mexico the diagonal approach.pdf,5,"['https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/cid-working-paper-no.-193', 'http://www.floridahealth.gov/diseases-and-conditions/diseases-from-animals/one-health-newsletter/_documents/spring2011-text.pdf', 'https://papers.nber.org/papers/w13498', 'http://www.floridahealth.gov/diseases-and-conditions/diseases-from-animals/one-health-newsletter/_documents/summer2011.pdf', 'https://www.nber.org/papers/w23239']","['The Global Health System: Institutions in a Time of Transition', 'Health Newsletter', 'Heterogeneous Impact of the ""Seguro Popular"" Program on the Utilization of Obstetrical Services in Mexico, 2001-2006: A Multinomial Probit Model with a Discrete Endogenous Variable', 'Health Newsletter', 'Urban Water Disinfection and Mortality Decline in Developing Countries']","['http://www.floridahealth.gov/diseases-and-conditions/diseases-from-animals/one-health-newsletter/_documents/summer2011.pdf', 'http://www.floridahealth.gov/diseases-and-conditions/diseases-from-animals/one-health-newsletter/_documents/spring2011-text.pdf']","['15676_3_health newsletter.pdf', '15676_1_health newsletter.pdf']",2,40.0,"['http://www.floridahealth.gov/diseases-and-conditions/diseases-from-animals/one-health-newsletter/_documents/summer2011.pdf', 'http://www.floridahealth.gov/diseases-and-conditions/diseases-from-animals/one-health-newsletter/_documents/spring2011-text.pdf']","['15676_3_health newsletter.pdf', '15676_1_health newsletter.pdf']","[0.302, 0.302]","[0.579, 0.579]","[0.665, 0.665]","[0.148, 0.148]","[0.16, 0.16]","[0.123, 0.124]","[0.721, 0.721]","[0.62, 0.619]","[0.668, 0.668]","[0.644, 0.645]","[0.832, 0.832]","[0.787, 0.787]","[0.659, 0.658]","[0.928, 0.927]","[0.859, 0.86]","[0.8, 0.8]","[0.841, 0.841]","[0.816, 0.816]",0.302,0.579,0.665,0.148,0.16,0.123,0.721,0.619,0.668,0.645,0.832,0.787,0.659,0.927,0.859,0.8,0.841,0.816
https://doi.org/10.1016/s0140-6736(07)60277-3,maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood alspac study an observational cohort study,15689_maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood alspac study an observational cohort study.pdf,9,"['http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2007_04.pdf', 'http://epibulletins.dhss.alaska.gov/Document/Display?DocumentId=185', 'http://epibulletins.dhss.alaska.gov/Document/Display?DocumentId=262', 'https://www.bakerinstitute.org/research/development-evidence-based-early-childhood-development-strategy/', 'https://www.federalregister.gov/documents/2012/02/16/2012-806/national-emission-standards-for-hazardous-air-pollutants-from-coal--and-oil-fired-electric-utility', 'http://epibulletins.dhss.alaska.gov/Document/Display?DocumentId=290', 'https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'http://dhss.alaska.gov/dph/Epi/eph/Documents/fish/FishConsumptionAdvice2014.pdf']","['Division of Public Health', 'Alaska Hair Mercury Biomonitoring Program Update, July 2002–May 2010', 'Fish Consumption Advice for Alaskans:', 'Development of an Evidence-based Early Childhood Development Strategy', 'National Emission Standards for Hazardous Air Pollutants From Coal- and Oil-Fired Electric Utility Steam Generating Units and Standards of Performance for Fossil-Fuel-Fired Electric Utility, Industrial-Commercial-Institutional, and Small Industrial-Commercial-Institutional Steam Generating Units', 'Alaska Mercury Biomonitoring Program Update, July 2002 – December 2006', 'DEVELOPMENT OF FISH CONTAMINANT GOALS AND ADVISORY TISSUE LEVELS (ATLs) FOR COMMON CONTAMINANTS IN CALIFORNIA SPORT FISH :', 'Omega‐3 fatty acid addition during pregnancy', 'Fish Consumption Advice for Alaskans: A Risk Management Strategy To Optimize the Public’s Health']","['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2007_04.pdf', 'http://dhss.alaska.gov/dph/Epi/eph/Documents/fish/FishConsumptionAdvice2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf']","['15689_6_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '15689_0_division of public health.pdf', '15689_8_fish consumption advice for alaskans a risk management strategy to optimize the publics health.pdf', '15689_7_omega‐3 fatty acid addition during pregnancy.pdf']",4,44.44,"['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2007_04.pdf', 'http://dhss.alaska.gov/dph/Epi/eph/Documents/fish/FishConsumptionAdvice2014.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf']","['15689_6_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '15689_0_division of public health.pdf', '15689_8_fish consumption advice for alaskans a risk management strategy to optimize the publics health.pdf', '15689_7_omega‐3 fatty acid addition during pregnancy.pdf']","[0.281, 0.254, 0.298, 0.285]","[0.491, 0.531, 0.539, 0.491]","[0.597, 0.626, 0.63, 0.589]","[0.13, 0.151, 0.158, 0.158]","[0.131, 0.157, 0.157, 0.147]","[0.108, 0.126, 0.128, 0.129]","[0.726, 0.727, 0.727, 0.729]","[0.632, 0.631, 0.632, 0.633]","[0.561, 0.613, 0.615, 0.566]","[0.667, 0.652, 0.662, 0.682]","[0.785, 0.812, 0.812, 0.776]","[0.687, 0.74, 0.735, 0.663]","[0.606, 0.624, 0.628, 0.574]","[0.914, 0.925, 0.923, 0.913]","[0.803, 0.826, 0.828, 0.798]","[0.731, 0.761, 0.766, 0.717]","[0.777, 0.813, 0.811, 0.769]","[0.766, 0.793, 0.794, 0.753]",0.279,0.513,0.61,0.149,0.148,0.123,0.727,0.632,0.589,0.666,0.796,0.706,0.608,0.919,0.814,0.744,0.792,0.777
https://doi.org/10.1016/s0140-6736(07)60367-5,global perspectives on the sexual and reproductive health of adolescents patterns prevention and potential,15693_global perspectives on the sexual and reproductive health of adolescents patterns prevention and potential.pdf,6,"['https://www.icrw.org/publications/understanding-the-adolescent-family-planning-evidence-base-review-of-literature/', 'https://www.fhi360.org/resource/assessment-integrated-workforce-development-and-sexual-and-reproductive-health', 'https://purl.fdlp.gov/GPO/gpo115993', 'https://www.icrw.org/publications/womens-demand-for-reproductive-control/', 'https://mathematica.org/publications/integrating-positive-youth-development-into-prep-programming', 'https://www.acf.hhs.gov/opre/report/integrating-positive-youth-development-prep-programming']","['Understanding the adolescent family planning evidence base', 'Assessment of Integrated Workforce Development and Sexual and Reproductive Health Interventions with Recommendations for the Future', 'Trends in adolescent reproductive and sexual behaviors /', ""Women's demand for reproductive control"", 'Integrating Positive Youth Development into PREP Programming', 'Integrating Positive Youth Development into PREP Programming']",['https://purl.fdlp.gov/GPO/gpo115993'],['15693_2_trends in adolescent reproductive and sexual behaviors .pdf'],1,16.67,['https://purl.fdlp.gov/GPO/gpo115993'],['15693_2_trends in adolescent reproductive and sexual behaviors .pdf'],[0.174],[0.482],[0.6],[0.163],[0.195],[0.158],[0.731],[0.635],[0.538],[0.667],[0.773],[0.652],[0.612],[0.922],[0.823],[0.722],[0.777],[0.761],0.174,0.482,0.6,0.163,0.195,0.158,0.731,0.635,0.538,0.667,0.773,0.652,0.612,0.922,0.823,0.722,0.777,0.761
https://doi.org/10.1016/s0140-6736(07)60710-7,developmental dysplasia of the hip,15704_developmental dysplasia of the hip.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464894/pdf'],['Screening programmes for developmental dysplasia of the hip in newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464894/pdf'],['15704_0_screening programmes for developmental dysplasia of the hip in newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464894/pdf'],['15704_0_screening programmes for developmental dysplasia of the hip in newborn infants.pdf'],[0.596],[0.541],[0.62],[0.2],[0.21],[0.171],[0.747],[0.651],[0.591],[0.671],[0.789],[0.728],[0.598],[0.909],[0.8],[0.74],[0.792],[0.766],0.596,0.541,0.62,0.2,0.21,0.171,0.747,0.651,0.591,0.671,0.789,0.728,0.598,0.909,0.8,0.74,0.792,0.766
https://doi.org/10.1016/s0140-6736(07)61239-2,resources for mental health scarcity inequity and inefficiency,15710_resources for mental health scarcity inequity and inefficiency.pdf,4,"['https://www.cgdev.org/publication/missed-opportunities-global-health-identifying-new-strategies-improve-mental-health', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797510/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217030/pdf']","['Missed Opportunities in Global Health: Identifying New Strategies to Improve Mental Health in LMICs', 'Challenges for the implementation of World Health Organization guidelines for acute stress, PTSD, and bereavement: a qualitative study in Uganda', 'Non-specialist health worker interventions for mental health care in low- and middle- income countries', 'Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217030/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797510/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf']","['15710_3_evidencebased guidelines for mental neurological and substance use disorders in low and middleincome countries summary of who recommendations.pdf', '15710_2_nonspecialist health worker interventions for mental health care in low and middle income countries.pdf', '15710_1_challenges for the implementation of world health organization guidelines for acute stress ptsd and bereavement a qualitative study in uganda.pdf']",3,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217030/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797510/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793547/pdf']","['15710_3_evidencebased guidelines for mental neurological and substance use disorders in low and middleincome countries summary of who recommendations.pdf', '15710_2_nonspecialist health worker interventions for mental health care in low and middle income countries.pdf', '15710_1_challenges for the implementation of world health organization guidelines for acute stress ptsd and bereavement a qualitative study in uganda.pdf']","[0.54, 0.574, 0.526]","[0.554, 0.507, 0.552]","[0.645, 0.611, 0.65]","[0.187, 0.151, 0.197]","[0.197, 0.167, 0.224]","[0.165, 0.145, 0.182]","[0.736, 0.731, 0.736]","[0.646, 0.635, 0.647]","[0.627, 0.569, 0.621]","[0.667, 0.705, 0.694]","[0.825, 0.78, 0.825]","[0.751, 0.696, 0.746]","[0.627, 0.588, 0.628]","[0.931, 0.909, 0.926]","[0.842, 0.818, 0.86]","[0.788, 0.734, 0.781]","[0.826, 0.782, 0.829]","[0.806, 0.764, 0.807]",0.547,0.538,0.635,0.178,0.196,0.164,0.734,0.643,0.606,0.689,0.81,0.731,0.614,0.922,0.84,0.768,0.812,0.792
https://doi.org/10.1016/s0140-6736(11)60130-x,allergic rhinitis,15820_allergic rhinitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317851/pdf'],"[""EAACI Allergen Immunotherapy User's Guide""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317851/pdf'],['15820_0_eaaci allergen immunotherapy users guide.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317851/pdf'],['15820_0_eaaci allergen immunotherapy users guide.pdf'],[0.612],[0.583],[0.653],[0.234],[0.259],[0.216],[0.761],[0.662],[0.646],[0.682],[0.824],[0.746],[0.64],[0.93],[0.839],[0.788],[0.828],[0.812],0.612,0.583,0.653,0.234,0.259,0.216,0.761,0.662,0.646,0.682,0.824,0.746,0.64,0.93,0.839,0.788,0.828,0.812
https://doi.org/10.1016/s0140-6736(11)60871-4,depression in adolescence,15832_depression in adolescence.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research', 'https://www.rand.org/pubs/research_reports/RR4431.html']","['New generation antidepressants for depression in children and adolescents: a network meta‐analysis', 'Treatment of Depression in Children and Adolescents', ""An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf'],['15832_0_new generation antidepressants for depression in children and adolescents a network meta‐analysis.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf'],['15832_0_new generation antidepressants for depression in children and adolescents a network meta‐analysis.pdf'],[0.477],[0.509],[0.601],[0.171],[0.179],[0.15],[0.737],[0.644],[0.581],[0.696],[0.784],[0.705],[0.582],[0.91],[0.815],[0.722],[0.781],[0.753],0.477,0.509,0.601,0.171,0.179,0.15,0.737,0.644,0.581,0.696,0.784,0.705,0.582,0.91,0.815,0.722,0.781,0.753
https://doi.org/10.1016/s0140-6736(14)60460-8,global regional and national prevalence of overweight and obesity in children and adults during 1980–2013 a systematic analysis for the global burden of disease study 2013,15922_global regional and national prevalence of overweight and obesity in children and adults during 1980–2013 a systematic analysis for the global burden of disease study 2013.pdf,4,"['https://www.wri.org/publication/shifting-diets', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133549', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133547', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410507/pdf']","['Shifting Diets for a Sustainable Food Future', 'Food systems for healthier diets in Bangladesh: Towards a research agenda', 'The effects of income fluctuations on rural health and nutrition', 'Gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410507/pdf'],['15922_3_gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410507/pdf'],['15922_3_gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines.pdf'],[0.176],[0.516],[0.622],[0.15],[0.158],[0.125],[0.729],[0.634],[0.599],[0.694],[0.793],[0.722],[0.609],[0.92],[0.821],[0.752],[0.791],[0.776],0.176,0.516,0.622,0.15,0.158,0.125,0.729,0.634,0.599,0.694,0.793,0.722,0.609,0.92,0.821,0.752,0.791,0.776
https://doi.org/10.1016/s0140-6736(15)00070-7,preeclampsia,15957_preeclampsia.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017474/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866036/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483745/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745517/pdf']","['An evaluation of the influence of the publication of the UK National Institute for health and Care Excellence’s guidance on hypertension in pregnancy: a retrospective analysis of clinical practice', 'Omega‐3 fatty acid addition during pregnancy', 'Should women be advised to use calcium supplements during pregnancy? A decision analysis', 'Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy', 'Antiplatelet agents for preventing pre‐eclampsia and its complications', 'Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483745/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745517/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866036/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017474/pdf']","['15957_3_calcium supplementation commencing before or early in pregnancy or food fortification with calcium for preventing hypertensive disorders of pregnancy.pdf', '15957_5_calcium supplementation commencing before or early in pregnancy for preventing hypertensive disorders of pregnancy.pdf', '15957_2_should women be advised to use calcium supplements during pregnancy a decision analysis.pdf', '15957_1_omega‐3 fatty acid addition during pregnancy.pdf', '15957_4_antiplatelet agents for preventing pre‐eclampsia and its complications.pdf', '15957_0_an evaluation of the influence of the publication of the uk national institute for health and care excellences guida.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483745/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745517/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866036/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516961/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820858/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017474/pdf']","['15957_3_calcium supplementation commencing before or early in pregnancy or food fortification with calcium for preventing hypertensive disorders of pregnancy.pdf', '15957_5_calcium supplementation commencing before or early in pregnancy for preventing hypertensive disorders of pregnancy.pdf', '15957_2_should women be advised to use calcium supplements during pregnancy a decision analysis.pdf', '15957_1_omega‐3 fatty acid addition during pregnancy.pdf', '15957_4_antiplatelet agents for preventing pre‐eclampsia and its complications.pdf', '15957_0_an evaluation of the influence of the publication of the uk national institute for health and care excellences guida.pdf']","[0.443, 0.256, 0.479, 0.507, 0.468, 0.524]","[0.545, 0.519, 0.54, 0.485, 0.487, 0.56]","[0.632, 0.612, 0.64, 0.584, 0.588, 0.647]","[0.193, 0.181, 0.169, 0.14, 0.155, 0.196]","[0.199, 0.185, 0.18, 0.137, 0.156, 0.213]","[0.162, 0.151, 0.149, 0.115, 0.127, 0.169]","[0.742, 0.741, 0.738, 0.734, 0.734, 0.743]","[0.65, 0.648, 0.648, 0.638, 0.642, 0.653]","[0.613, 0.58, 0.608, 0.56, 0.559, 0.63]","[0.667, 0.666, 0.651, 0.653, 0.662, 0.666]","[0.8, 0.779, 0.806, 0.776, 0.784, 0.81]","[0.732, 0.691, 0.731, 0.656, 0.66, 0.744]","[0.604, 0.594, 0.629, 0.576, 0.588, 0.62]","[0.916, 0.902, 0.928, 0.914, 0.913, 0.924]","[0.814, 0.804, 0.821, 0.791, 0.799, 0.828]","[0.753, 0.726, 0.772, 0.716, 0.71, 0.777]","[0.794, 0.771, 0.801, 0.764, 0.771, 0.811]","[0.775, 0.751, 0.792, 0.75, 0.756, 0.798]",0.446,0.523,0.617,0.172,0.178,0.145,0.739,0.646,0.592,0.661,0.793,0.702,0.602,0.916,0.809,0.742,0.785,0.77
https://doi.org/10.1016/s0140-6736(15)00149-x,atopic dermatitis,15961_atopic dermatitis.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360926/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552896/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128359/pdf']","['Strategies for using topical corticosteroids in children and adults with eczema', 'Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy', 'Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema', 'Phototherapy for atopic eczema', 'Emollients and moisturisers for eczema', 'Systemic treatments for eczema: a network meta‐analysis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128359/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552896/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360926/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['15961_6_systemic treatments for eczema a network meta‐analysis.pdf', '15961_4_phototherapy for atopic eczema.pdf', '15961_3_oral h1 antihistamines as add‐on therapy to topical treatment for eczema.pdf', '15961_2_skin care interventions in infants for preventing eczema and food allergy.pdf', '15961_5_emollients and moisturisers for eczema.pdf', '15961_0_strategies for using topical corticosteroids in children and adults with eczema.pdf', '15961_1_skin care interventions in infants for preventing eczema and food allergy.pdf']",7,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128359/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552896/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360926/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916090/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['15961_6_systemic treatments for eczema a network meta‐analysis.pdf', '15961_4_phototherapy for atopic eczema.pdf', '15961_3_oral h1 antihistamines as add‐on therapy to topical treatment for eczema.pdf', '15961_2_skin care interventions in infants for preventing eczema and food allergy.pdf', '15961_5_emollients and moisturisers for eczema.pdf', '15961_0_strategies for using topical corticosteroids in children and adults with eczema.pdf', '15961_1_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.305, 0.367, 0.365, 0.303, 0.332, 0.318, 0.364]","[0.529, 0.525, 0.525, 0.527, 0.5, 0.513, 0.524]","[0.622, 0.612, 0.612, 0.617, 0.596, 0.606, 0.614]","[0.148, 0.139, 0.146, 0.149, 0.136, 0.139, 0.145]","[0.169, 0.154, 0.163, 0.169, 0.15, 0.159, 0.166]","[0.133, 0.121, 0.125, 0.136, 0.118, 0.122, 0.132]","[0.741, 0.737, 0.737, 0.741, 0.736, 0.738, 0.741]","[0.646, 0.639, 0.642, 0.645, 0.638, 0.642, 0.645]","[0.605, 0.604, 0.602, 0.603, 0.579, 0.59, 0.598]","[0.664, 0.662, 0.664, 0.661, 0.66, 0.665, 0.663]","[0.793, 0.796, 0.79, 0.795, 0.78, 0.788, 0.793]","[0.719, 0.729, 0.718, 0.718, 0.705, 0.716, 0.719]","[0.592, 0.6, 0.587, 0.593, 0.587, 0.588, 0.589]","[0.925, 0.922, 0.922, 0.92, 0.914, 0.921, 0.921]","[0.826, 0.826, 0.82, 0.82, 0.803, 0.811, 0.817]","[0.731, 0.74, 0.734, 0.738, 0.712, 0.728, 0.736]","[0.791, 0.795, 0.788, 0.793, 0.779, 0.786, 0.792]","[0.77, 0.773, 0.766, 0.772, 0.748, 0.761, 0.769]",0.336,0.52,0.611,0.143,0.161,0.127,0.739,0.642,0.597,0.663,0.791,0.718,0.591,0.921,0.818,0.731,0.789,0.766
https://doi.org/10.1016/s0140-6736(16)30956-4,effectiveness of early lens extraction for the treatment of primary angleclosure glaucoma eagle a randomised controlled trial,15999_effectiveness of early lens extraction for the treatment of primary angleclosure glaucoma eagle a randomised controlled trial.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094223/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026549/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328531/pdf']","['Lens extraction for chronic angle‐closure glaucoma', 'Non‐contact tests for identifying people at risk of primary angle closure glaucoma', 'Iridotomy to slow progression of visual field loss in angle‐closure glaucoma', 'Acute primary angle closure–treatment strategies, evidences and economical considerations']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026549/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094223/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328531/pdf']","['15999_1_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf', '15999_2_iridotomy to slow progression of visual field loss in angle‐closure glaucoma.pdf', '15999_0_lens extraction for chronic angle‐closure glaucoma.pdf', '15999_3_acute primary angle closure–treatment strategies evidences and economical considerations.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026549/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094223/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328531/pdf']","['15999_1_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf', '15999_2_iridotomy to slow progression of visual field loss in angle‐closure glaucoma.pdf', '15999_0_lens extraction for chronic angle‐closure glaucoma.pdf', '15999_3_acute primary angle closure–treatment strategies evidences and economical considerations.pdf']","[0.569, 0.305, 0.491, 0.493]","[0.549, 0.551, 0.516, 0.548]","[0.63, 0.635, 0.606, 0.627]","[0.183, 0.198, 0.181, 0.189]","[0.191, 0.209, 0.193, 0.205]","[0.157, 0.166, 0.157, 0.169]","[0.738, 0.742, 0.741, 0.743]","[0.643, 0.65, 0.649, 0.651]","[0.62, 0.622, 0.582, 0.619]","[0.692, 0.687, 0.689, 0.671]","[0.796, 0.804, 0.781, 0.806]","[0.732, 0.733, 0.707, 0.737]","[0.625, 0.618, 0.609, 0.638]","[0.928, 0.929, 0.908, 0.928]","[0.819, 0.816, 0.782, 0.806]","[0.751, 0.759, 0.719, 0.769]","[0.801, 0.802, 0.779, 0.807]","[0.779, 0.785, 0.745, 0.789]",0.464,0.541,0.625,0.188,0.199,0.162,0.741,0.648,0.611,0.685,0.797,0.727,0.622,0.923,0.806,0.75,0.797,0.775
https://doi.org/10.1016/s0140-6736(16)32585-5,evidence for overuse of medical services around the world,16016_evidence for overuse of medical services around the world.pdf,6,"['https://www.cgdev.org/publication/whats-in-whats-out-designing-benefits-universal-health-coverage', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180663/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568024/pdf', 'https://www.thirdway.org/report/the-case-against-fee-for-service-health-care', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275495/pdf']","[""What's In, What's Out: Designing Benefits for Universal Health Coverage"", 'Quality appraisal of clinical guidelines for surgical site infection prevention: A systematic review', 'Protection against the overuse and underuse of health care – methodological considerations for establishing prioritization criteria and recommendations in general practice', 'Arthroscopic meniscal surgery - a national society treatment guideline and consensus statement', 'The Case Against Fee-for-Service Health Care – Third Way', 'A survey to assess awareness and opinion of initiatives and recommendations on low-value diagnostic practices']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568024/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180663/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275495/pdf']","['16016_3_arthroscopic meniscal surgery  a national society treatment guideline and consensus statement.pdf', '16016_2_protection against the overuse and underuse of health care – methodological considerations for establishing prioritization criteria and recommendations in general practice.pdf', '16016_1_quality appraisal of clinical guidelines for surgical site infection prevention a systematic review.pdf', '16016_5_a survey to assess awareness and opinion of initiatives and recommendations on lowvalue diagnostic practices.pdf']",4,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568024/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180663/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275495/pdf']","['16016_3_arthroscopic meniscal surgery  a national society treatment guideline and consensus statement.pdf', '16016_2_protection against the overuse and underuse of health care – methodological considerations for establishing prioritization criteria and recommendations in general practice.pdf', '16016_1_quality appraisal of clinical guidelines for surgical site infection prevention a systematic review.pdf', '16016_5_a survey to assess awareness and opinion of initiatives and recommendations on lowvalue diagnostic practices.pdf']","[0.274, 0.507, 0.26, 0.287]","[0.547, 0.54, 0.522, 0.49]","[0.635, 0.63, 0.608, 0.593]","[0.148, 0.165, 0.142, 0.149]","[0.15, 0.191, 0.154, 0.172]","[0.11, 0.141, 0.12, 0.126]","[0.735, 0.73, 0.731, 0.733]","[0.64, 0.639, 0.639, 0.638]","[0.614, 0.613, 0.59, 0.557]","[0.64, 0.692, 0.682, 0.688]","[0.805, 0.805, 0.792, 0.777]","[0.748, 0.75, 0.716, 0.67]","[0.615, 0.618, 0.602, 0.592]","[0.924, 0.926, 0.91, 0.917]","[0.835, 0.848, 0.83, 0.806]","[0.767, 0.768, 0.728, 0.728]","[0.809, 0.811, 0.798, 0.771]","[0.79, 0.791, 0.775, 0.761]",0.332,0.525,0.617,0.151,0.167,0.124,0.732,0.639,0.593,0.675,0.795,0.721,0.607,0.919,0.83,0.748,0.797,0.779
https://doi.org/10.1016/s0140-6736(18)31782-3,effects of the learning together intervention on bullying and aggression in english secondary schools inclusive a cluster randomised controlled trial,16039_effects of the learning together intervention on bullying and aggression in english secondary schools inclusive a cluster randomised controlled trial.pdf,2,"['https://nepc.colorado.edu/publication/restorative-justice', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/023600/023694/20190078e.pdf']","['The Starts and Stumbles of Restorative Justice in Education: Where Do We Go from Here?', 'Maryland Commission on the School-to-Prison Pipeline and Restorative Practices']",['https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/023600/023694/20190078e.pdf'],['16039_1_maryland commission on the schooltoprison pipeline and restorative practices.pdf'],1,50.0,['https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/023600/023694/20190078e.pdf'],['16039_1_maryland commission on the schooltoprison pipeline and restorative practices.pdf'],[0.596],[0.573],[0.648],[0.201],[0.221],[0.186],[0.734],[0.64],[0.656],[0.692],[0.824],[0.776],[0.643],[0.939],[0.858],[0.789],[0.832],[0.808],0.596,0.573,0.648,0.201,0.221,0.186,0.734,0.64,0.656,0.692,0.824,0.776,0.643,0.939,0.858,0.789,0.832,0.808
https://doi.org/10.1016/s0140-6736(18)32607-2,laser peripheral iridotomy for the prevention of angle closure a singlecentre randomised controlled trial,16042_laser peripheral iridotomy for the prevention of angle closure a singlecentre randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['Non‐contact tests for identifying people at risk of primary angle closure glaucoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['16042_0_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['16042_0_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf'],[0.355],[0.548],[0.636],[0.189],[0.194],[0.158],[0.738],[0.644],[0.621],[0.674],[0.8],[0.737],[0.63],[0.928],[0.823],[0.756],[0.806],[0.783],0.355,0.548,0.636,0.189,0.194,0.158,0.738,0.644,0.621,0.674,0.8,0.737,0.63,0.928,0.823,0.756,0.806,0.783
https://doi.org/10.1016/s0140-6736(19)30721-4,causes of severe pneumonia requiring hospital admission in children without hiv infection from africa and asia the perch multicountry casecontrol study,16047_causes of severe pneumonia requiring hospital admission in children without hiv infection from africa and asia the perch multicountry casecontrol study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222990/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237391/pdf']","['Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study', 'Screening tests for active pulmonary tuberculosis in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237391/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222990/pdf']","['16047_1_screening tests for active pulmonary tuberculosis in children.pdf', '16047_0_bacterial etiology of communityacquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations an international pointprevalence study.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237391/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222990/pdf']","['16047_1_screening tests for active pulmonary tuberculosis in children.pdf', '16047_0_bacterial etiology of communityacquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations an international pointprevalence study.pdf']","[0.257, 0.271]","[0.581, 0.528]","[0.653, 0.618]","[0.21, 0.223]","[0.191, 0.229]","[0.161, 0.193]","[0.741, 0.746]","[0.649, 0.66]","[0.646, 0.6]","[0.685, 0.686]","[0.809, 0.792]","[0.757, 0.722]","[0.629, 0.619]","[0.925, 0.91]","[0.848, 0.81]","[0.779, 0.755]","[0.817, 0.788]","[0.799, 0.775]",0.264,0.554,0.635,0.216,0.21,0.177,0.744,0.655,0.623,0.685,0.8,0.74,0.624,0.917,0.829,0.767,0.802,0.787
https://doi.org/10.1016/s0140-6736(19)31146-8,oral diseases a global public health challenge,16048_oral diseases a global public health challenge.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106870/pdf'],['Interventions for improving oral health in people after stroke'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106870/pdf'],['16048_0_interventions for improving oral health in people after stroke.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106870/pdf'],['16048_0_interventions for improving oral health in people after stroke.pdf'],[0.408],[0.514],[0.609],[0.162],[0.167],[0.14],[0.734],[0.641],[0.579],[0.69],[0.78],[0.7],[0.585],[0.916],[0.817],[0.724],[0.78],[0.76],0.408,0.514,0.609,0.162,0.167,0.14,0.734,0.641,0.579,0.69,0.78,0.7,0.585,0.916,0.817,0.724,0.78,0.76
https://doi.org/10.1016/s0140-6736(19)32472-9,the double burden of malnutrition aetiological pathways and consequences for health,16049_the double burden of malnutrition aetiological pathways and consequences for health.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508786/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133654', 'http://ebrary.ifpri.org/cdm/singleitem/collection/p15738coll2/id/133654/rec/5']","['Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes', 'Household food consumption patterns in Addis Ababa, Ethiopia', 'Household food consumption patterns in Addis Ababa, Ethiopia']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508786/pdf'],['16049_0_taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508786/pdf'],['16049_0_taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes.pdf'],[0.264],[0.515],[0.62],[0.146],[0.154],[0.121],[0.722],[0.622],[0.594],[0.688],[0.785],[0.711],[0.607],[0.926],[0.826],[0.744],[0.791],[0.771],0.264,0.515,0.62,0.146,0.154,0.121,0.722,0.622,0.594,0.688,0.785,0.711,0.607,0.926,0.826,0.744,0.791,0.771
https://doi.org/10.1016/s0140-6736(20)30528-6,investigation of three clusters of covid19 in singapore implications for surveillance and response measures,16053_investigation of three clusters of covid19 in singapore implications for surveillance and response measures.pdf,4,"['https://www.chicago.gov/content/dam/city/depts/cdph/HealthProtectionandResponse/MMWR_Ghinai.pdf', 'https://www.ida.org/research-and-publications/publications/all/i/im/implementing-covid-19-outbreak-control-measures-disease-specific-requirements', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094389/pdf', 'https://www.chicagofed.org/publications/working-papers/2020/2020-31']","['Morbidity and Mortality Weekly Report', 'Implementing COVID-19 Outbreak Control Measures: Disease-Specific Requirements', 'Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19', 'Pandemic Recessions and Contact Tracing']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094389/pdf', 'https://www.chicago.gov/content/dam/city/depts/cdph/HealthProtectionandResponse/MMWR_Ghinai.pdf']","['16053_2_chloroquine or hydroxychloroquine for prevention and treatment of covid‐19.pdf', '16053_0_morbidity and mortality weekly report.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094389/pdf', 'https://www.chicago.gov/content/dam/city/depts/cdph/HealthProtectionandResponse/MMWR_Ghinai.pdf']","['16053_2_chloroquine or hydroxychloroquine for prevention and treatment of covid‐19.pdf', '16053_0_morbidity and mortality weekly report.pdf']","[0.397, 0.269]","[0.534, 0.569]","[0.617, 0.647]","[0.165, 0.213]","[0.158, 0.225]","[0.128, 0.178]","[0.729, 0.744]","[0.634, 0.655]","[0.594, 0.633]","[0.651, 0.668]","[0.793, 0.819]","[0.724, 0.752]","[0.601, 0.654]","[0.914, 0.911]","[0.827, 0.855]","[0.745, 0.783]","[0.795, 0.824]","[0.771, 0.807]",0.333,0.551,0.632,0.189,0.192,0.153,0.736,0.645,0.613,0.659,0.806,0.738,0.627,0.913,0.841,0.764,0.809,0.789
https://doi.org/10.1016/s0140-6736(20)30547-x,mitigate the effects of home confinement on children during the covid19 outbreak,16054_mitigate the effects of home confinement on children during the covid19 outbreak.pdf,2,"['https://datapopalliance.org/publications/mental-health-and-gender-inequality-in-the-mena-region-an-analysis-of-shock-related-factors-within-the-context-of-the-covid-19-pandemic/', 'https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf']","['Mental Health and Gender Inequality in the MENA Region: An Analysis of Shock Related Factors within the Context of the COVID-19 Pandemic', 'California State Evaluation and Learning Support (Cal SEALS) for SB 82 Triage Grants']",['https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf'],['16054_1_california state evaluation and learning support cal seals for sb 82 triage grants.pdf'],1,50.0,['https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf'],['16054_1_california state evaluation and learning support cal seals for sb 82 triage grants.pdf'],[0.167],[0.556],[0.649],[0.144],[0.162],[0.132],[0.721],[0.624],[0.631],[0.665],[0.812],[0.747],[0.642],[0.915],[0.859],[0.783],[0.821],[0.802],0.167,0.556,0.649,0.144,0.162,0.132,0.721,0.624,0.631,0.665,0.812,0.747,0.642,0.915,0.859,0.783,0.821,0.802
https://doi.org/10.1016/s0140-6736(20)30551-1,are highperforming health systems resilient against the covid19 epidemic,16055_are highperforming health systems resilient against the covid19 epidemic.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789202/pdf', 'https://www.congress.gov/event/116th-congress/house-event/110776', 'https://www.nber.org/papers/w27401']","['Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance', 'No Worker Left Behind: Supporting Essential Workers', 'The Political Scar of Epidemics']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789202/pdf'],['16055_0_recommendations for sarscov2covid19 testing a scoping review of current guidance.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789202/pdf'],['16055_0_recommendations for sarscov2covid19 testing a scoping review of current guidance.pdf'],[0.253],[0.54],[0.63],[0.168],[0.19],[0.145],[0.726],[0.639],[0.618],[0.673],[0.811],[0.745],[0.628],[0.923],[0.848],[0.768],[0.822],[0.798],0.253,0.54,0.63,0.168,0.19,0.145,0.726,0.639,0.618,0.673,0.811,0.745,0.628,0.923,0.848,0.768,0.822,0.798
https://doi.org/10.1016/s0140-6736(20)31129-6,kawasakilike disease emerging complication during the covid19 pandemic,16058_kawasakilike disease emerging complication during the covid19 pandemic.pdf,4,"['https://www.heritage.org/public-health/report/policymakers-should-adapt-covid-19-responses-the-evidence', 'https://aspe.hhs.gov/reports/valuing-covid-19-risk-reductions-hhs-rias', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467754/pdf']","['Policymakers Should Adapt COVID-19 Responses to the Evidence', 'Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses', 'Clinical care of children and adolescents with COVID‐19: recommendations from the National COVID‐19 Clinical Evidence Taskforce', 'Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467754/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['16058_3_society for cardiovascular magnetic resonance scmr recommended cmr protocols for scanning patients with active or convalescent phase covid19 infection.pdf', '16058_2_clinical care of children and adolescents with covid‐19 recommendations from the national covid‐19 clinical evidence taskforce.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467754/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['16058_3_society for cardiovascular magnetic resonance scmr recommended cmr protocols for scanning patients with active or convalescent phase covid19 infection.pdf', '16058_2_clinical care of children and adolescents with covid‐19 recommendations from the national covid‐19 clinical evidence taskforce.pdf']","[0.476, 0.241]","[0.57, 0.572]","[0.652, 0.653]","[0.189, 0.207]","[0.196, 0.212]","[0.142, 0.165]","[0.744, 0.746]","[0.658, 0.659]","[0.636, 0.636]","[0.637, 0.663]","[0.808, 0.815]","[0.76, 0.761]","[0.588, 0.625]","[0.921, 0.923]","[0.841, 0.847]","[0.773, 0.777]","[0.813, 0.817]","[0.796, 0.8]",0.358,0.571,0.653,0.198,0.204,0.153,0.745,0.659,0.636,0.65,0.811,0.76,0.607,0.922,0.844,0.775,0.815,0.798
https://doi.org/10.1016/s0140-6736(20)31544-0,bipolar disorders,16060_bipolar disorders.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499740/pdf'],['Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499740/pdf'],['16060_0_ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499740/pdf'],['16060_0_ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.pdf'],[0.467],[0.501],[0.601],[0.164],[0.174],[0.14],[0.738],[0.647],[0.571],[0.695],[0.782],[0.693],[0.577],[0.909],[0.799],[0.716],[0.773],[0.75],0.467,0.501,0.601,0.164,0.174,0.14,0.738,0.647,0.571,0.695,0.782,0.693,0.577,0.909,0.799,0.716,0.773,0.75
https://doi.org/10.1016/s0149-7634(03)00007-1,the neurobiological consequences of early stress and childhood maltreatment,16179_the neurobiological consequences of early stress and childhood maltreatment.pdf,7,"['https://www.tn.gov/content/dam/tn/mentalhealth/documents/Pages_from_CY_BPGs_46-76.pdf', 'http://purl.fdlp.gov/GPO/gpo70861', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://bscc.ca.gov/wp-content/uploads/JOJJ0302.pdf']","['Tdmhsas Best Practice Guidelines', 'Childhood trauma and its effects :\xa0implications for police /', 'Best Practices', 'Cognitive‐behavioural interventions for children who have been sexually abused', 'Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft', 'Journal of Juvenile Justice']","['http://purl.fdlp.gov/GPO/gpo70861', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Pages_from_CY_BPGs_46-76.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['16179_1_childhood trauma and its effects \xa0implications for police .pdf', '16179_5_well and thriving prevention and early intervention in california  second public draft.pdf', '16179_2_best practices.pdf', '16179_3_cognitive‐behavioural interventions for children who have been sexually abused.pdf', '16179_0_tdmhsas best practice guidelines.pdf', '16179_4_well and thriving prevention and early intervention in california first public draft.pdf']",6,85.71,"['http://purl.fdlp.gov/GPO/gpo70861', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061273/pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Pages_from_CY_BPGs_46-76.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['16179_1_childhood trauma and its effects \xa0implications for police .pdf', '16179_5_well and thriving prevention and early intervention in california  second public draft.pdf', '16179_2_best practices.pdf', '16179_3_cognitive‐behavioural interventions for children who have been sexually abused.pdf', '16179_0_tdmhsas best practice guidelines.pdf', '16179_4_well and thriving prevention and early intervention in california first public draft.pdf']","[0.268, 0.332, 0.306, 0.271, 0.124, 0.124]","[0.492, 0.48, 0.492, 0.492, 0.496, 0.48]","[0.595, 0.594, 0.596, 0.59, 0.599, 0.594]","[0.138, 0.1, 0.122, 0.129, 0.137, 0.101]","[0.145, 0.103, 0.125, 0.131, 0.137, 0.104]","[0.124, 0.087, 0.108, 0.109, 0.117, 0.088]","[0.733, 0.723, 0.729, 0.729, 0.736, 0.723]","[0.644, 0.63, 0.635, 0.634, 0.648, 0.631]","[0.556, 0.56, 0.569, 0.57, 0.573, 0.559]","[0.672, 0.645, 0.66, 0.686, 0.663, 0.646]","[0.782, 0.789, 0.787, 0.781, 0.792, 0.788]","[0.691, 0.706, 0.708, 0.688, 0.712, 0.705]","[0.603, 0.593, 0.597, 0.574, 0.598, 0.592]","[0.907, 0.925, 0.92, 0.92, 0.919, 0.925]","[0.798, 0.804, 0.804, 0.808, 0.804, 0.804]","[0.742, 0.742, 0.746, 0.728, 0.751, 0.741]","[0.784, 0.792, 0.79, 0.779, 0.795, 0.792]","[0.77, 0.774, 0.775, 0.763, 0.78, 0.774]",0.238,0.489,0.595,0.121,0.124,0.105,0.729,0.637,0.565,0.662,0.787,0.702,0.593,0.919,0.804,0.742,0.789,0.773
https://doi.org/10.1016/s0261-5614(19)32880-8,sunpo250 implementing and pilot testing of a customized intervention to increase physical activity and healthy eating among preschool children a randomized controlled trial,16373_sunpo250 implementing and pilot testing of a customized intervention to increase physical activity and healthy eating among preschool children a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['16373_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['16373_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.383],[0.551],[0.637],[0.21],[0.211],[0.165],[0.731],[0.633],[0.61],[0.686],[0.784],[0.697],[0.603],[0.911],[0.832],[0.734],[0.788],[0.766],0.383,0.551,0.637,0.21,0.211,0.165,0.731,0.633,0.61,0.686,0.784,0.697,0.603,0.911,0.832,0.734,0.788,0.766
https://doi.org/10.1016/s0740-5472(02)00250-7,adolescent heroin use a review of the descriptive and treatment literature,16728_adolescent heroin use a review of the descriptive and treatment literature.pdf,2,"['https://www.rand.org/pubs/research_reports/RR2108.html', 'https://sitefinitystorage.blob.core.windows.net/sitefinity-production-blobs/docs/default-source/guidelines/npg-jam-supplement.pdf?sfvrsn=a00a52c2_4']","['Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes', 'The ASAM NATIONAL PRACTICE GUIDELINE For the Treatment of Opioid Use Disorder 2020 Focused Update']",['https://sitefinitystorage.blob.core.windows.net/sitefinity-production-blobs/docs/default-source/guidelines/npg-jam-supplement.pdf?sfvrsn=a00a52c2_4'],['16728_1_the asam national practice guideline for the treatment of opioid use disorder 2020 focused update.pdf'],1,50.0,['https://sitefinitystorage.blob.core.windows.net/sitefinity-production-blobs/docs/default-source/guidelines/npg-jam-supplement.pdf?sfvrsn=a00a52c2_4'],['16728_1_the asam national practice guideline for the treatment of opioid use disorder 2020 focused update.pdf'],[0.487],[0.562],[0.648],[0.213],[0.24],[0.202],[0.742],[0.645],[0.628],[0.67],[0.815],[0.757],[0.632],[0.931],[0.833],[0.783],[0.817],[0.802],0.487,0.562,0.648,0.213,0.24,0.202,0.742,0.645,0.628,0.67,0.815,0.757,0.632,0.931,0.833,0.783,0.817,0.802
https://doi.org/10.1016/s0923-7534(20)32539-4,issues associated with cancer in adolescents and young adults,16885_issues associated with cancer in adolescents and young adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478255/pdf'],['Autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478255/pdf'],['16885_0_autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478255/pdf'],['16885_0_autologous hematopoietic stem cell transplantation following high‐dose chemotherapy for nonrhabdomyosarcoma soft tissue sarcomas.pdf'],[0.21],[0.552],[0.628],[0.188],[0.176],[0.136],[0.732],[0.632],[0.623],[0.656],[0.798],[0.737],[0.619],[0.911],[0.83],[0.749],[0.803],[0.777],0.21,0.552,0.628,0.188,0.176,0.136,0.732,0.632,0.623,0.656,0.798,0.737,0.619,0.911,0.83,0.749,0.803,0.777
https://doi.org/10.1016/s0959-3780(01)00007-3,the causes of landuse and landcover change moving beyond the myths,16925_the causes of landuse and landcover change moving beyond the myths.pdf,3,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/9h1mtvcgyl_InVEST_Guide_high_resolution_FINAL.pdf', 'https://www.epa.gov/sites/default/files/2015-11/documents/nrc_stormwaterreport.pdf', 'https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/cid-working-paper-no.-113']","['Developing Scenarios to Assess Ecosystem Service Tradeoffs (application/pdf, 7.99 MB)', 'National Research Council Report: Urban Stormwater Management in the United States', 'Sustainability Values, Attitudes, and Behaviors: A Review of Multi-national and Global Trends']","['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/9h1mtvcgyl_InVEST_Guide_high_resolution_FINAL.pdf', 'https://www.epa.gov/sites/default/files/2015-11/documents/nrc_stormwaterreport.pdf']","['16925_0_developing scenarios to assess ecosystem service tradeoffs applicationpdf 799 mb.pdf', '16925_1_national research council report urban stormwater management in the united states.pdf']",2,66.67,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/9h1mtvcgyl_InVEST_Guide_high_resolution_FINAL.pdf', 'https://www.epa.gov/sites/default/files/2015-11/documents/nrc_stormwaterreport.pdf']","['16925_0_developing scenarios to assess ecosystem service tradeoffs applicationpdf 799 mb.pdf', '16925_1_national research council report urban stormwater management in the united states.pdf']","[0.341, 0.249]","[0.507, 0.496]","[0.612, 0.598]","[0.149, 0.12]","[0.149, 0.102]","[0.134, 0.095]","[0.728, 0.722]","[0.634, 0.626]","[0.561, 0.558]","[0.694, 0.675]","[0.787, 0.789]","[0.701, 0.698]","[0.639, 0.636]","[0.909, 0.909]","[0.822, 0.813]","[0.756, 0.75]","[0.793, 0.789]","[0.778, 0.778]",0.295,0.502,0.605,0.135,0.126,0.115,0.725,0.63,0.56,0.684,0.788,0.7,0.637,0.909,0.817,0.753,0.791,0.778
https://doi.org/10.1016/s1054-139x(04)00067-9,prevalence and correlates of illicit methylphenidate use among 8th 10th and 12th grade students in the united states 2001,17075_prevalence and correlates of illicit methylphenidate use among 8th 10th and 12th grade students in the united states 2001.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769556/pdf'],"['Responding to requests from adult patients for neuroenhancements - Guidance of the Ethics, Law and Humanities Committee']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769556/pdf'],['17075_0_responding to requests from adult patients for neuroenhancements  guidance of the ethics law and humanities committee.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769556/pdf'],['17075_0_responding to requests from adult patients for neuroenhancements  guidance of the ethics law and humanities committee.pdf'],[0.148],[0.509],[0.61],[0.144],[0.15],[0.125],[0.727],[0.629],[0.579],[0.656],[0.791],[0.704],[0.611],[0.91],[0.82],[0.751],[0.786],[0.772],0.148,0.509,0.61,0.144,0.15,0.125,0.727,0.629,0.579,0.656,0.791,0.704,0.611,0.91,0.82,0.751,0.786,0.772
https://doi.org/10.1016/s1056-4993(18)30137-8,pharmacologic treatment of tic disorders,17104_pharmacologic treatment of tic disorders.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065650/pdf'],['European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065650/pdf'],['17104_0_european clinical guidelines for tourette syndrome and other tic disorders part ii pharmacological treatment.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1016/s1470-2045(11)70336-9,efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced inflammatory or early her2positive breast cancer neosphere a randomised multicentre openlabel phase 2 trial,17203_efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced inflammatory or early her2positive breast cancer neosphere a randomised multicentre openlabel phase 2 trial.pdf,8,"['https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-medication-covered-under-medical.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982071/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516860/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339657/pdf', 'https://www.breastsurgeons.org/docs/statements/Performance-and-Practice-Guidelines-for-the-Use-of-Neoadjuvant-Systemic-Therapy-in-the-Management-of-Breast-Cancer.pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274745/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689767/pdf']","['Medications Covered Under Medical', '2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina', 'DEGRO practical guidelines for radiotherapy of breast cancer\xa0V - Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases', 'SEOM clinical guidelines in early stage breast cancer (2018)', 'Performance and Practice Guidelines for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer', 'AIM Cancer Treatment Pathways', 'Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline', 'SEOM clinical guidelines in early-stage breast cancer 2015']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982071/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516860/pdf', 'https://www.hca.wa.gov/sites/default/files/pebb/regence-ump-preauthreqs-medication-covered-under-medical.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339657/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689767/pdf', 'https://www.breastsurgeons.org/docs/statements/Performance-and-Practice-Guidelines-for-the-Use-of-Neoadjuvant-Systemic-Therapy-in-the-Management-of-Breast-Cancer.pdf']","['17203_1_2020 consensus guideline for optimal approach to the diagnosis and treatment of her2positive breast cancer in bosnia and herzegovina.pdf', '17203_5_aim cancer treatment pathways.pdf', '17203_2_DEGRO practical guidelines for radiotherapy of breast cancer V   Therapy for locally advanced and inflammatory breas.pdf', '17203_0_medications covered under medical.pdf', '17203_3_seom clinical guidelines in early stage breast cancer 2018.pdf', '17203_7_seom clinical guidelines in earlystage breast cancer 2015.pdf', '17203_4_performance and practice guidelines for the use of neoadjuvant systemic therapy in the management of breast cancer.pdf']",7,87.5,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1016/s1470-2045(18)30813-1,hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with highrisk breast cancer a randomised noninferiority openlabel phase 3 trial,17221_hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with highrisk breast cancer a randomised noninferiority openlabel phase 3 trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906308/pdf'],['Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906308/pdf'],['17221_0_customizing local and systemic therapies for women with early breast cancer the st gallen international consensus guidelines for treatment of early breast cancer 2021.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906308/pdf'],['17221_0_customizing local and systemic therapies for women with early breast cancer the st gallen international consensus guidelines for treatment of early breast cancer 2021.pdf'],[0.446],[0.578],[0.658],[0.217],[0.226],[0.178],[0.756],[0.678],[0.64],[0.709],[0.82],[0.764],[0.623],[0.925],[0.825],[0.775],[0.81],[0.799],0.446,0.578,0.658,0.217,0.226,0.178,0.756,0.678,0.64,0.709,0.82,0.764,0.623,0.925,0.825,0.775,0.81,0.799
https://doi.org/10.1016/s1470-2045(18)30903-3,risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer teenage and young adult cancer survivor study a populationbased cohort study,17222_risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer teenage and young adult cancer survivor study a populationbased cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919337/pdf'],"['Young Adult Cancer Survivorship: Recommendations for Patient Follow-up, Exercise Therapy, and Research']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919337/pdf'],['17222_0_young adult cancer survivorship recommendations for patient followup exercise therapy and research.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919337/pdf'],['17222_0_young adult cancer survivorship recommendations for patient followup exercise therapy and research.pdf'],[0.513],[0.552],[0.639],[0.186],[0.195],[0.152],[0.746],[0.662],[0.616],[0.697],[0.804],[0.751],[0.606],[0.908],[0.835],[0.758],[0.803],[0.784],0.513,0.552,0.639,0.186,0.195,0.152,0.746,0.662,0.616,0.697,0.804,0.751,0.606,0.908,0.835,0.758,0.803,0.784
https://doi.org/10.1016/s1470-2045(19)30273-6,global childhood cancer survival estimates and prioritysetting a simulationbased analysis,17223_global childhood cancer survival estimates and prioritysetting a simulationbased analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033595/pdf'],['Synthesizing the literature on physical activity among children and adolescents affected by cancer: evidence for the international Pediatric Oncology Exercise Guidelines (iPOEG)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033595/pdf'],['17223_0_synthesizing the literature on physical activity among children and adolescents affected by cancer evidence for the international pediatric oncology exercise guidelines ipoeg.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033595/pdf'],['17223_0_synthesizing the literature on physical activity among children and adolescents affected by cancer evidence for the international pediatric oncology exercise guidelines ipoeg.pdf'],[0.248],[0.579],[0.656],[0.18],[0.171],[0.136],[0.731],[0.639],[0.653],[0.698],[0.818],[0.78],[0.631],[0.931],[0.854],[0.785],[0.824],[0.803],0.248,0.579,0.656,0.18,0.171,0.136,0.731,0.639,0.653,0.698,0.818,0.78,0.631,0.931,0.854,0.785,0.824,0.803
https://doi.org/10.1016/s1470-2045(20)30388-0,the impact of the covid19 pandemic on cancer deaths due to delays in diagnosis in england uk a national populationbased modelling study,17224_the impact of the covid19 pandemic on cancer deaths due to delays in diagnosis in england uk a national populationbased modelling study.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528901/pdf', 'https://www.city-journal.org/lockdowns-must-end', 'https://www.nber.org/papers/w27757', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836265/pdf', 'https://www.gatestoneinstitute.org/18779/fauci-common-sense', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025749/pdf', 'https://www.nber.org/papers/w28930', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139430/pdf', 'https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2821%2903029-8', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206995/pdf']","['COVID-19: Combined supply-side and demand-side shocks, so lift restrictions (carefully) lest GPD declines ultimately kill more than COVID-19', 'A Failed Experiment | City Journal', 'Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses', 'Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)', 'The Fall of Faucism and the Return of Common Sense', 'A Review of Canadian Cancer-Related Clinical Practice Guidelines and Resources during the COVID-19 Pandemic', 'The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality', 'AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update', 'AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update', 'Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528901/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836265/pdf', 'https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2821%2903029-8', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139430/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025749/pdf']","['17224_0_covid19 combined supplyside and demandside shocks so lift restrictions carefully lest gpd declines ultimately kill more than covid19.pdf', '17224_3_management of digestive cancers during the covid19 second wave a french intergroup point of view snfge ffcd gercor unicancer sfcd sfed sfro achbt sfr.pdf', '17224_8_aga rapid review and guideline for sarscov2 testing and endoscopy postvaccination 2021 update.pdf', '17224_9_timing of surgery following sars‐cov‐2 infection an international prospective cohort study.pdf', '17224_7_aga rapid review and guideline for sarscov2 testing and endoscopy postvaccination 2021 update.pdf', '17224_5_a review of canadian cancerrelated clinical practice guidelines and resources during the covid19 pandemic.pdf']",6,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528901/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836265/pdf', 'https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2821%2903029-8', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139430/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025749/pdf']","['17224_0_covid19 combined supplyside and demandside shocks so lift restrictions carefully lest gpd declines ultimately kill more than covid19.pdf', '17224_3_management of digestive cancers during the covid19 second wave a french intergroup point of view snfge ffcd gercor unicancer sfcd sfed sfro achbt sfr.pdf', '17224_8_aga rapid review and guideline for sarscov2 testing and endoscopy postvaccination 2021 update.pdf', '17224_9_timing of surgery following sars‐cov‐2 infection an international prospective cohort study.pdf', '17224_7_aga rapid review and guideline for sarscov2 testing and endoscopy postvaccination 2021 update.pdf', '17224_5_a review of canadian cancerrelated clinical practice guidelines and resources during the covid19 pandemic.pdf']","[0.065, 0.369, 0.602, 0.358, 0.357, 0.24]","[0.554, 0.576, 0.59, 0.574, 0.59, 0.571]","[0.637, 0.653, 0.658, 0.656, 0.658, 0.653]","[0.182, 0.213, 0.213, 0.206, 0.213, 0.226]","[0.198, 0.227, 0.214, 0.211, 0.214, 0.233]","[0.146, 0.177, 0.172, 0.171, 0.172, 0.198]","[0.723, 0.742, 0.743, 0.743, 0.742, 0.751]","[0.632, 0.658, 0.654, 0.652, 0.654, 0.667]","[0.665, 0.647, 0.653, 0.639, 0.654, 0.643]","[0.663, 0.692, 0.678, 0.672, 0.678, 0.697]","[0.82, 0.819, 0.815, 0.805, 0.815, 0.82]","[0.757, 0.766, 0.757, 0.746, 0.757, 0.752]","[0.629, 0.632, 0.641, 0.627, 0.641, 0.641]","[0.939, 0.929, 0.925, 0.928, 0.926, 0.928]","[0.865, 0.853, 0.849, 0.831, 0.849, 0.856]","[0.749, 0.766, 0.772, 0.764, 0.772, 0.769]","[0.811, 0.81, 0.82, 0.806, 0.821, 0.821]","[0.777, 0.795, 0.794, 0.788, 0.795, 0.8]",0.332,0.576,0.652,0.209,0.216,0.173,0.741,0.653,0.65,0.68,0.816,0.756,0.635,0.929,0.85,0.765,0.815,0.791
https://doi.org/10.1016/s1473-3099(09)70071-4,the prevalence of hypoxaemia among ill children in developing countries a systematic review,17254_the prevalence of hypoxaemia among ill children in developing countries a systematic review.pdf,1,['https://www.aarc.org/wp-content/uploads/2021/08/management-of-pediatric-patients-with-oxygen-in-the-acute-setting.pdf'],['AARC Clinical Practice Guideline: Management of Pediatric Patients With Oxygen in the Acute Care Setting'],['https://www.aarc.org/wp-content/uploads/2021/08/management-of-pediatric-patients-with-oxygen-in-the-acute-setting.pdf'],['17254_0_aarc clinical practice guideline management of pediatric patients with oxygen in the acute care setting.pdf'],1,100.0,['https://www.aarc.org/wp-content/uploads/2021/08/management-of-pediatric-patients-with-oxygen-in-the-acute-setting.pdf'],['17254_0_aarc clinical practice guideline management of pediatric patients with oxygen in the acute care setting.pdf'],[0.308],[0.592],[0.658],[0.204],[0.218],[0.173],[0.745],[0.652],[0.663],[0.68],[0.824],[0.777],[0.652],[0.929],[0.849],[0.789],[0.834],[0.81],0.308,0.592,0.658,0.204,0.218,0.173,0.745,0.652,0.663,0.68,0.824,0.777,0.652,0.929,0.849,0.789,0.834,0.81
https://doi.org/10.1016/s1473-3099(17)30143-3,congenital cytomegalovirus infection in pregnancy and the neonate consensus recommendations for prevention diagnosis and therapy,17277_congenital cytomegalovirus infection in pregnancy and the neonate consensus recommendations for prevention diagnosis and therapy.pdf,1,['https://www.acmg.net/PDFLibrary/Hearing-Loss-Practice-Resource.pdf'],['Clinical evaluation and etiologic diagnosis of hearing loss: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)'],['https://www.acmg.net/PDFLibrary/Hearing-Loss-Practice-Resource.pdf'],['17277_0_clinical evaluation and etiologic diagnosis of hearing loss a clinical practice resource of the american college of medical genetics and genomics acmg.pdf'],1,100.0,['https://www.acmg.net/PDFLibrary/Hearing-Loss-Practice-Resource.pdf'],['17277_0_clinical evaluation and etiologic diagnosis of hearing loss a clinical practice resource of the american college of medical genetics and genomics acmg.pdf'],[0.216],[0.542],[0.631],[0.139],[0.148],[0.115],[0.745],[0.653],[0.609],[0.644],[0.808],[0.73],[0.615],[0.923],[0.809],[0.758],[0.802],[0.786],0.216,0.542,0.631,0.139,0.148,0.115,0.745,0.653,0.609,0.644,0.808,0.73,0.615,0.923,0.809,0.758,0.802,0.786
https://doi.org/10.1016/s1474-4422(18)30443-5,global regional and national burden of multiple sclerosis 1990–2016 a systematic analysis for the global burden of disease study 2016,17301_global regional and national burden of multiple sclerosis 1990–2016 a systematic analysis for the global burden of disease study 2016.pdf,6,"['https://www.wilsoncenter.org/publication/the-maternal-health-initiative-launches-the-code-blue-series-non-communicable-diseases', 'https://dbhds.virginia.gov/assets/doc/OIH/sepsis-h-s-alert.pdf', 'https://www.rand.org/pubs/research_reports/RR4262.html', 'https://www.census.gov/library/publications/2022/demo/p95-22.html', 'https://www.brookings.edu/research/brain-health-directed-policymaking-a-new-concept-to-strengthen-democracy/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388852/pdf']","['The Maternal Health Initiative launches the CODE BLUE series on non-communicable diseases and maternal health', 'Sepsis Health & Safety Alert', 'Exploring the societal burden of multiple sclerosis', 'Asia Aging: Demographic, Economic, and Health Transitions', 'Brain health-directed policymaking: A new concept to strengthen democracy', 'Pharmacological treatment of depression in people with a primary brain tumour']","['https://dbhds.virginia.gov/assets/doc/OIH/sepsis-h-s-alert.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388852/pdf']","['17301_1_sepsis health  safety alert.pdf', '17301_5_pharmacological treatment of depression in people with a primary brain tumour.pdf']",2,33.33,"['https://dbhds.virginia.gov/assets/doc/OIH/sepsis-h-s-alert.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388852/pdf']","['17301_1_sepsis health  safety alert.pdf', '17301_5_pharmacological treatment of depression in people with a primary brain tumour.pdf']","[0.104, 0.117]","[0.525, 0.543]","[0.621, 0.637]","[0.141, 0.16]","[0.127, 0.161]","[0.099, 0.124]","[0.733, 0.732]","[0.632, 0.633]","[0.595, 0.616]","[0.666, 0.7]","[0.794, 0.805]","[0.718, 0.728]","[0.62, 0.611]","[0.916, 0.926]","[0.825, 0.838]","[0.754, 0.76]","[0.8, 0.803]","[0.782, 0.789]",0.111,0.534,0.629,0.15,0.144,0.112,0.732,0.633,0.605,0.683,0.8,0.723,0.615,0.921,0.831,0.757,0.802,0.786
https://doi.org/10.1016/s1474-4422(18)30499-x,global regional and national burden of neurological disorders 1990–2016 a systematic analysis for the global burden of disease study 2016,17302_global regional and national burden of neurological disorders 1990–2016 a systematic analysis for the global burden of disease study 2016.pdf,3,"['https://www.rand.org/pubs/research_reports/RR2484z2.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127139/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/pdf']","['Healthy Vitality Age', 'Lacosamide add‐on therapy for focal epilepsy', 'Diagnosis and management of migraine in ten steps']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127139/pdf']","['17302_2_diagnosis and management of migraine in ten steps.pdf', '17302_1_lacosamide add‐on therapy for focal epilepsy.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127139/pdf']","['17302_2_diagnosis and management of migraine in ten steps.pdf', '17302_1_lacosamide add‐on therapy for focal epilepsy.pdf']","[0.07, 0.145]","[0.549, 0.496]","[0.64, 0.599]","[0.172, 0.166]","[0.177, 0.151]","[0.143, 0.122]","[0.734, 0.729]","[0.637, 0.635]","[0.623, 0.564]","[0.675, 0.699]","[0.798, 0.765]","[0.752, 0.696]","[0.613, 0.569]","[0.925, 0.905]","[0.839, 0.795]","[0.766, 0.707]","[0.805, 0.767]","[0.787, 0.735]",0.107,0.522,0.619,0.169,0.164,0.133,0.732,0.636,0.593,0.687,0.782,0.724,0.591,0.915,0.817,0.736,0.786,0.761
https://doi.org/10.1016/s1474-4422(19)30034-1,global regional and national burden of stroke 1990–2016 a systematic analysis for the global burden of disease study 2016,17303_global regional and national burden of stroke 1990–2016 a systematic analysis for the global burden of disease study 2016.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545241/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387239/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521523/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189995/pdf']","['The effect of time spent in rehabilitation on activity limitation and impairment after stroke', 'Cerebrolysin for acute ischaemic stroke', 'Patches of different types for carotid patch angioplasty', 'Information provision for stroke survivors and their carers', 'Iron chelators for acute stroke', 'Screening for aspiration risk associated with dysphagia in acute stroke', 'Implementation interventions to promote the uptake of evidence‐based practices in stroke rehabilitation', 'Diagnosis and management of migraine in ten steps', 'Electromechanical‐assisted training for walking after stroke']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521523/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387239/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545241/pdf']","['17303_2_patches of different types for carotid patch angioplasty.pdf', '17303_5_screening for aspiration risk associated with dysphagia in acute stroke.pdf', '17303_7_diagnosis and management of migraine in ten steps.pdf', '17303_6_implementation interventions to promote the uptake of evidence‐based practices in stroke rehabilitation.pdf', '17303_8_electromechanical‐assisted training for walking after stroke.pdf', '17303_1_cerebrolysin for acute ischaemic stroke.pdf', '17303_3_information provision for stroke survivors and their carers.pdf', '17303_4_iron chelators for acute stroke.pdf', '17303_0_the effect of time spent in rehabilitation on activity limitation and impairment after stroke.pdf']",9,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521523/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321897/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189995/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387239/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610078/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095068/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545241/pdf']","['17303_2_patches of different types for carotid patch angioplasty.pdf', '17303_5_screening for aspiration risk associated with dysphagia in acute stroke.pdf', '17303_7_diagnosis and management of migraine in ten steps.pdf', '17303_6_implementation interventions to promote the uptake of evidence‐based practices in stroke rehabilitation.pdf', '17303_8_electromechanical‐assisted training for walking after stroke.pdf', '17303_1_cerebrolysin for acute ischaemic stroke.pdf', '17303_3_information provision for stroke survivors and their carers.pdf', '17303_4_iron chelators for acute stroke.pdf', '17303_0_the effect of time spent in rehabilitation on activity limitation and impairment after stroke.pdf']","[0.228, 0.29, 0.148, 0.36, 0.28, 0.202, 0.268, 0.141, 0.238]","[0.499, 0.531, 0.545, 0.517, 0.508, 0.526, 0.527, 0.536, 0.521]","[0.596, 0.622, 0.634, 0.611, 0.61, 0.622, 0.618, 0.627, 0.613]","[0.16, 0.172, 0.153, 0.169, 0.161, 0.182, 0.189, 0.179, 0.179]","[0.151, 0.172, 0.164, 0.162, 0.16, 0.183, 0.189, 0.186, 0.177]","[0.127, 0.143, 0.128, 0.134, 0.137, 0.148, 0.16, 0.149, 0.147]","[0.733, 0.733, 0.732, 0.732, 0.735, 0.732, 0.738, 0.733, 0.734]","[0.641, 0.639, 0.637, 0.64, 0.64, 0.641, 0.647, 0.639, 0.642]","[0.565, 0.596, 0.616, 0.581, 0.576, 0.6, 0.593, 0.61, 0.589]","[0.691, 0.7, 0.666, 0.701, 0.691, 0.709, 0.706, 0.703, 0.7]","[0.767, 0.777, 0.796, 0.771, 0.767, 0.785, 0.778, 0.787, 0.775]","[0.691, 0.716, 0.745, 0.699, 0.686, 0.717, 0.712, 0.723, 0.706]","[0.581, 0.608, 0.611, 0.587, 0.583, 0.604, 0.597, 0.605, 0.595]","[0.904, 0.91, 0.922, 0.911, 0.913, 0.917, 0.912, 0.921, 0.916]","[0.802, 0.822, 0.834, 0.82, 0.822, 0.831, 0.826, 0.834, 0.825]","[0.711, 0.729, 0.765, 0.725, 0.72, 0.74, 0.733, 0.746, 0.732]","[0.762, 0.784, 0.8, 0.774, 0.767, 0.783, 0.78, 0.788, 0.775]","[0.735, 0.752, 0.78, 0.749, 0.749, 0.761, 0.754, 0.766, 0.756]",0.239,0.523,0.617,0.172,0.172,0.141,0.734,0.641,0.592,0.696,0.778,0.711,0.597,0.914,0.824,0.733,0.779,0.756
https://doi.org/10.1016/s2213-2600(19)30470-9,infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life a subanalysis of the maki randomised controlled trial,17379_infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life a subanalysis of the maki randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594174/pdf'],['Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594174/pdf'],['17379_0_palivizumab for preventing severe respiratory syncytial virus rsv infection in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594174/pdf'],['17379_0_palivizumab for preventing severe respiratory syncytial virus rsv infection in children.pdf'],[0.555],[0.525],[0.62],[0.169],[0.16],[0.129],[0.737],[0.648],[0.598],[0.683],[0.786],[0.713],[0.599],[0.916],[0.811],[0.737],[0.783],[0.763],0.555,0.525,0.62,0.169,0.16,0.129,0.737,0.648,0.598,0.683,0.786,0.713,0.599,0.916,0.811,0.737,0.783,0.763
https://doi.org/10.1016/s2213-2600(20)30121-1,planning and provision of ecmo services for severe ards during the covid19 pandemic and other outbreaks of emerging infectious diseases,17381_planning and provision of ecmo services for severe ards during the covid19 pandemic and other outbreaks of emerging infectious diseases.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011047/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227574/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078022/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149722/pdf']","['Developing a Thai national critical care allocation guideline during the COVID-19 pandemic: a rapid review and stakeholder consultation', 'Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: Guidance From an International Cardiac Surgery Consortium', 'EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic', 'Battling COVID‐19: critical care and peri‐operative healthcare resource management strategies in a tertiary academic medical centre in Singapore', 'Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization', 'The Saudi Critical Care Society extracorporeal life support chapter guidance on utilization of veno-venous extracorporeal membrane oxygenation in adults with acute respiratory distress syndrome and special considerations in the era of coronavirus disease 2019']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227574/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078022/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011047/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239193/pdf']","['17381_1_committee recommendations for resuming cardiac surgery activity in the sarscov2 era guidance from an international cardiac surgery consortium.pdf', '17381_4_extracorporeal membrane oxygenation for covid19 updated 2021 guidelines from the extracorporeal life support organization.pdf', '17381_3_battling covid‐19 critical care and peri‐operative healthcare resource management strategies in a tertiary academic medical centre in singapore.pdf', '17381_0_developing a thai national critical care allocation guideline during the covid19 pandemic a rapid review and stakeholder consultation.pdf', '17381_2_eapci position statement on invasive management of acute coronary syndromes during the covid19 pandemic.pdf']",5,83.33,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227574/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078022/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262214/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011047/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239193/pdf']","['17381_1_committee recommendations for resuming cardiac surgery activity in the sarscov2 era guidance from an international cardiac surgery consortium.pdf', '17381_4_extracorporeal membrane oxygenation for covid19 updated 2021 guidelines from the extracorporeal life support organization.pdf', '17381_3_battling covid‐19 critical care and peri‐operative healthcare resource management strategies in a tertiary academic medical centre in singapore.pdf', '17381_0_developing a thai national critical care allocation guideline during the covid19 pandemic a rapid review and stakeholder consultation.pdf', '17381_2_eapci position statement on invasive management of acute coronary syndromes during the covid19 pandemic.pdf']","[0.362, 0.357, 0.456, 0.474, 0.731]","[0.59, 0.609, 0.582, 0.557, 0.603]","[0.662, 0.674, 0.66, 0.64, 0.673]","[0.212, 0.247, 0.208, 0.183, 0.213]","[0.236, 0.263, 0.229, 0.2, 0.225]","[0.174, 0.207, 0.172, 0.153, 0.163]","[0.754, 0.757, 0.746, 0.74, 0.753]","[0.67, 0.678, 0.662, 0.652, 0.668]","[0.656, 0.681, 0.651, 0.625, 0.671]","[0.65, 0.65, 0.645, 0.656, 0.635]","[0.827, 0.839, 0.829, 0.811, 0.832]","[0.759, 0.787, 0.768, 0.752, 0.786]","[0.647, 0.659, 0.64, 0.628, 0.66]","[0.931, 0.933, 0.928, 0.921, 0.934]","[0.847, 0.854, 0.848, 0.842, 0.85]","[0.789, 0.812, 0.797, 0.771, 0.805]","[0.829, 0.839, 0.836, 0.81, 0.835]","[0.815, 0.823, 0.815, 0.795, 0.821]",0.476,0.588,0.662,0.213,0.231,0.174,0.75,0.666,0.657,0.647,0.828,0.77,0.647,0.929,0.848,0.795,0.83,0.814
https://doi.org/10.1016/s2213-2600(20)30316-7,case characteristics resource use and outcomes of 10 021 patients with covid19 admitted to 920 german hospitals an observational study,17382_case characteristics resource use and outcomes of 10 021 patients with covid19 admitted to 920 german hospitals an observational study.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406992/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521385/pdf']","['Remdesivir for the treatment of COVID‐19', 'Ivermectin for preventing and treating COVID‐19', 'Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19', 'Ivermectin for preventing and treating COVID‐19', 'Colchicine for the treatment of COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406992/pdf']","['17382_1_ivermectin for preventing and treating covid‐19.pdf', '17382_3_ivermectin for preventing and treating covid‐19.pdf', '17382_2_nirmatrelvir combined with ritonavir for preventing and treating covid‐19.pdf', '17382_4_colchicine for the treatment of covid‐19.pdf', '17382_0_remdesivir for the treatment of covid‐19.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215332/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521385/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406992/pdf']","['17382_1_ivermectin for preventing and treating covid‐19.pdf', '17382_3_ivermectin for preventing and treating covid‐19.pdf', '17382_2_nirmatrelvir combined with ritonavir for preventing and treating covid‐19.pdf', '17382_4_colchicine for the treatment of covid‐19.pdf', '17382_0_remdesivir for the treatment of covid‐19.pdf']","[0.336, 0.277, 0.308, 0.274, 0.302]","[0.542, 0.543, 0.551, 0.552, 0.53]","[0.631, 0.631, 0.635, 0.634, 0.618]","[0.185, 0.181, 0.184, 0.194, 0.185]","[0.185, 0.183, 0.189, 0.194, 0.186]","[0.142, 0.138, 0.144, 0.149, 0.142]","[0.734, 0.733, 0.733, 0.736, 0.734]","[0.641, 0.64, 0.64, 0.645, 0.643]","[0.606, 0.61, 0.62, 0.615, 0.592]","[0.671, 0.669, 0.666, 0.676, 0.677]","[0.794, 0.797, 0.798, 0.796, 0.786]","[0.72, 0.724, 0.736, 0.725, 0.708]","[0.591, 0.595, 0.603, 0.603, 0.598]","[0.921, 0.921, 0.924, 0.921, 0.916]","[0.83, 0.835, 0.835, 0.838, 0.819]","[0.745, 0.749, 0.756, 0.75, 0.737]","[0.792, 0.795, 0.801, 0.797, 0.785]","[0.771, 0.775, 0.779, 0.776, 0.761]",0.299,0.544,0.63,0.186,0.187,0.143,0.734,0.642,0.609,0.672,0.794,0.723,0.598,0.921,0.831,0.747,0.794,0.772
https://doi.org/10.1016/s2213-2600(21)00331-3,efficacy and safety of baricitinib for the treatment of hospitalised adults with covid19 covbarrier a randomised doubleblind parallelgroup placebocontrolled phase 3 trial,17383_efficacy and safety of baricitinib for the treatment of hospitalised adults with covid19 covbarrier a randomised doubleblind parallelgroup placebocontrolled phase 3 trial.pdf,1,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines'],['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['17383_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,100.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['17383_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.49],[0.559],[0.636],[0.19],[0.203],[0.148],[0.745],[0.655],[0.621],[0.672],[0.802],[0.722],[0.607],[0.906],[0.82],[0.773],[0.803],[0.79],0.49,0.559,0.636,0.19,0.203,0.148,0.745,0.655,0.621,0.672,0.802,0.722,0.607,0.906,0.82,0.773,0.803,0.79
https://doi.org/10.1016/s2213-2600(21)00358-1,baricitinib the first immunomodulatory treatment to reduce covid19 mortality in a placebocontrolled trial,17384_baricitinib the first immunomodulatory treatment to reduce covid19 mortality in a placebocontrolled trial.pdf,1,['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part2.pdf'],['Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit'],['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part2.pdf'],['17384_0_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf'],1,100.0,['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part2.pdf'],['17384_0_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf'],[0.26],[0.565],[0.645],[0.182],[0.168],[0.134],[0.736],[0.647],[0.641],[0.649],[0.817],[0.751],[0.629],[0.928],[0.832],[0.781],[0.82],[0.801],0.26,0.565,0.645,0.182,0.168,0.134,0.736,0.647,0.641,0.649,0.817,0.751,0.629,0.928,0.832,0.781,0.82,0.801
https://doi.org/10.1016/s2213-8587(20)30271-0,risk factors for covid19related mortality in people with type 1 and type 2 diabetes in england a populationbased cohort study,17394_risk factors for covid19related mortality in people with type 1 and type 2 diabetes in england a populationbased cohort study.pdf,3,"['https://www.congress.gov/event/117th-congress/house-event/111136', 'https://stacks.cdc.gov/view/cdc/94405', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf']","['“Road to Recovery: Ramping Up COVID-19 Vaccines, Testing, and Medical Supply Chain” (Virtual Hearing)', 'COVID-19 science update ; Edition 2020-09-25', 'ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization - A Report of the American College of Cardiology Solution Set Oversight Committee']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf'],['17394_2_acc health policy statement on cardiovascular disease considerations for covid19 vaccine prioritization  a report of the american college of cardiology solution set oversight committee.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf'],['17394_2_acc health policy statement on cardiovascular disease considerations for covid19 vaccine prioritization  a report of the american college of cardiology solution set oversight committee.pdf'],[0.43],[0.548],[0.635],[0.211],[0.226],[0.173],[0.746],[0.658],[0.608],[0.68],[0.798],[0.738],[0.625],[0.906],[0.815],[0.75],[0.798],[0.769],0.43,0.548,0.635,0.211,0.226,0.173,0.746,0.658,0.608,0.68,0.798,0.738,0.625,0.906,0.815,0.75,0.798,0.769
https://doi.org/10.1016/s2213-8587(20)30272-2,associations of type 1 and type 2 diabetes with covid19related mortality in england a wholepopulation study,17395_associations of type 1 and type 2 diabetes with covid19related mortality in england a wholepopulation study.pdf,4,"['https://stacks.cdc.gov/view/cdc/106171', 'https://stacks.cdc.gov/view/cdc/110771', 'https://stacks.cdc.gov/view/cdc/114448', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf']","['Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization - A Report of the American College of Cardiology Solution Set Oversight Committee']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf'],['17395_3_acc health policy statement on cardiovascular disease considerations for covid19 vaccine prioritization  a report of the american college of cardiology solution set oversight committee.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880623/pdf'],['17395_3_acc health policy statement on cardiovascular disease considerations for covid19 vaccine prioritization  a report of the american college of cardiology solution set oversight committee.pdf'],[0.406],[0.548],[0.638],[0.21],[0.227],[0.175],[0.746],[0.655],[0.609],[0.688],[0.798],[0.744],[0.625],[0.902],[0.818],[0.75],[0.799],[0.768],0.406,0.548,0.638,0.21,0.227,0.175,0.746,0.655,0.609,0.688,0.798,0.744,0.625,0.902,0.818,0.75,0.799,0.768
https://doi.org/10.1016/s2214-109x(17)30289-9,the global burden of tuberculosis mortality in children a mathematical modelling study,17429_the global burden of tuberculosis mortality in children a mathematical modelling study.pdf,2,"['https://dph.georgia.gov/document/document/world-health-organization-who-tuberculosis-report-2017/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf']","['Global', 'Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children']","['https://dph.georgia.gov/document/document/world-health-organization-who-tuberculosis-report-2017/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf']","['17429_0_global.pdf', '17429_1_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf']",2,100.0,"['https://dph.georgia.gov/document/document/world-health-organization-who-tuberculosis-report-2017/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf']","['17429_0_global.pdf', '17429_1_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf']","[0.322, 0.284]","[0.553, 0.538]","[0.648, 0.628]","[0.223, 0.186]","[0.238, 0.183]","[0.191, 0.153]","[0.739, 0.738]","[0.646, 0.636]","[0.621, 0.603]","[0.693, 0.695]","[0.81, 0.783]","[0.725, 0.717]","[0.644, 0.609]","[0.919, 0.911]","[0.845, 0.822]","[0.776, 0.734]","[0.822, 0.793]","[0.802, 0.758]",0.303,0.546,0.638,0.205,0.21,0.172,0.738,0.641,0.612,0.694,0.796,0.721,0.627,0.915,0.833,0.755,0.807,0.78
https://doi.org/10.1016/s2214-109x(21)00079-6,effects of the covid19 pandemic on maternal and perinatal outcomes a systematic review and metaanalysis,17453_effects of the covid19 pandemic on maternal and perinatal outcomes a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984859/pdf'],['The injustice of unfit clinical practice guidelines in low-resource realities'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984859/pdf'],['17453_0_the injustice of unfit clinical practice guidelines in lowresource realities.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984859/pdf'],['17453_0_the injustice of unfit clinical practice guidelines in lowresource realities.pdf'],[0.21],[0.569],[0.655],[0.182],[0.197],[0.149],[0.727],[0.638],[0.644],[0.674],[0.818],[0.771],[0.632],[0.931],[0.856],[0.784],[0.821],[0.8],0.21,0.569,0.655,0.182,0.197,0.149,0.727,0.638,0.644,0.674,0.818,0.771,0.632,0.931,0.856,0.784,0.821,0.8
https://doi.org/10.1016/s2215-0366(20)30356-4,international consensus on a standard set of outcome measures for child and youth anxiety depression obsessivecompulsive disorder and posttraumatic stress disorder,17484_international consensus on a standard set of outcome measures for child and youth anxiety depression obsessivecompulsive disorder and posttraumatic stress disorder.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf'],['New generation antidepressants for depression in children and adolescents: a network meta‐analysis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf'],['17484_0_new generation antidepressants for depression in children and adolescents a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143444/pdf'],['17484_0_new generation antidepressants for depression in children and adolescents a network meta‐analysis.pdf'],[0.435],[0.515],[0.607],[0.166],[0.176],[0.142],[0.733],[0.642],[0.584],[0.711],[0.785],[0.708],[0.589],[0.912],[0.818],[0.726],[0.785],[0.755],0.435,0.515,0.607,0.166,0.176,0.142,0.733,0.642,0.584,0.711,0.785,0.708,0.589,0.912,0.818,0.726,0.785,0.755
https://doi.org/10.1016/s2352-3018(18)30215-7,populationlevel effectiveness of rapid targeted highcoverage rollout of hiv preexposure prophylaxis in men who have sex with men the epicnsw prospective cohort study,17489_populationlevel effectiveness of rapid targeted highcoverage rollout of hiv preexposure prophylaxis in men who have sex with men the epicnsw prospective cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750495/pdf'],"['Assessing the performance of international pre‐exposure prophylaxis (PrEP) eligibility guidelines in a cohort of Chinese MSM, Beijing, China 2009 to 2016']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750495/pdf'],['17489_0_assessing the performance of international pre‐exposure prophylaxis prep eligibility guidelines in a cohort of chinese msm beijing china 2009 to 2016.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750495/pdf'],['17489_0_assessing the performance of international pre‐exposure prophylaxis prep eligibility guidelines in a cohort of chinese msm beijing china 2009 to 2016.pdf'],[0.557],[0.508],[0.598],[0.184],[0.198],[0.16],[0.732],[0.648],[0.556],[0.684],[0.767],[0.708],[0.609],[0.878],[0.788],[0.68],[0.768],[0.701],0.557,0.508,0.598,0.184,0.198,0.16,0.732,0.648,0.556,0.684,0.767,0.708,0.609,0.878,0.788,0.68,0.768,0.701
https://doi.org/10.1016/s2352-3018(19)30033-5,evaluation of a routine pointofcare intervention for early infant diagnosis of hiv an observational study in eight african countries,17492_evaluation of a routine pointofcare intervention for early infant diagnosis of hiv an observational study in eight african countries.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['17492_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['17492_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],[0.502],[0.559],[0.64],[0.202],[0.205],[0.166],[0.739],[0.649],[0.619],[0.688],[0.798],[0.738],[0.627],[0.914],[0.844],[0.751],[0.806],[0.774],0.502,0.559,0.64,0.202,0.205,0.166,0.739,0.649,0.619,0.688,0.798,0.738,0.627,0.914,0.844,0.751,0.806,0.774
https://doi.org/10.1016/s2352-4642(18)30022-1,the age of adolescence,17496_the age of adolescence.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_adoleshealth.pdf']","['Family therapy approaches for anorexia nervosa', 'Family therapy approaches for anorexia nervosa', 'Adolescent Oral Health Care']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_adoleshealth.pdf']","['17496_1_family therapy approaches for anorexia nervosa.pdf', '17496_0_family therapy approaches for anorexia nervosa.pdf', '17496_2_adolescent oral health care.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497182/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517149/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_adoleshealth.pdf']","['17496_1_family therapy approaches for anorexia nervosa.pdf', '17496_0_family therapy approaches for anorexia nervosa.pdf', '17496_2_adolescent oral health care.pdf']","[0.113, 0.131, 0.277]","[0.496, 0.496, 0.539]","[0.593, 0.591, 0.626]","[0.117, 0.116, 0.133]","[0.123, 0.121, 0.135]","[0.101, 0.1, 0.109]","[0.724, 0.723, 0.734]","[0.623, 0.623, 0.634]","[0.565, 0.567, 0.616]","[0.682, 0.68, 0.621]","[0.772, 0.776, 0.812]","[0.687, 0.693, 0.742]","[0.579, 0.579, 0.621]","[0.914, 0.909, 0.934]","[0.818, 0.815, 0.832]","[0.722, 0.726, 0.773]","[0.772, 0.774, 0.819]","[0.753, 0.754, 0.8]",0.174,0.51,0.603,0.122,0.126,0.103,0.727,0.627,0.583,0.661,0.787,0.707,0.593,0.919,0.822,0.74,0.788,0.769
https://doi.org/10.1016/s2352-4642(18)30278-5,associations between 24 hour movement behaviours and global cognition in us children a crosssectional observational study,17500_associations between 24 hour movement behaviours and global cognition in us children a crosssectional observational study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754464/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf', 'https://www.epi.org/publication/the-consequences-of-the-covid-19-pandemic-for-education-performance-and-equity-in-the-united-states-what-can-we-learn-from-pre-pandemic-research-to-inform-relief-recovery-and-rebuilding/']","['24‐hour activity for children with cerebral palsy: a clinical practice guide', 'The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan', 'COVID-19 and student performance, equity, and U.S. education policy: Lessons from pre-pandemic research to inform relief, recovery, and rebuilding']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754464/pdf']","['17500_1_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf', '17500_0_24‐hour activity for children with cerebral palsy a clinical practice guide.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754464/pdf']","['17500_1_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf', '17500_0_24‐hour activity for children with cerebral palsy a clinical practice guide.pdf']","[0.507, 0.489]","[0.585, 0.621]","[0.666, 0.687]","[0.206, 0.207]","[0.23, 0.236]","[0.178, 0.195]","[0.737, 0.738]","[0.649, 0.647]","[0.644, 0.689]","[0.717, 0.691]","[0.816, 0.839]","[0.768, 0.808]","[0.635, 0.662]","[0.934, 0.944]","[0.852, 0.872]","[0.785, 0.815]","[0.82, 0.85]","[0.802, 0.83]",0.498,0.603,0.677,0.206,0.233,0.186,0.738,0.648,0.666,0.704,0.827,0.788,0.649,0.939,0.862,0.8,0.835,0.816
https://doi.org/10.1016/s2352-4642(19)30292-5,maternal intramuscular dexamethasone versus betamethasone before preterm birth asteroid a multicentre doubleblind randomised controlled trial,17505_maternal intramuscular dexamethasone versus betamethasone before preterm birth asteroid a multicentre doubleblind randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692259/pdf'],['Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692259/pdf'],['17505_0_antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692259/pdf'],['17505_0_antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.pdf'],[0.524],[0.563],[0.654],[0.22],[0.22],[0.177],[0.742],[0.651],[0.63],[0.681],[0.802],[0.731],[0.615],[0.923],[0.839],[0.756],[0.796],[0.778],0.524,0.563,0.654,0.22,0.22,0.177,0.742,0.651,0.63,0.681,0.802,0.731,0.615,0.923,0.839,0.756,0.796,0.778
https://doi.org/10.1016/s2352-4642(19)30323-2,global trends in insufficient physical activity among adolescents a pooled analysis of 298 populationbased surveys with 1·6 million participants,17506_global trends in insufficient physical activity among adolescents a pooled analysis of 298 populationbased surveys with 1·6 million participants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf']","['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18', 'World Health Organization 2020 guidelines on physical activity and sedentary behaviour']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf']","['17506_1_world health organization 2020 guidelines on physical activity and sedentary behaviour.pdf', '17506_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf']","['17506_1_world health organization 2020 guidelines on physical activity and sedentary behaviour.pdf', '17506_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf']","[0.466, 0.536]","[0.589, 0.532]","[0.677, 0.633]","[0.225, 0.202]","[0.245, 0.215]","[0.192, 0.17]","[0.734, 0.734]","[0.641, 0.638]","[0.664, 0.602]","[0.714, 0.704]","[0.822, 0.789]","[0.778, 0.716]","[0.642, 0.607]","[0.929, 0.918]","[0.868, 0.844]","[0.791, 0.745]","[0.833, 0.795]","[0.813, 0.776]",0.501,0.56,0.655,0.214,0.23,0.181,0.734,0.639,0.633,0.709,0.805,0.747,0.625,0.923,0.856,0.768,0.814,0.794
https://doi.org/10.1016/s2352-4642(19)30335-9,clustering of suicides in children and adolescents,17507_clustering of suicides in children and adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['17507_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['17507_0_interventions for self‐harm in children and adolescents.pdf'],[0.241],[0.523],[0.612],[0.159],[0.171],[0.138],[0.732],[0.638],[0.588],[0.685],[0.787],[0.716],[0.599],[0.917],[0.824],[0.74],[0.789],[0.77],0.241,0.523,0.612,0.159,0.171,0.138,0.732,0.638,0.588,0.685,0.787,0.716,0.599,0.917,0.824,0.74,0.789,0.77
https://doi.org/10.1016/s2352-4642(20)30096-1,mental health considerations for children quarantined because of covid19,17511_mental health considerations for children quarantined because of covid19.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229975/pdf']","['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review', 'Prevención y tratamiento de la COVID-19 en la población pediátrica desde una perspectiva familiar y comunitaria: artículo especial']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229975/pdf']","['17511_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '17511_1_prevención y tratamiento de la covid19 en la población pediátrica desde una perspectiva familiar y comunitaria artículo especial.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229975/pdf']","['17511_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf', '17511_1_prevención y tratamiento de la covid19 en la población pediátrica desde una perspectiva familiar y comunitaria artículo especial.pdf']","[0.343, 0.041]","[0.55, 0.454]","[0.634, 0.569]","[0.159, 0.133]","[0.18, 0.166]","[0.159, 0.134]","[0.738, 0.725]","[0.646, 0.639]","[0.607, 0.525]","[0.635, 0.633]","[0.81, 0.786]","[0.744, 0.686]","[0.626, 0.57]","[0.925, 0.86]","[0.843, 0.811]","[0.764, 0.708]","[0.814, 0.754]","[0.795, 0.727]",0.192,0.502,0.601,0.146,0.173,0.147,0.732,0.643,0.566,0.634,0.798,0.715,0.598,0.893,0.827,0.736,0.784,0.761
https://doi.org/10.1016/s2352-4642(20)30097-3,protecting the psychological health of children through effective communication about covid19,17512_protecting the psychological health of children through effective communication about covid19.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf', 'https://www.rand.org/blog/2021/09/parenting-during-the-pandemic-communicating-with-children.html']","['American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 1', 'Parenting During the Pandemic: Communicating with Children About COVID-19']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['17512_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['17512_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],[0.242],[0.563],[0.646],[0.143],[0.157],[0.125],[0.734],[0.637],[0.63],[0.639],[0.81],[0.744],[0.643],[0.933],[0.844],[0.78],[0.816],[0.796],0.242,0.563,0.646,0.143,0.157,0.125,0.734,0.637,0.63,0.639,0.81,0.744,0.643,0.933,0.844,0.78,0.816,0.796
https://doi.org/10.1016/s2352-4642(20)30108-5,delayed access or provision of care in italy resulting from fear of covid19,17513_delayed access or provision of care in italy resulting from fear of covid19.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300556/pdf', 'https://www.nber.org/papers/w27322']","['Recommendations from the Italian Society of Pediatric Orthopaedics and Traumatology for the management of pediatric orthopaedic patients during the COVID19 pandemic and post-pandemic period in Italy', 'Collateral effects of COVID‐19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delay', 'Did the Wisconsin Supreme Court Restart a COVID-19 Epidemic? Evidence from a Natural Experiment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300556/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542566/pdf']","['17513_1_collateral effects of covid‐19 pandemic in pediatric hematooncology fatalities caused by diagnostic delay.pdf', '17513_0_Recommendations from the Italian Society of Pediatric Orthopaedics and Traumatology for the management of pediatric .pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300556/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542566/pdf']","['17513_1_collateral effects of covid‐19 pandemic in pediatric hematooncology fatalities caused by diagnostic delay.pdf', '17513_0_Recommendations from the Italian Society of Pediatric Orthopaedics and Traumatology for the management of pediatric .pdf']","[0.375, 0.405]","[0.585, 0.59]","[0.65, 0.668]","[0.219, 0.208]","[0.222, 0.215]","[0.174, 0.186]","[0.74, 0.737]","[0.649, 0.639]","[0.645, 0.656]","[0.625, 0.624]","[0.812, 0.818]","[0.773, 0.773]","[0.636, 0.628]","[0.902, 0.91]","[0.851, 0.849]","[0.784, 0.79]","[0.819, 0.828]","[0.794, 0.805]",0.39,0.587,0.659,0.213,0.218,0.18,0.738,0.644,0.651,0.625,0.815,0.773,0.632,0.906,0.85,0.787,0.823,0.8
https://doi.org/10.1016/s2352-4642(20)30109-7,mental health effects of school closures during covid19,17514_mental health effects of school closures during covid19.pdf,8,"['https://civilrights.org/resource/education-task-force-letter-on-covid-19-priorities/', 'https://blog.acton.org/archives/120487-a-silver-lining-in-the-golden-states-school-shutdowns.html', 'https://www.congress.gov/event/117th-congress/house-event/111298', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259042/pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://rlo.acton.org/archives/120487-a-silver-lining-in-the-golden-states-school-shutdowns.html', 'https://fee.org/articles/teachers-unions-politicized-us-schools-not-parents/', 'https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf']","['Civil Rights Priorities for Education Equity in COVID-19 Response', ""A silver lining in the Golden State's school shutdowns"", '“Kids Online During COVID: Child Safety in an Increasingly Digital Age”', ""COVID-19 effects on women's home and work life, family violence and mental health from the Women's Health Expert Panel of the American Academy of Nursing"", '173ÿ67172', ""A silver lining in the Golden State's school shutdowns"", 'Teachers Unions Politicized US Schools, Not Parents', 'California State Evaluation and Learning Support (Cal SEALS) for SB 82 Triage Grants']","['https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259042/pdf']","['17514_7_california state evaluation and learning support cal seals for sb 82 triage grants.pdf', '17514_4_173ÿ67172.pdf', '17514_3_covid19 effects on womens home and work life family violence and mental health from the womens health expert panel of the american academy of nursing.pdf']",3,37.5,"['https://mhsoac.ca.gov/wp-content/uploads/UCLA-Midpoint-Progress-Report-for-Formative-Process-Evaluations_ADA.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259042/pdf']","['17514_7_california state evaluation and learning support cal seals for sb 82 triage grants.pdf', '17514_4_173ÿ67172.pdf', '17514_3_covid19 effects on womens home and work life family violence and mental health from the womens health expert panel of the american academy of nursing.pdf']","[0.311, 0.38, 0.132]","[0.594, 0.33, 0.59]","[0.665, 0.473, 0.655]","[0.15, 0.052, 0.176]","[0.165, 0.055, 0.193]","[0.13, 0.042, 0.155]","[0.713, 0.712, 0.728]","[0.617, 0.611, 0.635]","[0.675, 0.329, 0.657]","[0.655, 0.625, 0.648]","[0.833, 0.644, 0.832]","[0.794, 0.526, 0.784]","[0.675, 0.558, 0.663]","[0.927, 0.877, 0.926]","[0.873, 0.686, 0.861]","[0.81, 0.612, 0.798]","[0.845, 0.637, 0.835]","[0.818, 0.624, 0.81]",0.274,0.505,0.598,0.126,0.138,0.109,0.718,0.621,0.554,0.643,0.77,0.701,0.632,0.91,0.807,0.74,0.772,0.751
https://doi.org/10.1016/s2352-4642(20)30145-0,the severity of covid19 in children on immunosuppressive medication,17516_the severity of covid19 in children on immunosuppressive medication.pdf,8,"['https://stacks.cdc.gov/view/cdc/106171', 'https://stacks.cdc.gov/view/cdc/91185', 'https://stacks.cdc.gov/view/cdc/90729', 'https://stacks.cdc.gov/view/cdc/90861', 'https://stacks.cdc.gov/view/cdc/110771', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://stacks.cdc.gov/view/cdc/114448', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf']","['Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['17516_7_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf'],1,12.5,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['17516_7_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf'],[0.307],[0.551],[0.644],[0.197],[0.192],[0.148],[0.74],[0.652],[0.619],[0.67],[0.798],[0.721],[0.601],[0.901],[0.847],[0.763],[0.789],[0.782],0.307,0.551,0.644,0.197,0.192,0.148,0.74,0.652,0.619,0.67,0.798,0.721,0.601,0.901,0.847,0.763,0.789,0.782
https://doi.org/10.1016/s2468-2667(19)30145-8,life course health consequences and associated annual costs of adverse childhood experiences across europe and north america a systematic review and metaanalysis,17546_life course health consequences and associated annual costs of adverse childhood experiences across europe and north america a systematic review and metaanalysis.pdf,10,"['https://stacks.cdc.gov/view/cdc/82319', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Social-Services-Sector-Brief_12092020.pdf?emrc=ff0d6f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Healthcare-Sector-Brief_12092020.pdf?emrc=1f10ac', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Education-Sector-Brief_12092020.pdf?emrc=c1f916', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Cost-of-ACEs_CA_OSG-Report_12092020.pdf?emrc=74439c', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Early-Childhood-Sector-Brief_12092020.pdf?emrc=68953e', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab']","['Vital Signs: Estimated proportion of adult health problems attributable to adverse childhood experiences and implications for prevention — 25 states, 2015–2017', 'Social Services Sector', 'From Adversity to Resilience in the Justice Sector – Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'From Adversity to Resilience in the Healthcare Sector – Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'From Adversity to Resilience in the Education Sector – Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'The Financial Costs of Adverse Childhood Experiences (ACEs) and Toxic Stress', 'Executive Summary – Findings from Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health', 'Public Health Sector', 'Early Childhood Sector', 'Roadmap for Resilience']","['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Healthcare-Sector-Brief_12092020.pdf?emrc=1f10ac', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Social-Services-Sector-Brief_12092020.pdf?emrc=ff0d6f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Cost-of-ACEs_CA_OSG-Report_12092020.pdf?emrc=74439c', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Early-Childhood-Sector-Brief_12092020.pdf?emrc=68953e', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Education-Sector-Brief_12092020.pdf?emrc=c1f916']","['17546_3_from adversity to resilience in the healthcare sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '17546_2_from adversity to resilience in the justice sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '17546_1_social services sector.pdf', '17546_9_roadmap for resilience.pdf', '17546_5_the financial costs of adverse childhood experiences aces and toxic stress.pdf', '17546_6_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '17546_7_public health sector.pdf', '17546_8_early childhood sector.pdf', '17546_4_from adversity to resilience in the education sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']",9,90.0,"['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Healthcare-Sector-Brief_12092020.pdf?emrc=1f10ac', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Social-Services-Sector-Brief_12092020.pdf?emrc=ff0d6f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/SG-Report_Preso_ACEs-Aware.pdf?emrc=510dab', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Cost-of-ACEs_CA_OSG-Report_12092020.pdf?emrc=74439c', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/Executive-Summary_Roadmap-for-Resilience_CA_OSG-Report_12092020.pdf?emrc=b9ce44', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Public-Health-Sector-Brief_12092020.pdf?emrc=151d2f', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Early-Childhood-Sector-Brief_12092020.pdf?emrc=68953e', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Education-Sector-Brief_12092020.pdf?emrc=c1f916']","['17546_3_from adversity to resilience in the healthcare sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '17546_2_from adversity to resilience in the justice sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '17546_1_social services sector.pdf', '17546_9_roadmap for resilience.pdf', '17546_5_the financial costs of adverse childhood experiences aces and toxic stress.pdf', '17546_6_executive summary – findings from roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf', '17546_7_public health sector.pdf', '17546_8_early childhood sector.pdf', '17546_4_from adversity to resilience in the education sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf']","[0.372, 0.409, 0.351, 0.329, 0.551, 0.406, 0.392, 0.349, 0.331]","[0.568, 0.581, 0.59, 0.532, 0.58, 0.578, 0.571, 0.578, 0.565]","[0.652, 0.663, 0.665, 0.625, 0.651, 0.661, 0.66, 0.665, 0.653]","[0.196, 0.19, 0.195, 0.174, 0.202, 0.202, 0.2, 0.196, 0.189]","[0.216, 0.203, 0.218, 0.186, 0.218, 0.218, 0.219, 0.217, 0.207]","[0.171, 0.16, 0.172, 0.144, 0.179, 0.171, 0.175, 0.174, 0.166]","[0.74, 0.739, 0.737, 0.732, 0.738, 0.738, 0.737, 0.741, 0.738]","[0.65, 0.651, 0.649, 0.641, 0.651, 0.651, 0.651, 0.654, 0.652]","[0.635, 0.648, 0.652, 0.604, 0.645, 0.648, 0.642, 0.648, 0.638]","[0.698, 0.691, 0.689, 0.695, 0.719, 0.701, 0.707, 0.698, 0.691]","[0.808, 0.818, 0.821, 0.796, 0.811, 0.818, 0.817, 0.815, 0.812]","[0.758, 0.769, 0.772, 0.733, 0.761, 0.766, 0.765, 0.771, 0.759]","[0.623, 0.628, 0.634, 0.614, 0.639, 0.634, 0.624, 0.619, 0.617]","[0.934, 0.938, 0.929, 0.928, 0.926, 0.935, 0.93, 0.937, 0.934]","[0.85, 0.854, 0.859, 0.837, 0.851, 0.857, 0.857, 0.855, 0.853]","[0.78, 0.783, 0.785, 0.76, 0.775, 0.785, 0.778, 0.785, 0.776]","[0.822, 0.828, 0.828, 0.803, 0.822, 0.827, 0.828, 0.828, 0.823]","[0.799, 0.805, 0.807, 0.78, 0.796, 0.806, 0.804, 0.806, 0.802]",0.388,0.571,0.655,0.194,0.211,0.168,0.738,0.65,0.64,0.699,0.813,0.762,0.626,0.932,0.853,0.779,0.823,0.801
https://doi.org/10.1016/s2468-2667(20)30082-7,impact of school closures for covid19 on the us healthcare workforce and net mortality a modelling study,17549_impact of school closures for covid19 on the us healthcare workforce and net mortality a modelling study.pdf,6,"['https://www.clevelandfed.org/publications/economic-commentary/ec-202104-covid19-and-education-a-survey-of-the-research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528894/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf', 'https://effectivehealthcare.ahrq.gov/products/allocation-scarce-resources/rapid-review', 'https://www.nber.org/papers/w27660', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf']","['COVID-19 and Education: A Survey of the Research', 'Safe school reopening under COVID-19 restrictions – Measures implemented in San Andrea Independent School in Malta', 'Holidays over: A review of actual COVID-19 school outbreaks up to September 2020', 'Resource Allocation and Pandemic Response: An Evidence Synthesis To Inform Decision Making', ""This Time It's Different: The Role of Women's Employment in a Pandemic Recession"", '173ÿ67172']","['http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528894/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf']","['17549_5_173ÿ67172.pdf', '17549_1_safe school reopening under covid19 restrictions – measures implemented in san andrea independent school in malta.pdf', '17549_2_holidays over a review of actual covid19 school outbreaks up to september 2020.pdf']",3,50.0,"['http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528894/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf']","['17549_5_173ÿ67172.pdf', '17549_1_safe school reopening under covid19 restrictions – measures implemented in san andrea independent school in malta.pdf', '17549_2_holidays over a review of actual covid19 school outbreaks up to september 2020.pdf']","[0.135, 0.094, 0.381]","[0.356, 0.565, 0.534]","[0.491, 0.642, 0.622]","[0.084, 0.162, 0.141]","[0.071, 0.186, 0.167]","[0.053, 0.138, 0.12]","[0.716, 0.714, 0.712]","[0.616, 0.615, 0.614]","[0.371, 0.678, 0.634]","[0.657, 0.673, 0.674]","[0.657, 0.833, 0.814]","[0.542, 0.785, 0.752]","[0.572, 0.65, 0.639]","[0.876, 0.945, 0.937]","[0.691, 0.864, 0.85]","[0.63, 0.762, 0.738]","[0.657, 0.827, 0.802]","[0.646, 0.787, 0.769]",0.203,0.485,0.585,0.129,0.141,0.104,0.714,0.615,0.561,0.668,0.768,0.693,0.62,0.919,0.802,0.71,0.762,0.734
https://doi.org/10.1016/s2468-2667(20)30084-0,covid19 school closures and child poverty a social crisis in the making,17550_covid19 school closures and child poverty a social crisis in the making.pdf,5,"['https://www.brookings.edu/research/rebalancing-children-first/', 'https://www.aei.org/research-products/report/rebalancing-children-first/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528894/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf', 'https://www.dir.ca.gov/dwc/MTUS/ACOEM-Guideline-COVID-19.pdf']","['Rebalancing: Children first', 'Rebalancing: Children first - AEI', 'Safe school reopening under COVID-19 restrictions – Measures implemented in San Andrea Independent School in Malta', 'Holidays over: A review of actual COVID-19 school outbreaks up to September 2020', 'ACOEM COVID-19 Guideline']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528894/pdf', 'https://www.dir.ca.gov/dwc/MTUS/ACOEM-Guideline-COVID-19.pdf']","['17550_3_holidays over a review of actual covid19 school outbreaks up to september 2020.pdf', '17550_2_safe school reopening under covid19 restrictions – measures implemented in san andrea independent school in malta.pdf', '17550_4_acoem covid19 guideline.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528894/pdf', 'https://www.dir.ca.gov/dwc/MTUS/ACOEM-Guideline-COVID-19.pdf']","['17550_3_holidays over a review of actual covid19 school outbreaks up to september 2020.pdf', '17550_2_safe school reopening under covid19 restrictions – measures implemented in san andrea independent school in malta.pdf', '17550_4_acoem covid19 guideline.pdf']","[0.106, 0.08, 0.156]","[0.51, 0.532, 0.49]","[0.609, 0.626, 0.588]","[0.12, 0.138, 0.09]","[0.128, 0.142, 0.091]","[0.106, 0.121, 0.07]","[0.713, 0.712, 0.71]","[0.608, 0.608, 0.608]","[0.601, 0.634, 0.571]","[0.66, 0.659, 0.615]","[0.804, 0.821, 0.794]","[0.723, 0.749, 0.705]","[0.608, 0.619, 0.595]","[0.936, 0.942, 0.924]","[0.826, 0.838, 0.811]","[0.722, 0.741, 0.746]","[0.78, 0.803, 0.781]","[0.756, 0.771, 0.772]",0.114,0.511,0.608,0.116,0.12,0.099,0.712,0.608,0.602,0.645,0.806,0.726,0.607,0.934,0.825,0.736,0.788,0.766
https://doi.org/10.1016/s2468-2667(20)30085-2,why inequality could spread covid19,17551_why inequality could spread covid19.pdf,2,"['https://piie.com/publications/working-papers/political-economy-pandemic-preparedness-and-effectiveness', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798550/pdf']","['The political economy of pandemic preparedness and effectiveness', 'Society of behavioral medicine statement on COVID-19 and rural health']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798550/pdf'],['17551_1_society of behavioral medicine statement on covid19 and rural health.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798550/pdf'],['17551_1_society of behavioral medicine statement on covid19 and rural health.pdf'],[0.258],[0.517],[0.624],[0.183],[0.187],[0.146],[0.721],[0.628],[0.589],[0.684],[0.799],[0.718],[0.614],[0.914],[0.835],[0.736],[0.793],[0.773],0.258,0.517,0.624,0.183,0.187,0.146,0.721,0.628,0.589,0.684,0.799,0.718,0.614,0.914,0.835,0.736,0.793,0.773
https://doi.org/10.1016/s2468-2667(20)30133-x,effects of nonpharmaceutical interventions on covid19 cases deaths and demand for hospital services in the uk a modelling study,17552_effects of nonpharmaceutical interventions on covid19 cases deaths and demand for hospital services in the uk a modelling study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf', 'https://www.nber.org/papers/w28741']","['Measures implemented in the school setting to contain the COVID‐19 pandemic: a rapid scoping review', 'Risk Perceptions and Protective Behaviors: Evidence from COVID-19 Pandemic']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf'],['17552_0_measures implemented in the school setting to contain the covid‐19 pandemic a rapid scoping review.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206727/pdf'],['17552_0_measures implemented in the school setting to contain the covid‐19 pandemic a rapid scoping review.pdf'],[0.423],[0.557],[0.642],[0.186],[0.189],[0.15],[0.732],[0.647],[0.621],[0.69],[0.801],[0.741],[0.632],[0.928],[0.859],[0.765],[0.811],[0.793],0.423,0.557,0.642,0.186,0.189,0.15,0.732,0.647,0.621,0.69,0.801,0.741,0.632,0.928,0.859,0.765,0.811,0.793
https://doi.org/10.1016/s2468-2667(20)30263-2,effect of internationally imported cases on internal spread of covid19 a mathematical modelling study,17554_effect of internationally imported cases on internal spread of covid19 a mathematical modelling study.pdf,9,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.migrationpolicy.org/research/covid19-mobility-systems-sub-saharan-africa', 'https://www.aei.org/research-products/report/international-civil-aviation-organization-united-states-should-repair-chinese-damage-and-focus-the-organization-on-its-core-mission/', 'https://www.heritage.org/global-politics/report/international-civil-aviation-organization-united-states-should-repair', 'https://www.migrationpolicy.org/research/covid-19-global-mobility-2021']","['International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review', 'A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers’ perceptions in high and low- and middle-income countries', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'From Unilateral Response to Coordinated Action: How Can Mobility Systems in Sub-Saharan Africa Adapt to the Public-Health Challenges of COVID-19?', 'International Civil Aviation Organization: United States should repair Chinese damage and focus the organization on its core mission - AEI', 'International Civil Aviation Organization: United States Should Repair Chinese Damage and Focus the Organization on Its Core Mission', 'COVID-19 and the State of Global Mobility in 2021']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['17554_3_master question list for covid19 caused by sarscov2.pdf', '17554_2_master question list for covid19 caused by sarscov2.pdf', '17554_1_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf', '17554_0_international travel‐related control measures to contain the covid‐19 pandemic a rapid review.pdf', '17554_4_master question list for covid19 caused by sarscov2.pdf']",5,55.56,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf']","['17554_3_master question list for covid19 caused by sarscov2.pdf', '17554_2_master question list for covid19 caused by sarscov2.pdf', '17554_1_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf', '17554_0_international travel‐related control measures to contain the covid‐19 pandemic a rapid review.pdf']","[0.386, 0.237, 0.262, 0.27]","[0.564, 0.562, 0.535, 0.55]","[0.653, 0.65, 0.625, 0.635]","[0.17, 0.172, 0.176, 0.178]","[0.177, 0.178, 0.183, 0.186]","[0.145, 0.146, 0.148, 0.154]","[0.737, 0.737, 0.728, 0.729]","[0.65, 0.65, 0.641, 0.638]","[0.647, 0.645, 0.599, 0.618]","[0.658, 0.663, 0.684, 0.702]","[0.816, 0.814, 0.799, 0.797]","[0.761, 0.759, 0.698, 0.723]","[0.649, 0.649, 0.621, 0.638]","[0.928, 0.928, 0.918, 0.923]","[0.852, 0.851, 0.847, 0.845]","[0.782, 0.78, 0.755, 0.759]","[0.825, 0.823, 0.804, 0.805]","[0.806, 0.803, 0.785, 0.783]",0.289,0.553,0.641,0.174,0.181,0.148,0.733,0.645,0.627,0.677,0.806,0.735,0.639,0.924,0.849,0.769,0.814,0.794
https://doi.org/10.1016/s2468-2667(20)30308-x,quarantine and testing strategies in contact tracing for sarscov2 a modelling study,17555_quarantine and testing strategies in contact tracing for sarscov2 a modelling study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/pdf', 'https://www.federalregister.gov/documents/2021/06/21/2021-12428/occupational-exposure-to-covid-19-emergency-temporary-standard', 'https://stacks.cdc.gov/view/cdc/101656']","['Revisiting the guidelines for ending isolation for COVID-19 patients', 'Occupational Exposure to COVID-19; Emergency Temporary Standard', 'COVID-19 science update ; Edition 2021-01-29 (74)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/pdf'],['17555_0_revisiting the guidelines for ending isolation for covid19 patients.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/pdf'],['17555_0_revisiting the guidelines for ending isolation for covid19 patients.pdf'],[0.306],[0.566],[0.658],[0.206],[0.21],[0.166],[0.745],[0.663],[0.63],[0.694],[0.807],[0.742],[0.64],[0.923],[0.847],[0.771],[0.808],[0.79],0.306,0.566,0.658,0.206,0.21,0.166,0.745,0.663,0.63,0.694,0.807,0.742,0.64,0.923,0.847,0.771,0.808,0.79
https://doi.org/10.1016/s2468-2667(21)00102-x,spatial temporal and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories 1990–2019,17556_spatial temporal and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories 1990–2019.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733777/pdf'],['Heated tobacco products for smoking cessation and reducing smoking prevalence'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733777/pdf'],['17556_0_heated tobacco products for smoking cessation and reducing smoking prevalence.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733777/pdf'],['17556_0_heated tobacco products for smoking cessation and reducing smoking prevalence.pdf'],[0.437],[0.513],[0.607],[0.178],[0.186],[0.151],[0.735],[0.639],[0.568],[0.718],[0.771],[0.705],[0.585],[0.91],[0.816],[0.722],[0.777],[0.746],0.437,0.513,0.607,0.178,0.186,0.151,0.735,0.639,0.568,0.718,0.771,0.705,0.585,0.91,0.816,0.722,0.777,0.746
https://doi.org/10.1016/s2589-7500(21)00017-0,indirect acute effects of the covid19 pandemic on physical and mental health in the uk a populationbased study,17561_indirect acute effects of the covid19 pandemic on physical and mental health in the uk a populationbased study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf'],['A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers’ perceptions in high and low- and middle-income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf'],['17561_0_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf'],['17561_0_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf'],[0.274],[0.532],[0.624],[0.17],[0.178],[0.143],[0.729],[0.644],[0.593],[0.683],[0.8],[0.692],[0.609],[0.92],[0.847],[0.749],[0.802],[0.782],0.274,0.532,0.624,0.17,0.178,0.143,0.729,0.644,0.593,0.683,0.8,0.692,0.609,0.92,0.847,0.749,0.802,0.782
https://doi.org/10.1016/s2665-9913(20)30096-5,silencing the cytokine storm the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome,17562_silencing the cytokine storm the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 1'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['17562_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['17562_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],[0.346],[0.573],[0.65],[0.176],[0.182],[0.142],[0.747],[0.655],[0.637],[0.647],[0.816],[0.741],[0.632],[0.931],[0.837],[0.78],[0.814],[0.799],0.346,0.573,0.65,0.176,0.182,0.142,0.747,0.655,0.637,0.647,0.816,0.741,0.632,0.931,0.837,0.78,0.814,0.799
https://doi.org/10.1016/s2666-5247(20)30121-x,assessing a novel labfree pointofcare test for sarscov2 covidnudge a diagnostic accuracy study,17565_assessing a novel labfree pointofcare test for sarscov2 covidnudge a diagnostic accuracy study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/pdf', 'https://stacks.cdc.gov/view/cdc/94564']","['Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection', 'COVID-19 science update ; Edition 2020-09-29']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/pdf'],['17565_0_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/pdf'],['17565_0_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf'],[0.442],[0.523],[0.611],[0.167],[0.167],[0.141],[0.738],[0.648],[0.581],[0.697],[0.778],[0.714],[0.611],[0.904],[0.821],[0.728],[0.786],[0.755],0.442,0.523,0.611,0.167,0.167,0.141,0.738,0.648,0.581,0.697,0.778,0.714,0.611,0.904,0.821,0.728,0.786,0.755
https://doi.org/10.1017/9780511777127.012,sexually harmful behaviour in young people,17572_sexually harmful behaviour in young people.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387234/pdf'],['Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387234/pdf'],['17572_0_cognitive‐behavioural therapy cbt interventions for young people aged 10 to 18 with harmful sexual behaviour.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387234/pdf'],['17572_0_cognitive‐behavioural therapy cbt interventions for young people aged 10 to 18 with harmful sexual behaviour.pdf'],[0.509],[0.541],[0.621],[0.179],[0.197],[0.174],[0.735],[0.639],[0.591],[0.688],[0.787],[0.709],[0.609],[0.909],[0.83],[0.741],[0.791],[0.772],0.509,0.541,0.621,0.179,0.197,0.174,0.735,0.639,0.591,0.688,0.787,0.709,0.609,0.909,0.83,0.741,0.791,0.772
https://doi.org/10.1017/cbo9780511499470.017,cambridge studies in criminology,17585_cambridge studies in criminology.pdf,1,['https://purl.fdlp.gov/GPO/gpo121975'],['Vocational/job training (United States. Office of Juvenile Justice and Delinquency Prevention)'],['https://purl.fdlp.gov/GPO/gpo121975'],['17585_0_vocationaljob training united states office of juvenile justice and delinquency prevention.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo121975'],['17585_0_vocationaljob training united states office of juvenile justice and delinquency prevention.pdf'],[0.069],[0.598],[0.693],[0.202],[0.226],[0.195],[0.745],[0.675],[0.69],[0.718],[0.762],[0.778],[0.669],[0.935],[0.861],[0.795],[0.818],[0.835],0.069,0.598,0.693,0.202,0.226,0.195,0.745,0.675,0.69,0.718,0.762,0.778,0.669,0.935,0.861,0.795,0.818,0.835
https://doi.org/10.1017/cbo9780511521232.009,is contact with nature important for healthy child development state of the evidence,17593_is contact with nature important for healthy child development state of the evidence.pdf,1,['https://purl.fdlp.gov/GPO/gpo119750'],['The constraints of connecting children with nature :\xa0a research literature review /'],['https://purl.fdlp.gov/GPO/gpo119750'],['17593_0_the constraints of connecting children with nature \xa0a research literature review .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo119750'],['17593_0_the constraints of connecting children with nature \xa0a research literature review .pdf'],[0.446],[0.564],[0.65],[0.19],[0.2],[0.167],[0.735],[0.638],[0.617],[0.698],[0.807],[0.741],[0.655],[0.916],[0.849],[0.78],[0.817],[0.799],0.446,0.564,0.65,0.19,0.2,0.167,0.735,0.638,0.617,0.698,0.807,0.741,0.655,0.916,0.849,0.78,0.817,0.799
https://doi.org/10.1017/cbo9780511526800.004,epidemiology of early onset schizophrenia,17597_epidemiology of early onset schizophrenia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593251/pdf'],['Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593251/pdf'],['17597_0_canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593251/pdf'],['17597_0_canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth.pdf'],[0.395],[0.527],[0.62],[0.176],[0.191],[0.161],[0.739],[0.647],[0.585],[0.688],[0.796],[0.715],[0.611],[0.92],[0.82],[0.757],[0.799],[0.782],0.395,0.527,0.62,0.176,0.191,0.161,0.739,0.647,0.585,0.688,0.796,0.715,0.611,0.92,0.82,0.757,0.799,0.782
https://doi.org/10.1017/cbo9780511529320.008,protective factors and individual resilience,17602_protective factors and individual resilience.pdf,1,['https://purl.fdlp.gov/GPO/gpo122617'],['Protective factors against delinquency.'],['https://purl.fdlp.gov/GPO/gpo122617'],['17602_0_protective factors against delinquency.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo122617'],['17602_0_protective factors against delinquency.pdf'],[0.483],[0.551],[0.64],[0.185],[0.203],[0.177],[0.739],[0.645],[0.611],[0.706],[0.808],[0.739],[0.643],[0.921],[0.841],[0.767],[0.818],[0.802],0.483,0.551,0.64,0.185,0.203,0.177,0.739,0.645,0.611,0.706,0.808,0.739,0.643,0.921,0.841,0.767,0.818,0.802
https://doi.org/10.1017/cbo9780511816840.026,violent juvenile delinquency changes consequences and implications,17648_violent juvenile delinquency changes consequences and implications.pdf,1,['https://purl.fdlp.gov/GPO/gpo83819'],"['Young offenders and an effective response in the juvenile and adult justice systems :\xa0what happens, what should happen, and what we need to know /']",['https://purl.fdlp.gov/GPO/gpo83819'],['17648_0_young offenders and an effective response in the juvenile and adult justice systems \xa0what happens what should happen and what we need to know .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo83819'],['17648_0_young offenders and an effective response in the juvenile and adult justice systems \xa0what happens what should happen and what we need to know .pdf'],[0.62],[0.519],[0.608],[0.2],[0.221],[0.193],[0.732],[0.636],[0.571],[0.711],[0.779],[0.72],[0.626],[0.923],[0.826],[0.752],[0.796],[0.782],0.62,0.519,0.608,0.2,0.221,0.193,0.732,0.636,0.571,0.711,0.779,0.72,0.626,0.923,0.826,0.752,0.796,0.782
https://doi.org/10.1017/cbo9781107284241.023,interconnecting school mental health and schoolwide positive behavior support,17650_interconnecting school mental health and schoolwide positive behavior support.pdf,1,['https://mhsoac.ca.gov/wp-content/uploads/schools_as_centers_of_wellness_final-2.pdf'],['Every Young Heart and Mind: Schools as Centers of Wellness'],['https://mhsoac.ca.gov/wp-content/uploads/schools_as_centers_of_wellness_final-2.pdf'],['17650_0_every young heart and mind schools as centers of wellness.pdf'],1,100.0,['https://mhsoac.ca.gov/wp-content/uploads/schools_as_centers_of_wellness_final-2.pdf'],['17650_0_every young heart and mind schools as centers of wellness.pdf'],[0.787],[0.575],[0.656],[0.216],[0.246],[0.203],[0.745],[0.658],[0.645],[0.696],[0.819],[0.76],[0.66],[0.928],[0.855],[0.795],[0.832],[0.812],0.787,0.575,0.656,0.216,0.246,0.203,0.745,0.658,0.645,0.696,0.819,0.76,0.66,0.928,0.855,0.795,0.832,0.812
https://doi.org/10.1017/cbo9781107784758.011,puerperal sepsis in low and middleincome settings past present and future,17653_puerperal sepsis in low and middleincome settings past present and future.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486135/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485970/pdf']","['Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity', 'Antibiotic prophylaxis for episiotomy repair following vaginal birth']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486135/pdf']","['17653_1_antibiotic prophylaxis for episiotomy repair following vaginal birth.pdf', '17653_0_routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485970/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486135/pdf']","['17653_1_antibiotic prophylaxis for episiotomy repair following vaginal birth.pdf', '17653_0_routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity.pdf']","[0.412, 0.39]","[0.569, 0.561]","[0.657, 0.649]","[0.177, 0.184]","[0.189, 0.195]","[0.147, 0.153]","[0.738, 0.738]","[0.642, 0.643]","[0.636, 0.628]","[0.641, 0.648]","[0.808, 0.804]","[0.743, 0.729]","[0.62, 0.623]","[0.926, 0.923]","[0.839, 0.837]","[0.769, 0.764]","[0.811, 0.806]","[0.79, 0.783]",0.401,0.565,0.653,0.18,0.192,0.15,0.738,0.643,0.632,0.645,0.806,0.736,0.621,0.925,0.838,0.766,0.808,0.786
https://doi.org/10.1017/cbo9781139167284.004,economic returns of investments in preschool education,17656_economic returns of investments in preschool education.pdf,4,"['https://www.nber.org/papers/w21766', 'http://mgaleg.maryland.gov/pubs/commtfworkgrp/2016-innovation-excellence-in-education-commission-2016-12-08.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/2016-12-08_APAReportDated11-30-2016.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/AppendixFSchoolCaseStudies113016.pdf']","['Early Childhood Education', 'William E. Kirwan, Chair', '2016 - Final Report of the Study of Adequacy of Funding for Education In Maryland', 'Final Report of the Study of Adequacy of Funding for Education in Maryland: Appendix F and Case Studies']","['http://mgaleg.maryland.gov/pubs/commtfworkgrp/2016-innovation-excellence-in-education-commission-2016-12-08.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/2016-12-08_APAReportDated11-30-2016.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/AppendixFSchoolCaseStudies113016.pdf']","['17656_1_william e kirwan chair.pdf', '17656_2_2016  final report of the study of adequacy of funding for education in maryland.pdf', '17656_3_final report of the study of adequacy of funding for education in maryland appendix f and case studies.pdf']",3,75.0,"['http://mgaleg.maryland.gov/pubs/commtfworkgrp/2016-innovation-excellence-in-education-commission-2016-12-08.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/2016-12-08_APAReportDated11-30-2016.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/AppendixFSchoolCaseStudies113016.pdf']","['17656_1_william e kirwan chair.pdf', '17656_2_2016  final report of the study of adequacy of funding for education in maryland.pdf', '17656_3_final report of the study of adequacy of funding for education in maryland appendix f and case studies.pdf']","[0.439, 0.438, 0.401]","[0.554, 0.557, 0.557]","[0.629, 0.631, 0.629]","[0.187, 0.188, 0.187]","[0.2, 0.201, 0.198]","[0.169, 0.17, 0.167]","[0.726, 0.726, 0.726]","[0.63, 0.63, 0.63]","[0.642, 0.645, 0.645]","[0.7, 0.7, 0.698]","[0.815, 0.817, 0.818]","[0.76, 0.763, 0.765]","[0.667, 0.668, 0.666]","[0.932, 0.932, 0.933]","[0.857, 0.858, 0.857]","[0.788, 0.79, 0.791]","[0.828, 0.829, 0.831]","[0.807, 0.808, 0.808]",0.426,0.556,0.63,0.187,0.2,0.169,0.726,0.63,0.644,0.699,0.817,0.763,0.667,0.932,0.857,0.79,0.829,0.808
https://doi.org/10.1017/s0012162201000949,life expectancy among people with cerebral palsy in western australia,17739_life expectancy among people with cerebral palsy in western australia.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews', 'Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['17739_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '17739_1_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483544/pdf']","['17739_0_neonatal interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf', '17739_1_antenatal and intrapartum interventions for preventing cerebral palsy an overview of cochrane systematic reviews.pdf']","[0.271, 0.273]","[0.525, 0.517]","[0.613, 0.606]","[0.173, 0.163]","[0.177, 0.167]","[0.145, 0.134]","[0.739, 0.734]","[0.642, 0.636]","[0.583, 0.578]","[0.692, 0.685]","[0.771, 0.772]","[0.703, 0.703]","[0.61, 0.609]","[0.89, 0.896]","[0.79, 0.789]","[0.704, 0.712]","[0.773, 0.774]","[0.726, 0.733]",0.272,0.521,0.609,0.168,0.172,0.14,0.736,0.639,0.581,0.689,0.772,0.703,0.609,0.893,0.79,0.708,0.774,0.73
https://doi.org/10.1017/s0012162203000732,electrical stimulation of gluteus maximus in children with cerebral palsy effects on gait characteristics and muscle strength,17747_electrical stimulation of gluteus maximus in children with cerebral palsy effects on gait characteristics and muscle strength.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481791/pdf'],['Exercise interventions for cerebral palsy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481791/pdf'],['17747_0_exercise interventions for cerebral palsy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481791/pdf'],['17747_0_exercise interventions for cerebral palsy.pdf'],[0.317],[0.519],[0.61],[0.163],[0.17],[0.129],[0.735],[0.638],[0.58],[0.686],[0.77],[0.71],[0.6],[0.901],[0.807],[0.717],[0.778],[0.741],0.317,0.519,0.61,0.163,0.17,0.129,0.735,0.638,0.58,0.686,0.77,0.71,0.6,0.901,0.807,0.717,0.778,0.741
https://doi.org/10.1017/s001216220400091x,care provider assessment of intrathecal baclofen in children,17751_care provider assessment of intrathecal baclofen in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361875/pdf'],['Intrathecal baclofen for treating spasticity in children with cerebral palsy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361875/pdf'],['17751_0_intrathecal baclofen for treating spasticity in children with cerebral palsy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361875/pdf'],['17751_0_intrathecal baclofen for treating spasticity in children with cerebral palsy.pdf'],[0.463],[0.547],[0.638],[0.184],[0.207],[0.16],[0.737],[0.642],[0.618],[0.666],[0.803],[0.725],[0.632],[0.929],[0.836],[0.763],[0.804],[0.786],0.463,0.547,0.638,0.184,0.207,0.16,0.737,0.642,0.618,0.666,0.803,0.725,0.632,0.929,0.836,0.763,0.804,0.786
https://doi.org/10.1017/s0012162206001745,initial development and validation of the caregiver priorities and child health index of life with disabilities cpchild,17766_initial development and validation of the caregiver priorities and child health index of life with disabilities cpchild.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779591/pdf'],['Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779591/pdf'],['17766_0_botulinum toxin type a in the treatment of lower limb spasticity in children with cerebral palsy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779591/pdf'],['17766_0_botulinum toxin type a in the treatment of lower limb spasticity in children with cerebral palsy.pdf'],[0.28],[0.507],[0.589],[0.137],[0.146],[0.124],[0.729],[0.629],[0.568],[0.703],[0.759],[0.693],[0.595],[0.906],[0.807],[0.718],[0.766],[0.746],0.28,0.507,0.589,0.137,0.146,0.124,0.729,0.629,0.568,0.703,0.759,0.693,0.595,0.906,0.807,0.718,0.766,0.746
https://doi.org/10.1017/s0022050704313124,forests in time the environmental consequences of 1000 years of change in new england edited by david r foster and john d aber new haven ct yale university press 2004 pp xiv 477 4500,17808_forests in time the environmental consequences of 1000 years of change in new england edited by david r foster and john d aber new haven ct yale university press 2004 pp xiv 477 4500.pdf,2,"['https://purl.fdlp.gov/GPO/gpo80285', 'https://www.wri.org/publication/restoration-diagnostic']","['Forests of Vermont and New Hampshire, 2012 /', 'The Restoration Diagnostic']",['https://purl.fdlp.gov/GPO/gpo80285'],['17808_0_forests of vermont and new hampshire 2012 .pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo80285'],['17808_0_forests of vermont and new hampshire 2012 .pdf'],[0.189],[0.509],[0.596],[0.084],[0.07],[0.061],[0.708],[0.605],[0.589],[0.653],[0.803],[0.751],[0.648],[0.909],[0.833],[0.77],[0.814],[0.789],0.189,0.509,0.596,0.084,0.07,0.061,0.708,0.605,0.589,0.653,0.803,0.751,0.648,0.909,0.833,0.77,0.814,0.789
https://doi.org/10.1017/s0033291701004809,early adolescent marijuana use risks for the transition to young adulthood,17842_early adolescent marijuana use risks for the transition to young adulthood.pdf,6,"['http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://doh.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/Marijuana%20Report%20Final%2005%2016%2016.pdf', 'https://www.rand.org/pubs/reprints/RP1192.html', 'https://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['Return on Investment: Evidence-Based Options to Improve Statewide Outcomes <br/> April 2012 Update - Technical Appendix', 'MARIJUANA in the DISTRICT OF COLUMBIA', 'Marijuana Use from Adolescence to Young Adulthood', 'Return on Investment : Evidence-Based Options to Improve Statewide Outcomes', 'Appendix', 'December 2019']","['http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'https://doh.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/Marijuana%20Report%20Final%2005%2016%2016.pdf', 'https://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['17842_4_appendix.pdf', '17842_1_marijuana in the district of columbia.pdf', '17842_3_return on investment  evidencebased options to improve statewide outcomes.pdf', '17842_0_return on investment evidencebased options to improve statewide outcomes br april 2012 update  technical appendix.pdf', '17842_5_december 2019.pdf']",5,83.33,"['http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'https://doh.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/Marijuana%20Report%20Final%2005%2016%2016.pdf', 'https://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['17842_4_appendix.pdf', '17842_1_marijuana in the district of columbia.pdf', '17842_3_return on investment  evidencebased options to improve statewide outcomes.pdf', '17842_0_return on investment evidencebased options to improve statewide outcomes br april 2012 update  technical appendix.pdf', '17842_5_december 2019.pdf']","[0.257, 0.54, 0.257, 0.279, 0.279]","[0.524, 0.533, 0.534, 0.534, 0.524]","[0.617, 0.627, 0.626, 0.626, 0.617]","[0.132, 0.183, 0.138, 0.138, 0.132]","[0.148, 0.202, 0.153, 0.153, 0.148]","[0.115, 0.167, 0.118, 0.118, 0.115]","[0.721, 0.731, 0.72, 0.72, 0.721]","[0.623, 0.637, 0.622, 0.622, 0.623]","[0.585, 0.602, 0.598, 0.598, 0.585]","[0.684, 0.673, 0.687, 0.687, 0.684]","[0.783, 0.806, 0.793, 0.793, 0.783]","[0.719, 0.747, 0.732, 0.732, 0.719]","[0.626, 0.637, 0.635, 0.635, 0.626]","[0.918, 0.922, 0.923, 0.923, 0.918]","[0.813, 0.834, 0.822, 0.822, 0.813]","[0.754, 0.764, 0.762, 0.762, 0.754]","[0.79, 0.808, 0.799, 0.799, 0.79]","[0.771, 0.788, 0.78, 0.78, 0.771]",0.322,0.53,0.623,0.145,0.161,0.127,0.723,0.625,0.594,0.683,0.792,0.73,0.632,0.921,0.821,0.759,0.797,0.778
https://doi.org/10.1017/s003329171400172x,the epidemiology and global burden of autism spectrum disorders,17869_the epidemiology and global burden of autism spectrum disorders.pdf,2,"['https://cei.org/content/fanning-flames', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098105/pdf']","['Fanning the Flames', 'Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098105/pdf'],['17869_1_introduction and methods of the evidencebased guidelines for the diagnosis and management of autism spectrum disorder by the italian national institute of health.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098105/pdf'],['17869_1_introduction and methods of the evidencebased guidelines for the diagnosis and management of autism spectrum disorder by the italian national institute of health.pdf'],[0.255],[0.528],[0.619],[0.145],[0.169],[0.13],[0.724],[0.629],[0.601],[0.707],[0.794],[0.729],[0.609],[0.921],[0.838],[0.759],[0.806],[0.786],0.255,0.528,0.619,0.145,0.169,0.13,0.724,0.629,0.601,0.707,0.794,0.729,0.609,0.921,0.838,0.759,0.806,0.786
https://doi.org/10.1017/s003329171900388x,longterm cardiac outcomes of depression screening diagnosis and treatment in patients with acute coronary syndrome the depacs study,17877_longterm cardiac outcomes of depression screening diagnosis and treatment in patients with acute coronary syndrome the depacs study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673695/pdf'],['Psychological and pharmacological interventions for depression in patients with coronary artery disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673695/pdf'],['17877_0_psychological and pharmacological interventions for depression in patients with coronary artery disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673695/pdf'],['17877_0_psychological and pharmacological interventions for depression in patients with coronary artery disease.pdf'],[0.488],[0.499],[0.59],[0.175],[0.177],[0.152],[0.741],[0.652],[0.56],[0.714],[0.759],[0.677],[0.586],[0.901],[0.787],[0.715],[0.76],[0.745],0.488,0.499,0.59,0.175,0.177,0.152,0.741,0.652,0.56,0.714,0.759,0.677,0.586,0.901,0.787,0.715,0.76,0.745
https://doi.org/10.1017/s003329172000241x,emotional distress in young adults during the covid19 pandemic evidence of risk and resilience from a longitudinal cohort study,17878_emotional distress in young adults during the covid19 pandemic evidence of risk and resilience from a longitudinal cohort study.pdf,4,"['https://www.congress.gov/event/116th-congress/house-event/111061', 'https://schoolsafety.dbs.idaho.gov/wp-content/uploads/sites/106/2021/06/DHS-Mitigating-the-Threat-of-School-Violence-as-US-Returns-to-Normal.pdf', 'https://www.dhs.gov/sites/default/files/publications/school_targeted_violence_awareness_bulletin.pdf', 'https://www.dhs.gov/sites/default/files/publications/school_targeted_violence_awareness_bulletin_-_final_0.pdf']","['Coping with Compound Crises: Extreme Weather, Social Injustice, and a Global Pandemic', 'Mitigating the Threat of School Violence as the U.S. ""Returns to Normal"" from the COVID-19 Pandemic and Beyond', 'Mitigating the Threat of School Violence as the U.S. ""Returns to Normal"" from the COVID-19 Pandemic and Beyond', 'Mitigating the Threat of School Violence as the U.S. ""Returns to Normal"" from the COVID-19 Pandemic and Beyond']","['https://www.dhs.gov/sites/default/files/publications/school_targeted_violence_awareness_bulletin.pdf', 'https://www.dhs.gov/sites/default/files/publications/school_targeted_violence_awareness_bulletin_-_final_0.pdf']","['17878_2_mitigating the threat of school violence as the us returns to normal from the covid19 pandemic and beyond.pdf', '17878_3_mitigating the threat of school violence as the us returns to normal from the covid19 pandemic and beyond.pdf']",2,50.0,"['https://www.dhs.gov/sites/default/files/publications/school_targeted_violence_awareness_bulletin.pdf', 'https://www.dhs.gov/sites/default/files/publications/school_targeted_violence_awareness_bulletin_-_final_0.pdf']","['17878_2_mitigating the threat of school violence as the us returns to normal from the covid19 pandemic and beyond.pdf', '17878_3_mitigating the threat of school violence as the us returns to normal from the covid19 pandemic and beyond.pdf']","[0.222, 0.222]","[0.534, 0.534]","[0.624, 0.624]","[0.158, 0.159]","[0.173, 0.173]","[0.142, 0.142]","[0.73, 0.73]","[0.635, 0.634]","[0.59, 0.59]","[0.674, 0.673]","[0.79, 0.79]","[0.711, 0.711]","[0.634, 0.634]","[0.915, 0.915]","[0.818, 0.818]","[0.754, 0.754]","[0.797, 0.797]","[0.766, 0.766]",0.222,0.534,0.624,0.159,0.173,0.142,0.73,0.635,0.59,0.673,0.79,0.711,0.634,0.915,0.818,0.754,0.797,0.766
https://doi.org/10.1017/s0098858800002707,coming of age devising legislation for adolescent medical decisionmaking,17889_coming of age devising legislation for adolescent medical decisionmaking.pdf,2,"['https://poverty.umich.edu/publications/a-way-home-why-supporting-youth-experiencing-homelessness-is-critical-in-michigan/', 'https://www.psychology.ca.gov/about_us/meetings/materials/20121018_7j_supporting.pdf']","['» A Way Home: Why Supporting Youth Experiencing Homelessness is Critical in Michigan', 'Report of the American Psychological Association Task Force on Appropriate Therapeutic Responses to Sexual Orientation']",['https://www.psychology.ca.gov/about_us/meetings/materials/20121018_7j_supporting.pdf'],['17889_1_report of the american psychological association task force on appropriate therapeutic responses to sexual orientation.pdf'],1,50.0,['https://www.psychology.ca.gov/about_us/meetings/materials/20121018_7j_supporting.pdf'],['17889_1_report of the american psychological association task force on appropriate therapeutic responses to sexual orientation.pdf'],[0.198],[0.491],[0.581],[0.119],[0.133],[0.112],[0.726],[0.626],[0.55],[0.67],[0.765],[0.679],[0.606],[0.908],[0.807],[0.734],[0.761],[0.751],0.198,0.491,0.581,0.119,0.133,0.112,0.726,0.626,0.55,0.67,0.765,0.679,0.606,0.908,0.807,0.734,0.761,0.751
https://doi.org/10.1017/s0144686x04003332,the prevalence of and risk factors for loneliness in later life a survey of older people in great britain,17899_the prevalence of and risk factors for loneliness in later life a survey of older people in great britain.pdf,1,['https://aging.idaho.gov/wp-content/uploads/2020/05/The-Missing-Million-report-FINAL.pdf'],['The Missing Million: searching for the loneliest in our communities'],['https://aging.idaho.gov/wp-content/uploads/2020/05/The-Missing-Million-report-FINAL.pdf'],['17899_0_the missing million searching for the loneliest in our communities.pdf'],1,100.0,['https://aging.idaho.gov/wp-content/uploads/2020/05/The-Missing-Million-report-FINAL.pdf'],['17899_0_the missing million searching for the loneliest in our communities.pdf'],[0.353],[0.544],[0.635],[0.159],[0.187],[0.15],[0.728],[0.633],[0.632],[0.699],[0.807],[0.752],[0.635],[0.908],[0.862],[0.772],[0.808],[0.786],0.353,0.544,0.635,0.159,0.187,0.15,0.728,0.633,0.632,0.699,0.807,0.752,0.635,0.908,0.862,0.772,0.808,0.786
https://doi.org/10.1017/s0954579401004072,child maltreatment and the early onset of problem behaviors can a program of nurse home visitation break the link,17969_child maltreatment and the early onset of problem behaviors can a program of nurse home visitation break the link.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://www.acf.hhs.gov/opre/report/design-mother-and-infant-home-visiting-program-evaluation-long-term-follow-up', 'https://www.acf.hhs.gov/opre/report/evidence-long-term-effects-home-visiting-programs-laying-groundwork-long-term-follow', 'https://mn.gov/dhs/assets/model-benefit-set-guide-grid-evidence-11-5-4_tcm1053-254514.pdf', 'https://www.acf.hhs.gov/opre/resource/evidence-long-term-effects-home-visiting-programs-laying-the-groundwork-long-term-follow-up']","['Home visits during pregnancy and after birth for women with an alcohol or drug problem', 'Design of the Mother and Infant Home Visiting Program Evaluation Long-Term Follow-Up', 'Evidence on the Long-Term Effects of Home Visiting Programs: Laying the Groundwork for Long-Term Follow-Up in the Mother and Infant Home Visiting Program Evaluation (MIHOPE)', 'MMHAG Eviidence-Based Modell Benefiit Set - Treatments and Necessary Supports for Mental and Co-Existing Chemical Health Disorders', 'Evidence on the Long-Term Effects of Home Visiting Programs: Laying the Groundwork for Long-Term Follow-Up in the Mother and Infant Home Visiting Program Evaluation (MIHOPE)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf'],['17969_0_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf'],1,20.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf'],['17969_0_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf'],[0.204],[0.523],[0.595],[0.168],[0.159],[0.138],[0.731],[0.634],[0.57],[0.682],[0.772],[0.686],[0.57],[0.906],[0.795],[0.726],[0.774],[0.751],0.204,0.523,0.595,0.168,0.159,0.138,0.731,0.634,0.57,0.682,0.772,0.686,0.57,0.906,0.795,0.726,0.774,0.751
https://doi.org/10.1017/s0954579401004114,the importance of timing the varying impact of childhood and adolescent maltreatment on multiple problem outcomes,17971_the importance of timing the varying impact of childhood and adolescent maltreatment on multiple problem outcomes.pdf,7,"['https://www.acf.hhs.gov/opre/report/nscaw-adolescents-involved-child-welfare-transition-adulthood', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'http://sac.ofm.wa.gov/sites/all/themes/wasac/assets/docs/gender_racial_differences_in_outcomes.pdf', 'https://www.acf.hhs.gov/opre/resource/nscaw-adolescents-involved-with-child-welfare-a-transition-to-adulthood', 'https://sac.ofm.wa.gov/sites/all/themes/wasac/assets/docs/gender_racial_differences_in_outcomes.pdf', 'https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['NSCAW, Adolescents Involved with Child Welfare: A Transition to Adulthood', 'Return on Investment: Evidence-Based Options to Improve Statewide Outcomes <br/> April 2012 Update - Technical Appendix', 'School Engagement and Juvenile Offending Among Maltreated Youth Who Vary by Race/ Ethnicity, Gender, and Type of Child Maltreatment', 'NSCAW, Adolescents Involved with Child Welfare: A Transition to Adulthood', 'School Engagement and Juvenile Offending Among Maltreated Youth Who Vary by Race / Ethnicity, Gender, and Type of Child Maltreatment', 'December 2019', 'Appendix']","['https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'http://sac.ofm.wa.gov/sites/all/themes/wasac/assets/docs/gender_racial_differences_in_outcomes.pdf', 'https://sac.ofm.wa.gov/sites/all/themes/wasac/assets/docs/gender_racial_differences_in_outcomes.pdf', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['17971_5_december 2019.pdf', '17971_1_return on investment evidencebased options to improve statewide outcomes br april 2012 update  technical appendix.pdf', '17971_2_school engagement and juvenile offending among maltreated youth who vary by race ethnicity gender and type of child maltreatment.pdf', '17971_4_school engagement and juvenile offending among maltreated youth who vary by race  ethnicity gender and type of child maltreatment.pdf', '17971_6_appendix.pdf']",5,71.43,"['https://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf', 'http://www.wsipp.wa.gov/ReportFile/1387/Wsipp_Return-on-Investment-Evidence-Based-Options-to-Improve-Statewide-Outcomes-April-2012-Update_Technical-Appendix.pdf', 'http://sac.ofm.wa.gov/sites/all/themes/wasac/assets/docs/gender_racial_differences_in_outcomes.pdf', 'https://sac.ofm.wa.gov/sites/all/themes/wasac/assets/docs/gender_racial_differences_in_outcomes.pdf', 'http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf']","['17971_5_december 2019.pdf', '17971_1_return on investment evidencebased options to improve statewide outcomes br april 2012 update  technical appendix.pdf', '17971_2_school engagement and juvenile offending among maltreated youth who vary by race ethnicity gender and type of child maltreatment.pdf', '17971_4_school engagement and juvenile offending among maltreated youth who vary by race  ethnicity gender and type of child maltreatment.pdf', '17971_6_appendix.pdf']","[0.28, 0.339, 0.339, 0.298, 0.298]","[0.528, 0.538, 0.497, 0.497, 0.528]","[0.612, 0.62, 0.592, 0.592, 0.612]","[0.138, 0.145, 0.175, 0.175, 0.138]","[0.154, 0.16, 0.19, 0.19, 0.154]","[0.119, 0.126, 0.164, 0.164, 0.119]","[0.725, 0.725, 0.731, 0.731, 0.725]","[0.628, 0.627, 0.633, 0.633, 0.628]","[0.59, 0.601, 0.555, 0.555, 0.59]","[0.694, 0.698, 0.715, 0.715, 0.694]","[0.786, 0.796, 0.768, 0.768, 0.786]","[0.72, 0.733, 0.702, 0.702, 0.72]","[0.636, 0.644, 0.629, 0.629, 0.636]","[0.918, 0.922, 0.91, 0.91, 0.918]","[0.821, 0.83, 0.808, 0.808, 0.821]","[0.763, 0.77, 0.745, 0.745, 0.763]","[0.797, 0.805, 0.776, 0.776, 0.797]","[0.778, 0.787, 0.761, 0.761, 0.778]",0.311,0.518,0.606,0.154,0.17,0.138,0.727,0.63,0.578,0.703,0.781,0.715,0.635,0.916,0.818,0.757,0.79,0.773
https://doi.org/10.1017/s1074070800020678,landowner decision making about riparian buffers,18096_landowner decision making about riparian buffers.pdf,2,"['https://www.lrl.mn.gov/docs/2010/mandated/100433.pdf', 'https://purl.fdlp.gov/GPO/gpo87614']","['Study of Riparian Buffer Areas - Report to the Legislature', 'Conservation reserve program (CRP) contributions to wildlife habitat, management issues, challenges and policy choices :\xa0an annotated bibliography /']","['https://www.lrl.mn.gov/docs/2010/mandated/100433.pdf', 'https://purl.fdlp.gov/GPO/gpo87614']","['18096_0_study of riparian buffer areas  report to the legislature.pdf', '18096_1_conservation reserve program crp contributions to wildlife habitat management issues challenges and policy choices \xa0an annotated bibliography .pdf']",2,100.0,"['https://www.lrl.mn.gov/docs/2010/mandated/100433.pdf', 'https://purl.fdlp.gov/GPO/gpo87614']","['18096_0_study of riparian buffer areas  report to the legislature.pdf', '18096_1_conservation reserve program crp contributions to wildlife habitat management issues challenges and policy choices \xa0an annotated bibliography .pdf']","[0.435, 0.314]","[0.607, 0.591]","[0.669, 0.646]","[0.242, 0.202]","[0.252, 0.202]","[0.224, 0.181]","[0.739, 0.733]","[0.652, 0.635]","[0.674, 0.657]","[0.694, 0.678]","[0.835, 0.834]","[0.785, 0.778]","[0.695, 0.686]","[0.938, 0.928]","[0.87, 0.85]","[0.813, 0.81]","[0.849, 0.847]","[0.826, 0.822]",0.374,0.599,0.657,0.222,0.227,0.203,0.736,0.643,0.665,0.686,0.835,0.782,0.691,0.933,0.86,0.811,0.848,0.824
https://doi.org/10.1017/s1368980014000330,parental and selfreported dietary and physical activity habits in preschool children and their socioeconomic determinants,18165_parental and selfreported dietary and physical activity habits in preschool children and their socioeconomic determinants.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['18165_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18165_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18165_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['18165_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18165_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18165_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.423, 0.425, 0.414]","[0.565, 0.572, 0.562]","[0.655, 0.656, 0.652]","[0.219, 0.225, 0.218]","[0.237, 0.244, 0.236]","[0.189, 0.191, 0.187]","[0.741, 0.742, 0.741]","[0.647, 0.648, 0.646]","[0.627, 0.637, 0.624]","[0.697, 0.697, 0.696]","[0.802, 0.809, 0.801]","[0.739, 0.752, 0.733]","[0.621, 0.629, 0.62]","[0.93, 0.927, 0.929]","[0.855, 0.848, 0.852]","[0.764, 0.777, 0.763]","[0.806, 0.814, 0.805]","[0.791, 0.795, 0.789]",0.421,0.566,0.654,0.221,0.239,0.189,0.741,0.647,0.629,0.697,0.804,0.741,0.623,0.929,0.852,0.768,0.808,0.792
https://doi.org/10.1017/s1368980018002653,mediators of the effectiveness of a kindergartenbased familyinvolved intervention on preschoolers’ snacking behaviour the toyboxstudy,18180_mediators of the effectiveness of a kindergartenbased familyinvolved intervention on preschoolers’ snacking behaviour the toyboxstudy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['18180_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18180_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['18180_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18180_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.459, 0.454]","[0.556, 0.558]","[0.647, 0.65]","[0.22, 0.222]","[0.228, 0.229]","[0.189, 0.191]","[0.74, 0.74]","[0.646, 0.647]","[0.621, 0.624]","[0.697, 0.698]","[0.799, 0.8]","[0.732, 0.737]","[0.615, 0.615]","[0.926, 0.927]","[0.854, 0.857]","[0.761, 0.763]","[0.806, 0.807]","[0.788, 0.789]",0.457,0.557,0.649,0.221,0.229,0.19,0.74,0.647,0.623,0.698,0.8,0.734,0.615,0.927,0.855,0.762,0.806,0.788
https://doi.org/10.1017/s136898001900260x,multisectoral community development in nepal has greater effects on child growth and diet than nutrition education alone,18181_multisectoral community development in nepal has greater effects on child growth and diet than nutrition education alone.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf']","['Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf']","['18181_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '18181_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '18181_2_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf']","['18181_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '18181_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '18181_2_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf']","[0.439, 0.427, 0.211]","[0.52, 0.519, 0.561]","[0.608, 0.608, 0.647]","[0.182, 0.178, 0.187]","[0.18, 0.177, 0.178]","[0.148, 0.145, 0.137]","[0.729, 0.729, 0.728]","[0.634, 0.634, 0.634]","[0.573, 0.57, 0.628]","[0.689, 0.691, 0.668]","[0.776, 0.776, 0.803]","[0.703, 0.704, 0.741]","[0.615, 0.611, 0.62]","[0.913, 0.914, 0.931]","[0.816, 0.814, 0.852]","[0.736, 0.736, 0.771]","[0.782, 0.782, 0.809]","[0.76, 0.759, 0.793]",0.359,0.533,0.621,0.182,0.178,0.143,0.729,0.634,0.59,0.683,0.785,0.716,0.615,0.919,0.827,0.748,0.791,0.771
https://doi.org/10.1021/acs.analchem.8b04576,monitoring early life mycotoxin exposures via lcmsms breast milk analysis,18217_monitoring early life mycotoxin exposures via lcmsms breast milk analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141997/pdf'],['Agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141997/pdf'],['18217_0_agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141997/pdf'],['18217_0_agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low‐ and middle‐income countries.pdf'],[0.236],[0.52],[0.609],[0.141],[0.135],[0.109],[0.729],[0.631],[0.596],[0.656],[0.782],[0.694],[0.593],[0.908],[0.826],[0.734],[0.786],[0.768],0.236,0.52,0.609,0.141,0.135,0.109,0.729,0.631,0.596,0.656,0.782,0.694,0.593,0.908,0.826,0.734,0.786,0.768
https://doi.org/10.1021/acs.chemrestox.8b00381,highnicotine electronic cigarette products toxicity of juul fluids and aerosols correlates strongly with nicotine and some flavor chemical concentrations,18222_highnicotine electronic cigarette products toxicity of juul fluids and aerosols correlates strongly with nicotine and some flavor chemical concentrations.pdf,3,"['https://www.fda.gov/media/153017/download', 'https://www.congress.gov/event/116th-congress/house-event/110071', 'https://ag.ny.gov/sites/default/files/11-18-2019_juul_complaint_-_final_dated_and_signed_correct.pdf']","['PM0000551', 'E-cigarettes: An Emerging Threat to Public Health', 'Complaint']","['https://ag.ny.gov/sites/default/files/11-18-2019_juul_complaint_-_final_dated_and_signed_correct.pdf', 'https://www.fda.gov/media/153017/download']","['18222_2_complaint.pdf', '18222_0_pm0000551.pdf']",2,66.67,"['https://ag.ny.gov/sites/default/files/11-18-2019_juul_complaint_-_final_dated_and_signed_correct.pdf', 'https://www.fda.gov/media/153017/download']","['18222_2_complaint.pdf', '18222_0_pm0000551.pdf']","[0.257, 0.238]","[0.501, 0.52]","[0.597, 0.6]","[0.142, 0.164]","[0.142, 0.164]","[0.126, 0.138]","[0.731, 0.738]","[0.637, 0.645]","[0.58, 0.582]","[0.649, 0.671]","[0.79, 0.786]","[0.69, 0.688]","[0.632, 0.641]","[0.894, 0.899]","[0.816, 0.807]","[0.752, 0.751]","[0.795, 0.794]","[0.781, 0.778]",0.247,0.51,0.599,0.153,0.153,0.132,0.734,0.641,0.581,0.66,0.788,0.689,0.637,0.897,0.811,0.752,0.794,0.78
https://doi.org/10.1021/acs.chemrestox.9b00192,neurodevelopmental and metabolomic responses from prenatal coexposure to perfluorooctanesulfonate pfos and methylmercury mehg in sprague–dawley rats,18223_neurodevelopmental and metabolomic responses from prenatal coexposure to perfluorooctanesulfonate pfos and methylmercury mehg in sprague–dawley rats.pdf,1,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft'],['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['18223_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,100.0,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['18223_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.417],[0.509],[0.609],[0.14],[0.135],[0.111],[0.74],[0.648],[0.579],[0.675],[0.791],[0.674],[0.616],[0.909],[0.812],[0.741],[0.785],[0.773],0.417,0.509,0.609,0.14,0.135,0.111,0.74,0.648,0.579,0.675,0.791,0.674,0.616,0.909,0.812,0.741,0.785,0.773
https://doi.org/10.1021/acs.energyfuels.8b02206,investigation of the effect of mid and highlevel ethanol blends on the particulate and the mobile source air toxic emissions from a gasoline direct injection flex fuel vehicle,18226_investigation of the effect of mid and highlevel ethanol blends on the particulate and the mobile source air toxic emissions from a gasoline direct injection flex fuel vehicle.pdf,1,['https://www.nyserda.ny.gov/-/media/Project/Climate/Files/Agriculture-and-Forestry-Advisory-Panel-recommendations.pdf'],['Presentation Title Goes Here and Can Be Two Lines'],['https://www.nyserda.ny.gov/-/media/Project/Climate/Files/Agriculture-and-Forestry-Advisory-Panel-recommendations.pdf'],['18226_0_presentation title goes here and can be two lines.pdf'],1,100.0,['https://www.nyserda.ny.gov/-/media/Project/Climate/Files/Agriculture-and-Forestry-Advisory-Panel-recommendations.pdf'],['18226_0_presentation title goes here and can be two lines.pdf'],[0.109],[0.54],[0.626],[0.109],[0.094],[0.064],[0.724],[0.629],[0.62],[0.61],[0.808],[0.742],[0.634],[0.918],[0.834],[0.786],[0.826],[0.803],0.109,0.54,0.626,0.109,0.094,0.064,0.724,0.629,0.62,0.61,0.808,0.742,0.634,0.918,0.834,0.786,0.826,0.803
https://doi.org/10.1021/acs.est.0c01951,legacy and novel per and polyfluoroalkyl substances in juvenile seabirds from the us atlantic coast,18227_legacy and novel per and polyfluoroalkyl substances in juvenile seabirds from the us atlantic coast.pdf,2,"['https://deq.nc.gov/media/25152/download?attachment', 'https://deq.nc.gov/media/25193/open']","['Appendix C. Public Comment Written Letters', 'Appendix C. Public Comment Written Letters']","['https://deq.nc.gov/media/25193/open', 'https://deq.nc.gov/media/25152/download?attachment']","['18227_1_appendix c public comment written letters.pdf', '18227_0_appendix c public comment written letters.pdf']",2,100.0,"['https://deq.nc.gov/media/25193/open', 'https://deq.nc.gov/media/25152/download?attachment']","['18227_1_appendix c public comment written letters.pdf', '18227_0_appendix c public comment written letters.pdf']","[0.188, 0.188]","[0.481, 0.481]","[0.588, 0.588]","[0.111, 0.11]","[0.104, 0.103]","[0.095, 0.095]","[0.724, 0.723]","[0.632, 0.632]","[0.561, 0.561]","[0.652, 0.651]","[0.79, 0.79]","[0.671, 0.671]","[0.617, 0.617]","[0.907, 0.907]","[0.824, 0.824]","[0.734, 0.734]","[0.79, 0.79]","[0.777, 0.777]",0.188,0.481,0.588,0.111,0.103,0.095,0.724,0.632,0.561,0.651,0.79,0.671,0.617,0.907,0.824,0.734,0.79,0.777
https://doi.org/10.1021/acs.est.0c07384,lifetime accumulation of microplastic in children and adults,18229_lifetime accumulation of microplastic in children and adults.pdf,2,"['https://www.ciel.org/reports/how-can-eu-legislation-tackle-microplastics-pollution-july-2022/', 'https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/microplastics/mp_hndbk_cmnts.pdf']","['How Can the European Union Legislation Tackle Microplastics Pollution (July, 2022)', 'Response to Comments for Proposed Policy Handbook Establishing a Standard Method of Testing and Reporting of Microplastics in Drinking Water']",['https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/microplastics/mp_hndbk_cmnts.pdf'],['18229_1_response to comments for proposed policy handbook establishing a standard method of testing and reporting of microplastics in drinking water.pdf'],1,50.0,['https://www.waterboards.ca.gov/drinking_water/certlic/drinkingwater/documents/microplastics/mp_hndbk_cmnts.pdf'],['18229_1_response to comments for proposed policy handbook establishing a standard method of testing and reporting of microplastics in drinking water.pdf'],[0.163],[0.513],[0.613],[0.134],[0.141],[0.122],[0.732],[0.637],[0.58],[0.688],[0.794],[0.702],[0.653],[0.919],[0.83],[0.748],[0.797],[0.783],0.163,0.513,0.613,0.134,0.141,0.122,0.732,0.637,0.58,0.688,0.794,0.702,0.653,0.919,0.83,0.748,0.797,0.783
https://doi.org/10.1021/acs.est.8b04709,impact of road salt on drinking water quality and infrastructure corrosion in private wells,18247_impact of road salt on drinking water quality and infrastructure corrosion in private wells.pdf,1,['https://spexternal.modot.mo.gov/sites/cm/CORDT/cmr21-009.pdf'],['Snow and Ice Treatment Products Evaluation'],['https://spexternal.modot.mo.gov/sites/cm/CORDT/cmr21-009.pdf'],['18247_0_snow and ice treatment products evaluation.pdf'],1,100.0,['https://spexternal.modot.mo.gov/sites/cm/CORDT/cmr21-009.pdf'],['18247_0_snow and ice treatment products evaluation.pdf'],[0.267],[0.511],[0.59],[0.14],[0.128],[0.112],[0.732],[0.633],[0.569],[0.666],[0.776],[0.689],[0.639],[0.909],[0.817],[0.74],[0.783],[0.772],0.267,0.511,0.59,0.14,0.128,0.112,0.732,0.633,0.569,0.666,0.776,0.689,0.639,0.909,0.817,0.74,0.783,0.772
https://doi.org/10.1021/acs.est.9b02372,phthalate and bpa exposure in women and newborns through personal care product use and food packaging,18249_phthalate and bpa exposure in women and newborns through personal care product use and food packaging.pdf,1,['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['Draft Regulatory Determinations: Report to the Legislature'],['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['18249_0_draft regulatory determinations report to the legislature.pdf'],1,100.0,['https://apps.ecology.wa.gov/publications/documents/2104047.pdf'],['18249_0_draft regulatory determinations report to the legislature.pdf'],[0.254],[0.506],[0.597],[0.137],[0.147],[0.122],[0.731],[0.639],[0.571],[0.667],[0.784],[0.675],[0.62],[0.915],[0.814],[0.744],[0.785],[0.776],0.254,0.506,0.597,0.137,0.147,0.122,0.731,0.639,0.571,0.667,0.784,0.675,0.62,0.915,0.814,0.744,0.785,0.776
https://doi.org/10.1024/0300-9831.74.4.264,effect of nutrition education and diet modification in iron depleted preschool children in nurseries in tehran a pilot study,18558_effect of nutrition education and diet modification in iron depleted preschool children in nurseries in tehran a pilot study.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483688/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged 5 years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483688/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf']","['18558_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_1_interventions for increasing fruit and vegetable consumption in children aged 5 years and under.pdf', '18558_5_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_4_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483688/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160655/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf']","['18558_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_1_interventions for increasing fruit and vegetable consumption in children aged 5 years and under.pdf', '18558_5_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_4_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '18558_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.329, 0.295, 0.343, 0.339, 0.345, 0.329]","[0.516, 0.516, 0.5, 0.516, 0.516, 0.516]","[0.599, 0.601, 0.589, 0.599, 0.599, 0.599]","[0.175, 0.169, 0.144, 0.169, 0.175, 0.174]","[0.181, 0.177, 0.161, 0.176, 0.182, 0.182]","[0.149, 0.146, 0.129, 0.146, 0.149, 0.149]","[0.735, 0.734, 0.726, 0.734, 0.735, 0.735]","[0.637, 0.637, 0.629, 0.636, 0.638, 0.638]","[0.577, 0.578, 0.571, 0.577, 0.577, 0.576]","[0.689, 0.689, 0.685, 0.689, 0.688, 0.689]","[0.774, 0.769, 0.762, 0.769, 0.775, 0.774]","[0.696, 0.686, 0.687, 0.682, 0.694, 0.693]","[0.614, 0.605, 0.586, 0.605, 0.614, 0.613]","[0.906, 0.909, 0.906, 0.908, 0.906, 0.906]","[0.797, 0.803, 0.789, 0.801, 0.797, 0.796]","[0.74, 0.73, 0.727, 0.729, 0.741, 0.741]","[0.776, 0.773, 0.762, 0.772, 0.776, 0.775]","[0.76, 0.759, 0.751, 0.758, 0.761, 0.76]",0.33,0.513,0.598,0.168,0.176,0.145,0.733,0.636,0.576,0.688,0.771,0.69,0.606,0.907,0.797,0.735,0.772,0.758
https://doi.org/10.1024/0939-5911.a000205,international translation of project ex a teen tobacco use cessation program,18562_international translation of project ex a teen tobacco use cessation program.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf'],['Tobacco cessation interventions for young people'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf'],['18562_0_tobacco cessation interventions for young people.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486118/pdf'],['18562_0_tobacco cessation interventions for young people.pdf'],[0.398],[0.523],[0.603],[0.172],[0.187],[0.154],[0.735],[0.642],[0.586],[0.693],[0.788],[0.711],[0.607],[0.911],[0.824],[0.737],[0.786],[0.767],0.398,0.523,0.603,0.172,0.187,0.154,0.735,0.642,0.586,0.693,0.788,0.711,0.607,0.911,0.824,0.737,0.786,0.767
https://doi.org/10.1034/j.1600-0536.2001.440509.x,prevention of workrelated skin problems in student auxiliary nurses an intervention study,18653_prevention of workrelated skin problems in student auxiliary nurses an intervention study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494486/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079999/pdf']","['Interventions for preventing occupational irritant hand dermatitis', 'Händehygiene in Einrichtungen des Gesundheitswesens - Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494486/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079999/pdf']","['18653_0_interventions for preventing occupational irritant hand dermatitis.pdf', '18653_1_händehygiene in einrichtungen des gesundheitswesens  empfehlung der kommission für krankenhaushygiene und infektionsprävention krinko beim robert kochinstitut rki.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494486/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079999/pdf']","['18653_0_interventions for preventing occupational irritant hand dermatitis.pdf', '18653_1_händehygiene in einrichtungen des gesundheitswesens  empfehlung der kommission für krankenhaushygiene und infektionsprävention krinko beim robert kochinstitut rki.pdf']","[0.563, 0.087]","[0.58, 0.485]","[0.651, 0.581]","[0.207, 0.151]","[0.222, 0.172]","[0.18, 0.137]","[0.739, 0.733]","[0.639, 0.636]","[0.648, 0.562]","[0.673, 0.626]","[0.816, 0.793]","[0.753, 0.686]","[0.652, 0.587]","[0.936, 0.89]","[0.85, 0.816]","[0.784, 0.717]","[0.819, 0.762]","[0.801, 0.731]",0.325,0.532,0.616,0.179,0.197,0.159,0.736,0.637,0.605,0.649,0.804,0.72,0.619,0.913,0.833,0.75,0.79,0.766
https://doi.org/10.1037/a0027583,predicting alcohol use across adolescence relative strength of individual family peer and contextual risk and protective factors,19380_predicting alcohol use across adolescence relative strength of individual family peer and contextual risk and protective factors.pdf,2,"['https://purl.fdlp.gov/GPO/gpo122617', 'https://purl.fdlp.gov/GPO/gpo122621']","['Protective factors against delinquency.', 'Alcohol and drug prevention and treatment/therapy.']","['https://purl.fdlp.gov/GPO/gpo122617', 'https://purl.fdlp.gov/GPO/gpo122621']","['19380_0_protective factors against delinquency.pdf', '19380_1_alcohol and drug prevention and treatmenttherapy.pdf']",2,100.0,"['https://purl.fdlp.gov/GPO/gpo122617', 'https://purl.fdlp.gov/GPO/gpo122621']","['19380_0_protective factors against delinquency.pdf', '19380_1_alcohol and drug prevention and treatmenttherapy.pdf']","[0.412, 0.457]","[0.535, 0.538]","[0.619, 0.624]","[0.169, 0.178]","[0.192, 0.204]","[0.161, 0.165]","[0.734, 0.733]","[0.637, 0.636]","[0.592, 0.593]","[0.708, 0.697]","[0.794, 0.8]","[0.724, 0.729]","[0.628, 0.632]","[0.923, 0.92]","[0.826, 0.819]","[0.754, 0.76]","[0.801, 0.801]","[0.785, 0.785]",0.434,0.536,0.621,0.173,0.198,0.163,0.734,0.637,0.593,0.702,0.797,0.726,0.63,0.921,0.823,0.757,0.801,0.785
https://doi.org/10.1037/a0040248,a randomized controlled trial of the family checkup model in public secondary schools examining links between parent engagement and substance use progressions from early adolescence to adulthood,19495_a randomized controlled trial of the family checkup model in public secondary schools examining links between parent engagement and substance use progressions from early adolescence to adulthood.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf'],['Family‐based prevention programmes for alcohol use in young people'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf'],['19495_0_family‐based prevention programmes for alcohol use in young people.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf'],['19495_0_family‐based prevention programmes for alcohol use in young people.pdf'],[0.483],[0.519],[0.601],[0.171],[0.185],[0.155],[0.733],[0.638],[0.573],[0.709],[0.771],[0.698],[0.58],[0.913],[0.808],[0.724],[0.766],[0.754],0.483,0.519,0.601,0.171,0.185,0.155,0.733,0.638,0.573,0.709,0.771,0.698,0.58,0.913,0.808,0.724,0.766,0.754
https://doi.org/10.1038/d41586-018-07545-0,genomeedited baby claim provokes international outcry,19979_genomeedited baby claim provokes international outcry.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418627/pdf'],['Sport and exercise genomics: the FIMS 2019 consensus statement update'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418627/pdf'],['19979_0_sport and exercise genomics the fims 2019 consensus statement update.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418627/pdf'],['19979_0_sport and exercise genomics the fims 2019 consensus statement update.pdf'],[0.178],[0.543],[0.633],[0.127],[0.127],[0.111],[0.717],[0.622],[0.609],[0.647],[0.817],[0.762],[0.646],[0.917],[0.845],[0.775],[0.82],[0.796],0.178,0.543,0.633,0.127,0.127,0.111,0.717,0.622,0.609,0.647,0.817,0.762,0.646,0.917,0.845,0.775,0.82,0.796
https://doi.org/10.1038/nature.2017.21484,brain scans spot early signs of autism in highrisk babies,20126_brain scans spot early signs of autism in highrisk babies.pdf,1,['https://biomonitoring.ca.gov/sites/default/files/downloads/CECBP-Fourth_Report_to_Legislature.pdf'],['Implementation of the California Environmental Contaminant Biomonitoring Program: 2014 -2015'],['https://biomonitoring.ca.gov/sites/default/files/downloads/CECBP-Fourth_Report_to_Legislature.pdf'],['20126_0_implementation of the california environmental contaminant biomonitoring program 2014 2015.pdf'],1,100.0,['https://biomonitoring.ca.gov/sites/default/files/downloads/CECBP-Fourth_Report_to_Legislature.pdf'],['20126_0_implementation of the california environmental contaminant biomonitoring program 2014 2015.pdf'],[0.001],[0.471],[0.597],[0.125],[0.156],[0.106],[0.693],[0.6],[0.597],[0.677],[0.814],[0.795],[0.559],[0.921],[0.795],[0.702],[0.751],[0.737],0.001,0.471,0.597,0.125,0.156,0.106,0.693,0.6,0.597,0.677,0.814,0.795,0.559,0.921,0.795,0.702,0.751,0.737
https://doi.org/10.1038/nature04246,widespread amphibian extinctions from epidemic disease driven by global warming,20136_widespread amphibian extinctions from epidemic disease driven by global warming.pdf,10,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/7sxn0x8ipr_Flowing_Forward_Freshwater_ecosystem_adaptation_to_climate_change_in_water_resources_management_and_biodiversity_conservation.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8viavapdvr_lpr_living_planet_report_2016.pdf', 'https://www.heartland.org/publications-resources/publications/climate-change-reconsidered-ii-biological-impacts', 'http://purl.fdlp.gov/GPO/gpo61055', 'https://www.cato.org/policy-analysis/sky-really-falling-review-recent-global-warming-scare-stories', 'https://www.nrdc.org/resources/rebalancing-carbon-cycle', 'https://www.eesi.org/papers/view/fact-sheet-annotated-bibliography-of-important-climate-science-papers', 'https://www.congress.gov/event/110th-congress/house-event/LC8708/text', 'https://www.tellus.org/tellus/publication/climate-change-redemption-through-crisis', 'https://www.rand.org/pubs/monographs/MG1255.html']","['Flowing Forward: Freshwater Ecosystem Adaptation to Climate Change in Water Resources Management and Biodiversity Conservation (application/pdf, 1.03 MB)', 'Living Planet Report 2016 (application/pdf, 19.1 MB)', 'Climate Change Reconsidered II: Biological Impacts', 'Merging science and management in a rapidly changing world :\xa0biodiversity and management of the Madrean Archipelago III and 7th Conference on Research and Resource Management in the Southwestern Deserts, 2012 May 1-5, Tucson, AZ /', 'Is the Sky Really Falling? A Review of Recent Global Warming Scare Stories', 'Rebalancing the Carbon Cycle', 'Fact Sheet | Annotated Bibliography of Important Climate Science Papers', 'House Hearing, 110th Congress — WILDLIFE AND OCEANS IN A CHANGING CLIMATE', 'Climate Change: Redemption through Crisis', 'Key Trends That Will Shape Army Installations of Tomorrow']","['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8viavapdvr_lpr_living_planet_report_2016.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/7sxn0x8ipr_Flowing_Forward_Freshwater_ecosystem_adaptation_to_climate_change_in_water_resources_management_and_biodiversity_conservation.pdf']","['20136_1_living planet report 2016 applicationpdf 191 mb.pdf', '20136_0_flowing forward freshwater ecosystem adaptation to climate change in water resources management and biodiversity conservation applicationpdf 103 mb.pdf']",2,20.0,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/8viavapdvr_lpr_living_planet_report_2016.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/7sxn0x8ipr_Flowing_Forward_Freshwater_ecosystem_adaptation_to_climate_change_in_water_resources_management_and_biodiversity_conservation.pdf']","['20136_1_living planet report 2016 applicationpdf 191 mb.pdf', '20136_0_flowing forward freshwater ecosystem adaptation to climate change in water resources management and biodiversity conservation applicationpdf 103 mb.pdf']","[0.32, 0.381]","[0.506, 0.543]","[0.603, 0.631]","[0.14, 0.166]","[0.132, 0.153]","[0.114, 0.125]","[0.728, 0.73]","[0.63, 0.634]","[0.58, 0.619]","[0.699, 0.69]","[0.791, 0.81]","[0.706, 0.75]","[0.645, 0.663]","[0.912, 0.919]","[0.822, 0.843]","[0.758, 0.782]","[0.798, 0.82]","[0.781, 0.802]",0.351,0.524,0.617,0.153,0.143,0.119,0.729,0.632,0.599,0.694,0.8,0.728,0.654,0.915,0.833,0.77,0.809,0.792
https://doi.org/10.1038/nature26147,moving magnetoencephalography towards realworld applications with a wearable system,20167_moving magnetoencephalography towards realworld applications with a wearable system.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045462/pdf'],['IFCN-endorsed practical guidelines for clinical magnetoencephalography (MEG)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045462/pdf'],['20167_0_ifcnendorsed practical guidelines for clinical magnetoencephalography meg.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045462/pdf'],['20167_0_ifcnendorsed practical guidelines for clinical magnetoencephalography meg.pdf'],[0.371],[0.522],[0.619],[0.131],[0.139],[0.113],[0.738],[0.644],[0.594],[0.705],[0.792],[0.717],[0.623],[0.912],[0.81],[0.749],[0.788],[0.777],0.371,0.522,0.619,0.131,0.139,0.113,0.738,0.644,0.594,0.705,0.792,0.717,0.623,0.912,0.81,0.749,0.788,0.777
https://doi.org/10.1038/ngeo1955,three decades of global methane sources and sinks,20201_three decades of global methane sources and sinks.pdf,6,"['https://www.nyserda.ny.gov/-/media/Files/Publications/Research/Environmental/20-06-GHG-Associated-with-NYSs-Natural-and-Working-Lands-Forests-Farms-and-Wetlands.pdf', 'https://purl.fdlp.gov/GPO/gpo117131', 'https://crsreports.congress.gov/product/pdf/download/R/R45482/R45482.pdf/', 'https://ww2.arb.ca.gov/sites/default/files/2020-07/ca_ch4_survey_phase1_report_2017.pdf', 'https://www.ida.org/research-and-publications/publications/all/r/re/review-of-federal-and-non-governmental-methane-measurement-and-monitoring', 'https://ww2.arb.ca.gov/sites/default/files/2020-07/final_SLCP_strategy.pdf']","[""Sources and Sinks of Major Greenhouse Gasses Associated with New York State's Natural and Working Lands: Forests, Farms and Wetlands"", 'Second state of the carbon cycle report :\xa0a sustained assessment report.', 'Background Ozone: Challenges in Science and Policy', 'Introduction to the Phase I Report of the California Methane Survey from the Staff of the California Air Resources Board (CARB)', 'Review of Federal and Non-Governmental Methane Measurement and Monitoring', 'Short-Lived Climate Pollutant Reduction Strategy']","['https://ww2.arb.ca.gov/sites/default/files/2020-07/ca_ch4_survey_phase1_report_2017.pdf', 'https://www.nyserda.ny.gov/-/media/Files/Publications/Research/Environmental/20-06-GHG-Associated-with-NYSs-Natural-and-Working-Lands-Forests-Farms-and-Wetlands.pdf', 'https://ww2.arb.ca.gov/sites/default/files/2020-07/final_SLCP_strategy.pdf', 'https://purl.fdlp.gov/GPO/gpo117131']","['20201_3_introduction to the phase i report of the california methane survey from the staff of the california air resources board carb.pdf', '20201_0_sources and sinks of major greenhouse gasses associated with new york states natural and working lands forests farms and wetlands.pdf', '20201_5_shortlived climate pollutant reduction strategy.pdf', '20201_1_second state of the carbon cycle report \xa0a sustained assessment report.pdf']",4,66.67,"['https://ww2.arb.ca.gov/sites/default/files/2020-07/ca_ch4_survey_phase1_report_2017.pdf', 'https://ww2.arb.ca.gov/sites/default/files/2020-07/final_SLCP_strategy.pdf', 'https://purl.fdlp.gov/GPO/gpo117131']","['20201_3_introduction to the phase i report of the california methane survey from the staff of the california air resources board carb.pdf', '20201_5_shortlived climate pollutant reduction strategy.pdf', '20201_1_second state of the carbon cycle report \xa0a sustained assessment report.pdf']","[0.468, 0.361, 0.371]","[0.407, 0.52, 0.526]","[0.504, 0.619, 0.628]","[0.103, 0.157, 0.189]","[0.088, 0.146, 0.173]","[0.111, 0.13, 0.156]","[0.746, 0.729, 0.744]","[0.652, 0.639, 0.656]","[0.456, 0.594, 0.59]","[0.734, 0.669, 0.706]","[0.676, 0.808, 0.804]","[0.517, 0.725, 0.711]","[0.598, 0.646, 0.644]","[0.852, 0.91, 0.906]","[0.724, 0.821, 0.816]","[0.61, 0.765, 0.759]","[0.677, 0.809, 0.8]","[0.639, 0.794, 0.789]",0.4,0.484,0.584,0.15,0.136,0.132,0.74,0.649,0.547,0.703,0.763,0.651,0.629,0.889,0.787,0.711,0.762,0.741
https://doi.org/10.1038/nn.4458,pregnancy leads to longlasting changes in human brain structure,20216_pregnancy leads to longlasting changes in human brain structure.pdf,1,['https://www.ctf.alabama.gov/wp-content/uploads/2018/04/Balancing-ACEs-with-HOPE-Report.pdf'],['Balancing Adverse Childhood Experiences (ACEs) With HOPE'],['https://www.ctf.alabama.gov/wp-content/uploads/2018/04/Balancing-ACEs-with-HOPE-Report.pdf'],['20216_0_balancing adverse childhood experiences aces with hope.pdf'],1,100.0,['https://www.ctf.alabama.gov/wp-content/uploads/2018/04/Balancing-ACEs-with-HOPE-Report.pdf'],['20216_0_balancing adverse childhood experiences aces with hope.pdf'],[0.105],[0.504],[0.597],[0.096],[0.091],[0.082],[0.718],[0.622],[0.577],[0.661],[0.778],[0.713],[0.602],[0.909],[0.811],[0.745],[0.782],[0.768],0.105,0.504,0.597,0.096,0.091,0.082,0.718,0.622,0.577,0.661,0.778,0.713,0.602,0.909,0.811,0.745,0.782,0.768
https://doi.org/10.1038/npp.2017.198,us epidemiology of cannabis use and associated problems,20229_us epidemiology of cannabis use and associated problems.pdf,7,"['https://www.rand.org/pubs/research_reports/RR4431.html', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://oehha.ca.gov/media/downloads/proposition-65/chemicals/cannabisdarthid100419.pdf', 'https://health.hawaii.gov/medicalcannabis/files/2019/09/2019-Petetion-to-add-Opiate-Use-Disorder-9.13.19.pdf', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf', 'https://www.congress.gov/event/116th-congress/senate-event/LC64544/text?s=1&r=16383', 'https://purl.fdlp.gov/GPO/gpo129289']","[""An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies"", 'Oppose HB0032 Cannabis - Legalization and Regulation (Inclusion, Restoration and Rehabilitation Act of 2021)', 'Evidence of Developmental Toxicity of Cannabis (Marijuana) Smoke and Delta Nine-THC', 'IN \u200b2019', 'Assessment Of The Potential Impact Of Regulated Marijuana In New York State', 'S.Hrg. 116-82 — CHALLENGES FOR CANNABIS AND BANKING: OUTSIDE PERSPECTIVES', 'Challenges for cannabis and banking :\xa0outside perspectives : hearing before the Committee on Banking, Housing, and Urban Affairs, United States Senate, One Hundred Sixteenth Congress, first session, on examining challenges that state-sanctioned businesses in the cannabis industry have when attempting to access mainstream financial services, July 23, 2019.']","['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://health.hawaii.gov/medicalcannabis/files/2019/09/2019-Petetion-to-add-Opiate-Use-Disorder-9.13.19.pdf', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf']","['20229_1_oppose hb0032 cannabis  legalization and regulation inclusion restoration and rehabilitation act of 2021.pdf', '20229_3_in \u200b2019.pdf', '20229_4_assessment of the potential impact of regulated marijuana in new york state.pdf']",3,42.86,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1OFh06cl9pAT0gDF-hnn7aKTpo1tcebSo.pdf', 'https://health.hawaii.gov/medicalcannabis/files/2019/09/2019-Petetion-to-add-Opiate-Use-Disorder-9.13.19.pdf', 'https://cannabis.ny.gov/system/files/documents/2021/09/marijuana_legalization_impact_assessment_7-13-18.pdf']","['20229_1_oppose hb0032 cannabis  legalization and regulation inclusion restoration and rehabilitation act of 2021.pdf', '20229_3_in \u200b2019.pdf', '20229_4_assessment of the potential impact of regulated marijuana in new york state.pdf']","[0.658, 0.52, 0.567]","[0.518, 0.494, 0.509]","[0.62, 0.594, 0.61]","[0.189, 0.155, 0.184]","[0.21, 0.165, 0.204]","[0.178, 0.141, 0.173]","[0.737, 0.737, 0.736]","[0.65, 0.647, 0.645]","[0.58, 0.566, 0.572]","[0.683, 0.668, 0.671]","[0.797, 0.784, 0.784]","[0.729, 0.699, 0.715]","[0.609, 0.583, 0.613]","[0.922, 0.91, 0.915]","[0.829, 0.803, 0.814]","[0.753, 0.727, 0.739]","[0.79, 0.771, 0.782]","[0.779, 0.761, 0.766]",0.582,0.507,0.608,0.176,0.193,0.164,0.737,0.647,0.573,0.674,0.788,0.714,0.602,0.916,0.815,0.74,0.781,0.769
https://doi.org/10.1038/nrendo.2016.55,analgesic use — prevalence biomonitoring and endocrine and reproductive effects,20253_analgesic use — prevalence biomonitoring and endocrine and reproductive effects.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037262/pdf'],['Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037262/pdf'],['20253_0_impact of the world health organization pain treatment guidelines and the european medicines agency safety recommend.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037262/pdf'],['20253_0_impact of the world health organization pain treatment guidelines and the european medicines agency safety recommend.pdf'],[0.336],[0.482],[0.59],[0.141],[0.144],[0.123],[0.74],[0.647],[0.556],[0.652],[0.778],[0.64],[0.613],[0.903],[0.793],[0.722],[0.766],[0.76],0.336,0.482,0.59,0.141,0.144,0.123,0.74,0.647,0.556,0.652,0.778,0.64,0.613,0.903,0.793,0.722,0.766,0.76
https://doi.org/10.1038/oby.2012.143,adolescent exergame play for weight loss and psychosocial improvement a controlled physical activity intervention,20340_adolescent exergame play for weight loss and psychosocial improvement a controlled physical activity intervention.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf']","['Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight', 'Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf']","['20340_0_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf', '20340_1_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491168/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865125/pdf']","['20340_0_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf', '20340_1_physical activity diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight.pdf']","[0.344, 0.347]","[0.487, 0.487]","[0.589, 0.589]","[0.159, 0.151]","[0.167, 0.16]","[0.134, 0.129]","[0.736, 0.735]","[0.636, 0.635]","[0.554, 0.554]","[0.708, 0.712]","[0.753, 0.75]","[0.688, 0.684]","[0.593, 0.583]","[0.888, 0.892]","[0.769, 0.771]","[0.709, 0.701]","[0.759, 0.756]","[0.729, 0.727]",0.345,0.487,0.589,0.155,0.164,0.132,0.736,0.635,0.554,0.71,0.752,0.686,0.588,0.89,0.77,0.705,0.758,0.728
https://doi.org/10.1038/s41366-018-0280-1,overweight and obesity in preschool aged children and risk of mental health service utilization,20354_overweight and obesity in preschool aged children and risk of mental health service utilization.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896489/pdf'],['Updating the Canadian clinical practice guideline for managing pediatric obesity: a protocol'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896489/pdf'],['20354_0_updating the canadian clinical practice guideline for managing pediatric obesity a protocol.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896489/pdf'],['20354_0_updating the canadian clinical practice guideline for managing pediatric obesity a protocol.pdf'],[0.396],[0.554],[0.636],[0.169],[0.183],[0.14],[0.727],[0.63],[0.628],[0.692],[0.811],[0.75],[0.614],[0.927],[0.844],[0.769],[0.814],[0.789],0.396,0.554,0.636,0.169,0.183,0.14,0.727,0.63,0.628,0.692,0.811,0.75,0.614,0.927,0.844,0.769,0.814,0.789
https://doi.org/10.1038/s41370-018-0094-1,a review of the pathways of human exposure to poly and perfluoroalkyl substances pfass and present understanding of health effects,20357_a review of the pathways of human exposure to poly and perfluoroalkyl substances pfass and present understanding of health effects.pdf,10,"['https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/11/Product-Chemical-Profile-for-Treatments-with-PFASs.pdf', 'https://www.congress.gov/event/117th-congress/house-event/112794', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2020/02/Final_Product-Chemical_Profile_Carpets_Rugs_PFASs_a.pdf', 'https://www.congress.gov/event/117th-congress/house-event/113939', 'https://www.congress.gov/congressional-report/117th-congress/house-report/86/1', 'https://stacks.cdc.gov/view/cdc/122063', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/10/Food-Packaging_Perfluoroalkyl-and-Polyfluoroalkyl-Substances-PFASs.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.dec.ny.gov/data/DecDocs/336089/Report.HW.336089.2022-06-29.CDC_ATSDR_Orange-County-Report-508.pdf']","['Product-Chemical Profile for Treatments Containing Perfluoroalkyl or Polyfluoroalkyl Substances for Use on Converted Textiles or Leathers', 'Drinking Water and PFAS Legislation', 'Procut-Chemical Profile for Carpets and Rugs Containing Perfluoroalkyl or Polyfluoroalkyl Substances', 'H.R. 3985—Allies Act of 2021; H.R. 2467—PFAS Action Act of 2021; H.R. 2668—Consumer Protection and Recovery Act', 'H. Rept. 117-86 - PFAS ACTION ACT OF 2021', 'PFAS Exposure Assessments Final Report', 'Food Packaging with PFASs', 'Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft', 'Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Per- and Polyfluoroalkyl Substances (PFAS) Exposure Assessment REPORT']","['https://www.dec.ny.gov/data/DecDocs/336089/Report.HW.336089.2022-06-29.CDC_ATSDR_Orange-County-Report-508.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2020/02/Final_Product-Chemical_Profile_Carpets_Rugs_PFASs_a.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/10/Food-Packaging_Perfluoroalkyl-and-Polyfluoroalkyl-Substances-PFASs.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/11/Product-Chemical-Profile-for-Treatments-with-PFASs.pdf']","['20357_9_per and polyfluoroalkyl substances pfas exposure assessment report.pdf', '20357_2_procutchemical profile for carpets and rugs containing perfluoroalkyl or polyfluoroalkyl substances.pdf', '20357_6_food packaging with pfass.pdf', '20357_8_per and polyfluoroalkyl substances chemical action plan.pdf', '20357_7_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '20357_0_productchemical profile for treatments containing perfluoroalkyl or polyfluoroalkyl substances for use on converted textiles or leathers.pdf']",6,60.0,"['https://www.dec.ny.gov/data/DecDocs/336089/Report.HW.336089.2022-06-29.CDC_ATSDR_Orange-County-Report-508.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2020/02/Final_Product-Chemical_Profile_Carpets_Rugs_PFASs_a.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/10/Food-Packaging_Perfluoroalkyl-and-Polyfluoroalkyl-Substances-PFASs.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2019/11/Product-Chemical-Profile-for-Treatments-with-PFASs.pdf']","['20357_9_per and polyfluoroalkyl substances pfas exposure assessment report.pdf', '20357_2_procutchemical profile for carpets and rugs containing perfluoroalkyl or polyfluoroalkyl substances.pdf', '20357_6_food packaging with pfass.pdf', '20357_8_per and polyfluoroalkyl substances chemical action plan.pdf', '20357_7_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '20357_0_productchemical profile for treatments containing perfluoroalkyl or polyfluoroalkyl substances for use on converted textiles or leathers.pdf']","[0.666, 0.71, 0.531, 0.651, 0.524, 0.437]","[0.539, 0.541, 0.548, 0.53, 0.521, 0.532]","[0.635, 0.646, 0.651, 0.63, 0.622, 0.641]","[0.182, 0.202, 0.211, 0.181, 0.16, 0.2]","[0.187, 0.207, 0.223, 0.19, 0.165, 0.204]","[0.143, 0.162, 0.173, 0.15, 0.129, 0.162]","[0.733, 0.748, 0.75, 0.738, 0.74, 0.749]","[0.642, 0.667, 0.667, 0.652, 0.652, 0.667]","[0.619, 0.623, 0.628, 0.615, 0.602, 0.61]","[0.675, 0.678, 0.665, 0.664, 0.674, 0.68]","[0.815, 0.826, 0.824, 0.815, 0.808, 0.818]","[0.726, 0.727, 0.745, 0.722, 0.705, 0.707]","[0.63, 0.63, 0.633, 0.627, 0.614, 0.626]","[0.919, 0.922, 0.921, 0.925, 0.918, 0.921]","[0.84, 0.834, 0.838, 0.833, 0.823, 0.827]","[0.777, 0.778, 0.783, 0.773, 0.759, 0.771]","[0.815, 0.815, 0.818, 0.812, 0.802, 0.807]","[0.799, 0.801, 0.807, 0.798, 0.785, 0.794]",0.586,0.535,0.638,0.189,0.196,0.153,0.743,0.658,0.616,0.673,0.818,0.722,0.627,0.921,0.832,0.773,0.811,0.797
https://doi.org/10.1038/s41370-018-0110-5,a transgenerational toxicokinetic model and its use in derivation of minnesota pfoa water guidance,20358_a transgenerational toxicokinetic model and its use in derivation of minnesota pfoa water guidance.pdf,7,"['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://www.mass.gov/files/documents/2019/12/27/PFAS%20TSD%202019-12-26%20FINAL.pdf', 'https://floridadep.gov/sites/default/files/PFAS_Comments_12Dec19_0.pdf', 'https://www.michigan.gov/documents/pfasresponse/Health-Based_Drinking_Water_Value_Recommendations_for_PFAS_in_Michigan_Report_659258_7.pdf', 'https://www.dhs.wisconsin.gov/publications/p02434v.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/SurfaceWater/PFASScopeComments.pdf', 'https://www.nj.gov/dep/rules/adoptions/adopt_20200601a.pdf']","['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft', 'Technical Support Document - Per- and Polyfluorinated Substances (PFAS): An Updated Subgroup Approach to Groundwater and Drinking Water Values', 'Comments Received on Provisional Cleanup Target Levels and Surface Water Screening Levels', 'Health-Based Drinking Water Value Recommendations for PFAS in Michigan Report', 'Recommended Public Health Groundwater Quality Standards, P-02434V', 'Tony Evers, Governor Preston D. Cole, Secretary', 'ENVIRONMENTAL PROTECTION WATER RESOURCE MANAGEMENT DIVISION OF WATER SUPPLY AND GEOSCIENCE Discharges of Petroleum and Other Hazardous Substances Rules']","['https://www.mass.gov/files/documents/2019/12/27/PFAS%20TSD%202019-12-26%20FINAL.pdf', 'https://www.nj.gov/dep/rules/adoptions/adopt_20200601a.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://www.michigan.gov/documents/pfasresponse/Health-Based_Drinking_Water_Value_Recommendations_for_PFAS_in_Michigan_Report_659258_7.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/SurfaceWater/PFASScopeComments.pdf', 'https://floridadep.gov/sites/default/files/PFAS_Comments_12Dec19_0.pdf']","['20358_1_technical support document  per and polyfluorinated substances pfas an updated subgroup approach to groundwater and drinking water values.pdf', '20358_6_environmental protection water resource management division of water supply and geoscience discharges of petroleum and other hazardous substances rules.pdf', '20358_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '20358_3_healthbased drinking water value recommendations for pfas in michigan report.pdf', '20358_5_tony evers governor preston d cole secretary.pdf', '20358_2_comments received on provisional cleanup target levels and surface water screening levels.pdf']",6,85.71,"['https://www.mass.gov/files/documents/2019/12/27/PFAS%20TSD%202019-12-26%20FINAL.pdf', 'https://www.nj.gov/dep/rules/adoptions/adopt_20200601a.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://www.michigan.gov/documents/pfasresponse/Health-Based_Drinking_Water_Value_Recommendations_for_PFAS_in_Michigan_Report_659258_7.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/SurfaceWater/PFASScopeComments.pdf', 'https://floridadep.gov/sites/default/files/PFAS_Comments_12Dec19_0.pdf']","['20358_1_technical support document  per and polyfluorinated substances pfas an updated subgroup approach to groundwater and drinking water values.pdf', '20358_6_environmental protection water resource management division of water supply and geoscience discharges of petroleum and other hazardous substances rules.pdf', '20358_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '20358_3_healthbased drinking water value recommendations for pfas in michigan report.pdf', '20358_5_tony evers governor preston d cole secretary.pdf', '20358_2_comments received on provisional cleanup target levels and surface water screening levels.pdf']","[0.493, 0.426, 0.452, 0.515, 0.261, 0.368]","[0.503, 0.544, 0.527, 0.549, 0.532, 0.551]","[0.596, 0.638, 0.619, 0.634, 0.629, 0.638]","[0.144, 0.15, 0.155, 0.174, 0.157, 0.172]","[0.139, 0.159, 0.151, 0.175, 0.158, 0.169]","[0.116, 0.124, 0.12, 0.139, 0.125, 0.138]","[0.737, 0.726, 0.736, 0.737, 0.727, 0.732]","[0.645, 0.631, 0.644, 0.644, 0.636, 0.642]","[0.568, 0.622, 0.596, 0.617, 0.616, 0.63]","[0.684, 0.664, 0.676, 0.683, 0.664, 0.673]","[0.776, 0.803, 0.794, 0.805, 0.805, 0.812]","[0.684, 0.735, 0.7, 0.723, 0.721, 0.735]","[0.628, 0.649, 0.629, 0.65, 0.634, 0.652]","[0.909, 0.921, 0.914, 0.921, 0.918, 0.919]","[0.802, 0.841, 0.823, 0.84, 0.838, 0.843]","[0.747, 0.766, 0.758, 0.774, 0.769, 0.782]","[0.783, 0.812, 0.797, 0.817, 0.812, 0.821]","[0.769, 0.795, 0.781, 0.798, 0.795, 0.803]",0.419,0.534,0.626,0.159,0.159,0.127,0.732,0.64,0.608,0.674,0.799,0.716,0.64,0.917,0.831,0.766,0.807,0.79
https://doi.org/10.1038/s41370-020-00267-4,health effects of wildfire smoke in children and public health tools a narrative review,20359_health effects of wildfire smoke in children and public health tools a narrative review.pdf,1,['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['Indicators of climate change in california'],['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['20359_0_indicators of climate change in california.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['20359_0_indicators of climate change in california.pdf'],[0.306],[0.523],[0.613],[0.116],[0.101],[0.083],[0.72],[0.622],[0.603],[0.64],[0.81],[0.738],[0.637],[0.921],[0.83],[0.765],[0.815],[0.793],0.306,0.523,0.613,0.116,0.101,0.083,0.72,0.622,0.603,0.64,0.81,0.738,0.637,0.921,0.83,0.765,0.815,0.793
https://doi.org/10.1038/s41380-021-01161-7,age at onset of mental disorders worldwide largescale metaanalysis of 192 epidemiological studies,20363_age at onset of mental disorders worldwide largescale metaanalysis of 192 epidemiological studies.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['20363_0_well and thriving prevention and early intervention in california first public draft.pdf', '20363_1_well and thriving prevention and early intervention in california  second public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['20363_0_well and thriving prevention and early intervention in california first public draft.pdf', '20363_1_well and thriving prevention and early intervention in california  second public draft.pdf']","[0.308, 0.307]","[0.514, 0.514]","[0.619, 0.619]","[0.15, 0.149]","[0.169, 0.169]","[0.139, 0.138]","[0.731, 0.731]","[0.638, 0.637]","[0.581, 0.581]","[0.69, 0.689]","[0.798, 0.798]","[0.719, 0.72]","[0.604, 0.604]","[0.926, 0.926]","[0.826, 0.826]","[0.756, 0.757]","[0.799, 0.799]","[0.781, 0.782]",0.307,0.514,0.619,0.149,0.169,0.139,0.731,0.637,0.581,0.69,0.798,0.72,0.604,0.926,0.826,0.756,0.799,0.782
https://doi.org/10.1038/s41392-020-00269-6,comparison of nonhuman primates identified the suitable model for covid19,20371_comparison of nonhuman primates identified the suitable model for covid19.pdf,2,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['20371_0_master question list for covid19 caused by sarscov2.pdf', '20371_1_master question list for covid19 caused by sarscov2.pdf']",2,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['20371_0_master question list for covid19 caused by sarscov2.pdf', '20371_1_master question list for covid19 caused by sarscov2.pdf']","[0.506, 0.512]","[0.531, 0.529]","[0.627, 0.625]","[0.175, 0.176]","[0.173, 0.173]","[0.143, 0.144]","[0.747, 0.747]","[0.658, 0.658]","[0.599, 0.598]","[0.644, 0.646]","[0.794, 0.794]","[0.713, 0.711]","[0.629, 0.63]","[0.91, 0.911]","[0.811, 0.811]","[0.761, 0.759]","[0.795, 0.795]","[0.779, 0.778]",0.509,0.53,0.626,0.175,0.173,0.143,0.747,0.658,0.599,0.645,0.794,0.712,0.629,0.911,0.811,0.76,0.795,0.778
https://doi.org/10.1038/s41395-018-0377-0,evidence for local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome a systematic review,20373_evidence for local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380508/pdf'],['British Society of Gastroenterology guidelines on the management of functional dyspepsia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380508/pdf'],['20373_0_british society of gastroenterology guidelines on the management of functional dyspepsia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380508/pdf'],['20373_0_british society of gastroenterology guidelines on the management of functional dyspepsia.pdf'],[0.592],[0.54],[0.644],[0.175],[0.212],[0.148],[0.744],[0.659],[0.601],[0.683],[0.807],[0.717],[0.612],[0.923],[0.813],[0.759],[0.798],[0.781],0.592,0.54,0.644,0.175,0.212,0.148,0.744,0.659,0.601,0.683,0.807,0.717,0.612,0.923,0.813,0.759,0.798,0.781
https://doi.org/10.1038/s41433-019-0634-5,has the eagle landed for the use of clear lens extraction in angleclosure glaucoma and how should primary angleclosure suspects be treated,20378_has the eagle landed for the use of clear lens extraction in angleclosure glaucoma and how should primary angleclosure suspects be treated.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['Non‐contact tests for identifying people at risk of primary angle closure glaucoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['20378_0_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390269/pdf'],['20378_0_non‐contact tests for identifying people at risk of primary angle closure glaucoma.pdf'],[0.342],[0.526],[0.614],[0.161],[0.175],[0.142],[0.733],[0.638],[0.602],[0.669],[0.791],[0.725],[0.628],[0.923],[0.812],[0.746],[0.797],[0.774],0.342,0.526,0.614,0.161,0.175,0.142,0.733,0.638,0.602,0.669,0.791,0.725,0.628,0.923,0.812,0.746,0.797,0.774
https://doi.org/10.1038/s41436-019-0563-5,a proposal for comprehensive newborn hearing screening to improve identification of deaf and hardofhearing children,20379_a proposal for comprehensive newborn hearing screening to improve identification of deaf and hardofhearing children.pdf,1,['https://www.acmg.net/PDFLibrary/Hearing-Loss-Practice-Resource.pdf'],['Clinical evaluation and etiologic diagnosis of hearing loss: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)'],['https://www.acmg.net/PDFLibrary/Hearing-Loss-Practice-Resource.pdf'],['20379_0_clinical evaluation and etiologic diagnosis of hearing loss a clinical practice resource of the american college of medical genetics and genomics acmg.pdf'],1,100.0,['https://www.acmg.net/PDFLibrary/Hearing-Loss-Practice-Resource.pdf'],['20379_0_clinical evaluation and etiologic diagnosis of hearing loss a clinical practice resource of the american college of medical genetics and genomics acmg.pdf'],[0.622],[0.552],[0.639],[0.187],[0.211],[0.167],[0.749],[0.66],[0.612],[0.691],[0.808],[0.741],[0.64],[0.918],[0.83],[0.769],[0.812],[0.795],0.622,0.552,0.639,0.187,0.211,0.167,0.749,0.66,0.612,0.691,0.808,0.741,0.64,0.918,0.83,0.769,0.812,0.795
https://doi.org/10.1038/s41576-019-0150-2,rna sequencing the teenage years,20428_rna sequencing the teenage years.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020655/pdf'],['A guide to Understanding “State-of-the-Art” Basic Research Techniques in Anesthesiology'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020655/pdf'],['20428_0_a guide to understanding “stateoftheart” basic research techniques in anesthesiology.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020655/pdf'],['20428_0_a guide to understanding “stateoftheart” basic research techniques in anesthesiology.pdf'],[0.318],[0.516],[0.635],[0.175],[0.19],[0.154],[0.752],[0.669],[0.593],[0.707],[0.782],[0.679],[0.609],[0.921],[0.809],[0.744],[0.779],[0.774],0.318,0.516,0.635,0.175,0.19,0.154,0.752,0.669,0.593,0.707,0.782,0.679,0.609,0.921,0.809,0.744,0.779,0.774
https://doi.org/10.1038/s41586-019-1193-4,increase in cfc11 emissions from eastern china based on atmospheric observations,20432_increase in cfc11 emissions from eastern china based on atmospheric observations.pdf,4,"['https://www.federalregister.gov/documents/2021/05/19/2021-09545/phasedown-of-hydrofluorocarbons-establishing-the-allowance-allocation-and-trading-program-under-the', 'https://www.federalregister.gov/documents/2021/10/05/2021-21030/phasedown-of-hydrofluorocarbons-establishing-the-allowance-allocation-and-trading-program-under-the', 'https://eia-global.org/reports/high-stakes-implementing-and-strengthening-climate-and-ozone-commitments-under-the-montreal-protocol', 'https://www.epa.gov/system/files/documents/2021-07/fy22-cj-04-epm.pdf']","['Phasedown of Hydrofluorocarbons: Establishing the Allowance Allocation and Trading Program Under the American Innovation and Manufacturing Act', 'Phasedown of Hydrofluorocarbons: Establishing the Allowance Allocation and Trading Program Under the American Innovation and Manufacturing Act', 'High Stakes: Implementing and strengthening climate and ozone commitments under the Montreal Protocol', 'EPA FY 2022 CJ: Tab 04 - Environmental Programs and Management']",['https://www.epa.gov/system/files/documents/2021-07/fy22-cj-04-epm.pdf'],['20432_3_epa fy 2022 cj tab 04  environmental programs and management.pdf'],1,25.0,['https://www.epa.gov/system/files/documents/2021-07/fy22-cj-04-epm.pdf'],['20432_3_epa fy 2022 cj tab 04  environmental programs and management.pdf'],[0.129],[0.508],[0.606],[0.114],[0.107],[0.095],[0.719],[0.624],[0.592],[0.656],[0.803],[0.724],[0.641],[0.916],[0.828],[0.764],[0.811],[0.787],0.129,0.508,0.606,0.114,0.107,0.095,0.719,0.624,0.592,0.656,0.803,0.724,0.641,0.916,0.828,0.764,0.811,0.787
https://doi.org/10.1038/s41586-019-1592-6,harnessing global fisheries to tackle micronutrient deficiencies,20437_harnessing global fisheries to tackle micronutrient deficiencies.pdf,3,"['https://www.congress.gov/event/116th-congress/house-event/111092', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/135901']","['Ocean Climate Action: Solutions to the Climate Crisis. Legislative hearing on H.R. 8632, the Ocean-Based Climate Solutions Act, and H.R. 3548, H.R. 3919, H.R. 4093, H.R. 5390, H.R.5589, H.R.7387, H.R. 8253, H.R.8627', 'Living Planet Report 2020 (application/pdf, 23.1 MB)', 'Nutrition as a basic need: A new method for utility-consistent and nutritionally adequate food poverty lines']",['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf'],['20437_1_living planet report 2020 applicationpdf 231 mb.pdf'],1,33.33,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf'],['20437_1_living planet report 2020 applicationpdf 231 mb.pdf'],[0.29],[0.508],[0.618],[0.133],[0.138],[0.116],[0.729],[0.634],[0.582],[0.682],[0.788],[0.706],[0.628],[0.92],[0.824],[0.756],[0.796],[0.778],0.29,0.508,0.618,0.133,0.138,0.116,0.729,0.634,0.582,0.682,0.788,0.706,0.628,0.92,0.824,0.756,0.796,0.778
https://doi.org/10.1038/s41586-019-1720-3,california’s methane superemitters,20438_california’s methane superemitters.pdf,7,"['https://science.house.gov/staff-reports/seeing-ch4-clearly-science-based-approaches-to-methane-monitoring-in-the-oil-and-gas-sector', 'https://climate.ny.gov/-/media/Project/Climate/Files/Draft-Scoping-Plan.ashx', 'https://climate.ny.gov/-/media/project/climate/files/NYS-Climate-Action-Council-Final-Scoping-Plan-2022.pdf', 'https://www.nyserda.ny.gov/-/media/Project/Climate/Files/2021-12-17-Draft-Scoping-Plan-for-Council-Consideration.pdf', 'https://climate.ny.gov/-/media/project/climate/files/Draft-Scoping-Plan-CJWG-Feedback.pdf', 'https://climate.ny.gov/-/media/project/climate/files/Draft-Scoping-Plan.pdf', 'https://climate.ny.gov/-/media/project/climate/files/2022-12-15-Draft-Final-Scoping-Plan.pdf']","['Seeing CH4 Clearly: Science-Based Approaches to Methane Monitoring in the Oil and Gas Sector', 'New York State Climate Action Council Draft Scoping Plan', 'Final Scoping Plan', 'New York State Climate Action Council Draft Scoping Plan', 'New York State Climate Action Council Draft Scoping Plan', 'New York State Climate Action Council Draft Scoping Plan', 'New York State Climate Action Council Scoping Plan']","['https://climate.ny.gov/-/media/project/climate/files/NYS-Climate-Action-Council-Final-Scoping-Plan-2022.pdf', 'https://climate.ny.gov/-/media/project/climate/files/2022-12-15-Draft-Final-Scoping-Plan.pdf', 'https://climate.ny.gov/-/media/project/climate/files/Draft-Scoping-Plan.pdf', 'https://climate.ny.gov/-/media/Project/Climate/Files/Draft-Scoping-Plan.ashx', 'https://www.nyserda.ny.gov/-/media/Project/Climate/Files/2021-12-17-Draft-Scoping-Plan-for-Council-Consideration.pdf', 'https://climate.ny.gov/-/media/project/climate/files/Draft-Scoping-Plan-CJWG-Feedback.pdf']","['20438_2_final scoping plan.pdf', '20438_6_new york state climate action council scoping plan.pdf', '20438_5_new york state climate action council draft scoping plan.pdf', '20438_1_new york state climate action council draft scoping plan.pdf', '20438_3_new york state climate action council draft scoping plan.pdf', '20438_4_new york state climate action council draft scoping plan.pdf']",6,85.71,"['https://climate.ny.gov/-/media/project/climate/files/NYS-Climate-Action-Council-Final-Scoping-Plan-2022.pdf', 'https://climate.ny.gov/-/media/project/climate/files/2022-12-15-Draft-Final-Scoping-Plan.pdf', 'https://climate.ny.gov/-/media/project/climate/files/Draft-Scoping-Plan.pdf', 'https://climate.ny.gov/-/media/Project/Climate/Files/Draft-Scoping-Plan.ashx', 'https://www.nyserda.ny.gov/-/media/Project/Climate/Files/2021-12-17-Draft-Scoping-Plan-for-Council-Consideration.pdf', 'https://climate.ny.gov/-/media/project/climate/files/Draft-Scoping-Plan-CJWG-Feedback.pdf']","['20438_2_final scoping plan.pdf', '20438_6_new york state climate action council scoping plan.pdf', '20438_5_new york state climate action council draft scoping plan.pdf', '20438_1_new york state climate action council draft scoping plan.pdf', '20438_3_new york state climate action council draft scoping plan.pdf', '20438_4_new york state climate action council draft scoping plan.pdf']","[0.275, 0.267, 0.276, 0.275, 0.275, 0.267]","[0.506, 0.506, 0.508, 0.508, 0.507, 0.508]","[0.61, 0.61, 0.611, 0.611, 0.611, 0.611]","[0.142, 0.142, 0.142, 0.142, 0.142, 0.142]","[0.127, 0.127, 0.127, 0.127, 0.127, 0.127]","[0.114, 0.114, 0.114, 0.114, 0.114, 0.114]","[0.728, 0.728, 0.727, 0.727, 0.727, 0.727]","[0.636, 0.636, 0.634, 0.634, 0.634, 0.634]","[0.579, 0.579, 0.581, 0.581, 0.581, 0.581]","[0.666, 0.666, 0.666, 0.666, 0.666, 0.666]","[0.794, 0.794, 0.795, 0.795, 0.795, 0.795]","[0.705, 0.705, 0.709, 0.709, 0.709, 0.709]","[0.632, 0.632, 0.633, 0.633, 0.633, 0.633]","[0.915, 0.915, 0.915, 0.915, 0.915, 0.915]","[0.825, 0.825, 0.827, 0.827, 0.827, 0.827]","[0.749, 0.749, 0.751, 0.751, 0.751, 0.751]","[0.797, 0.797, 0.798, 0.798, 0.798, 0.798]","[0.779, 0.779, 0.78, 0.78, 0.78, 0.78]",0.272,0.507,0.611,0.142,0.127,0.114,0.727,0.635,0.58,0.666,0.795,0.708,0.633,0.915,0.826,0.75,0.798,0.78
https://doi.org/10.1038/s41586-019-1799-6,international evaluation of an ai system for breast cancer screening,20439_international evaluation of an ai system for breast cancer screening.pdf,3,"['https://www.cna.org/CNA_files/PDF/DOP-2020-U-028073-Final.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598943/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598944/pdf']","['Artificial Intelligence: Emerging Themes, Issues, and Narratives', 'Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension', 'Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension']","['https://www.cna.org/CNA_files/PDF/DOP-2020-U-028073-Final.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598944/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598943/pdf']","['20439_0_artificial intelligence emerging themes issues and narratives.pdf', '20439_2_guidelines for clinical trial protocols for interventions involving artificial intelligence the spiritai extension.pdf', '20439_1_reporting guidelines for clinical trial reports for interventions involving artificial intelligence the consortai extension.pdf']",3,100.0,"['https://www.cna.org/CNA_files/PDF/DOP-2020-U-028073-Final.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598944/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598943/pdf']","['20439_0_artificial intelligence emerging themes issues and narratives.pdf', '20439_2_guidelines for clinical trial protocols for interventions involving artificial intelligence the spiritai extension.pdf', '20439_1_reporting guidelines for clinical trial reports for interventions involving artificial intelligence the consortai extension.pdf']","[0.394, 0.339, 0.337]","[0.517, 0.519, 0.518]","[0.614, 0.607, 0.606]","[0.109, 0.14, 0.143]","[0.101, 0.143, 0.148]","[0.093, 0.125, 0.131]","[0.726, 0.731, 0.732]","[0.631, 0.637, 0.637]","[0.603, 0.577, 0.575]","[0.684, 0.704, 0.707]","[0.789, 0.782, 0.781]","[0.728, 0.695, 0.693]","[0.629, 0.622, 0.621]","[0.905, 0.915, 0.916]","[0.833, 0.808, 0.806]","[0.761, 0.748, 0.745]","[0.797, 0.789, 0.788]","[0.779, 0.765, 0.764]",0.357,0.518,0.609,0.131,0.131,0.116,0.73,0.635,0.585,0.698,0.784,0.705,0.624,0.912,0.816,0.751,0.791,0.769
https://doi.org/10.1038/s41586-020-2798-3,sarscov2 vaccines in development,20442_sarscov2 vaccines in development.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf', 'https://stacks.cdc.gov/view/cdc/94875']","['AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories', 'COVID-19 science update ; Edition 2020-10-06']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['20442_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['20442_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],[0.347],[0.581],[0.66],[0.193],[0.188],[0.154],[0.744],[0.655],[0.653],[0.663],[0.815],[0.762],[0.656],[0.924],[0.843],[0.791],[0.824],[0.807],0.347,0.581,0.66,0.193,0.188,0.154,0.744,0.655,0.653,0.663,0.815,0.762,0.656,0.924,0.843,0.791,0.824,0.807
https://doi.org/10.1038/s41586-020-2944-y,a network of grassroots reserves protects tropical river fish diversity,20444_a network of grassroots reserves protects tropical river fish diversity.pdf,1,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/4x01xgpg0m_wwfintl_freshwater_fishes_report.pdf'],"[""The World's Forgotten Fishes (application/pdf, 52.4 MB)""]",['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/4x01xgpg0m_wwfintl_freshwater_fishes_report.pdf'],['20444_0_the worlds forgotten fishes applicationpdf 524 mb.pdf'],1,100.0,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/4x01xgpg0m_wwfintl_freshwater_fishes_report.pdf'],['20444_0_the worlds forgotten fishes applicationpdf 524 mb.pdf'],[0.321],[0.525],[0.619],[0.155],[0.161],[0.138],[0.725],[0.632],[0.608],[0.695],[0.807],[0.744],[0.639],[0.916],[0.849],[0.765],[0.813],[0.798],0.321,0.525,0.619,0.155,0.161,0.138,0.725,0.632,0.608,0.695,0.807,0.744,0.639,0.916,0.849,0.765,0.813,0.798
https://doi.org/10.1038/s41586-021-03426-1,increased mortality in communitytested cases of sarscov2 lineage b117,20447_increased mortality in communitytested cases of sarscov2 lineage b117.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://stacks.cdc.gov/view/cdc/104561']","['COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'COVID-19 science update ; 2021-03-26 (82)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/pdf']","['20447_1_master question list for covid19 caused by sarscov2.pdf', '20447_2_master question list for covid19 caused by sarscov2.pdf', '20447_0_covid19 vaccination in patients with multiple myeloma a consensus of the european myeloma network.pdf']",3,75.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553271/pdf']","['20447_1_master question list for covid19 caused by sarscov2.pdf', '20447_0_covid19 vaccination in patients with multiple myeloma a consensus of the european myeloma network.pdf']","[0.118, 0.198]","[0.546, 0.532]","[0.627, 0.616]","[0.152, 0.139]","[0.139, 0.136]","[0.12, 0.098]","[0.732, 0.729]","[0.64, 0.635]","[0.623, 0.612]","[0.672, 0.649]","[0.807, 0.804]","[0.742, 0.733]","[0.637, 0.621]","[0.921, 0.918]","[0.842, 0.834]","[0.768, 0.763]","[0.813, 0.809]","[0.792, 0.787]",0.158,0.539,0.621,0.146,0.138,0.109,0.73,0.637,0.617,0.661,0.806,0.738,0.629,0.919,0.838,0.766,0.811,0.79
https://doi.org/10.1038/s41598-017-07403-5,lc3a silencing hinders aggresome vimentin cage clearance in primary choroid plexus carcinoma,20474_lc3a silencing hinders aggresome vimentin cage clearance in primary choroid plexus carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996087/pdf'],['Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996087/pdf'],['20474_0_guidelines for the use and interpretation of assays for monitoring autophagy 4th edition.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996087/pdf'],['20474_0_guidelines for the use and interpretation of assays for monitoring autophagy 4th edition.pdf'],[0.354],[0.52],[0.618],[0.158],[0.167],[0.139],[0.75],[0.654],[0.59],[0.663],[0.786],[0.696],[0.609],[0.907],[0.804],[0.741],[0.788],[0.771],0.354,0.52,0.618,0.158,0.167,0.139,0.75,0.654,0.59,0.663,0.786,0.696,0.609,0.907,0.804,0.741,0.788,0.771
https://doi.org/10.1038/s41598-017-08922-x,mhealth intervention is effective in creating smokefree homes for newborns a randomized controlled trial study in china,20476_mhealth intervention is effective in creating smokefree homes for newborns a randomized controlled trial study in china.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804292/pdf'],['Mobile phone text messaging and app‐based interventions for smoking cessation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804292/pdf'],['20476_0_mobile phone text messaging and app‐based interventions for smoking cessation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804292/pdf'],['20476_0_mobile phone text messaging and app‐based interventions for smoking cessation.pdf'],[0.602],[0.532],[0.613],[0.182],[0.19],[0.167],[0.732],[0.637],[0.592],[0.704],[0.783],[0.698],[0.592],[0.918],[0.827],[0.74],[0.784],[0.764],0.602,0.532,0.613,0.182,0.19,0.167,0.732,0.637,0.592,0.704,0.783,0.698,0.592,0.918,0.827,0.74,0.784,0.764
https://doi.org/10.1038/s41598-018-22104-3,boat noise impacts risk assessment in a coral reef fish but effects depend on engine type,20481_boat noise impacts risk assessment in a coral reef fish but effects depend on engine type.pdf,1,['https://www.wsdot.wa.gov/research/reports/fullreports/891-1.pdf'],['Anthropogenic Sound and Fishes'],['https://www.wsdot.wa.gov/research/reports/fullreports/891-1.pdf'],['20481_0_anthropogenic sound and fishes.pdf'],1,100.0,['https://www.wsdot.wa.gov/research/reports/fullreports/891-1.pdf'],['20481_0_anthropogenic sound and fishes.pdf'],[0.507],[0.54],[0.628],[0.177],[0.183],[0.155],[0.741],[0.653],[0.602],[0.702],[0.796],[0.731],[0.658],[0.911],[0.819],[0.772],[0.801],[0.788],0.507,0.54,0.628,0.177,0.183,0.155,0.741,0.653,0.602,0.702,0.796,0.731,0.658,0.911,0.819,0.772,0.801,0.788
https://doi.org/10.1039/c9ew00364a,absorption of shortchain to longchain perfluoroalkyl substances using swellable organically modified silica,20764_absorption of shortchain to longchain perfluoroalkyl substances using swellable organically modified silica.pdf,1,['https://www.epa.gov/system/files/documents/2021-09/multi-industry-pfas-study_preliminary-2021-report_508_2021.09.08.pdf'],['Multi-Industry Per- and Polyfluoroalkyl Substances (PFAS) Study – 2021 Preliminary Report'],['https://www.epa.gov/system/files/documents/2021-09/multi-industry-pfas-study_preliminary-2021-report_508_2021.09.08.pdf'],['20764_0_multiindustry per and polyfluoroalkyl substances pfas study – 2021 preliminary report.pdf'],1,100.0,['https://www.epa.gov/system/files/documents/2021-09/multi-industry-pfas-study_preliminary-2021-report_508_2021.09.08.pdf'],['20764_0_multiindustry per and polyfluoroalkyl substances pfas study – 2021 preliminary report.pdf'],[0.439],[0.52],[0.611],[0.169],[0.161],[0.134],[0.737],[0.651],[0.596],[0.662],[0.807],[0.7],[0.629],[0.914],[0.814],[0.76],[0.805],[0.795],0.439,0.52,0.611,0.169,0.161,0.134,0.737,0.651,0.596,0.662,0.807,0.7,0.629,0.914,0.814,0.76,0.805,0.795
https://doi.org/10.1044/0161-1461.3103.280,facilitating language development for innercity children experimental evaluation of a collaborative classroombased intervention,20785_facilitating language development for innercity children experimental evaluation of a collaborative classroombased intervention.pdf,1,['https://dcps.dc.gov/sites/default/files/dc/sites/dcps/publication/attachments/J.10.pdf'],['School Year 2012-2013'],['https://dcps.dc.gov/sites/default/files/dc/sites/dcps/publication/attachments/J.10.pdf'],['20785_0_school year 20122013.pdf'],1,100.0,['https://dcps.dc.gov/sites/default/files/dc/sites/dcps/publication/attachments/J.10.pdf'],['20785_0_school year 20122013.pdf'],[0.488],[0.557],[0.63],[0.167],[0.19],[0.155],[0.732],[0.63],[0.635],[0.674],[0.812],[0.762],[0.66],[0.931],[0.845],[0.789],[0.826],[0.807],0.488,0.557,0.63,0.167,0.19,0.155,0.732,0.63,0.635,0.674,0.812,0.762,0.66,0.931,0.845,0.789,0.826,0.807
https://doi.org/10.1046/j.1365-2486.2001.00383.x,global response of terrestrial ecosystem structure and function to co2and climate change results from six dynamic global vegetation models,20972_global response of terrestrial ecosystem structure and function to co2and climate change results from six dynamic global vegetation models.pdf,8,"['https://www.dnr.wa.gov/publications/lm_hcp_oesf_halofsky_rpt_jan14.pdf', 'https://www.heartland.org/publications-resources/publications/climate-change-reconsidered-ii-biological-impacts', 'https://nicholasinstitute.duke.edu/publications/toward-blue-economy-pathway-sustainable-growth-bangladesh', 'https://purl.fdlp.gov/GPO/gpo86352', 'https://purl.fdlp.gov/GPO/gpo83912', 'https://purl.fdlp.gov/GPO/gpo75326', 'https://www.congress.gov/event/110th-congress/senate-event/LC8789/text?s=1&r=11659', 'https://files.hawaii.gov/dbedt/op/carbon_farming_task_force/agendas/usgs_fs_baseline_and_projected_future_carbon_storage_2017.pdf']","['Climate Change, Land Management, and Potential Northern Spotted Owl Habitat in Coastal Washington', 'Climate Change Reconsidered II: Biological Impacts', 'Toward a Blue Economy: A Pathway for Sustainable Growth in Bangladesh', 'Climate change vulnerability and adaptation in the Blue Mountains region /', 'Baseline and projected future carbon storage and carbon fluxes in ecosystems of Hawai’i /', 'Climate change effects on vegetation in the Pacific Northwest :\xa0a review and synthesis of the scientific literature and simulation model projections /', 'S.Hrg. 110-1091 — THE ISSUE OF POTENTIAL IMPACTS OF GLOBAL WARMING ON RECREATION AND THE RECREATION INDUSTRY', 'Baseline and Projected Future Carbon Storage and Carbon Fluxes in Ecosystems of Hawai‘i']","['https://www.dnr.wa.gov/publications/lm_hcp_oesf_halofsky_rpt_jan14.pdf', 'https://files.hawaii.gov/dbedt/op/carbon_farming_task_force/agendas/usgs_fs_baseline_and_projected_future_carbon_storage_2017.pdf', 'https://purl.fdlp.gov/GPO/gpo86352', 'https://purl.fdlp.gov/GPO/gpo83912', 'https://purl.fdlp.gov/GPO/gpo75326']","['20972_0_climate change land management and potential northern spotted owl habitat in coastal washington.pdf', '20972_7_baseline and projected future carbon storage and carbon fluxes in ecosystems of hawaii.pdf', '20972_3_climate change vulnerability and adaptation in the blue mountains region .pdf', '20972_4_baseline and projected future carbon storage and carbon fluxes in ecosystems of hawaii .pdf', '20972_5_climate change effects on vegetation in the pacific northwest \xa0a review and synthesis of the scientific literature and simulation model projections .pdf']",5,62.5,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1046/j.1440-1754.2000.00591.x,promoting secure attachment maternal mood and child health in a vulnerable population a randomized controlled trial,21091_promoting secure attachment maternal mood and child health in a vulnerable population a randomized controlled trial.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://dcs.az.gov/file/5664/download?token=LqVtCiut']","[""Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke"", 'Parenting interventions for the prevention of unintentional injuries in childhood', 'Home safety education and provision of safety equipment for injury prevention', 'Home visits during pregnancy and after birth for women with an alcohol or drug problem', '2008 Healthy Families Annual Report 2008']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://dcs.az.gov/file/5664/download?token=LqVtCiut']","['21091_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf', '21091_2_home safety education and provision of safety equipment for injury prevention.pdf', '21091_0_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf', '21091_3_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf', '21091_4_2008 healthy families annual report 2008.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491082/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544802/pdf', 'https://dcs.az.gov/file/5664/download?token=LqVtCiut']","['21091_1_parenting interventions for the prevention of unintentional injuries in childhood.pdf', '21091_2_home safety education and provision of safety equipment for injury prevention.pdf', '21091_0_family and carer smoking control programmes for reducing childrens exposure to environmental tobacco smoke.pdf', '21091_3_home visits during pregnancy and after birth for women with an alcohol or drug problem.pdf', '21091_4_2008 healthy families annual report 2008.pdf']","[0.568, 0.53, 0.387, 0.33, 0.428]","[0.529, 0.507, 0.526, 0.523, 0.512]","[0.603, 0.584, 0.603, 0.596, 0.586]","[0.163, 0.142, 0.161, 0.174, 0.145]","[0.166, 0.142, 0.158, 0.161, 0.156]","[0.14, 0.124, 0.138, 0.145, 0.138]","[0.73, 0.728, 0.731, 0.734, 0.727]","[0.636, 0.633, 0.637, 0.641, 0.629]","[0.577, 0.557, 0.576, 0.568, 0.561]","[0.701, 0.693, 0.691, 0.691, 0.688]","[0.776, 0.758, 0.776, 0.77, 0.769]","[0.706, 0.69, 0.701, 0.687, 0.692]","[0.593, 0.603, 0.614, 0.575, 0.629]","[0.918, 0.897, 0.914, 0.905, 0.907]","[0.802, 0.78, 0.802, 0.784, 0.8]","[0.727, 0.699, 0.728, 0.717, 0.733]","[0.778, 0.76, 0.778, 0.769, 0.773]","[0.759, 0.731, 0.761, 0.747, 0.758]",0.449,0.519,0.594,0.157,0.157,0.137,0.73,0.635,0.568,0.693,0.77,0.695,0.603,0.908,0.794,0.721,0.772,0.751
https://doi.org/10.1046/j.1467-789x.2003.00101.x,how much physical activity is enough to prevent unhealthy weight gain outcome of the iaso 1st stock conference and consensus statement,21166_how much physical activity is enough to prevent unhealthy weight gain outcome of the iaso 1st stock conference and consensus statement.pdf,4,"['https://aging.ny.gov/news/2013/Strategic_plan%20NYSDOH%20Obesity%202005.pdf', 'https://papers.nber.org/papers/w12954', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992225/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452117/pdf']","['Strategic Plan for Overweight and Obesity Prevention - New York State', 'Why Is The Developed World Obese?', 'Exercise and Type 2 Diabetes - The American College of Sports Medicine and the American Diabetes Association: joint position statement', 'Management of Obesity in Adults: European Clinical Practice Guidelines']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992225/pdf']","['21166_3_management of obesity in adults european clinical practice guidelines.pdf', '21166_2_exercise and type 2 diabetes  the american college of sports medicine and the american diabetes association joint position statement.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992225/pdf']","['21166_3_management of obesity in adults european clinical practice guidelines.pdf', '21166_2_exercise and type 2 diabetes  the american college of sports medicine and the american diabetes association joint position statement.pdf']","[0.388, 0.491]","[0.555, 0.537]","[0.644, 0.628]","[0.211, 0.183]","[0.229, 0.196]","[0.185, 0.156]","[0.745, 0.74]","[0.646, 0.642]","[0.634, 0.612]","[0.701, 0.691]","[0.814, 0.805]","[0.75, 0.732]","[0.643, 0.63]","[0.926, 0.926]","[0.852, 0.834]","[0.78, 0.774]","[0.819, 0.808]","[0.8, 0.79]",0.44,0.546,0.636,0.197,0.213,0.17,0.742,0.644,0.623,0.696,0.809,0.741,0.637,0.926,0.843,0.777,0.814,0.795
https://doi.org/10.1046/j.1523-536x.2003.00243.x,breastfeeding bedsharing and infant sleep,21211_breastfeeding bedsharing and infant sleep.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078207/pdf', 'https://phpa.health.maryland.gov/mch/Documents/Revisiting%20safe%20sleep%20recommendations%20for%20AA%20infants%20(Mat%20Child%20Health%20J%202014).pdf']","['Bed sharing versus no bed sharing for healthy term neonates', 'Revisiting Safe Sleep Recommendations for African-American Infants : Why Current Counseling is Insufficient']","['https://phpa.health.maryland.gov/mch/Documents/Revisiting%20safe%20sleep%20recommendations%20for%20AA%20infants%20(Mat%20Child%20Health%20J%202014).pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078207/pdf']","['21211_1_revisiting safe sleep recommendations for africanamerican infants  why current counseling is insufficient.pdf', '21211_0_bed sharing versus no bed sharing for healthy term neonates.pdf']",2,100.0,"['https://phpa.health.maryland.gov/mch/Documents/Revisiting%20safe%20sleep%20recommendations%20for%20AA%20infants%20(Mat%20Child%20Health%20J%202014).pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078207/pdf']","['21211_1_revisiting safe sleep recommendations for africanamerican infants  why current counseling is insufficient.pdf', '21211_0_bed sharing versus no bed sharing for healthy term neonates.pdf']","[0.331, 0.474]","[0.58, 0.564]","[0.658, 0.648]","[0.205, 0.198]","[0.229, 0.213]","[0.192, 0.175]","[0.736, 0.73]","[0.642, 0.639]","[0.648, 0.633]","[0.679, 0.682]","[0.819, 0.804]","[0.771, 0.742]","[0.65, 0.621]","[0.926, 0.926]","[0.856, 0.843]","[0.792, 0.769]","[0.829, 0.81]","[0.808, 0.793]",0.402,0.572,0.653,0.202,0.221,0.183,0.733,0.641,0.641,0.681,0.811,0.756,0.635,0.926,0.849,0.78,0.82,0.8
https://doi.org/10.1051/forest:2006066,an analysis of ecophysiological responses to drought in american chestnut,21252_an analysis of ecophysiological responses to drought in american chestnut.pdf,1,['https://purl.fdlp.gov/GPO/gpo105856'],"['The silvics of Castanea dentata (Marsh.) Borkh., American chestnut, Fagaceae (beech family) /']",['https://purl.fdlp.gov/GPO/gpo105856'],['21252_0_the silvics of castanea dentata marsh borkh american chestnut fagaceae beech family .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo105856'],['21252_0_the silvics of castanea dentata marsh borkh american chestnut fagaceae beech family .pdf'],[0.355],[0.5],[0.583],[0.131],[0.129],[0.109],[0.734],[0.639],[0.562],[0.678],[0.791],[0.7],[0.628],[0.9],[0.797],[0.755],[0.795],[0.781],0.355,0.5,0.583,0.131,0.129,0.109,0.734,0.639,0.562,0.678,0.791,0.7,0.628,0.9,0.797,0.755,0.795,0.781
https://doi.org/10.1053/jhep.2002.36806,natural history of chronic hepatitis c,21374_natural history of chronic hepatitis c.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364529/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545377/pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/dires/epi-aids-20051001.pdf', 'https://www.in.gov/health/hiv-std-viral-hepatitis/files/2015-Hepatitis-Epidemiologic-Profile-FINAL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477893/pdf', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403642/pdf']","['Current Standards in the Treatment of Chronic Hepatitis C', 'Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey', 'Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990 – 2001', 'Hepatitis C Epidemiologic Profile', 'Diagnosis, management, and treatment of hepatitis C: An update', 'A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report', 'Recommendations on hepatitis C screening for adults']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403642/pdf', 'https://www.in.gov/health/hiv-std-viral-hepatitis/files/2015-Hepatitis-Epidemiologic-Profile-FINAL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477893/pdf', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/dires/epi-aids-20051001.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364529/pdf']","['21374_6_recommendations on hepatitis c screening for adults.pdf', '21374_3_hepatitis c epidemiologic profile.pdf', '21374_4_diagnosis management and treatment of hepatitis c an update.pdf', '21374_5_a national strategy for the elimination of hepatitis b and c phase two report.pdf', '21374_2_reductions in hepatitis c virus and hiv infections among injecting drug users in new york city 1990 – 2001.pdf', '21374_0_current standards in the treatment of chronic hepatitis c.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403642/pdf', 'https://www.in.gov/health/hiv-std-viral-hepatitis/files/2015-Hepatitis-Epidemiologic-Profile-FINAL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477893/pdf', 'http://www.floridahealth.gov/diseases-and-conditions/hepatitis/_documents/docs-for-hepatitis-resource-page/a-national-strategy-for-the-elimination%20of-hepatitis-b-and-c-phase2.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/dires/epi-aids-20051001.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364529/pdf']","['21374_6_recommendations on hepatitis c screening for adults.pdf', '21374_3_hepatitis c epidemiologic profile.pdf', '21374_4_diagnosis management and treatment of hepatitis c an update.pdf', '21374_5_a national strategy for the elimination of hepatitis b and c phase two report.pdf', '21374_2_reductions in hepatitis c virus and hiv infections among injecting drug users in new york city 1990 – 2001.pdf', '21374_0_current standards in the treatment of chronic hepatitis c.pdf']","[0.263, 0.298, 0.348, 0.524, 0.548, 0.439]","[0.6, 0.529, 0.529, 0.539, 0.609, 0.608]","[0.661, 0.61, 0.63, 0.63, 0.668, 0.667]","[0.21, 0.166, 0.205, 0.175, 0.22, 0.226]","[0.215, 0.163, 0.221, 0.176, 0.204, 0.218]","[0.174, 0.134, 0.176, 0.148, 0.167, 0.18]","[0.747, 0.735, 0.752, 0.74, 0.75, 0.756]","[0.657, 0.641, 0.663, 0.648, 0.654, 0.665]","[0.666, 0.597, 0.602, 0.607, 0.674, 0.672]","[0.666, 0.648, 0.663, 0.661, 0.644, 0.649]","[0.827, 0.791, 0.787, 0.81, 0.829, 0.824]","[0.775, 0.719, 0.682, 0.727, 0.786, 0.769]","[0.647, 0.632, 0.605, 0.63, 0.661, 0.647]","[0.924, 0.912, 0.919, 0.919, 0.918, 0.925]","[0.861, 0.834, 0.828, 0.83, 0.862, 0.836]","[0.795, 0.751, 0.754, 0.762, 0.8, 0.786]","[0.831, 0.792, 0.785, 0.793, 0.833, 0.82]","[0.81, 0.774, 0.777, 0.785, 0.813, 0.797]",0.403,0.569,0.644,0.2,0.199,0.163,0.747,0.655,0.636,0.655,0.811,0.743,0.637,0.919,0.842,0.775,0.809,0.793
https://doi.org/10.1055/s-0037-1612589,successful suppression using rituximab of a factor viii inhibitor in a boy with severe congenital haemophilia an example of a significant decrease of treatment costs,21499_successful suppression using rituximab of a factor viii inhibitor in a boy with severe congenital haemophilia an example of a significant decrease of treatment costs.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407108/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483299/pdf']","['Rituximab for treating inhibitors in people with inherited severe hemophilia', 'Rituximab for treating inhibitors in people with inherited severe hemophilia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407108/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483299/pdf']","['21499_0_rituximab for treating inhibitors in people with inherited severe hemophilia.pdf', '21499_1_rituximab for treating inhibitors in people with inherited severe hemophilia.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407108/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483299/pdf']","['21499_0_rituximab for treating inhibitors in people with inherited severe hemophilia.pdf', '21499_1_rituximab for treating inhibitors in people with inherited severe hemophilia.pdf']","[0.415, 0.418]","[0.555, 0.56]","[0.65, 0.653]","[0.192, 0.195]","[0.198, 0.202]","[0.174, 0.175]","[0.73, 0.731]","[0.637, 0.638]","[0.638, 0.642]","[0.651, 0.651]","[0.81, 0.813]","[0.741, 0.743]","[0.631, 0.631]","[0.928, 0.93]","[0.842, 0.842]","[0.771, 0.775]","[0.808, 0.811]","[0.795, 0.798]",0.416,0.558,0.651,0.194,0.2,0.174,0.73,0.637,0.64,0.651,0.811,0.742,0.631,0.929,0.842,0.773,0.81,0.796
https://doi.org/10.1055/s-0037-1616782,successful use of mycophenolate mofetil and prednisone in a 14yearold girl with acquired hemophilia a,21501_successful use of mycophenolate mofetil and prednisone in a 14yearold girl with acquired hemophilia a.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663620/pdf'],['International recommendations on the diagnosis and treatment of patients with acquired hemophilia A'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663620/pdf'],['21501_0_international recommendations on the diagnosis and treatment of patients with acquired hemophilia a.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663620/pdf'],['21501_0_international recommendations on the diagnosis and treatment of patients with acquired hemophilia a.pdf'],[0.576],[0.639],[0.694],[0.245],[0.257],[0.196],[0.752],[0.659],[0.702],[0.664],[0.837],[0.789],[0.673],[0.932],[0.855],[0.817],[0.842],[0.827],0.576,0.639,0.694,0.245,0.257,0.196,0.752,0.659,0.702,0.664,0.837,0.789,0.673,0.932,0.855,0.817,0.842,0.827
https://doi.org/10.1055/s-0039-1699191,a comparative study of the efficacy of topical negative pressure moist dressings and conventional moist dressings in chronic wounds,21502_a comparative study of the efficacy of topical negative pressure moist dressings and conventional moist dressings in chronic wounds.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464010/pdf'],['Negative pressure wound therapy for treating leg ulcers'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464010/pdf'],['21502_0_negative pressure wound therapy for treating leg ulcers.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464010/pdf'],['21502_0_negative pressure wound therapy for treating leg ulcers.pdf'],[0.437],[0.543],[0.621],[0.166],[0.189],[0.136],[0.737],[0.637],[0.608],[0.669],[0.792],[0.733],[0.631],[0.924],[0.831],[0.754],[0.798],[0.777],0.437,0.543,0.621,0.166,0.189,0.136,0.737,0.637,0.608,0.669,0.792,0.733,0.631,0.924,0.831,0.754,0.798,0.777
https://doi.org/10.1055/s-0039-3400227,17ohpc to prevent recurrent preterm birth in singleton gestations prolong study a multicenter international randomized doubleblind trial,21503_17ohpc to prevent recurrent preterm birth in singleton gestations prolong study a multicenter international randomized doubleblind trial.pdf,2,"['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf']","['Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit', 'Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit']","['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf']","['21503_1_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '21503_0_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf']",2,100.0,"['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf']","['21503_1_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '21503_0_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf']","[0.266, 0.249]","[0.536, 0.539]","[0.605, 0.606]","[0.154, 0.156]","[0.147, 0.147]","[0.122, 0.121]","[0.729, 0.729]","[0.634, 0.634]","[0.606, 0.608]","[0.627, 0.625]","[0.796, 0.796]","[0.722, 0.724]","[0.619, 0.618]","[0.918, 0.918]","[0.816, 0.815]","[0.762, 0.764]","[0.8, 0.8]","[0.784, 0.783]",0.258,0.538,0.605,0.155,0.147,0.121,0.729,0.634,0.607,0.626,0.796,0.723,0.619,0.918,0.815,0.763,0.8,0.784
https://doi.org/10.1055/s-0040-1703561,a comparative study on effect of ambulation and birthing ball on maternal and newborn outcome among primigravida mothers in selected hospitals in mangalore,21505_a comparative study on effect of ambulation and birthing ball on maternal and newborn outcome among primigravida mothers in selected hospitals in mangalore.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494625/pdf', 'https://effectivehealthcare.ahrq.gov/products/labor-dystocia/research']","['Relaxation techniques for pain management in labour', 'Labor Dystocia']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494625/pdf'],['21505_0_relaxation techniques for pain management in labour.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494625/pdf'],['21505_0_relaxation techniques for pain management in labour.pdf'],[0.316],[0.515],[0.597],[0.163],[0.171],[0.134],[0.739],[0.642],[0.566],[0.668],[0.766],[0.685],[0.593],[0.906],[0.8],[0.714],[0.766],[0.741],0.316,0.515,0.597,0.163,0.171,0.134,0.739,0.642,0.566,0.668,0.766,0.685,0.593,0.906,0.8,0.714,0.766,0.741
https://doi.org/10.1055/s-0040-1705152,serratus anterior plane block and intercostal nerve block after thoracoscopic surgery,21506_serratus anterior plane block and intercostal nerve block after thoracoscopic surgery.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297998/pdf'],['PROSPECT guidelines for video‐assisted thoracoscopic surgery: a systematic review and procedure‐specific postoperative pain management recommendations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297998/pdf'],['21506_0_prospect guidelines for video‐assisted thoracoscopic surgery a systematic review and procedure‐specific postoperative pain management recommendations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297998/pdf'],['21506_0_prospect guidelines for video‐assisted thoracoscopic surgery a systematic review and procedure‐specific postoperative pain management recommendations.pdf'],[0.61],[0.574],[0.649],[0.213],[0.24],[0.178],[0.745],[0.655],[0.646],[0.67],[0.816],[0.745],[0.642],[0.932],[0.831],[0.789],[0.815],[0.802],0.61,0.574,0.649,0.213,0.24,0.178,0.745,0.655,0.646,0.67,0.816,0.745,0.642,0.932,0.831,0.789,0.815,0.802
https://doi.org/10.1055/s-0040-1709688,neonatal resuscitation and postresuscitation care of infants born to mothers with suspected or confirmed sarscov2 infection,21507_neonatal resuscitation and postresuscitation care of infants born to mothers with suspected or confirmed sarscov2 infection.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf']","['European Resuscitation Council COVID-19 guidelines executive summary', 'Adapting obstetric and neonatal services during the COVID-19 pandemic: a scoping review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276132/pdf']","['21507_1_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf', '21507_0_european resuscitation council covid19 guidelines executive summary.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276132/pdf']","['21507_1_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf', '21507_0_european resuscitation council covid19 guidelines executive summary.pdf']","[0.516, 0.617]","[0.555, 0.601]","[0.629, 0.664]","[0.178, 0.186]","[0.202, 0.203]","[0.157, 0.158]","[0.739, 0.739]","[0.651, 0.648]","[0.623, 0.677]","[0.622, 0.614]","[0.814, 0.835]","[0.747, 0.789]","[0.627, 0.663]","[0.923, 0.937]","[0.839, 0.847]","[0.784, 0.813]","[0.817, 0.845]","[0.803, 0.826]",0.567,0.578,0.647,0.182,0.203,0.158,0.739,0.649,0.65,0.618,0.825,0.768,0.645,0.93,0.843,0.798,0.831,0.815
https://doi.org/10.1055/s-0040-1710051,considerations for obstetric care during the covid19 pandemic,21508_considerations for obstetric care during the covid19 pandemic.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf'],['Adapting obstetric and neonatal services during the COVID-19 pandemic: a scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf'],['21508_0_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840792/pdf'],['21508_0_adapting obstetric and neonatal services during the covid19 pandemic a scoping review.pdf'],[0.643],[0.565],[0.634],[0.186],[0.206],[0.16],[0.738],[0.651],[0.63],[0.629],[0.816],[0.755],[0.628],[0.924],[0.842],[0.786],[0.818],[0.803],0.643,0.565,0.634,0.186,0.206,0.16,0.738,0.651,0.63,0.629,0.816,0.755,0.628,0.924,0.842,0.786,0.818,0.803
https://doi.org/10.1056/nejmc2003100,sarscov2 infection among travelers returning from wuhan china,21580_sarscov2 infection among travelers returning from wuhan china.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236848/pdf']","['International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review', 'Rapid Development and Deployment of an International Omaha System Evidence-Based Guideline to Support the COVID-19 Response']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236848/pdf']","['21580_0_international travel‐related control measures to contain the covid‐19 pandemic a rapid review.pdf', '21580_1_rapid development and deployment of an international omaha system evidencebased guideline to support the covid19 response.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406796/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236848/pdf']","['21580_0_international travel‐related control measures to contain the covid‐19 pandemic a rapid review.pdf', '21580_1_rapid development and deployment of an international omaha system evidencebased guideline to support the covid19 response.pdf']","[0.186, 0.137]","[0.486, 0.48]","[0.562, 0.568]","[0.129, 0.159]","[0.131, 0.167]","[0.111, 0.133]","[0.723, 0.732]","[0.633, 0.646]","[0.561, 0.562]","[0.693, 0.693]","[0.769, 0.788]","[0.676, 0.688]","[0.578, 0.59]","[0.915, 0.918]","[0.798, 0.798]","[0.721, 0.733]","[0.766, 0.78]","[0.76, 0.78]",0.162,0.483,0.565,0.144,0.149,0.122,0.728,0.639,0.562,0.693,0.778,0.682,0.584,0.917,0.798,0.727,0.773,0.77
https://doi.org/10.1056/nejmc2007575,coagulopathy and antiphospholipid antibodies in patients with covid19,21581_coagulopathy and antiphospholipid antibodies in patients with covid19.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299122/pdf']","['Atención al ictus agudo durante la pandemia por COVID-19. Recomendaciones Plan Ictus Madrid', 'COVID-19 Guide for the Rehabilitation Clinician: A Review of Non-Pulmonary Manifestations and Complications']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299122/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180371/pdf']","['21581_1_covid19 guide for the rehabilitation clinician a review of nonpulmonary manifestations and complications.pdf', '21581_0_atención al ictus agudo durante la pandemia por covid19 recomendaciones plan ictus madrid.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299122/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180371/pdf']","['21581_1_covid19 guide for the rehabilitation clinician a review of nonpulmonary manifestations and complications.pdf', '21581_0_atención al ictus agudo durante la pandemia por covid19 recomendaciones plan ictus madrid.pdf']","[0.024, 0.306]","[0.467, 0.395]","[0.544, 0.511]","[0.16, 0.132]","[0.172, 0.155]","[0.125, 0.11]","[0.747, 0.738]","[0.66, 0.657]","[0.533, 0.473]","[0.656, 0.645]","[0.776, 0.776]","[0.673, 0.63]","[0.568, 0.534]","[0.903, 0.872]","[0.747, 0.728]","[0.702, 0.653]","[0.754, 0.718]","[0.749, 0.701]",0.165,0.431,0.528,0.146,0.163,0.117,0.742,0.659,0.503,0.651,0.776,0.651,0.551,0.887,0.738,0.677,0.736,0.725
https://doi.org/10.1056/nejmc2031670,shedding of viable sarscov2 after immunosuppressive therapy for cancer,21584_shedding of viable sarscov2 after immunosuppressive therapy for cancer.pdf,7,"['https://stacks.cdc.gov/view/cdc/112950', 'https://stacks.cdc.gov/view/cdc/105815', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250763/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874914/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464362/pdf']","['Ending isolation and precautions for people with COVID-19 : interim guidance', 'Interim guidance on ending isolation and precautions for adults with COVID-19', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery - A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, the Centre for Peri‐operative Care, the Federation of Surgical Specialty Associations, the Royal College of Anaesthetists and the Royal College of Surgeons of England', '2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy', 'Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents', 'Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464362/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874914/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['21584_6_revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients august 2022.pdf', '21584_5_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf', '21584_4_2021 update of the agiho guideline on evidencebased management of covid19 in patients with cancer regarding diagnostics viral shedding vaccination and therapy.pdf', '21584_2_coronavirus disease 2019 covid19 treatment guidelines.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464362/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874914/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['21584_6_revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients august 2022.pdf', '21584_5_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf', '21584_4_2021 update of the agiho guideline on evidencebased management of covid19 in patients with cancer regarding diagnostics viral shedding vaccination and therapy.pdf', '21584_2_coronavirus disease 2019 covid19 treatment guidelines.pdf']","[0.346, 0.342, 0.217, 0.369]","[0.512, 0.515, 0.525, 0.503]","[0.582, 0.583, 0.591, 0.573]","[0.175, 0.176, 0.189, 0.155]","[0.181, 0.178, 0.188, 0.16]","[0.135, 0.134, 0.143, 0.124]","[0.744, 0.742, 0.747, 0.741]","[0.655, 0.651, 0.659, 0.651]","[0.59, 0.59, 0.598, 0.576]","[0.659, 0.657, 0.665, 0.658]","[0.792, 0.789, 0.791, 0.777]","[0.717, 0.721, 0.732, 0.691]","[0.59, 0.597, 0.595, 0.574]","[0.913, 0.912, 0.912, 0.894]","[0.812, 0.813, 0.825, 0.794]","[0.742, 0.745, 0.751, 0.735]","[0.786, 0.782, 0.79, 0.77]","[0.783, 0.78, 0.79, 0.773]",0.319,0.514,0.582,0.174,0.177,0.134,0.744,0.654,0.589,0.66,0.787,0.715,0.589,0.908,0.811,0.743,0.782,0.782
https://doi.org/10.1056/nejmcp1800468,diverticulitis,21591_diverticulitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878331/pdf'],['AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878331/pdf'],['21591_0_aga clinical practice update on medical management of colonic diverticulitis expert review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878331/pdf'],['21591_0_aga clinical practice update on medical management of colonic diverticulitis expert review.pdf'],[0.615],[0.562],[0.645],[0.221],[0.236],[0.194],[0.754],[0.663],[0.629],[0.667],[0.808],[0.729],[0.61],[0.929],[0.826],[0.774],[0.799],[0.797],0.615,0.562,0.645,0.221,0.236,0.194,0.754,0.663,0.629,0.667,0.808,0.729,0.61,0.929,0.826,0.774,0.799,0.797
https://doi.org/10.1056/nejmoa0908355,ferric carboxymaltose in patients with heart failure and iron deficiency,21659_ferric carboxymaltose in patients with heart failure and iron deficiency.pdf,8,"['https://www.hrsonline.org/documents/2013-management-heart-failurepdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886296/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607482/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165963/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899074/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924972/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-Anemia-Guideline-English.pdf', 'https://www.jacc.org/doi/pdf/10.1016/j.jacc.2021.12.012?_ga=2.252528333.578092439.1663172885-69663792.1662978003&_gl=1*ewjwn3*_ga*Njk2NjM3OTIuMTY2Mjk3ODAwMw..*_ga_2V8VW4Y237*MTY2MzE3Mjg4NS4yLjAuMTY2MzE3Mjg4OC41Ny4wLjA.']","['2013 ACCF/AHA Guideline for the Management of Heart Failure', 'The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method', 'Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice', 'Iron deficiency in chronic heart failure: case‐based practical guidance', 'Iron therapy for preoperative anaemia', 'Intravenous iron therapy for non‐anaemic, iron‐deficient adults', 'KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease', '2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure']","['https://www.hrsonline.org/documents/2013-management-heart-failurepdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886296/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924972/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607482/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899074/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165963/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-Anemia-Guideline-English.pdf']","['21659_0_2013 accfaha guideline for the management of heart failure.pdf', '21659_1_the management of iron deficiency in inflammatory bowel disease – an online tool developed by the randucla appropriateness method.pdf', '21659_5_intravenous iron therapy for non‐anaemic iron‐deficient adults.pdf', '21659_2_screening diagnosis and treatment of iron deficiency in chronic heart failure putting the 2016 european society of cardiology heart failure guidelines into clinical practice.pdf', '21659_4_iron therapy for preoperative anaemia.pdf', '21659_3_iron deficiency in chronic heart failure case‐based practical guidance.pdf', '21659_6_kdigo clinical practice guideline for anemia in chronic kidney disease.pdf']",7,87.5,"['https://www.hrsonline.org/documents/2013-management-heart-failurepdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886296/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924972/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607482/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899074/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165963/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-Anemia-Guideline-English.pdf']","['21659_0_2013 accfaha guideline for the management of heart failure.pdf', '21659_1_the management of iron deficiency in inflammatory bowel disease – an online tool developed by the randucla appropriateness method.pdf', '21659_5_intravenous iron therapy for non‐anaemic iron‐deficient adults.pdf', '21659_2_screening diagnosis and treatment of iron deficiency in chronic heart failure putting the 2016 european society of cardiology heart failure guidelines into clinical practice.pdf', '21659_4_iron therapy for preoperative anaemia.pdf', '21659_3_iron deficiency in chronic heart failure case‐based practical guidance.pdf', '21659_6_kdigo clinical practice guideline for anemia in chronic kidney disease.pdf']","[0.546, 0.408, 0.569, 0.594, 0.354, 0.431, 0.517]","[0.507, 0.522, 0.503, 0.516, 0.499, 0.517, 0.521]","[0.594, 0.603, 0.591, 0.604, 0.588, 0.599, 0.606]","[0.161, 0.176, 0.163, 0.182, 0.16, 0.183, 0.168]","[0.165, 0.189, 0.166, 0.182, 0.162, 0.18, 0.176]","[0.121, 0.139, 0.128, 0.141, 0.131, 0.139, 0.13]","[0.741, 0.736, 0.732, 0.74, 0.735, 0.74, 0.736]","[0.646, 0.639, 0.635, 0.642, 0.638, 0.641, 0.638]","[0.583, 0.601, 0.582, 0.592, 0.576, 0.596, 0.598]","[0.661, 0.672, 0.692, 0.664, 0.685, 0.662, 0.658]","[0.779, 0.795, 0.777, 0.788, 0.771, 0.79, 0.79]","[0.699, 0.727, 0.691, 0.711, 0.688, 0.716, 0.721]","[0.591, 0.607, 0.582, 0.6, 0.577, 0.611, 0.609]","[0.917, 0.921, 0.915, 0.914, 0.911, 0.921, 0.919]","[0.795, 0.819, 0.804, 0.802, 0.799, 0.806, 0.809]","[0.727, 0.751, 0.723, 0.74, 0.713, 0.746, 0.746]","[0.765, 0.793, 0.768, 0.78, 0.763, 0.784, 0.787]","[0.753, 0.777, 0.753, 0.763, 0.746, 0.768, 0.768]",0.488,0.512,0.598,0.17,0.174,0.133,0.737,0.64,0.59,0.671,0.784,0.708,0.597,0.917,0.805,0.735,0.777,0.761
https://doi.org/10.1056/nejmoa0909537,efficacy of quadrivalent hpv vaccine against hpv infection and disease in males,21660_efficacy of quadrivalent hpv vaccine against hpv infection and disease in males.pdf,10,"['https://nam.edu/perspectives-2015-assessing-the-population-impact-of-published-intervention-studies/', 'https://stacks.cdc.gov/view/cdc/82632', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820069/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964839/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169043/pdf', 'https://www.idsociety.org/contentassets/7ab3d1e72a9d4868be6d6c2c2553818e/adult_oi.pdf']","['Assessing the Population Impact of Published Intervention Studies', 'Evidence to Recommendations for Harmonization of Catch-Up HPV Vaccination through Age 26 Years', 'Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males', 'Molecular Cancer Prevention: Current Status & Future Directions', 'Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors', 'Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016', 'Physicians’ Human Papillomavirus Vaccine Recommendations in the Context of Permissive Guidelines for Male Patients: A National Study', 'Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)', 'Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children - Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics', 'Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820069/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://www.idsociety.org/contentassets/7ab3d1e72a9d4868be6d6c2c2553818e/adult_oi.pdf']","['21660_5_multidisciplinary evidencebased consensus guidelines for human papillomavirus hpv vaccination in highrisk populations spain 2016.pdf', '21660_2_comparison of different human papillomavirus hpv vaccine types and dose schedules for prevention of hpv‐related disease in females and males.pdf', '21660_6_physicians human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients a national study.pdf', '21660_3_molecular cancer prevention current status  future directions.pdf', '21660_4_prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.pdf', '21660_9_guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with hiv.pdf']",6,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381660/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873216/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184998/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820069/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494566/pdf', 'https://www.idsociety.org/contentassets/7ab3d1e72a9d4868be6d6c2c2553818e/adult_oi.pdf']","['21660_5_multidisciplinary evidencebased consensus guidelines for human papillomavirus hpv vaccination in highrisk populations spain 2016.pdf', '21660_2_comparison of different human papillomavirus hpv vaccine types and dose schedules for prevention of hpv‐related disease in females and males.pdf', '21660_6_physicians human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients a national study.pdf', '21660_3_molecular cancer prevention current status  future directions.pdf', '21660_4_prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.pdf', '21660_9_guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with hiv.pdf']","[0.597, 0.211, 0.575, 0.503, 0.37, 0.195]","[0.475, 0.492, 0.474, 0.466, 0.492, 0.475]","[0.56, 0.566, 0.554, 0.55, 0.565, 0.558]","[0.15, 0.163, 0.152, 0.143, 0.17, 0.128]","[0.175, 0.169, 0.166, 0.146, 0.174, 0.139]","[0.15, 0.15, 0.147, 0.119, 0.16, 0.118]","[0.748, 0.746, 0.744, 0.743, 0.749, 0.742]","[0.658, 0.654, 0.65, 0.652, 0.658, 0.647]","[0.542, 0.547, 0.543, 0.543, 0.549, 0.539]","[0.676, 0.698, 0.69, 0.679, 0.703, 0.646]","[0.751, 0.745, 0.74, 0.74, 0.743, 0.749]","[0.675, 0.677, 0.66, 0.657, 0.673, 0.659]","[0.583, 0.575, 0.563, 0.574, 0.586, 0.567]","[0.869, 0.869, 0.87, 0.871, 0.867, 0.869]","[0.753, 0.75, 0.752, 0.743, 0.747, 0.738]","[0.656, 0.66, 0.662, 0.66, 0.661, 0.668]","[0.746, 0.745, 0.739, 0.738, 0.741, 0.743]","[0.701, 0.687, 0.697, 0.699, 0.688, 0.699]",0.409,0.479,0.559,0.151,0.162,0.141,0.745,0.653,0.544,0.682,0.745,0.667,0.575,0.869,0.747,0.661,0.742,0.695
https://doi.org/10.1056/nejmoa1304572,abatacept in b71–positive proteinuric kidney disease,21695_abatacept in b71–positive proteinuric kidney disease.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686/pdf'],['IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686/pdf'],['21695_0_ipna clinical practice recommendations for the diagnosis and management of children with steroidresistant nephrotic syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686/pdf'],['21695_0_ipna clinical practice recommendations for the diagnosis and management of children with steroidresistant nephrotic syndrome.pdf'],[0.199],[0.531],[0.606],[0.163],[0.146],[0.123],[0.745],[0.644],[0.615],[0.627],[0.811],[0.734],[0.609],[0.918],[0.81],[0.757],[0.8],[0.791],0.199,0.531,0.606,0.163,0.146,0.123,0.745,0.644,0.615,0.627,0.811,0.734,0.609,0.918,0.81,0.757,0.8,0.791
https://doi.org/10.1056/nejmoa1306227,phase 2b trial of interferonfree therapy for hepatitis c virus genotype 1,21696_phase 2b trial of interferonfree therapy for hepatitis c virus genotype 1.pdf,3,"['https://watermark.silverchair.com/ciu617.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAyswggMnBgkqhkiG9w0BBwagggMYMIIDFAIBADCCAw0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM4g0njeAHro4RQhgIAgEQgIIC3jXe42mg61EqbrGtD-GGLuJcXoWdBElwZ-Xb2pl_KyfjStz8FIqfgokrQ_73XWBwobU1NW1EyvLnv3lhJbewinhJKrhbInPrJxoo6rkIw5Zme3FqQwwPvFwNinM-gUJ5Z8OebJ2n5oh-yw75dWVQ78nRuFjUjZikMgEdUE1Vp3bJJL8P9JxkFlC2ZSqyCcWxJooUyA3CwIE9youRm-oWiWtNnX6IDsDVO_PjZ9ueIfzVM8g7tZV4TE-lYNLSr44Wx_7pl0_gFcjp8C2E4UKFsARY6HfQZamSXatUEwP59hX6_jrpm8ljJPqu17nkVS19w-oqSwGy4MP44ZDeHK9EkX0TignEBhBXiuX3gvT6zy9aPfYDuOMvNc80A27gul5lyWE6UVLiMMdVF4W3xLZdWxiW1twfU-zDOKzom1Bmuyr29Dm0szD1FmDzj5dF68CKhATYLHGkzKGxZ5ICrLq3qRVmQWJ2bCZDsURs4Vm49cUjiRWnyjEcTL-j4qPtSlRYIK_EnCWGGkbiacBW6wua4pSBMjWQ-WDb08foRVZgtoBSL8D-9IF6LDhg9jYdsiHuuD5d0JOxB7m0XX65EGxmFJa4dSO2FCmKr40pPhAxeCjhibA6TsKgQfs3YzZ5sOvZUsd6gTOW7ufVQ3N7SV8Vfb16eEZMEtFLRNgB07UYyuq_asA4zhJ8cm1_BiS2e44Ba6EIUu5jO5zftb9t8clX8H52asMvC355IYUwdGmUIDZismeqRPqLGH7CUkVh3FWi5m7oVV4otK864E1GEnAUFQluCLbltlnqvmKKj7KxmjkXBcsI5i5fwFNN8qeWmMpWPNwHCzquH84A8KigNVuGgaygzAm8KZxd3pJxDP58oh1eIPqHQ34QpDN1CVj9b9wc5vyrmap5ex9uPXaSVFPPkAElPvItsvAIKY57VIoa-zBHu0PRgg3SMtrq9KOCUjojqJWHyEmWa3pvN5UsWpcs', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271038/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063106/pdf']","['Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America', 'Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America', 'HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271038/pdf']","['21696_2_hcv council – critical appraisal of data recommendations for clinical practice in a rapidly evolving therapeutic landscape.pdf', '21696_1_clinical practice guideline for the management of chronic kidney disease in patients infected with hiv 2014 update b.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063106/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271038/pdf']","['21696_2_hcv council – critical appraisal of data recommendations for clinical practice in a rapidly evolving therapeutic landscape.pdf', '21696_1_clinical practice guideline for the management of chronic kidney disease in patients infected with hiv 2014 update b.pdf']","[0.304, 0.572]","[0.56, 0.559]","[0.628, 0.632]","[0.206, 0.188]","[0.221, 0.186]","[0.171, 0.146]","[0.746, 0.749]","[0.657, 0.655]","[0.637, 0.635]","[0.675, 0.652]","[0.807, 0.806]","[0.75, 0.748]","[0.617, 0.612]","[0.928, 0.925]","[0.825, 0.818]","[0.77, 0.768]","[0.801, 0.798]","[0.792, 0.79]",0.438,0.56,0.63,0.197,0.204,0.159,0.748,0.656,0.636,0.663,0.806,0.749,0.615,0.927,0.821,0.769,0.8,0.791
https://doi.org/10.1056/nejmoa1605086,genetic risk adherence to a healthy lifestyle and coronary disease,21711_genetic risk adherence to a healthy lifestyle and coronary disease.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346975/pdf', 'https://watermark.silverchair.com/dgaa674.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsowggLGBgkqhkiG9w0BBwagggK3MIICswIBADCCAqwGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMcJI7_cHwtlfN60KyAgEQgIICfXBDs3oFAE5Qty6CEWVnikgIaAuY_RnhUGurZ3L55EKN9KIy4VHIict2gKUdYgCCwi5EBAaMbSNYmdlTfIwzGjbKg8UvI7VnU3tS8wlU7i8BOfxIqcaUeRFww7ri9sqbmL_LY01LwckOPqt-C_gMNIO8fvgYJ8Lco0VKtEi91S2RK-CdUelFJ4w3HcscdZcsmsf7U7hyXYPCii1aLVmm_bDp11nt6pLHegrs9D446qM5cTAwitsT3STBm9DJ5vFPeoyiWoeqtZjt-DynmG7DPNLhpKwwJRKTGwTCKWGg9YwgQbSu-ydDDr-Eb9gSFcZl0QkHf6p7wjzK7I_xyQPJZ1TCkS7hmsDGDGHMFrWYCa8RTsWGX0YE8xcqNs9vA4R4hecJtJ0dzAqAR6FCjfMBf9Mx8dUrPWzdcV-mizqK4Dp1k8OhBJRRkxsp_enXj6fPW48Utxu1jpD_1Aqm33Av09JbB4KGaEa-pT6QkkGSXeo9wt0GUlHyHW5VXPJqQHodpoB5_4-9EmPfGCzXabock_WbiwsZpRN8L0rPBBBAwuNwXliEAmnKIfIg9Hu9J5inBhijfilif6qrSTaGfit8LqkmjUTcr4f51z4_-J1UadMW8i_7j2VT3UHsYIt6QxmB-P3i73V3MobDsl6AU-qw4_eaopnsm4Ck-qi9cbJznEzAH7YVmyrHXFNZdKVHVSuLkIMebQhfeGp0K7WgmykujwezltagH_a_P2PdWYZvfuzKirYu0YA-c-slhBSv4DMWYRb7w1s3d8ADZG5RUZBbONmC4FY9fP52YJGSnTdJ4EHNFwnXftpIIp0t1MvsENDNpnnRL2jw15ahj7tfa4M']","['Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease', 'Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346975/pdf'],['21711_0_limitations of contemporary guidelines for managing patients at high genetic risk of coronary artery disease.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346975/pdf'],['21711_0_limitations of contemporary guidelines for managing patients at high genetic risk of coronary artery disease.pdf'],[0.431],[0.497],[0.574],[0.181],[0.2],[0.15],[0.742],[0.657],[0.569],[0.721],[0.769],[0.691],[0.581],[0.903],[0.79],[0.712],[0.763],[0.746],0.431,0.497,0.574,0.181,0.2,0.15,0.742,0.657,0.569,0.721,0.769,0.691,0.581,0.903,0.79,0.712,0.763,0.746
https://doi.org/10.1056/nejmoa1703058,time to treatment and mortality during mandated emergency care for sepsis,21720_time to treatment and mortality during mandated emergency care for sepsis.pdf,10,"['https://www.federalregister.gov/documents/2019/08/16/2019-16762/medicare-program-hospital-inpatient-prospective-payment-systems-for-acute-care-hospitals-and-the', 'https://datasociety.net/library/repairing-innovation/', 'https://phpa.health.maryland.gov/documents/HB-1467-2018-Report-on-the-Sepsis-Public-Awareness-Campaign-Workgroup.pdf', 'https://health.maryland.gov/phpa/documents/HB-1467-2018-Report-on-the-Sepsis-Public-Awareness-Campaign-Workgroup.pdf', 'https://pdfs.journals.lww.com/ccmjournal/2021/11000/Surviving_Sepsis_Campaign__International.21.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1675444890173;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzd9ia1/MJJUFmWp1b9urv13Jgb+h4gj8wm81wyFvJcaUg=;hash|5BPdbiIvIrHFyJFp99KCmQ==', 'https://www.idsociety.org/globalassets/idsa/practice-guidelines/2021-idsa-acep-sepsis-report.pdf', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/024100/024137/20190516e.pdf', 'https://journals.lww.com/ajg/Fulltext/2022/02000/Acute_on_Chronic_Liver_Failure_Clinical_Guidelines.15.aspx?context=FeaturedArticles&collectionId=2', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947898/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963440/pdf']","['Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2020 Rates; Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Requirements for Eligible Hospitals and Critical Access Hospitals', 'Repairing Innovation', 'MARYLAND Department of Health', 'MARYLAND Department of Health', 'Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021', 'Early Care of Adults With Suspected Sepsis in the Emergency Department and Out-of-Hospital Environment: A Consensus-Based Task Force Report', 'MARYLAND Department of Health', 'Acute-on-Chronic Liver Failure Clinical Guidelines', 'Perforated and bleeding peptic ulcer: WSES guidelines', 'The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963440/pdf', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/024100/024137/20190516e.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947898/pdf', 'https://phpa.health.maryland.gov/documents/HB-1467-2018-Report-on-the-Sepsis-Public-Awareness-Campaign-Workgroup.pdf', 'https://www.idsociety.org/globalassets/idsa/practice-guidelines/2021-idsa-acep-sepsis-report.pdf', 'https://health.maryland.gov/phpa/documents/HB-1467-2018-Report-on-the-Sepsis-Public-Awareness-Campaign-Workgroup.pdf']","['21720_9_the surviving sepsis campaign fluid resuscitation and vasopressor therapy research priorities in adult patients.pdf', '21720_6_maryland department of health.pdf', '21720_8_perforated and bleeding peptic ulcer wses guidelines.pdf', '21720_2_maryland department of health.pdf', '21720_5_early care of adults with suspected sepsis in the emergency department and outofhospital environment a consensusbased task force report.pdf', '21720_3_maryland department of health.pdf']",6,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963440/pdf', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/024100/024137/20190516e.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947898/pdf', 'https://phpa.health.maryland.gov/documents/HB-1467-2018-Report-on-the-Sepsis-Public-Awareness-Campaign-Workgroup.pdf', 'https://www.idsociety.org/globalassets/idsa/practice-guidelines/2021-idsa-acep-sepsis-report.pdf', 'https://health.maryland.gov/phpa/documents/HB-1467-2018-Report-on-the-Sepsis-Public-Awareness-Campaign-Workgroup.pdf']","['21720_9_the surviving sepsis campaign fluid resuscitation and vasopressor therapy research priorities in adult patients.pdf', '21720_6_maryland department of health.pdf', '21720_8_perforated and bleeding peptic ulcer wses guidelines.pdf', '21720_2_maryland department of health.pdf', '21720_5_early care of adults with suspected sepsis in the emergency department and outofhospital environment a consensusbased task force report.pdf', '21720_3_maryland department of health.pdf']","[0.237, 0.237, 0.501, 0.237, 0.22, 0.44]","[0.525, 0.509, 0.521, 0.509, 0.512, 0.509]","[0.606, 0.603, 0.6, 0.603, 0.592, 0.603]","[0.181, 0.17, 0.159, 0.17, 0.178, 0.17]","[0.185, 0.183, 0.153, 0.183, 0.195, 0.183]","[0.138, 0.146, 0.117, 0.146, 0.143, 0.146]","[0.739, 0.735, 0.738, 0.735, 0.74, 0.735]","[0.646, 0.643, 0.641, 0.643, 0.649, 0.643]","[0.593, 0.584, 0.591, 0.584, 0.58, 0.584]","[0.679, 0.673, 0.641, 0.673, 0.688, 0.673]","[0.786, 0.786, 0.783, 0.786, 0.778, 0.786]","[0.721, 0.72, 0.716, 0.72, 0.703, 0.72]","[0.616, 0.615, 0.599, 0.615, 0.597, 0.615]","[0.908, 0.91, 0.905, 0.91, 0.909, 0.91]","[0.811, 0.821, 0.793, 0.821, 0.804, 0.821]","[0.74, 0.735, 0.733, 0.735, 0.73, 0.735]","[0.782, 0.784, 0.777, 0.784, 0.775, 0.784]","[0.762, 0.761, 0.756, 0.761, 0.756, 0.761]",0.312,0.514,0.601,0.171,0.18,0.139,0.737,0.644,0.586,0.671,0.784,0.717,0.61,0.909,0.812,0.735,0.781,0.76
https://doi.org/10.1056/nejmoa1709937,durvalumab after chemoradiotherapy in stage iii non–smallcell lung cancer,21722_durvalumab after chemoradiotherapy in stage iii non–smallcell lung cancer.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788064/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253284/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339680/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647093/pdf']","['EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors', 'Guidelines for clinical evaluation of anti‐cancer drugs', 'AIM Cancer Treatment Pathways', 'SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)', 'Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339680/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647093/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788064/pdf']","['21722_3_seom clinical guidelines for the treatment of nonsmall cell lung cancer 2018.pdf', '21722_2_aim cancer treatment pathways.pdf', '21722_1_guidelines for clinical evaluation of anti‐cancer drugs.pdf', '21722_4_immunotherapy excluding checkpoint inhibitors for stage i to iii non‐small cell lung cancer treated with surgery or radiotherapy with curative intent.pdf', '21722_0_eular points to consider for the diagnosis and management of rheumatic immunerelated adverse events due to cancer immunotherapy with checkpoint inhibitors.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339680/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647093/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788064/pdf']","['21722_3_seom clinical guidelines for the treatment of nonsmall cell lung cancer 2018.pdf', '21722_2_aim cancer treatment pathways.pdf', '21722_1_guidelines for clinical evaluation of anti‐cancer drugs.pdf', '21722_4_immunotherapy excluding checkpoint inhibitors for stage i to iii non‐small cell lung cancer treated with surgery or radiotherapy with curative intent.pdf', '21722_0_eular points to consider for the diagnosis and management of rheumatic immunerelated adverse events due to cancer immunotherapy with checkpoint inhibitors.pdf']","[0.364, 0.378, 0.311, 0.495, 0.394]","[0.49, 0.462, 0.5, 0.495, 0.488]","[0.57, 0.547, 0.575, 0.571, 0.568]","[0.161, 0.136, 0.162, 0.158, 0.146]","[0.164, 0.164, 0.175, 0.153, 0.16]","[0.129, 0.143, 0.135, 0.128, 0.114]","[0.742, 0.75, 0.738, 0.736, 0.741]","[0.656, 0.669, 0.646, 0.642, 0.651]","[0.573, 0.546, 0.566, 0.565, 0.563]","[0.676, 0.702, 0.688, 0.697, 0.658]","[0.776, 0.762, 0.77, 0.76, 0.772]","[0.667, 0.642, 0.671, 0.657, 0.661]","[0.581, 0.555, 0.599, 0.575, 0.579]","[0.898, 0.866, 0.902, 0.896, 0.9]","[0.797, 0.785, 0.806, 0.795, 0.789]","[0.705, 0.628, 0.717, 0.7, 0.708]","[0.765, 0.741, 0.767, 0.754, 0.762]","[0.745, 0.734, 0.751, 0.733, 0.744]",0.388,0.487,0.566,0.153,0.163,0.13,0.741,0.653,0.563,0.684,0.768,0.66,0.578,0.892,0.794,0.692,0.758,0.741
https://doi.org/10.1056/nejmoa1714373,a icandida aurisi outbreak and its control in an intensive care setting,21724_a icandida aurisi outbreak and its control in an intensive care setting.pdf,1,['http://healthcarereportcard.illinois.gov/files/pdf/C_auris_2020Report_FINAL.pdf'],['Candida auris'],['http://healthcarereportcard.illinois.gov/files/pdf/C_auris_2020Report_FINAL.pdf'],['21724_0_candida auris.pdf'],1,100.0,['http://healthcarereportcard.illinois.gov/files/pdf/C_auris_2020Report_FINAL.pdf'],['21724_0_candida auris.pdf'],[0.351],[0.532],[0.608],[0.174],[0.189],[0.148],[0.737],[0.649],[0.606],[0.677],[0.798],[0.731],[0.616],[0.908],[0.826],[0.757],[0.8],[0.784],0.351,0.532,0.608,0.174,0.189,0.148,0.737,0.649,0.606,0.677,0.798,0.731,0.616,0.908,0.826,0.757,0.8,0.784
https://doi.org/10.1056/nejmoa1806828,attention deficit–hyperactivity disorder and month of school enrollment,21729_attention deficit–hyperactivity disorder and month of school enrollment.pdf,8,"['https://fee.org/articles/kids-who-are-young-for-their-grade-much-likelier-to-be-diagnosed-with-adhd-and-depression-study-finds/', 'https://fee.org/articles/why-you-should-redshirt-your-kindergartener-this-year/', 'https://fee.org/articles/public-kindergarten-enrollment-is-plummeting-here-s-why-that-s-a-good-thing/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067282/pdf', 'https://www.chicagofed.org/publications/working-papers/2022/2022-23', 'https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1078222/peds_20192528.pdf', 'https://www.nber.org/papers/w28334', 'https://fee.org/articles/more-states-are-mandating-kindergarten-here-are-3-reasons-why-that-s-a-bad-idea/']","['New Study: Kids Who Are Young for Their Grade Are Much Likelier to Be Diagnosed With ADHD and Depression', 'Why You Should Redshirt Your Kindergartener This Year', 'Public Kindergarten Enrollment is Plummeting—Here’s Why That’s a Good Thing', 'Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents', 'Mis(sed) Diagnosis: Physician Decision-Making and ADHD', 'Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents', 'Family Spillover Effects of Marginal Diagnoses: The Case of ADHD', 'More States Are Mandating Kindergarten. Here Are 3 Reasons Why That’s A Bad Idea.']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067282/pdf', 'https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1078222/peds_20192528.pdf']","['21729_3_clinical practice guideline for the diagnosis evaluation and treatment of attentiondeficithyperactivity disorder in children and adolescents.pdf', '21729_5_clinical practice guideline for the diagnosis evaluation and treatment of attentiondeficithyperactivity disorder in children and adolescents.pdf']",2,25.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067282/pdf', 'https://publications.aap.org/pediatrics/article-pdf/144/4/e20192528/1078222/peds_20192528.pdf']","['21729_3_clinical practice guideline for the diagnosis evaluation and treatment of attentiondeficithyperactivity disorder in children and adolescents.pdf', '21729_5_clinical practice guideline for the diagnosis evaluation and treatment of attentiondeficithyperactivity disorder in children and adolescents.pdf']","[0.371, 0.457]","[0.489, 0.507]","[0.579, 0.587]","[0.153, 0.156]","[0.17, 0.169]","[0.136, 0.14]","[0.726, 0.726]","[0.633, 0.63]","[0.565, 0.578]","[0.697, 0.688]","[0.77, 0.787]","[0.681, 0.707]","[0.567, 0.589]","[0.894, 0.904]","[0.796, 0.807]","[0.709, 0.726]","[0.766, 0.783]","[0.749, 0.76]",0.414,0.498,0.583,0.154,0.17,0.138,0.726,0.631,0.571,0.692,0.778,0.694,0.578,0.899,0.802,0.718,0.774,0.754
https://doi.org/10.1056/nejmoa1807801,radical prostatectomy or watchful waiting in prostate cancer — 29year followup,21730_radical prostatectomy or watchful waiting in prostate cancer — 29year followup.pdf,5,"['https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/report', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746600/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437391/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434138/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270852/pdf']","['Therapies for Clinically Localized Prostate Cancer', 'Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer', 'Retzius‐sparing versus standard robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.', 'Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer', 'Radical prostatectomy versus deferred treatment for localised prostate cancer']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270852/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434138/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746600/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437391/pdf']","['21730_4_radical prostatectomy versus deferred treatment for localised prostate cancer.pdf', '21730_3_panasian adapted esmo clinical practice guidelines for the diagnosis treatment and followup of patients with prostate cancer.pdf', '21730_1_posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.pdf', '21730_2_retzius‐sparing versus standard robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270852/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434138/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746600/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437391/pdf']","['21730_4_radical prostatectomy versus deferred treatment for localised prostate cancer.pdf', '21730_3_panasian adapted esmo clinical practice guidelines for the diagnosis treatment and followup of patients with prostate cancer.pdf', '21730_1_posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.pdf', '21730_2_retzius‐sparing versus standard robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.pdf']","[0.314, 0.34, 0.444, 0.497]","[0.494, 0.49, 0.495, 0.492]","[0.571, 0.569, 0.572, 0.574]","[0.159, 0.158, 0.145, 0.146]","[0.155, 0.162, 0.145, 0.148]","[0.138, 0.136, 0.125, 0.125]","[0.743, 0.742, 0.734, 0.733]","[0.651, 0.651, 0.639, 0.639]","[0.563, 0.559, 0.563, 0.564]","[0.714, 0.685, 0.695, 0.702]","[0.758, 0.773, 0.758, 0.76]","[0.674, 0.684, 0.671, 0.678]","[0.554, 0.588, 0.568, 0.569]","[0.896, 0.898, 0.898, 0.901]","[0.779, 0.78, 0.783, 0.786]","[0.698, 0.711, 0.7, 0.703]","[0.748, 0.763, 0.754, 0.757]","[0.73, 0.742, 0.729, 0.733]",0.399,0.493,0.571,0.152,0.152,0.131,0.738,0.645,0.562,0.699,0.762,0.677,0.57,0.898,0.782,0.703,0.756,0.734
https://doi.org/10.1056/nejmoa1809775,folfirinox or gemcitabine as adjuvant therapy for pancreatic cancer,21731_folfirinox or gemcitabine as adjuvant therapy for pancreatic cancer.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750387/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341025/pdf']","['Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy', 'SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)', 'Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750387/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341025/pdf']","['21731_1_seom clinical guidelines for pancreatic and biliary tract cancer 2020.pdf', '21731_0_antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy.pdf', '21731_2_considerations for the treatment of pancreatic cancer during the covid19 pandemic the uk consensus position.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058005/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750387/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341025/pdf']","['21731_1_seom clinical guidelines for pancreatic and biliary tract cancer 2020.pdf', '21731_0_antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy.pdf', '21731_2_considerations for the treatment of pancreatic cancer during the covid19 pandemic the uk consensus position.pdf']","[0.246, 0.507, 0.382]","[0.487, 0.482, 0.489]","[0.569, 0.564, 0.566]","[0.15, 0.14, 0.15]","[0.149, 0.137, 0.151]","[0.118, 0.114, 0.123]","[0.739, 0.735, 0.739]","[0.646, 0.639, 0.651]","[0.562, 0.556, 0.555]","[0.668, 0.675, 0.678]","[0.776, 0.758, 0.771]","[0.684, 0.672, 0.677]","[0.594, 0.575, 0.584]","[0.899, 0.897, 0.899]","[0.781, 0.774, 0.786]","[0.715, 0.692, 0.706]","[0.766, 0.75, 0.762]","[0.746, 0.726, 0.741]",0.378,0.486,0.566,0.147,0.146,0.118,0.738,0.645,0.558,0.674,0.768,0.678,0.584,0.898,0.78,0.704,0.759,0.738
https://doi.org/10.1056/nejmoa1810858,maintenance olaparib in patients with newly diagnosed advanced ovarian cancer,21732_maintenance olaparib in patients with newly diagnosed advanced ovarian cancer.pdf,8,"['https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item3t.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388889/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025745/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177100/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656152/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058000/pdf']","['Oncology Oral Other', 'PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline', 'ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies', 'An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma', 'AIM Cancer Treatment Pathways', 'Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis', 'Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care', 'SEOM clinical guideline in ovarian cancer (2020)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656152/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388889/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058000/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177100/pdf']","['21732_6_exploring international differences in ovarian cancer treatment a comparison of clinical practice guidelines and patterns of care.pdf', '21732_1_parp inhibitors in the management of ovarian cancer asco guideline.pdf', '21732_2_esmo management and treatment adapted recommendations in the covid19 era gynaecological malignancies.pdf', '21732_7_seom clinical guideline in ovarian cancer 2020.pdf', '21732_4_aim cancer treatment pathways.pdf', '21732_5_anticancer therapy and clinical trial considerations for gynecologic oncology patients during the covid19 pandemic crisis.pdf']",6,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656152/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942301/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388889/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058000/pdf', 'https://aimproviders.com/wp-content/uploads/2019/11/AIM_Workbook.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177100/pdf']","['21732_6_exploring international differences in ovarian cancer treatment a comparison of clinical practice guidelines and patterns of care.pdf', '21732_1_parp inhibitors in the management of ovarian cancer asco guideline.pdf', '21732_2_esmo management and treatment adapted recommendations in the covid19 era gynaecological malignancies.pdf', '21732_7_seom clinical guideline in ovarian cancer 2020.pdf', '21732_4_aim cancer treatment pathways.pdf', '21732_5_anticancer therapy and clinical trial considerations for gynecologic oncology patients during the covid19 pandemic crisis.pdf']","[0.498, 0.37, 0.303, 0.469, 0.399, 0.476]","[0.512, 0.488, 0.527, 0.515, 0.46, 0.473]","[0.597, 0.572, 0.604, 0.6, 0.561, 0.556]","[0.171, 0.169, 0.171, 0.183, 0.142, 0.144]","[0.175, 0.174, 0.167, 0.183, 0.168, 0.134]","[0.142, 0.136, 0.135, 0.146, 0.144, 0.12]","[0.736, 0.739, 0.742, 0.743, 0.749, 0.74]","[0.646, 0.652, 0.651, 0.657, 0.672, 0.653]","[0.588, 0.556, 0.596, 0.59, 0.531, 0.538]","[0.676, 0.69, 0.641, 0.668, 0.698, 0.668]","[0.785, 0.76, 0.792, 0.793, 0.766, 0.766]","[0.71, 0.687, 0.718, 0.711, 0.661, 0.659]","[0.583, 0.573, 0.599, 0.587, 0.546, 0.573]","[0.909, 0.889, 0.916, 0.906, 0.866, 0.899]","[0.802, 0.769, 0.806, 0.801, 0.783, 0.765]","[0.723, 0.693, 0.74, 0.727, 0.623, 0.703]","[0.778, 0.75, 0.787, 0.78, 0.739, 0.749]","[0.758, 0.722, 0.768, 0.765, 0.734, 0.738]",0.419,0.496,0.582,0.163,0.167,0.137,0.741,0.655,0.567,0.674,0.777,0.691,0.577,0.897,0.788,0.701,0.764,0.748
https://doi.org/10.1056/nejmoa1814917,mometasone or tiotropium in mild asthma with a low sputum eosinophil level,21734_mometasone or tiotropium in mild asthma with a low sputum eosinophil level.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096360/pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item4d.pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item4a.pdf']","['Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma', 'Glucocorticoids, Inhaled Review', 'Glucocorticoids, Inhaled Review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096360/pdf'],['21734_0_combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096360/pdf'],['21734_0_combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma.pdf'],[0.371],[0.502],[0.583],[0.169],[0.177],[0.144],[0.741],[0.649],[0.579],[0.692],[0.787],[0.689],[0.584],[0.91],[0.795],[0.725],[0.773],[0.762],0.371,0.502,0.583,0.169,0.177,0.144,0.741,0.649,0.579,0.692,0.787,0.689,0.584,0.91,0.795,0.725,0.773,0.762
https://doi.org/10.1056/nejmsr1804754,the major causes of death in children and adolescents in the united states,21783_the major causes of death in children and adolescents in the united states.pdf,5,"['https://stacks.cdc.gov/view/cdc/94307', 'https://www.whitehouse.gov/wp-content/uploads/2021/11/Infrastructure-brief-11.15-updated.pdf', 'https://www.whitehouse.gov/cea/written-materials/2021/11/15/the-time-is-now-to-modernize-u-s-infrastructure/', 'https://www.whitehouse.gov/cea/written-materials/2021/11/06/bringing-infrastructure-into-the-21st-century/', 'https://www.urban.org/research/publication/characteristics-medicaid-enrolled-adolescents-unhealthy-opioid-or-other-substance-use']","[""America's children in brief : key national indicators of well-being, 2020"", 'Bringing Infrastructure into the 21st Century', 'Modernizing U.S. Infrastructure: the Bipartisan Infrastructure Law', 'Bringing Infrastructure into the 21st Century', 'Characteristics of Medicaid-Enrolled Adolescents with Unhealthy Opioid or Other Substance Use']",['https://www.whitehouse.gov/wp-content/uploads/2021/11/Infrastructure-brief-11.15-updated.pdf'],['21783_1_bringing infrastructure into the 21st century.pdf'],1,20.0,['https://www.whitehouse.gov/wp-content/uploads/2021/11/Infrastructure-brief-11.15-updated.pdf'],['21783_1_bringing infrastructure into the 21st century.pdf'],[0.167],[0.507],[0.599],[0.11],[0.089],[0.076],[0.701],[0.598],[0.586],[0.634],[0.798],[0.733],[0.634],[0.909],[0.82],[0.747],[0.798],[0.766],0.167,0.507,0.599,0.11,0.089,0.076,0.701,0.598,0.586,0.634,0.798,0.733,0.634,0.909,0.82,0.747,0.798,0.766
https://doi.org/10.1061/40737(2004)180,twodimensional modeling of timevarying hydrodynamics and juvenile chinook salmon habitat in the hanford reach of the columbia river,21846_twodimensional modeling of timevarying hydrodynamics and juvenile chinook salmon habitat in the hanford reach of the columbia river.pdf,1,['http://purl.fdlp.gov/GPO/gpo84341'],['Modeling of radionuclide transport in freshwater systems associated with nuclear power plants /'],['http://purl.fdlp.gov/GPO/gpo84341'],['21846_0_modeling of radionuclide transport in freshwater systems associated with nuclear power plants .pdf'],1,100.0,['http://purl.fdlp.gov/GPO/gpo84341'],['21846_0_modeling of radionuclide transport in freshwater systems associated with nuclear power plants .pdf'],[0.255],[0.518],[0.598],[0.145],[0.137],[0.12],[0.74],[0.647],[0.58],[0.698],[0.777],[0.71],[0.648],[0.91],[0.81],[0.749],[0.769],[0.769],0.255,0.518,0.598,0.145,0.137,0.12,0.74,0.647,0.58,0.698,0.777,0.71,0.648,0.91,0.81,0.749,0.769,0.769
https://doi.org/10.1073/pnas.0808772106,science for managing ecosystem services beyond the millennium ecosystem assessment,22071_science for managing ecosystem services beyond the millennium ecosystem assessment.pdf,4,"['https://www.hks.harvard.edu/centers/cid/publications/fellow-graduate-student-working-papers/integrating-ecosystem-services-in-land-use-planning-concepts-and-applications', 'https://purl.fdlp.gov/GPO/gpo120183', 'https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/cid-working-paper-no.-196', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/9h1mtvcgyl_InVEST_Guide_high_resolution_FINAL.pdf']","['Integrating Ecosystem Services in Land Use Planning', 'The U.S. Geological Survey Ecosystem Science Strategy, 2012-2022 :\xa0advancing discovery and application through collaboration /', 'Toward a Science of Sustainability', 'Developing Scenarios to Assess Ecosystem Service Tradeoffs (application/pdf, 7.99 MB)']","['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/9h1mtvcgyl_InVEST_Guide_high_resolution_FINAL.pdf', 'https://purl.fdlp.gov/GPO/gpo120183']","['22071_3_developing scenarios to assess ecosystem service tradeoffs applicationpdf 799 mb.pdf', '22071_1_the us geological survey ecosystem science strategy 20122022 \xa0advancing discovery and application through collaboration .pdf']",2,50.0,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/9h1mtvcgyl_InVEST_Guide_high_resolution_FINAL.pdf', 'https://purl.fdlp.gov/GPO/gpo120183']","['22071_3_developing scenarios to assess ecosystem service tradeoffs applicationpdf 799 mb.pdf', '22071_1_the us geological survey ecosystem science strategy 20122022 \xa0advancing discovery and application through collaboration .pdf']","[0.596, 0.387]","[0.602, 0.636]","[0.677, 0.705]","[0.198, 0.244]","[0.204, 0.249]","[0.179, 0.219]","[0.738, 0.751]","[0.647, 0.667]","[0.665, 0.7]","[0.714, 0.73]","[0.828, 0.848]","[0.789, 0.819]","[0.68, 0.701]","[0.931, 0.939]","[0.867, 0.876]","[0.809, 0.831]","[0.841, 0.86]","[0.822, 0.842]",0.491,0.619,0.691,0.221,0.226,0.199,0.744,0.657,0.682,0.722,0.838,0.804,0.691,0.935,0.871,0.82,0.851,0.832
https://doi.org/10.1073/pnas.1015950108,exercise training increases size of hippocampus and improves memory,22092_exercise training increases size of hippocampus and improves memory.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426996/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415132/pdf']","['Exercise programs for people with dementia', 'Computerised cognitive training for preventing dementia in people with mild cognitive impairment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426996/pdf']","['22092_1_computerised cognitive training for preventing dementia in people with mild cognitive impairment.pdf', '22092_0_exercise programs for people with dementia.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426996/pdf']","['22092_1_computerised cognitive training for preventing dementia in people with mild cognitive impairment.pdf', '22092_0_exercise programs for people with dementia.pdf']","[0.326, 0.273]","[0.497, 0.492]","[0.584, 0.583]","[0.152, 0.148]","[0.152, 0.151]","[0.122, 0.12]","[0.733, 0.733]","[0.64, 0.638]","[0.562, 0.558]","[0.713, 0.707]","[0.766, 0.756]","[0.686, 0.672]","[0.591, 0.588]","[0.908, 0.912]","[0.78, 0.787]","[0.722, 0.711]","[0.762, 0.756]","[0.743, 0.74]",0.299,0.494,0.583,0.15,0.151,0.121,0.733,0.639,0.56,0.71,0.761,0.679,0.589,0.91,0.784,0.716,0.759,0.742
https://doi.org/10.1073/pnas.1804098115,predicting plant conservation priorities on a global scale,22198_predicting plant conservation priorities on a global scale.pdf,1,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf'],"['Living Planet Report 2020 (application/pdf, 23.1 MB)']",['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf'],['22198_0_living planet report 2020 applicationpdf 231 mb.pdf'],1,100.0,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf'],['22198_0_living planet report 2020 applicationpdf 231 mb.pdf'],[0.42],[0.512],[0.613],[0.151],[0.155],[0.139],[0.733],[0.641],[0.585],[0.717],[0.786],[0.698],[0.631],[0.912],[0.828],[0.755],[0.793],[0.776],0.42,0.512,0.613,0.151,0.155,0.139,0.733,0.641,0.585,0.717,0.786,0.698,0.631,0.912,0.828,0.755,0.793,0.776
https://doi.org/10.1073/pnas.1808976116,the criminogenic and psychological effects of police stops on adolescent black and latino boys,22200_the criminogenic and psychological effects of police stops on adolescent black and latino boys.pdf,7,"['https://www.urban.org/research/publication/investing-collaborative-safety-solutions-dc', 'https://www.urban.org/research/publication/strengthening-non-police-safety-infrastructure-dc-key-facts-and-considerations', 'https://www.hrw.org/report/2019/09/12/get-ground-policing-poverty-and-racial-inequality-tulsa-oklahoma/case-study-us-law', 'https://www.urban.org/research/publication/boosting-upward-mobility-metrics-inform-local-action', 'https://www.brookings.edu/blog/how-we-rise/2022/03/31/preventing-gun-violence-takes-more-than-police/', 'http://www.clrc.ca.gov/CRPC/Pub/Memos/CRPC22-07s1.pdf', 'https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf']","['Investing in Collaborative Safety Solutions in DC', 'Strengthening Non-Police Safety Infrastructure in DC: Key Facts and Considerations', 'A Case Study of US Law Enforcement', 'Boosting Upward Mobility: Metrics to Inform Local Action', 'Preventing gun violence takes more than police', 'First Supplement to Memorandum 2022-07 — First Contact with the Legal System: Traffic Enforcement and Assignment of Counsel', '2023 RIPA Board Annual Report - Racial and Identity Profiling Advisory Board - California Department of Justice']","['https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf', 'http://www.clrc.ca.gov/CRPC/Pub/Memos/CRPC22-07s1.pdf']","['22200_6_2023 ripa board annual report  racial and identity profiling advisory board  california department of justice.pdf', '22200_5_first supplement to memorandum 202207 — first contact with the legal system traffic enforcement and assignment of counsel.pdf']",2,28.57,"['https://oag.ca.gov/system/files/media/ripa-board-report-2023.pdf', 'http://www.clrc.ca.gov/CRPC/Pub/Memos/CRPC22-07s1.pdf']","['22200_6_2023 ripa board annual report  racial and identity profiling advisory board  california department of justice.pdf', '22200_5_first supplement to memorandum 202207 — first contact with the legal system traffic enforcement and assignment of counsel.pdf']","[0.2, 0.39]","[0.518, 0.51]","[0.596, 0.589]","[0.148, 0.129]","[0.16, 0.139]","[0.136, 0.12]","[0.727, 0.718]","[0.631, 0.62]","[0.579, 0.569]","[0.692, 0.677]","[0.777, 0.78]","[0.708, 0.702]","[0.634, 0.637]","[0.911, 0.911]","[0.814, 0.812]","[0.743, 0.743]","[0.781, 0.781]","[0.759, 0.755]",0.295,0.514,0.593,0.139,0.15,0.128,0.722,0.625,0.574,0.684,0.778,0.705,0.635,0.911,0.813,0.743,0.781,0.757
https://doi.org/10.1073/pnas.1813192115,pervasive iron limitation at subsurface chlorophyll maxima of the california current,22201_pervasive iron limitation at subsurface chlorophyll maxima of the california current.pdf,1,['https://www.edf.org/sites/default/files/2022-10/Natural%20Climate%20Solutions%20in%20the%20Open%20Ocean%20-%20EDF.pdf'],['Natural Climate Solutions in the Open Ocean'],['https://www.edf.org/sites/default/files/2022-10/Natural%20Climate%20Solutions%20in%20the%20Open%20Ocean%20-%20EDF.pdf'],['22201_0_natural climate solutions in the open ocean.pdf'],1,100.0,['https://www.edf.org/sites/default/files/2022-10/Natural%20Climate%20Solutions%20in%20the%20Open%20Ocean%20-%20EDF.pdf'],['22201_0_natural climate solutions in the open ocean.pdf'],[0.276],[0.527],[0.623],[0.165],[0.158],[0.132],[0.743],[0.657],[0.604],[0.701],[0.81],[0.716],[0.655],[0.907],[0.816],[0.774],[0.808],[0.794],0.276,0.527,0.623,0.165,0.158,0.132,0.743,0.657,0.604,0.701,0.81,0.716,0.655,0.907,0.816,0.774,0.808,0.794
https://doi.org/10.1073/pnas.2007476117,tracking the reach of covid19 kin loss with a bereavement multiplier applied to the united states,22218_tracking the reach of covid19 kin loss with a bereavement multiplier applied to the united states.pdf,3,"['https://nam.edu/patients-families-and-communities-covid-19-impact-assessment-lessons-learned-and-compelling-needs/', 'https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download', 'https://stacks.cdc.gov/view/cdc/94843']","['Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs', 'COVID-19 and the Massachusetts Juvenile Justice System', 'Disparities in COVID-19 incidence, severity, and outcomes']",['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download'],['22218_1_covid19 and the massachusetts juvenile justice system.pdf'],1,33.33,['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download'],['22218_1_covid19 and the massachusetts juvenile justice system.pdf'],[0.208],[0.521],[0.615],[0.129],[0.129],[0.112],[0.725],[0.625],[0.589],[0.661],[0.8],[0.717],[0.634],[0.91],[0.826],[0.752],[0.797],[0.783],0.208,0.521,0.615,0.129,0.129,0.112,0.725,0.625,0.589,0.661,0.8,0.717,0.634,0.91,0.826,0.752,0.797,0.783
https://doi.org/10.1076/chin.8.2.71.8724,assessment and development of executive function ef during childhood,22259_assessment and development of executive function ef during childhood.pdf,7,"['http://purl.fdlp.gov/GPO/gpo81368', 'https://bn.ocfs.ny.gov/programs/fostercare/assets/docs/Child-Development-Guide.pdf', 'https://ocfs.ny.gov/main/fostercare/assets/ChildDevelGuide.pdf', 'https://www.wallacefoundation.org/knowledge-center/Pages/navigating-social-and-emotional-learning-from-the-inside-out.aspx', 'https://www.fhi360.org/resource/key-soft-skills-cross-sectoral-youth-outcomes', 'https://www.nber.org/papers/w28250', 'https://www.acf.hhs.gov/opre/report/self-regulation-and-toxic-stress-foundations-understanding-self-regulation-applied']","['Executive function: implications for education /', 'Child Development Guide', 'Child Development Guide', 'Navigating Social and Emotional Learning from the Inside Out', 'Key Soft Skills for Cross-Sectoral Youth Outcomes', 'A Thousand Cuts: Cumulative Lead Exposure Reduces Academic Achievement', 'Self-Regulation and Toxic Stress: Foundations for Understanding Self-Regulation from an Applied Developmental Perspective']","['http://purl.fdlp.gov/GPO/gpo81368', 'https://bn.ocfs.ny.gov/programs/fostercare/assets/docs/Child-Development-Guide.pdf']","['22259_0_executive function implications for education .pdf', '22259_1_child development guide.pdf']",2,28.57,"['http://purl.fdlp.gov/GPO/gpo81368', 'https://bn.ocfs.ny.gov/programs/fostercare/assets/docs/Child-Development-Guide.pdf']","['22259_0_executive function implications for education .pdf', '22259_1_child development guide.pdf']","[0.719, 0.375]","[0.515, 0.522]","[0.611, 0.623]","[0.177, 0.144]","[0.195, 0.159]","[0.169, 0.141]","[0.74, 0.729]","[0.65, 0.634]","[0.565, 0.589]","[0.727, 0.697]","[0.781, 0.792]","[0.69, 0.725]","[0.619, 0.621]","[0.911, 0.906]","[0.801, 0.832]","[0.745, 0.759]","[0.782, 0.802]","[0.772, 0.784]",0.547,0.518,0.617,0.16,0.177,0.155,0.734,0.642,0.577,0.712,0.786,0.708,0.62,0.909,0.817,0.752,0.792,0.778
https://doi.org/10.1079/bjn20051502,effects of encapsulated green tea and guarana extracts containing a mixture of epigallocatechin3gallate and caffeine on 24 h energy expenditure and fat oxidation in men,22307_effects of encapsulated green tea and guarana extracts containing a mixture of epigallocatechin3gallate and caffeine on 24 h energy expenditure and fat oxidation in men.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406948/pdf'],['Green tea for weight loss and weight maintenance in overweight or obese adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406948/pdf'],['22307_0_green tea for weight loss and weight maintenance in overweight or obese adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406948/pdf'],['22307_0_green tea for weight loss and weight maintenance in overweight or obese adults.pdf'],[0.347],[0.508],[0.6],[0.168],[0.17],[0.133],[0.73],[0.638],[0.573],[0.695],[0.771],[0.692],[0.596],[0.906],[0.807],[0.72],[0.775],[0.753],0.347,0.508,0.6,0.168,0.17,0.133,0.73,0.638,0.573,0.695,0.771,0.692,0.596,0.906,0.807,0.72,0.775,0.753
https://doi.org/10.1079/pns2003301,the role of dietary calcium in bone health,22325_the role of dietary calcium in bone health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464928/pdf'],['Interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464928/pdf'],['22325_0_interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in duchenne muscular dystrophy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464928/pdf'],['22325_0_interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in duchenne muscular dystrophy.pdf'],[0.021],[0.455],[0.598],[0.017],[0.049],[0.002],[0.72],[0.65],[0.477],[0.664],[0.612],[0.586],[0.3],[0.919],[0.783],[0.643],[0.626],[0.66],0.021,0.455,0.598,0.017,0.049,0.002,0.72,0.65,0.477,0.664,0.612,0.586,0.3,0.919,0.783,0.643,0.626,0.66
https://doi.org/10.1080/00016350310007590,caries‐preventive effect of fluoride toothpaste a systematic review,22331_caries‐preventive effect of fluoride toothpaste a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398117/pdf', 'https://stacks.cdc.gov/view/cdc/41196']","['Fluoride toothpastes of different concentrations for preventing dental caries', 'Cost-effectiveness of preventing dental caries and full mouth dental reconstructions among Alaska Native children in the Yukon–Kuskokwim delta region of Alaska']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398117/pdf'],['22331_0_fluoride toothpastes of different concentrations for preventing dental caries.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398117/pdf'],['22331_0_fluoride toothpastes of different concentrations for preventing dental caries.pdf'],[0.09],[0.457],[0.61],[0.132],[0.178],[0.132],[0.745],[0.67],[0.534],[0.729],[0.739],[0.685],[0.371],[0.918],[0.806],[0.712],[0.709],[0.731],0.09,0.457,0.61,0.132,0.178,0.132,0.745,0.67,0.534,0.729,0.739,0.685,0.371,0.918,0.806,0.712,0.709,0.731
https://doi.org/10.1080/00028487.2016.1214177,abundance estimate for and habitat use by early juvenile atlantic sturgeon within the delaware river estuary,22359_abundance estimate for and habitat use by early juvenile atlantic sturgeon within the delaware river estuary.pdf,4,"['https://documents.dnrec.delaware.gov/coastal/Documents/Federal%20Consistency/2021-0045-Delaware-City-Refining-Company-Maintenance-Dredging.pdf', 'https://www.nj.gov/drbc/library/documents/Review_DOreq_KeySensSpecies_DelEstuary_ANStoDRBCnov2018.pdf', 'https://purl.fdlp.gov/GPO/gpo123956', 'https://purl.fdlp.gov/GPO/gpo123943']","['Duffield Associates, LLC 5400 Limestone Road', 'A Review of Dissolved Oxygen Requirements for Key Sensitive Species in the Delaware Estuary', 'Biological and conference opinion on the proposed implementation of a program for the issuance of permits for research and enhancement activities on threatened and endangered sea turtles pursuant to Section l0(a) of the Endangered Species Act /', 'Biological and conference opinion on the proposed implementation of a program for the issuance of permits for research and enhancement activities on threatened and endangered sea turtles pursuant to Section 10(a) of the Endangered Species Act (2018 reinitiation) /']","['https://www.nj.gov/drbc/library/documents/Review_DOreq_KeySensSpecies_DelEstuary_ANStoDRBCnov2018.pdf', 'https://documents.dnrec.delaware.gov/coastal/Documents/Federal%20Consistency/2021-0045-Delaware-City-Refining-Company-Maintenance-Dredging.pdf']","['22359_1_a review of dissolved oxygen requirements for key sensitive species in the delaware estuary.pdf', '22359_0_duffield associates llc 5400 limestone road.pdf']",2,50.0,"['https://www.nj.gov/drbc/library/documents/Review_DOreq_KeySensSpecies_DelEstuary_ANStoDRBCnov2018.pdf', 'https://documents.dnrec.delaware.gov/coastal/Documents/Federal%20Consistency/2021-0045-Delaware-City-Refining-Company-Maintenance-Dredging.pdf']","['22359_1_a review of dissolved oxygen requirements for key sensitive species in the delaware estuary.pdf', '22359_0_duffield associates llc 5400 limestone road.pdf']","[0.244, 0.398]","[0.519, 0.466]","[0.597, 0.556]","[0.17, 0.102]","[0.177, 0.105]","[0.137, 0.08]","[0.733, 0.726]","[0.642, 0.634]","[0.587, 0.543]","[0.694, 0.669]","[0.806, 0.772]","[0.721, 0.7]","[0.649, 0.615]","[0.895, 0.899]","[0.83, 0.814]","[0.767, 0.74]","[0.813, 0.776]","[0.787, 0.764]",0.321,0.493,0.577,0.136,0.141,0.109,0.73,0.638,0.565,0.681,0.789,0.71,0.632,0.897,0.822,0.754,0.794,0.776
https://doi.org/10.1080/00043125.2005.11651551,the role of media and emerging representation in early childhood,22382_the role of media and emerging representation in early childhood.pdf,1,['https://perpich.mn.gov/wp-content/uploads/2021/06/Child-Development-and-Arts-Education.pdf'],['Child Development and Arts Education :'],['https://perpich.mn.gov/wp-content/uploads/2021/06/Child-Development-and-Arts-Education.pdf'],['22382_0_child development and arts education .pdf'],1,100.0,['https://perpich.mn.gov/wp-content/uploads/2021/06/Child-Development-and-Arts-Education.pdf'],['22382_0_child development and arts education .pdf'],[0.352],[0.521],[0.61],[0.164],[0.179],[0.168],[0.74],[0.642],[0.583],[0.705],[0.79],[0.736],[0.651],[0.916],[0.828],[0.763],[0.802],[0.785],0.352,0.521,0.61,0.164,0.179,0.168,0.74,0.642,0.583,0.705,0.79,0.736,0.651,0.916,0.828,0.763,0.802,0.785
https://doi.org/10.1080/00043125.2008.11651144,“i know a lot of things that you dont you wanna hear some” adolescent themes and contemporary art practice,22384_“i know a lot of things that you dont you wanna hear some” adolescent themes and contemporary art practice.pdf,1,['https://perpich.mn.gov/wp-content/uploads/2021/06/Child-Development-and-Arts-Education.pdf'],['Child Development and Arts Education :'],['https://perpich.mn.gov/wp-content/uploads/2021/06/Child-Development-and-Arts-Education.pdf'],['22384_0_child development and arts education .pdf'],1,100.0,['https://perpich.mn.gov/wp-content/uploads/2021/06/Child-Development-and-Arts-Education.pdf'],['22384_0_child development and arts education .pdf'],[0.295],[0.483],[0.576],[0.119],[0.141],[0.133],[0.73],[0.631],[0.558],[0.708],[0.774],[0.704],[0.625],[0.899],[0.821],[0.744],[0.78],[0.767],0.295,0.483,0.576,0.119,0.141,0.133,0.73,0.631,0.558,0.708,0.774,0.704,0.625,0.899,0.821,0.744,0.78,0.767
https://doi.org/10.1080/00224499.2014.886321,gender minority social stress in adolescence disparities in adolescent bullying and substance use by gender identity,22508_gender minority social stress in adolescence disparities in adolescent bullying and substance use by gender identity.pdf,3,"['https://www.dshs.texas.gov/chs/tshp/2018-School-Health-Profiles-School-Principal-Item-Rationale.pdf', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf', 'https://www.wested.org/resources/lgbtq-students-in-california/']","['Item Rationale 2018 School Health Profiles School Principal Questionnaire', '2020 School Health Profiles Principal Item Rationale', 'Understanding the Experiences of LGBTQ Students in California']",['https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf'],['22508_1_2020 school health profiles principal item rationale.pdf'],1,33.33,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1080/00918369.2017.1317467,psychosocial risk and protective factors for depression among lesbian gay bisexual and queer youth a systematic review,22593_psychosocial risk and protective factors for depression among lesbian gay bisexual and queer youth a systematic review.pdf,1,['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf'],['Disproportionality and Disparities'],['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf'],['22593_0_disproportionality and disparities.pdf'],1,100.0,['https://www1.nyc.gov/assets/acs/pdf/about/2020/WellBeingStudyLGBTQ.pdf'],['22593_0_disproportionality and disparities.pdf'],[0.342],[0.493],[0.59],[0.155],[0.173],[0.145],[0.736],[0.64],[0.56],[0.684],[0.767],[0.685],[0.608],[0.908],[0.8],[0.741],[0.77],[0.753],0.342,0.493,0.59,0.155,0.173,0.145,0.736,0.64,0.56,0.684,0.767,0.685,0.608,0.908,0.8,0.741,0.77,0.753
https://doi.org/10.1080/00918369.2018.1538407,parentinitiated sexual orientation change efforts with lgbt adolescents implications for young adult mental health and adjustment,22595_parentinitiated sexual orientation change efforts with lgbt adolescents implications for young adult mental health and adjustment.pdf,4,"['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf', 'https://www.aclu.org/legal-document/doe-v-mmsd-amicus-brief-professors-psychology-and-human-development', 'https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf']","['Annual Report | 2019-2020', 'Annual Report | 2019-2020', 'Doe v. MMSD - Amicus Brief of Professors of Psychology and Human Development', '1']","['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf']","['22595_0_annual report  20192020.pdf', '22595_3_1.pdf', '22595_1_annual report  20192020.pdf']",3,75.0,"['https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report.pdf', 'https://www.mass.gov/files/documents/2019/04/04/MA-Commission-on-LGBTQ-Youth-2020-Report-and-Recommendations_0.pdf', 'https://leg.colorado.gov/sites/default/files/images/lcs/cdphe_office_of_suicide_prevention_annual_report_0.pdf']","['22595_0_annual report  20192020.pdf', '22595_3_1.pdf', '22595_1_annual report  20192020.pdf']","[0.201, 0.201, 0.301]","[0.544, 0.541, 0.544]","[0.638, 0.637, 0.638]","[0.15, 0.172, 0.15]","[0.171, 0.19, 0.171]","[0.125, 0.159, 0.125]","[0.722, 0.731, 0.722]","[0.626, 0.634, 0.626]","[0.604, 0.599, 0.604]","[0.65, 0.664, 0.65]","[0.809, 0.802, 0.809]","[0.733, 0.725, 0.733]","[0.636, 0.631, 0.636]","[0.923, 0.916, 0.923]","[0.841, 0.836, 0.841]","[0.775, 0.765, 0.775]","[0.817, 0.81, 0.817]","[0.794, 0.789, 0.794]",0.234,0.543,0.638,0.157,0.177,0.136,0.725,0.629,0.602,0.655,0.807,0.73,0.634,0.921,0.839,0.772,0.815,0.792
https://doi.org/10.1080/00952990.2019.1669626,early evidence of the impact of cannabis legalization on cannabis use cannabis use disorder and the use of other substances findings from state policy evaluations,22606_early evidence of the impact of cannabis legalization on cannabis use cannabis use disorder and the use of other substances findings from state policy evaluations.pdf,7,"['https://www.rand.org/pubs/research_reports/RR4431.html', 'https://www.rand.org/pubs/external_publications/EP68839.html', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'https://www.rstreet.org/2022/09/20/can-cannabis-help-solve-the-opioid-crisis/', 'https://www.rand.org/pubs/perspectives/PEA1363-6.html']","[""An Empirical Assessment of the U.S. Army's Enlistment Waiver Policies"", 'Commission on Combating Synthetic Opioid Trafficking: Technical Appendixes', 'Report to the Governor and the General Assembly of Virginia', 'Report to the Governor and the General Assembly of Virginia', 'Appendixes', 'Can Cannabis Help Solve the Opioid Crisis?', ""Psychedelics and Veterans' Mental Health""]","['http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf']","['22606_3_report to the governor and the general assembly of virginia.pdf', '22606_4_appendixes.pdf', '22606_2_report to the governor and the general assembly of virginia.pdf']",3,42.86,"['http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf']","['22606_3_report to the governor and the general assembly of virginia.pdf', '22606_4_appendixes.pdf', '22606_2_report to the governor and the general assembly of virginia.pdf']","[0.365, 0.368, 0.435]","[0.564, 0.538, 0.558]","[0.641, 0.623, 0.637]","[0.196, 0.181, 0.192]","[0.204, 0.19, 0.201]","[0.175, 0.162, 0.171]","[0.729, 0.729, 0.729]","[0.638, 0.638, 0.637]","[0.633, 0.605, 0.627]","[0.653, 0.659, 0.653]","[0.818, 0.807, 0.815]","[0.777, 0.75, 0.772]","[0.656, 0.643, 0.654]","[0.931, 0.924, 0.929]","[0.856, 0.848, 0.854]","[0.793, 0.776, 0.789]","[0.825, 0.812, 0.823]","[0.803, 0.791, 0.801]",0.389,0.553,0.634,0.19,0.198,0.169,0.729,0.638,0.622,0.655,0.813,0.766,0.651,0.928,0.853,0.786,0.82,0.798
https://doi.org/10.1080/0142159x.2018.1555639,“but dr google said…” – training medical students how to communicate with epatients,22642_“but dr google said…” – training medical students how to communicate with epatients.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],"[""Interventions for improving medical students' interpersonal communication in medical consultations""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['22642_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['22642_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],[0.513],[0.507],[0.592],[0.166],[0.169],[0.15],[0.737],[0.646],[0.568],[0.715],[0.768],[0.683],[0.59],[0.911],[0.811],[0.723],[0.766],[0.753],0.513,0.507,0.592,0.166,0.169,0.15,0.737,0.646,0.568,0.715,0.768,0.683,0.59,0.911,0.811,0.723,0.766,0.753
https://doi.org/10.1080/01443615.2019.1587598,efficacy comparison of titrated oral solution of misoprostol and intravenous oxytocin on labour induction in women with fullterm pregnancy,22676_efficacy comparison of titrated oral solution of misoprostol and intravenous oxytocin on labour induction in women with fullterm pregnancy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218159/pdf'],['Low‐dose oral misoprostol for induction of labour'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218159/pdf'],['22676_0_low‐dose oral misoprostol for induction of labour.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218159/pdf'],['22676_0_low‐dose oral misoprostol for induction of labour.pdf'],[0.533],[0.499],[0.604],[0.177],[0.178],[0.149],[0.738],[0.648],[0.566],[0.649],[0.774],[0.675],[0.58],[0.914],[0.79],[0.721],[0.766],[0.743],0.533,0.499,0.604,0.177,0.178,0.149,0.738,0.648,0.566,0.649,0.774,0.675,0.58,0.914,0.79,0.721,0.766,0.743
https://doi.org/10.1080/01587919.2018.1553566,k12 online learning journal articles trends from two decades of scholarship,22707_k12 online learning journal articles trends from two decades of scholarship.pdf,2,"['https://www.cde.ca.gov/ci/cr/dl/documents/dlintegrationstdsguide.pdf', 'https://nepc.colorado.edu/publication/virtual-schools-annual-2019']","['CA Digital Learning Integration & Stds. Guidance - Distance Learning (CA Dept of Education)', 'Virtual Schools in the U.S. 2019']",['https://www.cde.ca.gov/ci/cr/dl/documents/dlintegrationstdsguide.pdf'],['22707_0_ca digital learning integration  stds guidance  distance learning ca dept of education.pdf'],1,50.0,['https://www.cde.ca.gov/ci/cr/dl/documents/dlintegrationstdsguide.pdf'],['22707_0_ca digital learning integration  stds guidance  distance learning ca dept of education.pdf'],[0.26],[0.544],[0.639],[0.157],[0.162],[0.155],[0.738],[0.639],[0.615],[0.72],[0.801],[0.744],[0.644],[0.923],[0.839],[0.778],[0.809],[0.794],0.26,0.544,0.639,0.157,0.162,0.155,0.738,0.639,0.615,0.72,0.801,0.744,0.644,0.923,0.839,0.778,0.809,0.794
https://doi.org/10.1080/02724936.2000.11748151,typhoid fever ciprofloxacin and growth in young children,22885_typhoid fever ciprofloxacin and growth in young children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532635/pdf'],['Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532635/pdf'],['22885_0_azithromycin for treating uncomplicated typhoid and paratyphoid fever enteric fever.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532635/pdf'],['22885_0_azithromycin for treating uncomplicated typhoid and paratyphoid fever enteric fever.pdf'],[0.295],[0.515],[0.61],[0.15],[0.157],[0.125],[0.738],[0.645],[0.589],[0.657],[0.788],[0.704],[0.602],[0.916],[0.812],[0.746],[0.778],[0.77],0.295,0.515,0.61,0.15,0.157,0.125,0.738,0.645,0.589,0.657,0.788,0.704,0.602,0.916,0.812,0.746,0.778,0.77
https://doi.org/10.1080/02770903.2019.1702674,once daily combined inhaled steroid and ultra longacting bronchodilator prescribing in pediatric asthma a dual center retrospective cohort study,22904_once daily combined inhaled steroid and ultra longacting bronchodilator prescribing in pediatric asthma a dual center retrospective cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717339/pdf'],['ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717339/pdf'],['22904_0_icsultra laba in the treatment of obstructive airway diseases a consensus of indian experts.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717339/pdf'],['22904_0_icsultra laba in the treatment of obstructive airway diseases a consensus of indian experts.pdf'],[0.288],[0.506],[0.598],[0.178],[0.187],[0.154],[0.749],[0.659],[0.564],[0.676],[0.786],[0.657],[0.624],[0.903],[0.792],[0.744],[0.774],[0.771],0.288,0.506,0.598,0.178,0.187,0.154,0.749,0.659,0.564,0.676,0.786,0.657,0.624,0.903,0.792,0.744,0.774,0.771
https://doi.org/10.1080/02796015.2000.12086007,gender atypical youth clinical and social issues,22919_gender atypical youth clinical and social issues.pdf,1,['https://www.psychology.ca.gov/about_us/meetings/materials/20121018_7j_supporting.pdf'],['Report of the American Psychological Association Task Force on Appropriate Therapeutic Responses to Sexual Orientation'],['https://www.psychology.ca.gov/about_us/meetings/materials/20121018_7j_supporting.pdf'],['22919_0_report of the american psychological association task force on appropriate therapeutic responses to sexual orientation.pdf'],1,100.0,['https://www.psychology.ca.gov/about_us/meetings/materials/20121018_7j_supporting.pdf'],['22919_0_report of the american psychological association task force on appropriate therapeutic responses to sexual orientation.pdf'],[0.429],[0.545],[0.643],[0.189],[0.211],[0.179],[0.733],[0.638],[0.603],[0.689],[0.798],[0.732],[0.643],[0.918],[0.828],[0.768],[0.804],[0.789],0.429,0.545,0.643,0.189,0.211,0.179,0.733,0.638,0.603,0.689,0.798,0.732,0.643,0.918,0.828,0.768,0.804,0.789
https://doi.org/10.1080/03004430.2017.1412959,child care type access and quality in rural areas of the united states a review,22958_child care type access and quality in rural areas of the united states a review.pdf,7,"['https://www.acf.hhs.gov/opre/report/early-care-and-education-rural-communities', 'https://www.acf.hhs.gov/opre/report/research-agenda-home-based-child-care', 'https://www.acf.hhs.gov/opre/report/quality-home-based-child-care-review-selected-literature', 'https://mathematica.org/publications/a-research-agenda-for-home-based-child-care', 'https://mathematica.org/publications/quality-in-home-based-child-care-a-review-of-selected-literature', 'https://www.acf.hhs.gov/opre/resource/early-care-and-education-in-rural-communities', 'https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf']","['Early Care and Education in Rural Communities', 'Research Agenda for Home-Based Child Care', 'Quality in Home-Based Child Care: A Review of Selected Literature', 'A Research Agenda for Home-Based Child Care', 'Quality in Home-Based Child Care: A Review of Selected Literature', 'Early Care and Education in Rural Communities', 'State Of Washington']",['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['22958_6_state of washington.pdf'],1,14.29,['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['22958_6_state of washington.pdf'],[0.731],[0.55],[0.632],[0.194],[0.21],[0.188],[0.734],[0.64],[0.615],[0.694],[0.806],[0.739],[0.646],[0.917],[0.843],[0.772],[0.813],[0.792],0.731,0.55,0.632,0.194,0.21,0.188,0.734,0.64,0.615,0.694,0.806,0.739,0.646,0.917,0.843,0.772,0.813,0.792
https://doi.org/10.1080/03004430.2019.1641703,perspectives on the child care search process in lowincome urban neighbourhoods in the united states,22962_perspectives on the child care search process in lowincome urban neighbourhoods in the united states.pdf,3,"['https://www.acf.hhs.gov/opre/report/recruitment-selection-enrollment-and-retention-strategies-head-start-eligible-families', 'https://mathematica.org/publications/recruitment-selection-enrollment-and-retention-strategies-with-head-start-eligible-families', 'https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf']","['Recruitment, Selection, Enrollment, and Retention Strategies with Head Start-Eligible Families Experiencing Adversity: A Review of the Literature', 'Recruitment, Selection, Enrollment, and Retention Strategies with Head Start-Eligible Families Experiencing Adversity: A Review of the Literature', 'State Of Washington']",['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['22962_2_state of washington.pdf'],1,33.33,['https://www.commerce.wa.gov/wp-content/uploads/2020/08/Child-Care-Collaborative-Task-Force-Industry-Assessment-Report.pdf'],['22962_2_state of washington.pdf'],[0.829],[0.547],[0.628],[0.184],[0.199],[0.174],[0.731],[0.637],[0.615],[0.691],[0.804],[0.735],[0.639],[0.92],[0.846],[0.771],[0.812],[0.79],0.829,0.547,0.628,0.184,0.199,0.174,0.731,0.637,0.615,0.691,0.804,0.735,0.639,0.92,0.846,0.771,0.812,0.79
https://doi.org/10.1080/03009734.2020.1751752,dietary advice and oral nutritional supplements do not increase survival in older malnourished adults a multicentre randomised controlled trial,22981_dietary advice and oral nutritional supplements do not increase survival in older malnourished adults a multicentre randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691169/pdf'],['Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691169/pdf'],['22981_0_dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691169/pdf'],['22981_0_dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults.pdf'],[0.681],[0.529],[0.616],[0.188],[0.197],[0.157],[0.736],[0.64],[0.596],[0.711],[0.778],[0.702],[0.597],[0.917],[0.826],[0.739],[0.781],[0.763],0.681,0.529,0.616,0.188,0.197,0.157,0.736,0.64,0.596,0.711,0.778,0.702,0.597,0.917,0.826,0.739,0.781,0.763
https://doi.org/10.1080/03670244.2019.1695353,food preference infant and child feeding and household food security,23028_food preference infant and child feeding and household food security.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['23028_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['23028_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.278],[0.551],[0.651],[0.213],[0.228],[0.186],[0.744],[0.648],[0.618],[0.685],[0.805],[0.73],[0.633],[0.912],[0.85],[0.762],[0.801],[0.784],0.278,0.551,0.651,0.213,0.228,0.186,0.744,0.648,0.618,0.685,0.805,0.73,0.633,0.912,0.85,0.762,0.801,0.784
https://doi.org/10.1080/07448481.2017.1363765,toward a generation free of tuberculosis tb disease and infection in individuals of college age in the united states,23134_toward a generation free of tuberculosis tb disease and infection in individuals of college age in the united states.pdf,1,['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/TBCB-Published-Studies.pdf'],['Tuberculosis Control Branch Published Studies'],['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/TBCB-Published-Studies.pdf'],['23134_0_tuberculosis control branch published studies.pdf'],1,100.0,['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/TBCB-Published-Studies.pdf'],['23134_0_tuberculosis control branch published studies.pdf'],[0.259],[0.491],[0.582],[0.173],[0.182],[0.155],[0.741],[0.653],[0.552],[0.686],[0.785],[0.676],[0.591],[0.907],[0.806],[0.713],[0.785],[0.769],0.259,0.491,0.582,0.173,0.182,0.155,0.741,0.653,0.552,0.686,0.785,0.676,0.591,0.907,0.806,0.713,0.785,0.769
https://doi.org/10.1080/080352505100366750,the impact of newborn bathing on the prevalence of neonatal hypothermia in uganda a randomized controlled trial,23166_the impact of newborn bathing on the prevalence of neonatal hypothermia in uganda a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf'],['Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf'],['23166_0_interventions to prevent hypothermia at birth in preterm andor low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491068/pdf'],['23166_0_interventions to prevent hypothermia at birth in preterm andor low birth weight infants.pdf'],[0.304],[0.519],[0.601],[0.167],[0.165],[0.131],[0.735],[0.639],[0.578],[0.648],[0.775],[0.696],[0.608],[0.904],[0.799],[0.727],[0.779],[0.752],0.304,0.519,0.601,0.167,0.165,0.131,0.735,0.639,0.578,0.648,0.775,0.696,0.608,0.904,0.799,0.727,0.779,0.752
https://doi.org/10.1080/08974454.2019.1688222,does having a minor child affect criminal charges and sanctions imposed on female defendants,23235_does having a minor child affect criminal charges and sanctions imposed on female defendants.pdf,1,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['2021 : How Gender And Race'],['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['23235_0_2021  how gender and race.pdf'],1,100.0,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['23235_0_2021  how gender and race.pdf'],[0.434],[0.528],[0.613],[0.163],[0.174],[0.154],[0.727],[0.629],[0.583],[0.691],[0.787],[0.714],[0.643],[0.918],[0.82],[0.757],[0.787],[0.77],0.434,0.528,0.613,0.163,0.174,0.154,0.727,0.629,0.583,0.691,0.787,0.714,0.643,0.918,0.82,0.757,0.787,0.77
https://doi.org/10.1080/09540261.2020.1713056,cannabis use among us adolescents in the era of marijuana legalization a review of changing use patterns comorbidity and health correlates,23324_cannabis use among us adolescents in the era of marijuana legalization a review of changing use patterns comorbidity and health correlates.pdf,1,['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1fOpawhzqjMPW_Y8mEMyaqLSfh7rYh_2R.pdf'],['INFORMATIONAL TESTIMONY Bill No .:'],['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1fOpawhzqjMPW_Y8mEMyaqLSfh7rYh_2R.pdf'],['23324_0_informational testimony bill no .pdf'],1,100.0,['https://mgaleg.maryland.gov/cmte_testimony/2021/jud/1fOpawhzqjMPW_Y8mEMyaqLSfh7rYh_2R.pdf'],['23324_0_informational testimony bill no .pdf'],[0.84],[0.52],[0.619],[0.233],[0.262],[0.226],[0.758],[0.676],[0.576],[0.698],[0.793],[0.702],[0.616],[0.91],[0.819],[0.755],[0.784],[0.773],0.84,0.52,0.619,0.233,0.262,0.226,0.758,0.676,0.576,0.698,0.793,0.702,0.616,0.91,0.819,0.755,0.784,0.773
https://doi.org/10.1080/0960085x.2020.1816146,exposing patterns of adult solicitor behaviour towards a theory of control within the cybersexual abuse of youth,23354_exposing patterns of adult solicitor behaviour towards a theory of control within the cybersexual abuse of youth.pdf,1,['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],"['Child Sex Trafficking Team, Office of the Governor - Research Resources 2nd Edition for 2021']",['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],['23354_0_child sex trafficking team office of the governor  research resources 2nd edition for 2021.pdf'],1,100.0,['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],['23354_0_child sex trafficking team office of the governor  research resources 2nd edition for 2021.pdf'],[0.308],[0.572],[0.651],[0.156],[0.163],[0.141],[0.73],[0.636],[0.644],[0.657],[0.818],[0.772],[0.667],[0.92],[0.849],[0.792],[0.83],[0.806],0.308,0.572,0.651,0.156,0.163,0.141,0.73,0.636,0.644,0.657,0.818,0.772,0.667,0.92,0.849,0.792,0.83,0.806
https://doi.org/10.1080/09603123.2020.1805416,effects of prenatal and lactational bisphenol a andor di2ethylhexyl phthalate exposure on male reproductive system,23358_effects of prenatal and lactational bisphenol a andor di2ethylhexyl phthalate exposure on male reproductive system.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['23358_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['23358_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.63],[0.511],[0.611],[0.16],[0.165],[0.126],[0.742],[0.652],[0.582],[0.672],[0.791],[0.673],[0.617],[0.906],[0.801],[0.748],[0.781],[0.767],0.63,0.511,0.611,0.16,0.165,0.126,0.742,0.652,0.582,0.672,0.791,0.673,0.617,0.906,0.801,0.748,0.781,0.767
https://doi.org/10.1080/1028415x.2018.1529342,blunted serum 25ohd response to vitamin dsub3sub supplementation in children with autism,23425_blunted serum 25ohd response to vitamin dsub3sub supplementation in children with autism.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['23425_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['23425_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],[0.51],[0.538],[0.619],[0.188],[0.193],[0.159],[0.738],[0.646],[0.606],[0.691],[0.788],[0.71],[0.605],[0.92],[0.834],[0.747],[0.797],[0.775],0.51,0.538,0.619,0.188,0.193,0.159,0.738,0.646,0.606,0.691,0.788,0.71,0.605,0.92,0.834,0.747,0.797,0.775
https://doi.org/10.1080/1028415x.2019.1681065,prenatal exposure to artificial food colorings alters nmda receptor subunit concentrations in rat hippocampus,23426_prenatal exposure to artificial food colorings alters nmda receptor subunit concentrations in rat hippocampus.pdf,2,"['https://oehha.ca.gov/media/downloads/risk-assessment/report/healthefftsassess041621.pdf', 'https://oehha.ca.gov/media/downloads/risk-assessment/report/fooddyesassessmentdraft082820.pdf']","['Food Dyes Health Effects Assessment OEHHA', 'Food Dyes Health Effects Assessment']","['https://oehha.ca.gov/media/downloads/risk-assessment/report/fooddyesassessmentdraft082820.pdf', 'https://oehha.ca.gov/media/downloads/risk-assessment/report/healthefftsassess041621.pdf']","['23426_1_food dyes health effects assessment.pdf', '23426_0_food dyes health effects assessment oehha.pdf']",2,100.0,"['https://oehha.ca.gov/media/downloads/risk-assessment/report/fooddyesassessmentdraft082820.pdf', 'https://oehha.ca.gov/media/downloads/risk-assessment/report/healthefftsassess041621.pdf']","['23426_1_food dyes health effects assessment.pdf', '23426_0_food dyes health effects assessment oehha.pdf']","[0.48, 0.484]","[0.511, 0.512]","[0.593, 0.594]","[0.141, 0.142]","[0.146, 0.146]","[0.118, 0.119]","[0.73, 0.731]","[0.634, 0.635]","[0.581, 0.581]","[0.679, 0.678]","[0.776, 0.777]","[0.69, 0.69]","[0.626, 0.627]","[0.907, 0.907]","[0.815, 0.815]","[0.743, 0.744]","[0.781, 0.781]","[0.763, 0.764]",0.482,0.512,0.593,0.141,0.146,0.118,0.73,0.635,0.581,0.679,0.776,0.69,0.627,0.907,0.815,0.744,0.781,0.764
https://doi.org/10.1080/10511482.2018.1515099,housing subsidies and early childhood development a comprehensive review of policies and demonstration projects,23599_housing subsidies and early childhood development a comprehensive review of policies and demonstration projects.pdf,1,['https://purl.fdlp.gov/GPO/gpo139196'],"['Examining the effects of the Rental Assistance Demonstration on children living in public housing in Fresno, California /']",['https://purl.fdlp.gov/GPO/gpo139196'],['23599_0_examining the effects of the rental assistance demonstration on children living in public housing in fresno california .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo139196'],['23599_0_examining the effects of the rental assistance demonstration on children living in public housing in fresno california .pdf'],[0.603],[0.532],[0.625],[0.172],[0.192],[0.155],[0.726],[0.632],[0.593],[0.679],[0.798],[0.722],[0.638],[0.918],[0.843],[0.764],[0.805],[0.786],0.603,0.532,0.625,0.172,0.192,0.155,0.726,0.632,0.593,0.679,0.798,0.722,0.638,0.918,0.843,0.764,0.805,0.786
https://doi.org/10.1080/10538712.2019.1639093,group intervention with parents of juvenile sex offenders,23623_group intervention with parents of juvenile sex offenders.pdf,1,['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['Juvenile Justice Realignment Block Grant Annual Plan'],['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['23623_0_juvenile justice realignment block grant annual plan.pdf'],1,100.0,['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['23623_0_juvenile justice realignment block grant annual plan.pdf'],[0.288],[0.558],[0.64],[0.19],[0.209],[0.172],[0.736],[0.639],[0.62],[0.669],[0.81],[0.758],[0.657],[0.925],[0.841],[0.78],[0.819],[0.799],0.288,0.558,0.64,0.19,0.209,0.172,0.736,0.639,0.62,0.669,0.81,0.758,0.657,0.925,0.841,0.78,0.819,0.799
https://doi.org/10.1080/10543406.2020.1821705,the precision interventions for severe andor exacerbationprone asthma precise adaptive platform trial statistical considerations,23625_the precision interventions for severe andor exacerbationprone asthma precise adaptive platform trial statistical considerations.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874432/pdf'],['National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874432/pdf'],['23625_0_national asthma education and prevention program 2020 guideline update where do we go from here.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874432/pdf'],['23625_0_national asthma education and prevention program 2020 guideline update where do we go from here.pdf'],[0.224],[0.558],[0.643],[0.172],[0.183],[0.144],[0.737],[0.64],[0.638],[0.688],[0.811],[0.747],[0.631],[0.922],[0.835],[0.776],[0.812],[0.795],0.224,0.558,0.643,0.172,0.183,0.144,0.737,0.64,0.638,0.688,0.811,0.747,0.631,0.922,0.835,0.776,0.812,0.795
https://doi.org/10.1080/10588330008951128,biodegradation of phenol mechanisms and applications,23647_biodegradation of phenol mechanisms and applications.pdf,1,['https://www.epa.gov/sites/default/files/documents/hf-report20121214.pdf'],['Study of the Potential Impacts of Hydraulic Fracturing on Drinking Water Resources - Progress Report'],['https://www.epa.gov/sites/default/files/documents/hf-report20121214.pdf'],['23647_0_study of the potential impacts of hydraulic fracturing on drinking water resources  progress report.pdf'],1,100.0,['https://www.epa.gov/sites/default/files/documents/hf-report20121214.pdf'],['23647_0_study of the potential impacts of hydraulic fracturing on drinking water resources  progress report.pdf'],[0.133],[0.475],[0.574],[0.09],[0.077],[0.064],[0.727],[0.63],[0.558],[0.642],[0.792],[0.682],[0.618],[0.903],[0.794],[0.744],[0.787],[0.779],0.133,0.475,0.574,0.09,0.077,0.064,0.727,0.63,0.558,0.642,0.792,0.682,0.618,0.903,0.794,0.744,0.787,0.779
https://doi.org/10.1080/10640266.2020.1823173,lower rates of readmission following integration of familybased treatment in a higher level of care,23665_lower rates of readmission following integration of familybased treatment in a higher level of care.pdf,1,['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['The American Psychiatric Association Practice Guideline for the Treatment of Patients with Eating Disorders'],['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['23665_0_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf'],1,100.0,['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['23665_0_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf'],[0.623],[0.536],[0.643],[0.183],[0.197],[0.164],[0.742],[0.654],[0.599],[0.69],[0.804],[0.727],[0.626],[0.928],[0.819],[0.77],[0.797],[0.786],0.623,0.536,0.643,0.183,0.197,0.164,0.742,0.654,0.599,0.69,0.804,0.727,0.626,0.928,0.819,0.77,0.797,0.786
https://doi.org/10.1080/10668926.2019.1616635,the importance of institutional data reporting quality for understanding deved math enrollment and outcomes,23689_the importance of institutional data reporting quality for understanding deved math enrollment and outcomes.pdf,1,['https://mhec.maryland.gov/publications/Documents/Research/PolicyReports/2021AssessmentToolsReport.pdf'],['2021_JCR_p197_Report on Assessment Tools'],['https://mhec.maryland.gov/publications/Documents/Research/PolicyReports/2021AssessmentToolsReport.pdf'],['23689_0_2021jcrp197report on assessment tools.pdf'],1,100.0,['https://mhec.maryland.gov/publications/Documents/Research/PolicyReports/2021AssessmentToolsReport.pdf'],['23689_0_2021jcrp197report on assessment tools.pdf'],[0.567],[0.602],[0.681],[0.23],[0.273],[0.227],[0.742],[0.653],[0.675],[0.737],[0.826],[0.786],[0.684],[0.932],[0.873],[0.808],[0.843],[0.824],0.567,0.602,0.681,0.23,0.273,0.227,0.742,0.653,0.675,0.737,0.826,0.786,0.684,0.932,0.873,0.808,0.843,0.824
https://doi.org/10.1080/10835547.2000.12089617,institutional property tenure evidence from the ncreif database,23781_institutional property tenure evidence from the ncreif database.pdf,1,['https://www.dallasfed.org/-/media/documents/research/papers/2017/wp1703.pdf'],['How Taxes and Required Returns Drove Commercial Real Estate Valuations over the Past Four Decades'],['https://www.dallasfed.org/-/media/documents/research/papers/2017/wp1703.pdf'],['23781_0_how taxes and required returns drove commercial real estate valuations over the past four decades.pdf'],1,100.0,['https://www.dallasfed.org/-/media/documents/research/papers/2017/wp1703.pdf'],['23781_0_how taxes and required returns drove commercial real estate valuations over the past four decades.pdf'],[0.383],[0.579],[0.646],[0.207],[0.211],[0.187],[0.735],[0.64],[0.633],[0.723],[0.808],[0.724],[0.693],[0.92],[0.858],[0.787],[0.817],[0.8],0.383,0.579,0.646,0.207,0.211,0.187,0.735,0.64,0.633,0.723,0.808,0.724,0.693,0.92,0.858,0.787,0.817,0.8
https://doi.org/10.1080/13668800802024678,defining and conceptualizing workplace flexibility,23979_defining and conceptualizing workplace flexibility.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175959/pdf', 'https://equitablegrowth.org/working-papers/compensation-for-unstable-and-unpredictable-work-schedules-evidence-from-the-national-longitudinal-survey-of-youth-1997-cohort/']","['Flexible working conditions and their effects on employee health and wellbeing', 'Compensation for Unstable and Unpredictable Work Schedules: Evidence from the National Longitudinal Survey of Youth 1997 Cohort - Equitable Growth']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175959/pdf'],['23979_0_flexible working conditions and their effects on employee health and wellbeing.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175959/pdf'],['23979_0_flexible working conditions and their effects on employee health and wellbeing.pdf'],[0.322],[0.517],[0.613],[0.164],[0.173],[0.149],[0.735],[0.643],[0.575],[0.707],[0.775],[0.694],[0.606],[0.914],[0.822],[0.733],[0.778],[0.763],0.322,0.517,0.613,0.164,0.173,0.149,0.735,0.643,0.575,0.707,0.775,0.694,0.606,0.914,0.822,0.733,0.778,0.763
https://doi.org/10.1080/13676260120075464,citizenship youth councils and young peoples participation,23984_citizenship youth councils and young peoples participation.pdf,1,['https://www.oeo.wa.gov/sites/default/files/public/FullGuideforListeningandCoDesign.2018.07.02.pdf'],"['Reducing the Opportunity Gap by Empowering Students, Families, and Communities']",['https://www.oeo.wa.gov/sites/default/files/public/FullGuideforListeningandCoDesign.2018.07.02.pdf'],['23984_0_reducing the opportunity gap by empowering students families and communities.pdf'],1,100.0,['https://www.oeo.wa.gov/sites/default/files/public/FullGuideforListeningandCoDesign.2018.07.02.pdf'],['23984_0_reducing the opportunity gap by empowering students families and communities.pdf'],[0.201],[0.579],[0.653],[0.191],[0.207],[0.17],[0.735],[0.639],[0.649],[0.687],[0.821],[0.758],[0.665],[0.915],[0.876],[0.79],[0.829],[0.813],0.201,0.579,0.653,0.191,0.207,0.17,0.735,0.639,0.649,0.687,0.821,0.758,0.665,0.915,0.876,0.79,0.829,0.813
https://doi.org/10.1080/13811118.2010.494133,bullying cyberbullying and suicide,24035_bullying cyberbullying and suicide.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786270/pdf', 'https://www.mass.gov/doc/mahanoy-scotus-brief/download', 'https://www.rand.org/pubs/research_reports/RR695.html', 'https://www.brookings.edu/research/bystander-intervention-on-social-media-examining-cyberbullying-and-reactions-to-systemic-racism/', 'http://www.doe.virginia.gov/support/prevention/bullying/2011_legislative_study.pdf', 'http://www.doe.virginia.gov/support/prevention/bullying/model_policy_to_address_bullying_in_va_schools.pdf']","['Interventions for self‐harm in children and adolescents', 'In the Supreme Court of the United States', 'Technology and the Well-Being of U.S. Airmen', 'Bystander intervention on social media: Examining cyberbullying and reactions to systemic racism', ""Study of the Nature and Effectiveness of Virginia School Divisions' Antibullying Policies( HJR 625, 2011)"", ""Microsoft Word - 10.25.13 Model Policy to Address Bullying in Virginia's Schools - October 24, 2013_2.doc""]","['https://www.mass.gov/doc/mahanoy-scotus-brief/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786270/pdf']","['24035_1_in the supreme court of the united states.pdf', '24035_0_interventions for self‐harm in children and adolescents.pdf']",2,33.33,"['https://www.mass.gov/doc/mahanoy-scotus-brief/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786270/pdf']","['24035_1_in the supreme court of the united states.pdf', '24035_0_interventions for self‐harm in children and adolescents.pdf']","[0.24, 0.44]","[0.48, 0.507]","[0.579, 0.598]","[0.147, 0.138]","[0.164, 0.15]","[0.149, 0.123]","[0.732, 0.723]","[0.643, 0.628]","[0.548, 0.571]","[0.689, 0.686]","[0.762, 0.775]","[0.667, 0.703]","[0.604, 0.582]","[0.91, 0.915]","[0.805, 0.805]","[0.725, 0.723]","[0.762, 0.78]","[0.749, 0.754]",0.34,0.493,0.589,0.143,0.157,0.136,0.728,0.635,0.559,0.688,0.768,0.685,0.593,0.913,0.805,0.724,0.771,0.752
https://doi.org/10.1080/14653240600855905,minimal criteria for defining multipotent mesenchymal stromal cells the international society for cellular therapy position statement,24141_minimal criteria for defining multipotent mesenchymal stromal cells the international society for cellular therapy position statement.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353308/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503265/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438027/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441967/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485972/pdf', 'https://www.thoracic.org/statements/resources/research/stem-cells-wr.pdf', 'https://www.painphysicianjournal.com/current/pdf?article=NzAyNQ%3D%3D&journal=125']","['Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition', 'Stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants', 'Guidelines for Biobanking of Bone Marrow Adipose Tissue and Related Cell Types: Report of the Biobanking Working Group of the International Bone Marrow Adiposity Society', 'Stem cell‐based interventions for the prevention of morbidity and mortality following hypoxic‐ischaemic encephalopathy in newborn infants', 'Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases', 'Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants', 'An Official American Thoracic Society Workshop Report: Stem Cells and Cell Therapies in Lung Biology and Diseases', 'Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441967/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503265/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485972/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353308/pdf', 'https://www.thoracic.org/statements/resources/research/stem-cells-wr.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438027/pdf']","['24141_4_cellbased therapeutic strategies for replacement and preservation in retinal degenerative diseases.pdf', '24141_2_guidelines for biobanking of bone marrow adipose tissue and related cell types report of the biobanking working group of the international bone marrow adiposity society.pdf', '24141_5_mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.pdf', '24141_0_mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant hsct recipients with a haematological condition.pdf', '24141_6_an official american thoracic society workshop report stem cells and cell therapies in lung biology and diseases.pdf', '24141_1_stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants.pdf', '24141_3_stem cell‐based interventions for the prevention of morbidity and mortality following hypoxic‐ischaemic encephalopathy in newborn infants.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441967/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503265/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485972/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353308/pdf', 'https://www.thoracic.org/statements/resources/research/stem-cells-wr.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757514/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438027/pdf']","['24141_4_cellbased therapeutic strategies for replacement and preservation in retinal degenerative diseases.pdf', '24141_2_guidelines for biobanking of bone marrow adipose tissue and related cell types report of the biobanking working group of the international bone marrow adiposity society.pdf', '24141_5_mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants.pdf', '24141_0_mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant hsct recipients with a haematological condition.pdf', '24141_6_an official american thoracic society workshop report stem cells and cell therapies in lung biology and diseases.pdf', '24141_1_stem cell‐based interventions for the prevention and treatment of germinal matrix‐intraventricular haemorrhage in preterm infants.pdf', '24141_3_stem cell‐based interventions for the prevention of morbidity and mortality following hypoxic‐ischaemic encephalopathy in newborn infants.pdf']","[0.262, 0.366, 0.395, 0.367, 0.336, 0.312, 0.52]","[0.521, 0.574, 0.561, 0.532, 0.573, 0.543, 0.546]","[0.632, 0.656, 0.646, 0.616, 0.659, 0.637, 0.639]","[0.151, 0.175, 0.156, 0.15, 0.177, 0.142, 0.147]","[0.166, 0.179, 0.162, 0.136, 0.18, 0.149, 0.143]","[0.121, 0.13, 0.117, 0.106, 0.14, 0.109, 0.108]","[0.742, 0.744, 0.738, 0.737, 0.747, 0.736, 0.737]","[0.648, 0.649, 0.643, 0.641, 0.654, 0.641, 0.641]","[0.594, 0.643, 0.64, 0.6, 0.645, 0.614, 0.622]","[0.673, 0.678, 0.668, 0.684, 0.685, 0.666, 0.662]","[0.785, 0.806, 0.802, 0.78, 0.812, 0.789, 0.793]","[0.718, 0.756, 0.753, 0.714, 0.768, 0.731, 0.736]","[0.604, 0.649, 0.617, 0.587, 0.649, 0.602, 0.604]","[0.9, 0.912, 0.914, 0.906, 0.913, 0.914, 0.915]","[0.807, 0.837, 0.833, 0.824, 0.84, 0.827, 0.835]","[0.752, 0.787, 0.777, 0.74, 0.789, 0.762, 0.76]","[0.787, 0.821, 0.81, 0.787, 0.825, 0.797, 0.801]","[0.771, 0.803, 0.791, 0.763, 0.804, 0.78, 0.782]",0.365,0.55,0.641,0.157,0.159,0.119,0.74,0.645,0.623,0.674,0.795,0.739,0.616,0.911,0.829,0.767,0.804,0.785
https://doi.org/10.1080/14693062.2019.1657379,transitional assistance policies for just equitable and smooth lowcarbon transitions who what and how,24154_transitional assistance policies for just equitable and smooth lowcarbon transitions who what and how.pdf,1,['https://www.edf.org/sites/default/files/documents/UK_Report_Case_Study.pdf'],['Regional Just Transitions in the UK: Insights from 40 Years of Policy Experience'],['https://www.edf.org/sites/default/files/documents/UK_Report_Case_Study.pdf'],['24154_0_regional just transitions in the uk insights from 40 years of policy experience.pdf'],1,100.0,['https://www.edf.org/sites/default/files/documents/UK_Report_Case_Study.pdf'],['24154_0_regional just transitions in the uk insights from 40 years of policy experience.pdf'],[0.612],[0.559],[0.652],[0.187],[0.186],[0.159],[0.727],[0.638],[0.624],[0.695],[0.817],[0.751],[0.668],[0.923],[0.857],[0.786],[0.825],[0.807],0.612,0.559,0.652,0.187,0.186,0.159,0.727,0.638,0.624,0.695,0.817,0.751,0.668,0.923,0.857,0.786,0.825,0.807
https://doi.org/10.1080/14767058.2018.1535587,evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidity in earlyterm elective cesarean,24184_evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidity in earlyterm elective cesarean.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692259/pdf'],['Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692259/pdf'],['24184_0_antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692259/pdf'],['24184_0_antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.pdf'],[0.441],[0.537],[0.624],[0.194],[0.199],[0.151],[0.736],[0.644],[0.61],[0.656],[0.795],[0.712],[0.606],[0.912],[0.824],[0.741],[0.788],[0.77],0.441,0.537,0.624,0.194,0.199,0.151,0.736,0.644,0.61,0.656,0.795,0.712,0.606,0.912,0.824,0.741,0.788,0.77
https://doi.org/10.1080/14767058.2020.1763948,management of covid19 a practical guideline for maternal and newborn health care providers in subsaharan africa,24186_management of covid19 a practical guideline for maternal and newborn health care providers in subsaharan africa.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['24186_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['24186_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.56],[0.562],[0.637],[0.192],[0.217],[0.175],[0.744],[0.651],[0.626],[0.624],[0.817],[0.753],[0.638],[0.932],[0.846],[0.771],[0.82],[0.802],0.56,0.562,0.637,0.192,0.217,0.175,0.744,0.651,0.626,0.624,0.817,0.753,0.638,0.932,0.846,0.771,0.82,0.802
https://doi.org/10.1080/14767058.2020.1784873,management of mothers and neonates in low resources setting during covid19 pandemia,24187_management of mothers and neonates in low resources setting during covid19 pandemia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['24187_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['24187_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.546],[0.534],[0.62],[0.17],[0.192],[0.147],[0.745],[0.652],[0.597],[0.628],[0.805],[0.72],[0.616],[0.927],[0.829],[0.751],[0.805],[0.788],0.546,0.534,0.62,0.17,0.192,0.147,0.745,0.652,0.597,0.628,0.805,0.72,0.616,0.927,0.829,0.751,0.805,0.788
https://doi.org/10.1080/15313204.2018.1555498,microaggressions and racial privilege within the social work profession the social work licensing examinations,24273_microaggressions and racial privilege within the social work profession the social work licensing examinations.pdf,1,['https://bbs.ca.gov/pdf/agen_notice/2022/20221103_04_item_xxi_additional_materials.pdf'],['Item XXI Additional Materials'],['https://bbs.ca.gov/pdf/agen_notice/2022/20221103_04_item_xxi_additional_materials.pdf'],['24273_0_item xxi additional materials.pdf'],1,100.0,['https://bbs.ca.gov/pdf/agen_notice/2022/20221103_04_item_xxi_additional_materials.pdf'],['24273_0_item xxi additional materials.pdf'],[0.402],[0.583],[0.672],[0.197],[0.223],[0.184],[0.736],[0.644],[0.647],[0.703],[0.824],[0.772],[0.675],[0.931],[0.854],[0.789],[0.827],[0.808],0.402,0.583,0.672,0.197,0.223,0.184,0.736,0.644,0.647,0.703,0.824,0.772,0.675,0.931,0.854,0.789,0.827,0.808
https://doi.org/10.1080/15374416.2019.1591281,evidence base update of psychosocial treatments for selfinjurious thoughts and behaviors in youth,24380_evidence base update of psychosocial treatments for selfinjurious thoughts and behaviors in youth.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['24380_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['24380_0_interventions for self‐harm in children and adolescents.pdf'],[0.525],[0.528],[0.615],[0.187],[0.198],[0.162],[0.736],[0.646],[0.582],[0.71],[0.788],[0.707],[0.601],[0.919],[0.822],[0.743],[0.785],[0.77],0.525,0.528,0.615,0.187,0.198,0.162,0.736,0.646,0.582,0.71,0.788,0.707,0.601,0.919,0.822,0.743,0.785,0.77
https://doi.org/10.1080/15548627.2019.1596492,gca links traf6ulk1dependent autophagy activation in resistant chronic myeloid leukemia,24464_gca links traf6ulk1dependent autophagy activation in resistant chronic myeloid leukemia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996087/pdf'],['Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996087/pdf'],['24464_0_guidelines for the use and interpretation of assays for monitoring autophagy 4th edition.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996087/pdf'],['24464_0_guidelines for the use and interpretation of assays for monitoring autophagy 4th edition.pdf'],[0.295],[0.531],[0.625],[0.173],[0.17],[0.142],[0.753],[0.657],[0.602],[0.648],[0.794],[0.71],[0.615],[0.907],[0.806],[0.749],[0.798],[0.776],0.295,0.531,0.625,0.173,0.17,0.142,0.753,0.657,0.602,0.648,0.794,0.71,0.615,0.907,0.806,0.749,0.798,0.776
https://doi.org/10.1080/15563650.2019.1677022,2018 annual report of the american association of poison control centers’ national poison data system npds 36th annual report,24484_2018 annual report of the american association of poison control centers’ national poison data system npds 36th annual report.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780136/pdf'],['Oral antihistamine‐decongestant‐analgesic combinations for the common cold'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780136/pdf'],['24484_0_oral antihistamine‐decongestant‐analgesic combinations for the common cold.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780136/pdf'],['24484_0_oral antihistamine‐decongestant‐analgesic combinations for the common cold.pdf'],[0.059],[0.505],[0.593],[0.152],[0.158],[0.122],[0.731],[0.633],[0.569],[0.662],[0.758],[0.667],[0.593],[0.911],[0.809],[0.724],[0.761],[0.744],0.059,0.505,0.593,0.152,0.158,0.122,0.731,0.633,0.569,0.662,0.758,0.667,0.593,0.911,0.809,0.724,0.761,0.744
https://doi.org/10.1080/16549716.2017.1363506,effect of a participatory multisectoral maternal and newborn intervention on maternal health service utilization and newborn care practices a quasiexperimental study in three rural ugandan districts,24527_effect of a participatory multisectoral maternal and newborn intervention on maternal health service utilization and newborn care practices a quasiexperimental study in three rural ugandan districts.pdf,1,['https://purl.fdlp.gov/GPO/gpo113954'],"['Using the Uganda Demographic and Health Surveys from 2011 and 2016 to assess changes in Saving Mothers, Giving Life intervention districts /']",['https://purl.fdlp.gov/GPO/gpo113954'],['24527_0_using the uganda demographic and health surveys from 2011 and 2016 to assess changes in saving mothers giving life intervention districts .pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1080/1744666x.2019.1546577,important risk factors for the development of food allergy and potential options for prevention,24550_important risk factors for the development of food allergy and potential options for prevention.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['24550_0_skin care interventions in infants for preventing eczema and food allergy.pdf', '24550_1_skin care interventions in infants for preventing eczema and food allergy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['24550_0_skin care interventions in infants for preventing eczema and food allergy.pdf', '24550_1_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.408, 0.408]","[0.535, 0.538]","[0.631, 0.633]","[0.168, 0.173]","[0.183, 0.184]","[0.146, 0.149]","[0.739, 0.74]","[0.644, 0.644]","[0.597, 0.601]","[0.675, 0.673]","[0.786, 0.788]","[0.716, 0.716]","[0.6, 0.604]","[0.917, 0.916]","[0.819, 0.821]","[0.739, 0.74]","[0.788, 0.79]","[0.765, 0.767]",0.408,0.536,0.632,0.17,0.183,0.147,0.74,0.644,0.599,0.674,0.787,0.716,0.602,0.917,0.82,0.74,0.789,0.766
https://doi.org/10.1080/1744666x.2019.1561282,from mother to baby antenatal exposure to monoclonal antibody biologics,24551_from mother to baby antenatal exposure to monoclonal antibody biologics.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822421/pdf'],['Clinical practice guideline on pregnancy and renal disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822421/pdf'],['24551_0_clinical practice guideline on pregnancy and renal disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822421/pdf'],['24551_0_clinical practice guideline on pregnancy and renal disease.pdf'],[0.468],[0.558],[0.635],[0.167],[0.168],[0.134],[0.74],[0.644],[0.616],[0.622],[0.801],[0.722],[0.627],[0.916],[0.803],[0.764],[0.802],[0.788],0.468,0.558,0.635,0.167,0.168,0.134,0.74,0.644,0.616,0.622,0.801,0.722,0.627,0.916,0.803,0.764,0.802,0.788
https://doi.org/10.1080/19371918.2012.630965,mothers in prison maintaining connections with children,24650_mothers in prison maintaining connections with children.pdf,3,"['https://www.rand.org/pubs/research_reports/RRA1412-1.html', 'https://purl.fdlp.gov/GPO/gpo108591', 'https://www.urban.org/research/publication/parent-child-visiting-practices-prisons-and-jails']","['Programs for Incarcerated Parents', 'Child welfare practice with families affected by parental incarceration.', 'Parent-Child Visiting Practices in Prisons and Jails']",['https://purl.fdlp.gov/GPO/gpo108591'],['24650_1_child welfare practice with families affected by parental incarceration.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo108591'],['24650_1_child welfare practice with families affected by parental incarceration.pdf'],[0.662],[0.557],[0.651],[0.223],[0.246],[0.213],[0.745],[0.647],[0.616],[0.689],[0.805],[0.723],[0.649],[0.92],[0.836],[0.773],[0.807],[0.789],0.662,0.557,0.651,0.223,0.246,0.213,0.745,0.647,0.616,0.689,0.805,0.723,0.649,0.92,0.836,0.773,0.807,0.789
https://doi.org/10.1080/19440049.2019.1637548,acrylamide levels and dietary exposure from foods in the united states an update based on 20112015 data,24674_acrylamide levels and dietary exposure from foods in the united states an update based on 20112015 data.pdf,1,['https://www.oag.ca.gov/sites/default/files/injunction-ca-chamber-becerra.pdf'],['U.S. District Court for the Eastern District of California injunction order California Chamber of Commerce v. Becerra'],['https://www.oag.ca.gov/sites/default/files/injunction-ca-chamber-becerra.pdf'],['24674_0_us district court for the eastern district of california injunction order california chamber of commerce v becerra.pdf'],1,100.0,['https://www.oag.ca.gov/sites/default/files/injunction-ca-chamber-becerra.pdf'],['24674_0_us district court for the eastern district of california injunction order california chamber of commerce v becerra.pdf'],[0.276],[0.466],[0.559],[0.098],[0.107],[0.084],[0.718],[0.622],[0.538],[0.66],[0.762],[0.659],[0.612],[0.895],[0.803],[0.723],[0.758],[0.745],0.276,0.466,0.559,0.098,0.107,0.084,0.718,0.622,0.538,0.66,0.762,0.659,0.612,0.895,0.803,0.723,0.758,0.745
https://doi.org/10.1080/20008198.2018.1558708,treating children and adolescents with multiple traumas a randomized clinical trial of narrative exposure therapy,24683_treating children and adolescents with multiple traumas a randomized clinical trial of narrative exposure therapy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf'],['Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf'],['24683_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094402/pdf'],['24683_0_psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises.pdf'],[0.396],[0.519],[0.608],[0.164],[0.174],[0.147],[0.73],[0.638],[0.577],[0.706],[0.778],[0.699],[0.588],[0.918],[0.815],[0.733],[0.779],[0.762],0.396,0.519,0.608,0.164,0.174,0.147,0.73,0.638,0.577,0.706,0.778,0.699,0.588,0.918,0.815,0.733,0.779,0.762
https://doi.org/10.1080/20013078.2019.1575678,differences in the metabolite composition and mechanical properties of extracellular vesicles secreted by hepatic cellular models,24685_differences in the metabolite composition and mechanical properties of extracellular vesicles secreted by hepatic cellular models.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138533/pdf'],['Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138533/pdf'],['24685_0_urinary extracellular vesicles a position paper by the urine task force of the international society for extracellular vesicles.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138533/pdf'],['24685_0_urinary extracellular vesicles a position paper by the urine task force of the international society for extracellular vesicles.pdf'],[0.332],[0.503],[0.618],[0.125],[0.14],[0.112],[0.742],[0.655],[0.586],[0.677],[0.792],[0.709],[0.604],[0.914],[0.802],[0.753],[0.786],[0.778],0.332,0.503,0.618,0.125,0.14,0.112,0.742,0.655,0.586,0.677,0.792,0.709,0.604,0.914,0.802,0.753,0.786,0.778
https://doi.org/10.1080/20442041.2019.1700749,cyanotoxin occurrence in large rivers of the united states,24688_cyanotoxin occurrence in large rivers of the united states.pdf,1,['https://www.tn.gov/content/dam/tn/environment/water/tmdl-program/harpeth-river-watershed/wr_ws_tmdl-harpeth-mtg-presentation-hc-2020-0205.pdf'],['Harpeth :'],['https://www.tn.gov/content/dam/tn/environment/water/tmdl-program/harpeth-river-watershed/wr_ws_tmdl-harpeth-mtg-presentation-hc-2020-0205.pdf'],['24688_0_harpeth .pdf'],1,100.0,['https://www.tn.gov/content/dam/tn/environment/water/tmdl-program/harpeth-river-watershed/wr_ws_tmdl-harpeth-mtg-presentation-hc-2020-0205.pdf'],['24688_0_harpeth .pdf'],[0.31],[0.555],[0.639],[0.21],[0.21],[0.182],[0.746],[0.663],[0.627],[0.685],[0.823],[0.755],[0.655],[0.89],[0.845],[0.793],[0.83],[0.812],0.31,0.555,0.639,0.21,0.21,0.182,0.746,0.663,0.627,0.685,0.823,0.755,0.655,0.89,0.845,0.793,0.83,0.812
https://doi.org/10.1080/20469047.2020.1781356,human and novel coronavirus infections in children a review,24690_human and novel coronavirus infections in children a review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['24690_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['24690_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.589],[0.535],[0.615],[0.163],[0.182],[0.144],[0.743],[0.652],[0.596],[0.638],[0.8],[0.71],[0.613],[0.919],[0.825],[0.749],[0.802],[0.784],0.589,0.535,0.615,0.163,0.182,0.144,0.743,0.652,0.596,0.638,0.8,0.71,0.613,0.919,0.825,0.749,0.802,0.784
https://doi.org/10.1080/21645515.2017.1368601,improved parental attitudes and beliefs through stepwise perinatal vaccination education,24709_improved parental attitudes and beliefs through stepwise perinatal vaccination education.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494431/pdf'],['Face‐to‐face interventions for informing or educating parents about early childhood vaccination'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494431/pdf'],['24709_0_face‐to‐face interventions for informing or educating parents about early childhood vaccination.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494431/pdf'],['24709_0_face‐to‐face interventions for informing or educating parents about early childhood vaccination.pdf'],[0.488],[0.543],[0.621],[0.195],[0.2],[0.168],[0.737],[0.644],[0.597],[0.695],[0.781],[0.699],[0.609],[0.92],[0.832],[0.746],[0.784],[0.768],0.488,0.543,0.621,0.195,0.2,0.168,0.737,0.644,0.597,0.695,0.781,0.699,0.609,0.92,0.832,0.746,0.784,0.768
https://doi.org/10.1080/21645515.2019.1587276,caregiver acceptance of a patient navigation program to increase human papillomavirus vaccination in pediatric clinics a qualitative program evaluation,24717_caregiver acceptance of a patient navigation program to increase human papillomavirus vaccination in pediatric clinics a qualitative program evaluation.pdf,1,['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['Oversight Committee Meeting'],['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['24717_0_oversight committee meeting.pdf'],1,100.0,['https://cprit.texas.gov/media/2422/oc_packet_11182020.pdf'],['24717_0_oversight committee meeting.pdf'],[0.238],[0.495],[0.585],[0.099],[0.106],[0.088],[0.714],[0.613],[0.562],[0.644],[0.779],[0.692],[0.594],[0.912],[0.824],[0.737],[0.784],[0.765],0.238,0.495,0.585,0.099,0.106,0.088,0.714,0.613,0.562,0.644,0.779,0.692,0.594,0.912,0.824,0.737,0.784,0.765
https://doi.org/10.1080/21645515.2020.1733868,immunogenicity and safety of a quadrivalent meningococcal tetanus toxoidconjugate vaccine menacywtt in adults 56 years of age and older a phase ii randomized study,24722_immunogenicity and safety of a quadrivalent meningococcal tetanus toxoidconjugate vaccine menacywtt in adults 56 years of age and older a phase ii randomized study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf', 'https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research', 'https://stacks.cdc.gov/view/cdc/95034']","['Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020', 'Safety of Vaccines Used for Routine Immunization in the United States: An Update', 'Meningococcal vaccination : 5ecommendations of the Advisory Committee on Immunization Practices, United States, 2020']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf'],['24722_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf'],['24722_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf'],[0.536],[0.533],[0.614],[0.198],[0.213],[0.188],[0.75],[0.66],[0.596],[0.668],[0.789],[0.683],[0.622],[0.913],[0.814],[0.755],[0.784],[0.772],0.536,0.533,0.614,0.198,0.213,0.188,0.75,0.66,0.596,0.668,0.789,0.683,0.622,0.913,0.814,0.755,0.784,0.772
https://doi.org/10.1080/21645515.2020.1780846,social media and vaccine hesitancy new updates for the era of covid19 and globalized infectious diseases,24725_social media and vaccine hesitancy new updates for the era of covid19 and globalized infectious diseases.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528734/pdf'],['Vaccine hesitancy among Maltese healthcare workers toward influenza and novel COVID-19 vaccination'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528734/pdf'],['24725_0_vaccine hesitancy among maltese healthcare workers toward influenza and novel covid19 vaccination.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528734/pdf'],['24725_0_vaccine hesitancy among maltese healthcare workers toward influenza and novel covid19 vaccination.pdf'],[0.151],[0.537],[0.63],[0.193],[0.188],[0.156],[0.729],[0.634],[0.631],[0.672],[0.826],[0.756],[0.61],[0.939],[0.84],[0.745],[0.809],[0.773],0.151,0.537,0.63,0.193,0.188,0.156,0.729,0.634,0.631,0.672,0.826,0.756,0.61,0.939,0.84,0.745,0.809,0.773
https://doi.org/10.1080/23322705.2019.1698895,what are the human trafficking policies of professional medical organizations,24745_what are the human trafficking policies of professional medical organizations.pdf,2,"['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Research-1st-Edition-2020.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Archived-Research-Resources-2019.pdf']","['Child Sex Trafficking Team, Office of the Governor - Research Resources 1st Edition for 2020', 'Child Sex Trafficking Team, Office of the Governor - Archived Research Resources for 2019']","['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Research-1st-Edition-2020.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Archived-Research-Resources-2019.pdf']","['24745_0_child sex trafficking team office of the governor  research resources 1st edition for 2020.pdf', '24745_1_child sex trafficking team office of the governor  archived research resources for 2019.pdf']",2,100.0,"['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Research-1st-Edition-2020.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Archived-Research-Resources-2019.pdf']","['24745_0_child sex trafficking team office of the governor  research resources 1st edition for 2020.pdf', '24745_1_child sex trafficking team office of the governor  archived research resources for 2019.pdf']","[0.593, 0.603]","[0.61, 0.603]","[0.698, 0.69]","[0.262, 0.245]","[0.294, 0.274]","[0.237, 0.223]","[0.755, 0.751]","[0.669, 0.663]","[0.665, 0.66]","[0.686, 0.676]","[0.831, 0.829]","[0.773, 0.773]","[0.667, 0.661]","[0.935, 0.935]","[0.864, 0.86]","[0.798, 0.794]","[0.839, 0.835]","[0.82, 0.815]",0.598,0.607,0.694,0.254,0.284,0.23,0.753,0.666,0.663,0.681,0.83,0.773,0.664,0.935,0.862,0.796,0.837,0.817
https://doi.org/10.1080/23322705.2020.1850141,the impact of assembly trainings on awareness of human trafficking among middle school and high school age youth,24746_the impact of assembly trainings on awareness of human trafficking among middle school and high school age youth.pdf,1,['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],"['Child Sex Trafficking Team, Office of the Governor - Research Resources 2nd Edition for 2021']",['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],['24746_0_child sex trafficking team office of the governor  research resources 2nd edition for 2021.pdf'],1,100.0,['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],['24746_0_child sex trafficking team office of the governor  research resources 2nd edition for 2021.pdf'],[0.607],[0.586],[0.663],[0.203],[0.218],[0.184],[0.738],[0.651],[0.65],[0.657],[0.816],[0.769],[0.673],[0.926],[0.855],[0.794],[0.831],[0.806],0.607,0.586,0.663,0.203,0.218,0.184,0.738,0.651,0.65,0.657,0.816,0.769,0.673,0.926,0.855,0.794,0.831,0.806
https://doi.org/10.1086/499685,elementary and middle school students perceptions of violenceprone school subcontexts,24985_elementary and middle school students perceptions of violenceprone school subcontexts.pdf,5,"['https://www.wallacefoundation.org/knowledge-center/Pages/preparing-for-effective-sel-implementation.aspx', 'https://www.dhs.gov/sites/default/files/publications/OPSR_TP_Integrating-Mental-Health-Education_Oct2015-508.pdf', 'https://www.rand.org/pubs/research_reports/RR1488.html', 'https://www.wallacefoundation.org/knowledge-center/Pages/navigating-social-and-emotional-learning-from-the-inside-out.aspx', 'https://www.wallacefoundation.org/knowledge-center/Pages/The-Future-of-Children-Social-and-Emotional-Learning.aspx']","['Preparing for Effective SEL Implementation', 'Lessons Learned from Mental Health and Education : Identifying Best Practices for Addressing Violent Extremism', 'The Role of Technology in Improving School Safety', 'Navigating Social and Emotional Learning from the Inside Out', 'The Future of Children: Social and Emotional Learning']",['https://www.dhs.gov/sites/default/files/publications/OPSR_TP_Integrating-Mental-Health-Education_Oct2015-508.pdf'],['24985_1_lessons learned from mental health and education  identifying best practices for addressing violent extremism.pdf'],1,20.0,['https://www.dhs.gov/sites/default/files/publications/OPSR_TP_Integrating-Mental-Health-Education_Oct2015-508.pdf'],['24985_1_lessons learned from mental health and education  identifying best practices for addressing violent extremism.pdf'],[0.295],[0.526],[0.615],[0.153],[0.172],[0.146],[0.729],[0.631],[0.585],[0.678],[0.791],[0.726],[0.631],[0.919],[0.83],[0.762],[0.802],[0.781],0.295,0.526,0.615,0.153,0.172,0.146,0.729,0.631,0.585,0.678,0.791,0.726,0.631,0.919,0.83,0.762,0.802,0.781
https://doi.org/10.1086/652199,juvenile offenders in the adult criminal justice system,25091_juvenile offenders in the adult criminal justice system.pdf,2,"['https://purl.fdlp.gov/GPO/gpo91294', 'https://adjc.az.gov/sites/default/files/media/National%20Prison%20Rape%20Elimination%20Commission%20Report.pdf']","['National Prison Rape Elimination Commission report.', 'National Prison Rape Elimination Commission Report']","['https://purl.fdlp.gov/GPO/gpo91294', 'https://adjc.az.gov/sites/default/files/media/National%20Prison%20Rape%20Elimination%20Commission%20Report.pdf']","['25091_0_national prison rape elimination commission report.pdf', '25091_1_national prison rape elimination commission report.pdf']",2,100.0,"['https://purl.fdlp.gov/GPO/gpo91294', 'https://adjc.az.gov/sites/default/files/media/National%20Prison%20Rape%20Elimination%20Commission%20Report.pdf']","['25091_0_national prison rape elimination commission report.pdf', '25091_1_national prison rape elimination commission report.pdf']","[0.313, 0.313]","[0.569, 0.569]","[0.653, 0.653]","[0.191, 0.191]","[0.208, 0.208]","[0.187, 0.187]","[0.727, 0.727]","[0.629, 0.629]","[0.646, 0.646]","[0.698, 0.698]","[0.826, 0.826]","[0.765, 0.765]","[0.66, 0.66]","[0.93, 0.93]","[0.862, 0.862]","[0.798, 0.798]","[0.834, 0.834]","[0.815, 0.815]",0.313,0.569,0.653,0.191,0.208,0.187,0.727,0.629,0.646,0.698,0.826,0.765,0.66,0.93,0.862,0.798,0.834,0.815
https://doi.org/10.1086/652218,after the epidemic recent trends in youth violence in the united states,25092_after the epidemic recent trends in youth violence in the united states.pdf,10,"['https://www.aclu.org/legal-document/defendants-prehearing-brief-ex-h-n', 'https://www.aclu.org/legal-document/cost-death-penalty-kansas-philip-j-cook-and-frank-r-baumgartner', 'https://www.nber.org/papers/w15380?sy=380', 'https://papers.nber.org/papers/w13781', 'https://www.nber.org/papers/w15877', 'https://www.nber.org/papers/w16513', 'http://purl.fdlp.gov/GPO/gpo69314', 'https://purl.fdlp.gov/GPO/gpo92684', 'https://stacks.cdc.gov/view/cdc/6911', 'https://www.rand.org/pubs/technical_reports/TR622.html']","[""Defendant's Prehearing Brief Ex. H-N"", 'Cost of the Death Penalty in Kansas — Philip J. Cook and Frank R. Baumgartner', 'The Effects of School Desegregation on Crime', 'Assessing Urban Crime And Its Control: An Overview', 'Public Safety through Private Action: An economic assessment of BIDs, locks, and citizen cooperation', 'Economical Crime Control', 'Managing the group violence intervention :\xa0using schooting scorecards to track group violence /', 'The police and public discourse on ""black-on-black"" violence /', 'Effects on violence of laws and policies facilitating the transfer of youth from the juvenile to the adult justice system; a report on recommendations of the Task Force on Community Preventive Services', 'Neighborhood Effects on Crime and Youth Violence: The Role of Business Improvement Districts in Los Angeles']","['http://purl.fdlp.gov/GPO/gpo69314', 'https://purl.fdlp.gov/GPO/gpo92684']","['25092_6_managing the group violence intervention \xa0using schooting scorecards to track group violence .pdf', '25092_7_the police and public discourse on blackonblack violence .pdf']",2,20.0,"['http://purl.fdlp.gov/GPO/gpo69314', 'https://purl.fdlp.gov/GPO/gpo92684']","['25092_6_managing the group violence intervention \xa0using schooting scorecards to track group violence .pdf', '25092_7_the police and public discourse on blackonblack violence .pdf']","[0.323, 0.504]","[0.549, 0.544]","[0.641, 0.631]","[0.199, 0.209]","[0.23, 0.244]","[0.192, 0.205]","[0.731, 0.734]","[0.633, 0.635]","[0.634, 0.627]","[0.72, 0.736]","[0.818, 0.815]","[0.764, 0.753]","[0.656, 0.649]","[0.924, 0.921]","[0.864, 0.86]","[0.785, 0.776]","[0.83, 0.825]","[0.81, 0.806]",0.413,0.546,0.636,0.204,0.237,0.199,0.732,0.634,0.631,0.728,0.817,0.758,0.653,0.923,0.862,0.78,0.827,0.808
https://doi.org/10.1086/701422,house prices local demand and retail prices,25207_house prices local demand and retail prices.pdf,5,"['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2020/0398.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2013.pdf', 'https://www.nber.org/papers/w27958', 'https://www.nber.org/papers/w28221', 'https://www.federalreserve.gov/econres/ifdp/files/ifdp1259.pdf']","['How Do Housing Markets Affect Local Consumer Prices? – Evidence from U.S. Cities', 'Villains or Scapegoats? The Role of Subprime Borrowers in Driving the U.S. Housing Boom', 'Bottom-up Markup Fluctuations', 'Issuance and Incidence: SNAP Benefit Cycles and Grocery Prices', 'Scarred Consumption']","['https://www.federalreserve.gov/econres/ifdp/files/ifdp1259.pdf', 'https://www.dallasfed.org/~/media/documents/research/international/wpapers/2020/0398.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2013.pdf']","['25207_4_scarred consumption.pdf', '25207_0_how do housing markets affect local consumer prices – evidence from us cities.pdf', '25207_1_villains or scapegoats the role of subprime borrowers in driving the us housing boom.pdf']",3,60.0,"['https://www.federalreserve.gov/econres/ifdp/files/ifdp1259.pdf', 'https://www.dallasfed.org/~/media/documents/research/international/wpapers/2020/0398.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2013.pdf']","['25207_4_scarred consumption.pdf', '25207_0_how do housing markets affect local consumer prices – evidence from us cities.pdf', '25207_1_villains or scapegoats the role of subprime borrowers in driving the us housing boom.pdf']","[0.539, 0.461, 0.163]","[0.551, 0.512, 0.567]","[0.638, 0.615, 0.652]","[0.158, 0.149, 0.184]","[0.169, 0.165, 0.197]","[0.15, 0.147, 0.172]","[0.725, 0.723, 0.728]","[0.627, 0.628, 0.634]","[0.622, 0.581, 0.631]","[0.726, 0.724, 0.717]","[0.802, 0.783, 0.812]","[0.724, 0.677, 0.739]","[0.654, 0.642, 0.671]","[0.913, 0.904, 0.915]","[0.848, 0.819, 0.846]","[0.773, 0.751, 0.786]","[0.813, 0.791, 0.817]","[0.796, 0.772, 0.801]",0.388,0.543,0.635,0.164,0.177,0.156,0.725,0.63,0.611,0.722,0.799,0.713,0.656,0.911,0.838,0.77,0.807,0.79
https://doi.org/10.1086/701424,tax cuts for whom heterogeneous effects of income tax changes on growth and employment,25208_tax cuts for whom heterogeneous effects of income tax changes on growth and employment.pdf,8,"['https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2001r1.pdf', 'https://www.philadelphiafed.org/the-economy/macroeconomics/the-economic-effects-of-changes-in-personal-income-tax-rates', 'https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2001.pdf', 'https://www.taxpolicycenter.org/publications/tackling-tax-code-evaluating-fairness-efficiency-and-potential-spur-inclusive-economic', 'https://equitablegrowth.org/working-papers/taxing-the-rich-how-incentives-and-embeddedness-shape-millionaire-tax-flight/', 'https://www.brookings.edu/multi-chapter-report/tackling-the-tax-code-efficient-and-equitable-ways-to-raise-revenue/', 'https://www.brookings.edu/research/the-economics-of-federal-tax-policy/', 'https://taxfoundation.org/reviewing-recent-evidence-effect-taxes-economic-growth/']","['Did the Tax Cuts and Jobs Act Create Jobs and Stimulate Growth?', 'The Economic Effects of Changes in Personal Income Tax Rates', 'Original paper', 'Tackling the Tax Code: Evaluating Fairness, Efficiency, and Potential to Spur Inclusive Economic Growth', 'Taxing the Rich: How Incentives and Embeddedness Shape Millionaire Tax Flight - Equitable Growth', 'Tackling the tax code: Efficient and equitable ways to raise revenue', 'The economics of federal tax policy', 'Reviewing the Impact of Taxes on Economic Growth']","['https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2001.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2001r1.pdf']","['25208_2_original paper.pdf', '25208_0_did the tax cuts and jobs act create jobs and stimulate growth.pdf']",2,25.0,"['https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2001.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2020/wp2001r1.pdf']","['25208_2_original paper.pdf', '25208_0_did the tax cuts and jobs act create jobs and stimulate growth.pdf']","[0.758, 0.742]","[0.561, 0.557]","[0.642, 0.638]","[0.21, 0.204]","[0.236, 0.233]","[0.211, 0.209]","[0.743, 0.743]","[0.651, 0.649]","[0.618, 0.614]","[0.767, 0.767]","[0.804, 0.802]","[0.729, 0.723]","[0.669, 0.666]","[0.923, 0.921]","[0.847, 0.84]","[0.775, 0.77]","[0.809, 0.805]","[0.796, 0.791]",0.75,0.559,0.64,0.207,0.234,0.21,0.743,0.65,0.616,0.767,0.803,0.726,0.667,0.922,0.843,0.772,0.807,0.794
https://doi.org/10.1086/705718,quantifying the lifecycle benefits of an influential earlychildhood program,25222_quantifying the lifecycle benefits of an influential earlychildhood program.pdf,8,"['https://bipartisanpolicy.org/report/building-bipartisan-support-for-child-care-toolkit-2021-update/', 'https://www.whitehouse.gov/wp-content/uploads/2021/05/AJP-AFP-Narrative-2021-05-11-1930-.pdf', 'https://www.nber.org/papers/w29057', 'https://www.whitehouse.gov/cea/written-materials/2021/05/11/building-back-better-the-american-jobs-plan-and-the-american-families-plan/', 'https://www.clasp.org/publications/report/brief/child-care-assistance-spending-and-participation-in-2019/', 'https://www.nber.org/papers/w29004', 'https://www.frbsf.org/economic-research/publications/economic-letter/2021/october/from-gaps-to-growth-equity-as-path-to-prosperity/', 'https://www.nber.org/papers/w28756']","['Building Bipartisan Support for Child Care Toolkit: 2021 Update', 'Building Back Better: The American Jobs Plan and the American Families Plan', 'The Lasting Effects of Early Childhood Education on Promoting the Skills and Social Mobility of Disadvantaged African Americans', 'Building Back Better: The American Jobs Plan and the American Families Plan', 'Child Care Assistance Spending and Participation in 2019', 'The Dynastic Benefits of Early Childhood Education', 'From Gaps to Growth: Equity as a Path to Prosperity', 'The Long-Term Effects of Universal Preschool in Boston']",['https://www.whitehouse.gov/wp-content/uploads/2021/05/AJP-AFP-Narrative-2021-05-11-1930-.pdf'],['25222_1_building back better the american jobs plan and the american families plan.pdf'],1,12.5,['https://www.whitehouse.gov/wp-content/uploads/2021/05/AJP-AFP-Narrative-2021-05-11-1930-.pdf'],['25222_1_building back better the american jobs plan and the american families plan.pdf'],[0.152],[0.498],[0.618],[0.095],[0.113],[0.095],[0.695],[0.593],[0.595],[0.677],[0.801],[0.73],[0.618],[0.908],[0.842],[0.765],[0.808],[0.785],0.152,0.498,0.618,0.095,0.113,0.095,0.695,0.593,0.595,0.677,0.801,0.73,0.618,0.908,0.842,0.765,0.808,0.785
https://doi.org/10.1088/1748-9326/7/4/044035,comparing climate projections to observations up to 2011,25260_comparing climate projections to observations up to 2011.pdf,5,"['http://eng2.lacity.org/techdocs/emg/docs/vpp/Appendix%20H%20(Part%202).pdf', 'http://purl.fdlp.gov/GPO/gpo68967', 'https://ww2.arb.ca.gov/sites/default/files/2020-06/state_of_ca_comments_reconsider_ldghg_mte_ac_0.pdf', 'https://climateandsecurity.org/cnsareport1/', 'https://www.wri.org/publication/clearing-air']","['Appendix G Grand Canal Conceptual Plan-hydrology Plan', 'Climate change impacts in the United States :\xa0U.S. national climate assessment /', 'Requests for comment on reconsideration of the final determination of the mid-term evaluation of GHG emissions for model year 2022-2025 LDV', 'Working Group on Climate, Nuclear, and Security Affairs: Report One', 'Clearing the Air']","['http://eng2.lacity.org/techdocs/emg/docs/vpp/Appendix%20H%20(Part%202).pdf', 'http://purl.fdlp.gov/GPO/gpo68967', 'https://ww2.arb.ca.gov/sites/default/files/2020-06/state_of_ca_comments_reconsider_ldghg_mte_ac_0.pdf']","['25260_0_appendix g grand canal conceptual planhydrology plan.pdf', '25260_1_climate change impacts in the united states \xa0us national climate assessment .pdf', '25260_2_requests for comment on reconsideration of the final determination of the midterm evaluation of ghg emissions for model year 20222025 ldv.pdf']",3,60.0,"['http://eng2.lacity.org/techdocs/emg/docs/vpp/Appendix%20H%20(Part%202).pdf', 'http://purl.fdlp.gov/GPO/gpo68967', 'https://ww2.arb.ca.gov/sites/default/files/2020-06/state_of_ca_comments_reconsider_ldghg_mte_ac_0.pdf']","['25260_0_appendix g grand canal conceptual planhydrology plan.pdf', '25260_1_climate change impacts in the united states \xa0us national climate assessment .pdf', '25260_2_requests for comment on reconsideration of the final determination of the midterm evaluation of ghg emissions for model year 20222025 ldv.pdf']","[0.335, 0.369, 0.147]","[0.56, 0.56, 0.537]","[0.641, 0.651, 0.624]","[0.168, 0.202, 0.152]","[0.164, 0.187, 0.131]","[0.134, 0.152, 0.122]","[0.732, 0.736, 0.723]","[0.64, 0.647, 0.629]","[0.635, 0.638, 0.614]","[0.692, 0.716, 0.691]","[0.814, 0.82, 0.812]","[0.758, 0.757, 0.737]","[0.676, 0.673, 0.672]","[0.923, 0.923, 0.908]","[0.854, 0.852, 0.847]","[0.787, 0.785, 0.774]","[0.824, 0.827, 0.818]","[0.806, 0.809, 0.8]",0.284,0.552,0.639,0.174,0.161,0.136,0.73,0.639,0.629,0.7,0.815,0.751,0.674,0.918,0.851,0.782,0.823,0.805
https://doi.org/10.1089/apc.2019.0021,champ thailand pilot randomized control trial of a familybased psychosocial intervention for perinatally hivinfected early adolescents,25337_champ thailand pilot randomized control trial of a familybased psychosocial intervention for perinatally hivinfected early adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['25337_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['25337_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.394],[0.498],[0.594],[0.149],[0.149],[0.131],[0.734],[0.638],[0.56],[0.681],[0.754],[0.704],[0.576],[0.869],[0.78],[0.65],[0.758],[0.679],0.394,0.498,0.594,0.149,0.149,0.131,0.734,0.638,0.56,0.681,0.754,0.704,0.576,0.869,0.78,0.65,0.758,0.679
https://doi.org/10.1089/bfm.2019.0210,growth body composition and neurodevelopmental outcomes at 2 years among preterm infants fed an exclusive human milk diet in the neonatal intensive care unit a pilot study,25383_growth body composition and neurodevelopmental outcomes at 2 years among preterm infants fed an exclusive human milk diet in the neonatal intensive care unit a pilot study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146348/pdf'],['Update on Calcium and Phosphorus Requirements of Preterm Infants and Recommendations for Enteral Mineral Intake'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146348/pdf'],['25383_0_update on calcium and phosphorus requirements of preterm infants and recommendations for enteral mineral intake.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146348/pdf'],['25383_0_update on calcium and phosphorus requirements of preterm infants and recommendations for enteral mineral intake.pdf'],[0.522],[0.489],[0.581],[0.151],[0.155],[0.138],[0.737],[0.647],[0.559],[0.673],[0.774],[0.664],[0.607],[0.913],[0.796],[0.734],[0.77],[0.759],0.522,0.489,0.581,0.151,0.155,0.138,0.737,0.647,0.559,0.673,0.774,0.664,0.607,0.913,0.796,0.734,0.77,0.759
https://doi.org/10.1089/cap.2020.0050,severe psychotic symptoms in youth with panspandas caseseries,25497_severe psychotic symptoms in youth with panspandas caseseries.pdf,2,"['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2021/pansac-report-sept-2021.pdf']","['IL PANDAS-PANS Advisory Council Report - 2020', '2021 PANSAC Legislative Report']","['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2021/pansac-report-sept-2021.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf']","['25497_1_2021 pansac legislative report.pdf', '25497_0_il pandaspans advisory council report  2020.pdf']",2,100.0,"['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2021/pansac-report-sept-2021.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf']","['25497_1_2021 pansac legislative report.pdf', '25497_0_il pandaspans advisory council report  2020.pdf']","[0.334, 0.463]","[0.542, 0.532]","[0.631, 0.619]","[0.159, 0.157]","[0.165, 0.16]","[0.131, 0.129]","[0.734, 0.732]","[0.635, 0.639]","[0.624, 0.608]","[0.646, 0.65]","[0.805, 0.804]","[0.741, 0.725]","[0.622, 0.615]","[0.921, 0.913]","[0.838, 0.837]","[0.78, 0.76]","[0.816, 0.808]","[0.799, 0.79]",0.399,0.537,0.625,0.158,0.163,0.13,0.733,0.637,0.616,0.648,0.804,0.733,0.619,0.917,0.837,0.77,0.812,0.794
https://doi.org/10.1089/chi.2018.0010,impact of the coordinated approach to child health early childhood program for obesity prevention among preschool children the texas childhood obesity research demonstration study,25529_impact of the coordinated approach to child health early childhood program for obesity prevention among preschool children the texas childhood obesity research demonstration study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf', 'https://www.gao.gov/products/GAO-20-30']","['Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services', 'Childhood Obesity Research Demonstration: Efforts to Identify Effective Strategies for Low-Income Children']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf'],['25529_0_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf'],['25529_0_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf'],[0.437],[0.508],[0.593],[0.165],[0.173],[0.143],[0.73],[0.634],[0.572],[0.705],[0.758],[0.694],[0.592],[0.893],[0.799],[0.691],[0.769],[0.718],0.437,0.508,0.593,0.165,0.173,0.143,0.73,0.634,0.572,0.705,0.758,0.694,0.592,0.893,0.799,0.691,0.769,0.718
https://doi.org/10.1089/chi.2019.0064,competencybased approaches to community health a randomized controlled trial to reduce childhood obesity among latino preschoolaged children,25532_competencybased approaches to community health a randomized controlled trial to reduce childhood obesity among latino preschoolaged children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['25532_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['25532_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.572],[0.514],[0.598],[0.166],[0.174],[0.145],[0.731],[0.633],[0.582],[0.7],[0.769],[0.695],[0.591],[0.906],[0.807],[0.71],[0.774],[0.741],0.572,0.514,0.598,0.166,0.174,0.145,0.731,0.633,0.582,0.7,0.769,0.695,0.591,0.906,0.807,0.71,0.774,0.741
https://doi.org/10.1089/dia.2010.0021,continuous glucose monitoring in youth with type 1 diabetes 12month followup of the juvenile diabetes research foundation continuous glucose monitoring randomized trial,25547_continuous glucose monitoring in youth with type 1 diabetes 12month followup of the juvenile diabetes research foundation continuous glucose monitoring randomized trial.pdf,6,"['https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-final-rpt-20171221.pdf', 'https://www.hca.wa.gov/assets/program/glucose_comments_responses%5B1%5D.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105320/pdf', 'https://www.hca.wa.gov/assets/program/glucose_monitoring_final%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/cgm-draft-key-qs-comment-response-20170918.pdf', 'https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-drft-rpt-comment-response-20171220.pdf']","['Continuous glucose monitoring – update Final evidence report', 'Peer Reviews, Public Comments & Responses', 'Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association', 'Glucose Monitoring:', 'Glucose monitoring – re-review', 'Continuous glucose monitoring: re-review']","['https://www.hca.wa.gov/assets/program/cgm-draft-key-qs-comment-response-20170918.pdf', 'https://www.hca.wa.gov/assets/program/glucose_monitoring_final%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-drft-rpt-comment-response-20171220.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105320/pdf', 'https://www.hca.wa.gov/assets/program/glucose_comments_responses%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-final-rpt-20171221.pdf']","['25547_4_glucose monitoring – rereview.pdf', '25547_3_glucose monitoring.pdf', '25547_5_continuous glucose monitoring rereview.pdf', '25547_2_type 1 diabetes in children and adolescents a position statement by the american diabetes association.pdf', '25547_1_peer reviews public comments  responses.pdf', '25547_0_continuous glucose monitoring – update final evidence report.pdf']",6,100.0,"['https://www.hca.wa.gov/assets/program/cgm-draft-key-qs-comment-response-20170918.pdf', 'https://www.hca.wa.gov/assets/program/glucose_monitoring_final%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-drft-rpt-comment-response-20171220.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105320/pdf', 'https://www.hca.wa.gov/assets/program/glucose_comments_responses%5B1%5D.pdf', 'https://www.hca.wa.gov/assets/program/continuous-glucose-monitoring-final-rpt-20171221.pdf']","['25547_4_glucose monitoring – rereview.pdf', '25547_3_glucose monitoring.pdf', '25547_5_continuous glucose monitoring rereview.pdf', '25547_2_type 1 diabetes in children and adolescents a position statement by the american diabetes association.pdf', '25547_1_peer reviews public comments  responses.pdf', '25547_0_continuous glucose monitoring – update final evidence report.pdf']","[0.52, 0.453, 0.406, 0.515, 0.576, 0.589]","[0.494, 0.511, 0.502, 0.5, 0.497, 0.498]","[0.59, 0.602, 0.595, 0.592, 0.595, 0.589]","[0.17, 0.175, 0.167, 0.17, 0.157, 0.168]","[0.174, 0.177, 0.169, 0.175, 0.163, 0.165]","[0.144, 0.145, 0.139, 0.143, 0.134, 0.14]","[0.74, 0.736, 0.737, 0.742, 0.73, 0.739]","[0.647, 0.638, 0.642, 0.642, 0.631, 0.644]","[0.563, 0.581, 0.574, 0.577, 0.575, 0.56]","[0.708, 0.702, 0.705, 0.679, 0.686, 0.717]","[0.775, 0.782, 0.778, 0.79, 0.781, 0.767]","[0.686, 0.707, 0.7, 0.704, 0.707, 0.689]","[0.613, 0.627, 0.618, 0.607, 0.62, 0.61]","[0.914, 0.921, 0.921, 0.924, 0.919, 0.906]","[0.81, 0.831, 0.827, 0.827, 0.83, 0.803]","[0.737, 0.757, 0.75, 0.754, 0.755, 0.726]","[0.777, 0.792, 0.787, 0.792, 0.791, 0.773]","[0.757, 0.775, 0.769, 0.777, 0.772, 0.744]",0.51,0.5,0.594,0.168,0.171,0.141,0.737,0.641,0.572,0.699,0.779,0.699,0.616,0.917,0.821,0.746,0.785,0.766
https://doi.org/10.1089/jayao.2020.0012,standardizing risk assessment for treatmentrelated gonadal insufficiency and infertility in childhood adolescent and young adult cancer the pediatric initiative network risk stratification system,25595_standardizing risk assessment for treatmentrelated gonadal insufficiency and infertility in childhood adolescent and young adult cancer the pediatric initiative network risk stratification system.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919337/pdf'],"['Young Adult Cancer Survivorship: Recommendations for Patient Follow-up, Exercise Therapy, and Research']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919337/pdf'],['25595_0_young adult cancer survivorship recommendations for patient followup exercise therapy and research.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919337/pdf'],['25595_0_young adult cancer survivorship recommendations for patient followup exercise therapy and research.pdf'],[0.555],[0.535],[0.629],[0.159],[0.166],[0.135],[0.744],[0.655],[0.609],[0.66],[0.8],[0.728],[0.607],[0.914],[0.827],[0.755],[0.799],[0.781],0.555,0.535,0.629,0.159,0.166,0.135,0.744,0.655,0.609,0.66,0.8,0.728,0.607,0.914,0.827,0.755,0.799,0.781
https://doi.org/10.1089/thy.2019.0436,the relationship between perfluoroalkyl substances concentrations and thyroid function in early childhood a prospective cohort study,25669_the relationship between perfluoroalkyl substances concentrations and thyroid function in early childhood a prospective cohort study.pdf,1,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft'],['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['25669_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],1,100.0,['https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf'],['25669_0_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf'],[0.35],[0.5],[0.596],[0.156],[0.15],[0.12],[0.739],[0.645],[0.59],[0.692],[0.793],[0.691],[0.585],[0.915],[0.824],[0.767],[0.793],[0.783],0.35,0.5,0.596,0.156,0.15,0.12,0.739,0.645,0.59,0.692,0.793,0.691,0.585,0.915,0.824,0.767,0.793,0.783
https://doi.org/10.1093/advances/nmy101,perspective what does stunting really mean a critical review of the evidence,25727_perspective what does stunting really mean a critical review of the evidence.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf', 'https://www.nber.org/papers/w28443', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/135925', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133335', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133420', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133954', 'http://ebrary.ifpri.org/cdm/singleitem/collection/p15738coll2/id/133335/rec/19']","['Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age', 'Are Behavioral Change Interventions Needed to Make Cash Transfer Programs Work for Children? Experimental Evidence from Myanmar', 'Rwanda’s food systems transformation: A diagnostic of the public policy landscape shaping the transformation process', 'Nutrient and mycotoxin content of commercially-sold premixed infant cereals in Malawi', 'Food transfers, cash transfers, behavior change communication and child nutrition: Evidence from Bangladesh', 'Measuring the impact of agriculture programs on diets and nutrition', 'Nutrient and mycotoxin content of commercially-sold premixed infant cereals in Malawi']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['25727_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],1,14.29,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['25727_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],[0.291],[0.539],[0.627],[0.167],[0.156],[0.123],[0.724],[0.623],[0.606],[0.681],[0.789],[0.721],[0.61],[0.924],[0.847],[0.757],[0.798],[0.778],0.291,0.539,0.627,0.167,0.156,0.123,0.724,0.623,0.606,0.681,0.789,0.721,0.61,0.924,0.847,0.757,0.798,0.778
https://doi.org/10.1093/ajcn/72.4.1018,tracking of body mass index from childhood to adolescence a 6y followup study in china,25765_tracking of body mass index from childhood to adolescence a 6y followup study in china.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513603/pdf', 'https://www.nber.org/papers/w15864']","['Effects of total fat intake on bodyweight in children', 'Effects of total fat intake on bodyweight in children', 'Estimation of a Dynamic Model of Weight']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513603/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491333/pdf']","['25765_1_effects of total fat intake on bodyweight in children.pdf', '25765_0_effects of total fat intake on bodyweight in children.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513603/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491333/pdf']","['25765_1_effects of total fat intake on bodyweight in children.pdf', '25765_0_effects of total fat intake on bodyweight in children.pdf']","[0.424, 0.424]","[0.511, 0.508]","[0.588, 0.584]","[0.168, 0.172]","[0.175, 0.178]","[0.15, 0.152]","[0.735, 0.736]","[0.632, 0.635]","[0.566, 0.566]","[0.715, 0.716]","[0.769, 0.771]","[0.696, 0.704]","[0.616, 0.62]","[0.908, 0.905]","[0.808, 0.804]","[0.729, 0.73]","[0.774, 0.775]","[0.759, 0.759]",0.424,0.51,0.586,0.17,0.176,0.151,0.736,0.633,0.566,0.716,0.77,0.7,0.618,0.907,0.806,0.73,0.774,0.759
https://doi.org/10.1093/ajcn/74.6.808,postpartum thiamine deficiency in a karen displaced population,25773_postpartum thiamine deficiency in a karen displaced population.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586122/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783742/pdf']","['Evaluation of a treatment protocol for anaemia in pregnancy nested in routine antenatal care in a limited-resource setting', 'Supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783742/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586122/pdf']","['25773_1_supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.pdf', '25773_0_evaluation of a treatment protocol for anaemia in pregnancy nested in routine antenatal care in a limitedresource setting.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783742/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586122/pdf']","['25773_1_supplementation with multiple micronutrients for breastfeeding women for improving outcomes for the mother and baby.pdf', '25773_0_evaluation of a treatment protocol for anaemia in pregnancy nested in routine antenatal care in a limitedresource setting.pdf']","[0.352, 0.358]","[0.548, 0.54]","[0.633, 0.614]","[0.181, 0.166]","[0.199, 0.178]","[0.153, 0.139]","[0.731, 0.733]","[0.636, 0.637]","[0.626, 0.606]","[0.663, 0.644]","[0.799, 0.792]","[0.734, 0.729]","[0.622, 0.632]","[0.915, 0.913]","[0.836, 0.824]","[0.77, 0.767]","[0.806, 0.803]","[0.792, 0.785]",0.355,0.544,0.623,0.173,0.189,0.146,0.732,0.637,0.616,0.653,0.796,0.732,0.627,0.914,0.83,0.768,0.804,0.788
https://doi.org/10.1093/ajcn/75.6.1062,effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children a metaanalysis of randomized controlled trials,25777_effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children a metaanalysis of randomized controlled trials.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092450/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/133010', 'http://www.ifpri.org/publication/measuring-childcare-practices', 'http://www.ifpri.org/publication/micronutrient-malnutrition-obesity-and-chronic-disease-countries-undergoing-nutrition', 'https://www.nber.org/papers/w21849?sy=849', 'http://www.ifpri.org/publication/analyzing-health-benefits-biofortified-staple-crops-means-disability-adjusted-life-years']","['Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates', 'Invisible heterogeneity in crop zinc concentration and child zinc intake in rural Uganda', 'Measuring childcare practices', 'Micronutrient malnutrition, obesity, and chronic disease in countries', 'Expanding Governance as Development: Evidence on Child Nutrition in the Philippines', 'Analyzing the health benefits of biofortified staple crops by means']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092450/pdf'],['25777_0_enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.pdf'],1,16.67,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092450/pdf'],['25777_0_enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.pdf'],[0.54],[0.535],[0.619],[0.196],[0.203],[0.17],[0.734],[0.645],[0.598],[0.724],[0.785],[0.718],[0.607],[0.913],[0.821],[0.74],[0.782],[0.764],0.54,0.535,0.619,0.196,0.203,0.17,0.734,0.645,0.598,0.724,0.785,0.718,0.607,0.913,0.821,0.74,0.782,0.764
https://doi.org/10.1093/ajcn/78.5.993,calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche,25791_calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865374/pdf'],['Calcium supplementation for improving bone mineral density in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865374/pdf'],['25791_0_calcium supplementation for improving bone mineral density in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865374/pdf'],['25791_0_calcium supplementation for improving bone mineral density in children.pdf'],[0.434],[0.492],[0.588],[0.175],[0.157],[0.138],[0.738],[0.641],[0.558],[0.684],[0.769],[0.666],[0.587],[0.91],[0.808],[0.723],[0.766],[0.754],0.434,0.492,0.588,0.175,0.157,0.138,0.738,0.641,0.558,0.684,0.769,0.666,0.587,0.91,0.808,0.723,0.766,0.754
https://doi.org/10.1093/ajcn/79.3.466,relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western kenya,25796_relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western kenya.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf']","['Malaria chemoprophylaxis in sickle cell disease', 'Oral iron supplements for children in malaria‐endemic areas', 'Intermittent preventive antimalarial treatment for children with anaemia']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf']","['25796_0_malaria chemoprophylaxis in sickle cell disease.pdf', '25796_1_oral iron supplements for children in malaria‐endemic areas.pdf', '25796_2_intermittent preventive antimalarial treatment for children with anaemia.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532723/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf']","['25796_0_malaria chemoprophylaxis in sickle cell disease.pdf', '25796_1_oral iron supplements for children in malaria‐endemic areas.pdf', '25796_2_intermittent preventive antimalarial treatment for children with anaemia.pdf']","[0.226, 0.545, 0.451]","[0.516, 0.516, 0.524]","[0.602, 0.595, 0.599]","[0.154, 0.172, 0.176]","[0.163, 0.175, 0.178]","[0.125, 0.139, 0.136]","[0.734, 0.737, 0.738]","[0.637, 0.641, 0.644]","[0.588, 0.58, 0.586]","[0.667, 0.691, 0.681]","[0.783, 0.779, 0.789]","[0.702, 0.689, 0.699]","[0.604, 0.597, 0.603]","[0.917, 0.916, 0.915]","[0.812, 0.804, 0.801]","[0.741, 0.738, 0.747]","[0.783, 0.779, 0.784]","[0.766, 0.761, 0.765]",0.407,0.519,0.599,0.167,0.172,0.133,0.736,0.641,0.585,0.68,0.784,0.697,0.601,0.916,0.806,0.742,0.782,0.764
https://doi.org/10.1093/ajcn/79.6.1095,diet and blood pressure in 25yold danish children,25799_diet and blood pressure in 25yold danish children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759098/pdf']","['Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood', 'Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf']","['25799_1_supplementation with long chain polyunsaturated fatty acids lcpufa to breastfeeding mothers for improving child growth and development.pdf', '25799_0_maternal prenatal andor postnatal n‐3 long chain polyunsaturated fatty acids lcpufa supplementation for preventing allergies in early childhood.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759098/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783748/pdf']","['25799_1_supplementation with long chain polyunsaturated fatty acids lcpufa to breastfeeding mothers for improving child growth and development.pdf', '25799_0_maternal prenatal andor postnatal n‐3 long chain polyunsaturated fatty acids lcpufa supplementation for preventing allergies in early childhood.pdf']","[0.23, 0.299]","[0.532, 0.523]","[0.618, 0.608]","[0.167, 0.161]","[0.169, 0.156]","[0.126, 0.119]","[0.728, 0.733]","[0.629, 0.632]","[0.598, 0.587]","[0.66, 0.65]","[0.785, 0.781]","[0.706, 0.693]","[0.602, 0.599]","[0.911, 0.908]","[0.818, 0.811]","[0.741, 0.737]","[0.788, 0.782]","[0.762, 0.757]",0.265,0.528,0.613,0.164,0.163,0.122,0.73,0.631,0.593,0.655,0.783,0.7,0.601,0.909,0.815,0.739,0.785,0.76
https://doi.org/10.1093/ajcn/80.6.1595,bone mineralization and growth are enhanced in preterm infants fed an isocaloric nutrientenriched preterm formula through term,25805_bone mineralization and growth are enhanced in preterm infants fed an isocaloric nutrientenriched preterm formula through term.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463855/pdf'],['Nutrient‐enriched formula versus standard formula for preterm infants following hospital discharge'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463855/pdf'],['25805_0_nutrient‐enriched formula versus standard formula for preterm infants following hospital discharge.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463855/pdf'],['25805_0_nutrient‐enriched formula versus standard formula for preterm infants following hospital discharge.pdf'],[0.608],[0.533],[0.618],[0.193],[0.188],[0.155],[0.742],[0.65],[0.6],[0.679],[0.779],[0.693],[0.592],[0.92],[0.819],[0.744],[0.784],[0.769],0.608,0.533,0.618,0.193,0.188,0.155,0.742,0.65,0.6,0.679,0.779,0.693,0.592,0.92,0.819,0.744,0.784,0.769
https://doi.org/10.1093/ajcn/82.5.1004,the relation of sugar intake to β cell function in overweight latino children,25819_the relation of sugar intake to β cell function in overweight latino children.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'https://stacks.cdc.gov/view/cdc/44039', 'http://purl.fdlp.gov/GPO/gpo80463']","['Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews', 'Sugar-sweetened beverage consumption among U.S. youth, 2011-2014', 'Sugar-sweetened beverage consumption among U.S. youth, 2011-2014 /']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'http://purl.fdlp.gov/GPO/gpo80463']","['25819_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '25819_2_sugarsweetened beverage consumption among us youth 20112014 .pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388385/pdf', 'http://purl.fdlp.gov/GPO/gpo80463']","['25819_0_interventions to prevent women from developing gestational diabetes mellitus an overview of cochrane reviews.pdf', '25819_2_sugarsweetened beverage consumption among us youth 20112014 .pdf']","[0.189, 0.223]","[0.51, 0.516]","[0.604, 0.61]","[0.155, 0.186]","[0.152, 0.2]","[0.122, 0.171]","[0.731, 0.739]","[0.629, 0.636]","[0.587, 0.604]","[0.667, 0.69]","[0.778, 0.79]","[0.705, 0.733]","[0.599, 0.607]","[0.917, 0.924]","[0.808, 0.831]","[0.737, 0.759]","[0.78, 0.795]","[0.758, 0.78]",0.206,0.513,0.607,0.17,0.176,0.147,0.735,0.633,0.595,0.678,0.784,0.719,0.603,0.921,0.82,0.748,0.788,0.769
https://doi.org/10.1093/ajcn/85.1.144,evaluation of formulas for calculating total energy requirements of preadolescent children with cystic fibrosis,25827_evaluation of formulas for calculating total energy requirements of preadolescent children with cystic fibrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542104/pdf'],['Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542104/pdf'],['25827_0_academy of nutrition and dietetics 2020 cystic fibrosis evidence analysis center evidencebased nutrition practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542104/pdf'],['25827_0_academy of nutrition and dietetics 2020 cystic fibrosis evidence analysis center evidencebased nutrition practice guideline.pdf'],[0.292],[0.523],[0.619],[0.18],[0.194],[0.141],[0.737],[0.644],[0.614],[0.684],[0.797],[0.722],[0.601],[0.916],[0.839],[0.757],[0.799],[0.786],0.292,0.523,0.619,0.18,0.194,0.141,0.737,0.644,0.614,0.684,0.797,0.722,0.601,0.916,0.839,0.757,0.799,0.786
https://doi.org/10.1093/ajcn/85.3.887,zinc during and in convalescence from diarrhea has no demonstrable effect on subsequent morbidity and anthropometric status among infants 6 mo of age,25831_zinc during and in convalescence from diarrhea has no demonstrable effect on subsequent morbidity and anthropometric status among infants 6 mo of age.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140593/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392835/pdf']","['Oral zinc for treating diarrhoea in children', 'Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age', 'Zinc supplements for preventing otitis media']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140593/pdf']","['25831_2_zinc supplements for preventing otitis media.pdf', '25831_0_oral zinc for treating diarrhoea in children.pdf', '25831_1_zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140593/pdf']","['25831_2_zinc supplements for preventing otitis media.pdf', '25831_0_oral zinc for treating diarrhoea in children.pdf', '25831_1_zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.pdf']","[0.395, 0.517, 0.421]","[0.541, 0.513, 0.521]","[0.632, 0.605, 0.608]","[0.194, 0.177, 0.18]","[0.205, 0.186, 0.188]","[0.163, 0.151, 0.155]","[0.733, 0.732, 0.73]","[0.642, 0.64, 0.637]","[0.614, 0.575, 0.587]","[0.694, 0.699, 0.695]","[0.799, 0.779, 0.783]","[0.725, 0.688, 0.702]","[0.605, 0.582, 0.596]","[0.927, 0.917, 0.911]","[0.832, 0.812, 0.813]","[0.757, 0.731, 0.734]","[0.797, 0.775, 0.782]","[0.781, 0.754, 0.755]",0.444,0.525,0.615,0.184,0.193,0.156,0.732,0.64,0.592,0.696,0.787,0.705,0.594,0.918,0.819,0.741,0.785,0.763
https://doi.org/10.1093/ajcn/86.6.1806,maternal diet and infant size 2 y after the completion of a study of a lowglycemicindex diet in pregnancy,25837_maternal diet and infant size 2 y after the completion of a study of a lowglycemicindex diet in pregnancy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163963/pdf'],['Interventions for preventing excessive weight gain during pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163963/pdf'],['25837_0_interventions for preventing excessive weight gain during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163963/pdf'],['25837_0_interventions for preventing excessive weight gain during pregnancy.pdf'],[0.265],[0.537],[0.613],[0.207],[0.223],[0.177],[0.733],[0.641],[0.604],[0.692],[0.779],[0.727],[0.572],[0.913],[0.822],[0.735],[0.787],[0.758],0.265,0.537,0.613,0.207,0.223,0.177,0.733,0.641,0.604,0.692,0.779,0.727,0.572,0.913,0.822,0.735,0.787,0.758
https://doi.org/10.1093/ajcn/nqy383,portion size has sustained effects over 5 days in preschool children a randomized trial,25857_portion size has sustained effects over 5 days in preschool children a randomized trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['25857_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '25857_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['25857_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '25857_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.341, 0.336]","[0.546, 0.548]","[0.632, 0.635]","[0.195, 0.196]","[0.211, 0.211]","[0.172, 0.172]","[0.734, 0.734]","[0.635, 0.636]","[0.615, 0.618]","[0.702, 0.703]","[0.791, 0.792]","[0.719, 0.724]","[0.615, 0.616]","[0.925, 0.926]","[0.836, 0.84]","[0.752, 0.753]","[0.794, 0.796]","[0.779, 0.78]",0.339,0.547,0.633,0.196,0.211,0.172,0.734,0.635,0.617,0.702,0.792,0.722,0.615,0.925,0.838,0.752,0.795,0.78
https://doi.org/10.1093/aje/kwz118,maternal obesity birth size and risk of childhood cancer development,25975_maternal obesity birth size and risk of childhood cancer development.pdf,1,['https://www.health.pa.gov/topics/Documents/Environmental%20Health/Ewings%20Tumors%20SW%204%20Counties.pdf'],"[""Ewing's Sarcoma Report""]",['https://www.health.pa.gov/topics/Documents/Environmental%20Health/Ewings%20Tumors%20SW%204%20Counties.pdf'],['25975_0_ewings sarcoma report.pdf'],1,100.0,['https://www.health.pa.gov/topics/Documents/Environmental%20Health/Ewings%20Tumors%20SW%204%20Counties.pdf'],['25975_0_ewings sarcoma report.pdf'],[0.42],[0.528],[0.617],[0.186],[0.198],[0.168],[0.738],[0.644],[0.59],[0.715],[0.773],[0.716],[0.623],[0.91],[0.816],[0.746],[0.774],[0.763],0.42,0.528,0.617,0.186,0.198,0.168,0.738,0.644,0.59,0.715,0.773,0.716,0.623,0.91,0.816,0.746,0.774,0.763
https://doi.org/10.1093/ajhp/57.8.756,refill program using pharmacy student interns in a primary care clinic,25979_refill program using pharmacy student interns in a primary care clinic.pdf,1,['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['Texas Healthcare Transformation and Quality Improvement Program'],['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['25979_0_texas healthcare transformation and quality improvement program.pdf'],1,100.0,['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['25979_0_texas healthcare transformation and quality improvement program.pdf'],[0.364],[0.56],[0.636],[0.177],[0.197],[0.158],[0.737],[0.641],[0.627],[0.666],[0.813],[0.743],[0.655],[0.926],[0.847],[0.784],[0.82],[0.797],0.364,0.56,0.636,0.177,0.197,0.158,0.737,0.641,0.627,0.666,0.813,0.743,0.655,0.926,0.847,0.784,0.82,0.797
https://doi.org/10.1093/ajhp/59.23.2356,analysis of medication management activities for homedwelling patients,25980_analysis of medication management activities for homedwelling patients.pdf,1,['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['Texas Healthcare Transformation and Quality Improvement Program'],['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['25980_0_texas healthcare transformation and quality improvement program.pdf'],1,100.0,['https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP3Plan.pdf'],['25980_0_texas healthcare transformation and quality improvement program.pdf'],[0.376],[0.559],[0.632],[0.179],[0.188],[0.152],[0.734],[0.637],[0.622],[0.673],[0.805],[0.734],[0.647],[0.921],[0.838],[0.773],[0.816],[0.787],0.376,0.559,0.632,0.179,0.188,0.152,0.734,0.637,0.622,0.673,0.805,0.734,0.647,0.921,0.838,0.773,0.816,0.787
https://doi.org/10.1093/alcalc/ags083,adolescent drinking patterns across countries associations with alcohol policies,25996_adolescent drinking patterns across countries associations with alcohol policies.pdf,2,"['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/StAlcRegSafety/A-New-Scale-of-the-US-Alcohol-Policy-Environment-and-Its-Relationship-to-Binge-Drinking.pdf', 'http://dls.maryland.gov/pubs/prod/BusTech/Task_Force_to_Study_State_Alcohol_Regulation_Enforcement_Safety_and_Public_Health_Report.pdf']","['A New Scale of the U.S. Alcohol Policy Environment and Its Relationship to Binge Drinking', 'Task Force to Study State Alcohol Regulation, Enforcement, Safety, and Public Health Report']","['http://dls.maryland.gov/pubs/prod/BusTech/Task_Force_to_Study_State_Alcohol_Regulation_Enforcement_Safety_and_Public_Health_Report.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/StAlcRegSafety/A-New-Scale-of-the-US-Alcohol-Policy-Environment-and-Its-Relationship-to-Binge-Drinking.pdf']","['25996_1_task force to study state alcohol regulation enforcement safety and public health report.pdf', '25996_0_a new scale of the us alcohol policy environment and its relationship to binge drinking.pdf']",2,100.0,"['http://dls.maryland.gov/pubs/prod/BusTech/Task_Force_to_Study_State_Alcohol_Regulation_Enforcement_Safety_and_Public_Health_Report.pdf', 'http://dls.maryland.gov/pubs/prod/NoPblTabMtg/StAlcRegSafety/A-New-Scale-of-the-US-Alcohol-Policy-Environment-and-Its-Relationship-to-Binge-Drinking.pdf']","['25996_1_task force to study state alcohol regulation enforcement safety and public health report.pdf', '25996_0_a new scale of the us alcohol policy environment and its relationship to binge drinking.pdf']","[0.545, 0.394]","[0.557, 0.563]","[0.636, 0.645]","[0.173, 0.223]","[0.196, 0.26]","[0.161, 0.208]","[0.722, 0.74]","[0.625, 0.65]","[0.635, 0.626]","[0.681, 0.722]","[0.817, 0.81]","[0.761, 0.737]","[0.657, 0.648]","[0.931, 0.927]","[0.855, 0.845]","[0.785, 0.78]","[0.824, 0.813]","[0.799, 0.795]",0.47,0.56,0.641,0.198,0.228,0.184,0.731,0.637,0.631,0.702,0.814,0.749,0.653,0.929,0.85,0.782,0.819,0.797
https://doi.org/10.1093/auk/124.3.1023,survival and natal dispersal of juvenile snowy plovers charadrius alexandrinus in central coastal california,26014_survival and natal dispersal of juvenile snowy plovers charadrius alexandrinus in central coastal california.pdf,3,"['https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Conway_etal_2010_SnowyPlover.pdf', 'https://purl.fdlp.gov/GPO/gpo83967', 'https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Saalfeld_etal_2013_DeclinesSnowyPlover.pdf']","['Microsoft Word - Front Matter', 'The U.S. Geological Survey Bird Banding Laboratory :\xa0an integrated scientific program supporting research and conservation of North American birds /', 'Recent Declines in Apparent Survival and Survey Counts of Snowy Plovers Breeding in the Southern High Plains of Texas']","['https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Saalfeld_etal_2013_DeclinesSnowyPlover.pdf', 'https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Conway_etal_2010_SnowyPlover.pdf', 'https://purl.fdlp.gov/GPO/gpo83967']","['26014_2_recent declines in apparent survival and survey counts of snowy plovers breeding in the southern high plains of texas.pdf', '26014_0_microsoft word  front matter.pdf', '26014_1_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf']",3,100.0,"['https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Saalfeld_etal_2013_DeclinesSnowyPlover.pdf', 'https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Conway_etal_2010_SnowyPlover.pdf', 'https://purl.fdlp.gov/GPO/gpo83967']","['26014_2_recent declines in apparent survival and survey counts of snowy plovers breeding in the southern high plains of texas.pdf', '26014_0_microsoft word  front matter.pdf', '26014_1_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf']","[0.347, 0.272, 0.496]","[0.541, 0.53, 0.571]","[0.616, 0.607, 0.641]","[0.175, 0.167, 0.192]","[0.184, 0.173, 0.194]","[0.147, 0.138, 0.155]","[0.732, 0.733, 0.736]","[0.639, 0.64, 0.646]","[0.6, 0.59, 0.636]","[0.706, 0.702, 0.701]","[0.803, 0.795, 0.825]","[0.713, 0.71, 0.761]","[0.648, 0.644, 0.669]","[0.91, 0.906, 0.916]","[0.831, 0.826, 0.851]","[0.773, 0.769, 0.792]","[0.806, 0.799, 0.83]","[0.789, 0.782, 0.811]",0.372,0.547,0.621,0.178,0.184,0.147,0.734,0.642,0.609,0.703,0.808,0.728,0.654,0.911,0.836,0.778,0.812,0.794
https://doi.org/10.1093/bmb/ldg032,hazards of heavy metal contamination,26063_hazards of heavy metal contamination.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746524/pdf', 'https://www.dos.ny.gov/opd/programs/pdfs/Consistency/F-2018-0209PN-Material.pdf']","['Recommendations for the Development of Regulatory Guidelines for Registration of Traditional Medicines in South Africa', 'DEPARTMENT OF THE NAVY t ,. S. FLEET FORCES COII } I ,{ ND']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746524/pdf'],['26063_0_recommendations for the development of regulatory guidelines for registration of traditional medicines in south africa.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746524/pdf'],['26063_0_recommendations for the development of regulatory guidelines for registration of traditional medicines in south africa.pdf'],[0.118],[0.524],[0.62],[0.118],[0.114],[0.097],[0.724],[0.621],[0.599],[0.632],[0.808],[0.722],[0.642],[0.914],[0.82],[0.767],[0.803],[0.784],0.118,0.524,0.62,0.118,0.114,0.097,0.724,0.621,0.599,0.632,0.808,0.722,0.642,0.914,0.82,0.767,0.803,0.784
https://doi.org/10.1093/cid/ciaa1328,impact of social distancing and travel restrictions on non–coronavirus disease 2019 non–covid19 respiratory hospital admissions in young children in rural alaska,26096_impact of social distancing and travel restrictions on non–coronavirus disease 2019 non–covid19 respiratory hospital admissions in young children in rural alaska.pdf,2,"['http://www.epi.alaska.gov/bulletins/docs/b2021_20.pdf', 'https://aspe.hhs.gov/reports/antimicrobials-during-covid']","['RSV Bulletin 21-22 season', 'Trends in Antimicrobial Drug Prescribing During the COVID-19 Pandemic']",['http://www.epi.alaska.gov/bulletins/docs/b2021_20.pdf'],['26096_0_rsv bulletin 2122 season.pdf'],1,50.0,['http://www.epi.alaska.gov/bulletins/docs/b2021_20.pdf'],['26096_0_rsv bulletin 2122 season.pdf'],[0.37],[0.569],[0.632],[0.208],[0.217],[0.183],[0.74],[0.65],[0.635],[0.683],[0.816],[0.728],[0.65],[0.92],[0.846],[0.77],[0.814],[0.797],0.37,0.569,0.632,0.208,0.217,0.183,0.74,0.65,0.635,0.683,0.816,0.728,0.65,0.92,0.846,0.77,0.814,0.797
https://doi.org/10.1093/cid/ciaa1348,reconsidering assumptions of adolescent and young adult severe acute respiratory syndrome coronavirus 2 transmission dynamics,26097_reconsidering assumptions of adolescent and young adult severe acute respiratory syndrome coronavirus 2 transmission dynamics.pdf,4,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['26097_1_master question list for covid19 caused by sarscov2.pdf', '26097_2_master question list for covid19 caused by sarscov2.pdf', '26097_0_master question list for covid19 caused by sarscov2.pdf', '26097_3_master question list for covid19 caused by sarscov2.pdf']",4,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['26097_1_master question list for covid19 caused by sarscov2.pdf', '26097_2_master question list for covid19 caused by sarscov2.pdf', '26097_0_master question list for covid19 caused by sarscov2.pdf', '26097_3_master question list for covid19 caused by sarscov2.pdf']","[0.581, 0.572, 0.573, 0.573]","[0.579, 0.582, 0.579, 0.578]","[0.654, 0.655, 0.654, 0.653]","[0.195, 0.196, 0.195, 0.194]","[0.203, 0.205, 0.204, 0.202]","[0.16, 0.161, 0.161, 0.159]","[0.744, 0.744, 0.745, 0.744]","[0.656, 0.657, 0.657, 0.656]","[0.652, 0.654, 0.651, 0.65]","[0.645, 0.645, 0.646, 0.645]","[0.82, 0.82, 0.819, 0.82]","[0.762, 0.766, 0.762, 0.76]","[0.648, 0.65, 0.647, 0.648]","[0.921, 0.92, 0.921, 0.92]","[0.848, 0.85, 0.849, 0.849]","[0.794, 0.796, 0.793, 0.793]","[0.829, 0.83, 0.828, 0.829]","[0.812, 0.813, 0.811, 0.811]",0.575,0.58,0.654,0.195,0.204,0.16,0.744,0.657,0.652,0.645,0.82,0.762,0.648,0.921,0.849,0.794,0.829,0.812
https://doi.org/10.1093/cid/ciaa1391,primary care guidance for persons with human immunodeficiency virus 2020 update by the hiv medicine association of the infectious diseases society of america,26098_primary care guidance for persons with human immunodeficiency virus 2020 update by the hiv medicine association of the infectious diseases society of america.pdf,2,"['https://www.rand.org/pubs/research_reports/RRA1846-1.html', 'https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/California-STI-Screening-Recommendations.pdf']","['A Scoping Review of Guidelines and Quality Measures to Screen for Social and Caregiver Support and Cognitive Impairment in Primary Care', 'California Sexually Transmitted Infections (sti) Screening Recommendations']",['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/California-STI-Screening-Recommendations.pdf'],['26098_1_california sexually transmitted infections sti screening recommendations.pdf'],1,50.0,['https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/California-STI-Screening-Recommendations.pdf'],['26098_1_california sexually transmitted infections sti screening recommendations.pdf'],[0.475],[0.654],[0.709],[0.258],[0.251],[0.21],[0.766],[0.684],[0.708],[0.633],[0.849],[0.806],[0.66],[0.949],[0.849],[0.822],[0.854],[0.835],0.475,0.654,0.709,0.258,0.251,0.21,0.766,0.684,0.708,0.633,0.849,0.806,0.66,0.949,0.849,0.822,0.854,0.835
https://doi.org/10.1093/cid/ciaa1703,randomized doubleblinded placebocontrolled phase 2 trial of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in healthy adults,26100_randomized doubleblinded placebocontrolled phase 2 trial of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in healthy adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf'],['Efficacy and safety of COVID‐19 vaccines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf'],['26100_0_efficacy and safety of covid‐19 vaccines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf'],['26100_0_efficacy and safety of covid‐19 vaccines.pdf'],[0.281],[0.513],[0.594],[0.165],[0.153],[0.133],[0.741],[0.651],[0.566],[0.678],[0.756],[0.674],[0.594],[0.897],[0.799],[0.705],[0.762],[0.725],0.281,0.513,0.594,0.165,0.153,0.133,0.741,0.651,0.566,0.678,0.756,0.674,0.594,0.897,0.799,0.705,0.762,0.725
https://doi.org/10.1093/cid/ciaa198,a case series of children with 2019 novel coronavirus infection clinical and epidemiological features,26104_a case series of children with 2019 novel coronavirus infection clinical and epidemiological features.pdf,9,"['https://stacks.cdc.gov/view/cdc/96861', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://www.nber.org/papers/w28374', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165275/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229975/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283678/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273958/pdf']","['Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)', 'Management strategies for children with COVID-19: ESPR practical recommendations', 'A primer for pediatric radiologists on infection control in an era of COVID-19', 'The Impact of the Non-essential Business Closure Policy on Covid-19 Infection Rates', 'COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL)', 'Prevención y tratamiento de la COVID-19 en la población pediátrica desde una perspectiva familiar y comunitaria: artículo especial', 'Antibody tests for identification of current and past infection with SARS‐CoV‐2', 'Practical Guide for Pediatric Pulmonologists on Imaging Management of Pediatric Patients with COVID‐19', 'Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273958/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229975/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283678/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165275/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['26104_8_pediatric endoscopy in the era of coronavirus disease 2019 a north american society for pediatric gastroenterology hepatology and nutrition position paper.pdf', '26104_5_prevención y tratamiento de la covid19 en la población pediátrica desde una perspectiva familiar y comunitaria artículo especial.pdf', '26104_7_practical guide for pediatric pulmonologists on imaging management of pediatric patients with covid‐19.pdf', '26104_6_antibody tests for identification of current and past infection with sars‐cov‐2.pdf', '26104_4_covid19 and ent pediatric otolaryngology during the covid19 pandemic guidelines of the french association of pediatric otorhinolaryngology afop and french society of otorhinolaryngology sforl.pdf', '26104_2_a primer for pediatric radiologists on infection control in an era of covid19.pdf', '26104_1_management strategies for children with covid19 espr practical recommendations.pdf']",7,77.78,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273958/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229975/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283678/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165275/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332738/pdf']","['26104_8_pediatric endoscopy in the era of coronavirus disease 2019 a north american society for pediatric gastroenterology hepatology and nutrition position paper.pdf', '26104_5_prevención y tratamiento de la covid19 en la población pediátrica desde una perspectiva familiar y comunitaria artículo especial.pdf', '26104_7_practical guide for pediatric pulmonologists on imaging management of pediatric patients with covid‐19.pdf', '26104_6_antibody tests for identification of current and past infection with sars‐cov‐2.pdf', '26104_4_covid19 and ent pediatric otolaryngology during the covid19 pandemic guidelines of the french association of pediatric otorhinolaryngology afop and french society of otorhinolaryngology sforl.pdf', '26104_2_a primer for pediatric radiologists on infection control in an era of covid19.pdf', '26104_1_management strategies for children with covid19 espr practical recommendations.pdf']","[0.367, 0.299, 0.283, 0.036, 0.251, 0.304, 0.25]","[0.555, 0.452, 0.571, 0.532, 0.58, 0.551, 0.558]","[0.643, 0.553, 0.644, 0.619, 0.656, 0.635, 0.64]","[0.184, 0.142, 0.206, 0.162, 0.201, 0.187, 0.204]","[0.186, 0.179, 0.208, 0.151, 0.204, 0.186, 0.204]","[0.146, 0.119, 0.161, 0.121, 0.159, 0.144, 0.162]","[0.742, 0.729, 0.751, 0.732, 0.743, 0.743, 0.744]","[0.648, 0.643, 0.656, 0.635, 0.646, 0.645, 0.648]","[0.63, 0.537, 0.647, 0.602, 0.658, 0.639, 0.641]","[0.63, 0.63, 0.631, 0.649, 0.613, 0.622, 0.623]","[0.811, 0.789, 0.821, 0.787, 0.821, 0.812, 0.82]","[0.738, 0.685, 0.757, 0.721, 0.764, 0.745, 0.735]","[0.605, 0.565, 0.626, 0.595, 0.637, 0.62, 0.615]","[0.923, 0.861, 0.921, 0.915, 0.927, 0.923, 0.928]","[0.826, 0.796, 0.83, 0.819, 0.836, 0.835, 0.842]","[0.765, 0.702, 0.777, 0.732, 0.787, 0.777, 0.78]","[0.805, 0.751, 0.817, 0.787, 0.822, 0.813, 0.822]","[0.79, 0.724, 0.798, 0.757, 0.804, 0.789, 0.798]",0.256,0.543,0.627,0.184,0.188,0.145,0.741,0.646,0.622,0.628,0.809,0.735,0.609,0.914,0.826,0.76,0.802,0.78
https://doi.org/10.1093/cid/ciaa201,a well infant with coronavirus disease 2019 covid19 with high viral load,26105_a well infant with coronavirus disease 2019 covid19 with high viral load.pdf,4,"['https://stacks.cdc.gov/view/cdc/96861', 'https://www.michigan.gov/documents/coronavirus/COVID19_Practice_Management_Guide_Final_685523_7.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf', 'https://stacks.cdc.gov/view/cdc/86728']","['Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)', 'DoD COVID-19 Practice Management Guide', 'A primer for pediatric radiologists on infection control in an era of COVID-19', 'Information for pediatric healthcare providers']","['https://www.michigan.gov/documents/coronavirus/COVID19_Practice_Management_Guide_Final_685523_7.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf']","['26105_1_dod covid19 practice management guide.pdf', '26105_2_a primer for pediatric radiologists on infection control in an era of covid19.pdf']",2,50.0,"['https://www.michigan.gov/documents/coronavirus/COVID19_Practice_Management_Guide_Final_685523_7.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340753/pdf']","['26105_1_dod covid19 practice management guide.pdf', '26105_2_a primer for pediatric radiologists on infection control in an era of covid19.pdf']","[0.334, 0.32]","[0.563, 0.544]","[0.642, 0.631]","[0.155, 0.174]","[0.165, 0.175]","[0.119, 0.131]","[0.726, 0.731]","[0.63, 0.636]","[0.652, 0.638]","[0.606, 0.622]","[0.815, 0.812]","[0.77, 0.75]","[0.629, 0.62]","[0.923, 0.92]","[0.837, 0.839]","[0.785, 0.779]","[0.827, 0.818]","[0.805, 0.791]",0.327,0.553,0.637,0.164,0.17,0.125,0.728,0.633,0.645,0.614,0.814,0.76,0.625,0.921,0.838,0.782,0.823,0.798
https://doi.org/10.1093/cid/ciaa298,susceptibility to hepatitis a virus infection in the united states 2007–2016,26107_susceptibility to hepatitis a virus infection in the united states 2007–2016.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf', 'https://stacks.cdc.gov/view/cdc/90157']","['Sexually Transmitted Infections Treatment Guidelines, 2021', 'Prevention of hepatitis A virus infection in the United States : recommendations of the Advisory Committee on Immunization Practices, 2020']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],['26107_0_sexually transmitted infections treatment guidelines 2021.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968/pdf'],['26107_0_sexually transmitted infections treatment guidelines 2021.pdf'],[0.314],[0.507],[0.59],[0.134],[0.142],[0.118],[0.731],[0.634],[0.576],[0.638],[0.778],[0.695],[0.589],[0.898],[0.787],[0.704],[0.781],[0.747],0.314,0.507,0.59,0.134,0.142,0.118,0.731,0.634,0.576,0.638,0.778,0.695,0.589,0.898,0.787,0.704,0.781,0.747
https://doi.org/10.1093/cid/ciaa316,covid19 transmission within a family cluster by presymptomatic carriers in china,26108_covid19 transmission within a family cluster by presymptomatic carriers in china.pdf,3,"['https://stacks.cdc.gov/view/cdc/96861', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207070/pdf']","['Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)', 'COVID-19 Updates', 'Recommendations for COVID‐19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists']","['https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207070/pdf']","['26108_1_covid19 updates.pdf', '26108_2_recommendations for covid‐19 vaccination in people with rheumatic disease developed by the singapore chapter of rheumatologists.pdf']",2,66.67,"['https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207070/pdf']","['26108_1_covid19 updates.pdf', '26108_2_recommendations for covid‐19 vaccination in people with rheumatic disease developed by the singapore chapter of rheumatologists.pdf']","[0.358, 0.209]","[0.599, 0.564]","[0.668, 0.637]","[0.211, 0.198]","[0.218, 0.207]","[0.174, 0.15]","[0.732, 0.734]","[0.643, 0.644]","[0.678, 0.636]","[0.65, 0.638]","[0.833, 0.808]","[0.797, 0.752]","[0.633, 0.606]","[0.922, 0.913]","[0.863, 0.846]","[0.799, 0.776]","[0.846, 0.814]","[0.819, 0.792]",0.283,0.581,0.653,0.205,0.212,0.162,0.733,0.643,0.657,0.644,0.821,0.774,0.619,0.917,0.855,0.788,0.83,0.805
https://doi.org/10.1093/cid/ciaa352,maternal and neonatal outcomes of pregnant women with covid19 pneumonia a casecontrol study,26109_maternal and neonatal outcomes of pregnant women with covid19 pneumonia a casecontrol study.pdf,8,"['https://stacks.cdc.gov/view/cdc/90861', 'https://stacks.cdc.gov/view/cdc/90729', 'https://stacks.cdc.gov/view/cdc/91185', 'https://stacks.cdc.gov/view/cdc/114448', 'https://stacks.cdc.gov/view/cdc/89840', 'https://stacks.cdc.gov/view/cdc/106171', 'https://stacks.cdc.gov/view/cdc/110771', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078159/pdf']","['Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Routine laboratory testing to determine if a patient has COVID‐19']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078159/pdf'],['26109_7_routine laboratory testing to determine if a patient has covid‐19.pdf'],1,12.5,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078159/pdf'],['26109_7_routine laboratory testing to determine if a patient has covid‐19.pdf'],[0.383],[0.548],[0.621],[0.159],[0.154],[0.12],[0.727],[0.632],[0.61],[0.643],[0.788],[0.721],[0.61],[0.915],[0.828],[0.75],[0.794],[0.77],0.383,0.548,0.621,0.159,0.154,0.12,0.727,0.632,0.61,0.643,0.788,0.721,0.61,0.915,0.828,0.75,0.794,0.77
https://doi.org/10.1093/cid/ciaa530,bacterial and fungal coinfection in individuals with coronavirus a rapid review to support covid19 antimicrobial prescribing,26110_bacterial and fungal coinfection in individuals with coronavirus a rapid review to support covid19 antimicrobial prescribing.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309729/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386267/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/pdf', 'https://www.cambridge.org/core/services/aop-cambridge-core/content/view/C38220B116C139D007872C85A19968EA/S0899823X22001945a.pdf/shea-statement-on-antibiotic-stewardship-in-hospitals-during-public-health-emergencies.pdf']","['Severe COVID-19 and healthcare-associated infections on the ICU: time to remember the basics?', 'Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients', 'Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries', 'SHEA statement on antibiotic stewardship in hospitals during public health emergencies: 2022 update']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/pdf', 'https://www.cambridge.org/core/services/aop-cambridge-core/content/view/C38220B116C139D007872C85A19968EA/S0899823X22001945a.pdf/shea-statement-on-antibiotic-stewardship-in-hospitals-during-public-health-emergencies.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386267/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309729/pdf']","['26110_2_pragmatic recommendations for therapeutics of hospitalized covid19 patients in low and middleincome countries.pdf', '26110_3_shea statement on antibiotic stewardship in hospitals during public health emergencies 2022 update.pdf', '26110_1_guidelines for covid19 management in hematopoietic cell transplantation and cellular therapy recipients.pdf', '26110_0_severe covid19 and healthcareassociated infections on the icu time to remember the basics.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/pdf', 'https://www.cambridge.org/core/services/aop-cambridge-core/content/view/C38220B116C139D007872C85A19968EA/S0899823X22001945a.pdf/shea-statement-on-antibiotic-stewardship-in-hospitals-during-public-health-emergencies.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386267/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309729/pdf']","['26110_2_pragmatic recommendations for therapeutics of hospitalized covid19 patients in low and middleincome countries.pdf', '26110_3_shea statement on antibiotic stewardship in hospitals during public health emergencies 2022 update.pdf', '26110_1_guidelines for covid19 management in hematopoietic cell transplantation and cellular therapy recipients.pdf', '26110_0_severe covid19 and healthcareassociated infections on the icu time to remember the basics.pdf']","[0.428, 0.516, 0.434, 0.597]","[0.576, 0.606, 0.576, 0.562]","[0.649, 0.671, 0.653, 0.643]","[0.199, 0.25, 0.197, 0.198]","[0.221, 0.263, 0.209, 0.215]","[0.171, 0.223, 0.158, 0.169]","[0.745, 0.758, 0.747, 0.743]","[0.658, 0.674, 0.658, 0.656]","[0.647, 0.667, 0.64, 0.641]","[0.645, 0.672, 0.632, 0.655]","[0.82, 0.832, 0.82, 0.814]","[0.756, 0.775, 0.755, 0.757]","[0.632, 0.642, 0.627, 0.63]","[0.929, 0.927, 0.925, 0.919]","[0.839, 0.855, 0.837, 0.848]","[0.782, 0.798, 0.78, 0.78]","[0.819, 0.834, 0.821, 0.818]","[0.801, 0.816, 0.801, 0.801]",0.494,0.58,0.654,0.211,0.227,0.18,0.748,0.662,0.649,0.651,0.822,0.761,0.633,0.925,0.845,0.785,0.823,0.805
https://doi.org/10.1093/cid/ciaa556,sarscov2 covid19 what do we know about children a systematic review,26111_sarscov2 covid19 what do we know about children a systematic review.pdf,2,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['26111_1_update on the management of multiple sclerosis during the covid19 pandemic and post pandemic an international consensus statement.pdf', '26111_0_master question list for covid19 caused by sarscov2.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['26111_1_update on the management of multiple sclerosis during the covid19 pandemic and post pandemic an international consensus statement.pdf', '26111_0_master question list for covid19 caused by sarscov2.pdf']","[0.504, 0.396]","[0.506, 0.561]","[0.595, 0.643]","[0.143, 0.193]","[0.141, 0.198]","[0.116, 0.157]","[0.727, 0.739]","[0.637, 0.651]","[0.571, 0.632]","[0.658, 0.66]","[0.78, 0.804]","[0.693, 0.744]","[0.612, 0.635]","[0.909, 0.918]","[0.809, 0.843]","[0.738, 0.771]","[0.78, 0.812]","[0.765, 0.792]",0.45,0.534,0.619,0.168,0.169,0.137,0.733,0.644,0.601,0.659,0.792,0.718,0.623,0.913,0.826,0.754,0.796,0.778
https://doi.org/10.1093/cid/ciaa624,association of reninangiotensinaldosterone system inhibitors with coronavirus disease 2019 covid19 related outcomes in korea a nationwide populationbased cohort study,26112_association of reninangiotensinaldosterone system inhibitors with coronavirus disease 2019 covid19 related outcomes in korea a nationwide populationbased cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['26112_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['26112_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.43],[0.52],[0.604],[0.169],[0.175],[0.134],[0.739],[0.648],[0.583],[0.67],[0.775],[0.706],[0.605],[0.917],[0.818],[0.737],[0.777],[0.759],0.43,0.52,0.604,0.169,0.175,0.134,0.739,0.648,0.583,0.67,0.775,0.706,0.605,0.917,0.818,0.737,0.777,0.759
https://doi.org/10.1093/cid/ciaa793,identification and validation of a novel clinical signature to predict the prognosis in confirmed coronavirus disease 2019 patients,26113_identification and validation of a novel clinical signature to predict the prognosis in confirmed coronavirus disease 2019 patients.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf'],['Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf'],['26113_0_pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe covid19 in low and middleincome countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957242/pdf'],['26113_0_pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe covid19 in low and middleincome countries.pdf'],[0.48],[0.539],[0.623],[0.172],[0.18],[0.144],[0.744],[0.653],[0.602],[0.665],[0.789],[0.715],[0.624],[0.914],[0.824],[0.765],[0.789],[0.778],0.48,0.539,0.623,0.172,0.18,0.144,0.744,0.653,0.602,0.665,0.789,0.715,0.624,0.914,0.824,0.765,0.789,0.778
https://doi.org/10.1093/cid/ciaa794,novel coronavirus 2019 transmission risk in educational settings,26114_novel coronavirus 2019 transmission risk in educational settings.pdf,9,"['https://stacks.cdc.gov/view/cdc/111741', 'https://stacks.cdc.gov/view/cdc/112760', 'https://stacks.cdc.gov/view/cdc/107840', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Updated%20Public%20Health%20School%20Guidance%2010.15.21.pdf', 'https://www.dph.illinois.gov/sites/default/files/20210308_Updated_Public_Health_Guidance.pdf', 'https://dese.mo.gov/sites/default/files/COVID-MO-K12-Reopening-Guidance.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Public%20Health%20Guidance%20for%20Schools.pdf', 'https://www.congress.gov/event/117th-congress/house-event/111298']","['Science brief: Transmission of SARS-CoV-2 in K-12 schools and early care and education programs – updated', 'Science brief: Transmission of SARS-CoV-2 in K-12 schools and early care and education programs – updated', 'Science brief: Transmission of SARS-CoV-2 in K-12 schools', 'Public Health COVID-19 School Guidance', 'Revised Public Health Guidance for Schools', 'Wer', '173ÿ67172', 'Revised Public Health Guidance for Schools', '“Kids Online During COVID: Child Safety in an Increasingly Digital Age”']","['https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Updated%20Public%20Health%20School%20Guidance%2010.15.21.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Public%20Health%20Guidance%20for%20Schools.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf']","['26114_3_public health covid19 school guidance.pdf', '26114_7_revised public health guidance for schools.pdf', '26114_6_173ÿ67172.pdf']",3,33.33,"['https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Updated%20Public%20Health%20School%20Guidance%2010.15.21.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Public%20Health%20Guidance%20for%20Schools.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf']","['26114_3_public health covid19 school guidance.pdf', '26114_7_revised public health guidance for schools.pdf', '26114_6_173ÿ67172.pdf']","[0.456, 0.499, 0.452]","[0.559, 0.554, 0.384]","[0.639, 0.637, 0.501]","[0.184, 0.177, 0.087]","[0.204, 0.196, 0.087]","[0.165, 0.16, 0.084]","[0.733, 0.733, 0.727]","[0.64, 0.638, 0.631]","[0.635, 0.63, 0.401]","[0.645, 0.643, 0.657]","[0.819, 0.816, 0.668]","[0.754, 0.75, 0.548]","[0.644, 0.642, 0.566]","[0.93, 0.929, 0.882]","[0.84, 0.838, 0.688]","[0.791, 0.788, 0.64]","[0.826, 0.823, 0.666]","[0.809, 0.807, 0.665]",0.469,0.499,0.592,0.149,0.162,0.136,0.731,0.636,0.555,0.648,0.768,0.684,0.617,0.914,0.789,0.74,0.772,0.76
https://doi.org/10.1093/cid/ciaa855,asymptomatic transmission and the infection fatality risk for covid19 implications for school reopening,26116_asymptomatic transmission and the infection fatality risk for covid19 implications for school reopening.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf'],['Holidays over: A review of actual COVID-19 school outbreaks up to September 2020'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf'],['26116_0_holidays over a review of actual covid19 school outbreaks up to september 2020.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528890/pdf'],['26116_0_holidays over a review of actual covid19 school outbreaks up to september 2020.pdf'],[0.165],[0.526],[0.611],[0.171],[0.206],[0.149],[0.728],[0.637],[0.612],[0.678],[0.803],[0.732],[0.62],[0.925],[0.836],[0.73],[0.79],[0.764],0.165,0.526,0.611,0.171,0.206,0.149,0.728,0.637,0.612,0.678,0.803,0.732,0.62,0.925,0.836,0.73,0.79,0.764
https://doi.org/10.1093/cid/ciaa880,coronavirus 2019 and people living with human immunodeficiency virus outcomes for hospitalized patients in new york city,26117_coronavirus 2019 and people living with human immunodeficiency virus outcomes for hospitalized patients in new york city.pdf,2,"['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://stacks.cdc.gov/view/cdc/93279']","['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'COVID-19 science update ; Edition 2020-09-08']",['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['26117_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,50.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['26117_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.428],[0.546],[0.621],[0.178],[0.187],[0.144],[0.744],[0.653],[0.605],[0.659],[0.795],[0.711],[0.598],[0.903],[0.806],[0.765],[0.791],[0.783],0.428,0.546,0.621,0.178,0.187,0.144,0.744,0.653,0.605,0.659,0.795,0.711,0.598,0.903,0.806,0.765,0.791,0.783
https://doi.org/10.1093/cid/ciaa920,distinct clinical characteristics and risk factors for mortality in female inpatients with coronavirus disease 2019 covid19 a sexstratified largescale cohort study in wuhan china,26118_distinct clinical characteristics and risk factors for mortality in female inpatients with coronavirus disease 2019 covid19 a sexstratified largescale cohort study in wuhan china.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['26118_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf'],['26118_0_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf'],[0.439],[0.512],[0.592],[0.154],[0.161],[0.125],[0.739],[0.643],[0.575],[0.685],[0.768],[0.693],[0.604],[0.908],[0.81],[0.733],[0.772],[0.758],0.439,0.512,0.592,0.154,0.161,0.125,0.739,0.643,0.575,0.685,0.768,0.693,0.604,0.908,0.81,0.733,0.772,0.758
https://doi.org/10.1093/cid/ciaa955,sarscov2 antibody prevalence in blood in a large school community subject to a covid19 outbreak a crosssectional study,26119_sarscov2 antibody prevalence in blood in a large school community subject to a covid19 outbreak a crosssectional study.pdf,1,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf'],['Master Question List for COVID-19 (caused by SARS-CoV-2)'],['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf'],['26119_0_master question list for covid19 caused by sarscov2.pdf'],1,100.0,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf'],['26119_0_master question list for covid19 caused by sarscov2.pdf'],[0.364],[0.546],[0.63],[0.168],[0.171],[0.136],[0.739],[0.648],[0.623],[0.646],[0.802],[0.741],[0.639],[0.922],[0.837],[0.773],[0.81],[0.792],0.364,0.546,0.63,0.168,0.171,0.136,0.739,0.648,0.623,0.646,0.802,0.741,0.639,0.922,0.837,0.773,0.81,0.792
https://doi.org/10.1093/cid/ciab100,severe acute respiratory syndrome coronavirus 2 sarscov2 settingspecific transmission rates a systematic review and metaanalysis,26120_severe acute respiratory syndrome coronavirus 2 sarscov2 settingspecific transmission rates a systematic review and metaanalysis.pdf,7,"['https://stacks.cdc.gov/view/cdc/117889', 'https://stacks.cdc.gov/view/cdc/117886', 'https://stacks.cdc.gov/view/cdc/117888', 'https://stacks.cdc.gov/view/cdc/117890', 'https://stacks.cdc.gov/view/cdc/117887', 'https://stacks.cdc.gov/view/cdc/117891', 'https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/infection-prevention/idsa-covid-19-gl-ip-v2.0.0.pdf']","['Clinical considerations for care of children and adults with confirmed COVID-19 : Diagnosis', 'Clinical care considerations : clinical considerations for care of children and adults with confirmed COVID-19 : Reinfection', 'Clinical considerations for care of children and adults with confirmed COVID-19 : Clinical course: progression, management, and treatment', 'Clinical considerations for care of children and adults with confirmed COVID-19 : Clinical presentation', 'Clinical care considerations : clinical considerations for care of children and adults with confirmed COVID-19 : Special clinical considerations', 'Clinical care considerations : clinical considerations for care of children and adults with confirmed COVID-19 : Key points', 'Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19']",['https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/infection-prevention/idsa-covid-19-gl-ip-v2.0.0.pdf'],['26120_6_infectious diseases society of america guidelines on infection prevention for healthcare personnel caring for patients with suspected or known covid19.pdf'],1,14.29,['https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/infection-prevention/idsa-covid-19-gl-ip-v2.0.0.pdf'],['26120_6_infectious diseases society of america guidelines on infection prevention for healthcare personnel caring for patients with suspected or known covid19.pdf'],[0.37],[0.547],[0.617],[0.164],[0.177],[0.138],[0.734],[0.645],[0.61],[0.675],[0.798],[0.729],[0.607],[0.91],[0.825],[0.762],[0.8],[0.782],0.37,0.547,0.617,0.164,0.177,0.138,0.734,0.645,0.61,0.675,0.798,0.729,0.607,0.91,0.825,0.762,0.8,0.782
https://doi.org/10.1093/cid/ciab230,effectiveness of three versus six feet of physical distancing for controlling spread of covid19 among primary and secondary students and staff a retrospective statewide cohort study,26121_effectiveness of three versus six feet of physical distancing for controlling spread of covid19 among primary and secondary students and staff a retrospective statewide cohort study.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf', 'https://stacks.cdc.gov/view/cdc/104296', 'https://www.heritage.org/health-care-reform/report/covid-19-and-federalism-public-officials-accountability-and-comparative', 'https://stacks.cdc.gov/view/cdc/107840']","['Measures implemented in the school setting to contain the COVID‐19 pandemic', 'COVID-19 science update ; 2021-03-19 (81)', 'COVID-19 and Federalism: Public Officials’ Accountability and Comparative Performance', 'Science brief: Transmission of SARS-CoV-2 in K-12 schools']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf'],['26121_0_measures implemented in the school setting to contain the covid‐19 pandemic.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf'],['26121_0_measures implemented in the school setting to contain the covid‐19 pandemic.pdf'],[0.438],[0.547],[0.615],[0.193],[0.199],[0.164],[0.737],[0.645],[0.612],[0.693],[0.797],[0.723],[0.636],[0.911],[0.834],[0.749],[0.802],[0.772],0.438,0.547,0.615,0.193,0.199,0.164,0.737,0.645,0.612,0.693,0.797,0.723,0.636,0.911,0.834,0.749,0.802,0.772
https://doi.org/10.1093/cid/cir445,behavior change strategies to influence antimicrobial prescribing in acute care a systematic review,26130_behavior change strategies to influence antimicrobial prescribing in acute care a systematic review.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972159/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671626/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464541/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771635/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872779/pdf']","['The determinants of antimicrobial prescribing among hospital doctors in England: a framework to inform tailored stewardship interventions', 'Engaging Hospitalists in Antimicrobial Stewardship: Lessons From a Multihospital Collaborative', 'Interventions to improve antibiotic prescribing practices for hospital inpatients', 'The international dimensions of antimicrobial resistance: Contextual factors shape distinct ethical challenges in South Africa, Sri Lanka and the United Kingdom', 'Antimicrobial Stewardship in the Emergency Department and Guidelines for Development']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872779/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671626/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464541/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972159/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771635/pdf']","['26130_4_antimicrobial stewardship in the emergency department and guidelines for development.pdf', '26130_1_engaging hospitalists in antimicrobial stewardship lessons from a multihospital collaborative.pdf', '26130_2_interventions to improve antibiotic prescribing practices for hospital inpatients.pdf', '26130_0_the determinants of antimicrobial prescribing among hospital doctors in england a framework to inform tailored stewardship interventions.pdf', '26130_3_the international dimensions of antimicrobial resistance contextual factors shape distinct ethical challenges in south africa sri lanka and the united kingdom.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872779/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671626/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464541/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972159/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771635/pdf']","['26130_4_antimicrobial stewardship in the emergency department and guidelines for development.pdf', '26130_1_engaging hospitalists in antimicrobial stewardship lessons from a multihospital collaborative.pdf', '26130_2_interventions to improve antibiotic prescribing practices for hospital inpatients.pdf', '26130_0_the determinants of antimicrobial prescribing among hospital doctors in england a framework to inform tailored stewardship interventions.pdf', '26130_3_the international dimensions of antimicrobial resistance contextual factors shape distinct ethical challenges in south africa sri lanka and the united kingdom.pdf']","[0.513, 0.44, 0.473, 0.443, 0.448]","[0.534, 0.559, 0.571, 0.571, 0.561]","[0.64, 0.653, 0.644, 0.644, 0.646]","[0.215, 0.229, 0.205, 0.212, 0.201]","[0.214, 0.242, 0.202, 0.216, 0.204]","[0.192, 0.206, 0.18, 0.188, 0.185]","[0.748, 0.745, 0.734, 0.737, 0.739]","[0.659, 0.658, 0.644, 0.644, 0.649]","[0.612, 0.633, 0.631, 0.642, 0.633]","[0.684, 0.697, 0.7, 0.699, 0.69]","[0.792, 0.803, 0.801, 0.813, 0.81]","[0.696, 0.734, 0.735, 0.758, 0.756]","[0.597, 0.606, 0.617, 0.635, 0.639]","[0.918, 0.914, 0.919, 0.921, 0.92]","[0.836, 0.841, 0.846, 0.837, 0.845]","[0.756, 0.766, 0.763, 0.778, 0.774]","[0.795, 0.804, 0.806, 0.819, 0.812]","[0.78, 0.788, 0.785, 0.794, 0.787]",0.463,0.559,0.645,0.212,0.216,0.19,0.741,0.651,0.63,0.694,0.804,0.736,0.619,0.918,0.841,0.767,0.807,0.787
https://doi.org/10.1093/cid/cix229,an appraisal of the clinical features of pediatric enteric fever systematic review and metaanalysis of the agestratified disease occurrence,26195_an appraisal of the clinical features of pediatric enteric fever systematic review and metaanalysis of the agestratified disease occurrence.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494485/pdf'],['Vaccines for preventing typhoid fever'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494485/pdf'],['26195_0_vaccines for preventing typhoid fever.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494485/pdf'],['26195_0_vaccines for preventing typhoid fever.pdf'],[0.448],[0.527],[0.608],[0.175],[0.183],[0.144],[0.742],[0.648],[0.582],[0.667],[0.783],[0.712],[0.599],[0.902],[0.805],[0.73],[0.782],[0.752],0.448,0.527,0.608,0.175,0.183,0.144,0.742,0.648,0.582,0.667,0.783,0.712,0.599,0.902,0.805,0.73,0.782,0.752
https://doi.org/10.1093/condor/107.1.87,gender identification and growth of juvenile lesser prairiechickens,26218_gender identification and growth of juvenile lesser prairiechickens.pdf,1,['https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Holt_2012_PrairieChickenDissertation.pdf'],['Microsoft Word - Portrait Attempt.docx'],['https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Holt_2012_PrairieChickenDissertation.pdf'],['26218_0_microsoft word  portrait attemptdocx.pdf'],1,100.0,['https://tpwd.texas.gov/huntwild/wild/research/highlights/taxa/publications/Holt_2012_PrairieChickenDissertation.pdf'],['26218_0_microsoft word  portrait attemptdocx.pdf'],[0.319],[0.526],[0.605],[0.167],[0.179],[0.143],[0.733],[0.636],[0.592],[0.692],[0.798],[0.719],[0.643],[0.909],[0.827],[0.769],[0.808],[0.787],0.319,0.526,0.605,0.167,0.179,0.143,0.733,0.636,0.592,0.692,0.798,0.719,0.643,0.909,0.827,0.769,0.808,0.787
https://doi.org/10.1093/condor/107.2.388,resource selection by juvenile swainsons thrushes during the postfledging period,26219_resource selection by juvenile swainsons thrushes during the postfledging period.pdf,1,['https://purl.fdlp.gov/GPO/gpo83967'],['The U.S. Geological Survey Bird Banding Laboratory :\xa0an integrated scientific program supporting research and conservation of North American birds /'],['https://purl.fdlp.gov/GPO/gpo83967'],['26219_0_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo83967'],['26219_0_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf'],[0.212],[0.572],[0.645],[0.182],[0.175],[0.143],[0.735],[0.641],[0.64],[0.699],[0.828],[0.765],[0.668],[0.908],[0.858],[0.796],[0.832],[0.815],0.212,0.572,0.645,0.182,0.175,0.143,0.735,0.641,0.64,0.699,0.828,0.765,0.668,0.908,0.858,0.796,0.832,0.815
https://doi.org/10.1093/condor/108.2.253,juvenile movement and natal dispersal of northern goshawks in arizona,26220_juvenile movement and natal dispersal of northern goshawks in arizona.pdf,2,"['https://purl.fdlp.gov/GPO/gpo83967', 'http://purl.fdlp.gov/GPO/gpo64180']","['The U.S. Geological Survey Bird Banding Laboratory :\xa0an integrated scientific program supporting research and conservation of North American birds /', 'Rim fire reforestation (45612) :\xa0draft environmental impact statement : Stanislaus National Forest.']","['http://purl.fdlp.gov/GPO/gpo64180', 'https://purl.fdlp.gov/GPO/gpo83967']","['26220_1_rim fire reforestation 45612 \xa0draft environmental impact statement  stanislaus national forest.pdf', '26220_0_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf']",2,100.0,"['http://purl.fdlp.gov/GPO/gpo64180', 'https://purl.fdlp.gov/GPO/gpo83967']","['26220_1_rim fire reforestation 45612 \xa0draft environmental impact statement  stanislaus national forest.pdf', '26220_0_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf']","[0.244, 0.243]","[0.517, 0.555]","[0.596, 0.633]","[0.137, 0.189]","[0.133, 0.19]","[0.109, 0.151]","[0.724, 0.736]","[0.625, 0.644]","[0.587, 0.615]","[0.675, 0.704]","[0.797, 0.815]","[0.723, 0.749]","[0.653, 0.667]","[0.905, 0.907]","[0.819, 0.841]","[0.77, 0.783]","[0.807, 0.822]","[0.78, 0.798]",0.243,0.536,0.615,0.163,0.162,0.13,0.73,0.635,0.601,0.69,0.806,0.736,0.66,0.906,0.83,0.776,0.815,0.789
https://doi.org/10.1093/condor/108.2.282,survival and movements of juvenile burrowing owls during the postfledging period,26221_survival and movements of juvenile burrowing owls during the postfledging period.pdf,1,['https://dlnr.hawaii.gov/wildlife/files/2013/09/KWP2-Draft-HCP-amendment-DOFAW-9-27-17.pdf'],['KAHEAWA WIND POWER II'],['https://dlnr.hawaii.gov/wildlife/files/2013/09/KWP2-Draft-HCP-amendment-DOFAW-9-27-17.pdf'],['26221_0_kaheawa wind power ii.pdf'],1,100.0,['https://dlnr.hawaii.gov/wildlife/files/2013/09/KWP2-Draft-HCP-amendment-DOFAW-9-27-17.pdf'],['26221_0_kaheawa wind power ii.pdf'],[0.241],[0.53],[0.608],[0.144],[0.14],[0.113],[0.722],[0.627],[0.601],[0.672],[0.807],[0.728],[0.654],[0.901],[0.842],[0.778],[0.815],[0.796],0.241,0.53,0.608,0.144,0.14,0.113,0.722,0.627,0.601,0.672,0.807,0.728,0.654,0.901,0.842,0.778,0.815,0.796
https://doi.org/10.1093/condor/108.4.901,correlated growth and survival of juvenile spectacled eiders evidence of habitat limitation,26222_correlated growth and survival of juvenile spectacled eiders evidence of habitat limitation.pdf,1,['http://www.adfg.alaska.gov/static/species/specialstatus/pdfs/spectacledeider_2010_5year_fws.pdf'],['Microsoft Word - SPEI 5 year review FINAL 23 Aug 10'],['http://www.adfg.alaska.gov/static/species/specialstatus/pdfs/spectacledeider_2010_5year_fws.pdf'],['26222_0_microsoft word  spei 5 year review final 23 aug 10.pdf'],1,100.0,['http://www.adfg.alaska.gov/static/species/specialstatus/pdfs/spectacledeider_2010_5year_fws.pdf'],['26222_0_microsoft word  spei 5 year review final 23 aug 10.pdf'],[0.356],[0.519],[0.608],[0.153],[0.153],[0.126],[0.729],[0.634],[0.574],[0.678],[0.793],[0.71],[0.648],[0.898],[0.809],[0.764],[0.8],[0.779],0.356,0.519,0.608,0.153,0.153,0.126,0.729,0.634,0.574,0.678,0.793,0.71,0.648,0.898,0.809,0.764,0.8,0.779
https://doi.org/10.1093/condor/109.4.795,stopover ecology and habitat selection of juvenile swainsons thrushes during fall migration along the northern california coast,26223_stopover ecology and habitat selection of juvenile swainsons thrushes during fall migration along the northern california coast.pdf,1,['https://purl.fdlp.gov/GPO/gpo83967'],['The U.S. Geological Survey Bird Banding Laboratory :\xa0an integrated scientific program supporting research and conservation of North American birds /'],['https://purl.fdlp.gov/GPO/gpo83967'],['26223_0_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo83967'],['26223_0_the us geological survey bird banding laboratory \xa0an integrated scientific program supporting research and conservation of north american birds .pdf'],[0.389],[0.577],[0.647],[0.199],[0.197],[0.162],[0.737],[0.643],[0.642],[0.698],[0.83],[0.778],[0.669],[0.909],[0.857],[0.796],[0.837],[0.815],0.389,0.577,0.647,0.199,0.197,0.162,0.737,0.643,0.642,0.698,0.83,0.778,0.669,0.909,0.857,0.796,0.837,0.815
https://doi.org/10.1093/conphys/coz026,the impacts of warming and hypoxia on the performance of an obligate ram ventilator,26224_the impacts of warming and hypoxia on the performance of an obligate ram ventilator.pdf,1,['https://www.edf.org/sites/default/files/documents/An%20Assessment%20of%20Climate%20Change%20Impacts%20to%20HMS%20in%20the%20North%20Atlantic%20Ocean.pdf'],['Navigating Our Changing Oceans: An Assessment of Climate Change Impacts to Highly Migratory Species in the North Atlantic Ocean'],['https://www.edf.org/sites/default/files/documents/An%20Assessment%20of%20Climate%20Change%20Impacts%20to%20HMS%20in%20the%20North%20Atlantic%20Ocean.pdf'],['26224_0_navigating our changing oceans an assessment of climate change impacts to highly migratory species in the north atlantic ocean.pdf'],1,100.0,['https://www.edf.org/sites/default/files/documents/An%20Assessment%20of%20Climate%20Change%20Impacts%20to%20HMS%20in%20the%20North%20Atlantic%20Ocean.pdf'],['26224_0_navigating our changing oceans an assessment of climate change impacts to highly migratory species in the north atlantic ocean.pdf'],[0.475],[0.498],[0.611],[0.15],[0.148],[0.124],[0.733],[0.641],[0.571],[0.682],[0.794],[0.706],[0.631],[0.91],[0.81],[0.755],[0.788],[0.78],0.475,0.498,0.611,0.15,0.148,0.124,0.733,0.641,0.571,0.682,0.794,0.706,0.631,0.91,0.81,0.755,0.788,0.78
https://doi.org/10.1093/ecco-jcc/jjx109,research gaps in diet and nutrition in inflammatory bowel disease a topical review by decco working group dietitians of ecco,26249_research gaps in diet and nutrition in inflammatory bowel disease a topical review by decco working group dietitians of ecco.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872448/pdf'],['British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872448/pdf'],['26249_0_british society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872448/pdf'],['26249_0_british society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.pdf'],[0.668],[0.569],[0.651],[0.17],[0.182],[0.133],[0.745],[0.654],[0.632],[0.64],[0.815],[0.75],[0.634],[0.924],[0.827],[0.78],[0.815],[0.798],0.668,0.569,0.651,0.17,0.182,0.133,0.745,0.654,0.632,0.64,0.815,0.75,0.634,0.924,0.827,0.78,0.815,0.798
https://doi.org/10.1093/ej/ueaa135,household debt and monetary policy revealing the cashflow channel,26259_household debt and monetary policy revealing the cashflow channel.pdf,2,"['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2206.pdf', 'https://www.frbsf.org/economic-research/publications/working-papers/2020/03/']","['How Do Mortgage Rate Resets Affect Consumer Spending and Debt Repayment? Evidence from Canadian Consumers', 'The Transmission of Monetary Policy under the Microscope']",['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2206.pdf'],['26259_0_how do mortgage rate resets affect consumer spending and debt repayment evidence from canadian consumers.pdf'],1,50.0,['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2206.pdf'],['26259_0_how do mortgage rate resets affect consumer spending and debt repayment evidence from canadian consumers.pdf'],[0.468],[0.58],[0.652],[0.202],[0.21],[0.194],[0.733],[0.639],[0.641],[0.728],[0.815],[0.753],[0.675],[0.921],[0.857],[0.795],[0.827],[0.81],0.468,0.58,0.652,0.202,0.21,0.194,0.733,0.639,0.641,0.728,0.815,0.753,0.675,0.921,0.857,0.795,0.827,0.81
https://doi.org/10.1093/eurheartj/ehab075,patterns of myocardial injury in recovered troponinpositive covid19 patients assessed by cardiovascular magnetic resonance,26287_patterns of myocardial injury in recovered troponinpositive covid19 patients assessed by cardiovascular magnetic resonance.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180343/pdf'],"['Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180343/pdf'],['26287_0_long covid19 a primer for cardiovascular health professionals on behalf of the ccs rapid response team.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180343/pdf'],['26287_0_long covid19 a primer for cardiovascular health professionals on behalf of the ccs rapid response team.pdf'],[0.503],[0.587],[0.655],[0.221],[0.224],[0.17],[0.753],[0.662],[0.651],[0.661],[0.81],[0.768],[0.634],[0.925],[0.843],[0.782],[0.806],[0.791],0.503,0.587,0.655,0.221,0.224,0.17,0.753,0.662,0.651,0.661,0.81,0.768,0.634,0.925,0.843,0.782,0.806,0.791
https://doi.org/10.1093/geroni/igaa057.1466,predictors of change in osteoporosis knowledge health beliefs and selfefficacy after an education intervention,26350_predictors of change in osteoporosis knowledge health beliefs and selfefficacy after an education intervention.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575556/pdf'],['Decision coaching for people making healthcare decisions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575556/pdf'],['26350_0_decision coaching for people making healthcare decisions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575556/pdf'],['26350_0_decision coaching for people making healthcare decisions.pdf'],[0.194],[0.538],[0.629],[0.154],[0.152],[0.127],[0.729],[0.631],[0.605],[0.677],[0.796],[0.714],[0.6],[0.929],[0.834],[0.741],[0.793],[0.773],0.194,0.538,0.629,0.154,0.152,0.127,0.729,0.631,0.605,0.677,0.796,0.714,0.6,0.929,0.834,0.741,0.793,0.773
https://doi.org/10.1093/heapol/czz028,the effectiveness of training in emergency obstetric care a systematic literature review,26446_the effectiveness of training in emergency obstetric care a systematic literature review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093891/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094450/pdf']","['Death audits and reviews for reducing maternal, perinatal and child mortality', ""Multi‐professional simulation‐based team training in obstetric emergencies for improving patient outcomes and trainees' performance""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094450/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093891/pdf']","['26446_1_multi‐professional simulation‐based team training in obstetric emergencies for improving patient outcomes and trainees performance.pdf', '26446_0_death audits and reviews for reducing maternal perinatal and child mortality.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094450/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093891/pdf']","['26446_1_multi‐professional simulation‐based team training in obstetric emergencies for improving patient outcomes and trainees performance.pdf', '26446_0_death audits and reviews for reducing maternal perinatal and child mortality.pdf']","[0.247, 0.468]","[0.526, 0.513]","[0.623, 0.611]","[0.182, 0.169]","[0.199, 0.193]","[0.16, 0.151]","[0.735, 0.735]","[0.646, 0.643]","[0.587, 0.572]","[0.682, 0.685]","[0.793, 0.782]","[0.7, 0.69]","[0.607, 0.599]","[0.919, 0.912]","[0.819, 0.816]","[0.739, 0.73]","[0.782, 0.773]","[0.765, 0.757]",0.358,0.52,0.617,0.175,0.196,0.155,0.735,0.645,0.579,0.683,0.788,0.695,0.603,0.915,0.817,0.734,0.778,0.761
https://doi.org/10.1093/heapol/czz050,the cost of not breastfeeding global results from a new tool,26447_the cost of not breastfeeding global results from a new tool.pdf,1,['https://www.bfmed.org/assets/ABM%20protocol%2035%20Nov%202021.pdf'],['ABM Clinical Protocol #35: Supporting Breastfeeding During Maternal or Child Hospitalization'],['https://www.bfmed.org/assets/ABM%20protocol%2035%20Nov%202021.pdf'],['26447_0_abm clinical protocol 35 supporting breastfeeding during maternal or child hospitalization.pdf'],1,100.0,['https://www.bfmed.org/assets/ABM%20protocol%2035%20Nov%202021.pdf'],['26447_0_abm clinical protocol 35 supporting breastfeeding during maternal or child hospitalization.pdf'],[0.338],[0.531],[0.625],[0.156],[0.169],[0.137],[0.73],[0.636],[0.607],[0.636],[0.796],[0.701],[0.614],[0.919],[0.832],[0.756],[0.789],[0.777],0.338,0.531,0.625,0.156,0.169,0.137,0.73,0.636,0.607,0.636,0.796,0.701,0.614,0.919,0.832,0.756,0.789,0.777
https://doi.org/10.1093/heapol/czz156,factors that influence the scale up of new interventions in lowincome settings a qualitative case study of the introduction of chlorhexidine cleansing of the umbilical cord in bangladesh,26448_factors that influence the scale up of new interventions in lowincome settings a qualitative case study of the introduction of chlorhexidine cleansing of the umbilical cord in bangladesh.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202131/pdf'],['Strategies to adapt and implement health system guidelines and recommendations: a scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202131/pdf'],['26448_0_strategies to adapt and implement health system guidelines and recommendations a scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202131/pdf'],['26448_0_strategies to adapt and implement health system guidelines and recommendations a scoping review.pdf'],[0.75],[0.579],[0.669],[0.209],[0.228],[0.182],[0.738],[0.655],[0.64],[0.699],[0.819],[0.752],[0.647],[0.922],[0.864],[0.784],[0.823],[0.799],0.75,0.579,0.669,0.209,0.228,0.182,0.738,0.655,0.64,0.699,0.819,0.752,0.647,0.922,0.864,0.784,0.823,0.799
https://doi.org/10.1093/heapro/day085,costs and benefits of a schoolbased health intervention in portugal,26478_costs and benefits of a schoolbased health intervention in portugal.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['26478_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['26478_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.356],[0.524],[0.608],[0.168],[0.177],[0.142],[0.73],[0.636],[0.591],[0.695],[0.786],[0.696],[0.614],[0.916],[0.827],[0.736],[0.788],[0.768],0.356,0.524,0.608,0.168,0.177,0.142,0.73,0.636,0.591,0.695,0.786,0.696,0.614,0.916,0.827,0.736,0.788,0.768
https://doi.org/10.1093/her/cyw053,factors influencing implementation of a preschoolbased physical activity intervention,26555_factors influencing implementation of a preschoolbased physical activity intervention.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf'],"['Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf'],['26555_0_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf'],['26555_0_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf'],[0.4],[0.532],[0.609],[0.166],[0.169],[0.138],[0.73],[0.637],[0.591],[0.698],[0.774],[0.707],[0.61],[0.911],[0.817],[0.725],[0.779],[0.751],0.4,0.532,0.609,0.166,0.169,0.138,0.73,0.637,0.591,0.698,0.774,0.707,0.61,0.911,0.817,0.725,0.779,0.751
https://doi.org/10.1093/humrep/deaa182,the lhfsh ratio is not a sexdimorphic marker after infancy data from 6417 healthy individuals and 125 patients with differences of sex development,26588_the lhfsh ratio is not a sexdimorphic marker after infancy data from 6417 healthy individuals and 125 patients with differences of sex development.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['26588_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['26588_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.37],[0.562],[0.649],[0.194],[0.215],[0.166],[0.744],[0.647],[0.637],[0.677],[0.808],[0.735],[0.642],[0.922],[0.829],[0.785],[0.813],[0.796],0.37,0.562,0.649,0.194,0.215,0.166,0.744,0.647,0.637,0.677,0.808,0.735,0.642,0.922,0.829,0.785,0.813,0.796
https://doi.org/10.1093/humrep/dez079,endometrial preparation methods for frozenthawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy placenta accreta and gestational diabetes mellitus,26624_endometrial preparation methods for frozenthawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy placenta accreta and gestational diabetes mellitus.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095009/pdf'],['Fresh versus frozen embryo transfers in assisted reproduction'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095009/pdf'],['26624_0_fresh versus frozen embryo transfers in assisted reproduction.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095009/pdf'],['26624_0_fresh versus frozen embryo transfers in assisted reproduction.pdf'],[0.501],[0.523],[0.604],[0.173],[0.178],[0.143],[0.737],[0.64],[0.578],[0.675],[0.772],[0.69],[0.605],[0.909],[0.79],[0.73],[0.768],[0.75],0.501,0.523,0.604,0.173,0.178,0.143,0.737,0.64,0.578,0.675,0.772,0.69,0.605,0.909,0.79,0.73,0.768,0.75
https://doi.org/10.1093/icesjms/fsz064,identifying the distribution of atlantic cod spawning using multiple fixed and glidermounted acoustic technologies,26654_identifying the distribution of atlantic cod spawning using multiple fixed and glidermounted acoustic technologies.pdf,1,['https://documents.dps.ny.gov/public/Common/ViewDoc.aspx?DocRefId={F97DE47D-4CA7-4244-B07F-90410ED58DDD}'],['Order Adopting Terms Of A Joint Proposal'],['https://documents.dps.ny.gov/public/Common/ViewDoc.aspx?DocRefId={F97DE47D-4CA7-4244-B07F-90410ED58DDD}'],['26654_0_order adopting terms of a joint proposal.pdf'],1,100.0,['https://documents.dps.ny.gov/public/Common/ViewDoc.aspx?DocRefId={F97DE47D-4CA7-4244-B07F-90410ED58DDD}'],['26654_0_order adopting terms of a joint proposal.pdf'],[0.25],[0.54],[0.619],[0.142],[0.149],[0.122],[0.73],[0.639],[0.606],[0.667],[0.804],[0.743],[0.669],[0.909],[0.84],[0.778],[0.813],[0.796],0.25,0.54,0.619,0.142,0.149,0.122,0.73,0.639,0.606,0.667,0.804,0.743,0.669,0.909,0.84,0.778,0.813,0.796
https://doi.org/10.1093/ije/dyl284,teenage pregnancy and adverse birth outcomes a large population based retrospective cohort study,26694_teenage pregnancy and adverse birth outcomes a large population based retrospective cohort study.pdf,7,"['https://www.acf.hhs.gov/opre/report/early-look-families-and-local-programs-mother-and-infant-home-visiting-program', 'https://s-media.nyc.gov/agencies/childrenscabinet/NYCDOH_GrowingUP_Policy_Brochure_For_WEB.pdf', 'https://papers.nber.org/papers/w13386', 'https://www.acf.hhs.gov/opre/resource/an-early-look-at-families-and-local-programs-in-the-mother-and-infant-home-visiting-program-evaluation-strong-start', ""http://www.dcfs.louisiana.gov/assets/docs/searchable/WomensPolicy/Women's%20Policy%20Research%20Commission%202014%20Report%20FINAL.pdf"", 'https://www.nber.org/papers/w19479', 'https://purl.fdlp.gov/GPO/gpo115465']","['An Early Look at Families and Local Programs in the Mother and Infant Home Visiting Program Evaluation-Strong Start', 'A Policy Framework', 'Teen Smoking and Birth Outcomes', 'An Early Look at Families and Local Programs in the Mother and Infant Home Visiting Program Evaluation-Strong Start', 'Louisiana Women ’s Policy and Research Commission 2014 Report to the Governor', 'Girl Power: Cash Transfers and Adolescent Welfare. Evidence from a Cluster-Randomized Experiment in Malawi', 'Sexual and reproductive health in early and later adolescence :\xa0DHS data on yourth age 10-19 /']","[""http://www.dcfs.louisiana.gov/assets/docs/searchable/WomensPolicy/Women's%20Policy%20Research%20Commission%202014%20Report%20FINAL.pdf"", 'https://purl.fdlp.gov/GPO/gpo115465', 'https://s-media.nyc.gov/agencies/childrenscabinet/NYCDOH_GrowingUP_Policy_Brochure_For_WEB.pdf']","['26694_4_louisiana women s policy and research commission 2014 report to the governor.pdf', '26694_6_sexual and reproductive health in early and later adolescence \xa0dhs data on yourth age 1019 .pdf', '26694_1_a policy framework.pdf']",3,42.86,"[""http://www.dcfs.louisiana.gov/assets/docs/searchable/WomensPolicy/Women's%20Policy%20Research%20Commission%202014%20Report%20FINAL.pdf"", 'https://purl.fdlp.gov/GPO/gpo115465', 'https://s-media.nyc.gov/agencies/childrenscabinet/NYCDOH_GrowingUP_Policy_Brochure_For_WEB.pdf']","['26694_4_louisiana women s policy and research commission 2014 report to the governor.pdf', '26694_6_sexual and reproductive health in early and later adolescence \xa0dhs data on yourth age 1019 .pdf', '26694_1_a policy framework.pdf']","[0.188, 0.174, 0.324]","[0.529, 0.531, 0.517]","[0.623, 0.618, 0.61]","[0.116, 0.175, 0.122]","[0.121, 0.191, 0.129]","[0.097, 0.159, 0.116]","[0.717, 0.731, 0.721]","[0.614, 0.627, 0.619]","[0.599, 0.587, 0.58]","[0.609, 0.666, 0.637]","[0.803, 0.793, 0.783]","[0.741, 0.694, 0.717]","[0.623, 0.627, 0.606]","[0.916, 0.913, 0.919]","[0.839, 0.833, 0.818]","[0.763, 0.751, 0.749]","[0.806, 0.795, 0.788]","[0.785, 0.782, 0.772]",0.229,0.526,0.617,0.138,0.147,0.124,0.723,0.62,0.589,0.637,0.793,0.717,0.619,0.916,0.83,0.754,0.796,0.78
https://doi.org/10.1093/ije/dyn099,multicountry analysis of the effects of diarrhoea on childhood stunting,26700_multicountry analysis of the effects of diarrhoea on childhood stunting.pdf,10,"['http://www.ifpri.org/publication/assessing-health-and-nutrition-risks-smallholder-poultry-production-burkina-faso', 'https://nicholasinstitute.duke.edu/publications/bigger-change-faster', 'http://www.ifpri.org/publication/water-sanitation-and-child-health-evidence-subnational-panel-data-59-countries', 'https://www.nber.org/papers/w20997', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf', 'http://www.ifpri.org/publication/2016-global-food-policy-report', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/132796', 'https://mathematica.org/publications/mcc-indonesia-nutrition-project-impact-evaluation-design', 'https://mathematica.org/publications/mcc-indonesia-nutrition-project-impact-evaluation-final-report', 'https://www.csis.org/analysis/nutrition-policy-primer-untapped-path-global-health-economic-growth-and-human-security']","['Assessing the health and nutrition risks of smallholder poultry', 'Bigger Change Faster', 'Water, sanitation and child health: Evidence from subnational panel', 'How Does Health Promotion Work? Evidence From The Dirty Business of Eliminating Open Defecation', 'Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low‐ and middle‐income countries (LMIC)', '2016 Global Food Policy Report', 'Water, sanitation and child health: Evidence from subnational panel data in 59 countries', 'MCC Indonesia Nutrition Project Impact Evaluation Design', 'MCC Indonesia Nutrition Project Impact Evaluation Final Report', 'Nutrition Policy Primer: The Untapped Path to Global Health, Economic Growth, and Human Security']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf'],['26700_4_nutritional interventions for preventing stunting in children birth to 59 months living in urban slums in low‐ and middle‐income countries lmic.pdf'],1,10.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf'],['26700_4_nutritional interventions for preventing stunting in children birth to 59 months living in urban slums in low‐ and middle‐income countries lmic.pdf'],[0.374],[0.539],[0.63],[0.167],[0.187],[0.136],[0.728],[0.629],[0.612],[0.707],[0.793],[0.729],[0.617],[0.925],[0.839],[0.749],[0.797],[0.776],0.374,0.539,0.63,0.167,0.187,0.136,0.728,0.629,0.612,0.707,0.793,0.729,0.617,0.925,0.839,0.749,0.797,0.776
https://doi.org/10.1093/infdis/jiaa101,maternal secretor status affects oral rotavirus vaccine response in breastfed infants in bangladesh,26751_maternal secretor status affects oral rotavirus vaccine response in breastfed infants in bangladesh.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf'],['Vaccines for preventing rotavirus diarrhoea: vaccines in use'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf'],['26751_0_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597890/pdf'],['26751_0_vaccines for preventing rotavirus diarrhoea vaccines in use.pdf'],[0.302],[0.521],[0.608],[0.161],[0.155],[0.132],[0.737],[0.645],[0.588],[0.669],[0.783],[0.693],[0.578],[0.914],[0.801],[0.73],[0.78],[0.754],0.302,0.521,0.608,0.161,0.155,0.132,0.737,0.645,0.588,0.669,0.783,0.693,0.578,0.914,0.801,0.73,0.78,0.754
https://doi.org/10.1093/infdis/jiaa113,a 55dayold female infant infected with 2019 novel coronavirus disease presenting with pneumonia liver injury and heart damage,26752_a 55dayold female infant infected with 2019 novel coronavirus disease presenting with pneumonia liver injury and heart damage.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165275/pdf'],['COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165275/pdf'],['26752_0_covid19 and ent pediatric otolaryngology during the covid19 pandemic guidelines of the french association of pediatric otorhinolaryngology afop and french society of otorhinolaryngology sforl.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165275/pdf'],['26752_0_covid19 and ent pediatric otolaryngology during the covid19 pandemic guidelines of the french association of pediatric otorhinolaryngology afop and french society of otorhinolaryngology sforl.pdf'],[0.236],[0.593],[0.667],[0.203],[0.21],[0.159],[0.744],[0.65],[0.669],[0.611],[0.82],[0.774],[0.634],[0.916],[0.847],[0.792],[0.819],[0.806],0.236,0.593,0.667,0.203,0.21,0.159,0.744,0.65,0.669,0.611,0.82,0.774,0.634,0.916,0.847,0.792,0.819,0.806
https://doi.org/10.1093/infdis/jiaa119,clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in shenzhen china,26753_clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in shenzhen china.pdf,6,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_07.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_21.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_14.pdf', 'https://stacks.cdc.gov/view/cdc/96861', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732472/pdf']","['Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARs-CoV-2)', 'Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)', 'COVID-19 Updates', 'An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_07.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732472/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_21.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_14.pdf']","['26753_0_master question list for covid19 caused by sarscov2.pdf', '26753_4_covid19 updates.pdf', '26753_5_an italian guidance model for the management of suspected or confirmed covid19 patients in the primary care setting.pdf', '26753_1_master question list for covid19 caused by sarscov2.pdf', '26753_2_master question list for covid19 caused by sarscov2.pdf']",5,83.33,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_07.pdf', 'https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-providers-dear-colleague-updates.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732472/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_21.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_2020_04_14.pdf']","['26753_0_master question list for covid19 caused by sarscov2.pdf', '26753_4_covid19 updates.pdf', '26753_5_an italian guidance model for the management of suspected or confirmed covid19 patients in the primary care setting.pdf', '26753_1_master question list for covid19 caused by sarscov2.pdf', '26753_2_master question list for covid19 caused by sarscov2.pdf']","[0.411, 0.426, 0.414, 0.359, 0.462]","[0.578, 0.606, 0.56, 0.587, 0.584]","[0.656, 0.678, 0.642, 0.663, 0.661]","[0.199, 0.198, 0.189, 0.202, 0.197]","[0.206, 0.208, 0.201, 0.208, 0.206]","[0.167, 0.168, 0.155, 0.167, 0.165]","[0.746, 0.74, 0.743, 0.745, 0.745]","[0.652, 0.648, 0.649, 0.65, 0.649]","[0.653, 0.677, 0.625, 0.665, 0.663]","[0.649, 0.642, 0.649, 0.646, 0.646]","[0.814, 0.836, 0.807, 0.82, 0.82]","[0.766, 0.794, 0.739, 0.777, 0.775]","[0.635, 0.652, 0.623, 0.641, 0.639]","[0.91, 0.916, 0.903, 0.91, 0.91]","[0.854, 0.859, 0.838, 0.856, 0.855]","[0.783, 0.804, 0.769, 0.79, 0.789]","[0.821, 0.844, 0.81, 0.829, 0.828]","[0.802, 0.822, 0.79, 0.809, 0.808]",0.414,0.583,0.66,0.197,0.206,0.164,0.744,0.65,0.657,0.646,0.819,0.77,0.638,0.91,0.852,0.787,0.826,0.806
https://doi.org/10.1093/infdis/jiz390,safety and immunogenicity of a respiratory syncytial virus fusion f protein nanoparticle vaccine in healthy thirdtrimester pregnant women and their infants,26786_safety and immunogenicity of a respiratory syncytial virus fusion f protein nanoparticle vaccine in healthy thirdtrimester pregnant women and their infants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749450/pdf'],['Vaccines for the common cold'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749450/pdf'],['26786_0_vaccines for the common cold.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749450/pdf'],['26786_0_vaccines for the common cold.pdf'],[0.38],[0.514],[0.608],[0.159],[0.159],[0.136],[0.735],[0.644],[0.585],[0.666],[0.768],[0.681],[0.588],[0.92],[0.8],[0.742],[0.77],[0.758],0.38,0.514,0.608,0.159,0.159,0.136,0.735,0.644,0.585,0.666,0.768,0.681,0.588,0.92,0.8,0.742,0.77,0.758
https://doi.org/10.1093/jmammal/gyz134,physiological and behavioral responses to anthropogenic stressors in a humantolerant mammal,26868_physiological and behavioral responses to anthropogenic stressors in a humantolerant mammal.pdf,2,"['https://contracosta.ca.gov/AgendaCenter/ViewFile/Agenda/_06152022-4403', 'https://contracosta.ca.gov/AgendaCenter/ViewFile/ArchivedAgenda/_06152022-2292']","['Fish and Wildlife Committee (FWC)', 'Fish and Wildlife Committee (FWC)']","['https://contracosta.ca.gov/AgendaCenter/ViewFile/ArchivedAgenda/_06152022-2292', 'https://contracosta.ca.gov/AgendaCenter/ViewFile/Agenda/_06152022-4403']","['26868_1_fish and wildlife committee fwc.pdf', '26868_0_fish and wildlife committee fwc.pdf']",2,100.0,"['https://contracosta.ca.gov/AgendaCenter/ViewFile/ArchivedAgenda/_06152022-2292', 'https://contracosta.ca.gov/AgendaCenter/ViewFile/Agenda/_06152022-4403']","['26868_1_fish and wildlife committee fwc.pdf', '26868_0_fish and wildlife committee fwc.pdf']","[0.322, 0.322]","[0.483, 0.483]","[0.58, 0.58]","[0.105, 0.105]","[0.106, 0.106]","[0.089, 0.089]","[0.725, 0.725]","[0.627, 0.627]","[0.55, 0.55]","[0.678, 0.678]","[0.775, 0.775]","[0.684, 0.684]","[0.621, 0.621]","[0.909, 0.909]","[0.801, 0.801]","[0.742, 0.742]","[0.775, 0.775]","[0.76, 0.76]",0.322,0.483,0.58,0.105,0.106,0.089,0.725,0.627,0.55,0.678,0.775,0.684,0.621,0.909,0.801,0.742,0.775,0.76
https://doi.org/10.1093/jn/130.2.452s,supplementation with iron and folic acid enhances growth in adolescent indian girls,26878_supplementation with iron and folic acid enhances growth in adolescent indian girls.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf'],['Oral iron supplements for children in malaria‐endemic areas'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf'],['26878_0_oral iron supplements for children in malaria‐endemic areas.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf'],['26878_0_oral iron supplements for children in malaria‐endemic areas.pdf'],[0.28],[0.517],[0.604],[0.166],[0.18],[0.139],[0.729],[0.628],[0.578],[0.671],[0.777],[0.695],[0.596],[0.908],[0.813],[0.739],[0.785],[0.765],0.28,0.517,0.604,0.166,0.18,0.139,0.729,0.628,0.578,0.671,0.777,0.695,0.596,0.908,0.813,0.739,0.785,0.765
https://doi.org/10.1093/jn/132.11.3243,vitamin a supplementation of women postpartum and of their infants at immunization alters breast milk retinol and infant vitamin a status,26897_vitamin a supplementation of women postpartum and of their infants at immunization alters breast milk retinol and infant vitamin a status.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407451/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457829/pdf']","['Vitamin A supplementation for postpartum women', 'Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407451/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457829/pdf']","['26897_0_vitamin a supplementation for postpartum women.pdf', '26897_1_vitamin a supplementation for the prevention of morbidity and mortality in infants one to six months of age.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407451/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457829/pdf']","['26897_0_vitamin a supplementation for postpartum women.pdf', '26897_1_vitamin a supplementation for the prevention of morbidity and mortality in infants one to six months of age.pdf']","[0.518, 0.519]","[0.518, 0.521]","[0.596, 0.603]","[0.171, 0.176]","[0.178, 0.19]","[0.147, 0.154]","[0.739, 0.74]","[0.644, 0.646]","[0.576, 0.582]","[0.674, 0.677]","[0.778, 0.781]","[0.682, 0.687]","[0.599, 0.603]","[0.91, 0.912]","[0.8, 0.805]","[0.735, 0.735]","[0.777, 0.776]","[0.76, 0.761]",0.518,0.52,0.599,0.173,0.184,0.15,0.74,0.645,0.579,0.675,0.78,0.685,0.601,0.911,0.802,0.735,0.776,0.76
https://doi.org/10.1093/jn/132.6.1395s,nutrient requirements for preterm infant formulas23,26902_nutrient requirements for preterm infant formulas23.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636703/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513426/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478109/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912912/pdf']","['Higher versus lower protein intake in formula‐fed low birth weight infants', 'Carbohydrate supplementation of human milk to promote growth in preterm infants', 'Nutrient‐enriched formula versus standard formula for preterm infants', 'Carbohydrate supplementation of human milk to promote growth in preterm infants', 'Arginine supplementation for prevention of necrotising enterocolitis in preterm infants', 'Effect of taurine supplementation on growth and development in preterm or low birth weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912912/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513426/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478109/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636703/pdf']","['26902_5_effect of taurine supplementation on growth and development in preterm or low birth weight infants.pdf', '26902_1_carbohydrate supplementation of human milk to promote growth in preterm infants.pdf', '26902_3_carbohydrate supplementation of human milk to promote growth in preterm infants.pdf', '26902_0_higher versus lower protein intake in formula‐fed low birth weight infants.pdf', '26902_4_arginine supplementation for prevention of necrotising enterocolitis in preterm infants.pdf', '26902_2_nutrient‐enriched formula versus standard formula for preterm infants.pdf']",6,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912912/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094174/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513426/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387284/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478109/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636703/pdf']","['26902_5_effect of taurine supplementation on growth and development in preterm or low birth weight infants.pdf', '26902_1_carbohydrate supplementation of human milk to promote growth in preterm infants.pdf', '26902_3_carbohydrate supplementation of human milk to promote growth in preterm infants.pdf', '26902_0_higher versus lower protein intake in formula‐fed low birth weight infants.pdf', '26902_4_arginine supplementation for prevention of necrotising enterocolitis in preterm infants.pdf', '26902_2_nutrient‐enriched formula versus standard formula for preterm infants.pdf']","[0.477, 0.431, 0.452, 0.443, 0.309, 0.483]","[0.506, 0.511, 0.513, 0.514, 0.503, 0.495]","[0.6, 0.607, 0.608, 0.602, 0.594, 0.584]","[0.152, 0.147, 0.15, 0.157, 0.14, 0.148]","[0.156, 0.156, 0.16, 0.154, 0.138, 0.146]","[0.129, 0.124, 0.126, 0.132, 0.11, 0.128]","[0.734, 0.728, 0.73, 0.735, 0.731, 0.736]","[0.636, 0.632, 0.634, 0.64, 0.635, 0.639]","[0.576, 0.577, 0.579, 0.577, 0.565, 0.561]","[0.674, 0.672, 0.672, 0.682, 0.667, 0.683]","[0.774, 0.776, 0.777, 0.774, 0.77, 0.765]","[0.674, 0.691, 0.69, 0.679, 0.674, 0.662]","[0.599, 0.6, 0.6, 0.597, 0.593, 0.588]","[0.915, 0.911, 0.911, 0.909, 0.9, 0.904]","[0.798, 0.801, 0.799, 0.797, 0.784, 0.789]","[0.732, 0.724, 0.726, 0.727, 0.713, 0.714]","[0.771, 0.769, 0.77, 0.771, 0.763, 0.76]","[0.76, 0.755, 0.755, 0.758, 0.742, 0.746]",0.433,0.507,0.599,0.149,0.152,0.125,0.732,0.636,0.573,0.675,0.773,0.678,0.596,0.908,0.795,0.723,0.767,0.753
https://doi.org/10.1093/jn/133.11.3461,total body iron in hivpositive and hivnegative zimbabwean newborns strongly predicts anemia throughout infancy and is predicted by maternal hemoglobin concentration,26913_total body iron in hivpositive and hivnegative zimbabwean newborns strongly predicts anemia throughout infancy and is predicted by maternal hemoglobin concentration.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618453/pdf'],['Vitamin A supplements for reducing mother‐to‐child HIV transmission'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618453/pdf'],['26913_0_vitamin a supplements for reducing mother‐to‐child hiv transmission.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618453/pdf'],['26913_0_vitamin a supplements for reducing mother‐to‐child hiv transmission.pdf'],[0.189],[0.514],[0.606],[0.141],[0.146],[0.122],[0.732],[0.629],[0.575],[0.685],[0.771],[0.687],[0.589],[0.909],[0.801],[0.723],[0.771],[0.752],0.189,0.514,0.606,0.141,0.146,0.122,0.732,0.629,0.575,0.685,0.771,0.687,0.589,0.909,0.801,0.723,0.771,0.752
https://doi.org/10.1093/jn/134.5.1167,daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western kenya,26942_daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western kenya.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547491/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf']","['Intermittent iron supplementation for improving nutrition and development in children under 12 years of age', 'Oral iron supplements for children in malaria‐endemic areas']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547491/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf']","['26942_0_intermittent iron supplementation for improving nutrition and development in children under 12 years of age.pdf', '26942_1_oral iron supplements for children in malaria‐endemic areas.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547491/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916933/pdf']","['26942_0_intermittent iron supplementation for improving nutrition and development in children under 12 years of age.pdf', '26942_1_oral iron supplements for children in malaria‐endemic areas.pdf']","[0.575, 0.54]","[0.497, 0.511]","[0.583, 0.597]","[0.166, 0.167]","[0.162, 0.171]","[0.141, 0.139]","[0.74, 0.737]","[0.644, 0.641]","[0.555, 0.573]","[0.697, 0.694]","[0.768, 0.775]","[0.658, 0.684]","[0.592, 0.593]","[0.907, 0.913]","[0.794, 0.8]","[0.726, 0.733]","[0.765, 0.776]","[0.756, 0.76]",0.557,0.504,0.59,0.167,0.167,0.14,0.738,0.643,0.564,0.696,0.772,0.671,0.593,0.91,0.797,0.73,0.77,0.758
https://doi.org/10.1093/jn/135.4.910,public health strategies for dietary change schools and workplaces,26949_public health strategies for dietary change schools and workplaces.pdf,4,"['http://purl.fdlp.gov/GPO/gpo57549', 'https://www.nber.org/papers/w15436', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953356/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710643/pdf']","['Evaluation of the healthy incentives pilot (HIP), final report /', 'Effects of Urban Sprawl on Obesity', 'Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption', 'Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption']","['http://purl.fdlp.gov/GPO/gpo57549', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710643/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953356/pdf']","['26949_0_evaluation of the healthy incentives pilot hip final report .pdf', '26949_3_altering the availability or proximity of food alcohol and tobacco products to change their selection and consumption.pdf', '26949_2_altering the availability or proximity of food alcohol and tobacco products to change their selection and consumption.pdf']",3,75.0,"['http://purl.fdlp.gov/GPO/gpo57549', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710643/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953356/pdf']","['26949_0_evaluation of the healthy incentives pilot hip final report .pdf', '26949_3_altering the availability or proximity of food alcohol and tobacco products to change their selection and consumption.pdf', '26949_2_altering the availability or proximity of food alcohol and tobacco products to change their selection and consumption.pdf']","[0.175, 0.345, 0.378]","[0.512, 0.531, 0.522]","[0.6, 0.619, 0.614]","[0.144, 0.164, 0.156]","[0.155, 0.189, 0.179]","[0.141, 0.153, 0.147]","[0.723, 0.727, 0.727]","[0.623, 0.628, 0.627]","[0.586, 0.611, 0.597]","[0.682, 0.689, 0.69]","[0.779, 0.789, 0.781]","[0.71, 0.734, 0.72]","[0.638, 0.631, 0.617]","[0.921, 0.921, 0.924]","[0.81, 0.818, 0.817]","[0.75, 0.754, 0.741]","[0.787, 0.795, 0.786]","[0.768, 0.775, 0.768]",0.299,0.522,0.611,0.155,0.174,0.147,0.726,0.626,0.598,0.687,0.783,0.721,0.629,0.922,0.815,0.748,0.789,0.77
https://doi.org/10.1093/jn/138.1.73,maternal dietary intake of polyunsaturated fatty acids modifies the relationship between lead levels in bone and breast milk,26971_maternal dietary intake of polyunsaturated fatty acids modifies the relationship between lead levels in bone and breast milk.pdf,5,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://stacks.cdc.gov/view/cdc/78185', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://purl.fdlp.gov/GPO/gpo144830']","['2015-Lead-Poisoning', 'Toxicological Profile for Lead, Draft for Public Comment', 'Toxicological profile for lead : draft for public comment', 'Toxicological profile for lead: draft for public comment.', 'Toxicological profile for lead /']","['https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo144830']","['26971_3_toxicological profile for lead draft for public comment.pdf', '26971_0_2015leadpoisoning.pdf', '26971_1_toxicological profile for lead draft for public comment.pdf', '26971_4_toxicological profile for lead .pdf']",4,80.0,"['https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo144830']","['26971_3_toxicological profile for lead draft for public comment.pdf', '26971_0_2015leadpoisoning.pdf', '26971_1_toxicological profile for lead draft for public comment.pdf', '26971_4_toxicological profile for lead .pdf']","[0.446, 0.387, 0.387, 0.397]","[0.506, 0.508, 0.506, 0.501]","[0.607, 0.608, 0.607, 0.604]","[0.146, 0.145, 0.146, 0.147]","[0.153, 0.152, 0.153, 0.153]","[0.12, 0.119, 0.12, 0.12]","[0.734, 0.732, 0.734, 0.734]","[0.64, 0.638, 0.64, 0.64]","[0.573, 0.576, 0.573, 0.567]","[0.659, 0.656, 0.659, 0.66]","[0.785, 0.785, 0.785, 0.783]","[0.687, 0.691, 0.687, 0.682]","[0.609, 0.611, 0.609, 0.608]","[0.912, 0.912, 0.912, 0.911]","[0.798, 0.801, 0.798, 0.795]","[0.74, 0.741, 0.74, 0.737]","[0.776, 0.779, 0.776, 0.772]","[0.764, 0.766, 0.764, 0.761]",0.404,0.505,0.606,0.146,0.153,0.12,0.734,0.64,0.572,0.658,0.784,0.687,0.609,0.912,0.798,0.74,0.776,0.764
https://doi.org/10.1093/jnci/djz006,longitudinal ecigarette and cigarette use among us youth in the path study 2013–2015,27008_longitudinal ecigarette and cigarette use among us youth in the path study 2013–2015.pdf,2,"['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['PM0000529', 'PM0000551']","['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['27008_0_pm0000529.pdf', '27008_1_pm0000551.pdf']",2,100.0,"['https://www.fda.gov/media/158754/download', 'https://www.fda.gov/media/153017/download']","['27008_0_pm0000529.pdf', '27008_1_pm0000551.pdf']","[0.414, 0.548]","[0.524, 0.518]","[0.609, 0.604]","[0.172, 0.177]","[0.19, 0.196]","[0.155, 0.162]","[0.735, 0.74]","[0.645, 0.649]","[0.587, 0.579]","[0.674, 0.688]","[0.788, 0.786]","[0.724, 0.713]","[0.63, 0.622]","[0.917, 0.912]","[0.814, 0.807]","[0.761, 0.75]","[0.796, 0.792]","[0.776, 0.773]",0.481,0.521,0.607,0.174,0.193,0.159,0.738,0.647,0.583,0.681,0.787,0.718,0.626,0.915,0.81,0.756,0.794,0.774
https://doi.org/10.1093/jpids/piaa098,multidisciplinary guidance regarding the use of immunomodulatory therapies for acute coronavirus disease 2019 in pediatric patients,27091_multidisciplinary guidance regarding the use of immunomodulatory therapies for acute coronavirus disease 2019 in pediatric patients.pdf,1,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines'],['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['27091_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,100.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['27091_0_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.768],[0.568],[0.641],[0.192],[0.199],[0.154],[0.75],[0.66],[0.627],[0.643],[0.803],[0.725],[0.619],[0.908],[0.815],[0.777],[0.802],[0.792],0.768,0.568,0.641,0.192,0.199,0.154,0.75,0.66,0.627,0.643,0.803,0.725,0.619,0.908,0.815,0.777,0.802,0.792
https://doi.org/10.1093/jpids/piaa164,a surge in pediatric coronavirus disease 2019 cases the experience of texas children’s hospital from march to june 2020,27092_a surge in pediatric coronavirus disease 2019 cases the experience of texas children’s hospital from march to june 2020.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['27092_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['27092_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],[0.411],[0.527],[0.602],[0.16],[0.153],[0.125],[0.733],[0.636],[0.586],[0.683],[0.779],[0.697],[0.609],[0.914],[0.826],[0.736],[0.786],[0.765],0.411,0.527,0.602,0.16,0.153,0.125,0.733,0.636,0.586,0.683,0.779,0.697,0.609,0.914,0.826,0.736,0.786,0.765
https://doi.org/10.1093/jpids/piz018,evaluation and management of congenital chagas disease in the united states,27099_evaluation and management of congenital chagas disease in the united states.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218776/pdf'],['WHF IASC Roadmap on Chagas Disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218776/pdf'],['27099_0_whf iasc roadmap on chagas disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218776/pdf'],['27099_0_whf iasc roadmap on chagas disease.pdf'],[0.501],[0.566],[0.643],[0.175],[0.178],[0.133],[0.741],[0.646],[0.633],[0.633],[0.813],[0.754],[0.638],[0.92],[0.837],[0.779],[0.819],[0.803],0.501,0.566,0.643,0.175,0.178,0.133,0.741,0.646,0.633,0.633,0.813,0.754,0.638,0.92,0.837,0.779,0.819,0.803
https://doi.org/10.1093/jrr/rraa096,molecular pathogenesis of pediatric thyroid carcinoma,27100_molecular pathogenesis of pediatric thyroid carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716393/pdf'],['2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716393/pdf'],['27100_0_2022 european thyroid association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716393/pdf'],['27100_0_2022 european thyroid association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.pdf'],[0.488],[0.532],[0.611],[0.163],[0.169],[0.128],[0.741],[0.645],[0.606],[0.655],[0.802],[0.73],[0.619],[0.916],[0.813],[0.765],[0.798],[0.788],0.488,0.532,0.611,0.163,0.169,0.128,0.741,0.645,0.606,0.655,0.802,0.73,0.619,0.916,0.813,0.765,0.798,0.788
https://doi.org/10.1093/ndt/gfz158,outcome of children with shiga toxinassociated haemolytic uraemic syndrome treated with eculizumab a matched cohort study,27142_outcome of children with shiga toxinassociated haemolytic uraemic syndrome treated with eculizumab a matched cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078160/pdf'],['Interventions for atypical haemolytic uraemic syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078160/pdf'],['27142_0_interventions for atypical haemolytic uraemic syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078160/pdf'],['27142_0_interventions for atypical haemolytic uraemic syndrome.pdf'],[0.487],[0.559],[0.644],[0.194],[0.191],[0.153],[0.741],[0.649],[0.63],[0.668],[0.805],[0.734],[0.61],[0.927],[0.835],[0.763],[0.802],[0.785],0.487,0.559,0.644,0.194,0.191,0.153,0.741,0.649,0.63,0.668,0.805,0.734,0.61,0.927,0.835,0.763,0.802,0.785
https://doi.org/10.1093/neurosurgery/46.1.85,high thoracic midline dorsal column myelotomy for severe visceral pain due to advanced stomach cancer,27151_high thoracic midline dorsal column myelotomy for severe visceral pain due to advanced stomach cancer.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884142/pdf'],['Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Neuroablative Procedures for Patients With Cancer Pain'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884142/pdf'],['27151_0_congress of neurological surgeons systematic review and evidencebased guideline on neuroablative procedures for patients with cancer pain.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884142/pdf'],['27151_0_congress of neurological surgeons systematic review and evidencebased guideline on neuroablative procedures for patients with cancer pain.pdf'],[0.715],[0.585],[0.662],[0.218],[0.243],[0.19],[0.756],[0.664],[0.649],[0.653],[0.816],[0.75],[0.637],[0.926],[0.83],[0.786],[0.821],[0.807],0.715,0.585,0.662,0.218,0.243,0.19,0.756,0.664,0.649,0.653,0.816,0.75,0.637,0.926,0.83,0.786,0.821,0.807
https://doi.org/10.1093/njaf/17.4.149,growth of saplings after selection cutting in northern hardwoods,27152_growth of saplings after selection cutting in northern hardwoods.pdf,1,['https://www1.nyc.gov/assets/dep/downloads/pdf/watershed-protection/opportunities-on-city-lands/dep_forest_management_plan_2011.pdf'],['Resource Name (Heading 1)'],['https://www1.nyc.gov/assets/dep/downloads/pdf/watershed-protection/opportunities-on-city-lands/dep_forest_management_plan_2011.pdf'],['27152_0_resource name heading 1.pdf'],1,100.0,['https://www1.nyc.gov/assets/dep/downloads/pdf/watershed-protection/opportunities-on-city-lands/dep_forest_management_plan_2011.pdf'],['27152_0_resource name heading 1.pdf'],[0.223],[0.489],[0.564],[0.131],[0.127],[0.107],[0.731],[0.631],[0.549],[0.68],[0.775],[0.69],[0.634],[0.901],[0.808],[0.743],[0.788],[0.772],0.223,0.489,0.564,0.131,0.127,0.107,0.731,0.631,0.549,0.68,0.775,0.69,0.634,0.901,0.808,0.743,0.788,0.772
https://doi.org/10.1093/ntr/nty192,formation of flavorant–propylene glycol adducts with novel toxicological properties in chemically unstable ecigarette liquids,27185_formation of flavorant–propylene glycol adducts with novel toxicological properties in chemically unstable ecigarette liquids.pdf,4,"['https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://stacks.cdc.gov/view/cdc/84557', 'https://purl.fdlp.gov/GPO/gpo132839']","['Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'Smoking Cessation', 'Smoking cessation : a report of the Surgeon General', 'Smoking cessation: a report of the Surgeon General.']","['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['27185_3_smoking cessation a report of the surgeon general.pdf', '27185_0_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']",2,50.0,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['27185_3_smoking cessation a report of the surgeon general.pdf', '27185_0_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']","[0.11, 0.11]","[0.496, 0.496]","[0.591, 0.591]","[0.115, 0.115]","[0.114, 0.114]","[0.089, 0.089]","[0.732, 0.732]","[0.639, 0.639]","[0.582, 0.582]","[0.64, 0.64]","[0.789, 0.789]","[0.705, 0.705]","[0.606, 0.606]","[0.91, 0.91]","[0.805, 0.805]","[0.744, 0.744]","[0.783, 0.783]","[0.767, 0.767]",0.11,0.496,0.591,0.115,0.114,0.089,0.732,0.639,0.582,0.64,0.789,0.705,0.606,0.91,0.805,0.744,0.783,0.767
https://doi.org/10.1093/nutrit/nuab005,dietary recommendations for women with gestational diabetes mellitus a systematic review of clinical practice guidelines,27188_dietary recommendations for women with gestational diabetes mellitus a systematic review of clinical practice guidelines.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812839/pdf'],['Clinical practice guidelines and consensus statements for antenatal oral healthcare: An assessment of their methodological quality and content of recommendations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812839/pdf'],['27188_0_clinical practice guidelines and consensus statements for antenatal oral healthcare an assessment of their methodological quality and content of recommendations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812839/pdf'],['27188_0_clinical practice guidelines and consensus statements for antenatal oral healthcare an assessment of their methodological quality and content of recommendations.pdf'],[0.313],[0.538],[0.618],[0.157],[0.178],[0.133],[0.734],[0.642],[0.599],[0.675],[0.788],[0.721],[0.625],[0.91],[0.827],[0.74],[0.799],[0.783],0.313,0.538,0.618,0.157,0.178,0.133,0.734,0.642,0.599,0.675,0.788,0.721,0.625,0.91,0.827,0.74,0.799,0.783
https://doi.org/10.1093/ofid/ofaa439.738,544 severe covid19 in children and young adults in the washington dc metropolitan region,27205_544 severe covid19 in children and young adults in the washington dc metropolitan region.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2', 'Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['27205_0_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '27205_1_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['27205_0_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '27205_1_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf']","[0.291, 0.296]","[0.528, 0.565]","[0.621, 0.636]","[0.177, 0.21]","[0.174, 0.203]","[0.131, 0.16]","[0.736, 0.743]","[0.645, 0.653]","[0.6, 0.624]","[0.651, 0.649]","[0.784, 0.801]","[0.688, 0.719]","[0.603, 0.639]","[0.916, 0.919]","[0.827, 0.831]","[0.751, 0.771]","[0.788, 0.807]","[0.776, 0.787]",0.293,0.546,0.629,0.194,0.189,0.146,0.74,0.649,0.612,0.65,0.792,0.704,0.621,0.917,0.829,0.761,0.798,0.782
https://doi.org/10.1093/ofid/ofx163.1114,baseline characteristics from prep chicago a randomized controlled diffusionbased network intervention for hiv prevention among young black men who have sex with men,27208_baseline characteristics from prep chicago a randomized controlled diffusionbased network intervention for hiv prevention among young black men who have sex with men.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],"['Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],['27208_0_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406980/pdf'],['27208_0_behavioural interventions delivered through interactive social media for health behaviour change health outcomes and health equity in the adult population.pdf'],[0.226],[0.524],[0.599],[0.157],[0.156],[0.142],[0.73],[0.634],[0.581],[0.678],[0.769],[0.674],[0.586],[0.913],[0.827],[0.724],[0.769],[0.754],0.226,0.524,0.599,0.157,0.156,0.142,0.73,0.634,0.581,0.678,0.769,0.674,0.586,0.913,0.827,0.724,0.769,0.754
https://doi.org/10.1093/pch/15.10.667,retinopathy of prematurity recommendations for screening,27263_retinopathy of prematurity recommendations for screening.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969774/pdf'],['Evaluating Retinopathy of Prematurity Screening Guidelines for 24-27 Week Gestational Age Infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969774/pdf'],['27263_0_evaluating retinopathy of prematurity screening guidelines for 2427 week gestational age infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969774/pdf'],['27263_0_evaluating retinopathy of prematurity screening guidelines for 2427 week gestational age infants.pdf'],[0.435],[0.569],[0.653],[0.229],[0.257],[0.2],[0.752],[0.665],[0.651],[0.665],[0.804],[0.746],[0.612],[0.912],[0.839],[0.774],[0.811],[0.793],0.435,0.569,0.653,0.229,0.257,0.2,0.752,0.665,0.651,0.665,0.804,0.746,0.612,0.912,0.839,0.774,0.811,0.793
https://doi.org/10.1093/pch/15.suppl_a.68ab,comparison of parentperceived acceptance of two vitamin d supplementation modalities in newborn in fants,27264_comparison of parentperceived acceptance of two vitamin d supplementation modalities in newborn in fants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['27264_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['27264_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],[0.286],[0.547],[0.62],[0.173],[0.168],[0.143],[0.73],[0.629],[0.608],[0.678],[0.789],[0.724],[0.617],[0.919],[0.832],[0.757],[0.802],[0.777],0.286,0.547,0.62,0.173,0.168,0.143,0.73,0.629,0.608,0.678,0.789,0.724,0.617,0.919,0.832,0.757,0.802,0.777
https://doi.org/10.1093/pch/16.5.271,vision and hearing screening in school settings reducing barriers to childrens achievement,27266_vision and hearing screening in school settings reducing barriers to childrens achievement.pdf,2,"['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/09_21_2018_BCPSPovertyDocument.pdf', 'https://researchforevidence.fhi360.org/what-disability-screening-tools-are-available-to-use-in-low-resource-schools']","['BCPS Poverty', 'What disability screening tools are available to use in low-resource schools?']",['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/09_21_2018_BCPSPovertyDocument.pdf'],['27266_0_bcps poverty.pdf'],1,50.0,['http://dls.maryland.gov/pubs/prod/NoPblTabMtg/CmsnInnovEduc/09_21_2018_BCPSPovertyDocument.pdf'],['27266_0_bcps poverty.pdf'],[0.365],[0.532],[0.631],[0.155],[0.15],[0.124],[0.733],[0.635],[0.603],[0.647],[0.811],[0.751],[0.642],[0.923],[0.832],[0.772],[0.812],[0.794],0.365,0.532,0.631,0.155,0.15,0.124,0.733,0.635,0.603,0.647,0.811,0.751,0.642,0.923,0.832,0.772,0.812,0.794
https://doi.org/10.1093/pch/17.10.539,improving the odds for effective developmental surveillance,27271_improving the odds for effective developmental surveillance.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868607/pdf'],['Recommendations on screening for developmental delay'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868607/pdf'],['27271_0_recommendations on screening for developmental delay.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868607/pdf'],['27271_0_recommendations on screening for developmental delay.pdf'],[0.602],[0.641],[0.696],[0.288],[0.302],[0.244],[0.752],[0.666],[0.708],[0.723],[0.844],[0.811],[0.688],[0.941],[0.878],[0.822],[0.858],[0.835],0.602,0.641,0.696,0.288,0.302,0.244,0.752,0.666,0.708,0.723,0.844,0.811,0.688,0.941,0.878,0.822,0.858,0.835
https://doi.org/10.1093/pch/9.8.556,erbs palsy – who is to blame and what will happen,27280_erbs palsy – who is to blame and what will happen.pdf,1,['http://dhss.alaska.gov/dph/wcfh/Documents/disability/Teaming.For.Success_v2.Accessible.pdf'],['Teaming for Success'],['http://dhss.alaska.gov/dph/wcfh/Documents/disability/Teaming.For.Success_v2.Accessible.pdf'],['27280_0_teaming for success.pdf'],1,100.0,['http://dhss.alaska.gov/dph/wcfh/Documents/disability/Teaming.For.Success_v2.Accessible.pdf'],['27280_0_teaming for success.pdf'],[0.079],[0.534],[0.616],[0.08],[0.085],[0.07],[0.712],[0.598],[0.634],[0.587],[0.81],[0.782],[0.638],[0.921],[0.848],[0.79],[0.828],[0.803],0.079,0.534,0.616,0.08,0.085,0.07,0.712,0.598,0.634,0.587,0.81,0.782,0.638,0.921,0.848,0.79,0.828,0.803
https://doi.org/10.1093/pch/pxy127,facilitating discharge from hospital of the healthy term infant,27283_facilitating discharge from hospital of the healthy term infant.pdf,1,['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/ABM%20Protocol%20%232bfm.2022.29203.aeh.pdf'],"['Academy of Breastfeeding Medicine Clinical Protocol #2: Guidelines for Birth Hospitalization Discharge of Breastfeeding Dyads, Revised 2022']",['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/ABM%20Protocol%20%232bfm.2022.29203.aeh.pdf'],['27283_0_academy of breastfeeding medicine clinical protocol 2 guidelines for birth hospitalization discharge of breastfeeding dyads revised 2022.pdf'],1,100.0,['https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/ABM%20Protocol%20%232bfm.2022.29203.aeh.pdf'],['27283_0_academy of breastfeeding medicine clinical protocol 2 guidelines for birth hospitalization discharge of breastfeeding dyads revised 2022.pdf'],[0.497],[0.582],[0.654],[0.206],[0.22],[0.175],[0.751],[0.664],[0.643],[0.664],[0.812],[0.742],[0.63],[0.929],[0.849],[0.782],[0.81],[0.798],0.497,0.582,0.654,0.206,0.22,0.175,0.751,0.664,0.643,0.664,0.812,0.742,0.63,0.929,0.849,0.782,0.81,0.798
https://doi.org/10.1093/pch/pxz153,dietary intake of sodium by children why it matters,27284_dietary intake of sodium by children why it matters.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706/pdf'],['Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706/pdf'],['27284_0_management of congenital nephrotic syndrome consensus recommendations of the erknetespn working group.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128706/pdf'],['27284_0_management of congenital nephrotic syndrome consensus recommendations of the erknetespn working group.pdf'],[0.179],[0.518],[0.612],[0.136],[0.128],[0.102],[0.73],[0.63],[0.593],[0.616],[0.798],[0.703],[0.608],[0.917],[0.796],[0.748],[0.784],[0.768],0.179,0.518,0.612,0.136,0.128,0.102,0.73,0.63,0.593,0.616,0.798,0.703,0.608,0.917,0.796,0.748,0.784,0.768
https://doi.org/10.1093/qje/qjz028,diversification through trade,27337_diversification through trade.pdf,5,"['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2020/0404.pdf', 'https://www.chicagofed.org/publications/working-papers/2020/2020-26', 'https://www.nber.org/papers/w28549', 'https://www.nber.org/papers/w28087', 'https://www.nber.org/papers/w27920']","['Trade Integration, Global Value Chains and Capital Accumulation', 'Trade Integration, Global Value Chains, and Capital Accumulation (REVISED May 2021)', 'Global Value Chains', 'Trade Integration, Global Value Chains, and Capital Accumulation', 'Anxiety or Pain? The Impact of Tariffs and Uncertainty on Chinese Firms in the Trade War']",['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2020/0404.pdf'],['27337_0_trade integration global value chains and capital accumulation.pdf'],1,20.0,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2020/0404.pdf'],['27337_0_trade integration global value chains and capital accumulation.pdf'],[0.508],[0.621],[0.694],[0.219],[0.237],[0.21],[0.733],[0.636],[0.688],[0.745],[0.836],[0.787],[0.715],[0.928],[0.878],[0.818],[0.852],[0.835],0.508,0.621,0.694,0.219,0.237,0.21,0.733,0.636,0.688,0.745,0.836,0.787,0.715,0.928,0.878,0.818,0.852,0.835
https://doi.org/10.1093/rfs/hhz015,sex drugs and bitcoin how much illegal activity is financed through cryptocurrencies,27413_sex drugs and bitcoin how much illegal activity is financed through cryptocurrencies.pdf,5,"['https://www.rand.org/pubs/research_reports/RR4418.html', 'https://www.independent.org/news/article.asp?id=13811', 'https://www.rand.org/pubs/research_reports/RRA757-1.html', 'https://www.dallasfed.org/~/media/documents/research/international/wpapers/2019/0371.pdf', 'https://mises.org/wire/indias-crypto-clueless-regulators']","['Exploring the use of Zcash cryptocurrency for illicit or criminal purposes', 'How Innovative Is Crypto?', 'Updating Personnel Vetting and Security Clearance Guidelines for Future Generations', 'Embedded Supervision: How to Build Regulation into Blockchain Finance', ""India's Crypto-Clueless Regulators""]",['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2019/0371.pdf'],['27413_3_embedded supervision how to build regulation into blockchain finance.pdf'],1,20.0,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2019/0371.pdf'],['27413_3_embedded supervision how to build regulation into blockchain finance.pdf'],[0.21],[0.607],[0.684],[0.162],[0.167],[0.138],[0.723],[0.634],[0.689],[0.678],[0.837],[0.79],[0.697],[0.925],[0.88],[0.82],[0.848],[0.828],0.21,0.607,0.684,0.162,0.167,0.138,0.723,0.634,0.689,0.678,0.837,0.79,0.697,0.925,0.88,0.82,0.848,0.828
https://doi.org/10.1093/rfs/hhz016,life below zero bank lending under negative policy rates,27414_life below zero bank lending under negative policy rates.pdf,10,"['https://www.federalreserve.gov/econres/feds/files/2019064pap.pdf', 'https://www.nber.org/papers/w28298', 'https://www.nber.org/papers/w28540', 'https://research.stlouisfed.org/wp/more/2017-039', 'https://www.frbsf.org/economic-research/publications/working-papers/2022/12/', 'https://www.frbsf.org/economic-research/publications/working-papers/2020/31/', 'https://www.frbsf.org/economic-research/publications/working-papers/2020/07/', 'https://www.newyorkfed.org/research/staff_reports/sr1021.html', 'https://www.philadelphiafed.org/the-economy/monetary-policy/the-reversal-interest-rate', 'https://www.frbsf.org/economic-research/publications/economic-letter/2021/august/how-do-low-and-negative-interest-rates-affect-banks/']","['Monetary Policy and Bank Equity Values in a Time of Low and Negative Interest Rates', 'Dynamic Banking and the Value of Deposits', 'A Model of Credit, Money, Interest, and Prices', 'The (Unintended?) Consequences of the Largest Liquidity Injection Ever', 'Making Sense of Negative Nominal Interest Rates', 'Alternative Models of Interest Rate Pass-Through in Normal and Negative Territory', 'Banks, Maturity Transformation, and Monetary Policy', 'Income Inequality and Job Creation - FEDERAL RESERVE BANK of NEW YORK', 'The Reversal Interest Rate', 'How Do Low and Negative Interest Rates Affect Banks?']",['https://www.federalreserve.gov/econres/feds/files/2019064pap.pdf'],['27414_0_monetary policy and bank equity values in a time of low and negative interest rates.pdf'],1,10.0,['https://www.federalreserve.gov/econres/feds/files/2019064pap.pdf'],['27414_0_monetary policy and bank equity values in a time of low and negative interest rates.pdf'],[0.672],[0.617],[0.693],[0.25],[0.258],[0.232],[0.744],[0.649],[0.68],[0.755],[0.834],[0.786],[0.701],[0.928],[0.876],[0.815],[0.845],[0.826],0.672,0.617,0.693,0.25,0.258,0.232,0.744,0.649,0.68,0.755,0.834,0.786,0.701,0.928,0.876,0.815,0.845,0.826
https://doi.org/10.1093/rheumatology/keu098.013,58 a selfmonitoring and patientinitiated followup service for patients with rheumatoid or psoriatic arthritis a randomized controlled trial,27453_58 a selfmonitoring and patientinitiated followup service for patients with rheumatoid or psoriatic arthritis a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144896/pdf'],['Patient‐initiated appointment systems for adults with chronic conditions in secondary care'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144896/pdf'],['27453_0_patient‐initiated appointment systems for adults with chronic conditions in secondary care.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144896/pdf'],['27453_0_patient‐initiated appointment systems for adults with chronic conditions in secondary care.pdf'],[0.344],[0.564],[0.635],[0.219],[0.22],[0.177],[0.733],[0.641],[0.613],[0.688],[0.794],[0.727],[0.618],[0.921],[0.842],[0.753],[0.803],[0.778],0.344,0.564,0.635,0.219,0.22,0.177,0.733,0.641,0.613,0.688,0.794,0.727,0.618,0.921,0.842,0.753,0.803,0.778
https://doi.org/10.1093/rheumatology/keu107.002,171 ukbased physiotherapists’ current management of pregnancyrelated back pain a national survey,27454_171 ukbased physiotherapists’ current management of pregnancyrelated back pain a national survey.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053516/pdf'],['Interventions for preventing and treating low‐back and pelvic pain during pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053516/pdf'],['27454_0_interventions for preventing and treating low‐back and pelvic pain during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053516/pdf'],['27454_0_interventions for preventing and treating low‐back and pelvic pain during pregnancy.pdf'],[0.308],[0.569],[0.645],[0.195],[0.184],[0.143],[0.732],[0.633],[0.632],[0.682],[0.797],[0.746],[0.607],[0.922],[0.846],[0.76],[0.808],[0.778],0.308,0.569,0.645,0.195,0.184,0.143,0.732,0.633,0.632,0.682,0.797,0.746,0.607,0.922,0.846,0.76,0.808,0.778
https://doi.org/10.1093/rheumatology/key227,efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin g4related disease a randomized clinical trial,27461_efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin g4related disease a randomized clinical trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437085/pdf'],['European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437085/pdf'],['27461_0_european guideline on igg4related digestive disease – ueg and sgf evidencebased recommendations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437085/pdf'],['27461_0_european guideline on igg4related digestive disease – ueg and sgf evidencebased recommendations.pdf'],[0.461],[0.564],[0.648],[0.194],[0.204],[0.149],[0.75],[0.655],[0.622],[0.647],[0.805],[0.732],[0.633],[0.928],[0.832],[0.774],[0.801],[0.788],0.461,0.564,0.648,0.194,0.204,0.149,0.75,0.655,0.622,0.647,0.805,0.732,0.633,0.928,0.832,0.774,0.801,0.788
https://doi.org/10.1093/schbul/sbz021.209,o51 grey matter brain changes in medicated and unmedicated first episode psychosis a randomised placebocontrolled trial,27491_o51 grey matter brain changes in medicated and unmedicated first episode psychosis a randomised placebocontrolled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702459/pdf'],['Maintenance treatment with antipsychotic drugs for schizophrenia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702459/pdf'],['27491_0_maintenance treatment with antipsychotic drugs for schizophrenia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702459/pdf'],['27491_0_maintenance treatment with antipsychotic drugs for schizophrenia.pdf'],[0.232],[0.504],[0.591],[0.16],[0.145],[0.126],[0.732],[0.636],[0.561],[0.702],[0.761],[0.685],[0.585],[0.9],[0.775],[0.708],[0.763],[0.731],0.232,0.504,0.591,0.16,0.145,0.126,0.732,0.636,0.561,0.702,0.761,0.685,0.585,0.9,0.775,0.708,0.763,0.731
https://doi.org/10.1093/ser/mwx010,spatial mismatch and youth unemployment in us cities public transportation as a labor market institution,27493_spatial mismatch and youth unemployment in us cities public transportation as a labor market institution.pdf,1,['https://does.dc.gov/sites/default/files/dc/sites/does/publication/attachments/WorkforceforYouthDC_single.pdf'],['| Strategic Priorities To'],['https://does.dc.gov/sites/default/files/dc/sites/does/publication/attachments/WorkforceforYouthDC_single.pdf'],['27493_0_ strategic priorities to.pdf'],1,100.0,['https://does.dc.gov/sites/default/files/dc/sites/does/publication/attachments/WorkforceforYouthDC_single.pdf'],['27493_0_ strategic priorities to.pdf'],[0.264],[0.574],[0.662],[0.179],[0.178],[0.15],[0.724],[0.621],[0.656],[0.656],[0.831],[0.781],[0.675],[0.926],[0.864],[0.798],[0.841],[0.816],0.264,0.574,0.662,0.179,0.178,0.15,0.724,0.621,0.656,0.656,0.831,0.781,0.675,0.926,0.864,0.798,0.841,0.816
https://doi.org/10.1093/sf/soz095,unpacking the drivers of racial disparities in school suspension and expulsion,27504_unpacking the drivers of racial disparities in school suspension and expulsion.pdf,3,"['https://nepc.colorado.edu/publication/restorative-justice', 'https://www.heritage.org/civil-rights/report/misusing-disparate-impact-discriminate-against-students-school-discipline', 'http://hillsborough.floridahealth.gov/programs-and-services/community-health-planning-statistics/health-equity/_documents/health-equity-profile-2021-08-27-2021.pdf']","['The Starts and Stumbles of Restorative Justice in Education: Where Do We Go from Here?', 'Misusing “Disparate Impact” to Discriminate Against Students in School Discipline', 'Hillsborough County Health Equity Profile 2021']",['http://hillsborough.floridahealth.gov/programs-and-services/community-health-planning-statistics/health-equity/_documents/health-equity-profile-2021-08-27-2021.pdf'],['27504_2_hillsborough county health equity profile 2021.pdf'],1,33.33,['http://hillsborough.floridahealth.gov/programs-and-services/community-health-planning-statistics/health-equity/_documents/health-equity-profile-2021-08-27-2021.pdf'],['27504_2_hillsborough county health equity profile 2021.pdf'],[0.187],[0.526],[0.622],[0.123],[0.138],[0.107],[0.721],[0.616],[0.601],[0.671],[0.799],[0.715],[0.626],[0.912],[0.837],[0.758],[0.801],[0.78],0.187,0.526,0.622,0.123,0.138,0.107,0.721,0.616,0.601,0.671,0.799,0.715,0.626,0.912,0.837,0.758,0.801,0.78
https://doi.org/10.1093/sleep/25.7.746,effects of age and sleeping position on arousal from sleep in preterm infants,27506_effects of age and sleeping position on arousal from sleep in preterm infants.pdf,1,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['A Policy & Education Development Guide'],['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['27506_0_a policy  education development guide.pdf'],1,100.0,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['27506_0_a policy  education development guide.pdf'],[0.635],[0.537],[0.616],[0.159],[0.183],[0.153],[0.735],[0.636],[0.611],[0.666],[0.802],[0.734],[0.625],[0.922],[0.832],[0.767],[0.806],[0.792],0.635,0.537,0.616,0.159,0.183,0.153,0.735,0.636,0.611,0.666,0.802,0.734,0.625,0.922,0.832,0.767,0.806,0.792
https://doi.org/10.1093/sleep/25.8.8,shortterm variability of respiration and sleep during unattended nonlaboratory polysomnography—the sleep heart health study,27507_shortterm variability of respiration and sleep during unattended nonlaboratory polysomnography—the sleep heart health study.pdf,3,"['https://www.hca.wa.gov/assets/program/sleep-apnea-20120318.pdf', 'https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=48', 'https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=50']","['Microsoft PowerPoint - HTA HTCC Meeting Overview 02-29 MAD.pptx', 'Home diagnosis of Obstructive Sleep Apnea-Hypopnea Syndrome', 'Obstructive Sleep Apnea-Hypopnea Syndrome: modeling different diagnostic strategies']",['https://www.hca.wa.gov/assets/program/sleep-apnea-20120318.pdf'],['27507_0_microsoft powerpoint  hta htcc meeting overview 0229 madpptx.pdf'],1,33.33,['https://www.hca.wa.gov/assets/program/sleep-apnea-20120318.pdf'],['27507_0_microsoft powerpoint  hta htcc meeting overview 0229 madpptx.pdf'],[0.583],[0.552],[0.625],[0.164],[0.189],[0.147],[0.731],[0.639],[0.614],[0.696],[0.796],[0.726],[0.651],[0.915],[0.82],[0.772],[0.803],[0.786],0.583,0.552,0.625,0.164,0.189,0.147,0.731,0.639,0.614,0.696,0.796,0.726,0.651,0.915,0.82,0.772,0.803,0.786
https://doi.org/10.1093/sleep/27.8.1527,increased cardiac autonomic responses to auditory challenges in swaddled infants,27511_increased cardiac autonomic responses to auditory challenges in swaddled infants.pdf,1,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['A Policy & Education Development Guide'],['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['27511_0_a policy  education development guide.pdf'],1,100.0,['https://dph.georgia.gov/document/document/hospital-based-safe-infant-sleep-program-policy-and-education-development-guide/download'],['27511_0_a policy  education development guide.pdf'],[0.622],[0.549],[0.621],[0.151],[0.181],[0.144],[0.733],[0.636],[0.624],[0.667],[0.805],[0.749],[0.637],[0.925],[0.838],[0.777],[0.815],[0.797],0.622,0.549,0.621,0.151,0.181,0.144,0.733,0.636,0.624,0.667,0.805,0.749,0.637,0.925,0.838,0.777,0.815,0.797
https://doi.org/10.1093/sleep/33.7.956,short sleep duration as a risk factor for hypercholesterolemia analyses of the national longitudinal study of adolescent health,27516_short sleep duration as a risk factor for hypercholesterolemia analyses of the national longitudinal study of adolescent health.pdf,1,['https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf'],['Research & information'],['https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf'],['27516_0_research  information.pdf'],1,100.0,['https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf'],['27516_0_research  information.pdf'],[0.313],[0.521],[0.612],[0.129],[0.148],[0.119],[0.722],[0.626],[0.594],[0.663],[0.789],[0.72],[0.63],[0.923],[0.812],[0.751],[0.789],[0.768],0.313,0.521,0.612,0.129,0.148,0.119,0.722,0.626,0.594,0.663,0.789,0.72,0.63,0.923,0.812,0.751,0.789,0.768
https://doi.org/10.1093/socpro/spaa042,the usual racialized suspects the consequence of police contacts with black and white youth on adult arrest,27517_the usual racialized suspects the consequence of police contacts with black and white youth on adult arrest.pdf,4,"['https://www.aclu.org/report/joint-aclu-hrw-submission-un-racial-discrimination', 'https://www.aclu.org/report/joint-aclu-hrw-submission-un-racial-discrimination-us', 'https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf', 'https://www.rand.org/pubs/research_reports/RRA1663-1.html']","['JOINT ACLU-HRW SUBMISSION TO UN ON RACIAL DISCRIMINATION', 'JOINT ACLU-HRW SUBMISSION TO THE UN ON RACIAL DISCRIMINATION IN THE US', '2021 : How Gender And Race', 'A Gap Analysis of the Los Angeles County Juvenile Justice Crime Prevention Act Portfolio']",['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['27517_2_2021  how gender and race.pdf'],1,25.0,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['27517_2_2021  how gender and race.pdf'],[0.308],[0.534],[0.62],[0.153],[0.171],[0.144],[0.726],[0.627],[0.595],[0.69],[0.797],[0.72],[0.646],[0.918],[0.831],[0.759],[0.798],[0.78],0.308,0.534,0.62,0.153,0.171,0.144,0.726,0.627,0.595,0.69,0.797,0.72,0.646,0.918,0.831,0.759,0.798,0.78
https://doi.org/10.1093/sw/sww078,the schooltoprison pipeline a primer for social workers,27534_the schooltoprison pipeline a primer for social workers.pdf,1,['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618'],"['From Adversity to Resilience in the Justice Sector – Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health']",['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618'],['27534_0_from adversity to resilience in the justice sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf'],1,100.0,['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/CA_OSG-Report_Justice-Sector-Brief_12092020.pdf?emrc=0ff618'],['27534_0_from adversity to resilience in the justice sector – roadmap for resilience the california surgeon generals report on adverse childhood experiences toxic stress and health.pdf'],[0.196],[0.552],[0.646],[0.183],[0.188],[0.152],[0.739],[0.648],[0.62],[0.674],[0.812],[0.744],[0.647],[0.938],[0.847],[0.779],[0.82],[0.802],0.196,0.552,0.646,0.183,0.188,0.152,0.739,0.648,0.62,0.674,0.812,0.744,0.647,0.938,0.847,0.779,0.82,0.802
https://doi.org/10.1093/toxsci/kfz226,juvenile toxicity rodent model to study toxicological effects of bisphenol a bpa at dose levels derived from italian children biomonitoring study,27626_juvenile toxicity rodent model to study toxicological effects of bisphenol a bpa at dose levels derived from italian children biomonitoring study.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['27626_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['27626_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.55],[0.519],[0.615],[0.154],[0.154],[0.119],[0.739],[0.647],[0.589],[0.667],[0.794],[0.682],[0.623],[0.904],[0.811],[0.752],[0.785],[0.773],0.55,0.519,0.615,0.154,0.154,0.119,0.739,0.647,0.589,0.667,0.794,0.682,0.623,0.904,0.811,0.752,0.785,0.773
https://doi.org/10.1093/ve/vew034,geography and host species shape the evolutionary dynamics of u genogroup infectious hematopoietic necrosis virus,27666_geography and host species shape the evolutionary dynamics of u genogroup infectious hematopoietic necrosis virus.pdf,2,"['https://www.adfg.alaska.gov/FedAidPDFs/SP18-12.pdf', 'http://www.adfg.alaska.gov/static/regulations/regprocess/fisheriesboard/pdfs/2018-2019/ws/SP18-12.pdf']","['Salmon hatcheries in Alaska', 'Salmon Hatcheries in Alaska –A Review of the Implementation of Plans, Permits, and Policies Designed to Provide Protection for Wild Stocks']","['http://www.adfg.alaska.gov/static/regulations/regprocess/fisheriesboard/pdfs/2018-2019/ws/SP18-12.pdf', 'https://www.adfg.alaska.gov/FedAidPDFs/SP18-12.pdf']","['27666_1_salmon hatcheries in alaska –a review of the implementation of plans permits and policies designed to provide protection for wild stocks.pdf', '27666_0_salmon hatcheries in alaska.pdf']",2,100.0,"['http://www.adfg.alaska.gov/static/regulations/regprocess/fisheriesboard/pdfs/2018-2019/ws/SP18-12.pdf', 'https://www.adfg.alaska.gov/FedAidPDFs/SP18-12.pdf']","['27666_1_salmon hatcheries in alaska –a review of the implementation of plans permits and policies designed to provide protection for wild stocks.pdf', '27666_0_salmon hatcheries in alaska.pdf']","[0.292, 0.291]","[0.542, 0.543]","[0.627, 0.629]","[0.161, 0.161]","[0.158, 0.159]","[0.131, 0.132]","[0.732, 0.732]","[0.643, 0.643]","[0.621, 0.622]","[0.656, 0.656]","[0.812, 0.813]","[0.743, 0.744]","[0.668, 0.669]","[0.913, 0.914]","[0.833, 0.833]","[0.784, 0.784]","[0.824, 0.825]","[0.804, 0.805]",0.291,0.542,0.628,0.161,0.159,0.132,0.732,0.643,0.621,0.656,0.812,0.744,0.669,0.913,0.833,0.784,0.825,0.804
https://doi.org/10.1097/00003246-200003000-00041,sedation in the intensive care unit,27848_sedation in the intensive care unit.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830566/pdf']","['Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version', 'Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care – short version']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf']","['27848_1_evidence and consensusbased german guidelines for the management of analgesia sedation and delirium in intensive care – short version.pdf', '27848_0_evidence and consensus based guideline for the management of delirium analgesia and sedation in intensive care medicine revision 2015 dasguideline 2015 – short version.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830566/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645746/pdf']","['27848_1_evidence and consensusbased german guidelines for the management of analgesia sedation and delirium in intensive care – short version.pdf', '27848_0_evidence and consensus based guideline for the management of delirium analgesia and sedation in intensive care medicine revision 2015 dasguideline 2015 – short version.pdf']","[0.375, 0.372]","[0.486, 0.476]","[0.593, 0.581]","[0.173, 0.16]","[0.197, 0.176]","[0.146, 0.129]","[0.743, 0.738]","[0.651, 0.646]","[0.563, 0.547]","[0.662, 0.655]","[0.781, 0.776]","[0.674, 0.667]","[0.608, 0.602]","[0.908, 0.903]","[0.8, 0.796]","[0.727, 0.719]","[0.769, 0.763]","[0.749, 0.743]",0.373,0.481,0.587,0.166,0.186,0.138,0.74,0.649,0.555,0.659,0.778,0.671,0.605,0.905,0.798,0.723,0.766,0.746
https://doi.org/10.1097/00003246-200005000-00067,chest physiotherapy in mechanically ventilated children a review,27849_chest physiotherapy in mechanically ventilated children a review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717127/pdf'],['Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717127/pdf'],['27849_0_recommendations for mechanical ventilation of critically ill children from the paediatric mechanical ventilation consensus conference pemvecc.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717127/pdf'],['27849_0_recommendations for mechanical ventilation of critically ill children from the paediatric mechanical ventilation consensus conference pemvecc.pdf'],[0.355],[0.557],[0.643],[0.227],[0.236],[0.176],[0.749],[0.657],[0.609],[0.684],[0.805],[0.726],[0.64],[0.92],[0.818],[0.768],[0.8],[0.785],0.355,0.557,0.643,0.227,0.236,0.176,0.749,0.657,0.609,0.684,0.805,0.726,0.64,0.92,0.818,0.768,0.8,0.785
https://doi.org/10.1097/00003446-200004000-00005,the new york state universal newborn hearing screening demonstration project outpatient outcome measures,27853_the new york state universal newborn hearing screening demonstration project outpatient outcome measures.pdf,2,"['https://www.michigan.gov/documents/protocolfinal060102_53439_7.pdf', 'https://stacks.cdc.gov/view/cdc/7082']","['Microsoft Word - protocolfinal2003.doc', 'Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs Joint Committee on Infant Hearing']",['https://www.michigan.gov/documents/protocolfinal060102_53439_7.pdf'],['27853_0_microsoft word  protocolfinal2003doc.pdf'],1,50.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1097/00004583-200207000-00008,atomoxetine and methylphenidate treatment in children with adhd a prospective randomized openlabel trial,27962_atomoxetine and methylphenidate treatment in children with adhd a prospective randomized openlabel trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf'],['Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf'],['27962_0_methylphenidate for attention deficit hyperactivity disorder adhd in children and adolescents – assessment of adverse events in non‐randomised studies.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494554/pdf'],['27962_0_methylphenidate for attention deficit hyperactivity disorder adhd in children and adolescents – assessment of adverse events in non‐randomised studies.pdf'],[0.512],[0.503],[0.595],[0.184],[0.19],[0.16],[0.739],[0.646],[0.564],[0.701],[0.773],[0.686],[0.603],[0.91],[0.78],[0.722],[0.768],[0.752],0.512,0.503,0.595,0.184,0.19,0.16,0.739,0.646,0.564,0.701,0.773,0.686,0.603,0.91,0.78,0.722,0.768,0.752
https://doi.org/10.1097/00004583-201004000-00006,the long war and parental combat deployment,28014_the long war and parental combat deployment.pdf,6,"['https://www.rand.org/pubs/research_reports/RR994.html', 'https://www.rti.org/rti-press-publication/substance-misuse-prevention-program-attendance', 'https://www.rand.org/pubs/technical_reports/TR1243.html', 'https://www.rand.org/pubs/research_reports/RR4268.html', 'https://www.rand.org/pubs/research_reports/RR1647.html', 'https://lhc.ca.gov/sites/lhc.ca.gov/files/Reports/217/WrittenTestimony/BoylanAttachment.pdf']","['Public-Private Partnerships for Providing Behavioral Health Care to Veterans and Their Families', 'Substance misuse prevention program attendance', 'Assessing Operation Purple, a Summer Camp for Military Youth', 'Readiness of Soldiers and Adult Family Members Who Receive Behavioral Health Care', 'The Unified Behavioral Health Center for Military Veterans and Their Families', 'July 2012']",['https://lhc.ca.gov/sites/lhc.ca.gov/files/Reports/217/WrittenTestimony/BoylanAttachment.pdf'],['28014_5_july 2012.pdf'],1,16.67,['https://lhc.ca.gov/sites/lhc.ca.gov/files/Reports/217/WrittenTestimony/BoylanAttachment.pdf'],['28014_5_july 2012.pdf'],[0.2],[0.517],[0.607],[0.157],[0.184],[0.134],[0.729],[0.633],[0.578],[0.672],[0.796],[0.716],[0.62],[0.928],[0.824],[0.746],[0.799],[0.78],0.2,0.517,0.607,0.157,0.184,0.134,0.729,0.633,0.578,0.672,0.796,0.716,0.62,0.928,0.824,0.746,0.799,0.78
https://doi.org/10.1097/01.asw.0000672500.18525.2e,the effect of sunflower seed and almond oil on preterm infant skin a randomized controlled trial,28345_the effect of sunflower seed and almond oil on preterm infant skin a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104155/pdf'],['Topical emollient for preventing infection in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104155/pdf'],['28345_0_topical emollient for preventing infection in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104155/pdf'],['28345_0_topical emollient for preventing infection in preterm infants.pdf'],[0.412],[0.512],[0.599],[0.168],[0.168],[0.139],[0.73],[0.64],[0.572],[0.662],[0.77],[0.692],[0.594],[0.908],[0.805],[0.726],[0.768],[0.75],0.412,0.512,0.599,0.168,0.168,0.139,0.73,0.64,0.572,0.662,0.77,0.692,0.594,0.908,0.805,0.726,0.768,0.75
https://doi.org/10.1097/01.chi.0000046834.09750.5f,one‐year follow‐up of multisystemic therapy as an alternative to the hospitalization of youths in psychiatric crisis,28366_one‐year follow‐up of multisystemic therapy as an alternative to the hospitalization of youths in psychiatric crisis.pdf,5,"['https://tiac.wisconsin.gov/tiacfiles/pdf/multisystemic-therapy.pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Pages_from_CY_BPGs_387-419.pdf', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/documents/Bestpracreport.pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf']","['Section One: Overview and Determination', 'Washington State Institute for Public Policy', 'Appendices', 'A Literature Review & Resource Guide', 'Best Practices']","['https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://tiac.wisconsin.gov/tiacfiles/pdf/multisystemic-therapy.pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Pages_from_CY_BPGs_387-419.pdf', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/documents/Bestpracreport.pdf']","['28366_4_best practices.pdf', '28366_1_washington state institute for public policy.pdf', '28366_0_section one overview and determination.pdf', '28366_2_appendices.pdf', '28366_3_a literature review  resource guide.pdf']",5,100.0,"['https://www.tn.gov/content/dam/tn/mentalhealth/documents/Children_and_Youth_Best_Practice_Guidelines.pdf', 'http://www.wsipp.wa.gov/ReportFile/1611/Wsipp_Updated-Inventory-of-Evidence-based-Research-based-and-Promising-Practices-For-Prevention-and-Intervention-Services-for-Children-and-Juveniles-in-the-Child-Welfare-Juvenile-Justice-and-Mental-Health-Systems_Benefit-Cost-Results.pdf', 'https://www.tn.gov/content/dam/tn/mentalhealth/documents/Pages_from_CY_BPGs_387-419.pdf', 'https://www.dshs.wa.gov/sites/default/files/BHSIA/dbh/documents/Bestpracreport.pdf']","['28366_4_best practices.pdf', '28366_1_washington state institute for public policy.pdf', '28366_2_appendices.pdf', '28366_3_a literature review  resource guide.pdf']","[0.296, 0.539, 0.532, 0.557]","[0.538, 0.543, 0.547, 0.546]","[0.616, 0.608, 0.621, 0.621]","[0.169, 0.162, 0.188, 0.172]","[0.176, 0.172, 0.199, 0.179]","[0.145, 0.139, 0.162, 0.144]","[0.732, 0.732, 0.738, 0.732]","[0.637, 0.639, 0.646, 0.638]","[0.603, 0.603, 0.605, 0.607]","[0.688, 0.694, 0.691, 0.69]","[0.801, 0.798, 0.803, 0.804]","[0.727, 0.724, 0.729, 0.727]","[0.63, 0.622, 0.636, 0.635]","[0.921, 0.923, 0.921, 0.923]","[0.833, 0.829, 0.839, 0.834]","[0.771, 0.766, 0.774, 0.772]","[0.81, 0.809, 0.811, 0.813]","[0.791, 0.787, 0.792, 0.792]",0.481,0.544,0.617,0.173,0.181,0.148,0.734,0.64,0.605,0.691,0.802,0.727,0.631,0.922,0.834,0.771,0.811,0.79
https://doi.org/10.1097/cce.0000000000000203,the association of inflammatory cytokines in the pulmonary pathophysiology of respiratory failure in critically ill patients with coronavirus disease 2019,28759_the association of inflammatory cytokines in the pulmonary pathophysiology of respiratory failure in critically ill patients with coronavirus disease 2019.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406988/pdf'],['Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406988/pdf'],['28759_0_interleukin‐6 blocking agents for treating covid‐19 a living systematic review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406988/pdf'],['28759_0_interleukin‐6 blocking agents for treating covid‐19 a living systematic review.pdf'],[0.379],[0.542],[0.623],[0.177],[0.162],[0.132],[0.737],[0.644],[0.615],[0.663],[0.792],[0.719],[0.599],[0.922],[0.833],[0.744],[0.793],[0.771],0.379,0.542,0.623,0.177,0.162,0.132,0.737,0.644,0.615,0.663,0.792,0.719,0.599,0.922,0.833,0.744,0.793,0.771
https://doi.org/10.1097/chi.0b013e318172ef0d,characterizing adolescent prescription misusers,28785_characterizing adolescent prescription misusers.pdf,1,['http://dhss.alaska.gov/dph/Director/Documents/marijuana/Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf'],['Monitoring Health'],['http://dhss.alaska.gov/dph/Director/Documents/marijuana/Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf'],['28785_0_monitoring health.pdf'],1,100.0,['http://dhss.alaska.gov/dph/Director/Documents/marijuana/Monitoring_Health_Concerns_Related_to_Marijuana_in_Colorado_2014.pdf'],['28785_0_monitoring health.pdf'],[0.323],[0.497],[0.599],[0.162],[0.185],[0.144],[0.733],[0.638],[0.543],[0.679],[0.768],[0.674],[0.608],[0.906],[0.766],[0.723],[0.758],[0.746],0.323,0.497,0.599,0.162,0.185,0.144,0.733,0.638,0.543,0.679,0.768,0.674,0.608,0.906,0.766,0.723,0.758,0.746
https://doi.org/10.1097/dbp.0000000000000604,impact of “learn the signs act early” materials on parental engagement and doctor interaction regarding child development,28836_impact of “learn the signs act early” materials on parental engagement and doctor interaction regarding child development.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889967/pdf'],['Establishing New Norms for Developmental Milestones'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889967/pdf'],['28836_0_establishing new norms for developmental milestones.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889967/pdf'],['28836_0_establishing new norms for developmental milestones.pdf'],[0.447],[0.554],[0.629],[0.186],[0.204],[0.171],[0.735],[0.641],[0.616],[0.702],[0.803],[0.738],[0.626],[0.927],[0.846],[0.769],[0.808],[0.792],0.447,0.554,0.629,0.186,0.204,0.171,0.735,0.641,0.616,0.702,0.803,0.738,0.626,0.927,0.846,0.769,0.808,0.792
https://doi.org/10.1097/dbp.0000000000000657,when children are not read to at home the million word gap,28838_when children are not read to at home the million word gap.pdf,1,['https://www.ccfc.ca.gov/pdf/commission/meetings/handouts/Commission-Handouts-2020-01/Item-9-EARLY-LITERACY-AND-FAMILY-BOOK-DISTRIBUTION-IN-CALIFORNIA.pdf'],"['January 23, 2020']",['https://www.ccfc.ca.gov/pdf/commission/meetings/handouts/Commission-Handouts-2020-01/Item-9-EARLY-LITERACY-AND-FAMILY-BOOK-DISTRIBUTION-IN-CALIFORNIA.pdf'],['28838_0_january 23 2020.pdf'],1,100.0,['https://www.ccfc.ca.gov/pdf/commission/meetings/handouts/Commission-Handouts-2020-01/Item-9-EARLY-LITERACY-AND-FAMILY-BOOK-DISTRIBUTION-IN-CALIFORNIA.pdf'],['28838_0_january 23 2020.pdf'],[0.51],[0.571],[0.648],[0.224],[0.242],[0.214],[0.741],[0.648],[0.638],[0.717],[0.812],[0.762],[0.659],[0.928],[0.855],[0.783],[0.816],[0.801],0.51,0.571,0.648,0.224,0.242,0.214,0.741,0.648,0.638,0.717,0.812,0.762,0.659,0.928,0.855,0.783,0.816,0.801
https://doi.org/10.1097/dbp.0000000000000807,abrupt and severe obsessivecompulsive disorder in an 11yearold girl—pandaspans syndrome an entity to be considered—management implications  “retracted”,28840_abrupt and severe obsessivecompulsive disorder in an 11yearold girl—pandaspans syndrome an entity to be considered—management implications  “retracted”.pdf,1,['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf'],['IL PANDAS-PANS Advisory Council Report - 2020'],['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf'],['28840_0_il pandaspans advisory council report  2020.pdf'],1,100.0,['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/pandas-pans-advisory-council-2020-report.pdf'],['28840_0_il pandaspans advisory council report  2020.pdf'],[0.407],[0.535],[0.627],[0.167],[0.176],[0.144],[0.737],[0.645],[0.606],[0.657],[0.806],[0.73],[0.61],[0.916],[0.841],[0.758],[0.799],[0.787],0.407,0.535,0.627,0.167,0.176,0.144,0.737,0.645,0.606,0.657,0.806,0.73,0.61,0.916,0.841,0.758,0.799,0.787
https://doi.org/10.1097/dbp.0000000000000863,abrupt and severe obsessivecompulsive disorder in an 11yearold girlpandaspans syndrome an entity to be consideredmanagement implications retraction,28841_abrupt and severe obsessivecompulsive disorder in an 11yearold girlpandaspans syndrome an entity to be consideredmanagement implications retraction.pdf,1,['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2021/pansac-report-sept-2021.pdf'],['2021 PANSAC Legislative Report'],['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2021/pansac-report-sept-2021.pdf'],['28841_0_2021 pansac legislative report.pdf'],1,100.0,['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2021/pansac-report-sept-2021.pdf'],['28841_0_2021 pansac legislative report.pdf'],[0.211],[0.506],[0.592],[0.118],[0.136],[0.104],[0.731],[0.632],[0.566],[0.65],[0.772],[0.721],[0.572],[0.911],[0.806],[0.741],[0.778],[0.761],0.211,0.506,0.592,0.118,0.136,0.104,0.731,0.632,0.566,0.65,0.772,0.721,0.572,0.911,0.806,0.741,0.778,0.761
https://doi.org/10.1097/dbp.0b013e318264c10f,infant communication and subsequent language development in children from lowincome families,28862_infant communication and subsequent language development in children from lowincome families.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883766/pdf'],['Video feedback for parental sensitivity and attachment security in children under five years'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883766/pdf'],['28862_0_video feedback for parental sensitivity and attachment security in children under five years.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883766/pdf'],['28862_0_video feedback for parental sensitivity and attachment security in children under five years.pdf'],[0.276],[0.526],[0.614],[0.166],[0.169],[0.14],[0.735],[0.642],[0.583],[0.712],[0.775],[0.708],[0.583],[0.912],[0.814],[0.729],[0.777],[0.759],0.276,0.526,0.614,0.166,0.169,0.14,0.735,0.642,0.583,0.712,0.775,0.708,0.583,0.912,0.814,0.729,0.777,0.759
https://doi.org/10.1097/hjh.0000000000001039,2016 european society of hypertension guidelines for the management of high blood pressure in children and adolescents,28917_2016 european society of hypertension guidelines for the management of high blood pressure in children and adolescents.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162184/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf']","['IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome', 'Management of high blood pressure in children: Similarities and differences between US and European guidelines', 'KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162184/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686/pdf']","['28917_1_management of high blood pressure in children similarities and differences between us and european guidelines.pdf', '28917_2_kdigo 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.pdf', '28917_0_ipna clinical practice recommendations for the diagnosis and management of children with steroidresistant nephrotic syndrome.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162184/pdf', 'https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316686/pdf']","['28917_1_management of high blood pressure in children similarities and differences between us and european guidelines.pdf', '28917_2_kdigo 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.pdf', '28917_0_ipna clinical practice recommendations for the diagnosis and management of children with steroidresistant nephrotic syndrome.pdf']","[0.417, 0.589, 0.604]","[0.549, 0.569, 0.603]","[0.649, 0.651, 0.673]","[0.211, 0.189, 0.187]","[0.223, 0.195, 0.177]","[0.177, 0.152, 0.138]","[0.745, 0.741, 0.747]","[0.66, 0.648, 0.652]","[0.632, 0.642, 0.67]","[0.672, 0.658, 0.624]","[0.8, 0.817, 0.827]","[0.732, 0.757, 0.769]","[0.618, 0.642, 0.647]","[0.922, 0.932, 0.931]","[0.831, 0.835, 0.835]","[0.775, 0.791, 0.799]","[0.799, 0.82, 0.825]","[0.793, 0.806, 0.813]",0.537,0.574,0.658,0.196,0.198,0.156,0.744,0.653,0.648,0.651,0.815,0.753,0.636,0.928,0.834,0.788,0.815,0.804
https://doi.org/10.1097/ico.0000000000002400,the last 200 surgeonloaded descemet membrane endothelial keratoplasty tissue versus the first 200 preloaded descemet membrane endothelial keratoplasty tissue,28932_the last 200 surgeonloaded descemet membrane endothelial keratoplasty tissue versus the first 200 preloaded descemet membrane endothelial keratoplasty tissue.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672757/pdf'],['Preferred practice pattern for Descemet membrane endothelial keratoplasty surgeries: A survey of Indian corneal surgeons'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672757/pdf'],['28932_0_preferred practice pattern for descemet membrane endothelial keratoplasty surgeries a survey of indian corneal surgeons.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672757/pdf'],['28932_0_preferred practice pattern for descemet membrane endothelial keratoplasty surgeries a survey of indian corneal surgeons.pdf'],[0.445],[0.469],[0.564],[0.21],[0.203],[0.173],[0.748],[0.657],[0.597],[0.658],[0.781],[0.691],[0.571],[0.89],[0.822],[0.737],[0.764],[0.745],0.445,0.469,0.564,0.21,0.203,0.173,0.748,0.657,0.597,0.658,0.781,0.691,0.571,0.89,0.822,0.737,0.764,0.745
https://doi.org/10.1097/id.0000000000000814,comparative evaluation of recombinant human bone morphogenetic protein2hydroxyapatite and bovine bone for new bone formation in alveolar ridge preservation,28937_comparative evaluation of recombinant human bone morphogenetic protein2hydroxyapatite and bovine bone for new bone formation in alveolar ridge preservation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092674/pdf'],['Interventions for replacing missing teeth: alveolar ridge preservation techniques for dental implant site development'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092674/pdf'],['28937_0_interventions for replacing missing teeth alveolar ridge preservation techniques for dental implant site development.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092674/pdf'],['28937_0_interventions for replacing missing teeth alveolar ridge preservation techniques for dental implant site development.pdf'],[0.484],[0.526],[0.604],[0.163],[0.179],[0.135],[0.745],[0.651],[0.596],[0.662],[0.779],[0.71],[0.595],[0.913],[0.811],[0.736],[0.781],[0.764],0.484,0.526,0.604,0.163,0.179,0.135,0.745,0.651,0.596,0.662,0.779,0.71,0.595,0.913,0.811,0.736,0.781,0.764
https://doi.org/10.1097/inf.0000000000002225,effect of highdose vitamin d supplementation on upper respiratory tract infection symptom severity in healthy children,28953_effect of highdose vitamin d supplementation on upper respiratory tract infection symptom severity in healthy children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['28953_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121044/pdf'],['28953_0_effects of oral vitamin d supplementation on linear growth and other health outcomes among children under five years of age.pdf'],[0.503],[0.537],[0.613],[0.186],[0.181],[0.15],[0.735],[0.641],[0.607],[0.692],[0.788],[0.708],[0.608],[0.926],[0.834],[0.747],[0.792],[0.774],0.503,0.537,0.613,0.186,0.181,0.15,0.735,0.641,0.607,0.692,0.788,0.708,0.608,0.926,0.834,0.747,0.792,0.774
https://doi.org/10.1097/inf.0000000000002240,specimen pooling as a diagnostic strategy for microbiologic confirmation in children with intrathoracic tuberculosis,28955_specimen pooling as a diagnostic strategy for microbiologic confirmation in children with intrathoracic tuberculosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf'],['Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf'],['28955_0_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf'],['28955_0_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf'],[0.326],[0.531],[0.597],[0.17],[0.166],[0.149],[0.736],[0.643],[0.592],[0.696],[0.771],[0.695],[0.584],[0.906],[0.806],[0.728],[0.774],[0.747],0.326,0.531,0.597,0.17,0.166,0.149,0.736,0.643,0.592,0.696,0.771,0.695,0.584,0.906,0.806,0.728,0.774,0.747
https://doi.org/10.1097/inf.0000000000002501,lifetime changes in cd4 tcell count viral load suppression and adherence among adolescents living with hiv in urban peru,28957_lifetime changes in cd4 tcell count viral load suppression and adherence among adolescents living with hiv in urban peru.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['28957_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['28957_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.44],[0.536],[0.62],[0.186],[0.181],[0.155],[0.74],[0.646],[0.599],[0.686],[0.792],[0.711],[0.6],[0.926],[0.835],[0.744],[0.794],[0.773],0.44,0.536,0.62,0.186,0.181,0.155,0.74,0.646,0.599,0.686,0.792,0.711,0.6,0.926,0.835,0.744,0.794,0.773
https://doi.org/10.1097/inf.0b013e3181c81fd4,antiretroviralrelated hematologic shortterm toxicity in healthy infants,28982_antiretroviralrelated hematologic shortterm toxicity in healthy infants.pdf,1,['https://www.in.gov/isdh/files/perinatalgl.pdf'],['HIV/AIDS Guidelines'],['https://www.in.gov/isdh/files/perinatalgl.pdf'],['28982_0_hivaids guidelines.pdf'],1,100.0,['https://www.in.gov/isdh/files/perinatalgl.pdf'],['28982_0_hivaids guidelines.pdf'],[0.398],[0.536],[0.612],[0.181],[0.173],[0.147],[0.744],[0.65],[0.619],[0.613],[0.793],[0.703],[0.597],[0.911],[0.813],[0.751],[0.792],[0.763],0.398,0.536,0.612,0.181,0.173,0.147,0.744,0.65,0.619,0.613,0.793,0.703,0.597,0.911,0.813,0.751,0.792,0.763
https://doi.org/10.1097/inf.0b013e3181e9dea2,impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country,28986_impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156892/pdf'],['Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156892/pdf'],['28986_0_prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156892/pdf'],['28986_0_prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.pdf'],[0.315],[0.519],[0.603],[0.152],[0.152],[0.121],[0.736],[0.64],[0.583],[0.629],[0.779],[0.693],[0.578],[0.906],[0.793],[0.725],[0.774],[0.751],0.315,0.519,0.603,0.152,0.152,0.121,0.736,0.64,0.583,0.629,0.779,0.693,0.578,0.906,0.793,0.725,0.774,0.751
https://doi.org/10.1097/jcn.0000000000000546,individualized familycentered developmental care,29037_individualized familycentered developmental care.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079830/pdf'],['Holding and Mobility of Pediatric Patients with Transthoracic Intracardiac Catheters'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079830/pdf'],['29037_0_holding and mobility of pediatric patients with transthoracic intracardiac catheters.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079830/pdf'],['29037_0_holding and mobility of pediatric patients with transthoracic intracardiac catheters.pdf'],[0.263],[0.521],[0.617],[0.149],[0.168],[0.128],[0.74],[0.642],[0.593],[0.639],[0.78],[0.706],[0.596],[0.922],[0.813],[0.742],[0.782],[0.768],0.263,0.521,0.617,0.149,0.168,0.128,0.74,0.642,0.593,0.639,0.78,0.706,0.596,0.922,0.813,0.742,0.782,0.768
https://doi.org/10.1097/jto.0b013e3182a47181,stereotactic body radiation therapy for primary lung cancers 3 centimeters,29070_stereotactic body radiation therapy for primary lung cancers 3 centimeters.pdf,2,"['https://www.hca.wa.gov/assets/program/final-director-topic-selection_ltr-20170707.pdf', 'https://www.hca.wa.gov/assets/program/SRS-SBRT-update-lit-search-appendix-20170125.pdf']","['March 9, 2006', 'Attachment Appendix B.']","['https://www.hca.wa.gov/assets/program/SRS-SBRT-update-lit-search-appendix-20170125.pdf', 'https://www.hca.wa.gov/assets/program/final-director-topic-selection_ltr-20170707.pdf']","['29070_1_attachment appendix b.pdf', '29070_0_march 9 2006.pdf']",2,100.0,"['https://www.hca.wa.gov/assets/program/SRS-SBRT-update-lit-search-appendix-20170125.pdf', 'https://www.hca.wa.gov/assets/program/final-director-topic-selection_ltr-20170707.pdf']","['29070_1_attachment appendix b.pdf', '29070_0_march 9 2006.pdf']","[0.46, 0.39]","[0.501, 0.508]","[0.6, 0.603]","[0.138, 0.139]","[0.147, 0.143]","[0.118, 0.115]","[0.745, 0.742]","[0.649, 0.647]","[0.572, 0.576]","[0.674, 0.669]","[0.771, 0.773]","[0.695, 0.696]","[0.585, 0.59]","[0.92, 0.918]","[0.797, 0.797]","[0.747, 0.746]","[0.771, 0.773]","[0.767, 0.765]",0.425,0.504,0.601,0.139,0.145,0.116,0.744,0.648,0.574,0.671,0.772,0.696,0.587,0.919,0.797,0.746,0.772,0.766
https://doi.org/10.1097/jxx.0000000000000084,i serve 2,29072_i serve 2.pdf,1,['https://dbhds.virginia.gov/assets/doc/bh/msmvf/i-serve2card_virginia-edition.pdf'],['I SERVE 2 : Information For Healthcare Providers Caring For Military Children ©'],['https://dbhds.virginia.gov/assets/doc/bh/msmvf/i-serve2card_virginia-edition.pdf'],['29072_0_i serve 2  information for healthcare providers caring for military children ©.pdf'],1,100.0,['https://dbhds.virginia.gov/assets/doc/bh/msmvf/i-serve2card_virginia-edition.pdf'],['29072_0_i serve 2  information for healthcare providers caring for military children ©.pdf'],[0.633],[0.502],[0.602],[0.162],[0.194],[0.162],[0.738],[0.645],[0.564],[0.678],[0.753],[0.69],[0.626],[0.892],[0.819],[0.742],[0.77],[0.755],0.633,0.502,0.602,0.162,0.194,0.162,0.738,0.645,0.564,0.678,0.753,0.69,0.626,0.892,0.819,0.742,0.77,0.755
https://doi.org/10.1097/mcp.0000000000000732,monitoring early stage lung disease in cystic fibrosis,29088_monitoring early stage lung disease in cystic fibrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672941/pdf'],['Autogenic drainage for airway clearance in cystic fibrosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672941/pdf'],['29088_0_autogenic drainage for airway clearance in cystic fibrosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672941/pdf'],['29088_0_autogenic drainage for airway clearance in cystic fibrosis.pdf'],[0.317],[0.552],[0.63],[0.173],[0.184],[0.136],[0.731],[0.64],[0.623],[0.672],[0.802],[0.743],[0.621],[0.927],[0.835],[0.758],[0.8],[0.784],0.317,0.552,0.63,0.173,0.184,0.136,0.731,0.64,0.623,0.672,0.802,0.743,0.621,0.927,0.835,0.758,0.8,0.784
https://doi.org/10.1097/md.0000000000012152,antinatriuretic phenomena seen in children with acute pyelonephritis may be related to the activation of intrarenal raas,29101_antinatriuretic phenomena seen in children with acute pyelonephritis may be related to the activation of intrarenal raas.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479592/pdf'],"['Procalcitonin, C‐reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479592/pdf'],['29101_0_procalcitonin c‐reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479592/pdf'],['29101_0_procalcitonin c‐reactive protein and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.pdf'],[0.302],[0.493],[0.588],[0.129],[0.137],[0.1],[0.733],[0.633],[0.57],[0.674],[0.77],[0.679],[0.597],[0.912],[0.789],[0.722],[0.763],[0.752],0.302,0.493,0.588,0.129,0.137,0.1,0.733,0.633,0.57,0.674,0.77,0.679,0.597,0.912,0.789,0.722,0.763,0.752
https://doi.org/10.1097/md.0000000000012614,brief topical sodium nitrite and its impact on the quality of life in patients with sickle leg ulcers,29102_brief topical sodium nitrite and its impact on the quality of life in patients with sickle leg ulcers.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407242/pdf'],['Interventions for treating leg ulcers in people with sickle cell disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407242/pdf'],['29102_0_interventions for treating leg ulcers in people with sickle cell disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407242/pdf'],['29102_0_interventions for treating leg ulcers in people with sickle cell disease.pdf'],[0.49],[0.507],[0.601],[0.151],[0.168],[0.132],[0.735],[0.636],[0.578],[0.693],[0.771],[0.7],[0.587],[0.92],[0.806],[0.722],[0.773],[0.754],0.49,0.507,0.601,0.151,0.168,0.132,0.735,0.636,0.578,0.693,0.771,0.7,0.587,0.92,0.806,0.722,0.773,0.754
https://doi.org/10.1097/meg.0000000000001538,time to antibody detection and associated factors for presence of antidrug antibodies in pediatric inflammatory bowel disease patients treated with antitnf therapy,29113_time to antibody detection and associated factors for presence of antidrug antibodies in pediatric inflammatory bowel disease patients treated with antitnf therapy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386457/pdf'],"[""Adalimumab for maintenance of remission in Crohn's disease""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386457/pdf'],['29113_0_adalimumab for maintenance of remission in crohns disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386457/pdf'],['29113_0_adalimumab for maintenance of remission in crohns disease.pdf'],[0.353],[0.521],[0.599],[0.165],[0.163],[0.132],[0.738],[0.644],[0.584],[0.678],[0.776],[0.685],[0.585],[0.906],[0.794],[0.723],[0.773],[0.751],0.353,0.521,0.599,0.165,0.163,0.132,0.738,0.644,0.584,0.678,0.776,0.685,0.585,0.906,0.794,0.723,0.773,0.751
https://doi.org/10.1097/mlr.0b013e31821d2b1d,quality of data in perinatal population health databases,29127_quality of data in perinatal population health databases.pdf,5,"['https://www.acf.hhs.gov/opre/report/design-mother-and-infant-home-visiting-program-evaluation-strong-start', 'https://mathematica.org/publications/wic-medicaid-ii-feasibility-study-final-report', 'https://purl.fdlp.gov/GPO/gpo112757', 'https://www.acf.hhs.gov/opre/resource/design-mother-infant-home-visiting-program-evaluation-strong-start', 'https://www.nber.org/papers/w23810']","['Design for the Mother and Infant Home Visiting Program Evaluation—Strong Start', 'WIC-Medicaid II Feasibility Study: Final Report', 'Effective coverage of facility delivery in Bangladesh, Haiti, Malawi, Nepal, Senegal, and Tanzania /', 'Design for the Mother and Infant Home Visiting Program Evaluation—Strong Start', 'Multi-generational Impacts of Childhood Access to the Safety Net: Early Life Exposure to Medicaid and the Next Generation’s Health']",['https://purl.fdlp.gov/GPO/gpo112757'],['29127_2_effective coverage of facility delivery in bangladesh haiti malawi nepal senegal and tanzania .pdf'],1,20.0,['https://purl.fdlp.gov/GPO/gpo112757'],['29127_2_effective coverage of facility delivery in bangladesh haiti malawi nepal senegal and tanzania .pdf'],[0.18],[0.523],[0.618],[0.149],[0.163],[0.128],[0.731],[0.639],[0.581],[0.664],[0.78],[0.719],[0.626],[0.907],[0.81],[0.748],[0.79],[0.769],0.18,0.523,0.618,0.149,0.163,0.128,0.731,0.639,0.581,0.664,0.78,0.719,0.626,0.907,0.81,0.748,0.79,0.769
https://doi.org/10.1097/nmc.0000000000000312,simulation as part of discharge teaching for parents of infants in the neonatal intensive care unit,29202_simulation as part of discharge teaching for parents of infants in the neonatal intensive care unit.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326795/pdf'],['Consensus Guidelines for Perioperative Care in Neonatal Intestinal Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326795/pdf'],['29202_0_consensus guidelines for perioperative care in neonatal intestinal surgery enhanced recovery after surgery eras society recommendations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326795/pdf'],['29202_0_consensus guidelines for perioperative care in neonatal intestinal surgery enhanced recovery after surgery eras society recommendations.pdf'],[0.168],[0.546],[0.622],[0.146],[0.155],[0.124],[0.73],[0.635],[0.622],[0.627],[0.804],[0.754],[0.639],[0.923],[0.836],[0.766],[0.807],[0.789],0.168,0.546,0.622,0.146,0.155,0.124,0.73,0.635,0.622,0.627,0.804,0.754,0.639,0.923,0.836,0.766,0.807,0.789
https://doi.org/10.1097/opx.0000000000001443,treatment of symptomatic convergence insufficiency in children enrolled in the convergence insufficiency treatment trial–attention amp reading trial a randomized clinical trial,29239_treatment of symptomatic convergence insufficiency in children enrolled in the convergence insufficiency treatment trial–attention amp reading trial a randomized clinical trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092638/pdf'],['Interventions for convergence insufficiency: a network meta‐analysis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092638/pdf'],['29239_0_interventions for convergence insufficiency a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092638/pdf'],['29239_0_interventions for convergence insufficiency a network meta‐analysis.pdf'],[0.644],[0.537],[0.615],[0.175],[0.183],[0.16],[0.738],[0.647],[0.602],[0.706],[0.78],[0.706],[0.61],[0.906],[0.813],[0.725],[0.785],[0.752],0.644,0.537,0.615,0.175,0.183,0.16,0.738,0.647,0.602,0.706,0.78,0.706,0.61,0.906,0.813,0.725,0.785,0.752
https://doi.org/10.1097/pcc.0000000000001942,development of an antibiotic guideline for children with suspected ventilatorassociated infections,29252_development of an antibiotic guideline for children with suspected ventilatorassociated infections.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['Antibiotics for hospital‐acquired pneumonia in neonates and children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['29252_0_antibiotics for hospital‐acquired pneumonia in neonates and children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562877/pdf'],['29252_0_antibiotics for hospital‐acquired pneumonia in neonates and children.pdf'],[0.355],[0.555],[0.634],[0.194],[0.198],[0.155],[0.739],[0.644],[0.621],[0.696],[0.799],[0.732],[0.603],[0.926],[0.839],[0.758],[0.799],[0.783],0.355,0.555,0.634,0.194,0.198,0.155,0.739,0.644,0.621,0.696,0.799,0.732,0.603,0.926,0.839,0.758,0.799,0.783
https://doi.org/10.1097/pec.0000000000001705,lung ultrasound findings and bronchiolitis ultrasound score for predicting hospital admission in children with acute bronchiolitis,29263_lung ultrasound findings and bronchiolitis ultrasound score for predicting hospital admission in children with acute bronchiolitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697535/pdf'],['Consensus on the Application of Lung Ultrasound in Pneumonia and Bronchiolitis in Children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697535/pdf'],['29263_0_consensus on the application of lung ultrasound in pneumonia and bronchiolitis in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697535/pdf'],['29263_0_consensus on the application of lung ultrasound in pneumonia and bronchiolitis in children.pdf'],[0.434],[0.494],[0.578],[0.146],[0.152],[0.124],[0.741],[0.644],[0.558],[0.676],[0.768],[0.649],[0.605],[0.91],[0.781],[0.728],[0.764],[0.755],0.434,0.494,0.578,0.146,0.152,0.124,0.741,0.644,0.558,0.676,0.768,0.649,0.605,0.91,0.781,0.728,0.764,0.755
https://doi.org/10.1097/pep.0000000000000621,physical therapy scoliosisspecific exercises may reduce curve progression in mild adolescent idiopathic scoliosis curves,29270_physical therapy scoliosisspecific exercises may reduce curve progression in mild adolescent idiopathic scoliosis curves.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201698/pdf'],['Network meta-analysis of short-term effects of different strategies in the conservative treatment of AIS'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201698/pdf'],['29270_0_network metaanalysis of shortterm effects of different strategies in the conservative treatment of ais.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201698/pdf'],['29270_0_network metaanalysis of shortterm effects of different strategies in the conservative treatment of ais.pdf'],[0.411],[0.535],[0.611],[0.16],[0.183],[0.143],[0.734],[0.634],[0.609],[0.689],[0.795],[0.729],[0.607],[0.925],[0.831],[0.766],[0.798],[0.785],0.411,0.535,0.611,0.16,0.183,0.143,0.734,0.634,0.609,0.689,0.795,0.729,0.607,0.925,0.831,0.766,0.798,0.785
https://doi.org/10.1097/pep.0000000000000638,healthrelated quality of life in children with chronic illness compared to parents a systematic review,29271_healthrelated quality of life in children with chronic illness compared to parents a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['29271_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['29271_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.201],[0.539],[0.616],[0.13],[0.134],[0.099],[0.73],[0.631],[0.606],[0.641],[0.797],[0.733],[0.611],[0.921],[0.82],[0.763],[0.8],[0.779],0.201,0.539,0.616,0.13,0.134,0.099,0.73,0.631,0.606,0.641,0.797,0.733,0.611,0.921,0.82,0.763,0.8,0.779
https://doi.org/10.1097/phh.0000000000000888,successfully changing a states climate to increase blood lead level testing,29277_successfully changing a states climate to increase blood lead level testing.pdf,3,"['http://www.houstontx.gov/health/Environmental/bcceh/documents/lead-screening-guidelines-for-children-in-houston.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_11352-866.pdf']","['HOUSTON HEALTH SAS i', '2015-Lead-Poisoning', 'Comparative Assessment of Lead Poisoning Screening Practices in Maine Final 3.14.19']","['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_11352-866.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'http://www.houstontx.gov/health/Environmental/bcceh/documents/lead-screening-guidelines-for-children-in-houston.pdf']","['29277_2_comparative assessment of lead poisoning screening practices in maine final 31419.pdf', '29277_1_2015leadpoisoning.pdf', '29277_0_houston health sas i.pdf']",3,100.0,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_11352-866.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'http://www.houstontx.gov/health/Environmental/bcceh/documents/lead-screening-guidelines-for-children-in-houston.pdf']","['29277_2_comparative assessment of lead poisoning screening practices in maine final 31419.pdf', '29277_1_2015leadpoisoning.pdf', '29277_0_houston health sas i.pdf']","[0.585, 0.385, 0.562]","[0.543, 0.491, 0.582]","[0.621, 0.586, 0.659]","[0.206, 0.142, 0.261]","[0.23, 0.153, 0.284]","[0.184, 0.118, 0.221]","[0.741, 0.729, 0.751]","[0.654, 0.635, 0.664]","[0.615, 0.565, 0.662]","[0.686, 0.66, 0.693]","[0.806, 0.785, 0.838]","[0.718, 0.682, 0.771]","[0.645, 0.6, 0.661]","[0.92, 0.912, 0.933]","[0.855, 0.814, 0.876]","[0.766, 0.737, 0.795]","[0.808, 0.776, 0.839]","[0.785, 0.762, 0.819]",0.511,0.539,0.622,0.203,0.222,0.174,0.74,0.651,0.614,0.68,0.81,0.724,0.635,0.922,0.848,0.766,0.808,0.789
https://doi.org/10.1097/qad.0000000000002301,nonadherence and unsuppressed viral load across adolescence among us youth with perinatally acquired hiv,29301_nonadherence and unsuppressed viral load across adolescence among us youth with perinatally acquired hiv.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['Accuracy of measures for antiretroviral adherence in people living with HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['29301_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309033/pdf'],['29301_0_accuracy of measures for antiretroviral adherence in people living with hiv.pdf'],[0.451],[0.561],[0.645],[0.189],[0.188],[0.16],[0.742],[0.651],[0.628],[0.676],[0.804],[0.742],[0.607],[0.934],[0.847],[0.764],[0.801],[0.788],0.451,0.561,0.645,0.189,0.188,0.16,0.742,0.651,0.628,0.676,0.804,0.742,0.607,0.934,0.847,0.764,0.801,0.788
https://doi.org/10.1097/qai.0000000000000803,effective treatment of depressive disorders in medical clinics for adolescents and young adults living with hiv,29320_effective treatment of depressive disorders in medical clinics for adolescents and young adults living with hiv.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491182/pdf', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research', 'https://www.rand.org/pubs/research_reports/RR2111.html']","['Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions', 'Antidepressants for depression in adults with HIV infection', 'Treatment of Depression in Children and Adolescents', 'Provider Interventions to Increase Uptake of Evidence-Based Treatment for Depression']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491182/pdf']","['29320_0_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '29320_1_antidepressants for depression in adults with hiv infection.pdf']",2,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353208/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491182/pdf']","['29320_0_psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions.pdf', '29320_1_antidepressants for depression in adults with hiv infection.pdf']","[0.414, 0.444]","[0.508, 0.518]","[0.595, 0.605]","[0.164, 0.171]","[0.17, 0.179]","[0.142, 0.147]","[0.736, 0.732]","[0.642, 0.64]","[0.573, 0.588]","[0.706, 0.7]","[0.775, 0.782]","[0.681, 0.698]","[0.577, 0.576]","[0.914, 0.918]","[0.81, 0.815]","[0.721, 0.729]","[0.77, 0.779]","[0.754, 0.758]",0.429,0.513,0.6,0.168,0.174,0.144,0.734,0.641,0.581,0.703,0.778,0.69,0.577,0.916,0.812,0.725,0.774,0.756
https://doi.org/10.1097/qai.0b013e318074eeca,flashheat inactivation of hiv1 in human milk,29327_flashheat inactivation of hiv1 in human milk.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389566/pdf'],['Interventions for preventing late postnatal mother‐to‐child transmission of HIV'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389566/pdf'],['29327_0_interventions for preventing late postnatal mother‐to‐child transmission of hiv.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389566/pdf'],['29327_0_interventions for preventing late postnatal mother‐to‐child transmission of hiv.pdf'],[0.49],[0.52],[0.604],[0.181],[0.181],[0.154],[0.742],[0.651],[0.586],[0.652],[0.775],[0.691],[0.603],[0.909],[0.811],[0.723],[0.774],[0.745],0.49,0.52,0.604,0.181,0.181,0.154,0.742,0.651,0.586,0.652,0.775,0.691,0.603,0.909,0.811,0.723,0.774,0.745
https://doi.org/10.1097/rti.0000000000000533,diagnostic performance of chest xray for covid19 pneumonia during the sarscov2 pandemic in lombardy italy,29348_diagnostic performance of chest xray for covid19 pneumonia during the sarscov2 pandemic in lombardy italy.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078565/pdf']","['Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)', 'Thoracic imaging tests for the diagnosis of COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078565/pdf']","['29348_0_chemoprophylaxis diagnosis treatments and discharge management of covid19 an evidencebased clinical practice guideline updated version.pdf', '29348_1_thoracic imaging tests for the diagnosis of covid‐19.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472403/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078565/pdf']","['29348_0_chemoprophylaxis diagnosis treatments and discharge management of covid19 an evidencebased clinical practice guideline updated version.pdf', '29348_1_thoracic imaging tests for the diagnosis of covid‐19.pdf']","[0.371, 0.334]","[0.537, 0.545]","[0.612, 0.619]","[0.193, 0.197]","[0.18, 0.184]","[0.147, 0.152]","[0.744, 0.742]","[0.653, 0.651]","[0.601, 0.601]","[0.662, 0.711]","[0.798, 0.788]","[0.693, 0.707]","[0.627, 0.615]","[0.914, 0.91]","[0.827, 0.835]","[0.762, 0.744]","[0.792, 0.786]","[0.781, 0.767]",0.353,0.541,0.615,0.195,0.182,0.149,0.743,0.652,0.601,0.686,0.793,0.7,0.621,0.912,0.831,0.753,0.789,0.774
https://doi.org/10.1097/won.0000000000000545,bladder selfmanagement in the transition to adulthood with spina bifida in 3 countries,29376_bladder selfmanagement in the transition to adulthood with spina bifida in 3 countries.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838981/pdf'],['Self-management and independence guidelines for the care of people with spina bifida'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838981/pdf'],['29376_0_selfmanagement and independence guidelines for the care of people with spina bifida.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838981/pdf'],['29376_0_selfmanagement and independence guidelines for the care of people with spina bifida.pdf'],[0.261],[0.517],[0.595],[0.13],[0.143],[0.12],[0.73],[0.629],[0.582],[0.66],[0.785],[0.712],[0.61],[0.918],[0.811],[0.748],[0.783],[0.768],0.261,0.517,0.595,0.13,0.143,0.12,0.73,0.629,0.582,0.66,0.785,0.712,0.61,0.918,0.811,0.748,0.783,0.768
https://doi.org/10.1098/rspb.2019.2736,global shifts in mammalian population trends reveal key predictors of virus spillover risk,29434_global shifts in mammalian population trends reveal key predictors of virus spillover risk.pdf,3,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/dndcz1okh_Southeast_Asia_Snaring_Crisis_WWF_9July2020_V2_LowRes.pdf', 'https://c4ads.org/s/Animal-Smuggling-in-Air-Transport-and-Preventing-Zoonotic-Spillover.pdf', 'https://www.americanprogress.org/issues/green/reports/2020/04/20/483455/confronting-pandemic-must-save-nature-save/']","[""Silence of the Snares: Southeast Asia's Snaring Crisis (application/pdf, 14.3 MB)"", 'Animal Smuggling In Air Transport And Preventing Zoonotic Spillover', 'When Confronting a Pandemic, We Must Save Nature to Save Ourselves - Center for American Progress']",['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/dndcz1okh_Southeast_Asia_Snaring_Crisis_WWF_9July2020_V2_LowRes.pdf'],['29434_0_silence of the snares southeast asias snaring crisis applicationpdf 143 mb.pdf'],1,33.33,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/dndcz1okh_Southeast_Asia_Snaring_Crisis_WWF_9July2020_V2_LowRes.pdf'],['29434_0_silence of the snares southeast asias snaring crisis applicationpdf 143 mb.pdf'],[0.285],[0.5],[0.591],[0.137],[0.139],[0.127],[0.736],[0.642],[0.561],[0.681],[0.78],[0.7],[0.631],[0.902],[0.812],[0.744],[0.782],[0.769],0.285,0.5,0.591,0.137,0.139,0.127,0.736,0.642,0.561,0.681,0.78,0.7,0.631,0.902,0.812,0.744,0.782,0.769
https://doi.org/10.1100/tsw.2007.179,transition to adulthood in spina bifida changing roles and expectations,29470_transition to adulthood in spina bifida changing roles and expectations.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838978/pdf'],['Care coordination guidelines for the care of people with spina bifida'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838978/pdf'],['29470_0_care coordination guidelines for the care of people with spina bifida.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838978/pdf'],['29470_0_care coordination guidelines for the care of people with spina bifida.pdf'],[0.558],[0.57],[0.653],[0.199],[0.226],[0.192],[0.748],[0.655],[0.622],[0.683],[0.814],[0.758],[0.647],[0.932],[0.833],[0.781],[0.813],[0.799],0.558,0.57,0.653,0.199,0.226,0.192,0.748,0.655,0.622,0.683,0.814,0.758,0.647,0.932,0.833,0.781,0.813,0.799
https://doi.org/10.1100/tsw.2009.51,the management of ureteropelvic junction obstruction presenting with prenatal hydronephrosis,29471_the management of ureteropelvic junction obstruction presenting with prenatal hydronephrosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457949/pdf'],['Surgery versus non‐surgical management for unilateral ureteric‐pelvic junction obstruction in newborns and infants less than two years of age'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457949/pdf'],['29471_0_surgery versus non‐surgical management for unilateral ureteric‐pelvic junction obstruction in newborns and infants less than two years of age.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457949/pdf'],['29471_0_surgery versus non‐surgical management for unilateral ureteric‐pelvic junction obstruction in newborns and infants less than two years of age.pdf'],[0.332],[0.567],[0.646],[0.196],[0.197],[0.149],[0.737],[0.637],[0.63],[0.65],[0.801],[0.732],[0.627],[0.929],[0.82],[0.761],[0.798],[0.781],0.332,0.567,0.646,0.196,0.197,0.149,0.737,0.637,0.63,0.65,0.801,0.732,0.627,0.929,0.82,0.761,0.798,0.781
https://doi.org/10.1101/mcs.a003715,vac14 syndrome in two siblings with retinitis pigmentosa and neurodegeneration with brain iron accumulation,29564_vac14 syndrome in two siblings with retinitis pigmentosa and neurodegeneration with brain iron accumulation.pdf,1,['https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf'],['2019 Ibr Staff Publications'],['https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf'],['29564_0_2019 ibr staff publications.pdf'],1,100.0,['https://opwdd.ny.gov/system/files/documents/2020/08/2019-staff-publications_5-14-2020.pdf'],['29564_0_2019 ibr staff publications.pdf'],[0.133],[0.485],[0.588],[0.125],[0.129],[0.107],[0.739],[0.642],[0.55],[0.663],[0.783],[0.673],[0.596],[0.908],[0.804],[0.731],[0.78],[0.764],0.133,0.485,0.588,0.125,0.129,0.107,0.739,0.642,0.55,0.663,0.783,0.673,0.596,0.908,0.804,0.731,0.78,0.764
https://doi.org/10.1108/edi-10-2018-0177,work matters formerly incarcerated men’s resiliency in reentry,29609_work matters formerly incarcerated men’s resiliency in reentry.pdf,1,['http://www.bscc.ca.gov/wp-content/uploads/pv_jobs_eval_rpt.pdf'],['Evaluation Report'],['http://www.bscc.ca.gov/wp-content/uploads/pv_jobs_eval_rpt.pdf'],['29609_0_evaluation report.pdf'],1,100.0,['http://www.bscc.ca.gov/wp-content/uploads/pv_jobs_eval_rpt.pdf'],['29609_0_evaluation report.pdf'],[0.308],[0.545],[0.63],[0.147],[0.168],[0.132],[0.719],[0.624],[0.603],[0.692],[0.791],[0.726],[0.635],[0.912],[0.838],[0.763],[0.8],[0.778],0.308,0.545,0.63,0.147,0.168,0.132,0.719,0.624,0.603,0.692,0.791,0.726,0.635,0.912,0.838,0.763,0.8,0.778
https://doi.org/10.1108/jmhtep-04-2019-0023,the benefits of studentled health promotion intervention,29614_the benefits of studentled health promotion intervention.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf']","['Well and Thriving: Prevention and Early Intervention in California, First Public Draft', 'Well and Thriving: Prevention and Early Intervention in California - Second Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['29614_1_well and thriving prevention and early intervention in california  second public draft.pdf', '29614_0_well and thriving prevention and early intervention in california first public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['29614_1_well and thriving prevention and early intervention in california  second public draft.pdf', '29614_0_well and thriving prevention and early intervention in california first public draft.pdf']","[0.602, 0.6]","[0.528, 0.527]","[0.625, 0.625]","[0.155, 0.156]","[0.163, 0.164]","[0.14, 0.141]","[0.728, 0.728]","[0.636, 0.637]","[0.593, 0.592]","[0.672, 0.672]","[0.794, 0.794]","[0.709, 0.708]","[0.618, 0.618]","[0.92, 0.92]","[0.834, 0.833]","[0.752, 0.752]","[0.794, 0.793]","[0.774, 0.774]",0.601,0.528,0.625,0.155,0.164,0.141,0.728,0.637,0.593,0.672,0.794,0.708,0.618,0.92,0.833,0.752,0.794,0.774
https://doi.org/10.1109/mts.2021.3056293,bias and discrimination in ai a crossdisciplinary perspective,29660_bias and discrimination in ai a crossdisciplinary perspective.pdf,1,['https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1270.pdf'],['(DOC/NIST) Towards a Standard for Identifying and Managing Bias in Artificial Intelligence'],['https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1270.pdf'],['29660_0_docnist towards a standard for identifying and managing bias in artificial intelligence.pdf'],1,100.0,['https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1270.pdf'],['29660_0_docnist towards a standard for identifying and managing bias in artificial intelligence.pdf'],[0.661],[0.542],[0.644],[0.162],[0.174],[0.151],[0.738],[0.652],[0.598],[0.726],[0.792],[0.703],[0.628],[0.904],[0.833],[0.762],[0.782],[0.778],0.661,0.542,0.644,0.162,0.174,0.151,0.738,0.652,0.598,0.726,0.792,0.703,0.628,0.904,0.833,0.762,0.782,0.778
https://doi.org/10.1111/0038-4941.00014,building citizenship how student voice in servicelearning develops civic values,29696_building citizenship how student voice in servicelearning develops civic values.pdf,5,"['https://www.tn.gov/content/dam/tn/volunteertn/documents/service_learning/serve-indeed/TNJournalofService-LearningandCivicEngagementVol2Issue1.pdf', 'https://massinc.org/research/leading-together-5/', 'https://massinc.org/research/leading-together-4/', 'https://www.nj.gov/education/students/safety/behavior/hib/guidance.pdf', 'https://www.nj.gov/oag/dcr/downloads/Anti-Bullying_Bill-of-Rights.pdf']","['Serve InDEED', 'Leading Together', 'Leading Together', 'Guidance for Schools on Implementing the Anti-Bullying Bill of Rights Act', 'Guidance for Schools on Implementing the Anti-Bullying Bill of Rights Act']",['https://www.tn.gov/content/dam/tn/volunteertn/documents/service_learning/serve-indeed/TNJournalofService-LearningandCivicEngagementVol2Issue1.pdf'],['29696_0_serve indeed.pdf'],1,20.0,['https://www.tn.gov/content/dam/tn/volunteertn/documents/service_learning/serve-indeed/TNJournalofService-LearningandCivicEngagementVol2Issue1.pdf'],['29696_0_serve indeed.pdf'],[0.674],[0.556],[0.645],[0.175],[0.201],[0.171],[0.731],[0.634],[0.626],[0.697],[0.813],[0.747],[0.656],[0.923],[0.856],[0.781],[0.823],[0.803],0.674,0.556,0.645,0.175,0.201,0.171,0.731,0.634,0.626,0.697,0.813,0.747,0.656,0.923,0.856,0.781,0.823,0.803
https://doi.org/10.1111/1467-8624.00273,selfefficacy beliefs as shapers of childrens aspirations and career trajectories,29762_selfefficacy beliefs as shapers of childrens aspirations and career trajectories.pdf,3,"['http://purl.fdlp.gov/GPO/gpo62982', 'https://www.lni.wa.gov/patient-care/advisory-committees/_docs/2016PDIRResourceFinal.pdf', 'https://www.acf.hhs.gov/opre/resource/staff-development-and-training']","['Expanding opportunities for women in business.', 'Reducing Disability: Psychosocial Determinants Influencing Recovery (PDIR)', 'Staff Development and Training']","['http://purl.fdlp.gov/GPO/gpo62982', 'https://www.lni.wa.gov/patient-care/advisory-committees/_docs/2016PDIRResourceFinal.pdf']","['29762_0_expanding opportunities for women in business.pdf', '29762_1_reducing disability psychosocial determinants influencing recovery pdir.pdf']",2,66.67,"['http://purl.fdlp.gov/GPO/gpo62982', 'https://www.lni.wa.gov/patient-care/advisory-committees/_docs/2016PDIRResourceFinal.pdf']","['29762_0_expanding opportunities for women in business.pdf', '29762_1_reducing disability psychosocial determinants influencing recovery pdir.pdf']","[0.263, 0.219]","[0.534, 0.529]","[0.62, 0.617]","[0.155, 0.115]","[0.172, 0.122]","[0.144, 0.103]","[0.724, 0.721]","[0.622, 0.622]","[0.596, 0.594]","[0.686, 0.667]","[0.8, 0.79]","[0.731, 0.727]","[0.632, 0.619]","[0.923, 0.926]","[0.834, 0.817]","[0.759, 0.762]","[0.808, 0.801]","[0.785, 0.779]",0.241,0.532,0.619,0.135,0.147,0.123,0.722,0.622,0.595,0.677,0.795,0.729,0.625,0.925,0.825,0.76,0.804,0.782
https://doi.org/10.1111/1468-0009.12417,childhood vaccination mandates scope sanctions severity selectivity and salience,29885_childhood vaccination mandates scope sanctions severity selectivity and salience.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['Improving vaccination uptake among adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['29885_0_improving vaccination uptake among adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['29885_0_improving vaccination uptake among adolescents.pdf'],[0.314],[0.545],[0.623],[0.188],[0.189],[0.177],[0.73],[0.636],[0.606],[0.681],[0.794],[0.731],[0.603],[0.922],[0.831],[0.749],[0.797],[0.77],0.314,0.545,0.623,0.188,0.189,0.177,0.73,0.636,0.606,0.681,0.794,0.731,0.603,0.922,0.831,0.749,0.797,0.77
https://doi.org/10.1111/1471-0528.16719,impact of analysis technique on our understanding of the natural history of labour a simulation study,29987_impact of analysis technique on our understanding of the natural history of labour a simulation study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564810/pdf'],['The effect of Zhang’s guideline vs the WHO partograph on childbirth experience measured by the Childbirth Experience Questionnaire in the Labor Progression Study (LaPS): A cluster randomized trial'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564810/pdf'],['29987_0_the effect of zhangs guideline vs the who partograph on childbirth experience measured by the childbirth experience .pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564810/pdf'],['29987_0_the effect of zhangs guideline vs the who partograph on childbirth experience measured by the childbirth experience .pdf'],[0.19],[0.529],[0.606],[0.153],[0.188],[0.152],[0.729],[0.635],[0.598],[0.678],[0.785],[0.728],[0.611],[0.912],[0.813],[0.75],[0.785],[0.763],0.19,0.529,0.606,0.153,0.188,0.152,0.729,0.635,0.598,0.678,0.785,0.728,0.611,0.912,0.813,0.75,0.785,0.763
https://doi.org/10.1111/1745-9125.12208,does gang membership pay illegal and legal earnings through emerging adulthood,30065_does gang membership pay illegal and legal earnings through emerging adulthood.pdf,2,"['https://www.oag.ca.gov/sites/all/files/agweb/pdfs/jdis/ch7-5-ab-90-052020.pdf', 'https://www.oag.ca.gov/sites/all/files/agweb/pdfs/jdis/ch7-6-ab-90-052020.pdf']","['Gang Member Definitions, Criteria, and Identification : AB 90 Empirical Literature Review Supplement', 'AB 90 Empirical Literature Review Supplement']","['https://www.oag.ca.gov/sites/all/files/agweb/pdfs/jdis/ch7-6-ab-90-052020.pdf', 'https://www.oag.ca.gov/sites/all/files/agweb/pdfs/jdis/ch7-5-ab-90-052020.pdf']","['30065_1_ab 90 empirical literature review supplement.pdf', '30065_0_gang member definitions criteria and identification  ab 90 empirical literature review supplement.pdf']",2,100.0,"['https://www.oag.ca.gov/sites/all/files/agweb/pdfs/jdis/ch7-6-ab-90-052020.pdf', 'https://www.oag.ca.gov/sites/all/files/agweb/pdfs/jdis/ch7-5-ab-90-052020.pdf']","['30065_1_ab 90 empirical literature review supplement.pdf', '30065_0_gang member definitions criteria and identification  ab 90 empirical literature review supplement.pdf']","[0.618, 0.618]","[0.526, 0.526]","[0.619, 0.619]","[0.193, 0.193]","[0.242, 0.242]","[0.203, 0.203]","[0.739, 0.739]","[0.648, 0.648]","[0.582, 0.582]","[0.717, 0.717]","[0.786, 0.786]","[0.711, 0.711]","[0.63, 0.63]","[0.919, 0.919]","[0.816, 0.816]","[0.752, 0.752]","[0.788, 0.788]","[0.778, 0.778]",0.618,0.526,0.619,0.193,0.242,0.203,0.739,0.648,0.582,0.717,0.786,0.711,0.63,0.919,0.816,0.752,0.788,0.778
https://doi.org/10.1111/add.14711,associations between young adult marijuana outcomes and availability of medical marijuana dispensaries and storefront signage,30106_associations between young adult marijuana outcomes and availability of medical marijuana dispensaries and storefront signage.pdf,2,"['https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg5_publiccomments_10.6.20.pdf', 'https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg4_publiccomments_6.25.20.pdf']","['Marijuana Licensing Workgroup Meeting 5 Public Comments', 'The ravaging ellacts']","['https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg5_publiccomments_10.6.20.pdf', 'https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg4_publiccomments_6.25.20.pdf']","['30106_0_marijuana licensing workgroup meeting 5 public comments.pdf', '30106_1_the ravaging ellacts.pdf']",2,100.0,"['https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg5_publiccomments_10.6.20.pdf', 'https://denvergov.org/files/assets/public/marijuana-info/documents/mlwg4_publiccomments_6.25.20.pdf']","['30106_0_marijuana licensing workgroup meeting 5 public comments.pdf', '30106_1_the ravaging ellacts.pdf']","[0.259, 0.33]","[0.534, 0.537]","[0.615, 0.618]","[0.136, 0.143]","[0.149, 0.159]","[0.125, 0.134]","[0.72, 0.724]","[0.623, 0.628]","[0.606, 0.612]","[0.643, 0.647]","[0.796, 0.803]","[0.749, 0.757]","[0.641, 0.645]","[0.924, 0.924]","[0.827, 0.829]","[0.763, 0.768]","[0.804, 0.808]","[0.778, 0.785]",0.294,0.536,0.617,0.14,0.154,0.13,0.722,0.625,0.609,0.645,0.8,0.753,0.643,0.924,0.828,0.766,0.806,0.782
https://doi.org/10.1111/add.15403,dependence on nicotine in us high school students in the context of changing patterns of tobacco product use,30107_dependence on nicotine in us high school students in the context of changing patterns of tobacco product use.pdf,2,"['https://mgaleg.maryland.gov/cmte_testimony/2021/fin/1LmJwCCHssPFEGcQ71c7BvqQ89pv4V_Ev.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/fin/272_01282021_84045-138.pdf']","['January 26, 2121', '3b - FIN -SB 177 - FIN - Tobacco Flavor Ban - MACH']","['https://mgaleg.maryland.gov/cmte_testimony/2021/fin/1LmJwCCHssPFEGcQ71c7BvqQ89pv4V_Ev.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/fin/272_01282021_84045-138.pdf']","['30107_0_january 26 2121.pdf', '30107_1_3b  fin sb 177  fin  tobacco flavor ban  mach.pdf']",2,100.0,"['https://mgaleg.maryland.gov/cmte_testimony/2021/fin/1LmJwCCHssPFEGcQ71c7BvqQ89pv4V_Ev.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/fin/272_01282021_84045-138.pdf']","['30107_0_january 26 2121.pdf', '30107_1_3b  fin sb 177  fin  tobacco flavor ban  mach.pdf']","[0.39, 0.563]","[0.551, 0.508]","[0.635, 0.598]","[0.221, 0.174]","[0.249, 0.199]","[0.205, 0.172]","[0.738, 0.732]","[0.641, 0.634]","[0.626, 0.574]","[0.686, 0.699]","[0.811, 0.778]","[0.748, 0.694]","[0.655, 0.628]","[0.912, 0.898]","[0.844, 0.819]","[0.771, 0.732]","[0.815, 0.786]","[0.787, 0.753]",0.476,0.53,0.617,0.198,0.224,0.189,0.735,0.637,0.6,0.693,0.794,0.721,0.641,0.905,0.831,0.752,0.8,0.77
https://doi.org/10.1111/ajo.13006,the association between induction of labour at 38 to 39 weeks pregnancy and indication for caesarean delivery an observational study,30126_the association between induction of labour at 38 to 39 weeks pregnancy and indication for caesarean delivery an observational study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf'],"[""Induction of labour at or beyond 37 weeks' gestation""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf'],['30126_0_induction of labour at or beyond 37 weeks gestation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389871/pdf'],['30126_0_induction of labour at or beyond 37 weeks gestation.pdf'],[0.523],[0.531],[0.61],[0.192],[0.196],[0.163],[0.741],[0.648],[0.588],[0.677],[0.776],[0.698],[0.595],[0.91],[0.81],[0.728],[0.775],[0.753],0.523,0.531,0.61,0.192,0.196,0.163,0.741,0.648,0.588,0.677,0.776,0.698,0.595,0.91,0.81,0.728,0.775,0.753
https://doi.org/10.1111/all.13825,the impact of prescribed fire versus wildfire on the immune and cardiovascular systems of children,30147_the impact of prescribed fire versus wildfire on the immune and cardiovascular systems of children.pdf,5,"['https://www.manhattan-institute.org/managing-california-wildfire-risk', 'https://www.congress.gov/event/117th-congress/house-event/111306', 'https://purl.fdlp.gov/GPO/gpo125866', 'https://fmtf.fire.ca.gov/media/vuahweso/ca-rx-fire-strategic-plan-2021_10-17-21draft.pdf', 'https://lao.ca.gov/reports/2022/4644/Understanding-the-Challenges-of-CA-Wildfire-Smoke-111422.pdf']","[""Managing California's Wildfire Risk"", 'The Science Behind Impacts of the Climate Crisis', 'Creating a clmate resilient America :\xa0hearing before the Select Committee on the Climate Crisis, House of Representatives, One Hundred Sixteenth Congress, first session, hearing held May 23, 2019.', 'California’s Strategic Plan for Prescribed Fire, Cultural Burning & Prescribed Natural Fire', 'Living Under Smoky Skies—Understanding the Challenges Posed by Wildfire Smoke in California']","['https://purl.fdlp.gov/GPO/gpo125866', 'https://lao.ca.gov/reports/2022/4644/Understanding-the-Challenges-of-CA-Wildfire-Smoke-111422.pdf']","['30147_2_creating a clmate resilient america \xa0hearing before the select committee on the climate crisis house of representatives one hundred sixteenth congress first session hearing held may 23 2019.pdf', '30147_4_living under smoky skies—understanding the challenges posed by wildfire smoke in california.pdf']",2,40.0,"['https://purl.fdlp.gov/GPO/gpo125866', 'https://lao.ca.gov/reports/2022/4644/Understanding-the-Challenges-of-CA-Wildfire-Smoke-111422.pdf']","['30147_2_creating a clmate resilient america \xa0hearing before the select committee on the climate crisis house of representatives one hundred sixteenth congress first session hearing held may 23 2019.pdf', '30147_4_living under smoky skies—understanding the challenges posed by wildfire smoke in california.pdf']","[0.143, 0.386]","[0.477, 0.506]","[0.564, 0.595]","[0.084, 0.152]","[0.082, 0.161]","[0.077, 0.128]","[0.715, 0.734]","[0.615, 0.639]","[0.557, 0.579]","[0.669, 0.677]","[0.783, 0.789]","[0.694, 0.724]","[0.615, 0.618]","[0.901, 0.912]","[0.81, 0.812]","[0.731, 0.748]","[0.787, 0.791]","[0.771, 0.778]",0.265,0.491,0.579,0.118,0.121,0.103,0.724,0.627,0.568,0.673,0.786,0.709,0.617,0.907,0.811,0.74,0.789,0.774
https://doi.org/10.1111/all.14771,childhood vaccination and allergy a systematic review and meta‐analysis,30148_childhood vaccination and allergy a systematic review and meta‐analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543786/pdf'],['Whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543786/pdf'],['30148_0_whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543786/pdf'],['30148_0_whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children.pdf'],[0.606],[0.547],[0.63],[0.206],[0.214],[0.174],[0.745],[0.655],[0.602],[0.694],[0.79],[0.708],[0.622],[0.916],[0.812],[0.746],[0.788],[0.769],0.606,0.547,0.63,0.206,0.214,0.174,0.745,0.655,0.602,0.694,0.79,0.708,0.622,0.916,0.812,0.746,0.788,0.769
https://doi.org/10.1111/anae.15047,videolaryngoscopy increases ‘mouth‐to‐mouth’ distance compared with direct laryngoscopy,30150_videolaryngoscopy increases ‘mouth‐to‐mouth’ distance compared with direct laryngoscopy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['COVID-19 PICU guidelines: for high- and limited-resource settings'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['30150_0_covid19 picu guidelines for high and limitedresource settings.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577838/pdf'],['30150_0_covid19 picu guidelines for high and limitedresource settings.pdf'],[0.184],[0.54],[0.634],[0.142],[0.15],[0.102],[0.738],[0.639],[0.604],[0.619],[0.792],[0.733],[0.621],[0.93],[0.805],[0.76],[0.799],[0.776],0.184,0.54,0.634,0.142,0.15,0.102,0.738,0.639,0.604,0.619,0.792,0.733,0.621,0.93,0.805,0.76,0.799,0.776
https://doi.org/10.1111/andr.12636,eaa clinical practice guidelines—gynecomastia evaluation and management,30156_eaa clinical practice guidelines—gynecomastia evaluation and management.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['30156_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['30156_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.384],[0.567],[0.654],[0.192],[0.205],[0.16],[0.747],[0.651],[0.634],[0.655],[0.81],[0.731],[0.641],[0.928],[0.821],[0.784],[0.814],[0.8],0.384,0.567,0.654,0.192,0.205,0.16,0.747,0.651,0.634,0.655,0.81,0.731,0.641,0.928,0.821,0.784,0.814,0.8
https://doi.org/10.1111/apa.14405,community case management of lower chest indrawing pneumonia with oral amoxicillin in children in kenya,30182_community case management of lower chest indrawing pneumonia with oral amoxicillin in children in kenya.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['Integrated community case management of childhood illness in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['30182_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['30182_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],[0.478],[0.524],[0.611],[0.166],[0.174],[0.143],[0.733],[0.637],[0.586],[0.677],[0.784],[0.708],[0.6],[0.917],[0.823],[0.727],[0.784],[0.758],0.478,0.524,0.611,0.166,0.174,0.143,0.733,0.637,0.586,0.677,0.784,0.708,0.6,0.917,0.823,0.727,0.784,0.758
https://doi.org/10.1111/apa.15155,cystic fibrosis in the year 2020 a disease with a new face,30184_cystic fibrosis in the year 2020 a disease with a new face.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf'],['Recombinant growth hormone therapy for cystic fibrosis in children and young adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf'],['30184_0_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407505/pdf'],['30184_0_recombinant growth hormone therapy for cystic fibrosis in children and young adults.pdf'],[0.192],[0.493],[0.575],[0.135],[0.131],[0.101],[0.73],[0.634],[0.561],[0.669],[0.774],[0.688],[0.592],[0.903],[0.804],[0.71],[0.767],[0.745],0.192,0.493,0.575,0.135,0.131,0.101,0.73,0.634,0.561,0.669,0.774,0.688,0.592,0.903,0.804,0.71,0.767,0.745
https://doi.org/10.1111/apa.15371,children are unlikely to be the main drivers of the covid‐19 pandemic – a systematic review,30185_children are unlikely to be the main drivers of the covid‐19 pandemic – a systematic review.pdf,9,"['https://stacks.cdc.gov/view/cdc/111741', 'https://stacks.cdc.gov/view/cdc/107840', 'https://www.aei.org/research-products/report/is-it-safe-to-reopen-schools-an-extensive-review-of-the-research/', 'https://stacks.cdc.gov/view/cdc/112760', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20%28Late%29.pdf', 'https://files.nc.gov/covid/documents/guidance/education/What-Are-We-Learning-About-Children-and-COVID-English.pdf', 'https://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20(Late).pdf', 'https://www.nber.org/papers/w28753', 'https://www.nber.org/papers/w28455']","['Science brief: Transmission of SARS-CoV-2 in K-12 schools and early care and education programs – updated', 'Science brief: Transmission of SARS-CoV-2 in K-12 schools', 'Is it safe to reopen schools? An extensive review of the research - AEI', 'Science brief: Transmission of SARS-CoV-2 in K-12 schools and early care and education programs – updated', '312345678', 'What Are We Learning About Children and COVID-19?', '312345678', 'School Reopenings, Mobility, and COVID-19 Spread: Evidence from Texas', 'To What Extent Does In-Person Schooling Contribute to the Spread of COVID-19? Evidence from Michigan and Washington']","['http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20%28Late%29.pdf', 'https://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20(Late).pdf']","['30185_4_312345678.pdf', '30185_6_312345678.pdf']",2,22.22,"['http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20%28Late%29.pdf', 'https://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200730%20Special%20(Late).pdf']","['30185_4_312345678.pdf', '30185_6_312345678.pdf']","[0.348, 0.348]","[0.41, 0.41]","[0.528, 0.528]","[0.095, 0.095]","[0.105, 0.105]","[0.099, 0.099]","[0.728, 0.728]","[0.632, 0.632]","[0.458, 0.458]","[0.68, 0.68]","[0.705, 0.705]","[0.606, 0.606]","[0.569, 0.569]","[0.892, 0.892]","[0.733, 0.733]","[0.668, 0.668]","[0.689, 0.689]","[0.688, 0.688]",0.348,0.41,0.528,0.095,0.105,0.099,0.728,0.632,0.458,0.68,0.705,0.606,0.569,0.892,0.733,0.668,0.689,0.688
https://doi.org/10.1111/apa.15455,promoting attachment between parents and neonates despite the covid‐19 pandemic,30186_promoting attachment between parents and neonates despite the covid‐19 pandemic.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['30186_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['30186_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.394],[0.535],[0.616],[0.163],[0.186],[0.153],[0.738],[0.649],[0.603],[0.643],[0.797],[0.723],[0.614],[0.926],[0.826],[0.75],[0.787],[0.775],0.394,0.535,0.616,0.163,0.186,0.153,0.738,0.649,0.603,0.643,0.797,0.723,0.614,0.926,0.826,0.75,0.787,0.775
https://doi.org/10.1111/bjh.15841,index of pain experience in sickle cell anaemia ipesca development from daily pain diaries and initial findings from use with children and adults with sickle cell anaemia,30217_index of pain experience in sickle cell anaemia ipesca development from daily pain diaries and initial findings from use with children and adults with sickle cell anaemia.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609827/pdf']","['Interventions for preventing silent cerebral infarcts in people with sickle cell disease', 'Interventions for treating neuropathic pain in people with sickle cell disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609827/pdf']","['30217_0_interventions for preventing silent cerebral infarcts in people with sickle cell disease.pdf', '30217_1_interventions for treating neuropathic pain in people with sickle cell disease.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134371/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609827/pdf']","['30217_0_interventions for preventing silent cerebral infarcts in people with sickle cell disease.pdf', '30217_1_interventions for treating neuropathic pain in people with sickle cell disease.pdf']","[0.141, 0.422]","[0.527, 0.534]","[0.614, 0.619]","[0.145, 0.164]","[0.153, 0.176]","[0.113, 0.141]","[0.733, 0.735]","[0.638, 0.64]","[0.594, 0.603]","[0.678, 0.707]","[0.781, 0.789]","[0.698, 0.709]","[0.589, 0.597]","[0.918, 0.926]","[0.816, 0.827]","[0.735, 0.751]","[0.78, 0.788]","[0.761, 0.778]",0.281,0.53,0.617,0.154,0.164,0.127,0.734,0.639,0.599,0.693,0.785,0.704,0.593,0.922,0.821,0.743,0.784,0.77
https://doi.org/10.1111/cch.12707,comparing parent and provider priorities in discussions of early detection and intervention for infants with and at risk of cerebral palsy,30266_comparing parent and provider priorities in discussions of early detection and intervention for infants with and at risk of cerebral palsy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193973/pdf'],['Network Implementation of Guideline for Early Detection Decreases Age at Cerebral Palsy Diagnosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193973/pdf'],['30266_0_network implementation of guideline for early detection decreases age at cerebral palsy diagnosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193973/pdf'],['30266_0_network implementation of guideline for early detection decreases age at cerebral palsy diagnosis.pdf'],[0.526],[0.548],[0.631],[0.179],[0.19],[0.159],[0.738],[0.648],[0.606],[0.687],[0.793],[0.728],[0.622],[0.914],[0.824],[0.757],[0.799],[0.771],0.526,0.548,0.631,0.179,0.19,0.159,0.738,0.648,0.606,0.687,0.793,0.728,0.622,0.914,0.824,0.757,0.799,0.771
https://doi.org/10.1111/cdev.12737,resilient adaptation among atrisk children harnessing science toward maximizing salutary environments,30317_resilient adaptation among atrisk children harnessing science toward maximizing salutary environments.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121081/pdf'],['Psychological interventions to foster resilience in healthcare professionals'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121081/pdf'],['30317_0_psychological interventions to foster resilience in healthcare professionals.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121081/pdf'],['30317_0_psychological interventions to foster resilience in healthcare professionals.pdf'],[0.293],[0.507],[0.598],[0.147],[0.152],[0.128],[0.732],[0.639],[0.567],[0.709],[0.77],[0.692],[0.583],[0.912],[0.809],[0.73],[0.767],[0.76],0.293,0.507,0.598,0.147,0.152,0.128,0.732,0.639,0.567,0.709,0.77,0.692,0.583,0.912,0.809,0.73,0.767,0.76
https://doi.org/10.1111/cdev.12995,promoting resilience among african american girls racial identity as a protective factor,30329_promoting resilience among african american girls racial identity as a protective factor.pdf,5,"['https://www.aclu.org/legal-document/amended-complaint-8', 'https://www.aclu.org/legal-document/pernell-v-florida-board-governors-complaint', 'https://www.aclu.org/letter/pernell-et-al-v-florida-board-governors-et-al-complaint', 'https://www.columbus.gov/cobgreport/', 'https://dchealth.dc.gov/sites/default/files/dc/sites/doh/page_content/attachments/DOH_CHNA_ExecSummary_Web_Spreads%20Reduced.pdf']","['Amended Complaint', 'Pernell v. Florida Board of Governors Complaint', 'Pernell, et al. v Florida Board of Governors, et al Complaint', 'A Report On The', 'Executive Summary']","['https://www.columbus.gov/cobgreport/', 'https://dchealth.dc.gov/sites/default/files/dc/sites/doh/page_content/attachments/DOH_CHNA_ExecSummary_Web_Spreads%20Reduced.pdf']","['30329_3_a report on the.pdf', '30329_4_executive summary.pdf']",2,40.0,"['https://www.columbus.gov/cobgreport/', 'https://dchealth.dc.gov/sites/default/files/dc/sites/doh/page_content/attachments/DOH_CHNA_ExecSummary_Web_Spreads%20Reduced.pdf']","['30329_3_a report on the.pdf', '30329_4_executive summary.pdf']","[0.377, 0.06]","[0.524, 0.502]","[0.616, 0.607]","[0.164, 0.117]","[0.183, 0.131]","[0.159, 0.096]","[0.729, 0.722]","[0.632, 0.624]","[0.591, 0.576]","[0.694, 0.658]","[0.787, 0.782]","[0.728, 0.712]","[0.63, 0.619]","[0.914, 0.911]","[0.833, 0.814]","[0.756, 0.746]","[0.794, 0.79]","[0.773, 0.766]",0.218,0.513,0.611,0.141,0.157,0.128,0.726,0.628,0.583,0.676,0.784,0.72,0.625,0.913,0.823,0.751,0.792,0.77
https://doi.org/10.1111/cdev.13296,impact of process quality in early childhood education and care on academic outcomes longitudinal meta‐analysis,30336_impact of process quality in early childhood education and care on academic outcomes longitudinal meta‐analysis.pdf,1,['http://www.wsipp.wa.gov/ReportFile/1712/Wsipp_Early-Achievers-Evaluation-Report-One-Background-and-Research-Design_Report.pdf'],['Washington State Institute for Public Policy'],['http://www.wsipp.wa.gov/ReportFile/1712/Wsipp_Early-Achievers-Evaluation-Report-One-Background-and-Research-Design_Report.pdf'],['30336_0_washington state institute for public policy.pdf'],1,100.0,['http://www.wsipp.wa.gov/ReportFile/1712/Wsipp_Early-Achievers-Evaluation-Report-One-Background-and-Research-Design_Report.pdf'],['30336_0_washington state institute for public policy.pdf'],[0.457],[0.534],[0.62],[0.162],[0.173],[0.142],[0.727],[0.636],[0.595],[0.71],[0.798],[0.723],[0.64],[0.923],[0.829],[0.767],[0.801],[0.783],0.457,0.534,0.62,0.162,0.173,0.142,0.727,0.636,0.595,0.71,0.798,0.723,0.64,0.923,0.829,0.767,0.801,0.783
https://doi.org/10.1111/ced.14303,what’s new in atopic eczema an analysis of systematic reviews published in 2018 part 1 prevention and topical therapies,30349_what’s new in atopic eczema an analysis of systematic reviews published in 2018 part 1 prevention and topical therapies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['Skin care interventions in infants for preventing eczema and food allergy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['30349_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['30349_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],[0.435],[0.546],[0.632],[0.175],[0.187],[0.147],[0.739],[0.646],[0.607],[0.666],[0.799],[0.723],[0.617],[0.921],[0.819],[0.754],[0.801],[0.777],0.435,0.546,0.632,0.175,0.187,0.147,0.739,0.646,0.607,0.666,0.799,0.723,0.617,0.921,0.819,0.754,0.801,0.777
https://doi.org/10.1111/cen.14052,longitudinal changes in bone density in adolescents and young adults with cerebral palsy a case for early intervention,30357_longitudinal changes in bone density in adolescents and young adults with cerebral palsy a case for early intervention.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256778/pdf'],['Bisphosphonate use in children with cerebral palsy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256778/pdf'],['30357_0_bisphosphonate use in children with cerebral palsy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256778/pdf'],['30357_0_bisphosphonate use in children with cerebral palsy.pdf'],[0.383],[0.522],[0.608],[0.161],[0.168],[0.138],[0.734],[0.636],[0.599],[0.679],[0.789],[0.717],[0.608],[0.923],[0.82],[0.75],[0.79],[0.775],0.383,0.522,0.608,0.161,0.168,0.138,0.734,0.636,0.599,0.679,0.789,0.717,0.608,0.923,0.82,0.75,0.79,0.775
https://doi.org/10.1111/cen.14359,a survey of the young person’s experience of graves’ disease and its management,30358_a survey of the young person’s experience of graves’ disease and its management.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142815/pdf'],['2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142815/pdf'],['30358_0_2022 european thyroid association guideline for the management of pediatric graves disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142815/pdf'],['30358_0_2022 european thyroid association guideline for the management of pediatric graves disease.pdf'],[0.436],[0.534],[0.626],[0.161],[0.165],[0.131],[0.736],[0.639],[0.619],[0.644],[0.793],[0.73],[0.601],[0.925],[0.821],[0.763],[0.786],[0.777],0.436,0.534,0.626,0.161,0.165,0.131,0.736,0.639,0.619,0.644,0.793,0.73,0.601,0.925,0.821,0.763,0.786,0.777
https://doi.org/10.1111/cge.12989,parents’ attitudes toward genetic testing of children for health conditions a systematic review,30364_parents’ attitudes toward genetic testing of children for health conditions a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946213/pdf'],['Methodological quality of clinical practice guidelines for genetic testing in children - A systematic assessment using the appraisal of guidelines for research and evaluation II instrument'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946213/pdf'],['30364_0_methodological quality of clinical practice guidelines for genetic testing in children  a systematic assessment using the appraisal of guidelines for research and evaluation ii instrument.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946213/pdf'],['30364_0_methodological quality of clinical practice guidelines for genetic testing in children  a systematic assessment using the appraisal of guidelines for research and evaluation ii instrument.pdf'],[0.409],[0.543],[0.627],[0.178],[0.188],[0.154],[0.734],[0.638],[0.609],[0.702],[0.802],[0.747],[0.628],[0.925],[0.835],[0.762],[0.808],[0.785],0.409,0.543,0.627,0.178,0.188,0.154,0.734,0.638,0.609,0.702,0.802,0.747,0.628,0.925,0.835,0.762,0.808,0.785
https://doi.org/10.1111/clr.13423,a randomized controlled clinical trial evaluating efficacy and adverse events of different types of recombinant human bone morphogenetic protein‐2 delivery systems for alveolar ridge preservation,30369_a randomized controlled clinical trial evaluating efficacy and adverse events of different types of recombinant human bone morphogenetic protein‐2 delivery systems for alveolar ridge preservation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092674/pdf'],['Interventions for replacing missing teeth: alveolar ridge preservation techniques for dental implant site development'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092674/pdf'],['30369_0_interventions for replacing missing teeth alveolar ridge preservation techniques for dental implant site development.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092674/pdf'],['30369_0_interventions for replacing missing teeth alveolar ridge preservation techniques for dental implant site development.pdf'],[0.492],[0.522],[0.61],[0.159],[0.162],[0.127],[0.745],[0.65],[0.591],[0.664],[0.774],[0.694],[0.602],[0.916],[0.811],[0.736],[0.776],[0.762],0.492,0.522,0.61,0.159,0.162,0.127,0.745,0.65,0.591,0.664,0.774,0.694,0.602,0.916,0.811,0.736,0.776,0.762
https://doi.org/10.1111/coa.13683,course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the covid‐19 pandemic our experience,30370_course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the covid‐19 pandemic our experience.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['30370_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121352/pdf'],['30370_0_signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has covid‐19.pdf'],[0.262],[0.507],[0.592],[0.144],[0.147],[0.127],[0.731],[0.639],[0.567],[0.716],[0.753],[0.68],[0.598],[0.904],[0.801],[0.715],[0.75],[0.734],0.262,0.507,0.592,0.144,0.147,0.127,0.731,0.639,0.567,0.716,0.753,0.68,0.598,0.904,0.801,0.715,0.75,0.734
https://doi.org/10.1111/dmcn.14223,patterns of daily activity among young people with epilepsy,30419_patterns of daily activity among young people with epilepsy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['30419_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['30419_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.425],[0.562],[0.644],[0.19],[0.205],[0.165],[0.737],[0.646],[0.619],[0.709],[0.8],[0.733],[0.635],[0.925],[0.845],[0.772],[0.805],[0.788],0.425,0.562,0.644,0.19,0.205,0.165,0.737,0.646,0.619,0.709,0.8,0.733,0.635,0.925,0.845,0.772,0.805,0.788
https://doi.org/10.1111/eci.13357,diagnostic accuracy of augurix covid‐19 igg serology rapid test,30443_diagnostic accuracy of augurix covid‐19 igg serology rapid test.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671206/pdf', 'https://effectivehealthcare.ahrq.gov/products/immunity-after-covid/rapid-review']","['Antibody tests for identification of current and past infection with SARS‐CoV‐2', 'Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671206/pdf'],['30443_0_antibody tests for identification of current and past infection with sars‐cov‐2.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671206/pdf'],['30443_0_antibody tests for identification of current and past infection with sars‐cov‐2.pdf'],[0.366],[0.54],[0.61],[0.183],[0.172],[0.142],[0.74],[0.65],[0.598],[0.705],[0.78],[0.695],[0.602],[0.91],[0.842],[0.741],[0.787],[0.771],0.366,0.54,0.61,0.183,0.172,0.142,0.74,0.65,0.598,0.705,0.78,0.695,0.602,0.91,0.842,0.741,0.787,0.771
https://doi.org/10.1111/eff.12505,dissolved oxygen controls summer habitat of clear lake hitch  ilavinia exilicauda chii  an imperilled potamodromous cyprinid,30492_dissolved oxygen controls summer habitat of clear lake hitch  ilavinia exilicauda chii  an imperilled potamodromous cyprinid.pdf,1,['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['Indicators of climate change in california'],['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['30492_0_indicators of climate change in california.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/climate-change/document/2022caindicatorsreport.pdf'],['30492_0_indicators of climate change in california.pdf'],[0.302],[0.504],[0.602],[0.138],[0.131],[0.106],[0.728],[0.632],[0.586],[0.68],[0.802],[0.723],[0.635],[0.914],[0.827],[0.763],[0.806],[0.79],0.302,0.504,0.602,0.138,0.131,0.106,0.728,0.632,0.586,0.68,0.802,0.723,0.635,0.914,0.827,0.763,0.806,0.79
https://doi.org/10.1111/emip.12357,the potential impact of covid‐19 on student learning and how schools can respond,30509_the potential impact of covid‐19 on student learning and how schools can respond.pdf,1,['https://www.tn.gov/content/dam/tn/education/tcap/spring-2021/TN-AcademicPerformance2020-2021.pdf'],['Best Practices for Using This Template'],['https://www.tn.gov/content/dam/tn/education/tcap/spring-2021/TN-AcademicPerformance2020-2021.pdf'],['30509_0_best practices for using this template.pdf'],1,100.0,['https://www.tn.gov/content/dam/tn/education/tcap/spring-2021/TN-AcademicPerformance2020-2021.pdf'],['30509_0_best practices for using this template.pdf'],[0.466],[0.595],[0.655],[0.238],[0.262],[0.232],[0.744],[0.653],[0.678],[0.728],[0.837],[0.781],[0.674],[0.943],[0.883],[0.807],[0.851],[0.83],0.466,0.595,0.655,0.238,0.262,0.232,0.744,0.653,0.678,0.728,0.837,0.781,0.674,0.943,0.883,0.807,0.851,0.83
https://doi.org/10.1111/epi.13121,a definition and classification of status epilepticus  report of the ilae task force on classification of status epilepticus,30515_a definition and classification of status epilepticus  report of the ilae task force on classification of status epilepticus.pdf,2,"['https://journals.lww.com/clinicalneurophys/Fulltext/2021/01000/American_Clinical_Neurophysiology_Society_s.1.aspx', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491279/pdf']","[""American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version"", 'Drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491279/pdf'],['30515_1_drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491279/pdf'],['30515_1_drug management for acute tonic‐clonic convulsions including convulsive status epilepticus in children.pdf'],[0.244],[0.51],[0.612],[0.174],[0.17],[0.141],[0.737],[0.645],[0.579],[0.683],[0.775],[0.699],[0.595],[0.907],[0.806],[0.727],[0.774],[0.748],0.244,0.51,0.612,0.174,0.17,0.141,0.737,0.645,0.579,0.683,0.775,0.699,0.595,0.907,0.806,0.727,0.774,0.748
https://doi.org/10.1111/gcb.14532,elevated co2impairs olfactorymediated neural and behavioral responses and gene expression in oceanphase coho salmon oncorhynchus kisutch,30563_elevated co2impairs olfactorymediated neural and behavioral responses and gene expression in oceanphase coho salmon oncorhynchus kisutch.pdf,3,"['https://www.governor.wa.gov/sites/default/files/OrcaTaskForce_FinalReportandRecommendations_11.07.19.pdf', 'https://www.governor.wa.gov/sites/default/files/YR2Report_DRAFT_V8.pdf', 'https://fortress.wa.gov/ecy/publications/documents/1904020.pdf']","['Final Report and Recommendations', 'DRAFT Year 2 Report and Recommendations', 'Antifouling Paints in Washington State Report and Recommendations']","['https://www.governor.wa.gov/sites/default/files/OrcaTaskForce_FinalReportandRecommendations_11.07.19.pdf', 'https://www.governor.wa.gov/sites/default/files/YR2Report_DRAFT_V8.pdf', 'https://fortress.wa.gov/ecy/publications/documents/1904020.pdf']","['30563_0_final report and recommendations.pdf', '30563_1_draft year 2 report and recommendations.pdf', '30563_2_antifouling paints in washington state report and recommendations.pdf']",3,100.0,"['https://www.governor.wa.gov/sites/default/files/OrcaTaskForce_FinalReportandRecommendations_11.07.19.pdf', 'https://www.governor.wa.gov/sites/default/files/YR2Report_DRAFT_V8.pdf', 'https://fortress.wa.gov/ecy/publications/documents/1904020.pdf']","['30563_0_final report and recommendations.pdf', '30563_1_draft year 2 report and recommendations.pdf', '30563_2_antifouling paints in washington state report and recommendations.pdf']","[0.158, 0.174, 0.155]","[0.504, 0.501, 0.481]","[0.606, 0.606, 0.583]","[0.099, 0.107, 0.104]","[0.094, 0.099, 0.102]","[0.073, 0.078, 0.084]","[0.718, 0.722, 0.729]","[0.622, 0.625, 0.634]","[0.596, 0.591, 0.562]","[0.628, 0.634, 0.66]","[0.806, 0.802, 0.783]","[0.742, 0.735, 0.681]","[0.636, 0.632, 0.613]","[0.923, 0.92, 0.913]","[0.83, 0.826, 0.808]","[0.775, 0.772, 0.747]","[0.81, 0.807, 0.783]","[0.791, 0.789, 0.774]",0.162,0.495,0.598,0.103,0.098,0.078,0.723,0.627,0.583,0.641,0.797,0.719,0.627,0.919,0.821,0.765,0.8,0.785
https://doi.org/10.1111/gcb.15155,watershed‐scale climate influences productivity of chinook salmon populations across southcentral alaska,30564_watershed‐scale climate influences productivity of chinook salmon populations across southcentral alaska.pdf,3,"['https://eia-global.org/reports/20220119-five-years-of-failure-petition', 'https://eia-global.org/reports/20220119-five-years-of-failure', 'https://wdfw.wa.gov/sites/default/files/2021-10/wilsonetal08312021.pdf']","['Petition to Cap Cook Inlet Beluga Whale Take Authorizations and for Associated Actions and Rulemaking – EIA Global', 'Five Years of Failure – EIA Global', 'Marine and freshwater regime changes impact a community of migratory Pacific salmonids in decline']",['https://wdfw.wa.gov/sites/default/files/2021-10/wilsonetal08312021.pdf'],['30564_2_marine and freshwater regime changes impact a community of migratory pacific salmonids in decline.pdf'],1,33.33,['https://wdfw.wa.gov/sites/default/files/2021-10/wilsonetal08312021.pdf'],['30564_2_marine and freshwater regime changes impact a community of migratory pacific salmonids in decline.pdf'],[0.592],[0.529],[0.625],[0.188],[0.187],[0.159],[0.741],[0.653],[0.591],[0.708],[0.799],[0.735],[0.642],[0.915],[0.82],[0.771],[0.803],[0.792],0.592,0.529,0.625,0.188,0.187,0.159,0.741,0.653,0.591,0.708,0.799,0.735,0.642,0.915,0.82,0.771,0.803,0.792
https://doi.org/10.1111/hae.14294,protect viii kids extension study long‐term safety and efficacy of bay 94‐9027 damoctocog alfa pegol in children with severe haemophilia a,30575_protect viii kids extension study long‐term safety and efficacy of bay 94‐9027 damoctocog alfa pegol in children with severe haemophilia a.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407508/pdf'],['Clotting factor concentrates for preventing bleeding and bleeding‐related complications in previously treated individuals with haemophilia A or B'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407508/pdf'],['30575_0_clotting factor concentrates for preventing bleeding and bleeding‐related complications in previously treated individuals with haemophilia a or b.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407508/pdf'],['30575_0_clotting factor concentrates for preventing bleeding and bleeding‐related complications in previously treated individuals with haemophilia a or b.pdf'],[0.366],[0.528],[0.61],[0.178],[0.176],[0.143],[0.738],[0.643],[0.589],[0.69],[0.773],[0.687],[0.609],[0.908],[0.821],[0.741],[0.778],[0.76],0.366,0.528,0.61,0.178,0.176,0.143,0.738,0.643,0.589,0.69,0.773,0.687,0.609,0.908,0.821,0.741,0.778,0.76
https://doi.org/10.1111/ijd.13735,neonatal skin care what should we do a fourweek followup randomized controlled trial at zagazig university hospitals,30597_neonatal skin care what should we do a fourweek followup randomized controlled trial at zagazig university hospitals.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['30597_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '30597_0_skin care interventions in infants for preventing eczema and food allergy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['30597_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '30597_0_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.491, 0.497]","[0.536, 0.533]","[0.621, 0.618]","[0.174, 0.168]","[0.187, 0.185]","[0.154, 0.15]","[0.738, 0.738]","[0.642, 0.641]","[0.596, 0.592]","[0.652, 0.653]","[0.789, 0.787]","[0.704, 0.704]","[0.613, 0.609]","[0.915, 0.916]","[0.822, 0.82]","[0.746, 0.745]","[0.791, 0.789]","[0.772, 0.77]",0.494,0.534,0.619,0.171,0.186,0.152,0.738,0.641,0.594,0.653,0.788,0.704,0.611,0.915,0.821,0.746,0.79,0.771
https://doi.org/10.1111/ijpo.12561,changes in the prevalence of overweight obesity and severe obesity between 2010 and 2017 in preschoolers a population‐based study,30606_changes in the prevalence of overweight obesity and severe obesity between 2010 and 2017 in preschoolers a population‐based study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896489/pdf'],['Updating the Canadian clinical practice guideline for managing pediatric obesity: a protocol'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896489/pdf'],['30606_0_updating the canadian clinical practice guideline for managing pediatric obesity a protocol.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896489/pdf'],['30606_0_updating the canadian clinical practice guideline for managing pediatric obesity a protocol.pdf'],[0.399],[0.525],[0.615],[0.166],[0.182],[0.136],[0.721],[0.624],[0.591],[0.7],[0.792],[0.73],[0.614],[0.918],[0.829],[0.749],[0.799],[0.773],0.399,0.525,0.615,0.166,0.182,0.136,0.721,0.624,0.591,0.7,0.792,0.73,0.614,0.918,0.829,0.749,0.799,0.773
https://doi.org/10.1111/j.1360-0443.2007.02110.x,outcomes from a randomized controlled trial of a multicomponent alcohol use preventive intervention for urban youth project northland chicago,30748_outcomes from a randomized controlled trial of a multicomponent alcohol use preventive intervention for urban youth project northland chicago.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf', 'https://aspe.hhs.gov/reports/state-science-practice-parenting-interventions-across-childhood-literature-review-synthesis', 'https://aspe.hhs.gov/reports/state-science-practice-parenting-interventions-across-childhood-literature-review-synthesis-0', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1563/Wsipp_Preventing-Youth-Substance-Use-A-Review-of-Thirteen-Programs_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/9/Wsipp_BenefitCost_ProgramDetails_Public-Health-Prevention']","['Family‐based programmes for preventing smoking by children and adolescents', 'State of the Science and Practice in Parenting Interventions across Childhood: Literature Review and Synthesis', 'State of the Science and Practice in Parenting Interventions across Childhood: Literature Review and Synthesis', 'Washington State Institute for Public Policy', 'WashingtonS tate Institute for Public Policy', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1563/Wsipp_Preventing-Youth-Substance-Use-A-Review-of-Thirteen-Programs_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf']","['30748_0_family‐based programmes for preventing smoking by children and adolescents.pdf', '30748_4_washingtons tate institute for public policy.pdf', '30748_5_washington state institute for public policy.pdf', '30748_3_washington state institute for public policy.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486099/pdf', 'http://www.wsipp.wa.gov/ReportFile/1572/Wsipp_Preventing-and-Treating-Youth-Marijuana-Use-An-Updated-Review-of-the-Evidence_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1563/Wsipp_Preventing-Youth-Substance-Use-A-Review-of-Thirteen-Programs_Benefit-Cost-Results.pdf', 'http://www.wsipp.wa.gov/ReportFile/1579/Wsipp_Tobacco-and-E-Cigarette-Prevention-What-Works_Benefit-Cost-Results.pdf']","['30748_0_family‐based programmes for preventing smoking by children and adolescents.pdf', '30748_4_washingtons tate institute for public policy.pdf', '30748_5_washington state institute for public policy.pdf', '30748_3_washington state institute for public policy.pdf']","[0.507, 0.31, 0.333, 0.346]","[0.577, 0.547, 0.557, 0.534]","[0.646, 0.619, 0.63, 0.61]","[0.211, 0.171, 0.176, 0.161]","[0.228, 0.199, 0.211, 0.187]","[0.179, 0.155, 0.164, 0.144]","[0.736, 0.731, 0.731, 0.729]","[0.644, 0.637, 0.637, 0.634]","[0.64, 0.603, 0.618, 0.589]","[0.7, 0.692, 0.694, 0.689]","[0.812, 0.798, 0.802, 0.792]","[0.76, 0.736, 0.748, 0.724]","[0.633, 0.633, 0.638, 0.628]","[0.928, 0.924, 0.93, 0.922]","[0.844, 0.823, 0.83, 0.817]","[0.779, 0.766, 0.775, 0.757]","[0.816, 0.802, 0.809, 0.796]","[0.797, 0.784, 0.791, 0.779]",0.374,0.554,0.626,0.18,0.206,0.161,0.732,0.638,0.612,0.694,0.801,0.742,0.633,0.926,0.829,0.769,0.806,0.788
https://doi.org/10.1111/j.1360-0443.2008.02360.x,longterm effects of the focus on families project on substance use disorders among children of parents in methadone treatment,30762_longterm effects of the focus on families project on substance use disorders among children of parents in methadone treatment.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf']","['Family‐based prevention programmes for alcohol use in young people', 'Effectiveness of psychosocial interventions for reducing parental substance misuse']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf']","['30762_0_family‐based prevention programmes for alcohol use in young people.pdf', '30762_1_effectiveness of psychosocial interventions for reducing parental substance misuse.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423557/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094759/pdf']","['30762_0_family‐based prevention programmes for alcohol use in young people.pdf', '30762_1_effectiveness of psychosocial interventions for reducing parental substance misuse.pdf']","[0.513, 0.627]","[0.529, 0.529]","[0.61, 0.607]","[0.195, 0.191]","[0.205, 0.196]","[0.172, 0.165]","[0.737, 0.734]","[0.641, 0.638]","[0.577, 0.578]","[0.703, 0.702]","[0.779, 0.778]","[0.706, 0.709]","[0.602, 0.602]","[0.918, 0.917]","[0.809, 0.805]","[0.732, 0.734]","[0.774, 0.776]","[0.759, 0.758]",0.57,0.529,0.609,0.193,0.201,0.168,0.736,0.639,0.577,0.702,0.778,0.708,0.602,0.917,0.807,0.733,0.775,0.758
https://doi.org/10.1111/j.1365-3016.2007.00786.x,rates of caesarean section analysis of global regional and national estimates,31090_rates of caesarean section analysis of global regional and national estimates.pdf,8,"['https://purl.fdlp.gov/GPO/gpo134802', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547819/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701535/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161199/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923051/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf']","['Private delivery care in developing countries :\xa0trends and determinants /', 'SIMPLE: implementation of recommendations from international evidence-based guidelines on caesarean sections in the Netherlands. Protocol for a controlled before and after study', 'Complementary and alternative therapies for post‐caesarean pain', 'Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care', 'Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries', 'Package of care for active management in labour for reducing caesarean section rates in low-risk women', 'Oral analgesia for relieving post‐caesarean pain', 'Techniques for caesarean section']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923051/pdf', 'https://purl.fdlp.gov/GPO/gpo134802', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547819/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701535/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161199/pdf']","['31090_4_oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.pdf', '31090_7_techniques for caesarean section.pdf', '31090_6_oral analgesia for relieving post‐caesarean pain.pdf', '31090_0_private delivery care in developing countries \xa0trends and determinants .pdf', '31090_1_simple implementation of recommendations from international evidencebased guidelines on caesarean sections in the netherlands protocol for a controlled before and after study.pdf', '31090_2_complementary and alternative therapies for post‐caesarean pain.pdf', '31090_3_early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneous labour compared with routine care.pdf', '31090_5_package of care for active management in labour for reducing caesarean section rates in lowrisk women.pdf']",8,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133539/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845034/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923051/pdf', 'https://purl.fdlp.gov/GPO/gpo134802', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547819/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701535/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160792/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161199/pdf']","['31090_4_oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries.pdf', '31090_7_techniques for caesarean section.pdf', '31090_6_oral analgesia for relieving post‐caesarean pain.pdf', '31090_0_private delivery care in developing countries \xa0trends and determinants .pdf', '31090_1_simple implementation of recommendations from international evidencebased guidelines on caesarean sections in the netherlands protocol for a controlled before and after study.pdf', '31090_2_complementary and alternative therapies for post‐caesarean pain.pdf', '31090_3_early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneous labour compared with routine care.pdf', '31090_5_package of care for active management in labour for reducing caesarean section rates in lowrisk women.pdf']","[0.315, 0.193, 0.111, 0.106, 0.141, 0.159, 0.101, 0.151]","[0.482, 0.475, 0.475, 0.493, 0.503, 0.482, 0.485, 0.485]","[0.59, 0.574, 0.581, 0.603, 0.61, 0.581, 0.593, 0.589]","[0.12, 0.115, 0.11, 0.155, 0.155, 0.118, 0.124, 0.127]","[0.131, 0.117, 0.116, 0.171, 0.171, 0.117, 0.136, 0.144]","[0.108, 0.102, 0.094, 0.139, 0.132, 0.097, 0.107, 0.116]","[0.724, 0.728, 0.723, 0.731, 0.727, 0.724, 0.723, 0.723]","[0.623, 0.628, 0.623, 0.636, 0.632, 0.624, 0.623, 0.624]","[0.556, 0.552, 0.551, 0.558, 0.567, 0.558, 0.557, 0.559]","[0.663, 0.672, 0.667, 0.69, 0.662, 0.685, 0.677, 0.689]","[0.781, 0.776, 0.781, 0.794, 0.801, 0.78, 0.778, 0.776]","[0.662, 0.658, 0.661, 0.673, 0.679, 0.667, 0.673, 0.672]","[0.571, 0.576, 0.57, 0.618, 0.612, 0.568, 0.542, 0.561]","[0.912, 0.913, 0.911, 0.917, 0.917, 0.912, 0.915, 0.911]","[0.805, 0.799, 0.803, 0.818, 0.834, 0.812, 0.808, 0.812]","[0.703, 0.7, 0.704, 0.723, 0.732, 0.703, 0.708, 0.704]","[0.773, 0.772, 0.774, 0.788, 0.802, 0.774, 0.774, 0.772]","[0.745, 0.747, 0.746, 0.766, 0.777, 0.75, 0.753, 0.748]",0.16,0.485,0.59,0.128,0.138,0.112,0.725,0.627,0.557,0.676,0.783,0.668,0.577,0.914,0.811,0.71,0.779,0.754
https://doi.org/10.1111/j.1399-0004.2006.00692.x,presymptomatic and predictive genetic testing in minors a systematic review of guidelines and position papers,31170_presymptomatic and predictive genetic testing in minors a systematic review of guidelines and position papers.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136168/pdf', 'https://www.acmg.net/PDFLibrary/Ethical-Policy-Issues-Genetic-Screening-Children.pdf', 'https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1399-0004.2012.01900.x', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950962/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987480/pdf']","['International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people', 'Technical report: ethical and policy issues in genetic testing and screening of children', 'Recommendations for the predictive genetictest in Huntington’s disease', 'ADDRESSING THE ETHICAL CHALLENGES IN GENETIC TESTING AND SEQUENCING OF CHILDREN', 'Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136168/pdf', 'https://www.acmg.net/PDFLibrary/Ethical-Policy-Issues-Genetic-Screening-Children.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950962/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987480/pdf']","['31170_0_international consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.pdf', '31170_1_technical report ethical and policy issues in genetic testing and screening of children.pdf', '31170_3_addressing the ethical challenges in genetic testing and sequencing of children.pdf', '31170_4_consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136168/pdf', 'https://www.acmg.net/PDFLibrary/Ethical-Policy-Issues-Genetic-Screening-Children.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950962/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987480/pdf']","['31170_0_international consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.pdf', '31170_1_technical report ethical and policy issues in genetic testing and screening of children.pdf', '31170_3_addressing the ethical challenges in genetic testing and sequencing of children.pdf', '31170_4_consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.pdf']","[0.246, 0.726, 0.533, 0.259]","[0.519, 0.602, 0.569, 0.6]","[0.624, 0.682, 0.666, 0.677]","[0.15, 0.253, 0.252, 0.198]","[0.149, 0.272, 0.279, 0.216]","[0.12, 0.228, 0.225, 0.175]","[0.736, 0.754, 0.755, 0.743]","[0.636, 0.662, 0.667, 0.651]","[0.575, 0.661, 0.628, 0.671]","[0.651, 0.708, 0.723, 0.692]","[0.788, 0.831, 0.805, 0.83]","[0.712, 0.781, 0.737, 0.782]","[0.622, 0.669, 0.64, 0.671]","[0.924, 0.94, 0.929, 0.931]","[0.801, 0.864, 0.849, 0.858]","[0.753, 0.801, 0.772, 0.802]","[0.778, 0.838, 0.81, 0.838]","[0.768, 0.821, 0.8, 0.822]",0.441,0.573,0.662,0.213,0.229,0.187,0.747,0.654,0.634,0.694,0.814,0.753,0.651,0.931,0.843,0.782,0.816,0.803
https://doi.org/10.1111/j.1399-3046.2006.00585.x,current role of liver transplantation for methylmalonic acidemia a review of the literature,31197_current role of liver transplantation for methylmalonic acidemia a review of the literature.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First\xa0revision'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['31197_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252715/pdf'],['31197_0_guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia first\xa0revision.pdf'],[0.442],[0.572],[0.648],[0.186],[0.2],[0.143],[0.749],[0.65],[0.635],[0.638],[0.812],[0.754],[0.641],[0.932],[0.84],[0.783],[0.81],[0.798],0.442,0.572,0.648,0.186,0.2,0.143,0.749,0.65,0.635,0.638,0.812,0.754,0.641,0.932,0.84,0.783,0.81,0.798
https://doi.org/10.1111/j.1467-6419.2011.00719.x,trade diversification income and growth what do we know,31376_trade diversification income and growth what do we know.pdf,5,"['https://www.dallasfed.org/-/media/documents/research/international/wpapers/2014/0192.pdf', 'https://www.hks.harvard.edu/centers/cid/publications/fellow-graduate-student-working-papers/growth-accelerations-strategies', 'https://www.hks.harvard.edu/centers/cid/publications/fellow-graduate-student-working-papers/diversity-economic-complexity', 'https://www.nber.org/papers/w21777', 'https://www.nber.org/papers/w20851']","['Trade Partner Diversification and Growth: How Trade Links Matter', 'Growth Accelerations Strategies', 'Does Birthplace Diversity Affect Economic Complexity?', 'Stages of Diversification: France, 1836-1938', 'Technology and Geography in the Second Industrial Revolution: New Evidence from the Margins of Trade']",['https://www.dallasfed.org/-/media/documents/research/international/wpapers/2014/0192.pdf'],['31376_0_trade partner diversification and growth how trade links matter.pdf'],1,20.0,['https://www.dallasfed.org/-/media/documents/research/international/wpapers/2014/0192.pdf'],['31376_0_trade partner diversification and growth how trade links matter.pdf'],[0.55],[0.554],[0.652],[0.223],[0.227],[0.209],[0.739],[0.644],[0.62],[0.738],[0.802],[0.715],[0.65],[0.915],[0.848],[0.771],[0.812],[0.797],0.55,0.554,0.652,0.223,0.227,0.209,0.739,0.644,0.62,0.738,0.802,0.715,0.65,0.915,0.848,0.771,0.812,0.797
https://doi.org/10.1111/j.1467-8624.2011.01677.x,school attendance problems and youth psychopathology structural crosslagged regression models in three longitudinal data sets,31586_school attendance problems and youth psychopathology structural crosslagged regression models in three longitudinal data sets.pdf,2,"['https://mhsoac.ca.gov/sites/default/files/1687%20MHSOAC%20Mental%20Health%20in%20Schools%20design%20DRAFT.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/schools_as_centers_of_wellness_final-2.pdf']","['School as Centers of Wellness', 'Every Young Heart and Mind: Schools as Centers of Wellness']","['https://mhsoac.ca.gov/wp-content/uploads/schools_as_centers_of_wellness_final-2.pdf', 'https://mhsoac.ca.gov/sites/default/files/1687%20MHSOAC%20Mental%20Health%20in%20Schools%20design%20DRAFT.pdf']","['31586_1_every young heart and mind schools as centers of wellness.pdf', '31586_0_school as centers of wellness.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/schools_as_centers_of_wellness_final-2.pdf', 'https://mhsoac.ca.gov/sites/default/files/1687%20MHSOAC%20Mental%20Health%20in%20Schools%20design%20DRAFT.pdf']","['31586_1_every young heart and mind schools as centers of wellness.pdf', '31586_0_school as centers of wellness.pdf']","[0.361, 0.356]","[0.502, 0.506]","[0.597, 0.6]","[0.145, 0.148]","[0.165, 0.167]","[0.137, 0.137]","[0.726, 0.727]","[0.628, 0.63]","[0.572, 0.576]","[0.673, 0.669]","[0.784, 0.787]","[0.714, 0.719]","[0.618, 0.621]","[0.922, 0.922]","[0.809, 0.811]","[0.752, 0.757]","[0.789, 0.793]","[0.771, 0.775]",0.358,0.504,0.599,0.146,0.166,0.137,0.726,0.629,0.574,0.671,0.786,0.716,0.619,0.922,0.81,0.754,0.791,0.773
https://doi.org/10.1111/j.1467-9280.2007.02008.x,childhood poverty and health,31611_childhood poverty and health.pdf,7,"['https://www.endocrine.org/~/media/endosociety/files/advocacy-and-outreach/important-documents/increasingminorityparticipationinclinicalresearch.pdf?la=en', 'https://aspe.hhs.gov/reports/sdoh-evidence-review', 'https://www.leg.mn.gov/docs/2016/mandated/160992.pdf', 'https://equitablegrowth.org/working-papers/parental-exposure-to-routine-work-schedule-uncertainty-and-child-behavior/', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast', 'https://www.nber.org/papers/w16296', 'https://www.ccf.ny.gov/files/3213/8255/2339/ChildPoverty.pdf']","['Increasing Minority Participation in Clinical Research', 'Addressing Social Determinants of Health: Examples of Successful Evidence-Based Strategies and Current Federal Efforts', 'Accounting for Social Risk Factors in Minnesota Health Care Program Payments', 'Parental Exposure to Routine Work Schedule Uncertainty and Child Behavior - Equitable Growth', 'Vol6_WebCover.indd', 'Giving Mom a Break: The Impact of Higher EITC Payments on Maternal Health', 'In New York State']","['https://www.endocrine.org/~/media/endosociety/files/advocacy-and-outreach/important-documents/increasingminorityparticipationinclinicalresearch.pdf?la=en', 'https://www.ccf.ny.gov/files/3213/8255/2339/ChildPoverty.pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast', 'https://www.leg.mn.gov/docs/2016/mandated/160992.pdf']","['31611_0_increasing minority participation in clinical research.pdf', '31611_6_in new york state.pdf', '31611_4_vol6webcoverindd.pdf', '31611_2_accounting for social risk factors in minnesota health care program payments.pdf']",4,57.14,"['https://www.endocrine.org/~/media/endosociety/files/advocacy-and-outreach/important-documents/increasingminorityparticipationinclinicalresearch.pdf?la=en', 'https://www.ccf.ny.gov/files/3213/8255/2339/ChildPoverty.pdf', 'https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast', 'https://www.leg.mn.gov/docs/2016/mandated/160992.pdf']","['31611_0_increasing minority participation in clinical research.pdf', '31611_6_in new york state.pdf', '31611_4_vol6webcoverindd.pdf', '31611_2_accounting for social risk factors in minnesota health care program payments.pdf']","[0.138, 0.31, 0.232, 0.397]","[0.503, 0.506, 0.49, 0.515]","[0.601, 0.602, 0.586, 0.609]","[0.124, 0.14, 0.13, 0.14]","[0.13, 0.152, 0.135, 0.151]","[0.103, 0.136, 0.117, 0.127]","[0.718, 0.729, 0.729, 0.724]","[0.616, 0.628, 0.63, 0.626]","[0.568, 0.568, 0.548, 0.572]","[0.666, 0.684, 0.681, 0.681]","[0.781, 0.78, 0.765, 0.782]","[0.714, 0.708, 0.686, 0.715]","[0.613, 0.621, 0.603, 0.617]","[0.916, 0.916, 0.911, 0.919]","[0.808, 0.802, 0.779, 0.812]","[0.746, 0.75, 0.734, 0.752]","[0.787, 0.787, 0.77, 0.792]","[0.768, 0.769, 0.757, 0.772]",0.269,0.503,0.599,0.134,0.142,0.121,0.725,0.625,0.564,0.678,0.777,0.706,0.613,0.916,0.8,0.746,0.784,0.766
https://doi.org/10.1111/j.1468-1331.2011.03590.x,the economic cost of brain disorders in europe,31759_the economic cost of brain disorders in europe.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078495/pdf'],['Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078495/pdf'],['31759_0_prognostic value of tests for o6‐methylguanine–dna methyltransferase mgmt promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078495/pdf'],['31759_0_prognostic value of tests for o6‐methylguanine–dna methyltransferase mgmt promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.pdf'],[0.111],[0.509],[0.607],[0.123],[0.132],[0.1],[0.727],[0.631],[0.584],[0.676],[0.777],[0.712],[0.61],[0.911],[0.814],[0.73],[0.778],[0.754],0.111,0.509,0.607,0.123,0.132,0.1,0.727,0.631,0.584,0.676,0.777,0.712,0.61,0.911,0.814,0.73,0.778,0.754
https://doi.org/10.1111/j.1469-7610.2008.01920.x,a multicomponent social skills intervention for children with asperger syndrome the junior detective training program,31857_a multicomponent social skills intervention for children with asperger syndrome the junior detective training program.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923148/pdf', 'https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf', 'https://tiac.wisconsin.gov/tiacfiles/pdf/2014-ebp-report.pdf']","['Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD)', 'Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update', 'Evidence-Based Practices for Children, Youth, and Young Adults with Autism Spectrum Disorder']","['https://tiac.wisconsin.gov/tiacfiles/pdf/2014-ebp-report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923148/pdf', 'https://tiac.wisconsin.gov/tiacfiles/pdf/ahrq-therapies-asd.pdf']","['31857_2_evidencebased practices for children youth and young adults with autism spectrum disorder.pdf', '31857_0_interventions based on the theory of mind cognitive model for autism spectrum disorder asd.pdf', '31857_1_therapies for children with autism spectrum disorder behavioral interventions update.pdf']",3,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923148/pdf'],['31857_0_interventions based on the theory of mind cognitive model for autism spectrum disorder asd.pdf'],[0.442],[0.53],[0.613],[0.162],[0.176],[0.148],[0.731],[0.637],[0.588],[0.715],[0.778],[0.719],[0.602],[0.919],[0.818],[0.742],[0.783],[0.765],0.442,0.53,0.613,0.162,0.176,0.148,0.731,0.637,0.588,0.715,0.778,0.719,0.602,0.919,0.818,0.742,0.783,0.765
https://doi.org/10.1111/j.1475-3588.2008.00515.x,systematic review of evidence and treatment approaches psychosocial and mental health care for children in war,32049_systematic review of evidence and treatment approaches psychosocial and mental health care for children in war.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390394/pdf', 'https://www.cgdev.org/publication/missed-opportunities-global-health-identifying-new-strategies-improve-mental-health']","['Sports and games for post‐traumatic stress disorder (PTSD)', 'Missed Opportunities in Global Health: Identifying New Strategies to Improve Mental Health in LMICs']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390394/pdf'],['32049_0_sports and games for post‐traumatic stress disorder ptsd.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390394/pdf'],['32049_0_sports and games for post‐traumatic stress disorder ptsd.pdf'],[0.423],[0.517],[0.615],[0.162],[0.179],[0.147],[0.732],[0.64],[0.576],[0.705],[0.78],[0.699],[0.601],[0.925],[0.822],[0.738],[0.782],[0.769],0.423,0.517,0.615,0.162,0.179,0.147,0.732,0.64,0.576,0.705,0.78,0.699,0.601,0.925,0.822,0.738,0.782,0.769
https://doi.org/10.1111/j.1532-7795.2008.00556.x,the continued importance of quality parent–adolescent relationships during late adolescence,32297_the continued importance of quality parent–adolescent relationships during late adolescence.pdf,6,"['https://aspe.hhs.gov/reports/marital-quality-parent-adolescent-relationships-components-relationship-strengths-married-couple-0', 'https://aspe.hhs.gov/reports/marital-quality-parent-adolescent-relationships-effects-educational-outcomes-youth', 'https://aspe.hhs.gov/reports/marital-quality-parent-adolescent-relationships-components-relationship-strengths-married-couple', 'https://aspe.hhs.gov/reports/marital-quality-parent-adolescent-relationships-effects-educational-outcomes-youth-0', 'https://www.urban.org/research/publication/understanding-environmental-contexts-boys-and-young-men-color', 'http://purl.fdlp.gov/GPO/gpo59093']","['Marital Quality and Parent-Adolescent Relationships: Components of Relationship Strengths in Married Couple Families', 'Marital Quality and Parent-Adolescent Relationships: Effects on Educational Outcomes for Youth', 'Marital Quality and Parent-Adolescent Relationships: Components of Relationship Strengths in Married Couple Families', 'Marital Quality and Parent-Adolescent Relationships: Effects on Educational Outcomes for Youth', 'Understanding the Environmental Contexts of Boys and Young Men of Color', 'Fathers’ involvement with their children: United States, 2006-2010 /']",['http://purl.fdlp.gov/GPO/gpo59093'],['32297_5_fathers involvement with their children united states 20062010 .pdf'],1,16.67,['http://purl.fdlp.gov/GPO/gpo59093'],['32297_5_fathers involvement with their children united states 20062010 .pdf'],[0.168],[0.523],[0.618],[0.17],[0.187],[0.173],[0.738],[0.636],[0.594],[0.706],[0.784],[0.72],[0.596],[0.904],[0.833],[0.758],[0.793],[0.774],0.168,0.523,0.618,0.17,0.187,0.173,0.738,0.636,0.594,0.706,0.784,0.72,0.596,0.904,0.833,0.758,0.793,0.774
https://doi.org/10.1111/j.1728-4465.2001.00230.x,impact of an integrated adolescent reproductive health program in brazil,32689_impact of an integrated adolescent reproductive health program in brazil.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570008/pdf'],['What Does Not Work in Adolescent Sexual and Reproductive Health: A Review of Evidence on Interventions Commonly Accepted as Best Practices'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570008/pdf'],['32689_0_what does not work in adolescent sexual and reproductive health a review of evidence on interventions commonly accepted as best practices.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1111/j.1728-4465.2012.00308.x,effects of birth spacing on maternal perinatal infant and child health a systematic review of causal mechanisms,32705_effects of birth spacing on maternal perinatal infant and child health a systematic review of causal mechanisms.pdf,9,"['https://www.acf.hhs.gov/opre/resource/effects-home-visiting-prenatal-health-birth-outcomes-health-care-first-year-final-implementation-impact-findings-strong-start', 'https://purl.fdlp.gov/GPO/gpo112759', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ms/srh-clinical-guide.pdf', 'https://www.congress.gov/event/116th-congress/house-event/110504', 'https://www.icrw.org/publications/the-impact-of-family-planning-on-womens-educational-advancement-in-tehran-iran/', 'https://www.guttmacher.org/article/2018/10/guttmacher-institute-amicus-brief-filed-us-court-appeals-first-circuit-commonwealth', 'https://purl.fdlp.gov/GPO/gpo116474', 'https://www.acf.hhs.gov/opre/report/effects-home-visiting-prenatal-health-birth-outcomes-and-health-care-use-first-year', 'https://health.mo.gov/living/families/wic/localagency/wom/pdf/332-definition.pdf']","['The Effects of Home Visiting on Prenatal Health, Birth Outcomes, and Health Care Use in the First Year of Life: Final Implementation and Impact Findings from the Mother and Infant Home Visiting Program Evaluation-Strong Start', 'Potential implications of the Ghana and Nepal follow-up studies for DHS questionnaires and fieldwork procedures /', 'Best Practices For Adolescents And Adults', '""Protecting Women\'s Access to Reproductive Health Care""', 'The impact of family planning on women’s educational advancement in Tehran, Iran', 'Guttmacher Institute Amicus Brief Filed with the U.S. Court of Appeals for the First Circuit: Commonwealth of Massachusetts v. U.S. Department of Health and Human Services', 'Contraception needed to avoid high-fertility-risk births, and maternal and child deaths that would be averted /', 'The Effects of Home Visiting on Prenatal Health, Birth Outcomes, and Health Care Use in the First Year of Life: Final Implementation and Impact Findings from the Mother and Infant Home Visiting Program Evaluation-Strong Start', 'Elevated Blood Lead Levels_2001.04']","['https://purl.fdlp.gov/GPO/gpo116474', 'https://purl.fdlp.gov/GPO/gpo112759', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ms/srh-clinical-guide.pdf']","['32705_6_contraception needed to avoid highfertilityrisk births and maternal and child deaths that would be averted .pdf', '32705_1_potential implications of the ghana and nepal followup studies for dhs questionnaires and fieldwork procedures .pdf', '32705_2_best practices for adolescents and adults.pdf']",3,33.33,"['https://purl.fdlp.gov/GPO/gpo116474', 'https://purl.fdlp.gov/GPO/gpo112759', 'https://www1.nyc.gov/assets/doh/downloads/pdf/ms/srh-clinical-guide.pdf']","['32705_6_contraception needed to avoid highfertilityrisk births and maternal and child deaths that would be averted .pdf', '32705_1_potential implications of the ghana and nepal followup studies for dhs questionnaires and fieldwork procedures .pdf', '32705_2_best practices for adolescents and adults.pdf']","[0.266, 0.126, 0.29]","[0.525, 0.565, 0.562]","[0.624, 0.646, 0.643]","[0.179, 0.16, 0.152]","[0.175, 0.165, 0.149]","[0.157, 0.14, 0.133]","[0.735, 0.73, 0.727]","[0.636, 0.633, 0.627]","[0.586, 0.627, 0.631]","[0.647, 0.633, 0.607]","[0.809, 0.808, 0.818]","[0.694, 0.73, 0.737]","[0.644, 0.654, 0.626]","[0.918, 0.921, 0.93]","[0.824, 0.832, 0.827]","[0.749, 0.78, 0.778]","[0.805, 0.809, 0.822]","[0.79, 0.793, 0.803]",0.227,0.551,0.638,0.164,0.163,0.143,0.731,0.632,0.615,0.629,0.812,0.72,0.641,0.923,0.828,0.769,0.812,0.795
https://doi.org/10.1111/j.1728-4465.2012.00327.x,what works to prevent child marriage a review of the evidence,32709_what works to prevent child marriage a review of the evidence.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570008/pdf', 'https://www.fordfoundation.org/work/learning/research-reports/ending-child-marriage-in-a-generation/', 'https://www.icrw.org/publications/what-works-for-adolescents-empowerment/', 'https://www.mckinsey.com/featured-insights/employment-and-growth/how-advancing-womens-equality-can-add-12-trillion-to-global-growth', 'https://www.icrw.org/publications/more-power-to-her-how-empowering-girls-can-end-child-marriage/', 'https://purl.fdlp.gov/GPO/gpo116493']","['What Does Not Work in Adolescent Sexual and Reproductive Health: A Review of Evidence on Interventions Commonly Accepted as Best Practices', 'Ending Child Marriage in a Generation', ""What Works for Adolescents' Empowerment"", 'How advancing womenâ\x80\x99s equality can add $12 trillion to global growth', 'More power to her: how empowering girls can end child marriage', 'Marriage and fertility dynamics :\xa0the influence of marriage age on the timing of first birth and birth spacing /']","['https://purl.fdlp.gov/GPO/gpo116493', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570008/pdf']","['32709_5_marriage and fertility dynamics \xa0the influence of marriage age on the timing of first birth and birth spacing .pdf', '32709_0_what does not work in adolescent sexual and reproductive health a review of evidence on interventions commonly accepted as best practices.pdf']",2,33.33,"['https://purl.fdlp.gov/GPO/gpo116493', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570008/pdf']","['32709_5_marriage and fertility dynamics \xa0the influence of marriage age on the timing of first birth and birth spacing .pdf', '32709_0_what does not work in adolescent sexual and reproductive health a review of evidence on interventions commonly accepted as best practices.pdf']","[0.416, 0.237]","[0.483, 0.551]","[0.581, 0.636]","[0.134, 0.18]","[0.143, 0.191]","[0.12, 0.154]","[0.716, 0.73]","[0.616, 0.64]","[0.539, 0.616]","[0.679, 0.68]","[0.771, 0.816]","[0.681, 0.723]","[0.632, 0.642]","[0.897, 0.916]","[0.818, 0.847]","[0.729, 0.773]","[0.777, 0.815]","[0.757, 0.797]",0.327,0.517,0.609,0.157,0.167,0.137,0.723,0.628,0.578,0.679,0.793,0.702,0.637,0.907,0.833,0.751,0.796,0.777
https://doi.org/10.1111/j.1741-3737.2006.00238.x,parentadolescent involvement the relative influence of parent gender and residence,32791_parentadolescent involvement the relative influence of parent gender and residence.pdf,1,['https://purl.fdlp.gov/GPO/gpo116165'],['Single father custodial families.'],['https://purl.fdlp.gov/GPO/gpo116165'],['32791_0_single father custodial families.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo116165'],['32791_0_single father custodial families.pdf'],[0.412],[0.509],[0.607],[0.186],[0.207],[0.181],[0.745],[0.644],[0.556],[0.72],[0.78],[0.691],[0.622],[0.906],[0.825],[0.747],[0.786],[0.771],0.412,0.509,0.607,0.186,0.207,0.181,0.745,0.644,0.556,0.72,0.78,0.691,0.622,0.906,0.825,0.747,0.786,0.771
https://doi.org/10.1111/j.1746-1561.2000.tb06468.x,social and emotional learning a framework for promoting mental health and reducing risk behavior in children and youth,32931_social and emotional learning a framework for promoting mental health and reducing risk behavior in children and youth.pdf,2,"['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2961773-1', 'https://www.rand.org/pubs/research_reports/RR2670.html']","['Practice Parameter for Psychiatric Consultation to Schools', 'Air Force Morale, Welfare, and Recreation Programs and Services']",['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2961773-1'],['32931_0_practice parameter for psychiatric consultation to schools.pdf'],1,50.0,['https://www.jaacap.org/action/showPdf?pii=S0890-8567%2809%2961773-1'],['32931_0_practice parameter for psychiatric consultation to schools.pdf'],[0.463],[0.577],[0.649],[0.202],[0.216],[0.184],[0.746],[0.652],[0.638],[0.688],[0.817],[0.763],[0.651],[0.931],[0.853],[0.788],[0.824],[0.807],0.463,0.577,0.649,0.202,0.216,0.184,0.746,0.652,0.638,0.688,0.817,0.763,0.651,0.931,0.853,0.788,0.824,0.807
https://doi.org/10.1111/jan.14204,flying by the seat of their pants a grounded theory of school nurse case management,33294_flying by the seat of their pants a grounded theory of school nurse case management.pdf,1,['https://communityaffairs.dc.gov/sites/moca/files/dc/sites/moca/publication/attachments/Amended%20RFA%20SHSP%206.18.21.pdf'],['District Of Columbia Department Of Health Community Health Administration (cha)'],['https://communityaffairs.dc.gov/sites/moca/files/dc/sites/moca/publication/attachments/Amended%20RFA%20SHSP%206.18.21.pdf'],['33294_0_district of columbia department of health community health administration cha.pdf'],1,100.0,['https://communityaffairs.dc.gov/sites/moca/files/dc/sites/moca/publication/attachments/Amended%20RFA%20SHSP%206.18.21.pdf'],['33294_0_district of columbia department of health community health administration cha.pdf'],[0.464],[0.477],[0.589],[0.159],[0.187],[0.145],[0.735],[0.639],[0.591],[0.666],[0.782],[0.716],[0.589],[0.9],[0.846],[0.74],[0.775],[0.756],0.464,0.477,0.589,0.159,0.187,0.145,0.735,0.639,0.591,0.666,0.782,0.716,0.589,0.9,0.846,0.74,0.775,0.756
https://doi.org/10.1111/jcpp.12980,research review the effects of mindfulness‐based interventions on cognition and mental health in children and adolescents – a meta‐analysis of randomized controlled trials,33354_research review the effects of mindfulness‐based interventions on cognition and mental health in children and adolescents – a meta‐analysis of randomized controlled trials.pdf,3,"['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://effectivehealthcare.ahrq.gov/products/childhood-depression/research']","['MHSOAC Meeting Packet', 'MHSOAC Meeting Packet', 'Treatment of Depression in Children and Adolescents']","['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['33354_0_mhsoac meeting packet.pdf', '33354_1_mhsoac meeting packet.pdf']",2,66.67,"['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['33354_0_mhsoac meeting packet.pdf', '33354_1_mhsoac meeting packet.pdf']","[0.238, 0.238]","[0.494, 0.494]","[0.591, 0.591]","[0.12, 0.12]","[0.141, 0.141]","[0.108, 0.108]","[0.72, 0.72]","[0.625, 0.625]","[0.554, 0.554]","[0.675, 0.675]","[0.778, 0.778]","[0.705, 0.705]","[0.604, 0.604]","[0.91, 0.91]","[0.806, 0.806]","[0.728, 0.728]","[0.779, 0.779]","[0.751, 0.751]",0.238,0.494,0.591,0.12,0.141,0.108,0.72,0.625,0.554,0.675,0.778,0.705,0.604,0.91,0.806,0.728,0.779,0.751
https://doi.org/10.1111/jcpp.13129,parenting for lifelong health for young children a randomized controlled trial of a parenting program in south africa to prevent harsh parenting and child conduct problems,33356_parenting for lifelong health for young children a randomized controlled trial of a parenting program in south africa to prevent harsh parenting and child conduct problems.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf', 'https://www.fhi360.org/resource/lego-nurturing-care-and-covid-19-research-briefs', 'https://stacks.cdc.gov/view/cdc/108199']","['Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries', 'LEGO Nurturing Care and COVID-19: Research Briefs', 'Children : the hidden pandemic 2021 : a joint report of COVID-19- associated orphanhood and a strategy for action']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['33356_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['33356_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf'],[0.387],[0.522],[0.606],[0.15],[0.158],[0.14],[0.732],[0.638],[0.571],[0.702],[0.773],[0.696],[0.589],[0.917],[0.814],[0.728],[0.775],[0.755],0.387,0.522,0.606,0.15,0.158,0.14,0.732,0.638,0.571,0.702,0.773,0.696,0.589,0.917,0.814,0.728,0.775,0.755
https://doi.org/10.1111/jfb.14100,periodicity of the growth‐band formation in vertebrae of juvenile scalloped hammerhead shark sphyrna lewini from the mexican pacific ocean,33377_periodicity of the growth‐band formation in vertebrae of juvenile scalloped hammerhead shark sphyrna lewini from the mexican pacific ocean.pdf,1,['https://purl.fdlp.gov/GPO/gpo143144'],['Scalloped hammerhead shark (Sphyrna lewini) 5 year review :\xa0summary and evaluation.'],['https://purl.fdlp.gov/GPO/gpo143144'],['33377_0_scalloped hammerhead shark sphyrna lewini 5 year review \xa0summary and evaluation.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo143144'],['33377_0_scalloped hammerhead shark sphyrna lewini 5 year review \xa0summary and evaluation.pdf'],[0.474],[0.494],[0.591],[0.132],[0.136],[0.113],[0.73],[0.639],[0.561],[0.681],[0.786],[0.695],[0.64],[0.898],[0.808],[0.756],[0.787],[0.776],0.474,0.494,0.591,0.132,0.136,0.113,0.73,0.639,0.561,0.681,0.786,0.695,0.64,0.898,0.808,0.756,0.787,0.776
https://doi.org/10.1111/jfcj.12127,juvenile justice in pennsylvania mission‐driven performance‐ based outcome‐focused,33389_juvenile justice in pennsylvania mission‐driven performance‐ based outcome‐focused.pdf,1,['https://www.jcjc.pa.gov/Balanced-Restorative-Mission/Documents/A%20Family%20Guide%20to%20Pennsylvania%20Juvenile%20Justice%20System.pdf'],['Pennsylvania ’ s'],['https://www.jcjc.pa.gov/Balanced-Restorative-Mission/Documents/A%20Family%20Guide%20to%20Pennsylvania%20Juvenile%20Justice%20System.pdf'],['33389_0_pennsylvania  s.pdf'],1,100.0,['https://www.jcjc.pa.gov/Balanced-Restorative-Mission/Documents/A%20Family%20Guide%20to%20Pennsylvania%20Juvenile%20Justice%20System.pdf'],['33389_0_pennsylvania  s.pdf'],[0.625],[0.59],[0.686],[0.234],[0.264],[0.248],[0.751],[0.653],[0.666],[0.708],[0.831],[0.771],[0.674],[0.934],[0.877],[0.805],[0.841],[0.826],0.625,0.59,0.686,0.234,0.264,0.248,0.751,0.653,0.666,0.708,0.831,0.771,0.674,0.934,0.877,0.805,0.841,0.826
https://doi.org/10.1111/jgh.15442,radiofrequency ablation iversusi stereotactic body radiation therapy for small ≤ 3 cm hepatocellular carcinoma a retrospective comparison analysis,33400_radiofrequency ablation iversusi stereotactic body radiation therapy for small ≤ 3 cm hepatocellular carcinoma a retrospective comparison analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['33400_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/pdf'],['33400_0_2022 klcancc korea practice guidelines for the management of hepatocellular carcinoma.pdf'],[0.626],[0.526],[0.604],[0.169],[0.172],[0.136],[0.749],[0.659],[0.586],[0.66],[0.79],[0.676],[0.628],[0.913],[0.811],[0.751],[0.785],[0.772],0.626,0.526,0.604,0.169,0.172,0.136,0.749,0.659,0.586,0.66,0.79,0.676,0.628,0.913,0.811,0.751,0.785,0.772
https://doi.org/10.1111/joca.12068,foundations of financial wellbeing insights into the role of executive function financial socialization and experiencebased learning in childhood and youth,33433_foundations of financial wellbeing insights into the role of executive function financial socialization and experiencebased learning in childhood and youth.pdf,4,"['https://purl.fdlp.gov/GPO/gpo87823', 'https://www.acf.hhs.gov/opre/report/conceptual-models-adulthood-preparation-subjects-within-personal-responsibility', 'https://mathematica.org/publications/conceptual-models-for-adulthood-preparation-subjects-within-the-prep', 'https://www.brookings.edu/research/are-states-providing-adequate-financial-literacy-education/']","['Building blocks to help youth achieve financial capability :\xa0a new model and recommendations.', 'Conceptual Models for Adulthood Preparation Subjects within the Personal Responsibility Education Program (PREP)', 'Conceptual Models for Adulthood Preparation Subjects within the Personal Responsibility Education Program (PREP)', 'Are states providing adequate financial literacy education?']",['https://purl.fdlp.gov/GPO/gpo87823'],['33433_0_building blocks to help youth achieve financial capability \xa0a new model and recommendations.pdf'],1,25.0,['https://purl.fdlp.gov/GPO/gpo87823'],['33433_0_building blocks to help youth achieve financial capability \xa0a new model and recommendations.pdf'],[0.814],[0.617],[0.695],[0.252],[0.281],[0.253],[0.755],[0.666],[0.68],[0.7],[0.838],[0.784],[0.675],[0.933],[0.869],[0.806],[0.851],[0.83],0.814,0.617,0.695,0.252,0.281,0.253,0.755,0.666,0.68,0.7,0.838,0.784,0.675,0.933,0.869,0.806,0.851,0.83
https://doi.org/10.1111/jofi.12778,what is the expected return on a stock,33444_what is the expected return on a stock.pdf,1,['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2202.pdf'],['Endogenous Option Pricing'],['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2202.pdf'],['33444_0_endogenous option pricing.pdf'],1,100.0,['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2202.pdf'],['33444_0_endogenous option pricing.pdf'],[0.424],[0.557],[0.63],[0.161],[0.167],[0.144],[0.743],[0.648],[0.589],[0.756],[0.786],[0.697],[0.675],[0.91],[0.816],[0.774],[0.794],[0.781],0.424,0.557,0.63,0.161,0.167,0.144,0.743,0.648,0.589,0.756,0.786,0.697,0.675,0.91,0.816,0.774,0.794,0.781
https://doi.org/10.1111/joim.12842,evidence supporting the best clinical management of patients with multimorbidity and polypharmacy a systematic guideline review and expert consensus,33455_evidence supporting the best clinical management of patients with multimorbidity and polypharmacy a systematic guideline review and expert consensus.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407330/pdf'],['Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition: a mixed methods review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407330/pdf'],['33455_0_tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition a mixed methods review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407330/pdf'],['33455_0_tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition a mixed methods review.pdf'],[0.403],[0.549],[0.637],[0.19],[0.192],[0.154],[0.739],[0.648],[0.615],[0.712],[0.796],[0.727],[0.604],[0.924],[0.845],[0.752],[0.799],[0.78],0.403,0.549,0.637,0.19,0.192,0.154,0.739,0.648,0.615,0.712,0.796,0.727,0.604,0.924,0.845,0.752,0.799,0.78
https://doi.org/10.1111/jomf.12499,when home is still unsafe from family reunification to foster care reentry,33467_when home is still unsafe from family reunification to foster care reentry.pdf,2,"['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['MHSOAC Meeting Packet', 'MHSOAC Meeting Packet']","['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['33467_0_mhsoac meeting packet.pdf', '33467_1_mhsoac meeting packet.pdf']",2,100.0,"['https://mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf', 'https://www.mhsoac.ca.gov/sites/default/files/Combined%20Packet%20-%20FINAL.pdf']","['33467_0_mhsoac meeting packet.pdf', '33467_1_mhsoac meeting packet.pdf']","[0.284, 0.284]","[0.564, 0.564]","[0.641, 0.641]","[0.142, 0.142]","[0.166, 0.166]","[0.127, 0.127]","[0.722, 0.722]","[0.622, 0.622]","[0.634, 0.634]","[0.667, 0.667]","[0.817, 0.817]","[0.763, 0.763]","[0.651, 0.651]","[0.932, 0.932]","[0.846, 0.846]","[0.786, 0.786]","[0.826, 0.826]","[0.804, 0.804]",0.284,0.564,0.641,0.142,0.166,0.127,0.722,0.622,0.634,0.667,0.817,0.763,0.651,0.932,0.846,0.786,0.826,0.804
https://doi.org/10.1111/jora.12408,understanding the role of puberty in structural and functional development of the adolescent brain,33485_understanding the role of puberty in structural and functional development of the adolescent brain.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['33485_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['33485_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.44],[0.561],[0.648],[0.174],[0.18],[0.154],[0.748],[0.651],[0.628],[0.648],[0.807],[0.744],[0.636],[0.926],[0.816],[0.784],[0.81],[0.796],0.44,0.561,0.648,0.174,0.18,0.154,0.748,0.651,0.628,0.648,0.807,0.744,0.636,0.926,0.816,0.784,0.81,0.796
https://doi.org/10.1111/josh.12048,is it bullying or sexual harassment knowledge attitudes and professional development experiences of middle school staff,33493_is it bullying or sexual harassment knowledge attitudes and professional development experiences of middle school staff.pdf,6,"['https://dph.georgia.gov/document/document/2014-middle-and-high-school-safe-and-supportive-school-environment-data-summary/download', 'https://stacks.cdc.gov/view/cdc/36620', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf', 'https://www.dshs.texas.gov/chs/tshp/2018-School-Health-Profiles-School-Principal-Item-Rationale.pdf', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale-0/download']","['2014 Georgia Middle and High School Safe and Supportive School Environment Data Summary', 'School health profiles 2014 : characteristics of health programs among secondary schools', '2016 School Health Profiles School Principal Questionnaire', '2020 School Health Profiles Principal Item Rationale', 'Item Rationale 2018 School Health Profiles School Principal Questionnaire', '2014 Profiles Principal Item Rationale']","['https://dph.georgia.gov/document/document/2014-middle-and-high-school-safe-and-supportive-school-environment-data-summary/download', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://www.dshs.texas.gov/chs/tshp/2020-Item-Rationale-Principal.pdf', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale-0/download']","['33493_0_2014 georgia middle and high school safe and supportive school environment data summary.pdf', '33493_2_2016 school health profiles school principal questionnaire.pdf', '33493_3_2020 school health profiles principal item rationale.pdf', '33493_5_2014 profiles principal item rationale.pdf']",4,66.67,"['https://dph.georgia.gov/document/document/2014-middle-and-high-school-safe-and-supportive-school-environment-data-summary/download', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale/download', 'https://dph.georgia.gov/document/document/principal-questionnaire-item-rationale-0/download']","['33493_0_2014 georgia middle and high school safe and supportive school environment data summary.pdf', '33493_2_2016 school health profiles school principal questionnaire.pdf', '33493_5_2014 profiles principal item rationale.pdf']","[0.596, 0.484, 0.49]","[0.591, 0.529, 0.528]","[0.666, 0.625, 0.623]","[0.241, 0.165, 0.164]","[0.264, 0.174, 0.174]","[0.226, 0.147, 0.147]","[0.752, 0.735, 0.734]","[0.662, 0.637, 0.636]","[0.665, 0.61, 0.61]","[0.693, 0.66, 0.66]","[0.831, 0.803, 0.802]","[0.773, 0.722, 0.723]","[0.654, 0.614, 0.614]","[0.939, 0.925, 0.926]","[0.865, 0.842, 0.845]","[0.795, 0.759, 0.76]","[0.838, 0.804, 0.806]","[0.817, 0.788, 0.789]",0.523,0.549,0.638,0.19,0.204,0.173,0.74,0.645,0.628,0.671,0.812,0.739,0.627,0.93,0.851,0.771,0.816,0.798
https://doi.org/10.1111/josh.12808,evaluation of an intervention to increase physical activity in low‐income urban middle schools,33524_evaluation of an intervention to increase physical activity in low‐income urban middle schools.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['33524_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['33524_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.566],[0.521],[0.605],[0.177],[0.189],[0.159],[0.738],[0.642],[0.588],[0.701],[0.773],[0.693],[0.6],[0.916],[0.825],[0.733],[0.78],[0.764],0.566,0.521,0.605,0.177,0.189,0.159,0.738,0.642,0.588,0.701,0.773,0.693,0.6,0.916,0.825,0.733,0.78,0.764
https://doi.org/10.1111/josh.13058,covid ‐19 transmission during transportation of 1st to 12th grade students experience of an independent school in virginia,33526_covid ‐19 transmission during transportation of 1st to 12th grade students experience of an independent school in virginia.pdf,4,"['https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Public%20Health%20Guidance%20for%20Schools.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/DPH-ISBE%20School%20FAQ_1.2022.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/School%20Guidance%20Rapid%20POC%20Testing%20Update_20220112.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/DPH-ISBE%20School%20FAQ.pdf']","['Revised Public Health Guidance for Schools', 'Frequently Asked Questions (FAQs) for Schools', 'Interim Guidance on Testing for COVID-19 in Community Settings and Schools', 'Frequently Asked Questions (FAQs) for Schools']","['https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/DPH-ISBE%20School%20FAQ_1.2022.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/School%20Guidance%20Rapid%20POC%20Testing%20Update_20220112.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Public%20Health%20Guidance%20for%20Schools.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/DPH-ISBE%20School%20FAQ.pdf']","['33526_1_frequently asked questions faqs for schools.pdf', '33526_2_interim guidance on testing for covid19 in community settings and schools.pdf', '33526_0_revised public health guidance for schools.pdf', '33526_3_frequently asked questions faqs for schools.pdf']",4,100.0,"['https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/DPH-ISBE%20School%20FAQ_1.2022.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/School%20Guidance%20Rapid%20POC%20Testing%20Update_20220112.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/Public%20Health%20Guidance%20for%20Schools.pdf', 'https://dph.illinois.gov/content/dam/soi/en/web/idph/covid19/guidance/school/DPH-ISBE%20School%20FAQ.pdf']","['33526_1_frequently asked questions faqs for schools.pdf', '33526_2_interim guidance on testing for covid19 in community settings and schools.pdf', '33526_0_revised public health guidance for schools.pdf', '33526_3_frequently asked questions faqs for schools.pdf']","[0.659, 0.655, 0.398, 0.649]","[0.567, 0.589, 0.565, 0.576]","[0.641, 0.659, 0.646, 0.647]","[0.195, 0.19, 0.195, 0.203]","[0.219, 0.212, 0.218, 0.228]","[0.177, 0.158, 0.173, 0.185]","[0.738, 0.732, 0.737, 0.739]","[0.639, 0.633, 0.639, 0.64]","[0.656, 0.684, 0.658, 0.667]","[0.651, 0.644, 0.644, 0.651]","[0.816, 0.832, 0.822, 0.822]","[0.763, 0.791, 0.772, 0.771]","[0.666, 0.672, 0.665, 0.67]","[0.932, 0.939, 0.934, 0.933]","[0.853, 0.863, 0.853, 0.856]","[0.791, 0.807, 0.795, 0.797]","[0.827, 0.846, 0.834, 0.833]","[0.802, 0.82, 0.808, 0.808]",0.59,0.574,0.648,0.196,0.219,0.173,0.736,0.638,0.666,0.647,0.823,0.774,0.668,0.935,0.856,0.798,0.835,0.809
https://doi.org/10.1111/josi.12030,determinants of radicalization of islamic youth in the netherlands personal uncertainty perceived injustice and perceived group threat,33527_determinants of radicalization of islamic youth in the netherlands personal uncertainty perceived injustice and perceived group threat.pdf,1,['https://www.dhs.gov/sites/default/files/publications/OPSR_TP_CVE-Use-Assessment-Tools-Measuring-Violence-Risk_Literature-Review_March2017-508.pdf'],['Countering Violent Extremism : The Use of Assessment Tools for Measuring Violence Risk'],['https://www.dhs.gov/sites/default/files/publications/OPSR_TP_CVE-Use-Assessment-Tools-Measuring-Violence-Risk_Literature-Review_March2017-508.pdf'],['33527_0_countering violent extremism  the use of assessment tools for measuring violence risk.pdf'],1,100.0,['https://www.dhs.gov/sites/default/files/publications/OPSR_TP_CVE-Use-Assessment-Tools-Measuring-Violence-Risk_Literature-Review_March2017-508.pdf'],['33527_0_countering violent extremism  the use of assessment tools for measuring violence risk.pdf'],[0.226],[0.546],[0.639],[0.162],[0.195],[0.153],[0.73],[0.637],[0.596],[0.716],[0.795],[0.727],[0.644],[0.917],[0.834],[0.768],[0.806],[0.789],0.226,0.546,0.639,0.162,0.195,0.153,0.73,0.637,0.596,0.716,0.795,0.727,0.644,0.917,0.834,0.768,0.806,0.789
https://doi.org/10.1111/jpc.14258,gene expression in kawasaki disease,33539_gene expression in kawasaki disease.pdf,1,['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf'],['Whole Exome Sequencing Final evidence report'],['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf'],['33539_0_whole exome sequencing final evidence report.pdf'],1,100.0,['https://www.hca.wa.gov/assets/program/whole-exome-sequencing-final-rpt-20191022.pdf'],['33539_0_whole exome sequencing final evidence report.pdf'],[0.241],[0.496],[0.588],[0.134],[0.138],[0.117],[0.743],[0.649],[0.556],[0.69],[0.766],[0.666],[0.606],[0.886],[0.784],[0.681],[0.76],[0.736],0.241,0.496,0.588,0.134,0.138,0.117,0.743,0.649,0.556,0.69,0.766,0.666,0.606,0.886,0.784,0.681,0.76,0.736
https://doi.org/10.1111/jpc.14409_88,dietary intervention andor probiotic capsules in obese pregnant women and infant growth and feeding at 5 months healthy mums and babies humba trial,33540_dietary intervention andor probiotic capsules in obese pregnant women and infant growth and feeding at 5 months healthy mums and babies humba trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['Probiotics for preventing gestational diabetes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['33540_0_probiotics for preventing gestational diabetes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094741/pdf'],['33540_0_probiotics for preventing gestational diabetes.pdf'],[0.236],[0.52],[0.611],[0.18],[0.146],[0.129],[0.733],[0.635],[0.586],[0.667],[0.777],[0.707],[0.583],[0.91],[0.787],[0.729],[0.778],[0.754],0.236,0.52,0.611,0.18,0.146,0.129,0.733,0.635,0.586,0.667,0.777,0.707,0.583,0.91,0.787,0.729,0.778,0.754
https://doi.org/10.1111/jpc.14448,management of status epilepticus in children prior to medical retrieval deviations from the guidelines,33541_management of status epilepticus in children prior to medical retrieval deviations from the guidelines.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015475/pdf'],['Evaluation of adherence to pediatric status epilepticus management guidelines in Saudi Arabia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015475/pdf'],['33541_0_evaluation of adherence to pediatric status epilepticus management guidelines in saudi arabia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015475/pdf'],['33541_0_evaluation of adherence to pediatric status epilepticus management guidelines in saudi arabia.pdf'],[0.546],[0.567],[0.64],[0.226],[0.229],[0.19],[0.744],[0.654],[0.625],[0.671],[0.798],[0.737],[0.647],[0.923],[0.834],[0.771],[0.806],[0.789],0.546,0.567,0.64,0.226,0.229,0.19,0.744,0.654,0.625,0.671,0.798,0.737,0.647,0.923,0.834,0.771,0.806,0.789
https://doi.org/10.1111/jspn.12239,first bathing time of newborn infants after birth a comparative analysis,33551_first bathing time of newborn infants after birth a comparative analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['33551_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['33551_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.133],[0.497],[0.581],[0.118],[0.128],[0.097],[0.73],[0.634],[0.562],[0.64],[0.776],[0.691],[0.616],[0.918],[0.807],[0.73],[0.775],[0.761],0.133,0.497,0.581,0.118,0.128,0.097,0.73,0.634,0.562,0.64,0.776,0.691,0.616,0.918,0.807,0.73,0.775,0.761
https://doi.org/10.1111/liv.14592,identifying gaps across the cascade of care for the prevention of hbv mother‐to‐child transmission in burkina faso findings from the real world,33566_identifying gaps across the cascade of care for the prevention of hbv mother‐to‐child transmission in burkina faso findings from the real world.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607275/pdf'],['Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607275/pdf'],['33566_0_arresting vertical transmission of hepatitis b virus averthbv in pregnant women and their neonates in the democratic republic of the congo a feasibility study.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607275/pdf'],['33566_0_arresting vertical transmission of hepatitis b virus averthbv in pregnant women and their neonates in the democratic republic of the congo a feasibility study.pdf'],[0.492],[0.542],[0.628],[0.194],[0.2],[0.169],[0.738],[0.65],[0.61],[0.649],[0.794],[0.707],[0.619],[0.923],[0.815],[0.753],[0.796],[0.778],0.492,0.542,0.628,0.194,0.2,0.169,0.738,0.65,0.61,0.649,0.794,0.707,0.619,0.923,0.815,0.753,0.796,0.778
https://doi.org/10.1111/mcn.12654,complementary feeding practices among rural bangladeshi mothers results from wash benefits study,33619_complementary feeding practices among rural bangladeshi mothers results from wash benefits study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497129/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497129/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['33619_2_preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health nutrition and developmental outcomes.pdf', '33619_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '33619_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497129/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['33619_2_preventive lipid‐based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health nutrition and developmental outcomes.pdf', '33619_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '33619_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.546, 0.543, 0.468]","[0.493, 0.524, 0.526]","[0.583, 0.615, 0.617]","[0.155, 0.181, 0.181]","[0.158, 0.194, 0.195]","[0.128, 0.156, 0.157]","[0.73, 0.734, 0.734]","[0.633, 0.637, 0.637]","[0.55, 0.585, 0.587]","[0.698, 0.697, 0.697]","[0.761, 0.781, 0.781]","[0.659, 0.691, 0.695]","[0.593, 0.609, 0.609]","[0.91, 0.927, 0.928]","[0.795, 0.824, 0.827]","[0.72, 0.741, 0.741]","[0.76, 0.783, 0.785]","[0.744, 0.77, 0.771]",0.519,0.514,0.605,0.172,0.182,0.147,0.733,0.636,0.574,0.697,0.774,0.682,0.604,0.922,0.815,0.734,0.776,0.762
https://doi.org/10.1111/mcn.12972,dietary patterns and diet quality during pregnancy and low birthweight the princesa cohort,33625_dietary patterns and diet quality during pregnancy and low birthweight the princesa cohort.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf'],"['Quality Appraisal of Nutritional Guidelines to Prevent, Diagnose, and Treat Malnutrition in All Its Forms during Pregnancy']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf'],['33625_0_quality appraisal of nutritional guidelines to prevent diagnose and treat malnutrition in all its forms during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf'],['33625_0_quality appraisal of nutritional guidelines to prevent diagnose and treat malnutrition in all its forms during pregnancy.pdf'],[0.358],[0.485],[0.585],[0.136],[0.148],[0.127],[0.734],[0.64],[0.546],[0.692],[0.758],[0.65],[0.597],[0.904],[0.785],[0.725],[0.76],[0.75],0.358,0.485,0.585,0.136,0.148,0.127,0.734,0.64,0.546,0.692,0.758,0.65,0.597,0.904,0.785,0.725,0.76,0.75
https://doi.org/10.1111/nyas.14009,new york city panel on climate change 2019 report chapter 6 community‐based assessments of adaptation and equity,33673_new york city panel on climate change 2019 report chapter 6 community‐based assessments of adaptation and equity.pdf,2,"['https://www1.nyc.gov/assets/orr/pdf/publications/Coastal-Protection-Guidance.pdf', 'https://www.belfercenter.org/publication/increasing-access-multi-hazard-early-warning-systems-promoting-climate-change']","['Neighborhood Coastal Flood Protection Project Planning Guidance', 'Increasing Access to Multi-Hazard Early Warning Systems: Promoting Climate Change Adaptation in the Hindu Kush Himalayan Region']",['https://www1.nyc.gov/assets/orr/pdf/publications/Coastal-Protection-Guidance.pdf'],['33673_0_neighborhood coastal flood protection project planning guidance.pdf'],1,50.0,['https://www1.nyc.gov/assets/orr/pdf/publications/Coastal-Protection-Guidance.pdf'],['33673_0_neighborhood coastal flood protection project planning guidance.pdf'],[0.527],[0.537],[0.634],[0.181],[0.184],[0.152],[0.733],[0.642],[0.607],[0.677],[0.81],[0.742],[0.659],[0.922],[0.853],[0.775],[0.819],[0.798],0.527,0.537,0.634,0.181,0.184,0.152,0.733,0.642,0.607,0.677,0.81,0.742,0.659,0.922,0.853,0.775,0.819,0.798
https://doi.org/10.1111/nyas.14010,new york city panel on climate change 2019 report chapter 7 resilience strategies for critical infrastructures and their interdependencies,33674_new york city panel on climate change 2019 report chapter 7 resilience strategies for critical infrastructures and their interdependencies.pdf,1,['https://www1.nyc.gov/assets/nycha/downloads/pdf/Climate-Change-at-NYCHA_lores_single-pages.pdf'],['Climate Change at NYCHA'],['https://www1.nyc.gov/assets/nycha/downloads/pdf/Climate-Change-at-NYCHA_lores_single-pages.pdf'],['33674_0_climate change at nycha.pdf'],1,100.0,['https://www1.nyc.gov/assets/nycha/downloads/pdf/Climate-Change-at-NYCHA_lores_single-pages.pdf'],['33674_0_climate change at nycha.pdf'],[0.441],[0.536],[0.64],[0.207],[0.206],[0.18],[0.743],[0.655],[0.611],[0.662],[0.822],[0.733],[0.669],[0.919],[0.864],[0.783],[0.825],[0.807],0.441,0.536,0.64,0.207,0.206,0.18,0.743,0.655,0.611,0.662,0.822,0.733,0.669,0.919,0.864,0.783,0.825,0.807
https://doi.org/10.1111/nyas.14477,transmission of sars‐cov‐2 through breast milk and breastfeeding a living systematic review,33676_transmission of sars‐cov‐2 through breast milk and breastfeeding a living systematic review.pdf,3,"['https://stacks.cdc.gov/view/cdc/118106', 'https://stacks.cdc.gov/view/cdc/118438', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['Operational considerations for maintaining essential services for and providing maternal, newborn, and child healthcare in low-resource countries', 'Operational considerations for maintaining essential services for and providing maternal, newborn, and child healthcare in low-resource countries', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines']",['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['33676_2_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,33.33,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['33676_2_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.498],[0.497],[0.585],[0.139],[0.154],[0.124],[0.741],[0.649],[0.547],[0.632],[0.772],[0.652],[0.587],[0.896],[0.774],[0.726],[0.763],[0.757],0.498,0.497,0.585,0.139,0.154,0.124,0.741,0.649,0.547,0.632,0.772,0.652,0.587,0.896,0.774,0.726,0.763,0.757
https://doi.org/10.1111/obr.12812,the effect of screen advertising on childrens dietary intake a systematic review and metaanalysis,33710_the effect of screen advertising on childrens dietary intake a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141932/pdf'],['Taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141932/pdf'],['33710_0_taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141932/pdf'],['33710_0_taxation of unprocessed sugar or sugar‐added foods for reducing their consumption and preventing obesity or other adverse health outcomes.pdf'],[0.435],[0.53],[0.622],[0.165],[0.178],[0.145],[0.731],[0.631],[0.598],[0.711],[0.786],[0.705],[0.605],[0.925],[0.824],[0.746],[0.789],[0.773],0.435,0.53,0.622,0.165,0.178,0.145,0.731,0.631,0.598,0.711,0.786,0.705,0.605,0.925,0.824,0.746,0.789,0.773
https://doi.org/10.1111/obr.13109,effectiveness of lifestyle interventions in preventing harmful weight gain among adolescents a systematic review of systematic reviews,33712_effectiveness of lifestyle interventions in preventing harmful weight gain among adolescents a systematic review of systematic reviews.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['How effects on health equity are assessed in systematic reviews of interventions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['33712_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['33712_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],[0.63],[0.553],[0.642],[0.2],[0.206],[0.174],[0.74],[0.649],[0.615],[0.726],[0.797],[0.715],[0.617],[0.922],[0.846],[0.755],[0.797],[0.784],0.63,0.553,0.642,0.2,0.206,0.174,0.74,0.649,0.615,0.726,0.797,0.715,0.617,0.922,0.846,0.755,0.797,0.784
https://doi.org/10.1111/ocr.12377,changes in canine inclination after rapid and slow maxillary expansion compared to untreated controls,33713_changes in canine inclination after rapid and slow maxillary expansion compared to untreated controls.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709729/pdf']","['Interventions for promoting the eruption of palatally displaced permanent canine teeth, without the need for surgical exposure, in children aged 9 to 14 years', 'Orthodontic treatment for posterior crossbites']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709729/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf']","['33713_1_orthodontic treatment for posterior crossbites.pdf', '33713_0_interventions for promoting the eruption of palatally displaced permanent canine teeth without the need for surgical exposure in children aged 9 to 14 years.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709729/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717471/pdf']","['33713_1_orthodontic treatment for posterior crossbites.pdf', '33713_0_interventions for promoting the eruption of palatally displaced permanent canine teeth without the need for surgical exposure in children aged 9 to 14 years.pdf']","[0.325, 0.425]","[0.528, 0.54]","[0.605, 0.615]","[0.154, 0.162]","[0.166, 0.172]","[0.131, 0.142]","[0.74, 0.738]","[0.645, 0.644]","[0.591, 0.6]","[0.673, 0.671]","[0.783, 0.789]","[0.709, 0.722]","[0.605, 0.616]","[0.919, 0.916]","[0.807, 0.811]","[0.736, 0.741]","[0.786, 0.79]","[0.764, 0.767]",0.375,0.534,0.61,0.158,0.169,0.137,0.739,0.645,0.595,0.672,0.786,0.716,0.611,0.917,0.809,0.738,0.788,0.766
https://doi.org/10.1111/pde.14037,babys first bath changes in skin barrier function after bathing full‐term newborns with water vs liquid baby cleanser,33732_babys first bath changes in skin barrier function after bathing full‐term newborns with water vs liquid baby cleanser.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['33732_0_skin care interventions in infants for preventing eczema and food allergy.pdf', '33732_1_skin care interventions in infants for preventing eczema and food allergy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['33732_0_skin care interventions in infants for preventing eczema and food allergy.pdf', '33732_1_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.291, 0.295]","[0.532, 0.535]","[0.619, 0.621]","[0.162, 0.166]","[0.159, 0.162]","[0.123, 0.128]","[0.737, 0.738]","[0.641, 0.642]","[0.6, 0.605]","[0.646, 0.645]","[0.791, 0.793]","[0.718, 0.717]","[0.608, 0.611]","[0.919, 0.918]","[0.822, 0.824]","[0.745, 0.746]","[0.793, 0.794]","[0.768, 0.771]",0.293,0.534,0.62,0.164,0.161,0.126,0.738,0.641,0.603,0.645,0.792,0.718,0.609,0.919,0.823,0.746,0.794,0.77
https://doi.org/10.1111/ped.14571,management of infants born to mothers with suspected or confirmed sars‐cov‐2 infection in the delivery room a tentative proposal 2020,33738_management of infants born to mothers with suspected or confirmed sars‐cov‐2 infection in the delivery room a tentative proposal 2020.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013812/pdf'],['Management of infants born to mothers with suspected or confirmed SARS‐CoV‐2 infection in the delivery room: A tentative proposal 2020'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013812/pdf'],['33738_0_management of infants born to mothers with suspected or confirmed sars‐cov‐2 infection in the delivery room a tentative proposal 2020.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013812/pdf'],['33738_0_management of infants born to mothers with suspected or confirmed sars‐cov‐2 infection in the delivery room a tentative proposal 2020.pdf'],[1.0],[0.577],[0.657],[0.203],[0.215],[0.169],[0.746],[0.661],[0.627],[0.636],[0.817],[0.756],[0.656],[0.92],[0.83],[0.781],[0.822],[0.808],1.0,0.577,0.657,0.203,0.215,0.169,0.746,0.661,0.627,0.636,0.817,0.756,0.656,0.92,0.83,0.781,0.822,0.808
https://doi.org/10.1111/pedi.13158,children and youth with diabetes are not at increased risk for hospitalization due to covid ‐19,33747_children and youth with diabetes are not at increased risk for hospitalization due to covid ‐19.pdf,3,"['https://stacks.cdc.gov/view/cdc/106171', 'https://stacks.cdc.gov/view/cdc/114448', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf']","['Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf'],['33747_2_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903349/pdf'],['33747_2_updated guidance on use and prioritization of monoclonal antibody therapy for treatment of covid19 in adolescents.pdf'],[0.5],[0.562],[0.635],[0.207],[0.214],[0.17],[0.74],[0.654],[0.619],[0.655],[0.802],[0.732],[0.626],[0.915],[0.835],[0.765],[0.802],[0.786],0.5,0.562,0.635,0.207,0.214,0.17,0.74,0.654,0.619,0.655,0.802,0.732,0.626,0.915,0.835,0.765,0.802,0.786
https://doi.org/10.1111/ppc.12643,principles of approach to suspected or infected patients related covid‐19 in newborn intensive care unit and pediatric intensive care unit,33754_principles of approach to suspected or infected patients related covid‐19 in newborn intensive care unit and pediatric intensive care unit.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['33754_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['33754_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.662],[0.551],[0.63],[0.175],[0.196],[0.163],[0.745],[0.653],[0.614],[0.641],[0.81],[0.735],[0.631],[0.924],[0.839],[0.764],[0.813],[0.793],0.662,0.551,0.63,0.175,0.196,0.163,0.745,0.653,0.614,0.641,0.81,0.735,0.631,0.924,0.839,0.764,0.813,0.793
https://doi.org/10.1111/sms.13726,step by step association of device‐measured daily steps with all‐cause mortality—a prospective cohort study,33801_step by step association of device‐measured daily steps with all‐cause mortality—a prospective cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273687/pdf'],['Recommendations for determining the validity of consumer wearable and smartphone step count: expert statement and checklist of the INTERLIVE network'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273687/pdf'],['33801_0_recommendations for determining the validity of consumer wearable and smartphone step count expert statement and checklist of the interlive network.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273687/pdf'],['33801_0_recommendations for determining the validity of consumer wearable and smartphone step count expert statement and checklist of the interlive network.pdf'],[0.4],[0.519],[0.608],[0.148],[0.173],[0.139],[0.732],[0.639],[0.585],[0.724],[0.774],[0.705],[0.599],[0.9],[0.813],[0.71],[0.772],[0.735],0.4,0.519,0.608,0.148,0.173,0.139,0.732,0.639,0.585,0.724,0.774,0.705,0.599,0.9,0.813,0.71,0.772,0.735
https://doi.org/10.1111/trf.16047,scpanti‐sars‐covscp ‐2 spike antibodies are stable in convalescent plasma when stored at 4° celsius for at least 6 weeks,33825_scpanti‐sars‐covscp ‐2 spike antibodies are stable in convalescent plasma when stored at 4° celsius for at least 6 weeks.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['33825_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['33825_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],[0.312],[0.548],[0.624],[0.16],[0.165],[0.132],[0.74],[0.65],[0.61],[0.659],[0.795],[0.728],[0.637],[0.915],[0.819],[0.772],[0.802],[0.79],0.312,0.548,0.624,0.16,0.165,0.132,0.74,0.65,0.61,0.659,0.795,0.728,0.637,0.915,0.819,0.772,0.802,0.79
https://doi.org/10.11124/jbisrir-2012-408,demandside financing measures to increase maternal health service utilisation and improve health outcomes a systematic review of evidence from low and middleincome countries,33834_demandside financing measures to increase maternal health service utilisation and improve health outcomes a systematic review of evidence from low and middleincome countries.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618451/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621088/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618470/pdf']","['Delivery arrangements for health systems in low‐income countries: an overview of systematic reviews', 'Governance arrangements for health systems in low‐income countries: an overview of systematic reviews', 'Implementation strategies for health systems in low‐income countries: an overview of systematic reviews', 'Financial arrangements for health systems in low‐income countries: an overview of systematic reviews']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621088/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618470/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618451/pdf']","['33834_0_delivery arrangements for health systems in low‐income countries an overview of systematic reviews.pdf', '33834_2_implementation strategies for health systems in low‐income countries an overview of systematic reviews.pdf', '33834_3_financial arrangements for health systems in low‐income countries an overview of systematic reviews.pdf', '33834_1_governance arrangements for health systems in low‐income countries an overview of systematic reviews.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621087/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621088/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618470/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618451/pdf']","['33834_0_delivery arrangements for health systems in low‐income countries an overview of systematic reviews.pdf', '33834_2_implementation strategies for health systems in low‐income countries an overview of systematic reviews.pdf', '33834_3_financial arrangements for health systems in low‐income countries an overview of systematic reviews.pdf', '33834_1_governance arrangements for health systems in low‐income countries an overview of systematic reviews.pdf']","[0.575, 0.573, 0.514, 0.59]","[0.561, 0.555, 0.55, 0.555]","[0.643, 0.637, 0.637, 0.641]","[0.176, 0.169, 0.174, 0.171]","[0.185, 0.177, 0.187, 0.183]","[0.151, 0.145, 0.152, 0.147]","[0.727, 0.724, 0.724, 0.723]","[0.633, 0.63, 0.63, 0.629]","[0.627, 0.623, 0.617, 0.621]","[0.674, 0.673, 0.682, 0.68]","[0.81, 0.806, 0.806, 0.808]","[0.743, 0.742, 0.738, 0.739]","[0.638, 0.636, 0.635, 0.637]","[0.922, 0.921, 0.921, 0.922]","[0.852, 0.848, 0.849, 0.851]","[0.775, 0.772, 0.77, 0.773]","[0.813, 0.81, 0.809, 0.81]","[0.793, 0.788, 0.789, 0.791]",0.563,0.555,0.639,0.172,0.183,0.149,0.724,0.63,0.622,0.677,0.808,0.74,0.637,0.922,0.85,0.773,0.81,0.79
https://doi.org/10.1115/power2018-7140,additive manufacturing a new paradigm for the next generation of highpowerdensity directdrive electric generators,33841_additive manufacturing a new paradigm for the next generation of highpowerdensity directdrive electric generators.pdf,3,"['https://www.osti.gov/biblio/1508509', 'https://www.osti.gov/biblio/1508509-iea-wind-tcp-results-iea-wind-tcp-workshop-grand-vision-wind-energy-technology', 'https://purl.fdlp.gov/GPO/gpo122261']","['IEA Wind TCP: Results of IEA Wind TCP Workshop on a Grand Vision for Wind Energy Technology', 'IEA Wind TCP: Results of IEA Wind TCP Workshop on a Grand Vision for Wind Energy Technology', 'Results of IEA Wind TCP workshop on a grand vision for wind energy technology /']",['https://purl.fdlp.gov/GPO/gpo122261'],['33841_2_results of iea wind tcp workshop on a grand vision for wind energy technology .pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo122261'],['33841_2_results of iea wind tcp workshop on a grand vision for wind energy technology .pdf'],[0.28],[0.541],[0.618],[0.115],[0.103],[0.092],[0.731],[0.636],[0.603],[0.666],[0.803],[0.724],[0.655],[0.92],[0.839],[0.78],[0.809],[0.794],0.28,0.541,0.618,0.115,0.103,0.092,0.731,0.636,0.603,0.666,0.803,0.724,0.655,0.92,0.839,0.78,0.809,0.794
https://doi.org/10.1126/science.1201783,improved learning in a largeenrollment physics class,33980_improved learning in a largeenrollment physics class.pdf,9,"['https://www.rand.org/pubs/research_reports/RR941.html', 'https://www.rand.org/pubs/research_reports/RR1589.html', 'https://www.aei.org/research-products/report/elevating-college-completion/', 'https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/two-stage-examinations', 'https://www.aei.org/research-products/report/completion-reforms-that-work-how-leading-colleges-are-improving-the-attainment-of-high-value-degrees/', 'https://www.congress.gov/event/112th-congress/senate-event/LC1156/text?s=1&r=8212', 'https://www.brookings.edu/research/education-technology-success-stories/', 'https://www.rand.org/pubs/research_reports/RR2167.html', 'https://lhc.ca.gov/sites/lhc.ca.gov/files/Reports/218/WrittenTestimony/KollerFeb2013.pdf']","['Hazing Prevention in the U.S. Armed Forces', 'Air Force Sexual Assault Situations, Settings, and Offender Behaviors', 'Elevating college completion - AEI', 'Two-Stage Examinations', 'Completion reforms that work: How leading colleges are improving the attainment of high-value degrees - AEI', 'S.Hrg. 112-844 — FIVE YEARS OF THE AMERICA COMPETES ACT: PROGRESS, CHALLENGES, AND NEXT STEPS', 'Education Technology Success Stories', 'Needs of Male Sexual Assault Victims in the U.S. Armed Forces', 'Assive']",['https://lhc.ca.gov/sites/lhc.ca.gov/files/Reports/218/WrittenTestimony/KollerFeb2013.pdf'],['33980_8_assive.pdf'],1,11.11,['https://lhc.ca.gov/sites/lhc.ca.gov/files/Reports/218/WrittenTestimony/KollerFeb2013.pdf'],['33980_8_assive.pdf'],[0.273],[0.537],[0.625],[0.194],[0.21],[0.189],[0.744],[0.652],[0.591],[0.733],[0.799],[0.712],[0.638],[0.928],[0.842],[0.768],[0.8],[0.794],0.273,0.537,0.625,0.194,0.21,0.189,0.744,0.652,0.591,0.733,0.799,0.712,0.638,0.928,0.842,0.768,0.8,0.794
https://doi.org/10.1126/science.aax3100,pervasive humandriven decline of life on earth points to the need for transformative change,34032_pervasive humandriven decline of life on earth points to the need for transformative change.pdf,3,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/ocuoxmdil_Deforestation_fronts___drivers_and_responses_in_a_changing_world___full_report__1_.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=9036553&GUID=FEBCE132-C6F6-41B5-AC66-F5D462AB932C']","['Deforestation Fronts: Drivers and Responses in a Changing World - Full Report (application/pdf, 42.1 MB)', 'Living Planet Report 2020 (application/pdf, 23.1 MB)', 'Testimony by the New York City Department of Sanitation December 18, 2020 @ 11:00 a. m. Oversight Hearing on Community Composting in New York City']","['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/ocuoxmdil_Deforestation_fronts___drivers_and_responses_in_a_changing_world___full_report__1_.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=9036553&GUID=FEBCE132-C6F6-41B5-AC66-F5D462AB932C']","['34032_0_deforestation fronts drivers and responses in a changing world  full report applicationpdf 421 mb.pdf', '34032_1_living planet report 2020 applicationpdf 231 mb.pdf', '34032_2_testimony by the new york city department of sanitation december 18 2020  1100 a m oversight hearing on community composting in new york city.pdf']",3,100.0,"['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/ocuoxmdil_Deforestation_fronts___drivers_and_responses_in_a_changing_world___full_report__1_.pdf', 'https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/279c656a32_ENGLISH_FULL.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=9036553&GUID=FEBCE132-C6F6-41B5-AC66-F5D462AB932C']","['34032_0_deforestation fronts drivers and responses in a changing world  full report applicationpdf 421 mb.pdf', '34032_1_living planet report 2020 applicationpdf 231 mb.pdf', '34032_2_testimony by the new york city department of sanitation december 18 2020  1100 a m oversight hearing on community composting in new york city.pdf']","[0.329, 0.771, 0.161]","[0.498, 0.499, 0.483]","[0.605, 0.611, 0.589]","[0.164, 0.173, 0.119]","[0.159, 0.186, 0.115]","[0.132, 0.155, 0.11]","[0.736, 0.74, 0.716]","[0.645, 0.653, 0.621]","[0.563, 0.559, 0.549]","[0.683, 0.707, 0.67]","[0.787, 0.776, 0.784]","[0.684, 0.682, 0.69]","[0.628, 0.631, 0.63]","[0.905, 0.906, 0.901]","[0.823, 0.817, 0.829]","[0.75, 0.742, 0.742]","[0.788, 0.778, 0.782]","[0.774, 0.765, 0.763]",0.42,0.493,0.602,0.152,0.153,0.132,0.731,0.64,0.557,0.687,0.782,0.685,0.63,0.904,0.823,0.745,0.783,0.767
https://doi.org/10.1126/science.aax9387,extinction filters mediate the global effects of habitat fragmentation on animals,34034_extinction filters mediate the global effects of habitat fragmentation on animals.pdf,1,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/ocuoxmdil_Deforestation_fronts___drivers_and_responses_in_a_changing_world___full_report__1_.pdf'],"['Deforestation Fronts: Drivers and Responses in a Changing World - Full Report (application/pdf, 42.1 MB)']",['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/ocuoxmdil_Deforestation_fronts___drivers_and_responses_in_a_changing_world___full_report__1_.pdf'],['34034_0_deforestation fronts drivers and responses in a changing world  full report applicationpdf 421 mb.pdf'],1,100.0,['https://files.worldwildlife.org/wwfcmsprod/files/Publication/file/ocuoxmdil_Deforestation_fronts___drivers_and_responses_in_a_changing_world___full_report__1_.pdf'],['34034_0_deforestation fronts drivers and responses in a changing world  full report applicationpdf 421 mb.pdf'],[0.358],[0.52],[0.615],[0.156],[0.153],[0.137],[0.735],[0.641],[0.59],[0.692],[0.803],[0.711],[0.622],[0.914],[0.837],[0.758],[0.807],[0.785],0.358,0.52,0.615,0.156,0.153,0.137,0.735,0.641,0.59,0.692,0.803,0.711,0.622,0.914,0.837,0.758,0.807,0.785
https://doi.org/10.1126/science.abb8001,changes in contact patterns shape the dynamics of the covid19 outbreak in china,34036_changes in contact patterns shape the dynamics of the covid19 outbreak in china.pdf,8,"['https://mathematica.org/publications/considerations-for-reopening-pennsylvania-schools', 'https://www.mass.gov/doc/dese-fall-reopening-guidance/download', 'https://www.congress.gov/event/116th-congress/house-event/110924', 'https://www.nber.org/papers/w27401', 'https://files.nc.gov/covid/documents/guidance/education/What-Are-We-Learning-About-Children-and-COVID-English.pdf', 'https://files.nc.gov/covid/documents/guidance/education/What-Are-We-Learning-About-Children-and-COVID-Spanish.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200723%20GBM%20%281%29.pdf']","['Considerations for Reopening Pennsylvania Schools', 'Initial Fall School Reopening Guidance', 'Former Federal Reserve Chairs on Responding to Our Nation’s Economic Crisis', 'The Political Scar of Epidemics', 'What Are We Learning About Children and COVID-19?', '¿ Qué estamos aprendiendo acerca de los niños y COVID-19?', '173ÿ67172', 'ÿ36ÿ3ÿ411734']","['https://www.mass.gov/doc/dese-fall-reopening-guidance/download', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200723%20GBM%20%281%29.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf']","['34036_1_initial fall school reopening guidance.pdf', '34036_7_ÿ36ÿ3ÿ411734.pdf', '34036_6_173ÿ67172.pdf']",3,37.5,"['https://www.mass.gov/doc/dese-fall-reopening-guidance/download', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200723%20GBM%20%281%29.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Testimony%2020200709%20GBM%20%283%29.pdf']","['34036_1_initial fall school reopening guidance.pdf', '34036_7_ÿ36ÿ3ÿ411734.pdf', '34036_6_173ÿ67172.pdf']","[0.246, 0.304, 0.187]","[0.5, 0.426, 0.424]","[0.594, 0.529, 0.527]","[0.133, 0.116, 0.12]","[0.135, 0.105, 0.109]","[0.109, 0.122, 0.126]","[0.728, 0.741, 0.744]","[0.631, 0.647, 0.651]","[0.567, 0.457, 0.452]","[0.661, 0.731, 0.735]","[0.787, 0.695, 0.687]","[0.689, 0.585, 0.574]","[0.627, 0.593, 0.595]","[0.914, 0.887, 0.887]","[0.813, 0.713, 0.701]","[0.749, 0.672, 0.666]","[0.786, 0.687, 0.681]","[0.77, 0.692, 0.686]",0.246,0.45,0.55,0.123,0.116,0.119,0.738,0.643,0.492,0.709,0.723,0.616,0.605,0.896,0.742,0.696,0.718,0.716
https://doi.org/10.1126/science.abc0035,the impact of covid19 and strategies for mitigation and suppression in low and middleincome countries,34037_the impact of covid19 and strategies for mitigation and suppression in low and middleincome countries.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.nber.org/papers/w28519', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.cgdev.org/publication/macroeconomics-pandemics-developing-countries-application-uganda', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.cgdev.org/publication/indirect-health-effects-covid-19-emerging-findings-kenya-philippines-south-africa-and', 'https://www.cgdev.org/publication/predicted-covid-19-fatality-rates-based-age-sex-comorbidities-and-health-system-capacity']","['A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers’ perceptions in high and low- and middle-income countries', 'The Trade-off Between Prioritization and Vaccination Speed Depends on Mitigation Measures', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-Cov-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'The Macroeconomics of Pandemics in Developing Countries: An Application to Uganda', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'The Indirect Health Effects of COVID-19: Emerging Findings from Kenya, the Philippines, South Africa, and Uganda', 'Predicted COVID-19 Fatality Rates Based on Age, Sex, Comorbidities, and Health System Capacity']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['34037_0_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf', '34037_7_master question list for covid19 caused by sarscov2.pdf', '34037_4_master question list for covid19 caused by sarscov2.pdf', '34037_3_master question list for covid19 caused by sarscov2.pdf', '34037_5_master question list for covid19 caused by sarscov2.pdf', '34037_2_master question list for covid19 caused by sarscov2.pdf']",6,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200721.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20200915.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['34037_0_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf', '34037_7_master question list for covid19 caused by sarscov2.pdf', '34037_4_master question list for covid19 caused by sarscov2.pdf', '34037_3_master question list for covid19 caused by sarscov2.pdf', '34037_5_master question list for covid19 caused by sarscov2.pdf', '34037_2_master question list for covid19 caused by sarscov2.pdf']","[0.331, 0.35, 0.358, 0.343, 0.347, 0.357]","[0.519, 0.53, 0.527, 0.531, 0.53, 0.529]","[0.61, 0.623, 0.619, 0.624, 0.623, 0.622]","[0.159, 0.151, 0.148, 0.151, 0.15, 0.15]","[0.157, 0.143, 0.139, 0.142, 0.142, 0.141]","[0.129, 0.124, 0.121, 0.123, 0.122, 0.122]","[0.732, 0.74, 0.737, 0.739, 0.739, 0.739]","[0.646, 0.652, 0.65, 0.651, 0.651, 0.651]","[0.577, 0.597, 0.596, 0.598, 0.597, 0.597]","[0.698, 0.662, 0.662, 0.661, 0.661, 0.661]","[0.787, 0.798, 0.796, 0.799, 0.799, 0.799]","[0.667, 0.706, 0.707, 0.709, 0.706, 0.704]","[0.615, 0.635, 0.635, 0.637, 0.636, 0.636]","[0.906, 0.912, 0.91, 0.911, 0.912, 0.911]","[0.833, 0.833, 0.832, 0.833, 0.832, 0.832]","[0.742, 0.757, 0.757, 0.759, 0.758, 0.758]","[0.785, 0.798, 0.797, 0.799, 0.799, 0.799]","[0.771, 0.781, 0.779, 0.782, 0.782, 0.781]",0.348,0.528,0.62,0.151,0.144,0.123,0.738,0.65,0.594,0.667,0.796,0.7,0.632,0.91,0.832,0.755,0.796,0.779
https://doi.org/10.1126/science.abc1917,introductions and early spread of sarscov2 in the new york city area,34038_introductions and early spread of sarscov2 in the new york city area.pdf,2,"['https://www.nber.org/papers/w28132', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['Geospatial Analysis of the September 2020 Coronavirus Outbreak at the University of Wisconsin – Madison: Did a Cluster of Local Bars Play a Critical Role?', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']",['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf'],['34038_1_master question list for covid19 caused by sarscov2.pdf'],1,50.0,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf'],['34038_1_master question list for covid19 caused by sarscov2.pdf'],[0.097],[0.541],[0.631],[0.133],[0.142],[0.103],[0.738],[0.649],[0.62],[0.664],[0.784],[0.754],[0.57],[0.933],[0.805],[0.76],[0.778],[0.774],0.097,0.541,0.631,0.133,0.142,0.103,0.738,0.649,0.62,0.664,0.784,0.754,0.57,0.933,0.805,0.76,0.778,0.774
https://doi.org/10.1126/science.abd7728,robust neutralizing antibodies to sarscov2 infection persist for months,34039_robust neutralizing antibodies to sarscov2 infection persist for months.pdf,3,"['https://stacks.cdc.gov/view/cdc/96952', 'https://www.congress.gov/event/117th-congress/house-event/111137', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf']","['COVID-19 science update ; Edition 2020-11-10', '""No Time to Lose: Solutions to Increase COVID-19 Vaccinations in the States"" (Virtual Hearing)', 'AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['34039_2_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['34039_2_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],[0.441],[0.521],[0.608],[0.17],[0.159],[0.132],[0.741],[0.653],[0.585],[0.69],[0.783],[0.697],[0.625],[0.911],[0.811],[0.753],[0.788],[0.773],0.441,0.521,0.608,0.17,0.159,0.132,0.741,0.653,0.585,0.69,0.783,0.697,0.625,0.911,0.811,0.753,0.788,0.773
https://doi.org/10.1126/science.abd9338,inferring the effectiveness of government interventions against covid19,34040_inferring the effectiveness of government interventions against covid19.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers’ perceptions in high and low- and middle-income countries', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['34040_2_master question list for covid19 caused by sarscov2.pdf', '34040_0_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf', '34040_1_master question list for covid19 caused by sarscov2.pdf']",3,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612542/pdf']","['34040_2_master question list for covid19 caused by sarscov2.pdf', '34040_0_a snapshot of the practicality and barriers to covid19 interventions public health and healthcare workers perceptions in high and low and middleincome countries.pdf']","[0.298, 0.363]","[0.516, 0.515]","[0.612, 0.605]","[0.137, 0.148]","[0.124, 0.141]","[0.106, 0.121]","[0.733, 0.728]","[0.644, 0.64]","[0.586, 0.574]","[0.665, 0.708]","[0.794, 0.786]","[0.708, 0.673]","[0.625, 0.605]","[0.913, 0.908]","[0.825, 0.827]","[0.749, 0.738]","[0.794, 0.785]","[0.777, 0.77]",0.331,0.516,0.609,0.143,0.133,0.113,0.73,0.642,0.58,0.686,0.79,0.691,0.615,0.911,0.826,0.744,0.79,0.774
https://doi.org/10.1126/science.abg3055,estimated transmissibility and impact of sarscov2 lineage b117 in england,34043_estimated transmissibility and impact of sarscov2 lineage b117 in england.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/pdf', 'https://www.ida.org/research-and-publications/publications/all/i/im/implementing-covid-19-outbreak-control-measures-disease-specific-requirements', 'https://www.rand.org/pubs/research_reports/RRA1277-1.html']","['Revisiting the guidelines for ending isolation for COVID-19 patients', 'Implementing COVID-19 Outbreak Control Measures: Disease-Specific Requirements', 'COVID-19 Genomics UK (COG-UK) Consortium']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/pdf'],['34043_0_revisiting the guidelines for ending isolation for covid19 patients.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/pdf'],['34043_0_revisiting the guidelines for ending isolation for covid19 patients.pdf'],[0.333],[0.529],[0.62],[0.162],[0.159],[0.129],[0.737],[0.648],[0.591],[0.698],[0.787],[0.707],[0.632],[0.907],[0.828],[0.753],[0.791],[0.774],0.333,0.529,0.62,0.162,0.159,0.129,0.737,0.648,0.591,0.698,0.787,0.707,0.632,0.907,0.828,0.753,0.791,0.774
https://doi.org/10.1126/science.abh2939,household covid19 risk and inperson schooling,34044_household covid19 risk and inperson schooling.pdf,6,"['https://stacks.cdc.gov/view/cdc/105945', 'https://stacks.cdc.gov/view/cdc/107712', 'https://stacks.cdc.gov/view/cdc/114614', 'https://stacks.cdc.gov/view/cdc/106198', 'https://stacks.cdc.gov/view/cdc/106675', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf']","['COVID-19 science update ; Edition 2021-04-07 (88)', 'EtR framework : Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years', 'Meeting of the Advisory Committee on Immunization Practices (ACIP), MAY 12, 2021', 'Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 Years — United States, January–March 2021', 'The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021', 'Measures implemented in the school setting to contain the COVID‐19 pandemic']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf'],['34044_5_measures implemented in the school setting to contain the covid‐19 pandemic.pdf'],1,16.67,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762709/pdf'],['34044_5_measures implemented in the school setting to contain the covid‐19 pandemic.pdf'],[0.47],[0.516],[0.596],[0.168],[0.165],[0.144],[0.733],[0.642],[0.572],[0.711],[0.774],[0.693],[0.616],[0.888],[0.805],[0.718],[0.777],[0.745],0.47,0.516,0.596,0.168,0.165,0.144,0.733,0.642,0.572,0.711,0.774,0.693,0.616,0.888,0.805,0.718,0.777,0.745
https://doi.org/10.1126/scitranslmed.abd5487,immune responses to sarscov2 infection in hospitalized pediatric and adult patients,34059_immune responses to sarscov2 infection in hospitalized pediatric and adult patients.pdf,4,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf', 'https://www.aei.org/research-products/report/is-it-safe-to-reopen-schools-an-extensive-review-of-the-research/', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://files.nc.gov/covid/documents/guidance/education/What-Are-We-Learning-About-Children-and-COVID-Spanish.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Is it safe to reopen schools? An extensive review of the research - AEI', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', '¿ Qué estamos aprendiendo acerca de los niños y COVID-19?']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['34059_2_master question list for covid19 caused by sarscov2.pdf', '34059_0_master question list for covid19 caused by sarscov2.pdf']",2,50.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201020.pdf']","['34059_2_master question list for covid19 caused by sarscov2.pdf', '34059_0_master question list for covid19 caused by sarscov2.pdf']","[0.394, 0.393]","[0.53, 0.529]","[0.62, 0.619]","[0.166, 0.165]","[0.146, 0.145]","[0.126, 0.125]","[0.744, 0.744]","[0.652, 0.651]","[0.594, 0.593]","[0.649, 0.649]","[0.792, 0.792]","[0.705, 0.704]","[0.632, 0.632]","[0.917, 0.916]","[0.814, 0.814]","[0.751, 0.751]","[0.793, 0.792]","[0.777, 0.777]",0.394,0.53,0.619,0.166,0.145,0.126,0.744,0.651,0.593,0.649,0.792,0.704,0.632,0.917,0.814,0.751,0.792,0.777
https://doi.org/10.1128/aac.01140-19,a randomized controlled trial of three versus fiveday artemetherlumefantrine regimens for treatment of uncomplicated plasmodium falciparum malaria in pregnancy in africa,34068_a randomized controlled trial of three versus fiveday artemetherlumefantrine regimens for treatment of uncomplicated plasmodium falciparum malaria in pregnancy in africa.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825227/pdf'],['Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825227/pdf'],['34068_0_drug treatment and prevention of malaria in pregnancy a critical review of the guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825227/pdf'],['34068_0_drug treatment and prevention of malaria in pregnancy a critical review of the guidelines.pdf'],[0.373],[0.515],[0.598],[0.14],[0.148],[0.121],[0.733],[0.638],[0.589],[0.634],[0.784],[0.686],[0.622],[0.91],[0.801],[0.742],[0.782],[0.758],0.373,0.515,0.598,0.14,0.148,0.121,0.733,0.638,0.589,0.634,0.784,0.686,0.622,0.91,0.801,0.742,0.782,0.758
https://doi.org/10.1128/aac.02193-17,population pharmacokinetics of the antimalarial amodiaquine a pooled analysis to optimize dosing,34071_population pharmacokinetics of the antimalarial amodiaquine a pooled analysis to optimize dosing.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520416/pdf'],['Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520416/pdf'],['34071_0_prior information for population pharmacokinetic and pharmacokineticpharmacodynamic analysis overview and guidance with a focus on the nonmem prior subroutine.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520416/pdf'],['34071_0_prior information for population pharmacokinetic and pharmacokineticpharmacodynamic analysis overview and guidance with a focus on the nonmem prior subroutine.pdf'],[0.343],[0.576],[0.653],[0.148],[0.143],[0.113],[0.737],[0.647],[0.662],[0.672],[0.826],[0.781],[0.661],[0.923],[0.841],[0.799],[0.825],[0.808],0.343,0.576,0.653,0.148,0.143,0.113,0.737,0.647,0.662,0.672,0.826,0.781,0.661,0.923,0.841,0.799,0.825,0.808
https://doi.org/10.1128/jcm.02104-20,comparison of the clinical performances of the abbott alinity igg abbott architect igm and roche elecsys total sarscov2 antibody assays,34113_comparison of the clinical performances of the abbott alinity igg abbott architect igm and roche elecsys total sarscov2 antibody assays.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['34113_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777/pdf'],['34113_0_aacc practical recommendations for implementing and interpreting sarscov2 eua and ldt serologic testing in clinical laboratories.pdf'],[0.56],[0.568],[0.642],[0.216],[0.209],[0.174],[0.751],[0.664],[0.636],[0.699],[0.799],[0.728],[0.651],[0.912],[0.843],[0.778],[0.809],[0.797],0.56,0.568,0.642,0.216,0.209,0.174,0.751,0.664,0.636,0.699,0.799,0.728,0.651,0.912,0.843,0.778,0.809,0.797
https://doi.org/10.1128/jcm.02338-20,clinical evaluation of bd veritor sarscov2 pointofcare test performance compared to pcrbased testing and versus the sofia 2 sars antigen pointofcare test,34115_clinical evaluation of bd veritor sarscov2 pointofcare test performance compared to pcrbased testing and versus the sofia 2 sars antigen pointofcare test.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/pdf']","['Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection', 'Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/pdf']","['34115_1_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf', '34115_0_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305720/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078597/pdf']","['34115_1_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf', '34115_0_rapid point‐of‐care antigen tests for diagnosis of sars‐cov‐2 infection.pdf']","[0.483, 0.477]","[0.534, 0.539]","[0.605, 0.609]","[0.168, 0.173]","[0.162, 0.169]","[0.138, 0.142]","[0.741, 0.741]","[0.651, 0.651]","[0.581, 0.588]","[0.721, 0.722]","[0.773, 0.776]","[0.693, 0.699]","[0.616, 0.617]","[0.899, 0.901]","[0.819, 0.823]","[0.729, 0.734]","[0.78, 0.784]","[0.753, 0.757]",0.48,0.536,0.607,0.17,0.166,0.14,0.741,0.651,0.585,0.722,0.774,0.696,0.617,0.9,0.821,0.732,0.782,0.755
https://doi.org/10.1128/msphere.00261-17,meningococcal antigen typing system matsbased neisseria meningitidis serogroup b coverage prediction for the menb4c vaccine in the united states,34144_meningococcal antigen typing system matsbased neisseria meningitidis serogroup b coverage prediction for the menb4c vaccine in the united states.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930067/pdf', 'https://stacks.cdc.gov/view/cdc/95034']","['Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020', 'A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine', 'Meningococcal vaccination : 5ecommendations of the Advisory Committee on Immunization Practices, United States, 2020']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf']","['34144_1_a physicians guide to the 2dose schedule of menbfhbp vaccine.pdf', '34144_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930067/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527029/pdf']","['34144_1_a physicians guide to the 2dose schedule of menbfhbp vaccine.pdf', '34144_0_meningococcal vaccination recommendations of the advisory committee on immunization practices united states 2020.pdf']","[0.42, 0.475]","[0.551, 0.545]","[0.63, 0.621]","[0.211, 0.192]","[0.215, 0.198]","[0.195, 0.179]","[0.755, 0.75]","[0.669, 0.661]","[0.618, 0.616]","[0.669, 0.656]","[0.796, 0.794]","[0.727, 0.712]","[0.648, 0.635]","[0.909, 0.908]","[0.821, 0.819]","[0.768, 0.762]","[0.806, 0.798]","[0.784, 0.78]",0.448,0.548,0.625,0.202,0.207,0.187,0.752,0.665,0.617,0.663,0.795,0.72,0.641,0.909,0.82,0.765,0.802,0.782
https://doi.org/10.1136/adc.2006.104786,effects of dietary management of phenylketonuria on longterm cognitive outcome,34229_effects of dietary management of phenylketonuria on longterm cognitive outcome.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769157/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639803/pdf', 'https://health.hawaii.gov/genetics/files/2019/08/NSM_Hawaii2012_rev_081419.pdf']","['Sapropterin dihydrochloride for phenylketonuria', 'The complete European guidelines on phenylketonuria: diagnosis and treatment', 'Hawai`i Practitioner ’s Manual']","['https://health.hawaii.gov/genetics/files/2019/08/NSM_Hawaii2012_rev_081419.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639803/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769157/pdf']","['34229_2_hawaii practitioner s manual.pdf', '34229_1_the complete european guidelines on phenylketonuria diagnosis and treatment.pdf', '34229_0_sapropterin dihydrochloride for phenylketonuria.pdf']",3,100.0,"['https://health.hawaii.gov/genetics/files/2019/08/NSM_Hawaii2012_rev_081419.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639803/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769157/pdf']","['34229_2_hawaii practitioner s manual.pdf', '34229_1_the complete european guidelines on phenylketonuria diagnosis and treatment.pdf', '34229_0_sapropterin dihydrochloride for phenylketonuria.pdf']","[0.261, 0.479, 0.155]","[0.508, 0.509, 0.5]","[0.597, 0.601, 0.595]","[0.102, 0.129, 0.129]","[0.109, 0.138, 0.135]","[0.084, 0.104, 0.107]","[0.725, 0.731, 0.732]","[0.62, 0.633, 0.633]","[0.584, 0.582, 0.57]","[0.632, 0.663, 0.691]","[0.782, 0.785, 0.774]","[0.711, 0.709, 0.688]","[0.61, 0.602, 0.585]","[0.91, 0.909, 0.907]","[0.803, 0.802, 0.795]","[0.745, 0.74, 0.72]","[0.785, 0.782, 0.77]","[0.765, 0.765, 0.75]",0.298,0.506,0.598,0.12,0.127,0.098,0.729,0.629,0.579,0.662,0.78,0.703,0.599,0.909,0.8,0.735,0.779,0.76
https://doi.org/10.1136/annrheumdis-2019-eular.1623,op0208 effect of serum urate lowering with allopurinol on blood pressure in young adults,34405_op0208 effect of serum urate lowering with allopurinol on blood pressure in young adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094453/pdf'],['Pharmacotherapy for hyperuricaemia in hypertensive patients'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094453/pdf'],['34405_0_pharmacotherapy for hyperuricaemia in hypertensive patients.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094453/pdf'],['34405_0_pharmacotherapy for hyperuricaemia in hypertensive patients.pdf'],[0.232],[0.518],[0.61],[0.164],[0.156],[0.13],[0.734],[0.64],[0.598],[0.667],[0.783],[0.703],[0.595],[0.907],[0.826],[0.741],[0.783],[0.764],0.232,0.518,0.61,0.164,0.156,0.13,0.734,0.64,0.598,0.667,0.783,0.703,0.595,0.907,0.826,0.741,0.783,0.764
https://doi.org/10.1136/annrheumdis-2021-eular.4034,pos1262 a cohort study of covid19 related multisystem inflammatory syndrome in children and adolescents from multiple tertiary care centres in south india,34406_pos1262 a cohort study of covid19 related multisystem inflammatory syndrome in children and adolescents from multiple tertiary care centres in south india.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821846/pdf'],['Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821846/pdf'],['34406_0_coronavirus disease 2019 covid19 vaccination for children position statement of indian academy of pediatrics advisory committee on vaccination and immunization practices.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821846/pdf'],['34406_0_coronavirus disease 2019 covid19 vaccination for children position statement of indian academy of pediatrics advisory committee on vaccination and immunization practices.pdf'],[0.322],[0.558],[0.628],[0.194],[0.185],[0.147],[0.737],[0.64],[0.624],[0.644],[0.81],[0.73],[0.647],[0.905],[0.843],[0.767],[0.81],[0.789],0.322,0.558,0.628,0.194,0.185,0.147,0.737,0.64,0.624,0.644,0.81,0.73,0.647,0.905,0.843,0.767,0.81,0.789
https://doi.org/10.1136/archdischild-2018-315391,newborn selfinflating manual resuscitators precision robotic testing of safety and reliability,34478_newborn selfinflating manual resuscitators precision robotic testing of safety and reliability.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080446/pdf'],['Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080446/pdf'],['34478_0_sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080446/pdf'],['34478_0_sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes.pdf'],[0.26],[0.511],[0.586],[0.139],[0.142],[0.112],[0.73],[0.636],[0.579],[0.686],[0.77],[0.7],[0.581],[0.904],[0.801],[0.724],[0.778],[0.75],0.26,0.511,0.586,0.139,0.142,0.112,0.73,0.636,0.579,0.686,0.77,0.7,0.581,0.904,0.801,0.724,0.778,0.75
https://doi.org/10.1136/archdischild-2018-315946,milk feed osmolality and adverse events in newborn infants and animals a systematic review,34479_milk feed osmolality and adverse events in newborn infants and animals a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710607/pdf'],['Formula versus maternal breast milk for feeding preterm or low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710607/pdf'],['34479_0_formula versus maternal breast milk for feeding preterm or low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710607/pdf'],['34479_0_formula versus maternal breast milk for feeding preterm or low birth weight infants.pdf'],[0.413],[0.548],[0.636],[0.175],[0.188],[0.148],[0.732],[0.644],[0.623],[0.669],[0.798],[0.727],[0.59],[0.923],[0.839],[0.753],[0.797],[0.784],0.413,0.548,0.636,0.175,0.188,0.148,0.732,0.644,0.623,0.669,0.798,0.727,0.59,0.923,0.839,0.753,0.797,0.784
https://doi.org/10.1136/archdischild-2018-316118,respiratory monitors to teach newborn facemask ventilation a randomised trial,34480_respiratory monitors to teach newborn facemask ventilation a randomised trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013812/pdf'],['Management of infants born to mothers with suspected or confirmed SARS‐CoV‐2 infection in the delivery room: A tentative proposal 2020'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013812/pdf'],['34480_0_management of infants born to mothers with suspected or confirmed sars‐cov‐2 infection in the delivery room a tentative proposal 2020.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013812/pdf'],['34480_0_management of infants born to mothers with suspected or confirmed sars‐cov‐2 infection in the delivery room a tentative proposal 2020.pdf'],[0.317],[0.556],[0.63],[0.15],[0.163],[0.12],[0.731],[0.637],[0.619],[0.63],[0.806],[0.752],[0.621],[0.917],[0.83],[0.772],[0.813],[0.793],0.317,0.556,0.63,0.15,0.163,0.12,0.731,0.637,0.619,0.63,0.806,0.752,0.621,0.917,0.83,0.772,0.813,0.793
https://doi.org/10.1136/archdischild-2019-316871,feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants,34481_feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690212/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092644/pdf']","['Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants', 'Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092644/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690212/pdf']","['34481_1_continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.pdf', '34481_0_continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092644/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690212/pdf']","['34481_1_continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.pdf', '34481_0_continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.pdf']","[0.491, 0.496]","[0.531, 0.529]","[0.618, 0.616]","[0.17, 0.167]","[0.175, 0.171]","[0.142, 0.14]","[0.733, 0.732]","[0.642, 0.641]","[0.602, 0.6]","[0.686, 0.684]","[0.78, 0.78]","[0.711, 0.71]","[0.588, 0.586]","[0.915, 0.915]","[0.825, 0.824]","[0.739, 0.738]","[0.786, 0.784]","[0.764, 0.764]",0.493,0.53,0.617,0.169,0.173,0.141,0.732,0.641,0.601,0.685,0.78,0.71,0.587,0.915,0.825,0.738,0.785,0.764
https://doi.org/10.1136/archdischild-2019-317501,core outcomes in neonatology development of a core outcome set for neonatal research,34482_core outcomes in neonatology development of a core outcome set for neonatal research.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095061/pdf'],['Indomethacin for symptomatic patent ductus arteriosus in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095061/pdf'],['34482_0_indomethacin for symptomatic patent ductus arteriosus in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095061/pdf'],['34482_0_indomethacin for symptomatic patent ductus arteriosus in preterm infants.pdf'],[0.275],[0.51],[0.593],[0.155],[0.16],[0.126],[0.731],[0.635],[0.579],[0.688],[0.769],[0.699],[0.575],[0.909],[0.8],[0.72],[0.769],[0.747],0.275,0.51,0.593,0.155,0.16,0.126,0.731,0.635,0.579,0.688,0.769,0.699,0.575,0.909,0.8,0.72,0.769,0.747
https://doi.org/10.1136/bcr-2013-008840,vitamin b12 deficiency presenting as acute ataxia,34516_vitamin b12 deficiency presenting as acute ataxia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356233/pdf'],['Vegan Nutrition for Mothers and Children: Practical Tools for Healthcare Providers'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356233/pdf'],['34516_0_vegan nutrition for mothers and children practical tools for healthcare providers.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356233/pdf'],['34516_0_vegan nutrition for mothers and children practical tools for healthcare providers.pdf'],[0.388],[0.49],[0.588],[0.136],[0.139],[0.118],[0.73],[0.632],[0.569],[0.641],[0.778],[0.683],[0.6],[0.911],[0.798],[0.736],[0.78],[0.766],0.388,0.49,0.588,0.136,0.139,0.118,0.73,0.632,0.569,0.641,0.778,0.683,0.6,0.911,0.798,0.736,0.78,0.766
https://doi.org/10.1136/bcr-2016-217546,a complicated multisystem flare of systemic lupus erythematosus during pregnancy,34517_a complicated multisystem flare of systemic lupus erythematosus during pregnancy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822421/pdf'],['Clinical practice guideline on pregnancy and renal disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822421/pdf'],['34517_0_clinical practice guideline on pregnancy and renal disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822421/pdf'],['34517_0_clinical practice guideline on pregnancy and renal disease.pdf'],[0.659],[0.557],[0.637],[0.182],[0.194],[0.149],[0.741],[0.647],[0.615],[0.629],[0.807],[0.734],[0.62],[0.917],[0.81],[0.769],[0.805],[0.792],0.659,0.557,0.637,0.182,0.194,0.149,0.741,0.647,0.615,0.629,0.807,0.734,0.62,0.917,0.81,0.769,0.805,0.792
https://doi.org/10.1136/bcr-2017-223387,nivolumabinduced polyarthritis,34518_nivolumabinduced polyarthritis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788064/pdf'],['EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788064/pdf'],['34518_0_eular points to consider for the diagnosis and management of rheumatic immunerelated adverse events due to cancer immunotherapy with checkpoint inhibitors.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788064/pdf'],['34518_0_eular points to consider for the diagnosis and management of rheumatic immunerelated adverse events due to cancer immunotherapy with checkpoint inhibitors.pdf'],[0.306],[0.509],[0.59],[0.158],[0.175],[0.126],[0.736],[0.649],[0.592],[0.651],[0.793],[0.709],[0.571],[0.9],[0.807],[0.734],[0.774],[0.768],0.306,0.509,0.59,0.158,0.175,0.126,0.736,0.649,0.592,0.651,0.793,0.709,0.571,0.9,0.807,0.734,0.774,0.768
https://doi.org/10.1136/bcr-2019-229708,highdose anakinra as treatment for macrophage activation syndrome caused by refractory kawasaki disease in an infant,34519_highdose anakinra as treatment for macrophage activation syndrome caused by refractory kawasaki disease in an infant.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf']","['American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2', 'American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['34519_0_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf'],['34519_0_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf'],[0.394],[0.532],[0.625],[0.171],[0.183],[0.13],[0.737],[0.644],[0.61],[0.651],[0.794],[0.71],[0.601],[0.915],[0.831],[0.756],[0.79],[0.782],0.394,0.532,0.625,0.171,0.183,0.13,0.737,0.644,0.61,0.651,0.794,0.71,0.601,0.915,0.831,0.756,0.79,0.782
https://doi.org/10.1136/bcr-2020-237521,severe preeclampsia complicated by acute fatty liver disease of pregnancy hellp syndrome and acute kidney injury following sarscov2 infection,34520_severe preeclampsia complicated by acute fatty liver disease of pregnancy hellp syndrome and acute kidney injury following sarscov2 infection.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf'],['Infection par le SARS-CoV-2 chez les femmes enceintes. Actualisation de l’état des connaissances et de la proposition de prise en charge. CNGOF'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf'],['34520_0_infection par le sarscov2 chez les femmes enceintes actualisation de létat des connaissances et de la proposition de prise en charge cngof.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534662/pdf'],['34520_0_infection par le sarscov2 chez les femmes enceintes actualisation de létat des connaissances et de la proposition de prise en charge cngof.pdf'],[0.073],[0.48],[0.571],[0.119],[0.152],[0.101],[0.733],[0.644],[0.55],[0.622],[0.784],[0.69],[0.557],[0.883],[0.811],[0.708],[0.765],[0.734],0.073,0.48,0.571,0.119,0.152,0.101,0.733,0.644,0.55,0.622,0.784,0.69,0.557,0.883,0.811,0.708,0.765,0.734
https://doi.org/10.1136/bjsports-2011-090185,physical activity and mental health in children and adolescents a review of reviews,34548_physical activity and mental health in children and adolescents a review of reviews.pdf,3,"['https://purl.fdlp.gov/GPO/gpo108779', 'https://www.ncbi.nlm.nih.gov/books/n/surgwalking/', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850610/pdf']","['Step it up! (United States. Public Health Service. Office of the Surgeon General)', 'Step It Up!', 'International clinical practice recommendations on the definition, diagnosis, assessment, intervention, and psychosocial aspects of developmental coordination disorder']","['https://purl.fdlp.gov/GPO/gpo108779', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850610/pdf']","['34548_0_step it up united states public health service office of the surgeon general.pdf', '34548_2_international clinical practice recommendations on the definition diagnosis assessment intervention and psychosocial aspects of developmental coordination disorder.pdf']",2,66.67,"['https://purl.fdlp.gov/GPO/gpo108779', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850610/pdf']","['34548_0_step it up united states public health service office of the surgeon general.pdf', '34548_2_international clinical practice recommendations on the definition diagnosis assessment intervention and psychosocial aspects of developmental coordination disorder.pdf']","[0.474, 0.367]","[0.543, 0.595]","[0.629, 0.66]","[0.153, 0.188]","[0.167, 0.198]","[0.138, 0.163]","[0.723, 0.732]","[0.625, 0.635]","[0.625, 0.67]","[0.678, 0.69]","[0.815, 0.827]","[0.753, 0.789]","[0.608, 0.635]","[0.93, 0.927]","[0.848, 0.863]","[0.764, 0.796]","[0.818, 0.834]","[0.793, 0.81]",0.42,0.569,0.645,0.17,0.182,0.151,0.728,0.63,0.647,0.684,0.821,0.771,0.621,0.929,0.855,0.78,0.826,0.802
https://doi.org/10.1136/bjsports-2011-090199,physical activity and obesity in children,34550_physical activity and obesity in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['34550_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['34550_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.525],[0.534],[0.628],[0.203],[0.218],[0.177],[0.741],[0.647],[0.605],[0.703],[0.792],[0.718],[0.608],[0.922],[0.84],[0.744],[0.792],[0.776],0.525,0.534,0.628,0.203,0.218,0.177,0.741,0.647,0.605,0.703,0.792,0.718,0.608,0.922,0.84,0.744,0.792,0.776
https://doi.org/10.1136/bjsports-2018-100056,2019 canadian guideline for physical activity throughout pregnancy,34552_2019 canadian guideline for physical activity throughout pregnancy.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802999/pdf']","['Quality Appraisal of Nutritional Guidelines to Prevent, Diagnose, and Treat Malnutrition in All Its Forms during Pregnancy', 'World Health Organization 2020 guidelines on physical activity and sedentary behaviour', 'Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802999/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf']","['34552_0_quality appraisal of nutritional guidelines to prevent diagnose and treat malnutrition in all its forms during pregnancy.pdf', '34552_2_exercisephysical activity in individuals with type 2 diabetes a consensus statement from the american college of sports medicine.pdf', '34552_1_world health organization 2020 guidelines on physical activity and sedentary behaviour.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659219/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802999/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf']","['34552_0_quality appraisal of nutritional guidelines to prevent diagnose and treat malnutrition in all its forms during pregnancy.pdf', '34552_2_exercisephysical activity in individuals with type 2 diabetes a consensus statement from the american college of sports medicine.pdf', '34552_1_world health organization 2020 guidelines on physical activity and sedentary behaviour.pdf']","[0.37, 0.664, 0.381]","[0.488, 0.49, 0.555]","[0.587, 0.604, 0.641]","[0.134, 0.153, 0.182]","[0.142, 0.161, 0.2]","[0.117, 0.129, 0.156]","[0.733, 0.735, 0.736]","[0.637, 0.643, 0.641]","[0.555, 0.558, 0.622]","[0.666, 0.67, 0.681]","[0.762, 0.77, 0.8]","[0.66, 0.658, 0.748]","[0.58, 0.567, 0.615]","[0.908, 0.901, 0.924]","[0.801, 0.811, 0.841]","[0.718, 0.729, 0.768]","[0.766, 0.776, 0.811]","[0.749, 0.758, 0.791]",0.472,0.511,0.611,0.156,0.168,0.134,0.735,0.64,0.578,0.672,0.777,0.689,0.587,0.911,0.818,0.738,0.784,0.766
https://doi.org/10.1136/bjsports-2019-101205,exercise treatment effect modifiers in persistent low back pain an individual participant data metaanalysis of 3514 participants from 27 randomised controlled trials,34553_exercise treatment effect modifiers in persistent low back pain an individual participant data metaanalysis of 3514 participants from 27 randomised controlled trials.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477273/pdf'],['Exercise therapy for chronic low back pain'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477273/pdf'],['34553_0_exercise therapy for chronic low back pain.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477273/pdf'],['34553_0_exercise therapy for chronic low back pain.pdf'],[0.574],[0.506],[0.594],[0.172],[0.182],[0.154],[0.739],[0.645],[0.563],[0.734],[0.746],[0.677],[0.561],[0.882],[0.787],[0.664],[0.75],[0.7],0.574,0.506,0.594,0.172,0.182,0.154,0.739,0.645,0.563,0.734,0.746,0.677,0.561,0.882,0.787,0.664,0.75,0.7
https://doi.org/10.1136/bjsports-2019-101268,optimising outcomes of exercise and corticosteroid injection in patients with subacromial pain impingement syndrome a factorial randomised trial,34554_optimising outcomes of exercise and corticosteroid injection in patients with subacromial pain impingement syndrome a factorial randomised trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407470/pdf'],['Image‐guided glucocorticoid injection versus injection without image guidance for shoulder pain'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407470/pdf'],['34554_0_image‐guided glucocorticoid injection versus injection without image guidance for shoulder pain.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407470/pdf'],['34554_0_image‐guided glucocorticoid injection versus injection without image guidance for shoulder pain.pdf'],[0.628],[0.48],[0.565],[0.145],[0.148],[0.118],[0.734],[0.638],[0.539],[0.689],[0.732],[0.663],[0.564],[0.865],[0.748],[0.636],[0.735],[0.665],0.628,0.48,0.565,0.145,0.148,0.118,0.734,0.638,0.539,0.689,0.732,0.663,0.564,0.865,0.748,0.636,0.735,0.665
https://doi.org/10.1136/bjsports-2021-104080,physical inactivity is associated with a higher risk for severe covid19 outcomes a study in 48 440 adult patients,34555_physical inactivity is associated with a higher risk for severe covid19 outcomes a study in 48 440 adult patients.pdf,3,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://stacks.cdc.gov/view/cdc/105945', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'COVID-19 science update ; Edition 2021-04-07 (88)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf']","['34555_2_master question list for covid19 caused by sarscov2.pdf', '34555_0_master question list for covid19 caused by sarscov2.pdf']",2,66.67,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf'],['34555_0_master question list for covid19 caused by sarscov2.pdf'],[0.301],[0.506],[0.598],[0.143],[0.134],[0.112],[0.734],[0.641],[0.574],[0.652],[0.779],[0.7],[0.599],[0.906],[0.808],[0.725],[0.781],[0.752],0.301,0.506,0.598,0.143,0.134,0.112,0.734,0.641,0.574,0.652,0.779,0.7,0.599,0.906,0.808,0.725,0.781,0.752
https://doi.org/10.1136/bmj.320.7231.328,childhood obesity time for action not complacency,34563_childhood obesity time for action not complacency.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118061/pdf'],['Guideline for prescribing vigabatrin in children has been revised'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118061/pdf'],['34563_0_guideline for prescribing vigabatrin in children has been revised.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118061/pdf'],['34563_0_guideline for prescribing vigabatrin in children has been revised.pdf'],[0.386],[0.542],[0.633],[0.136],[0.14],[0.117],[0.717],[0.615],[0.624],[0.645],[0.813],[0.736],[0.643],[0.92],[0.833],[0.77],[0.82],[0.795],0.386,0.542,0.633,0.136,0.14,0.117,0.717,0.615,0.624,0.645,0.813,0.736,0.643,0.92,0.833,0.77,0.82,0.795
https://doi.org/10.1136/bmj.321.7258.420,influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood prospective population based family study,34574_influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood prospective population based family study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120536/pdf'],['Referral guidelines for cancer need closer scrutiny'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120536/pdf'],['34574_0_referral guidelines for cancer need closer scrutiny.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1120536/pdf'],['34574_0_referral guidelines for cancer need closer scrutiny.pdf'],[0.468],[0.521],[0.616],[0.131],[0.133],[0.105],[0.722],[0.617],[0.588],[0.664],[0.782],[0.724],[0.636],[0.891],[0.802],[0.718],[0.784],[0.734],0.468,0.521,0.616,0.131,0.133,0.105,0.722,0.617,0.588,0.664,0.782,0.724,0.636,0.891,0.802,0.718,0.784,0.734
https://doi.org/10.1136/bmj.322.7302.1567,effect of zinc supplementation on malaria and other causes of morbidity in west african children randomised double blind placebo controlled,34596_effect of zinc supplementation on malaria and other causes of morbidity in west african children randomised double blind placebo controlled.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140593/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/pdf']","['Zinc supplements for preventing otitis media', 'Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age', 'Oral zinc for treating diarrhoea in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140593/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/pdf']","['34596_1_zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.pdf', '34596_0_zinc supplements for preventing otitis media.pdf', '34596_2_oral zinc for treating diarrhoea in children.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140593/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392835/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450879/pdf']","['34596_1_zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.pdf', '34596_0_zinc supplements for preventing otitis media.pdf', '34596_2_oral zinc for treating diarrhoea in children.pdf']","[0.545, 0.584, 0.546]","[0.502, 0.513, 0.497]","[0.585, 0.6, 0.584]","[0.158, 0.165, 0.154]","[0.162, 0.175, 0.158]","[0.135, 0.138, 0.13]","[0.729, 0.73, 0.732]","[0.634, 0.637, 0.637]","[0.573, 0.588, 0.566]","[0.696, 0.69, 0.701]","[0.764, 0.775, 0.762]","[0.689, 0.702, 0.677]","[0.58, 0.587, 0.568]","[0.898, 0.91, 0.903]","[0.794, 0.808, 0.794]","[0.7, 0.716, 0.699]","[0.764, 0.773, 0.758]","[0.73, 0.749, 0.731]",0.558,0.504,0.59,0.159,0.165,0.134,0.73,0.636,0.576,0.696,0.767,0.689,0.578,0.904,0.799,0.705,0.765,0.737
https://doi.org/10.1136/bmj.a2981,outcomes of conduct problems in adolescence 40 year followup of national cohort,34725_outcomes of conduct problems in adolescence 40 year followup of national cohort.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239537/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544776/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344948/pdf']","['Parent training interventions for attention deficit hyperactivity disorder', 'Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years', 'Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents With Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239537/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544776/pdf']","['34725_0_parent training interventions for attention deficit hyperactivity disorder.pdf', '34725_1_parent training interventions for attention deficit hyperactivity disorder adhd in children aged 5 to 18 years.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239537/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544776/pdf']","['34725_0_parent training interventions for attention deficit hyperactivity disorder.pdf', '34725_1_parent training interventions for attention deficit hyperactivity disorder adhd in children aged 5 to 18 years.pdf']","[0.312, 0.292]","[0.494, 0.512]","[0.592, 0.599]","[0.146, 0.165]","[0.163, 0.171]","[0.138, 0.149]","[0.728, 0.733]","[0.63, 0.634]","[0.566, 0.576]","[0.708, 0.707]","[0.757, 0.77]","[0.683, 0.709]","[0.563, 0.585]","[0.888, 0.886]","[0.786, 0.796]","[0.692, 0.709]","[0.762, 0.777]","[0.725, 0.732]",0.302,0.503,0.595,0.155,0.167,0.144,0.73,0.632,0.571,0.708,0.764,0.696,0.574,0.887,0.791,0.7,0.77,0.728
https://doi.org/10.1136/bmj.a3026,effectiveness of policy to provide breastfeeding groups big for pregnant and breastfeeding mothers in primary care cluster randomised controlled trial,34726_effectiveness of policy to provide breastfeeding groups big for pregnant and breastfeeding mothers in primary care cluster randomised controlled trial.pdf,7,"['https://effectivehealthcare.ahrq.gov/products/breastfeeding/research', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(editorial%20-%20JAMA%202016).pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf']","['Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries', 'Support for healthy breastfeeding mothers with healthy term babies', 'Interventions for promoting the initiation of breastfeeding', 'Support for healthy breastfeeding mothers with healthy term babies', 'Interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese', 'Interventions Intended to Support BreastfeedingUpdated Assessment of Benefits and Harms', 'Primary Care Interventions to Support BreastfeedingUpdated Evidence Report and Systematic Review for the US Preventive Services Task Force']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(editorial%20-%20JAMA%202016).pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf']","['34726_2_interventions for promoting the initiation of breastfeeding.pdf', '34726_1_support for healthy breastfeeding mothers with healthy term babies.pdf', '34726_3_support for healthy breastfeeding mothers with healthy term babies.pdf', '34726_4_interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.pdf', '34726_5_interventions intended to support breastfeedingupdated assessment of benefits and harms.pdf', '34726_6_primary care interventions to support breastfeedingupdated evidence report and systematic review for the us preventive services task force.pdf']",6,85.71,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966266/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464485/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747740/pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(editorial%20-%20JAMA%202016).pdf', 'https://phpa.health.maryland.gov/mch/Documents/Benefit%20of%20interventions%20to%20support%20BF%20(USPSTF%20-%20JAMA%202016).pdf']","['34726_2_interventions for promoting the initiation of breastfeeding.pdf', '34726_1_support for healthy breastfeeding mothers with healthy term babies.pdf', '34726_3_support for healthy breastfeeding mothers with healthy term babies.pdf', '34726_4_interventions for supporting the initiation and continuation of breastfeeding among women who are overweight or obese.pdf', '34726_5_interventions intended to support breastfeedingupdated assessment of benefits and harms.pdf', '34726_6_primary care interventions to support breastfeedingupdated evidence report and systematic review for the us preventive services task force.pdf']","[0.518, 0.575, 0.512, 0.47, 0.415, 0.459]","[0.554, 0.544, 0.542, 0.533, 0.555, 0.487]","[0.631, 0.623, 0.614, 0.609, 0.633, 0.587]","[0.212, 0.203, 0.198, 0.2, 0.205, 0.179]","[0.222, 0.217, 0.203, 0.2, 0.22, 0.188]","[0.181, 0.172, 0.168, 0.17, 0.181, 0.156]","[0.735, 0.736, 0.734, 0.736, 0.735, 0.734]","[0.645, 0.647, 0.645, 0.645, 0.644, 0.644]","[0.615, 0.606, 0.598, 0.588, 0.624, 0.556]","[0.697, 0.697, 0.697, 0.695, 0.68, 0.695]","[0.798, 0.787, 0.79, 0.779, 0.813, 0.776]","[0.727, 0.72, 0.702, 0.697, 0.749, 0.673]","[0.619, 0.601, 0.61, 0.602, 0.619, 0.592]","[0.92, 0.915, 0.917, 0.91, 0.912, 0.904]","[0.845, 0.834, 0.837, 0.821, 0.845, 0.802]","[0.759, 0.751, 0.747, 0.738, 0.769, 0.714]","[0.804, 0.793, 0.793, 0.783, 0.798, 0.76]","[0.781, 0.773, 0.771, 0.76, 0.788, 0.742]",0.492,0.536,0.616,0.2,0.208,0.171,0.735,0.645,0.598,0.693,0.79,0.711,0.607,0.913,0.831,0.746,0.788,0.769
https://doi.org/10.1136/bmj.i6583,vitamin d supplementation to prevent acute respiratory tract infections systematic review and metaanalysis of individual participant data,34824_vitamin d supplementation to prevent acute respiratory tract infections systematic review and metaanalysis of individual participant data.pdf,6,"['https://www.city-journal.org/lockdowns-more-about-faith-than-science', 'https://dallascityhall.com/government/citymanager/Documents/FY19-20_Memos/Council-Memos_041020.pdf', 'https://dallascityhall.com/government/citymanager/Documents/FY19-20_Memos/Responses-to-City-Council-Questions-on-TOD-Briefing_Memo_041020.pdf', 'http://www.epi.alaska.gov/bulletins/docs/rr2017_3.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406457/pdf']","['Pandemic Penitents | City Journal', 'Memorandum', 'Memorandum', 'A Brief Overview on Vitamin D for Alaska Health Care Providers', 'ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis', 'Vitamin D supplementation for the treatment of COVID‐19: a living systematic review']","['https://dallascityhall.com/government/citymanager/Documents/FY19-20_Memos/Council-Memos_041020.pdf', 'https://dallascityhall.com/government/citymanager/Documents/FY19-20_Memos/Responses-to-City-Council-Questions-on-TOD-Briefing_Memo_041020.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406457/pdf']","['34824_1_memorandum.pdf', '34824_2_memorandum.pdf', '34824_4_endocrinology in the time of covid19 management of calcium metabolic disorders and osteoporosis.pdf', '34824_5_vitamin d supplementation for the treatment of covid‐19 a living systematic review.pdf']",4,66.67,"['https://dallascityhall.com/government/citymanager/Documents/FY19-20_Memos/Council-Memos_041020.pdf', 'https://dallascityhall.com/government/citymanager/Documents/FY19-20_Memos/Responses-to-City-Council-Questions-on-TOD-Briefing_Memo_041020.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938011/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406457/pdf']","['34824_1_memorandum.pdf', '34824_2_memorandum.pdf', '34824_4_endocrinology in the time of covid19 management of calcium metabolic disorders and osteoporosis.pdf', '34824_5_vitamin d supplementation for the treatment of covid‐19 a living systematic review.pdf']","[0.057, 0.065, 0.173, 0.473]","[0.461, 0.466, 0.501, 0.504]","[0.556, 0.566, 0.59, 0.592]","[0.076, 0.065, 0.135, 0.164]","[0.075, 0.07, 0.134, 0.166]","[0.061, 0.051, 0.098, 0.134]","[0.708, 0.71, 0.729, 0.737]","[0.608, 0.611, 0.63, 0.645]","[0.533, 0.532, 0.559, 0.564]","[0.633, 0.619, 0.635, 0.705]","[0.754, 0.754, 0.761, 0.754]","[0.7, 0.709, 0.705, 0.687]","[0.599, 0.599, 0.601, 0.587]","[0.878, 0.878, 0.881, 0.88]","[0.779, 0.78, 0.774, 0.783]","[0.673, 0.671, 0.684, 0.674]","[0.759, 0.759, 0.762, 0.756]","[0.689, 0.685, 0.696, 0.7]",0.192,0.483,0.576,0.11,0.111,0.086,0.721,0.623,0.547,0.648,0.756,0.7,0.597,0.879,0.779,0.675,0.759,0.693
https://doi.org/10.1136/bmj.j1,obesity and pregnancy mechanisms of short term and long term adverse consequences for mother and child,34825_obesity and pregnancy mechanisms of short term and long term adverse consequences for mother and child.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263936/pdf']","['Guidelines for the management of pregnant women with obesity: A systematic review', 'A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263936/pdf']","['34825_0_guidelines for the management of pregnant women with obesity a systematic review.pdf', '34825_1_a cautionary response to smfm statement pharmacological treatment of gestational diabetes.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064940/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263936/pdf']","['34825_0_guidelines for the management of pregnant women with obesity a systematic review.pdf', '34825_1_a cautionary response to smfm statement pharmacological treatment of gestational diabetes.pdf']","[0.439, 0.349]","[0.497, 0.496]","[0.594, 0.605]","[0.14, 0.154]","[0.172, 0.181]","[0.135, 0.151]","[0.732, 0.744]","[0.641, 0.653]","[0.563, 0.574]","[0.676, 0.669]","[0.781, 0.778]","[0.691, 0.669]","[0.596, 0.589]","[0.904, 0.9]","[0.808, 0.801]","[0.728, 0.721]","[0.777, 0.771]","[0.758, 0.76]",0.394,0.496,0.599,0.147,0.176,0.143,0.738,0.647,0.569,0.673,0.78,0.68,0.593,0.902,0.804,0.724,0.774,0.759
https://doi.org/10.1136/bmj.k341,trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients cohort study,34838_trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312557/pdf'],['Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312557/pdf'],['34838_0_antimicrobial treatment and prophylaxis of plague recommendations for naturally acquired infections and bioterrorism response.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312557/pdf'],['34838_0_antimicrobial treatment and prophylaxis of plague recommendations for naturally acquired infections and bioterrorism response.pdf'],[0.172],[0.533],[0.627],[0.147],[0.152],[0.129],[0.736],[0.645],[0.602],[0.639],[0.788],[0.713],[0.6],[0.901],[0.803],[0.719],[0.784],[0.75],0.172,0.533,0.627,0.147,0.152,0.129,0.736,0.645,0.602,0.639,0.788,0.713,0.6,0.901,0.803,0.719,0.784,0.75
https://doi.org/10.1136/bmj.l5119,diagnosis and management of hypertension in pregnancy summary of updated nice guidance,34844_diagnosis and management of hypertension in pregnancy summary of updated nice guidance.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081556/pdf'],['Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081556/pdf'],['34844_0_society for maternalfetal medicine consult series 50 the role of activity restriction in obstetric management.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081556/pdf'],['34844_0_society for maternalfetal medicine consult series 50 the role of activity restriction in obstetric management.pdf'],[0.293],[0.554],[0.649],[0.196],[0.209],[0.163],[0.741],[0.655],[0.627],[0.653],[0.798],[0.717],[0.61],[0.923],[0.826],[0.753],[0.79],[0.784],0.293,0.554,0.649,0.196,0.209,0.163,0.741,0.655,0.627,0.653,0.798,0.717,0.61,0.923,0.826,0.753,0.79,0.784
https://doi.org/10.1136/bmj.l5275,what are the respiratory effects of ecigarettes,34845_what are the respiratory effects of ecigarettes.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491408/pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://www.bakerinstitute.org/research/vaping-clearing-air/', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://coronavirus.idaho.gov/wp-content/uploads/2020/04/PF_COVID19_FINAL_20200417.pdf', 'https://stacks.cdc.gov/view/cdc/84557']","['E-Cigarette or Vaping Product Use–associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report', 'Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'Smoking Cessation', 'Vaping: Clearing the Air', 'Smoking cessation: a report of the Surgeon General.', 'Smoking And Vaping Can Increase Your Covid-19 Risks', 'Smoking cessation : a report of the Surgeon General']","['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491408/pdf', 'https://coronavirus.idaho.gov/wp-content/uploads/2020/04/PF_COVID19_FINAL_20200417.pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['34845_4_smoking cessation a report of the surgeon general.pdf', '34845_0_ecigarette or vaping product use–associated lung injury developing a research agenda an nih workshop report.pdf', '34845_5_smoking and vaping can increase your covid19 risks.pdf', '34845_1_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']",4,57.14,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491408/pdf', 'https://coronavirus.idaho.gov/wp-content/uploads/2020/04/PF_COVID19_FINAL_20200417.pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['34845_4_smoking cessation a report of the surgeon general.pdf', '34845_0_ecigarette or vaping product use–associated lung injury developing a research agenda an nih workshop report.pdf', '34845_5_smoking and vaping can increase your covid19 risks.pdf', '34845_1_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']","[0.47, 0.513, 0.513, 0.266]","[0.505, 0.551, 0.525, 0.505]","[0.604, 0.636, 0.616, 0.604]","[0.159, 0.191, 0.176, 0.159]","[0.161, 0.197, 0.173, 0.161]","[0.126, 0.144, 0.139, 0.126]","[0.74, 0.751, 0.743, 0.74]","[0.65, 0.666, 0.651, 0.65]","[0.586, 0.63, 0.598, 0.586]","[0.667, 0.661, 0.676, 0.667]","[0.795, 0.816, 0.803, 0.795]","[0.704, 0.745, 0.731, 0.704]","[0.597, 0.622, 0.605, 0.597]","[0.913, 0.91, 0.919, 0.913]","[0.811, 0.846, 0.829, 0.811]","[0.743, 0.775, 0.756, 0.743]","[0.788, 0.816, 0.802, 0.788]","[0.775, 0.803, 0.789, 0.775]",0.441,0.521,0.615,0.171,0.173,0.134,0.744,0.654,0.6,0.668,0.802,0.721,0.605,0.914,0.824,0.754,0.798,0.785
https://doi.org/10.1136/bmj.m1557,mitigating the wider health effects of covid19 pandemic response,34849_mitigating the wider health effects of covid19 pandemic response.pdf,2,"['https://www.cgdev.org/publication/effects-covid-19-pandemic-health-services-and-mitigation-measures-uganda-descriptive', 'https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/COVID-19-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=e02e07']","['Effects of the COVID-19 Pandemic on Health Services and Mitigation Measures in Uganda', 'Coronavirus Disease 2019 (COVID-19) and Toxic Stress']",['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/COVID-19-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=e02e07'],['34849_1_coronavirus disease 2019 covid19 and toxic stress.pdf'],1,50.0,['https://osg.ca.gov/wp-content/uploads/sites/266/2020/12/COVID-19-ACEs-and-Toxic-Stress_CA_OSG-Report_12092020.pdf?emrc=e02e07'],['34849_1_coronavirus disease 2019 covid19 and toxic stress.pdf'],[0.374],[0.553],[0.644],[0.152],[0.159],[0.128],[0.732],[0.642],[0.625],[0.67],[0.814],[0.745],[0.62],[0.927],[0.847],[0.77],[0.814],[0.797],0.374,0.553,0.644,0.152,0.159,0.128,0.732,0.642,0.625,0.67,0.814,0.745,0.62,0.927,0.847,0.77,0.814,0.797
https://doi.org/10.1136/bmj.m1966,factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new york city prospective cohort study,34850_factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new york city prospective cohort study.pdf,7,"['https://stacks.cdc.gov/view/cdc/106171', 'https://stacks.cdc.gov/view/cdc/110771', 'https://stacks.cdc.gov/view/cdc/114448', 'https://www.nber.org/papers/w28958', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406992/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/pdf']","['Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'The Great Unequalizer: Initial Health Effects of COVID-19 in the United States', 'Remdesivir for the treatment of COVID‐19', 'COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies', 'Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406992/pdf']","['34850_6_nirmatrelvir combined with ritonavir for preventing and treating covid‐19.pdf', '34850_5_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf', '34850_4_remdesivir for the treatment of covid‐19.pdf']",3,42.86,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487421/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078349/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406992/pdf']","['34850_6_nirmatrelvir combined with ritonavir for preventing and treating covid‐19.pdf', '34850_5_covid‐19 and its cardiovascular effects a systematic review of prevalence studies.pdf', '34850_4_remdesivir for the treatment of covid‐19.pdf']","[0.362, 0.434, 0.379]","[0.446, 0.463, 0.464]","[0.547, 0.548, 0.552]","[0.117, 0.13, 0.133]","[0.121, 0.132, 0.132]","[0.106, 0.117, 0.119]","[0.728, 0.74, 0.735]","[0.63, 0.645, 0.64]","[0.501, 0.524, 0.518]","[0.694, 0.712, 0.712]","[0.704, 0.709, 0.711]","[0.655, 0.653, 0.657]","[0.557, 0.576, 0.566]","[0.835, 0.838, 0.835]","[0.728, 0.735, 0.729]","[0.583, 0.598, 0.597]","[0.706, 0.713, 0.711]","[0.612, 0.627, 0.623]",0.392,0.458,0.549,0.127,0.128,0.114,0.734,0.638,0.514,0.706,0.708,0.655,0.566,0.836,0.731,0.593,0.71,0.621
https://doi.org/10.1136/bmj.m2094,kawasakilike multisystem inflammatory syndrome in children during the covid19 pandemic in paris france prospective observational study,34851_kawasakilike multisystem inflammatory syndrome in children during the covid19 pandemic in paris france prospective observational study.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2', 'Clinical care of children and adolescents with COVID‐19: recommendations from the National COVID‐19 Clinical Evidence Taskforce']","['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['34851_1_coronavirus disease 2019 covid19 treatment guidelines.pdf', '34851_2_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '34851_3_clinical care of children and adolescents with covid‐19 recommendations from the national covid‐19 clinical evidence taskforce.pdf']",3,75.0,"['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661691/pdf']","['34851_1_coronavirus disease 2019 covid19 treatment guidelines.pdf', '34851_2_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '34851_3_clinical care of children and adolescents with covid‐19 recommendations from the national covid‐19 clinical evidence taskforce.pdf']","[0.491, 0.54, 0.398]","[0.536, 0.532, 0.552]","[0.612, 0.621, 0.631]","[0.161, 0.178, 0.179]","[0.166, 0.184, 0.182]","[0.122, 0.131, 0.129]","[0.74, 0.743, 0.738]","[0.646, 0.65, 0.644]","[0.599, 0.605, 0.623]","[0.642, 0.655, 0.648]","[0.785, 0.784, 0.805]","[0.701, 0.705, 0.742]","[0.597, 0.596, 0.617]","[0.9, 0.916, 0.922]","[0.802, 0.822, 0.83]","[0.748, 0.743, 0.759]","[0.784, 0.784, 0.806]","[0.772, 0.772, 0.786]",0.476,0.54,0.621,0.173,0.177,0.127,0.74,0.647,0.609,0.648,0.791,0.716,0.603,0.913,0.818,0.75,0.791,0.777
https://doi.org/10.1136/bmjgh-2018-001184,effect of resultsbased financing on facilitybased maternal mortality at birth an interrupted timeseries analysis with independent controls in malawi,34874_effect of resultsbased financing on facilitybased maternal mortality at birth an interrupted timeseries analysis with independent controls in malawi.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099148/pdf'],['Paying for performance to improve the delivery of health interventions in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099148/pdf'],['34874_0_paying for performance to improve the delivery of health interventions in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099148/pdf'],['34874_0_paying for performance to improve the delivery of health interventions in low‐ and middle‐income countries.pdf'],[0.461],[0.549],[0.626],[0.178],[0.186],[0.151],[0.73],[0.637],[0.615],[0.721],[0.792],[0.726],[0.593],[0.912],[0.843],[0.74],[0.795],[0.766],0.461,0.549,0.626,0.178,0.186,0.151,0.73,0.637,0.615,0.721,0.792,0.726,0.593,0.912,0.843,0.74,0.795,0.766
https://doi.org/10.1136/bmjgh-2018-001306,poor availability of essential medicines for women and children threatens progress towards sustainable development goal 3 in africa,34876_poor availability of essential medicines for women and children threatens progress towards sustainable development goal 3 in africa.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526094/pdf'],"['Components of antenatal care received by women in fishing communities on Lake Victoria, Uganda; a cross sectional survey']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526094/pdf'],['34876_0_components of antenatal care received by women in fishing communities on lake victoria uganda a cross sectional survey.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526094/pdf'],['34876_0_components of antenatal care received by women in fishing communities on lake victoria uganda a cross sectional survey.pdf'],[0.354],[0.508],[0.597],[0.16],[0.175],[0.133],[0.731],[0.635],[0.584],[0.673],[0.785],[0.696],[0.596],[0.911],[0.821],[0.739],[0.782],[0.765],0.354,0.508,0.597,0.16,0.175,0.133,0.731,0.635,0.584,0.673,0.785,0.696,0.596,0.911,0.821,0.739,0.782,0.765
https://doi.org/10.1136/bmjgh-2019-001643,early implementation of guidelines for managing young infants with possible serious bacterial infection in bangladesh,34877_early implementation of guidelines for managing young infants with possible serious bacterial infection in bangladesh.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755274/pdf'],"['Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755274/pdf'],['34877_0_management of possible serious bacterial infection in young infants closer to home when referral is not feasible lessons from implementation research in himachal pradesh india.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755274/pdf'],['34877_0_management of possible serious bacterial infection in young infants closer to home when referral is not feasible lessons from implementation research in himachal pradesh india.pdf'],[0.728],[0.558],[0.637],[0.203],[0.212],[0.17],[0.735],[0.648],[0.627],[0.661],[0.816],[0.745],[0.637],[0.915],[0.849],[0.758],[0.816],[0.791],0.728,0.558,0.637,0.203,0.212,0.17,0.735,0.648,0.627,0.661,0.816,0.745,0.637,0.915,0.849,0.758,0.816,0.791
https://doi.org/10.1136/bmjgh-2019-001769,institutionalising participatory health governance lessons from nine years of the national health assembly model in thailand,34879_institutionalising participatory health governance lessons from nine years of the national health assembly model in thailand.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011047/pdf'],['Developing a Thai national critical care allocation guideline during the COVID-19 pandemic: a rapid review and stakeholder consultation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011047/pdf'],['34879_0_developing a thai national critical care allocation guideline during the covid19 pandemic a rapid review and stakeholder consultation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011047/pdf'],['34879_0_developing a thai national critical care allocation guideline during the covid19 pandemic a rapid review and stakeholder consultation.pdf'],[0.406],[0.561],[0.648],[0.187],[0.199],[0.166],[0.73],[0.64],[0.63],[0.709],[0.813],[0.759],[0.635],[0.916],[0.859],[0.773],[0.812],[0.796],0.406,0.561,0.648,0.187,0.199,0.166,0.73,0.64,0.63,0.709,0.813,0.759,0.635,0.916,0.859,0.773,0.812,0.796
https://doi.org/10.1136/bmjopen-2012-001570,a systematic review of evidence on the links between patient experience and clinical safety and effectiveness,34902_a systematic review of evidence on the links between patient experience and clinical safety and effectiveness.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839851/pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000114?download=true', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000382?download=true', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949936/pdf', 'https://mathematica.org/publications/maternal-health-care-quality-and-outcomes-under-the-utkrisht-impact-bond-midline-findings']","['How do and could clinical guidelines support patient-centred care for women: Content analysis of guidelines', 'Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association', 'Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association', 'Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation', 'Adherence to evidence‐based pressure injury prevention guidelines in routine clinical practice: a longitudinal study', 'Maternal Health Care Quality and Outcomes Under the Utkrisht Impact Bond: Midline Findings and Insights']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839851/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949936/pdf']","['34902_0_how do and could clinical guidelines support patientcentred care for women content analysis of guidelines.pdf', '34902_3_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf', '34902_4_adherence to evidence‐based pressure injury prevention guidelines in routine clinical practice a longitudinal study.pdf']",3,50.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839851/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949936/pdf']","['34902_0_how do and could clinical guidelines support patientcentred care for women content analysis of guidelines.pdf', '34902_3_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf', '34902_4_adherence to evidence‐based pressure injury prevention guidelines in routine clinical practice a longitudinal study.pdf']","[0.398, 0.435, 0.495]","[0.526, 0.569, 0.623]","[0.615, 0.651, 0.685]","[0.175, 0.209, 0.239]","[0.195, 0.218, 0.247]","[0.157, 0.179, 0.193]","[0.739, 0.746, 0.753]","[0.652, 0.659, 0.665]","[0.583, 0.63, 0.687]","[0.714, 0.714, 0.71]","[0.777, 0.796, 0.824]","[0.708, 0.735, 0.797]","[0.59, 0.609, 0.642]","[0.899, 0.921, 0.927]","[0.833, 0.851, 0.873]","[0.714, 0.759, 0.8]","[0.778, 0.795, 0.829]","[0.76, 0.781, 0.813]",0.443,0.573,0.65,0.208,0.22,0.176,0.746,0.659,0.633,0.713,0.799,0.747,0.614,0.916,0.852,0.758,0.801,0.785
https://doi.org/10.1136/bmjopen-2017-019036,impact of a modified version of babyled weaning on iron intake and status a randomised controlled trial,34957_impact of a modified version of babyled weaning on iron intake and status a randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf'],['Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf'],['34957_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf'],['34957_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf'],[0.465],[0.508],[0.59],[0.156],[0.161],[0.137],[0.733],[0.636],[0.571],[0.693],[0.758],[0.689],[0.59],[0.886],[0.789],[0.691],[0.758],[0.719],0.465,0.508,0.59,0.156,0.161,0.137,0.733,0.636,0.571,0.693,0.758,0.689,0.59,0.886,0.789,0.691,0.758,0.719
https://doi.org/10.1136/bmjopen-2018-023191,effects of screentime on the health and wellbeing of children and adolescents a systematic review of reviews,34960_effects of screentime on the health and wellbeing of children and adolescents a systematic review of reviews.pdf,3,"['https://www.capitol.hawaii.gov/Session2020/Testimony/SB2458_TESTIMONY_CPH-TEC_02-11-20_.PDF', 'https://www.capitol.hawaii.gov/Session2020/Testimony/SB2458_SD1_TESTIMONY_WAM_02-27-20_.PDF', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/134412']","['Testimony COMMENTING on SB 2458 RELATING TO SCREEN TIME AWARENESS', 'Testimony COMMENTING on SB 2458 RELATING TO SCREEN TIME AWARENESS', 'Design of a mobile phone-based Artificial Intelligence (AI) application to assess dietary intake and provide nudges to improve healthy eating choices: Formative research in Ghana and Vietnam']","['https://www.capitol.hawaii.gov/Session2020/Testimony/SB2458_TESTIMONY_CPH-TEC_02-11-20_.PDF', 'https://www.capitol.hawaii.gov/Session2020/Testimony/SB2458_SD1_TESTIMONY_WAM_02-27-20_.PDF']","['34960_0_testimony commenting on sb 2458 relating to screen time awareness.pdf', '34960_1_testimony commenting on sb 2458 relating to screen time awareness.pdf']",2,66.67,"['https://www.capitol.hawaii.gov/Session2020/Testimony/SB2458_TESTIMONY_CPH-TEC_02-11-20_.PDF', 'https://www.capitol.hawaii.gov/Session2020/Testimony/SB2458_SD1_TESTIMONY_WAM_02-27-20_.PDF']","['34960_0_testimony commenting on sb 2458 relating to screen time awareness.pdf', '34960_1_testimony commenting on sb 2458 relating to screen time awareness.pdf']","[0.27, 0.275]","[0.535, 0.534]","[0.625, 0.627]","[0.152, 0.155]","[0.189, 0.184]","[0.163, 0.161]","[0.717, 0.72]","[0.628, 0.631]","[0.619, 0.614]","[0.687, 0.684]","[0.808, 0.803]","[0.749, 0.743]","[0.61, 0.612]","[0.912, 0.909]","[0.843, 0.84]","[0.757, 0.755]","[0.805, 0.801]","[0.774, 0.772]",0.273,0.534,0.626,0.153,0.186,0.162,0.718,0.629,0.617,0.685,0.806,0.746,0.611,0.911,0.841,0.756,0.803,0.773
https://doi.org/10.1136/bmjopen-2018-023707,adapting the toybox obesity prevention intervention for use in scottish preschools protocol for a feasibility cluster randomised controlled trial,34961_adapting the toybox obesity prevention intervention for use in scottish preschools protocol for a feasibility cluster randomised controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf']","['34961_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '34961_0_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008062/pdf']","['34961_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '34961_0_strategies to improve the implementation of healthy eating physical activity and obesity prevention policies practices or programmes within childcare services.pdf']","[0.467, 0.511]","[0.544, 0.537]","[0.625, 0.614]","[0.181, 0.175]","[0.186, 0.185]","[0.153, 0.148]","[0.732, 0.73]","[0.639, 0.637]","[0.615, 0.603]","[0.689, 0.694]","[0.798, 0.788]","[0.724, 0.72]","[0.595, 0.595]","[0.921, 0.913]","[0.844, 0.831]","[0.75, 0.736]","[0.797, 0.789]","[0.782, 0.765]",0.489,0.54,0.619,0.178,0.185,0.15,0.731,0.638,0.609,0.692,0.793,0.722,0.595,0.917,0.837,0.743,0.793,0.774
https://doi.org/10.1136/bmjopen-2018-028361,mhealth tool to improve community health agent performance for child development study protocol for a clusterrandomised controlled trial in peru,34968_mhealth tool to improve community health agent performance for child development study protocol for a clusterrandomised controlled trial in peru.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['Integrated community case management of childhood illness in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['34968_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['34968_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],[0.445],[0.522],[0.606],[0.149],[0.166],[0.134],[0.728],[0.632],[0.578],[0.695],[0.78],[0.703],[0.59],[0.912],[0.821],[0.725],[0.777],[0.749],0.445,0.522,0.606,0.149,0.166,0.134,0.728,0.632,0.578,0.695,0.78,0.703,0.59,0.912,0.821,0.725,0.777,0.749
https://doi.org/10.1136/bmjopen-2019-030538,cluster randomised controlled trial of an online intervention to improve healthy food purchases from primary school canteens a study protocol of the ‘click amp crunch’ trial,34969_cluster randomised controlled trial of an online intervention to improve healthy food purchases from primary school canteens a study protocol of the ‘click amp crunch’ trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['34969_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['34969_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.358],[0.544],[0.63],[0.178],[0.188],[0.158],[0.735],[0.641],[0.617],[0.695],[0.8],[0.73],[0.606],[0.927],[0.847],[0.754],[0.799],[0.784],0.358,0.544,0.63,0.178,0.188,0.158,0.735,0.641,0.617,0.695,0.8,0.73,0.606,0.927,0.847,0.754,0.799,0.784
https://doi.org/10.1136/bmjopen-2019-030656,effect of a simple intervention on hand hygiene related diseases in preschools in south africa research protocol for an intervention study,34970_effect of a simple intervention on hand hygiene related diseases in preschools in south africa research protocol for an intervention study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['Rinse‐free hand wash for reducing absenteeism among preschool and school children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['34970_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141998/pdf'],['34970_0_rinse‐free hand wash for reducing absenteeism among preschool and school children.pdf'],[0.555],[0.536],[0.621],[0.165],[0.179],[0.14],[0.731],[0.636],[0.606],[0.68],[0.792],[0.725],[0.601],[0.922],[0.835],[0.748],[0.796],[0.775],0.555,0.536,0.621,0.165,0.179,0.14,0.731,0.636,0.606,0.68,0.792,0.725,0.601,0.922,0.835,0.748,0.796,0.775
https://doi.org/10.1136/bmjopen-2020-042446,implementing telehealth support to increase physical activity in girls and women with rett syndromei—iactivrett protocol for a waitlist randomised controlled trial,34974_implementing telehealth support to increase physical activity in girls and women with rett syndromei—iactivrett protocol for a waitlist randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493442/pdf'],['Interventions for preventing weight gain after smoking cessation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493442/pdf'],['34974_0_interventions for preventing weight gain after smoking cessation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493442/pdf'],['34974_0_interventions for preventing weight gain after smoking cessation.pdf'],[0.281],[0.519],[0.6],[0.143],[0.154],[0.125],[0.729],[0.634],[0.587],[0.695],[0.784],[0.714],[0.573],[0.915],[0.825],[0.732],[0.784],[0.764],0.281,0.519,0.6,0.143,0.154,0.125,0.729,0.634,0.587,0.695,0.784,0.714,0.573,0.915,0.825,0.732,0.784,0.764
https://doi.org/10.1136/gutjnl-2020-321185,practice of endoscopy during covid19 pandemic position statements of the asian pacific society for digestive endoscopy apsdecovid statements,35068_practice of endoscopy during covid19 pandemic position statements of the asian pacific society for digestive endoscopy apsdecovid statements.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456726/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804823/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833070/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385767/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361408/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273958/pdf']","['Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic', 'Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und\xa0Antworten', 'Adherence to recommendations for endoscopy practice during COVID-19 pandemic in Latin America: how are we doing it?', 'Recomendaciones para la reapertura y reinicio de actividades de las Unidades de Neurogastroenterología ante la pandemia por COVID-19. Posicionamiento de la Sociedad Latinoamericana de Neurogastroenterología', 'Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: Guidance from the British Society of Gastroenterology', 'COVID-19 Pandemic: Which IBD Patients Need to Be Scoped—Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal', 'Recommendations for the Operation of Endoscopy Centers in the setting of the COVID19 pandemic – A WEO guidance document', 'Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385767/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804823/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273958/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456726/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361408/pdf']","['35068_4_restarting gastrointestinal endoscopy in the deceleration and early recovery phases of covid19 pandemic guidance from the british society of gastroenterology.pdf', '35068_2_adherence to recommendations for endoscopy practice during covid19 pandemic in latin america how are we doing it.pdf', '35068_7_pediatric endoscopy in the era of coronavirus disease 2019 a north american society for pediatric gastroenterology hepatology and nutrition position paper.pdf', '35068_5_covid19 pandemic which ibd patients need to be scoped—who gets scoped now who can wait and how to resume to normal.pdf', '35068_0_reorganisation of faecal microbiota transplant services during the covid19 pandemic.pdf', '35068_1_addendum zu den s3leitlinien morbus crohn und colitis ulcerosa betreuung von patienten mit chronisch entzündlichen darmerkrankungen in der covid19pandemie – offene fragen und\xa0antworten.pdf', '35068_6_recommendations for the operation of endoscopy centers in the setting of the covid19 pandemic – a weo guidance document.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385767/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804823/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273958/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456726/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416209/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361408/pdf']","['35068_4_restarting gastrointestinal endoscopy in the deceleration and early recovery phases of covid19 pandemic guidance from the british society of gastroenterology.pdf', '35068_2_adherence to recommendations for endoscopy practice during covid19 pandemic in latin america how are we doing it.pdf', '35068_7_pediatric endoscopy in the era of coronavirus disease 2019 a north american society for pediatric gastroenterology hepatology and nutrition position paper.pdf', '35068_5_covid19 pandemic which ibd patients need to be scoped—who gets scoped now who can wait and how to resume to normal.pdf', '35068_0_reorganisation of faecal microbiota transplant services during the covid19 pandemic.pdf', '35068_1_addendum zu den s3leitlinien morbus crohn und colitis ulcerosa betreuung von patienten mit chronisch entzündlichen darmerkrankungen in der covid19pandemie – offene fragen und\xa0antworten.pdf', '35068_6_recommendations for the operation of endoscopy centers in the setting of the covid19 pandemic – a weo guidance document.pdf']","[0.57, 0.131, 0.609, 0.663, 0.698, 0.672, 0.673]","[0.553, 0.529, 0.539, 0.565, 0.545, 0.463, 0.544]","[0.635, 0.612, 0.63, 0.645, 0.626, 0.56, 0.622]","[0.203, 0.172, 0.191, 0.209, 0.178, 0.134, 0.174]","[0.218, 0.194, 0.203, 0.226, 0.197, 0.156, 0.192]","[0.177, 0.152, 0.166, 0.179, 0.156, 0.113, 0.152]","[0.752, 0.742, 0.75, 0.757, 0.747, 0.737, 0.744]","[0.661, 0.649, 0.662, 0.667, 0.657, 0.654, 0.649]","[0.616, 0.598, 0.602, 0.623, 0.604, 0.539, 0.608]","[0.661, 0.668, 0.663, 0.663, 0.653, 0.635, 0.66]","[0.805, 0.792, 0.798, 0.808, 0.799, 0.778, 0.798]","[0.739, 0.725, 0.72, 0.741, 0.73, 0.672, 0.731]","[0.625, 0.609, 0.602, 0.63, 0.612, 0.559, 0.617]","[0.926, 0.92, 0.922, 0.928, 0.923, 0.891, 0.928]","[0.824, 0.818, 0.821, 0.828, 0.826, 0.807, 0.826]","[0.763, 0.748, 0.752, 0.772, 0.757, 0.694, 0.758]","[0.794, 0.787, 0.786, 0.801, 0.792, 0.737, 0.793]","[0.785, 0.769, 0.778, 0.789, 0.781, 0.709, 0.782]",0.574,0.534,0.619,0.18,0.198,0.156,0.747,0.657,0.599,0.658,0.797,0.723,0.608,0.92,0.821,0.749,0.784,0.77
https://doi.org/10.1136/injuryprev-2020-044050,adolescent mental health covid19 and the value of schoolcommunity partnerships,35090_adolescent mental health covid19 and the value of schoolcommunity partnerships.pdf,2,"['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf', 'https://fee.org/articles/cambridge-study-children-s-mental-health-has-deteriorated-substantially-during-lockdown/']","['Supporting Child and Student Social, Emotional, Behavioral, and Mental Health Needs (PDF)', ""Cambridge Study: Children’s Mental Health Deteriorated 'Substantially' During Lockdown""]",['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['35090_0_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],1,50.0,['https://sde.idaho.gov/re-opening/files/student-learning/sped/other-resources/USDE-Supporting-Child-Student-Social-Emotional-Behavioral-and-Mental-Health-Needs-October-19-2021.pdf'],['35090_0_supporting child and student social emotional behavioral and mental health needs pdf.pdf'],[0.755],[0.544],[0.635],[0.187],[0.209],[0.176],[0.743],[0.655],[0.609],[0.681],[0.806],[0.749],[0.609],[0.921],[0.842],[0.768],[0.814],[0.795],0.755,0.544,0.635,0.187,0.209,0.176,0.743,0.655,0.609,0.681,0.806,0.749,0.609,0.921,0.842,0.768,0.814,0.795
https://doi.org/10.1136/openhrt-2019-001120,needs analysis of parents following sudden cardiac death in the young,35248_needs analysis of parents following sudden cardiac death in the young.pdf,2,"['https://www.hrsonline.org/documents/2020-aphrs-hrs-investigation-sudden-cardiac-arrestpdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194370/pdf']","['2020 APHRS/HRS Expert Consensus Statement on the Investigation of Decedents with Sudden Unexplained Death and Patients with Sudden Cardiac Arrest, and of Their Families', '2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families']","['https://www.hrsonline.org/documents/2020-aphrs-hrs-investigation-sudden-cardiac-arrestpdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194370/pdf']","['35248_0_2020 aphrshrs expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest and of their families.pdf', '35248_1_2020 aphrshrs expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest and of their families.pdf']",2,100.0,"['https://www.hrsonline.org/documents/2020-aphrs-hrs-investigation-sudden-cardiac-arrestpdf/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194370/pdf']","['35248_0_2020 aphrshrs expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest and of their families.pdf', '35248_1_2020 aphrshrs expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest and of their families.pdf']","[0.415, 0.359]","[0.568, 0.505]","[0.633, 0.607]","[0.163, 0.152]","[0.186, 0.183]","[0.136, 0.133]","[0.739, 0.735]","[0.643, 0.64]","[0.639, 0.58]","[0.651, 0.664]","[0.808, 0.771]","[0.762, 0.687]","[0.615, 0.573]","[0.916, 0.906]","[0.845, 0.816]","[0.772, 0.732]","[0.81, 0.77]","[0.793, 0.76]",0.387,0.536,0.62,0.158,0.184,0.135,0.737,0.641,0.609,0.657,0.79,0.725,0.594,0.911,0.831,0.752,0.79,0.776
https://doi.org/10.1136/tc.2003.006361,industry sponsored antismoking ads and adolescent reactance test of a boomerang effect,35313_industry sponsored antismoking ads and adolescent reactance test of a boomerang effect.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgtobyouth/', 'https://stacks.cdc.gov/view/cdc/42440']","['AHA Scientific Statement Population Approaches to Improve Diet, Physical Activity, and Smoking Habits A Scientific Statement From the American Heart Association', 'Preventing Tobacco Use Among Youth and Young Adults', 'Preventing initiation of tobacco use : outcome indicators for comprehensive tobacco control programs–2014']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf'],['35313_0_aha scientific statement population approaches to improve diet physical activity and smoking habits a scientific statement from the american heart association.pdf'],1,33.33,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881293/pdf'],['35313_0_aha scientific statement population approaches to improve diet physical activity and smoking habits a scientific statement from the american heart association.pdf'],[0.242],[0.494],[0.6],[0.154],[0.172],[0.133],[0.73],[0.629],[0.574],[0.685],[0.769],[0.684],[0.592],[0.916],[0.811],[0.722],[0.774],[0.762],0.242,0.494,0.6,0.154,0.172,0.133,0.73,0.629,0.574,0.685,0.769,0.684,0.592,0.916,0.811,0.722,0.774,0.762
https://doi.org/10.1136/tobaccocontrol-2018-054446,examining the relationship of vaping to smoking initiation among us youth and young adults a reality check,35429_examining the relationship of vaping to smoking initiation among us youth and young adults a reality check.pdf,8,"['https://www.rstreet.org/2019/03/10/e-cigarettes-myths-vs-facts/', 'https://www.rstreet.org/2019/02/06/reviewed-work-examining-the-relationship-of-vaping-to-smoking-initiation-among-us-youth-and-young-adults-a-reality-check/', 'https://www.aei.org/research-products/testimony/testimony-putting-teen-vaping-in-perspective-balancing-protection-of-youth-with-health-of-smokers/', 'https://www.congress.gov/event/116th-congress/house-event/110071', 'https://www.pacificresearch.org/new-study-u-k-vaping-regulations-based-on-risks-of-vaping-relative-to-smoking-provide-lessons-for-u-s/', 'https://www.capitol.hawaii.gov/Session2020/Testimony/HB2457_HD2_TESTIMONY_CPH-EDU_03-11-20_.PDF', 'https://www.rstreet.org/2020/06/11/in-support-of-risk-proportionate-regulation-of-e-cigarettes-and-heated-tobacco-products/', 'https://www.rstreet.org/2019/08/07/tobacco-harm-reduction-evidence-update/']","['E-Cigarettes: Myths Vs. Facts', 'Reviewed work: “Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check”', 'Testimony | Putting teen vaping in perspective: Balancing protection of youth with health of smokers - AEI', 'E-cigarettes: An Emerging Threat to Public Health', 'NEW STUDY: U.K. Vaping Regulations Based on Risks of Vaping Relative to Smoking Provide Lessons for U.S. - Pacific Research Institute', 'Dr. Christina M. Kishimoto', 'In Support of Risk-Proportionate Regulation of E-cigarettes and Heated Tobacco Products', 'Tobacco Harm Reduction: Evidence Update']",['https://www.capitol.hawaii.gov/Session2020/Testimony/HB2457_HD2_TESTIMONY_CPH-EDU_03-11-20_.PDF'],['35429_5_dr christina m kishimoto.pdf'],1,12.5,['https://www.capitol.hawaii.gov/Session2020/Testimony/HB2457_HD2_TESTIMONY_CPH-EDU_03-11-20_.PDF'],['35429_5_dr christina m kishimoto.pdf'],[0.335],[0.517],[0.602],[0.15],[0.17],[0.147],[0.72],[0.622],[0.594],[0.679],[0.801],[0.759],[0.63],[0.914],[0.854],[0.765],[0.81],[0.789],0.335,0.517,0.602,0.15,0.17,0.147,0.72,0.622,0.594,0.679,0.801,0.759,0.63,0.914,0.854,0.765,0.81,0.789
https://doi.org/10.1136/tobaccocontrol-2018-054693,prevalence and correlates of juul use among a national sample of youth and young adults,35431_prevalence and correlates of juul use among a national sample of youth and young adults.pdf,5,"['https://www.denvergov.org/content/dam/denvergov/Portals/772/Documents/Denver_Complaint_040120.pdf', 'https://www.congress.gov/event/116th-congress/house-event/109844', 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-priorities-electronic-nicotine-delivery-system-ends-and-other-deemed-products-market', 'https://www.congress.gov/event/116th-congress/house-event/109846', 'https://www.fda.gov/regulatory-information/search-fda-guidance-documents/modifications-compliance-policy-certain-deemed-tobacco-products']","['In The United States District Court For The District Of Colorado', 'Examining JUUL’s Role in the Youth Nicotine Epidemic: Part I', 'Enforcement Priorities for ENDS and Other Deemed Products', 'Examining JUUL’s Role in the Youth Nicotine Epidemic: Part II', 'Modifications to Compliance Policy for Certain Deemed Tobacco Products']",['https://www.denvergov.org/content/dam/denvergov/Portals/772/Documents/Denver_Complaint_040120.pdf'],['35431_0_in the united states district court for the district of colorado.pdf'],1,20.0,['https://www.denvergov.org/content/dam/denvergov/Portals/772/Documents/Denver_Complaint_040120.pdf'],['35431_0_in the united states district court for the district of colorado.pdf'],[0.341],[0.493],[0.582],[0.139],[0.154],[0.129],[0.731],[0.638],[0.559],[0.69],[0.763],[0.693],[0.615],[0.883],[0.805],[0.71],[0.77],[0.73],0.341,0.493,0.582,0.139,0.154,0.129,0.731,0.638,0.559,0.69,0.763,0.693,0.615,0.883,0.805,0.71,0.77,0.73
https://doi.org/10.1136/tobaccocontrol-2018-054764,impact of ecigarette and cigarette prices on youth and young adult ecigarette and cigarette behaviour evidence from a national longitudinal cohort,35432_impact of ecigarette and cigarette prices on youth and young adult ecigarette and cigarette behaviour evidence from a national longitudinal cohort.pdf,3,"['https://data.nber.org/papers/w26724', 'https://www.nber.org/papers/w26017', 'https://lao.ca.gov/reports/2020/4171/ecigarette-taxation-022420.pdf']","['The Effects of E-Cigarette Taxes on E-Cigarette Prices and Tobacco Product Sales: Evidence from Retail Panel Data', 'The Effects of Traditional Cigarette and E-Cigarette Taxes on Adult Tobacco Product Use', 'The 2020-21 Budget: Taxation of E-Cigarettes']",['https://lao.ca.gov/reports/2020/4171/ecigarette-taxation-022420.pdf'],['35432_2_the 202021 budget taxation of ecigarettes.pdf'],1,33.33,['https://lao.ca.gov/reports/2020/4171/ecigarette-taxation-022420.pdf'],['35432_2_the 202021 budget taxation of ecigarettes.pdf'],[0.35],[0.521],[0.605],[0.184],[0.174],[0.16],[0.733],[0.634],[0.588],[0.687],[0.783],[0.732],[0.642],[0.9],[0.812],[0.719],[0.791],[0.744],0.35,0.521,0.605,0.184,0.174,0.16,0.733,0.634,0.588,0.687,0.783,0.732,0.642,0.9,0.812,0.719,0.791,0.744
https://doi.org/10.1136/tobaccocontrol-2018-054852,flavour types used by youth and adult tobacco users in wave 2 of the population assessment of tobacco and health path study 2014–2015,35433_flavour types used by youth and adult tobacco users in wave 2 of the population assessment of tobacco and health path study 2014–2015.pdf,7,"['https://www.federalregister.gov/documents/2022/05/04/2022-08994/tobacco-product-standard-for-menthol-in-cigarettes', 'https://www.fda.gov/media/158754/download', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://www.denvergov.org/content/dam/denvergov/Portals/772/Documents/Denver_Complaint_040120.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://stacks.cdc.gov/view/cdc/84557']","['Tobacco Product Standard for Menthol in Cigarettes', 'PM0000529', 'Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'In The United States District Court For The District Of Colorado', 'Smoking Cessation', 'Smoking cessation: a report of the Surgeon General.', 'Smoking cessation : a report of the Surgeon General']","['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.fda.gov/media/158754/download', 'https://www.denvergov.org/content/dam/denvergov/Portals/772/Documents/Denver_Complaint_040120.pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['35433_5_smoking cessation a report of the surgeon general.pdf', '35433_1_pm0000529.pdf', '35433_3_in the united states district court for the district of colorado.pdf', '35433_2_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']",4,57.14,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://www.fda.gov/media/158754/download', 'https://www.denvergov.org/content/dam/denvergov/Portals/772/Documents/Denver_Complaint_040120.pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['35433_5_smoking cessation a report of the surgeon general.pdf', '35433_1_pm0000529.pdf', '35433_3_in the united states district court for the district of colorado.pdf', '35433_2_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']","[0.491, 0.341, 0.375, 0.341]","[0.456, 0.457, 0.464, 0.456]","[0.55, 0.547, 0.557, 0.55]","[0.121, 0.127, 0.129, 0.121]","[0.129, 0.136, 0.14, 0.129]","[0.114, 0.118, 0.126, 0.114]","[0.732, 0.726, 0.731, 0.732]","[0.636, 0.63, 0.636, 0.636]","[0.517, 0.493, 0.513, 0.517]","[0.7, 0.686, 0.7, 0.7]","[0.728, 0.721, 0.729, 0.728]","[0.66, 0.665, 0.666, 0.66]","[0.591, 0.618, 0.623, 0.591]","[0.844, 0.841, 0.844, 0.844]","[0.751, 0.755, 0.765, 0.751]","[0.626, 0.626, 0.635, 0.626]","[0.727, 0.733, 0.736, 0.727]","[0.653, 0.647, 0.658, 0.653]",0.387,0.458,0.551,0.124,0.134,0.118,0.73,0.635,0.51,0.697,0.726,0.663,0.606,0.843,0.755,0.628,0.731,0.653
https://doi.org/10.1139/apnm-2019-0137,effects of highintensity interval training and nutrition advice on cardiometabolic markers and aerobic fitness in adolescent girls with obesity,35443_effects of highintensity interval training and nutrition advice on cardiometabolic markers and aerobic fitness in adolescent girls with obesity.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['35443_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['35443_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.341],[0.479],[0.578],[0.147],[0.146],[0.122],[0.735],[0.639],[0.553],[0.696],[0.758],[0.645],[0.571],[0.901],[0.788],[0.705],[0.759],[0.748],0.341,0.479,0.578,0.147,0.146,0.122,0.735,0.639,0.553,0.696,0.758,0.645,0.571,0.901,0.788,0.705,0.759,0.748
https://doi.org/10.1146/annurev.clinpsy.1.102803.144141,stress and health psychological behavioral and biological determinants,35584_stress and health psychological behavioral and biological determinants.pdf,5,"['https://www.nber.org/papers/w17310', 'https://www.mass.gov/files/documents/2019/02/14/Health-Impact-Assessment-Weymouth-Final-Report.pdf', 'https://www.nber.org/papers/w23334?sy=334', 'https://www.atlantafed.org/research/publications/wp/2016/14-killer-debt-the-impact-of-debt-on-mortality-2016-11-30.aspx', 'https://www.painphysicianjournal.com/current/pdf?article=NDIwMg%3D%3D&journal=103']","['Is there a Link Between Foreclosure and Health?', 'Health Impact Assessment of a Proposed Natural Gas Compressor Station in Weymouth, MA', 'The Effect of Stress on Later-Life Health: Evidence from the Vietnam Draft', 'Killer Debt: The Impact of Debt on Mortality', 'Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines']",['https://www.mass.gov/files/documents/2019/02/14/Health-Impact-Assessment-Weymouth-Final-Report.pdf'],['35584_1_health impact assessment of a proposed natural gas compressor station in weymouth ma.pdf'],1,20.0,['https://www.mass.gov/files/documents/2019/02/14/Health-Impact-Assessment-Weymouth-Final-Report.pdf'],['35584_1_health impact assessment of a proposed natural gas compressor station in weymouth ma.pdf'],[0.25],[0.485],[0.589],[0.09],[0.081],[0.065],[0.719],[0.62],[0.563],[0.64],[0.786],[0.702],[0.617],[0.91],[0.819],[0.745],[0.791],[0.773],0.25,0.485,0.589,0.09,0.081,0.065,0.719,0.62,0.563,0.64,0.786,0.702,0.617,0.91,0.819,0.745,0.791,0.773
https://doi.org/10.1146/annurev.ecolsys.37.091305.110251,the population biology of large brown seaweeds ecological consequences of multiphase life histories in dynamic coastal environments,35593_the population biology of large brown seaweeds ecological consequences of multiphase life histories in dynamic coastal environments.pdf,1,['https://purl.fdlp.gov/GPO/gpo91139'],['Climate change vulnerability assessment for the north-central California coast and ocean /'],['https://purl.fdlp.gov/GPO/gpo91139'],['35593_0_climate change vulnerability assessment for the northcentral california coast and ocean .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo91139'],['35593_0_climate change vulnerability assessment for the northcentral california coast and ocean .pdf'],[0.265],[0.49],[0.588],[0.137],[0.128],[0.11],[0.735],[0.642],[0.559],[0.684],[0.784],[0.687],[0.624],[0.9],[0.786],[0.742],[0.784],[0.778],0.265,0.49,0.588,0.137,0.128,0.11,0.735,0.642,0.559,0.684,0.784,0.687,0.624,0.9,0.786,0.742,0.784,0.778
https://doi.org/10.1146/annurev.med.050108.151127,growing up with hiv children adolescents and young adults with perinatally acquired hiv infection,35597_growing up with hiv children adolescents and young adults with perinatally acquired hiv infection.pdf,1,['https://www.in.gov/isdh/files/perinatalgl.pdf'],['HIV/AIDS Guidelines'],['https://www.in.gov/isdh/files/perinatalgl.pdf'],['35597_0_hivaids guidelines.pdf'],1,100.0,['https://www.in.gov/isdh/files/perinatalgl.pdf'],['35597_0_hivaids guidelines.pdf'],[0.487],[0.502],[0.597],[0.189],[0.181],[0.161],[0.75],[0.659],[0.587],[0.626],[0.786],[0.665],[0.588],[0.901],[0.808],[0.732],[0.772],[0.749],0.487,0.502,0.597,0.189,0.181,0.161,0.75,0.659,0.587,0.626,0.786,0.665,0.588,0.901,0.808,0.732,0.772,0.749
https://doi.org/10.1146/annurev.psych.59.103006.093633,the education of dyslexic children from childhood to young adulthood,35621_the education of dyslexic children from childhood to young adulthood.pdf,6,"['https://tea.texas.gov/sites/default/files/21-07-figure-19-0074-0028-1.pdf', 'https://tea.texas.gov/sites/default/files/september-2021-sboe-agenda-final.pdf', 'https://tea.texas.gov/sites/default/files/2018_Updates_Dyslexia_Handbook_11-2018%20Accessible.pdf', 'https://tea.texas.gov/sites/default/files/2018-Dyslexia-Handbook_Approved_Accomodated_12_11_2018.pdf', 'http://www.doe.virginia.gov/special_ed/disabilities/learning_disability/sld-dyslexia-guide.pdf', 'https://tea.texas.gov/sites/default/files/Spanish_Dyslexia_Handbook_2018.pdf']","['2018 Dyslexia Handbook', 'Agenda', 'The Dyslexia Handbook 2018 Update', '2018 Dyslexia Handbook', 'Virginia Department of Education February 2017', 'Dyslexia Handbook--2018 in Spanish']","['https://tea.texas.gov/sites/default/files/Spanish_Dyslexia_Handbook_2018.pdf', 'https://tea.texas.gov/sites/default/files/2018-Dyslexia-Handbook_Approved_Accomodated_12_11_2018.pdf', 'https://tea.texas.gov/sites/default/files/21-07-figure-19-0074-0028-1.pdf', 'https://tea.texas.gov/sites/default/files/september-2021-sboe-agenda-final.pdf', 'https://tea.texas.gov/sites/default/files/2018_Updates_Dyslexia_Handbook_11-2018%20Accessible.pdf']","['35621_5_dyslexia handbook2018 in spanish.pdf', '35621_3_2018 dyslexia handbook.pdf', '35621_0_2018 dyslexia handbook.pdf', '35621_1_agenda.pdf', '35621_2_the dyslexia handbook 2018 update.pdf']",5,83.33,"['https://tea.texas.gov/sites/default/files/Spanish_Dyslexia_Handbook_2018.pdf', 'https://tea.texas.gov/sites/default/files/2018-Dyslexia-Handbook_Approved_Accomodated_12_11_2018.pdf', 'https://tea.texas.gov/sites/default/files/21-07-figure-19-0074-0028-1.pdf', 'https://tea.texas.gov/sites/default/files/september-2021-sboe-agenda-final.pdf', 'https://tea.texas.gov/sites/default/files/2018_Updates_Dyslexia_Handbook_11-2018%20Accessible.pdf']","['35621_5_dyslexia handbook2018 in spanish.pdf', '35621_3_2018 dyslexia handbook.pdf', '35621_0_2018 dyslexia handbook.pdf', '35621_1_agenda.pdf', '35621_2_the dyslexia handbook 2018 update.pdf']","[0.516, 0.229, 0.473, 0.473, 0.055]","[0.409, 0.475, 0.495, 0.455, 0.476]","[0.541, 0.584, 0.604, 0.566, 0.584]","[0.126, 0.157, 0.18, 0.11, 0.156]","[0.161, 0.178, 0.206, 0.123, 0.178]","[0.128, 0.159, 0.181, 0.107, 0.159]","[0.736, 0.742, 0.746, 0.729, 0.742]","[0.642, 0.643, 0.647, 0.628, 0.643]","[0.495, 0.556, 0.575, 0.542, 0.556]","[0.691, 0.698, 0.701, 0.669, 0.698]","[0.76, 0.775, 0.784, 0.76, 0.775]","[0.62, 0.67, 0.693, 0.656, 0.67]","[0.556, 0.604, 0.616, 0.592, 0.605]","[0.875, 0.907, 0.914, 0.91, 0.907]","[0.776, 0.803, 0.814, 0.792, 0.803]","[0.68, 0.736, 0.752, 0.726, 0.736]","[0.725, 0.772, 0.785, 0.756, 0.772]","[0.71, 0.768, 0.78, 0.754, 0.768]",0.349,0.462,0.576,0.146,0.169,0.147,0.739,0.641,0.545,0.691,0.771,0.662,0.595,0.903,0.798,0.726,0.762,0.756
https://doi.org/10.1148/radiol.2020202568,efficacy of chest ct for covid19 pneumonia diagnosis in france,35655_efficacy of chest ct for covid19 pneumonia diagnosis in france.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078565/pdf']","['Thoracic imaging tests for the diagnosis of COVID‐19', 'Thoracic imaging tests for the diagnosis of COVID‐19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078565/pdf']","['35655_0_thoracic imaging tests for the diagnosis of covid‐19.pdf', '35655_1_thoracic imaging tests for the diagnosis of covid‐19.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109458/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078565/pdf']","['35655_0_thoracic imaging tests for the diagnosis of covid‐19.pdf', '35655_1_thoracic imaging tests for the diagnosis of covid‐19.pdf']","[0.379, 0.4]","[0.569, 0.564]","[0.635, 0.632]","[0.211, 0.206]","[0.204, 0.203]","[0.174, 0.171]","[0.742, 0.741]","[0.651, 0.649]","[0.629, 0.624]","[0.708, 0.707]","[0.796, 0.793]","[0.744, 0.742]","[0.639, 0.635]","[0.93, 0.928]","[0.842, 0.838]","[0.757, 0.752]","[0.808, 0.805]","[0.781, 0.776]",0.39,0.567,0.633,0.208,0.204,0.172,0.742,0.65,0.627,0.708,0.794,0.743,0.637,0.929,0.84,0.754,0.806,0.778
https://doi.org/10.1152/jappl.2001.90.3.1111,methodology for the measurement of mucociliary function in the mouse by scintigraphy,35682_methodology for the measurement of mucociliary function in the mouse by scintigraphy.pdf,2,"['https://purl.fdlp.gov/GPO/gpo77764', 'https://stacks.cdc.gov/view/cdc/42315']","['Occupational exposure to diacetyl and 2,3-pentanedione /', 'Occupational exposure to diacetyl and 2,3-pentanedione']",['https://purl.fdlp.gov/GPO/gpo77764'],['35682_0_occupational exposure to diacetyl and 23pentanedione .pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo77764'],['35682_0_occupational exposure to diacetyl and 23pentanedione .pdf'],[0.146],[0.551],[0.636],[0.143],[0.143],[0.105],[0.742],[0.644],[0.637],[0.64],[0.812],[0.745],[0.645],[0.917],[0.825],[0.782],[0.822],[0.801],0.146,0.551,0.636,0.143,0.143,0.105,0.742,0.644,0.637,0.64,0.812,0.745,0.645,0.917,0.825,0.782,0.822,0.801
https://doi.org/10.1152/japplphysiol.00246.2005,dose response to rhcc10augmented surfactant therapy in a lamb model of infant respiratory distress syndrome physiological inflammatory and kinetic profiles,35685_dose response to rhcc10augmented surfactant therapy in a lamb model of infant respiratory distress syndrome physiological inflammatory and kinetic profiles.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464311/pdf'],['Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464311/pdf'],['35685_0_intratracheal clara cell secretory protein ccsp administration in preterm infants with or at risk of respiratory distress syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464311/pdf'],['35685_0_intratracheal clara cell secretory protein ccsp administration in preterm infants with or at risk of respiratory distress syndrome.pdf'],[0.346],[0.526],[0.609],[0.174],[0.155],[0.136],[0.743],[0.651],[0.594],[0.671],[0.786],[0.702],[0.595],[0.909],[0.803],[0.745],[0.792],[0.769],0.346,0.526,0.609,0.174,0.155,0.136,0.743,0.651,0.594,0.671,0.786,0.702,0.595,0.909,0.803,0.745,0.792,0.769
https://doi.org/10.1152/japplphysiol.00849.2002,effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns,35687_effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119450/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060021/pdf']","['Recombinant human growth hormone for treating burns and donor sites', 'Quantification of an Exercise Rehabilitation Program for Severely Burned Children: The Standard of Care at Shriners Hospitals for Children—Galveston']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060021/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119450/pdf']","['35687_1_quantification of an exercise rehabilitation program for severely burned children the standard of care at shriners hospitals for children—galveston.pdf', '35687_0_recombinant human growth hormone for treating burns and donor sites.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060021/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119450/pdf']","['35687_1_quantification of an exercise rehabilitation program for severely burned children the standard of care at shriners hospitals for children—galveston.pdf', '35687_0_recombinant human growth hormone for treating burns and donor sites.pdf']","[0.346, 0.563]","[0.564, 0.528]","[0.635, 0.604]","[0.204, 0.161]","[0.21, 0.165]","[0.167, 0.124]","[0.739, 0.727]","[0.641, 0.626]","[0.635, 0.595]","[0.675, 0.661]","[0.802, 0.781]","[0.746, 0.713]","[0.643, 0.607]","[0.933, 0.915]","[0.831, 0.812]","[0.783, 0.744]","[0.811, 0.79]","[0.799, 0.768]",0.454,0.546,0.619,0.182,0.188,0.146,0.733,0.633,0.615,0.668,0.792,0.73,0.625,0.924,0.822,0.764,0.8,0.784
https://doi.org/10.1155/2009/304625,a child with raccoon roundworm meningoencephalitis a pathogen emerging in your own backyard,35701_a child with raccoon roundworm meningoencephalitis a pathogen emerging in your own backyard.pdf,1,['http://purl.fdlp.gov/GPO/gpo82626'],['Baylisascaris larva migrans /'],['http://purl.fdlp.gov/GPO/gpo82626'],['35701_0_baylisascaris larva migrans .pdf'],1,100.0,['http://purl.fdlp.gov/GPO/gpo82626'],['35701_0_baylisascaris larva migrans .pdf'],[0.348],[0.503],[0.59],[0.127],[0.117],[0.104],[0.727],[0.633],[0.592],[0.594],[0.799],[0.699],[0.623],[0.894],[0.828],[0.764],[0.798],[0.782],0.348,0.503,0.59,0.127,0.117,0.104,0.727,0.633,0.592,0.594,0.799,0.699,0.623,0.894,0.828,0.764,0.798,0.782
https://doi.org/10.1159/000442758,longterm 7 years followup of rouxeny gastric bypass on obese adolescent patients 18 years,35968_longterm 7 years followup of rouxeny gastric bypass on obese adolescent patients 18 years.pdf,1,['https://asmbs.org/app/uploads/2018/08/PIIS155072891830145X-Pediatric-in-Press.pdf'],"['ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018']",['https://asmbs.org/app/uploads/2018/08/PIIS155072891830145X-Pediatric-in-Press.pdf'],['35968_0_asmbs pediatric metabolic and bariatric surgery guidelines 2018.pdf'],1,100.0,['https://asmbs.org/app/uploads/2018/08/PIIS155072891830145X-Pediatric-in-Press.pdf'],['35968_0_asmbs pediatric metabolic and bariatric surgery guidelines 2018.pdf'],[0.717],[0.551],[0.624],[0.186],[0.186],[0.152],[0.74],[0.643],[0.617],[0.66],[0.803],[0.73],[0.635],[0.925],[0.829],[0.771],[0.807],[0.79],0.717,0.551,0.624,0.186,0.186,0.152,0.74,0.643,0.617,0.66,0.803,0.73,0.635,0.925,0.829,0.771,0.807,0.79
https://doi.org/10.1159/000464105,sociocultural influence on obesity and lifestyle in children a study of daily activities leisure time behavior motor skills and weight status,35978_sociocultural influence on obesity and lifestyle in children a study of daily activities leisure time behavior motor skills and weight status.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['35978_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '35978_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['35978_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '35978_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.391, 0.383]","[0.533, 0.531]","[0.621, 0.619]","[0.168, 0.168]","[0.173, 0.172]","[0.14, 0.139]","[0.729, 0.729]","[0.627, 0.626]","[0.604, 0.601]","[0.688, 0.688]","[0.789, 0.788]","[0.713, 0.708]","[0.608, 0.607]","[0.923, 0.922]","[0.844, 0.841]","[0.743, 0.742]","[0.791, 0.789]","[0.776, 0.775]",0.387,0.532,0.62,0.168,0.172,0.14,0.729,0.627,0.603,0.688,0.788,0.71,0.607,0.923,0.843,0.742,0.79,0.776
https://doi.org/10.1159/000478980,venous stasis and cerebrovascular complications in cerebral venous sinus thrombosis,35981_venous stasis and cerebrovascular complications in cerebral venous sinus thrombosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164341/pdf'],['Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164341/pdf'],['35981_0_diagnostic and treatment recommendations from the facme adhoc expert working group on the management of cerebral venous sinus thrombosis associated with covid19 vaccination.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164341/pdf'],['35981_0_diagnostic and treatment recommendations from the facme adhoc expert working group on the management of cerebral venous sinus thrombosis associated with covid19 vaccination.pdf'],[0.215],[0.548],[0.621],[0.178],[0.179],[0.141],[0.747],[0.655],[0.617],[0.641],[0.806],[0.739],[0.626],[0.922],[0.839],[0.769],[0.805],[0.786],0.215,0.548,0.621,0.178,0.179,0.141,0.747,0.655,0.617,0.641,0.806,0.739,0.626,0.922,0.839,0.769,0.805,0.786
https://doi.org/10.1159/000492813,camostat mesilate pancrelipase and rabeprazole combination therapy improves epigastric pain in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities,35984_camostat mesilate pancrelipase and rabeprazole combination therapy improves epigastric pain in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831363/pdf'],['Evidence-based clinical practice guidelines for functional dyspepsia 2021'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831363/pdf'],['35984_0_evidencebased clinical practice guidelines for functional dyspepsia 2021.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831363/pdf'],['35984_0_evidencebased clinical practice guidelines for functional dyspepsia 2021.pdf'],[0.586],[0.581],[0.664],[0.207],[0.236],[0.165],[0.751],[0.662],[0.641],[0.675],[0.825],[0.755],[0.645],[0.931],[0.842],[0.785],[0.827],[0.811],0.586,0.581,0.664,0.207,0.236,0.165,0.751,0.662,0.641,0.675,0.825,0.755,0.645,0.931,0.842,0.785,0.827,0.811
https://doi.org/10.1159/000495767,fatty liver and autoimmune hepatitis two forms of liver involvement in lipodystrophies,35985_fatty liver and autoimmune hepatitis two forms of liver involvement in lipodystrophies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936/pdf'],['Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936/pdf'],['35985_0_dunnigan lipodystrophy syndrome french national diagnosis and care protocol pnds protocole national de diagnostic et de soins.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936/pdf'],['35985_0_dunnigan lipodystrophy syndrome french national diagnosis and care protocol pnds protocole national de diagnostic et de soins.pdf'],[0.449],[0.568],[0.643],[0.188],[0.193],[0.13],[0.744],[0.642],[0.636],[0.619],[0.815],[0.743],[0.636],[0.924],[0.834],[0.78],[0.818],[0.799],0.449,0.568,0.643,0.188,0.193,0.13,0.744,0.642,0.636,0.619,0.815,0.743,0.636,0.924,0.834,0.78,0.818,0.799
https://doi.org/10.1159/000496214,evidencebased practice improving the quality of perinatal care,35986_evidencebased practice improving the quality of perinatal care.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf']","['Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants', 'Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf']","['35986_0_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf', '35986_1_slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407506/pdf']","['35986_0_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf', '35986_1_slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.pdf']","[0.203, 0.184]","[0.523, 0.523]","[0.61, 0.609]","[0.168, 0.167]","[0.173, 0.175]","[0.151, 0.15]","[0.735, 0.734]","[0.644, 0.643]","[0.585, 0.583]","[0.684, 0.682]","[0.786, 0.784]","[0.696, 0.7]","[0.601, 0.599]","[0.913, 0.913]","[0.818, 0.817]","[0.735, 0.732]","[0.78, 0.778]","[0.765, 0.761]",0.194,0.523,0.609,0.168,0.174,0.15,0.734,0.643,0.584,0.683,0.785,0.698,0.6,0.913,0.817,0.734,0.779,0.763
https://doi.org/10.1159/000499881,randomised controlled trials for informing perinatal care,35987_randomised controlled trials for informing perinatal care.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf']","['Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants', 'Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf']","['35987_1_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf', '35987_0_probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094746/pdf']","['35987_1_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf', '35987_0_probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.pdf']","[0.414, 0.412]","[0.516, 0.494]","[0.608, 0.589]","[0.173, 0.15]","[0.179, 0.15]","[0.153, 0.132]","[0.74, 0.737]","[0.646, 0.642]","[0.581, 0.561]","[0.693, 0.685]","[0.784, 0.776]","[0.688, 0.669]","[0.597, 0.578]","[0.912, 0.908]","[0.812, 0.797]","[0.725, 0.713]","[0.774, 0.76]","[0.76, 0.749]",0.413,0.505,0.599,0.161,0.164,0.143,0.738,0.644,0.571,0.689,0.78,0.678,0.587,0.91,0.804,0.719,0.767,0.754
https://doi.org/10.1159/000501636,skin care and synbiotics for prevention of atopic dermatitis or food allergy in newborn infants a 2 × 2 factorial randomized nontreatment controlled trial,35988_skin care and synbiotics for prevention of atopic dermatitis or food allergy in newborn infants a 2 × 2 factorial randomized nontreatment controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf']","['Skin care interventions in infants for preventing eczema and food allergy', 'Skin care interventions in infants for preventing eczema and food allergy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['35988_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '35988_0_skin care interventions in infants for preventing eczema and food allergy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094581/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf']","['35988_1_skin care interventions in infants for preventing eczema and food allergy.pdf', '35988_0_skin care interventions in infants for preventing eczema and food allergy.pdf']","[0.509, 0.518]","[0.525, 0.524]","[0.61, 0.608]","[0.153, 0.149]","[0.162, 0.16]","[0.132, 0.129]","[0.734, 0.734]","[0.639, 0.639]","[0.585, 0.582]","[0.672, 0.674]","[0.782, 0.78]","[0.693, 0.694]","[0.607, 0.604]","[0.912, 0.913]","[0.813, 0.81]","[0.735, 0.734]","[0.783, 0.782]","[0.762, 0.76]",0.514,0.524,0.609,0.151,0.161,0.131,0.734,0.639,0.583,0.673,0.781,0.694,0.605,0.913,0.811,0.734,0.782,0.761
https://doi.org/10.1159/000504335,how to intervene in the caries process early childhood caries – a systematic review,35989_how to intervene in the caries process early childhood caries – a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079355/pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/bp_cariesriskassessment.pdf?v=new']","['Recommended procedures for the management of early childhood caries lesions – a scoping review by the Children Experiencing Dental Anxiety: Collaboration on Research and Education (CEDACORE)', 'Caries-risk Assessment and Management for Infants, Children, and Adolescents']","['https://www.aapd.org/globalassets/media/policies_guidelines/bp_cariesriskassessment.pdf?v=new', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079355/pdf']","['35989_1_cariesrisk assessment and management for infants children and adolescents.pdf', '35989_0_recommended procedures for the management of early childhood caries lesions – a scoping review by the children experiencing dental anxiety collaboration on research and education cedacore.pdf']",2,100.0,"['https://www.aapd.org/globalassets/media/policies_guidelines/bp_cariesriskassessment.pdf?v=new', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079355/pdf']","['35989_1_cariesrisk assessment and management for infants children and adolescents.pdf', '35989_0_recommended procedures for the management of early childhood caries lesions – a scoping review by the children experiencing dental anxiety collaboration on research and education cedacore.pdf']","[0.478, 0.372]","[0.537, 0.524]","[0.615, 0.607]","[0.179, 0.178]","[0.191, 0.186]","[0.144, 0.143]","[0.742, 0.74]","[0.652, 0.653]","[0.595, 0.592]","[0.686, 0.68]","[0.798, 0.798]","[0.707, 0.702]","[0.627, 0.618]","[0.912, 0.912]","[0.817, 0.814]","[0.759, 0.749]","[0.798, 0.789]","[0.785, 0.778]",0.425,0.53,0.611,0.178,0.189,0.143,0.741,0.653,0.593,0.683,0.798,0.704,0.623,0.912,0.815,0.754,0.794,0.782
https://doi.org/10.1159/000512988,commentary on “enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants”,35990_commentary on “enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants”.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf'],['Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf'],['35990_0_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771918/pdf'],['35990_0_delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.pdf'],[0.437],[0.519],[0.607],[0.18],[0.179],[0.154],[0.742],[0.653],[0.583],[0.705],[0.78],[0.696],[0.596],[0.903],[0.794],[0.714],[0.772],[0.741],0.437,0.519,0.607,0.18,0.179,0.154,0.742,0.653,0.583,0.705,0.78,0.696,0.596,0.903,0.794,0.714,0.772,0.741
https://doi.org/10.1161/01.cir.103.22.2705,high prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults,36010_high prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529794/pdf'],['A Default Normal Chest CT Structured Reporting Field for Coronary Calcifications does not Cause Excessive False Negative Reporting'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529794/pdf'],['36010_0_a default normal chest ct structured reporting field for coronary calcifications does not cause excessive false negative reporting.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529794/pdf'],['36010_0_a default normal chest ct structured reporting field for coronary calcifications does not cause excessive false negative reporting.pdf'],[0.191],[0.513],[0.612],[0.158],[0.168],[0.122],[0.736],[0.639],[0.585],[0.674],[0.772],[0.708],[0.595],[0.905],[0.803],[0.739],[0.772],[0.758],0.191,0.513,0.612,0.158,0.168,0.122,0.736,0.639,0.585,0.674,0.772,0.708,0.595,0.905,0.803,0.739,0.772,0.758
https://doi.org/10.1161/cir.0000000000000484,diagnosis treatment and longterm management of kawasaki disease a scientific statement for health professionals from the american heart association,36020_diagnosis treatment and longterm management of kawasaki disease a scientific statement for health professionals from the american heart association.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830049/pdf', 'https://www.asecho.org/wp-content/uploads/2022/10/PIIS0894731721000274.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953355/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116479/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405113/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868856/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf']","['Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease', 'ASE Statement on Adapting Pediatric, Fetal, and Congenital Heart Disease Echocardiographic Services to the Evolving COVID-19 Pandemic', 'TNF‐α blockers for the treatment of Kawasaki disease in children', 'Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks', 'American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics', 'American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868856/pdf', 'https://www.asecho.org/wp-content/uploads/2022/10/PIIS0894731721000274.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830049/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953355/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116479/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['36020_6_childhood multisystem inflammatory syndrome associated with covid19 misc a diagnostic and treatment guidance from the rheumatology study group of the italian society of pediatrics.pdf', '36020_1_ase statement on adapting pediatric fetal and congenital heart disease echocardiographic services to the evolving covid19 pandemic.pdf', '36020_7_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '36020_0_revised recommendations of the italian society of pediatrics about the general management of kawasaki disease.pdf', '36020_2_tnf‐α blockers for the treatment of kawasaki disease in children.pdf', '36020_3_kawasaki disease guidelines of italian society of pediatrics part ii  treatment of resistant forms and cardiovascular complications followup lifestyle and prevention of cardiovascular risks.pdf', '36020_5_coronavirus disease 2019 covid19 treatment guidelines.pdf']",7,87.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868856/pdf', 'https://www.asecho.org/wp-content/uploads/2022/10/PIIS0894731721000274.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559788/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830049/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953355/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116479/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['36020_6_childhood multisystem inflammatory syndrome associated with covid19 misc a diagnostic and treatment guidance from the rheumatology study group of the italian society of pediatrics.pdf', '36020_1_ase statement on adapting pediatric fetal and congenital heart disease echocardiographic services to the evolving covid19 pandemic.pdf', '36020_7_american college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with sars–cov2 and hyperinflammation in pediatric covid19 version 2.pdf', '36020_0_revised recommendations of the italian society of pediatrics about the general management of kawasaki disease.pdf', '36020_2_tnf‐α blockers for the treatment of kawasaki disease in children.pdf', '36020_3_kawasaki disease guidelines of italian society of pediatrics part ii  treatment of resistant forms and cardiovascular complications followup lifestyle and prevention of cardiovascular risks.pdf', '36020_5_coronavirus disease 2019 covid19 treatment guidelines.pdf']","[0.754, 0.454, 0.367, 0.81, 0.396, 0.312, 0.412]","[0.555, 0.579, 0.534, 0.565, 0.524, 0.557, 0.539]","[0.637, 0.651, 0.625, 0.641, 0.608, 0.638, 0.615]","[0.166, 0.181, 0.163, 0.178, 0.15, 0.178, 0.148]","[0.162, 0.17, 0.161, 0.178, 0.145, 0.181, 0.14]","[0.117, 0.129, 0.119, 0.134, 0.114, 0.134, 0.11]","[0.742, 0.748, 0.746, 0.75, 0.736, 0.75, 0.744]","[0.648, 0.656, 0.653, 0.655, 0.639, 0.655, 0.648]","[0.626, 0.645, 0.607, 0.63, 0.593, 0.625, 0.599]","[0.631, 0.624, 0.639, 0.637, 0.647, 0.638, 0.627]","[0.8, 0.816, 0.788, 0.807, 0.784, 0.803, 0.787]","[0.736, 0.763, 0.706, 0.741, 0.705, 0.739, 0.703]","[0.604, 0.639, 0.604, 0.629, 0.593, 0.629, 0.605]","[0.92, 0.926, 0.918, 0.923, 0.916, 0.921, 0.901]","[0.825, 0.829, 0.812, 0.817, 0.803, 0.816, 0.792]","[0.765, 0.786, 0.752, 0.77, 0.735, 0.769, 0.757]","[0.798, 0.816, 0.783, 0.8, 0.776, 0.797, 0.783]","[0.785, 0.801, 0.775, 0.787, 0.759, 0.784, 0.774]",0.501,0.55,0.631,0.166,0.162,0.122,0.745,0.651,0.618,0.635,0.798,0.728,0.615,0.918,0.813,0.762,0.793,0.781
https://doi.org/10.1161/cir.0000000000000618,cardiovascular risk reduction in highrisk pediatric patients a scientific statement from the american heart association,36024_cardiovascular risk reduction in highrisk pediatric patients a scientific statement from the american heart association.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020870/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733163/pdf']","['Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019', 'Knowledge Gaps in Cardiovascular Care of the Older Adult Population - A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020870/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733163/pdf']","['36024_0_updated cardiovascular prevention guideline of the brazilian society of cardiology  2019.pdf', '36024_1_knowledge gaps in cardiovascular care of the older adult population  a scientific statement from the american heart association american college of cardiology and american geriatrics society.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020870/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733163/pdf']","['36024_0_updated cardiovascular prevention guideline of the brazilian society of cardiology  2019.pdf', '36024_1_knowledge gaps in cardiovascular care of the older adult population  a scientific statement from the american heart association american college of cardiology and american geriatrics society.pdf']","[0.705, 0.429]","[0.519, 0.522]","[0.609, 0.613]","[0.156, 0.175]","[0.155, 0.168]","[0.118, 0.125]","[0.742, 0.75]","[0.646, 0.658]","[0.591, 0.599]","[0.656, 0.664]","[0.788, 0.782]","[0.704, 0.71]","[0.611, 0.594]","[0.912, 0.912]","[0.806, 0.797]","[0.749, 0.745]","[0.783, 0.776]","[0.77, 0.766]",0.567,0.52,0.611,0.165,0.162,0.121,0.746,0.652,0.595,0.66,0.785,0.707,0.603,0.912,0.802,0.747,0.78,0.768
https://doi.org/10.1161/cir.0000000000000895,neonatal life support 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations,36025_neonatal life support 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207961/pdf'],['Tracheal suction at birth in non‐vigorous neonates born through meconium‐stained amniotic fluid'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207961/pdf'],['36025_0_tracheal suction at birth in non‐vigorous neonates born through meconium‐stained amniotic fluid.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207961/pdf'],['36025_0_tracheal suction at birth in non‐vigorous neonates born through meconium‐stained amniotic fluid.pdf'],[0.433],[0.531],[0.617],[0.181],[0.182],[0.144],[0.737],[0.645],[0.594],[0.679],[0.782],[0.713],[0.611],[0.907],[0.799],[0.732],[0.781],[0.757],0.433,0.531,0.617,0.181,0.182,0.144,0.737,0.645,0.594,0.679,0.782,0.713,0.611,0.907,0.799,0.732,0.781,0.757
https://doi.org/10.1161/circresaha.117.309711,classification epidemiology and global burden of cardiomyopathies,36028_classification epidemiology and global burden of cardiomyopathies.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406792/pdf'],['Stem cell therapy for dilated cardiomyopathy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406792/pdf'],['36028_0_stem cell therapy for dilated cardiomyopathy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406792/pdf'],['36028_0_stem cell therapy for dilated cardiomyopathy.pdf'],[0.213],[0.503],[0.599],[0.146],[0.141],[0.102],[0.736],[0.638],[0.577],[0.661],[0.777],[0.704],[0.586],[0.912],[0.804],[0.725],[0.77],[0.754],0.213,0.503,0.599,0.146,0.141,0.102,0.736,0.638,0.577,0.661,0.777,0.704,0.586,0.912,0.804,0.725,0.77,0.754
https://doi.org/10.1161/circulationaha.118.034516,effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke,36060_effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],"['Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],['36060_0_dipeptidyl peptidase‐4 inhibitors glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],['36060_0_dipeptidyl peptidase‐4 inhibitors glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease a network meta‐analysis.pdf'],[0.489],[0.507],[0.59],[0.178],[0.178],[0.138],[0.744],[0.654],[0.572],[0.698],[0.766],[0.671],[0.589],[0.906],[0.787],[0.718],[0.763],[0.739],0.489,0.507,0.59,0.178,0.178,0.138,0.744,0.654,0.572,0.698,0.766,0.671,0.589,0.906,0.787,0.718,0.763,0.739
https://doi.org/10.1161/circulationaha.120.050147,addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multiinflammatory syndrome in children,36062_addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multiinflammatory syndrome in children.pdf,2,"['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483317/pdf']","['Coronavirus Disease 2019 (COVID-19) Treatment Guidelines', 'Guidelines for the prevention and management of children and adolescents with COVID-19']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483317/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['36062_1_guidelines for the prevention and management of children and adolescents with covid19.pdf', '36062_0_coronavirus disease 2019 covid19 treatment guidelines.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483317/pdf', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['36062_1_guidelines for the prevention and management of children and adolescents with covid19.pdf', '36062_0_coronavirus disease 2019 covid19 treatment guidelines.pdf']","[0.381, 0.281]","[0.499, 0.532]","[0.586, 0.61]","[0.157, 0.16]","[0.144, 0.158]","[0.108, 0.118]","[0.737, 0.74]","[0.644, 0.649]","[0.559, 0.596]","[0.664, 0.656]","[0.769, 0.787]","[0.689, 0.697]","[0.605, 0.602]","[0.89, 0.898]","[0.779, 0.805]","[0.709, 0.757]","[0.761, 0.787]","[0.731, 0.778]",0.331,0.516,0.598,0.159,0.151,0.113,0.738,0.647,0.578,0.66,0.778,0.693,0.603,0.894,0.792,0.733,0.774,0.754
https://doi.org/10.1161/jaha.118.009860,improved cardiopulmonary resuscitation performance with code aces sup2sup  a resuscitation quality bundle,36088_improved cardiopulmonary resuscitation performance with code aces sup2sup  a resuscitation quality bundle.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678815/pdf'],['Association Between Hospital Debriefing Practices with Adherence to Resuscitation Process Measures and Outcomes for In-Hospital Cardiac Arrest'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678815/pdf'],['36088_0_association between hospital debriefing practices with adherence to resuscitation process measures and outcomes for inhospital cardiac arrest.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678815/pdf'],['36088_0_association between hospital debriefing practices with adherence to resuscitation process measures and outcomes for inhospital cardiac arrest.pdf'],[0.323],[0.515],[0.612],[0.179],[0.184],[0.148],[0.738],[0.645],[0.588],[0.675],[0.776],[0.698],[0.606],[0.913],[0.814],[0.741],[0.78],[0.76],0.323,0.515,0.612,0.179,0.184,0.148,0.738,0.645,0.588,0.675,0.776,0.698,0.606,0.913,0.814,0.741,0.78,0.76
https://doi.org/10.1161/str.0000000000000183,management of stroke in neonates and children a scientific statement from the american heart associationamerican stroke association,36090_management of stroke in neonates and children a scientific statement from the american heart associationamerican stroke association.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093252/pdf', 'https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000183?download=true']","['Recommendations for Clinical Trials in ICH: The Second HEmorrhagic stroke Academia inDuStry (HEADS) Roundtable', 'Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093252/pdf'],['36090_0_recommendations for clinical trials in ich the second hemorrhagic stroke academia industry heads roundtable.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093252/pdf'],['36090_0_recommendations for clinical trials in ich the second hemorrhagic stroke academia industry heads roundtable.pdf'],[0.316],[0.535],[0.629],[0.167],[0.173],[0.135],[0.748],[0.653],[0.614],[0.653],[0.782],[0.716],[0.613],[0.921],[0.828],[0.762],[0.788],[0.776],0.316,0.535,0.629,0.167,0.173,0.135,0.748,0.653,0.614,0.653,0.782,0.716,0.613,0.921,0.828,0.762,0.788,0.776
https://doi.org/10.1162/rest_a_00677,childhood medicaid coverage and laterlife health care utilization,36239_childhood medicaid coverage and laterlife health care utilization.pdf,9,"['https://www.whitehouse.gov/cea/written-materials/2021/06/22/the-effects-of-earlier-medicaid-expansions-a-literature-review/', 'https://www.whitehouse.gov/wp-content/uploads/2021/06/Medicaid-Expansions-Lit-Review-CEA-.pdf', 'https://www.brookings.edu/research/rebalancing-children-first/', 'https://www.aei.org/research-products/report/rebalancing-children-first/', 'https://www.census.gov/content/census/en/library/publications/2019/adrm/2018-ces-annual-report.html', 'https://www.cbpp.org/research/health/expanding-medicaid-for-parents-improves-coverage-and-health-for-both-parents-and', 'https://www.census.gov/content/census/en/library/publications/2019/adrm/2018-ces-selected-publications-and-working-papers.html', 'https://www.census.gov/library/publications/2019/adrm/2018-ces-annual-report.html', 'https://www.census.gov/library/publications/2019/adrm/2018-ces-selected-publications-and-working-papers.html']","['The Effects of Earlier Medicaid Expansions: A Literature Review', 'The Effects of Earlier Medicaid Expansions: A Literature Review', 'Rebalancing: Children first', 'Rebalancing: Children first - AEI', 'CES and Research Data Centers Research Report: 2018', 'Expanding Medicaid for Parents Improves Coverage and Health for Both Parents and Children', '2018 CES Selected Publications and Working Papers', 'CES and Research Data Centers Research Report: 2018', '2018 CES Selected Publications and Working Papers']",['https://www.whitehouse.gov/wp-content/uploads/2021/06/Medicaid-Expansions-Lit-Review-CEA-.pdf'],['36239_1_the effects of earlier medicaid expansions a literature review.pdf'],1,11.11,['https://www.whitehouse.gov/wp-content/uploads/2021/06/Medicaid-Expansions-Lit-Review-CEA-.pdf'],['36239_1_the effects of earlier medicaid expansions a literature review.pdf'],[0.474],[0.549],[0.64],[0.204],[0.228],[0.188],[0.728],[0.637],[0.613],[0.733],[0.809],[0.724],[0.652],[0.92],[0.839],[0.766],[0.808],[0.791],0.474,0.549,0.64,0.204,0.228,0.188,0.728,0.637,0.613,0.733,0.809,0.724,0.652,0.92,0.839,0.766,0.808,0.791
https://doi.org/10.1164/rccm.201807-1318oc,amikacin liposome inhalation suspension for treatmentrefractory lung disease caused by mycobacterium avium complex convert a prospective openlabel randomized study,36334_amikacin liposome inhalation suspension for treatmentrefractory lung disease caused by mycobacterium avium complex convert a prospective openlabel randomized study.pdf,8,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768748/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768745/pdf', 'https://watermark.silverchair.com/ciaa241.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAr8wggK7BgkqhkiG9w0BBwagggKsMIICqAIBADCCAqEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMUVruILzRpqdwBaqvAgEQgIICcvqSBHHCWGwe24rISk2H1FWensh8IJXLFhEpbqasUHPwfEeZpdFYwzkyPdLD0rl_gMoAEYoC8J27xpC4OajqMO5qqGaocb43w2UWflAH_7R1GMRb3xc7wTtk6BsDdqgpoe0F4M3TZ5Vl8pi6qVgpCzQ8ZU8JyMm2zAZOb2-QGp8ZRoBUfF5ByA4B-x80YfPjiwIMft0v-xl_fxnrh0FM5A2FdPBoJDJu0m1CFBG21SrkhZw11MTIZ7BZcHmux4M6Eh8YqG0qJ-Niiv3cyH6gTmUnmxG268VlFniN5fKWWZWlcRs-9SUHazRueueVaxkbjPEJwEbkFRcSdcokfXOcP99ktoaxUutlgEk7JxVBmSAhyK8b5PvvexolCCTWnAtEAB8xxxoLbY9TpfD3oHBh_GchpsUu0hdivrb-Iuv8YVZkXZ-DcSopwD27rlH1gBlp_c9A9QCAn_GBj1F34JuCQLFwYpMrHhBEIVwY4FgB6hRlVTtDDlL7Cvm-UksVMypKJlx1rk-dUVlKObb0b5RnMa0XK0NYFJ_zqDa5RufW6KtnU4P-NVBbAjxHCxqq2ExuZkPgZrZYrY0Fh1WpQ-J4697CZnEQ2QZtr_o16HL7CXpBCKp3VD7fCmMqQ74OWxSNyW9UebcE_nyZ1o20P0I9HjvdMvP6LxlW9U-km5gsQBbrM2Qd7J5-kJlS5z9jBsNX7FOdEIgsDzJKRcsSCQCVWVJcFhSV54cKEz7BRZaRct6Oop6YzwHEgySdLluPuE5KQ1FFvEEIdVGeqFagwDhv-kHHArNZ1hrIUr6sVRCZLl2260ab-Cn02wls0h5yl-3vVBJ8', 'https://watermark.silverchair.com/ciaa241.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAy0wggMpBgkqhkiG9w0BBwagggMaMIIDFgIBADCCAw8GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMQjha4Ge9y-egA1AFAgEQgIIC4HEBVjqnlyl_UOf9DlIhJxOEVHJEE-4LMG_JG4Ww-tBFgHhzK-FOBF_QNS5WrqboE08zsPHy9L2mrnbMqnFrbE2J3781HSRk1yrWUjBEkHIqXkUJSSE8di_A_8oWAoChNbyDK_O-AbUi1Q5v4g1HL8xi4GjlSt3RhrYc_Hm-JPVLM5PcQgoyRxERfWbc8-OQZabJe3nhI8iZtIt1sI2uPj99ztECBoS6xA4OeT8nBvAjDIYZJqaD0cPzhuuMK1gZjjZbq4PBDLtZwy7jVuf1BapXeACugArQZsc9uVOX1cgac0VGbkSxQMnHXeAnXaWO7f6_1Zq5YRirVtxGJEX_NPhIKJPUPEw7FrWp_VjBUgt6cwwJBw1ie3mH8E3QsjRd-8pWC31Za7uHNEJp6yKOH9372hxkoinG7qiQCZKISiZvnskuXAWPVrYkd1VZURHxP4-ukdS3kJtlaYInSnIOcYzQqFdfe8QpxjoawV7qKgf7coSV618g22nsp7DjMHVuoEWWeBgtGi3nXlE7DQUrhxW3ryupu5YNRtKpAe_1q4crmyXotMVgJZRSMGWXl5iKzDWMiwC_7quEsZJT2cHAmP3_LSuUr9kHplGzht7tWCp5rQBSjUpemf3jlXFwmuRFvHy878n6Vhb29XovmZfEcrq_u59ttS4qHrL6SiKwf6slVqXxJ0kerW6TqFLS45uI-i0RjWZguv5iHRT4sCur9fYgygGg_lMs--YLt6EjU3m_ZHXc2JY-B25ut4Hz1a6emis3-npCWfl0YLJvTRjeJ4-SJ9pPDlbLD8IplgmUIFyyhhQM8Haz_87-jVC0aS64N_Ca4yDQAur14h9QniO3ZdWAL9ZKH3ALzGbUmSbV4T1LxqJrnjuJcMBKZCHe8DnbgndkdFZW-C8T37gDUDXGUhXkWi8GJqsPK5maslpCmZV4guu9TfT5I7Wi0JM0OGfe19ODtr177ajI1OyZrkoQhd4', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/moda-ump-preauthreqs.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874432/pdf']","['Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline', 'Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline', 'Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline', 'Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline', 'Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit', 'Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit', 'Uniform Medical Plan( UMP) coverage limits for drugs covered under UMP ’s prescription drug benefit', 'National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874432/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768745/pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/moda-ump-preauthreqs.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768748/pdf']","['36334_7_national asthma education and prevention program 2020 guideline update where do we go from here.pdf', '36334_1_treatment of nontuberculous mycobacterial pulmonary disease an official atsersescmididsa clinical practice guideline.pdf', '36334_4_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '36334_5_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '36334_6_uniform medical plan ump coverage limits for drugs covered under ump s prescription drug benefit.pdf', '36334_0_treatment of nontuberculous mycobacterial pulmonary disease an official atsersescmididsa clinical practice guideline.pdf']",6,75.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874432/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768745/pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/moda-ump-preauthreqs.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768748/pdf']","['36334_7_national asthma education and prevention program 2020 guideline update where do we go from here.pdf', '36334_1_treatment of nontuberculous mycobacterial pulmonary disease an official atsersescmididsa clinical practice guideline.pdf', '36334_4_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '36334_5_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '36334_6_uniform medical plan ump coverage limits for drugs covered under ump s prescription drug benefit.pdf', '36334_0_treatment of nontuberculous mycobacterial pulmonary disease an official atsersescmididsa clinical practice guideline.pdf']","[0.652, 0.555, 0.42, 0.405, 0.405, 0.249]","[0.524, 0.541, 0.522, 0.52, 0.52, 0.548]","[0.612, 0.624, 0.602, 0.6, 0.6, 0.628]","[0.171, 0.188, 0.148, 0.147, 0.147, 0.187]","[0.169, 0.182, 0.136, 0.135, 0.135, 0.181]","[0.128, 0.141, 0.108, 0.109, 0.109, 0.141]","[0.74, 0.748, 0.734, 0.734, 0.734, 0.749]","[0.642, 0.653, 0.638, 0.638, 0.638, 0.655]","[0.602, 0.608, 0.593, 0.591, 0.591, 0.616]","[0.663, 0.649, 0.637, 0.638, 0.638, 0.646]","[0.79, 0.786, 0.785, 0.784, 0.784, 0.793]","[0.706, 0.708, 0.703, 0.701, 0.701, 0.715]","[0.605, 0.62, 0.61, 0.611, 0.611, 0.629]","[0.916, 0.917, 0.913, 0.913, 0.913, 0.916]","[0.81, 0.815, 0.807, 0.807, 0.807, 0.816]","[0.747, 0.759, 0.753, 0.752, 0.752, 0.767]","[0.786, 0.783, 0.786, 0.786, 0.786, 0.794]","[0.769, 0.769, 0.77, 0.77, 0.77, 0.778]",0.448,0.529,0.611,0.165,0.156,0.123,0.74,0.644,0.6,0.645,0.787,0.706,0.614,0.915,0.81,0.755,0.787,0.771
https://doi.org/10.1164/rccm.201904-0772oc,tuberculosis diagnosis in children using xpert ultra on different respiratory specimens,36335_tuberculosis diagnosis in children using xpert ultra on different respiratory specimens.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf'],['Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf'],['36335_0_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078611/pdf'],['36335_0_xpert mtbrif and xpert mtbrif ultra assays for active tuberculosis and rifampicin resistance in children.pdf'],[0.404],[0.554],[0.635],[0.192],[0.186],[0.16],[0.744],[0.65],[0.616],[0.676],[0.791],[0.728],[0.626],[0.916],[0.827],[0.745],[0.801],[0.767],0.404,0.554,0.635,0.192,0.186,0.16,0.744,0.65,0.616,0.676,0.791,0.728,0.626,0.916,0.827,0.745,0.801,0.767
https://doi.org/10.1172/jci21682,antimalarial drug resistance,36366_antimalarial drug resistance.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448218/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453860/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf', 'https://www.nber.org/papers/w17943?sy=943', 'https://www.rand.org/pubs/research_reports/RR911.html']","['Artesunate plus pyronaridine for treating uncomplicated malaria', 'Artemisinin‐naphthoquine for treating uncomplicated malaria', 'Intermittent preventive antimalarial treatment for children with anaemia', 'Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial', 'The Economic Costs of Antimicrobial Resistance']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448218/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453860/pdf']","['36366_2_intermittent preventive antimalarial treatment for children with anaemia.pdf', '36366_0_artesunate plus pyronaridine for treating uncomplicated malaria.pdf', '36366_1_artemisinin‐naphthoquine for treating uncomplicated malaria.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447115/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448218/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453860/pdf']","['36366_2_intermittent preventive antimalarial treatment for children with anaemia.pdf', '36366_0_artesunate plus pyronaridine for treating uncomplicated malaria.pdf', '36366_1_artemisinin‐naphthoquine for treating uncomplicated malaria.pdf']","[0.155, 0.197, 0.158]","[0.511, 0.502, 0.518]","[0.596, 0.587, 0.602]","[0.142, 0.143, 0.146]","[0.128, 0.124, 0.139]","[0.103, 0.111, 0.121]","[0.73, 0.734, 0.734]","[0.632, 0.638, 0.637]","[0.577, 0.575, 0.587]","[0.649, 0.652, 0.657]","[0.786, 0.785, 0.789]","[0.695, 0.684, 0.698]","[0.595, 0.586, 0.586]","[0.906, 0.901, 0.904]","[0.787, 0.779, 0.792]","[0.732, 0.728, 0.737]","[0.776, 0.774, 0.778]","[0.758, 0.752, 0.76]",0.17,0.51,0.595,0.144,0.13,0.112,0.733,0.636,0.58,0.653,0.787,0.692,0.589,0.904,0.786,0.732,0.776,0.757
https://doi.org/10.1176/appi.ajp.2011.10101532,prevalence of autism spectrum disorders in a total population sample,36435_prevalence of autism spectrum disorders in a total population sample.pdf,1,['http://www.vdh.virginia.gov/content/uploads/sites/30/2018/01/AutismSpeaks_dental-toolkit_downloaded_Feb2015.pdf'],['Treating Children with Autism Spectrum Disorders'],['http://www.vdh.virginia.gov/content/uploads/sites/30/2018/01/AutismSpeaks_dental-toolkit_downloaded_Feb2015.pdf'],['36435_0_treating children with autism spectrum disorders.pdf'],1,100.0,['http://www.vdh.virginia.gov/content/uploads/sites/30/2018/01/AutismSpeaks_dental-toolkit_downloaded_Feb2015.pdf'],['36435_0_treating children with autism spectrum disorders.pdf'],[0.238],[0.558],[0.637],[0.144],[0.158],[0.132],[0.724],[0.624],[0.635],[0.652],[0.817],[0.762],[0.641],[0.925],[0.845],[0.785],[0.827],[0.802],0.238,0.558,0.637,0.144,0.158,0.132,0.724,0.624,0.635,0.652,0.817,0.762,0.641,0.925,0.845,0.785,0.827,0.802
https://doi.org/10.1176/appi.ps.57.8.1162,transformational and transactional leadership association with attitudes toward evidencebased practice,36497_transformational and transactional leadership association with attitudes toward evidencebased practice.pdf,1,['https://www.nj.gov/dcf/about/divisions/strategicdev/Blueprints_Sept2017.pdf'],['An Implementation Science and Service Provider-Informed Blueprint for Integration of Evidence-Based/ Evidence-Informed Practices into New Jersey ’s Child Welfare System'],['https://www.nj.gov/dcf/about/divisions/strategicdev/Blueprints_Sept2017.pdf'],['36497_0_an implementation science and service providerinformed blueprint for integration of evidencebased evidenceinformed practices into new jersey s child welfare system.pdf'],1,100.0,['https://www.nj.gov/dcf/about/divisions/strategicdev/Blueprints_Sept2017.pdf'],['36497_0_an implementation science and service providerinformed blueprint for integration of evidencebased evidenceinformed practices into new jersey s child welfare system.pdf'],[0.333],[0.568],[0.661],[0.184],[0.204],[0.157],[0.738],[0.644],[0.631],[0.682],[0.805],[0.737],[0.628],[0.927],[0.848],[0.779],[0.815],[0.797],0.333,0.568,0.661,0.184,0.204,0.157,0.738,0.644,0.631,0.682,0.805,0.737,0.628,0.927,0.848,0.779,0.815,0.797
https://doi.org/10.1177/0002764202250670,media contagion and suicide among the young,36546_media contagion and suicide among the young.pdf,9,"['https://stacks.cdc.gov/view/cdc/21769', 'https://purl.fdlp.gov/GPO/gpo88249', 'http://purl.fdlp.gov/GPO/gpo73785', 'https://schoolsafety.dbs.idaho.gov/wp-content/uploads/sites/106/2020/03/After-a-Suicide-toolkit-AFSP-4.21.111.pdf', 'https://www.brookings.edu/research/a-reality-check-on-suicides-in-india/', 'https://schoolsafety.dbs.idaho.gov/wp-content/uploads/sites/106/2020/03/sma12-4669.pdf', 'https://www.capitol.hawaii.gov/session2018/bills/DC175_.PDF', 'https://health.hawaii.gov/opppd/files/2018/01/HCR66-stratplan_report_180109_final2_with-appendix.pdf', 'https://www.capitol.hawaii.gov/session2018/bills/DC286_.PDF']","['CDC injury research agenda 2009-2018', 'Preventing and responding to suicide clusters in American Indian and Alaska native communities.', 'To live to see the great day that dawns :\xa0preventing suicide by American Indian and Alaska Native youth and young adults /', 'A Toolkit for Schools', 'A Reality Check on Suicides in India', ""Substance Abuse and Mental Health Services Administration's Suicide Prevention Toolkit for High Schools"", 'SUICIDE', 'REPORT TO THE HAWAI ‛I STATE LEGISLATURE TWENTY-NINTH LEGISLATURE, 2018 STATE OF HAWAI ‛I', 'Senate House Legislative Reference Bureau SOH Library System(7 copies) University of Hawaii']","['https://health.hawaii.gov/opppd/files/2018/01/HCR66-stratplan_report_180109_final2_with-appendix.pdf', 'https://www.capitol.hawaii.gov/session2018/bills/DC175_.PDF', 'https://www.capitol.hawaii.gov/session2018/bills/DC286_.PDF', 'http://purl.fdlp.gov/GPO/gpo73785', 'https://purl.fdlp.gov/GPO/gpo88249']","['36546_7_report to the hawai ‛i state legislature twentyninth legislature 2018 state of hawai ‛i.pdf', '36546_6_suicide.pdf', '36546_8_senate house legislative reference bureau soh library system7 copies university of hawaii.pdf', '36546_2_to live to see the great day that dawns \xa0preventing suicide by american indian and alaska native youth and young adults .pdf', '36546_1_preventing and responding to suicide clusters in american indian and alaska native communities.pdf']",5,55.56,"['https://health.hawaii.gov/opppd/files/2018/01/HCR66-stratplan_report_180109_final2_with-appendix.pdf', 'https://www.capitol.hawaii.gov/session2018/bills/DC175_.PDF', 'https://www.capitol.hawaii.gov/session2018/bills/DC286_.PDF', 'http://purl.fdlp.gov/GPO/gpo73785', 'https://purl.fdlp.gov/GPO/gpo88249']","['36546_7_report to the hawai ‛i state legislature twentyninth legislature 2018 state of hawai ‛i.pdf', '36546_6_suicide.pdf', '36546_8_senate house legislative reference bureau soh library system7 copies university of hawaii.pdf', '36546_2_to live to see the great day that dawns \xa0preventing suicide by american indian and alaska native youth and young adults .pdf', '36546_1_preventing and responding to suicide clusters in american indian and alaska native communities.pdf']","[0.552, 0.594, 0.696, 0.667, 0.665]","[0.516, 0.513, 0.516, 0.517, 0.515]","[0.619, 0.616, 0.619, 0.619, 0.615]","[0.171, 0.172, 0.171, 0.154, 0.165]","[0.203, 0.205, 0.203, 0.184, 0.192]","[0.171, 0.173, 0.171, 0.153, 0.159]","[0.736, 0.736, 0.736, 0.73, 0.731]","[0.641, 0.641, 0.641, 0.634, 0.637]","[0.573, 0.571, 0.573, 0.58, 0.577]","[0.69, 0.692, 0.69, 0.691, 0.685]","[0.793, 0.792, 0.793, 0.795, 0.796]","[0.713, 0.712, 0.713, 0.721, 0.716]","[0.618, 0.619, 0.618, 0.626, 0.628]","[0.918, 0.915, 0.918, 0.919, 0.915]","[0.834, 0.833, 0.834, 0.838, 0.835]","[0.756, 0.756, 0.756, 0.759, 0.754]","[0.798, 0.797, 0.798, 0.801, 0.802]","[0.783, 0.782, 0.783, 0.784, 0.784]",0.635,0.515,0.618,0.167,0.197,0.165,0.734,0.639,0.575,0.69,0.794,0.715,0.622,0.917,0.835,0.756,0.799,0.783
https://doi.org/10.1177/000313481107700337,performance in ‘war game’ simulations between medical students and interns,36576_performance in ‘war game’ simulations between medical students and interns.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389433/pdf'],['Educational games for health professionals'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389433/pdf'],['36576_0_educational games for health professionals.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389433/pdf'],['36576_0_educational games for health professionals.pdf'],[0.138],[0.476],[0.573],[0.086],[0.083],[0.07],[0.719],[0.616],[0.552],[0.596],[0.761],[0.68],[0.59],[0.914],[0.793],[0.726],[0.768],[0.751],0.138,0.476,0.573,0.086,0.083,0.07,0.719,0.616,0.552,0.596,0.761,0.68,0.59,0.914,0.793,0.726,0.768,0.751
https://doi.org/10.1177/000313481207800234,right hemicolectomy is not routinely indicated in pseudomyxoma peritonei,36577_right hemicolectomy is not routinely indicated in pseudomyxoma peritonei.pdf,1,['https://fascrs.org/ascrs/media/files/published-DCR-appy-CPG-12-19-(002).pdf'],"['The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms']",['https://fascrs.org/ascrs/media/files/published-DCR-appy-CPG-12-19-(002).pdf'],['36577_0_the american society of colon and rectal surgeons clinical practice guidelines for the management of appendiceal neoplasms.pdf'],1,100.0,['https://fascrs.org/ascrs/media/files/published-DCR-appy-CPG-12-19-(002).pdf'],['36577_0_the american society of colon and rectal surgeons clinical practice guidelines for the management of appendiceal neoplasms.pdf'],[0.601],[0.563],[0.639],[0.176],[0.203],[0.165],[0.75],[0.666],[0.624],[0.663],[0.816],[0.735],[0.633],[0.924],[0.817],[0.772],[0.807],[0.798],0.601,0.563,0.639,0.176,0.203,0.165,0.75,0.666,0.624,0.663,0.816,0.735,0.633,0.924,0.817,0.772,0.807,0.798
https://doi.org/10.1177/000313481207800710,mri as an adjunct to cervical spine clearance a utility analysis,36578_mri as an adjunct to cervical spine clearance a utility analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409130/pdf'],['Cervical spine collar clearance in the obtunded adult blunt trauma patient: A systematic review and practice management guideline from the Eastern Association for the Surgery of Trauma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409130/pdf'],['36578_0_cervical spine collar clearance in the obtunded adult blunt trauma patient a systematic review and practice management guideline from the eastern association for the surgery of trauma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409130/pdf'],['36578_0_cervical spine collar clearance in the obtunded adult blunt trauma patient a systematic review and practice management guideline from the eastern association for the surgery of trauma.pdf'],[0.542],[0.493],[0.59],[0.178],[0.201],[0.162],[0.744],[0.651],[0.562],[0.672],[0.774],[0.674],[0.608],[0.919],[0.812],[0.735],[0.771],[0.76],0.542,0.493,0.59,0.178,0.201,0.162,0.744,0.651,0.562,0.672,0.774,0.674,0.608,0.919,0.812,0.735,0.771,0.76
https://doi.org/10.1177/000313481508100420,can routine trauma bay chest xray be bypassed with an extended focused assessment with sonography for trauma examination,36580_can routine trauma bay chest xray be bypassed with an extended focused assessment with sonography for trauma examination.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517180/pdf'],['Point‐of‐care ultrasonography for diagnosing thoracoabdominal injuries in patients with blunt trauma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517180/pdf'],['36580_0_point‐of‐care ultrasonography for diagnosing thoracoabdominal injuries in patients with blunt trauma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517180/pdf'],['36580_0_point‐of‐care ultrasonography for diagnosing thoracoabdominal injuries in patients with blunt trauma.pdf'],[0.398],[0.537],[0.606],[0.175],[0.182],[0.148],[0.74],[0.645],[0.596],[0.684],[0.784],[0.713],[0.637],[0.911],[0.833],[0.745],[0.795],[0.773],0.398,0.537,0.606,0.175,0.182,0.148,0.74,0.645,0.596,0.684,0.784,0.713,0.637,0.911,0.833,0.745,0.795,0.773
https://doi.org/10.1177/000331970105202s07,flight microangiopathy in mediumto longdistance flights prevention of edema and microcirculation alterations with total triterpenic fraction of centella asiatica,36584_flight microangiopathy in mediumto longdistance flights prevention of edema and microcirculation alterations with total triterpenic fraction of centella asiatica.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173720/pdf'],['Phlebotonics for venous insufficiency'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173720/pdf'],['36584_0_phlebotonics for venous insufficiency.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173720/pdf'],['36584_0_phlebotonics for venous insufficiency.pdf'],[0.174],[0.501],[0.584],[0.145],[0.133],[0.105],[0.733],[0.641],[0.566],[0.674],[0.781],[0.67],[0.608],[0.915],[0.823],[0.74],[0.782],[0.767],0.174,0.501,0.584,0.145,0.133,0.105,0.733,0.641,0.566,0.674,0.781,0.67,0.608,0.915,0.823,0.74,0.782,0.767
https://doi.org/10.1177/00034894021110s512,pediatric outcomes with the nucleus 24 contour north american clinical trial,36592_pediatric outcomes with the nucleus 24 contour north american clinical trial.pdf,1,['https://www.hca.wa.gov/assets/program/ci_report_final_041713[1].pdf'],['Cochlear Implants : Bilateral versus Unilateral'],['https://www.hca.wa.gov/assets/program/ci_report_final_041713[1].pdf'],['36592_0_cochlear implants  bilateral versus unilateral.pdf'],1,100.0,['https://www.hca.wa.gov/assets/program/ci_report_final_041713[1].pdf'],['36592_0_cochlear implants  bilateral versus unilateral.pdf'],[0.375],[0.538],[0.615],[0.175],[0.182],[0.153],[0.738],[0.645],[0.595],[0.708],[0.791],[0.717],[0.642],[0.912],[0.797],[0.755],[0.793],[0.768],0.375,0.538,0.615,0.175,0.182,0.153,0.738,0.645,0.595,0.708,0.791,0.717,0.642,0.912,0.797,0.755,0.793,0.768
https://doi.org/10.1177/0008417419832466,meaningful occupations of young adults with muscular dystrophy and other neuromuscular disorders,36602_meaningful occupations of young adults with muscular dystrophy and other neuromuscular disorders.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673515/pdf'],['Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular Dystrophy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673515/pdf'],['36602_0_adult north star network ansn consensus guideline for the standard of care of adults with duchenne muscular dystrophy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673515/pdf'],['36602_0_adult north star network ansn consensus guideline for the standard of care of adults with duchenne muscular dystrophy.pdf'],[0.233],[0.532],[0.617],[0.104],[0.112],[0.091],[0.723],[0.621],[0.613],[0.6],[0.799],[0.749],[0.616],[0.911],[0.825],[0.771],[0.806],[0.785],0.233,0.532,0.617,0.104,0.112,0.091,0.723,0.621,0.613,0.6,0.799,0.749,0.616,0.911,0.825,0.771,0.806,0.785
https://doi.org/10.1177/0009922814561593,parent participation in a childhood immunization pain reduction method,36648_parent participation in a childhood immunization pain reduction method.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517234/pdf'],['Psychological interventions for needle‐related procedural pain and distress in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517234/pdf'],['36648_0_psychological interventions for needle‐related procedural pain and distress in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517234/pdf'],['36648_0_psychological interventions for needle‐related procedural pain and distress in children and adolescents.pdf'],[0.493],[0.53],[0.613],[0.18],[0.186],[0.154],[0.736],[0.644],[0.588],[0.693],[0.771],[0.692],[0.606],[0.918],[0.82],[0.733],[0.772],[0.76],0.493,0.53,0.613,0.18,0.186,0.154,0.736,0.644,0.588,0.693,0.771,0.692,0.606,0.918,0.82,0.733,0.772,0.76
https://doi.org/10.1177/0011128720926115,the impact of pretrial juvenile detention on 12month recidivism a matched comparison study,36687_the impact of pretrial juvenile detention on 12month recidivism a matched comparison study.pdf,6,"['http://www.bscc.ca.gov/wp-content/uploads/Beyond-Juvenile-Justice-February-2021.pdf', 'https://www.bscc.ca.gov/wp-content/uploads/C.-2-Beyond-Juvenile-Justice-February-2021.pdf', 'https://www.bscc.ca.gov/wp-content/uploads/E.-1-2021-23-State-Plan-CA-Juvenile-Justice-Description-and-Needs-DRAFT.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2021-2023-Title-II-3-Year-State-Plan-Final.pdf', 'https://www.bscc.ca.gov/wp-content/uploads/C.-1-Beyond-Juvenile-Justice.pdf', 'https://bscc.ca.gov/wp-content/uploads/D.-1-2021-2023-Title-II-3-Year-State-Plan-DRAFT.pdf']","['Beyond Juvenile Justice', 'Beyond Juvenile Justice', 'Program Narrative', 'California ’ s Comprehensive State Plan', 'Beyond Juvenile Justice', 'California ’ s Comprehensive State Plan']","['http://www.bscc.ca.gov/wp-content/uploads/Beyond-Juvenile-Justice-February-2021.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2021-2023-Title-II-3-Year-State-Plan-Final.pdf']","['36687_0_beyond juvenile justice.pdf', '36687_3_california  s comprehensive state plan.pdf']",2,33.33,"['http://www.bscc.ca.gov/wp-content/uploads/Beyond-Juvenile-Justice-February-2021.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2021-2023-Title-II-3-Year-State-Plan-Final.pdf']","['36687_0_beyond juvenile justice.pdf', '36687_3_california  s comprehensive state plan.pdf']","[0.367, 0.288]","[0.537, 0.539]","[0.623, 0.62]","[0.17, 0.176]","[0.21, 0.209]","[0.163, 0.173]","[0.724, 0.73]","[0.622, 0.632]","[0.598, 0.602]","[0.684, 0.69]","[0.811, 0.793]","[0.752, 0.74]","[0.645, 0.638]","[0.928, 0.927]","[0.835, 0.835]","[0.768, 0.765]","[0.818, 0.803]","[0.791, 0.785]",0.328,0.538,0.621,0.173,0.209,0.168,0.727,0.627,0.6,0.687,0.802,0.746,0.641,0.927,0.835,0.766,0.81,0.788
https://doi.org/10.1177/003335490512000203,rethinking raceethnicity income and childhood asthma racialethnic disparities concentrated among the very poor,36927_rethinking raceethnicity income and childhood asthma racialethnic disparities concentrated among the very poor.pdf,7,"['https://www.energy.ca.gov/sites/default/files/2019-11/Statewide%20Reports-%20SUM-CCCA4-2018-012%20ClimateJusticeSummary_ADA.pdf', 'https://louisvilleky.gov/sites/default/files/health_and_wellness/che/health_equity_report/health_equity_report.pdf', 'https://louisvilleky.gov/sites/default/files/health_and_wellness/che/health_equity_report/health_equity_report_as_pages.pdf', 'http://caa.wa.gov/sites/default/files/public/documents/OfficeDocs/Creating%20an%20Equitable%20Future%20Publication.pdf', 'https://www.sbe.wa.gov/sites/default/files/public/documents/BoardMeetings/2015/July/03RaceAndSocialJustice.pdf', 'https://www.rand.org/pubs/working_papers/WR310.html', 'https://www.sbe.wa.gov/sites/default/files/public/documents/BoardMeetings/2015/July/July2015CompletePacket5.pdf']","['Climate Justice Report', 'Health Equity', 'Health Equity', '20 15', 'Title: As Related To:', 'Neighborhood Effects and the Role of Communities in Restructuring', 'June 26, 2015']","['http://caa.wa.gov/sites/default/files/public/documents/OfficeDocs/Creating%20an%20Equitable%20Future%20Publication.pdf', 'https://www.energy.ca.gov/sites/default/files/2019-11/Statewide%20Reports-%20SUM-CCCA4-2018-012%20ClimateJusticeSummary_ADA.pdf', 'https://www.sbe.wa.gov/sites/default/files/public/documents/BoardMeetings/2015/July/July2015CompletePacket5.pdf', 'https://www.sbe.wa.gov/sites/default/files/public/documents/BoardMeetings/2015/July/03RaceAndSocialJustice.pdf']","['36927_3_20 15.pdf', '36927_0_climate justice report.pdf', '36927_6_june 26 2015.pdf', '36927_4_title as related to.pdf']",4,57.14,"['http://caa.wa.gov/sites/default/files/public/documents/OfficeDocs/Creating%20an%20Equitable%20Future%20Publication.pdf', 'https://www.energy.ca.gov/sites/default/files/2019-11/Statewide%20Reports-%20SUM-CCCA4-2018-012%20ClimateJusticeSummary_ADA.pdf', 'https://www.sbe.wa.gov/sites/default/files/public/documents/BoardMeetings/2015/July/July2015CompletePacket5.pdf', 'https://www.sbe.wa.gov/sites/default/files/public/documents/BoardMeetings/2015/July/03RaceAndSocialJustice.pdf']","['36927_3_20 15.pdf', '36927_0_climate justice report.pdf', '36927_6_june 26 2015.pdf', '36927_4_title as related to.pdf']","[0.129, 0.308, 0.271, 0.12]","[0.552, 0.526, 0.513, 0.543]","[0.638, 0.615, 0.599, 0.629]","[0.15, 0.129, 0.114, 0.133]","[0.173, 0.138, 0.128, 0.154]","[0.142, 0.107, 0.09, 0.125]","[0.724, 0.724, 0.717, 0.721]","[0.627, 0.625, 0.611, 0.62]","[0.621, 0.596, 0.604, 0.62]","[0.673, 0.656, 0.654, 0.669]","[0.815, 0.807, 0.799, 0.81]","[0.755, 0.719, 0.735, 0.752]","[0.643, 0.627, 0.631, 0.635]","[0.918, 0.909, 0.919, 0.918]","[0.842, 0.828, 0.836, 0.844]","[0.785, 0.757, 0.764, 0.777]","[0.823, 0.807, 0.807, 0.819]","[0.799, 0.785, 0.78, 0.794]",0.207,0.534,0.62,0.132,0.148,0.116,0.722,0.621,0.61,0.663,0.808,0.74,0.634,0.916,0.837,0.771,0.814,0.789
https://doi.org/10.1177/003335490512000315,screening housing to prevent lead toxicity in children,36928_screening housing to prevent lead toxicity in children.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461195/pdf']","['Household interventions for secondary prevention of domestic lead exposure in children', 'Household interventions for preventing domestic lead exposure in children']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461195/pdf']","['36928_0_household interventions for secondary prevention of domestic lead exposure in children.pdf', '36928_1_household interventions for preventing domestic lead exposure in children.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094406/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461195/pdf']","['36928_0_household interventions for secondary prevention of domestic lead exposure in children.pdf', '36928_1_household interventions for preventing domestic lead exposure in children.pdf']","[0.576, 0.631]","[0.523, 0.519]","[0.601, 0.6]","[0.178, 0.18]","[0.174, 0.179]","[0.151, 0.155]","[0.736, 0.738]","[0.64, 0.643]","[0.574, 0.571]","[0.695, 0.697]","[0.784, 0.781]","[0.688, 0.682]","[0.608, 0.61]","[0.913, 0.911]","[0.82, 0.817]","[0.739, 0.735]","[0.78, 0.777]","[0.764, 0.761]",0.603,0.521,0.601,0.179,0.176,0.153,0.737,0.641,0.573,0.696,0.782,0.685,0.609,0.912,0.819,0.737,0.778,0.762
https://doi.org/10.1177/003335490712200209,determining the effect of newborn hearing screening legislation an analysis of state hearing screening rates,36934_determining the effect of newborn hearing screening legislation an analysis of state hearing screening rates.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821847/pdf'],['Newborn Hearing Screening and Follow-up: Are Children Receiving Recommended Services?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821847/pdf'],['36934_0_newborn hearing screening and followup are children receiving recommended services.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821847/pdf'],['36934_0_newborn hearing screening and followup are children receiving recommended services.pdf'],[0.424],[0.55],[0.624],[0.201],[0.211],[0.178],[0.729],[0.637],[0.613],[0.698],[0.799],[0.706],[0.656],[0.913],[0.834],[0.775],[0.804],[0.783],0.424,0.55,0.624,0.201,0.211,0.178,0.729,0.637,0.613,0.698,0.799,0.706,0.656,0.913,0.834,0.775,0.804,0.783
https://doi.org/10.1177/00333549111260s106,making child care centers safer a nonregulatory approach to improving child care center siting,36945_making child care centers safer a nonregulatory approach to improving child care center siting.pdf,2,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.eli.org/research-report/reducing-environmental-exposures-child-care-facilities-review-state-policy']","['America’s children and the environment.', 'Reducing Environmental Exposures in Child Care Facilities: A Review of State Policy']",['https://purl.fdlp.gov/GPO/gpo63641'],['36945_0_americas children and the environment.pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo63641'],['36945_0_americas children and the environment.pdf'],[0.434],[0.525],[0.613],[0.137],[0.14],[0.106],[0.719],[0.622],[0.596],[0.646],[0.81],[0.727],[0.644],[0.915],[0.834],[0.769],[0.81],[0.794],0.434,0.525,0.613,0.137,0.14,0.106,0.719,0.622,0.596,0.646,0.81,0.727,0.644,0.915,0.834,0.769,0.81,0.794
https://doi.org/10.1177/003335491312800508,from newborn screening to population health research implementation of the michigan biotrust for health,36951_from newborn screening to population health research implementation of the michigan biotrust for health.pdf,1,['https://www.lrl.mn.gov/docs/2014/mandated/140069.pdf'],['Newborn Screening Program Study On Comprehensive and Sustainable Long-Term Storage and Use: Report to the Minnesota Legislature 2014'],['https://www.lrl.mn.gov/docs/2014/mandated/140069.pdf'],['36951_0_newborn screening program study on comprehensive and sustainable longterm storage and use report to the minnesota legislature 2014.pdf'],1,100.0,['https://www.lrl.mn.gov/docs/2014/mandated/140069.pdf'],['36951_0_newborn screening program study on comprehensive and sustainable longterm storage and use report to the minnesota legislature 2014.pdf'],[0.472],[0.605],[0.674],[0.213],[0.223],[0.179],[0.733],[0.638],[0.683],[0.673],[0.836],[0.792],[0.68],[0.935],[0.874],[0.812],[0.852],[0.825],0.472,0.605,0.674,0.213,0.223,0.179,0.733,0.638,0.683,0.673,0.836,0.792,0.68,0.935,0.874,0.812,0.852,0.825
https://doi.org/10.1177/0093854819835277,preventing juvenile transitions to adult crime a pilot study of probation interventions for older highrisk juvenile delinquents,37116_preventing juvenile transitions to adult crime a pilot study of probation interventions for older highrisk juvenile delinquents.pdf,1,['https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/1/Wsipp_BenefitCost_ProgramDetails_Juvenile-Justice'],['Washington State Institute for Public Policy'],['https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/1/Wsipp_BenefitCost_ProgramDetails_Juvenile-Justice'],['37116_0_washington state institute for public policy.pdf'],1,100.0,['https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/1/Wsipp_BenefitCost_ProgramDetails_Juvenile-Justice'],['37116_0_washington state institute for public policy.pdf'],[0.249],[0.556],[0.637],[0.159],[0.186],[0.148],[0.72],[0.624],[0.616],[0.701],[0.801],[0.743],[0.652],[0.928],[0.833],[0.775],[0.813],[0.794],0.249,0.556,0.637,0.159,0.186,0.148,0.72,0.624,0.616,0.701,0.801,0.743,0.652,0.928,0.833,0.775,0.813,0.794
https://doi.org/10.1177/0093854819859045,the application of risk–needs programming in a juvenile diversion program,37117_the application of risk–needs programming in a juvenile diversion program.pdf,2,"['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf']","['Qe UNC CHARLOTTE UrbanInstitute ai', 'CMPD Youth Program Assessment']","['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf']","['37117_0_qe unc charlotte urbaninstitute ai.pdf', '37117_1_cmpd youth program assessment.pdf']",2,100.0,"['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf']","['37117_0_qe unc charlotte urbaninstitute ai.pdf', '37117_1_cmpd youth program assessment.pdf']","[0.435, 0.418]","[0.558, 0.546]","[0.646, 0.634]","[0.19, 0.175]","[0.222, 0.212]","[0.176, 0.166]","[0.735, 0.731]","[0.64, 0.634]","[0.616, 0.61]","[0.687, 0.681]","[0.803, 0.799]","[0.742, 0.741]","[0.65, 0.647]","[0.918, 0.918]","[0.842, 0.84]","[0.779, 0.773]","[0.815, 0.812]","[0.796, 0.792]",0.426,0.552,0.64,0.182,0.217,0.171,0.733,0.637,0.613,0.684,0.801,0.742,0.649,0.918,0.841,0.776,0.814,0.794
https://doi.org/10.1177/0093854820952115,protective factors for reducing juvenile reoffending an examination of incremental and differential predictive validity,37118_protective factors for reducing juvenile reoffending an examination of incremental and differential predictive validity.pdf,1,['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf'],['Qe UNC CHARLOTTE UrbanInstitute ai'],['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf'],['37118_0_qe unc charlotte urbaninstitute ai.pdf'],1,100.0,['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf'],['37118_0_qe unc charlotte urbaninstitute ai.pdf'],[0.307],[0.553],[0.641],[0.184],[0.213],[0.17],[0.734],[0.639],[0.603],[0.69],[0.8],[0.731],[0.644],[0.921],[0.833],[0.772],[0.808],[0.79],0.307,0.553,0.641,0.184,0.213,0.17,0.734,0.639,0.603,0.69,0.8,0.731,0.644,0.921,0.833,0.772,0.808,0.79
https://doi.org/10.1177/0194599820931836,endoscopic skull base surgery protocol from the frontlines transnasal surgery during the covid19 pandemic,37303_endoscopic skull base surgery protocol from the frontlines transnasal surgery during the covid19 pandemic.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714255/pdf'],['CSO (Canadian Society of Otolaryngology - Head & Neck Surgery) position paper on rhinologic and skull base surgery during the COVID-19 pandemic'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714255/pdf'],['37303_0_cso canadian society of otolaryngology  head  neck surgery position paper on rhinologic and skull base surgery during the covid19 pandemic.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714255/pdf'],['37303_0_cso canadian society of otolaryngology  head  neck surgery position paper on rhinologic and skull base surgery during the covid19 pandemic.pdf'],[0.702],[0.562],[0.64],[0.178],[0.19],[0.143],[0.744],[0.653],[0.632],[0.634],[0.813],[0.749],[0.632],[0.927],[0.839],[0.778],[0.817],[0.802],0.702,0.562,0.64,0.178,0.19,0.143,0.744,0.653,0.632,0.634,0.813,0.749,0.632,0.927,0.839,0.778,0.817,0.802
https://doi.org/10.1177/019874290202800103,teacherreported behavior problems and language delays in boys and girls enrolled in head start,37306_teacherreported behavior problems and language delays in boys and girls enrolled in head start.pdf,2,"['https://www.ccf.ny.gov/files/2713/8262/0297/Resource20Guide20FULL.pdf', 'https://www.ccf.ny.gov/files/4013/8262/0206/Resource20Guide20Section20320Data20for20System20Change.pdf']","['Using Data to Build Comprehensive Systems for Infants and Families', 'Session Three : Using Data For System Change']","['https://www.ccf.ny.gov/files/2713/8262/0297/Resource20Guide20FULL.pdf', 'https://www.ccf.ny.gov/files/4013/8262/0206/Resource20Guide20Section20320Data20for20System20Change.pdf']","['37306_0_using data to build comprehensive systems for infants and families.pdf', '37306_1_session three  using data for system change.pdf']",2,100.0,"['https://www.ccf.ny.gov/files/2713/8262/0297/Resource20Guide20FULL.pdf', 'https://www.ccf.ny.gov/files/4013/8262/0206/Resource20Guide20Section20320Data20for20System20Change.pdf']","['37306_0_using data to build comprehensive systems for infants and families.pdf', '37306_1_session three  using data for system change.pdf']","[0.39, 0.414]","[0.536, 0.547]","[0.617, 0.623]","[0.138, 0.173]","[0.153, 0.198]","[0.13, 0.168]","[0.723, 0.733]","[0.62, 0.631]","[0.605, 0.607]","[0.681, 0.698]","[0.797, 0.793]","[0.737, 0.735]","[0.634, 0.638]","[0.925, 0.926]","[0.83, 0.826]","[0.767, 0.77]","[0.805, 0.804]","[0.785, 0.788]",0.402,0.542,0.62,0.155,0.175,0.149,0.728,0.625,0.606,0.69,0.795,0.736,0.636,0.925,0.828,0.768,0.804,0.786
https://doi.org/10.1177/019874291003600106,improving family involvement for juvenile offenders with emotionalbehavioral disorders and related disabilities,37312_improving family involvement for juvenile offenders with emotionalbehavioral disorders and related disabilities.pdf,1,['http://purl.fdlp.gov/GPO/gpo71059'],['Guiding principles for providing quality high-quality education in juvenile justice secure care settings /'],['http://purl.fdlp.gov/GPO/gpo71059'],['37312_0_guiding principles for providing quality highquality education in juvenile justice secure care settings .pdf'],1,100.0,['http://purl.fdlp.gov/GPO/gpo71059'],['37312_0_guiding principles for providing quality highquality education in juvenile justice secure care settings .pdf'],[0.38],[0.578],[0.661],[0.209],[0.224],[0.194],[0.742],[0.649],[0.644],[0.665],[0.825],[0.765],[0.663],[0.924],[0.849],[0.792],[0.832],[0.817],0.38,0.578,0.661,0.209,0.224,0.194,0.742,0.649,0.644,0.665,0.825,0.765,0.663,0.924,0.849,0.792,0.832,0.817
https://doi.org/10.1177/0267659119827231,risk factors for critical limb ischemia in patients undergoing femoral cannulation for venoarterial extracorporeal membrane oxygenation is distal limb perfusion a mandatory approach,37327_risk factors for critical limb ischemia in patients undergoing femoral cannulation for venoarterial extracorporeal membrane oxygenation is distal limb perfusion a mandatory approach.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984716/pdf'],['Extracorporeal Cardiopulmonary Resuscitation in Adults. Interim Guideline Consensus Statement From the Extracorporeal Life Support Organization'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984716/pdf'],['37327_0_extracorporeal cardiopulmonary resuscitation in adults interim guideline consensus statement from the extracorporeal life support organization.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984716/pdf'],['37327_0_extracorporeal cardiopulmonary resuscitation in adults interim guideline consensus statement from the extracorporeal life support organization.pdf'],[0.311],[0.58],[0.644],[0.2],[0.215],[0.154],[0.747],[0.654],[0.644],[0.647],[0.808],[0.757],[0.632],[0.93],[0.838],[0.79],[0.818],[0.803],0.311,0.58,0.644,0.2,0.215,0.154,0.747,0.654,0.644,0.647,0.808,0.757,0.632,0.93,0.838,0.79,0.818,0.803
https://doi.org/10.1177/0269215519865993,effects of a robot intervention on visuospatial hemineglect in postacute stroke patients a randomized controlled trial,37334_effects of a robot intervention on visuospatial hemineglect in postacute stroke patients a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247630/pdf'],['Non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain injury'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247630/pdf'],['37334_0_non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain injury.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247630/pdf'],['37334_0_non‐pharmacological interventions for spatial neglect or inattention following stroke and other non‐progressive brain injury.pdf'],[0.469],[0.507],[0.591],[0.162],[0.156],[0.135],[0.736],[0.643],[0.567],[0.704],[0.763],[0.664],[0.59],[0.912],[0.812],[0.722],[0.761],[0.75],0.469,0.507,0.591,0.162,0.156,0.135,0.736,0.643,0.567,0.704,0.763,0.664,0.59,0.912,0.812,0.722,0.761,0.75
https://doi.org/10.1177/0269216319857622,challenges and support needs of parents and children when a parent is at end of life a systematic review,37341_challenges and support needs of parents and children when a parent is at end of life a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411064/pdf'],['Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411064/pdf'],['37341_0_care of the adult cancer patient at the end of life esmo clinical practice guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411064/pdf'],['37341_0_care of the adult cancer patient at the end of life esmo clinical practice guidelines.pdf'],[0.329],[0.553],[0.631],[0.14],[0.155],[0.122],[0.729],[0.635],[0.624],[0.654],[0.806],[0.754],[0.627],[0.924],[0.838],[0.778],[0.816],[0.799],0.329,0.553,0.631,0.14,0.155,0.122,0.729,0.635,0.624,0.654,0.806,0.754,0.627,0.924,0.838,0.778,0.816,0.799
https://doi.org/10.1177/0306624x18811083,unpacking adultification institutional experiences and misconduct of adult court and juvenile court youth living under the same roof,37501_unpacking adultification institutional experiences and misconduct of adult court and juvenile court youth living under the same roof.pdf,1,['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['Juvenile Justice Realignment Block Grant Annual Plan'],['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['37501_0_juvenile justice realignment block grant annual plan.pdf'],1,100.0,['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['37501_0_juvenile justice realignment block grant annual plan.pdf'],[0.408],[0.561],[0.641],[0.192],[0.222],[0.181],[0.733],[0.639],[0.626],[0.677],[0.809],[0.75],[0.658],[0.929],[0.839],[0.781],[0.816],[0.798],0.408,0.561,0.641,0.192,0.222,0.181,0.733,0.639,0.626,0.677,0.809,0.75,0.658,0.929,0.839,0.781,0.816,0.798
https://doi.org/10.1177/0310057x0403200613,sedation for paediatric stereotactic radiosurgery the dexmedetomidine experience,37516_sedation for paediatric stereotactic radiosurgery the dexmedetomidine experience.pdf,1,['https://www.hca.wa.gov/assets/program/appendix_b_excluded_references_103112[1].pdf'],['Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy'],['https://www.hca.wa.gov/assets/program/appendix_b_excluded_references_103112[1].pdf'],['37516_0_stereotactic radiosurgery and stereotactic body radiation therapy.pdf'],1,100.0,['https://www.hca.wa.gov/assets/program/appendix_b_excluded_references_103112[1].pdf'],['37516_0_stereotactic radiosurgery and stereotactic body radiation therapy.pdf'],[0.184],[0.505],[0.591],[0.14],[0.136],[0.106],[0.744],[0.643],[0.571],[0.607],[0.782],[0.695],[0.597],[0.92],[0.785],[0.738],[0.779],[0.766],0.184,0.505,0.591,0.14,0.136,0.106,0.744,0.643,0.571,0.607,0.782,0.695,0.597,0.92,0.785,0.738,0.779,0.766
https://doi.org/10.1177/0361198106198000109,eyeglance behavior of novice teen and experienced adult drivers,37519_eyeglance behavior of novice teen and experienced adult drivers.pdf,1,['https://www.mass.gov/doc/mitigation-techniques-to-modify-driver-performance-to-improve-fuel-economy-reduce-emissions-and/download'],"['Mitigation Techniques to Modify Driver Performance to Improve Fuel Economy, Reduce Emissions and Improve Safety']",['https://www.mass.gov/doc/mitigation-techniques-to-modify-driver-performance-to-improve-fuel-economy-reduce-emissions-and/download'],['37519_0_mitigation techniques to modify driver performance to improve fuel economy reduce emissions and improve safety.pdf'],1,100.0,['https://www.mass.gov/doc/mitigation-techniques-to-modify-driver-performance-to-improve-fuel-economy-reduce-emissions-and/download'],['37519_0_mitigation techniques to modify driver performance to improve fuel economy reduce emissions and improve safety.pdf'],[0.267],[0.526],[0.614],[0.145],[0.151],[0.128],[0.736],[0.633],[0.587],[0.712],[0.778],[0.718],[0.645],[0.925],[0.826],[0.751],[0.785],[0.773],0.267,0.526,0.614,0.145,0.151,0.128,0.736,0.633,0.587,0.712,0.778,0.718,0.645,0.925,0.826,0.751,0.785,0.773
https://doi.org/10.1177/0361684319889595,an inhospitable world exploring a model of objectification theory with trans women,37522_an inhospitable world exploring a model of objectification theory with trans women.pdf,1,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['Report & Recommendations For Fiscal Year 2022'],['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['37522_0_report  recommendations for fiscal year 2022.pdf'],1,100.0,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['37522_0_report  recommendations for fiscal year 2022.pdf'],[0.151],[0.54],[0.627],[0.131],[0.152],[0.117],[0.721],[0.626],[0.602],[0.642],[0.809],[0.749],[0.639],[0.926],[0.83],[0.773],[0.814],[0.793],0.151,0.54,0.627,0.131,0.152,0.117,0.721,0.626,0.602,0.642,0.809,0.749,0.639,0.926,0.83,0.773,0.814,0.793
https://doi.org/10.1177/0363546509350325,biodegradable screw versus a pressfit bone plug fixation for hamstring anterior cruciate ligament reconstruction,37524_biodegradable screw versus a pressfit bone plug fixation for hamstring anterior cruciate ligament reconstruction.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458013/pdf'],['Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458013/pdf'],['37524_0_bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458013/pdf'],['37524_0_bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction.pdf'],[0.379],[0.51],[0.59],[0.155],[0.144],[0.115],[0.736],[0.638],[0.574],[0.663],[0.771],[0.687],[0.604],[0.906],[0.788],[0.729],[0.773],[0.752],0.379,0.51,0.59,0.155,0.144,0.115,0.736,0.638,0.574,0.663,0.771,0.687,0.604,0.906,0.788,0.729,0.773,0.752
https://doi.org/10.1177/070674370200601s07,responses to methylphenidate in attentiondeficithyperactivity disorder and normal children update 2002,37542_responses to methylphenidate in attentiondeficithyperactivity disorder and normal children update 2002.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485546/pdf'],['Bupropion for attention deficit hyperactivity disorder (ADHD) in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485546/pdf'],['37542_0_bupropion for attention deficit hyperactivity disorder adhd in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485546/pdf'],['37542_0_bupropion for attention deficit hyperactivity disorder adhd in adults.pdf'],[0.243],[0.503],[0.587],[0.148],[0.155],[0.134],[0.734],[0.639],[0.579],[0.701],[0.774],[0.697],[0.586],[0.918],[0.801],[0.734],[0.775],[0.76],0.243,0.503,0.587,0.148,0.155,0.134,0.734,0.639,0.579,0.701,0.774,0.697,0.586,0.918,0.801,0.734,0.775,0.76
https://doi.org/10.1177/0885412218812080,housing tenure and social vulnerability to disasters a review of the evidence,37709_housing tenure and social vulnerability to disasters a review of the evidence.pdf,2,"['https://stormrecovery.ny.gov/sites/default/files/crp/community/documents/NYS%20Action%20Plan%20-%20Hurricane%20Ida.pdf', 'https://www.recovery.texas.gov/files/resources/planning/alternative-housing-study-findings-report.pdf']","['Public Action Plan', 'Disaster Recovery Alternative Housing Study']","['https://stormrecovery.ny.gov/sites/default/files/crp/community/documents/NYS%20Action%20Plan%20-%20Hurricane%20Ida.pdf', 'https://www.recovery.texas.gov/files/resources/planning/alternative-housing-study-findings-report.pdf']","['37709_0_public action plan.pdf', '37709_1_disaster recovery alternative housing study.pdf']",2,100.0,"['https://stormrecovery.ny.gov/sites/default/files/crp/community/documents/NYS%20Action%20Plan%20-%20Hurricane%20Ida.pdf', 'https://www.recovery.texas.gov/files/resources/planning/alternative-housing-study-findings-report.pdf']","['37709_0_public action plan.pdf', '37709_1_disaster recovery alternative housing study.pdf']","[0.501, 0.459]","[0.548, 0.53]","[0.636, 0.613]","[0.189, 0.146]","[0.204, 0.16]","[0.161, 0.125]","[0.728, 0.724]","[0.633, 0.628]","[0.617, 0.597]","[0.686, 0.673]","[0.819, 0.807]","[0.736, 0.72]","[0.663, 0.653]","[0.923, 0.923]","[0.859, 0.852]","[0.783, 0.768]","[0.826, 0.817]","[0.805, 0.796]",0.48,0.539,0.625,0.167,0.182,0.143,0.726,0.631,0.607,0.679,0.813,0.728,0.658,0.923,0.855,0.776,0.821,0.8
https://doi.org/10.1177/0886260502017009001,findings from a communitybased program for battered women and their children,37719_findings from a communitybased program for battered women and their children.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485809/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.acf.hhs.gov/opre/report/state-evidence-evidence-recognizing-and-addressing-intimate-partner-violence-healthy', 'https://www.pccd.pa.gov/Victim-Services/Documents/Volume%20VI%20final.pdf', 'https://www.acf.hhs.gov/opre/resource/state-of-the-evidence-evidence-on-recognizing-and-addressing-intimate-partner-violence-in-healthy-relationship-programs', 'https://www.urban.org/research/publication/evaluation-polyvictimization-initiative-queens-family-justice-center']","['Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases', 'Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse', 'A realist review of which advocacy interventions work for which abused women under what circumstances', 'State of the Evidence: Evidence on Recognizing and Addressing Intimate Partner Violence in Healthy Relationship Programs', 'Volume VI : Crime Victim Needs : Insights from Research', 'State of the Evidence: Evidence on Recognizing and Addressing Intimate Partner Violence in Healthy Relationship Programs', 'Evaluation of the Polyvictimization Initiative at the Queens Family Justice Center']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485809/pdf', 'https://www.pccd.pa.gov/Victim-Services/Documents/Volume%20VI%20final.pdf']","['37719_1_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse.pdf', '37719_2_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf', '37719_0_lay health workers in primary and community health care for maternal and child health and the management of infectious diseases.pdf', '37719_4_volume vi  crime victim needs  insights from research.pdf']",4,57.14,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485809/pdf', 'https://www.pccd.pa.gov/Victim-Services/Documents/Volume%20VI%20final.pdf']","['37719_1_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse.pdf', '37719_2_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf', '37719_0_lay health workers in primary and community health care for maternal and child health and the management of infectious diseases.pdf', '37719_4_volume vi  crime victim needs  insights from research.pdf']","[0.358, 0.481, 0.453, 0.293]","[0.512, 0.529, 0.518, 0.522]","[0.592, 0.61, 0.596, 0.614]","[0.159, 0.163, 0.14, 0.163]","[0.166, 0.173, 0.142, 0.183]","[0.143, 0.145, 0.119, 0.151]","[0.729, 0.726, 0.722, 0.726]","[0.636, 0.632, 0.627, 0.633]","[0.563, 0.583, 0.577, 0.57]","[0.709, 0.696, 0.683, 0.683]","[0.768, 0.782, 0.772, 0.781]","[0.691, 0.713, 0.701, 0.712]","[0.591, 0.616, 0.595, 0.627]","[0.911, 0.918, 0.919, 0.918]","[0.802, 0.824, 0.813, 0.809]","[0.714, 0.74, 0.727, 0.742]","[0.769, 0.788, 0.781, 0.788]","[0.748, 0.77, 0.759, 0.767]",0.396,0.52,0.603,0.156,0.166,0.139,0.726,0.632,0.573,0.693,0.776,0.704,0.607,0.917,0.812,0.731,0.782,0.761
https://doi.org/10.1177/0886260519844277,childhood adversity and intimate partner violence in adulthood the mediating influence of ptsd in a sample of women prisoners,37804_childhood adversity and intimate partner violence in adulthood the mediating influence of ptsd in a sample of women prisoners.pdf,1,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['2021 : How Gender And Race'],['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['37804_0_2021  how gender and race.pdf'],1,100.0,['https://www.courts.wa.gov/subsite/gjc/documents/2021_Gender_Justice_Study_Report.pdf'],['37804_0_2021  how gender and race.pdf'],[0.333],[0.515],[0.605],[0.139],[0.154],[0.13],[0.724],[0.626],[0.569],[0.672],[0.779],[0.704],[0.622],[0.91],[0.817],[0.748],[0.781],[0.764],0.333,0.515,0.605,0.139,0.154,0.13,0.724,0.626,0.569,0.672,0.779,0.704,0.622,0.91,0.817,0.748,0.781,0.764
https://doi.org/10.1177/0886260519865972,evaluation of a multisession group designed to prevent commercial sexual exploitation of minors the “my life my choice” curriculum,37805_evaluation of a multisession group designed to prevent commercial sexual exploitation of minors the “my life my choice” curriculum.pdf,4,"['https://aspe.hhs.gov/reports/peer-support-social-capital-development', 'https://www.acf.hhs.gov/opre/report/survey-youth-currently-and-formerly-foster-care-risk-human-trafficking-final-report', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Research-1st-Edition-2020.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Archived-Research-Resources-2019.pdf']","['Peer Support as a Social Capital Strategy for Programs Serving Individuals Reentering from Incarceration and Survivors of Intimate Partner Violence or Human Sex Trafficking', 'Survey of Youth Currently and Formerly in Foster Care at Risk for Human Trafficking: Final Report', 'Child Sex Trafficking Team, Office of the Governor - Research Resources 1st Edition for 2020', 'Child Sex Trafficking Team, Office of the Governor - Archived Research Resources for 2019']","['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Research-1st-Edition-2020.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Archived-Research-Resources-2019.pdf']","['37805_2_child sex trafficking team office of the governor  research resources 1st edition for 2020.pdf', '37805_3_child sex trafficking team office of the governor  archived research resources for 2019.pdf']",2,50.0,"['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Research-1st-Edition-2020.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-Archived-Research-Resources-2019.pdf']","['37805_2_child sex trafficking team office of the governor  research resources 1st edition for 2020.pdf', '37805_3_child sex trafficking team office of the governor  archived research resources for 2019.pdf']","[0.391, 0.43]","[0.558, 0.557]","[0.643, 0.64]","[0.176, 0.171]","[0.194, 0.188]","[0.154, 0.15]","[0.734, 0.732]","[0.639, 0.638]","[0.618, 0.617]","[0.657, 0.654]","[0.802, 0.802]","[0.744, 0.747]","[0.646, 0.644]","[0.919, 0.919]","[0.839, 0.835]","[0.781, 0.778]","[0.815, 0.813]","[0.796, 0.793]",0.41,0.558,0.641,0.173,0.191,0.152,0.733,0.639,0.617,0.655,0.802,0.746,0.645,0.919,0.837,0.78,0.814,0.794
https://doi.org/10.1177/0886260520915554,suicidality among transgender youth elucidating the role of interpersonal risk factors,37806_suicidality among transgender youth elucidating the role of interpersonal risk factors.pdf,2,"['https://oag.ca.gov/system/files/attachments/press-docs/Comment%20Letter.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf']","['Letitia James Attorney General', 'In The United States Court Of Appeals For The Eleventh Circuit']","['https://oag.ca.gov/system/files/attachments/press-docs/Comment%20Letter.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf']","['37806_0_letitia james attorney general.pdf', '37806_1_in the united states court of appeals for the eleventh circuit.pdf']",2,100.0,"['https://oag.ca.gov/system/files/attachments/press-docs/Comment%20Letter.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Eknes-Tucker%20amicus.pdf']","['37806_0_letitia james attorney general.pdf', '37806_1_in the united states court of appeals for the eleventh circuit.pdf']","[0.271, 0.379]","[0.479, 0.481]","[0.578, 0.574]","[0.12, 0.134]","[0.132, 0.147]","[0.109, 0.126]","[0.722, 0.729]","[0.629, 0.635]","[0.543, 0.545]","[0.663, 0.674]","[0.756, 0.766]","[0.671, 0.667]","[0.6, 0.603]","[0.908, 0.91]","[0.786, 0.794]","[0.717, 0.726]","[0.758, 0.759]","[0.739, 0.742]",0.325,0.48,0.576,0.127,0.14,0.117,0.726,0.632,0.544,0.669,0.761,0.669,0.601,0.909,0.79,0.722,0.758,0.74
https://doi.org/10.1177/0890334404266881,transfer of naltrexone and its metabolite 6 βnaltrexol into human milk,37850_transfer of naltrexone and its metabolite 6 βnaltrexol into human milk.pdf,2,"['https://purl.fdlp.gov/GPO/gpo89222', 'https://dcs.az.gov/sites/default/files/Clinical%20Guidance%20for%20Treating%20Pregnant%20and%20Parenting%20Women%20with%20Opiod%20Use%20Disorder.pdf']","['Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants.', 'Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants']","['https://purl.fdlp.gov/GPO/gpo89222', 'https://dcs.az.gov/sites/default/files/Clinical%20Guidance%20for%20Treating%20Pregnant%20and%20Parenting%20Women%20with%20Opiod%20Use%20Disorder.pdf']","['37850_0_clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants.pdf', '37850_1_clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants.pdf']",2,100.0,"['https://purl.fdlp.gov/GPO/gpo89222', 'https://dcs.az.gov/sites/default/files/Clinical%20Guidance%20for%20Treating%20Pregnant%20and%20Parenting%20Women%20with%20Opiod%20Use%20Disorder.pdf']","['37850_0_clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants.pdf', '37850_1_clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants.pdf']","[0.214, 0.214]","[0.529, 0.529]","[0.624, 0.624]","[0.149, 0.149]","[0.178, 0.178]","[0.142, 0.142]","[0.736, 0.736]","[0.644, 0.644]","[0.601, 0.601]","[0.639, 0.639]","[0.796, 0.796]","[0.725, 0.725]","[0.616, 0.616]","[0.925, 0.925]","[0.821, 0.821]","[0.765, 0.765]","[0.8, 0.8]","[0.787, 0.787]",0.214,0.529,0.624,0.149,0.178,0.142,0.736,0.644,0.601,0.639,0.796,0.725,0.616,0.925,0.821,0.765,0.8,0.787
https://doi.org/10.1177/0890334417726305,lactation consultants’ perceived barriers to providing professional breastfeeding support,37911_lactation consultants’ perceived barriers to providing professional breastfeeding support.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf'],['Barriers Perceived by Managers and Clinical Professionals Related to the Implementation of Clinical Practice Guidelines for Breastfeeding through the Best Practice Spotlight Organization Program'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf'],['37911_0_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guideli.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504213/pdf'],['37911_0_barriers perceived by managers and clinical professionals related to the implementation of clinical practice guideli.pdf'],[0.476],[0.523],[0.614],[0.149],[0.163],[0.144],[0.724],[0.632],[0.591],[0.677],[0.792],[0.712],[0.628],[0.91],[0.844],[0.758],[0.802],[0.783],0.476,0.523,0.614,0.149,0.163,0.144,0.724,0.632,0.591,0.677,0.792,0.712,0.628,0.91,0.844,0.758,0.802,0.783
https://doi.org/10.1177/0890334420907898,incidence of and risk factors for lactational mastitis a systematic review,37913_incidence of and risk factors for lactational mastitis a systematic review.pdf,1,['https://www.bfmed.org/assets/ABM%20Protocol%20%2336.pdf'],"['Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022']",['https://www.bfmed.org/assets/ABM%20Protocol%20%2336.pdf'],['37913_0_academy of breastfeeding medicine clinical protocol 36 the mastitis spectrum revised 2022.pdf'],1,100.0,['https://www.bfmed.org/assets/ABM%20Protocol%20%2336.pdf'],['37913_0_academy of breastfeeding medicine clinical protocol 36 the mastitis spectrum revised 2022.pdf'],[0.528],[0.56],[0.637],[0.195],[0.229],[0.176],[0.75],[0.659],[0.617],[0.647],[0.798],[0.739],[0.625],[0.92],[0.83],[0.775],[0.801],[0.789],0.528,0.56,0.637,0.195,0.229,0.176,0.75,0.659,0.617,0.647,0.798,0.739,0.625,0.92,0.83,0.775,0.801,0.789
https://doi.org/10.1177/089686080102100506,dissociation between clearances of small and middle molecules in incremental peritoneal dialysis,37936_dissociation between clearances of small and middle molecules in incremental peritoneal dialysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691857/pdf'],['Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691857/pdf'],['37936_0_renal association clinical practice guideline on peritoneal dialysis in adults and children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691857/pdf'],['37936_0_renal association clinical practice guideline on peritoneal dialysis in adults and children.pdf'],[0.551],[0.572],[0.65],[0.206],[0.227],[0.174],[0.749],[0.659],[0.635],[0.67],[0.821],[0.746],[0.643],[0.929],[0.832],[0.795],[0.818],[0.809],0.551,0.572,0.65,0.206,0.227,0.174,0.749,0.659,0.635,0.67,0.821,0.746,0.643,0.929,0.832,0.795,0.818,0.809
https://doi.org/10.1177/089686080302300118,tuberculosis peritonitis with clear fluid accompanying systemic disseminated tuberculosis in a capd patient,37937_tuberculosis peritonitis with clear fluid accompanying systemic disseminated tuberculosis in a capd patient.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033625/pdf'],['ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033625/pdf'],['37937_0_ispd peritonitis recommendations 2016 update on prevention and treatment.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033625/pdf'],['37937_0_ispd peritonitis recommendations 2016 update on prevention and treatment.pdf'],[0.466],[0.575],[0.649],[0.186],[0.195],[0.148],[0.743],[0.646],[0.653],[0.614],[0.829],[0.755],[0.636],[0.914],[0.836],[0.798],[0.825],[0.81],0.466,0.575,0.649,0.186,0.195,0.148,0.743,0.646,0.653,0.614,0.829,0.755,0.636,0.914,0.836,0.798,0.825,0.81
https://doi.org/10.1177/089686080402400509,pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis,37938_pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524923/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033625/pdf']","['Consensus Guidelines for the Prevention and Treatment of Catheter-related Infections and Peritonitis in Pediatric Patients Receiving Peritoneal Dialysis: 2012 Update', 'ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524923/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033625/pdf']","['37938_0_consensus guidelines for the prevention and treatment of catheterrelated infections and peritonitis in pediatric patients receiving peritoneal dialysis 2012 update.pdf', '37938_1_ispd peritonitis recommendations 2016 update on prevention and treatment.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524923/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033625/pdf']","['37938_0_consensus guidelines for the prevention and treatment of catheterrelated infections and peritonitis in pediatric patients receiving peritoneal dialysis 2012 update.pdf', '37938_1_ispd peritonitis recommendations 2016 update on prevention and treatment.pdf']","[0.44, 0.444]","[0.567, 0.57]","[0.645, 0.65]","[0.176, 0.184]","[0.185, 0.195]","[0.14, 0.149]","[0.745, 0.748]","[0.652, 0.656]","[0.647, 0.652]","[0.632, 0.633]","[0.816, 0.821]","[0.738, 0.744]","[0.651, 0.643]","[0.917, 0.923]","[0.822, 0.828]","[0.794, 0.796]","[0.812, 0.814]","[0.802, 0.803]",0.442,0.569,0.647,0.18,0.19,0.145,0.746,0.654,0.649,0.633,0.819,0.741,0.647,0.92,0.825,0.795,0.813,0.802
https://doi.org/10.1177/089686080802800521,comparative study of adequacy of dialysis and healthrelated quality of life in patients on capd and apd,37939_comparative study of adequacy of dialysis and healthrelated quality of life in patients on capd and apd.pdf,1,['https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/esrd/esrd-report.pdf'],['End Stage Renal Disease in the Medicare Population'],['https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/esrd/esrd-report.pdf'],['37939_0_end stage renal disease in the medicare population.pdf'],1,100.0,['https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/esrd/esrd-report.pdf'],['37939_0_end stage renal disease in the medicare population.pdf'],[0.306],[0.543],[0.628],[0.178],[0.185],[0.141],[0.738],[0.644],[0.604],[0.654],[0.793],[0.711],[0.628],[0.91],[0.81],[0.745],[0.789],[0.762],0.306,0.543,0.628,0.178,0.185,0.141,0.738,0.644,0.604,0.654,0.793,0.711,0.628,0.91,0.81,0.745,0.789,0.762
https://doi.org/10.1177/0961203319853621,depressive and anxiety symptom prevalence in childhoodonset systemic lupus erythematosus a systematic review,38010_depressive and anxiety symptom prevalence in childhoodonset systemic lupus erythematosus a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID‐19 Pandemic: Version 1'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['38010_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404941/pdf'],['38010_0_american college of rheumatology guidance for the management of children with pediatric rheumatic disease during the covid‐19 pandemic version 1.pdf'],[0.192],[0.565],[0.634],[0.146],[0.153],[0.118],[0.732],[0.638],[0.624],[0.651],[0.807],[0.743],[0.626],[0.926],[0.835],[0.773],[0.809],[0.785],0.192,0.565,0.634,0.146,0.153,0.118,0.732,0.638,0.624,0.651,0.807,0.743,0.626,0.926,0.835,0.773,0.809,0.785
https://doi.org/10.1177/1043659617719139,homebased and technologycentered childhood obesity prevention for chinese mothers with preschoolaged children,38057_homebased and technologycentered childhood obesity prevention for chinese mothers with preschoolaged children.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for preventing obesity in children', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['38057_1_interventions for preventing obesity in children.pdf', '38057_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '38057_4_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '38057_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '38057_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",5,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646867/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373580/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['38057_1_interventions for preventing obesity in children.pdf', '38057_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '38057_4_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '38057_3_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '38057_2_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.464, 0.49, 0.462, 0.456, 0.455]","[0.519, 0.528, 0.528, 0.527, 0.527]","[0.606, 0.618, 0.615, 0.614, 0.616]","[0.158, 0.164, 0.167, 0.167, 0.163]","[0.167, 0.174, 0.178, 0.177, 0.174]","[0.14, 0.145, 0.145, 0.144, 0.144]","[0.734, 0.733, 0.733, 0.733, 0.734]","[0.636, 0.635, 0.636, 0.636, 0.635]","[0.579, 0.59, 0.589, 0.588, 0.588]","[0.7, 0.694, 0.692, 0.693, 0.694]","[0.769, 0.778, 0.783, 0.782, 0.778]","[0.69, 0.704, 0.712, 0.711, 0.7]","[0.597, 0.601, 0.608, 0.607, 0.601]","[0.918, 0.924, 0.921, 0.92, 0.923]","[0.815, 0.824, 0.817, 0.816, 0.821]","[0.722, 0.735, 0.746, 0.745, 0.734]","[0.777, 0.785, 0.789, 0.788, 0.784]","[0.757, 0.769, 0.771, 0.77, 0.768]",0.465,0.526,0.614,0.164,0.174,0.144,0.733,0.636,0.587,0.695,0.778,0.703,0.603,0.921,0.819,0.736,0.785,0.767
https://doi.org/10.1177/1059840518817870,systematic review of school telehealth evaluations,38205_systematic review of school telehealth evaluations.pdf,2,"['https://mhcc.maryland.gov/mhcc/pages/home/workgroups/documents/SBTele/SBT_Final_Report.pdf', 'https://www.rti.org/publication/reducing-barriers-furnishing-substance-use-disorder-sud-services-using-telehealth-and']","['School-Based', 'Reducing barriers to furnishing substance use disorder (SUD) services using telehealth and remote patient monitoring for pediatric populations under Medicaid']",['https://mhcc.maryland.gov/mhcc/pages/home/workgroups/documents/SBTele/SBT_Final_Report.pdf'],['38205_0_schoolbased.pdf'],1,50.0,['https://mhcc.maryland.gov/mhcc/pages/home/workgroups/documents/SBTele/SBT_Final_Report.pdf'],['38205_0_schoolbased.pdf'],[0.612],[0.565],[0.654],[0.218],[0.242],[0.195],[0.741],[0.654],[0.648],[0.704],[0.823],[0.762],[0.65],[0.924],[0.851],[0.793],[0.828],[0.808],0.612,0.565,0.654,0.218,0.242,0.195,0.741,0.654,0.648,0.704,0.823,0.762,0.65,0.924,0.851,0.793,0.828,0.808
https://doi.org/10.1177/1073191111408231,psychometric properties of the five facet mindfulness questionnaire in depressed adults and development of a short form,38245_psychometric properties of the five facet mindfulness questionnaire in depressed adults and development of a short form.pdf,3,"['https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalAppendices.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalFinalReport.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalExecSummary.pdf']","['Maternal, Infant, and Early Childhood Home Visiting (MIECHV) APPENDICES', 'Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Region X', 'Evaluation Executive Summary']","['https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalAppendices.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalExecSummary.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalFinalReport.pdf']","['38245_0_maternal infant and early childhood home visiting miechv appendices.pdf', '38245_2_evaluation executive summary.pdf', '38245_1_maternal infant and early childhood home visiting miechv region x.pdf']",3,100.0,"['https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalAppendices.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalExecSummary.pdf', 'https://www.dcyf.wa.gov/sites/default/files/pdf/RegionXEvalFinalReport.pdf']","['38245_0_maternal infant and early childhood home visiting miechv appendices.pdf', '38245_2_evaluation executive summary.pdf', '38245_1_maternal infant and early childhood home visiting miechv region x.pdf']","[0.157, 0.123, 0.094]","[0.504, 0.532, 0.528]","[0.592, 0.61, 0.61]","[0.114, 0.117, 0.117]","[0.129, 0.124, 0.13]","[0.114, 0.095, 0.102]","[0.725, 0.718, 0.716]","[0.623, 0.622, 0.619]","[0.555, 0.583, 0.581]","[0.718, 0.664, 0.675]","[0.766, 0.787, 0.784]","[0.687, 0.726, 0.724]","[0.605, 0.617, 0.62]","[0.916, 0.915, 0.916]","[0.82, 0.829, 0.833]","[0.739, 0.763, 0.76]","[0.771, 0.795, 0.79]","[0.753, 0.771, 0.768]",0.125,0.521,0.604,0.116,0.128,0.104,0.72,0.621,0.573,0.686,0.779,0.712,0.614,0.916,0.827,0.754,0.785,0.764
https://doi.org/10.1177/1074840720940674,the impact of family strengths oriented therapeutic conversations on parents of children with a new chronic illness diagnosis,38258_the impact of family strengths oriented therapeutic conversations on parents of children with a new chronic illness diagnosis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723860/pdf'],['The Usefulness of Brief Family Health Conversations Offered to Families Following the Diagnosis of Breast Cancer'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723860/pdf'],['38258_0_the usefulness of brief family health conversations offered to families following the diagnosis of breast cancer.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723860/pdf'],['38258_0_the usefulness of brief family health conversations offered to families following the diagnosis of breast cancer.pdf'],[0.647],[0.533],[0.612],[0.184],[0.217],[0.184],[0.743],[0.653],[0.589],[0.698],[0.796],[0.723],[0.632],[0.919],[0.824],[0.76],[0.796],[0.783],0.647,0.533,0.612,0.184,0.217,0.184,0.743,0.653,0.589,0.698,0.796,0.723,0.632,0.919,0.824,0.76,0.796,0.783
https://doi.org/10.1177/1077559519883010,does a close relationship with an adult reduce the risk of juvenile offending for youth with a history of maltreatment,38384_does a close relationship with an adult reduce the risk of juvenile offending for youth with a history of maltreatment.pdf,3,"['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-1.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf']","['CMPD Youth Program Assessment', 'Child Sex Trafficking Team, Office of the Governor - Research Resources 1st Edition for 2021', 'Qe UNC CHARLOTTE UrbanInstitute ai']","['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-1.pdf']","['38384_2_qe unc charlotte urbaninstitute ai.pdf', '38384_0_cmpd youth program assessment.pdf', '38384_1_child sex trafficking team office of the governor  research resources 1st edition for 2021.pdf']",3,100.0,"['https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment-Appendices.pdf', 'https://charlottenc.gov/safecharlotte/Documents/CMPD-Youth-Program-Assessment.pdf', 'https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-1.pdf']","['38384_2_qe unc charlotte urbaninstitute ai.pdf', '38384_0_cmpd youth program assessment.pdf', '38384_1_child sex trafficking team office of the governor  research resources 1st edition for 2021.pdf']","[0.298, 0.34, 0.329]","[0.553, 0.538, 0.568]","[0.643, 0.63, 0.649]","[0.19, 0.176, 0.187]","[0.213, 0.202, 0.206]","[0.174, 0.164, 0.173]","[0.737, 0.733, 0.738]","[0.643, 0.636, 0.642]","[0.6, 0.594, 0.616]","[0.684, 0.676, 0.675]","[0.796, 0.791, 0.803]","[0.728, 0.727, 0.745]","[0.635, 0.63, 0.649]","[0.921, 0.921, 0.923]","[0.82, 0.817, 0.825]","[0.771, 0.764, 0.779]","[0.803, 0.8, 0.811]","[0.787, 0.783, 0.794]",0.322,0.553,0.641,0.184,0.207,0.17,0.736,0.64,0.603,0.678,0.797,0.733,0.638,0.922,0.821,0.771,0.805,0.788
https://doi.org/10.1177/1077559520963916,how covid19 is placing vulnerable children at risk and why we need a different approach to child welfare,38387_how covid19 is placing vulnerable children at risk and why we need a different approach to child welfare.pdf,1,['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],"['Child Sex Trafficking Team, Office of the Governor - Research Resources 2nd Edition for 2021']",['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],['38387_0_child sex trafficking team office of the governor  research resources 2nd edition for 2021.pdf'],1,100.0,['https://gov.texas.gov/uploads/files/organization/criminal-justice/CSTT-2021-Research-Volume-2.pdf'],['38387_0_child sex trafficking team office of the governor  research resources 2nd edition for 2021.pdf'],[0.249],[0.581],[0.66],[0.183],[0.192],[0.152],[0.731],[0.641],[0.639],[0.663],[0.821],[0.766],[0.659],[0.917],[0.847],[0.791],[0.829],[0.809],0.249,0.581,0.66,0.183,0.192,0.152,0.731,0.641,0.639,0.663,0.821,0.766,0.659,0.917,0.847,0.791,0.829,0.809
https://doi.org/10.1177/107906320401600205,an exploration of developmental factors related to deviant sexual preferences among adult rapists,38434_an exploration of developmental factors related to deviant sexual preferences among adult rapists.pdf,2,"['https://purl.fdlp.gov/GPO/gpo111573', 'https://bscc.ca.gov/wp-content/uploads/JOJJVol2_Iss2.pdf']","['Sex offender management assessment and planning initiative', 'Journal of Juvenile Justice']",['https://purl.fdlp.gov/GPO/gpo111573'],['38434_0_sex offender management assessment and planning initiative.pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo111573'],['38434_0_sex offender management assessment and planning initiative.pdf'],[0.567],[0.552],[0.64],[0.202],[0.229],[0.203],[0.744],[0.649],[0.598],[0.697],[0.797],[0.738],[0.64],[0.924],[0.825],[0.767],[0.806],[0.788],0.567,0.552,0.64,0.202,0.229,0.203,0.744,0.649,0.598,0.697,0.797,0.738,0.64,0.924,0.825,0.767,0.806,0.788
https://doi.org/10.1177/1096250618810706,rethinking “we are all special” antiableism curricula in early childhood classrooms,38582_rethinking “we are all special” antiableism curricula in early childhood classrooms.pdf,1,['https://oeo.wa.gov/sites/default/files/public/Disability_Teaches_Us_Slides_with_Activity_and_Extension_2020_05_27.pdf.pdf'],['Disability Teaches Us: Introduction to Disability Justice in Schools'],['https://oeo.wa.gov/sites/default/files/public/Disability_Teaches_Us_Slides_with_Activity_and_Extension_2020_05_27.pdf.pdf'],['38582_0_disability teaches us introduction to disability justice in schools.pdf'],1,100.0,['https://oeo.wa.gov/sites/default/files/public/Disability_Teaches_Us_Slides_with_Activity_and_Extension_2020_05_27.pdf.pdf'],['38582_0_disability teaches us introduction to disability justice in schools.pdf'],[0.357],[0.588],[0.685],[0.197],[0.238],[0.195],[0.752],[0.658],[0.64],[0.708],[0.815],[0.755],[0.65],[0.913],[0.868],[0.791],[0.823],[0.802],0.357,0.588,0.685,0.197,0.238,0.195,0.752,0.658,0.64,0.708,0.815,0.755,0.65,0.913,0.868,0.791,0.823,0.802
https://doi.org/10.1177/112067210301300704,prognosis of juvenile rheumatoid arthritisassociated uveitis,38614_prognosis of juvenile rheumatoid arthritisassociated uveitis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261704/pdf'],['Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261704/pdf'],['38614_0_childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritisassociated and idiopathic chronic anterior uveitis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261704/pdf'],['38614_0_childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritisassociated and idiopathic chronic anterior uveitis.pdf'],[0.455],[0.517],[0.608],[0.183],[0.22],[0.169],[0.747],[0.654],[0.596],[0.658],[0.789],[0.691],[0.605],[0.913],[0.806],[0.754],[0.784],[0.781],0.455,0.517,0.608,0.183,0.22,0.169,0.747,0.654,0.596,0.658,0.789,0.691,0.605,0.913,0.806,0.754,0.784,0.781
https://doi.org/10.1177/112067210801800118,ocular findings in low birthweight and premature babies in the first year do we need to screen,38616_ocular findings in low birthweight and premature babies in the first year do we need to screen.pdf,1,['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast'],['Vol6_WebCover.indd'],['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast'],['38616_0_vol6webcoverindd.pdf'],1,100.0,['https://cms.agr.wa.gov/getmedia/aee27553-7c63-44fe-85a7-cf3dec16b653/Healthier_Students_are_Better_Learners_-_Universal_Breakfast'],['38616_0_vol6webcoverindd.pdf'],[0.208],[0.484],[0.575],[0.103],[0.105],[0.092],[0.726],[0.625],[0.552],[0.636],[0.768],[0.688],[0.608],[0.914],[0.757],[0.733],[0.768],[0.755],0.208,0.484,0.575,0.103,0.105,0.092,0.726,0.625,0.552,0.636,0.768,0.688,0.608,0.914,0.757,0.733,0.768,0.755
https://doi.org/10.1177/1352458520949152,ms pregnancy and covid19,38622_ms pregnancy and covid19.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf'],['Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf'],['38622_0_update on the management of multiple sclerosis during the covid19 pandemic and post pandemic an international consensus statement.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/pdf'],['38622_0_update on the management of multiple sclerosis during the covid19 pandemic and post pandemic an international consensus statement.pdf'],[0.665],[0.517],[0.609],[0.143],[0.147],[0.117],[0.74],[0.651],[0.579],[0.618],[0.79],[0.7],[0.621],[0.916],[0.806],[0.749],[0.786],[0.774],0.665,0.517,0.609,0.143,0.147,0.117,0.74,0.651,0.579,0.618,0.79,0.7,0.621,0.916,0.806,0.749,0.786,0.774
https://doi.org/10.1177/1359104519843956,coping long term with active suicide in adolescents results from a pilot randomized controlled trial,38652_coping long term with active suicide in adolescents results from a pilot randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['38652_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['38652_0_interventions for self‐harm in children and adolescents.pdf'],[0.457],[0.525],[0.605],[0.169],[0.183],[0.152],[0.729],[0.635],[0.577],[0.7],[0.779],[0.707],[0.6],[0.923],[0.82],[0.737],[0.784],[0.765],0.457,0.525,0.605,0.169,0.183,0.152,0.729,0.635,0.577,0.7,0.779,0.707,0.6,0.923,0.82,0.737,0.784,0.765
https://doi.org/10.1177/1362361319830523,the aaspire practicebased guidelines for the inclusion of autistic adults in research as coresearchers and study participants,38766_the aaspire practicebased guidelines for the inclusion of autistic adults in research as coresearchers and study participants.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130283/pdf'],['Cultures and cures: neurodiversity and brain organoids'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130283/pdf'],['38766_0_cultures and cures neurodiversity and brain organoids.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130283/pdf'],['38766_0_cultures and cures neurodiversity and brain organoids.pdf'],[0.303],[0.563],[0.656],[0.16],[0.173],[0.154],[0.733],[0.644],[0.627],[0.679],[0.815],[0.772],[0.628],[0.926],[0.844],[0.785],[0.817],[0.8],0.303,0.563,0.656,0.16,0.173,0.154,0.733,0.644,0.627,0.679,0.815,0.772,0.628,0.926,0.844,0.785,0.817,0.8
https://doi.org/10.1177/1473325020981080,critical reflections and reflexivity on responding to the needs of lgbtq youth in a global pandemic,38836_critical reflections and reflexivity on responding to the needs of lgbtq youth in a global pandemic.pdf,1,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['Report & Recommendations For Fiscal Year 2022'],['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['38836_0_report  recommendations for fiscal year 2022.pdf'],1,100.0,['https://www.mass.gov/doc/mclgbtqy-annual-recommendations-fy-2022/download'],['38836_0_report  recommendations for fiscal year 2022.pdf'],[0.562],[0.598],[0.684],[0.229],[0.25],[0.205],[0.74],[0.652],[0.664],[0.678],[0.841],[0.785],[0.661],[0.918],[0.87],[0.806],[0.85],[0.826],0.562,0.598,0.684,0.229,0.25,0.205,0.74,0.652,0.664,0.678,0.841,0.785,0.661,0.918,0.87,0.806,0.85,0.826
https://doi.org/10.1177/1541204017708017,drawing the line,39042_drawing the line.pdf,1,['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['Juvenile Justice Realignment Block Grant Annual Plan'],['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['39042_0_juvenile justice realignment block grant annual plan.pdf'],1,100.0,['https://www.chhs.ca.gov/wp-content/uploads/2022/07/Contra-Costa-Revised_Redacted.pdf'],['39042_0_juvenile justice realignment block grant annual plan.pdf'],[0.275],[0.533],[0.622],[0.17],[0.194],[0.155],[0.728],[0.634],[0.597],[0.671],[0.795],[0.732],[0.644],[0.922],[0.831],[0.764],[0.802],[0.782],0.275,0.533,0.622,0.17,0.194,0.155,0.728,0.634,0.597,0.671,0.795,0.732,0.644,0.922,0.831,0.764,0.802,0.782
https://doi.org/10.1177/1541204018790667,do disproportionate minority contact dmc mandate reforms change decisionmaking decomposing disparities in the juvenile justice system,39045_do disproportionate minority contact dmc mandate reforms change decisionmaking decomposing disparities in the juvenile justice system.pdf,1,['https://files.nc.gov/ncdps/documents/files/DMC-Report-Final-.pdf'],['Disproportionate Minority Contact in North Carolina: An Assessment Study'],['https://files.nc.gov/ncdps/documents/files/DMC-Report-Final-.pdf'],['39045_0_disproportionate minority contact in north carolina an assessment study.pdf'],1,100.0,['https://files.nc.gov/ncdps/documents/files/DMC-Report-Final-.pdf'],['39045_0_disproportionate minority contact in north carolina an assessment study.pdf'],[0.498],[0.538],[0.616],[0.183],[0.211],[0.167],[0.734],[0.636],[0.597],[0.701],[0.783],[0.709],[0.656],[0.921],[0.826],[0.758],[0.792],[0.775],0.498,0.538,0.616,0.183,0.211,0.167,0.734,0.636,0.597,0.701,0.783,0.709,0.656,0.921,0.826,0.758,0.792,0.775
https://doi.org/10.1177/1541204020972487,positive childhood experiences pce cumulative resiliency in the face of adverse childhood experiences,39047_positive childhood experiences pce cumulative resiliency in the face of adverse childhood experiences.pdf,1,['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download'],['COVID-19 and the Massachusetts Juvenile Justice System'],['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download'],['39047_0_covid19 and the massachusetts juvenile justice system.pdf'],1,100.0,['https://www.mass.gov/doc/covid-19-and-the-massachusetts-juvenile-justice-system-jjpad-report-october-2021/download'],['39047_0_covid19 and the massachusetts juvenile justice system.pdf'],[0.465],[0.535],[0.63],[0.178],[0.2],[0.167],[0.734],[0.64],[0.592],[0.677],[0.796],[0.725],[0.639],[0.923],[0.82],[0.762],[0.8],[0.785],0.465,0.535,0.63,0.178,0.2,0.167,0.734,0.64,0.592,0.677,0.796,0.725,0.639,0.923,0.82,0.762,0.8,0.785
https://doi.org/10.1177/183693910803300405,the social attention skills of preschool children with an intellectual disability and children with a hearing loss,39151_the social attention skills of preschool children with an intellectual disability and children with a hearing loss.pdf,1,['https://tea.texas.gov/sites/default/files/Early_Childhood_Outcomes_FINAL.pdf'],['Early Childhood Outcomes and Prekindergarten Guideline Alignment - Updated with the Revised 2015 Texas Pre-K Guidelines'],['https://tea.texas.gov/sites/default/files/Early_Childhood_Outcomes_FINAL.pdf'],['39151_0_early childhood outcomes and prekindergarten guideline alignment  updated with the revised 2015 texas prek guidelines.pdf'],1,100.0,['https://tea.texas.gov/sites/default/files/Early_Childhood_Outcomes_FINAL.pdf'],['39151_0_early childhood outcomes and prekindergarten guideline alignment  updated with the revised 2015 texas prek guidelines.pdf'],[0.357],[0.52],[0.615],[0.141],[0.161],[0.137],[0.734],[0.632],[0.579],[0.708],[0.778],[0.714],[0.635],[0.916],[0.822],[0.764],[0.795],[0.772],0.357,0.52,0.615,0.141,0.161,0.137,0.734,0.632,0.579,0.708,0.778,0.714,0.635,0.916,0.822,0.764,0.795,0.772
https://doi.org/10.1177/183693910803300406,is allday kindergarten better for childrens academic performance,39152_is allday kindergarten better for childrens academic performance.pdf,3,"['http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/269/Full-day-kindergarten', 'http://www.wsipp.wa.gov/ReportFile/1548/Wsipp_Full-Day-Kindergarten-A-Review-of-the-Evidence-and-Benefit-Cost-Analysis_Final-Report.pdf', 'https://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/4/Wsipp_BenefitCost_ProgramDetails_Pre-K-to-12-Education']","['Washington State Institute for Public Policy', 'Full-Day Kindergarten: A Review of the Evidence and Benefit-Cost Analysis - Final Report', 'Washington State Institute for Public Policy']","['http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/269/Full-day-kindergarten', 'http://www.wsipp.wa.gov/ReportFile/1548/Wsipp_Full-Day-Kindergarten-A-Review-of-the-Evidence-and-Benefit-Cost-Analysis_Final-Report.pdf']","['39152_0_washington state institute for public policy.pdf', '39152_1_fullday kindergarten a review of the evidence and benefitcost analysis  final report.pdf']",2,66.67,"['http://www.wsipp.wa.gov/BenefitCost/ProgramPdf/269/Full-day-kindergarten', 'http://www.wsipp.wa.gov/ReportFile/1548/Wsipp_Full-Day-Kindergarten-A-Review-of-the-Evidence-and-Benefit-Cost-Analysis_Final-Report.pdf']","['39152_0_washington state institute for public policy.pdf', '39152_1_fullday kindergarten a review of the evidence and benefitcost analysis  final report.pdf']","[0.305, 0.448]","[0.518, 0.527]","[0.613, 0.618]","[0.146, 0.167]","[0.162, 0.193]","[0.141, 0.157]","[0.723, 0.727]","[0.628, 0.633]","[0.582, 0.591]","[0.722, 0.732]","[0.779, 0.78]","[0.719, 0.716]","[0.639, 0.644]","[0.919, 0.92]","[0.812, 0.815]","[0.749, 0.748]","[0.791, 0.785]","[0.771, 0.767]",0.377,0.522,0.615,0.157,0.177,0.149,0.725,0.631,0.587,0.727,0.78,0.718,0.641,0.919,0.814,0.748,0.788,0.769
https://doi.org/10.1177/1941738120941490,cardiopulmonary considerations for high school studentathletes during the covid19 pandemic nfhsamssm guidance statement,39167_cardiopulmonary considerations for high school studentathletes during the covid19 pandemic nfhsamssm guidance statement.pdf,1,['https://education.delaware.gov/diaa/wp-content/uploads/sites/2/2021/09/Updated-2021-NFHS-AMSSM-Guidance-Statement-on-Cardiac-Considerations-with-COVID-19-FINAL-8-17-21.pdf'],['Cardiopulmonary Considerations for High School Student-Athletes During the COVID-19 Pandemic : Update to the NFHS-AMSSM Guidance Statement'],['https://education.delaware.gov/diaa/wp-content/uploads/sites/2/2021/09/Updated-2021-NFHS-AMSSM-Guidance-Statement-on-Cardiac-Considerations-with-COVID-19-FINAL-8-17-21.pdf'],['39167_0_cardiopulmonary considerations for high school studentathletes during the covid19 pandemic  update to the nfhsamssm guidance statement.pdf'],1,100.0,['https://education.delaware.gov/diaa/wp-content/uploads/sites/2/2021/09/Updated-2021-NFHS-AMSSM-Guidance-Statement-on-Cardiac-Considerations-with-COVID-19-FINAL-8-17-21.pdf'],['39167_0_cardiopulmonary considerations for high school studentathletes during the covid19 pandemic  update to the nfhsamssm guidance statement.pdf'],[0.614],[0.554],[0.635],[0.238],[0.251],[0.192],[0.761],[0.676],[0.609],[0.676],[0.801],[0.751],[0.617],[0.921],[0.835],[0.773],[0.8],[0.786],0.614,0.554,0.635,0.238,0.251,0.192,0.761,0.676,0.609,0.676,0.801,0.751,0.617,0.921,0.835,0.773,0.8,0.786
https://doi.org/10.1177/1942602x19852295,a new framework for school nurse selfreflection and evaluation,39183_a new framework for school nurse selfreflection and evaluation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411510/pdf'],['School Nurses: Living the Framework During COVID-19'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411510/pdf'],['39183_0_school nurses living the framework during covid19.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411510/pdf'],['39183_0_school nurses living the framework during covid19.pdf'],[0.722],[0.566],[0.644],[0.235],[0.273],[0.224],[0.753],[0.665],[0.649],[0.708],[0.822],[0.763],[0.677],[0.936],[0.861],[0.789],[0.833],[0.808],0.722,0.566,0.644,0.235,0.273,0.224,0.753,0.665,0.649,0.708,0.822,0.763,0.677,0.936,0.861,0.789,0.833,0.808
https://doi.org/10.1177/2332858418766291,state prekindergarten effects on early learning at kindergarten entry an analysis of eight state programs,39252_state prekindergarten effects on early learning at kindergarten entry an analysis of eight state programs.pdf,4,"['https://www.mass.gov/files/documents/2019/06/10/Massachusetts%20PEG%20Impact%20Evaluation%20Report%20and%20Appendix.pdf', 'https://www.nber.org/papers/w28722', 'https://nepc.colorado.edu/publication/newsletter-preschool-041619', 'https://www.michigan.gov/documents/mde/GSRP_Public_Service_734420_7.pdf']","['Impact Evaluation Report', 'Early Childhood Education in the United States: What, When, Where, Who, How, and Why', 'Are Preschool Programs Designed to Live Up to Their Potential?', 'MDE Memo Template']","['https://www.michigan.gov/documents/mde/GSRP_Public_Service_734420_7.pdf', 'https://www.mass.gov/files/documents/2019/06/10/Massachusetts%20PEG%20Impact%20Evaluation%20Report%20and%20Appendix.pdf']","['39252_3_mde memo template.pdf', '39252_0_impact evaluation report.pdf']",2,50.0,"['https://www.michigan.gov/documents/mde/GSRP_Public_Service_734420_7.pdf', 'https://www.mass.gov/files/documents/2019/06/10/Massachusetts%20PEG%20Impact%20Evaluation%20Report%20and%20Appendix.pdf']","['39252_3_mde memo template.pdf', '39252_0_impact evaluation report.pdf']","[0.609, 0.302]","[0.554, 0.528]","[0.633, 0.611]","[0.182, 0.164]","[0.207, 0.186]","[0.161, 0.146]","[0.726, 0.73]","[0.635, 0.636]","[0.636, 0.587]","[0.699, 0.723]","[0.819, 0.783]","[0.768, 0.724]","[0.656, 0.643]","[0.926, 0.919]","[0.859, 0.815]","[0.785, 0.757]","[0.829, 0.791]","[0.804, 0.772]",0.456,0.541,0.622,0.173,0.197,0.153,0.728,0.635,0.611,0.711,0.801,0.746,0.649,0.923,0.837,0.771,0.81,0.788
https://doi.org/10.1177/2332858418799085,the longterm impact of systemic student support in elementary school reducing high school dropout,39254_the longterm impact of systemic student support in elementary school reducing high school dropout.pdf,3,"['https://www.rand.org/pubs/research_reports/RRA230-1.html', 'https://dallascityhall.com/departments/office-of-equity/DCH%20Documents/equality-indicators-booklet-2019.pdf', 'https://dallascityhall.com/departments/office-of-equity/DCH%20Documents/equity-indicators-booklet-2019.pdf']","[""Evaluation of Delaware's Opportunity Funding and Student Success Block Grant Programs"", 'Dallas', 'Dallas']",['https://dallascityhall.com/departments/office-of-equity/DCH%20Documents/equity-indicators-booklet-2019.pdf'],['39254_2_dallas.pdf'],1,33.33,['https://dallascityhall.com/departments/office-of-equity/DCH%20Documents/equity-indicators-booklet-2019.pdf'],['39254_2_dallas.pdf'],[0.266],[0.508],[0.59],[0.128],[0.143],[0.117],[0.72],[0.618],[0.575],[0.702],[0.778],[0.714],[0.634],[0.922],[0.817],[0.749],[0.794],[0.774],0.266,0.508,0.59,0.128,0.143,0.117,0.72,0.618,0.575,0.702,0.778,0.714,0.634,0.922,0.817,0.749,0.794,0.774
https://doi.org/10.1177/2332858418815661,school climate student engagement and academic achievement a latent variable multilevel multiinformant examination,39255_school climate student engagement and academic achievement a latent variable multilevel multiinformant examination.pdf,4,"['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_14.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/2020_secondary_school_climate_survey_technical_report.pdf?utm_campaign=The%20Blunderbuss&utm_medium=email&utm_source=Revue%20newsletter', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_17.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/2019-secondary-school-climate-survey-technical-report.pdf']","['School Climate, Student Engagement, and Academic Achievement: A Latent Variable, Multilevel Multi-Informant Examination', 'School Climate and Safety in Virginia High Schools :', 'School Climate and Safety in Virginia High Schools :', 'School Climate and Safety in Virginia Middle Schools :']","['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_17.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/2019-secondary-school-climate-survey-technical-report.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_14.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/2020_secondary_school_climate_survey_technical_report.pdf?utm_campaign=The%20Blunderbuss&utm_medium=email&utm_source=Revue%20newsletter']","['39255_2_school climate and safety in virginia high schools .pdf', '39255_3_school climate and safety in virginia middle schools .pdf', '39255_0_school climate student engagement and academic achievement a latent variable multilevel multiinformant examination.pdf', '39255_1_school climate and safety in virginia high schools .pdf']",4,100.0,"['https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_17.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/2019-secondary-school-climate-survey-technical-report.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/publications/law-enforcement/_14.pdf', 'https://www.dcjs.virginia.gov/sites/dcjs.virginia.gov/files/2020_secondary_school_climate_survey_technical_report.pdf?utm_campaign=The%20Blunderbuss&utm_medium=email&utm_source=Revue%20newsletter']","['39255_2_school climate and safety in virginia high schools .pdf', '39255_3_school climate and safety in virginia middle schools .pdf', '39255_0_school climate student engagement and academic achievement a latent variable multilevel multiinformant examination.pdf', '39255_1_school climate and safety in virginia high schools .pdf']","[1.0, 0.776, 0.776, 0.772]","[0.503, 0.512, 0.524, 0.503]","[0.591, 0.596, 0.614, 0.591]","[0.166, 0.174, 0.206, 0.166]","[0.193, 0.203, 0.235, 0.193]","[0.173, 0.181, 0.209, 0.173]","[0.732, 0.734, 0.747, 0.732]","[0.636, 0.638, 0.655, 0.636]","[0.577, 0.587, 0.588, 0.577]","[0.723, 0.725, 0.739, 0.723]","[0.774, 0.781, 0.776, 0.774]","[0.709, 0.718, 0.702, 0.709]","[0.623, 0.627, 0.633, 0.623]","[0.909, 0.912, 0.906, 0.909]","[0.816, 0.822, 0.806, 0.816]","[0.741, 0.747, 0.742, 0.741]","[0.784, 0.791, 0.786, 0.784]","[0.761, 0.767, 0.763, 0.761]",0.831,0.511,0.598,0.178,0.206,0.184,0.736,0.641,0.582,0.727,0.776,0.71,0.627,0.909,0.815,0.743,0.786,0.763
https://doi.org/10.1182/blood-2011-07-370148,hypomorphic mutations in prf1 munc134 and stxbp2 are associated with adultonset familial hlh,39347_hypomorphic mutations in prf1 munc134 and stxbp2 are associated with adultonset familial hlh.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004414/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340087/pdf']","['Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies', 'Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004414/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340087/pdf']","['39347_0_consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.pdf', '39347_1_challenges in the diagnosis of hemophagocytic lymphohistiocytosis recommendations from the north american consortium for histiocytosis nacho.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004414/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340087/pdf']","['39347_0_consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.pdf', '39347_1_challenges in the diagnosis of hemophagocytic lymphohistiocytosis recommendations from the north american consortium for histiocytosis nacho.pdf']","[0.383, 0.36]","[0.526, 0.492]","[0.616, 0.605]","[0.173, 0.167]","[0.191, 0.197]","[0.136, 0.144]","[0.751, 0.748]","[0.655, 0.657]","[0.596, 0.576]","[0.668, 0.678]","[0.787, 0.765]","[0.716, 0.67]","[0.609, 0.575]","[0.917, 0.91]","[0.821, 0.817]","[0.756, 0.728]","[0.787, 0.763]","[0.775, 0.757]",0.371,0.509,0.611,0.17,0.194,0.14,0.75,0.656,0.586,0.673,0.776,0.693,0.592,0.913,0.819,0.742,0.775,0.766
https://doi.org/10.1182/blood.v95.4.1406.004k26_1406_1412,hhv8 is associated with a plasmablastic variant of castleman disease that is linked to hhv8–positive plasmablastic lymphoma,39426_hhv8 is associated with a plasmablastic variant of castleman disease that is linked to hhv8–positive plasmablastic lymphoma.pdf,1,['https://ntp.niehs.nih.gov/ntp/roc/monographs/kshv_final201608_508.pdf'],['Kaposi Sarcoma-Associated Herpesvirus (KSHV)'],['https://ntp.niehs.nih.gov/ntp/roc/monographs/kshv_final201608_508.pdf'],['39426_0_kaposi sarcomaassociated herpesvirus kshv.pdf'],1,100.0,['https://ntp.niehs.nih.gov/ntp/roc/monographs/kshv_final201608_508.pdf'],['39426_0_kaposi sarcomaassociated herpesvirus kshv.pdf'],[0.453],[0.53],[0.627],[0.174],[0.186],[0.144],[0.753],[0.665],[0.593],[0.662],[0.797],[0.709],[0.622],[0.915],[0.81],[0.748],[0.786],[0.769],0.453,0.53,0.627,0.174,0.186,0.144,0.753,0.665,0.593,0.662,0.797,0.709,0.622,0.915,0.81,0.748,0.786,0.769
https://doi.org/10.1182/bloodadvances.2019000931,2019 sickle cell disease guidelines by the american society of hematology methodology challenges and innovations,39436_2019 sickle cell disease guidelines by the american society of hematology methodology challenges and innovations.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945587/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759117/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988392/pdf']","['American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation', 'How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines', 'American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945587/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988392/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759117/pdf']","['39436_0_american society of hematology 2021 guidelines for sickle cell disease stem cell transplantation.pdf', '39436_2_american society of hematology 2020 guidelines for sickle cell disease transfusion support.pdf', '39436_1_how to write a guideline a proposal for a manuscript template that supports the creation of trustworthy guidelines.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945587/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988392/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759117/pdf']","['39436_0_american society of hematology 2021 guidelines for sickle cell disease stem cell transplantation.pdf', '39436_2_american society of hematology 2020 guidelines for sickle cell disease transfusion support.pdf', '39436_1_how to write a guideline a proposal for a manuscript template that supports the creation of trustworthy guidelines.pdf']","[0.604, 0.368, 0.492]","[0.583, 0.573, 0.541]","[0.649, 0.646, 0.63]","[0.188, 0.172, 0.176]","[0.209, 0.185, 0.2]","[0.148, 0.132, 0.141]","[0.738, 0.739, 0.734]","[0.646, 0.642, 0.646]","[0.646, 0.64, 0.606]","[0.676, 0.657, 0.715]","[0.808, 0.807, 0.793]","[0.772, 0.767, 0.752]","[0.645, 0.641, 0.625]","[0.93, 0.928, 0.926]","[0.844, 0.831, 0.842]","[0.784, 0.781, 0.765]","[0.822, 0.82, 0.803]","[0.797, 0.795, 0.784]",0.488,0.566,0.642,0.179,0.198,0.14,0.737,0.645,0.631,0.683,0.803,0.764,0.637,0.928,0.839,0.777,0.815,0.792
https://doi.org/10.1182/bloodadvances.2020002623,the association of abo blood group with indices of disease severity and multiorgan dysfunction in covid19,39438_the association of abo blood group with indices of disease severity and multiorgan dysfunction in covid19.pdf,2,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']","['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['39438_0_master question list for covid19 caused by sarscov2.pdf', '39438_1_master question list for covid19 caused by sarscov2.pdf']",2,100.0,"['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20201103.pdf']","['39438_0_master question list for covid19 caused by sarscov2.pdf', '39438_1_master question list for covid19 caused by sarscov2.pdf']","[0.398, 0.384]","[0.548, 0.548]","[0.63, 0.63]","[0.166, 0.165]","[0.153, 0.152]","[0.126, 0.125]","[0.744, 0.743]","[0.65, 0.649]","[0.613, 0.613]","[0.65, 0.648]","[0.801, 0.802]","[0.738, 0.738]","[0.623, 0.624]","[0.92, 0.92]","[0.833, 0.833]","[0.767, 0.768]","[0.805, 0.806]","[0.789, 0.789]",0.391,0.548,0.63,0.166,0.152,0.126,0.744,0.649,0.613,0.649,0.802,0.738,0.623,0.92,0.833,0.768,0.806,0.789
https://doi.org/10.1186/1471-2458-12-1009,a cluster randomised trial of a schoolbased resilience intervention to decrease tobacco alcohol and illicit drug use in secondary school students study protocol,39822_a cluster randomised trial of a schoolbased resilience intervention to decrease tobacco alcohol and illicit drug use in secondary school students study protocol.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486103/pdf']","['Universal school‐based prevention for illicit drug use', 'Strategies for enhancing the implementation of school‐based policies or practices targeting risk factors for chronic disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf']","['39822_1_strategies for enhancing the implementation of school‐based policies or practices targeting risk factors for chronic disease.pdf', '39822_0_universal school‐based prevention for illicit drug use.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486103/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483627/pdf']","['39822_1_strategies for enhancing the implementation of school‐based policies or practices targeting risk factors for chronic disease.pdf', '39822_0_universal school‐based prevention for illicit drug use.pdf']","[0.499, 0.647]","[0.576, 0.547]","[0.645, 0.627]","[0.214, 0.21]","[0.223, 0.222]","[0.185, 0.185]","[0.737, 0.742]","[0.645, 0.648]","[0.641, 0.601]","[0.691, 0.693]","[0.815, 0.796]","[0.745, 0.723]","[0.627, 0.611]","[0.933, 0.919]","[0.859, 0.841]","[0.775, 0.748]","[0.82, 0.795]","[0.798, 0.773]",0.573,0.561,0.636,0.212,0.223,0.185,0.74,0.647,0.621,0.692,0.805,0.734,0.619,0.926,0.85,0.762,0.807,0.786
https://doi.org/10.1186/1471-2458-13-s3-s18,breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two a systematic literature review and metaanalysis,39893_breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two a systematic literature review and metaanalysis.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf', 'https://mathematica.org/publications/mcc-indonesia-nutrition-project-impact-evaluation-final-report']","['Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low‐ and middle‐income countries (LMIC)', 'MCC Indonesia Nutrition Project Impact Evaluation Final Report']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf'],['39893_0_nutritional interventions for preventing stunting in children birth to 59 months living in urban slums in low‐ and middle‐income countries lmic.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572871/pdf'],['39893_0_nutritional interventions for preventing stunting in children birth to 59 months living in urban slums in low‐ and middle‐income countries lmic.pdf'],[0.415],[0.546],[0.627],[0.191],[0.187],[0.153],[0.731],[0.637],[0.605],[0.704],[0.791],[0.724],[0.621],[0.922],[0.83],[0.756],[0.795],[0.772],0.415,0.546,0.627,0.191,0.187,0.153,0.731,0.637,0.605,0.704,0.791,0.724,0.621,0.922,0.83,0.756,0.795,0.772
https://doi.org/10.1186/1757-1626-1-16,snake bite mimicking brain death,40382_snake bite mimicking brain death.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570725/pdf'],['ACMT Position Statement: Determining Brain Death in Adults After Drug Overdose'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570725/pdf'],['40382_0_acmt position statement determining brain death in adults after drug overdose.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570725/pdf'],['40382_0_acmt position statement determining brain death in adults after drug overdose.pdf'],[0.187],[0.524],[0.621],[0.143],[0.161],[0.121],[0.726],[0.629],[0.608],[0.604],[0.799],[0.733],[0.625],[0.917],[0.831],[0.768],[0.798],[0.781],0.187,0.524,0.621,0.143,0.161,0.121,0.726,0.629,0.608,0.604,0.799,0.733,0.625,0.917,0.831,0.768,0.798,0.781
https://doi.org/10.1186/s12199-019-0774-z,effects of water sanitation and hygiene wash education on childhood intestinal parasitic infections in rural dembiya northwest ethiopia an uncontrolled beforeandafter intervention study,40456_effects of water sanitation and hygiene wash education on childhood intestinal parasitic infections in rural dembiya northwest ethiopia an uncontrolled beforeandafter intervention study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156140/pdf'],['Anthelmintic drugs for treating ascariasis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156140/pdf'],['40456_0_anthelmintic drugs for treating ascariasis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156140/pdf'],['40456_0_anthelmintic drugs for treating ascariasis.pdf'],[0.266],[0.516],[0.612],[0.144],[0.151],[0.114],[0.729],[0.633],[0.595],[0.668],[0.791],[0.705],[0.585],[0.92],[0.818],[0.742],[0.792],[0.773],0.266,0.516,0.612,0.144,0.151,0.114,0.729,0.633,0.595,0.668,0.791,0.705,0.585,0.92,0.818,0.742,0.792,0.773
https://doi.org/10.1186/s12199-020-00864-7,cumulative inactivated vaccine exposure and allergy development among children a birth cohort from japan,40457_cumulative inactivated vaccine exposure and allergy development among children a birth cohort from japan.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543786/pdf'],['Whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543786/pdf'],['40457_0_whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543786/pdf'],['40457_0_whole‐cell pertussis vaccine in early infancy for the prevention of allergy in children.pdf'],[0.514],[0.543],[0.63],[0.183],[0.192],[0.156],[0.74],[0.644],[0.605],[0.68],[0.789],[0.711],[0.61],[0.921],[0.816],[0.744],[0.793],[0.774],0.514,0.543,0.63,0.183,0.192,0.156,0.74,0.644,0.605,0.68,0.789,0.711,0.61,0.921,0.816,0.744,0.793,0.774
https://doi.org/10.1186/s12865-018-0270-z,altered endotoxin responsiveness in healthy children with down syndrome,40462_altered endotoxin responsiveness in healthy children with down syndrome.pdf,1,['https://dbhds.virginia.gov/assets/doc/OIH/sepsis-h-s-alert.pdf'],['Sepsis Health & Safety Alert'],['https://dbhds.virginia.gov/assets/doc/OIH/sepsis-h-s-alert.pdf'],['40462_0_sepsis health  safety alert.pdf'],1,100.0,['https://dbhds.virginia.gov/assets/doc/OIH/sepsis-h-s-alert.pdf'],['40462_0_sepsis health  safety alert.pdf'],[0.212],[0.492],[0.595],[0.119],[0.13],[0.098],[0.733],[0.639],[0.57],[0.646],[0.781],[0.685],[0.6],[0.914],[0.804],[0.741],[0.783],[0.771],0.212,0.492,0.595,0.119,0.13,0.098,0.733,0.639,0.57,0.646,0.781,0.685,0.6,0.914,0.804,0.741,0.783,0.771
https://doi.org/10.1186/s12879-019-3759-z,the impact of childhood varicella vaccination on the incidence of herpes zoster in the general population modelling the effect of exogenous and endogenous varicellazoster virus immunity boosting,40477_the impact of childhood varicella vaccination on the incidence of herpes zoster in the general population modelling the effect of exogenous and endogenous varicellazoster virus immunity boosting.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801194/pdf'],"['Prevención de las enfermedades infecciosas. Actualización en vacunas, 2020']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801194/pdf'],['40477_0_prevención de las enfermedades infecciosas actualización en vacunas 2020.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801194/pdf'],['40477_0_prevención de las enfermedades infecciosas actualización en vacunas 2020.pdf'],[0.06],[0.428],[0.541],[0.127],[0.15],[0.121],[0.733],[0.65],[0.513],[0.634],[0.784],[0.641],[0.562],[0.869],[0.785],[0.696],[0.739],[0.711],0.06,0.428,0.541,0.127,0.15,0.121,0.733,0.65,0.513,0.634,0.784,0.641,0.562,0.869,0.785,0.696,0.739,0.711
https://doi.org/10.1186/s12879-021-05791-8,a case series of children and young people admitted to a tertiary care hospital in germany with covid19,40478_a case series of children and young people admitted to a tertiary care hospital in germany with covid19.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['40478_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['40478_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.526],[0.56],[0.637],[0.179],[0.199],[0.159],[0.743],[0.652],[0.623],[0.63],[0.809],[0.75],[0.615],[0.922],[0.841],[0.764],[0.812],[0.794],0.526,0.56,0.637,0.179,0.199,0.159,0.743,0.652,0.623,0.63,0.809,0.75,0.615,0.922,0.841,0.764,0.812,0.794
https://doi.org/10.1186/s12882-019-1539-z,mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis a randomised controlled trial,40482_mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis a randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591447/pdf'],['Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591447/pdf'],['40482_0_immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591447/pdf'],['40482_0_immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.pdf'],[0.417],[0.517],[0.612],[0.176],[0.172],[0.135],[0.74],[0.649],[0.582],[0.674],[0.782],[0.688],[0.573],[0.912],[0.815],[0.723],[0.775],[0.755],0.417,0.517,0.612,0.176,0.172,0.135,0.74,0.649,0.582,0.674,0.782,0.688,0.573,0.912,0.815,0.723,0.775,0.755
https://doi.org/10.1186/s12884-018-2036-2,implementation of community based advance distribution of misoprostol in himachal pradesh india lessons and way forward,40542_implementation of community based advance distribution of misoprostol in himachal pradesh india lessons and way forward.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390441/pdf'],['Advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390441/pdf'],['40542_0_advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390441/pdf'],['40542_0_advance misoprostol distribution to pregnant women for preventing and treating postpartum haemorrhage.pdf'],[0.451],[0.553],[0.635],[0.185],[0.202],[0.162],[0.73],[0.641],[0.619],[0.647],[0.805],[0.736],[0.622],[0.92],[0.841],[0.76],[0.809],[0.784],0.451,0.553,0.635,0.185,0.202,0.162,0.73,0.641,0.619,0.647,0.805,0.736,0.622,0.92,0.841,0.76,0.809,0.784
https://doi.org/10.1186/s12884-020-02960-6,health management committee strengthening and community mobilisation through women’s groups to improve trained health worker attendance at birth in rural nepal a cluster randomised controlled trial,40545_health management committee strengthening and community mobilisation through women’s groups to improve trained health worker attendance at birth in rural nepal a cluster randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf'],"['Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf'],['40545_0_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1186/s12884-020-03004-9,does growth hormone supplementation improve oocyte competence and ivf outcomes in patients with poor embryonic development a randomized controlled trial,40546_does growth hormone supplementation improve oocyte competence and ivf outcomes in patients with poor embryonic development a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608438/pdf'],['Growth hormone for in vitro fertilisation (IVF)'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608438/pdf'],['40546_0_growth hormone for in vitro fertilisation ivf.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608438/pdf'],['40546_0_growth hormone for in vitro fertilisation ivf.pdf'],[0.444],[0.514],[0.602],[0.16],[0.155],[0.126],[0.737],[0.643],[0.584],[0.664],[0.776],[0.685],[0.581],[0.912],[0.789],[0.723],[0.775],[0.752],0.444,0.514,0.602,0.16,0.155,0.126,0.737,0.643,0.584,0.664,0.776,0.685,0.581,0.912,0.789,0.723,0.775,0.752
https://doi.org/10.1186/s12884-020-03239-6,coverage of the who’s four essential elements of newborn care and their association with neonatal survival in southern nepal,40547_coverage of the who’s four essential elements of newborn care and their association with neonatal survival in southern nepal.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['Skin care interventions in infants for preventing eczema and food allergy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['40547_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['40547_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],[0.326],[0.525],[0.61],[0.15],[0.145],[0.116],[0.73],[0.634],[0.583],[0.657],[0.777],[0.693],[0.595],[0.916],[0.809],[0.733],[0.779],[0.759],0.326,0.525,0.61,0.15,0.145,0.116,0.73,0.634,0.583,0.657,0.777,0.693,0.595,0.916,0.809,0.733,0.779,0.759
https://doi.org/10.1186/s12884-020-03249-4,identifying fear of childbirth in a uk population qualitative examination of the clarity and acceptability of existing measurement tools in a small uk sample,40548_identifying fear of childbirth in a uk population qualitative examination of the clarity and acceptability of existing measurement tools in a small uk sample.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261458/pdf'],['Interventions for fear of childbirth including tocophobia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261458/pdf'],['40548_0_interventions for fear of childbirth including tocophobia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261458/pdf'],['40548_0_interventions for fear of childbirth including tocophobia.pdf'],[0.566],[0.559],[0.64],[0.181],[0.207],[0.167],[0.73],[0.636],[0.62],[0.7],[0.801],[0.742],[0.611],[0.921],[0.846],[0.764],[0.81],[0.787],0.566,0.559,0.64,0.181,0.207,0.167,0.73,0.636,0.62,0.7,0.801,0.742,0.611,0.921,0.846,0.764,0.81,0.787
https://doi.org/10.1186/s12884-020-2721-9,a condom uterine balloon device among referral facilities in dar es salaam an assessment of perceptions barriers and facilitators one year after implementation,40549_a condom uterine balloon device among referral facilities in dar es salaam an assessment of perceptions barriers and facilitators one year after implementation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843394/pdf'],['World Health Organization Recommendation for Using Uterine Balloon Tamponade to Treat Postpartum Hemorrhage'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843394/pdf'],['40549_0_world health organization recommendation for using uterine balloon tamponade to treat postpartum hemorrhage.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843394/pdf'],['40549_0_world health organization recommendation for using uterine balloon tamponade to treat postpartum hemorrhage.pdf'],[0.422],[0.553],[0.645],[0.18],[0.206],[0.154],[0.739],[0.651],[0.622],[0.64],[0.803],[0.733],[0.634],[0.921],[0.831],[0.768],[0.806],[0.786],0.422,0.553,0.645,0.18,0.206,0.154,0.739,0.651,0.622,0.64,0.803,0.733,0.634,0.921,0.831,0.768,0.806,0.786
https://doi.org/10.1186/s12884-021-03623-w,colostrum avoidance practice among primipara mothers in urban northwest ethiopia a crosssectional study,40550_colostrum avoidance practice among primipara mothers in urban northwest ethiopia a crosssectional study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['Skin care interventions in infants for preventing eczema and food allergy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['40550_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661877/pdf'],['40550_0_skin care interventions in infants for preventing eczema and food allergy.pdf'],[0.197],[0.513],[0.6],[0.126],[0.13],[0.104],[0.727],[0.627],[0.578],[0.637],[0.775],[0.692],[0.59],[0.913],[0.807],[0.726],[0.775],[0.753],0.197,0.513,0.6,0.126,0.13,0.104,0.727,0.627,0.578,0.637,0.775,0.692,0.59,0.913,0.807,0.726,0.775,0.753
https://doi.org/10.1186/s12887-019-1541-4,study protocol for a cluster randomized controlled trial to test “¡míranos look at us we are healthy” – an early childhood obesity prevention program,40583_study protocol for a cluster randomized controlled trial to test “¡míranos look at us we are healthy” – an early childhood obesity prevention program.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf'],"[""Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf'],['40583_0_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956675/pdf'],['40583_0_caregiver involvement in interventions for improving childrens dietary intake and physical activity behaviors.pdf'],[0.566],[0.538],[0.617],[0.169],[0.181],[0.151],[0.732],[0.633],[0.602],[0.698],[0.79],[0.717],[0.611],[0.918],[0.838],[0.743],[0.795],[0.775],0.566,0.538,0.617,0.169,0.181,0.151,0.732,0.633,0.602,0.698,0.79,0.717,0.611,0.918,0.838,0.743,0.795,0.775
https://doi.org/10.1186/s12887-019-1627-z,baby’s first bites a randomized controlled trial to assess the effects of vegetableexposure and sensitive feeding on vegetable acceptance eating behavior and weight gain in infants and toddlers,40584_baby’s first bites a randomized controlled trial to assess the effects of vegetableexposure and sensitive feeding on vegetable acceptance eating behavior and weight gain in infants and toddlers.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40584_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40584_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.608],[0.548],[0.635],[0.191],[0.201],[0.171],[0.735],[0.642],[0.613],[0.697],[0.795],[0.721],[0.61],[0.927],[0.842],[0.754],[0.799],[0.786],0.608,0.548,0.635,0.191,0.201,0.171,0.735,0.642,0.613,0.697,0.795,0.721,0.61,0.927,0.842,0.754,0.799,0.786
https://doi.org/10.1186/s12887-019-1871-2,impact of sunflower seed oil versus mustard seed oil on skin barrier function in newborns a communitybased clusterrandomized trial,40585_impact of sunflower seed oil versus mustard seed oil on skin barrier function in newborns a communitybased clusterrandomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104155/pdf'],['Topical emollient for preventing infection in preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104155/pdf'],['40585_0_topical emollient for preventing infection in preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104155/pdf'],['40585_0_topical emollient for preventing infection in preterm infants.pdf'],[0.41],[0.489],[0.575],[0.141],[0.139],[0.115],[0.734],[0.641],[0.555],[0.689],[0.75],[0.67],[0.576],[0.881],[0.757],[0.697],[0.752],[0.724],0.41,0.489,0.575,0.141,0.139,0.115,0.734,0.641,0.555,0.689,0.75,0.67,0.576,0.881,0.757,0.697,0.752,0.724
https://doi.org/10.1186/s12888-019-2422-y,a suicide prevention strategy for youth presenting to the emergency department with suicide related behaviour protocol for a randomized controlled trial,40616_a suicide prevention strategy for youth presenting to the emergency department with suicide related behaviour protocol for a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094743/pdf'],['Psychosocial interventions for self‐harm in adults'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094743/pdf'],['40616_0_psychosocial interventions for self‐harm in adults.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094743/pdf'],['40616_0_psychosocial interventions for self‐harm in adults.pdf'],[0.44],[0.521],[0.603],[0.181],[0.194],[0.153],[0.731],[0.638],[0.582],[0.698],[0.786],[0.707],[0.587],[0.919],[0.819],[0.729],[0.787],[0.759],0.44,0.521,0.603,0.181,0.194,0.153,0.731,0.638,0.582,0.698,0.786,0.707,0.587,0.919,0.819,0.729,0.787,0.759
https://doi.org/10.1186/s12888-020-02672-3,a randomized crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes a canadian biomarker integration network in depression canbind study protocol,40618_a randomized crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes a canadian biomarker integration network in depression canbind study protocol.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434915/pdf'],['Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434915/pdf'],['40618_0_ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434915/pdf'],['40618_0_ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.pdf'],[0.339],[0.477],[0.578],[0.162],[0.164],[0.13],[0.736],[0.646],[0.542],[0.691],[0.764],[0.675],[0.558],[0.902],[0.79],[0.695],[0.757],[0.731],0.339,0.477,0.578,0.162,0.164,0.13,0.736,0.646,0.542,0.691,0.764,0.675,0.558,0.902,0.79,0.695,0.757,0.731
https://doi.org/10.1186/s12889-017-4851-1,systematic review of the relationships between combinations of movement behaviours and health indicators in the early years 04 years,40692_systematic review of the relationships between combinations of movement behaviours and health indicators in the early years 04 years.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40692_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40692_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.583],[0.58],[0.654],[0.221],[0.242],[0.187],[0.738],[0.649],[0.638],[0.735],[0.808],[0.754],[0.629],[0.929],[0.843],[0.774],[0.81],[0.792],0.583,0.58,0.654,0.221,0.242,0.187,0.738,0.649,0.638,0.735,0.808,0.754,0.629,0.929,0.843,0.774,0.81,0.792
https://doi.org/10.1186/s12889-018-6179-x,do sex differences in reported weight loss intentions and behaviours persist across demographic characteristics and weight status in youth a systematic review,40716_do sex differences in reported weight loss intentions and behaviours persist across demographic characteristics and weight status in youth a systematic review.pdf,1,['https://purl.fdlp.gov/GPO/gpo133119'],"['Attempts to lose weight among adolescents aged 16-19 in the United States, 2013-2016 /']",['https://purl.fdlp.gov/GPO/gpo133119'],['40716_0_attempts to lose weight among adolescents aged 1619 in the united states 20132016 .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo133119'],['40716_0_attempts to lose weight among adolescents aged 1619 in the united states 20132016 .pdf'],[0.432],[0.517],[0.617],[0.184],[0.219],[0.175],[0.736],[0.643],[0.593],[0.725],[0.786],[0.722],[0.591],[0.916],[0.836],[0.747],[0.782],[0.773],0.432,0.517,0.617,0.184,0.219,0.175,0.736,0.643,0.593,0.725,0.786,0.722,0.591,0.916,0.836,0.747,0.782,0.773
https://doi.org/10.1186/s12889-019-6478-x,using physical education to promote outof school physical activity in lower secondary school students – a randomized controlled trial protocol,40718_using physical education to promote outof school physical activity in lower secondary school students – a randomized controlled trial protocol.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40718_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40718_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.587],[0.54],[0.632],[0.183],[0.195],[0.162],[0.736],[0.643],[0.606],[0.701],[0.793],[0.72],[0.608],[0.922],[0.84],[0.749],[0.799],[0.78],0.587,0.54,0.632,0.183,0.195,0.162,0.736,0.643,0.606,0.701,0.793,0.72,0.608,0.922,0.84,0.749,0.799,0.78
https://doi.org/10.1186/s12889-019-6640-5,coaching andor education intervention for parents with overweightobesity and their children study protocol of a singlecentre randomized controlled trial,40719_coaching andor education intervention for parents with overweightobesity and their children study protocol of a singlecentre randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40719_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40719_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.476],[0.538],[0.629],[0.182],[0.188],[0.155],[0.734],[0.638],[0.607],[0.691],[0.794],[0.718],[0.597],[0.926],[0.839],[0.746],[0.797],[0.78],0.476,0.538,0.629,0.182,0.188,0.155,0.734,0.638,0.607,0.691,0.794,0.718,0.597,0.926,0.839,0.746,0.797,0.78
https://doi.org/10.1186/s12889-019-6704-6,improving nutrition and physical activity environments of family child care homes the rationale design and study protocol of the ‘healthy startcomienzos sanos’ cluster randomized trial,40720_improving nutrition and physical activity environments of family child care homes the rationale design and study protocol of the ‘healthy startcomienzos sanos’ cluster randomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40720_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40720_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.514],[0.546],[0.634],[0.181],[0.193],[0.161],[0.734],[0.638],[0.615],[0.693],[0.8],[0.724],[0.61],[0.933],[0.845],[0.754],[0.804],[0.788],0.514,0.546,0.634,0.181,0.193,0.161,0.734,0.638,0.615,0.693,0.8,0.724,0.61,0.933,0.845,0.754,0.804,0.788
https://doi.org/10.1186/s12889-019-6742-0,rationale and methods of the movida10 study –a clusterrandomized controlled trial of the impact of classroombased physical activity programs on children’s adiposity cognition and motor competence,40721_rationale and methods of the movida10 study –a clusterrandomized controlled trial of the impact of classroombased physical activity programs on children’s adiposity cognition and motor competence.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40721_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40721_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.599],[0.524],[0.609],[0.175],[0.187],[0.15],[0.735],[0.64],[0.598],[0.7],[0.79],[0.712],[0.602],[0.923],[0.835],[0.741],[0.793],[0.775],0.599,0.524,0.609,0.175,0.187,0.15,0.735,0.64,0.598,0.7,0.79,0.712,0.602,0.923,0.835,0.741,0.793,0.775
https://doi.org/10.1186/s12889-019-6915-x,the food4toddlers study  study protocol for a webbased intervention to promote healthy diets for toddlers a randomized controlled trial,40722_the food4toddlers study  study protocol for a webbased intervention to promote healthy diets for toddlers a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40722_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40722_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.538],[0.551],[0.636],[0.197],[0.205],[0.171],[0.734],[0.64],[0.617],[0.699],[0.799],[0.727],[0.612],[0.93],[0.848],[0.758],[0.806],[0.79],0.538,0.551,0.636,0.197,0.205,0.171,0.734,0.64,0.617,0.699,0.799,0.727,0.612,0.93,0.848,0.758,0.806,0.79
https://doi.org/10.1186/s12889-019-6990-z,pointofcare hiv testing best practice for early infant diagnosis an implementation study,40725_pointofcare hiv testing best practice for early infant diagnosis an implementation study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['Point‐of‐care tests detecting HIV nucleic acids for diagnosis of HIV‐1 or HIV‐2 infection in infants and children aged 18 months or less'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['40725_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406580/pdf'],['40725_0_point‐of‐care tests detecting hiv nucleic acids for diagnosis of hiv‐1 or hiv‐2 infection in infants and children aged 18 months or less.pdf'],[0.504],[0.554],[0.635],[0.195],[0.197],[0.166],[0.74],[0.647],[0.616],[0.667],[0.795],[0.732],[0.619],[0.915],[0.839],[0.748],[0.804],[0.771],0.504,0.554,0.635,0.195,0.197,0.166,0.74,0.647,0.616,0.667,0.795,0.732,0.619,0.915,0.839,0.748,0.804,0.771
https://doi.org/10.1186/s12889-019-7012-x,protocol for a cluster randomised controlled trial of a peerled physical activity intervention for adolescent girls plana,40726_protocol for a cluster randomised controlled trial of a peerled physical activity intervention for adolescent girls plana.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40726_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40726_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.653],[0.538],[0.626],[0.189],[0.202],[0.169],[0.738],[0.646],[0.603],[0.703],[0.792],[0.715],[0.602],[0.922],[0.836],[0.741],[0.793],[0.774],0.653,0.538,0.626,0.189,0.202,0.169,0.738,0.646,0.603,0.703,0.792,0.715,0.602,0.922,0.836,0.741,0.793,0.774
https://doi.org/10.1186/s12889-019-7102-9,a physical activity nutrition and oral health intervention in nursery settings process evaluation of the nap sacc uk feasibility cluster rct,40727_a physical activity nutrition and oral health intervention in nursery settings process evaluation of the nap sacc uk feasibility cluster rct.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40727_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40727_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.423],[0.543],[0.628],[0.179],[0.183],[0.155],[0.728],[0.634],[0.614],[0.682],[0.796],[0.72],[0.605],[0.929],[0.848],[0.753],[0.798],[0.782],0.423,0.543,0.628,0.179,0.183,0.155,0.728,0.634,0.614,0.682,0.796,0.72,0.605,0.929,0.848,0.753,0.798,0.782
https://doi.org/10.1186/s12889-019-7436-3,effects of a cluster randomized controlled kindergartenbased intervention trial on vegetable consumption among norwegian 3–5yearolds the brastudy,40728_effects of a cluster randomized controlled kindergartenbased intervention trial on vegetable consumption among norwegian 3–5yearolds the brastudy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40728_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40728_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.652],[0.545],[0.634],[0.209],[0.225],[0.187],[0.738],[0.644],[0.615],[0.702],[0.794],[0.719],[0.614],[0.926],[0.844],[0.754],[0.8],[0.786],0.652,0.545,0.634,0.209,0.225,0.187,0.738,0.644,0.615,0.702,0.794,0.719,0.614,0.926,0.844,0.754,0.8,0.786
https://doi.org/10.1186/s12889-019-7545-z,a process evaluation of the plana intervention peerled physical activity intervention for adolescent girls,40729_a process evaluation of the plana intervention peerled physical activity intervention for adolescent girls.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40729_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40729_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.506],[0.534],[0.628],[0.175],[0.192],[0.154],[0.732],[0.64],[0.605],[0.69],[0.789],[0.72],[0.6],[0.916],[0.845],[0.746],[0.795],[0.775],0.506,0.534,0.628,0.175,0.192,0.154,0.732,0.64,0.605,0.69,0.789,0.72,0.6,0.916,0.845,0.746,0.795,0.775
https://doi.org/10.1186/s12889-019-7742-9,are young female suicides increasing a comparison of sexspecific rates and characteristics of youth suicides in australia over 2004–2014,40731_are young female suicides increasing a comparison of sexspecific rates and characteristics of youth suicides in australia over 2004–2014.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['40731_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['40731_0_interventions for self‐harm in children and adolescents.pdf'],[0.247],[0.512],[0.594],[0.158],[0.165],[0.135],[0.728],[0.633],[0.576],[0.7],[0.783],[0.695],[0.591],[0.914],[0.812],[0.727],[0.779],[0.758],0.247,0.512,0.594,0.158,0.165,0.135,0.728,0.633,0.576,0.7,0.783,0.695,0.591,0.914,0.812,0.727,0.779,0.758
https://doi.org/10.1186/s12889-019-7856-0,the impact of interventions for youth experiencing homelessness on housing mental health substance use and family cohesion a systematic review,40732_the impact of interventions for youth experiencing homelessness on housing mental health substance use and family cohesion a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663114/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062440/pdf']","['Determinants of Implementation of a Clinical Practice Guideline for Homeless Health', 'Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663114/pdf']","['40732_1_clinical guideline for homeless and vulnerably housed people and people with lived homelessness experience.pdf', '40732_0_determinants of implementation of a clinical practice guideline for homeless health.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062440/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663114/pdf']","['40732_1_clinical guideline for homeless and vulnerably housed people and people with lived homelessness experience.pdf', '40732_0_determinants of implementation of a clinical practice guideline for homeless health.pdf']","[0.468, 0.641]","[0.54, 0.503]","[0.619, 0.593]","[0.18, 0.153]","[0.196, 0.166]","[0.15, 0.135]","[0.731, 0.728]","[0.642, 0.636]","[0.6, 0.56]","[0.688, 0.692]","[0.796, 0.771]","[0.728, 0.675]","[0.607, 0.588]","[0.92, 0.909]","[0.817, 0.804]","[0.753, 0.731]","[0.798, 0.773]","[0.771, 0.757]",0.554,0.522,0.606,0.166,0.181,0.143,0.73,0.639,0.58,0.69,0.784,0.702,0.597,0.915,0.81,0.742,0.786,0.764
https://doi.org/10.1186/s12903-020-01067-w,recommended procedures for the management of early childhood caries lesions – a scoping review by the children experiencing dental anxiety collaboration on research and education cedacore,40759_recommended procedures for the management of early childhood caries lesions – a scoping review by the children experiencing dental anxiety collaboration on research and education cedacore.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407050/pdf'],['Direct composite resin fillings versus amalgam fillings for permanent posterior teeth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407050/pdf'],['40759_0_direct composite resin fillings versus amalgam fillings for permanent posterior teeth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407050/pdf'],['40759_0_direct composite resin fillings versus amalgam fillings for permanent posterior teeth.pdf'],[0.318],[0.528],[0.615],[0.173],[0.176],[0.144],[0.735],[0.643],[0.603],[0.678],[0.793],[0.712],[0.591],[0.917],[0.818],[0.735],[0.788],[0.769],0.318,0.528,0.615,0.173,0.176,0.144,0.735,0.643,0.603,0.678,0.793,0.712,0.591,0.917,0.818,0.735,0.788,0.769
https://doi.org/10.1186/s12909-020-02171-9,a randomised controlled trial of feedback to improve patient satisfaction and consultation skills in medical students,40783_a randomised controlled trial of feedback to improve patient satisfaction and consultation skills in medical students.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],"[""Interventions for improving medical students' interpersonal communication in medical consultations""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['40783_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['40783_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],[0.575],[0.528],[0.606],[0.186],[0.189],[0.167],[0.739],[0.649],[0.588],[0.706],[0.774],[0.702],[0.599],[0.919],[0.819],[0.725],[0.776],[0.761],0.575,0.528,0.606,0.186,0.189,0.167,0.739,0.649,0.588,0.706,0.774,0.702,0.599,0.919,0.819,0.725,0.776,0.761
https://doi.org/10.1186/s12911-019-0835-7,development and evaluation of a mobile application for case management of small and sick newborns in bangladesh,40784_development and evaluation of a mobile application for case management of small and sick newborns in bangladesh.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406991/pdf'],['Decision‐support tools via mobile devices to improve quality of care in primary healthcare settings'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406991/pdf'],['40784_0_decision‐support tools via mobile devices to improve quality of care in primary healthcare settings.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406991/pdf'],['40784_0_decision‐support tools via mobile devices to improve quality of care in primary healthcare settings.pdf'],[0.308],[0.545],[0.632],[0.17],[0.176],[0.14],[0.732],[0.64],[0.607],[0.691],[0.794],[0.727],[0.606],[0.924],[0.832],[0.748],[0.801],[0.775],0.308,0.545,0.632,0.17,0.176,0.14,0.732,0.64,0.607,0.691,0.794,0.727,0.606,0.924,0.832,0.748,0.801,0.775
https://doi.org/10.1186/s12912-018-0310-2,design and evaluation of the startingtogether app for home visits in preventive child health care,40785_design and evaluation of the startingtogether app for home visits in preventive child health care.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098082/pdf'],['Health workers’ perceptions and experiences of using mHealth technologies to deliver primary healthcare services: a qualitative evidence synthesis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098082/pdf'],['40785_0_health workers perceptions and experiences of using mhealth technologies to deliver primary healthcare services a qualitative evidence synthesis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098082/pdf'],['40785_0_health workers perceptions and experiences of using mhealth technologies to deliver primary healthcare services a qualitative evidence synthesis.pdf'],[0.232],[0.546],[0.63],[0.166],[0.185],[0.154],[0.73],[0.636],[0.613],[0.695],[0.802],[0.737],[0.63],[0.928],[0.84],[0.762],[0.805],[0.788],0.232,0.546,0.63,0.166,0.185,0.154,0.73,0.636,0.613,0.695,0.802,0.737,0.63,0.928,0.84,0.762,0.805,0.788
https://doi.org/10.1186/s12913-019-4203-1,the impact of paid community health worker deployment on child survival the connect randomized cluster trial in rural tanzania,40807_the impact of paid community health worker deployment on child survival the connect randomized cluster trial in rural tanzania.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['Integrated community case management of childhood illness in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['40807_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['40807_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],[0.528],[0.533],[0.618],[0.177],[0.186],[0.152],[0.731],[0.642],[0.594],[0.691],[0.793],[0.712],[0.607],[0.92],[0.831],[0.739],[0.794],[0.766],0.528,0.533,0.618,0.177,0.186,0.152,0.731,0.642,0.594,0.691,0.793,0.712,0.607,0.92,0.831,0.739,0.794,0.766
https://doi.org/10.1186/s12913-019-4468-4,systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low and middleincome countries,40808_systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low and middleincome countries.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf']","['Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Community‐level interventions for improving access to food in low‐ and middle‐income countries']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf']","['40808_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '40808_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf']","['40808_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '40808_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']","[0.38, 0.386]","[0.508, 0.508]","[0.593, 0.594]","[0.159, 0.158]","[0.162, 0.162]","[0.129, 0.128]","[0.725, 0.725]","[0.631, 0.632]","[0.567, 0.565]","[0.706, 0.709]","[0.769, 0.769]","[0.697, 0.7]","[0.598, 0.595]","[0.911, 0.912]","[0.797, 0.796]","[0.718, 0.719]","[0.773, 0.773]","[0.746, 0.746]",0.383,0.508,0.593,0.159,0.162,0.129,0.725,0.631,0.566,0.708,0.769,0.698,0.597,0.911,0.796,0.718,0.773,0.746
https://doi.org/10.1186/s12916-020-01597-8,quantifying the impact of physical distance measures on the transmission of covid19 in the uk,40827_quantifying the impact of physical distance measures on the transmission of covid19 in the uk.pdf,3,"['https://www.nber.org/papers/w28741', 'https://www.nber.org/papers/w28519', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['Risk Perceptions and Protective Behaviors: Evidence from COVID-19 Pandemic', 'The Trade-off Between Prioritization and Vaccination Speed Depends on Mitigation Measures', 'Master Question List for COVID-19 (caused by SARS-CoV-2)']",['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf'],['40827_2_master question list for covid19 caused by sarscov2.pdf'],1,33.33,['https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf'],['40827_2_master question list for covid19 caused by sarscov2.pdf'],[0.304],[0.536],[0.625],[0.138],[0.133],[0.106],[0.73],[0.638],[0.615],[0.66],[0.804],[0.738],[0.623],[0.917],[0.842],[0.763],[0.811],[0.792],0.304,0.536,0.625,0.138,0.133,0.106,0.73,0.638,0.615,0.66,0.804,0.738,0.623,0.917,0.842,0.763,0.811,0.792
https://doi.org/10.1186/s12916-020-01791-8,response to covid19 in south korea and implications for lifting stringent interventions,40828_response to covid19 in south korea and implications for lifting stringent interventions.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053855/pdf'],['Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053855/pdf'],['40828_0_guidelines for cancer care during the covid19 pandemic in south korea.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053855/pdf'],['40828_0_guidelines for cancer care during the covid19 pandemic in south korea.pdf'],[0.209],[0.556],[0.632],[0.168],[0.176],[0.134],[0.731],[0.637],[0.641],[0.613],[0.823],[0.763],[0.637],[0.937],[0.856],[0.784],[0.829],[0.807],0.209,0.556,0.632,0.168,0.176,0.134,0.731,0.637,0.641,0.613,0.823,0.763,0.637,0.937,0.856,0.784,0.829,0.807
https://doi.org/10.1186/s12920-018-0423-1,personal genome project uk pgpuk a research and citizen science hybrid project in support of personalized medicine,40829_personal genome project uk pgpuk a research and citizen science hybrid project in support of personalized medicine.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533659/pdf'],['Points-to-consider on the return of results in epigenetic research'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533659/pdf'],['40829_0_pointstoconsider on the return of results in epigenetic research.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533659/pdf'],['40829_0_pointstoconsider on the return of results in epigenetic research.pdf'],[0.433],[0.531],[0.636],[0.175],[0.193],[0.161],[0.743],[0.657],[0.611],[0.705],[0.801],[0.728],[0.622],[0.927],[0.84],[0.763],[0.804],[0.787],0.433,0.531,0.636,0.175,0.193,0.161,0.743,0.657,0.611,0.705,0.801,0.728,0.622,0.927,0.84,0.763,0.804,0.787
https://doi.org/10.1186/s12933-020-01127-z,effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus the embody trial,40831_effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus the embody trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],"['Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],['40831_0_dipeptidyl peptidase‐4 inhibitors glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease a network meta‐analysis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812344/pdf'],['40831_0_dipeptidyl peptidase‐4 inhibitors glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease a network meta‐analysis.pdf'],[0.417],[0.502],[0.592],[0.161],[0.156],[0.127],[0.739],[0.647],[0.576],[0.694],[0.769],[0.685],[0.581],[0.908],[0.791],[0.72],[0.765],[0.742],0.417,0.502,0.592,0.161,0.156,0.127,0.739,0.647,0.576,0.694,0.769,0.685,0.581,0.908,0.791,0.72,0.765,0.742
https://doi.org/10.1186/s12936-020-03417-z,malaria case management and elimination readiness in health facilities of five districts of madagascar in 2018,40833_malaria case management and elimination readiness in health facilities of five districts of madagascar in 2018.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788114/pdf'],"['Adherence to malaria management guidelines by health care workers in the Busoga sub-region, eastern Uganda']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788114/pdf'],['40833_0_adherence to malaria management guidelines by health care workers in the busoga subregion eastern uganda.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788114/pdf'],['40833_0_adherence to malaria management guidelines by health care workers in the busoga subregion eastern uganda.pdf'],[0.537],[0.547],[0.618],[0.173],[0.184],[0.144],[0.729],[0.637],[0.612],[0.668],[0.799],[0.733],[0.637],[0.917],[0.838],[0.767],[0.81],[0.787],0.537,0.547,0.618,0.173,0.184,0.144,0.729,0.637,0.612,0.668,0.799,0.733,0.637,0.917,0.838,0.767,0.81,0.787
https://doi.org/10.1186/s12954-020-00438-4,implementation of a medical studentrun telemedicine program for medications for opioid use disorder during the covid19 pandemic,40872_implementation of a medical studentrun telemedicine program for medications for opioid use disorder during the covid19 pandemic.pdf,4,"['https://stacks.cdc.gov/view/cdc/98848', 'https://health.mo.gov/emergencies/ert/alertsadvisories/pdf/cdc-advisory121720.pdf', 'https://dph.georgia.gov/document/document/cdc-han-00438pdf/download', 'https://dhss.alaska.gov/dph/Epi/Documents/phan/AKPHAN_20201222_OD_COVID.pdf']","['Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic', 'This is an official CDC HEALTH ADVISORY', 'This is an official CDC HEALTH ADVISORY', 'This is an official CDC HEALTH ADVISORY']","['https://dhss.alaska.gov/dph/Epi/Documents/phan/AKPHAN_20201222_OD_COVID.pdf', 'https://health.mo.gov/emergencies/ert/alertsadvisories/pdf/cdc-advisory121720.pdf', 'https://dph.georgia.gov/document/document/cdc-han-00438pdf/download']","['40872_3_this is an official cdc health advisory.pdf', '40872_1_this is an official cdc health advisory.pdf', '40872_2_this is an official cdc health advisory.pdf']",3,75.0,"['https://dhss.alaska.gov/dph/Epi/Documents/phan/AKPHAN_20201222_OD_COVID.pdf', 'https://health.mo.gov/emergencies/ert/alertsadvisories/pdf/cdc-advisory121720.pdf', 'https://dph.georgia.gov/document/document/cdc-han-00438pdf/download']","['40872_3_this is an official cdc health advisory.pdf', '40872_1_this is an official cdc health advisory.pdf', '40872_2_this is an official cdc health advisory.pdf']","[0.262, 0.253, 0.256]","[0.546, 0.547, 0.547]","[0.632, 0.632, 0.632]","[0.172, 0.173, 0.172]","[0.192, 0.192, 0.192]","[0.145, 0.145, 0.144]","[0.733, 0.733, 0.733]","[0.64, 0.64, 0.64]","[0.62, 0.62, 0.621]","[0.663, 0.664, 0.663]","[0.814, 0.814, 0.814]","[0.758, 0.758, 0.759]","[0.609, 0.609, 0.609]","[0.933, 0.933, 0.934]","[0.844, 0.844, 0.843]","[0.771, 0.771, 0.772]","[0.821, 0.821, 0.822]","[0.8, 0.8, 0.8]",0.257,0.547,0.632,0.172,0.192,0.145,0.733,0.64,0.62,0.663,0.814,0.758,0.609,0.933,0.844,0.771,0.821,0.8
https://doi.org/10.1186/s12957-019-1676-7,prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer a systematic review and metaanalysis,40879_prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428759/pdf'],"['Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428759/pdf'],['40879_0_vascular endothelial growth factor vegf targeting therapy for persistent recurrent or metastatic cervical cancer.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428759/pdf'],['40879_0_vascular endothelial growth factor vegf targeting therapy for persistent recurrent or metastatic cervical cancer.pdf'],[0.384],[0.501],[0.598],[0.154],[0.148],[0.129],[0.738],[0.648],[0.574],[0.695],[0.766],[0.67],[0.57],[0.906],[0.8],[0.707],[0.761],[0.739],0.384,0.501,0.598,0.154,0.148,0.129,0.738,0.648,0.574,0.695,0.766,0.67,0.57,0.906,0.8,0.707,0.761,0.739
https://doi.org/10.1186/s12958-018-0448-5,water and soil pollution as determinant of water and food qualitycontamination and its impact on female fertility,40883_water and soil pollution as determinant of water and food qualitycontamination and its impact on female fertility.pdf,2,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/1PoEIfm1jF3VghG0I4EjWTmdPKilrV-6b.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/464_01222021_16727-422.pdf']","['SB0334 - Water Pollution Control - Intervention in Civil Action - Rights and Authority', 'AG Letter on HB 76 SB0334 (002 ). pdf']","['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/464_01222021_16727-422.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/1PoEIfm1jF3VghG0I4EjWTmdPKilrV-6b.pdf']","['40883_1_ag letter on hb 76 sb0334 002  pdf.pdf', '40883_0_sb0334  water pollution control  intervention in civil action  rights and authority.pdf']",2,100.0,"['https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/464_01222021_16727-422.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2021/jpr/1PoEIfm1jF3VghG0I4EjWTmdPKilrV-6b.pdf']","['40883_1_ag letter on hb 76 sb0334 002  pdf.pdf', '40883_0_sb0334  water pollution control  intervention in civil action  rights and authority.pdf']","[0.123, 0.056]","[0.478, 0.492]","[0.59, 0.605]","[0.067, 0.14]","[0.073, 0.169]","[0.04, 0.128]","[0.7, 0.733]","[0.605, 0.641]","[0.581, 0.567]","[0.572, 0.641]","[0.808, 0.791]","[0.726, 0.68]","[0.606, 0.603]","[0.925, 0.902]","[0.817, 0.803]","[0.755, 0.73]","[0.803, 0.79]","[0.778, 0.767]",0.089,0.485,0.597,0.104,0.121,0.084,0.716,0.623,0.574,0.607,0.8,0.703,0.605,0.913,0.81,0.742,0.796,0.772
https://doi.org/10.1186/s12961-019-0488-0,developing evidence briefs for policy a qualitative case study comparing the process of using a guidancecontextualization workbook in peru and uganda,40891_developing evidence briefs for policy a qualitative case study comparing the process of using a guidancecontextualization workbook in peru and uganda.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202131/pdf'],['Strategies to adapt and implement health system guidelines and recommendations: a scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202131/pdf'],['40891_0_strategies to adapt and implement health system guidelines and recommendations a scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202131/pdf'],['40891_0_strategies to adapt and implement health system guidelines and recommendations a scoping review.pdf'],[0.575],[0.589],[0.671],[0.215],[0.24],[0.192],[0.743],[0.659],[0.653],[0.719],[0.82],[0.768],[0.643],[0.924],[0.87],[0.789],[0.833],[0.811],0.575,0.589,0.671,0.215,0.24,0.192,0.743,0.659,0.653,0.719,0.82,0.768,0.643,0.924,0.87,0.789,0.833,0.811
https://doi.org/10.1186/s12966-016-0449-8,proportion of children meeting recommendations for 24hour movement guidelines and associations with adiposity in a 12country study,40908_proportion of children meeting recommendations for 24hour movement guidelines and associations with adiposity in a 12country study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40908_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40908_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.542],[0.552],[0.641],[0.192],[0.215],[0.171],[0.735],[0.646],[0.617],[0.721],[0.804],[0.74],[0.623],[0.929],[0.842],[0.764],[0.805],[0.789],0.542,0.552,0.641,0.192,0.215,0.171,0.735,0.646,0.617,0.721,0.804,0.74,0.623,0.929,0.842,0.764,0.805,0.789
https://doi.org/10.1186/s12966-018-0664-6,effectiveness of the ‘girls active’ schoolbased physical activity programme a cluster randomised controlled trial,40914_effectiveness of the ‘girls active’ schoolbased physical activity programme a cluster randomised controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['School‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40914_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459921/pdf'],['40914_0_school‐based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.pdf'],[0.583],[0.49],[0.577],[0.154],[0.165],[0.135],[0.735],[0.639],[0.554],[0.716],[0.746],[0.668],[0.584],[0.875],[0.772],[0.667],[0.747],[0.7],0.583,0.49,0.577,0.154,0.165,0.135,0.735,0.639,0.554,0.716,0.746,0.668,0.584,0.875,0.772,0.667,0.747,0.7
https://doi.org/10.1186/s12966-018-0714-0,latina mothers as agents of change in children’s eating habits findings from the randomized controlled trial entre familia reflejos de salud,40915_latina mothers as agents of change in children’s eating habits findings from the randomized controlled trial entre familia reflejos de salud.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf']","['Interventions for increasing fruit and vegetable consumption in children aged five years and under', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['40915_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '40915_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837849/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['40915_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '40915_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf']","[0.593, 0.592]","[0.546, 0.548]","[0.628, 0.63]","[0.197, 0.198]","[0.209, 0.21]","[0.174, 0.175]","[0.736, 0.736]","[0.639, 0.64]","[0.613, 0.616]","[0.698, 0.698]","[0.795, 0.795]","[0.721, 0.726]","[0.605, 0.605]","[0.928, 0.929]","[0.838, 0.841]","[0.752, 0.753]","[0.8, 0.802]","[0.784, 0.786]",0.593,0.547,0.629,0.198,0.209,0.174,0.736,0.639,0.615,0.698,0.795,0.724,0.605,0.929,0.839,0.752,0.801,0.785
https://doi.org/10.1186/s12966-018-0753-6,24h movement behaviors from infancy to preschool crosssectional and longitudinal relationships with body composition and bone health,40917_24h movement behaviors from infancy to preschool crosssectional and longitudinal relationships with body composition and bone health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40917_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40917_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.478],[0.537],[0.621],[0.185],[0.207],[0.164],[0.735],[0.642],[0.597],[0.726],[0.788],[0.719],[0.619],[0.916],[0.811],[0.749],[0.787],[0.77],0.478,0.537,0.621,0.185,0.207,0.164,0.735,0.642,0.597,0.726,0.788,0.719,0.619,0.916,0.811,0.749,0.787,0.77
https://doi.org/10.1186/s12966-018-0763-4,evaluation of an ehealth intervention aiming to promote healthy food habits from infancy the norwegian randomized controlled trial early food for future health,40918_evaluation of an ehealth intervention aiming to promote healthy food habits from infancy the norwegian randomized controlled trial early food for future health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40918_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40918_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.641],[0.541],[0.629],[0.193],[0.204],[0.173],[0.733],[0.637],[0.607],[0.704],[0.786],[0.718],[0.605],[0.916],[0.83],[0.735],[0.791],[0.766],0.641,0.541,0.629,0.193,0.204,0.173,0.733,0.637,0.607,0.704,0.786,0.718,0.605,0.916,0.83,0.735,0.791,0.766
https://doi.org/10.1186/s12966-019-0774-9,differential reporting of fruit and vegetable intake among youth in a randomized controlled trial of a behavioral nutrition intervention,40919_differential reporting of fruit and vegetable intake among youth in a randomized controlled trial of a behavioral nutrition intervention.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40919_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40919_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.441],[0.548],[0.634],[0.197],[0.207],[0.17],[0.736],[0.64],[0.617],[0.697],[0.794],[0.717],[0.606],[0.929],[0.837],[0.748],[0.795],[0.781],0.441,0.548,0.634,0.197,0.207,0.17,0.736,0.64,0.617,0.697,0.794,0.717,0.606,0.929,0.837,0.748,0.795,0.781
https://doi.org/10.1186/s12966-019-0834-1,sociodemographic and maternal predictors of adherence to 24hour movement guidelines in singaporean children,40920_sociodemographic and maternal predictors of adherence to 24hour movement guidelines in singaporean children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['The whole day matters: Understanding 24-hour movement guideline adherence and relationships with health indicators across the lifespan'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40920_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749249/pdf'],['40920_0_the whole day matters understanding 24hour movement guideline adherence and relationships with health indicators across the lifespan.pdf'],[0.616],[0.548],[0.631],[0.189],[0.211],[0.167],[0.735],[0.645],[0.61],[0.711],[0.8],[0.725],[0.621],[0.922],[0.836],[0.76],[0.799],[0.784],0.616,0.548,0.631,0.189,0.211,0.167,0.735,0.645,0.61,0.711,0.8,0.725,0.621,0.922,0.836,0.76,0.799,0.784
https://doi.org/10.1186/s12966-019-0858-6,substituting prolonged sedentary time and cardiovascular risk in children and youth a metaanalysis within the international children’s accelerometry database icad,40921_substituting prolonged sedentary time and cardiovascular risk in children and youth a metaanalysis within the international children’s accelerometry database icad.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf'],['World Health Organization 2020 guidelines on physical activity and sedentary behaviour'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf'],['40921_0_world health organization 2020 guidelines on physical activity and sedentary behaviour.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719906/pdf'],['40921_0_world health organization 2020 guidelines on physical activity and sedentary behaviour.pdf'],[0.473],[0.536],[0.625],[0.187],[0.195],[0.155],[0.732],[0.635],[0.607],[0.706],[0.788],[0.734],[0.606],[0.926],[0.826],[0.751],[0.795],[0.777],0.473,0.536,0.625,0.187,0.195,0.155,0.732,0.635,0.607,0.706,0.788,0.734,0.606,0.926,0.826,0.751,0.795,0.777
https://doi.org/10.1186/s12966-020-00987-8,impact of the covid19 virus outbreak on movement and play behaviours of canadian children and youth a national survey,40922_impact of the covid19 virus outbreak on movement and play behaviours of canadian children and youth a national survey.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['40922_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['40922_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.336],[0.5],[0.586],[0.123],[0.13],[0.102],[0.729],[0.627],[0.57],[0.636],[0.78],[0.674],[0.598],[0.917],[0.819],[0.73],[0.784],[0.764],0.336,0.5,0.586,0.123,0.13,0.102,0.729,0.627,0.57,0.636,0.78,0.674,0.598,0.917,0.819,0.73,0.784,0.764
https://doi.org/10.1186/s12966-020-01023-5,gardenbased interventions and early childhood health an umbrella review,40923_gardenbased interventions and early childhood health an umbrella review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['How effects on health equity are assessed in systematic reviews of interventions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['40923_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['40923_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],[0.554],[0.564],[0.653],[0.202],[0.199],[0.168],[0.733],[0.641],[0.63],[0.712],[0.802],[0.735],[0.613],[0.929],[0.842],[0.755],[0.804],[0.786],0.554,0.564,0.653,0.202,0.199,0.168,0.733,0.641,0.63,0.712,0.802,0.735,0.613,0.929,0.842,0.755,0.804,0.786
https://doi.org/10.1186/s12969-018-0231-3,varicellazostervirus vaccination in immunosuppressed children with rheumatic diseases using a prevaccination check list,40941_varicellazostervirus vaccination in immunosuppressed children with rheumatic diseases using a prevaccination check list.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169786/pdf'],"['Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169786/pdf'],['40941_0_recommendations for vaccination in children with atopic dermatitis treated with dupilumab a consensus meeting 2020.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169786/pdf'],['40941_0_recommendations for vaccination in children with atopic dermatitis treated with dupilumab a consensus meeting 2020.pdf'],[0.504],[0.527],[0.618],[0.18],[0.189],[0.157],[0.75],[0.659],[0.588],[0.659],[0.784],[0.711],[0.618],[0.9],[0.807],[0.739],[0.766],[0.761],0.504,0.527,0.618,0.18,0.189,0.157,0.75,0.659,0.588,0.659,0.784,0.711,0.618,0.9,0.807,0.739,0.766,0.761
https://doi.org/10.1186/s12969-020-00476-z,telemedicine in pediatric rheumatology this is the time for the community to embrace a new way of clinical practice,40943_telemedicine in pediatric rheumatology this is the time for the community to embrace a new way of clinical practice.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735733/pdf'],['Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735733/pdf'],['40943_0_telehealth in rheumatology the 2021 arab league of rheumatology best practice guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735733/pdf'],['40943_0_telehealth in rheumatology the 2021 arab league of rheumatology best practice guidelines.pdf'],[0.444],[0.576],[0.66],[0.21],[0.229],[0.194],[0.749],[0.66],[0.636],[0.685],[0.819],[0.747],[0.629],[0.924],[0.847],[0.779],[0.816],[0.797],0.444,0.576,0.66,0.21,0.229,0.194,0.749,0.66,0.636,0.685,0.819,0.747,0.629,0.924,0.847,0.779,0.816,0.797
https://doi.org/10.1186/s12978-018-0628-y,childbirth experiences and their derived meaning a qualitative study among postnatal mothers in mbale regional referral hospital uganda,40960_childbirth experiences and their derived meaning a qualitative study among postnatal mothers in mbale regional referral hospital uganda.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993433/pdf'],['Developing of a new guideline for improving birth experiences among Iranian women: a mixed method study protocol'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993433/pdf'],['40960_0_developing of a new guideline for improving birth experiences among iranian women a mixed method study protocol.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993433/pdf'],['40960_0_developing of a new guideline for improving birth experiences among iranian women a mixed method study protocol.pdf'],[0.673],[0.561],[0.638],[0.178],[0.22],[0.174],[0.732],[0.639],[0.625],[0.686],[0.804],[0.753],[0.633],[0.911],[0.847],[0.775],[0.821],[0.796],0.673,0.561,0.638,0.178,0.22,0.174,0.732,0.639,0.625,0.686,0.804,0.753,0.633,0.911,0.847,0.775,0.821,0.796
https://doi.org/10.1186/s12978-019-0729-2,the giving voice to mothers study inequity and mistreatment during pregnancy and childbirth in the united states,40961_the giving voice to mothers study inequity and mistreatment during pregnancy and childbirth in the united states.pdf,6,"['https://www.mass.gov/doc/presentation-1062021-cdt-meeting/download?fbclid=IwAR3Lx1zJ6bp1wPmjBlYM99NorXMc0q3DehPfLwVvCIQShKtdalQeE_l1AgU', 'https://www.mass.gov/doc/certified-nurse-midwives-and-maternity-care-in-massachusetts-chartpack-1/download', 'http://www.mgaleg.maryland.gov/pubs-current/SenatePresidentAdvisoryWorkgrouponEquityandInclusion.pdf', 'https://www.americanprogress.org/issues/women/reports/2020/04/14/483114/community-based-doulas-midwives/', 'https://www.aspeninstitute.org/publications/reversing-the-u-s-maternal-mortality-crisis/', 'https://www.mercatus.org/publications/healthcare/midwifery-licensing-medicalization-birth-and-special-interests']","['Meeting of the Care Delivery Transformation Committee', 'Certified Nurse Midwives and Maternity Care in Massachusetts', 'Report of the Senate President’s Advisory Workgroup on Equity and Inclusion', 'Community-Based Doulas and Midwives - Center for American Progress', 'Reversing the U.S. Maternal Mortality Crisis - The Aspen Institute', 'Midwifery Licensing: Medicalization of Birth and Special Interests']","['https://www.mass.gov/doc/certified-nurse-midwives-and-maternity-care-in-massachusetts-chartpack-1/download', 'https://www.mass.gov/doc/presentation-1062021-cdt-meeting/download?fbclid=IwAR3Lx1zJ6bp1wPmjBlYM99NorXMc0q3DehPfLwVvCIQShKtdalQeE_l1AgU']","['40961_1_certified nurse midwives and maternity care in massachusetts.pdf', '40961_0_meeting of the care delivery transformation committee.pdf']",2,33.33,"['https://www.mass.gov/doc/certified-nurse-midwives-and-maternity-care-in-massachusetts-chartpack-1/download', 'https://www.mass.gov/doc/presentation-1062021-cdt-meeting/download?fbclid=IwAR3Lx1zJ6bp1wPmjBlYM99NorXMc0q3DehPfLwVvCIQShKtdalQeE_l1AgU']","['40961_1_certified nurse midwives and maternity care in massachusetts.pdf', '40961_0_meeting of the care delivery transformation committee.pdf']","[0.51, 0.493]","[0.565, 0.564]","[0.65, 0.65]","[0.196, 0.186]","[0.22, 0.209]","[0.174, 0.164]","[0.737, 0.735]","[0.645, 0.643]","[0.62, 0.62]","[0.684, 0.679]","[0.813, 0.811]","[0.746, 0.746]","[0.634, 0.632]","[0.928, 0.926]","[0.841, 0.841]","[0.767, 0.769]","[0.821, 0.82]","[0.794, 0.794]",0.502,0.565,0.65,0.191,0.214,0.169,0.736,0.644,0.62,0.681,0.812,0.746,0.633,0.927,0.841,0.768,0.821,0.794
https://doi.org/10.1186/s12989-019-0293-5,effects of neonatal inhalation exposure to ultrafine carbon particles on pathology and behavioral outcomes in c57bl6j mice,40966_effects of neonatal inhalation exposure to ultrafine carbon particles on pathology and behavioral outcomes in c57bl6j mice.pdf,1,['https://www.cdpr.ca.gov/docs/risk/rcd/aitc-external-scientific-review-draft-risk-characterization.pdf'],"[""Interim Response to Request for External Peer Review of the Department of Pesticide Regulation's Risk Characterization Document for Allyl Isothiocyanate (AITC)""]",['https://www.cdpr.ca.gov/docs/risk/rcd/aitc-external-scientific-review-draft-risk-characterization.pdf'],['40966_0_interim response to request for external peer review of the department of pesticide regulations risk characterization document for allyl isothiocyanate aitc.pdf'],1,100.0,['https://www.cdpr.ca.gov/docs/risk/rcd/aitc-external-scientific-review-draft-risk-characterization.pdf'],['40966_0_interim response to request for external peer review of the department of pesticide regulations risk characterization document for allyl isothiocyanate aitc.pdf'],[0.324],[0.494],[0.594],[0.118],[0.116],[0.097],[0.73],[0.633],[0.575],[0.675],[0.785],[0.704],[0.6],[0.913],[0.807],[0.739],[0.786],[0.771],0.324,0.494,0.594,0.118,0.116,0.097,0.73,0.633,0.575,0.675,0.785,0.704,0.6,0.913,0.807,0.739,0.786,0.771
https://doi.org/10.1186/s13006-020-00314-8,breastfeeding mothers with covid19 infection a case series,40980_breastfeeding mothers with covid19 infection a case series.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['40980_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812980/pdf'],['40980_0_nursing care recommendation for pediatric covid19 patients in the hospital setting a brief scoping review.pdf'],[0.367],[0.542],[0.625],[0.167],[0.188],[0.153],[0.74],[0.65],[0.605],[0.621],[0.799],[0.725],[0.61],[0.92],[0.829],[0.757],[0.803],[0.786],0.367,0.542,0.625,0.167,0.188,0.153,0.74,0.65,0.605,0.621,0.799,0.725,0.61,0.92,0.829,0.757,0.803,0.786
https://doi.org/10.1186/s13012-018-0741-x,an integrated community health worker intervention in rural nepal a type 2 hybrid effectivenessimplementation study protocol,40990_an integrated community health worker intervention in rural nepal a type 2 hybrid effectivenessimplementation study protocol.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['Integrated community case management of childhood illness in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['40990_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094443/pdf'],['40990_0_integrated community case management of childhood illness in low‐ and middle‐income countries.pdf'],[0.461],[0.538],[0.628],[0.173],[0.184],[0.15],[0.727],[0.635],[0.599],[0.69],[0.796],[0.726],[0.606],[0.915],[0.828],[0.741],[0.799],[0.767],0.461,0.538,0.628,0.173,0.184,0.15,0.727,0.635,0.599,0.69,0.796,0.726,0.606,0.915,0.828,0.741,0.799,0.767
https://doi.org/10.1186/s13012-019-0933-z,implementation of the uterine fibroids option grid patient decision aids across five organizational settings a randomized steppedwedge study protocol,40994_implementation of the uterine fibroids option grid patient decision aids across five organizational settings a randomized steppedwedge study protocol.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575556/pdf'],['Decision coaching for people making healthcare decisions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575556/pdf'],['40994_0_decision coaching for people making healthcare decisions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575556/pdf'],['40994_0_decision coaching for people making healthcare decisions.pdf'],[0.382],[0.547],[0.638],[0.178],[0.192],[0.157],[0.737],[0.648],[0.601],[0.701],[0.79],[0.724],[0.612],[0.929],[0.837],[0.751],[0.795],[0.777],0.382,0.547,0.638,0.178,0.192,0.157,0.737,0.648,0.601,0.701,0.79,0.724,0.612,0.929,0.837,0.751,0.795,0.777
https://doi.org/10.1186/s13012-019-0949-4,the impact of basic vs enhanced go napsacc on child care centers’ healthy eating and physical activity practices protocol for a type 3 hybrid effectivenessimplementation clusterrandomized trial,40995_the impact of basic vs enhanced go napsacc on child care centers’ healthy eating and physical activity practices protocol for a type 3 hybrid effectivenessimplementation clusterrandomized trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['Interventions for increasing fruit and vegetable consumption in children aged five years and under'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40995_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf'],['40995_0_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf'],[0.311],[0.548],[0.632],[0.167],[0.171],[0.139],[0.729],[0.634],[0.616],[0.685],[0.803],[0.728],[0.61],[0.932],[0.848],[0.759],[0.807],[0.791],0.311,0.548,0.632,0.167,0.171,0.139,0.729,0.634,0.616,0.685,0.803,0.728,0.61,0.932,0.848,0.759,0.807,0.791
https://doi.org/10.1186/s13033-019-0306-7,key attributes of integrated communitybased youth service hubs for mental health a scoping review,41018_key attributes of integrated communitybased youth service hubs for mental health a scoping review.pdf,2,"['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['Well and Thriving: Prevention and Early Intervention in California - Second Public Draft', 'Well and Thriving: Prevention and Early Intervention in California, First Public Draft']","['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['41018_0_well and thriving prevention and early intervention in california  second public draft.pdf', '41018_1_well and thriving prevention and early intervention in california first public draft.pdf']",2,100.0,"['https://mhsoac.ca.gov/wp-content/uploads/PEI-Draft-report_v2_20220923.pdf', 'https://mhsoac.ca.gov/wp-content/uploads/PEIDraftReport_09072022.pdf']","['41018_0_well and thriving prevention and early intervention in california  second public draft.pdf', '41018_1_well and thriving prevention and early intervention in california first public draft.pdf']","[0.647, 0.647]","[0.535, 0.534]","[0.63, 0.63]","[0.18, 0.18]","[0.201, 0.201]","[0.161, 0.162]","[0.734, 0.735]","[0.646, 0.647]","[0.601, 0.6]","[0.693, 0.694]","[0.806, 0.806]","[0.735, 0.734]","[0.623, 0.623]","[0.931, 0.931]","[0.843, 0.842]","[0.769, 0.768]","[0.816, 0.816]","[0.795, 0.795]",0.647,0.534,0.63,0.18,0.201,0.162,0.734,0.647,0.601,0.694,0.806,0.734,0.623,0.931,0.843,0.768,0.816,0.795
https://doi.org/10.1186/s13034-016-0127-2,childhood traumatic experiences and mental health problems in sexually offending and nonsexually offending juveniles,41034_childhood traumatic experiences and mental health problems in sexually offending and nonsexually offending juveniles.pdf,2,"['http://vcoy.virginia.gov/documents/collection/028%20Sexual%20offending2.pdf', 'http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf']","['SEXUAL OFFENDING', 'Collection of Evidence-based Practices for Children and Adolescents with Mental Health Treatment Needs']","['http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/028%20Sexual%20offending2.pdf']","['41034_1_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '41034_0_sexual offending.pdf']",2,100.0,"['http://vcoy.virginia.gov/documents/collection/Collection2017online.pdf', 'http://vcoy.virginia.gov/documents/collection/028%20Sexual%20offending2.pdf']","['41034_1_collection of evidencebased practices for children and adolescents with mental health treatment needs.pdf', '41034_0_sexual offending.pdf']","[0.509, 0.372]","[0.544, 0.569]","[0.633, 0.649]","[0.173, 0.218]","[0.187, 0.244]","[0.159, 0.21]","[0.733, 0.746]","[0.635, 0.649]","[0.61, 0.628]","[0.685, 0.697]","[0.806, 0.813]","[0.746, 0.76]","[0.623, 0.634]","[0.924, 0.924]","[0.83, 0.841]","[0.774, 0.784]","[0.814, 0.824]","[0.797, 0.805]",0.441,0.556,0.641,0.196,0.215,0.184,0.74,0.642,0.619,0.691,0.809,0.753,0.629,0.924,0.835,0.779,0.819,0.801
https://doi.org/10.1186/s13034-018-0248-x,multidimensional family therapy in adolescents with a cannabis use disorder longterm effects on delinquency in a randomized controlled trial,41041_multidimensional family therapy in adolescents with a cannabis use disorder longterm effects on delinquency in a randomized controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910124/pdf', 'https://effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research']","['Interventions for female drug‐using offenders', 'Interventions for Substance Use Disorders in Adolescents: A Systematic Review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910124/pdf'],['41041_0_interventions for female drug‐using offenders.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910124/pdf'],['41041_0_interventions for female drug‐using offenders.pdf'],[0.383],[0.517],[0.602],[0.181],[0.184],[0.153],[0.733],[0.64],[0.576],[0.701],[0.779],[0.708],[0.59],[0.908],[0.803],[0.723],[0.777],[0.753],0.383,0.517,0.602,0.181,0.184,0.153,0.733,0.64,0.576,0.701,0.779,0.708,0.59,0.908,0.803,0.723,0.777,0.753
https://doi.org/10.1186/s13047-020-00390-3,effectiveness of therapeutic footwear for children a systematic review,41051_effectiveness of therapeutic footwear for children a systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759438/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790962/pdf']","['Foot orthoses for treating paediatric flat feet', 'Foot orthoses for treating paediatric flat feet']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759438/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790962/pdf']","['41051_0_foot orthoses for treating paediatric flat feet.pdf', '41051_1_foot orthoses for treating paediatric flat feet.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759438/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790962/pdf']","['41051_0_foot orthoses for treating paediatric flat feet.pdf', '41051_1_foot orthoses for treating paediatric flat feet.pdf']","[0.426, 0.425]","[0.51, 0.511]","[0.587, 0.588]","[0.163, 0.164]","[0.165, 0.166]","[0.14, 0.141]","[0.738, 0.738]","[0.645, 0.645]","[0.575, 0.576]","[0.71, 0.71]","[0.772, 0.772]","[0.692, 0.692]","[0.596, 0.596]","[0.913, 0.913]","[0.805, 0.806]","[0.724, 0.724]","[0.773, 0.773]","[0.754, 0.754]",0.425,0.51,0.587,0.164,0.166,0.141,0.738,0.645,0.575,0.71,0.772,0.692,0.596,0.913,0.806,0.724,0.773,0.754
https://doi.org/10.1186/s13052-018-0589-3,siaip position paper provocation challenge to antibiotics and nonsteroidal antiinflammatory drugs in children,41059_siaip position paper provocation challenge to antibiotics and nonsteroidal antiinflammatory drugs in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694633/pdf'],['Management of chronic urticaria in children: a clinical guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694633/pdf'],['41059_0_management of chronic urticaria in children a clinical guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694633/pdf'],['41059_0_management of chronic urticaria in children a clinical guideline.pdf'],[0.358],[0.575],[0.645],[0.185],[0.212],[0.173],[0.749],[0.654],[0.639],[0.652],[0.811],[0.733],[0.628],[0.935],[0.835],[0.775],[0.811],[0.797],0.358,0.575,0.645,0.185,0.212,0.173,0.749,0.654,0.639,0.652,0.811,0.733,0.628,0.935,0.835,0.775,0.811,0.797
https://doi.org/10.1186/s13052-019-0734-7,italian guidelines for the prevention and management of dental trauma in children,41060_italian guidelines for the prevention and management of dental trauma in children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894327/pdf'],['Italian guidelines for the prevention and management of dental trauma in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894327/pdf'],['41060_0_italian guidelines for the prevention and management of dental trauma in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894327/pdf'],['41060_0_italian guidelines for the prevention and management of dental trauma in children.pdf'],[1.0],[0.564],[0.641],[0.219],[0.237],[0.201],[0.754],[0.664],[0.621],[0.668],[0.809],[0.74],[0.627],[0.928],[0.837],[0.774],[0.806],[0.793],1.0,0.564,0.641,0.219,0.237,0.201,0.754,0.664,0.621,0.668,0.809,0.74,0.627,0.928,0.837,0.774,0.806,0.793
https://doi.org/10.1186/s13054-019-2354-4,permissive versus restrictive temperature thresholds in critically ill children with fever and infection a multicentre randomized clinical pilot trial,41063_permissive versus restrictive temperature thresholds in critically ill children with fever and infection a multicentre randomized clinical pilot trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211223/pdf'],['Symptomatic fever management in children: A systematic review of national and international guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211223/pdf'],['41063_0_symptomatic fever management in children a systematic review of national and international guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211223/pdf'],['41063_0_symptomatic fever management in children a systematic review of national and international guidelines.pdf'],[0.297],[0.486],[0.583],[0.138],[0.163],[0.133],[0.734],[0.642],[0.549],[0.682],[0.772],[0.679],[0.579],[0.899],[0.824],[0.692],[0.776],[0.76],0.297,0.486,0.583,0.138,0.163,0.133,0.734,0.642,0.549,0.682,0.772,0.679,0.579,0.899,0.824,0.692,0.776,0.76
https://doi.org/10.1186/s13063-018-2935-6,a communitybased intervention young smiles to improve the healthrelated quality of life of children and young people of parents with serious mental illness randomised feasibility protocol,41101_a communitybased intervention young smiles to improve the healthrelated quality of life of children and young people of parents with serious mental illness randomised feasibility protocol.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf']","['Parenting interventions for people with schizophrenia or related serious mental illness', 'Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf']","['41101_0_parenting interventions for people with schizophrenia or related serious mental illness.pdf', '41101_1_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440158/pdf']","['41101_0_parenting interventions for people with schizophrenia or related serious mental illness.pdf', '41101_1_effects of consumers and health providers working in partnership on health services planning delivery and evaluation.pdf']","[0.604, 0.498]","[0.561, 0.569]","[0.643, 0.649]","[0.185, 0.185]","[0.205, 0.198]","[0.171, 0.16]","[0.734, 0.733]","[0.639, 0.64]","[0.627, 0.633]","[0.709, 0.698]","[0.807, 0.806]","[0.741, 0.742]","[0.61, 0.619]","[0.931, 0.93]","[0.85, 0.852]","[0.769, 0.769]","[0.812, 0.812]","[0.793, 0.793]",0.551,0.565,0.646,0.185,0.202,0.166,0.734,0.639,0.63,0.704,0.806,0.742,0.615,0.931,0.851,0.769,0.812,0.793
https://doi.org/10.1186/s13063-018-3048-y,treatment effectiveness of a mindfulnessbased inpatient group psychotherapy in adolescent substance use disorder  study protocol for a randomized controlled trial,41103_treatment effectiveness of a mindfulnessbased inpatient group psychotherapy in adolescent substance use disorder  study protocol for a randomized controlled trial.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527365/pdf', 'https://effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/research']","['Mindfulness‐based interventions for substance use disorders', 'Interventions for Substance Use Disorders in Adolescents: A Systematic Review']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527365/pdf'],['41103_0_mindfulness‐based interventions for substance use disorders.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527365/pdf'],['41103_0_mindfulness‐based interventions for substance use disorders.pdf'],[0.556],[0.529],[0.622],[0.181],[0.194],[0.162],[0.736],[0.644],[0.59],[0.71],[0.781],[0.704],[0.578],[0.92],[0.826],[0.733],[0.784],[0.767],0.556,0.529,0.622,0.181,0.194,0.162,0.736,0.644,0.59,0.71,0.781,0.704,0.578,0.92,0.826,0.733,0.784,0.767
https://doi.org/10.1186/s13063-019-3191-0,via family—a familybased early intervention versus treatment as usual for familial highrisk children a study protocol for a randomized clinical trial,41105_via family—a familybased early intervention versus treatment as usual for familial highrisk children a study protocol for a randomized clinical trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf'],['Parenting interventions for people with schizophrenia or related serious mental illness'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf'],['41105_0_parenting interventions for people with schizophrenia or related serious mental illness.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526162/pdf'],['41105_0_parenting interventions for people with schizophrenia or related serious mental illness.pdf'],[0.612],[0.548],[0.632],[0.185],[0.201],[0.171],[0.734],[0.639],[0.612],[0.71],[0.8],[0.732],[0.606],[0.929],[0.846],[0.763],[0.803],[0.79],0.612,0.548,0.632,0.185,0.201,0.171,0.734,0.639,0.612,0.71,0.8,0.732,0.606,0.929,0.846,0.763,0.803,0.79
https://doi.org/10.1186/s13063-019-3249-z,the assist study  the bd odon device for assisted vaginal birth a safety and feasibility study,41109_the assist study  the bd odon device for assisted vaginal birth a safety and feasibility study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf'],['Instruments for assisted vaginal birth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf'],['41109_0_instruments for assisted vaginal birth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462579/pdf'],['41109_0_instruments for assisted vaginal birth.pdf'],[0.264],[0.509],[0.598],[0.171],[0.167],[0.143],[0.732],[0.638],[0.566],[0.677],[0.771],[0.696],[0.578],[0.904],[0.811],[0.72],[0.772],[0.747],0.264,0.509,0.598,0.171,0.167,0.143,0.732,0.638,0.566,0.677,0.771,0.696,0.578,0.904,0.811,0.72,0.772,0.747
https://doi.org/10.1186/s13063-019-3369-5,are stagebased health information messages effective and good value for money in improving maternal newborn and child health outcomes in india protocol for an individually randomized controlled trial,41111_are stagebased health information messages effective and good value for money in improving maternal newborn and child health outcomes in india protocol for an individually randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf'],"['Targeted client communication via mobile devices for improving maternal, neonatal, and child health']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf'],['41111_0_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1186/s13063-019-3467-4,collaborative care for child and youth mental health problems in a middleincome country study protocol for a randomized controlled trial training general practitioners,41112_collaborative care for child and youth mental health problems in a middleincome country study protocol for a randomized controlled trial training general practitioners.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['Primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['41112_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406740/pdf'],['41112_0_primary‐level worker interventions for the care of people living with mental disorders and distress in low‐ and middle‐income countries.pdf'],[0.543],[0.545],[0.627],[0.178],[0.192],[0.161],[0.736],[0.644],[0.598],[0.693],[0.796],[0.72],[0.606],[0.921],[0.831],[0.746],[0.798],[0.774],0.543,0.545,0.627,0.178,0.192,0.161,0.736,0.644,0.598,0.693,0.796,0.72,0.606,0.921,0.831,0.746,0.798,0.774
https://doi.org/10.1186/s13063-019-3486-1,effect of motivational interviewing in hypertensive patients midnight study protocol for a randomized controlled trial,41113_effect of motivational interviewing in hypertensive patients midnight study protocol for a randomized controlled trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543670/pdf'],['Strategies to improve smoking cessation rates in primary care'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543670/pdf'],['41113_0_strategies to improve smoking cessation rates in primary care.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543670/pdf'],['41113_0_strategies to improve smoking cessation rates in primary care.pdf'],[0.385],[0.539],[0.629],[0.186],[0.192],[0.15],[0.736],[0.647],[0.605],[0.699],[0.792],[0.716],[0.592],[0.923],[0.832],[0.741],[0.79],[0.772],0.385,0.539,0.629,0.186,0.192,0.15,0.736,0.647,0.605,0.699,0.792,0.716,0.592,0.923,0.832,0.741,0.79,0.772
https://doi.org/10.1186/s13584-018-0258-4,should we use palivizumab immunoprophylaxis for infants against respiratory syncytial virus – a costutility analysis,41154_should we use palivizumab immunoprophylaxis for infants against respiratory syncytial virus – a costutility analysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594174/pdf'],['Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594174/pdf'],['41154_0_palivizumab for preventing severe respiratory syncytial virus rsv infection in children.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594174/pdf'],['41154_0_palivizumab for preventing severe respiratory syncytial virus rsv infection in children.pdf'],[0.514],[0.514],[0.606],[0.166],[0.163],[0.133],[0.735],[0.643],[0.587],[0.687],[0.777],[0.689],[0.597],[0.917],[0.803],[0.723],[0.776],[0.755],0.514,0.514,0.606,0.166,0.163,0.133,0.735,0.643,0.587,0.687,0.777,0.689,0.597,0.917,0.803,0.723,0.776,0.755
https://doi.org/10.1186/s13643-018-0843-1,the quality of clinical practice guidelines for management of pediatric type 2 diabetes mellitus a systematic review using the agree ii instrument,41162_the quality of clinical practice guidelines for management of pediatric type 2 diabetes mellitus a systematic review using the agree ii instrument.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827207/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497296/pdf']","['The structure of the quality of clinical practice guidelines with the items and overall assessment in AGREE II: a regression analysis', 'Quality assessment of clinical practice guidelines using the AGREE instrument in Japan: A time trend analysis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497296/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827207/pdf']","['41162_1_quality assessment of clinical practice guidelines using the agree instrument in japan a time trend analysis.pdf', '41162_0_the structure of the quality of clinical practice guidelines with the items and overall assessment in agree ii a regression analysis.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497296/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827207/pdf']","['41162_1_quality assessment of clinical practice guidelines using the agree instrument in japan a time trend analysis.pdf', '41162_0_the structure of the quality of clinical practice guidelines with the items and overall assessment in agree ii a regression analysis.pdf']","[0.279, 0.326]","[0.514, 0.482]","[0.598, 0.569]","[0.149, 0.134]","[0.153, 0.128]","[0.133, 0.111]","[0.728, 0.728]","[0.63, 0.628]","[0.582, 0.512]","[0.683, 0.697]","[0.778, 0.749]","[0.647, 0.678]","[0.615, 0.61]","[0.906, 0.91]","[0.834, 0.754]","[0.737, 0.723]","[0.787, 0.751]","[0.768, 0.734]",0.302,0.498,0.583,0.142,0.141,0.122,0.728,0.629,0.547,0.69,0.764,0.663,0.613,0.908,0.794,0.73,0.769,0.751
https://doi.org/10.1186/s13643-018-0859-6,deworming in nonpregnant adolescent girls and adult women a systematic review and metaanalysis,41163_deworming in nonpregnant adolescent girls and adult women a systematic review and metaanalysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127571/pdf'],['Effect of mass deworming with antihelminthics for soil‐transmitted helminths during pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127571/pdf'],['41163_0_effect of mass deworming with antihelminthics for soil‐transmitted helminths during pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127571/pdf'],['41163_0_effect of mass deworming with antihelminthics for soil‐transmitted helminths during pregnancy.pdf'],[0.667],[0.526],[0.616],[0.168],[0.172],[0.136],[0.735],[0.641],[0.598],[0.695],[0.788],[0.708],[0.593],[0.915],[0.807],[0.73],[0.786],[0.761],0.667,0.526,0.616,0.168,0.172,0.136,0.735,0.641,0.598,0.695,0.788,0.708,0.593,0.915,0.807,0.73,0.786,0.761
https://doi.org/10.1186/s13643-018-0900-9,health outcomes of maternal smoking during pregnancy and postpartum period for the mother and infant protocol for an umbrella review,41164_health outcomes of maternal smoking during pregnancy and postpartum period for the mother and infant protocol for an umbrella review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['How effects on health equity are assessed in systematic reviews of interventions'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['41164_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764740/pdf'],['41164_0_how effects on health equity are assessed in systematic reviews of interventions.pdf'],[0.632],[0.566],[0.66],[0.202],[0.211],[0.181],[0.734],[0.643],[0.637],[0.742],[0.808],[0.741],[0.605],[0.93],[0.851],[0.761],[0.809],[0.792],0.632,0.566,0.66,0.202,0.211,0.181,0.734,0.643,0.637,0.742,0.808,0.741,0.605,0.93,0.851,0.761,0.809,0.792
https://doi.org/10.1186/s13643-020-01436-0,opioids and alpha2agonists for analgesia and sedation in newborn infants protocol of a systematic review,41168_opioids and alpha2agonists for analgesia and sedation in newborn infants protocol of a systematic review.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf'],['Opioids for newborn infants receiving mechanical ventilation'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf'],['41168_0_opioids for newborn infants receiving mechanical ventilation.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121090/pdf'],['41168_0_opioids for newborn infants receiving mechanical ventilation.pdf'],[0.629],[0.515],[0.617],[0.182],[0.181],[0.144],[0.736],[0.645],[0.578],[0.691],[0.777],[0.703],[0.575],[0.913],[0.807],[0.721],[0.773],[0.752],0.629,0.515,0.617,0.182,0.181,0.144,0.736,0.645,0.578,0.691,0.777,0.703,0.575,0.913,0.807,0.721,0.773,0.752
https://doi.org/10.1186/s13690-018-0321-1,does treatment of short or stunted children aged 6–59 months for severe acute malnutrition using ready to use therapeutic food make them overweight data from malawi,41170_does treatment of short or stunted children aged 6–59 months for severe acute malnutrition using ready to use therapeutic food make them overweight data from malawi.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537457/pdf'],['Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537457/pdf'],['41170_0_ready‐to‐use therapeutic food rutf for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537457/pdf'],['41170_0_ready‐to‐use therapeutic food rutf for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age.pdf'],[0.465],[0.509],[0.601],[0.163],[0.164],[0.132],[0.73],[0.636],[0.574],[0.684],[0.78],[0.69],[0.604],[0.91],[0.808],[0.727],[0.781],[0.756],0.465,0.509,0.601,0.163,0.164,0.132,0.73,0.636,0.574,0.684,0.78,0.69,0.604,0.91,0.808,0.727,0.781,0.756
https://doi.org/10.1186/s13756-020-00875-7,nosocomial transmission and outbreaks of coronavirus disease 2019 the need to protect both patients and healthcare workers,41174_nosocomial transmission and outbreaks of coronavirus disease 2019 the need to protect both patients and healthcare workers.pdf,1,['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/A2124BA9B088027AE30BE46C28887084/S0899823X22000885a.pdf/strategies-to-prevent-ventilator-associated-pneumonia-ventilator-associated-events-and-nonventilator-hospital-acquired-pneumonia-in-acute-care-hospitals-2022-update.pdf'],"['Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update']",['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/A2124BA9B088027AE30BE46C28887084/S0899823X22000885a.pdf/strategies-to-prevent-ventilator-associated-pneumonia-ventilator-associated-events-and-nonventilator-hospital-acquired-pneumonia-in-acute-care-hospitals-2022-update.pdf'],['41174_0_strategies to prevent ventilatorassociated pneumonia ventilatorassociated events and nonventilator hospitalacquired pneumonia in acutecare hospitals 2022 update.pdf'],1,100.0,['https://www.cambridge.org/core/services/aop-cambridge-core/content/view/A2124BA9B088027AE30BE46C28887084/S0899823X22000885a.pdf/strategies-to-prevent-ventilator-associated-pneumonia-ventilator-associated-events-and-nonventilator-hospital-acquired-pneumonia-in-acute-care-hospitals-2022-update.pdf'],['41174_0_strategies to prevent ventilatorassociated pneumonia ventilatorassociated events and nonventilator hospitalacquired pneumonia in acutecare hospitals 2022 update.pdf'],[0.393],[0.582],[0.652],[0.174],[0.175],[0.137],[0.744],[0.659],[0.648],[0.647],[0.823],[0.761],[0.623],[0.927],[0.847],[0.787],[0.827],[0.806],0.393,0.582,0.652,0.174,0.175,0.137,0.744,0.659,0.648,0.647,0.823,0.761,0.623,0.927,0.847,0.787,0.827,0.806
https://doi.org/10.1186/s40176-018-0124-8,gender gaps in the path to adulthood for young females and males in six african countries from the 1990s to the 2010s,41190_gender gaps in the path to adulthood for young females and males in six african countries from the 1990s to the 2010s.pdf,2,"['https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_french.pdf', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_english.pdf']","['Examen Des Données Probantes Relatives à La Crise Mondiale Des Services De Garde D’enfants Et De La Voie à Suivre Pour La Reprise Et La Résilience Après La Covid-19', 'Evidence Review Of The Global Childcare Crisis And The Road For Post-covid-19 Recovery And Resilience']","['https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_french.pdf', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_english.pdf']","['41190_0_examen des données probantes relatives à la crise mondiale des services de garde denfants et de la voie à suivre pour la reprise et la résilience après la covid19.pdf', '41190_1_evidence review of the global childcare crisis and the road for postcovid19 recovery and resilience.pdf']",2,100.0,"['https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_french.pdf', 'https://docs.gatesfoundation.org/documents/evidence_review_of_the_global_childcare_crisis_and_the_road_ahead_for_covid-19_recovery_and_resilience_english.pdf']","['41190_0_examen des données probantes relatives à la crise mondiale des services de garde denfants et de la voie à suivre pour la reprise et la résilience après la covid19.pdf', '41190_1_evidence review of the global childcare crisis and the road for postcovid19 recovery and resilience.pdf']","[0.055, 0.398]","[0.442, 0.52]","[0.555, 0.623]","[0.111, 0.158]","[0.144, 0.165]","[0.113, 0.143]","[0.725, 0.725]","[0.629, 0.626]","[0.5, 0.589]","[0.675, 0.676]","[0.751, 0.792]","[0.643, 0.715]","[0.55, 0.641]","[0.863, 0.911]","[0.786, 0.821]","[0.687, 0.757]","[0.738, 0.799]","[0.698, 0.773]",0.227,0.481,0.589,0.135,0.154,0.128,0.725,0.627,0.544,0.675,0.772,0.679,0.596,0.887,0.803,0.722,0.768,0.736
https://doi.org/10.1186/s40337-020-00318-z,an audit of the changes in thiamine levels during higher caloric nutritional rehabilitation of adolescent patients hospitalised with a restrictive eating disorder,41199_an audit of the changes in thiamine levels during higher caloric nutritional rehabilitation of adolescent patients hospitalised with a restrictive eating disorder.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747364/pdf'],['To Improve the Initial Inpatient Management of Adolescents Admitted with Severe Anorexia Nervosa: A Narrative Review and a Convenient Protocol'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747364/pdf'],['41199_0_to improve the initial inpatient management of adolescents admitted with severe anorexia nervosa a narrative review and a convenient protocol.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747364/pdf'],['41199_0_to improve the initial inpatient management of adolescents admitted with severe anorexia nervosa a narrative review and a convenient protocol.pdf'],[0.536],[0.507],[0.606],[0.164],[0.177],[0.141],[0.74],[0.648],[0.576],[0.675],[0.778],[0.682],[0.603],[0.917],[0.806],[0.74],[0.783],[0.768],0.536,0.507,0.606,0.164,0.177,0.141,0.74,0.648,0.576,0.675,0.778,0.682,0.603,0.917,0.806,0.74,0.783,0.768
https://doi.org/10.1186/s40352-015-0025-3,an examination of the relationship between childhood abuse anger and violent behavior among a sample of sex offenders,41202_an examination of the relationship between childhood abuse anger and violent behavior among a sample of sex offenders.pdf,1,['https://purl.fdlp.gov/GPO/gpo111573'],['Sex offender management assessment and planning initiative'],['https://purl.fdlp.gov/GPO/gpo111573'],['41202_0_sex offender management assessment and planning initiative.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo111573'],['41202_0_sex offender management assessment and planning initiative.pdf'],[0.557],[0.528],[0.62],[0.188],[0.212],[0.186],[0.74],[0.645],[0.572],[0.703],[0.785],[0.714],[0.629],[0.913],[0.801],[0.747],[0.788],[0.772],0.557,0.528,0.62,0.188,0.212,0.186,0.74,0.645,0.572,0.703,0.785,0.714,0.629,0.913,0.801,0.747,0.788,0.772
https://doi.org/10.1186/s40352-019-0093-x,juvenile justice systems of care results of a national survey of community supervision agencies and behavioral health providers on services provision and crosssystem interactions,41204_juvenile justice systems of care results of a national survey of community supervision agencies and behavioral health providers on services provision and crosssystem interactions.pdf,1,['https://www.justice.gov/file/1340216/download'],['President’s Commission on Law Enforcement and the Administration of Justice'],['https://www.justice.gov/file/1340216/download'],['41204_0_presidents commission on law enforcement and the administration of justice.pdf'],1,100.0,['https://www.justice.gov/file/1340216/download'],['41204_0_presidents commission on law enforcement and the administration of justice.pdf'],[0.325],[0.557],[0.644],[0.157],[0.179],[0.142],[0.723],[0.629],[0.63],[0.662],[0.815],[0.766],[0.647],[0.931],[0.85],[0.785],[0.824],[0.802],0.325,0.557,0.644,0.157,0.179,0.142,0.723,0.629,0.63,0.662,0.815,0.766,0.647,0.931,0.85,0.785,0.824,0.802
https://doi.org/10.1186/s40462-019-0149-5,modeling the active dispersal of juvenile leatherback turtles in the north atlantic ocean,41212_modeling the active dispersal of juvenile leatherback turtles in the north atlantic ocean.pdf,1,['https://purl.fdlp.gov/GPO/gpo143099'],['Endangered Species Act status review of the leatherback turtle (Dermochelys coriacea).'],['https://purl.fdlp.gov/GPO/gpo143099'],['41212_0_endangered species act status review of the leatherback turtle dermochelys coriacea.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo143099'],['41212_0_endangered species act status review of the leatherback turtle dermochelys coriacea.pdf'],[0.501],[0.524],[0.612],[0.162],[0.163],[0.136],[0.73],[0.634],[0.598],[0.68],[0.804],[0.734],[0.662],[0.909],[0.836],[0.768],[0.809],[0.794],0.501,0.524,0.612,0.162,0.163,0.136,0.73,0.634,0.598,0.68,0.804,0.734,0.662,0.909,0.836,0.768,0.809,0.794
https://doi.org/10.1186/s40479-020-00123-9,does treatment method matter a metaanalysis of the past 20 years of research on therapeutic interventions for selfharm and suicidal ideation in adolescents,41215_does treatment method matter a metaanalysis of the past 20 years of research on therapeutic interventions for selfharm and suicidal ideation in adolescents.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['Interventions for self‐harm in children and adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['41215_0_interventions for self‐harm in children and adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094399/pdf'],['41215_0_interventions for self‐harm in children and adolescents.pdf'],[0.626],[0.532],[0.612],[0.195],[0.205],[0.164],[0.74],[0.651],[0.594],[0.711],[0.791],[0.709],[0.593],[0.92],[0.826],[0.74],[0.791],[0.773],0.626,0.532,0.612,0.195,0.205,0.164,0.74,0.651,0.594,0.711,0.791,0.709,0.593,0.92,0.826,0.74,0.791,0.773
https://doi.org/10.1186/s40557-018-0237-9,environmental exposure of heavy metal lead and cadmium and hearing loss data from the korea national health and nutrition examination survey knhanes 2010–2013,41217_environmental exposure of heavy metal lead and cadmium and hearing loss data from the korea national health and nutrition examination survey knhanes 2010–2013.pdf,1,['https://purl.fdlp.gov/GPO/gpo144830'],['Toxicological profile for lead /'],['https://purl.fdlp.gov/GPO/gpo144830'],['41217_0_toxicological profile for lead .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo144830'],['41217_0_toxicological profile for lead .pdf'],[0.349],[0.496],[0.593],[0.14],[0.141],[0.116],[0.733],[0.638],[0.561],[0.688],[0.779],[0.671],[0.605],[0.91],[0.788],[0.731],[0.768],[0.757],0.349,0.496,0.593,0.14,0.141,0.116,0.733,0.638,0.561,0.688,0.779,0.671,0.605,0.91,0.788,0.731,0.768,0.757
https://doi.org/10.1186/s40608-019-0233-9,family spirit nurture fsn – a randomized controlled trial to prevent early childhood obesity in american indian populations trial rationale and study protocol,41223_family spirit nurture fsn – a randomized controlled trial to prevent early childhood obesity in american indian populations trial rationale and study protocol.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf']","['Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants', 'Interventions for increasing fruit and vegetable consumption in children aged five years and under']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf']","['41223_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '41223_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273132/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388772/pdf']","['41223_1_interventions for increasing fruit and vegetable consumption in children aged five years and under.pdf', '41223_0_education of family members to support weaning to solids and nutrition in later infancy in term‐born infants.pdf']","[0.564, 0.511]","[0.542, 0.523]","[0.628, 0.609]","[0.178, 0.169]","[0.18, 0.173]","[0.15, 0.145]","[0.732, 0.731]","[0.633, 0.632]","[0.609, 0.583]","[0.688, 0.69]","[0.792, 0.775]","[0.72, 0.705]","[0.605, 0.6]","[0.927, 0.911]","[0.84, 0.813]","[0.75, 0.724]","[0.796, 0.778]","[0.781, 0.754]",0.537,0.532,0.619,0.173,0.176,0.147,0.732,0.633,0.596,0.689,0.784,0.712,0.603,0.919,0.827,0.737,0.787,0.768
https://doi.org/10.1186/s40621-020-00245-2,largescale evaluation of interventions designed to reduce childhood drownings in rural bangladesh a before and after cohort study,41225_largescale evaluation of interventions designed to reduce childhood drownings in rural bangladesh a before and after cohort study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406676/pdf'],['Day care as a strategy for drowning prevention in children under 6 years of age in low‐ and middle‐income countries'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406676/pdf'],['41225_0_day care as a strategy for drowning prevention in children under 6 years of age in low‐ and middle‐income countries.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406676/pdf'],['41225_0_day care as a strategy for drowning prevention in children under 6 years of age in low‐ and middle‐income countries.pdf'],[0.559],[0.547],[0.626],[0.192],[0.202],[0.165],[0.731],[0.637],[0.609],[0.691],[0.797],[0.725],[0.621],[0.92],[0.839],[0.753],[0.798],[0.779],0.559,0.547,0.626,0.192,0.202,0.165,0.731,0.637,0.609,0.691,0.797,0.725,0.621,0.92,0.839,0.753,0.798,0.779
https://doi.org/10.1192/bjp.2019.113,anorexia nervosa 30year outcome,41338_anorexia nervosa 30year outcome.pdf,1,['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['The American Psychiatric Association Practice Guideline for the Treatment of Patients with Eating Disorders'],['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['41338_0_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf'],1,100.0,['https://www.psychiatry.org/getmedia/97405f0d-1bd4-43d0-abdd-c013fcd8686d/APA-Eating-Disorders-Practice-Guideline-Under-Copyediting.pdf'],['41338_0_the american psychiatric association practice guideline for the treatment of patients with eating disorders.pdf'],[0.475],[0.559],[0.654],[0.218],[0.241],[0.197],[0.744],[0.651],[0.623],[0.708],[0.814],[0.736],[0.629],[0.927],[0.828],[0.776],[0.808],[0.794],0.475,0.559,0.654,0.218,0.241,0.197,0.744,0.651,0.623,0.708,0.814,0.736,0.629,0.927,0.828,0.776,0.808,0.794
https://doi.org/10.1192/pb.bp.108.019810,use and perceived utility of structured violence risk assessments in english medium secure forensic units,41370_use and perceived utility of structured violence risk assessments in english medium secure forensic units.pdf,2,"['https://www.cdcr.ca.gov/bph/wp-content/uploads/sites/161/2021/04/PV.BPH-RN-16-01-SECTION-2240-CRA-Complete-Rulemaking-File-Print-Version-Excluding-Hyperlink-Documents.pdf', 'https://www.cdcr.ca.gov/bph/wp-content/uploads/sites/161/2019/06/BPH-RN-16-01-SECTION-2240-CRA-Complete-Rulemaking-File-Print-Version-Excluding-Hyperlink-Documents.pdf']","['‘= Ceive', '‘= Ceive']","['https://www.cdcr.ca.gov/bph/wp-content/uploads/sites/161/2019/06/BPH-RN-16-01-SECTION-2240-CRA-Complete-Rulemaking-File-Print-Version-Excluding-Hyperlink-Documents.pdf', 'https://www.cdcr.ca.gov/bph/wp-content/uploads/sites/161/2021/04/PV.BPH-RN-16-01-SECTION-2240-CRA-Complete-Rulemaking-File-Print-Version-Excluding-Hyperlink-Documents.pdf']","['41370_1_ ceive.pdf', '41370_0_ ceive.pdf']",2,100.0,"['https://www.cdcr.ca.gov/bph/wp-content/uploads/sites/161/2019/06/BPH-RN-16-01-SECTION-2240-CRA-Complete-Rulemaking-File-Print-Version-Excluding-Hyperlink-Documents.pdf', 'https://www.cdcr.ca.gov/bph/wp-content/uploads/sites/161/2021/04/PV.BPH-RN-16-01-SECTION-2240-CRA-Complete-Rulemaking-File-Print-Version-Excluding-Hyperlink-Documents.pdf']","['41370_1_ ceive.pdf', '41370_0_ ceive.pdf']","[0.469, 0.469]","[0.556, 0.556]","[0.63, 0.63]","[0.165, 0.165]","[0.182, 0.182]","[0.148, 0.148]","[0.725, 0.725]","[0.632, 0.632]","[0.615, 0.615]","[0.696, 0.696]","[0.803, 0.803]","[0.743, 0.743]","[0.64, 0.64]","[0.927, 0.927]","[0.844, 0.844]","[0.767, 0.767]","[0.813, 0.813]","[0.787, 0.787]",0.469,0.556,0.63,0.165,0.182,0.148,0.725,0.632,0.615,0.696,0.803,0.743,0.64,0.927,0.844,0.767,0.813,0.787
https://doi.org/10.1200/jco.2000.18.12.2435,second cancers among longterm survivors of hodgkin’s disease diagnosed in childhood and adolescence,41432_second cancers among longterm survivors of hodgkin’s disease diagnosed in childhood and adolescence.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257601/pdf']","[""Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk"", 'Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group', 'Recommendations for Breast Cancer Surveillance for Female Childhood, Adolescent and Young Adult Cancer Survivors Treated with Chest Radiation: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf']","['41432_0_chemotherapy radiotherapy and combined modality for hodgkins disease with emphasis on second cancer risk.pdf', '41432_1_updated breast cancer surveillance recommendations for female survivors of childhood adolescent and young adult cancer from the international guideline harmonization group.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723685/pdf']","['41432_0_chemotherapy radiotherapy and combined modality for hodgkins disease with emphasis on second cancer risk.pdf', '41432_1_updated breast cancer surveillance recommendations for female survivors of childhood adolescent and young adult cancer from the international guideline harmonization group.pdf']","[0.276, 0.583]","[0.482, 0.555]","[0.563, 0.637]","[0.141, 0.206]","[0.127, 0.203]","[0.11, 0.179]","[0.739, 0.753]","[0.644, 0.664]","[0.552, 0.606]","[0.705, 0.711]","[0.768, 0.808]","[0.646, 0.73]","[0.588, 0.617]","[0.896, 0.9]","[0.784, 0.812]","[0.704, 0.751]","[0.755, 0.796]","[0.743, 0.774]",0.429,0.518,0.6,0.173,0.165,0.144,0.746,0.654,0.579,0.708,0.788,0.688,0.603,0.898,0.798,0.728,0.776,0.758
https://doi.org/10.1200/jco.2000.18.24.4067,quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage iv neuroblastoma a children’s cancer group study,41436_quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage iv neuroblastoma a children’s cancer group study.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783746/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483698/pdf']","['High‐dose chemotherapy and autologous haematopoietic stem cell rescue for children with high‐risk neuroblastoma', 'Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483698/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783746/pdf']","['41436_1_retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.pdf', '41436_0_high‐dose chemotherapy and autologous haematopoietic stem cell rescue for children with high‐risk neuroblastoma.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483698/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783746/pdf']","['41436_1_retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.pdf', '41436_0_high‐dose chemotherapy and autologous haematopoietic stem cell rescue for children with high‐risk neuroblastoma.pdf']","[0.406, 0.332]","[0.545, 0.543]","[0.639, 0.632]","[0.186, 0.188]","[0.174, 0.17]","[0.137, 0.139]","[0.744, 0.744]","[0.653, 0.651]","[0.617, 0.611]","[0.68, 0.686]","[0.798, 0.793]","[0.723, 0.72]","[0.591, 0.593]","[0.916, 0.913]","[0.826, 0.814]","[0.745, 0.739]","[0.784, 0.781]","[0.777, 0.769]",0.369,0.544,0.635,0.187,0.172,0.138,0.744,0.652,0.614,0.683,0.796,0.722,0.592,0.915,0.82,0.742,0.782,0.773
https://doi.org/10.1200/jco.2000.18.3.487,longterm risk of second malignancy in survivors of hodgkin’s disease treated during adolescence or young adulthood,41437_longterm risk of second malignancy in survivors of hodgkin’s disease treated during adolescence or young adulthood.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017637/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066773/pdf']","[""Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk"", 'ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II', 'Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma', 'Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinum']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066773/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017637/pdf']","['41437_2_chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage hodgkin lymphoma.pdf', '41437_1_acr appropriateness criteria® hodgkin lymphomafavorable prognosis stage i and ii.pdf', '41437_3_fondazione italiana linfomi fil expert consensus on the use of intensitymodulated and imageguided radiotherapy for hodgkins lymphoma involving the mediastinum.pdf', '41437_0_chemotherapy radiotherapy and combined modality for hodgkins disease with emphasis on second cancer risk.pdf']",4,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433865/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066773/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017637/pdf']","['41437_2_chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage hodgkin lymphoma.pdf', '41437_1_acr appropriateness criteria® hodgkin lymphomafavorable prognosis stage i and ii.pdf', '41437_3_fondazione italiana linfomi fil expert consensus on the use of intensitymodulated and imageguided radiotherapy for hodgkins lymphoma involving the mediastinum.pdf', '41437_0_chemotherapy radiotherapy and combined modality for hodgkins disease with emphasis on second cancer risk.pdf']","[0.349, 0.326, 0.234, 0.329]","[0.499, 0.504, 0.504, 0.482]","[0.581, 0.606, 0.593, 0.559]","[0.171, 0.178, 0.171, 0.15]","[0.163, 0.196, 0.178, 0.139]","[0.137, 0.148, 0.138, 0.122]","[0.741, 0.744, 0.745, 0.738]","[0.649, 0.66, 0.659, 0.646]","[0.559, 0.577, 0.57, 0.548]","[0.718, 0.709, 0.692, 0.715]","[0.768, 0.778, 0.78, 0.767]","[0.664, 0.674, 0.691, 0.64]","[0.584, 0.576, 0.597, 0.59]","[0.892, 0.893, 0.904, 0.899]","[0.784, 0.803, 0.786, 0.786]","[0.703, 0.714, 0.723, 0.704]","[0.753, 0.764, 0.769, 0.752]","[0.737, 0.756, 0.753, 0.742]",0.309,0.497,0.585,0.168,0.169,0.136,0.742,0.654,0.564,0.708,0.773,0.667,0.587,0.897,0.79,0.711,0.76,0.747
https://doi.org/10.1200/jco.2000.18.7.1492,second malignant neoplasms after treatment for hodgkin’s disease in childhood or adolescence,41438_second malignant neoplasms after treatment for hodgkin’s disease in childhood or adolescence.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261/pdf'],['Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261/pdf'],['41438_0_chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage hodgkin lymphoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478261/pdf'],['41438_0_chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage hodgkin lymphoma.pdf'],[0.272],[0.495],[0.574],[0.159],[0.151],[0.136],[0.742],[0.649],[0.554],[0.717],[0.754],[0.665],[0.583],[0.88],[0.764],[0.688],[0.744],[0.718],0.272,0.495,0.574,0.159,0.151,0.136,0.742,0.649,0.554,0.717,0.754,0.665,0.583,0.88,0.764,0.688,0.744,0.718
https://doi.org/10.1200/jco.2001.19.11.2875,clinical evaluation of onceweekly dosing of epoetin alfa in chemotherapy patients improvements in hemoglobin and quality of life are similar to threetimesweekly dosing,41439_clinical evaluation of onceweekly dosing of epoetin alfa in chemotherapy patients improvements in hemoglobin and quality of life are similar to threetimesweekly dosing.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145276/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388847/pdf', 'https://www.cms.gov/medicare-coverage-database/details/nca-details.aspx?NCAId=203&type=Closed']","['Erythropoietin or darbepoetin for patients with cancer', 'Blood transfusions for anaemia in patients with advanced cancer', 'National Coverage Analysis (NCA) for Erythropoiesis Stimulating Agents (ESAs) for non-renal disease indications (CAG-00383N)']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145276/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388847/pdf']","['41439_0_erythropoietin or darbepoetin for patients with cancer.pdf', '41439_1_blood transfusions for anaemia in patients with advanced cancer.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145276/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388847/pdf']","['41439_0_erythropoietin or darbepoetin for patients with cancer.pdf', '41439_1_blood transfusions for anaemia in patients with advanced cancer.pdf']","[0.309, 0.355]","[0.473, 0.526]","[0.562, 0.616]","[0.141, 0.16]","[0.134, 0.173]","[0.114, 0.136]","[0.737, 0.734]","[0.641, 0.636]","[0.542, 0.595]","[0.698, 0.686]","[0.745, 0.774]","[0.626, 0.693]","[0.577, 0.595]","[0.903, 0.912]","[0.77, 0.808]","[0.699, 0.734]","[0.738, 0.775]","[0.731, 0.761]",0.332,0.499,0.589,0.15,0.153,0.125,0.736,0.639,0.569,0.692,0.76,0.659,0.586,0.907,0.789,0.716,0.756,0.746
https://doi.org/10.1200/jco.2016.71.7066,financial burden in survivors of childhood cancer a report from the childhood cancer survivor study,41525_financial burden in survivors of childhood cancer a report from the childhood cancer survivor study.pdf,3,"['https://effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/research', 'https://www.gao.gov/products/GAO-20-636R', 'https://www.michigan.gov/documents/mdhhs/Childhood_2019_660139_7.pdf']","['Disparities and Barriers to Pediatric Cancer Survivorship Care', 'Survivors of Childhood Cancer: Factors Affecting Access to Follow-up Care', 'Breast Cancer in Michigan']",['https://www.michigan.gov/documents/mdhhs/Childhood_2019_660139_7.pdf'],['41525_2_breast cancer in michigan.pdf'],1,33.33,['https://www.michigan.gov/documents/mdhhs/Childhood_2019_660139_7.pdf'],['41525_2_breast cancer in michigan.pdf'],[0.277],[0.491],[0.599],[0.16],[0.161],[0.14],[0.734],[0.64],[0.552],[0.691],[0.755],[0.69],[0.596],[0.876],[0.789],[0.685],[0.762],[0.715],0.277,0.491,0.599,0.16,0.161,0.14,0.734,0.64,0.552,0.691,0.755,0.69,0.596,0.876,0.789,0.685,0.762,0.715
https://doi.org/10.1200/jco.2017.77.0446,clinical cancer advances 2018 annual report on progress against cancer from the american society of clinical oncology,41526_clinical cancer advances 2018 annual report on progress against cancer from the american society of clinical oncology.pdf,8,"['https://www.congress.gov/event/115th-congress/senate-event/LC68660/text', 'https://www.congress.gov/event/117th-congress/senate-event/LC68498/text', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hhs.texas.gov/sites/default/files/documents/about-hhs/communications-events/meetings-events/dur/jan-2021-durb-agenda-item3s.pdf', 'https://www.congress.gov/event/117th-congress/senate-event/LC65823/text', 'https://www.congress.gov/event/116th-congress/senate-event/LC64453/text?s=1&r=16589', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/moda-ump-preauthreqs.pdf']","['S.Hrg. 115-709 — DEPARTMENT OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 2019', 'DEPARTMENT OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 2019', 'Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit', 'Oncology Oral, Lung Cancer Therapeutic Class Review (TCR)', 'Senate Hearing, 117th Congress — DEPARTMENT OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 2020', 'Senate Hearing, 116th Congress — DEPARTMENT OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS FOR FISCAL YEAR 2019', 'Uniform Medical Plan (UMP) coverage limits for drugs covered under UMP ’ s prescription drug benefit', 'Uniform Medical Plan( UMP) coverage limits for drugs covered under UMP ’s prescription drug benefit']","['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/moda-ump-preauthreqs.pdf']","['41526_6_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '41526_2_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '41526_7_uniform medical plan ump coverage limits for drugs covered under ump s prescription drug benefit.pdf']",3,37.5,"['https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs.pdf', 'https://www.hca.wa.gov/assets/pebb/sebb-moda-ump-preauthreqs-part1.pdf', 'https://www.hca.wa.gov/assets/pebb/moda-ump-preauthreqs.pdf']","['41526_6_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '41526_2_uniform medical plan ump coverage limits for drugs covered under ump  s prescription drug benefit.pdf', '41526_7_uniform medical plan ump coverage limits for drugs covered under ump s prescription drug benefit.pdf']","[0.448, 0.433, 0.433]","[0.559, 0.563, 0.559]","[0.638, 0.64, 0.638]","[0.169, 0.171, 0.169]","[0.149, 0.15, 0.149]","[0.122, 0.122, 0.122]","[0.735, 0.735, 0.735]","[0.644, 0.644, 0.644]","[0.637, 0.64, 0.637]","[0.641, 0.642, 0.641]","[0.816, 0.817, 0.816]","[0.751, 0.754, 0.751]","[0.616, 0.615, 0.616]","[0.921, 0.922, 0.921]","[0.826, 0.825, 0.826]","[0.777, 0.779, 0.777]","[0.812, 0.812, 0.812]","[0.799, 0.799, 0.799]",0.438,0.56,0.639,0.17,0.149,0.122,0.735,0.644,0.638,0.641,0.816,0.752,0.616,0.921,0.826,0.778,0.812,0.799
https://doi.org/10.1200/jco.2018.78.2516,highdose chemotherapy and blood autologous stemcell rescue compared with standard chemotherapy in localized highrisk ewing sarcoma results of euroewing99 and ewing2008,41528_highdose chemotherapy and blood autologous stemcell rescue compared with standard chemotherapy in localized highrisk ewing sarcoma results of euroewing99 and ewing2008.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444131/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428235/pdf']","['2021 版美国国家综合癌症网络（NCCN）《骨肿瘤临床实践指南》更新与解读', 'High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma', 'High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444131/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428235/pdf']","['41528_1_high‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children adolescents and young adults with first recurrence of ewing sarcoma.pdf', '41528_0_2021 版美国国家综合癌症网络（nccn）《骨肿瘤临床实践指南》更新与解读.pdf', '41528_2_high‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children adolescents and young adults with primary metastatic ewing sarcoma.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411193/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444131/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428235/pdf']","['41528_1_high‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children adolescents and young adults with first recurrence of ewing sarcoma.pdf', '41528_0_2021 版美国国家综合癌症网络（nccn）《骨肿瘤临床实践指南》更新与解读.pdf', '41528_2_high‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children adolescents and young adults with primary metastatic ewing sarcoma.pdf']","[0.261, 0.284, 0.34]","[0.496, 0.483, 0.496]","[0.593, 0.572, 0.588]","[0.16, 0.138, 0.163]","[0.163, 0.149, 0.164]","[0.136, 0.126, 0.137]","[0.739, 0.749, 0.741]","[0.645, 0.662, 0.648]","[0.563, 0.55, 0.563]","[0.697, 0.702, 0.703]","[0.762, 0.76, 0.759]","[0.689, 0.684, 0.686]","[0.574, 0.568, 0.572]","[0.884, 0.876, 0.88]","[0.782, 0.767, 0.78]","[0.684, 0.679, 0.681]","[0.751, 0.751, 0.751]","[0.715, 0.719, 0.711]",0.295,0.492,0.584,0.154,0.159,0.133,0.743,0.652,0.559,0.701,0.76,0.686,0.571,0.88,0.776,0.681,0.751,0.715
https://doi.org/10.1207/s15326918cs0504_5,interventions for maltreated children to reduce their likelihood of engaging in juvenile delinquency,41650_interventions for maltreated children to reduce their likelihood of engaging in juvenile delinquency.pdf,1,['https://isc.idaho.gov/juvenile/pdfs/Improving_Court_Practice_Juvenile_Delinquency_Cases.pdf'],['Juvenile Delinquency Guidelines'],['https://isc.idaho.gov/juvenile/pdfs/Improving_Court_Practice_Juvenile_Delinquency_Cases.pdf'],['41650_0_juvenile delinquency guidelines.pdf'],1,100.0,['https://isc.idaho.gov/juvenile/pdfs/Improving_Court_Practice_Juvenile_Delinquency_Cases.pdf'],['41650_0_juvenile delinquency guidelines.pdf'],[0.133],[0.537],[0.631],[0.171],[0.187],[0.17],[0.732],[0.63],[0.594],[0.66],[0.798],[0.742],[0.637],[0.922],[0.822],[0.769],[0.803],[0.788],0.133,0.537,0.631,0.171,0.187,0.17,0.732,0.63,0.594,0.66,0.798,0.742,0.637,0.922,0.822,0.769,0.803,0.788
https://doi.org/10.1207/s15374424jccp3504_5,body dissatisfaction prospectively predicts depressive mood and low selfesteem in adolescent girls and boys,41778_body dissatisfaction prospectively predicts depressive mood and low selfesteem in adolescent girls and boys.pdf,1,['https://health.hawaii.gov/hjmph/files/2013/09/Volume3.1.pdf'],['Microsoft Word - Table of Contents.doc'],['https://health.hawaii.gov/hjmph/files/2013/09/Volume3.1.pdf'],['41778_0_microsoft word  table of contentsdoc.pdf'],1,100.0,['https://health.hawaii.gov/hjmph/files/2013/09/Volume3.1.pdf'],['41778_0_microsoft word  table of contentsdoc.pdf'],[0.211],[0.496],[0.59],[0.116],[0.126],[0.102],[0.72],[0.619],[0.562],[0.682],[0.777],[0.7],[0.613],[0.911],[0.801],[0.732],[0.78],[0.757],0.211,0.496,0.59,0.116,0.126,0.102,0.72,0.619,0.562,0.682,0.777,0.7,0.613,0.911,0.801,0.732,0.78,0.757
https://doi.org/10.1210/endrev/bnaa003,androgens during infancy childhood and adolescence physiology and use in clinical practice,41832_androgens during infancy childhood and adolescence physiology and use in clinical practice.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['41832_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['41832_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.574],[0.568],[0.653],[0.212],[0.227],[0.185],[0.75],[0.656],[0.64],[0.67],[0.812],[0.732],[0.635],[0.926],[0.825],[0.784],[0.817],[0.8],0.574,0.568,0.653,0.212,0.227,0.185,0.75,0.656,0.64,0.67,0.812,0.732,0.635,0.926,0.825,0.784,0.817,0.8
https://doi.org/10.1210/er.2018-00116,clinical management of congenital hypogonadotropic hypogonadism,41839_clinical management of congenital hypogonadotropic hypogonadism.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['41839_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066594/pdf'],['41839_0_pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency an endoern clinical practice guideline.pdf'],[0.624],[0.576],[0.656],[0.209],[0.219],[0.177],[0.75],[0.654],[0.646],[0.666],[0.814],[0.734],[0.643],[0.926],[0.826],[0.79],[0.821],[0.803],0.624,0.576,0.656,0.209,0.219,0.177,0.75,0.654,0.646,0.666,0.814,0.734,0.643,0.926,0.826,0.79,0.821,0.803
https://doi.org/10.1210/jc.2018-00602,high pregnancy cord blood and infant vitamin d concentrations may predict slower infant growth,41884_high pregnancy cord blood and infant vitamin d concentrations may predict slower infant growth.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf'],['Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf'],['41884_0_vitamin d supplementation for term breastfed infants to prevent vitamin d deficiency and improve bone health.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812278/pdf'],['41884_0_vitamin d supplementation for term breastfed infants to prevent vitamin d deficiency and improve bone health.pdf'],[0.531],[0.511],[0.596],[0.178],[0.172],[0.147],[0.742],[0.649],[0.576],[0.706],[0.761],[0.68],[0.588],[0.885],[0.79],[0.697],[0.765],[0.721],0.531,0.511,0.596,0.178,0.172,0.147,0.742,0.649,0.576,0.706,0.761,0.68,0.588,0.885,0.79,0.697,0.765,0.721
https://doi.org/10.1210/jc.2018-01307,the natural history of adrenal insufficiency in xlinked adrenoleukodystrophy an international collaboration,41885_the natural history of adrenal insufficiency in xlinked adrenoleukodystrophy an international collaboration.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['41885_0_mri surveillance of boys with xlinked adrenoleukodystrophy identified by newborn screening metaanalysis and consensus guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['41885_0_mri surveillance of boys with xlinked adrenoleukodystrophy identified by newborn screening metaanalysis and consensus guidelines.pdf'],[0.307],[0.502],[0.588],[0.149],[0.165],[0.119],[0.735],[0.634],[0.576],[0.672],[0.765],[0.674],[0.599],[0.908],[0.8],[0.726],[0.769],[0.75],0.307,0.502,0.588,0.149,0.165,0.119,0.735,0.634,0.576,0.672,0.765,0.674,0.599,0.908,0.8,0.726,0.769,0.75
https://doi.org/10.1212/wnl.0000000000007755,pearls amp oysters adolescentonset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy,41930_pearls amp oysters adolescentonset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['41930_0_mri surveillance of boys with xlinked adrenoleukodystrophy identified by newborn screening metaanalysis and consensus guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['41930_0_mri surveillance of boys with xlinked adrenoleukodystrophy identified by newborn screening metaanalysis and consensus guidelines.pdf'],[0.421],[0.518],[0.604],[0.164],[0.183],[0.128],[0.732],[0.635],[0.593],[0.652],[0.78],[0.702],[0.587],[0.918],[0.814],[0.749],[0.785],[0.768],0.421,0.518,0.604,0.164,0.183,0.128,0.732,0.635,0.593,0.652,0.78,0.702,0.587,0.918,0.814,0.749,0.785,0.768
https://doi.org/10.1212/wnl.0000000000009033,practice guideline treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder,41932_practice guideline treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder.pdf,1,['https://n.neurology.org/content/neurology/94/9/392.full.pdf'],['Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder'],['https://n.neurology.org/content/neurology/94/9/392.full.pdf'],['41932_0_practice guideline treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder.pdf'],1,100.0,['https://n.neurology.org/content/neurology/94/9/392.full.pdf'],['41932_0_practice guideline treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder.pdf'],[1.0],[0.509],[0.591],[0.178],[0.193],[0.168],[0.734],[0.643],[0.57],[0.704],[0.774],[0.698],[0.598],[0.881],[0.781],[0.711],[0.776],[0.721],1.0,0.509,0.591,0.178,0.193,0.168,0.734,0.643,0.57,0.704,0.774,0.698,0.598,0.881,0.781,0.711,0.776,0.721
https://doi.org/10.1212/wnl.0000000000009929,neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy,41933_neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['41933_0_mri surveillance of boys with xlinked adrenoleukodystrophy identified by newborn screening metaanalysis and consensus guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113077/pdf'],['41933_0_mri surveillance of boys with xlinked adrenoleukodystrophy identified by newborn screening metaanalysis and consensus guidelines.pdf'],[0.39],[0.518],[0.607],[0.156],[0.164],[0.127],[0.737],[0.642],[0.583],[0.681],[0.766],[0.695],[0.595],[0.905],[0.807],[0.725],[0.772],[0.746],0.39,0.518,0.607,0.156,0.164,0.127,0.737,0.642,0.583,0.681,0.766,0.695,0.595,0.905,0.807,0.725,0.772,0.746
https://doi.org/10.1245/s10434-020-08443-4,quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy early results from a prospective cohort study of 115 patients,41996_quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy early results from a prospective cohort study of 115 patients.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454505/pdf'],['Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454505/pdf'],['41996_0_comprehensive treatment algorithms of the swiss peritoneal cancer group for peritoneal cancer of gastrointestinal origin.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454505/pdf'],['41996_0_comprehensive treatment algorithms of the swiss peritoneal cancer group for peritoneal cancer of gastrointestinal origin.pdf'],[0.473],[0.484],[0.584],[0.138],[0.132],[0.122],[0.742],[0.654],[0.556],[0.671],[0.766],[0.65],[0.597],[0.91],[0.792],[0.726],[0.761],[0.754],0.473,0.484,0.584,0.138,0.132,0.122,0.742,0.654,0.556,0.671,0.766,0.65,0.597,0.91,0.792,0.726,0.761,0.754
https://doi.org/10.1249/mss.0b013e3181c619b2,early physical activity provides sustained bone health benefits later in childhood,42020_early physical activity provides sustained bone health benefits later in childhood.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464928/pdf'],['Interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464928/pdf'],['42020_0_interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in duchenne muscular dystrophy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464928/pdf'],['42020_0_interventions to prevent and treat corticosteroid‐induced osteoporosis and prevent osteoporotic fractures in duchenne muscular dystrophy.pdf'],[0.252],[0.482],[0.595],[0.144],[0.161],[0.126],[0.737],[0.638],[0.564],[0.684],[0.761],[0.658],[0.576],[0.912],[0.786],[0.718],[0.76],[0.745],0.252,0.482,0.595,0.144,0.161,0.126,0.737,0.638,0.564,0.684,0.761,0.658,0.576,0.912,0.786,0.718,0.76,0.745
https://doi.org/10.1257/aer.20140832,the wind of change maritime technology trade and economic development,42093_the wind of change maritime technology trade and economic development.pdf,4,"['https://www.nber.org/papers/w28274', 'https://piie.com/publications/working-papers/does-trade-reform-promote-economic-growth-review-recent-evidence', 'https://www.federalreserve.gov/econres/feds/files/2018045pap.pdf', 'https://sevenpillarsinstitute.org/wp-content/uploads/2021/04/Why-Some-Nations-Are-Rich-While-Others-Are-Poor-Edited.pdf']","['Specialization, Market Access and Real Income', 'Does Trade Reform Promote Economic Growth? A Review of Recent Evidence', 'The Local Impact of Containerization', 'Why Some Countries are Rich While Others are Poor']",['https://www.federalreserve.gov/econres/feds/files/2018045pap.pdf'],['42093_2_the local impact of containerization.pdf'],1,25.0,['https://www.federalreserve.gov/econres/feds/files/2018045pap.pdf'],['42093_2_the local impact of containerization.pdf'],[0.305],[0.555],[0.638],[0.162],[0.186],[0.145],[0.725],[0.629],[0.625],[0.717],[0.806],[0.742],[0.675],[0.922],[0.862],[0.775],[0.818],[0.798],0.305,0.555,0.638,0.162,0.186,0.145,0.725,0.629,0.625,0.717,0.806,0.742,0.675,0.922,0.862,0.775,0.818,0.798
https://doi.org/10.1257/aer.20160034,some causal effects of an industrial policy,42101_some causal effects of an industrial policy.pdf,9,"['https://www.federalreserve.gov/econres/feds/files/2019062pap.pdf', 'http://ceepr.mit.edu/publications/working-papers/754', 'https://equitablegrowth.org/working-papers/capital-investment-and-labor-demand/', 'https://www.brookings.edu/research/innovation-policies-to-boost-productivity/', 'https://www.federalreserve.gov/econres/feds/files/2019080pap.pdf', 'https://www.brookings.edu/research/an-industrial-policy-for-good-jobs/', 'https://www.ineteconomics.org/research/research-papers/the-geography-of-new-technologies', 'https://www.edf.org/sites/default/files/documents/UK_Report_Case_Study.pdf', 'https://www.nber.org/papers/w28573']","['Parental Proximity and Earnings After Job Displacements', 'Are ""Complementary Policies"" Substitutes? Evidence from R&D Subsidies in the UK', 'Capital Investment and Labor Demand - Equitable Growth', 'Innovation policies to boost productivity', 'Local Ties in Spatial Equilibrium', 'An industrial policy for good jobs', 'The Geography of New Technologies', 'Regional Just Transitions in the UK: Insights from 40 Years of Policy Experience', 'JUE Insight: The Impacts of Opportunity Zones on Zone Residents']","['https://www.federalreserve.gov/econres/feds/files/2019080pap.pdf', 'https://www.federalreserve.gov/econres/feds/files/2019062pap.pdf', 'https://www.edf.org/sites/default/files/documents/UK_Report_Case_Study.pdf']","['42101_4_local ties in spatial equilibrium.pdf', '42101_0_parental proximity and earnings after job displacements.pdf', '42101_7_regional just transitions in the uk insights from 40 years of policy experience.pdf']",3,33.33,"['https://www.federalreserve.gov/econres/feds/files/2019080pap.pdf', 'https://www.federalreserve.gov/econres/feds/files/2019062pap.pdf', 'https://www.edf.org/sites/default/files/documents/UK_Report_Case_Study.pdf']","['42101_4_local ties in spatial equilibrium.pdf', '42101_0_parental proximity and earnings after job displacements.pdf', '42101_7_regional just transitions in the uk insights from 40 years of policy experience.pdf']","[0.232, 0.341, 0.396]","[0.577, 0.582, 0.559]","[0.652, 0.657, 0.642]","[0.171, 0.168, 0.168]","[0.194, 0.187, 0.178]","[0.16, 0.155, 0.152]","[0.724, 0.726, 0.72]","[0.625, 0.627, 0.623]","[0.647, 0.649, 0.639]","[0.74, 0.734, 0.705]","[0.819, 0.818, 0.82]","[0.749, 0.754, 0.748]","[0.682, 0.681, 0.666]","[0.927, 0.928, 0.93]","[0.865, 0.86, 0.864]","[0.79, 0.788, 0.787]","[0.829, 0.826, 0.83]","[0.811, 0.809, 0.81]",0.323,0.573,0.65,0.169,0.186,0.156,0.723,0.625,0.645,0.726,0.819,0.75,0.676,0.928,0.863,0.788,0.828,0.81
https://doi.org/10.1257/aer.20170666,rich pickings risk return and skill in household wealth,42111_rich pickings risk return and skill in household wealth.pdf,9,"['https://www.nber.org/papers/w28468', 'https://www.nber.org/papers/w28580', 'https://www.nber.org/papers/w28613', 'https://www.chicagofed.org/publications/working-papers/2022/2022-03', 'https://www.clevelandfed.org/publications/working-paper/wp-2228-accounting-for-wealth-concentration-in-the-united-states', 'https://www.nber.org/papers/w28788', 'https://www.dallasfed.org/-/media/documents/research/papers/2021/wp2114.pdf', 'https://www.nber.org/papers/w28869', 'https://www.nber.org/papers/w29065']","['Reparations and Persistent Racial Wealth Gaps', 'Real and Private-Value Assets', 'Financial and Total Wealth Inequality with Declining Interest Rates', 'A Fair Day’s Pay for a Fair Day’s Work: Optimal Tax Design as Redistributional Arbitrage', 'Accounting for Wealth Concentration in the United States', 'The Cross-Section of Household Preferences', 'Wealth Inequality and Return Heterogeneity During the COVID-19 Pandemic', 'Monetary Policy, Redistribution, and Risk Premia', 'Who Owns What? A Factor Model for Direct Stock Holding']",['https://www.dallasfed.org/-/media/documents/research/papers/2021/wp2114.pdf'],['42111_6_wealth inequality and return heterogeneity during the covid19 pandemic.pdf'],1,11.11,['https://www.dallasfed.org/-/media/documents/research/papers/2021/wp2114.pdf'],['42111_6_wealth inequality and return heterogeneity during the covid19 pandemic.pdf'],[0.735],[0.552],[0.65],[0.217],[0.225],[0.214],[0.742],[0.647],[0.603],[0.748],[0.795],[0.731],[0.684],[0.91],[0.829],[0.774],[0.8],[0.784],0.735,0.552,0.65,0.217,0.225,0.214,0.742,0.647,0.603,0.748,0.795,0.731,0.684,0.91,0.829,0.774,0.8,0.784
https://doi.org/10.1257/aer.20180086,the effect of house prices on household borrowing a new approach,42118_the effect of house prices on household borrowing a new approach.pdf,4,"['https://www.dallasfed.org/-/media/documents/research/papers/2021/wp2103.pdf', 'https://www.minneapolisfed.org/research/staff-reports/housing-wealth-effects-the-long-view', 'https://www.nber.org/papers/w28574', 'https://www.federalreserve.gov/econres/feds/files/2020002pap.pdf']","['Mortgage Borrowing and the Boom-Bust Cycle in Consumption and Residential Investment', 'Housing Wealth Effects: The Long View', 'The Mortgage Piggy Bank: Building Wealth through Amortization', 'Monetary Policy and Birth Rates: The Effect of Mortgage Rate Pass-Through on Fertility']","['https://www.dallasfed.org/-/media/documents/research/papers/2021/wp2103.pdf', 'https://www.federalreserve.gov/econres/feds/files/2020002pap.pdf']","['42118_0_mortgage borrowing and the boombust cycle in consumption and residential investment.pdf', '42118_3_monetary policy and birth rates the effect of mortgage rate passthrough on fertility.pdf']",2,50.0,"['https://www.dallasfed.org/-/media/documents/research/papers/2021/wp2103.pdf', 'https://www.federalreserve.gov/econres/feds/files/2020002pap.pdf']","['42118_0_mortgage borrowing and the boombust cycle in consumption and residential investment.pdf', '42118_3_monetary policy and birth rates the effect of mortgage rate passthrough on fertility.pdf']","[0.556, 0.377]","[0.606, 0.594]","[0.683, 0.672]","[0.227, 0.207]","[0.244, 0.217]","[0.224, 0.197]","[0.744, 0.737]","[0.649, 0.645]","[0.658, 0.653]","[0.742, 0.736]","[0.824, 0.821]","[0.76, 0.759]","[0.703, 0.696]","[0.926, 0.927]","[0.868, 0.863]","[0.802, 0.795]","[0.836, 0.832]","[0.816, 0.811]",0.467,0.6,0.677,0.217,0.23,0.211,0.74,0.647,0.655,0.739,0.823,0.76,0.7,0.927,0.865,0.798,0.834,0.814
https://doi.org/10.1257/aer.20180865,sources of inaction in household finance evidence from the danish mortgage market,42123_sources of inaction in household finance evidence from the danish mortgage market.pdf,10,"['https://www.brookings.edu/research/bolstering-the-housing-safety-net-the-promise-of-automatic-stabilizers/', 'https://www.nber.org/papers/w29094', 'https://www.nber.org/papers/w28357', 'https://www.nber.org/papers/w28574', 'https://www.atlantafed.org/research/publications/wp/2020/12/18/22-mortgage-prepayment-race-monetary-policy.aspx', 'https://www.clevelandfed.org/publications/working-paper/wp-2026r-average-inflation-targeting-and-household-expectations', 'https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2206.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2203.pdf', 'https://www.bostonfed.org/publications/current-policy-perspectives/2022/lessons-learned-from-mortgage-borrower-policies-and-outcomes-during-the-covid-19-pandemic.aspx', 'https://www.bostonfed.org/publications/research-department-working-paper/2020/mortgage-prepayment-race-and-monetary-policy']","['Bolstering the housing safety net: The promise of automatic stabilizers', 'Present Bias Amplifies the Household Balance-Sheet Channels of Macroeconomic Policy', 'Government and Private Household Debt Relief during COVID-19', 'The Mortgage Piggy Bank: Building Wealth through Amortization', 'Mortgage Prepayment, Race, and Monetary Policy', 'Average Inflation Targeting and Household Expectations', 'How Do Mortgage Rate Resets Affect Consumer Spending and Debt Repayment? Evidence from Canadian Consumers', 'Original paper', 'Lessons Learned from Mortgage Borrower Policies and Outcomes during the COVID-19 Pandemic', 'Mortgage Prepayment, Race, and Monetary Policy']","['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2203.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2206.pdf']","['42123_7_original paper.pdf', '42123_6_how do mortgage rate resets affect consumer spending and debt repayment evidence from canadian consumers.pdf']",2,20.0,"['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2203.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2206.pdf']","['42123_7_original paper.pdf', '42123_6_how do mortgage rate resets affect consumer spending and debt repayment evidence from canadian consumers.pdf']","[0.395, 0.348]","[0.568, 0.573]","[0.649, 0.646]","[0.185, 0.204]","[0.203, 0.215]","[0.184, 0.193]","[0.733, 0.736]","[0.64, 0.643]","[0.632, 0.633]","[0.715, 0.723]","[0.812, 0.814]","[0.738, 0.738]","[0.682, 0.682]","[0.92, 0.921]","[0.855, 0.855]","[0.79, 0.788]","[0.818, 0.822]","[0.805, 0.807]",0.371,0.571,0.647,0.195,0.209,0.189,0.734,0.641,0.633,0.719,0.813,0.738,0.682,0.921,0.855,0.789,0.82,0.806
https://doi.org/10.1257/mac.20140003,the effects of monetary policy on stock market bubbles some evidence,42242_the effects of monetary policy on stock market bubbles some evidence.pdf,8,"['https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2213.pdf', 'https://www.dallasfed.org/-/media/documents/research/international/wpapers/2017/0314.pdf', 'https://www.philadelphiafed.org/the-economy/macroeconomics/macroeconomic-forecasting-and-variable-ordering-in-multivariate-stochastic-volatility-models', 'https://www.frbsf.org/economic-research/publications/working-papers/2017/09/', 'https://www.frbsf.org/economic-research/publications/working-papers/2018/05/', 'https://www.bostonfed.org/publications/research-department-working-paper/2022/interest-rate-surprises-a-tale-of-two-shocks', 'https://www.bostonfed.org/publications/research-department-working-paper/2016/monetary-policy-and-regional-house-price-appreciation.aspx', 'https://www.nber.org/papers/w22639']","['Interest Rate Surprises: A Tale of Two Shocks', 'Financial Globalisation, Monetary Policy Spillovers and Macro-modelling: Tales from 1001 Shocks', 'Macroeconomic Forecasting and Variable Ordering in Multivariate Stochastic Volatility Models', 'The Time-Varying Effect of Monetary Policy on Asset Prices', 'Global Financial Cycles and Risk Premiums', 'Interest Rate Surprises: A Tale of Two Shocks', 'Monetary Policy and Regional House-Price Appreciation', 'Monetary Policy for a Bubbly World']","['https://www.dallasfed.org/-/media/documents/research/international/wpapers/2017/0314.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2213.pdf']","['42242_1_financial globalisation monetary policy spillovers and macromodelling tales from 1001 shocks.pdf', '42242_0_interest rate surprises a tale of two shocks.pdf']",2,25.0,"['https://www.dallasfed.org/-/media/documents/research/international/wpapers/2017/0314.pdf', 'https://www.dallasfed.org/-/media/documents/research/papers/2022/wp2213.pdf']","['42242_1_financial globalisation monetary policy spillovers and macromodelling tales from 1001 shocks.pdf', '42242_0_interest rate surprises a tale of two shocks.pdf']","[0.517, 0.369]","[0.531, 0.548]","[0.632, 0.636]","[0.176, 0.186]","[0.199, 0.203]","[0.179, 0.186]","[0.736, 0.739]","[0.646, 0.65]","[0.589, 0.601]","[0.732, 0.748]","[0.789, 0.797]","[0.708, 0.714]","[0.652, 0.66]","[0.917, 0.909]","[0.828, 0.838]","[0.762, 0.77]","[0.793, 0.801]","[0.784, 0.791]",0.443,0.54,0.634,0.181,0.201,0.182,0.738,0.648,0.595,0.74,0.793,0.711,0.656,0.913,0.833,0.766,0.797,0.788
https://doi.org/10.1257/mac.20150171,oil and macroeconomic instability,42243_oil and macroeconomic instability.pdf,2,"['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2019/0376.pdf', 'https://www.clevelandfed.org/publications/working-paper/wp-2233-the-us-banks-balance-sheet-transmission-channel-of-oil-price-shocks']","['Forecasting Energy Commodity Prices: A Large Global Dataset Sparse Approach', 'The US Banks’ Balance Sheet Transmission Channel of Oil Price Shocks']",['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2019/0376.pdf'],['42243_0_forecasting energy commodity prices a large global dataset sparse approach.pdf'],1,50.0,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2019/0376.pdf'],['42243_0_forecasting energy commodity prices a large global dataset sparse approach.pdf'],[0.424],[0.491],[0.606],[0.133],[0.148],[0.129],[0.726],[0.629],[0.553],[0.734],[0.788],[0.653],[0.645],[0.907],[0.818],[0.729],[0.786],[0.772],0.424,0.491,0.606,0.133,0.148,0.129,0.726,0.629,0.553,0.734,0.788,0.653,0.645,0.907,0.818,0.729,0.786,0.772
https://doi.org/10.1257/mac.4.3.153,a quantitative theory of information and unsecured credit,42248_a quantitative theory of information and unsecured credit.pdf,9,"['https://www.bostonfed.org/publications/research-department-working-paper/2019/how-magic-a-bullet-is-machine-learning-for-credit-analysis', 'https://www.dallasfed.org/~/media/documents/research/international/wpapers/2018/0340.pdf', 'https://www.philadelphiafed.org/consumer-finance/consumer-credit/consumer-credit-with-over-optimistic-borrowers', 'https://www.minneapolisfed.org/research/working-papers/a-quantitative-theory-of-the-credit-score', 'https://research.stlouisfed.org/wp/more/2010-022', 'https://www.richmondfed.org/publications/research/working_papers/2016/wp_16-12', 'https://research.stlouisfed.org/wp/more/2012-042', 'https://www.richmondfed.org/publications/research/working_papers/2014/wp_14-01', 'https://www.nber.org/papers/w19850']","['How Magic a Bullet Is Machine Learning for Credit Analysis? An Exploration with FinTech Lending Data', 'Macro Aspects of Housing', 'Consumer Credit with Over-Optimistic Borrowers', 'A Quantitative Theory of the Credit Score', 'The IT revolution and the unsecured credit market', 'Bankruptcy and Delinquency in a Model of Unsecured Debt', 'Bankruptcy and Delinquency in a Model of Unsecured Debt', 'Does Greater Inequality Lead to More Household Borrowing? New Evidence from Household Data', 'Does Greater Inequality Lead to More Household Borrowing? New Evidence from Household Data']",['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2018/0340.pdf'],['42248_1_macro aspects of housing.pdf'],1,11.11,['https://www.dallasfed.org/~/media/documents/research/international/wpapers/2018/0340.pdf'],['42248_1_macro aspects of housing.pdf'],[0.296],[0.525],[0.619],[0.147],[0.159],[0.146],[0.721],[0.627],[0.579],[0.715],[0.789],[0.694],[0.648],[0.907],[0.831],[0.755],[0.793],[0.779],0.296,0.525,0.619,0.147,0.159,0.146,0.721,0.627,0.579,0.715,0.789,0.694,0.648,0.907,0.831,0.755,0.793,0.779
https://doi.org/10.1257/mac.5.1.135,on the real effects of bank bailouts micro evidence from japan,42249_on the real effects of bank bailouts micro evidence from japan.pdf,2,"['https://www.newyorkfed.org/research/staff_reports/sr955.html', 'https://www.federalreserve.gov/econres/feds/files/2017084pap.pdf']","['Zombie Credit and (Dis-)Inflation: Evidence from Europe - FEDERAL RESERVE BANK of NEW YORK', 'Why Are Banks Not Recapitalized During Crises?']",['https://www.federalreserve.gov/econres/feds/files/2017084pap.pdf'],['42249_1_why are banks not recapitalized during crises.pdf'],1,50.0,['https://www.federalreserve.gov/econres/feds/files/2017084pap.pdf'],['42249_1_why are banks not recapitalized during crises.pdf'],[0.467],[0.584],[0.67],[0.224],[0.231],[0.214],[0.734],[0.639],[0.641],[0.737],[0.811],[0.756],[0.689],[0.917],[0.863],[0.8],[0.823],[0.808],0.467,0.584,0.67,0.224,0.231,0.214,0.734,0.639,0.641,0.737,0.811,0.756,0.689,0.917,0.863,0.8,0.823,0.808
https://doi.org/10.1257/mic.5.2.33,marry for what caste and mate selection in modern india,42252_marry for what caste and mate selection in modern india.pdf,6,"['https://www.dallasfed.org/-/media/documents/research/papers/2016/wp1610r1.pdf', 'https://www.nber.org/papers/w28462', 'https://www.nber.org/papers/w19848', 'https://www.nber.org/papers/w23604', 'https://www.icrw.org/publications/district-level-study-on-child-marriage-in-india/', 'https://www.brookings.edu/research/credit-scores-and-committed-relationships/']","['Targeted Search in Matching Markets', 'A Division of Laborers: Identity and Efficiency in India', 'Under the Thumb of History? Political Institutions and the Scope for Action', 'Age of Marriage, Weather Shocks, and the Direction of Marriage Payments', 'District-level study on child marriage in India', 'Credit scores and committed relationships']",['https://www.dallasfed.org/-/media/documents/research/papers/2016/wp1610r1.pdf'],['42252_0_targeted search in matching markets.pdf'],1,16.67,['https://www.dallasfed.org/-/media/documents/research/papers/2016/wp1610r1.pdf'],['42252_0_targeted search in matching markets.pdf'],[0.399],[0.553],[0.64],[0.142],[0.161],[0.135],[0.73],[0.633],[0.623],[0.73],[0.798],[0.737],[0.662],[0.917],[0.847],[0.778],[0.803],[0.788],0.399,0.553,0.64,0.142,0.161,0.135,0.73,0.633,0.623,0.73,0.798,0.737,0.662,0.917,0.847,0.778,0.803,0.788
https://doi.org/10.1257/pol.20140224,why is infant mortality higher in the united states than in europe,42262_why is infant mortality higher in the united states than in europe.pdf,5,"['https://www.acf.hhs.gov/opre/resource/experiences-of-parents-and-children-living-in-poverty-a-review-of-the-qualitative-literature', 'https://purl.fdlp.gov/GPO/gpo111964', 'https://www.acf.hhs.gov/opre/report/experiences-parents-and-children-living-poverty-review-qualitative-literature', 'https://www.nber.org/papers/w28621', 'https://hhs.texas.gov/sites/default/files/documents/laws-regulations/reports-presentations/2017/HHS-Healthcare-Quality-Plan-2017.pdf']","['Experiences of Parents and Children Living in Poverty: A Review of the Qualitative Literature', 'Infant mortality by age at death in the United States, 2016 /', 'Experiences of Parents and Children Living in Poverty: A Review of the Qualitative Literature', 'Public Health Policy at Scale: Impact of a Government-sponsored Information Campaign on Infant Mortality in Denmark', 'Health and Human Services Healthcare Quality Plan']",['https://purl.fdlp.gov/GPO/gpo111964'],['42262_1_infant mortality by age at death in the united states 2016 .pdf'],1,20.0,['https://purl.fdlp.gov/GPO/gpo111964'],['42262_1_infant mortality by age at death in the united states 2016 .pdf'],[0.477],[0.53],[0.633],[0.199],[0.23],[0.193],[0.739],[0.638],[0.6],[0.724],[0.792],[0.721],[0.634],[0.921],[0.834],[0.761],[0.79],[0.782],0.477,0.53,0.633,0.199,0.23,0.193,0.739,0.638,0.6,0.724,0.792,0.721,0.634,0.921,0.834,0.761,0.79,0.782
https://doi.org/10.1257/pol.20140344,do cash transfers improve birth outcomes evidence from matched vital statistics and program and social security data,42263_do cash transfers improve birth outcomes evidence from matched vital statistics and program and social security data.pdf,7,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486161/pdf', 'http://ebrary.ifpri.org/digital/collection/p15738coll2/id/136350', 'https://www.nber.org/papers/w22955', 'http://www.ifpri.org/publication/aspirations-and-womens-empowerment-evidence-kyrgyzstan-0', 'https://www.brookings.edu/research/assessing-the-long-run-benefits-of-transfers-to-low-income-families/']","['Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low‐ and middle‐income countries', 'Improving agricultural value chain coordination and gender inclusiveness in PNG', 'Agricultural Fires and Infant Health', 'Aspirations and women’s empowerment: Evidence from Kyrgyzstan', 'Assessing the long-run benefits of transfers to low-income families']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486161/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf']","['42263_2_unconditional cash transfers for reducing poverty and vulnerabilities effect on use of health services and health outcomes in low‐ and middle‐income countries.pdf', '42263_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '42263_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']",3,42.86,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486161/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf']","['42263_2_unconditional cash transfers for reducing poverty and vulnerabilities effect on use of health services and health outcomes in low‐ and middle‐income countries.pdf', '42263_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '42263_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']","[0.338, 0.331, 0.385]","[0.526, 0.505, 0.505]","[0.615, 0.593, 0.593]","[0.147, 0.133, 0.137]","[0.159, 0.141, 0.145]","[0.127, 0.115, 0.119]","[0.722, 0.724, 0.724]","[0.627, 0.626, 0.627]","[0.591, 0.564, 0.566]","[0.709, 0.7, 0.698]","[0.784, 0.767, 0.767]","[0.704, 0.689, 0.687]","[0.613, 0.604, 0.608]","[0.91, 0.907, 0.906]","[0.819, 0.797, 0.798]","[0.736, 0.723, 0.722]","[0.783, 0.769, 0.769]","[0.761, 0.747, 0.747]",0.351,0.512,0.6,0.139,0.148,0.12,0.723,0.627,0.574,0.702,0.773,0.693,0.608,0.908,0.805,0.727,0.774,0.752
https://doi.org/10.1257/pol.20150374,college on the cheap consequences of community college tuition reductions,42267_college on the cheap consequences of community college tuition reductions.pdf,10,"['https://research.stlouisfed.org/wp/more/2020-048', 'https://www.urban.org/research/publication/racial-and-ethnic-representation-postsecondary-education', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/11/Wsipp_BenefitCost_ProgramDetails_Higher-Education', 'https://www.federalreserve.gov/econres/feds/files/2016010r1pap.pdf', 'https://tcf.org/content/report/financing-institutions-free-college-debate/', 'https://www.rand.org/pubs/research_reports/RRA101-1.html', 'https://www.rand.org/pubs/working_papers/WR1307.html', 'https://www.brookings.edu/research/student-outcomes-at-community-colleges-what-factors-explain-variation-in-loan-repayment-and-earnings/', 'http://www.wsipp.wa.gov/ReportFile/1684/Wsipp_Interventions-to-Promote-Postsecondary-Attainment-April-2018-Update_Report.pdf', 'https://www.urban.org/research/publication/impact-state-higher-education-finance-attainment']","['Raising College Access and Completion: How Much Can Free College Help?', 'Racial and Ethnic Representation in Postsecondary Education', 'Washington State Institute for Public Policy', 'Student Loans and Homeownership', 'Financing Institutions in the Free College Debate', 'Cutting the College Price TAG', 'When Financial Aid is Scarce', 'Student outcomes at community colleges: What factors explain variation in loan repayment and earnings?', 'Washington State Institute for Public Policy', 'Impact of State Higher Education Finance on Attainment']","['http://www.wsipp.wa.gov/ReportFile/1684/Wsipp_Interventions-to-Promote-Postsecondary-Attainment-April-2018-Update_Report.pdf', 'https://www.federalreserve.gov/econres/feds/files/2016010r1pap.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/11/Wsipp_BenefitCost_ProgramDetails_Higher-Education']","['42267_8_washington state institute for public policy.pdf', '42267_3_student loans and homeownership.pdf', '42267_2_washington state institute for public policy.pdf']",3,30.0,"['http://www.wsipp.wa.gov/ReportFile/1684/Wsipp_Interventions-to-Promote-Postsecondary-Attainment-April-2018-Update_Report.pdf', 'https://www.federalreserve.gov/econres/feds/files/2016010r1pap.pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/11/Wsipp_BenefitCost_ProgramDetails_Higher-Education']","['42267_8_washington state institute for public policy.pdf', '42267_3_student loans and homeownership.pdf', '42267_2_washington state institute for public policy.pdf']","[0.379, 0.362, 0.655]","[0.549, 0.59, 0.586]","[0.636, 0.665, 0.667]","[0.187, 0.209, 0.171]","[0.222, 0.234, 0.204]","[0.198, 0.204, 0.174]","[0.738, 0.734, 0.728]","[0.639, 0.635, 0.631]","[0.623, 0.664, 0.659]","[0.736, 0.741, 0.737]","[0.809, 0.827, 0.819]","[0.742, 0.779, 0.776]","[0.66, 0.692, 0.676]","[0.928, 0.925, 0.936]","[0.852, 0.865, 0.86]","[0.78, 0.806, 0.8]","[0.815, 0.835, 0.832]","[0.799, 0.814, 0.814]",0.465,0.575,0.656,0.189,0.22,0.192,0.733,0.635,0.649,0.738,0.818,0.766,0.676,0.93,0.859,0.795,0.827,0.809
https://doi.org/10.1257/pol.3.3.62,as from zzzzs the causal effect of school start time on the academic achievement of adolescents,42277_as from zzzzs the causal effect of school start time on the academic achievement of adolescents.pdf,10,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483483/pdf', 'https://comptroller.tn.gov/content/dam/cot/orea/advanced-search/2013/2013_OREA_SchoolStartTimes.pdf', 'https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf', 'https://www.urban.org/research/publication/student-transportation-and-educational-access', 'https://www.urban.org/research/publication/road-school-how-far-students-travel-school-choice-rich-cities-denver-detroit-new-orleans-new-york-city-and-washington-dc', 'https://www.rand.org/pubs/research_reports/RR2109.html', 'https://nepc.colorado.edu/thinktank/review-organizing-schools', 'https://www.brookings.edu/research/organizing-schools-to-improve-student-achievement-start-times-grade-configurations-and-teacher-assignments/', 'https://www.nj.gov/education/students/safety/health/StartTimes.pdf', 'https://www.rand.org/pubs/research_reports/RR1791.html']","['Later school start times for supporting the education, health, and well‐being of high school students', 'School Day Start Times', 'Research & information', 'Student Transportation and Educational Access', 'The Road to School: How Far Students Travel to School in the Choice-Rich Cities of Denver, Detroit, New Orleans, New York City, and Washington, DC', 'Starting School Later Would Boost the Economy', 'Review of Organizing Schools to Improve Student Achievement', 'Organizing Schools to Improve Student Achievement: Start Times, Grade Configurations, and Teacher Assignments', 'Final Report Study Group On Later School Start Times', 'Sleep Deprivation Has Economic, Physical, and Social Consequences']","['https://comptroller.tn.gov/content/dam/cot/orea/advanced-search/2013/2013_OREA_SchoolStartTimes.pdf', 'https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483483/pdf']","['42277_1_school day start times.pdf', '42277_2_research  information.pdf', '42277_0_later school start times for supporting the education health and well‐being of high school students.pdf']",3,30.0,"['https://comptroller.tn.gov/content/dam/cot/orea/advanced-search/2013/2013_OREA_SchoolStartTimes.pdf', 'https://sd25.senate.ca.gov/sites/sd25.senate.ca.gov/files/Research%20Booklet%20SB%20328.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483483/pdf']","['42277_1_school day start times.pdf', '42277_2_research  information.pdf', '42277_0_later school start times for supporting the education health and well‐being of high school students.pdf']","[0.508, 0.558, 0.739]","[0.548, 0.552, 0.535]","[0.634, 0.639, 0.625]","[0.192, 0.189, 0.171]","[0.215, 0.214, 0.196]","[0.184, 0.183, 0.16]","[0.74, 0.736, 0.732]","[0.645, 0.642, 0.636]","[0.622, 0.625, 0.601]","[0.701, 0.707, 0.707]","[0.808, 0.807, 0.788]","[0.717, 0.736, 0.71]","[0.663, 0.66, 0.618]","[0.92, 0.922, 0.916]","[0.848, 0.843, 0.83]","[0.767, 0.778, 0.746]","[0.802, 0.807, 0.786]","[0.79, 0.792, 0.771]",0.602,0.545,0.633,0.184,0.208,0.176,0.736,0.641,0.616,0.705,0.801,0.721,0.647,0.919,0.84,0.764,0.798,0.784
https://doi.org/10.1258/004947506775598879,babies who die from labourrelated intrapartum hypoxia a confidential enquiry in south african public hospitals,42292_babies who die from labourrelated intrapartum hypoxia a confidential enquiry in south african public hospitals.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634341/pdf'],['Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634341/pdf'],['42292_0_titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634341/pdf'],['42292_0_titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes.pdf'],[0.197],[0.544],[0.628],[0.188],[0.18],[0.151],[0.734],[0.638],[0.606],[0.621],[0.796],[0.725],[0.625],[0.909],[0.822],[0.756],[0.798],[0.772],0.197,0.544,0.628,0.188,0.18,0.151,0.734,0.638,0.606,0.621,0.796,0.725,0.625,0.909,0.822,0.756,0.798,0.772
https://doi.org/10.1258/0956462001915778,prevalence of hiv infection and risk behaviours among montreal street youth,42294_prevalence of hiv infection and risk behaviours among montreal street youth.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['Interventions to modify sexual risk behaviours for preventing HIV in homeless youth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['42294_0_interventions to modify sexual risk behaviours for preventing hiv in homeless youth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['42294_0_interventions to modify sexual risk behaviours for preventing hiv in homeless youth.pdf'],[0.45],[0.517],[0.607],[0.158],[0.177],[0.151],[0.726],[0.63],[0.587],[0.669],[0.778],[0.698],[0.597],[0.909],[0.819],[0.74],[0.781],[0.76],0.45,0.517,0.607,0.158,0.177,0.151,0.726,0.63,0.587,0.669,0.778,0.698,0.597,0.909,0.819,0.74,0.781,0.76
https://doi.org/10.1258/095646207779949880,high hepatitis c virus prevalence and incidence among canadian intravenous drug users,42299_high hepatitis c virus prevalence and incidence among canadian intravenous drug users.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621373/pdf'],['Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621373/pdf'],['42299_0_needle syringe programmes and opioid substitution therapy for preventing hepatitis c transmission in people who inject drugs.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621373/pdf'],['42299_0_needle syringe programmes and opioid substitution therapy for preventing hepatitis c transmission in people who inject drugs.pdf'],[0.361],[0.52],[0.602],[0.17],[0.176],[0.142],[0.732],[0.637],[0.574],[0.686],[0.772],[0.7],[0.601],[0.909],[0.818],[0.73],[0.772],[0.751],0.361,0.52,0.602,0.17,0.176,0.142,0.732,0.637,0.574,0.686,0.772,0.7,0.601,0.909,0.818,0.73,0.772,0.751
https://doi.org/10.1258/095646207782212180,behavioural interventions and abuse secondary analysis of reinfection in minority women,42300_behavioural interventions and abuse secondary analysis of reinfection in minority women.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf']","['A realist review of which advocacy interventions work for which abused women under what circumstances', 'Interventions for encouraging sexual behaviours intended to prevent cervical cancer', 'Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf']","['42300_0_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf', '42300_2_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse.pdf', '42300_1_interventions for encouraging sexual behaviours intended to prevent cervical cancer.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392211/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040418/pdf']","['42300_0_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf', '42300_2_advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse.pdf', '42300_1_interventions for encouraging sexual behaviours intended to prevent cervical cancer.pdf']","[0.534, 0.398, 0.458]","[0.559, 0.53, 0.547]","[0.632, 0.607, 0.623]","[0.182, 0.172, 0.184]","[0.191, 0.178, 0.187]","[0.16, 0.153, 0.164]","[0.732, 0.733, 0.732]","[0.636, 0.638, 0.638]","[0.618, 0.58, 0.605]","[0.672, 0.68, 0.672]","[0.798, 0.778, 0.789]","[0.728, 0.696, 0.715]","[0.627, 0.601, 0.619]","[0.919, 0.91, 0.921]","[0.838, 0.813, 0.822]","[0.766, 0.731, 0.753]","[0.807, 0.782, 0.797]","[0.783, 0.754, 0.769]",0.463,0.545,0.621,0.179,0.185,0.159,0.732,0.637,0.601,0.675,0.788,0.713,0.616,0.917,0.824,0.75,0.795,0.769
https://doi.org/10.1258/096914103321610725,short report falsenegative primary neonatal thyroid screening the need for clinical vigilance and secondary screening,42301_short report falsenegative primary neonatal thyroid screening the need for clinical vigilance and secondary screening.pdf,1,['https://health.hawaii.gov/genetics/files/2019/08/NSM_Hawaii2012_rev_081419.pdf'],['Hawai`i Practitioner ’s Manual'],['https://health.hawaii.gov/genetics/files/2019/08/NSM_Hawaii2012_rev_081419.pdf'],['42301_0_hawaii practitioner s manual.pdf'],1,100.0,['https://health.hawaii.gov/genetics/files/2019/08/NSM_Hawaii2012_rev_081419.pdf'],['42301_0_hawaii practitioner s manual.pdf'],[0.496],[0.566],[0.644],[0.171],[0.182],[0.139],[0.735],[0.636],[0.635],[0.652],[0.805],[0.743],[0.644],[0.924],[0.833],[0.781],[0.817],[0.798],0.496,0.566,0.644,0.171,0.182,0.139,0.735,0.636,0.635,0.652,0.805,0.743,0.644,0.924,0.833,0.781,0.817,0.798
https://doi.org/10.1258/096914103771773267,the quality of routine examinations of the newborn performed by midwives and shos an evaluation using video recordings,42303_the quality of routine examinations of the newborn performed by midwives and shos an evaluation using video recordings.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464894/pdf'],['Screening programmes for developmental dysplasia of the hip in newborn infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464894/pdf'],['42303_0_screening programmes for developmental dysplasia of the hip in newborn infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464894/pdf'],['42303_0_screening programmes for developmental dysplasia of the hip in newborn infants.pdf'],[0.256],[0.545],[0.621],[0.19],[0.195],[0.163],[0.741],[0.644],[0.607],[0.673],[0.786],[0.728],[0.614],[0.911],[0.811],[0.749],[0.793],[0.767],0.256,0.545,0.621,0.19,0.195,0.163,0.741,0.644,0.607,0.673,0.786,0.728,0.614,0.911,0.811,0.749,0.793,0.767
https://doi.org/10.1258/096914106776179764,an analysis of the costs of implementing the national newborn hearing screening programme in england,42304_an analysis of the costs of implementing the national newborn hearing screening programme in england.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459803/pdf'],['Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459803/pdf'],['42304_0_specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459803/pdf'],['42304_0_specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening.pdf'],[0.361],[0.603],[0.669],[0.22],[0.243],[0.208],[0.741],[0.654],[0.665],[0.711],[0.82],[0.773],[0.665],[0.93],[0.86],[0.798],[0.834],[0.811],0.361,0.603,0.669,0.22,0.243,0.208,0.741,0.654,0.665,0.711,0.82,0.773,0.665,0.93,0.86,0.798,0.834,0.811
https://doi.org/10.1258/096914106777589650,neonatal haemoglobinopathy screening review of a 10year programme in brussels,42305_neonatal haemoglobinopathy screening review of a 10year programme in brussels.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407242/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175837/pdf']","['Interventions for treating leg ulcers in people with sickle cell disease', 'Interventions for treating leg ulcers in people with sickle cell disease']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175837/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407242/pdf']","['42305_1_interventions for treating leg ulcers in people with sickle cell disease.pdf', '42305_0_interventions for treating leg ulcers in people with sickle cell disease.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175837/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407242/pdf']","['42305_1_interventions for treating leg ulcers in people with sickle cell disease.pdf', '42305_0_interventions for treating leg ulcers in people with sickle cell disease.pdf']","[0.136, 0.144]","[0.549, 0.545]","[0.643, 0.64]","[0.172, 0.171]","[0.16, 0.152]","[0.128, 0.127]","[0.738, 0.735]","[0.639, 0.635]","[0.618, 0.613]","[0.617, 0.614]","[0.795, 0.794]","[0.722, 0.72]","[0.605, 0.604]","[0.925, 0.925]","[0.83, 0.83]","[0.752, 0.747]","[0.796, 0.794]","[0.773, 0.77]",0.14,0.547,0.641,0.171,0.156,0.128,0.736,0.637,0.615,0.615,0.794,0.721,0.605,0.925,0.83,0.75,0.795,0.772
https://doi.org/10.1258/135581902760082517,what does access to health care mean,42306_what does access to health care mean.pdf,7,"['https://louisvilleky.gov/sites/default/files/health_and_wellness/che/health_equity_report/health_equity_report_as_pages.pdf', 'https://louisvilleky.gov/sites/default/files/health_and_wellness/che/health_equity_report/health_equity_report.pdf', 'https://www.rand.org/pubs/rgs_dissertations/RGSD396.html', 'https://www.ppic.org/publication/access-to-the-health-care-safety-net-in-california/', 'https://stacks.cdc.gov/view/cdc/31044', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/DelridgeActionPlan/DelridgeActionPlanHealthImpactAssessment.pdf', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/IndustrialMaritimeStrategy/Spring2020_InterbayHIA_Document.pdf']","['Health Equity', 'Health Equity', 'The Impact of Nurse Practitioner Scope-of-Practice Regulations in Primary Care', 'Access to the Health Care Safety Net in California - Public Policy Institute of California', 'Health, United States 2014 : with special feature on adults aged 55–64', 'Seattle DPD - Delridge Action Plan Health Impact Assessment', 'The Interbay Project A Health Impact Assessment']","['http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/DelridgeActionPlan/DelridgeActionPlanHealthImpactAssessment.pdf', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/IndustrialMaritimeStrategy/Spring2020_InterbayHIA_Document.pdf']","['42306_5_seattle dpd  delridge action plan health impact assessment.pdf', '42306_6_the interbay project a health impact assessment.pdf']",2,28.57,"['http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/DelridgeActionPlan/DelridgeActionPlanHealthImpactAssessment.pdf', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/IndustrialMaritimeStrategy/Spring2020_InterbayHIA_Document.pdf']","['42306_5_seattle dpd  delridge action plan health impact assessment.pdf', '42306_6_the interbay project a health impact assessment.pdf']","[0.327, 0.328]","[0.566, 0.564]","[0.655, 0.651]","[0.154, 0.156]","[0.162, 0.157]","[0.124, 0.129]","[0.723, 0.722]","[0.626, 0.627]","[0.633, 0.637]","[0.662, 0.661]","[0.818, 0.821]","[0.762, 0.768]","[0.652, 0.661]","[0.926, 0.922]","[0.853, 0.856]","[0.785, 0.787]","[0.829, 0.83]","[0.805, 0.807]",0.328,0.565,0.653,0.155,0.16,0.127,0.722,0.627,0.635,0.661,0.819,0.765,0.657,0.924,0.855,0.786,0.829,0.806
https://doi.org/10.1258/1355819054308530,realist review  a new method of systematic review designed for complex policy interventions,42307_realist review  a new method of systematic review designed for complex policy interventions.pdf,9,"['https://effectivehealthcare.ahrq.gov/products/high-utilizers-health-care/research', 'https://www.rand.org/pubs/working_papers/WR820.html', 'https://effectivehealthcare.ahrq.gov/products/high-utilizers-health-care/protocol', 'https://www.cgdev.org/publication/searching-devil-details-learning-about-development-program-design-working-paper-434', 'https://effectivehealthcare.ahrq.gov/products/health-care-interventions-review/white-paper', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196863/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686511/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691169/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf']","['Management of High-Need, High-Cost Patients: A “Best Fit” Framework Synthesis, Realist Review, and Systematic Review', ""Delivering the aims of the CLAHRCs: evaluating CLAHRCs' strategies and contributions"", 'Management of High-Need, High-Cost Patients: A Realist and Systematic Review', 'Searching for the Devil in the Details: Learning about Development Program Design - Working Paper 434', 'Systematic Reviews of Complex Multicomponent Health Care Interventions', 'Appraising the quality standard underpinning international clinical practice guidelines for the selection and care of vascular access devices: a systematic review of reviews', 'Qualitative Evidence Synthesis (QES)\xa0for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements', 'Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults', 'A realist review of which advocacy interventions work for which abused women under what circumstances']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691169/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196863/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686511/pdf']","['42307_7_dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults.pdf', '42307_5_appraising the quality standard underpinning international clinical practice guidelines for the selection and care of vascular access devices a systematic review of reviews.pdf', '42307_8_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf', '42307_6_qualitative evidence synthesis qes\xa0for guidelines paper 1 – using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements.pdf']",4,44.44,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691169/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196863/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598804/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686511/pdf']","['42307_7_dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults.pdf', '42307_5_appraising the quality standard underpinning international clinical practice guidelines for the selection and care of vascular access devices a systematic review of reviews.pdf', '42307_8_a realist review of which advocacy interventions work for which abused women under what circumstances.pdf', '42307_6_qualitative evidence synthesis qes\xa0for guidelines paper 1 – using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements.pdf']","[0.281, 0.501, 0.277, 0.392]","[0.521, 0.597, 0.584, 0.619]","[0.616, 0.672, 0.659, 0.687]","[0.151, 0.182, 0.18, 0.222]","[0.149, 0.193, 0.186, 0.242]","[0.123, 0.156, 0.159, 0.191]","[0.72, 0.729, 0.725, 0.741]","[0.622, 0.637, 0.631, 0.653]","[0.592, 0.679, 0.652, 0.685]","[0.704, 0.713, 0.707, 0.741]","[0.783, 0.829, 0.817, 0.831]","[0.722, 0.807, 0.773, 0.795]","[0.602, 0.649, 0.654, 0.675]","[0.918, 0.936, 0.928, 0.933]","[0.841, 0.873, 0.873, 0.875]","[0.752, 0.803, 0.793, 0.81]","[0.791, 0.843, 0.827, 0.843]","[0.771, 0.823, 0.811, 0.827]",0.363,0.58,0.659,0.184,0.193,0.157,0.729,0.636,0.652,0.716,0.815,0.774,0.645,0.929,0.865,0.79,0.826,0.808
https://doi.org/10.1258/1355819054308576,systematically reviewing qualitative and quantitative evidence to inform management and policymaking in the health field,42308_systematically reviewing qualitative and quantitative evidence to inform management and policymaking in the health field.pdf,5,"['https://stacks.cdc.gov/view/cdc/6921', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234680/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072935/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372446/pdf']","['Improving population health; the uses of systematic reviews', 'Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review', 'Understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake: protocol for a realist review', 'How can we improve guideline use? A conceptual framework of implementability', ""'How to know what you need to do': a cross-country comparison of maternal health guidelines in Burkina Faso, Ghana and Tanzania""]","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372446/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072935/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234680/pdf']","['42308_4_how to know what you need to do a crosscountry comparison of maternal health guidelines in burkina faso ghana and tanzania.pdf', '42308_2_understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake protocol for a realist review.pdf', '42308_3_how can we improve guideline use a conceptual framework of implementability.pdf', '42308_1_healthcare provider knowledge attitudes beliefs and practices surrounding the prescription of opioids for chronic noncancer pain in north america protocol for a mixedmethod systematic review.pdf']",4,80.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372446/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224565/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072935/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234680/pdf']","['42308_4_how to know what you need to do a crosscountry comparison of maternal health guidelines in burkina faso ghana and tanzania.pdf', '42308_2_understanding the relationship between the perceived characteristics of clinical practice guidelines and their uptake protocol for a realist review.pdf', '42308_3_how can we improve guideline use a conceptual framework of implementability.pdf', '42308_1_healthcare provider knowledge attitudes beliefs and practices surrounding the prescription of opioids for chronic noncancer pain in north america protocol for a mixedmethod systematic review.pdf']","[0.342, 0.594, 0.41, 0.297]","[0.652, 0.679, 0.625, 0.576]","[0.718, 0.739, 0.694, 0.663]","[0.234, 0.282, 0.246, 0.19]","[0.247, 0.289, 0.258, 0.199]","[0.194, 0.242, 0.217, 0.155]","[0.741, 0.761, 0.752, 0.734]","[0.65, 0.673, 0.663, 0.64]","[0.732, 0.742, 0.689, 0.645]","[0.726, 0.779, 0.76, 0.718]","[0.852, 0.855, 0.824, 0.814]","[0.837, 0.837, 0.793, 0.781]","[0.684, 0.695, 0.663, 0.631]","[0.938, 0.94, 0.933, 0.932]","[0.892, 0.895, 0.872, 0.857]","[0.834, 0.838, 0.807, 0.789]","[0.866, 0.866, 0.835, 0.823]","[0.843, 0.848, 0.813, 0.806]",0.411,0.633,0.704,0.238,0.248,0.202,0.747,0.656,0.702,0.746,0.836,0.812,0.668,0.936,0.879,0.817,0.848,0.827
https://doi.org/10.1258/1357633011937074,evaluating satisfaction with a child and adolescent psychological telemedicine outreach service,42309_evaluating satisfaction with a child and adolescent psychological telemedicine outreach service.pdf,1,['http://dls.virginia.gov/groups/mhs/telepsychiatry082216.pdf'],['Telepsychiatry at the University of Virginia'],['http://dls.virginia.gov/groups/mhs/telepsychiatry082216.pdf'],['42309_0_telepsychiatry at the university of virginia.pdf'],1,100.0,['http://dls.virginia.gov/groups/mhs/telepsychiatry082216.pdf'],['42309_0_telepsychiatry at the university of virginia.pdf'],[0.311],[0.568],[0.665],[0.194],[0.232],[0.186],[0.732],[0.653],[0.64],[0.707],[0.814],[0.752],[0.657],[0.931],[0.858],[0.787],[0.822],[0.803],0.311,0.568,0.665,0.194,0.232,0.186,0.732,0.653,0.64,0.707,0.814,0.752,0.657,0.931,0.858,0.787,0.822,0.803
https://doi.org/10.1258/135763303771005207,the socioeconomic impact of telehealth a systematic review,42311_the socioeconomic impact of telehealth a systematic review.pdf,5,"['https://dph.georgia.gov/sites/dph.georgia.gov/files/GuidelinesTelemedicineTelenursingFINALRevisedMarch122013.pdf', 'https://www.rand.org/pubs/research_reports/RR308.html', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433298/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685592/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407490/pdf']","['Georgia Department of Public Health', 'Redirecting Innovation in U.S. Health Care: Decreasing Spending, Increasing Value', 'Home telemonitoring and remote feedback between clinic visits for asthma', 'Psychological therapies (Internet‐delivered) for the management of chronic pain in adults', 'Remote versus face‐to‐face check‐ups for asthma']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685592/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407490/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433298/pdf']","['42311_3_psychological therapies internet‐delivered for the management of chronic pain in adults.pdf', '42311_4_remote versus face‐to‐face check‐ups for asthma.pdf', '42311_2_home telemonitoring and remote feedback between clinic visits for asthma.pdf']",3,60.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685592/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407490/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433298/pdf']","['42311_3_psychological therapies internet‐delivered for the management of chronic pain in adults.pdf', '42311_4_remote versus face‐to‐face check‐ups for asthma.pdf', '42311_2_home telemonitoring and remote feedback between clinic visits for asthma.pdf']","[0.383, 0.29, 0.391]","[0.538, 0.561, 0.55]","[0.631, 0.648, 0.642]","[0.166, 0.187, 0.191]","[0.176, 0.192, 0.197]","[0.136, 0.148, 0.159]","[0.738, 0.74, 0.742]","[0.647, 0.65, 0.652]","[0.594, 0.618, 0.609]","[0.692, 0.699, 0.699]","[0.79, 0.806, 0.801]","[0.716, 0.737, 0.721]","[0.621, 0.625, 0.626]","[0.919, 0.925, 0.923]","[0.822, 0.835, 0.83]","[0.746, 0.761, 0.753]","[0.788, 0.805, 0.799]","[0.767, 0.783, 0.777]",0.355,0.55,0.64,0.181,0.188,0.148,0.74,0.65,0.607,0.697,0.799,0.725,0.624,0.922,0.829,0.753,0.797,0.776
https://doi.org/10.1258/cr.2008.080042,why children die the report of a pilot confidential enquiry into child death by cemach confidential enquiry into maternal and child health,42314_why children die the report of a pilot confidential enquiry into child death by cemach confidential enquiry into maternal and child health.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093891/pdf'],"['Death audits and reviews for reducing maternal, perinatal and child mortality']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093891/pdf'],['42314_0_death audits and reviews for reducing maternal perinatal and child mortality.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093891/pdf'],['42314_0_death audits and reviews for reducing maternal perinatal and child mortality.pdf'],[0.418],[0.571],[0.649],[0.218],[0.232],[0.191],[0.733],[0.639],[0.624],[0.692],[0.801],[0.751],[0.634],[0.915],[0.857],[0.773],[0.809],[0.785],0.418,0.571,0.649,0.218,0.232,0.191,0.733,0.639,0.624,0.692,0.801,0.751,0.634,0.915,0.857,0.773,0.809,0.785
https://doi.org/10.1258/ijsa.2007.007264,sms sti a review of the uses of mobile phone text messaging in sexual health,42315_sms sti a review of the uses of mobile phone text messaging in sexual health.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957844/pdf', 'https://www.cgdev.org/publication/mixed-method-evaluation-passive-health-sexual-information-texting-service-uganda-working', 'https://www.nber.org/papers/w19107', 'https://www.urban.org/research/publication/evaluation-impacts-two-rules-thumb-credit-card-revolvers']","['The : a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections', 'Mixed Method Evaluation of a Passive Health Sexual Information Texting Service in Uganda - Working Paper 332', 'Mixed Method Evaluation of a Passive mHealth Sexual Information Texting Service in Uganda', 'An Evaluation of the Impacts of Two â\x80\x9cRules of Thumbâ\x80\x9d for Credit Card Revolvers']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957844/pdf'],['42315_0_the  a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957844/pdf'],['42315_0_the  a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections.pdf'],[0.423],[0.556],[0.642],[0.18],[0.196],[0.175],[0.742],[0.652],[0.634],[0.665],[0.821],[0.759],[0.625],[0.934],[0.851],[0.775],[0.827],[0.805],0.423,0.556,0.642,0.18,0.196,0.175,0.742,0.652,0.634,0.665,0.821,0.759,0.625,0.934,0.851,0.775,0.827,0.805
https://doi.org/10.1258/ijsa.2008.008279,uk national guidelines on the management of syphilis 2008,42316_uk national guidelines on the management of syphilis 2008.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536092/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378924/pdf']","['Antibiotic therapy for adults with neurosyphilis', 'Antibiotic treatment for newborns with congenital syphilis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536092/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378924/pdf']","['42316_0_antibiotic therapy for adults with neurosyphilis.pdf', '42316_1_antibiotic treatment for newborns with congenital syphilis.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536092/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378924/pdf']","['42316_0_antibiotic therapy for adults with neurosyphilis.pdf', '42316_1_antibiotic treatment for newborns with congenital syphilis.pdf']","[0.352, 0.559]","[0.546, 0.551]","[0.633, 0.631]","[0.189, 0.191]","[0.187, 0.199]","[0.153, 0.169]","[0.746, 0.746]","[0.652, 0.652]","[0.62, 0.619]","[0.636, 0.637]","[0.808, 0.805]","[0.725, 0.731]","[0.609, 0.607]","[0.925, 0.924]","[0.826, 0.826]","[0.766, 0.764]","[0.801, 0.802]","[0.789, 0.787]",0.456,0.548,0.632,0.19,0.193,0.161,0.746,0.652,0.619,0.637,0.806,0.728,0.608,0.925,0.826,0.765,0.802,0.788
https://doi.org/10.1258/ijsa.2008.008510,iusti 2008 european guidelines on the management of syphilis,42317_iusti 2008 european guidelines on the management of syphilis.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536092/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378924/pdf']","['Antibiotic therapy for adults with neurosyphilis', 'Antibiotic treatment for newborns with congenital syphilis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536092/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378924/pdf']","['42317_0_antibiotic therapy for adults with neurosyphilis.pdf', '42317_1_antibiotic treatment for newborns with congenital syphilis.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536092/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378924/pdf']","['42317_0_antibiotic therapy for adults with neurosyphilis.pdf', '42317_1_antibiotic treatment for newborns with congenital syphilis.pdf']","[0.355, 0.547]","[0.547, 0.552]","[0.639, 0.638]","[0.201, 0.205]","[0.197, 0.21]","[0.162, 0.18]","[0.748, 0.749]","[0.656, 0.656]","[0.623, 0.623]","[0.646, 0.645]","[0.808, 0.806]","[0.722, 0.729]","[0.612, 0.611]","[0.924, 0.923]","[0.83, 0.83]","[0.768, 0.766]","[0.803, 0.804]","[0.791, 0.79]",0.451,0.55,0.639,0.203,0.204,0.171,0.748,0.656,0.623,0.645,0.807,0.726,0.611,0.923,0.83,0.767,0.804,0.79
https://doi.org/10.1258/ijsa.2010.010097,multicity hiv seroprevalence in street youth ukraine,42318_multicity hiv seroprevalence in street youth ukraine.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['Interventions to modify sexual risk behaviours for preventing HIV in homeless youth'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['42318_0_interventions to modify sexual risk behaviours for preventing hiv in homeless youth.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624078/pdf'],['42318_0_interventions to modify sexual risk behaviours for preventing hiv in homeless youth.pdf'],[0.489],[0.517],[0.616],[0.165],[0.182],[0.154],[0.732],[0.638],[0.585],[0.677],[0.774],[0.693],[0.59],[0.916],[0.804],[0.735],[0.776],[0.76],0.489,0.517,0.616,0.165,0.182,0.154,0.732,0.638,0.585,0.677,0.774,0.693,0.59,0.916,0.804,0.735,0.776,0.76
https://doi.org/10.1258/jhsrp.2010.009113,impact of pay for performance on inequalities in health care systematic review,42319_impact of pay for performance on inequalities in health care systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204491/pdf', 'https://www.nber.org/papers/w19046?sy=046']","['An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes', 'Using Performance Incentives to Improve Medical Care Productivity and Health Outcomes']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204491/pdf'],['42319_0_an overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204491/pdf'],['42319_0_an overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes.pdf'],[0.383],[0.52],[0.608],[0.182],[0.176],[0.149],[0.734],[0.643],[0.576],[0.728],[0.78],[0.71],[0.627],[0.907],[0.815],[0.717],[0.777],[0.737],0.383,0.52,0.608,0.182,0.176,0.149,0.734,0.643,0.576,0.728,0.78,0.71,0.627,0.907,0.815,0.717,0.777,0.737
https://doi.org/10.1258/jrsm.2008.070363,perceptions of childhood immunization in a minority community qualitative study,42320_perceptions of childhood immunization in a minority community qualitative study.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461870/pdf', 'https://www.nber.org/papers/w19528']","[""Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis"", ""Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence"", 'Conforming and Non-conforming Peer Effects in Vaccination Decisions']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461870/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf']","['42320_1_parents and informal caregivers views and experiences of communication about routine childhood vaccination a synthesis of qualitative evidence.pdf', '42320_0_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461870/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550333/pdf']","['42320_1_parents and informal caregivers views and experiences of communication about routine childhood vaccination a synthesis of qualitative evidence.pdf', '42320_0_factors that influence parents and informal caregivers views and practices regarding routine childhood vaccination a qualitative evidence synthesis.pdf']","[0.338, 0.303]","[0.556, 0.554]","[0.641, 0.64]","[0.176, 0.177]","[0.192, 0.191]","[0.164, 0.162]","[0.729, 0.728]","[0.636, 0.635]","[0.624, 0.625]","[0.695, 0.694]","[0.805, 0.805]","[0.745, 0.748]","[0.628, 0.631]","[0.915, 0.915]","[0.863, 0.863]","[0.774, 0.775]","[0.813, 0.815]","[0.796, 0.797]",0.321,0.555,0.641,0.176,0.192,0.163,0.728,0.635,0.625,0.694,0.805,0.746,0.629,0.915,0.863,0.774,0.814,0.796
https://doi.org/10.1258/jrsm.2008.080149,health information for patients time to look beyond patient information leaflets,42321_health information for patients time to look beyond patient information leaflets.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586858/pdf'],['Air and oxygen flowmeter confusion'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586858/pdf'],['42321_0_air and oxygen flowmeter confusion.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586858/pdf'],['42321_0_air and oxygen flowmeter confusion.pdf'],[0.213],[0.579],[0.658],[0.16],[0.171],[0.13],[0.729],[0.631],[0.666],[0.67],[0.827],[0.791],[0.652],[0.937],[0.872],[0.803],[0.837],[0.816],0.213,0.579,0.658,0.16,0.171,0.13,0.729,0.631,0.666,0.67,0.827,0.791,0.652,0.937,0.872,0.803,0.837,0.816
https://doi.org/10.1258/jtt.2011.110416,mobilephone text messaging sms for providing oral health education to mothers of preschool children in belgaum city,42324_mobilephone text messaging sms for providing oral health education to mothers of preschool children in belgaum city.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791116/pdf']","['Targeted client communication via mobile devices for improving maternal, neonatal, and child health', 'Clients’ perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive, maternal, newborn, child, and adolescent health: a qualitative evidence synthesis']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791116/pdf']","['42324_0_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '42324_1_clients perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477611/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791116/pdf']","['42324_0_targeted client communication via mobile devices for improving maternal neonatal and child health.pdf', '42324_1_clients perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive.pdf']","[0.391, 0.416]","[0.533, 0.538]","[0.615, 0.625]","[0.151, 0.15]","[0.155, 0.164]","[0.129, 0.136]","[0.728, 0.732]","[0.63, 0.633]","[0.593, 0.599]","[0.673, 0.675]","[0.78, 0.787]","[0.712, 0.718]","[0.606, 0.62]","[0.918, 0.924]","[0.824, 0.836]","[0.743, 0.756]","[0.785, 0.791]","[0.763, 0.778]",0.403,0.536,0.62,0.15,0.16,0.133,0.73,0.631,0.596,0.674,0.784,0.715,0.613,0.921,0.83,0.75,0.788,0.77
https://doi.org/10.1258/shorts.2011.011112,primary care strategies to improve childhood immunisation uptake in developed countries systematic review,42326_primary care strategies to improve childhood immunisation uptake in developed countries systematic review.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf']","['Improving vaccination uptake among adolescents', 'Patient reminder and recall interventions to improve immunization rates']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf']","['42326_0_improving vaccination uptake among adolescents.pdf', '42326_1_patient reminder and recall interventions to improve immunization rates.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491344/pdf']","['42326_0_improving vaccination uptake among adolescents.pdf', '42326_1_patient reminder and recall interventions to improve immunization rates.pdf']","[0.432, 0.593]","[0.554, 0.535]","[0.633, 0.621]","[0.209, 0.207]","[0.213, 0.213]","[0.178, 0.181]","[0.743, 0.746]","[0.653, 0.655]","[0.61, 0.591]","[0.709, 0.711]","[0.79, 0.78]","[0.727, 0.705]","[0.61, 0.612]","[0.924, 0.917]","[0.829, 0.821]","[0.748, 0.732]","[0.792, 0.78]","[0.767, 0.76]",0.512,0.544,0.627,0.208,0.213,0.179,0.744,0.654,0.601,0.71,0.785,0.716,0.611,0.921,0.825,0.74,0.786,0.764
https://doi.org/10.1258/smj.2011.011036,the prevalence of ear nose and throat disorders in preschool children with downs syndrome in glasgow,42327_the prevalence of ear nose and throat disorders in preschool children with downs syndrome in glasgow.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf'],['Parent‐mediated interventions for promoting communication and language development in young children with Down syndrome'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf'],['42327_0_parent‐mediated interventions for promoting communication and language development in young children with down syndrome.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516877/pdf'],['42327_0_parent‐mediated interventions for promoting communication and language development in young children with down syndrome.pdf'],[0.409],[0.58],[0.647],[0.181],[0.184],[0.157],[0.732],[0.635],[0.648],[0.627],[0.816],[0.761],[0.643],[0.926],[0.84],[0.783],[0.82],[0.801],0.409,0.58,0.647,0.181,0.184,0.157,0.732,0.635,0.648,0.627,0.816,0.761,0.643,0.926,0.84,0.783,0.82,0.801
https://doi.org/10.1258/td.2010.090513,effect of kangaroo mother care on physical growth breastfeeding and its acceptability,42328_effect of kangaroo mother care on physical growth breastfeeding and its acceptability.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf', 'https://effectivehealthcare.ahrq.gov/products/breastfeeding/research']","['Kangaroo mother care to reduce morbidity and mortality in low birthweight infants', 'Early skin‐to‐skin contact for mothers and their healthy newborn infants', 'Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf']","['42328_0_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf', '42328_1_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf']",2,66.67,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464509/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464366/pdf']","['42328_0_kangaroo mother care to reduce morbidity and mortality in low birthweight infants.pdf', '42328_1_early skin‐to‐skin contact for mothers and their healthy newborn infants.pdf']","[0.401, 0.44]","[0.502, 0.537]","[0.587, 0.616]","[0.17, 0.182]","[0.172, 0.197]","[0.148, 0.156]","[0.733, 0.734]","[0.634, 0.636]","[0.562, 0.606]","[0.679, 0.681]","[0.766, 0.788]","[0.665, 0.704]","[0.595, 0.624]","[0.905, 0.916]","[0.809, 0.837]","[0.721, 0.753]","[0.769, 0.797]","[0.745, 0.775]",0.42,0.52,0.601,0.176,0.184,0.152,0.734,0.635,0.584,0.68,0.777,0.684,0.609,0.911,0.823,0.737,0.783,0.76
https://doi.org/10.1258/td.2010.100151,the role of the periosteum in healing a large structural defect following sequestrectomy,42329_the role of the periosteum in healing a large structural defect following sequestrectomy.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573297/pdf'],['The Beit CURE Classification of Childhood Chronic Haematogenous Osteomyelitis—a guide to treatment'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573297/pdf'],['42329_0_the beit cure classification of childhood chronic haematogenous osteomyelitis—a guide to treatment.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573297/pdf'],['42329_0_the beit cure classification of childhood chronic haematogenous osteomyelitis—a guide to treatment.pdf'],[0.318],[0.569],[0.65],[0.197],[0.215],[0.16],[0.74],[0.64],[0.637],[0.645],[0.822],[0.753],[0.637],[0.908],[0.841],[0.784],[0.823],[0.806],0.318,0.569,0.65,0.197,0.215,0.16,0.74,0.64,0.637,0.645,0.822,0.753,0.637,0.908,0.841,0.784,0.823,0.806
https://doi.org/10.1259/bjr.75.898.750819,influence of patient age on normalized effective doses calculated for ct examinations,42331_influence of patient age on normalized effective doses calculated for ct examinations.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726384/pdf', 'https://cdn.ymaws.com/scct.org/resource/resmgr/Docs/Fellows&Residents_of_SCCT/Technical_Recommendations.pdf']","['The NICE guidelines for the management of head injury: the view from a district hospital', 'Computed Tomography Imaging in Patients with Congenital Heart Disease, Part 2: Technical Recommendations. An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT) Endorsed by the Society of Pediatric Radiology (SPR) and the North American Society of Cardiac Imaging (NASCI)']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726384/pdf'],['42331_0_the nice guidelines for the management of head injury the view from a district hospital.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1726384/pdf'],['42331_0_the nice guidelines for the management of head injury the view from a district hospital.pdf'],[0.173],[0.578],[0.645],[0.156],[0.159],[0.137],[0.728],[0.631],[0.661],[0.664],[0.823],[0.784],[0.674],[0.933],[0.839],[0.79],[0.829],[0.802],0.173,0.578,0.645,0.156,0.159,0.137,0.728,0.631,0.661,0.664,0.823,0.784,0.674,0.933,0.839,0.79,0.829,0.802
https://doi.org/10.1259/bjr/29806327,effect of antenatal iodinated contrast agent on neonatal thyroid function,42332_effect of antenatal iodinated contrast agent on neonatal thyroid function.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258928/pdf'],['American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258928/pdf'],['42332_0_american society of hematology 2018 guidelines for management of venous thromboembolism venous thromboembolism in the context of pregnancy.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258928/pdf'],['42332_0_american society of hematology 2018 guidelines for management of venous thromboembolism venous thromboembolism in the context of pregnancy.pdf'],[0.223],[0.564],[0.633],[0.164],[0.158],[0.123],[0.739],[0.641],[0.622],[0.631],[0.8],[0.742],[0.641],[0.915],[0.807],[0.773],[0.806],[0.785],0.223,0.564,0.633,0.164,0.158,0.123,0.739,0.641,0.622,0.631,0.8,0.742,0.641,0.915,0.807,0.773,0.806,0.785
https://doi.org/10.1259/bjr/74105551,ct evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis relationship between imaging appearance and baseline liver function,42333_ct evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis relationship between imaging appearance and baseline liver function.pdf,1,['https://www.hca.wa.gov/assets/program/appendix_b_excluded_references_103112[1].pdf'],['Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy'],['https://www.hca.wa.gov/assets/program/appendix_b_excluded_references_103112[1].pdf'],['42333_0_stereotactic radiosurgery and stereotactic body radiation therapy.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.12669/pjms.341.14092,comparison of volume and frequency advancement feeding protocols in very low birth weight neonates,42334_comparison of volume and frequency advancement feeding protocols in very low birth weight neonates.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407504/pdf'],['Short versus long feeding interval for bolus feedings in very preterm infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407504/pdf'],['42334_0_short versus long feeding interval for bolus feedings in very preterm infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407504/pdf'],['42334_0_short versus long feeding interval for bolus feedings in very preterm infants.pdf'],[0.455],[0.528],[0.616],[0.175],[0.179],[0.148],[0.731],[0.639],[0.598],[0.672],[0.785],[0.703],[0.591],[0.914],[0.824],[0.736],[0.78],[0.765],0.455,0.528,0.616,0.175,0.179,0.148,0.731,0.639,0.598,0.672,0.785,0.703,0.591,0.914,0.824,0.736,0.78,0.765
https://doi.org/10.12688/f1000research.14452.1,normal human lactation closing the gap,42337_normal human lactation closing the gap.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063164/pdf'],"['Integrating approaches for quality guideline development in LactaMap, an online lactation care support system']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063164/pdf'],['42337_0_integrating approaches for quality guideline development in lactamap an online lactation care support system.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063164/pdf'],['42337_0_integrating approaches for quality guideline development in lactamap an online lactation care support system.pdf'],[0.119],[0.533],[0.621],[0.128],[0.153],[0.111],[0.724],[0.627],[0.615],[0.654],[0.795],[0.748],[0.595],[0.931],[0.835],[0.766],[0.803],[0.79],0.119,0.533,0.621,0.128,0.153,0.111,0.724,0.627,0.615,0.654,0.795,0.748,0.595,0.931,0.835,0.766,0.803,0.79
https://doi.org/10.1272/jnms.71.360,fetal and neonatal thermoregulation,42346_fetal and neonatal thermoregulation.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507500/pdf'],['Amnioinfusion for chorioamnionitis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507500/pdf'],['42346_0_amnioinfusion for chorioamnionitis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507500/pdf'],['42346_0_amnioinfusion for chorioamnionitis.pdf'],[0.104],[0.54],[0.622],[0.13],[0.145],[0.105],[0.731],[0.627],[0.616],[0.618],[0.799],[0.734],[0.606],[0.918],[0.818],[0.753],[0.801],[0.778],0.104,0.54,0.622,0.13,0.145,0.105,0.731,0.627,0.616,0.618,0.799,0.734,0.606,0.918,0.818,0.753,0.801,0.778
https://doi.org/10.1272/jnms.71.5,the effect of noise on the health of children,42347_the effect of noise on the health of children.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989790/pdf'],['Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989790/pdf'],['42347_0_sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989790/pdf'],['42347_0_sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants.pdf'],[0.239],[0.547],[0.627],[0.175],[0.175],[0.15],[0.732],[0.634],[0.61],[0.664],[0.802],[0.736],[0.633],[0.923],[0.832],[0.757],[0.803],[0.78],0.239,0.547,0.627,0.175,0.175,0.15,0.732,0.634,0.61,0.664,0.802,0.736,0.633,0.923,0.832,0.757,0.803,0.78
https://doi.org/10.1272/jnms.72.149,are sterile water and brushes necessary for hand washing before surgery in japan,42348_are sterile water and brushes necessary for hand washing before surgery in japan.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647968/pdf'],['Surgical hand antisepsis to reduce surgical site infection'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647968/pdf'],['42348_0_surgical hand antisepsis to reduce surgical site infection.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647968/pdf'],['42348_0_surgical hand antisepsis to reduce surgical site infection.pdf'],[0.245],[0.521],[0.607],[0.149],[0.153],[0.119],[0.731],[0.633],[0.59],[0.659],[0.793],[0.713],[0.611],[0.917],[0.828],[0.753],[0.796],[0.777],0.245,0.521,0.607,0.149,0.153,0.119,0.731,0.633,0.59,0.659,0.793,0.713,0.611,0.917,0.828,0.753,0.796,0.777
https://doi.org/10.1272/jnms.72.364,effect of bicarbonated ringers solution on the acidbase balance in patients undergoing abdominal aortic aneurysm repair,42349_effect of bicarbonated ringers solution on the acidbase balance in patients undergoing abdominal aortic aneurysm repair.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047941/pdf'],['Intravenous fluids for abdominal aortic surgery'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047941/pdf'],['42349_0_intravenous fluids for abdominal aortic surgery.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047941/pdf'],['42349_0_intravenous fluids for abdominal aortic surgery.pdf'],[0.404],[0.545],[0.632],[0.173],[0.18],[0.123],[0.732],[0.632],[0.616],[0.655],[0.791],[0.73],[0.623],[0.929],[0.828],[0.766],[0.802],[0.78],0.404,0.545,0.632,0.173,0.18,0.123,0.732,0.632,0.616,0.655,0.791,0.73,0.623,0.929,0.828,0.766,0.802,0.78
https://doi.org/10.1272/jnms.77.93,increased rate of elective cesarean delivery and neonatal respiratory disorders in twin pregnancies,42351_increased rate of elective cesarean delivery and neonatal respiratory disorders in twin pregnancies.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110647/pdf']","['Planned caesarean section for women with a twin pregnancy', 'Planned caesarean section for women with a twin pregnancy']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110647/pdf']","['42351_0_planned caesarean section for women with a twin pregnancy.pdf', '42351_1_planned caesarean section for women with a twin pregnancy.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507501/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110647/pdf']","['42351_0_planned caesarean section for women with a twin pregnancy.pdf', '42351_1_planned caesarean section for women with a twin pregnancy.pdf']","[0.212, 0.266]","[0.533, 0.523]","[0.614, 0.613]","[0.188, 0.171]","[0.207, 0.197]","[0.171, 0.162]","[0.744, 0.74]","[0.652, 0.645]","[0.587, 0.586]","[0.672, 0.669]","[0.773, 0.771]","[0.699, 0.693]","[0.601, 0.595]","[0.903, 0.913]","[0.796, 0.793]","[0.724, 0.733]","[0.772, 0.77]","[0.747, 0.757]",0.239,0.528,0.613,0.179,0.202,0.167,0.742,0.649,0.587,0.671,0.772,0.696,0.598,0.908,0.794,0.728,0.771,0.752
https://doi.org/10.1272/jnms.79.204,efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer,42352_efficacy and safety of gemcitabine monotherapy for patients with advanced biliary tract cancer.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772383/pdf'],['Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772383/pdf'],['42352_0_radiologic evaluation and structured reporting form for extrahepatic bile duct cancer 2019 consensus recommendations from the korean society of abdominal radiology.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772383/pdf'],['42352_0_radiologic evaluation and structured reporting form for extrahepatic bile duct cancer 2019 consensus recommendations from the korean society of abdominal radiology.pdf'],[0.425],[0.537],[0.623],[0.154],[0.173],[0.14],[0.745],[0.657],[0.608],[0.651],[0.791],[0.717],[0.606],[0.912],[0.81],[0.751],[0.789],[0.776],0.425,0.537,0.623,0.154,0.173,0.14,0.745,0.657,0.608,0.651,0.791,0.717,0.606,0.912,0.81,0.751,0.789,0.776
https://doi.org/10.1272/jnms.80.438,left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma,42353_left posterior approach pancreaticoduodenectomy with total mesopancreas excision and circumferential lymphadenectomy around the superior mesenteric artery for pancreatic head carcinoma.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094380/pdf'],['Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094380/pdf'],['42353_0_extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094380/pdf'],['42353_0_extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.pdf'],[0.368],[0.517],[0.615],[0.165],[0.161],[0.128],[0.736],[0.642],[0.588],[0.657],[0.783],[0.709],[0.598],[0.914],[0.806],[0.734],[0.78],[0.761],0.368,0.517,0.615,0.165,0.161,0.128,0.736,0.642,0.588,0.657,0.783,0.709,0.598,0.914,0.806,0.734,0.78,0.761
https://doi.org/10.1272/jnms.82.21,comparison of pain and efficacy of darbepoetin alfa and epoetin beta pegol treatment in patients receiving peritoneal dialysis,42354_comparison of pain and efficacy of darbepoetin alfa and epoetin beta pegol treatment in patients receiving peritoneal dialysis.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483666/pdf'],['Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483666/pdf'],['42354_0_continuous erythropoiesis receptor activator cera for the anaemia of chronic kidney disease.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483666/pdf'],['42354_0_continuous erythropoiesis receptor activator cera for the anaemia of chronic kidney disease.pdf'],[0.39],[0.514],[0.6],[0.174],[0.171],[0.136],[0.738],[0.64],[0.572],[0.676],[0.779],[0.684],[0.597],[0.9],[0.804],[0.72],[0.775],[0.75],0.39,0.514,0.6,0.174,0.171,0.136,0.738,0.64,0.572,0.676,0.779,0.684,0.597,0.9,0.804,0.72,0.775,0.75
https://doi.org/10.1287/mnsc.2018.3093,algorithmic bias an empirical study of apparent genderbased discrimination in the display of stem career ads,42375_algorithmic bias an empirical study of apparent genderbased discrimination in the display of stem career ads.pdf,5,"['https://www.nber.org/papers/w29017', 'https://www.whitehouse.gov/cea/written-materials/2022/12/05/the-impact-of-artificial-intelligence/', 'https://www.whitehouse.gov/wp-content/uploads/2022/12/TTC-EC-CEA-AI-Report-12052022-1.pdf', 'https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1270-draft.pdf', 'https://www.nber.org/papers/w28882']","['Playlisting Favorites: Measuring Platform Bias in the Music Industry', 'The Impact of Artificial Intelligence on the Future of Workforces in the European Union and the United States of America', 'The Impact of Artificial Intelligence on the Future of Workforces in the European Union and the United States of America (CEA)', '(DOC/NIST) (Draft) A Proposal for Managing and Mitigating Bias in Artificial Intelligence', 'Biased Sampling of Early Users and the Direction of Startup Innovation']","['https://www.whitehouse.gov/wp-content/uploads/2022/12/TTC-EC-CEA-AI-Report-12052022-1.pdf', 'https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1270-draft.pdf']","['42375_2_the impact of artificial intelligence on the future of workforces in the european union and the united states of america cea.pdf', '42375_3_docnist draft a proposal for managing and mitigating bias in artificial intelligence.pdf']",2,40.0,"['https://www.whitehouse.gov/wp-content/uploads/2022/12/TTC-EC-CEA-AI-Report-12052022-1.pdf', 'https://nvlpubs.nist.gov/nistpubs/SpecialPublications/NIST.SP.1270-draft.pdf']","['42375_2_the impact of artificial intelligence on the future of workforces in the european union and the united states of america cea.pdf', '42375_3_docnist draft a proposal for managing and mitigating bias in artificial intelligence.pdf']","[0.174, 0.218]","[0.546, 0.551]","[0.643, 0.648]","[0.13, 0.143]","[0.133, 0.149]","[0.111, 0.125]","[0.716, 0.722]","[0.613, 0.627]","[0.618, 0.623]","[0.683, 0.7]","[0.811, 0.81]","[0.741, 0.741]","[0.656, 0.647]","[0.922, 0.924]","[0.849, 0.853]","[0.774, 0.781]","[0.816, 0.818]","[0.798, 0.802]",0.196,0.548,0.645,0.137,0.141,0.118,0.719,0.62,0.621,0.692,0.81,0.741,0.651,0.923,0.851,0.778,0.817,0.8
https://doi.org/10.1287/mnsc.46.2.186.11926,a theoretical extension of the technology acceptance model four longitudinal field studies,42378_a theoretical extension of the technology acceptance model four longitudinal field studies.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875623/pdf', 'https://mhcc.maryland.gov/mhcc/pages/hit/hit_telemedicine/documents/Telehealth_Brief_Reports_FINAL_031617.pdf', 'https://www.rand.org/pubs/research_reports/RR112.html']","['Attitudes of pediatric intensive care unit physicians towards the use of cognitive aids: a qualitative study', 'Remote Patient Monitoring Telehealth Grants', 'Patient Privacy, Consent, and Identity Management in Health Information Exchange: Issues for the Military Health System']","['https://mhcc.maryland.gov/mhcc/pages/hit/hit_telemedicine/documents/Telehealth_Brief_Reports_FINAL_031617.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875623/pdf']","['42378_1_remote patient monitoring telehealth grants.pdf', '42378_0_attitudes of pediatric intensive care unit physicians towards the use of cognitive aids a qualitative study.pdf']",2,66.67,"['https://mhcc.maryland.gov/mhcc/pages/hit/hit_telemedicine/documents/Telehealth_Brief_Reports_FINAL_031617.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875623/pdf']","['42378_1_remote patient monitoring telehealth grants.pdf', '42378_0_attitudes of pediatric intensive care unit physicians towards the use of cognitive aids a qualitative study.pdf']","[0.21, 0.153]","[0.527, 0.548]","[0.61, 0.632]","[0.114, 0.155]","[0.128, 0.162]","[0.104, 0.135]","[0.717, 0.728]","[0.619, 0.635]","[0.592, 0.604]","[0.666, 0.696]","[0.788, 0.794]","[0.721, 0.731]","[0.642, 0.636]","[0.921, 0.921]","[0.832, 0.84]","[0.759, 0.761]","[0.796, 0.799]","[0.77, 0.774]",0.181,0.538,0.621,0.135,0.145,0.119,0.722,0.627,0.598,0.681,0.791,0.726,0.639,0.921,0.836,0.76,0.798,0.772
https://doi.org/10.1287/orsc.14.1.69.12813,contextual confidence and active trust development in the chinese business environment,42382_contextual confidence and active trust development in the chinese business environment.pdf,1,['https://www.cna.org/CNA_files/PDF/DRM-2016-U-013349-Final.pdf'],['Social Networks in Crisis Response: Trust is Vital'],['https://www.cna.org/CNA_files/PDF/DRM-2016-U-013349-Final.pdf'],['42382_0_social networks in crisis response trust is vital.pdf'],1,100.0,['https://www.cna.org/CNA_files/PDF/DRM-2016-U-013349-Final.pdf'],['42382_0_social networks in crisis response trust is vital.pdf'],[0.215],[0.537],[0.624],[0.129],[0.127],[0.115],[0.716],[0.616],[0.614],[0.676],[0.811],[0.745],[0.661],[0.914],[0.857],[0.776],[0.812],[0.798],0.215,0.537,0.624,0.129,0.127,0.115,0.716,0.616,0.614,0.676,0.811,0.745,0.661,0.914,0.857,0.776,0.812,0.798
https://doi.org/10.1289/ehp.001081099,the association between caries and childhood lead exposure,42383_the association between caries and childhood lead exposure.pdf,6,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo144830', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://stacks.cdc.gov/view/cdc/78185', 'https://stacks.cdc.gov/view/cdc/37676']","['2015-Lead-Poisoning', 'Toxicological Profile for Lead, Draft for Public Comment', 'Toxicological profile for lead /', 'Toxicological profile for lead: draft for public comment.', 'Toxicological profile for lead : draft for public comment', 'Toxicological profile for lead']","['https://purl.fdlp.gov/GPO/gpo144830', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf']","['42383_2_toxicological profile for lead .pdf', '42383_1_toxicological profile for lead draft for public comment.pdf', '42383_3_toxicological profile for lead draft for public comment.pdf', '42383_0_2015leadpoisoning.pdf']",4,66.67,"['https://purl.fdlp.gov/GPO/gpo144830', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf']","['42383_2_toxicological profile for lead .pdf', '42383_1_toxicological profile for lead draft for public comment.pdf', '42383_3_toxicological profile for lead draft for public comment.pdf', '42383_0_2015leadpoisoning.pdf']","[0.577, 0.474, 0.491, 0.474]","[0.498, 0.504, 0.504, 0.508]","[0.593, 0.596, 0.596, 0.598]","[0.146, 0.145, 0.145, 0.148]","[0.149, 0.149, 0.149, 0.152]","[0.117, 0.116, 0.116, 0.12]","[0.734, 0.734, 0.734, 0.734]","[0.637, 0.636, 0.636, 0.636]","[0.558, 0.564, 0.564, 0.569]","[0.678, 0.677, 0.677, 0.677]","[0.782, 0.784, 0.784, 0.785]","[0.683, 0.688, 0.688, 0.692]","[0.619, 0.621, 0.621, 0.624]","[0.913, 0.913, 0.913, 0.914]","[0.793, 0.796, 0.796, 0.8]","[0.741, 0.743, 0.743, 0.746]","[0.774, 0.778, 0.778, 0.781]","[0.763, 0.765, 0.765, 0.767]",0.504,0.504,0.596,0.146,0.15,0.117,0.734,0.636,0.564,0.677,0.784,0.688,0.621,0.913,0.796,0.743,0.778,0.765
https://doi.org/10.1289/ehp.001081203,immunologic effects of background exposure to polychlorinated biphenyls and dioxins in dutch preschool children,42384_immunologic effects of background exposure to polychlorinated biphenyls and dioxins in dutch preschool children.pdf,5,"['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2004_08.pdf', 'https://www.congress.gov/event/107th-congress/senate-event/LC17875/text?s=1&r=15684', 'https://www3.epa.gov/hudson/Resp_Summ_Files/rsbk_2.pdf']","['DEVELOPMENT OF FISH CONTAMINANT GOALS AND ADVISORY TISSUE LEVELS (ATLs) FOR COMMON CONTAMINANTS IN CALIFORNIA SPORT FISH :', 'America’s children and the environment.', 'Draft Report', 'S.Hrg. 107-997 — PROTOCOL ON PERSISTENT ORGANIC POLLUTANTS (POPs) IMPLEMENTATION ACT', 'RESPONSIVENESS SUMMARY HUDSON RIVER PCBs SITE RECORD OF DECISION']","['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www3.epa.gov/hudson/Resp_Summ_Files/rsbk_2.pdf', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2004_08.pdf']","['42384_0_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '42384_1_americas children and the environment.pdf', '42384_4_responsiveness summary hudson river pcbs site record of decision.pdf', '42384_2_draft report.pdf']",4,80.0,"['https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www3.epa.gov/hudson/Resp_Summ_Files/rsbk_2.pdf', 'http://www.dhss.alaska.gov/dph/Epi/eph/Documents/bulletins/docs/rr2004_08.pdf']","['42384_0_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '42384_1_americas children and the environment.pdf', '42384_4_responsiveness summary hudson river pcbs site record of decision.pdf', '42384_2_draft report.pdf']","[0.226, 0.426, 0.419, 0.177]","[0.494, 0.519, 0.521, 0.512]","[0.59, 0.608, 0.605, 0.599]","[0.125, 0.142, 0.099, 0.137]","[0.121, 0.139, 0.086, 0.135]","[0.098, 0.109, 0.064, 0.107]","[0.732, 0.731, 0.718, 0.733]","[0.637, 0.636, 0.622, 0.639]","[0.561, 0.592, 0.607, 0.583]","[0.645, 0.655, 0.609, 0.641]","[0.778, 0.794, 0.801, 0.791]","[0.675, 0.703, 0.717, 0.693]","[0.618, 0.628, 0.644, 0.624]","[0.908, 0.909, 0.916, 0.908]","[0.796, 0.812, 0.819, 0.802]","[0.736, 0.759, 0.771, 0.754]","[0.774, 0.798, 0.807, 0.791]","[0.763, 0.783, 0.79, 0.777]",0.312,0.511,0.601,0.126,0.12,0.095,0.729,0.633,0.586,0.637,0.791,0.697,0.629,0.91,0.807,0.755,0.792,0.778
https://doi.org/10.1289/ehp.00108173,outdoor air pollution low birth weight and prematurity,42386_outdoor air pollution low birth weight and prematurity.pdf,10,"['https://www.congress.gov/event/116th-congress/house-event/110433', 'https://www.congress.gov/event/116th-congress/house-event/LC65539/text', 'https://papers.nber.org/papers/W10251', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf', 'https://www.mass.gov/doc/evaluation-of-health-outcome-data-in-northampton-and-easthampton-ma-and-among-neighborhoods-in/download', 'https://pacinst.org/publication/paying-with-our-health-the-real-cost-of-freight-transport-in-california/', 'https://oehha.ca.gov/media/downloads/proposition-65/chemicals/so2hid022511.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'https://ww2.arb.ca.gov/sites/default/files/barcu/board/books/2005/031705/start.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/reports/l3041.pdf']","['Creating a Climate Resilient America: Overcoming the Health Risks of the Climate Crisis', 'House Hearing, 116th Congress — CREATING A CLIMATE RESILIENT AMERICA: OVERCOMING THE HEALTH RISKS OF THE CLIMATE CRISIS', ""Air Pollution and Infant Health: What Can We Learn From California's Recent Experience"", 'Health: Adverse Birth Outcomes', 'Evaluation of Health Outcome Data in Northampton and Easthampton, MA and among Neighborhoods in Closest Proximity to the Northampton Regional Landfill', 'Paying With Our Health: The Real Cost of Freight Transport in California', 'Evidence on the Developmental and Reproductive Toxicity of Sulfur Dioxide', 'Preconception Care: A New Standard of Care within Maternal Health Services', 'Public Meeting Agenda', 'Report to the legislature: Indoor Air Pollution in California.']","['https://oehha.ca.gov/media/downloads/proposition-65/chemicals/so2hid022511.pdf', 'https://www.mass.gov/doc/evaluation-of-health-outcome-data-in-northampton-and-easthampton-ma-and-among-neighborhoods-in/download', 'https://ww2.arb.ca.gov/sites/default/files/barcu/board/books/2005/031705/start.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/reports/l3041.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf']","['42386_6_evidence on the developmental and reproductive toxicity of sulfur dioxide.pdf', '42386_4_evaluation of health outcome data in northampton and easthampton ma and among neighborhoods in closest proximity to the northampton regional landfill.pdf', '42386_8_public meeting agenda.pdf', '42386_3_health adverse birth outcomes.pdf', '42386_9_report to the legislature indoor air pollution in california.pdf', '42386_7_preconception care a new standard of care within maternal health services.pdf']",6,60.0,"['https://oehha.ca.gov/media/downloads/proposition-65/chemicals/so2hid022511.pdf', 'https://www.mass.gov/doc/evaluation-of-health-outcome-data-in-northampton-and-easthampton-ma-and-among-neighborhoods-in/download', 'https://ww2.arb.ca.gov/sites/default/files/barcu/board/books/2005/031705/start.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/reports/l3041.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf']","['42386_6_evidence on the developmental and reproductive toxicity of sulfur dioxide.pdf', '42386_4_evaluation of health outcome data in northampton and easthampton ma and among neighborhoods in closest proximity to the northampton regional landfill.pdf', '42386_8_public meeting agenda.pdf', '42386_3_health adverse birth outcomes.pdf', '42386_9_report to the legislature indoor air pollution in california.pdf', '42386_7_preconception care a new standard of care within maternal health services.pdf']","[0.565, 0.162, 0.61, 0.257, 0.303, 0.301]","[0.533, 0.527, 0.532, 0.514, 0.531, 0.487]","[0.618, 0.618, 0.615, 0.609, 0.616, 0.588]","[0.191, 0.155, 0.154, 0.213, 0.156, 0.151]","[0.198, 0.148, 0.151, 0.218, 0.153, 0.139]","[0.16, 0.107, 0.12, 0.174, 0.122, 0.13]","[0.736, 0.729, 0.725, 0.746, 0.725, 0.737]","[0.644, 0.631, 0.627, 0.656, 0.627, 0.643]","[0.591, 0.594, 0.604, 0.608, 0.602, 0.535]","[0.703, 0.676, 0.675, 0.706, 0.675, 0.684]","[0.792, 0.796, 0.802, 0.798, 0.801, 0.751]","[0.69, 0.706, 0.71, 0.7, 0.708, 0.617]","[0.646, 0.632, 0.643, 0.609, 0.642, 0.606]","[0.907, 0.91, 0.912, 0.909, 0.913, 0.898]","[0.806, 0.806, 0.818, 0.824, 0.817, 0.775]","[0.762, 0.761, 0.771, 0.759, 0.769, 0.714]","[0.786, 0.798, 0.803, 0.795, 0.802, 0.733]","[0.774, 0.783, 0.788, 0.775, 0.788, 0.731]",0.366,0.521,0.611,0.17,0.168,0.135,0.733,0.638,0.589,0.687,0.79,0.689,0.63,0.908,0.808,0.756,0.786,0.773
https://doi.org/10.1289/ehp.00108675,blue babies and nitratecontaminated well water,42388_blue babies and nitratecontaminated well water.pdf,9,"['https://health.hawaii.gov/wastewater/files/2015/09/OSDS_OAHU.pdf', 'https://pacinst.org/publication/human-costs-of-nitrate-contaminated-drinking-water-in-the-san-joaquin-valley/', 'https://www.congress.gov/event/115th-congress/house-event/LC63021/text', 'https://www.congress.gov/event/115th-congress/house-event/106603', 'https://stacks.cdc.gov/view/cdc/5216', 'https://pfbc.pa.gov/promo/grants/sinn/SinnemahoningCkConservationPlan.pdf', 'https://purl.fdlp.gov/GPO/gpo116148', 'https://health.hawaii.gov/wastewater/files/2018/02/Upcountry_report.pdf', 'https://health.hawaii.gov/wastewater/files/2015/09/OSDS_NI.pdf']","['Microsoft Word - OSDS_Report_Final-Draft.doc', 'The Human Costs of Nitrate-Contaminated Drinking Water in the San Joaquin Valley', 'House Hearing, 115th Congress — H.R., THE FARM REGULATORY CERTAINTY ACT', 'H.R.___, Farm Regulatory Certainty Act', 'Nitrate/nitrite toxicity', 'Sinnemahoning Creek Watershed Conservation Plan', 'H.R. _____, the Farm Regulatory Certainty Act :\xa0hearing before the Subcommittee on Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, November 9, 2017.', 'Upcountry Maui NO3 Investigation Report', 'FINAL']","['https://health.hawaii.gov/wastewater/files/2015/09/OSDS_OAHU.pdf', 'https://health.hawaii.gov/wastewater/files/2015/09/OSDS_NI.pdf', 'https://health.hawaii.gov/wastewater/files/2018/02/Upcountry_report.pdf']","['42388_0_microsoft word  osdsreportfinaldraftdoc.pdf', '42388_8_final.pdf', '42388_7_upcountry maui no3 investigation report.pdf']",3,33.33,"['https://health.hawaii.gov/wastewater/files/2015/09/OSDS_OAHU.pdf', 'https://health.hawaii.gov/wastewater/files/2015/09/OSDS_NI.pdf', 'https://health.hawaii.gov/wastewater/files/2018/02/Upcountry_report.pdf']","['42388_0_microsoft word  osdsreportfinaldraftdoc.pdf', '42388_8_final.pdf', '42388_7_upcountry maui no3 investigation report.pdf']","[0.236, 0.372, 0.23]","[0.498, 0.535, 0.537]","[0.58, 0.61, 0.614]","[0.091, 0.108, 0.143]","[0.095, 0.111, 0.148]","[0.069, 0.082, 0.12]","[0.72, 0.716, 0.725]","[0.617, 0.615, 0.628]","[0.568, 0.617, 0.615]","[0.617, 0.612, 0.619]","[0.774, 0.813, 0.813]","[0.703, 0.742, 0.739]","[0.633, 0.662, 0.661]","[0.902, 0.917, 0.91]","[0.814, 0.826, 0.824]","[0.754, 0.783, 0.781]","[0.781, 0.819, 0.818]","[0.76, 0.799, 0.795]",0.279,0.523,0.601,0.114,0.118,0.09,0.72,0.62,0.6,0.616,0.8,0.728,0.652,0.91,0.821,0.773,0.806,0.785
https://doi.org/10.1289/ehp.00108887,semen quality and reproductive health of young czech men exposed to seasonal air pollution,42391_semen quality and reproductive health of young czech men exposed to seasonal air pollution.pdf,3,"['https://fortress.wa.gov/ecy/publications/publications/0602022.pdf', 'https://oehha.ca.gov/media/downloads/proposition-65/chemicals/so2hid022511.pdf', 'https://ww2.arb.ca.gov/sites/default/files/2020-11/16rd005.pdf']","['Diesel Emission Reduction Strategy for Washington State', 'Evidence on the Developmental and Reproductive Toxicity of Sulfur Dioxide', ""Women's Cardiovascular Risk from PM Exposure: A Laboratory-based Toxicology Study Using a Sensitive Animal Model""]","['https://ww2.arb.ca.gov/sites/default/files/2020-11/16rd005.pdf', 'https://oehha.ca.gov/media/downloads/proposition-65/chemicals/so2hid022511.pdf', 'https://fortress.wa.gov/ecy/publications/publications/0602022.pdf']","['42391_2_womens cardiovascular risk from pm exposure a laboratorybased toxicology study using a sensitive animal model.pdf', '42391_1_evidence on the developmental and reproductive toxicity of sulfur dioxide.pdf', '42391_0_diesel emission reduction strategy for washington state.pdf']",3,100.0,"['https://ww2.arb.ca.gov/sites/default/files/2020-11/16rd005.pdf', 'https://oehha.ca.gov/media/downloads/proposition-65/chemicals/so2hid022511.pdf', 'https://fortress.wa.gov/ecy/publications/publications/0602022.pdf']","['42391_2_womens cardiovascular risk from pm exposure a laboratorybased toxicology study using a sensitive animal model.pdf', '42391_1_evidence on the developmental and reproductive toxicity of sulfur dioxide.pdf', '42391_0_diesel emission reduction strategy for washington state.pdf']","[0.14, 0.484, 0.296]","[0.539, 0.529, 0.514]","[0.62, 0.611, 0.597]","[0.147, 0.165, 0.097]","[0.139, 0.162, 0.101]","[0.108, 0.13, 0.077]","[0.73, 0.729, 0.717]","[0.633, 0.633, 0.616]","[0.613, 0.593, 0.598]","[0.66, 0.684, 0.633]","[0.797, 0.789, 0.797]","[0.735, 0.713, 0.736]","[0.644, 0.645, 0.637]","[0.917, 0.914, 0.924]","[0.819, 0.809, 0.822]","[0.771, 0.762, 0.768]","[0.8, 0.787, 0.802]","[0.785, 0.775, 0.783]",0.307,0.527,0.609,0.136,0.134,0.105,0.725,0.627,0.601,0.659,0.794,0.728,0.642,0.918,0.817,0.767,0.796,0.781
https://doi.org/10.1289/ehp.00108895,identification of phthalate esters in the serum of young puerto rican girls with premature breast development,42392_identification of phthalate esters in the serum of young puerto rican girls with premature breast development.pdf,5,"['https://www.federalregister.gov/documents/2012/03/28/2012-7208/benzidine-based-chemical-substances-di-n', 'https://www.federalregister.gov/documents/2017/10/27/2017-23267/prohibition-of-childrens-toys-and-child-care-articles-containing-specified-phthalates', 'https://purl.fdlp.gov/GPO/gpo87759', 'https://www.congress.gov/event/110th-congress/senate-event/LC9690/text?s=1&r=14323', 'https://stacks.cdc.gov/view/cdc/6532']","['Benzidine-Based Chemical Substances; Di-n', ""Prohibition of Children's Toys and Child Care Articles Containing Specified Phthalates"", 'An integrated environmental assessment of the St. Thomas East End Reserves (STEER) /', 'S.Hrg. 110-1186 — PLASTIC ADDITIVES IN CONSUMER PRODUCTS', 'Toxicological profile for di-n-butyl phthalate']",['https://purl.fdlp.gov/GPO/gpo87759'],['42392_2_an integrated environmental assessment of the st thomas east end reserves steer .pdf'],1,20.0,['https://purl.fdlp.gov/GPO/gpo87759'],['42392_2_an integrated environmental assessment of the st thomas east end reserves steer .pdf'],[0.213],[0.525],[0.596],[0.127],[0.114],[0.089],[0.73],[0.633],[0.598],[0.633],[0.801],[0.721],[0.648],[0.908],[0.817],[0.766],[0.803],[0.784],0.213,0.525,0.596,0.127,0.114,0.089,0.73,0.633,0.598,0.633,0.801,0.721,0.648,0.908,0.817,0.766,0.803,0.784
https://doi.org/10.1289/ehp.00108979,levels of seven urinary phthalate metabolites in a human reference population,42393_levels of seven urinary phthalate metabolites in a human reference population.pdf,7,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://stacks.cdc.gov/view/cdc/21813', 'https://stacks.cdc.gov/view/cdc/21808', 'https://stacks.cdc.gov/view/cdc/26593', 'https://stacks.cdc.gov/view/cdc/21811', 'https://stacks.cdc.gov/view/cdc/21806', 'https://www.congress.gov/event/110th-congress/senate-event/LC9690/text?s=1&r=14323']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'Fourth national report on human exposure to environmental chemicals', 'Third national report on human exposure to environmental chemicals', 'Centers for Disease Control and Prevention standards for nationally consistent data and measures within the Environmental Public Health Tracking Network. Version 3.0', 'Third national report on human exposure to environmental chemicals [revised]', 'Second national report on human exposure to environmental chemicals', 'S.Hrg. 110-1186 — PLASTIC ADDITIVES IN CONSUMER PRODUCTS']",['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705'],['42393_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf'],1,14.29,['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705'],['42393_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf'],[0.289],[0.525],[0.613],[0.139],[0.151],[0.103],[0.73],[0.635],[0.606],[0.646],[0.808],[0.72],[0.627],[0.916],[0.81],[0.767],[0.802],[0.79],0.289,0.525,0.613,0.139,0.151,0.103,0.73,0.635,0.606,0.646,0.808,0.72,0.627,0.916,0.81,0.767,0.802,0.79
https://doi.org/10.1289/ehp.00108s113,mechanisms underlying childrens susceptibility to environmental toxicants,42394_mechanisms underlying childrens susceptibility to environmental toxicants.pdf,6,"['https://stacks.cdc.gov/view/cdc/120137', 'https://stacks.cdc.gov/view/cdc/120136', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.congress.gov/event/109th-congress/senate-event/LC10822/text', 'https://www.hrw.org/report/2015/12/09/teens-tobacco-fields/child-labor-united-states-tobacco-farming', 'https://www.hrw.org/report/2017/12/01/if-youre-inhaling-your-death/health-risks-burning-waste-lebanon']","['Technical documentation for the Environmental Justice Index 2022', 'Environmental Justice Index indicators', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'S.Hrg. 109-1078 — TOXIC SUBSTANCES CONTROL ACT AND THE CHEMICALS MANAGEMENT PROGRAM AT EPA', 'Child Labor in United States Tobacco Farming', 'The Health Risks of Burning Waste in Lebanon']",['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf'],['42394_2_recognition and management of pesticide poisonings sixth edition 2013.pdf'],1,16.67,['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf'],['42394_2_recognition and management of pesticide poisonings sixth edition 2013.pdf'],[0.463],[0.568],[0.649],[0.158],[0.167],[0.131],[0.738],[0.636],[0.65],[0.627],[0.825],[0.766],[0.65],[0.929],[0.842],[0.796],[0.832],[0.814],0.463,0.568,0.649,0.158,0.167,0.131,0.738,0.636,0.65,0.627,0.825,0.766,0.65,0.929,0.842,0.796,0.832,0.814
https://doi.org/10.1289/ehp.00108s2215,mutagenicity of trichloroethylene and its metabolites implications for the risk assessment of trichloroethylene,42395_mutagenicity of trichloroethylene and its metabolites implications for the risk assessment of trichloroethylene.pdf,5,"['https://ntp.niehs.nih.gov/ntp/roc/monographs/finaltce_508.pdf', 'https://stacks.cdc.gov/view/cdc/11696', 'https://stacks.cdc.gov/view/cdc/7001', 'https://www.epa.gov/sites/default/files/2014-03/documents/naphthalene_toxicology_profile_tp67_3v.pdf', 'https://stacks.cdc.gov/view/cdc/5215']","['Trichloroethylene (TCE)', 'Trichloroethylene toxicity', 'Toxicological profile for naphthalene, 1-methylnaphthalene, and 2-methylnaphthalene', 'Toxicological Profile For Naphthalene, 1-methylnaphthalene, And 2-methylnaphthalene', 'Trichloroethylene toxicity']","['https://ntp.niehs.nih.gov/ntp/roc/monographs/finaltce_508.pdf', 'https://www.epa.gov/sites/default/files/2014-03/documents/naphthalene_toxicology_profile_tp67_3v.pdf']","['42395_0_trichloroethylene tce.pdf', '42395_3_toxicological profile for naphthalene 1methylnaphthalene and 2methylnaphthalene.pdf']",2,40.0,"['https://ntp.niehs.nih.gov/ntp/roc/monographs/finaltce_508.pdf', 'https://www.epa.gov/sites/default/files/2014-03/documents/naphthalene_toxicology_profile_tp67_3v.pdf']","['42395_0_trichloroethylene tce.pdf', '42395_3_toxicological profile for naphthalene 1methylnaphthalene and 2methylnaphthalene.pdf']","[0.439, 0.295]","[0.551, 0.548]","[0.647, 0.637]","[0.173, 0.15]","[0.193, 0.171]","[0.13, 0.12]","[0.742, 0.738]","[0.657, 0.647]","[0.621, 0.627]","[0.688, 0.665]","[0.813, 0.814]","[0.73, 0.728]","[0.641, 0.645]","[0.916, 0.916]","[0.826, 0.829]","[0.777, 0.777]","[0.806, 0.813]","[0.791, 0.799]",0.367,0.55,0.642,0.161,0.182,0.125,0.74,0.652,0.624,0.676,0.813,0.729,0.643,0.916,0.827,0.777,0.809,0.795
https://doi.org/10.1289/ehp.00108s3405,parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys,42396_parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys.pdf,3,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://stacks.cdc.gov/view/cdc/6480', 'https://stacks.cdc.gov/view/cdc/6419']","['America’s children and the environment.', 'Toxicological profile for polychlorinated biphenyls (PCBs)', 'Toxicological profile for methylene chloride']",['https://purl.fdlp.gov/GPO/gpo63641'],['42396_0_americas children and the environment.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo63641'],['42396_0_americas children and the environment.pdf'],[0.307],[0.517],[0.602],[0.12],[0.116],[0.089],[0.725],[0.627],[0.591],[0.663],[0.793],[0.724],[0.626],[0.914],[0.815],[0.757],[0.8],[0.78],0.307,0.517,0.602,0.12,0.116,0.089,0.725,0.627,0.591,0.663,0.793,0.724,0.626,0.914,0.815,0.757,0.8,0.78
https://doi.org/10.1289/ehp.00108s3451,identifying critical windows of exposure for childrens health,42398_identifying critical windows of exposure for childrens health.pdf,4,"['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.capitol.hawaii.gov/Session2015/Testimony/HB1514_TESTIMONY_EEP_02-05-15_.PDF', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.capitol.hawaii.gov/Session2015/Testimony/HB1514_HD1_TESTIMONY_AGR_02-19-15_.PDF']","['Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Before The House Committee On And Energy And Environmental Protection', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic Effects', 'Testimony Of Scott E. Enright Chairperson, Board Of Agriculture']","['https://www.capitol.hawaii.gov/Session2015/Testimony/HB1514_HD1_TESTIMONY_AGR_02-19-15_.PDF', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.capitol.hawaii.gov/Session2015/Testimony/HB1514_TESTIMONY_EEP_02-05-15_.PDF']","['42398_3_testimony of scott e enright chairperson board of agriculture.pdf', '42398_2_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42398_0_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42398_1_before the house committee on and energy and environmental protection.pdf']",4,100.0,"['https://www.capitol.hawaii.gov/Session2015/Testimony/HB1514_HD1_TESTIMONY_AGR_02-19-15_.PDF', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.capitol.hawaii.gov/Session2015/Testimony/HB1514_TESTIMONY_EEP_02-05-15_.PDF']","['42398_3_testimony of scott e enright chairperson board of agriculture.pdf', '42398_2_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42398_0_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42398_1_before the house committee on and energy and environmental protection.pdf']","[0.375, 0.161, 0.53, 0.194]","[0.563, 0.562, 0.553, 0.558]","[0.633, 0.639, 0.63, 0.63]","[0.149, 0.186, 0.148, 0.154]","[0.166, 0.192, 0.152, 0.171]","[0.138, 0.151, 0.12, 0.142]","[0.723, 0.745, 0.734, 0.721]","[0.625, 0.648, 0.632, 0.62]","[0.642, 0.625, 0.627, 0.639]","[0.633, 0.678, 0.635, 0.64]","[0.826, 0.816, 0.816, 0.825]","[0.77, 0.746, 0.745, 0.77]","[0.65, 0.63, 0.634, 0.644]","[0.92, 0.925, 0.926, 0.916]","[0.867, 0.838, 0.843, 0.869]","[0.795, 0.78, 0.782, 0.794]","[0.831, 0.818, 0.819, 0.83]","[0.812, 0.802, 0.804, 0.81]",0.315,0.559,0.633,0.159,0.17,0.138,0.731,0.631,0.633,0.646,0.821,0.758,0.64,0.922,0.854,0.788,0.825,0.807
https://doi.org/10.1289/ehp.00108s3535,workshop to identify critical windows of exposure for childrens health neurobehavioral work group summary,42400_workshop to identify critical windows of exposure for childrens health neurobehavioral work group summary.pdf,4,"['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'http://purl.fdlp.gov/GPO/LPS96949', 'https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'https://oehha.ca.gov/media/downloads/advisories/tomalesbayguidef.pdf']","['Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Final report :\xa0Workshop to Develop a Framework for Assessing Risks to Children from Exposures to Environmental Agents.', 'DEVELOPMENT OF FISH CONTAMINANT GOALS AND ADVISORY TISSUE LEVELS (ATLs) FOR COMMON CONTAMINANTS IN CALIFORNIA SPORT FISH :', 'Health Advisory Guidelines for Consumption of Fish and Shellfish from Tomales Bay (Marin County)']","['https://oehha.ca.gov/media/downloads/advisories/tomalesbayguidef.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'http://purl.fdlp.gov/GPO/LPS96949']","['42400_3_health advisory guidelines for consumption of fish and shellfish from tomales bay marin county.pdf', '42400_0_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42400_2_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '42400_1_final report \xa0workshop to develop a framework for assessing risks to children from exposures to environmental agents.pdf']",4,100.0,"['https://oehha.ca.gov/media/downloads/advisories/tomalesbayguidef.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://oehha.ca.gov/media/downloads/fish/report/atlmhgandothers2008c.pdf', 'http://purl.fdlp.gov/GPO/LPS96949']","['42400_3_health advisory guidelines for consumption of fish and shellfish from tomales bay marin county.pdf', '42400_0_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42400_2_development of fish contaminant goals and advisory tissue levels atls for common contaminants in california sport fish .pdf', '42400_1_final report \xa0workshop to develop a framework for assessing risks to children from exposures to environmental agents.pdf']","[0.366, 0.594, 0.286, 0.204]","[0.527, 0.553, 0.495, 0.592]","[0.618, 0.641, 0.602, 0.673]","[0.114, 0.142, 0.126, 0.183]","[0.126, 0.147, 0.127, 0.187]","[0.085, 0.11, 0.095, 0.145]","[0.72, 0.732, 0.729, 0.743]","[0.628, 0.633, 0.636, 0.651]","[0.618, 0.642, 0.564, 0.665]","[0.646, 0.623, 0.665, 0.672]","[0.81, 0.823, 0.784, 0.829]","[0.748, 0.762, 0.696, 0.776]","[0.647, 0.641, 0.626, 0.663]","[0.923, 0.931, 0.913, 0.931]","[0.836, 0.84, 0.812, 0.855]","[0.775, 0.792, 0.743, 0.803]","[0.817, 0.826, 0.782, 0.836]","[0.799, 0.811, 0.77, 0.823]",0.362,0.542,0.633,0.141,0.147,0.109,0.731,0.637,0.622,0.652,0.811,0.746,0.644,0.925,0.836,0.778,0.815,0.801
https://doi.org/10.1289/ehp.00108s3573,critical windows of exposure for childrens health cancer in human epidemiological studies and neoplasms in experimental animal models,42401_critical windows of exposure for childrens health cancer in human epidemiological studies and neoplasms in experimental animal models.pdf,6,"['https://stacks.cdc.gov/view/cdc/115424', 'https://www.health.pa.gov/topics/Documents/Environmental%20Health/Ewings%20Tumors%20SW%204%20Counties.pdf', 'https://www.epa.gov/sites/default/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf', 'https://stacks.cdc.gov/view/cdc/11657', 'http://purl.fdlp.gov/GPO/LPS96949', 'https://oehha.ca.gov/media/downloads/crnr/appendixjearly.pdf']","['Toxicological profile for n-nitrosodimethylamine (NDMA) : draft for public comment', ""Ewing's Sarcoma Report"", 'Guidelines for Carcinogen Risk Assessment', 'Taking a pediatric exposure history', 'Final report :\xa0Workshop to Develop a Framework for Assessing Risks to Children from Exposures to Environmental Agents.', 'In Utero']","['https://www.health.pa.gov/topics/Documents/Environmental%20Health/Ewings%20Tumors%20SW%204%20Counties.pdf', 'https://oehha.ca.gov/media/downloads/crnr/appendixjearly.pdf', 'http://purl.fdlp.gov/GPO/LPS96949', 'https://www.epa.gov/sites/default/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf']","['42401_1_ewings sarcoma report.pdf', '42401_5_in utero.pdf', '42401_4_final report \xa0workshop to develop a framework for assessing risks to children from exposures to environmental agents.pdf', '42401_2_guidelines for carcinogen risk assessment.pdf']",4,66.67,"['https://www.health.pa.gov/topics/Documents/Environmental%20Health/Ewings%20Tumors%20SW%204%20Counties.pdf', 'https://oehha.ca.gov/media/downloads/crnr/appendixjearly.pdf', 'http://purl.fdlp.gov/GPO/LPS96949', 'https://www.epa.gov/sites/default/files/2013-09/documents/cancer_guidelines_final_3-25-05.pdf']","['42401_1_ewings sarcoma report.pdf', '42401_5_in utero.pdf', '42401_4_final report \xa0workshop to develop a framework for assessing risks to children from exposures to environmental agents.pdf', '42401_2_guidelines for carcinogen risk assessment.pdf']","[0.285, 0.368, 0.394, 0.325]","[0.528, 0.542, 0.564, 0.562]","[0.613, 0.628, 0.644, 0.644]","[0.163, 0.159, 0.152, 0.156]","[0.177, 0.175, 0.156, 0.169]","[0.146, 0.133, 0.117, 0.125]","[0.741, 0.746, 0.741, 0.741]","[0.649, 0.655, 0.646, 0.649]","[0.598, 0.614, 0.636, 0.634]","[0.688, 0.686, 0.657, 0.681]","[0.782, 0.796, 0.813, 0.807]","[0.727, 0.732, 0.751, 0.749]","[0.63, 0.642, 0.641, 0.643]","[0.913, 0.916, 0.924, 0.926]","[0.822, 0.832, 0.842, 0.842]","[0.758, 0.774, 0.786, 0.786]","[0.784, 0.799, 0.818, 0.814]","[0.771, 0.791, 0.804, 0.801]",0.343,0.549,0.632,0.158,0.169,0.13,0.742,0.65,0.62,0.678,0.799,0.74,0.639,0.92,0.835,0.776,0.804,0.792
https://doi.org/10.1289/ehp.00108s4643,environmental tobacco smoke indoor allergens and childhood asthma,42402_environmental tobacco smoke indoor allergens and childhood asthma.pdf,3,"['http://www.floridahealth.gov/diseases-and-conditions/asthma/_documents/burden-report2009.pdf', 'https://www.columbus.gov/uploadedFiles/Columbus/Departments/Public_Health/All_Programs/Health_Equity/Overcoming%20Obstacles%20to%20Health.pdf', 'https://stacks.cdc.gov/view/cdc/5791']","['Burden of Asthma', 'Overcoming Obstacles to Health', 'Catching your breath; strategies to reduce environmental factors that contribute to asthma in children']",['http://www.floridahealth.gov/diseases-and-conditions/asthma/_documents/burden-report2009.pdf'],['42402_0_burden of asthma.pdf'],1,33.33,['http://www.floridahealth.gov/diseases-and-conditions/asthma/_documents/burden-report2009.pdf'],['42402_0_burden of asthma.pdf'],[0.357],[0.547],[0.626],[0.202],[0.213],[0.185],[0.748],[0.649],[0.606],[0.678],[0.806],[0.734],[0.631],[0.925],[0.834],[0.76],[0.803],[0.791],0.357,0.547,0.626,0.202,0.213,0.185,0.748,0.649,0.606,0.678,0.806,0.734,0.631,0.925,0.834,0.76,0.803,0.791
https://doi.org/10.1289/ehp.02110319,childhood cancer and agricultural pesticide use an ecologic study in california,42424_childhood cancer and agricultural pesticide use an ecologic study in california.pdf,5,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch9_otherinsecticides.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://files.nc.gov/ncdeq/GenX/SAB/Methyl-Bromide-AAL-public-comments-SELC-attachments.pdf']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 9 Other Insecticides', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic Effects', 'Attachment 1']","['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch9_otherinsecticides.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://files.nc.gov/ncdeq/GenX/SAB/Methyl-Bromide-AAL-public-comments-SELC-attachments.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf']","['42424_1_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42424_2_recognition and management of pesticide poisonings sixth edition 2013 chapter 9 other insecticides.pdf', '42424_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42424_4_attachment 1.pdf', '42424_3_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf']",5,100.0,"['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch9_otherinsecticides.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://files.nc.gov/ncdeq/GenX/SAB/Methyl-Bromide-AAL-public-comments-SELC-attachments.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf']","['42424_1_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42424_2_recognition and management of pesticide poisonings sixth edition 2013 chapter 9 other insecticides.pdf', '42424_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42424_4_attachment 1.pdf', '42424_3_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf']","[0.629, 0.387, 0.154, 0.591, 0.202]","[0.529, 0.521, 0.527, 0.519, 0.54]","[0.618, 0.61, 0.619, 0.612, 0.627]","[0.144, 0.131, 0.166, 0.124, 0.185]","[0.157, 0.139, 0.177, 0.129, 0.205]","[0.117, 0.105, 0.138, 0.1, 0.155]","[0.73, 0.724, 0.735, 0.726, 0.742]","[0.629, 0.623, 0.641, 0.628, 0.648]","[0.609, 0.605, 0.598, 0.596, 0.61]","[0.633, 0.621, 0.669, 0.644, 0.676]","[0.808, 0.804, 0.8, 0.795, 0.81]","[0.736, 0.734, 0.721, 0.722, 0.739]","[0.629, 0.626, 0.63, 0.637, 0.629]","[0.926, 0.924, 0.919, 0.922, 0.925]","[0.825, 0.813, 0.822, 0.822, 0.822]","[0.77, 0.765, 0.759, 0.764, 0.769]","[0.805, 0.801, 0.795, 0.795, 0.804]","[0.792, 0.786, 0.782, 0.783, 0.791]",0.393,0.527,0.617,0.15,0.161,0.123,0.731,0.634,0.604,0.649,0.803,0.73,0.63,0.923,0.821,0.765,0.8,0.787
https://doi.org/10.1289/ehp.02110575,the influence of ambient coarse particulate matter on asthma hospitalization in children casecrossover and timeseries analyses,42428_the influence of ambient coarse particulate matter on asthma hospitalization in children casecrossover and timeseries analyses.pdf,8,"['https://www.federalregister.gov/documents/2006/10/17/06-8477/national-ambient-air-quality-standards-for-particulate-matter', 'https://www.energy.ca.gov/sites/default/files/2019-11/Statewide%20Reports-%20SUM-CCCA4-2018-012%20ClimateJusticeSummary_ADA.pdf', 'https://pacinst.org/publication/study-maps-social-vulnerability-to-climate-change-in-california-and-identifies-need-for-adaptation-planning/', 'https://phpa.health.maryland.gov/OEHFP/EH/Shared%20Documents/Marcellus%20Shale/MDMarcellusShalePublicHealthFinalReport08.15.2014.pdf?Mobile=1&Source=%2FOEHFP%2FEH%2F_layouts%2Fmobile%2Fview.aspx%3FList%3Db0da7e96%252D4e9e%252D4178%252D92a7%252D136a2256a896%26View%3D6a27ee6f%252D8271%252D4e22%252D823c%252D8c0d04ae5698%26RootFolder%3D%252FOEHFP%252FEH%252FShared%2520Documents%252FMarcellus%2520Shale%26CurrentPage%3D1', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/020000/020470/unrestricted/20141565e.pdf', 'https://www.congress.gov/event/116th-congress/house-event/110157', 'https://papers.nber.org/papers/w12106', 'https://www3.epa.gov/ttnamti1/files/ambient/pm25/pt5006.pdf']","['National Ambient Air Quality Standards for Particulate Matter', 'Climate Justice Report', 'Social Vulnerability to Climate Change in California', 'Potential Public Health Impacts of Natural Gas Development and Production in the Marcellus Shale in Western Maryland', 'July 2014', 'Trump’s Wrong Turn on Clean Cars: The Effects of Fuel Efficiency Rollbacks on the Climate, Car Companies and California', 'Migration and Hedonic Valuation: The Case of Air Quality', 'Tuesday, October 17, 2006']","['https://www.energy.ca.gov/sites/default/files/2019-11/Statewide%20Reports-%20SUM-CCCA4-2018-012%20ClimateJusticeSummary_ADA.pdf', 'https://www3.epa.gov/ttnamti1/files/ambient/pm25/pt5006.pdf', 'https://phpa.health.maryland.gov/OEHFP/EH/Shared%20Documents/Marcellus%20Shale/MDMarcellusShalePublicHealthFinalReport08.15.2014.pdf?Mobile=1&Source=%2FOEHFP%2FEH%2F_layouts%2Fmobile%2Fview.aspx%3FList%3Db0da7e96%252D4e9e%252D4178%252D92a7%252D136a2256a896%26View%3D6a27ee6f%252D8271%252D4e22%252D823c%252D8c0d04ae5698%26RootFolder%3D%252FOEHFP%252FEH%252FShared%2520Documents%252FMarcellus%2520Shale%26CurrentPage%3D1', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/020000/020470/unrestricted/20141565e.pdf']","['42428_1_climate justice report.pdf', '42428_7_tuesday october 17 2006.pdf', '42428_3_potential public health impacts of natural gas development and production in the marcellus shale in western maryland.pdf', '42428_4_july 2014.pdf']",4,50.0,"['https://www.energy.ca.gov/sites/default/files/2019-11/Statewide%20Reports-%20SUM-CCCA4-2018-012%20ClimateJusticeSummary_ADA.pdf', 'https://www3.epa.gov/ttnamti1/files/ambient/pm25/pt5006.pdf', 'https://phpa.health.maryland.gov/OEHFP/EH/Shared%20Documents/Marcellus%20Shale/MDMarcellusShalePublicHealthFinalReport08.15.2014.pdf?Mobile=1&Source=%2FOEHFP%2FEH%2F_layouts%2Fmobile%2Fview.aspx%3FList%3Db0da7e96%252D4e9e%252D4178%252D92a7%252D136a2256a896%26View%3D6a27ee6f%252D8271%252D4e22%252D823c%252D8c0d04ae5698%26RootFolder%3D%252FOEHFP%252FEH%252FShared%2520Documents%252FMarcellus%2520Shale%26CurrentPage%3D1', 'https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/020000/020470/unrestricted/20141565e.pdf']","['42428_1_climate justice report.pdf', '42428_7_tuesday october 17 2006.pdf', '42428_3_potential public health impacts of natural gas development and production in the marcellus shale in western maryland.pdf', '42428_4_july 2014.pdf']","[0.114, 0.292, 0.292, 0.477]","[0.52, 0.543, 0.536, 0.536]","[0.603, 0.618, 0.613, 0.613]","[0.117, 0.168, 0.139, 0.139]","[0.119, 0.18, 0.142, 0.142]","[0.092, 0.151, 0.106, 0.106]","[0.722, 0.73, 0.724, 0.724]","[0.621, 0.637, 0.625, 0.625]","[0.586, 0.602, 0.604, 0.604]","[0.673, 0.719, 0.674, 0.674]","[0.801, 0.794, 0.801, 0.801]","[0.711, 0.721, 0.731, 0.731]","[0.633, 0.659, 0.65, 0.65]","[0.908, 0.914, 0.917, 0.917]","[0.812, 0.82, 0.817, 0.817]","[0.758, 0.771, 0.773, 0.773]","[0.805, 0.802, 0.811, 0.811]","[0.783, 0.784, 0.789, 0.789]",0.294,0.534,0.612,0.141,0.146,0.114,0.725,0.627,0.599,0.685,0.799,0.723,0.648,0.914,0.817,0.769,0.807,0.786
https://doi.org/10.1289/ehp.02110601,the exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth,42429_the exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth.pdf,5,"['https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf', 'https://ww2.arb.ca.gov/sites/default/files/barcu/regact/ets2006/app3partc.pdf', 'https://www.ncbi.nlm.nih.gov/books/n/surgsmokcess/', 'https://purl.fdlp.gov/GPO/gpo132839', 'https://stacks.cdc.gov/view/cdc/84557']","['Chapter 1 Introduction, Conclusions, and the Evolving Landscape of Smoking Cessation', 'Part C Table of Contents', 'Smoking Cessation', 'Smoking cessation: a report of the Surgeon General.', 'Smoking cessation : a report of the Surgeon General']","['https://purl.fdlp.gov/GPO/gpo132839', 'https://ww2.arb.ca.gov/sites/default/files/barcu/regact/ets2006/app3partc.pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['42429_3_smoking cessation a report of the surgeon general.pdf', '42429_1_part c table of contents.pdf', '42429_0_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']",3,60.0,"['https://purl.fdlp.gov/GPO/gpo132839', 'https://ww2.arb.ca.gov/sites/default/files/barcu/regact/ets2006/app3partc.pdf', 'https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf']","['42429_3_smoking cessation a report of the surgeon general.pdf', '42429_1_part c table of contents.pdf', '42429_0_chapter 1 introduction conclusions and the evolving landscape of smoking cessation.pdf']","[0.439, 0.475, 0.439]","[0.534, 0.56, 0.534]","[0.614, 0.626, 0.614]","[0.182, 0.2, 0.182]","[0.184, 0.203, 0.184]","[0.157, 0.163, 0.157]","[0.739, 0.735, 0.739]","[0.645, 0.642, 0.645]","[0.599, 0.623, 0.599]","[0.683, 0.702, 0.683]","[0.801, 0.807, 0.801]","[0.716, 0.746, 0.716]","[0.632, 0.655, 0.632]","[0.913, 0.912, 0.913]","[0.822, 0.839, 0.822]","[0.76, 0.776, 0.76]","[0.795, 0.809, 0.795]","[0.78, 0.791, 0.78]",0.451,0.543,0.618,0.188,0.19,0.159,0.738,0.644,0.607,0.689,0.803,0.726,0.64,0.913,0.828,0.765,0.8,0.784
https://doi.org/10.1289/ehp.02110655,apartment residents and day care workers exposures to tetrachloroethylene and deficits in visual contrast sensitivity,42430_apartment residents and day care workers exposures to tetrachloroethylene and deficits in visual contrast sensitivity.pdf,9,"['https://purl.fdlp.gov/GPO/gpo132702', 'https://fortress.wa.gov/ecy/publications/documents/0907014.pdf', 'https://stacks.cdc.gov/view/cdc/26478', 'https://stacks.cdc.gov/view/cdc/79529', 'https://www.epa.gov/sites/default/files/2015-06/documents/riskassessment_dry_cleaners.pdf', 'http://www.vdh.virginia.gov/content/uploads/sites/12/2016/01/Henrico_Sandston_9-30-2015-revised.pdf', 'https://purl.fdlp.gov/GPO/gpo91500', 'https://stacks.cdc.gov/view/cdc/48568', 'https://oag.ca.gov/system/files/attachments/press-docs/Mutistate%20Comments%20on%20Draft%20TSCA%20Risk%20Evaluation%20for%20Perc.pdf']","['Toxicological profile for tetrachloroethylene.', 'Children ’s Safe Product Act Report', 'Draft toxicological profile for tetrachloroethylene', 'Toxicological profile for tetrachloroethylene (PERC)', 'Perchloroethylene Dry Cleaners Refined Human Health Risk Characterization', 'Microsoft Word - revised - Sandston air LHC 09 24 2015 clean', 'Comparison of mold exposures, work-related symptoms, and visual contrast sensitivity between employees at a severely water-damaged school and employees at a school without significant water damage /', 'Comparison of mold exposures, work-related symptoms, and visual contrast sensitivity between employees at a severely water-damaged school and employees at a school without significant water damage, Alcee Fortier Senior High School, New Orleans', 'Multistate Comments on Draft TSCA Risk Evaluation for PERC']","['https://www.epa.gov/sites/default/files/2015-06/documents/riskassessment_dry_cleaners.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Mutistate%20Comments%20on%20Draft%20TSCA%20Risk%20Evaluation%20for%20Perc.pdf', 'https://purl.fdlp.gov/GPO/gpo132702', 'http://www.vdh.virginia.gov/content/uploads/sites/12/2016/01/Henrico_Sandston_9-30-2015-revised.pdf', 'https://fortress.wa.gov/ecy/publications/documents/0907014.pdf']","['42430_4_perchloroethylene dry cleaners refined human health risk characterization.pdf', '42430_8_multistate comments on draft tsca risk evaluation for perc.pdf', '42430_0_toxicological profile for tetrachloroethylene.pdf', '42430_5_microsoft word  revised  sandston air lhc 09 24 2015 clean.pdf', '42430_1_children s safe product act report.pdf']",5,55.56,"['https://www.epa.gov/sites/default/files/2015-06/documents/riskassessment_dry_cleaners.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Mutistate%20Comments%20on%20Draft%20TSCA%20Risk%20Evaluation%20for%20Perc.pdf', 'https://purl.fdlp.gov/GPO/gpo132702', 'http://www.vdh.virginia.gov/content/uploads/sites/12/2016/01/Henrico_Sandston_9-30-2015-revised.pdf', 'https://fortress.wa.gov/ecy/publications/documents/0907014.pdf']","['42430_4_perchloroethylene dry cleaners refined human health risk characterization.pdf', '42430_8_multistate comments on draft tsca risk evaluation for perc.pdf', '42430_0_toxicological profile for tetrachloroethylene.pdf', '42430_5_microsoft word  revised  sandston air lhc 09 24 2015 clean.pdf', '42430_1_children s safe product act report.pdf']","[0.431, 0.191, 0.371, 0.356, 0.258]","[0.557, 0.513, 0.528, 0.544, 0.545]","[0.636, 0.601, 0.623, 0.625, 0.624]","[0.159, 0.139, 0.154, 0.159, 0.136]","[0.155, 0.142, 0.157, 0.166, 0.144]","[0.123, 0.117, 0.118, 0.122, 0.112]","[0.731, 0.726, 0.734, 0.729, 0.723]","[0.636, 0.627, 0.64, 0.631, 0.623]","[0.631, 0.576, 0.595, 0.615, 0.618]","[0.669, 0.666, 0.664, 0.656, 0.654]","[0.812, 0.784, 0.805, 0.811, 0.811]","[0.744, 0.687, 0.715, 0.73, 0.742]","[0.659, 0.644, 0.637, 0.649, 0.65]","[0.924, 0.914, 0.92, 0.921, 0.931]","[0.838, 0.816, 0.815, 0.83, 0.835]","[0.783, 0.75, 0.766, 0.779, 0.777]","[0.821, 0.786, 0.804, 0.818, 0.817]","[0.802, 0.768, 0.786, 0.799, 0.798]",0.321,0.537,0.622,0.149,0.153,0.118,0.729,0.631,0.607,0.662,0.805,0.724,0.648,0.922,0.827,0.771,0.809,0.791
https://doi.org/10.1289/ehp.02110955,critical windows of exposure to household pesticides and risk of childhood leukemia,42432_critical windows of exposure to household pesticides and risk of childhood leukemia.pdf,7,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Community%20Meeting%2020190624%20Comments.pdf', 'https://stacks.cdc.gov/view/cdc/33133']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'America’s children and the environment.', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Childhood Cancer', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic Effects', 'The following individuals added their name(s) to the petition that can be found on page 12:', 'A Story of health']","['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Community%20Meeting%2020190624%20Comments.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf']","['42432_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42432_4_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42432_3_childhood cancer.pdf', '42432_1_americas children and the environment.pdf', '42432_5_the following individuals added their names to the petition that can be found on page 12.pdf', '42432_2_recognition and management of pesticide poisonings sixth edition 2013.pdf']",6,85.71,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Community%20Meeting%2020190624%20Comments.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf']","['42432_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42432_4_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42432_3_childhood cancer.pdf', '42432_1_americas children and the environment.pdf', '42432_5_the following individuals added their names to the petition that can be found on page 12.pdf', '42432_2_recognition and management of pesticide poisonings sixth edition 2013.pdf']","[0.622, 0.358, 0.366, 0.276, 0.52, 0.329]","[0.527, 0.538, 0.534, 0.523, 0.533, 0.529]","[0.613, 0.62, 0.621, 0.61, 0.615, 0.61]","[0.159, 0.181, 0.151, 0.148, 0.15, 0.14]","[0.164, 0.191, 0.155, 0.148, 0.16, 0.15]","[0.132, 0.152, 0.125, 0.116, 0.125, 0.114]","[0.731, 0.739, 0.732, 0.728, 0.722, 0.727]","[0.638, 0.646, 0.635, 0.634, 0.628, 0.628]","[0.595, 0.607, 0.601, 0.587, 0.609, 0.608]","[0.671, 0.678, 0.697, 0.68, 0.649, 0.636]","[0.793, 0.802, 0.792, 0.791, 0.805, 0.8]","[0.705, 0.722, 0.704, 0.701, 0.724, 0.72]","[0.628, 0.628, 0.644, 0.634, 0.638, 0.627]","[0.907, 0.912, 0.907, 0.903, 0.91, 0.913]","[0.817, 0.818, 0.823, 0.814, 0.831, 0.82]","[0.758, 0.767, 0.763, 0.757, 0.775, 0.77]","[0.795, 0.804, 0.797, 0.796, 0.812, 0.805]","[0.778, 0.787, 0.78, 0.779, 0.792, 0.788]",0.412,0.531,0.615,0.155,0.161,0.127,0.73,0.635,0.601,0.668,0.797,0.713,0.633,0.909,0.821,0.765,0.801,0.784
https://doi.org/10.1289/ehp.02110s3415,exposure to a low dose of bisphenol a during fetal life or in adulthood alters maternal behavior in mice,42435_exposure to a low dose of bisphenol a during fetal life or in adulthood alters maternal behavior in mice.pdf,1,['https://purl.fdlp.gov/GPO/gpo63641'],['America’s children and the environment.'],['https://purl.fdlp.gov/GPO/gpo63641'],['42435_0_americas children and the environment.pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo63641'],['42435_0_americas children and the environment.pdf'],[0.246],[0.523],[0.609],[0.127],[0.126],[0.097],[0.726],[0.625],[0.603],[0.649],[0.803],[0.728],[0.633],[0.912],[0.824],[0.768],[0.809],[0.789],0.246,0.523,0.609,0.127,0.126,0.097,0.726,0.625,0.603,0.649,0.803,0.728,0.633,0.912,0.824,0.768,0.809,0.789
https://doi.org/10.1289/ehp.0800047,a physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies,42437_a physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies.pdf,3,"['https://stacks.cdc.gov/view/cdc/83602', 'https://stacks.cdc.gov/view/cdc/84022', 'https://purl.fdlp.gov/GPO/gpo132907']","['Toxicological profile for DDT, DDE, and DDD : draft for public comment', 'Toxicological profile for 1,1-Dichloroethene : draft for public comment', 'Toxicological profile for DDT, DDE, and DDD: draft for public comment.']",['https://purl.fdlp.gov/GPO/gpo132907'],['42437_2_toxicological profile for ddt dde and ddd draft for public comment.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo132907'],['42437_2_toxicological profile for ddt dde and ddd draft for public comment.pdf'],[0.497],[0.524],[0.615],[0.146],[0.15],[0.115],[0.738],[0.645],[0.586],[0.675],[0.793],[0.695],[0.626],[0.91],[0.819],[0.754],[0.791],[0.775],0.497,0.524,0.615,0.146,0.15,0.115,0.738,0.645,0.586,0.675,0.793,0.695,0.626,0.91,0.819,0.754,0.791,0.775
https://doi.org/10.1289/ehp.0800084,impacts of climate change on indirect human exposure to pathogens and chemicals from agriculture,42439_impacts of climate change on indirect human exposure to pathogens and chemicals from agriculture.pdf,5,"['https://stacks.cdc.gov/view/cdc/5569', 'https://purl.fdlp.gov/GPO/gpo90991', 'https://www.osti.gov/biblio/1782447-national-alliance-water-innovation-nawi-technology-roadmap-agriculture-sector', 'https://purl.fdlp.gov/GPO/gpo68498', 'https://www.osti.gov/biblio/1782447']","['A Human health perspective on climate change; a report outlining the research needs on the human health effects of climate change', 'Agroforestry: enhancing resiliency in U.S. agricultural landscapes under changing conditions /', 'National Alliance for Water Innovation (NAWI) Technology Roadmap: Agriculture Sector', 'The impacts of climate change on human health in the United States :\xa0a scientific assessment /', 'National Alliance for Water Innovation (NAWI) Agriculture Sector Technology Roadmap 2021']","['https://purl.fdlp.gov/GPO/gpo90991', 'https://purl.fdlp.gov/GPO/gpo68498']","['42439_1_agroforestry enhancing resiliency in us agricultural landscapes under changing conditions .pdf', '42439_3_the impacts of climate change on human health in the united states \xa0a scientific assessment .pdf']",2,40.0,"['https://purl.fdlp.gov/GPO/gpo90991', 'https://purl.fdlp.gov/GPO/gpo68498']","['42439_1_agroforestry enhancing resiliency in us agricultural landscapes under changing conditions .pdf', '42439_3_the impacts of climate change on human health in the united states \xa0a scientific assessment .pdf']","[0.42, 0.628]","[0.506, 0.508]","[0.606, 0.6]","[0.137, 0.14]","[0.122, 0.129]","[0.108, 0.111]","[0.733, 0.737]","[0.638, 0.644]","[0.57, 0.57]","[0.662, 0.672]","[0.796, 0.79]","[0.694, 0.688]","[0.621, 0.623]","[0.911, 0.91]","[0.805, 0.803]","[0.75, 0.749]","[0.791, 0.789]","[0.781, 0.776]",0.524,0.507,0.603,0.139,0.126,0.11,0.735,0.641,0.57,0.667,0.793,0.691,0.622,0.911,0.804,0.75,0.79,0.778
https://doi.org/10.1289/ehp.0800209,parental exposure to pesticides and childhood brain cancer us atlantic coast childhood brain cancer study,42440_parental exposure to pesticides and childhood brain cancer us atlantic coast childhood brain cancer study.pdf,1,['https://www.mass.gov/doc/full-study-report/download'],['The Wilmington Childhood Cancer Study'],['https://www.mass.gov/doc/full-study-report/download'],['42440_0_the wilmington childhood cancer study.pdf'],1,100.0,['https://www.mass.gov/doc/full-study-report/download'],['42440_0_the wilmington childhood cancer study.pdf'],[0.542],[0.524],[0.62],[0.158],[0.167],[0.125],[0.732],[0.637],[0.59],[0.677],[0.799],[0.709],[0.626],[0.917],[0.822],[0.753],[0.792],[0.778],0.542,0.524,0.62,0.158,0.167,0.125,0.732,0.637,0.59,0.677,0.799,0.709,0.626,0.917,0.822,0.753,0.792,0.778
https://doi.org/10.1289/ehp.0900582,a systematic review and metaanalysis of childhood leukemia and parental occupational pesticide exposure,42442_a systematic review and metaanalysis of childhood leukemia and parental occupational pesticide exposure.pdf,8,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.mass.gov/doc/full-study-report/download', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'https://stacks.cdc.gov/view/cdc/33133']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'The Wilmington Childhood Cancer Study', 'America’s children and the environment.', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Childhood Cancer', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic Effects', 'Preconception Care: A New Standard of Care within Maternal Health Services', 'A Story of health']","['https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.mass.gov/doc/full-study-report/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf']","['42442_5_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42442_2_americas children and the environment.pdf', '42442_1_the wilmington childhood cancer study.pdf', '42442_6_preconception care a new standard of care within maternal health services.pdf', '42442_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42442_4_childhood cancer.pdf', '42442_3_recognition and management of pesticide poisonings sixth edition 2013.pdf']",7,87.5,"['https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.mass.gov/doc/full-study-report/download', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf']","['42442_5_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42442_2_americas children and the environment.pdf', '42442_1_the wilmington childhood cancer study.pdf', '42442_6_preconception care a new standard of care within maternal health services.pdf', '42442_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42442_4_childhood cancer.pdf', '42442_3_recognition and management of pesticide poisonings sixth edition 2013.pdf']","[0.734, 0.482, 0.392, 0.416, 0.237, 0.757, 0.365]","[0.516, 0.5, 0.511, 0.485, 0.503, 0.502, 0.501]","[0.609, 0.597, 0.605, 0.585, 0.598, 0.6, 0.592]","[0.178, 0.147, 0.158, 0.148, 0.155, 0.146, 0.136]","[0.19, 0.149, 0.163, 0.132, 0.162, 0.15, 0.148]","[0.152, 0.12, 0.127, 0.122, 0.132, 0.122, 0.116]","[0.746, 0.736, 0.737, 0.743, 0.738, 0.737, 0.735]","[0.652, 0.64, 0.642, 0.652, 0.643, 0.638, 0.635]","[0.582, 0.564, 0.57, 0.535, 0.57, 0.568, 0.575]","[0.69, 0.691, 0.684, 0.68, 0.681, 0.709, 0.644]","[0.796, 0.785, 0.787, 0.752, 0.788, 0.78, 0.792]","[0.705, 0.686, 0.697, 0.623, 0.69, 0.685, 0.697]","[0.608, 0.609, 0.615, 0.592, 0.604, 0.61, 0.603]","[0.916, 0.906, 0.911, 0.907, 0.911, 0.909, 0.916]","[0.8, 0.798, 0.805, 0.771, 0.8, 0.804, 0.8]","[0.746, 0.736, 0.74, 0.705, 0.735, 0.735, 0.743]","[0.787, 0.781, 0.781, 0.73, 0.779, 0.777, 0.784]","[0.771, 0.766, 0.765, 0.73, 0.764, 0.761, 0.769]",0.483,0.503,0.598,0.153,0.156,0.127,0.739,0.643,0.566,0.683,0.783,0.683,0.606,0.911,0.797,0.734,0.774,0.761
https://doi.org/10.1289/ehp.0900583,residential exposure to polychlorinated biphenyls and organochlorine pesticides and risk of childhood leukemia,42443_residential exposure to polychlorinated biphenyls and organochlorine pesticides and risk of childhood leukemia.pdf,5,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://stacks.cdc.gov/view/cdc/33133', 'https://ntp.niehs.nih.gov/ntp/roc/thirteenth/monographs_final/pentachlorophenol_508.pdf', 'https://ecology.wa.gov/DOE/files/63/63636d42-0a0d-4932-8da8-f0374488c45e.pdf']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'America’s children and the environment.', 'A Story of health', 'Pentachlorophenol and By-Products of Its Synthesis (PCP)', 'Microsoft Outlook - Memo Style']","['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://ecology.wa.gov/DOE/files/63/63636d42-0a0d-4932-8da8-f0374488c45e.pdf', 'https://ntp.niehs.nih.gov/ntp/roc/thirteenth/monographs_final/pentachlorophenol_508.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42443_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42443_4_microsoft outlook  memo style.pdf', '42443_3_pentachlorophenol and byproducts of its synthesis pcp.pdf', '42443_1_americas children and the environment.pdf']",4,80.0,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://ecology.wa.gov/DOE/files/63/63636d42-0a0d-4932-8da8-f0374488c45e.pdf', 'https://ntp.niehs.nih.gov/ntp/roc/thirteenth/monographs_final/pentachlorophenol_508.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42443_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42443_4_microsoft outlook  memo style.pdf', '42443_3_pentachlorophenol and byproducts of its synthesis pcp.pdf', '42443_1_americas children and the environment.pdf']","[0.629, 0.48, 0.506, 0.247]","[0.494, 0.482, 0.489, 0.492]","[0.592, 0.579, 0.597, 0.591]","[0.143, 0.127, 0.149, 0.142]","[0.148, 0.135, 0.152, 0.145]","[0.115, 0.11, 0.115, 0.112]","[0.73, 0.733, 0.733, 0.73]","[0.637, 0.64, 0.645, 0.636]","[0.559, 0.546, 0.553, 0.553]","[0.68, 0.682, 0.69, 0.694]","[0.785, 0.774, 0.787, 0.783]","[0.691, 0.674, 0.687, 0.688]","[0.603, 0.599, 0.608, 0.609]","[0.899, 0.894, 0.898, 0.895]","[0.793, 0.784, 0.791, 0.792]","[0.72, 0.717, 0.724, 0.723]","[0.776, 0.765, 0.774, 0.778]","[0.752, 0.747, 0.752, 0.755]",0.466,0.489,0.59,0.14,0.145,0.113,0.732,0.64,0.553,0.686,0.782,0.685,0.605,0.897,0.79,0.721,0.773,0.752
https://doi.org/10.1289/ehp.0900625,lead exposure and behavior among young children in chennai india,42444_lead exposure and behavior among young children in chennai india.pdf,10,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/leadappendixa_final_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/monographhealtheffectslowlevellead_newissn_508.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/appendicesathrue_final_508.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://stacks.cdc.gov/view/cdc/78185', 'https://purl.fdlp.gov/GPO/gpo144830']","['2015-Lead-Poisoning', 'Toxicological Profile for Lead, Draft for Public Comment', 'Lead', 'Lead', 'Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'Lead', 'America’s children and the environment.', 'Toxicological profile for lead: draft for public comment.', 'Toxicological profile for lead : draft for public comment', 'Toxicological profile for lead /']","['https://ntp.niehs.nih.gov/ntp/ohat/lead/final/appendicesathrue_final_508.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo144830', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/monographhealtheffectslowlevellead_newissn_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/leadappendixa_final_508.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42444_5_lead.pdf', '42444_4_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42444_9_toxicological profile for lead .pdf', '42444_1_toxicological profile for lead draft for public comment.pdf', '42444_7_toxicological profile for lead draft for public comment.pdf', '42444_0_2015leadpoisoning.pdf', '42444_3_lead.pdf', '42444_2_lead.pdf', '42444_6_americas children and the environment.pdf']",9,90.0,"['https://ntp.niehs.nih.gov/ntp/ohat/lead/final/appendicesathrue_final_508.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo144830', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/monographhealtheffectslowlevellead_newissn_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/leadappendixa_final_508.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42444_5_lead.pdf', '42444_4_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42444_9_toxicological profile for lead .pdf', '42444_1_toxicological profile for lead draft for public comment.pdf', '42444_7_toxicological profile for lead draft for public comment.pdf', '42444_0_2015leadpoisoning.pdf', '42444_3_lead.pdf', '42444_2_lead.pdf', '42444_6_americas children and the environment.pdf']","[0.656, 0.572, 0.396, 0.481, 0.395, 0.322, 0.451, 0.572, 0.593]","[0.473, 0.509, 0.494, 0.498, 0.498, 0.5, 0.535, 0.464, 0.506]","[0.566, 0.603, 0.595, 0.597, 0.597, 0.597, 0.626, 0.557, 0.601]","[0.143, 0.131, 0.147, 0.146, 0.146, 0.148, 0.176, 0.143, 0.139]","[0.128, 0.133, 0.149, 0.148, 0.148, 0.15, 0.172, 0.131, 0.138]","[0.115, 0.099, 0.122, 0.121, 0.121, 0.123, 0.141, 0.121, 0.106]","[0.735, 0.725, 0.733, 0.733, 0.733, 0.732, 0.736, 0.738, 0.728]","[0.641, 0.628, 0.64, 0.64, 0.64, 0.639, 0.645, 0.645, 0.63]","[0.532, 0.583, 0.561, 0.565, 0.565, 0.567, 0.599, 0.518, 0.577]","[0.693, 0.664, 0.683, 0.681, 0.681, 0.68, 0.68, 0.703, 0.681]","[0.755, 0.792, 0.78, 0.781, 0.781, 0.782, 0.803, 0.747, 0.789]","[0.661, 0.709, 0.679, 0.684, 0.684, 0.687, 0.717, 0.649, 0.706]","[0.604, 0.607, 0.602, 0.603, 0.603, 0.605, 0.619, 0.604, 0.613]","[0.9, 0.908, 0.905, 0.905, 0.905, 0.906, 0.912, 0.897, 0.904]","[0.757, 0.805, 0.788, 0.791, 0.791, 0.794, 0.813, 0.745, 0.805]","[0.707, 0.738, 0.726, 0.728, 0.728, 0.729, 0.752, 0.7, 0.739]","[0.75, 0.789, 0.769, 0.772, 0.772, 0.774, 0.795, 0.741, 0.79]","[0.729, 0.765, 0.752, 0.754, 0.754, 0.755, 0.775, 0.72, 0.767]",0.493,0.497,0.593,0.147,0.144,0.119,0.733,0.639,0.563,0.683,0.779,0.686,0.607,0.905,0.788,0.727,0.772,0.752
https://doi.org/10.1289/ehp.0900844,shortterm effects of pm 10 and no 2 on respiratory health among children with asthma or asthmalike symptoms a systematic review and metaanalysis,42445_shortterm effects of pm 10 and no 2 on respiratory health among children with asthma or asthmalike symptoms a systematic review and metaanalysis.pdf,9,"['https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2015AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2015_CO_5yr_Network_Assessment.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2019AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2016AnnualDataReport.pdf', 'https://www.denvergov.org/content/dam/denvergov/Portals/771/documents/hia/HIA%20Composite%20Report_9-18-14.pdf', 'https://www.congress.gov/event/112th-congress/house-event/LC3042/text', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2020_CO_5yr_Network_Assessment.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2017AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2018AnnualDataReport.pdf']","['2015 Air Quality Data Report', '2015 Ambient Air Monitoring Network Assessment', 'Technical Services Program', '2016 Air Quality Data Report', 'How Neighborhood Planning Affects Health in Globeville and Elyria Swansea', 'House Hearing, 112th Congress — HITTING THE ETHANOL BLEND WALL: EXAMINING THE SCIENCE ON E15', 'Technical Services Program', 'Technical Services Program', 'Technical Services Program']","['https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2015AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2019AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2020_CO_5yr_Network_Assessment.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2018AnnualDataReport.pdf', 'https://www.denvergov.org/content/dam/denvergov/Portals/771/documents/hia/HIA%20Composite%20Report_9-18-14.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2016AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2015_CO_5yr_Network_Assessment.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2017AnnualDataReport.pdf']","['42445_0_2015 air quality data report.pdf', '42445_2_technical services program.pdf', '42445_6_technical services program.pdf', '42445_8_technical services program.pdf', '42445_4_how neighborhood planning affects health in globeville and elyria swansea.pdf', '42445_3_2016 air quality data report.pdf', '42445_1_2015 ambient air monitoring network assessment.pdf', '42445_7_technical services program.pdf']",8,88.89,"['https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2015AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2019AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2020_CO_5yr_Network_Assessment.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2018AnnualDataReport.pdf', 'https://www.denvergov.org/content/dam/denvergov/Portals/771/documents/hia/HIA%20Composite%20Report_9-18-14.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2016AnnualDataReport.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2015_CO_5yr_Network_Assessment.pdf', 'https://www.colorado.gov/airquality/tech_doc_repository.aspx?action=open&file=2017AnnualDataReport.pdf']","['42445_0_2015 air quality data report.pdf', '42445_2_technical services program.pdf', '42445_6_technical services program.pdf', '42445_8_technical services program.pdf', '42445_4_how neighborhood planning affects health in globeville and elyria swansea.pdf', '42445_3_2016 air quality data report.pdf', '42445_1_2015 ambient air monitoring network assessment.pdf', '42445_7_technical services program.pdf']","[0.108, 0.161, 0.141, 0.101, 0.118, 0.153, 0.131, 0.13]","[0.453, 0.46, 0.468, 0.46, 0.445, 0.452, 0.471, 0.46]","[0.555, 0.56, 0.561, 0.561, 0.566, 0.554, 0.568, 0.561]","[0.097, 0.097, 0.095, 0.1, 0.097, 0.098, 0.097, 0.099]","[0.106, 0.108, 0.107, 0.108, 0.113, 0.107, 0.108, 0.108]","[0.089, 0.089, 0.088, 0.09, 0.084, 0.089, 0.09, 0.089]","[0.722, 0.722, 0.722, 0.722, 0.719, 0.722, 0.723, 0.722]","[0.624, 0.625, 0.624, 0.625, 0.619, 0.624, 0.626, 0.625]","[0.517, 0.522, 0.528, 0.521, 0.512, 0.517, 0.53, 0.52]","[0.711, 0.709, 0.712, 0.709, 0.669, 0.71, 0.708, 0.706]","[0.754, 0.763, 0.76, 0.763, 0.76, 0.753, 0.763, 0.763]","[0.658, 0.659, 0.659, 0.66, 0.66, 0.657, 0.664, 0.661]","[0.593, 0.6, 0.597, 0.599, 0.585, 0.593, 0.598, 0.6]","[0.886, 0.889, 0.89, 0.888, 0.884, 0.886, 0.889, 0.887]","[0.771, 0.775, 0.773, 0.775, 0.775, 0.77, 0.777, 0.774]","[0.687, 0.693, 0.692, 0.693, 0.681, 0.687, 0.693, 0.694]","[0.738, 0.746, 0.743, 0.746, 0.745, 0.737, 0.747, 0.747]","[0.708, 0.713, 0.714, 0.713, 0.705, 0.708, 0.717, 0.713]",0.13,0.459,0.561,0.098,0.108,0.088,0.722,0.624,0.521,0.704,0.76,0.66,0.596,0.887,0.774,0.69,0.744,0.711
https://doi.org/10.1289/ehp.0900916,effect of early life exposure to air pollution on development of childhood asthma,42446_effect of early life exposure to air pollution on development of childhood asthma.pdf,9,"['https://www.federalregister.gov/documents/2017/07/26/2017-15591/review-of-the-primary-national-ambient-air-quality-standards-for-oxides-of-nitrogen', 'https://www.epa.gov/sites/default/files/2017-04/documents/policy_assessment_for_the_review_of_the_no2_naaqs_-_final_report.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121214rtc.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121213psa.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/nox/data/20160927-no2-pa-external-review-draft.pdf', 'https://www.federalregister.gov/documents/2018/04/18/2018-07741/review-of-the-primary-national-ambient-air-quality-standards-for-oxides-of-nitrogen', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://health.mo.gov/living/environment/bridgeton/pdf/bridgeton-healthconsult.pdf', 'https://stacks.cdc.gov/view/cdc/12384']","['Review of the Primary National Ambient Air Quality Standards for Oxides of Nitrogen', 'OEPA =', 'Docket Number EPA-HQ-OAR-2007-0492', 'Provisional Assessment of Recent Studies on Health Effects of Particulate Matter Exposure', 'SEPAft', 'Review of the Primary National Ambient Air Quality Standards for Oxides of Nitrogen', 'America’s children and the environment.', 'PUBLIC HEALTH ASSESSMENT Bridgeton Sanitary Landfill', 'Toxicological profile for carbon monoxide']","['https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121213psa.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/nox/data/20160927-no2-pa-external-review-draft.pdf', 'https://health.mo.gov/living/environment/bridgeton/pdf/bridgeton-healthconsult.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121214rtc.pdf', 'https://www.epa.gov/sites/default/files/2017-04/documents/policy_assessment_for_the_review_of_the_no2_naaqs_-_final_report.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42446_3_provisional assessment of recent studies on health effects of particulate matter exposure.pdf', '42446_4_sepaft.pdf', '42446_7_public health assessment bridgeton sanitary landfill.pdf', '42446_2_docket number epahqoar20070492.pdf', '42446_1_oepa .pdf', '42446_6_americas children and the environment.pdf']",6,66.67,"['https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121213psa.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/nox/data/20160927-no2-pa-external-review-draft.pdf', 'https://health.mo.gov/living/environment/bridgeton/pdf/bridgeton-healthconsult.pdf', 'https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121214rtc.pdf', 'https://www.epa.gov/sites/default/files/2017-04/documents/policy_assessment_for_the_review_of_the_no2_naaqs_-_final_report.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42446_3_provisional assessment of recent studies on health effects of particulate matter exposure.pdf', '42446_4_sepaft.pdf', '42446_7_public health assessment bridgeton sanitary landfill.pdf', '42446_2_docket number epahqoar20070492.pdf', '42446_1_oepa .pdf', '42446_6_americas children and the environment.pdf']","[0.41, 0.39, 0.56, 0.4, 0.481, 0.253]","[0.518, 0.532, 0.538, 0.533, 0.533, 0.517]","[0.615, 0.623, 0.626, 0.621, 0.624, 0.61]","[0.171, 0.163, 0.168, 0.159, 0.165, 0.149]","[0.184, 0.17, 0.174, 0.173, 0.171, 0.153]","[0.148, 0.136, 0.14, 0.136, 0.137, 0.121]","[0.737, 0.73, 0.733, 0.728, 0.731, 0.732]","[0.644, 0.638, 0.641, 0.634, 0.638, 0.634]","[0.571, 0.598, 0.603, 0.593, 0.599, 0.579]","[0.717, 0.704, 0.69, 0.707, 0.704, 0.696]","[0.796, 0.801, 0.809, 0.802, 0.8, 0.798]","[0.696, 0.713, 0.728, 0.719, 0.715, 0.703]","[0.619, 0.622, 0.635, 0.634, 0.624, 0.619]","[0.91, 0.916, 0.916, 0.914, 0.916, 0.907]","[0.797, 0.825, 0.821, 0.822, 0.825, 0.81]","[0.741, 0.755, 0.764, 0.754, 0.755, 0.746]","[0.779, 0.794, 0.804, 0.796, 0.794, 0.792]","[0.765, 0.78, 0.786, 0.778, 0.78, 0.775]",0.416,0.528,0.62,0.163,0.171,0.136,0.732,0.638,0.591,0.703,0.801,0.712,0.626,0.913,0.817,0.752,0.793,0.777
https://doi.org/10.1289/ehp.0900966,residential pesticides and childhood leukemia a systematic review and metaanalysis,42447_residential pesticides and childhood leukemia a systematic review and metaanalysis.pdf,8,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=5480523&GUID=73FA02F7-60D1-4AC7-B4B6-470EC190CE38', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Community%20Meeting%2020190624%20Comments.pdf', 'https://stacks.cdc.gov/view/cdc/33133']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'Health', 'America’s children and the environment.', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Childhood Cancer', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic Effects', 'The following individuals added their name(s) to the petition that can be found on page 12:', 'A Story of health']","['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=5480523&GUID=73FA02F7-60D1-4AC7-B4B6-470EC190CE38', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Community%20Meeting%2020190624%20Comments.pdf']","['42447_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42447_3_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42447_4_childhood cancer.pdf', '42447_1_health.pdf', '42447_5_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42447_2_americas children and the environment.pdf', '42447_6_the following individuals added their names to the petition that can be found on page 12.pdf']",7,87.5,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=5480523&GUID=73FA02F7-60D1-4AC7-B4B6-470EC190CE38', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'http://boe.hawaii.gov/Meetings/Notices/Meeting%20Material%20Library/Community%20Meeting%2020190624%20Comments.pdf']","['42447_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42447_3_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42447_4_childhood cancer.pdf', '42447_1_health.pdf', '42447_5_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42447_2_americas children and the environment.pdf', '42447_6_the following individuals added their names to the petition that can be found on page 12.pdf']","[0.69, 0.5, 0.357, 0.361, 0.258, 0.662, 0.297]","[0.51, 0.504, 0.513, 0.503, 0.522, 0.507, 0.504]","[0.605, 0.598, 0.61, 0.605, 0.616, 0.603, 0.599]","[0.151, 0.127, 0.15, 0.149, 0.169, 0.147, 0.132]","[0.161, 0.143, 0.159, 0.165, 0.187, 0.149, 0.142]","[0.125, 0.106, 0.12, 0.13, 0.14, 0.115, 0.11]","[0.732, 0.727, 0.733, 0.729, 0.739, 0.73, 0.72]","[0.637, 0.627, 0.635, 0.633, 0.645, 0.634, 0.625]","[0.583, 0.589, 0.584, 0.578, 0.595, 0.576, 0.585]","[0.682, 0.645, 0.715, 0.667, 0.689, 0.693, 0.651]","[0.795, 0.8, 0.79, 0.797, 0.802, 0.792, 0.801]","[0.699, 0.708, 0.695, 0.691, 0.714, 0.695, 0.711]","[0.605, 0.603, 0.615, 0.608, 0.609, 0.61, 0.611]","[0.913, 0.919, 0.912, 0.917, 0.918, 0.908, 0.914]","[0.818, 0.819, 0.824, 0.82, 0.817, 0.816, 0.83]","[0.745, 0.753, 0.747, 0.745, 0.755, 0.744, 0.756]","[0.787, 0.793, 0.787, 0.788, 0.794, 0.788, 0.798]","[0.771, 0.777, 0.771, 0.775, 0.778, 0.772, 0.781]",0.446,0.509,0.605,0.146,0.158,0.121,0.73,0.634,0.584,0.677,0.797,0.702,0.609,0.914,0.821,0.749,0.791,0.775
https://doi.org/10.1289/ehp.0900979,prenatal bisphenol a exposure and early childhood behavior,42448_prenatal bisphenol a exposure and early childhood behavior.pdf,3,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.congress.gov/event/111th-congress/house-event/LC5623/text', 'https://www.nrdc.org/resources/congress-must-protect-children-developmental-toxic-bisphenol-bpa']","['America’s children and the environment.', 'House Hearing, 111th Congress — H.R. 5820, THE TOXIC CHEMICALS SAFETY ACT OF 2010', 'Congress Must Protect Children from a Developmental Toxic: Bisphenol A (BPA)']",['https://purl.fdlp.gov/GPO/gpo63641'],['42448_0_americas children and the environment.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo63641'],['42448_0_americas children and the environment.pdf'],[0.434],[0.472],[0.57],[0.116],[0.123],[0.103],[0.728],[0.629],[0.537],[0.697],[0.748],[0.674],[0.598],[0.869],[0.76],[0.667],[0.747],[0.691],0.434,0.472,0.57,0.116,0.123,0.103,0.728,0.629,0.537,0.697,0.748,0.674,0.598,0.869,0.76,0.667,0.747,0.691
https://doi.org/10.1289/ehp.0901143,formaldehyde exposure and asthma in children a systematic review,42449_formaldehyde exposure and asthma in children a systematic review.pdf,6,"['https://www.federalregister.gov/documents/2011/05/03/2011-7237/national-emission-standards-for-hazardous-air-pollutants-from-coal--and-oil-fired-electric-utility', 'https://www.ucsusa.org/resources/climate-change-and-your-health-hidden-health-risks-flooding-warming-world', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://stacks.cdc.gov/view/cdc/77066', 'https://stacks.cdc.gov/view/cdc/42327', 'https://www.epa.gov/sites/production/files/2019-07/documents/hazardous_air_pollutants_report_section_23_july_2019.pdf']","['National Emission Standards for Hazardous Air Pollutants From Coal- and Oil-Fired Electric Utility Steam Generating Units and Standards of Performance for Fossil-Fuel-Fired Electric Utility, Industrial-Commercial-Institutional, and Small Industrial-Commercial-Institutional Steam Generating Units', 'Climate Change and Your Health: The Hidden Health Risks of Flooding in a Warming World', 'America’s children and the environment.', 'Addendum to the Toxicological profile for formaldehyde', 'Possible health implications from exposure to formaldehyde emitted from laminate flooring samples tested by the Consumer Product Safety Commission', 'Hazardous Air Pollutants']","['https://www.epa.gov/sites/production/files/2019-07/documents/hazardous_air_pollutants_report_section_23_july_2019.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42449_5_hazardous air pollutants.pdf', '42449_2_americas children and the environment.pdf']",2,33.33,"['https://www.epa.gov/sites/production/files/2019-07/documents/hazardous_air_pollutants_report_section_23_july_2019.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42449_5_hazardous air pollutants.pdf', '42449_2_americas children and the environment.pdf']","[0.346, 0.268]","[0.488, 0.501]","[0.591, 0.596]","[0.151, 0.14]","[0.153, 0.141]","[0.123, 0.107]","[0.73, 0.729]","[0.636, 0.632]","[0.553, 0.568]","[0.717, 0.699]","[0.789, 0.787]","[0.691, 0.692]","[0.611, 0.612]","[0.903, 0.904]","[0.809, 0.806]","[0.724, 0.743]","[0.778, 0.781]","[0.767, 0.769]",0.307,0.494,0.593,0.146,0.147,0.115,0.73,0.634,0.56,0.708,0.788,0.692,0.611,0.903,0.808,0.734,0.78,0.768
https://doi.org/10.1289/ehp.0901150,maternal serum preconception polychlorinated biphenyl concentrations and infant birth weight,42450_maternal serum preconception polychlorinated biphenyl concentrations and infant birth weight.pdf,3,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf']","['America’s children and the environment.', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Health: Adverse Birth Outcomes']","['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf']","['42450_1_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42450_0_americas children and the environment.pdf', '42450_2_health adverse birth outcomes.pdf']",3,100.0,"['https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf']","['42450_1_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42450_0_americas children and the environment.pdf', '42450_2_health adverse birth outcomes.pdf']","[0.377, 0.233, 0.332]","[0.511, 0.506, 0.503]","[0.6, 0.6, 0.599]","[0.124, 0.143, 0.189]","[0.13, 0.144, 0.181]","[0.097, 0.111, 0.148]","[0.726, 0.729, 0.741]","[0.628, 0.635, 0.651]","[0.59, 0.572, 0.592]","[0.627, 0.679, 0.689]","[0.792, 0.783, 0.787]","[0.713, 0.698, 0.709]","[0.612, 0.617, 0.595]","[0.905, 0.896, 0.901]","[0.803, 0.801, 0.816]","[0.734, 0.727, 0.728]","[0.79, 0.784, 0.786]","[0.757, 0.753, 0.744]",0.314,0.507,0.6,0.152,0.152,0.119,0.732,0.638,0.585,0.665,0.787,0.707,0.608,0.901,0.807,0.73,0.787,0.751
https://doi.org/10.1289/ehp.0901331,childhood exposure to phthalates associations with thyroid function insulinlike growth factor i and growth,42451_childhood exposure to phthalates associations with thyroid function insulinlike growth factor i and growth.pdf,3,"['https://stacks.cdc.gov/view/cdc/113705', 'https://purl.fdlp.gov/GPO/gpo132911', 'https://stacks.cdc.gov/view/cdc/84188']","['Toxicological profile for Di(2-Ethylhexyl)Phthalate (DEHP)', 'Toxicological profile for di(2-ethylhexyl)phthalate (DEHP): draft for public comment.', 'Toxicological profile for Di(2-Ethylhexyl)Phthalate : draft for public comment']",['https://purl.fdlp.gov/GPO/gpo132911'],['42451_1_toxicological profile for di2ethylhexylphthalate dehp draft for public comment.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo132911'],['42451_1_toxicological profile for di2ethylhexylphthalate dehp draft for public comment.pdf'],[0.64],[0.508],[0.609],[0.17],[0.168],[0.131],[0.74],[0.647],[0.579],[0.682],[0.787],[0.668],[0.617],[0.908],[0.798],[0.744],[0.777],[0.767],0.64,0.508,0.609,0.17,0.168,0.131,0.74,0.647,0.579,0.682,0.787,0.668,0.617,0.908,0.798,0.744,0.777,0.767
https://doi.org/10.1289/ehp.0901470,prenatal phthalate exposure is associated with childhood behavior and executive functioning,42452_prenatal phthalate exposure is associated with childhood behavior and executive functioning.pdf,6,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/default/files/2015-05/documents/biomonitoring-phthalates.pdf', 'https://ecology.wa.gov/DOE/files/63/63636d42-0a0d-4932-8da8-f0374488c45e.pdf', 'https://mathematica.org/publications/regional-partnership-grant-program-cross-site-evaluation-design-report', 'https://www.epa.gov/sites/default/files/2015-09/documents/cehc-brochure-2014.pdf', 'http://purl.fdlp.gov/GPO/gpo72216']","['America’s children and the environment.', 'Biominitoring: Phthalates', 'Microsoft Outlook - Memo Style', 'Regional Partnership Grant Program Cross-Site Evaluation Design Report', 'NIEHS/EPA Children’s Environmental Health and Disease Prevention Research Center', 'NIEHS/EPA children’s environmental health and disease prevention research centers :\xa0protecting chidren’s health for a lifetime.']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://ecology.wa.gov/DOE/files/63/63636d42-0a0d-4932-8da8-f0374488c45e.pdf', 'https://www.epa.gov/sites/default/files/2015-09/documents/cehc-brochure-2014.pdf', 'http://purl.fdlp.gov/GPO/gpo72216', 'https://www.epa.gov/sites/default/files/2015-05/documents/biomonitoring-phthalates.pdf']","['42452_0_americas children and the environment.pdf', '42452_2_microsoft outlook  memo style.pdf', '42452_4_niehsepa childrens environmental health and disease prevention research center.pdf', '42452_5_niehsepa childrens environmental health and disease prevention research centers \xa0protecting chidrens health for a lifetime.pdf', '42452_1_biominitoring phthalates.pdf']",5,83.33,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://ecology.wa.gov/DOE/files/63/63636d42-0a0d-4932-8da8-f0374488c45e.pdf', 'https://www.epa.gov/sites/default/files/2015-09/documents/cehc-brochure-2014.pdf', 'http://purl.fdlp.gov/GPO/gpo72216', 'https://www.epa.gov/sites/default/files/2015-05/documents/biomonitoring-phthalates.pdf']","['42452_0_americas children and the environment.pdf', '42452_2_microsoft outlook  memo style.pdf', '42452_4_niehsepa childrens environmental health and disease prevention research center.pdf', '42452_5_niehsepa childrens environmental health and disease prevention research centers \xa0protecting chidrens health for a lifetime.pdf', '42452_1_biominitoring phthalates.pdf']","[0.393, 0.411, 0.24, 0.291, 0.291]","[0.485, 0.473, 0.485, 0.485, 0.474]","[0.582, 0.57, 0.598, 0.598, 0.579]","[0.121, 0.112, 0.138, 0.138, 0.155]","[0.125, 0.116, 0.149, 0.149, 0.159]","[0.097, 0.098, 0.108, 0.108, 0.126]","[0.729, 0.732, 0.73, 0.73, 0.737]","[0.632, 0.637, 0.628, 0.628, 0.641]","[0.548, 0.538, 0.551, 0.551, 0.557]","[0.683, 0.668, 0.67, 0.67, 0.67]","[0.76, 0.752, 0.766, 0.766, 0.763]","[0.673, 0.659, 0.685, 0.685, 0.671]","[0.602, 0.59, 0.586, 0.586, 0.591]","[0.887, 0.886, 0.889, 0.889, 0.886]","[0.778, 0.769, 0.78, 0.78, 0.79]","[0.698, 0.693, 0.698, 0.698, 0.699]","[0.76, 0.748, 0.764, 0.764, 0.76]","[0.721, 0.714, 0.721, 0.721, 0.712]",0.325,0.48,0.585,0.133,0.14,0.107,0.732,0.633,0.549,0.672,0.761,0.675,0.591,0.887,0.779,0.697,0.759,0.718
https://doi.org/10.1289/ehp.1001975,serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants,42453_serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants.pdf,2,"['https://purl.fdlp.gov/GPO/gpo94037', 'https://www.congress.gov/event/116th-congress/house-event/109020']","['Toxicological profile for perfluoroalkyls: draft for public comment.', 'Examining PFAS Chemicals and their Risks']",['https://purl.fdlp.gov/GPO/gpo94037'],['42453_0_toxicological profile for perfluoroalkyls draft for public comment.pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo94037'],['42453_0_toxicological profile for perfluoroalkyls draft for public comment.pdf'],[0.38],[0.512],[0.605],[0.147],[0.143],[0.11],[0.734],[0.641],[0.577],[0.665],[0.786],[0.679],[0.623],[0.908],[0.803],[0.744],[0.78],[0.764],0.38,0.512,0.605,0.147,0.143,0.11,0.734,0.641,0.577,0.665,0.786,0.679,0.623,0.908,0.803,0.744,0.78,0.764
https://doi.org/10.1289/ehp.1002176,proton magnetic resonance spectroscopy in adults with childhood lead exposure,42454_proton magnetic resonance spectroscopy in adults with childhood lead exposure.pdf,8,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://www.congress.gov/event/114th-congress/house-event/LC41563/text', 'https://purl.fdlp.gov/GPO/gpo144830', 'https://purl.fdlp.gov/GPO/gpo73259', 'https://www.michigan.gov/documents/deq/deq-dwmad-cws-Lead.Cost.Report.Designed.Final2016pdf_602173_7.pdf', 'https://stacks.cdc.gov/view/cdc/78185', 'https://purl.fdlp.gov/GPO/gpo132915']","['2015-Lead-Poisoning', 'Toxicological Profile for Lead, Draft for Public Comment', ""House Hearing, 114th Congress — HEARING TO CONSIDER THE IMPACTS OF THE ENVIRONMENTAL PROTECTION AGENCY'S ACTIONS ON THE RURAL ECONOMY"", 'Toxicological profile for lead /', 'Hearing to consider the impacts of the Environmental Protection Agency’s actions on the rural economy :\xa0hearing before the Committee on Agriculture, House of Representatives, One Hundred Fourteenth Congress, second session, February 11, 2016.', 'Microsoft Word - Lead.Report.Designed.Final.docx', 'Toxicological profile for lead : draft for public comment', 'Toxicological profile for lead: draft for public comment.']","['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://purl.fdlp.gov/GPO/gpo144830', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf', 'https://www.michigan.gov/documents/deq/deq-dwmad-cws-Lead.Cost.Report.Designed.Final2016pdf_602173_7.pdf']","['42454_0_2015leadpoisoning.pdf', '42454_3_toxicological profile for lead .pdf', '42454_7_toxicological profile for lead draft for public comment.pdf', '42454_1_toxicological profile for lead draft for public comment.pdf', '42454_5_microsoft word  leadreportdesignedfinaldocx.pdf']",5,62.5,"['https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03092020_164049-438.pdf', 'https://purl.fdlp.gov/GPO/gpo144830', 'https://purl.fdlp.gov/GPO/gpo132915', 'https://mgaleg.maryland.gov/cmte_testimony/2020/ent/3757_03062020_113519-199.pdf']","['42454_0_2015leadpoisoning.pdf', '42454_3_toxicological profile for lead .pdf', '42454_7_toxicological profile for lead draft for public comment.pdf', '42454_1_toxicological profile for lead draft for public comment.pdf']","[0.755, 0.707, 0.731, 0.707]","[0.485, 0.484, 0.486, 0.486]","[0.586, 0.586, 0.588, 0.588]","[0.141, 0.143, 0.143, 0.143]","[0.146, 0.148, 0.147, 0.147]","[0.125, 0.128, 0.127, 0.127]","[0.738, 0.741, 0.74, 0.74]","[0.648, 0.65, 0.65, 0.65]","[0.554, 0.553, 0.555, 0.555]","[0.69, 0.694, 0.693, 0.693]","[0.772, 0.772, 0.773, 0.773]","[0.67, 0.666, 0.669, 0.669]","[0.602, 0.601, 0.602, 0.602]","[0.888, 0.888, 0.888, 0.888]","[0.779, 0.775, 0.777, 0.777]","[0.706, 0.706, 0.706, 0.706]","[0.76, 0.757, 0.76, 0.76]","[0.733, 0.732, 0.733, 0.733]",0.725,0.485,0.587,0.142,0.147,0.127,0.74,0.649,0.554,0.693,0.773,0.668,0.602,0.888,0.777,0.706,0.759,0.733
https://doi.org/10.1289/ehp.1002233,global climate change and children’s health threats and strategies for prevention,42455_global climate change and children’s health threats and strategies for prevention.pdf,7,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.congress.gov/event/116th-congress/house-event/110433', 'https://www.congress.gov/event/116th-congress/house-event/LC65539/text', 'http://purl.fdlp.gov/GPO/gpo68969', 'http://purl.fdlp.gov/GPO/gpo68967', 'http://www.climatechange.nc.gov/Climate_Ready_North_Carolina_Building_a_Resilient_Future.pdf', 'https://purl.fdlp.gov/GPO/gpo68498']","['America’s children and the environment.', 'Creating a Climate Resilient America: Overcoming the Health Risks of the Climate Crisis', 'House Hearing, 116th Congress — CREATING A CLIMATE RESILIENT AMERICA: OVERCOMING THE HEALTH RISKS OF THE CLIMATE CRISIS', 'Climate change impacts in the United States, highlights :\xa0U.S. national climate assessment /', 'Climate change impacts in the United States :\xa0U.S. national climate assessment /', 'Buildinga Resilient Future', 'The impacts of climate change on human health in the United States :\xa0a scientific assessment /']","['http://purl.fdlp.gov/GPO/gpo68967', 'http://www.climatechange.nc.gov/Climate_Ready_North_Carolina_Building_a_Resilient_Future.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://purl.fdlp.gov/GPO/gpo68498', 'http://purl.fdlp.gov/GPO/gpo68969']","['42455_4_climate change impacts in the united states \xa0us national climate assessment .pdf', '42455_5_buildinga resilient future.pdf', '42455_0_americas children and the environment.pdf', '42455_6_the impacts of climate change on human health in the united states \xa0a scientific assessment .pdf', '42455_3_climate change impacts in the united states highlights \xa0us national climate assessment .pdf']",5,71.43,"['http://purl.fdlp.gov/GPO/gpo68967', 'http://www.climatechange.nc.gov/Climate_Ready_North_Carolina_Building_a_Resilient_Future.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://purl.fdlp.gov/GPO/gpo68498', 'http://purl.fdlp.gov/GPO/gpo68969']","['42455_4_climate change impacts in the united states \xa0us national climate assessment .pdf', '42455_5_buildinga resilient future.pdf', '42455_0_americas children and the environment.pdf', '42455_6_the impacts of climate change on human health in the united states \xa0a scientific assessment .pdf', '42455_3_climate change impacts in the united states highlights \xa0us national climate assessment .pdf']","[0.485, 0.573, 0.575, 0.45, 0.773]","[0.537, 0.534, 0.511, 0.509, 0.536]","[0.633, 0.626, 0.61, 0.604, 0.632]","[0.163, 0.163, 0.15, 0.161, 0.167]","[0.154, 0.159, 0.145, 0.157, 0.16]","[0.124, 0.126, 0.118, 0.133, 0.129]","[0.734, 0.731, 0.732, 0.739, 0.735]","[0.643, 0.639, 0.636, 0.647, 0.644]","[0.613, 0.618, 0.581, 0.572, 0.613]","[0.671, 0.651, 0.677, 0.685, 0.67]","[0.812, 0.813, 0.796, 0.792, 0.812]","[0.739, 0.742, 0.706, 0.696, 0.738]","[0.633, 0.637, 0.619, 0.622, 0.632]","[0.923, 0.921, 0.911, 0.911, 0.922]","[0.835, 0.842, 0.817, 0.81, 0.837]","[0.767, 0.772, 0.749, 0.746, 0.769]","[0.814, 0.817, 0.797, 0.791, 0.816]","[0.799, 0.8, 0.783, 0.778, 0.799]",0.571,0.525,0.621,0.161,0.155,0.126,0.734,0.642,0.599,0.671,0.805,0.724,0.629,0.918,0.828,0.761,0.807,0.792
https://doi.org/10.1289/ehp.1002321,intellectual impairment in schoolage children exposed to manganese from drinking water,42457_intellectual impairment in schoolage children exposed to manganese from drinking water.pdf,5,"['https://purl.fdlp.gov/GPO/gpo93654', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://purl.fdlp.gov/GPO/gpo75779', 'https://files.nc.gov/ncdeq/Environmental%20Management%20Commission/EMC%20Meetings/2014/November%202014/Attachments/AttachA_to14-42HOR_triennial_review.pdf', 'https://stacks.cdc.gov/view/cdc/12399']","['Critical mineral resources of the United States :\xa0economic and environmental geology and prospects for future supply /', 'America’s children and the environment.', 'Arsenic, iron, lead, manganese, and uranium concentrations in private bedrock wells in southeastern New Hampshire, 2012-2013.', 'Triennial Review', 'Toxicological profile for manganese']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://files.nc.gov/ncdeq/Environmental%20Management%20Commission/EMC%20Meetings/2014/November%202014/Attachments/AttachA_to14-42HOR_triennial_review.pdf', 'https://purl.fdlp.gov/GPO/gpo75779']","['42457_1_americas children and the environment.pdf', '42457_3_triennial review.pdf', '42457_2_arsenic iron lead manganese and uranium concentrations in private bedrock wells in southeastern new hampshire 20122013.pdf']",3,60.0,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://files.nc.gov/ncdeq/Environmental%20Management%20Commission/EMC%20Meetings/2014/November%202014/Attachments/AttachA_to14-42HOR_triennial_review.pdf', 'https://purl.fdlp.gov/GPO/gpo75779']","['42457_1_americas children and the environment.pdf', '42457_3_triennial review.pdf', '42457_2_arsenic iron lead manganese and uranium concentrations in private bedrock wells in southeastern new hampshire 20122013.pdf']","[0.438, 0.319, 0.279]","[0.495, 0.482, 0.512]","[0.589, 0.578, 0.597]","[0.132, 0.112, 0.148]","[0.134, 0.131, 0.145]","[0.107, 0.109, 0.117]","[0.728, 0.72, 0.731]","[0.63, 0.627, 0.637]","[0.563, 0.558, 0.574]","[0.69, 0.679, 0.678]","[0.775, 0.774, 0.783]","[0.696, 0.701, 0.706]","[0.619, 0.621, 0.637]","[0.892, 0.901, 0.899]","[0.79, 0.803, 0.799]","[0.717, 0.721, 0.733]","[0.778, 0.779, 0.788]","[0.745, 0.748, 0.753]",0.345,0.496,0.588,0.131,0.137,0.111,0.726,0.631,0.565,0.682,0.777,0.701,0.626,0.897,0.797,0.724,0.782,0.749
https://doi.org/10.1289/ehp.1002928,impact of reduced maternal exposures to wood smoke from an introduced chimney stove on newborn birth weight in rural guatemala,42458_impact of reduced maternal exposures to wood smoke from an introduced chimney stove on newborn birth weight in rural guatemala.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498021/pdf', 'https://www.nber.org/papers/w18033', 'https://www.hks.harvard.edu/centers/cid/publications/faculty-working-papers/smoke', 'http://ceepr.mit.edu/publications/working-papers/17']","['Community‐based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes', 'Up in Smoke: The Influence of Household Behavior on the Long-Run Impact of Improved Cooking Stoves', 'The Long-Run Impact of Improved Cooking Stoves', 'Up in Smoke: The Influence of Household Behavior on the Long-Run Impact of Improved Cooking Stoves']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498021/pdf'],['42458_0_community‐based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes.pdf'],1,25.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498021/pdf'],['42458_0_community‐based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes.pdf'],[0.322],[0.528],[0.608],[0.164],[0.166],[0.13],[0.727],[0.63],[0.589],[0.677],[0.786],[0.704],[0.601],[0.911],[0.813],[0.738],[0.786],[0.764],0.322,0.528,0.608,0.164,0.166,0.13,0.727,0.63,0.589,0.677,0.786,0.704,0.601,0.911,0.813,0.738,0.786,0.764
https://doi.org/10.1289/ehp.1003035,neurotoxicity of brominated flame retardants indirect effects of parent and hydroxylated polybrominated diphenyl ethers on the developing nervous system,42459_neurotoxicity of brominated flame retardants indirect effects of parent and hydroxylated polybrominated diphenyl ethers on the developing nervous system.pdf,4,"['https://ntp.niehs.nih.gov/go/tr589abs', 'https://purl.fdlp.gov/GPO/gpo132700', 'https://purl.fdlp.gov/GPO/gpo88882', 'https://stacks.cdc.gov/view/cdc/45158']","['Toxicology Studies of a Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)] in F344/N Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of a Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)] in Wistar Han [Crl:WI(Han)] Rats and B6C3F1/N Mice (Gavage Studies)', 'Toxicological profile for polybrominated diphenyl ethers (PBDEs).', 'Exposure to a mixture of toxic chemicals :\xa0implications for the health of endangered southern resident killer whales /', 'Toxicological profile for polybrominated diphenyl ethers (PBDEs)']",['https://purl.fdlp.gov/GPO/gpo88882'],['42459_2_exposure to a mixture of toxic chemicals \xa0implications for the health of endangered southern resident killer whales .pdf'],1,25.0,['https://purl.fdlp.gov/GPO/gpo88882'],['42459_2_exposure to a mixture of toxic chemicals \xa0implications for the health of endangered southern resident killer whales .pdf'],[0.639],[0.488],[0.603],[0.141],[0.143],[0.112],[0.744],[0.657],[0.566],[0.672],[0.794],[0.661],[0.611],[0.909],[0.803],[0.736],[0.776],[0.77],0.639,0.488,0.603,0.141,0.143,0.112,0.744,0.657,0.566,0.672,0.794,0.661,0.611,0.909,0.803,0.736,0.776,0.77
https://doi.org/10.1289/ehp.1003178,prenatal exposure to phthalates and infant development at 6 months prospective mothers and children’s environmental health moceh study,42461_prenatal exposure to phthalates and infant development at 6 months prospective mothers and children’s environmental health moceh study.pdf,3,"['https://stacks.cdc.gov/view/cdc/113705', 'https://stacks.cdc.gov/view/cdc/84188', 'https://purl.fdlp.gov/GPO/gpo132911']","['Toxicological profile for Di(2-Ethylhexyl)Phthalate (DEHP)', 'Toxicological profile for Di(2-Ethylhexyl)Phthalate : draft for public comment', 'Toxicological profile for di(2-ethylhexyl)phthalate (DEHP): draft for public comment.']",['https://purl.fdlp.gov/GPO/gpo132911'],['42461_2_toxicological profile for di2ethylhexylphthalate dehp draft for public comment.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo132911'],['42461_2_toxicological profile for di2ethylhexylphthalate dehp draft for public comment.pdf'],[0.644],[0.473],[0.568],[0.142],[0.139],[0.113],[0.738],[0.643],[0.536],[0.689],[0.755],[0.649],[0.611],[0.868],[0.757],[0.673],[0.747],[0.698],0.644,0.473,0.568,0.142,0.139,0.113,0.738,0.643,0.536,0.689,0.755,0.649,0.611,0.868,0.757,0.673,0.747,0.698
https://doi.org/10.1289/ehp.10088,home indoor pollutant exposures among innercity children with and without asthma,42464_home indoor pollutant exposures among innercity children with and without asthma.pdf,2,"['https://www.allergyparameters.org/app/download/7983255270/2012+Furry+Animal+Allergy.pdf?t=1515169884', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519933/pdf']","['Environmental assessment and exposure control: a practice parameter—furry animals', 'Environmental assessment and exposure control: a practice parameter–furry animals']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519933/pdf', 'https://www.allergyparameters.org/app/download/7983255270/2012+Furry+Animal+Allergy.pdf?t=1515169884']","['42464_1_environmental assessment and exposure control a practice parameter–furry animals.pdf', '42464_0_environmental assessment and exposure control a practice parameter—furry animals.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519933/pdf', 'https://www.allergyparameters.org/app/download/7983255270/2012+Furry+Animal+Allergy.pdf?t=1515169884']","['42464_1_environmental assessment and exposure control a practice parameter–furry animals.pdf', '42464_0_environmental assessment and exposure control a practice parameter—furry animals.pdf']","[0.462, 0.444]","[0.514, 0.545]","[0.612, 0.626]","[0.154, 0.159]","[0.176, 0.181]","[0.14, 0.144]","[0.733, 0.732]","[0.633, 0.631]","[0.589, 0.61]","[0.666, 0.66]","[0.786, 0.806]","[0.69, 0.727]","[0.604, 0.63]","[0.914, 0.919]","[0.811, 0.824]","[0.744, 0.769]","[0.789, 0.811]","[0.775, 0.792]",0.453,0.53,0.619,0.157,0.178,0.142,0.732,0.632,0.599,0.663,0.796,0.708,0.617,0.917,0.818,0.756,0.8,0.784
https://doi.org/10.1289/ehp.10131,arsenic as an endocrine disruptor arsenic disrupts retinoic acid receptor–and thyroid hormone receptor–mediated gene regulation and thyroid hormone–mediated amphibian tail metamorphosis,42465_arsenic as an endocrine disruptor arsenic disrupts retinoic acid receptor–and thyroid hormone receptor–mediated gene regulation and thyroid hormone–mediated amphibian tail metamorphosis.pdf,2,"['http://purl.fdlp.gov/GPO/gpo68729', 'https://www.congress.gov/event/111th-congress/house-event/LC7159/text']","['Arsenic concentrations, related environmental factors, and the predicted probability of elevated arsenic in groundwater in Pennsylvania /', 'House Hearing, 111th Congress — ENDOCRINE-DISRUPTING CHEMICALS IN DRINKING WATER: RISKS TO HUMAN HEALTH AND THE ENVIRONMENT']",['http://purl.fdlp.gov/GPO/gpo68729'],['42465_0_arsenic concentrations related environmental factors and the predicted probability of elevated arsenic in groundwater in pennsylvania .pdf'],1,50.0,['http://purl.fdlp.gov/GPO/gpo68729'],['42465_0_arsenic concentrations related environmental factors and the predicted probability of elevated arsenic in groundwater in pennsylvania .pdf'],[0.132],[0.493],[0.587],[0.088],[0.072],[0.059],[0.726],[0.628],[0.582],[0.633],[0.792],[0.701],[0.607],[0.901],[0.812],[0.756],[0.791],[0.779],0.132,0.493,0.587,0.088,0.072,0.059,0.726,0.628,0.582,0.633,0.792,0.701,0.607,0.901,0.812,0.756,0.791,0.779
https://doi.org/10.1289/ehp.10155,developing asthma in childhood from exposure to secondhand tobacco smoke  insights from a metaregression,42466_developing asthma in childhood from exposure to secondhand tobacco smoke  insights from a metaregression.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770205/pdf'],['Allergy Prevention'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770205/pdf'],['42466_0_allergy prevention.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770205/pdf'],['42466_0_allergy prevention.pdf'],[0.414],[0.541],[0.637],[0.185],[0.212],[0.161],[0.73],[0.632],[0.613],[0.693],[0.81],[0.736],[0.62],[0.924],[0.832],[0.768],[0.803],[0.785],0.414,0.541,0.637,0.185,0.212,0.161,0.73,0.632,0.613,0.693,0.81,0.736,0.62,0.924,0.832,0.768,0.803,0.785
https://doi.org/10.1289/ehp.10166,depuration of polybrominated diphenyl ethers pbdes and polychlorinated biphenyls pcbs in breast milk from california firsttime mothers primiparae,42467_depuration of polybrominated diphenyl ethers pbdes and polychlorinated biphenyls pcbs in breast milk from california firsttime mothers primiparae.pdf,3,"['https://purl.fdlp.gov/GPO/gpo132700', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://stacks.cdc.gov/view/cdc/45158']","['Toxicological profile for polybrominated diphenyl ethers (PBDEs).', 'America’s children and the environment.', 'Toxicological profile for polybrominated diphenyl ethers (PBDEs)']",['https://purl.fdlp.gov/GPO/gpo63641'],['42467_1_americas children and the environment.pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo63641'],['42467_1_americas children and the environment.pdf'],[0.266],[0.509],[0.601],[0.129],[0.135],[0.1],[0.727],[0.633],[0.582],[0.686],[0.794],[0.696],[0.621],[0.907],[0.815],[0.753],[0.796],[0.781],0.266,0.509,0.601,0.129,0.135,0.1,0.727,0.633,0.582,0.686,0.794,0.696,0.621,0.907,0.815,0.753,0.796,0.781
https://doi.org/10.1289/ehp.10497,ambient ozone concentrations cause increased hospitalizations for asthma in children an 18year study in southern california,42472_ambient ozone concentrations cause increased hospitalizations for asthma in children an 18year study in southern california.pdf,9,"['http://purl.fdlp.gov/GPO/gpo57115', 'https://planning.lacity.org/StaffRpt/InitialRpts/DIR-2017-1708.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/07-309.pdf', 'http://purl.fdlp.gov/GPO/gpo54607', 'https://www3.epa.gov/ttn/naaqs/standards/ozone/data/20140829healthrea.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreenver11report.pdf', 'https://clkrep.lacity.org/onlinedocs/2021/21-0134_misc_01-29-2021.0001.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/ces20publicreview04212014.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/ces3report.pdf']","['Policy assessment for the review of the Ozone National Ambient Air Quality Standards /', 'City Planning Commission', 'Is disparity in asthma among Californians due to higher pollution exposures, greater vulnerability, or both?', 'Health risk and exposure assessment for ozone :\xa0final report.', 'Health Risk and Exposure Assessment for Ozone', 'CalEnviroscreen Version 1.1', 'City Planning Commission', 'Draft California Communities Environmental Health Screening Tool (CalEnviroScreen 2.0)', 'CalEnviroScreen 3.0']",['https://oehha.ca.gov/media/downloads/calenviroscreen/report/ces3report.pdf'],['42472_8_calenviroscreen 30.pdf'],1,11.11,['https://oehha.ca.gov/media/downloads/calenviroscreen/report/ces3report.pdf'],['42472_8_calenviroscreen 30.pdf'],[0.397],[0.532],[0.622],[0.144],[0.151],[0.117],[0.727],[0.631],[0.61],[0.703],[0.81],[0.736],[0.636],[0.918],[0.838],[0.768],[0.81],[0.793],0.397,0.532,0.622,0.144,0.151,0.117,0.727,0.631,0.61,0.703,0.81,0.736,0.636,0.918,0.838,0.768,0.81,0.793
https://doi.org/10.1289/ehp.10553,prenatal organochlorine exposure and measures of behavior in infancy using the neonatal behavioral assessment scale nbas,42474_prenatal organochlorine exposure and measures of behavior in infancy using the neonatal behavioral assessment scale nbas.pdf,8,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://stacks.cdc.gov/view/cdc/84022', 'https://stacks.cdc.gov/view/cdc/83602', 'https://purl.fdlp.gov/GPO/gpo132907', 'https://www.congress.gov/event/111th-congress/house-event/LC5623/text', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'America’s children and the environment.', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013', 'Toxicological profile for 1,1-Dichloroethene : draft for public comment', 'Toxicological profile for DDT, DDE, and DDD : draft for public comment', 'Toxicological profile for DDT, DDE, and DDD: draft for public comment.', 'House Hearing, 111th Congress — H.R. 5820, THE TOXIC CHEMICALS SAFETY ACT OF 2010', 'Recognition and Management of Pesticide Poisonings: Sixth Edition: 2013: Chapter 21 Chronic Effects']","['https://purl.fdlp.gov/GPO/gpo132907', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42474_5_toxicological profile for ddt dde and ddd draft for public comment.pdf', '42474_7_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42474_2_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42474_1_americas children and the environment.pdf']",4,50.0,"['https://purl.fdlp.gov/GPO/gpo132907', 'https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch21_chroniceffects.pdf', 'https://www.epa.gov/sites/default/files/2015-01/documents/rmpp_6thed_final_lowresopt.pdf', 'https://purl.fdlp.gov/GPO/gpo63641']","['42474_5_toxicological profile for ddt dde and ddd draft for public comment.pdf', '42474_7_recognition and management of pesticide poisonings sixth edition 2013 chapter 21 chronic effects.pdf', '42474_2_recognition and management of pesticide poisonings sixth edition 2013.pdf', '42474_1_americas children and the environment.pdf']","[0.394, 0.255, 0.578, 0.388]","[0.512, 0.519, 0.502, 0.501]","[0.607, 0.615, 0.601, 0.602]","[0.137, 0.145, 0.112, 0.133]","[0.136, 0.149, 0.118, 0.133]","[0.105, 0.109, 0.086, 0.103]","[0.733, 0.732, 0.724, 0.729]","[0.641, 0.638, 0.624, 0.633]","[0.577, 0.592, 0.588, 0.572]","[0.673, 0.667, 0.627, 0.68]","[0.789, 0.799, 0.797, 0.788]","[0.675, 0.708, 0.703, 0.689]","[0.609, 0.608, 0.607, 0.612]","[0.905, 0.916, 0.917, 0.906]","[0.807, 0.807, 0.81, 0.806]","[0.743, 0.752, 0.752, 0.742]","[0.78, 0.791, 0.791, 0.785]","[0.766, 0.776, 0.776, 0.77]",0.404,0.509,0.606,0.132,0.134,0.101,0.73,0.634,0.582,0.662,0.793,0.694,0.609,0.911,0.808,0.747,0.787,0.772
https://doi.org/10.1289/ehp.10596,household exposure to pesticides and risk of childhood hematopoietic malignancies the escale study sfce,42475_household exposure to pesticides and risk of childhood hematopoietic malignancies the escale study sfce.pdf,3,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'America’s children and the environment.', 'Childhood Cancer']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf']","['42475_1_americas children and the environment.pdf', '42475_2_childhood cancer.pdf']",2,66.67,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf']","['42475_1_americas children and the environment.pdf', '42475_2_childhood cancer.pdf']","[0.299, 0.269]","[0.505, 0.511]","[0.599, 0.607]","[0.144, 0.143]","[0.146, 0.154]","[0.112, 0.116]","[0.727, 0.728]","[0.628, 0.627]","[0.573, 0.582]","[0.677, 0.696]","[0.793, 0.79]","[0.692, 0.692]","[0.616, 0.623]","[0.906, 0.91]","[0.809, 0.816]","[0.748, 0.751]","[0.789, 0.788]","[0.773, 0.772]",0.284,0.508,0.603,0.143,0.15,0.114,0.728,0.627,0.577,0.686,0.792,0.692,0.619,0.908,0.812,0.75,0.788,0.772
https://doi.org/10.1289/ehp.10767,longterm effects of trafficrelated air pollution on mortality in a dutch cohort nlcsair study,42476_longterm effects of trafficrelated air pollution on mortality in a dutch cohort nlcsair study.pdf,9,"['https://www.tceq.texas.gov/assets/public/implementation/tox/comments/2014%20epa%20%20nox.pdf', 'https://www3.epa.gov/ttnamti1/files/20072008csatam/bostonbcreport.pdf', 'https://www.congress.gov/event/112th-congress/house-event/LC3819/text', 'https://clkrep.lacity.org/onlinedocs/2021/21-0134_misc_01-29-2021.0001.pdf', 'https://www.c2es.org/document/black-carbon-a-sciencepolicy-primer/', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf', 'https://www.michigan.gov/documents/mdhhs/MI_Climate_and_Health_Profile_517517_7.pdf', 'https://dnr.mo.gov/env/apcp/docs/appndx-g-modeling-reports.pdf', 'https://planning.lacity.org/StaffRpt/InitialRpts/DIR-2017-1708.pdf']","['Microsoft Word - TD_NOx ISA comments.docx', 'Prepared by NESCAUM', ""House Hearing, 112th Congress — THE AMERICAN ENERGY INITIATIVE, PART 15: WHAT EPA'S UTILITY MACT RULE WILL COST U.S. CONSUMERS"", 'City Planning Commission', 'Black Carbon: A Science/Policy Primer', 'Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association', 'Michigan Climate and Health Profile Report 2015', 'Microsoft Word - Appendix G.docx', 'City Planning Commission']","['https://www.michigan.gov/documents/mdhhs/MI_Climate_and_Health_Profile_517517_7.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf']","['42476_6_michigan climate and health profile report 2015.pdf', '42476_5_particulate matter air pollution and cardiovascular disease an update to the scientific statement from the american heart association.pdf']",2,22.22,"['https://www.michigan.gov/documents/mdhhs/MI_Climate_and_Health_Profile_517517_7.pdf', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf']","['42476_6_michigan climate and health profile report 2015.pdf', '42476_5_particulate matter air pollution and cardiovascular disease an update to the scientific statement from the american heart association.pdf']","[0.511, 0.21]","[0.515, 0.534]","[0.607, 0.623]","[0.132, 0.174]","[0.122, 0.176]","[0.104, 0.141]","[0.721, 0.734]","[0.619, 0.639]","[0.59, 0.61]","[0.681, 0.708]","[0.796, 0.8]","[0.719, 0.735]","[0.633, 0.626]","[0.915, 0.914]","[0.818, 0.822]","[0.754, 0.76]","[0.8, 0.801]","[0.777, 0.78]",0.36,0.524,0.615,0.153,0.149,0.122,0.728,0.629,0.6,0.695,0.798,0.727,0.629,0.915,0.82,0.757,0.8,0.778
https://doi.org/10.1289/ehp.108-1638158,childrens exposure assessment a review of factors influencing childrens exposure and the data available to characterize and assess that exposure,42479_childrens exposure assessment a review of factors influencing childrens exposure and the data available to characterize and assess that exposure.pdf,5,"['https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreenver11report.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/spanishces20publicreview04222014posted.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreen2011spanish.pdf', 'https://www.epa.gov/sites/default/files/2020-01/documents/guidelines_for_human_exposure_assessment_final2019.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/document-calenviroscreen/raceageces3analysis.pdf']","['CalEnviroscreen Version 1.1', 'Instrumento Instrumento Tentativo de Evaluación de la Salud Ambiental en las Comunidades de California, Versión 2.0', 'INSTRUMENTO DE EVALUACIÓN DE LA SALUD AMBIENTAL EN LAS COMUNIDADES DE CALIFORNIA, CalEnviroScreen 1.1', 'Guidelines for Human Exposure Assessment Risk Assessment Forum', 'Analysis of Race/Ethnicity, Age, and CalEnviroScreen 3.0 Scores']","['https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreenver11report.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreen2011spanish.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/document-calenviroscreen/raceageces3analysis.pdf', 'https://www.epa.gov/sites/default/files/2020-01/documents/guidelines_for_human_exposure_assessment_final2019.pdf']","['42479_0_calenviroscreen version 11.pdf', '42479_2_instrumento de evaluación de la salud ambiental en las comunidades de california calenviroscreen 11.pdf', '42479_4_analysis of raceethnicity age and calenviroscreen 30 scores.pdf', '42479_3_guidelines for human exposure assessment risk assessment forum.pdf']",4,80.0,"['https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreenver11report.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreen2011spanish.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/document-calenviroscreen/raceageces3analysis.pdf', 'https://www.epa.gov/sites/default/files/2020-01/documents/guidelines_for_human_exposure_assessment_final2019.pdf']","['42479_0_calenviroscreen version 11.pdf', '42479_2_instrumento de evaluación de la salud ambiental en las comunidades de california calenviroscreen 11.pdf', '42479_4_analysis of raceethnicity age and calenviroscreen 30 scores.pdf', '42479_3_guidelines for human exposure assessment risk assessment forum.pdf']","[0.335, 0.023, 0.549, 0.344]","[0.562, 0.45, 0.573, 0.559]","[0.651, 0.57, 0.658, 0.653]","[0.156, 0.128, 0.18, 0.17]","[0.16, 0.143, 0.18, 0.181]","[0.128, 0.109, 0.144, 0.15]","[0.727, 0.719, 0.735, 0.735]","[0.627, 0.629, 0.634, 0.635]","[0.638, 0.519, 0.642, 0.621]","[0.673, 0.645, 0.678, 0.683]","[0.82, 0.784, 0.826, 0.804]","[0.762, 0.692, 0.775, 0.74]","[0.655, 0.568, 0.662, 0.654]","[0.927, 0.863, 0.929, 0.926]","[0.847, 0.811, 0.854, 0.843]","[0.789, 0.712, 0.792, 0.774]","[0.827, 0.756, 0.831, 0.815]","[0.808, 0.729, 0.811, 0.797]",0.313,0.536,0.633,0.159,0.166,0.133,0.729,0.631,0.605,0.67,0.808,0.742,0.635,0.911,0.839,0.767,0.807,0.786
https://doi.org/10.1289/ehp.10829,exposure to bisphenol a prenatally or in adulthood promotes t h 2 cytokine production associated with reduction of cd4  cd25  regulatory t cells,42480_exposure to bisphenol a prenatally or in adulthood promotes t h 2 cytokine production associated with reduction of cd4  cd25  regulatory t cells.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['42480_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['42480_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.553],[0.534],[0.625],[0.151],[0.153],[0.118],[0.74],[0.647],[0.604],[0.652],[0.802],[0.703],[0.621],[0.91],[0.815],[0.762],[0.798],[0.783],0.553,0.534,0.625,0.151,0.153,0.118,0.74,0.647,0.604,0.652,0.802,0.703,0.621,0.91,0.815,0.762,0.798,0.783
https://doi.org/10.1289/ehp.10831,relation between cord blood mercury levels and early child development in a world trade center cohort,42481_relation between cord blood mercury levels and early child development in a world trade center cohort.pdf,10,"['https://www.federalregister.gov/documents/2012/02/16/2012-806/national-emission-standards-for-hazardous-air-pollutants-from-coal--and-oil-fired-electric-utility', 'https://stacks.cdc.gov/view/cdc/117446', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf', 'https://www.nrdc.org/resources/strengthening-toxic-chemical-risk-assessments-protect-human-health', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.congress.gov/event/116th-congress/house-event/110455', 'https://www.congress.gov/event/112th-congress/house-event/LC3819/text', 'https://www.congress.gov/event/111th-congress/house-event/LC5623/text', 'https://www.rand.org/pubs/research_reports/RRA390-1.html', 'https://stacks.cdc.gov/view/cdc/5976']","['National Emission Standards for Hazardous Air Pollutants From Coal- and Oil-Fired Electric Utility Steam Generating Units and Standards of Performance for Fossil-Fuel-Fired Electric Utility, Industrial-Commercial-Institutional, and Small Industrial-Commercial-Institutional Steam Generating Units', 'Toxicological profile for mercury : draft for public comment : April 2022', 'Pmangrum on DSK3VPTVN1PROD with RULES', 'Strengthening Toxic Chemical Risk Assessments to Protect Human Health', 'America’s children and the environment.', '“A Threat to America’s Children: The Trump Administration’s Proposal to Undermine Protections from Mercury Air Toxics Standards.”', ""House Hearing, 112th Congress — THE AMERICAN ENERGY INITIATIVE, PART 15: WHAT EPA'S UTILITY MACT RULE WILL COST U.S. CONSUMERS"", 'House Hearing, 111th Congress — H.R. 5820, THE TOXIC CHEMICALS SAFETY ACT OF 2010', 'Translational Impacts of World Trade Center Health Program Research', 'First periodic review of scientific and medical evidence related to cancer for the World Trade Center Health Program']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf']","['42481_4_americas children and the environment.pdf', '42481_2_pmangrum on dsk3vptvn1prod with rules.pdf']",2,20.0,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf']","['42481_4_americas children and the environment.pdf', '42481_2_pmangrum on dsk3vptvn1prod with rules.pdf']","[0.001, 0.385]","[0.509, 0.464]","[0.599, 0.576]","[0.14, 0.027]","[0.142, 0.038]","[0.109, 0.018]","[0.727, 0.696]","[0.634, 0.568]","[0.577, 0.567]","[0.678, 0.708]","[0.792, 0.812]","[0.699, 0.753]","[0.62, 0.558]","[0.91, 0.929]","[0.81, 0.852]","[0.749, 0.68]","[0.792, 0.814]","[0.778, 0.787]",0.193,0.487,0.587,0.084,0.09,0.064,0.712,0.601,0.572,0.693,0.802,0.726,0.589,0.919,0.831,0.715,0.803,0.782
https://doi.org/10.1289/ehp.10862,lowlevel human equivalent gestational lead exposure produces sexspecific motor and coordination abnormalities and lateonset obesity in yearold mice,42482_lowlevel human equivalent gestational lead exposure produces sexspecific motor and coordination abnormalities and lateonset obesity in yearold mice.pdf,3,"['https://purl.fdlp.gov/GPO/gpo119412', 'https://stacks.cdc.gov/view/cdc/26445', 'https://stacks.cdc.gov/view/cdc/11859']","['Low level lead exposure harms children :\xa0a renewed call for primary prevention /', 'Low level lead exposure harms children : a renewed call for primary prevention : report of the Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention', 'Low level lead exposure harms children; a renewed call for primary prevention']",['https://purl.fdlp.gov/GPO/gpo119412'],['42482_0_low level lead exposure harms children \xa0a renewed call for primary prevention .pdf'],1,33.33,['https://purl.fdlp.gov/GPO/gpo119412'],['42482_0_low level lead exposure harms children \xa0a renewed call for primary prevention .pdf'],[0.416],[0.53],[0.627],[0.151],[0.161],[0.126],[0.724],[0.629],[0.607],[0.641],[0.808],[0.727],[0.615],[0.919],[0.828],[0.769],[0.806],[0.794],0.416,0.53,0.627,0.151,0.161,0.126,0.724,0.629,0.607,0.641,0.808,0.727,0.615,0.919,0.828,0.769,0.806,0.794
https://doi.org/10.1289/ehp.109-1240626,review of the epidemiologic literature on emf and health,42483_review of the epidemiologic literature on emf and health.pdf,1,['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf'],"['Martin Blank, PhD Columbia University New York, NY 10032 email : mb32 @ cumc. columbia. edu']",['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf'],['42483_0_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf'],1,100.0,['http://clkrep.lacity.org/onlinedocs/2013/13-0953_pc_05-05-16c.pdf'],['42483_0_martin blank phd columbia university new york ny 10032 email  mb32  cumc columbia edu.pdf'],[0.497],[0.547],[0.626],[0.135],[0.125],[0.097],[0.73],[0.636],[0.625],[0.671],[0.805],[0.745],[0.645],[0.916],[0.832],[0.776],[0.806],[0.789],0.497,0.547,0.626,0.135,0.125,0.097,0.73,0.636,0.625,0.671,0.805,0.745,0.645,0.916,0.832,0.776,0.806,0.789
https://doi.org/10.1289/ehp.10945,environmental public health tracking of childhood asthma using california health interview survey traffic and outdoor air pollution data,42484_environmental public health tracking of childhood asthma using california health interview survey traffic and outdoor air pollution data.pdf,2,"['https://www.nrdc.org/resources/clean-cargo-center', 'https://www.sanjoseca.gov/Home/ShowDocument?id=59127']","['Clean Cargo Center', 'Draft Environmental Impact Report']",['https://www.sanjoseca.gov/Home/ShowDocument?id=59127'],['42484_1_draft environmental impact report.pdf'],1,50.0,['https://www.sanjoseca.gov/Home/ShowDocument?id=59127'],['42484_1_draft environmental impact report.pdf'],[0.221],[0.539],[0.621],[0.131],[0.134],[0.104],[0.715],[0.615],[0.615],[0.673],[0.809],[0.732],[0.646],[0.917],[0.847],[0.772],[0.813],[0.795],0.221,0.539,0.621,0.131,0.134,0.104,0.715,0.615,0.615,0.673,0.809,0.732,0.646,0.917,0.847,0.772,0.813,0.795
https://doi.org/10.1289/ehp.1103639,lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke shape of the exposure–response relationships,42485_lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke shape of the exposure–response relationships.pdf,7,"['https://www.nber.org/papers/w28708', 'https://www.nber.org/papers/w19881?sy=881', 'https://www.rff.org/publications/working-papers/one-off-subsidies-and-long-run-adoption-experimental-evidence-on-improved-cooking-stoves-in-senegal/', 'https://www.rff.org/publications/working-papers/how-should-the-world-bank-estimate-air-pollution-damages/', 'https://www.nber.org/papers/w21647?sy=647', 'https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121214rtc.pdf', 'https://www.nber.org/papers/w21301?sy=301']","['(Re)scheduling Pollution Exposure: The Case of Surgery Schedules', 'Coal, Smoke, and Death: Bituminous Coal and American Home Heating', 'One-Off Subsidies and Long-Run Adoption: Experimental Evidence on Improved Cooking Stoves in Senegal', 'How Should the World Bank Estimate Air Pollution Damages?', 'Pollution and Mortality in the 19th Century', 'Docket Number EPA-HQ-OAR-2007-0492', 'Self-Protection Investment Exacerbates Air Pollution Exposure Inequality in Urban China']",['https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121214rtc.pdf'],['42485_5_docket number epahqoar20070492.pdf'],1,14.29,['https://www3.epa.gov/ttn/naaqs/standards/pm/data/20121214rtc.pdf'],['42485_5_docket number epahqoar20070492.pdf'],[0.439],[0.535],[0.623],[0.165],[0.175],[0.141],[0.73],[0.638],[0.593],[0.717],[0.795],[0.716],[0.645],[0.915],[0.823],[0.759],[0.801],[0.78],0.439,0.535,0.623,0.165,0.175,0.141,0.73,0.638,0.593,0.717,0.795,0.716,0.645,0.915,0.823,0.759,0.801,0.78
https://doi.org/10.1289/ehp.1103942,in utero pesticide exposure and leukemia in brazilian children  2 years of age,42486_in utero pesticide exposure and leukemia in brazilian children  2 years of age.pdf,3,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=5480523&GUID=73FA02F7-60D1-4AC7-B4B6-470EC190CE38', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.epa.gov/sites/default/files/2019-08/documents/tier-ii-epidemiology-report.pdf']","['Health', 'Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'US EPA - Pyrethroids: Tier II Epidemiology Report']","['https://www.epa.gov/sites/default/files/2019-08/documents/tier-ii-epidemiology-report.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=5480523&GUID=73FA02F7-60D1-4AC7-B4B6-470EC190CE38']","['42486_2_us epa  pyrethroids tier ii epidemiology report.pdf', '42486_0_health.pdf']",2,66.67,"['https://www.epa.gov/sites/default/files/2019-08/documents/tier-ii-epidemiology-report.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=5480523&GUID=73FA02F7-60D1-4AC7-B4B6-470EC190CE38']","['42486_2_us epa  pyrethroids tier ii epidemiology report.pdf', '42486_0_health.pdf']","[0.527, 0.575]","[0.483, 0.468]","[0.579, 0.572]","[0.149, 0.14]","[0.15, 0.148]","[0.123, 0.128]","[0.734, 0.735]","[0.643, 0.641]","[0.532, 0.532]","[0.692, 0.669]","[0.759, 0.765]","[0.653, 0.648]","[0.611, 0.602]","[0.897, 0.906]","[0.766, 0.772]","[0.722, 0.717]","[0.747, 0.751]","[0.739, 0.748]",0.551,0.476,0.575,0.145,0.149,0.126,0.734,0.642,0.532,0.68,0.762,0.651,0.607,0.901,0.769,0.72,0.749,0.744
https://doi.org/10.1289/ehp.1104315,prenatal polycyclic aromatic hydrocarbon pah exposure and child behavior at age 6–7 years,42488_prenatal polycyclic aromatic hydrocarbon pah exposure and child behavior at age 6–7 years.pdf,5,"['https://www.nber.org/papers/w18935', 'http://purl.fdlp.gov/GPO/gpo72216', 'https://www.epa.gov/sites/default/files/2015-09/documents/cehc-brochure-2014.pdf', 'https://www.epa.gov/sites/default/files/2020-01/documents/memphis_pahs_study_final_report_08.pdf', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/DelridgeActionPlan/DelridgeActionPlanHealthImpactAssessment.pdf']","['Environment, Health, and Human Capital', 'NIEHS/EPA children’s environmental health and disease prevention research centers :\xa0protecting chidren’s health for a lifetime.', 'NIEHS/EPA Children’s Environmental Health and Disease Prevention Research Center', 'Characterizing Community Exposure to Atmospheric Polycyclic Aromatic Hydrocarbons (PAHs) in The Memphis Tri-State Area', 'Seattle DPD - Delridge Action Plan Health Impact Assessment']","['https://www.epa.gov/sites/default/files/2015-09/documents/cehc-brochure-2014.pdf', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/DelridgeActionPlan/DelridgeActionPlanHealthImpactAssessment.pdf', 'https://www.epa.gov/sites/default/files/2020-01/documents/memphis_pahs_study_final_report_08.pdf', 'http://purl.fdlp.gov/GPO/gpo72216']","['42488_2_niehsepa childrens environmental health and disease prevention research center.pdf', '42488_4_seattle dpd  delridge action plan health impact assessment.pdf', '42488_3_characterizing community exposure to atmospheric polycyclic aromatic hydrocarbons pahs in the memphis tristate area.pdf', '42488_1_niehsepa childrens environmental health and disease prevention research centers \xa0protecting chidrens health for a lifetime.pdf']",4,80.0,"['https://www.epa.gov/sites/default/files/2015-09/documents/cehc-brochure-2014.pdf', 'http://www.seattle.gov/Documents/Departments/OPCD/OngoingInitiatives/DelridgeActionPlan/DelridgeActionPlanHealthImpactAssessment.pdf', 'https://www.epa.gov/sites/default/files/2020-01/documents/memphis_pahs_study_final_report_08.pdf', 'http://purl.fdlp.gov/GPO/gpo72216']","['42488_2_niehsepa childrens environmental health and disease prevention research center.pdf', '42488_4_seattle dpd  delridge action plan health impact assessment.pdf', '42488_3_characterizing community exposure to atmospheric polycyclic aromatic hydrocarbons pahs in the memphis tristate area.pdf', '42488_1_niehsepa childrens environmental health and disease prevention research centers \xa0protecting chidrens health for a lifetime.pdf']","[0.385, 0.385, 0.27, 0.176]","[0.513, 0.493, 0.497, 0.513]","[0.622, 0.591, 0.587, 0.622]","[0.164, 0.092, 0.126, 0.164]","[0.178, 0.099, 0.126, 0.178]","[0.136, 0.077, 0.098, 0.136]","[0.738, 0.72, 0.729, 0.738]","[0.64, 0.62, 0.633, 0.64]","[0.59, 0.573, 0.568, 0.59]","[0.68, 0.637, 0.679, 0.68]","[0.8, 0.792, 0.782, 0.8]","[0.717, 0.707, 0.685, 0.717]","[0.604, 0.616, 0.619, 0.604]","[0.91, 0.912, 0.904, 0.91]","[0.805, 0.805, 0.805, 0.805]","[0.751, 0.744, 0.739, 0.751]","[0.794, 0.789, 0.776, 0.794]","[0.78, 0.77, 0.764, 0.78]",0.304,0.504,0.606,0.137,0.145,0.112,0.731,0.633,0.58,0.669,0.794,0.707,0.611,0.909,0.805,0.746,0.788,0.774
https://doi.org/10.1289/ehp.1104526,bisphenol a induces gene expression changes and proliferative effects through gper in breast cancer cells and cancerassociated fibroblasts,42490_bisphenol a induces gene expression changes and proliferative effects through gper in breast cancer cells and cancerassociated fibroblasts.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['42490_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['42490_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.594],[0.524],[0.617],[0.157],[0.151],[0.116],[0.743],[0.654],[0.6],[0.671],[0.795],[0.689],[0.618],[0.9],[0.803],[0.759],[0.791],[0.778],0.594,0.524,0.617,0.157,0.151,0.116,0.743,0.654,0.6,0.671,0.795,0.689,0.618,0.9,0.803,0.759,0.791,0.778
https://doi.org/10.1289/ehp.1104538,relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother–child pairs in a population with perfluorooctanoate exposure from drinking water,42491_relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother–child pairs in a population with perfluorooctanoate exposure from drinking water.pdf,9,"['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.congress.gov/event/116th-congress/house-event/109020', 'https://www.epa.gov/sites/default/files/2016-05/documents/hesd_pfos_final-plain.pdf', 'https://purl.fdlp.gov/GPO/gpo94037', 'https://www.nj.gov/dep/watersupply/pdf/pfna-health-effects.pdf', 'https://www.nj.gov/dep/dsr/supportdocs/PFNA_TSD.pdf', 'https://www.nj.gov/dep/watersupply/pdf/pfoa-hb--mcl-public-review-draftwithappendices.pdf', 'https://www.nj.gov/dep/dsr/supportdocs/PFOA_TSD.pdf', 'https://www.nj.gov/dep/watersupply/pdf/pfoa-appendixa.pdf']","['Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Examining PFAS Chemicals and their Risks', 'Health Effects Support Document for Perfluorooctane Sulfonate (PFOS)', 'Toxicological profile for perfluoroalkyls: draft for public comment.', 'HEALTH-BASED MAXIMUM CONTAMINANT LEVEL SUPPORT DOCUMENT: PERFLUORONONANOIC ACID( PFNA)', 'TECHNICAL SUPPORT DOCUMENT: INTERIM SPECIFIC GROUND WATER CRITERION FOR PERFLUORONONANOIC ACID (PFNA, C9) (CAS #: 375-95-1; Chemical Structure: CF3(CF2)7COOH)', 'PUBLIC REVIEW DRAFT', 'TECHNICAL SUPPORT DOCUMENT : INTERIM SPECIFIC GROUND WATER CRITERION FOR PERFLUOROOCTANOIC ACID (PFOA, C8) (CAS #: 335-67-1 ; Chemical Structure : CF3 (CF2) 6COOH )*', 'HEALTH-BASED MAXIMUM CONTAMINANT LEVEL SUPPORT DOCUMENT - PFOA - APPENDIX A']","['https://www.nj.gov/dep/watersupply/pdf/pfna-health-effects.pdf', 'https://www.epa.gov/sites/default/files/2016-05/documents/hesd_pfos_final-plain.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.nj.gov/dep/dsr/supportdocs/PFNA_TSD.pdf']","['42491_4_healthbased maximum contaminant level support document perfluorononanoic acid pfna.pdf', '42491_2_health effects support document for perfluorooctane sulfonate pfos.pdf', '42491_0_per and polyfluoroalkyl substances chemical action plan.pdf', '42491_5_technical support document interim specific ground water criterion for perfluorononanoic acid pfna c9 cas  375951 chemical structure cf3cf27cooh.pdf']",4,44.44,"['https://www.nj.gov/dep/watersupply/pdf/pfna-health-effects.pdf', 'https://www.epa.gov/sites/default/files/2016-05/documents/hesd_pfos_final-plain.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.nj.gov/dep/dsr/supportdocs/PFNA_TSD.pdf']","['42491_4_healthbased maximum contaminant level support document perfluorononanoic acid pfna.pdf', '42491_2_health effects support document for perfluorooctane sulfonate pfos.pdf', '42491_0_per and polyfluoroalkyl substances chemical action plan.pdf', '42491_5_technical support document interim specific ground water criterion for perfluorononanoic acid pfna c9 cas  375951 chemical structure cf3cf27cooh.pdf']","[0.284, 0.492, 0.359, 0.366]","[0.502, 0.512, 0.511, 0.501]","[0.598, 0.605, 0.611, 0.597]","[0.151, 0.162, 0.157, 0.15]","[0.145, 0.159, 0.156, 0.144]","[0.122, 0.133, 0.129, 0.123]","[0.734, 0.736, 0.732, 0.735]","[0.644, 0.643, 0.64, 0.644]","[0.568, 0.577, 0.587, 0.567]","[0.684, 0.677, 0.657, 0.681]","[0.784, 0.786, 0.795, 0.785]","[0.662, 0.67, 0.688, 0.659]","[0.613, 0.624, 0.62, 0.615]","[0.903, 0.902, 0.911, 0.902]","[0.804, 0.806, 0.818, 0.809]","[0.739, 0.745, 0.751, 0.737]","[0.774, 0.777, 0.786, 0.774]","[0.759, 0.761, 0.772, 0.761]",0.375,0.506,0.603,0.155,0.151,0.127,0.734,0.643,0.575,0.675,0.788,0.67,0.618,0.905,0.809,0.743,0.778,0.763
https://doi.org/10.1289/ehp.1104785,nearroadway pollution and childhood asthma implications for developing “win–win” compact urban development and clean vehicle strategies,42492_nearroadway pollution and childhood asthma implications for developing “win–win” compact urban development and clean vehicle strategies.pdf,4,"['https://www.ncbi.nlm.nih.gov/books/n/surgwalking/', 'http://cao.lacity.org/minwagerfp-2014/RFP%20Response%20for%20UCBerkeley.pdf', 'https://purl.fdlp.gov/GPO/gpo108779', 'https://www.cdph.ca.gov/Programs/CCDPHP/DEODC/EHIB/CPE/CDPH%20Document%20Library/Mold/HealthyHousingIndicators.pdf']","['Step It Up!', 'Berkeley • Davis • Irvine • Los Angeles • Merced • Riverside • San Diego • San Francisco Santa Barbara • Santa Cruz', 'Step it up! (United States. Public Health Service. Office of the Surgeon General)', 'The Overlapping Issues of Health and Housing: A Report on California Statewide Data and Healthy Housing Indicators']","['https://www.cdph.ca.gov/Programs/CCDPHP/DEODC/EHIB/CPE/CDPH%20Document%20Library/Mold/HealthyHousingIndicators.pdf', 'https://purl.fdlp.gov/GPO/gpo108779']","['42492_3_the overlapping issues of health and housing a report on california statewide data and healthy housing indicators.pdf', '42492_2_step it up united states public health service office of the surgeon general.pdf']",2,50.0,"['https://www.cdph.ca.gov/Programs/CCDPHP/DEODC/EHIB/CPE/CDPH%20Document%20Library/Mold/HealthyHousingIndicators.pdf', 'https://purl.fdlp.gov/GPO/gpo108779']","['42492_3_the overlapping issues of health and housing a report on california statewide data and healthy housing indicators.pdf', '42492_2_step it up united states public health service office of the surgeon general.pdf']","[0.199, 0.228]","[0.531, 0.511]","[0.617, 0.607]","[0.156, 0.133]","[0.155, 0.137]","[0.128, 0.11]","[0.727, 0.728]","[0.63, 0.628]","[0.597, 0.585]","[0.686, 0.676]","[0.796, 0.794]","[0.726, 0.716]","[0.642, 0.608]","[0.911, 0.919]","[0.822, 0.812]","[0.761, 0.74]","[0.801, 0.797]","[0.781, 0.773]",0.214,0.521,0.612,0.145,0.146,0.119,0.728,0.629,0.591,0.681,0.795,0.721,0.625,0.915,0.817,0.75,0.799,0.777
https://doi.org/10.1289/ehp.1104802,serum pbdes in a north carolina toddler cohort associations with handwipes house dust and socioeconomic variables,42494_serum pbdes in a north carolina toddler cohort associations with handwipes house dust and socioeconomic variables.pdf,5,"['https://www.congress.gov/event/112th-congress/senate-event/LC57384/text?s=1&r=10218', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf', 'https://www.nrdc.org/resources/safer-sofas-how-do-major-furniture-stores-compare', 'https://fortress.wa.gov/ecy/publications/documents/1404047.pdf', 'https://apps.ecology.wa.gov/publications/documents/1404047.pdf']","['S.Hrg. 112-974 — OVERSIGHT OF EPA AUTHORITIES AND ACTIONS TO CONTROL EXPOSURES TO TOXIC CHEMICALS', 'Draft Priority Product Report, Safer Products for Washington', 'Safer Sofas: How do Major Furniture Stores Compare?', 'Flame Retardants - A Report to the Legislature', 'Flame Retardants - A Report to the Legislature']",['https://fortress.wa.gov/ecy/publications/documents/2004004.pdf'],['42494_1_draft priority product report safer products for washington.pdf'],1,20.0,['https://fortress.wa.gov/ecy/publications/documents/2004004.pdf'],['42494_1_draft priority product report safer products for washington.pdf'],[0.391],[0.515],[0.607],[0.146],[0.154],[0.115],[0.733],[0.64],[0.592],[0.663],[0.804],[0.707],[0.622],[0.916],[0.819],[0.761],[0.799],[0.788],0.391,0.515,0.607,0.146,0.154,0.115,0.733,0.64,0.592,0.663,0.804,0.707,0.622,0.916,0.819,0.761,0.799,0.788
https://doi.org/10.1289/ehp.1307049,an integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure,42522_an integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure.pdf,5,"['https://www.thoracic.org/statements/resources/eold/air-pollution.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/17rd006.pdf', 'https://purl.fdlp.gov/GPO/gpo68498', 'http://ceepr.mit.edu/publications/working-papers/750', 'https://www.rff.org/publications/working-papers/one-off-subsidies-and-long-run-adoption-experimental-evidence-on-improved-cooking-stoves-in-senegal/']","['A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework', 'A Method to Prioritize Sources for Reducing High PM2.5 Exposures in Environmental Justice Communities in California', 'The impacts of climate change on human health in the United States :\xa0a scientific assessment /', 'Learning from Supply Shocks in the Energy Market: Evidence from Local and Global Impacts of the Shale Revolution', 'One-Off Subsidies and Long-Run Adoption: Experimental Evidence on Improved Cooking Stoves in Senegal']",['https://www.thoracic.org/statements/resources/eold/air-pollution.pdf'],['42522_0_a joint ersats policy statement what constitutes an adverse health effect of air pollution an analytical framework.pdf'],1,20.0,['https://www.thoracic.org/statements/resources/eold/air-pollution.pdf'],['42522_0_a joint ersats policy statement what constitutes an adverse health effect of air pollution an analytical framework.pdf'],[0.52],[0.527],[0.622],[0.174],[0.187],[0.153],[0.739],[0.648],[0.6],[0.722],[0.801],[0.732],[0.626],[0.919],[0.827],[0.764],[0.804],[0.787],0.52,0.527,0.622,0.174,0.187,0.153,0.739,0.648,0.6,0.722,0.801,0.732,0.626,0.919,0.827,0.764,0.804,0.787
https://doi.org/10.1289/ehp.1307234,urinary polycyclic aromatic hydrocarbons and childhood obesity nhanes 2001–2006,42525_urinary polycyclic aromatic hydrocarbons and childhood obesity nhanes 2001–2006.pdf,2,"['https://www.epa.gov/sites/default/files/2020-01/documents/memphis_pahs_study_final_report_08.pdf', 'https://stacks.cdc.gov/view/cdc/35713']","['Characterizing Community Exposure to Atmospheric Polycyclic Aromatic Hydrocarbons (PAHs) in The Memphis Tri-State Area', '2015 Charles C. Shepard Science Awards : Ending the HIV/AIDS pandemic : from scientific advances to public health implementation']",['https://www.epa.gov/sites/default/files/2020-01/documents/memphis_pahs_study_final_report_08.pdf'],['42525_0_characterizing community exposure to atmospheric polycyclic aromatic hydrocarbons pahs in the memphis tristate area.pdf'],1,50.0,['https://www.epa.gov/sites/default/files/2020-01/documents/memphis_pahs_study_final_report_08.pdf'],['42525_0_characterizing community exposure to atmospheric polycyclic aromatic hydrocarbons pahs in the memphis tristate area.pdf'],[0.231],[0.494],[0.59],[0.124],[0.124],[0.088],[0.727],[0.629],[0.578],[0.676],[0.785],[0.686],[0.617],[0.904],[0.819],[0.745],[0.783],[0.771],0.231,0.494,0.59,0.124,0.124,0.088,0.727,0.629,0.578,0.676,0.785,0.686,0.617,0.904,0.819,0.745,0.783,0.771
https://doi.org/10.1289/ehp.1408554,relation of prenatal methylmercury exposure from environmental sources to childhood iq,42531_relation of prenatal methylmercury exposure from environmental sources to childhood iq.pdf,4,"['https://stacks.cdc.gov/view/cdc/117446', 'https://www.waterboards.ca.gov/board_info/agendas/2017/may/050217_6_rev_drft_final_stff_rpt_with_app_b-u.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/hg_SR_final.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/staff_report/hg_apndx_s.pdf']","['Toxicological profile for mercury : draft for public comment : April 2022', 'Revised Draft Final', 'Tribal And Subsistence Fishing Beneficial Uses And Mercury Provisions', 'Appendix S. Responses to the External Peer Review']",['https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/staff_report/hg_apndx_s.pdf'],['42531_3_appendix s responses to the external peer review.pdf'],1,25.0,['https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/staff_report/hg_apndx_s.pdf'],['42531_3_appendix s responses to the external peer review.pdf'],[0.267],[0.522],[0.613],[0.15],[0.149],[0.113],[0.725],[0.634],[0.596],[0.671],[0.799],[0.724],[0.644],[0.914],[0.819],[0.762],[0.798],[0.782],0.267,0.522,0.613,0.15,0.149,0.113,0.725,0.634,0.596,0.671,0.799,0.724,0.644,0.914,0.819,0.762,0.798,0.782
https://doi.org/10.1289/ehp.1408803,prenatal and childhood trafficrelated pollution exposure and childhood cognition in the project viva cohort massachusetts usa,42532_prenatal and childhood trafficrelated pollution exposure and childhood cognition in the project viva cohort massachusetts usa.pdf,4,"['https://clkrep.lacity.org/onlinedocs/2021/21-0134_misc_01-29-2021.0001.pdf', 'https://www.thoracic.org/statements/resources/eold/air-pollution.pdf', 'https://planning.lacity.org/StaffRpt/InitialRpts/DIR-2017-1708.pdf', 'https://www.sanjoseca.gov/Home/ShowDocument?id=59127']","['City Planning Commission', 'A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework', 'City Planning Commission', 'Draft Environmental Impact Report']","['https://www.sanjoseca.gov/Home/ShowDocument?id=59127', 'https://www.thoracic.org/statements/resources/eold/air-pollution.pdf', 'https://planning.lacity.org/StaffRpt/InitialRpts/DIR-2017-1708.pdf', 'https://clkrep.lacity.org/onlinedocs/2021/21-0134_misc_01-29-2021.0001.pdf']","['42532_3_draft environmental impact report.pdf', '42532_1_a joint ersats policy statement what constitutes an adverse health effect of air pollution an analytical framework.pdf', '42532_2_city planning commission.pdf', '42532_0_city planning commission.pdf']",4,100.0,"['https://www.sanjoseca.gov/Home/ShowDocument?id=59127', 'https://www.thoracic.org/statements/resources/eold/air-pollution.pdf', 'https://planning.lacity.org/StaffRpt/InitialRpts/DIR-2017-1708.pdf', 'https://clkrep.lacity.org/onlinedocs/2021/21-0134_misc_01-29-2021.0001.pdf']","['42532_3_draft environmental impact report.pdf', '42532_1_a joint ersats policy statement what constitutes an adverse health effect of air pollution an analytical framework.pdf', '42532_2_city planning commission.pdf', '42532_0_city planning commission.pdf']","[0.176, 0.412, 0.169, 0.166]","[0.521, 0.528, 0.505, 0.505]","[0.601, 0.624, 0.592, 0.592]","[0.118, 0.167, 0.117, 0.117]","[0.117, 0.17, 0.114, 0.113]","[0.095, 0.127, 0.09, 0.089]","[0.713, 0.735, 0.718, 0.718]","[0.613, 0.642, 0.622, 0.621]","[0.601, 0.604, 0.583, 0.583]","[0.656, 0.696, 0.649, 0.649]","[0.803, 0.805, 0.792, 0.793]","[0.718, 0.716, 0.706, 0.706]","[0.627, 0.602, 0.614, 0.614]","[0.92, 0.923, 0.919, 0.918]","[0.843, 0.829, 0.829, 0.829]","[0.762, 0.757, 0.748, 0.748]","[0.803, 0.8, 0.79, 0.791]","[0.785, 0.783, 0.769, 0.77]",0.231,0.515,0.602,0.13,0.129,0.1,0.721,0.624,0.593,0.662,0.798,0.711,0.614,0.92,0.833,0.754,0.796,0.777
https://doi.org/10.1289/ehp.1409276,ambient pm 25  o 3  and no 2 exposures and associations with mortality over 16 years of followup in the canadian census health and environment cohort canchec,42533_ambient pm 25  o 3  and no 2 exposures and associations with mortality over 16 years of followup in the canadian census health and environment cohort canchec.pdf,9,"['https://stacks.cdc.gov/view/cdc/120137', 'https://stacks.cdc.gov/view/cdc/120136', 'https://purl.fdlp.gov/GPO/gpo139414', 'https://purl.fdlp.gov/GPO/gpo131976', 'https://purl.fdlp.gov/GPO/gpo128868', 'https://www.epa.gov/sites/production/files/2019-09/documents/draft_policy_assessment_for_pm_naaqs_09-05-2019.pdf', 'https://www.epa.gov/sites/production/files/2020-01/documents/final_policy_assessment_for_the_review_of_the_pm_naaqs_01-2020.pdf', 'https://www.congress.gov/event/116th-congress/house-event/109615', 'https://purl.fdlp.gov/GPO/gpo141478']","['Technical documentation for the Environmental Justice Index 2022', 'Environmental Justice Index indicators', 'Policy assessment for the review of the national ambient air quality standards for particulate matter.', 'Policy assessment for the review of the Ozone National Ambient Air Quality Standards :\xa0external review draft.', 'Policy assessment for the review of the national ambient air quality standards for particulate matter, external review draft.', 'MIA noniang cED Siq', 'Y agenc ’', '""Critical Mission: Former Administrators Address the Direction of the EPA""', 'Policy assessment for the review of the ozone national ambient air quality standards.']","['https://purl.fdlp.gov/GPO/gpo131976', 'https://purl.fdlp.gov/GPO/gpo128868', 'https://purl.fdlp.gov/GPO/gpo139414', 'https://purl.fdlp.gov/GPO/gpo141478', 'https://www.epa.gov/sites/production/files/2019-09/documents/draft_policy_assessment_for_pm_naaqs_09-05-2019.pdf']","['42533_3_policy assessment for the review of the ozone national ambient air quality standards \xa0external review draft.pdf', '42533_4_policy assessment for the review of the national ambient air quality standards for particulate matter external review draft.pdf', '42533_2_policy assessment for the review of the national ambient air quality standards for particulate matter.pdf', '42533_8_policy assessment for the review of the ozone national ambient air quality standards.pdf', '42533_5_mia noniang ced siq.pdf']",5,55.56,"['https://purl.fdlp.gov/GPO/gpo131976', 'https://purl.fdlp.gov/GPO/gpo128868', 'https://purl.fdlp.gov/GPO/gpo139414', 'https://purl.fdlp.gov/GPO/gpo141478', 'https://www.epa.gov/sites/production/files/2019-09/documents/draft_policy_assessment_for_pm_naaqs_09-05-2019.pdf']","['42533_3_policy assessment for the review of the ozone national ambient air quality standards \xa0external review draft.pdf', '42533_4_policy assessment for the review of the national ambient air quality standards for particulate matter external review draft.pdf', '42533_2_policy assessment for the review of the national ambient air quality standards for particulate matter.pdf', '42533_8_policy assessment for the review of the ozone national ambient air quality standards.pdf', '42533_5_mia noniang ced siq.pdf']","[0.544, 0.351, 0.495, 0.495, 0.389]","[0.528, 0.534, 0.534, 0.528, 0.534]","[0.617, 0.617, 0.616, 0.617, 0.617]","[0.151, 0.164, 0.166, 0.153, 0.164]","[0.153, 0.169, 0.17, 0.153, 0.169]","[0.126, 0.142, 0.143, 0.126, 0.142]","[0.728, 0.731, 0.733, 0.729, 0.731]","[0.634, 0.639, 0.64, 0.636, 0.639]","[0.589, 0.59, 0.591, 0.59, 0.59]","[0.724, 0.736, 0.737, 0.722, 0.736]","[0.794, 0.789, 0.789, 0.793, 0.789]","[0.712, 0.72, 0.72, 0.712, 0.72]","[0.641, 0.645, 0.645, 0.642, 0.645]","[0.911, 0.906, 0.907, 0.912, 0.906]","[0.817, 0.821, 0.82, 0.817, 0.821]","[0.754, 0.759, 0.759, 0.755, 0.759]","[0.797, 0.795, 0.795, 0.796, 0.795]","[0.781, 0.777, 0.776, 0.78, 0.777]",0.455,0.532,0.617,0.16,0.163,0.136,0.73,0.638,0.59,0.731,0.791,0.717,0.644,0.908,0.819,0.757,0.796,0.778
https://doi.org/10.1289/ehp.1509838,childhood exposure to ambient air pollutants and the onset of asthma an administrative cohort study in québec,42534_childhood exposure to ambient air pollutants and the onset of asthma an administrative cohort study in québec.pdf,8,"['https://purl.fdlp.gov/GPO/gpo128868', 'https://www.epa.gov/sites/production/files/2019-09/documents/draft_policy_assessment_for_pm_naaqs_09-05-2019.pdf', 'https://www.epa.gov/sites/production/files/2020-01/documents/final_policy_assessment_for_the_review_of_the_pm_naaqs_01-2020.pdf', 'https://health.mo.gov/living/environment/bridgeton/pdf/bridgeton-healthconsult.pdf', 'https://www.thoracic.org/statements/resources/allergy-asthma/6th-jack-pepys.pdf', 'https://purl.fdlp.gov/GPO/gpo141478', 'https://purl.fdlp.gov/GPO/gpo139414', 'https://ww2.arb.ca.gov/sites/default/files/2022-11/California%20Air%20Resources%20Board%20Updated%20Health%20Endpoints%20Bulletin%20-%20Edited%20Nov%202022_0.pdf']","['Policy assessment for the review of the national ambient air quality standards for particulate matter, external review draft.', 'MIA noniang cED Siq', 'Y agenc ’', 'PUBLIC HEALTH ASSESSMENT Bridgeton Sanitary Landfill', 'An Official American Thoracic Society Workshop Report: Presentations and Discussion of the Sixth Jack Pepys Workshop on Asthma in the Workplace', 'Policy assessment for the review of the ozone national ambient air quality standards.', 'Policy assessment for the review of the national ambient air quality standards for particulate matter.', 'California Air Resources Board Updated Health Endpoints Bulletin']","['https://purl.fdlp.gov/GPO/gpo139414', 'https://purl.fdlp.gov/GPO/gpo141478', 'https://ww2.arb.ca.gov/sites/default/files/2022-11/California%20Air%20Resources%20Board%20Updated%20Health%20Endpoints%20Bulletin%20-%20Edited%20Nov%202022_0.pdf', 'https://purl.fdlp.gov/GPO/gpo128868', 'https://www.thoracic.org/statements/resources/allergy-asthma/6th-jack-pepys.pdf', 'https://www.epa.gov/sites/production/files/2019-09/documents/draft_policy_assessment_for_pm_naaqs_09-05-2019.pdf', 'https://health.mo.gov/living/environment/bridgeton/pdf/bridgeton-healthconsult.pdf']","['42534_6_policy assessment for the review of the national ambient air quality standards for particulate matter.pdf', '42534_5_policy assessment for the review of the ozone national ambient air quality standards.pdf', '42534_7_california air resources board updated health endpoints bulletin.pdf', '42534_0_policy assessment for the review of the national ambient air quality standards for particulate matter external review draft.pdf', '42534_4_an official american thoracic society workshop report presentations and discussion of the sixth jack pepys workshop on asthma in the workplace.pdf', '42534_1_mia noniang ced siq.pdf', '42534_3_public health assessment bridgeton sanitary landfill.pdf']",7,87.5,"['https://purl.fdlp.gov/GPO/gpo139414', 'https://purl.fdlp.gov/GPO/gpo141478', 'https://ww2.arb.ca.gov/sites/default/files/2022-11/California%20Air%20Resources%20Board%20Updated%20Health%20Endpoints%20Bulletin%20-%20Edited%20Nov%202022_0.pdf', 'https://purl.fdlp.gov/GPO/gpo128868', 'https://www.thoracic.org/statements/resources/allergy-asthma/6th-jack-pepys.pdf', 'https://www.epa.gov/sites/production/files/2019-09/documents/draft_policy_assessment_for_pm_naaqs_09-05-2019.pdf', 'https://health.mo.gov/living/environment/bridgeton/pdf/bridgeton-healthconsult.pdf']","['42534_6_policy assessment for the review of the national ambient air quality standards for particulate matter.pdf', '42534_5_policy assessment for the review of the ozone national ambient air quality standards.pdf', '42534_7_california air resources board updated health endpoints bulletin.pdf', '42534_0_policy assessment for the review of the national ambient air quality standards for particulate matter external review draft.pdf', '42534_4_an official american thoracic society workshop report presentations and discussion of the sixth jack pepys workshop on asthma in the workplace.pdf', '42534_1_mia noniang ced siq.pdf', '42534_3_public health assessment bridgeton sanitary landfill.pdf']","[0.415, 0.415, 0.246, 0.406, 0.529, 0.455, 0.351]","[0.524, 0.518, 0.527, 0.524, 0.508, 0.524, 0.52]","[0.608, 0.609, 0.616, 0.609, 0.599, 0.609, 0.61]","[0.155, 0.146, 0.164, 0.153, 0.145, 0.153, 0.152]","[0.161, 0.149, 0.18, 0.16, 0.153, 0.16, 0.153]","[0.135, 0.125, 0.142, 0.134, 0.122, 0.134, 0.121]","[0.732, 0.731, 0.733, 0.731, 0.735, 0.731, 0.728]","[0.638, 0.637, 0.64, 0.637, 0.636, 0.637, 0.637]","[0.578, 0.577, 0.586, 0.577, 0.576, 0.577, 0.585]","[0.727, 0.715, 0.73, 0.726, 0.685, 0.726, 0.69]","[0.788, 0.792, 0.801, 0.788, 0.796, 0.788, 0.8]","[0.706, 0.698, 0.712, 0.706, 0.702, 0.706, 0.714]","[0.636, 0.634, 0.633, 0.636, 0.612, 0.636, 0.637]","[0.905, 0.908, 0.907, 0.904, 0.91, 0.904, 0.912]","[0.811, 0.808, 0.812, 0.811, 0.798, 0.811, 0.81]","[0.748, 0.744, 0.747, 0.748, 0.736, 0.748, 0.757]","[0.789, 0.79, 0.798, 0.789, 0.791, 0.789, 0.799]","[0.769, 0.773, 0.777, 0.77, 0.772, 0.77, 0.778]",0.402,0.521,0.609,0.153,0.159,0.13,0.732,0.637,0.579,0.714,0.793,0.706,0.632,0.907,0.809,0.747,0.792,0.773
https://doi.org/10.1289/ehp.1509869,perfluoroalkyl substances sex hormones and insulinlike growth factor1 at 6–9 years of age a crosssectional analysis within the c8 health project,42535_perfluoroalkyl substances sex hormones and insulinlike growth factor1 at 6–9 years of age a crosssectional analysis within the c8 health project.pdf,4,"['https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://purl.fdlp.gov/GPO/gpo94037', 'https://www.congress.gov/event/116th-congress/house-event/109020']","['Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Public Health Goals for Perfluorooctanoic Acid and Perfluorooctane Sulfonic Acid in Drinking Water- First Public Review Draft', 'Toxicological profile for perfluoroalkyls: draft for public comment.', 'Examining PFAS Chemicals and their Risks']","['https://purl.fdlp.gov/GPO/gpo94037', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf']","['42535_2_toxicological profile for perfluoroalkyls draft for public comment.pdf', '42535_1_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '42535_0_per and polyfluoroalkyl substances chemical action plan.pdf']",3,75.0,"['https://purl.fdlp.gov/GPO/gpo94037', 'https://oehha.ca.gov/sites/default/files/media/downloads/crnr/pfoapfosphgdraft061021.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf']","['42535_2_toxicological profile for perfluoroalkyls draft for public comment.pdf', '42535_1_public health goals for perfluorooctanoic acid and perfluorooctane sulfonic acid in drinking water first public review draft.pdf', '42535_0_per and polyfluoroalkyl substances chemical action plan.pdf']","[0.43, 0.648, 0.651]","[0.508, 0.519, 0.507]","[0.604, 0.611, 0.601]","[0.168, 0.165, 0.139]","[0.166, 0.161, 0.134]","[0.137, 0.132, 0.107]","[0.738, 0.739, 0.728]","[0.649, 0.648, 0.635]","[0.581, 0.589, 0.589]","[0.683, 0.683, 0.641]","[0.792, 0.795, 0.798]","[0.67, 0.683, 0.694]","[0.619, 0.622, 0.619]","[0.904, 0.906, 0.911]","[0.81, 0.815, 0.817]","[0.751, 0.758, 0.761]","[0.781, 0.789, 0.792]","[0.769, 0.775, 0.78]",0.576,0.511,0.605,0.157,0.154,0.125,0.735,0.644,0.586,0.669,0.795,0.682,0.62,0.907,0.814,0.757,0.787,0.775
https://doi.org/10.1289/ehp.1510514,reducing phthalate paraben and phenol exposure from personal care products in adolescent girls findings from the hermosa intervention study,42536_reducing phthalate paraben and phenol exposure from personal care products in adolescent girls findings from the hermosa intervention study.pdf,6,"['https://apps.ecology.wa.gov/publications/documents/2104047.pdf', 'https://www.ezview.wa.gov/Portals/_1962/Documents/saferproducts/Priority%20Consumer%20Products%20%E2%80%93%20Report%20to%20the%20Legislature.pdf', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2021/04/Final-2021-2023-Priority-Product-Work-Plan.pdf', 'https://biomonitoring.ca.gov/sites/default/files/downloads/EHL_Update110316.pdf', 'https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf']","['Draft Regulatory Determinations: Report to the Legislature', 'Priority Consumer Products – Report to the Legislature', 'Draft Priority Product Report, Safer Products for Washington', 'Stakeholder Discussion Draft Proposed 2021-23 PPWP Working Copy', 'Report to Scientific Guidance Panel', 'Evidence on the Carcinogenicity of Bisphenol A (BPA)']","['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf', 'https://www.ezview.wa.gov/Portals/_1962/Documents/saferproducts/Priority%20Consumer%20Products%20%E2%80%93%20Report%20to%20the%20Legislature.pdf', 'https://biomonitoring.ca.gov/sites/default/files/downloads/EHL_Update110316.pdf', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2021/04/Final-2021-2023-Priority-Product-Work-Plan.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104047.pdf']","['42536_5_evidence on the carcinogenicity of bisphenol a bpa.pdf', '42536_1_priority consumer products – report to the legislature.pdf', '42536_4_report to scientific guidance panel.pdf', '42536_2_draft priority product report safer products for washington.pdf', '42536_3_stakeholder discussion draft proposed 202123 ppwp working copy.pdf', '42536_0_draft regulatory determinations report to the legislature.pdf']",6,100.0,"['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf', 'https://www.ezview.wa.gov/Portals/_1962/Documents/saferproducts/Priority%20Consumer%20Products%20%E2%80%93%20Report%20to%20the%20Legislature.pdf', 'https://biomonitoring.ca.gov/sites/default/files/downloads/EHL_Update110316.pdf', 'https://fortress.wa.gov/ecy/publications/documents/2004004.pdf', 'https://dtsc.ca.gov/wp-content/uploads/sites/31/2021/04/Final-2021-2023-Priority-Product-Work-Plan.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104047.pdf']","['42536_5_evidence on the carcinogenicity of bisphenol a bpa.pdf', '42536_1_priority consumer products – report to the legislature.pdf', '42536_4_report to scientific guidance panel.pdf', '42536_2_draft priority product report safer products for washington.pdf', '42536_3_stakeholder discussion draft proposed 202123 ppwp working copy.pdf', '42536_0_draft regulatory determinations report to the legislature.pdf']","[0.312, 0.427, 0.449, 0.422, 0.268, 0.355]","[0.515, 0.509, 0.492, 0.523, 0.52, 0.521]","[0.609, 0.604, 0.595, 0.613, 0.611, 0.609]","[0.138, 0.134, 0.158, 0.142, 0.139, 0.143]","[0.14, 0.151, 0.175, 0.159, 0.152, 0.153]","[0.108, 0.119, 0.142, 0.124, 0.121, 0.125]","[0.731, 0.728, 0.741, 0.729, 0.726, 0.727]","[0.641, 0.637, 0.657, 0.638, 0.631, 0.635]","[0.589, 0.582, 0.559, 0.596, 0.596, 0.592]","[0.655, 0.658, 0.683, 0.655, 0.654, 0.663]","[0.802, 0.798, 0.797, 0.806, 0.803, 0.795]","[0.697, 0.695, 0.705, 0.709, 0.722, 0.702]","[0.613, 0.617, 0.602, 0.625, 0.629, 0.628]","[0.909, 0.913, 0.912, 0.914, 0.916, 0.914]","[0.804, 0.808, 0.822, 0.814, 0.822, 0.815]","[0.756, 0.752, 0.763, 0.763, 0.773, 0.763]","[0.789, 0.788, 0.782, 0.797, 0.8, 0.793]","[0.777, 0.78, 0.782, 0.788, 0.787, 0.782]",0.372,0.513,0.607,0.142,0.155,0.123,0.73,0.64,0.586,0.661,0.8,0.705,0.619,0.913,0.814,0.762,0.792,0.783
https://doi.org/10.1289/ehp.5355,association of lung function with declining ambient air pollution,42538_association of lung function with declining ambient air pollution.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526394/pdf', 'https://www.thoracic.org/statements/resources/copd/novel-risk-factors-and-the-global-burden-of-copd.pdf', 'https://www.congress.gov/event/108th-congress/senate-event/LC13987/text?s=1&r=12227', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/94-331c.pdf']","['Interventions to reduce ambient particulate matter air pollution and their effect on health', 'An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease', 'S.Hrg. 108-502 — IMPLEMENTATION OF THE NEW AIR QUALITY STANDARDS FOR PARTICULATE MATTER AND OZONE', 'Research Contract Report']","['https://www.thoracic.org/statements/resources/copd/novel-risk-factors-and-the-global-burden-of-copd.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526394/pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/94-331c.pdf']","['42538_1_an official american thoracic society public policy statement novel risk factors and the global burden of chronic obstructive pulmonary disease.pdf', '42538_0_interventions to reduce ambient particulate matter air pollution and their effect on health.pdf', '42538_3_research contract report.pdf']",3,75.0,"['https://www.thoracic.org/statements/resources/copd/novel-risk-factors-and-the-global-burden-of-copd.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526394/pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/94-331c.pdf']","['42538_1_an official american thoracic society public policy statement novel risk factors and the global burden of chronic obstructive pulmonary disease.pdf', '42538_0_interventions to reduce ambient particulate matter air pollution and their effect on health.pdf', '42538_3_research contract report.pdf']","[0.416, 0.48, 0.657]","[0.537, 0.521, 0.517]","[0.621, 0.605, 0.603]","[0.184, 0.16, 0.163]","[0.198, 0.168, 0.176]","[0.152, 0.133, 0.144]","[0.735, 0.722, 0.729]","[0.641, 0.628, 0.633]","[0.61, 0.59, 0.579]","[0.69, 0.718, 0.711]","[0.802, 0.786, 0.786]","[0.736, 0.72, 0.705]","[0.636, 0.625, 0.634]","[0.92, 0.908, 0.912]","[0.822, 0.821, 0.803]","[0.768, 0.742, 0.751]","[0.8, 0.786, 0.783]","[0.782, 0.764, 0.767]",0.518,0.525,0.61,0.169,0.181,0.143,0.729,0.634,0.593,0.706,0.791,0.72,0.632,0.913,0.815,0.754,0.79,0.771
https://doi.org/10.1289/ehp.5461,effects of pcb exposure on neuropsychological function in children,42539_effects of pcb exposure on neuropsychological function in children.pdf,5,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.deq.virginia.gov/Portals/0/DEQ/LawsAndRegulations/App_B-VCU_portion_HG_report_pldf_final.pdf', 'https://nepc.colorado.edu/publication/poverty-and-potential', 'https://www.epa.gov/sites/production/files/2019-07/documents/hazardous_air_pollutants_report_section_23_july_2019.pdf', 'https://stacks.cdc.gov/view/cdc/45600']","['America’s children and the environment.', 'Outline of Literature Review', 'Poverty and Potential: Out-of-School Factors and School Success', 'Hazardous Air Pollutants', 'Polychlorinated biphenyls (PCBs) toxicity']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2019-07/documents/hazardous_air_pollutants_report_section_23_july_2019.pdf']","['42539_0_americas children and the environment.pdf', '42539_3_hazardous air pollutants.pdf']",2,40.0,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2019-07/documents/hazardous_air_pollutants_report_section_23_july_2019.pdf']","['42539_0_americas children and the environment.pdf', '42539_3_hazardous air pollutants.pdf']","[0.476, 0.274]","[0.513, 0.489]","[0.606, 0.596]","[0.146, 0.143]","[0.148, 0.142]","[0.11, 0.104]","[0.726, 0.723]","[0.631, 0.63]","[0.583, 0.558]","[0.676, 0.681]","[0.796, 0.793]","[0.709, 0.702]","[0.633, 0.629]","[0.906, 0.904]","[0.813, 0.814]","[0.756, 0.735]","[0.795, 0.788]","[0.78, 0.775]",0.375,0.501,0.601,0.144,0.145,0.107,0.724,0.631,0.571,0.679,0.794,0.706,0.631,0.905,0.813,0.746,0.792,0.778
https://doi.org/10.1289/ehp.5589,assessing potential risk of heavy metal exposure from consumption of homeproduced vegetables by urban populations,42541_assessing potential risk of heavy metal exposure from consumption of homeproduced vegetables by urban populations.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746524/pdf', 'https://stacks.cdc.gov/view/cdc/75410']","['Recommendations for the Development of Regulatory Guidelines for Registration of Traditional Medicines in South Africa', 'Report to Congress : Tar Creek Superfund Site, Ottawa County, Oklahoma']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746524/pdf'],['42541_0_recommendations for the development of regulatory guidelines for registration of traditional medicines in south africa.pdf'],1,50.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746524/pdf'],['42541_0_recommendations for the development of regulatory guidelines for registration of traditional medicines in south africa.pdf'],[0.143],[0.507],[0.599],[0.107],[0.103],[0.089],[0.725],[0.626],[0.579],[0.647],[0.793],[0.699],[0.631],[0.913],[0.818],[0.755],[0.796],[0.777],0.143,0.507,0.599,0.107,0.103,0.089,0.725,0.626,0.579,0.647,0.793,0.699,0.631,0.913,0.818,0.755,0.796,0.777
https://doi.org/10.1289/ehp.5603,biotransformations of bisphenol a in a mammalian model answers and new questions raised by lowdose metabolic fate studies in pregnant cd1 mice,42542_biotransformations of bisphenol a in a mammalian model answers and new questions raised by lowdose metabolic fate studies in pregnant cd1 mice.pdf,1,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['Evidence on the Carcinogenicity of Bisphenol A (BPA)'],['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['42542_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],1,100.0,['https://oehha.ca.gov/media/downloads/crnr/bpahid093022.pdf'],['42542_0_evidence on the carcinogenicity of bisphenol a bpa.pdf'],[0.28],[0.54],[0.626],[0.161],[0.158],[0.12],[0.74],[0.648],[0.614],[0.648],[0.806],[0.72],[0.635],[0.908],[0.82],[0.774],[0.803],[0.79],0.28,0.54,0.626,0.161,0.158,0.12,0.74,0.648,0.614,0.648,0.806,0.72,0.635,0.908,0.82,0.774,0.803,0.79
https://doi.org/10.1289/ehp.5619,exposure to indoor pesticides during pregnancy in a multiethnic urban cohort,42543_exposure to indoor pesticides during pregnancy in a multiethnic urban cohort.pdf,5,"['https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://www.federalregister.gov/documents/2015/11/06/2015-28083/chlorpyrifos-tolerance-revocations', 'https://stacks.cdc.gov/view/cdc/21813', 'https://www.cdpr.ca.gov/docs/risk/rcd/chlorpyrifos_draft_evaluation_2017.pdf', 'https://ntp.niehs.nih.gov/ntp/roc/thirteenth/monographs_final/pentachlorophenol_508.pdf']","['Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis', 'Chlorpyrifos; Tolerance Revocations', 'Fourth national report on human exposure to environmental chemicals', 'Draft Evaluation of Chlorpyrifos as a Toxic Air Contaminant', 'Pentachlorophenol and By-Products of Its Synthesis (PCP)']","['https://www.cdpr.ca.gov/docs/risk/rcd/chlorpyrifos_draft_evaluation_2017.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://ntp.niehs.nih.gov/ntp/roc/thirteenth/monographs_final/pentachlorophenol_508.pdf']","['42543_3_draft evaluation of chlorpyrifos as a toxic air contaminant.pdf', '42543_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42543_4_pentachlorophenol and byproducts of its synthesis pcp.pdf']",3,60.0,"['https://www.cdpr.ca.gov/docs/risk/rcd/chlorpyrifos_draft_evaluation_2017.pdf', 'https://legistar.council.nyc.gov/View.ashx?M=F&ID=8054715&GUID=130C0D8E-A159-4050-96D2-B96AA0D42705', 'https://ntp.niehs.nih.gov/ntp/roc/thirteenth/monographs_final/pentachlorophenol_508.pdf']","['42543_3_draft evaluation of chlorpyrifos as a toxic air contaminant.pdf', '42543_0_pesticide exposure as risk factor for nonhodgkin lymphoma including histopathological subgroup analysis.pdf', '42543_4_pentachlorophenol and byproducts of its synthesis pcp.pdf']","[0.597, 0.381, 0.328]","[0.529, 0.522, 0.517]","[0.609, 0.61, 0.615]","[0.143, 0.147, 0.15]","[0.142, 0.153, 0.152]","[0.115, 0.121, 0.117]","[0.726, 0.726, 0.728]","[0.632, 0.63, 0.636]","[0.596, 0.596, 0.584]","[0.668, 0.667, 0.672]","[0.794, 0.799, 0.799]","[0.71, 0.719, 0.714]","[0.642, 0.629, 0.631]","[0.91, 0.913, 0.912]","[0.825, 0.821, 0.818]","[0.763, 0.759, 0.759]","[0.796, 0.797, 0.792]","[0.782, 0.781, 0.779]",0.435,0.523,0.611,0.147,0.149,0.118,0.727,0.633,0.592,0.669,0.797,0.714,0.634,0.912,0.821,0.76,0.795,0.781
https://doi.org/10.1289/ehp.5754,organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets,42545_organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets.pdf,6,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'https://www.lrl.mn.gov/docs/2007/mandated/070191.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://stacks.cdc.gov/view/cdc/21813', 'https://foe.org/resources/farming-for-the-future-organic-and-agroecological-solutions-to-feed-the-world/', 'https://www.dhcs.ca.gov/formsandpubs/publications/CaliforniaFoodGuide/26EnvironmentalContaminants.pdf']","['Preconception Care: A New Standard of Care within Maternal Health Services', 'Report: 2006 Status of Organic Agriculture in Minnesota - Report to the Legislature', 'California Food Guide :', 'Fourth national report on human exposure to environmental chemicals', 'Farming for the Future: Organic and Agroecological Solutions to Feed the World • Friends of the Earth', 'California Food Guide: Environmental Contaminants of Food']","['https://www.lrl.mn.gov/docs/2007/mandated/070191.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf']","['42545_1_report 2006 status of organic agriculture in minnesota  report to the legislature.pdf', '42545_2_california food guide .pdf', '42545_0_preconception care a new standard of care within maternal health services.pdf']",3,50.0,"['https://www.lrl.mn.gov/docs/2007/mandated/070191.pdf', 'http://www.bscc.ca.gov/wp-content/uploads/2008-California-Food-Guide.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf']","['42545_1_report 2006 status of organic agriculture in minnesota  report to the legislature.pdf', '42545_2_california food guide .pdf', '42545_0_preconception care a new standard of care within maternal health services.pdf']","[0.265, 0.352, 0.29]","[0.52, 0.514, 0.476]","[0.619, 0.612, 0.577]","[0.153, 0.125, 0.126]","[0.156, 0.129, 0.115]","[0.132, 0.1, 0.106]","[0.722, 0.716, 0.728]","[0.625, 0.616, 0.636]","[0.6, 0.599, 0.531]","[0.633, 0.638, 0.654]","[0.797, 0.797, 0.748]","[0.712, 0.715, 0.622]","[0.637, 0.623, 0.602]","[0.915, 0.916, 0.9]","[0.834, 0.824, 0.782]","[0.763, 0.759, 0.711]","[0.806, 0.803, 0.734]","[0.786, 0.784, 0.731]",0.302,0.503,0.603,0.135,0.133,0.113,0.722,0.626,0.577,0.642,0.781,0.683,0.621,0.91,0.813,0.744,0.781,0.767
https://doi.org/10.1289/ehp.5761,the high cost of improper removal of leadbased paint from housing a case report,42546_the high cost of improper removal of leadbased paint from housing a case report.pdf,2,"['https://stacks.cdc.gov/view/cdc/11854', 'https://mde.maryland.gov/programs/LAND/Documents/LeadFactSheets/2017InspectorContractorForumpowerpoint.pdf']","['Guidelines for the identification and management of lead exposure in pregnant and lactating women', 'Maryland ’ s Primary Prevention Law']",['https://mde.maryland.gov/programs/LAND/Documents/LeadFactSheets/2017InspectorContractorForumpowerpoint.pdf'],['42546_1_maryland  s primary prevention law.pdf'],1,50.0,['https://mde.maryland.gov/programs/LAND/Documents/LeadFactSheets/2017InspectorContractorForumpowerpoint.pdf'],['42546_1_maryland  s primary prevention law.pdf'],[0.393],[0.546],[0.63],[0.169],[0.183],[0.148],[0.734],[0.639],[0.606],[0.679],[0.805],[0.728],[0.648],[0.922],[0.857],[0.774],[0.814],[0.8],0.393,0.546,0.63,0.169,0.183,0.148,0.734,0.639,0.606,0.679,0.805,0.728,0.648,0.922,0.857,0.774,0.814,0.8
https://doi.org/10.1289/ehp.5837,mercury levels in highend consumers of fish,42548_mercury levels in highend consumers of fish.pdf,9,"['https://www.federalregister.gov/documents/2012/02/16/2012-806/national-emission-standards-for-hazardous-air-pollutants-from-coal--and-oil-fired-electric-utility', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/staff_report/hg_staff_report.pdf', 'https://www.waterboards.ca.gov/board_info/agendas/2017/may/050217_6_rev_drft_final_stff_rpt_with_app_b-u.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/hg_SR_final.pdf', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf', 'https://www.michigan.gov/documents/deq/deq-aqd-air-aqe-mercury-report_272074_7.pdf', 'https://www.michigan.gov/documents/MESB_Biomonitoring_Report_69163_7.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/MercuryExposurePeerReviewSummary.pdf', 'https://oceana.org/reports/risks-and-benefits-fish-consumption-yes-mercury-problem']","['National Emission Standards for Hazardous Air Pollutants From Coal- and Oil-Fired Electric Utility Steam Generating Units and Standards of Performance for Fossil-Fuel-Fired Electric Utility, Industrial-Commercial-Institutional, and Small Industrial-Commercial-Institutional Steam Generating Units', 'Division Of Water Quality', 'Revised Draft Final', 'Tribal And Subsistence Fishing Beneficial Uses And Mercury Provisions', 'Pmangrum on DSK3VPTVN1PROD with RULES', 'Mercury Electric Utility Workgroup Final Report', 'Microsoft Word - 03-06-27 MESB Biomonitoring Report.doc', 'Memorandum', 'Risks and Benefits of Fish Consumption: Yes Mercury is a Problem']","['https://www.michigan.gov/documents/deq/deq-aqd-air-aqe-mercury-report_272074_7.pdf', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/hg_SR_final.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/staff_report/hg_staff_report.pdf', 'https://www.waterboards.ca.gov/board_info/agendas/2017/may/050217_6_rev_drft_final_stff_rpt_with_app_b-u.pdf', 'https://www.michigan.gov/documents/MESB_Biomonitoring_Report_69163_7.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/MercuryExposurePeerReviewSummary.pdf']","['42548_5_mercury electric utility workgroup final report.pdf', '42548_4_pmangrum on dsk3vptvn1prod with rules.pdf', '42548_3_tribal and subsistence fishing beneficial uses and mercury provisions.pdf', '42548_1_division of water quality.pdf', '42548_2_revised draft final.pdf', '42548_6_microsoft word  030627 mesb biomonitoring reportdoc.pdf', '42548_7_memorandum.pdf']",7,77.78,"['https://www.michigan.gov/documents/deq/deq-aqd-air-aqe-mercury-report_272074_7.pdf', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/hg_SR_final.pdf', 'https://www.waterboards.ca.gov/water_issues/programs/mercury/docs/staff_report/hg_staff_report.pdf', 'https://www.waterboards.ca.gov/board_info/agendas/2017/may/050217_6_rev_drft_final_stff_rpt_with_app_b-u.pdf', 'https://www3.epa.gov/ttnecas1/regdata/Benefits/MercuryExposurePeerReviewSummary.pdf']","['42548_5_mercury electric utility workgroup final report.pdf', '42548_4_pmangrum on dsk3vptvn1prod with rules.pdf', '42548_3_tribal and subsistence fishing beneficial uses and mercury provisions.pdf', '42548_1_division of water quality.pdf', '42548_2_revised draft final.pdf', '42548_7_memorandum.pdf']","[0.327, 0.362, 0.362, 0.0, 0.404, 0.419]","[0.514, 0.463, 0.522, 0.521, 0.522, 0.525]","[0.594, 0.582, 0.607, 0.607, 0.607, 0.605]","[0.123, 0.008, 0.133, 0.126, 0.132, 0.125]","[0.118, 0.034, 0.138, 0.132, 0.138, 0.137]","[0.106, 0.016, 0.118, 0.114, 0.118, 0.117]","[0.719, 0.693, 0.719, 0.717, 0.719, 0.716]","[0.625, 0.567, 0.626, 0.622, 0.625, 0.619]","[0.594, 0.568, 0.6, 0.601, 0.6, 0.601]","[0.649, 0.709, 0.654, 0.645, 0.654, 0.692]","[0.797, 0.807, 0.8, 0.8, 0.8, 0.79]","[0.719, 0.757, 0.725, 0.726, 0.725, 0.73]","[0.641, 0.577, 0.645, 0.645, 0.645, 0.645]","[0.911, 0.919, 0.912, 0.913, 0.912, 0.91]","[0.821, 0.853, 0.826, 0.825, 0.826, 0.833]","[0.758, 0.684, 0.765, 0.766, 0.765, 0.768]","[0.803, 0.814, 0.806, 0.806, 0.806, 0.801]","[0.784, 0.788, 0.789, 0.789, 0.789, 0.786]",0.312,0.511,0.6,0.108,0.116,0.098,0.714,0.614,0.594,0.667,0.799,0.73,0.633,0.913,0.831,0.751,0.806,0.788
https://doi.org/10.1289/ehp.5986,childhood cancer incidence rates and hazardous air pollutants in california an exploratory analysis,42550_childhood cancer incidence rates and hazardous air pollutants in california an exploratory analysis.pdf,9,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://purl.fdlp.gov/GPO/gpo68498', 'https://stacks.cdc.gov/view/cdc/33133', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://stacks.cdc.gov/view/cdc/5479', 'https://stacks.cdc.gov/view/cdc/12389', 'https://bipartisanpolicy.org/library/technical-appendix-chapter-2-reducing-risks-climate-change/', 'https://stacks.cdc.gov/view/cdc/120136', 'https://stacks.cdc.gov/view/cdc/120137']","['America’s children and the environment.', 'The impacts of climate change on human health in the United States :\xa0a scientific assessment /', 'A Story of health', 'Childhood Cancer', 'Draft toxicological profile for 1,3-butadiene', 'Toxicological profile for 1,3-butadiene', 'Technical Appendix - Chapter 2 : Reducing Risks from Climate Change', 'Environmental Justice Index indicators', 'Technical documentation for the Environmental Justice Index 2022']","['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://purl.fdlp.gov/GPO/gpo68498']","['42550_0_americas children and the environment.pdf', '42550_3_childhood cancer.pdf', '42550_1_the impacts of climate change on human health in the united states \xa0a scientific assessment .pdf']",3,33.33,"['https://purl.fdlp.gov/GPO/gpo63641', 'https://www.epa.gov/sites/production/files/2015-06/documents/ace3childhoodcancerreviewpackage3-02-11.pdf', 'https://purl.fdlp.gov/GPO/gpo68498']","['42550_0_americas children and the environment.pdf', '42550_3_childhood cancer.pdf', '42550_1_the impacts of climate change on human health in the united states \xa0a scientific assessment .pdf']","[0.466, 0.24, 0.415]","[0.521, 0.533, 0.505]","[0.612, 0.623, 0.594]","[0.153, 0.166, 0.133]","[0.16, 0.176, 0.13]","[0.123, 0.141, 0.109]","[0.731, 0.737, 0.73]","[0.637, 0.64, 0.634]","[0.585, 0.599, 0.566]","[0.702, 0.725, 0.692]","[0.8, 0.8, 0.791]","[0.714, 0.716, 0.698]","[0.631, 0.639, 0.623]","[0.909, 0.914, 0.909]","[0.819, 0.828, 0.806]","[0.756, 0.762, 0.746]","[0.8, 0.801, 0.79]","[0.785, 0.786, 0.773]",0.374,0.52,0.61,0.151,0.155,0.124,0.733,0.637,0.583,0.706,0.797,0.709,0.631,0.911,0.818,0.755,0.797,0.781
https://doi.org/10.1289/ehp.6011,exposure assessment of particulate matter for susceptible populations in seattle,42551_exposure assessment of particulate matter for susceptible populations in seattle.pdf,10,"['https://purl.fdlp.gov/GPO/gpo107154', 'https://purl.fdlp.gov/GPO/gpo131976', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/98-330.pdf', 'https://purl.fdlp.gov/GPO/gpo131918', 'https://www.nyserda.ny.gov/Publications/Research-and-Development-Technical-Reports/Environmental-Reports/EMEP-Publications/-/media/Files/Publications/Research/Environmental/EMEP/Ambient-Air-Contaminants-Asthma-NYC.ashx', 'https://purl.fdlp.gov/GPO/gpo141478', 'https://www3.epa.gov/ttn/naaqs/standards/co/data/CO-REA-Amended-July2010.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/11-324.pdf', 'https://ww2.arb.ca.gov/sites/default/files/barcu/board/books/2005/031705/start.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/reports/l3041.pdf']","['Risk and exposure assessment for the review of the primary National Ambient Air Quality Standard for sulfur oxides.', 'Policy assessment for the review of the Ozone National Ambient Air Quality Standards :\xa0external review draft.', 'Report: 2003-03-01 Characterization of the Composition of Personal, Indoor and Outdoor Particulate Exposures', 'The Consolidated Human Activity Database (CHAD) :\xa0documentation and users’ guide /', 'A Study Of Ambient Air Contaminants And Asthma In New York City', 'Policy assessment for the review of the ozone national ambient air quality standards.', 'Quantitative Risk and Exposure Assessment for Carbon Monoxide - Amended', 'Final Report Benefits Of High Efficiency Filtration To Children With Asthma', 'Public Meeting Agenda', 'Report to the legislature: Indoor Air Pollution in California.']","['https://purl.fdlp.gov/GPO/gpo107154', 'https://www3.epa.gov/ttn/naaqs/standards/co/data/CO-REA-Amended-July2010.pdf', 'https://purl.fdlp.gov/GPO/gpo131918', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/98-330.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/reports/l3041.pdf']","['42551_0_risk and exposure assessment for the review of the primary national ambient air quality standard for sulfur oxides.pdf', '42551_6_quantitative risk and exposure assessment for carbon monoxide  amended.pdf', '42551_3_the consolidated human activity database chad \xa0documentation and users guide .pdf', '42551_2_report 20030301 characterization of the composition of personal indoor and outdoor particulate exposures.pdf', '42551_9_report to the legislature indoor air pollution in california.pdf']",5,50.0,"['https://purl.fdlp.gov/GPO/gpo107154', 'https://www3.epa.gov/ttn/naaqs/standards/co/data/CO-REA-Amended-July2010.pdf', 'https://purl.fdlp.gov/GPO/gpo131918', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/past/98-330.pdf', 'https://ww2.arb.ca.gov/sites/default/files/classic/research/apr/reports/l3041.pdf']","['42551_0_risk and exposure assessment for the review of the primary national ambient air quality standard for sulfur oxides.pdf', '42551_6_quantitative risk and exposure assessment for carbon monoxide  amended.pdf', '42551_3_the consolidated human activity database chad \xa0documentation and users guide .pdf', '42551_2_report 20030301 characterization of the composition of personal indoor and outdoor particulate exposures.pdf', '42551_9_report to the legislature indoor air pollution in california.pdf']","[0.289, 0.706, 0.181, 0.322, 0.424]","[0.502, 0.511, 0.503, 0.508, 0.504]","[0.586, 0.596, 0.58, 0.589, 0.593]","[0.131, 0.142, 0.11, 0.15, 0.142]","[0.133, 0.141, 0.115, 0.149, 0.144]","[0.121, 0.129, 0.102, 0.139, 0.121]","[0.733, 0.732, 0.724, 0.733, 0.724]","[0.637, 0.637, 0.624, 0.638, 0.627]","[0.555, 0.568, 0.574, 0.564, 0.568]","[0.724, 0.716, 0.698, 0.722, 0.696]","[0.763, 0.772, 0.77, 0.768, 0.781]","[0.664, 0.678, 0.689, 0.68, 0.692]","[0.634, 0.64, 0.627, 0.642, 0.64]","[0.903, 0.906, 0.908, 0.901, 0.909]","[0.794, 0.81, 0.82, 0.803, 0.811]","[0.732, 0.743, 0.741, 0.743, 0.752]","[0.767, 0.779, 0.781, 0.775, 0.787]","[0.754, 0.766, 0.764, 0.765, 0.771]",0.384,0.506,0.589,0.135,0.136,0.122,0.729,0.633,0.566,0.711,0.771,0.681,0.637,0.905,0.808,0.742,0.778,0.764
https://doi.org/10.1289/ehp.6053,low birth weight and residential proximity to pcbcontaminated waste sites,42552_low birth weight and residential proximity to pcbcontaminated waste sites.pdf,10,"['https://www.dec.ny.gov/docs/legal_protection_pdf/cwm00113ex7ex8.pdf', 'https://purl.fdlp.gov/GPO/gpo63641', 'https://www.chicago.gov/content/dam/city/depts/cdph/CDPH/Englewood_Line_Trail_HIA.pdf', 'https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreenver11report.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/spanishces20publicreview04222014posted.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/calenviroscreen2011spanish.pdf', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/ces20publicreview04212014.pdf', 'https://stacks.cdc.gov/view/cdc/45503', 'https://oehha.ca.gov/media/downloads/calenviroscreen/report/ces3report.pdf']","['CWM - R. Nils Olsen - Petition', 'America’s children and the environment.', 'Health Impact', 'Health: Adverse Birth Outcomes', 'CalEnviroscreen Version 1.1', 'Instrumento Instrumento Tentativo de Evaluación de la Salud Ambiental en las Comunidades de California, Versión 2.0', 'INSTRUMENTO DE EVALUACIÓN DE LA SALUD AMBIENTAL EN LAS COMUNIDADES DE CALIFORNIA, CalEnviroScreen 1.1', 'Draft California Communities Environmental Health Screening Tool (CalEnviroScreen 2.0)', 'ATSDR studies on chemical releases in the Great Lakes Region', 'CalEnviroScreen 3.0']",['https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf'],['42552_3_health adverse birth outcomes.pdf'],1,10.0,['https://www.epa.gov/sites/production/files/2015-06/documents/health-adverse-birth-outcomes.pdf'],['42552_3_health adverse birth outcomes.pdf'],[0.538],[0.504],[0.603],[0.19],[0.198],[0.162],[0.743],[0.652],[0.594],[0.698],[0.795],[0.708],[0.595],[0.915],[0.825],[0.75],[0.792],[0.77],0.538,0.504,0.603,0.19,0.198,0.162,0.743,0.652,0.594,0.698,0.795,0.708,0.595,0.915,0.825,0.75,0.792,0.77
https://doi.org/10.1289/ehp.6331,effect of succimer on growth of preschool children with moderate blood lead levels,42559_effect of succimer on growth of preschool children with moderate blood lead levels.pdf,3,"['https://ntp.niehs.nih.gov/ntp/ohat/lead/final/leadappendixe_final_508.pdf', 'https://ntp.niehs.nih.gov/ntp/ohat/lead/final/appendicesathrue_final_508.pdf', 'https://stacks.cdc.gov/view/cdc/37676']","['Lead', 'Lead', 'Toxicological profile for lead']",['https://ntp.niehs.nih.gov/ntp/ohat/lead/final/appendicesathrue_final_508.pdf'],['42559_1_lead.pdf'],1,33.33,['https://ntp.niehs.nih.gov/ntp/ohat/lead/final/appendicesathrue_final_508.pdf'],['42559_1_lead.pdf'],[0.394],[0.48],[0.567],[0.136],[0.124],[0.116],[0.739],[0.643],[0.538],[0.703],[0.75],[0.66],[0.617],[0.894],[0.758],[0.699],[0.749],[0.723],0.394,0.48,0.567,0.136,0.124,0.116,0.739,0.643,0.538,0.703,0.75,0.66,0.617,0.894,0.758,0.699,0.749,0.723
https://doi.org/10.1289/ehp.7712,comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal,42602_comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal.pdf,1,['http://www.dnrec.delaware.gov/dwhs/Info/Regs/Documents/27ea7054b08747eab93b5d7f43ca209dEUECSusceptibleSubpopulationexpanded.pdf'],['2006 Electric Utility Environmental Conference'],['http://www.dnrec.delaware.gov/dwhs/Info/Regs/Documents/27ea7054b08747eab93b5d7f43ca209dEUECSusceptibleSubpopulationexpanded.pdf'],['42602_0_2006 electric utility environmental conference.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.1289/ehp.7856,transport of methylmercury and inorganic mercury to the fetus and breastfed infant,42604_transport of methylmercury and inorganic mercury to the fetus and breastfed infant.pdf,3,"['https://stacks.cdc.gov/view/cdc/117446', 'https://fortress.wa.gov/ecy/publications/documents/0907014.pdf', 'https://stacks.cdc.gov/view/cdc/21813']","['Toxicological profile for mercury : draft for public comment : April 2022', 'Children ’s Safe Product Act Report', 'Fourth national report on human exposure to environmental chemicals']",['https://fortress.wa.gov/ecy/publications/documents/0907014.pdf'],['42604_1_children s safe product act report.pdf'],1,33.33,['https://fortress.wa.gov/ecy/publications/documents/0907014.pdf'],['42604_1_children s safe product act report.pdf'],[0.096],[0.518],[0.61],[0.114],[0.129],[0.1],[0.716],[0.622],[0.593],[0.648],[0.796],[0.718],[0.628],[0.918],[0.825],[0.763],[0.803],[0.786],0.096,0.518,0.61,0.114,0.129,0.1,0.716,0.622,0.593,0.648,0.796,0.718,0.628,0.918,0.825,0.763,0.803,0.786
https://doi.org/10.1289/ehp.9303,dose–response relationship of prenatal mercury exposure and iq an integrative analysis of epidemiologic data,42626_dose–response relationship of prenatal mercury exposure and iq an integrative analysis of epidemiologic data.pdf,10,"['https://www3.epa.gov/ttn/atw/utility/revisedmercurytsd.pdf', 'https://www.deq.virginia.gov/Portals/0/DEQ/LawsAndRegulations/App_B-VCU_portion_HG_report_pldf_final.pdf', 'https://www3.epa.gov/ttn/ecas/docs/ria/utilities_ria_final-mats_2011-12.pdf', 'https://www.congress.gov/event/110th-congress/senate-event/LC8788/text', 'https://www.federalregister.gov/documents/2012/02/16/2012-806/national-emission-standards-for-hazardous-air-pollutants-from-coal--and-oil-fired-electric-utility', 'https://www.cabq.gov/airquality/air-quality-control-board/documents/NSPSNESHAPs_83011_through_91313_Portfolio.pdf', 'https://oceana.org/reports/hidden-costs-reduced-iq-chlor-alkali-plant-mercury-emissions-harms-economy', 'https://stacks.cdc.gov/view/cdc/117446', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903143/pdf', 'http://dhss.alaska.gov/dph/Epi/eph/Documents/fish/FishConsumptionAdvice2014.pdf']","['Revised Technical Support Document : National-Scale Assessment of Mercury Risk to Populations with High Consumption of Self-caught Freshwater Fish', 'Outline of Literature Review', 'Regulatory Impact Analysis for the Final Mercury and Air Toxics Standards', 'S.Hrg. 110-1090 — THE STATE OF MERCURY REGULATION, SCIENCE AND TECHNOLOGY', 'National Emission Standards for Hazardous Air Pollutants From Coal- and Oil-Fired Electric Utility Steam Generating Units and Standards of Performance for Fossil-Fuel-Fired Electric Utility, Industrial-Commercial-Institutional, and Small Industrial-Commercial-Institutional Steam Generating Units', 'Pmangrum on DSK3VPTVN1PROD with RULES', 'Hidden Costs: Reduced IQ from Chlor-Alkali Plant Mercury Emissions Harms the Economy', 'Toxicological profile for mercury : draft for public comment : April 2022', 'Preconception Care: A New Standard of Care within Maternal Health Services', 'Fish Consumption Advice for Alaskans: A Risk Management Strategy To Optimize the Public’s Health']",['https://www3.epa.gov/ttn/atw/utility/revisedmercurytsd.pdf'],['42626_0_revised technical support document  nationalscale assessment of mercury risk to populations with high consumption of selfcaught freshwater fish.pdf'],1,10.0,['https://www3.epa.gov/ttn/atw/utility/revisedmercurytsd.pdf'],['42626_0_revised technical support document  nationalscale assessment of mercury risk to populations with high consumption of selfcaught freshwater fish.pdf'],[0.338],[0.55],[0.634],[0.16],[0.163],[0.133],[0.734],[0.644],[0.613],[0.702],[0.8],[0.734],[0.659],[0.907],[0.823],[0.757],[0.806],[0.775],0.338,0.55,0.634,0.16,0.163,0.133,0.734,0.644,0.613,0.702,0.8,0.734,0.659,0.907,0.823,0.757,0.806,0.775
https://doi.org/10.1289/ehp.9762,mortality effects of a copper smelter strike and reduced ambient sulfate particulate matter air pollution,42633_mortality effects of a copper smelter strike and reduced ambient sulfate particulate matter air pollution.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526394/pdf', 'https://www.nber.org/papers/w19881?sy=881', 'https://www.nber.org/papers/w22155', 'https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf']","['Interventions to reduce ambient particulate matter air pollution and their effect on health', 'Coal, Smoke, and Death: Bituminous Coal and American Home Heating', 'Canary in a Coal Mine: Infant Mortality, Property Values, and Tradeoffs Associated with Mid-20th Century Air Pollution', 'Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association']",['https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf'],['42633_3_particulate matter air pollution and cardiovascular disease an update to the scientific statement from the american heart association.pdf'],1,25.0,['https://dnr.wisconsin.gov/sites/default/files/topic/AirQuality/AHA_Circulation_2010.pdf'],['42633_3_particulate matter air pollution and cardiovascular disease an update to the scientific statement from the american heart association.pdf'],[0.415],[0.539],[0.625],[0.171],[0.173],[0.136],[0.736],[0.642],[0.615],[0.704],[0.81],[0.741],[0.628],[0.918],[0.831],[0.765],[0.81],[0.787],0.415,0.539,0.625,0.171,0.173,0.136,0.736,0.642,0.615,0.704,0.81,0.741,0.628,0.918,0.831,0.765,0.81,0.787
https://doi.org/10.1292/jvms.64.855,a case of chronic wasting disease in an elk imported to korea from canada,42647_a case of chronic wasting disease in an elk imported to korea from canada.pdf,3,"['https://purl.fdlp.gov/GPO/gpo91729', 'https://wdfw.wa.gov/sites/default/files/2021-07/plan_draft_wdfw_cwd_plan_20210322_revised.pdf', 'https://www.michigan.gov/documents/emergingdiseases/CWDContingencyPlan_2012Update_FinalDraft_391020_7.pdf']","['Chronic wasting disease :\xa0status, science, and management support by the U.S. Geological Survey /', 'Washington State Chronic Wasting Disease (CWD) Management Plan', 'Michigan Surveillance and Response Plan for Chronic Wasting Disease  (CWD) of Free-Ranging and Privately Owned Cervids']",['https://www.michigan.gov/documents/emergingdiseases/CWDContingencyPlan_2012Update_FinalDraft_391020_7.pdf'],['42647_2_michigan surveillance and response plan for chronic wasting disease  cwd of freeranging and privately owned cervids.pdf'],1,33.33,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.12968/bjon.2008.17.13.30535,the missing link paediatric to adult transition in diabetes services,42662_the missing link paediatric to adult transition in diabetes services.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320668/pdf'],['Transitioning the Adolescent Inflammatory Bowel Disease Patient: Guidelines for the Adult and Pediatric Gastroenterologist'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320668/pdf'],['42662_0_transitioning the adolescent inflammatory bowel disease patient guidelines for the adult and pediatric gastroenterologist.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320668/pdf'],['42662_0_transitioning the adolescent inflammatory bowel disease patient guidelines for the adult and pediatric gastroenterologist.pdf'],[0.612],[0.513],[0.636],[0.198],[0.205],[0.167],[0.745],[0.654],[0.594],[0.673],[0.793],[0.688],[0.593],[0.906],[0.841],[0.757],[0.789],[0.781],0.612,0.513,0.636,0.198,0.205,0.167,0.745,0.654,0.594,0.673,0.793,0.688,0.593,0.906,0.841,0.757,0.789,0.781
https://doi.org/10.12968/nrec.2012.14.3.149,devising a dementia toolkit for effective communication,42674_devising a dementia toolkit for effective communication.pdf,2,"['https://aging.idaho.gov/wp-content/uploads/2019/06/communicating-well-2.pdf', 'https://aging.idaho.gov/wp-content/uploads/2019/06/knowing-the-person-behind-the-dementia.pdf']","['Dementia Gateway : Communicating well', 'Dementia Gateway : Knowing the person behind the dementia']",['https://aging.idaho.gov/wp-content/uploads/2019/06/communicating-well-2.pdf'],['42674_0_dementia gateway  communicating well.pdf'],1,50.0,['https://aging.idaho.gov/wp-content/uploads/2019/06/communicating-well-2.pdf'],['42674_0_dementia gateway  communicating well.pdf'],[0.655],[0.65],[0.712],[0.263],[0.283],[0.248],[0.761],[0.674],[0.717],[0.719],[0.848],[0.817],[0.683],[0.917],[0.884],[0.83],[0.852],[0.84],0.655,0.65,0.712,0.263,0.283,0.248,0.761,0.674,0.717,0.719,0.848,0.817,0.683,0.917,0.884,0.83,0.852,0.84
https://doi.org/10.1371/journal.pone.0078888,exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal leydig cells,43751_exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal leydig cells.pdf,4,"['https://files.nc.gov/ncdeq/sab/Conley-et-al.-2019.pdf', 'https://apps.ecology.wa.gov/publications/documents/2104048.pdf', 'https://www.epa.gov/sites/default/files/2016-05/documents/hesd_pfos_final-plain.pdf', 'https://oehha.ca.gov/media/downloads/water/chemicals/nl/final-pfoa-pfosnl082119.pdf']","['Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats', 'Per- and Polyfluoroalkyl Substances Chemical Action Plan', 'Health Effects Support Document for Perfluorooctane Sulfonate (PFOS)', 'Notification Level Recommendations for Perfluorooctanoic Acid and Perfluorooctane Sulfonate in Drinking Water']",['https://www.epa.gov/sites/default/files/2016-05/documents/hesd_pfos_final-plain.pdf'],['43751_2_health effects support document for perfluorooctane sulfonate pfos.pdf'],1,25.0,['https://www.epa.gov/sites/default/files/2016-05/documents/hesd_pfos_final-plain.pdf'],['43751_2_health effects support document for perfluorooctane sulfonate pfos.pdf'],[0.615],[0.525],[0.609],[0.17],[0.154],[0.128],[0.739],[0.644],[0.594],[0.659],[0.79],[0.703],[0.64],[0.908],[0.806],[0.763],[0.795],[0.777],0.615,0.525,0.609,0.17,0.154,0.128,0.739,0.644,0.594,0.659,0.79,0.703,0.64,0.908,0.806,0.763,0.795,0.777
https://doi.org/10.1371/journal.pone.0126425,perinatal outcomes and unconventional natural gas operations in southwest pennsylvania,43872_perinatal outcomes and unconventional natural gas operations in southwest pennsylvania.pdf,6,"['https://pacinst.org/publication/california-fracking-report-issue-briefs-evaluate-risks-provide-recommendations/', 'https://clkrep.lacity.org/onlinedocs/2017/17-0447_rpt_BPW_07-29-2019.pdf', 'https://www.congress.gov/event/116th-congress/house-event/109796', 'https://www.nj.gov/drbc/library/documents/CRD_HVHFrulemaking.pdf', 'https://www.rff.org/publications/reports/health-impacts-of-unconventional-oil-and-gas-development/', 'https://www.gov.ca.gov/wp-content/uploads/2021/10/Public-Health-Panel-Memo.pdf']","['An Independent Scientific Assessment of Well Stimulation in California and Fracking Issue Briefs', 'City of Los Angeles', '""Oil and Gas Development: Impacts of Business-as-Usual on the Climate and Public Health""', 'Comment and Response Document', 'Health Impacts of Unconventional Oil and Gas Development', 'RE : Response to CalGEM Questions for the California Oil and Gas Public Health Rulemaking Scientific Advisory Panel']",['https://www.gov.ca.gov/wp-content/uploads/2021/10/Public-Health-Panel-Memo.pdf'],['43872_5_re  response to calgem questions for the california oil and gas public health rulemaking scientific advisory panel.pdf'],1,16.67,['https://www.gov.ca.gov/wp-content/uploads/2021/10/Public-Health-Panel-Memo.pdf'],['43872_5_re  response to calgem questions for the california oil and gas public health rulemaking scientific advisory panel.pdf'],[0.502],[0.503],[0.606],[0.145],[0.159],[0.119],[0.73],[0.638],[0.564],[0.685],[0.781],[0.692],[0.61],[0.915],[0.81],[0.732],[0.775],[0.761],0.502,0.503,0.606,0.145,0.159,0.119,0.73,0.638,0.564,0.685,0.781,0.692,0.61,0.915,0.81,0.732,0.775,0.761
https://doi.org/10.1371/journal.pone.0209749,gender and cultural bias in student evaluations why representation matters,44081_gender and cultural bias in student evaluations why representation matters.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413740/pdf'],['Actionable recommendations from trainees to improve science training'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413740/pdf'],['44081_0_actionable recommendations from trainees to improve science training.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413740/pdf'],['44081_0_actionable recommendations from trainees to improve science training.pdf'],[0.158],[0.553],[0.639],[0.155],[0.165],[0.137],[0.729],[0.633],[0.63],[0.699],[0.811],[0.749],[0.641],[0.929],[0.856],[0.78],[0.815],[0.797],0.158,0.553,0.639,0.155,0.165,0.137,0.729,0.633,0.63,0.699,0.811,0.749,0.641,0.929,0.856,0.78,0.815,0.797
https://doi.org/10.5539/res.v8n1p212,finding high risk persons with internet tests to manage risk—a literature review with policy implications to avoid violent tragedies save lives and money,51644_finding high risk persons with internet tests to manage risk—a literature review with policy implications to avoid violent tragedies save lives and money.pdf,1,['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/publicationsohpmspjj-training-content.pdf'],['Suicide Prevention for Juvenile Justice Populations'],['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/publicationsohpmspjj-training-content.pdf'],['51644_0_suicide prevention for juvenile justice populations.pdf'],1,100.0,['https://dph.illinois.gov/content/dam/soi/en/web/idph/files/publications/publicationsohpmspjj-training-content.pdf'],['51644_0_suicide prevention for juvenile justice populations.pdf'],[0.296],[0.506],[0.6],[0.12],[0.136],[0.12],[0.721],[0.622],[0.57],[0.674],[0.78],[0.689],[0.621],[0.921],[0.83],[0.743],[0.789],[0.773],0.296,0.506,0.6,0.12,0.136,0.12,0.721,0.622,0.57,0.674,0.78,0.689,0.621,0.921,0.83,0.743,0.789,0.773
https://doi.org/10.5625/lar.2011.27.2.161,transcriptome analysis of the effects of gomisin a on the recovery of carbon tetrachlorideinduced damage in rat liver,51664_transcriptome analysis of the effects of gomisin a on the recovery of carbon tetrachlorideinduced damage in rat liver.pdf,1,['https://www.epa.gov/sites/default/files/2017-06/documents/ccl4_comp_bib_0.pdf'],['Carbon Tetrachloride (CASRN : 56‐23‐5) Bibliography : Supplemental File for the TSCA Scope Document'],['https://www.epa.gov/sites/default/files/2017-06/documents/ccl4_comp_bib_0.pdf'],['51664_0_carbon tetrachloride casrn  56‐23‐5 bibliography  supplemental file for the tsca scope document.pdf'],1,100.0,['https://www.epa.gov/sites/default/files/2017-06/documents/ccl4_comp_bib_0.pdf'],['51664_0_carbon tetrachloride casrn  56‐23‐5 bibliography  supplemental file for the tsca scope document.pdf'],[0.391],[0.481],[0.59],[0.091],[0.092],[0.073],[0.741],[0.645],[0.574],[0.638],[0.787],[0.689],[0.586],[0.919],[0.806],[0.736],[0.781],[0.767],0.391,0.481,0.59,0.091,0.092,0.073,0.741,0.645,0.574,0.638,0.787,0.689,0.586,0.919,0.806,0.736,0.781,0.767
https://doi.org/10.5664/jcsm.6358,high school start times and the impact on high school students what we know and what we hope to learn,51673_high school start times and the impact on high school students what we know and what we hope to learn.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359340/pdf'],['Delaying Middle School and High School Start Times Promotes Student Health and Performance: An American Academy of Sleep Medicine Position Statement'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359340/pdf'],['51673_0_delaying middle school and high school start times promotes student health and performance an american academy of sleep medicine position statement.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359340/pdf'],['51673_0_delaying middle school and high school start times promotes student health and performance an american academy of sleep medicine position statement.pdf'],[0.814],[0.551],[0.627],[0.232],[0.262],[0.225],[0.746],[0.664],[0.606],[0.718],[0.806],[0.72],[0.628],[0.927],[0.837],[0.762],[0.797],[0.785],0.814,0.551,0.627,0.232,0.262,0.225,0.746,0.664,0.606,0.718,0.806,0.72,0.628,0.927,0.837,0.762,0.797,0.785
https://doi.org/10.5688/ajpe808133,motivations and predictors of cheating in pharmacy school,51682_motivations and predictors of cheating in pharmacy school.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325455/pdf'],"['Best Practices on Examination Construction, Administration, and Feedback']",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325455/pdf'],['51682_0_best practices on examination construction administration and feedback.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325455/pdf'],['51682_0_best practices on examination construction administration and feedback.pdf'],[0.474],[0.527],[0.611],[0.166],[0.181],[0.165],[0.736],[0.642],[0.592],[0.687],[0.783],[0.701],[0.628],[0.922],[0.822],[0.756],[0.783],[0.771],0.474,0.527,0.611,0.166,0.181,0.165,0.736,0.642,0.592,0.687,0.783,0.701,0.628,0.922,0.822,0.756,0.783,0.771
https://doi.org/10.5694/j.1326-5377.2000.tb123977.x,prevention of perinatal group b streptococcal disease screening practice in public hospitals in victoria,51684_prevention of perinatal group b streptococcal disease screening practice in public hospitals in victoria.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852267/pdf'],['Compliance With Protocols for Prevention of Neonatal Group B Streptococcal Sepsis: Practicalities and Limitations'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852267/pdf'],['51684_0_compliance with protocols for prevention of neonatal group b streptococcal sepsis practicalities and limitations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852267/pdf'],['51684_0_compliance with protocols for prevention of neonatal group b streptococcal sepsis practicalities and limitations.pdf'],[0.547],[0.611],[0.68],[0.246],[0.255],[0.204],[0.748],[0.667],[0.685],[0.669],[0.833],[0.784],[0.665],[0.93],[0.855],[0.811],[0.842],[0.822],0.547,0.611,0.68,0.246,0.255,0.204,0.748,0.667,0.685,0.669,0.833,0.784,0.665,0.93,0.855,0.811,0.842,0.822
https://doi.org/10.5694/j.1326-5377.2000.tb124123.x,newborn screening for cystic fibrosis in victoria 10 years experience 1989‐1998,51685_newborn screening for cystic fibrosis in victoria 10 years experience 1989‐1998.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810958/pdf'],['Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810958/pdf'],['51685_0_guidelines for diagnosis of cystic fibrosis in newborns through older adults cystic fibrosis foundation consensus report.pdf'],1,100.0,[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],[],,,,,,,,,,,,,,,,,,
https://doi.org/10.5751/es-07801-200336,climateinduced community relocations using integrated socialecological assessments to foster adaptation and resilience,51715_climateinduced community relocations using integrated socialecological assessments to foster adaptation and resilience.pdf,1,['https://purl.fdlp.gov/GPO/gpo75211'],['Climate change and indigenous peoples :\xa0a synthesis of current impacts and experiences /'],['https://purl.fdlp.gov/GPO/gpo75211'],['51715_0_climate change and indigenous peoples \xa0a synthesis of current impacts and experiences .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo75211'],['51715_0_climate change and indigenous peoples \xa0a synthesis of current impacts and experiences .pdf'],[0.537],[0.539],[0.635],[0.174],[0.175],[0.143],[0.729],[0.642],[0.602],[0.676],[0.814],[0.726],[0.657],[0.921],[0.84],[0.773],[0.814],[0.797],0.537,0.539,0.635,0.174,0.175,0.143,0.729,0.642,0.602,0.676,0.814,0.726,0.657,0.921,0.84,0.773,0.814,0.797
https://doi.org/10.5811/westjem.2018.11.44318,a multimodal curriculum with patient feedback to improve medical student communication pilot study,51721_a multimodal curriculum with patient feedback to improve medical student communication pilot study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],"[""Interventions for improving medical students' interpersonal communication in medical consultations""]",['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['51721_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094582/pdf'],['51721_0_interventions for improving medical students interpersonal communication in medical consultations.pdf'],[0.584],[0.526],[0.612],[0.182],[0.196],[0.166],[0.739],[0.648],[0.588],[0.696],[0.776],[0.694],[0.6],[0.918],[0.823],[0.727],[0.773],[0.761],0.584,0.526,0.612,0.182,0.196,0.166,0.739,0.648,0.588,0.696,0.776,0.694,0.6,0.918,0.823,0.727,0.773,0.761
https://doi.org/10.5888/pcd10.120281,incarceration of a household member and hispanic health disparities childhood exposure and adult chronic disease risk behaviors,51756_incarceration of a household member and hispanic health disparities childhood exposure and adult chronic disease risk behaviors.pdf,4,"['https://www.urban.org/research/publication/parent-child-visiting-practices-prisons-and-jails', 'https://ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf', 'https://www.ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf', 'https://ur.ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf']","['Parent-Child Visiting Practices in Prisons and Jails', 'Preventive Services Practice Guidance Manual', 'Preventive Services Practice Guidance Manual', 'Preventive Services Practice Guidance Manual']","['https://ur.ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf', 'https://ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf', 'https://www.ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf']","['51756_3_preventive services practice guidance manual.pdf', '51756_1_preventive services practice guidance manual.pdf', '51756_2_preventive services practice guidance manual.pdf']",3,75.0,"['https://ur.ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf', 'https://ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf', 'https://www.ocfs.ny.gov/main/publications/Preventive%20Services%20Guide%202015.pdf']","['51756_3_preventive services practice guidance manual.pdf', '51756_1_preventive services practice guidance manual.pdf', '51756_2_preventive services practice guidance manual.pdf']","[0.168, 0.168, 0.168]","[0.533, 0.533, 0.533]","[0.63, 0.63, 0.63]","[0.13, 0.13, 0.13]","[0.15, 0.15, 0.15]","[0.124, 0.124, 0.124]","[0.72, 0.72, 0.72]","[0.616, 0.616, 0.616]","[0.601, 0.601, 0.601]","[0.663, 0.663, 0.663]","[0.792, 0.792, 0.792]","[0.721, 0.721, 0.721]","[0.607, 0.607, 0.607]","[0.923, 0.923, 0.923]","[0.839, 0.839, 0.839]","[0.758, 0.758, 0.758]","[0.803, 0.803, 0.803]","[0.783, 0.783, 0.783]",0.168,0.533,0.63,0.13,0.15,0.124,0.72,0.616,0.601,0.663,0.792,0.721,0.607,0.923,0.839,0.758,0.803,0.783
https://doi.org/10.5888/pcd10.130009,adverse childhood experiences and adult smoking nebraska 2011,51757_adverse childhood experiences and adult smoking nebraska 2011.pdf,1,['http://www.dhss.alaska.gov/abada/ace-ak/Documents/ACEsReportAlaska.pdf'],['Adverse Childhood Experiences-Overcoming ACEs in Alaska'],['http://www.dhss.alaska.gov/abada/ace-ak/Documents/ACEsReportAlaska.pdf'],['51757_0_adverse childhood experiencesovercoming aces in alaska.pdf'],1,100.0,['http://www.dhss.alaska.gov/abada/ace-ak/Documents/ACEsReportAlaska.pdf'],['51757_0_adverse childhood experiencesovercoming aces in alaska.pdf'],[0.432],[0.533],[0.627],[0.158],[0.181],[0.144],[0.728],[0.635],[0.601],[0.689],[0.793],[0.713],[0.623],[0.924],[0.847],[0.758],[0.807],[0.787],0.432,0.533,0.627,0.158,0.181,0.144,0.728,0.635,0.601,0.689,0.793,0.713,0.623,0.924,0.847,0.758,0.807,0.787
https://doi.org/10.5888/pcd13.150535,clinical and economic burden of mental disorders among children with chronic physical conditions united states 2008–2013,51762_clinical and economic burden of mental disorders among children with chronic physical conditions united states 2008–2013.pdf,2,"['https://purl.fdlp.gov/GPO/gpo113527', 'https://schoolsafety.dbs.idaho.gov/wp-content/uploads/sites/106/2020/03/Federal-Commission-school-safety-report.pdf']","['Final report of the Federal Commission on School Safety :\xa0presented to the President of the United States, December 18, 2018.', 'Final Report of the Federal Commission on School Safety (PDF)']",['https://purl.fdlp.gov/GPO/gpo113527'],['51762_0_final report of the federal commission on school safety \xa0presented to the president of the united states december 18 2018.pdf'],1,50.0,['https://purl.fdlp.gov/GPO/gpo113527'],['51762_0_final report of the federal commission on school safety \xa0presented to the president of the united states december 18 2018.pdf'],[0.272],[0.531],[0.622],[0.137],[0.139],[0.112],[0.723],[0.624],[0.612],[0.652],[0.807],[0.737],[0.624],[0.929],[0.837],[0.765],[0.814],[0.79],0.272,0.531,0.622,0.137,0.139,0.112,0.723,0.624,0.612,0.652,0.807,0.737,0.624,0.929,0.837,0.765,0.814,0.79
https://doi.org/10.5888/pcd9.110312,asthmarelated school absenteeism and school concentration of lowincome students in california,51779_asthmarelated school absenteeism and school concentration of lowincome students in california.pdf,4,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478185/pdf', 'https://purl.fdlp.gov/GPO/gpo139196', 'https://www.urban.org/research/publication/people-and-place-matter-using-integrated-data-systems-understand-chronic-absenteeism', 'https://www.brookings.edu/research/community-based-approaches-for-optimal-asthma-outcomes-and-accountable-population-health/']","['Asthma education for school staff', 'Examining the effects of the Rental Assistance Demonstration on children living in public housing in Fresno, California /', 'People and Place Matter: Using Integrated Data Systems to Understand Chronic Absenteeism', 'Community based approaches for optimal asthma outcomes and accountable population health']","['https://purl.fdlp.gov/GPO/gpo139196', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478185/pdf']","['51779_1_examining the effects of the rental assistance demonstration on children living in public housing in fresno california .pdf', '51779_0_asthma education for school staff.pdf']",2,50.0,"['https://purl.fdlp.gov/GPO/gpo139196', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478185/pdf']","['51779_1_examining the effects of the rental assistance demonstration on children living in public housing in fresno california .pdf', '51779_0_asthma education for school staff.pdf']","[0.593, 0.21]","[0.523, 0.525]","[0.616, 0.616]","[0.135, 0.187]","[0.147, 0.206]","[0.114, 0.173]","[0.715, 0.734]","[0.616, 0.635]","[0.603, 0.596]","[0.664, 0.697]","[0.795, 0.787]","[0.718, 0.698]","[0.627, 0.597]","[0.917, 0.918]","[0.838, 0.826]","[0.757, 0.74]","[0.805, 0.789]","[0.784, 0.771]",0.401,0.524,0.616,0.161,0.176,0.143,0.724,0.625,0.599,0.68,0.791,0.708,0.612,0.917,0.832,0.748,0.797,0.778
https://doi.org/10.5888/pcd9.120082,opportunities for policy interventions to reduce youth hookah smoking in the united states,51781_opportunities for policy interventions to reduce youth hookah smoking in the united states.pdf,1,['https://monocounty.ca.gov/sites/default/files/fileattachments/public_health/page/9062/final_flavored_tobacco_fact_sheet-color.pdf'],['Flavored Tobacco Products'],['https://monocounty.ca.gov/sites/default/files/fileattachments/public_health/page/9062/final_flavored_tobacco_fact_sheet-color.pdf'],['51781_0_flavored tobacco products.pdf'],1,100.0,['https://monocounty.ca.gov/sites/default/files/fileattachments/public_health/page/9062/final_flavored_tobacco_fact_sheet-color.pdf'],['51781_0_flavored tobacco products.pdf'],[0.586],[0.514],[0.624],[0.211],[0.24],[0.205],[0.75],[0.657],[0.584],[0.696],[0.796],[0.697],[0.613],[0.923],[0.808],[0.745],[0.794],[0.782],0.586,0.514,0.624,0.211,0.24,0.205,0.75,0.657,0.584,0.696,0.796,0.697,0.613,0.923,0.808,0.745,0.794,0.782
https://doi.org/10.5978/islsm.27_18-or-24,efficacy comparison of ndyag laser diode laser and dentine bonding agent in dentine hypersensitivity reduction a clinical trial,51797_efficacy comparison of ndyag laser diode laser and dentine bonding agent in dentine hypersensitivity reduction a clinical trial.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276937/pdf'],['Laser therapy for dentinal hypersensitivity'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276937/pdf'],['51797_0_laser therapy for dentinal hypersensitivity.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276937/pdf'],['51797_0_laser therapy for dentinal hypersensitivity.pdf'],[0.567],[0.533],[0.62],[0.181],[0.188],[0.153],[0.746],[0.652],[0.594],[0.659],[0.786],[0.708],[0.623],[0.913],[0.802],[0.745],[0.784],[0.768],0.567,0.533,0.62,0.181,0.188,0.153,0.746,0.652,0.594,0.659,0.786,0.708,0.623,0.913,0.802,0.745,0.784,0.768
https://doi.org/10.7196/sajog.869,are we missing atrisk babies comparison of customised growth charts v standard population charts in a diabetic population,51853_are we missing atrisk babies comparison of customised growth charts v standard population charts in a diabetic population.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464609/pdf'],['Different insulin types and regimens for pregnant women with pre‐existing diabetes'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464609/pdf'],['51853_0_different insulin types and regimens for pregnant women with pre‐existing diabetes.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464609/pdf'],['51853_0_different insulin types and regimens for pregnant women with pre‐existing diabetes.pdf'],[0.119],[0.519],[0.606],[0.16],[0.166],[0.145],[0.735],[0.638],[0.589],[0.673],[0.768],[0.694],[0.596],[0.903],[0.81],[0.725],[0.773],[0.749],0.119,0.519,0.606,0.16,0.166,0.145,0.735,0.638,0.589,0.673,0.768,0.694,0.596,0.903,0.81,0.725,0.773,0.749
https://doi.org/10.7196/samj.2018.v109i1.13723,human papillomavirus vaccination acceptance and hesitancy in south africa research and policy agenda,51854_human papillomavirus vaccination acceptance and hesitancy in south africa research and policy agenda.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['Improving vaccination uptake among adolescents'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['51854_0_improving vaccination uptake among adolescents.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984618/pdf'],['51854_0_improving vaccination uptake among adolescents.pdf'],[0.462],[0.543],[0.629],[0.204],[0.211],[0.188],[0.744],[0.653],[0.599],[0.683],[0.786],[0.707],[0.607],[0.912],[0.823],[0.743],[0.787],[0.765],0.462,0.543,0.629,0.204,0.211,0.188,0.744,0.653,0.599,0.683,0.786,0.707,0.607,0.912,0.823,0.743,0.787,0.765
https://doi.org/10.7205/milmed-d-03-0208,adenovirus serotype 14 pneumonia at a basic military training site in the united states spring 2007 a case series,51859_adenovirus serotype 14 pneumonia at a basic military training site in the united states spring 2007 a case series.pdf,1,['https://purl.fdlp.gov/GPO/gpo76007'],['USAMRMC products portfolio /'],['https://purl.fdlp.gov/GPO/gpo76007'],['51859_0_usamrmc products portfolio .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo76007'],['51859_0_usamrmc products portfolio .pdf'],[0.261],[0.56],[0.633],[0.132],[0.126],[0.099],[0.738],[0.636],[0.642],[0.604],[0.811],[0.762],[0.654],[0.922],[0.836],[0.791],[0.828],[0.808],0.261,0.56,0.633,0.132,0.126,0.099,0.738,0.636,0.642,0.604,0.811,0.762,0.654,0.922,0.836,0.791,0.828,0.808
https://doi.org/10.7205/milmed-d-10-00394,a randomized clinical trial of group prenatal care in two military settings,51862_a randomized clinical trial of group prenatal care in two military settings.pdf,5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465187/pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/6/Wsipp_BenefitCost_ProgramDetails_Health-Care', 'https://www.rand.org/pubs/research_reports/RR1993.html', 'http://www.wsipp.wa.gov/ReportFile/1661/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-December-2016-Update_Report.pdf', 'http://www.wsipp.wa.gov/ReportFile/1665/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-May-2017-Update_Report.pdf']","['Group versus conventional antenatal care for women', 'Washington State Institute for Public Policy', 'Early Childhood Programs Can Improve Outcomes and Outweigh Costs', 'Washington State Institute for Public Policy', 'Washington State Institute for Public Policy']","['http://www.wsipp.wa.gov/ReportFile/1661/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-December-2016-Update_Report.pdf', 'http://www.wsipp.wa.gov/ReportFile/1665/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-May-2017-Update_Report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465187/pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/6/Wsipp_BenefitCost_ProgramDetails_Health-Care']","['51862_3_washington state institute for public policy.pdf', '51862_4_washington state institute for public policy.pdf', '51862_0_group versus conventional antenatal care for women.pdf', '51862_1_washington state institute for public policy.pdf']",4,80.0,"['http://www.wsipp.wa.gov/ReportFile/1661/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-December-2016-Update_Report.pdf', 'http://www.wsipp.wa.gov/ReportFile/1665/Wsipp_Interventions-to-Promote-Health-and-Increase-Health-Care-Efficiency-May-2017-Update_Report.pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465187/pdf', 'http://www.wsipp.wa.gov/BenefitCost/ProgramsByTopicPdf/6/Wsipp_BenefitCost_ProgramDetails_Health-Care']","['51862_3_washington state institute for public policy.pdf', '51862_4_washington state institute for public policy.pdf', '51862_0_group versus conventional antenatal care for women.pdf', '51862_1_washington state institute for public policy.pdf']","[0.58, 0.243, 0.478, 0.463]","[0.493, 0.492, 0.544, 0.548]","[0.579, 0.578, 0.618, 0.626]","[0.134, 0.133, 0.192, 0.136]","[0.141, 0.14, 0.198, 0.147]","[0.118, 0.119, 0.165, 0.119]","[0.725, 0.725, 0.734, 0.719]","[0.63, 0.63, 0.638, 0.622]","[0.548, 0.549, 0.598, 0.611]","[0.668, 0.669, 0.689, 0.68]","[0.776, 0.776, 0.789, 0.797]","[0.687, 0.685, 0.711, 0.737]","[0.605, 0.605, 0.609, 0.636]","[0.909, 0.909, 0.907, 0.922]","[0.794, 0.796, 0.824, 0.829]","[0.737, 0.736, 0.741, 0.768]","[0.779, 0.778, 0.793, 0.809]","[0.761, 0.761, 0.765, 0.786]",0.441,0.519,0.6,0.149,0.157,0.13,0.726,0.63,0.577,0.677,0.785,0.705,0.614,0.912,0.811,0.746,0.79,0.768
https://doi.org/10.7205/milmed.173.1.105,the use of a dermal regeneration template following excision of a giant melanocytic nevus in a potential army recruit,51871_the use of a dermal regeneration template following excision of a giant melanocytic nevus in a potential army recruit.pdf,1,['https://www.hca.wa.gov/assets/program/director-selections-2016.pdf'],['List of contents'],['https://www.hca.wa.gov/assets/program/director-selections-2016.pdf'],['51871_0_list of contents.pdf'],1,100.0,['https://www.hca.wa.gov/assets/program/director-selections-2016.pdf'],['51871_0_list of contents.pdf'],[0.238],[0.532],[0.606],[0.137],[0.155],[0.12],[0.736],[0.634],[0.597],[0.624],[0.788],[0.722],[0.625],[0.906],[0.812],[0.762],[0.792],[0.771],0.238,0.532,0.606,0.137,0.155,0.12,0.736,0.634,0.597,0.624,0.788,0.722,0.625,0.906,0.812,0.762,0.792,0.771
https://doi.org/10.7326/0003-4819-134-8-200104170-00010,neocytolysis on descent from altitude a newly recognized mechanism for the control of red cell mass,51960_neocytolysis on descent from altitude a newly recognized mechanism for the control of red cell mass.pdf,1,['https://purl.fdlp.gov/GPO/gpo75897'],['Human adaptation to space flight :\xa0the role of nutrition /'],['https://purl.fdlp.gov/GPO/gpo75897'],['51960_0_human adaptation to space flight \xa0the role of nutrition .pdf'],1,100.0,['https://purl.fdlp.gov/GPO/gpo75897'],['51960_0_human adaptation to space flight \xa0the role of nutrition .pdf'],[0.179],[0.515],[0.606],[0.131],[0.131],[0.098],[0.733],[0.633],[0.596],[0.65],[0.797],[0.728],[0.62],[0.916],[0.818],[0.737],[0.798],[0.784],0.179,0.515,0.606,0.131,0.131,0.098,0.733,0.633,0.596,0.65,0.797,0.728,0.62,0.916,0.818,0.737,0.798,0.784
https://doi.org/10.7326/0003-4819-135-12-200112180-00006,newspaper reporting of screening mammography,51964_newspaper reporting of screening mammography.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086941/pdf'],['Mammography Screening of Women in Their 40s - Impact of Changes in Screening Guidelines'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086941/pdf'],['51964_0_mammography screening of women in their 40s  impact of changes in screening guidelines.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086941/pdf'],['51964_0_mammography screening of women in their 40s  impact of changes in screening guidelines.pdf'],[0.53],[0.49],[0.603],[0.195],[0.222],[0.182],[0.747],[0.656],[0.57],[0.727],[0.773],[0.665],[0.585],[0.91],[0.821],[0.696],[0.771],[0.762],0.53,0.49,0.603,0.195,0.222,0.182,0.747,0.656,0.57,0.727,0.773,0.665,0.585,0.91,0.821,0.696,0.771,0.762
https://doi.org/10.7326/0003-4819-143-11-200512060-00010,pathogenesis of early lung disease in cystic fibrosis a window of opportunity to eradicate bacteria,52017_pathogenesis of early lung disease in cystic fibrosis a window of opportunity to eradicate bacteria.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728060/pdf'],['Duration of intravenous antibiotic therapy in people with cystic fibrosis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728060/pdf'],['52017_0_duration of intravenous antibiotic therapy in people with cystic fibrosis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728060/pdf'],['52017_0_duration of intravenous antibiotic therapy in people with cystic fibrosis.pdf'],[0.437],[0.51],[0.618],[0.157],[0.179],[0.144],[0.746],[0.656],[0.581],[0.67],[0.79],[0.691],[0.588],[0.897],[0.825],[0.671],[0.778],[0.767],0.437,0.51,0.618,0.157,0.179,0.144,0.746,0.656,0.581,0.67,0.79,0.691,0.588,0.897,0.825,0.671,0.778,0.767
https://doi.org/10.7326/0003-4819-153-11-201012070-00010,defragmenting care,52068_defragmenting care.pdf,3,"['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP1Plan.pdf', 'https://www.dshs.texas.gov/thcic/hospitals/2014-PPR-Report-unmasked-20180209.pdf', 'https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP1Plan.pdf']","['Texas Healthcare Transformation and Quality Improvement Program', 'HHS Template for Reports, with Full Instructions', 'Microsoft Word - RHP Plan Clean Version 03.07.2013.docx']","['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP1Plan.pdf', 'https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP1Plan.pdf', 'https://www.dshs.texas.gov/thcic/hospitals/2014-PPR-Report-unmasked-20180209.pdf']","['52068_0_texas healthcare transformation and quality improvement program.pdf', '52068_2_microsoft word  rhp plan clean version 03072013docx.pdf', '52068_1_hhs template for reports with full instructions.pdf']",3,100.0,"['https://www.hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP1Plan.pdf', 'https://hhs.texas.gov/sites/default/files/documents/laws-regulations/policies-rules/1115-docs/RHP/Plans/RHP1Plan.pdf']","['52068_0_texas healthcare transformation and quality improvement program.pdf', '52068_2_microsoft word  rhp plan clean version 03072013docx.pdf']","[0.509, 0.509]","[0.569, 0.569]","[0.653, 0.653]","[0.229, 0.229]","[0.243, 0.243]","[0.186, 0.186]","[0.743, 0.743]","[0.653, 0.653]","[0.632, 0.632]","[0.7, 0.7]","[0.817, 0.817]","[0.742, 0.742]","[0.65, 0.65]","[0.918, 0.918]","[0.857, 0.857]","[0.761, 0.761]","[0.82, 0.82]","[0.798, 0.798]",0.509,0.569,0.653,0.229,0.243,0.186,0.743,0.653,0.632,0.7,0.817,0.742,0.65,0.918,0.857,0.761,0.82,0.798
https://doi.org/10.7326/m17-1987,intermediate diabetes outcomes in patients managed by physicians nurse practitioners or physician assistants,52120_intermediate diabetes outcomes in patients managed by physicians nurse practitioners or physician assistants.pdf,3,"['https://www.capitol.hawaii.gov/session2019/testimony/SB1406_TESTIMONY_CPH-JDC_02-27-19_.PDF', 'https://www.mercatus.org/publications/healthcare/nursing-opioid-crisis', 'https://www.capitol.hawaii.gov/Session2019/Testimony/HB935_HD1_TESTIMONY_CPC_02-13-19_.PDF']","['Sb 1406', 'Nursing the Opioid Crisis', 'While RICO appreciates the intent of section 15 in strengthening the enforcement of physician licensing laws, it has concerns about the vagueness and overbreadth of that section. In particular, section 15 uses certain terms without clarifying what conduct those terms are meant to encompass: “ abandoning ” on page 40, line7; “ immoral conduct ” on page 40, line8; “ sexual contact ” on page 40, line 10; “ secret method ” on page 40, line 19; and “ exploits ” on page 41, line9. This vagueness will make it difficult to enforce these provisions. Additionally, this measure app...']",['https://www.capitol.hawaii.gov/session2019/testimony/SB1406_TESTIMONY_CPH-JDC_02-27-19_.PDF'],['52120_0_sb 1406.pdf'],1,33.33,['https://www.capitol.hawaii.gov/session2019/testimony/SB1406_TESTIMONY_CPH-JDC_02-27-19_.PDF'],['52120_0_sb 1406.pdf'],[0.375],[0.439],[0.551],[0.126],[0.136],[0.121],[0.723],[0.626],[0.488],[0.678],[0.741],[0.658],[0.597],[0.863],[0.771],[0.632],[0.737],[0.667],0.375,0.439,0.551,0.126,0.136,0.121,0.723,0.626,0.488,0.678,0.741,0.658,0.597,0.863,0.771,0.632,0.737,0.667
https://doi.org/10.7326/m18-1206,increasing safe outpatient management of emergency department patients with pulmonary embolism,52123_increasing safe outpatient management of emergency department patients with pulmonary embolism.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402388/pdf'],['Outpatient versus inpatient treatment for acute pulmonary embolism'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402388/pdf'],['52123_0_outpatient versus inpatient treatment for acute pulmonary embolism.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402388/pdf'],['52123_0_outpatient versus inpatient treatment for acute pulmonary embolism.pdf'],[0.5],[0.515],[0.597],[0.171],[0.179],[0.149],[0.737],[0.647],[0.581],[0.698],[0.778],[0.697],[0.585],[0.909],[0.807],[0.717],[0.778],[0.756],0.5,0.515,0.597,0.171,0.179,0.149,0.737,0.647,0.581,0.698,0.778,0.697,0.585,0.909,0.807,0.717,0.778,0.756
https://doi.org/10.7326/m18-3573,hepatitis c virus screening and care complexity of implementation in primary care practices serving disadvantaged populations,52127_hepatitis c virus screening and care complexity of implementation in primary care practices serving disadvantaged populations.pdf,2,"['https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/hepatitis-c-screening1', 'https://www.uspreventiveservicestaskforce.org/home/getfilebytoken/4GH3or2_-oQ7ChXfjCB2ux']","['Final Update Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening Task Force', 'Screening for Hepatitis C Virus Infection in Adolescents and Adults US Preventive Services Task Force Recommendation Statement']",['https://www.uspreventiveservicestaskforce.org/home/getfilebytoken/4GH3or2_-oQ7ChXfjCB2ux'],['52127_1_screening for hepatitis c virus infection in adolescents and adults us preventive services task force recommendation statement.pdf'],1,50.0,['https://www.uspreventiveservicestaskforce.org/home/getfilebytoken/4GH3or2_-oQ7ChXfjCB2ux'],['52127_1_screening for hepatitis c virus infection in adolescents and adults us preventive services task force recommendation statement.pdf'],[0.361],[0.516],[0.598],[0.178],[0.194],[0.158],[0.739],[0.647],[0.585],[0.681],[0.792],[0.691],[0.591],[0.912],[0.819],[0.729],[0.786],[0.768],0.361,0.516,0.598,0.178,0.194,0.158,0.739,0.647,0.585,0.681,0.792,0.691,0.591,0.912,0.819,0.729,0.786,0.768
https://doi.org/10.7326/m19-0322,costeffectiveness analysis of lung cancer screening in the united states,52128_costeffectiveness analysis of lung cancer screening in the united states.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237943/pdf'],['Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations?'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237943/pdf'],['52128_0_pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic should we revisit the recommendations.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237943/pdf'],['52128_0_pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic should we revisit the recommendations.pdf'],[0.517],[0.537],[0.626],[0.198],[0.199],[0.173],[0.741],[0.652],[0.604],[0.705],[0.809],[0.711],[0.633],[0.921],[0.846],[0.749],[0.801],[0.781],0.517,0.537,0.626,0.198,0.199,0.173,0.741,0.652,0.604,0.705,0.809,0.711,0.633,0.921,0.846,0.749,0.801,0.781
https://doi.org/10.7326/m20-4986,covid19 mortality risk in down syndrome results from a cohort study of 8 million adults,52130_covid19 mortality risk in down syndrome results from a cohort study of 8 million adults.pdf,8,"['https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://stacks.cdc.gov/view/cdc/110771', 'https://stacks.cdc.gov/view/cdc/96131', 'https://stacks.cdc.gov/view/cdc/106171', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf', 'https://addpc.az.gov/sites/default/files/DocforParents-spanishoctober%20(2).pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442144/pdf']","['Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Science brief: evidence used to update the list of underlying medical conditions associated with higher risk for severe COVID-19', 'COVID-19 science update ; Edition 2020-10-30', 'Science brief : Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Master Question List for COVID-19 (caused by SARS-CoV-2)', 'Covid-19', 'Non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent SARS‐CoV‐2 infections and their consequences: a rapid review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442144/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://www.dhs.gov/sites/default/files/publications/21_1102_st_mql_sars2_cov2.pdf', 'https://addpc.az.gov/sites/default/files/DocforParents-spanishoctober%20(2).pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['52130_7_non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent sars‐cov‐2 infections and their consequences a rapid review.pdf', '52130_4_master question list for covid19 caused by sarscov2.pdf', '52130_0_master question list for covid19 caused by sarscov2.pdf', '52130_6_covid19.pdf', '52130_5_master question list for covid19 caused by sarscov2.pdf']",5,62.5,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442144/pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210713.pdf', 'https://addpc.az.gov/sites/default/files/DocforParents-spanishoctober%20(2).pdf', 'https://www.dhs.gov/sites/default/files/publications/mql_sars-cov-2_-_cleared_for_public_release_20210105.pdf']","['52130_7_non‐pharmacological measures implemented in the setting of long‐term care facilities to prevent sars‐cov‐2 infections and their consequences a rapid review.pdf', '52130_4_master question list for covid19 caused by sarscov2.pdf', '52130_6_covid19.pdf', '52130_5_master question list for covid19 caused by sarscov2.pdf']","[0.323, 0.337, 0.035, 0.213]","[0.49, 0.481, 0.364, 0.482]","[0.577, 0.581, 0.493, 0.583]","[0.136, 0.137, 0.103, 0.138]","[0.14, 0.126, 0.133, 0.126]","[0.116, 0.111, 0.097, 0.111]","[0.728, 0.736, 0.726, 0.737]","[0.635, 0.642, 0.642, 0.642]","[0.553, 0.543, 0.47, 0.542]","[0.689, 0.651, 0.657, 0.649]","[0.758, 0.767, 0.747, 0.767]","[0.656, 0.656, 0.586, 0.656]","[0.609, 0.611, 0.544, 0.61]","[0.894, 0.902, 0.863, 0.901]","[0.789, 0.794, 0.762, 0.794]","[0.702, 0.714, 0.654, 0.715]","[0.765, 0.77, 0.713, 0.77]","[0.733, 0.745, 0.674, 0.746]",0.227,0.454,0.558,0.129,0.131,0.109,0.732,0.64,0.527,0.661,0.76,0.639,0.594,0.89,0.785,0.696,0.755,0.725
https://doi.org/10.7326/m20-5261,the covidnma project building an evidence ecosystem for the covid19 pandemic,52131_the covidnma project building an evidence ecosystem for the covid19 pandemic.pdf,3,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791232/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406988/pdf']","['Efficacy and safety of COVID‐19 vaccines', 'Interleukin‐1 blocking agents for treating COVID‐19', 'Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406988/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791232/pdf']","['52131_0_efficacy and safety of covid‐19 vaccines.pdf', '52131_2_interleukin‐6 blocking agents for treating covid‐19 a living systematic review.pdf', '52131_1_interleukin‐1 blocking agents for treating covid‐19.pdf']",3,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726273/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406988/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791232/pdf']","['52131_0_efficacy and safety of covid‐19 vaccines.pdf', '52131_2_interleukin‐6 blocking agents for treating covid‐19 a living systematic review.pdf', '52131_1_interleukin‐1 blocking agents for treating covid‐19.pdf']","[0.278, 0.395, 0.385]","[0.508, 0.542, 0.532]","[0.599, 0.628, 0.618]","[0.158, 0.173, 0.173]","[0.168, 0.181, 0.178]","[0.14, 0.151, 0.15]","[0.731, 0.73, 0.732]","[0.64, 0.641, 0.642]","[0.571, 0.613, 0.599]","[0.715, 0.699, 0.712]","[0.774, 0.798, 0.79]","[0.7, 0.723, 0.709]","[0.581, 0.598, 0.598]","[0.903, 0.922, 0.915]","[0.815, 0.849, 0.842]","[0.711, 0.747, 0.733]","[0.778, 0.8, 0.792]","[0.738, 0.776, 0.764]",0.353,0.527,0.615,0.168,0.176,0.147,0.731,0.641,0.594,0.709,0.787,0.711,0.592,0.913,0.835,0.73,0.79,0.759
https://doi.org/10.7326/m20-6306,racial and ethnic disparities in covid19–related infections hospitalizations and deaths,52133_racial and ethnic disparities in covid19–related infections hospitalizations and deaths.pdf,5,"['https://stacks.cdc.gov/view/cdc/111198', 'https://stacks.cdc.gov/view/cdc/108158', 'https://nam.edu/researchers-should-consider-how-disparities-change-over-time-and-space-lessons-from-the-covid-19-pandemic/', 'https://stacks.cdc.gov/view/cdc/115795', 'https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf']","['COVID-19 vaccine equity for racial and ethnic minority groups', 'COVID-19 vaccine equity for racial and ethnic minority groups', 'Researchers Should Consider How Disparities Change Over Time and Space: Lessons from the COVID-19 Pandemic', 'COVID-19 vaccine equity for racial and ethnic minority groups', 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines']",['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['52133_4_coronavirus disease 2019 covid19 treatment guidelines.pdf'],1,20.0,['https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf'],['52133_4_coronavirus disease 2019 covid19 treatment guidelines.pdf'],[0.401],[0.51],[0.597],[0.153],[0.159],[0.13],[0.738],[0.648],[0.572],[0.665],[0.781],[0.679],[0.583],[0.895],[0.796],[0.734],[0.782],[0.769],0.401,0.51,0.597,0.153,0.159,0.13,0.738,0.648,0.572,0.665,0.781,0.679,0.583,0.895,0.796,0.734,0.782,0.769
https://doi.org/10.7759/cureus.1184,health care disparities among lesbian gay bisexual and transgender youth a literature review,52203_health care disparities among lesbian gay bisexual and transgender youth a literature review.pdf,4,"['https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://ag.ny.gov/sites/default/files/final_hhs_comment_letter_02.18.20.pdf', 'https://www.aapd.org/globalassets/media/policies_guidelines/p_vulnerablepopulations.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Comment%20Letter.pdf']","['THE STATE OF CALIFORNIA', 'February 18, 2020', 'Policy on Care for Vulnerable Populations in a Dental Setting', 'Letitia James Attorney General']","['https://www.aapd.org/globalassets/media/policies_guidelines/p_vulnerablepopulations.pdf', 'https://ag.ny.gov/sites/default/files/final_hhs_comment_letter_02.18.20.pdf', 'https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Comment%20Letter.pdf']","['52203_2_policy on care for vulnerable populations in a dental setting.pdf', '52203_1_february 18 2020.pdf', '52203_0_the state of california.pdf', '52203_3_letitia james attorney general.pdf']",4,100.0,"['https://www.aapd.org/globalassets/media/policies_guidelines/p_vulnerablepopulations.pdf', 'https://ag.ny.gov/sites/default/files/final_hhs_comment_letter_02.18.20.pdf', 'https://ag.hawaii.gov/wp-content/uploads/2019/08/Comment-Letter-re-1557-Regulations.pdf', 'https://oag.ca.gov/system/files/attachments/press-docs/Comment%20Letter.pdf']","['52203_2_policy on care for vulnerable populations in a dental setting.pdf', '52203_1_february 18 2020.pdf', '52203_0_the state of california.pdf', '52203_3_letitia james attorney general.pdf']","[0.231, 0.231, 0.454, 0.317]","[0.546, 0.488, 0.469, 0.477]","[0.631, 0.583, 0.564, 0.573]","[0.166, 0.123, 0.114, 0.128]","[0.184, 0.141, 0.13, 0.146]","[0.139, 0.107, 0.107, 0.117]","[0.738, 0.721, 0.722, 0.727]","[0.644, 0.623, 0.623, 0.632]","[0.609, 0.559, 0.54, 0.544]","[0.667, 0.653, 0.659, 0.659]","[0.812, 0.782, 0.76, 0.761]","[0.739, 0.686, 0.672, 0.674]","[0.623, 0.602, 0.595, 0.596]","[0.931, 0.917, 0.918, 0.915]","[0.827, 0.81, 0.789, 0.79]","[0.767, 0.722, 0.706, 0.71]","[0.817, 0.777, 0.761, 0.763]","[0.795, 0.758, 0.74, 0.743]",0.308,0.495,0.588,0.133,0.15,0.117,0.727,0.63,0.563,0.659,0.779,0.693,0.604,0.92,0.804,0.726,0.779,0.759
https://doi.org/10.7812/tpp/03-089,childhood abuse household dysfunction and indicators of impaired adult worker performance,52213_childhood abuse household dysfunction and indicators of impaired adult worker performance.pdf,5,"['https://www.medicaid.gov/federal-policy-guidance/downloads/SMD-13-07-11.pdf', 'https://stacks.cdc.gov/view/cdc/39032', 'http://purl.fdlp.gov/GPO/gpo56263', 'http://www.floridahealth.gov/programs-and-services/prevention/sexual-violence-prevention/rcptf-report.pdf', 'https://www.americanprogress.org/issues/women/reports/2017/11/17/443028/unequal-toll-toxic-stress/']","['Tri-Agency Letter on Trauma-Informed Treatment', 'Boost your competitive edge : actions for a healthy, productive workforce', 'Women and trauma :\xa0report of the Federal Partners Committee on Women and Trauma : a working document.', 'This is our top priority that acknowledges that victims of sexual assault in the state of Florida should have access to basic', 'The Unequal Toll of Toxic Stress - Center for American Progress']","['http://purl.fdlp.gov/GPO/gpo56263', 'http://www.floridahealth.gov/programs-and-services/prevention/sexual-violence-prevention/rcptf-report.pdf', 'https://www.medicaid.gov/federal-policy-guidance/downloads/SMD-13-07-11.pdf']","['52213_2_women and trauma \xa0report of the federal partners committee on women and trauma  a working document.pdf', '52213_3_this is our top priority that acknowledges that victims of sexual assault in the state of florida should have access to basic.pdf', '52213_0_triagency letter on traumainformed treatment.pdf']",3,60.0,"['http://purl.fdlp.gov/GPO/gpo56263', 'http://www.floridahealth.gov/programs-and-services/prevention/sexual-violence-prevention/rcptf-report.pdf', 'https://www.medicaid.gov/federal-policy-guidance/downloads/SMD-13-07-11.pdf']","['52213_2_women and trauma \xa0report of the federal partners committee on women and trauma  a working document.pdf', '52213_3_this is our top priority that acknowledges that victims of sexual assault in the state of florida should have access to basic.pdf', '52213_0_triagency letter on traumainformed treatment.pdf']","[0.259, 0.339, 0.106]","[0.525, 0.513, 0.543]","[0.631, 0.614, 0.642]","[0.138, 0.134, 0.16]","[0.166, 0.151, 0.182]","[0.131, 0.115, 0.147]","[0.726, 0.729, 0.73]","[0.63, 0.635, 0.638]","[0.601, 0.589, 0.622]","[0.674, 0.65, 0.665]","[0.792, 0.786, 0.807]","[0.736, 0.715, 0.742]","[0.628, 0.625, 0.641]","[0.913, 0.91, 0.921]","[0.849, 0.838, 0.848]","[0.767, 0.754, 0.777]","[0.801, 0.798, 0.812]","[0.787, 0.781, 0.794]",0.235,0.527,0.629,0.144,0.166,0.131,0.728,0.634,0.604,0.663,0.795,0.731,0.631,0.915,0.845,0.766,0.804,0.787
https://doi.org/10.7812/tpp/12-072,adverse childhood experiences and adult criminality how long must we live before we possess our own lives,52217_adverse childhood experiences and adult criminality how long must we live before we possess our own lives.pdf,2,"['http://purl.fdlp.gov/GPO/gpo58902', 'http://ajc.alaska.gov/acjc/docs/ar/risk_factors_related_to_criminal_activity.pdf']","['Safeguarding children of arrested parents /', 'A Study of Risk Factors Related to Criminal Activity']",['http://purl.fdlp.gov/GPO/gpo58902'],['52217_0_safeguarding children of arrested parents .pdf'],1,50.0,['http://purl.fdlp.gov/GPO/gpo58902'],['52217_0_safeguarding children of arrested parents .pdf'],[0.14],[0.563],[0.643],[0.138],[0.155],[0.135],[0.725],[0.621],[0.638],[0.66],[0.807],[0.765],[0.648],[0.922],[0.858],[0.788],[0.813],[0.799],0.14,0.563,0.643,0.138,0.155,0.135,0.725,0.621,0.638,0.66,0.807,0.765,0.648,0.922,0.858,0.788,0.813,0.799
https://doi.org/10.7860/jcdr/2017/29599.10362,comparative evaluation of platelet rich fibrin and dehydrated amniotic membrane for the treatment of gingival recession a clinical study,52224_comparative evaluation of platelet rich fibrin and dehydrated amniotic membrane for the treatment of gingival recession a clinical study.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517255/pdf'],['Root coverage procedures for treating localised and multiple recession‐type defects'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517255/pdf'],['52224_0_root coverage procedures for treating localised and multiple recession‐type defects.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517255/pdf'],['52224_0_root coverage procedures for treating localised and multiple recession‐type defects.pdf'],[0.399],[0.489],[0.576],[0.16],[0.163],[0.133],[0.744],[0.653],[0.559],[0.678],[0.759],[0.673],[0.601],[0.895],[0.775],[0.707],[0.757],[0.732],0.399,0.489,0.576,0.16,0.163,0.133,0.744,0.653,0.559,0.678,0.759,0.673,0.601,0.895,0.775,0.707,0.757,0.732
https://doi.org/10.7870/cjcmh-2008-0015,peer support shows promise in helping persons living with mental illness address their physical health needs,52231_peer support shows promise in helping persons living with mental illness address their physical health needs.pdf,2,"['https://www.mass.gov/doc/peer-based-health-interventions-submitted-by-kim-krawczyk/download', 'https://www.mass.gov/files/documents/2019/08/01/Cabassa%20et%20al%20%202017%20Peer-based%20health%20interventions%20SMI.PDF']","['Peer-based health interventions for people with serious mental illness: A systematic literature review', 'Peer-based health interventions for people with serious mental illness: A systematic literature review']","['https://www.mass.gov/files/documents/2019/08/01/Cabassa%20et%20al%20%202017%20Peer-based%20health%20interventions%20SMI.PDF', 'https://www.mass.gov/doc/peer-based-health-interventions-submitted-by-kim-krawczyk/download']","['52231_1_peerbased health interventions for people with serious mental illness a systematic literature review.pdf', '52231_0_peerbased health interventions for people with serious mental illness a systematic literature review.pdf']",2,100.0,"['https://www.mass.gov/files/documents/2019/08/01/Cabassa%20et%20al%20%202017%20Peer-based%20health%20interventions%20SMI.PDF', 'https://www.mass.gov/doc/peer-based-health-interventions-submitted-by-kim-krawczyk/download']","['52231_1_peerbased health interventions for people with serious mental illness a systematic literature review.pdf', '52231_0_peerbased health interventions for people with serious mental illness a systematic literature review.pdf']","[0.487, 0.487]","[0.507, 0.507]","[0.606, 0.606]","[0.166, 0.166]","[0.186, 0.186]","[0.157, 0.157]","[0.731, 0.731]","[0.645, 0.645]","[0.552, 0.552]","[0.703, 0.703]","[0.782, 0.782]","[0.691, 0.691]","[0.611, 0.611]","[0.912, 0.912]","[0.805, 0.805]","[0.737, 0.737]","[0.771, 0.771]","[0.756, 0.756]",0.487,0.507,0.606,0.166,0.186,0.157,0.731,0.645,0.552,0.703,0.782,0.691,0.611,0.912,0.805,0.737,0.771,0.756
https://doi.org/10.9745/ghsp-d-17-00203,food security and nutrition outcomes of farmer field schools in eastern democratic republic of the congo,52260_food security and nutrition outcomes of farmer field schools in eastern democratic republic of the congo.pdf,2,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf']","['Community‐level interventions for improving access to food in low‐ and middle‐income countries', 'Community‐level interventions for improving access to food in low‐ and middle‐income countries']","['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf']","['52260_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '52260_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']",2,100.0,"['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890130/pdf', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390433/pdf']","['52260_1_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf', '52260_0_community‐level interventions for improving access to food in low‐ and middle‐income countries.pdf']","[0.613, 0.6]","[0.494, 0.495]","[0.58, 0.58]","[0.15, 0.154]","[0.15, 0.153]","[0.132, 0.135]","[0.731, 0.731]","[0.636, 0.636]","[0.552, 0.553]","[0.707, 0.705]","[0.752, 0.753]","[0.676, 0.674]","[0.591, 0.595]","[0.881, 0.881]","[0.774, 0.775]","[0.679, 0.679]","[0.755, 0.755]","[0.706, 0.706]",0.607,0.494,0.58,0.152,0.151,0.134,0.731,0.636,0.552,0.706,0.752,0.675,0.593,0.881,0.774,0.679,0.755,0.706
https://doi.org/10.9745/ghsp-d-18-00275,mlearning in the democratic republic of the congo a mixedmethods feasibility and pilot cluster randomized trial using the safe delivery app,52264_mlearning in the democratic republic of the congo a mixedmethods feasibility and pilot cluster randomized trial using the safe delivery app.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098082/pdf'],['Health workers’ perceptions and experiences of using mHealth technologies to deliver primary healthcare services: a qualitative evidence synthesis'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098082/pdf'],['52264_0_health workers perceptions and experiences of using mhealth technologies to deliver primary healthcare services a qualitative evidence synthesis.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098082/pdf'],['52264_0_health workers perceptions and experiences of using mhealth technologies to deliver primary healthcare services a qualitative evidence synthesis.pdf'],[0.49],[0.531],[0.62],[0.157],[0.167],[0.143],[0.734],[0.642],[0.599],[0.689],[0.797],[0.709],[0.612],[0.921],[0.839],[0.751],[0.797],[0.776],0.49,0.531,0.62,0.157,0.167,0.143,0.734,0.642,0.599,0.689,0.797,0.709,0.612,0.921,0.839,0.751,0.797,0.776
https://doi.org/10.9745/ghsp-d-19-00195,effectiveness of an electronic partogram a mixedmethod quasiexperimental study among skilled birth attendants in kenya,52266_effectiveness of an electronic partogram a mixedmethod quasiexperimental study among skilled birth attendants in kenya.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984859/pdf'],['The injustice of unfit clinical practice guidelines in low-resource realities'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984859/pdf'],['52266_0_the injustice of unfit clinical practice guidelines in lowresource realities.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984859/pdf'],['52266_0_the injustice of unfit clinical practice guidelines in lowresource realities.pdf'],[0.254],[0.56],[0.64],[0.168],[0.175],[0.146],[0.731],[0.641],[0.64],[0.665],[0.816],[0.748],[0.638],[0.928],[0.854],[0.784],[0.822],[0.801],0.254,0.56,0.64,0.168,0.175,0.146,0.731,0.641,0.64,0.665,0.816,0.748,0.638,0.928,0.854,0.784,0.822,0.801
https://doi.org/10.9758/cpn.2013.11.3.107,the neuroimmunology of schizophrenia,52270_the neuroimmunology of schizophrenia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699651/pdf'],['Acetylsalicylic acid (aspirin) for schizophrenia'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699651/pdf'],['52270_0_acetylsalicylic acid aspirin for schizophrenia.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699651/pdf'],['52270_0_acetylsalicylic acid aspirin for schizophrenia.pdf'],[0.257],[0.507],[0.604],[0.143],[0.145],[0.106],[0.736],[0.645],[0.593],[0.67],[0.787],[0.709],[0.59],[0.917],[0.817],[0.738],[0.781],[0.761],0.257,0.507,0.604,0.143,0.145,0.106,0.736,0.645,0.593,0.67,0.787,0.709,0.59,0.917,0.817,0.738,0.781,0.761
https://doi.org/10.9758/cpn.2013.11.3.118,transcranial direct current stimulation in schizophrenia,52271_transcranial direct current stimulation in schizophrenia.pdf,1,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059493/pdf'],['Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders'],['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059493/pdf'],['52271_0_evidencebased guidelines and secondary metaanalysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders.pdf'],1,100.0,['https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059493/pdf'],['52271_0_evidencebased guidelines and secondary metaanalysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders.pdf'],[0.685],[0.583],[0.668],[0.244],[0.224],[0.185],[0.756],[0.682],[0.651],[0.685],[0.828],[0.764],[0.65],[0.924],[0.846],[0.795],[0.824],[0.807],0.685,0.583,0.668,0.244,0.224,0.185,0.756,0.682,0.651,0.685,0.828,0.764,0.65,0.924,0.846,0.795,0.824,0.807
https://doi.org/10.9778/cmajo.20190026,cannabis use during methadone maintenance treatment for opioid use disorder a systematic review and metaanalysis,52275_cannabis use during methadone maintenance treatment for opioid use disorder a systematic review and metaanalysis.pdf,3,"['http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf']","['Report to the Governor and the General Assembly of Virginia', 'Report to the Governor and the General Assembly of Virginia', 'Appendixes']","['http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf']","['52275_0_report to the governor and the general assembly of virginia.pdf', '52275_2_appendixes.pdf', '52275_1_report to the governor and the general assembly of virginia.pdf']",3,100.0,"['http://jlarc.virginia.gov/pdfs/reports/Rpt542-6.pdf', 'http://jlarc.virginia.gov/pdfs/other/Marijuana_Legalization_online_appendixes-2.pdf', 'http://jlarc.virginia.gov/pdfs/reports/Rpt542-4.pdf']","['52275_0_report to the governor and the general assembly of virginia.pdf', '52275_2_appendixes.pdf', '52275_1_report to the governor and the general assembly of virginia.pdf']","[0.156, 0.158, 0.235]","[0.536, 0.521, 0.541]","[0.616, 0.608, 0.62]","[0.139, 0.138, 0.141]","[0.15, 0.151, 0.152]","[0.132, 0.131, 0.135]","[0.716, 0.718, 0.717]","[0.621, 0.624, 0.621]","[0.614, 0.596, 0.62]","[0.624, 0.638, 0.624]","[0.81, 0.803, 0.812]","[0.754, 0.735, 0.759]","[0.615, 0.605, 0.617]","[0.924, 0.919, 0.925]","[0.834, 0.83, 0.836]","[0.772, 0.761, 0.776]","[0.812, 0.803, 0.815]","[0.789, 0.781, 0.791]",0.183,0.533,0.615,0.139,0.151,0.133,0.717,0.622,0.61,0.629,0.808,0.749,0.612,0.923,0.833,0.77,0.81,0.787
